PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Hochhaus, A; Kreil, S; Corbin, A; La Rosee, P; Lahaye, T; Berger, U; Cross, NCP; Linkesch, W; Druker, BJ; Hehlmann, R				Hochhaus, A; Kreil, S; Corbin, A; La Rosee, P; Lahaye, T; Berger, U; Cross, NCP; Linkesch, W; Druker, BJ; Hehlmann, R			Roots of clinical resistance to STI-571 cancer therapy	SCIENCE			English	Editorial Material									Univ Heidelberg, Fak Klin Med Mannheim, Med Klin 3, D-6800 Mannheim, Germany; Oregon Hlth & Sci Univ, Div Hematol & Med Oncol, Portland, OR 97207 USA; Hammersmith Hosp, Imperial Coll Sch med, Dept Haematol, London, England; Karl Franzens Univ Graz, Med Klin, Hamatol Abt, Graz, Austria	Ruprecht Karls University Heidelberg; Oregon Health & Science University; Imperial College London; University of Graz	Hochhaus, A (corresponding author), Univ Heidelberg, Fak Klin Med Mannheim, Med Klin 3, D-6800 Mannheim, Germany.	hochhaus@uni-hd.de	Cross, Nicholas/B-4817-2009; D'Incalci, Maurizio/AAA-9021-2020	Cross, Nicholas/0000-0001-5481-2555; D'Incalci, Maurizio/0000-0001-8784-1360; Druker, Brian/0000-0001-8331-8206; GAMBACORTI PASSERINI, CARLO/0000-0001-6058-515X; Hochhaus, Andreas/0000-0003-0626-0834; La Rosee, Paul/0000-0002-6758-7809				Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; *GENB, U07563 GENB; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Senechal K, 1998, MOL CELL BIOL, V18, P5082, DOI 10.1128/MCB.18.9.5082	4	233	243	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 21	2001	293	5538					2163	2163						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475AL	11569495				2022-12-24	WOS:000171139400002
J	Billuart, P; Winter, CG; Maresh, A; Zhao, XS; Luo, LQ				Billuart, P; Winter, CG; Maresh, A; Zhao, XS; Luo, LQ			Regulating axon branch stability: The role of p190 RhoGAP in repressing a retraction signaling pathway	CELL			English	Article							LONG-TERM POTENTIATION; NUCLEOTIDE EXCHANGE FACTOR; GTPASE-ACTIVATING PROTEIN; LINKED MENTAL-RETARDATION; C-SRC; ACTIN CYTOSKELETON; NEUROBLAST PROLIFERATION; NEURONAL MORPHOGENESIS; MUSHROOM BODIES; CELL-ADHESION	Mechanisms that regulate axon branch stability are largely unknown. Genome-wide analyses of Rho GTPase activating protein (RhoGAP) function in Drosophila using RNA interference identified p190 RhoGAP as essential for axon stability in mushroom body neurons, the olfactory learning and memory center. p190 inactivation leads to axon branch retraction, a phenotype mimicked by activation of GTPase RhoA and its effector kinase Drok and modulated by the level and phosphorylation of myosin regulatory light chain. Thus, there exists a retraction pathway from RhoA to myosin in maturing neurons, which is normally repressed by p190. Local regulation of p190 could control the structural plasticity of neurons. Indeed, genetic evidence supports negative regulation of p190 by integrin and Src, both implicated in neural plasticity.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	Stanford University	Luo, LQ (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	lluo@stanford.edu	Billuart, Pierre/K-3832-2017; Zhao, Xuesong/B-2762-2012	Billuart, Pierre/0000-0003-1913-1687; Zhao, Xuesong/0000-0003-3007-7124; Luo, Liqun/0000-0001-5467-9264	NINDS NIH HHS [R01-NS 36632] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AGNEL M, 1992, MOL CELL BIOL, V12, P5111, DOI 10.1128/MCB.12.11.5111; Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308; Arthur WT, 2000, CURR BIOL, V10, P719, DOI 10.1016/S0960-9822(00)00537-6; Awasaki T, 2000, NEURON, V26, P119, DOI 10.1016/S0896-6273(00)81143-5; Bateman J, 2000, NEURON, V26, P93, DOI 10.1016/S0896-6273(00)81141-1; Bernstein M, 1999, CURR OPIN NEUROBIOL, V9, P364, DOI 10.1016/S0959-4388(99)80053-1; Beumer KJ, 1999, DEVELOPMENT, V126, P5833; Billuart P, 1998, NATURE, V392, P923, DOI 10.1038/31940; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; Bonini NM, 1997, DEVELOPMENT, V124, P4819; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brouns MR, 2000, DEVELOPMENT, V127, P4891; Brouns MR, 2001, NAT CELL BIOL, V3, P361, DOI 10.1038/35070042; BUNCH TA, 1992, GENETICS, V132, P519; Burbelo PD, 1995, J BIOL CHEM, V270, P30919, DOI 10.1074/jbc.270.52.30919; CHANG JH, 1995, J CELL BIOL, V130, P355, DOI 10.1083/jcb.130.2.355; Crittenden JR, 1998, LEARN MEMORY, V5, P38; Dickson BJ, 2001, CURR OPIN NEUROBIOL, V11, P103, DOI 10.1016/S0959-4388(00)00180-X; Dodson GS, 1998, DEVELOPMENT, V125, P2883; ELLIS C, 1990, NATURE, V343, P377, DOI 10.1038/343377a0; Fanto M, 2000, CURR BIOL, V10, P979, DOI 10.1016/S0960-9822(00)00645-X; GRANT SGN, 1992, SCIENCE, V258, P1903, DOI 10.1126/science.1361685; Grotewiel MS, 1998, NATURE, V391, P455, DOI 10.1038/35079; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Haskell MD, 2001, J CELL SCI, V114, P1699; Heisenberg M, 1998, LEARN MEMORY, V5, P1; HU HL, 2001, IN PRESS NEURON; Hu KQ, 1997, EMBO J, V16, P473, DOI 10.1093/emboj/16.3.473; Hynes RO, 2000, J CELL BIOL, V150, pF89, DOI 10.1083/jcb.150.2.F89; Ito K, 1997, DEVELOPMENT, V124, P761; Jordan P, 1997, J CELL BIOL, V139, P1805, DOI 10.1083/jcb.139.7.1805; Jullien-Flores V, 2000, J CELL SCI, V113, P2837; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; Kojima N, 1997, P NATL ACAD SCI USA, V94, P4761, DOI 10.1073/pnas.94.9.4761; Kutsche K, 2000, NAT GENET, V26, P247, DOI 10.1038/80002; LAMARCHE N, 1994, TRENDS GENET, V10, P436, DOI 10.1016/0168-9525(94)90114-7; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee T, 1999, DEVELOPMENT, V126, P4065; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lee TM, 2000, NEURON, V25, P307, DOI 10.1016/S0896-6273(00)80896-X; Li R, 1997, J BIOL CHEM, V272, P32830, DOI 10.1074/jbc.272.52.32830; Li Z, 2000, NAT NEUROSCI, V3, P217, DOI 10.1038/72920; Liebl EC, 2000, NEURON, V26, P107, DOI 10.1016/S0896-6273(00)81142-3; Liu Z, 2000, NAT CELL BIOL, V2, P776, DOI 10.1038/35041011; Lu YM, 1998, SCIENCE, V279, P1363, DOI 10.1126/science.279.5355.1363; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Nakahara H, 1998, J BIOL CHEM, V273, P9, DOI 10.1074/jbc.273.1.9; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; Newsome TP, 2000, CELL, V101, P283, DOI 10.1016/S0092-8674(00)80838-7; Parrish S, 2000, MOL CELL, V6, P1077, DOI 10.1016/S1097-2765(00)00106-4; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; RIDLEY AJ, 1993, EMBO J, V12, P5151, DOI 10.1002/j.1460-2075.1993.tb06210.x; Rohrbough J, 2000, J NEUROSCI, V20, P6868, DOI 10.1523/JNEUROSCI.20-18-06868.2000; Roof RW, 2000, FEBS LETT, V472, P117, DOI 10.1016/S0014-5793(00)01439-3; Roof RW, 1998, MOL CELL BIOL, V18, P7052, DOI 10.1128/MCB.18.12.7052; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Sagnier T, 2000, MECH DEVELOP, V94, P267, DOI 10.1016/S0925-4773(00)00291-4; Sahai E, 1998, EMBO J, V17, P1350, DOI 10.1093/emboj/17.5.1350; Scott EK, 2001, NAT NEUROSCI, V4, P359, DOI 10.1038/86006; SETTLEMAN J, 1992, CELL, V69, P539, DOI 10.1016/0092-8674(92)90454-K; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Sharma SV, 1998, ONCOGENE, V17, P271, DOI 10.1038/sj.onc.1201921; Sotillos S, 2000, DEVELOPMENT, V127, P5427; Staubli U, 1998, J NEUROSCI, V18, P3460; Steven R, 1998, CELL, V92, P785, DOI 10.1016/S0092-8674(00)81406-3; Tashiro A, 2000, CEREB CORTEX, V10, P927, DOI 10.1093/cercor/10.10.927; Tatsis N, 1998, J BIOL CHEM, V273, P34631, DOI 10.1074/jbc.273.51.34631; Tavernarakis N, 2000, NAT GENET, V24, P180, DOI 10.1038/72850; Trachtenberg JT, 2001, J NEUROSCI, V21, P3476, DOI 10.1523/JNEUROSCI.21-10-03476.2001; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; WILDER EL, 1995, DEVELOPMENT, V121, P477; Winter CG, 2001, CELL, V105, P81, DOI 10.1016/S0092-8674(01)00298-7; Wong WT, 2000, J NEUROSCI, V20, P5024	73	171	174	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 19	2001	107	2					195	207		10.1016/S0092-8674(01)00522-0	http://dx.doi.org/10.1016/S0092-8674(01)00522-0			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	484MU	11672527	Bronze			2022-12-24	WOS:000171694800009
J	Schaefer, M; Petronczki, M; Dorner, D; Forte, M; Knoblich, JA				Schaefer, M; Petronczki, M; Dorner, D; Forte, M; Knoblich, JA			Heterotrimeric G proteins direct two modes of asymmetric cell division in the Drosophila nervous system	CELL			English	Article							NEURAL PRECURSOR GENE; ELEGANS EMBRYOS; SUBUNIT GENE; LOCALIZATION; PROSPERO; MELANOGASTER; NEUROBLASTS; BAZOOKA; ORIENTATION; SEGREGATION	In Drosophila, distinct mechanisms orient asymmetric cell division along the apical-basal axis in neuroblasts and along the anterior-posterior axis in sensory organ precursor (SOP) cells. Here, we show that heterotrimeric G proteins are essential for asymmetric cell division in both cell types. The G protein subunit G alphai localizes apically in neuroblasts and anteriorly in SOP cells before and during mitosis. Interfering with G protein function by G alphai overexpression or depletion of heterotrimeric G protein complexes causes defects in spindle orientation and asymmetric localization of determinants. G alphai is colocalized and associated with Pins, a protein that induces the release of the beta gamma subunit and might act as a receptor-independent G protein activator. Thus, asymmetric activation of heterotrimeric G proteins by a receptor-independent mechanism may orient asymmetric cell divisions in different cell types.	Res Inst Mol Pathol, IMP, A-1030 Vienna, Austria; Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97212 USA	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Oregon Health & Science University	Knoblich, JA (corresponding author), Res Inst Mol Pathol, IMP, Dr Bohr Gasse 7, A-1030 Vienna, Austria.	knoblich@nt.imp.univie.ac.at	Matthias, Schaefer Ronald/E-9157-2015; Knoblich, Juergen A/C-2974-2015	Matthias, Schaefer Ronald/0000-0003-1952-8115; Knoblich, Juergen A/0000-0002-6751-3404; Petronczki, Mark/0000-0003-0139-5692				BRAND AH, 1993, DEVELOPMENT, V118, P401; BRAND M, 1993, DEVELOPMENT, V119, P1; Broadus J, 1997, CURR BIOL, V7, P827, DOI 10.1016/S0960-9822(06)00370-8; Chant T, 1999, ANNU REV CELL DEV BI, V15, P365, DOI 10.1146/annurev.cellbio.15.1.365; CHOU TB, 1992, GENETICS, V131, P643; Doe CQ, 2001, CURR OPIN CELL BIOL, V13, P68, DOI 10.1016/S0955-0674(00)00176-9; DOLPH PJ, 1994, NATURE, V370, P59, DOI 10.1038/370059a0; Gho M, 1998, NATURE, V393, P178, DOI 10.1038/30265; Gonczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526; Gotta M, 2001, NAT CELL BIOL, V3, P297, DOI 10.1038/35060092; HIRATA J, 1995, NATURE, V377, P627, DOI 10.1038/377627a0; HORVITZ HR, 1992, CELL, V68, P237, DOI 10.1016/0092-8674(92)90468-R; IkeshimaKataoka H, 1997, NATURE, V390, P625, DOI 10.1038/37641; Jones KH, 1996, GENETICS, V142, P205; Kennerdell JR, 2000, NAT BIOTECHNOL, V18, P896, DOI 10.1038/78531; KNOBLICH JA, 1995, NATURE, V377, P624, DOI 10.1038/377624a0; Knoblich JA, 2001, NAT REV MOL CELL BIO, V2, P11, DOI 10.1038/35048085; Kraut R, 1996, NATURE, V383, P50, DOI 10.1038/383050a0; Kraut R, 1996, DEV BIOL, V174, P65, DOI 10.1006/dbio.1996.0052; Kuchinke U, 1998, CURR BIOL, V8, P1357, DOI 10.1016/S0960-9822(98)00016-5; Liu T, 2001, SCIENCE, V292, P1718, DOI 10.1126/science.1060100; MASTERS SB, 1989, J BIOL CHEM, V264, P15467; Mochizuki N, 1996, GENE, V181, P39, DOI 10.1016/S0378-1119(96)00456-8; Natochin M, 2000, J BIOL CHEM, V275, P40981, DOI 10.1074/jbc.M006478200; Nern A, 2000, J CELL BIOL, V148, P1115, DOI 10.1083/jcb.148.6.1115; Newsome TP, 2000, DEVELOPMENT, V127, P851; Offermanns S, 2001, ONCOGENE, V20, P1635, DOI 10.1038/sj.onc.1204189; Parent CA, 1999, SCIENCE, V284, P765, DOI 10.1126/science.284.5415.765; PARKS S, 1991, CELL, V64, P447, DOI 10.1016/0092-8674(91)90652-F; Petronczki M, 2001, NAT CELL BIOL, V3, P43, DOI 10.1038/35050550; PROVOST NM, 1988, J BIOL CHEM, V263, P12070; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; RUDOLPH U, 1995, NAT GENET, V10, P143, DOI 10.1038/ng0695-143; Schaefer M, 2000, CURR BIOL, V10, P353, DOI 10.1016/S0960-9822(00)00401-2; Schober M, 1999, NATURE, V402, P548, DOI 10.1038/990135; Schuldt AJ, 1998, GENE DEV, V12, P1847, DOI 10.1101/gad.12.12.1847; SCHUPBACH T, 1989, GENETICS, V121, P101; Shen CP, 1997, CELL, V90, P449, DOI 10.1016/S0092-8674(00)80505-X; SPANA EP, 1995, DEVELOPMENT, V121, P3187; STROME S, 1983, CELL, V35, P15, DOI 10.1016/0092-8674(83)90203-9; Takesono A, 1999, J BIOL CHEM, V274, P33202, DOI 10.1074/jbc.274.47.33202; THAMBI NC, 1989, J BIOL CHEM, V264, P18552; Wodarz A, 2000, J CELL BIOL, V150, P1361, DOI 10.1083/jcb.150.6.1361; Wodarz A, 1999, NATURE, V402, P544, DOI 10.1038/990128; YARFITZ S, 1991, NEURON, V7, P429, DOI 10.1016/0896-6273(91)90295-B; YARFITZ S, 1988, P NATL ACAD SCI USA, V85, P7134, DOI 10.1073/pnas.85.19.7134; Yu FW, 2000, CELL, V100, P399, DOI 10.1016/S0092-8674(00)80676-5; Zwaal RR, 1996, CELL, V86, P619, DOI 10.1016/S0092-8674(00)80135-X	48	258	264	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 19	2001	107	2					183	194		10.1016/S0092-8674(01)00521-9	http://dx.doi.org/10.1016/S0092-8674(01)00521-9			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	484MU	11672526	Bronze			2022-12-24	WOS:000171694800008
J	Vaziri, H; Dessain, SK; Eagon, EN; Imai, SI; Frye, RA; Pandita, TK; Guarente, L; Weinberg, RA				Vaziri, H; Dessain, SK; Eagon, EN; Imai, SI; Frye, RA; Pandita, TK; Guarente, L; Weinberg, RA			hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase	CELL			English	Article							HUMAN-DIPLOID FIBROBLASTS; DNA-DAMAGE; IONIZING-RADIATION; SILENCING PROTEIN; STRAND BREAKS; SIR2 PROTEIN; CELL-LINES; PHOSPHORYLATION; ACTIVATION; ACETYLATION	DNA damage-induced acetylation of p53 protein leads to its activation and either growth arrest or apoptosis. We show here that the protein product of the gene hSIR2(SIRT1), the human homolog of the S. cerevisiae Sir2 protein known to be involved in cell aging and in the response to DNA damage, binds and deacetylates the p53 protein with a specificity for its C-terminal Lys382 residue, modification of which has been implicated in the activation of p53 as a transcription factor. Expression of wild-type hSir2 in human cells reduces the transcriptional activity of p53. In contrast, expression of a catalytically inactive hSir2 protein potentiates p53-dependent apoptosis and radiosensitivity. We propose that hSir2 is involved in the regulation of p53 function via deacetylation.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Columbia Univ, Ctr Radiol Res, New York, NY 10032 USA; Vet Adm Med Ctr, Pittsburgh, PA 15240 USA; Massachusetts Gen Hosp, Div Hematol Oncol, Boston, MA 02114 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Columbia University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; Massachusetts General Hospital	Weinberg, RA (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.		Pandita, Tej K/AAM-9188-2020		NCI NIH HHS [R01 CA78461] Funding Source: Medline; NHLBI NIH HHS [K08HL04463] Funding Source: Medline; NINDS NIH HHS [NS34746] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA078461] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL004463] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034746] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abraham J, 2000, J MOL BIOL, V295, P853, DOI 10.1006/jmbi.1999.3415; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Chehab NH, 1999, P NATL ACAD SCI USA, V96, P13777, DOI 10.1073/pnas.96.24.13777; Dhar S, 2000, MOL CELL BIOL, V20, P7764, DOI 10.1128/MCB.20.20.7764-7772.2000; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Guarente L, 1999, NAT GENET, V23, P281, DOI 10.1038/15458; HOLLSTEIN M, 1994, NUCLEIC ACIDS RES, V22, P3551; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Kobet E, 2000, P NATL ACAD SCI USA, V97, P12547, DOI 10.1073/pnas.97.23.12547; Lambert PF, 1998, J BIOL CHEM, V273, P33048, DOI 10.1074/jbc.273.49.33048; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Lin YP, 2000, NAT GENET, V26, P122, DOI 10.1038/79102; Liu L, 1999, MOL CELL BIOL, V19, P1202; Luo JY, 2000, NATURE, V408, P377, DOI 10.1038/35042612; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Martin SG, 1999, CELL, V97, P621, DOI 10.1016/S0092-8674(00)80773-4; McAinsh AD, 1999, CURR BIOL, V9, P963, DOI 10.1016/S0960-9822(99)80424-2; Mills KD, 1999, CELL, V97, P609, DOI 10.1016/S0092-8674(00)80772-2; MITSUDOMI T, 1992, ONCOGENE, V7, P171; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Oren M, 1999, J BIOL CHEM, V274, P36031, DOI 10.1074/jbc.274.51.36031; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; SHAULIAN E, 1992, MOL CELL BIOL, V12, P5581, DOI 10.1128/MCB.12.12.5581; Shieh SY, 2000, GENE DEV, V14, P289; Siliciano JD, 1997, GENE DEV, V11, P3471, DOI 10.1101/gad.11.24.3471; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Tanny JC, 1999, CELL, V99, P735, DOI 10.1016/S0092-8674(00)81671-2; TSANG NM, 1995, ONCOGENE, V10, P2403; Vaziri H, 1997, EMBO J, V16, P6018, DOI 10.1093/emboj/16.19.6018; Vaziri H, 1999, MOL CELL BIOL, V19, P2373; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675	34	2136	2263	5	157	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 19	2001	107	2					149	159		10.1016/S0092-8674(01)00527-X	http://dx.doi.org/10.1016/S0092-8674(01)00527-X			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	484MU	11672523	Bronze			2022-12-24	WOS:000171694800005
J	Stead, ML; Fallowfield, L; Brown, JM; Selby, P				Stead, ML; Fallowfield, L; Brown, JM; Selby, P			Communication about sexual problems and sexual concerns in ovarian cancer: qualitative study	BRITISH MEDICAL JOURNAL			English	Article							OUTCOMES; WOMEN		No & Yorkshire Clin Trials & Res Unit, Leeds LS2 9NG, W Yorkshire, England; Univ Sussex, Canc Res Campaign, Psychosocial Oncol Grp, Sch Biol Sci, Brighton BN1 9QG, E Sussex, England; St James Univ Hosp, Imperial Canc Res Fund, Canc Med Res Unit, Leeds LS9 7TF, W Yorkshire, England	University of Leeds; University of Sussex; Saint James's University Hospital	Stead, ML (corresponding author), No & Yorkshire Clin Trials & Res Unit, Leeds LS2 9NG, W Yorkshire, England.			brown, julia/0000-0002-2719-7064; Fallowfield, Lesley/0000-0003-0577-4518				ANDERSEN BL, 1989, J CONSULT CLIN PSYCH, V57, P683, DOI 10.1037/0022-006X.57.6.683; CORNEY RH, 1993, BRIT J OBSTET GYNAEC, V100, P73, DOI 10.1111/j.1471-0528.1993.tb12955.x; CULL A, 1993, BRIT J CANCER, V68, P1216, DOI 10.1038/bjc.1993.507; Lamb M A, 1994, Cancer Pract, V2, P103; Strauss A., 1990, BASICS QUALITATIVE R	5	82	84	0	7	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 13	2001	323	7317					836	837		10.1136/bmj.323.7317.836	http://dx.doi.org/10.1136/bmj.323.7317.836			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	483RW	11597967	Bronze, Green Accepted, Green Published			2022-12-24	WOS:000171650500025
J	Anand, SS; Yusuf, S; Jacobs, R; Davis, AD; Yi, QL; Gerstein, H; Montague, PA; Lonn, E				Anand, SS; Yusuf, S; Jacobs, R; Davis, AD; Yi, QL; Gerstein, H; Montague, PA; Lonn, E		SHARE-AP Investigators	Risk factors, atherosclerosis, and cardiovascular disease among Aboriginal people in Canada: the Study of Health Assessment and Risk Evaluation in Aboriginal Peoples (SHARE-AP)	LANCET			English	Article							DENSITY LIPOPROTEIN CHOLESTEROL; ISCHEMIC-HEART-DISEASE; ETHNIC-GROUPS SHARE; MYOCARDIAL-INFARCTION; THICKNESS; MORTALITY; DESIGN; PLASMA	Background Little is known about the rates of cardiovascular disease (CVD), atherosclerosis, and their risk factors among Canada's Aboriginal people. To establish the relative prevalence of risk factors, atherosclerosis, and CVD, we undertook a population-based study among people of Aboriginal and European ancestry in Canada. Methods We randomly recruited 301 Aboriginal people from the Six Nations Reservation, and 326 people of European origin from Hamilton, Toronto, and Edmonton, Canada. Clinical CVD was defined by history or electrocardiographic findings, atherosclerosis was measured by B-mode carotid ultrasonography, and conventional and new CVD risk factors were measured using standardised methods. Findings Aboriginal people had significantly more carotid atherosclerosis (mean of the maximum intimal-medial thickness 0.82 (SD 0.20) mm vs 0.78 (0.20) mm, p = 0.027), and had a higher frequency of CVD (18.5% vs 7.6%, p = 0.00002) compared with Europeans. Aboriginal people had significantly higher rates of smoking, glucose intolerance, obesity, abdominal obesity, and substantially higher concentrations of fibrinogen, and plasminogen activator inhibitor-1. Aboriginal people had significantly higher rates of unemployment and a lower annual household income. For any given income level, Aboriginal people had higher rates of risk factors and CVD compared with the Europeans. Interpretation A significant proportion of Aboriginal people live in poverty which is associated with high rates of CVD and CVD risk factors. Improvement of the socioeconomic status of Aboriginal people might be a key to reduce CVD in this group.	McMaster Univ, Dept Med, Prevent Cardiol & Therapeut Res Program, Hamilton, ON L8L 2X2, Canada; Six Nations Hlth Serv, Ohsweken, ON, Canada	McMaster University	Anand, SS (corresponding author), McMaster Univ, Dept Med, Prevent Cardiol & Therapeut Res Program, Hamilton, ON L8L 2X2, Canada.		Gerstein, Hertzel C/B-1235-2013; Gerstein, Hertzel/ABB-8781-2020	Gerstein, Hertzel C/0000-0001-8072-2836; Gerstein, Hertzel/0000-0001-8072-2836; Yusuf, Salim/0000-0003-4776-5601				ALLAIN CC, 1974, CLIN CHEM, V20, P470; Anand S, 1999, Can J Cardiol, V15 Suppl G, p44G; Anand SS, 1998, CAN J CARDIOL, V14, P1349; Anand SS, 2000, LANCET, V356, P279, DOI 10.1016/S0140-6736(00)02502-2; Armitage P., 2001, STAT METHODS MED RES; BLACKBURN H, 1982, MINNESOTA CODE MANUA; Chambless LE, 1997, AM J EPIDEMIOL, V146, P483, DOI 10.1093/oxfordjournals.aje.a009302; CHOCKALINGHAM A, 2000, LANCET, V356, P347; CLAUSS A., 1957, ACTA HAEMATOL, V17, P237; ERIKSSON E, 1988, THROMB RES, V50, P91, DOI 10.1016/0049-3848(88)90177-6; FORTIN LJ, 1995, CLIN BIOCHEM, V28, P155, DOI 10.1016/0009-9120(94)00073-5; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Harris SB, 1997, DIABETES CARE, V20, P185, DOI 10.2337/diacare.20.2.185; Hosmer D.W., 2004, APPL LOGISTIC REGRES, VSecond; Lonn EM, 1996, AM J CARDIOL, V78, P914, DOI 10.1016/S0002-9149(96)00467-5; Lynch JW, 1997, SOC SCI MED, V44, P809, DOI 10.1016/S0277-9536(96)00191-8; MCGOWAN MW, 1983, CLIN CHEM, V29, P538; Meigs JB, 2000, JAMA-J AM MED ASSOC, V283, P221, DOI 10.1001/jama.283.2.221; NEELEY WE, 1972, CLIN CHEM, V18, P509; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; *ROYAL COMM AB PEO, 1996, REP ROYAL COMM AB PE, V3; Scarabin PY, 1998, THROMB HAEMOSTASIS, V80, P749; Shah BR, 2000, ARCH INTERN MED, V160, P1862, DOI 10.1001/archinte.160.12.1862; Smith GD, 1997, BMJ-BRIT MED J, V314, P547, DOI 10.1136/bmj.314.7080.547; *STAT CAN, 1996, 1996 CENS DIR; SYME SL, 1976, AM J EPIDEMIOL, V104, P1; Vartiainen E, 2000, INT J EPIDEMIOL, V29, P49, DOI 10.1093/ije/29.1.49; WARNICK GR, 1985, CLIN CHEM, V31, P217; Zatonski WA, 1998, BMJ-BRIT MED J, V316, P1047	29	225	234	0	16	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 6	2001	358	9288					1147	1153		10.1016/S0140-6736(01)06255-9	http://dx.doi.org/10.1016/S0140-6736(01)06255-9			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	479HM	11597669				2022-12-24	WOS:000171399000012
J	Goodman, WG				Goodman, WG			Vascular calcification in chronic renal failure	LANCET			English	Editorial Material							MINERALIZATION-REGULATING PROTEINS; CALCIPHYLAXIS; ASSOCIATION; DISEASE; OSTEODYSTROPHY; DIALYSIS		Univ Calif Los Angeles, Sch Med, Dept Med, Div Nephrol, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Goodman, WG (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Med, Div Nephrol, Los Angeles, CA 90024 USA.							Ahmed S, 2001, AM J KIDNEY DIS, V37, P1267, DOI 10.1053/ajkd.2001.24533; ANDROGUE H, 1983, J UROLOGY, V129, P362; CONN J, 1973, ANN SURG, V177, P206, DOI 10.1097/00000658-197302000-00015; FOX R, 1983, J UROLOGY, V129, P362, DOI 10.1016/S0022-5347(17)52098-4; GIPSTEIN RM, 1976, ARCH INTERN MED, V136, P1273, DOI 10.1001/archinte.136.11.1273; Goodman WG, 2000, NEW ENGL J MED, V342, P1478, DOI 10.1056/NEJM200005183422003; Guerin AP, 2000, NEPHROL DIAL TRANSPL, V15, P1014, DOI 10.1093/ndt/15.7.1014; HUTCHISON AJ, 1994, AM J NEPHROL, V14, P19, DOI 10.1159/000168681; Llach F, 2001, NEPHROL DIAL TRANSPL, V16, P448, DOI 10.1093/ndt/16.3.448; Luo GB, 1997, NATURE, V386, P78, DOI 10.1038/386078a0; Marchais SJ, 1999, NEPHROL DIAL TRANSPL, V14, P2178, DOI 10.1093/ndt/14.9.2178; Mawad HW, 1999, CLIN NEPHROL, V52, P160; Mazhar AR, 2001, KIDNEY INT, V60, P324, DOI 10.1046/j.1523-1755.2001.00803.x; Ruggian JC, 1996, AM J KIDNEY DIS, V28, P409, DOI 10.1016/S0272-6386(96)90499-0; SALUSKY IB, 1994, KIDNEY INT, V45, P253, DOI 10.1038/ki.1994.31; SELYE H, 1962, ENDOCRINOLOGY, V71, P554, DOI 10.1210/endo-71-4-554; Shanahan CM, 1999, CIRCULATION, V100, P2168, DOI 10.1161/01.CIR.100.21.2168; Shanahan CM, 1998, CRIT REV EUKAR GENE, V8, P357, DOI 10.1615/CritRevEukarGeneExpr.v8.i3-4.60; Shanahan CM, 2000, Z KARDIOL, V89, P63; Sherrard DJ, 1996, NEPHROL DIAL TRANSPL, V11, P29; Zacharias JM, 1999, PERITON DIALYSIS INT, V19, P248	21	56	57	1	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 6	2001	358	9288					1115	1116		10.1016/S0140-6736(01)06299-7	http://dx.doi.org/10.1016/S0140-6736(01)06299-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	479HM	11597661				2022-12-24	WOS:000171399000004
J	Polyak, VJ; Asmerom, Y				Polyak, VJ; Asmerom, Y			Late Holocene climate and cultural changes in the southwestern United States	SCIENCE			English	Article							NEW-MEXICO; ARIZONA; SPELEOTHEM; HISTORY; RECORD; CAVE; PALEOCLIMATE; ENVIRONMENTS; STALAGMITES; VEGETATION	Columnar stalagmites in caves of the Guadalupe Mountains during the late Holocene record a 4000-year annually resolved climate history for the southwestern United States. Annual banding, hiatuses, and high-precision uranium-series dating show a present day-like climate from 4000 to 3000 years ago, following a drier middle Holocene. A distinctly wetter and cooler period from 3000 to 800 years ago was followed by a period of present day-like conditions, with the exception of a slightly wetter interval from 440 to 290 years before the present. The stalagmite record correlates well with the archaeological record of changes in cultural activities of indigenous people. Such climate change may help to explain evidence of dwelling abandonment and population redistribution.	Univ New Mexico, Dept Earth & Planetary Sci, Albuquerque, NM 87131 USA	University of New Mexico	Polyak, VJ (corresponding author), Univ New Mexico, Dept Earth & Planetary Sci, 200 Yale Blvd, Albuquerque, NM 87131 USA.							ANDERSON RS, 1993, QUATERNARY RES, V40, P351, DOI 10.1006/qres.1993.1088; Antevs E, 1955, AM ANTIQUITY, V20, P317, DOI 10.2307/277066; APPLEGARTH JS, 1979, US NATL PARK SERVICE, V4, P159; BAKER A, 1993, NATURE, V364, P518, DOI 10.1038/364518a0; Betancourt JL, 2001, PALAEOGEOGR PALAEOCL, V165, P71, DOI 10.1016/S0031-0182(00)00154-1; Brook GA, 1999, HOLOCENE, V9, P695, DOI 10.1191/095968399677907790; Buck BJ, 1999, J ARID ENVIRON, V43, P357, DOI 10.1006/jare.1999.0584; Cheng H, 2000, CHEM GEOL, V169, P17, DOI 10.1016/S0009-2541(99)00157-6; Cordell L. S., 1997, ARCHAEOLOGY SW; DAVIS OK, 1992, PALAEOGEOGR PALAEOCL, V92, P107, DOI 10.1016/0031-0182(92)90137-T; Denniston RF, 2000, QUATERNARY RES, V53, P196, DOI 10.1006/qres.1999.2111; DORALE JA, 1992, SCIENCE, V258, P1626, DOI 10.1126/science.258.5088.1626; EULER RC, 1979, SCIENCE, V205, P1089, DOI 10.1126/science.205.4411.1089; Genty D, 1996, J SEDIMENT RES, V66, P275; HALL SA, 1977, GEOL SOC AM BULL, V88, P1593, DOI 10.1130/0016-7606(1977)88<1593:LQSAPH>2.0.CO;2; HENDY CH, 1971, GEOCHIM COSMOCHIM AC, V35, P801, DOI 10.1016/0016-7037(71)90127-X; HILL CA, 1987, NEW MEXICO BUREAU MI, V117; HOLLIDAY VT, 1989, QUATERNARY RES, V31, P74, DOI 10.1016/0033-5894(89)90086-0; Krider PR, 1998, QUATERNARY RES, V50, P283, DOI 10.1006/qres.1998.1997; Lamb H.H., 1977, CLIMATIC HIST FUTURE; LUNDELIUS EL, 1979, US NATL PARK SERVICE, V4, P239; McFadden LD, 1997, GEOMORPHOLOGY, V19, P303, DOI 10.1016/S0169-555X(97)00017-2; MURRAY JW, 1954, J GEOL, V62, P481, DOI 10.1086/626192; Polyak VJ, 2001, GEOLOGY, V29, P643, DOI 10.1130/0091-7613(2001)029<0643:WACLHC>2.0.CO;2; RAILSBACK LB, 1994, J SEDIMENT RES A, V64, P147; SHOPOV YY, 1994, GEOLOGY, V22, P407, DOI 10.1130/0091-7613(1994)022<0407:LMISHR>2.3.CO;2; SMITH GI, 1983, LATE QUATERNARY ENV, V1, P190; STUART DE, 1996, PREHISTORIC NEW MEXI; Tagg MD, 1996, AM ANTIQUITY, V61, P311, DOI 10.2307/282428; Van Geel B, 1998, RADIOCARBON, V40, P535, DOI 10.1017/S0033822200018403; VANDEVENDER TR, 1994, QUATERNARY RES, V41, P99, DOI 10.1006/qres.1994.1011; Weng CY, 1999, PALAEOGEOGR PALAEOCL, V153, P179, DOI 10.1016/S0031-0182(99)00070-X; Wilkins DE, 1999, HOLOCENE, V9, P363, DOI 10.1191/095968399677728249	33	182	214	3	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 5	2001	294	5540					148	151		10.1126/science.1062771	http://dx.doi.org/10.1126/science.1062771			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480EJ	11588259				2022-12-24	WOS:000171448800048
J	Ruegsegger, U; Leber, JH; Walter, P				Ruegsegger, U; Leber, JH; Walter, P			Block of HAC1 mRNA translation by long-range base pairing is released by cytoplasmic splicing upon induction of the unfolded protein response	CELL			English	Article							TRANSFER-RNA LIGASE; MESSENGER-RNA; ENDOPLASMIC-RETICULUM; TRANSMEMBRANE PROTEIN; TRANSCRIPTION FACTOR; C-ELEGANS; KINASE; YEAST; ER; INITIATION	Expression of the yeast transcription factor Hac1p, which controls the unfolded protein response, is regulated posttranscriptionally. Hac1p is only produced when an intron at the 3' end of its mRNA is removed by a nonconventional, regulated splicing reaction. We show that a previously unrecognized base-pairing interaction between the intron and the 5' untranslated region is required and sufficient to block mRNA translation. Unspliced HAC1 mRNA is stable, located in the cytosol, and is associated with polyribosomes, yet does not produce protein, indicating that the ribosomes engaged on the rnRNA are stalled. We show that the polysomal, cytoplasmic pool of HAC1 mRNA is a substrate for splicing, suggesting that the stalled ribosomes may resume translation after the intron is removed.	Univ Calif San Francisco, Dept Biochem & Biophys, Howard Hughes Med Inst, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco	Walter, P (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	walter@cgl.ucsf.edu						Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Chapman RE, 1997, CURR BIOL, V7, P850, DOI 10.1016/S0960-9822(06)00373-3; Clark IE, 2000, CURR BIOL, V10, P1311, DOI 10.1016/S0960-9822(00)00754-5; CLARK MW, 1987, J CELL BIOL, V105, P1515, DOI 10.1083/jcb.105.4.1515; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; Gonzalez TN, 1999, EMBO J, V18, P3119, DOI 10.1093/emboj/18.11.3119; Gray NK, 1998, ANNU REV CELL DEV BI, V14, P399, DOI 10.1146/annurev.cellbio.14.1.399; JOHANSSON HE, 1994, NUCLEIC ACIDS RES, V22, P4591, DOI 10.1093/nar/22.22.4591; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kawahara T, 1997, MOL BIOL CELL, V8, P1845, DOI 10.1091/mbc.8.10.1845; KOHRER K, 1991, METHOD ENZYMOL, V194, P398; KOZAK M, 1989, MOL CELL BIOL, V9, P5134, DOI 10.1128/MCB.9.11.5134; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; MEHLIN H, 1992, CELL, V69, P605, DOI 10.1016/0092-8674(92)90224-Z; Mori K, 2000, CELL, V101, P451, DOI 10.1016/S0092-8674(00)80855-7; MORI K, 1993, CELL, V74, P743; NONET M, 1987, MOL CELL BIOL, V7, P1602, DOI 10.1128/MCB.7.5.1602; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; OKA T, 1991, J CELL BIOL, V114, P671, DOI 10.1083/jcb.114.4.671; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Patil C, 2001, CURR OPIN CELL BIOL, V13, P349, DOI 10.1016/S0955-0674(00)00219-2; Shamu CE, 1996, EMBO J, V15, P3028, DOI 10.1002/j.1460-2075.1996.tb00666.x; Sidrauski C, 1997, CELL, V90, P1031, DOI 10.1016/S0092-8674(00)80369-4; Sidrauski C, 1996, CELL, V87, P405, DOI 10.1016/S0092-8674(00)81361-6; SPENA A, 1985, EMBO J, V4, P2153, DOI 10.1002/j.1460-2075.1985.tb03909.x; TARUN SZ, 1995, GENE DEV, V9, P2997, DOI 10.1101/gad.9.23.2997; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Urano F, 2000, J CELL SCI, V113, P3697; VANDENHEUVEL JJ, 1990, YEAST, V6, P473, DOI 10.1002/yea.320060604; Vega Laso Maria R., 1993, Journal of Biological Chemistry, V268, P6453; Welihinda AA, 1996, J BIOL CHEM, V271, P18181, DOI 10.1074/jbc.271.30.18181; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4	33	224	234	1	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 5	2001	107	1					103	114		10.1016/S0092-8674(01)00505-0	http://dx.doi.org/10.1016/S0092-8674(01)00505-0			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	480GF	11595189	Bronze			2022-12-24	WOS:000171453100013
J	Stevens, RC; Yokoyama, S; Wilson, IA				Stevens, RC; Yokoyama, S; Wilson, IA			Global efforts in structural genomics	SCIENCE			English	Editorial Material							PROJECT	A worldwide initiative in structural genomics aims to capitalize on the recent successes of the genome projects. Substantial new investments in structural genomics in the past 2 years indicate the high level of support for these international efforts. Already, enormous progress has been made on high-throughput methodologies and technologies that will speed up macromolecular structure determinations. Recent international meetings have resulted in the formation of an International Structural Genomics Organization to formulate policy and foster cooperation between the public and private efforts.	Scripps Res Inst, Joint Ctr Struct Genom, La Jolla, CA 92037 USA; RIKEN, Genom Sci Ctr, Yokohama, Kanagawa 2300045, Japan	Scripps Research Institute; RIKEN	Stevens, RC (corresponding author), Scripps Res Inst, Joint Ctr Struct Genom, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Yokoyama, Shigeyuki/N-6911-2015; Stevens, Raymond/K-7272-2015	Yokoyama, Shigeyuki/0000-0003-3133-7338; Stevens, Raymond/0000-0002-4522-8725	NIGMS NIH HHS [P50 GM62411] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM062411] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Burley SK, 1999, NAT GENET, V23, P151, DOI 10.1038/13783; Kim SH, 1998, NAT STRUCT BIOL, V5, P643, DOI 10.1038/1334; Marshall E, 2001, SCIENCE, V292, P188; Montelione GT, 1999, NAT STRUCT BIOL, V6, P11, DOI 10.1038/4878; Stevens RC, 2001, SCIENCE, V293, P519, DOI 10.1126/science.293.5529.519; Terwilliger TC, 2000, NAT STRUCT BIOL, V7, P935, DOI 10.1038/80700; Vitkup D, 2001, NAT STRUCT BIOL, V8, P559, DOI 10.1038/88640	9	152	161	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 5	2001	294	5540					89	92		10.1126/science.1066011	http://dx.doi.org/10.1126/science.1066011			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480EJ	11588249				2022-12-24	WOS:000171448800037
J	Quill, TE; Arnold, RM; Platt, F				Quill, TE; Arnold, RM; Platt, F			"I wish things were different": Expressing wishes in response to loss, futility, and unrealistic hopes	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							EMPATHIC COMMUNICATION; PHYSICIANS; CARE		Univ Rochester, Sch Med & Dent, Rochester, NY 14642 USA; Univ Pittsburgh, Sch Med, Pittsburgh, PA 15213 USA; Univ Colorado, Sch Med, Denver, CO 80205 USA	University of Rochester; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Quill, TE (corresponding author), Univ Rochester, Med Ctr, 601 Elmwood Ave,Box 601, Rochester, NY 14642 USA.							ACKERMAN F, 1991, HASTINGS CENT REP, V21, P27, DOI 10.2307/3562998; BARRETTLENNARD GT, 1993, BRIT J MED PSYCHOL, V66, P3, DOI 10.1111/j.2044-8341.1993.tb01722.x; BRANCH WT, 1993, JAMA-J AM MED ASSOC, V269, P1667, DOI 10.1001/jama.269.13.1667; Byock I, 1997, DYING WELL PROSPECT; Coulehan JL, 2001, ANN INTERN MED, V135, P221, DOI 10.7326/0003-4819-135-3-200108070-00022; FOX RC, 1959, EXPT PERILOUS PHYSIC; GOOD MJD, 1990, CULT MED PSYCHIAT, V14, P59; Kohn L.T., 2000, TO ERR IS HUMAN BUIL; LAZARE A, 1989, OUTPATIENT PSYCHIAT, P157; Levinson W, 2000, JAMA-J AM MED ASSOC, V284, P1021, DOI 10.1001/jama.284.8.1021; Lo B, 1999, ANN INTERN MED, V130, P744, DOI 10.7326/0003-4819-130-9-199905040-00015; MATTHEWS DA, 1993, ANN INTERN MED, V118, P973, DOI 10.7326/0003-4819-118-12-199306150-00010; NIGHTINGALE SD, 1991, J GEN INTERN MED, V6, P420, DOI 10.1007/BF02598163; PLATT FW, 1994, J GEN INTERN MED, V9, P222, DOI 10.1007/BF02600129; Quill T, 1996, MIDWIFE DYING PROCES; QUILL TE, 1995, ANN INTERN MED, V122, P368, DOI 10.7326/0003-4819-122-5-199503010-00008; Quill TE, 2000, JAMA-J AM MED ASSOC, V284, P2502, DOI 10.1001/jama.284.19.2502; RIE MA, 1991, HASTINGS CENT REP, V21, P24, DOI 10.2307/3562997; ROTER DL, 1995, ARCH INTERN MED, V155, P1877, DOI 10.1001/archinte.155.17.1877; Suchman AL, 1997, JAMA-J AM MED ASSOC, V277, P678, DOI 10.1001/jama.277.8.678; [No title captured]; 1993, CONCISE OXFORD ENGLI	22	91	93	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 2	2001	135	7					551	555		10.7326/0003-4819-135-7-200110020-00022	http://dx.doi.org/10.7326/0003-4819-135-7-200110020-00022			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	477EF	11578166				2022-12-24	WOS:000171269600017
J	Waugh, J; Johnson, A; Farkas, A				Waugh, J; Johnson, A; Farkas, A			Analysis of cord blood gas at delivery: questionnaire study of practice in the United Kingdom	BRITISH MEDICAL JOURNAL			English	Article									Royal Hallamshire Hosp, Dept Obstet & Gynaecol, Sheffield S10 2SF, S Yorkshire, England	University of Sheffield	Farkas, A (corresponding author), Royal Hallamshire Hosp, Dept Obstet & Gynaecol, Sheffield S10 2SF, S Yorkshire, England.							GELDABER GK, 1991, OBSTET GYNECOL, V78, P1103; MacLennan A, 1999, BMJ-BRIT MED J, V319, P1054, DOI 10.1136/bmj.319.7216.1054; *ROYAL COLL OBST G, 1999, SAF CHILDB MIN STAND, P22; WESTGATE J, 1994, BRIT J OBSTET GYNAEC, V101, P1054, DOI 10.1111/j.1471-0528.1994.tb13581.x	4	7	8	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 29	2001	323	7315					727	727		10.1136/bmj.323.7315.727	http://dx.doi.org/10.1136/bmj.323.7315.727			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	478HJ	11576980	Bronze, Green Published			2022-12-24	WOS:000171340700020
J	Downing, PE; Jiang, YH; Shuman, M; Kanwisher, N				Downing, PE; Jiang, YH; Shuman, M; Kanwisher, N			A cortical area selective for visual processing of the human body	SCIENCE			English	Article							TEMPORAL CORTEX; PERCEPTION; REPRESENTATION; ACTIVATION; MOTION; PARTS	Despite extensive evidence for regions of human visual cortex that respond selectively to faces, few studies have considered the cortical representation of the appearance of the rest of the human body. We present a series of functional magnetic resonance imaging (fMRI) studies revealing substantial evidence for a distinct cortical region in humans that responds selectively to images of the human body, as compared with a wide range of control stimuli. This region was found in the lateral occipitotemporal cortex in all subjects tested and apparently reflects a specialized neural system for the visual perception of the human body.	Univ Wales, Ctr Cognit Neurosci, Sch Psychol, Bangor LL57 2AS, Gwynedd, Wales; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; Massachusetts Gen Hosp, Nucl Magnet Resonance Imaging Ctr, Charlestown, MA 02129 USA	Bangor University; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital	Downing, PE (corresponding author), Univ Wales, Ctr Cognit Neurosci, Sch Psychol, Bangor LL57 2AS, Gwynedd, Wales.	p.downing@bangor.ac.uk		Downing, Paul/0000-0002-5046-2858				Amedi A, 2001, NAT NEUROSCI, V4, P324, DOI 10.1038/85201; Chao LL, 1999, NAT NEUROSCI, V2, P913, DOI 10.1038/13217; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Gauthier I, 2000, NAT NEUROSCI, V3, P191, DOI 10.1038/72140; Grill-Spector K, 2001, VISION RES, V41, P1409, DOI 10.1016/S0042-6989(01)00073-6; Grossman E, 2000, J COGNITIVE NEUROSCI, V12, P711, DOI 10.1162/089892900562417; Howard RJ, 1996, CURR BIOL, V6, P1015, DOI 10.1016/S0960-9822(02)00646-2; Jellema T, 2000, BRAIN COGNITION, V44, P280, DOI 10.1006/brcg.2000.1231; JOHANSSON G, 1973, PERCEPT PSYCHOPHYS, V14, P201, DOI 10.3758/BF03212378; Kanwisher N, 2000, NAT NEUROSCI, V3, P759, DOI 10.1038/77664; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kourtzi Z, 2000, J NEUROSCI, V20, P3310, DOI 10.1523/JNEUROSCI.20-09-03310.2000; Kourtzi Z, 2000, J COGNITIVE NEUROSCI, V12, P48, DOI 10.1162/08989290051137594; Le Clec'H G, 2000, NEUROIMAGE, V12, P381, DOI 10.1006/nimg.2000.0627; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; Puce A, 1996, J NEUROSCI, V16, P5205; Puce A, 1998, J NEUROSCI, V18, P2188; Rizzolatti G, 1997, CURR OPIN NEUROBIOL, V7, P562, DOI 10.1016/S0959-4388(97)80037-2; Shelton JR, 1998, NEUROCASE, V4, P339, DOI 10.1093/neucas/4.4.339; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; WACHSMUTH E, 1994, CEREB CORTEX, V4, P509, DOI 10.1093/cercor/4.5.509	21	1363	1377	12	128	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 28	2001	293	5539					2470	2473		10.1126/science.1063414	http://dx.doi.org/10.1126/science.1063414			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	476PD	11577239				2022-12-24	WOS:000171237200052
J	Groom, AV; Wolsey, DH; Naimi, TS; Smith, K; Johnson, S; Boxrud, D; Moore, KA; Cheek, JE				Groom, AV; Wolsey, DH; Naimi, TS; Smith, K; Johnson, S; Boxrud, D; Moore, KA; Cheek, JE			Community-acquired methicillin-resistant Staphylococcus aureus in a rural American Indian community	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FIELD GEL-ELECTROPHORESIS; CHILDREN; OUTBREAK; CLONE; RISK; EPIDEMIOLOGY; STRAINS; MRSA; MEC	Context Until recently, methicillin-resistant Staphylococcus aureus (MRSA) infections have been acquired primarily in nosocomial settings. Four recent deaths due to MRSA infection in previously healthy children in the Midwest suggest that serious MRSA infections can be acquired in the community in rural as well as urban locations. Objectives To document the occurrence of community-acquired MRSA infections and evaluate risk factors for community-acquired MRSA infection compared with methicillin-susceptible S aureus (MSSA) infection. Design Retrospective cohort study with medical record review. Setting Indian Health Service facility in a rural midwestern American Indian community. Patients Patients whose medical records indicated laboratory-confirmed S aureus infection diagnosed during 1997. Main Outcome Measures Proportion of MRSA infections classified as community acquired based on standardized criteria; risk factors for community-acquired MRSA infection compared with those for community-acquired MSSA infection; and relatedness of MRSA strains, determined by pulsed-field gel electrophoresis (PFGE). Results Of 112 S aureus isolates, 62 (55%) were MRSA and 50 (45%) were MSSA. Forty-six (74%) of the 62 MRSA infections were classified as community acquired. Risk factors for community-acquired MRSA infections were not significantly different from those for community-acquired MSSA. Pulsed-field gel electrophoresis subtyping indicated that 34 (89%) of 38 community-acquired MRSA isolates were clonally related and distinct from nosocomial MRSA isolates found in the region. Conclusions Community-acquired MRSA may have replaced community-acquired MSSA as the dominant strain in this community. Antimicrobial susceptibility patterns and PFGE subtyping support the finding that MRSA is circulating beyond nosocomial settings in this and possibly other rural US communities.	Indian Hlth Serv, Natl Epidemiol Program, Albuquerque, NM 87110 USA; Ctr Dis Control & Prevent, Epidemiol Program Off, Atlanta, GA USA; Minnesota Dept Hlth, Acute Dis Epidemiol Sect, Minneapolis, MN USA; Minnesota Dept Hlth, Div Publ Hlth Labs, Minneapolis, MN USA; ICAN Inc, Eden Prairie, MN USA	Centers for Disease Control & Prevention - USA; Minnesota Department of Health (MHD); Minnesota Department of Health (MHD)	Cheek, JE (corresponding author), Indian Hlth Serv, Natl Epidemiol Program, 5300 Homestead Rd NE,Headquarters, Albuquerque, NM 87110 USA.			Naimi, Timothy/0000-0001-9849-4413	PHS HHS [U50/CCU511190] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Abi-Hanna P, 2000, CLIN INFECT DIS, V30, P630, DOI 10.1086/313706; ANTHONY BF, 1967, PEDIATRICS, V39, P263; Ayliffe GAJ, 1997, CLIN INFECT DIS, V24, pS74, DOI 10.1093/clinids/24.Supplement_1.S74; BANNERMAN TL, 1995, J CLIN MICROBIOL, V33, P551, DOI 10.1128/JCM.33.3.551-555.1995; Boyce JM, 1998, JAMA-J AM MED ASSOC, V279, P623, DOI 10.1001/jama.279.8.623; *CDCP, 1998, NAT NOS INF SURV SYS; *CDCP, 1999, MMWR-MORBID MORTAL W, V48, P707; *CDCP, 1997, EP INF VERS 6 04C; Cockerill FR, 1997, JAMA-J AM MED ASSOC, V277, P38, DOI 10.1001/jama.277.1.38; Cookson BD, 2000, INFECT CONT HOSP EP, V21, P398, DOI 10.1086/501781; *CYT SOFTW CORP, 1997, STATX 3; DAJANI AS, 1973, ARCH DERMATOL, V108, P517, DOI 10.1001/archderm.108.4.517; de Sousa MA, 1998, J CLIN MICROBIOL, V36, P2590, DOI 10.1128/JCM.36.9.2590-2596.1998; EMBIL J, 1994, INFECT CONT HOSP EP, V15, P646; Frank AL, 1999, PEDIATR INFECT DIS J, V18, P993, DOI 10.1097/00006454-199911000-00012; Gorak EJ, 1999, CLIN INFECT DIS, V29, P797, DOI 10.1086/520437; HARTMAN BJ, 1984, J BACTERIOL, V158, P513, DOI 10.1128/JB.158.2.513-516.1984; Herold BC, 1998, JAMA-J AM MED ASSOC, V279, P593, DOI 10.1001/jama.279.8.593; Joe J R, 1996, J Am Med Womens Assoc (1972), V51, P141; JORGENSEN JH, 1986, EUR J CLIN MICROBIOL, V5, P693, DOI 10.1007/BF02013307; Kallen AJ, 2000, INFECT CONT HOSP EP, V21, P223, DOI 10.1086/501750; KREISWIRTH B, 1993, SCIENCE, V259, P227, DOI 10.1126/science.8093647; Macfarlane L, 1999, J HOSP INFECT, V41, P29, DOI 10.1016/S0195-6701(99)90034-8; Maguire GP, 1996, MED J AUSTRALIA, V164, P721, DOI 10.5694/j.1326-5377.1996.tb122270.x; Monnet DL, 1998, INFECT CONT HOSP EP, V19, P552; MORENO F, 1995, CLIN INFECT DIS, V21, P1308, DOI 10.1093/clinids/21.5.1308; MUSSER JM, 1992, J CLIN MICROBIOL, V30, P2058, DOI 10.1128/JCM.30.8.2058-2063.1992; National Committee for Clinical Laboratory Standards, 1997, M2A6 NCCLS CLIN LAB, V6th; National Committee for Clinical Laboratory Standars, 1999, M100S9 NAT COMM CLIN; NISHI JI, 1995, J LAB CLIN MED, V126, P29; O'Brien FG, 1999, J CLIN MICROBIOL, V37, P2858; RHOADES ER, 1987, PUBLIC HEALTH REP, V102, P361; Roberts RB, 1998, MICROB DRUG RESIST, V4, P175, DOI 10.1089/mdr.1998.4.175; Roberts RB, 1998, J INFECT DIS, V178, P164, DOI 10.1086/515610; Shopsin B, 2000, J INFECT DIS, V182, P359, DOI 10.1086/315695; Tenover F, 1998, BACTERIAL INFECT HUM, P83; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Warshawsky B, 2000, INFECT CONT HOSP EP, V21, P724, DOI 10.1086/501718; Wayne P.A, 1997, PERF VOL ANT SUSC FL, Vsixth; Wu SW, 1996, MICROB DRUG RESIST, V2, P435, DOI 10.1089/mdr.1996.2.435	40	282	296	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 12	2001	286	10					1201	1205		10.1001/jama.286.10.1201	http://dx.doi.org/10.1001/jama.286.10.1201			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	471CR	11559265	Bronze			2022-12-24	WOS:000170910400030
J	Bedford, H; de Louvois, J; Halket, S; Peckham, C; Hurley, R; Harvey, D				Bedford, H; de Louvois, J; Halket, S; Peckham, C; Hurley, R; Harvey, D			Meningitis in infancy in England and Wales: follow up at age 5 years	BRITISH MEDICAL JOURNAL			English	Article							BACTERIAL-MENINGITIS; INFLUENZAE MENINGITIS; HEARING-LOSS; CHILDREN; OUTCOMES; SEQUELA	Objective To describe important sequelae occurring among a cohort of children aged 5 years who had had meningitis during the first year of life and who had been identified by a prospective national study of meningitis in infancy in England and Wales between 1985 and 1987. Design Follow up questionnaires asking about the children's health and development were sent to general practitioners and parents of the children and to parents of matched controls. The organism that caused the infection and age at infection were also recorded. Setting England and Wales. Participants General practitioners and parents of children who had had meningitis before the age of 1 year and of matched controls. Main outcome measures The prevalence of health and developmental problems and overall disability among children who had had meningitis compared with controls. Results Altogether, 1584 of 1717 (92.2%) children who had had meningitis mid 1391 of 1485 (93.6'%) controls were successfully followed up, Among children who survived to age 5 years 247 of 1584 (15.6%) had a disability; there was a 10-fold increase in the risk of severe or moderate disability at 5 years of age among children who had had meningitis (relative risk 10.3, 95% confidence interval 6.7 to 16.0, P<0.001). There was considerable variation in the rates of severe or moderate disability in children infected with different organisms. Conclusion The long term consequences of having meningitis during the first year of life are significant: 32 of 1717 (1.8%) children died within five years. Not only did almost a fifth of children with meningitis have a permanent, severe or moderately severe disability, but subtle deficits were also more prevalent.	Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, London WC1N 1EH, England; Publ Hlth Lab Serv, Environm Surveillance Unit, London NW9 5EQ, England; Queen Charlottes & Chelsea Hosp, Dept Paediat & Neonatal Med, Imperial Coll Sch Med, Karim Ctr Meningitis Res, London W6 0XG, England	University of London; University College London; Public Health England; Imperial College London	Bedford, H (corresponding author), Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, 30 Guilford St, London WC1N 1EH, England.		peckham, catherine s/I-6300-2013					BARAFF LJ, 1993, PEDIATR INFECT DIS J, V12, P389, DOI 10.1097/00006454-199305000-00008; BERLOW SJ, 1980, LARYNGOSCOPE, V90, P1445, DOI 10.1288/00005537-198009000-00004; CRIMWOOD K, 1995, PEDIATRICS, V95, P646; DAVIES PA, 1994, NEONATAL MENINGITIS, P140; DELOUVOIS J, 1991, ARCH DIS CHILD, V66, P603, DOI 10.1136/adc.66.5.603; DODGE PR, 1984, NEW ENGL J MED, V311, P869, DOI 10.1056/NEJM198410043111401; FELDMAN HM, 1988, PEDIATRICS, V81, P339; FORTNUM HM, 1992, ARCH DIS CHILD, V67, P1111, DOI 10.1136/adc.67.9.1111; GRIMWOOD K, 1995, PEDIATRICS, V95, P646; Holt DE, 2001, ARCH DIS CHILD-FETAL, V84, pF85, DOI 10.1136/fn.84.2.F85; KAPLAN SL, 1981, PEDIATRICS, V68, P8; MCINTYRE P, 1993, MED J AUSTRALIA, V159, P766, DOI 10.5694/j.1326-5377.1993.tb141344.x; NADOL JB, 1978, LARYNGOSCOPE, V88, P739; RIORDAN A, 1993, BRIT J AUDIOL, V27, P375, DOI 10.3109/03005369309076713; Shields M D, 1995, Qual Health Care, V4, P269, DOI 10.1136/qshc.4.4.269; UNHANAND M, 1993, J PEDIATR-US, V122, P15, DOI 10.1016/S0022-3476(05)83480-8	16	178	186	0	5	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 8	2001	323	7312					533	536		10.1136/bmj.323.7312.533	http://dx.doi.org/10.1136/bmj.323.7312.533			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	471NC	11546697	Green Submitted, Bronze, Green Published			2022-12-24	WOS:000170934600017
J	Puthalakath, H; Villunger, A; O'Reilly, LA; Beaumont, JG; Coultas, L; Cheney, RE; Huang, DCS; Strasser, A				Puthalakath, H; Villunger, A; O'Reilly, LA; Beaumont, JG; Coultas, L; Cheney, RE; Huang, DCS; Strasser, A			Bmf: A proapoptotic BH3-only protein regulated by interaction with the myosin V actin motor complex, activated by anoikis	SCIENCE			English	Article							BCL-2 FAMILY; LIGHT-CHAIN; CELL-DEATH; APOPTOSIS; DYNEIN; MEMBER; BIM; PURIFICATION; INTEGRINS	Bcl-2 family members bearing only the BH3 domain are essential inducers of apoptosis. We identified a BH3-only protein, Bmf, and show that its BH3 domain is required both for binding to prosurvival Bcl-2 proteins and for triggering apoptosis. In healthy cells, Bmf is sequestered to myosin V motors by association with dynein light chain 2. Certain damage signals, such as loss of cell attachment (anoikis), unleash Bmf, allowing it to translocate and bind prosurvival. Bcl-2 proteins. Thus, at least two mammalian BH3-only proteins, Bmf and Bim, function to sense intracellular damage by their localization to distinct cytoskeletal structures.	Walter & Eliza Hall Inst Med Res, PO Royal Melbourne Hosp, Melbourne, Vic 3050, Australia; Univ N Carolina, Chapel Hill, NC 27599 USA	Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of North Carolina; University of North Carolina Chapel Hill	Strasser, A (corresponding author), Walter & Eliza Hall Inst Med Res, PO Royal Melbourne Hosp, Melbourne, Vic 3050, Australia.	strasser@wehi.edu.au	Huang, David C. S./C-7586-2013; Puthalakath, Hamsa/B-8541-2011; Strasser, Andreas/C-7581-2013	Huang, David C. S./0000-0002-3101-4873; Strasser, Andreas/0000-0002-5020-4891; Cheney, Richard/0000-0001-6565-7888	NATIONAL CANCER INSTITUTE [R01CA080188] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R29DC003299] Funding Source: NIH RePORTER; NCI NIH HHS [CA 80188] Funding Source: Medline; NIDCD NIH HHS [R29 DC003299] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Benashski SE, 1997, J BIOL CHEM, V272, P20929, DOI 10.1074/jbc.272.33.20929; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Cheney RE, 1998, METHOD ENZYMOL, V298, P3, DOI 10.1016/S0076-6879(98)98003-X; Conradt B, 1998, CELL, V93, P519, DOI 10.1016/S0092-8674(00)81182-4; ESPREAFICO EM, 1992, J CELL BIOL, V119, P1541, DOI 10.1083/jcb.119.6.1541; Frisch SM, 1997, CURR OPIN CELL BIOL, V9, P701, DOI 10.1016/S0955-0674(97)80124-X; Huang DCS, 2000, CELL, V103, P839, DOI 10.1016/S0092-8674(00)00187-2; KROGH A, 1994, J MOL BIOL, V235, P1501, DOI 10.1006/jmbi.1994.1104; Lo KWH, 2001, J BIOL CHEM, V276, P14059, DOI 10.1074/jbc.M010320200; Naisbitt S, 2000, J NEUROSCI, V20, P4524, DOI 10.1523/JNEUROSCI.20-12-04524.2000; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; O'Reilly LA, 1998, BIOTECHNIQUES, V25, P824, DOI 10.2144/98255st03; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Puthalakath H, 1999, MOL CELL, V3, P287, DOI 10.1016/S1097-2765(00)80456-6; PUTHALAKATH H, UNPUB; RUOSLAHTI E, 1994, CELL, V77, P477, DOI 10.1016/0092-8674(94)90209-7; STRASSER A, 1990, NATURE, V348, P331, DOI 10.1038/348331a0; Wick W, 1996, ONCOGENE, V12, P973; YIN XM, 1994, NATURE, V369, P321, DOI 10.1038/369321a0; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3; [No title captured]	23	470	503	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2001	293	5536					1829	1832		10.1126/science.1062257	http://dx.doi.org/10.1126/science.1062257			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	470WN	11546872				2022-12-24	WOS:000170894400047
J	Astagneau, P; Desplaces, N; Vincent, V; Chicheportiche, V; Botherel, AH; Maugat, S; Lebascle, K; Leonard, P; Desenclos, JC; Grosset, J; Ziza, JM; Brucker, G				Astagneau, P; Desplaces, N; Vincent, V; Chicheportiche, V; Botherel, AH; Maugat, S; Lebascle, K; Leonard, P; Desenclos, JC; Grosset, J; Ziza, JM; Brucker, G			Mycobacterium xenopi spinal infections after discovertebral surgery: investigation and screening of a large outbreak	LANCET			English	Article							IMMUNOCOMPETENT PATIENT; DISEASE; PREVENTION; ARTHRITIS; GUIDELINE; FRANCE	Background Mycobacterium xenopi spinal infections were diagnosed in 1993 in patients who had undergone surgical microdiscectomy for disc hernia, by nucleotomy or microsurgery, in a private hospital. Contaminated tap water, used for rinsing surgical devices after disinfection, was identified as the source of the outbreak. Several cases were recorded in the 4 years after implementation of effective control measures because of the long time between discectomy and case detection. The national health authorities decided to launch a retrospective investigation in patients who were exposed to M xenopi contamination in that hospital. Methods Mailing and media campaigns were undertaken concurrently to trace exposed patients for spinal infections. Patients we re screened by magnetic resonance imaging (MRI), and the scans were reviewed by a radiologist who was unaware of the diagnosis. Suspected cases had discovertebral biopsy for histopathological and bacteriological examination. Findings Of 3244 exposed patients, 2971 (92%) were informed about the risk of infection and 2454 (76%) had MRI, Overall, 58 cases of M xenopi spinal infection were identified (overall cumulative frequency 1.8%), including 26 by the campaign (mean delay in detection 5.2 years, SD 2.4, range 1-10 years). Multivariate analysis showed that the risk of M xenopi spinal infection was related to nucleotomy and high number of patients per operating session. Interpretation Failures in hygiene practices could result in an uncontrolled outbreak of nosocomial infection. Patients who have been exposed to an iatrogenic infectious hazard should be screened promptly and receive effective information.	CCLIN Paris Nord, Inst Cordeliers, F-75006 Paris, France; Hop Croix St Simon, Paris, France; Inst Pasteur, Paris, France; Hop Lariboisiere, F-75475 Paris, France; Hop La Pitie Salpetriere, Paris, France; Inst Veille Sanitaire, St Maurice, France	UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Universite Paris 13; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institute of Public Health Surveillance	Astagneau, P (corresponding author), CCLIN Paris Nord, Inst Cordeliers, 15 Rue Ecole Med, F-75006 Paris, France.		Astagneau, Pascal/AAF-3473-2020					Astagneau P, 2001, J HOSP INFECT, V47, P84, DOI 10.1053/jhin.2000.0874; BANKS J, 1984, THORAX, V39, P376, DOI 10.1136/thx.39.5.376; BENNETT SN, 1994, AM J RESP CRIT CARE, V150, P245, DOI 10.1164/ajrccm.150.1.8025757; BULLIN CH, 1970, J HYG-CAMB, V68, P97, DOI 10.1017/S0022172400028540; Coombes GM, 1996, BRIT J RHEUMATOL, V35, P1008; Danesh-Clough R, 2000, SPINE, V25, P626, DOI 10.1097/00007632-200003010-00015; DECLUDT B, 2000, B EPIDEMIOL HEBD, V17, P71; ElHelou P, 1997, CLIN INFECT DIS, V25, P206, DOI 10.1086/514525; Falkinham JO, 1996, CLIN MICROBIOL REV, V9, P177, DOI 10.1128/CMR.9.2.177; FEYEN J, 1983, CLIN ORTHOP RELAT R, P189; Froideveaux D, 1996, CLIN INFECT DIS, V22, P723, DOI 10.1093/clinids/22.4.723; GHOSEZ JP, 1994, RACHIS, V6, P147; GOUJARD J, 1988, INT J EPIDEMIOL, V17, P423, DOI 10.1093/ije/17.2.423; GROSS W M, 1976, Bulletin of the International Union Against Tuberculosis, V51, P267; Jiva TM, 1997, CLIN INFECT DIS, V24, P226, DOI 10.1093/clinids/24.2.226; JONES PG, 1995, CLIN INFECT DIS, V21, P1352, DOI 10.1093/clinids/21.5.1352-a; Kelly M, 1999, CLIN INFECT DIS, V29, P1342, DOI 10.1086/313447; Lot F, 1999, ANN INTERN MED, V130, P1, DOI 10.7326/0003-4819-130-1-199901050-00002; Mangram AJ, 1999, AM J INFECT CONTROL, V27, P97, DOI 10.1016/S0196-6553(99)70088-X; MARKS J, 1975, TUBERCLE, V56, P157, DOI 10.1016/0041-3879(75)90026-4; MILLER WC, 1994, CLIN INFECT DIS, V19, P1024, DOI 10.1093/clinids/19.6.1024; PICARDEAU M, 1995, RES MICROBIOL, V146, P237, DOI 10.1016/0923-2508(96)80279-8; PROSSER AJ, 1986, TUBERCLE, V67, P229, DOI 10.1016/S0041-3879(86)80030-7; RAHMAN MAA, 1992, TUBERCLE LUNG DIS, V73, P392, DOI 10.1016/0962-8479(92)90047-N; Rutala WA, 1996, AM J INFECT CONTROL, V24, P313, DOI 10.1016/S0196-6553(96)90066-8; SCHWABACHER HERTA, 1959, JOUR HYG, V57, P57; SMITH MJ, 1983, THORAX, V38, P373, DOI 10.1136/thx.38.5.373; SNIADACK DH, 1993, INFECT CONT HOSP EP, V14, P636; Telgt DSC, 1997, BRIT J RHEUMATOL, V36, P1025; VESTAL ASM, 1975, PROCEDURES ISOLATION	30	72	75	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 1	2001	358	9283					747	751		10.1016/S0140-6736(01)05843-3	http://dx.doi.org/10.1016/S0140-6736(01)05843-3			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	467XR	11551599				2022-12-24	WOS:000170729500031
J	Bodine, SC; Latres, E; Baumhueter, S; Lai, VKM; Nunez, L; Clarke, BA; Poueymirou, WT; Panaro, FJ; Na, EQ; Dharmarajan, K; Pan, ZQ; Valenzuela, DM; DeChiara, TM; Stitt, TN; Yancopoulos, GD; Glass, DJ				Bodine, SC; Latres, E; Baumhueter, S; Lai, VKM; Nunez, L; Clarke, BA; Poueymirou, WT; Panaro, FJ; Na, EQ; Dharmarajan, K; Pan, ZQ; Valenzuela, DM; DeChiara, TM; Stitt, TN; Yancopoulos, GD; Glass, DJ			Identification of ubiquitin ligases required for skeletal muscle atrophy	SCIENCE			English	Article							PROTEIN-TURNOVER; FINGER; FAMILY; RING	Skeletal muscle adapts to decreases in activity and load by undergoing atrophy. To identify candidate molecular mediators of muscle atrophy, we performed transcript profiling. Although many genes were up-regulated in a single rat model of atrophy, only a small subset was universal in all atrophy models. Two of these genes encode ubiquitin ligases: Muscle RING Finger 1 (MuRF1), and a gene we designate Muscle Atrophy F-box (MAFbx), the latter being a member of the SCF family of E3 ubiquitin ligases. Overexpression of MAFbx in myotubes produced atrophy, whereas mice deficient in either MAFbx or MuRF1 were found to be resistant to atrophy. These proteins are potential drug targets for the treatment of muscle atrophy.	Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA; Appl Biosyst Inc, Foster City, CA 94404 USA; Mt Sinai Sch Med, Derald H Ruttenberg Canc Ctr, New York, NY 10029 USA	Regeneron; Thermo Fisher Scientific; Applied Biosystems; Icahn School of Medicine at Mount Sinai	Glass, DJ (corresponding author), Regeneron Pharmaceut Inc, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA.	david.glass@regeneron.com	Glass, David/AAI-3910-2021; Panaro, Fabrizio/Q-1355-2017; Xia, Xianfeng/F-9169-2011; Glass, David/C-4782-2012	Bodine, Sue/0000-0002-5742-9145; Glass, David/0000-0001-6187-4164				BAINS W, 1984, MOL CELL BIOL, V4, P1449, DOI 10.1128/MCB.4.8.1449; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Cenciarelli C, 1999, CURR BIOL, V9, P1177, DOI 10.1016/S0960-9822(00)80020-2; Centner T, 2001, J MOL BIOL, V306, P717, DOI 10.1006/jmbi.2001.4448; Chen A, 2000, J BIOL CHEM, V275, P15432, DOI 10.1074/jbc.M907300199; Cooney RN, 1997, SHOCK, V7, P1, DOI 10.1097/00024382-199701000-00001; DECHIARA TM, UNPUB; Freemont PS, 2000, CURR BIOL, V10, pR84, DOI 10.1016/S0960-9822(00)00287-6; GOLDBERG AL, 1969, J BIOL CHEM, V244, P3223; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Jagoe RT, 2001, CURR OPIN CLIN NUTR, V4, P183, DOI 10.1097/00075197-200105000-00003; JOAEIRO CA, 2000, CELL, V102, P549; Kipreos ET, 2000, GENOME BIOL, V1, DOI 10.1186/gb-2000-1-5-reviews3002; Lisztwan J, 1998, EMBO J, V17, P368, DOI 10.1093/emboj/17.2.368; NUNEZ L, UNPUB; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; THOMASON DB, 1987, J APPL PHYSIOL, V63, P130, DOI 10.1152/jappl.1987.63.1.130; Winston JT, 1999, CURR BIOL, V9, P1180, DOI 10.1016/S0960-9822(00)80021-4	19	2466	2594	13	212	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 23	2001	294	5547					1704	1708		10.1126/science.1065874	http://dx.doi.org/10.1126/science.1065874			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494VW	11679633				2022-12-24	WOS:000172307400041
J	Woloshin, S; Schwartz, LM; Tremmel, J; Welch, HG				Woloshin, S; Schwartz, LM; Tremmel, J; Welch, HG			Direct-to-consumer advertisements for prescription drugs: what are Americans being sold?	LANCET			English	Article							JOURNALS; BENEFITS	Background Pharmaceutical companies spent US$1.8 billion on direct-to-consumer advertisements for prescription drugs in 1999. Our aim was to establish what messages are being communicated to the public by these advertisements. Methods We investigated the content of advertisements, which appeared in ten magazines in the USA. We examined seven issues of each of these published between July, 1998, and July, 1999. Findings 67 advertisements appeared a total of 211 times during our study. Of these, 133 (63%) were for drugs to ameliorate symptoms, 54 (26%) to treat disease, and 23 (11%) to prevent illness. In the 67 unique advertisements, promotional techniques used included emotional appeals (45, 67%) and encouragement of consumers to consider medical causes for their experiences (26, 39%). More advertisements described the benefit of medication with vague, qualitative terms (58, 87%), than with data (9, 13%). However, half the advertisements used data to describe side-effects, typically with lists of side-effects that generally occurred infrequently. None mentioned cost. Interpretation Provision of complete information about the benefit of prescription drugs in advertisements would serve the interests of physicians and the public.	Dept Vet Affairs Med Ctr, VA Outcomes Grp, White River Jct, VT 05009 USA; Dartmouth Coll Sch Med, Ctr Evaluat Clin Sci, Hanover, NH USA; Norris Cotton Canc Ctr, Lebanon, NH USA; Dartmouth Hitchcock Med Ctr, Dept Med, Lebanon, NH 03766 USA	VA Outcomes Group; Dartmouth College; Norris Cotton Cancer Center; Dartmouth College	Schwartz, LM (corresponding author), Dept Vet Affairs Med Ctr, VA Outcomes Grp, White River Jct, VT 05009 USA.				NATIONAL CANCER INSTITUTE [R18CA091052] Funding Source: NIH RePORTER; NCI NIH HHS [CA9 1052-01] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		*AM PHARM ASS, 1997, AM PHARM ASS PREV MA; Bell RA, 1999, J GEN INTERN MED, V14, P651, DOI 10.1046/j.1525-1497.1999.01049.x; Bell RA, 1999, J FAM PRACTICE, V48, P446; Bell RA, 2000, J FAM PRACTICE, V49, P1092; Charatan F, 2000, BRIT MED J, V321, P783, DOI 10.1136/bmj.321.7264.783; COHEN EP, 1988, NEW ENGL J MED, V318, P373, DOI 10.1056/NEJM198802113180608; Ferriman, 1999, BMJ, V319, P1208; *FOOD DRUGS ADM, 1985, FED REGISTER, V50, P36677; HAYNES RB, 1978, NEW ENGL J MED, V299, P741, DOI 10.1056/NEJM197810052991403; HERXHEIMER A, 1993, INT J HEALTH SERV, V23, P161, DOI 10.2190/1AK2-X8CX-QQ9E-F6ED; Hoffman JR, 1999, BRIT MED J, V318, P1301, DOI 10.1136/bmj.318.7194.1301; Hollon MF, 1999, JAMA-J AM MED ASSOC, V281, P382, DOI 10.1001/jama.281.4.382; HOMER A, 1999, JAMA-J AM MED ASSOC, V281, P380; Hueston WJ, 1997, ACAD MED, V72, P804, DOI 10.1097/00001888-199709000-00018; HUX JE, 1995, MED DECIS MAKING, V15, P152, DOI 10.1177/0272989X9501500208; Jones M, 1999, J CLIN PHARM THER, V24, P451, DOI 10.1046/j.1365-2710.1999.00255.x; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; LEXCHIN J, 1994, CAN MED ASSOC J, V151, P47; Lipsky MS, 1997, J FAM PRACTICE, V45, P495; Moynihan R, 2000, NEW ENGL J MED, V342, P1645, DOI 10.1056/NEJM200006013422206; *OFF MED POL, 2000, ATT BEH ASS DIR CONS; Pines WL, 1999, FOOD DRUG LAW J, V54, P489; Stryer D, 1996, J GEN INTERN MED, V11, P575, DOI 10.1007/BF02599024; TIMMINS N, FINANCIAL TIMES 0720, P200; *US C, 1984, STAFF REP PRESCR DRU; Wilkes MS, 2000, HEALTH AFFAIR, V19, P110, DOI 10.1377/hlthaff.19.2.110; 1998, LANCET, V351, P921; 2001, NUTR FACTS BOX; 2001, DIRECT CONSUMER ADVE; 1998, MEDIAMARK RES MAGAZI; 1996, CONSUMER REPORTS, V61, P62	31	131	132	1	10	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 6	2001	358	9288					1141	1146		10.1016/S0140-6736(01)06254-7	http://dx.doi.org/10.1016/S0140-6736(01)06254-7			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	479HM	11597668				2022-12-24	WOS:000171399000011
J	Wong, TY; Klein, R; Couper, DJ; Cooper, LS; Shahar, E; Hubbard, LD; Wofford, MR; Sharrett, AR				Wong, TY; Klein, R; Couper, DJ; Cooper, LS; Shahar, E; Hubbard, LD; Wofford, MR; Sharrett, AR			Retinal microvascular abnormalities and incident stroke: the atherosclerosis risk in communities study	LANCET			English	Article							JAPANESE PROVINCIAL CITY; BLOOD-PRESSURE; FOLLOW-UP; HYPERTENSION; RETINOPATHY; POPULATION; DISEASE; SHIBATA; COHORT	Background Retinal microvascular abnormalities reflect damage from hypertension and other vascular processes. We examined the relation of such abnormalities to incident stroke. Methods A cohort of 10 358 men and women (aged 51 to 72 years) living in four US communities underwent retinal photography and standard grading for retinal microvascular abnormalities. The calibres of all retinal arterioles and venules were measured after digital conversion of the photographs, and a summary arteriole-to-venule ratio (AVR) was calculated as an index of arteriolar narrowing (smaller AVR indicates greater narrowing). Cases of incident stroke admitted to hospital were identified and validated by case record reviews. Findings Over an average of 3.5 years, 110 participants had incident strokes. After adjustment for age, sex, race, 6-year mean arterial blood pressure, diabetes, and other stroke risk factors, most retinal microvascular characteristics were predictive of incident stroke, with adjusted relative risks of 2.58 (1.59-4.20) for any retinopathy, 3.11 (1.71-5.65) for microaneurysms, 3.08 (1.42-6.68) for soft exudates, 2.55 (1.27-5.14) for blot haemorrhages, 2.26 (1.00-5.12) for flame-shaped haemorrhages, and 1.60 (1.03-2.47) for arteriovenous nicking. The relative risk of stroke increased with decreasing AVR (p = 0.03). The associations were similar for ischaemic strokes specifically, and for strokes in individuals with hypertension, either with or without diabetes. Interpretation Retinal microvascular abnormalities are related to incident stroke. The findings support a microvascular role in the pathogenesis of stroke. They suggest that retinal photography may be useful for cerebrovascular-risk stratification in appropriate populations.	Univ Wisconsin, Dept Ophthalmol, Madison, WI 53705 USA; Natl Univ Singapore, Singapore Natl Eye Ctr, Singapore 117548, Singapore; Natl Univ Singapore, Dept Ophthalmol, Singapore 117548, Singapore; Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD USA; Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; NHLBI, Bethesda, MD 20892 USA; Univ Minnesota, Div Epidemiol, Minneapolis, MN 55455 USA; Univ Mississippi, Med Ctr, Div Hypertens, Jackson, MS 39216 USA	University of Wisconsin System; University of Wisconsin Madison; National University of Singapore; Singapore National Eye Center; National University of Singapore; Johns Hopkins University; University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Minnesota System; University of Minnesota Twin Cities; University of Mississippi; University of Mississippi Medical Center	Wong, TY (corresponding author), Univ Wisconsin, Dept Ophthalmol & Visual Sci, 610 N Walnut St,460 WARF, Madison, WI 53705 USA.	wong@epi.ophth.wisc.edu	Wong, Tien Yin/AAC-9724-2020	Wong, Tien Yin/0000-0002-8448-1264; Couper, David/0000-0002-4313-9235	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC055018, N01HC055020, N01HC035126, N01HC055016, N01HC055015, N01HC055021, N01HC035125, N01HC055022] Funding Source: NIH RePORTER; NHLBI NIH HHS [N01-HC-55021, N01-HC-55018, N01-HC-55020, N01-HC-55016, N01-HC-35126, N01-HC-55022, N01-HC-55015, N01-HC-35125] Funding Source: Medline; PHS HHS [N01-C-55019] Funding Source: Medline	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		AOKI N, 1975, JPN CIRC J, V39, P271, DOI 10.1253/jcj.39.271; DIMMITT SB, 1989, LANCET, V1, P1103; FUCHS FD, 1995, J HUM HYPERTENS, V9, P547; GARNER A, 1975, BRIT J OPHTHALMOL, V59, P3, DOI 10.1136/bjo.59.1.3; GOTO I, 1975, STROKE, V6, P263, DOI 10.1161/01.STR.6.3.263; Hubbard LD, 1999, OPHTHALMOLOGY, V106, P2269, DOI 10.1016/S0161-6420(99)90525-0; Jackson R, 1996, J CLIN EPIDEMIOL, V49, P1441, DOI 10.1016/0895-4356(95)00047-X; *JOINT NAT COMM PR, 1997, NIH PUBL; KAGAN A, 1966, B WORLD HEALTH ORGAN, V34, P955; Kahn HA, 1989, STAT METHODS EPIDEMI; KLEIN R, 1994, ARCH OPHTHALMOL-CHIC, V112, P92, DOI 10.1001/archopht.1994.01090130102026; Klein R, 2000, ARTERIOSCL THROM VAS, V20, P1644, DOI 10.1161/01.ATV.20.6.1644; KORBER N, 1986, J NEUROL, V233, P30, DOI 10.1007/BF00313988; Lammie GA, 1997, STROKE, V28, P2222, DOI 10.1161/01.STR.28.11.2222; Leppala JM, 1999, STROKE, V30, P2535, DOI 10.1161/01.STR.30.12.2535; Nakayama T, 1997, STROKE, V28, P45, DOI 10.1161/01.STR.28.1.45; OKADA H, 1976, STROKE, V7, P599, DOI 10.1161/01.STR.7.6.599; PARR JC, 1974, AM J OPHTHALMOL, V77, P472, DOI 10.1016/0002-9394(74)90457-7; PARR JC, 1974, AM J OPHTHALMOL, V77, P478, DOI 10.1016/0002-9394(74)90458-9; Rosamond WD, 1999, STROKE, V30, P736, DOI 10.1161/01.STR.30.4.736; SCHNEIDER R, 1993, STROKE, V24, P1874, DOI 10.1161/01.STR.24.12.1874; Shahar E, 1996, ANN EPIDEMIOL, V6, P498, DOI 10.1016/S1047-2797(96)00104-4; Sharrett AR, 1999, AM J EPIDEMIOL, V150, P263; SVARDSUDD K, 1978, ACTA MED SCAND, V204, P159; TANAKA H, 1985, STROKE, V16, P773, DOI 10.1161/01.STR.16.5.773; TSO MOM, 1982, OPHTHALMOLOGY, V89, P1132; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Wong TY, 2001, SURV OPHTHALMOL, V46, P59, DOI 10.1016/S0039-6257(01)00234-X	28	620	646	0	27	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 6	2001	358	9288					1134	1140		10.1016/S0140-6736(01)06253-5	http://dx.doi.org/10.1016/S0140-6736(01)06253-5			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	479HM	11597667				2022-12-24	WOS:000171399000010
J	Gabriel, JCP; Camerel, F; Lemaire, BJ; Desvaux, H; Davidson, P; Batail, P				Gabriel, JCP; Camerel, F; Lemaire, BJ; Desvaux, H; Davidson, P; Batail, P			Swollen liquid-crystalline lamellar phase based on extended solid-like sheets	NATURE			English	Article							SUSPENSIONS; MEMBRANES; DIAGRAM; SYSTEM	Ordering particles at the nanometre length scale is a challenging and active research area in materials science. Several approaches have so far been developed, ranging from the manipulation of individual particles(1,2) to the exploitation of self-assembly in colloids(3). Nanometre-scale ordering is well known to appear spontaneously when anisotropic organic moieties form liquid-crystalline phases; this behaviour is also observed for anisotropic mineral nanoparticles(4,5) resulting in the formation of nematic(4-7), smectic(8) and hexagonal(9,10) mesophases. Here we describe a lyotropic liquid-crystalline lamellar phase comprising an aqueous dispersion of planar solid-like sheets in which all the atoms involved in a layer are covalently bonded. The spacing of these phosphatoantimonate single layers can be increased 100-fold, resulting in one-dimensional structures whose periodicity can be tuned from 1.5 to 225 nanometres. These highly organized materials can be mechanically or magnetically aligned over large pH and temperature ranges, and this property can be used to measure residual dipolar couplings for the structure determination of biomolecules by liquid-state NMR. We also expect that our approach will result in the discovery of other classes of mineral lyotropic lamellar phases.	CNRS, FRE 2068, F-44322 Nantes 3, France; Univ Paris Sud, Phys Solides Lab, CNRS, UMR 8502, F-91405 Orsay, France; CEA Saclay, Serv Chim Mol, CNRS, URA 331, F-91191 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS)	Gabriel, JCP (corresponding author), CNRS, FRE 2068, 2 Rue Houssiniere,BP 32229, F-44322 Nantes 3, France.		Davidson, Patrick/Q-6691-2019; Davidson, Patrick/F-7874-2017; Gabriel, Jean-Christophe P/H-9959-2014	Davidson, Patrick/0000-0002-1363-6062; Davidson, Patrick/0000-0002-1363-6062; Gabriel, Jean-Christophe P/0000-0002-0194-683X; Lemaire, Bruno J./0000-0002-0227-0106				Blanco A, 2000, NATURE, V405, P437, DOI 10.1038/35013024; BOESECKE P, 1995, REV SCI INSTRUM, V66, P1636; Brown ABD, 1999, EUR PHYS J B, V11, P481, DOI 10.1007/s100510050959; DAVIDSON P, 1993, ADV MATER, V5, P665, DOI 10.1002/adma.19930050916; DERYAGUIN BV, 1941, ACTA PHYSICOCHIM USS, V14, P633; Desvaux H, 2001, ANGEW CHEM INT EDIT, V40, P373, DOI 10.1002/1521-3773(20010119)40:2<373::AID-ANIE373>3.0.CO;2-R; EIGLER DM, 1990, NATURE, V344, P524, DOI 10.1038/344524a0; Fang MM, 1999, CHEM MATER, V11, P1526, DOI 10.1021/cm981066k; Fraden S, 1995, NATO ADV SCI INST SE, V460, P113; Gabriel JCP, 1996, J PHYS CHEM-US, V100, P11139, DOI 10.1021/jp961088z; Gabriel JCP, 2000, ADV MATER, V12, P9, DOI 10.1002/(SICI)1521-4095(200001)12:1<9::AID-ADMA9>3.0.CO;2-6; JANIAK MJ, 1976, BIOCHEMISTRY-US, V15, P4575, DOI 10.1021/bi00666a005; KAJIWARA K, 1986, MAKROMOL CHEM, V187, P2883; Kaschak DM, 1998, J AM CHEM SOC, V120, P10887, DOI 10.1021/ja9818710; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; MAEDA Y, 1983, COLLOID SURFACE, V6, P1, DOI 10.1016/0166-6622(83)80001-8; Mourchid A, 1998, LANGMUIR, V14, P4718, DOI 10.1021/la980117p; NIKOOBAKHT B, 2000, J PHYS CHEM B, V104, P1346; PIFFARD Y, 1986, REV CHIM MINER, V23, P766; Poncharal P, 1999, SCIENCE, V283, P1513, DOI 10.1126/science.283.5407.1513; Ramirez BE, 1998, J AM CHEM SOC, V120, P9106, DOI 10.1021/ja982310b; SAFINYA CR, 1993, SCIENCE, V261, P588, DOI 10.1126/science.261.5121.588; SAFINYA CR, 1986, PHYS REV LETT, V57, P2718, DOI 10.1103/PhysRevLett.57.2718; Salditt T, 1999, PHYS REV E, V60, P7285, DOI 10.1103/PhysRevE.60.7285; Tjandra N, 1997, SCIENCE, V278, P1111, DOI 10.1126/science.278.5340.1111; TONER J, 1990, PHYS REV LETT, V64, P1741, DOI 10.1103/PhysRevLett.64.1741; van der Kooij FM, 2000, NATURE, V406, P868, DOI 10.1038/35022535; Verwey E. J. Y., 1948, THEORY STABILITY LYO; Whittingham MS, 1982, INTERCALATION CHEM	29	228	230	1	134	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 4	2001	413	6855					504	508		10.1038/35097046	http://dx.doi.org/10.1038/35097046			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	478HG	11586355	Green Published			2022-12-24	WOS:000171340500042
J	Farley, KA; Mukhopadhyay, S				Farley, KA; Mukhopadhyay, S			An extraterrestrial impact at the Permian-Triassic boundary?	SCIENCE			English	Editorial Material							EXTINCTION		CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA	California Institute of Technology	Farley, KA (corresponding author), CALTECH, Div Geol & Planetary Sci, MS 170-25, Pasadena, CA 91125 USA.	farley@gps.caltech.edu	Isozaki, Yukio/A-1806-2009; Farley, Kenneth/AAE-7735-2020	Isozaki, Yukio/0000-0002-3596-581X; Farley, Kenneth/0000-0002-7846-7546				ALVAREZ LW, 1980, SCIENCE, V208, P1095, DOI 10.1126/science.208.4448.1095; ANDREWS JN, 1985, CHEM GEOL, V49, P339, DOI 10.1016/0009-2541(85)90166-4; Becker L, 2001, SCIENCE, V291, P1530, DOI 10.1126/science.1057243; Bowring SA, 1998, SCIENCE, V280, P1039, DOI 10.1126/science.280.5366.1039; HEYMANN D, 1996, GEOL SOC AM SPEC PAP, V307, P453; Mukhopadhyay S, 2001, GEOCHIM COSMOCHIM AC, V65, P653, DOI 10.1016/S0016-7037(00)00555-X; ROBL TL, 1993, ORG GEOCHEM, V20, P249, DOI 10.1016/0146-6380(93)90042-A	7	75	80	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 28	2001	293	5539					2343	+						3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	476PD	11577203				2022-12-24	WOS:000171237200001
J	Brott, LL; Naik, RR; Pikas, DJ; Kirkpatrick, SM; Tomlin, DW; Whitlock, PW; Clarson, SJ; Stone, MO				Brott, LL; Naik, RR; Pikas, DJ; Kirkpatrick, SM; Tomlin, DW; Whitlock, PW; Clarson, SJ; Stone, MO			Ultrafast holographic nanopatterning of biocatalytically formed silica	NATURE			English	Article								Diatoms are of interest to the materials research community because of their ability to create highly complex and intricate silica structures under physiological conditions: what these single-cell organisms accomplish so elegantly in nature requires extreme laboratory conditions to duplicate(1,2) -this is true for even the simplest of structures. Following the identification of polycationic peptides from the diatom Cylindrotheca fusiformis, simple silica nanospheres can now be synthesized in vitro from silanes at nearly neutral pH and at ambient temperatures and pressures(3,4). Here we describe a method for creating a hybrid organic/inorganic ordered nanostructure of silica spheres through the incorporation of a polycationic peptide (derived from the C. fusiformis silaffin-1 protein) into a polymer hologram created by two-photon-induced photopolymerization. When these peptide nanopatterned holographic structures are exposed to a silicic acid, an ordered array of silica nanospheres is deposited onto the clear polymer substrate. These structures exhibit a nearly fifty-fold increase in diffraction efficiency over a comparable polymer hologram without silica. This approach, combining the ease of processability of an organic polymer with the improved mechanical and optical properties of an inorganic material, could be of practical use for the fabrication of photonic devices.	USAF, Res Lab, Mat & Mfg Directorate, Wright Patterson AFB, OH 45433 USA; Univ Cincinnati, Dept Mat Sci & Engn, Cincinnati, OH 45221 USA	United States Department of Defense; United States Air Force; US Air Force Research Laboratory; University System of Ohio; University of Cincinnati	Stone, MO (corresponding author), USAF, Res Lab, Mat & Mfg Directorate, 3005 P St, Wright Patterson AFB, OH 45433 USA.							Belfield KD, 2000, J PHYS ORG CHEM, V13, P837, DOI 10.1002/1099-1395(200012)13:12<837::AID-POC315>3.0.CO;2-5; BROTT LL, 2001, POLYM PREPRINTS, V42, P675; BUNNING TJ, 1995, POLYMER, V36, P2699, DOI 10.1016/0032-3861(95)93646-4; Cha JN, 2000, NATURE, V403, P289, DOI 10.1038/35002038; Kirkpatrick SM, 1999, APPL PHYS A-MATER, V69, P461, DOI 10.1007/s003390051033; Kroger N, 1999, SCIENCE, V286, P1129, DOI 10.1126/science.286.5442.1129; Kroger N, 2001, J BIOL CHEM, V276, P26066, DOI 10.1074/jbc.M102093200; Morse DE, 1999, TRENDS BIOTECHNOL, V17, P230, DOI 10.1016/S0167-7799(99)01309-8; Parkinson J, 1999, TRENDS BIOTECHNOL, V17, P190, DOI 10.1016/S0167-7799(99)01321-9; Wang C, 2000, CHEM MATER, V12, P3662, DOI 10.1021/cm990738j	10	209	226	2	77	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 20	2001	413	6853					291	293		10.1038/35095031	http://dx.doi.org/10.1038/35095031			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473KB	11565027				2022-12-24	WOS:000171040500034
J	Boulay, F; Berthier, F; Schoukroun, G; Raybaut, C; Gendreike, Y; Blaive, B				Boulay, F; Berthier, F; Schoukroun, G; Raybaut, C; Gendreike, Y; Blaive, B			Seasonal variations in hospital admission for deep vein thrombosis and pulmonary embolism: analysis of discharge data	BRITISH MEDICAL JOURNAL			English	Article									Nice Teaching Hosp, Dept Resp Med, F-06003 Nice 1, France; Nice Teaching Hosp, Dept Publ Hlth & Med Informat, F-06003 Nice, France	CHU Nice; CHU Nice	Boulay, F (corresponding author), Nice Teaching Hosp, Dept Publ Hlth & Med Informat, BP 1179, F-06003 Nice 1, France.							Allan TM, 1996, BRIT MED J, V312, P1227; Bounameaux H, 1996, BMJ-BRIT MED J, V312, P284; Oger E, 2000, THROMB HAEMOSTASIS, V83, P657; ROGER JH, 1977, BIOMETRIKA, V64, P152, DOI 10.2307/2335789; WOODHOUSE PR, 1994, LANCET, V343, P435, DOI 10.1016/S0140-6736(94)92689-1	5	77	79	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 15	2001	323	7313					601	602		10.1136/bmj.323.7313.601	http://dx.doi.org/10.1136/bmj.323.7313.601			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	474CT	11557707	Bronze, Green Published			2022-12-24	WOS:000171087300018
J	Cowan, CA; Henkemeyer, M				Cowan, CA; Henkemeyer, M			The SH2/SH3 adaptor Grb4 transduces B-ephrin reverse signals	NATURE			English	Article							ABL TRANSFORMING ACTIVITY; CENTRAL-NERVOUS-SYSTEM; TYROSINE KINASE; TRANSMEMBRANE LIGANDS; BINDING PROTEINS; SH3 DOMAIN; NCK; RECEPTORS; CATENIN; PATHWAY	Bidirectional signals mediated by membrane-anchored ephrins and Eph receptor tyrosine kinases have important functions in cell-cell recognition events, including those that occur during axon pathfinding(1,2) and hindbrain segmentation(3,4). The reverse signal that is transduced into B-ephrin-expressing cells is thought to involve tyrosine phosphorylation of the signal's short, conserved carboxy-terminal cytoplasmic domain(5,6). The Src-homology-2 (SH2) domain proteins that associate with activated tyrosine-phosphorylated B-subclass ephrins have not been identified, nor has a defined cellular response to reverse signals been described. Here we show that the SH2/SH3 domain adaptor protein Grb4 binds to the cytoplasmic domain of B ephrins in a phosphotyrosine-dependent manner. In response to B-ephrin reverse signalling, cells increase FAK catalytic activity, redistribute paxillin, lose focal adhesions, round up, and disassemble F-actin-containing stress fibres. These cellular responses can be blocked in a dominant-negative fashion by expression of the isolated Grb4 SH2 domain. The Grb4 SH3 domains bind a unique set of other proteins that are implicated in cytoskeletal regulation, including the Cbl-associated protein (CAP/ponsin), the Abl-interacting protein-1 (Abi-1), dynamin, PAK1, hnRNPK and axin. These data provide a biochemical pathway whereby cytoskeletal regulators are recruited to Eph-ephrin bidirectional signalling complexes.	Univ Texas, SW Med Ctr, Ctr Dev Biol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Kent Waldrep Fdn Ctr Basic Res Nerve Growth & Reg, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Henkemeyer, M (corresponding author), Univ Texas, SW Med Ctr, Ctr Dev Biol, Dallas, TX 75390 USA.			Henkemeyer, Mark/0000-0002-7525-1061				Asakura T, 1999, GENES CELLS, V4, P573, DOI 10.1046/j.1365-2443.1999.00283.x; Birgbauer E, 2000, DEVELOPMENT, V127, P1231; Bruckner K, 1997, SCIENCE, V275, P1640, DOI 10.1126/science.275.5306.1640; BUSTELO XR, 1995, MOL CELL BIOL, V15, P1324; Chen M, 1998, J BIOL CHEM, V273, P25171, DOI 10.1074/jbc.273.39.25171; Chen M, 2000, MOL CELL BIOL, V20, P7867, DOI 10.1128/MCB.20.21.7867-7880.2000; DAI ZH, 1995, GENE DEV, V9, P2569, DOI 10.1101/gad.9.21.2569; Davy A, 1999, GENE DEV, V13, P3125, DOI 10.1101/gad.13.23.3125; FRADKIN LG, 1995, DEV BIOL, V168, P202, DOI 10.1006/dbio.1995.1072; Garrity PA, 1996, CELL, V85, P639, DOI 10.1016/S0092-8674(00)81231-3; George SE, 1998, CELL, V92, P633, DOI 10.1016/S0092-8674(00)81131-9; Hamada F, 1999, SCIENCE, V283, P1739, DOI 10.1126/science.283.5408.1739; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; HOBERT O, 1994, J BIOL CHEM, V269, P20225; Holland SJ, 1996, NATURE, V383, P722, DOI 10.1038/383722a0; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Keegan K, 1996, ONCOGENE, V12, P1537; Kurakin A, 1998, J PEPT RES, V52, P331; Loureiro J, 1998, CURR BIOL, V8, P622, DOI 10.1016/S0960-9822(98)70249-0; Lu WG, 1997, CURR BIOL, V7, P85, DOI 10.1016/S0960-9822(06)00052-2; Mandai K, 1999, J CELL BIOL, V144, P1001, DOI 10.1083/jcb.144.5.1001; MARGOLIS B, 1992, P NATL ACAD SCI USA, V89, P8894, DOI 10.1073/pnas.89.19.8894; Mellitzer G, 1999, NATURE, V400, P77, DOI 10.1038/21907; REN RB, 1993, SCIENCE, V259, P1157, DOI 10.1126/science.8438166; Ribon V, 1998, J BIOL CHEM, V273, P4073, DOI 10.1074/jbc.273.7.4073; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; SHI YG, 1995, GENE DEV, V9, P2583, DOI 10.1101/gad.9.21.2583; Tu YZ, 1998, MOL BIOL CELL, V9, P3367, DOI 10.1091/mbc.9.12.3367; Wunderlich L, 1999, CELL SIGNAL, V11, P25, DOI 10.1016/S0898-6568(98)00027-8; Xu QL, 1999, NATURE, V399, P267, DOI 10.1038/20452; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4	31	278	284	0	7	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 13	2001	413	6852					174	179		10.1038/35093123	http://dx.doi.org/10.1038/35093123			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471FU	11557983				2022-12-24	WOS:000170918800049
J	Lapostolle, F; Surget, V; Borron, SW; Desmaizieres, M; Sordelet, D; Lapandry, C; Cupa, M; Adnet, F				Lapostolle, F; Surget, V; Borron, SW; Desmaizieres, M; Sordelet, D; Lapandry, C; Cupa, M; Adnet, F			Severe pulmonary embolism associated with air travel	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ECONOMY-CLASS SYNDROME; THROMBOEMBOLIC DISEASE; VENOUS THROMBOEMBOLISM; RISK-FACTORS; THROMBOSIS; FLIGHTS	Background Air travel is believed to be a risk factor for pulmonary embolism, but the relation between pulmonary embolism and distance flown has not been documented. The aim of this study was to investigate whether the duration of air travel is related to the risk of pulmonary embolism. Methods From November 1993 to December 2000, we systematically reviewed all cases of pulmonary embolism requiring medical care on arrival at France's busiest international airport. Data on the geographic origins of all flights and the numbers of passengers were collected in order to evaluate the incidence of pulmonary embolism per million passenger arrivals as a function of the distance traveled. Results A total of 135.29 million passengers from 145 countries or other areas arrived at Charles de Gaulle Airport during the period of the study, of whom 56 had confirmed pulmonary embolism. The incidence of pulmonary embolism was much higher among passengers traveling more than 5000 km (3100 mi) (1.5 cases per million, as compared with 0.01 case per million among those traveling less than 5000 km). The incidence of pulmonary embolism was 4.8 cases per million for those traveling more than 10,000 km (6200 mi). Conclusions A greater distance traveled is a significant contributing risk factor for pulmonary embolism associated with air travel. (N Engl J Med 2001; 345: 779-83.) Copyright (C) 2001 Massachusetts Medical Society.	Univ Paris 13, SAMU 93, Hop Avicenne, F-93009 Bobigny, France; George Washington Univ, Sch Med, Dept Emergency Med, Washington, DC USA; George Washington Univ, Sch Med, Div Occupat & Environm Hlth, Washington, DC USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13; George Washington University; George Washington University	Lapostolle, F (corresponding author), Univ Paris 13, SAMU 93, Hop Avicenne, 125 Rue Stalingrad, F-93009 Bobigny, France.	frederic.lapostolle@avc.ap-hop-paris.fr						BEIGHTON PH, 1968, BRIT HEART J, V30, P367; BENOIT R, 1992, J MAL VASCUL, V17, P84; CRUICKSHANK JM, 1988, LANCET, V2, P497, DOI 10.1016/S0140-6736(88)90134-1; DRUILHE L, 1994, J MED LEG DROIT MED, V37, P429; Eklof B, 1996, DERMATOL SURG, V22, P637, DOI 10.1111/j.1524-4725.1996.tb00610.x; Ferrari E, 1999, CHEST, V115, P440, DOI 10.1378/chest.115.2.440; Ferriman A, 2000, BRIT MED J, V321, P1310, DOI 10.1136/bmj.321.7272.1310; FINCH PJ, 1988, LANCET, V2, P1025; Geroulakos G, 2001, BRIT MED J, V322, P188, DOI 10.1136/bmj.322.7280.188; GOBIN JP, 1994, ARTERES VEINES, V13, P5; Goldhaber SZ, 1998, NEW ENGL J MED, V339, P93, DOI 10.1056/NEJM199807093390207; Heit JA, 2000, ARCH INTERN MED, V160, P809, DOI 10.1001/archinte.160.6.809; HOMANS J, 1954, NEW ENGL J MED, V250, P148, DOI 10.1056/NEJM195401282500404; KIEFFER B, 1989, MED AERONAUTIQUE SPA, V28, P300; LANDGRAF H, 1994, AVIAT SPACE ENVIR MD, V65, P930; LEDERMANN JA, 1983, POSTGRAD MED J, V59, P104, DOI 10.1136/pgmj.59.688.104; LEVY Y, 1995, ISRAEL J MED SCI, V31, P621; MARSEPOIL T, 1991, PRESSE MED, V20, P383; Mercer A, 1998, AVIAT SPACE ENVIR MD, V69, P154; MILLER GAH, 1971, BRIT MED J, V2, P681, DOI 10.1136/bmj.2.5763.681; MILLS FJ, 1983, BMJ-BRIT MED J, V286, P1131, DOI 10.1136/bmj.286.6371.1131; MOYSES C, 1987, INT J MICROCIRC, V5, P311; Nissen P, 1997, VASA-J VASCULAR DIS, V26, P239; NODDELAND H, 1988, EUR J APPL PHYSIOL O, V57, P409, DOI 10.1007/BF00417985; Paganin F, 1996, LANCET, V347, P1195, DOI 10.1016/S0140-6736(96)90659-5; Ribeiro A, 1997, AM HEART J, V134, P479, DOI 10.1016/S0002-8703(97)70085-1; Ribier G, 1997, REV MED INTERNE, V18, P601, DOI 10.1016/S0248-8663(97)82460-5; Rosendaal FR, 1999, THROMB HAEMOSTASIS, V82, P610; SARVESVARAN R, 1986, MED SCI LAW, V26, P35, DOI 10.1177/002580248602600108; Satoh A, 1998, Nihon Kokyuki Gakkai Zasshi, V36, P524; Simon R, 1999, WIEN KLIN WOCHENSCHR, V111, P596; Sinzinger H, 1999, VASA-J VASCULAR DIS, V28, P199, DOI 10.1024/0301-1526.28.3.199; SYMINGTON IS, 1977, BRIT J DIS CHEST, V71, P138, DOI 10.1016/0007-0971(77)90097-3; VOLLSET SE, 1993, STAT MED, V12, P809, DOI 10.1002/sim.4780120902; 1985, LANCET, V1, P353; 1988, LANCET, V2, P797	36	260	274	2	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 13	2001	345	11					779	783		10.1056/NEJMoa010378	http://dx.doi.org/10.1056/NEJMoa010378			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	471BK	11556296				2022-12-24	WOS:000170906800001
J	Fortnum, HM; Summerfield, AQ; Marshall, DH; Davis, AC; Bamford, JM				Fortnum, HM; Summerfield, AQ; Marshall, DH; Davis, AC; Bamford, JM			Prevalence of permanent childhood hearing impairment in the United Kingdom and implications for universal neonatal hearing screening: questionnaire based ascertainment study	BRITISH MEDICAL JOURNAL			English	Article							EARLY IDENTIFICATION; EPIDEMIOLOGY; CHILDREN; INTERVENTION	Objective To estimate the prevalence of confirmed permanent childhood hearing impairment and its profile across age and degree of impairment in the United Kingdom. Design Retrospective total ascertainment through sources in the health and education sectors by postal questionnaire. Setting Hospital based otology and audiology departments, community health clinics, education services for hearing impaired children. Participants Children born from 1980 to 1995, resident in United Kingdom in 1998, with permanent childhood hearing impairment (hearing level in the better ear >40 dB averaged over 0.5,1, 2, and 4 kHz). Main outcome measures Numbers of cases with date of birth and severity of impairment converted to prevalences for each annual birth cohort (cases/1000 live births) and adjusted for underascertainment. Results 26000 notifications ascertained 17160 individual children. Prevalence rose from 0.91 (95% confidence interval 0.85 to 0.98) for 3 year olds to 1.65 (1.62 to 1.68) for children aged 9-16 years. Adjustment for underascertainment increased estimates to 1.07 (1.03 to 1.12) and 2.05 (2.02 to 2.08). Comparison With previous studies showed that prevalence increases with age, rather than declining With year of birth. Conclusions Prevalence of confirmed permanent childhood hearing impairment increases until the age of 9 years to a level higher than previously estimated. Relative to current yields of universal neonatal hearing screening mi the United Kingdom, which are close to 1/1000 live births, 50-90% more children are diagnosed with permanent childhood hearing impairment by the age of 9 years. Paediatric audiology services must have the capacity to achieve early identification and confirmation of these additional cases.	MRC, Inst Hearing Res, Nottingham NG7 2RD, England; Univ Manchester, Human Commun & Deafness Grp, Manchester M13 9PL, Lancs, England	University of Manchester	Fortnum, HM (corresponding author), MRC, Inst Hearing Res, Univ Pk, Nottingham NG7 2RD, England.		Davis, Adrian C/E-6022-2015	Davis, Adrian C/0000-0001-7134-7528				Bloor M, 2000, J Health Serv Res Policy, V5, P89; British Society of Audiology, 1988, BRIT J AUDIOL, V22, P123, DOI DOI 10.3109/03005368809077807; Cheng AK, 2000, JAMA-J AM MED ASSOC, V284, P850, DOI 10.1001/jama.284.7.850; Conrad R., 1979, DEAF SCHOOLCHILD LAN; Cormack RM, 1999, J CLIN EPIDEMIOL, V52, P909, DOI 10.1016/S0895-4356(99)00058-X; Dalzell L, 2000, EAR HEARING, V21, P118, DOI 10.1097/00003446-200004000-00006; Davis A, 1997, HEALTH TECHNOL ASSES, V1, P1; Davis A., 1993, J AUDIOL MED, V3, P35; DAVIS A, 1997, HEALTH TECHNOL ASSES, V1, P10; *DEP HLTH, 2001, PIL INTR UN NEON HEA; Downs MP, 1999, PEDIATR CLIN N AM, V46, P79, DOI 10.1016/S0031-3955(05)70082-1; Fortnum H, 1997, BRIT J AUDIOL, V31, P409, DOI 10.3109/03005364000000037; Gregory S, 1995, DEAF CHILDREN THEIR; Kennedy CR, 1999, ACTA PAEDIATR, V88, P73, DOI 10.1080/080352599750029448; LAPORTE RE, 1992, LANCET, V339, P494, DOI 10.1016/0140-6736(92)91103-F; Maki-Torkko EM, 1998, SCAND AUDIOL, V27, P95, DOI 10.1080/010503998420333; Mohr PE, 2000, INT J TECHNOL ASSESS, V16, P1120, DOI 10.1017/S0266462300103162; *NHS EX, 2001, LAUNCH PIL PROJ PROV; *NIH, 1993, AM FAM PHYSICIAN, V48, P521; *OFF NAT STAT, 1999, POP TRENDS SUMM 1992; *OFF NAT STAT, 1999, POP TRENDS SUMM 1999; Steel KP, 2000, BRIT MED J, V320, P622, DOI 10.1136/bmj.320.7235.622; Uus K, 2000, AUDIOLOGY, V39, P192; Van Naarden K, 1999, PEDIATRICS, V103, P570, DOI 10.1542/peds.103.3.570; VANCAMP G, 2001, HEREDITARY HEARING L; Watkin PM, 1999, ARCH DIS CHILD, V81, P380, DOI 10.1136/adc.81.5.380; WOOD D, 1986, TEACHING TALKING DEA; YIP PSF, 1995, AM J EPIDEMIOL, V142, P1047	28	278	300	1	24	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 8	2001	323	7312					536	539		10.1136/bmj.323.7312.536	http://dx.doi.org/10.1136/bmj.323.7312.536			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	471NC	11546698	Bronze, Green Published			2022-12-24	WOS:000170934600018
J	Gibbs, MJ; Armstrong, JS; Gibbs, AJ				Gibbs, MJ; Armstrong, JS; Gibbs, AJ			Recombination in the hemagglutinin gene of the 1918 "Spanish flu"	SCIENCE			English	Article							INFLUENZA-VIRUS; EVOLUTION; SEQUENCE; ORIGIN	When gene sequences from the influenza virus that caused the 1918 pandemic were first compared with those of related viruses, they yielded few clues about its origins and virulence. Our reanalysis indicates that the hemagglutinin gene, a key virulence determinant, originated by recombination. The "globular domain" of the 1918 hemagglutinin protein was encoded by a part of a gene derived from a swine-lineage influenza, whereas the "stalk" was encoded by parts derived from a human-lineage influenza. Phylogenetic analyses showed that this recombination, which probably changed the virulence of the virus, occurred at the start of, or immediately before, the pandemic and thus may have triggered it.	Australian Natl Univ, Fac Sci, Div Bot & Zool, Canberra, ACT 2601, Australia	Australian National University	Gibbs, AJ (corresponding author), Australian Natl Univ, Fac Sci, Div Bot & Zool, Canberra, ACT 2601, Australia.	mark.gibbs@anu.edu.au						Anderson JP, 2000, J VIROL, V74, P10752, DOI 10.1128/JVI.74.22.10752-10765.2000; Basler CF, 2001, P NATL ACAD SCI USA, V98, P2746, DOI 10.1073/pnas.031575198; BEKLEMISHEV AB, 1993, MOL GEN MIKROBIOL VI, V1, P24; BERGMANN M, 1992, J VIROL, V66, P7576, DOI 10.1128/JVI.66.12.7576-7580.1992; BIKOUR MH, 1995, J GEN VIROL, V76, P2539, DOI 10.1099/0022-1317-76-10-2539; CROSBY AW, 1989, AM FORGOTTEN PLAGUE; FIELDS S, 1982, CELL, V28, P303, DOI 10.1016/0092-8674(82)90348-8; Garcia M, 1996, J GEN VIROL, V77, P1493, DOI 10.1099/0022-1317-77-7-1493; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; Gibbs MJ, 1999, P NATL ACAD SCI USA, V96, P8022, DOI 10.1073/pnas.96.14.8022; GORMAN OT, 1991, J VIROL, V65, P3704, DOI 10.1128/JVI.65.7.3704-3714.1991; Holmes EC, 1999, MOL BIOL EVOL, V16, P405, DOI 10.1093/oxfordjournals.molbev.a026121; Huson DH, 1998, BIOINFORMATICS, V14, P68, DOI 10.1093/bioinformatics/14.1.68; KHATCHIKIAN D, 1989, NATURE, V340, P156, DOI 10.1038/340156a0; KILBOURNE ED, 1977, JAMA-J AM MED ASSOC, V237, P1225, DOI 10.1001/jama.237.12.1225; Lederberg J, 2001, P NATL ACAD SCI USA, V98, P2115, DOI 10.1073/pnas.051000798; Pita JS, 2001, J GEN VIROL, V82, P655, DOI 10.1099/0022-1317-82-3-655; Reid AH, 2000, P NATL ACAD SCI USA, V97, P6785, DOI 10.1073/pnas.100140097; Reid AH, 1999, P NATL ACAD SCI USA, V96, P1651, DOI 10.1073/pnas.96.4.1651; SCHOLTISSEK C, 1993, ARCH VIROL, V131, P237, DOI 10.1007/BF01378629; Shope RE, 1936, J EXP MED, V63, P669, DOI 10.1084/jem.63.5.669; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Strimmer K, 1996, MOL BIOL EVOL, V13, P964, DOI 10.1093/oxfordjournals.molbev.a025664; Subbarao K, 1998, SCIENCE, V279, P393, DOI 10.1126/science.279.5349.393; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Taubenberger JK, 2000, VIROLOGY, V274, P241, DOI 10.1006/viro.2000.0495; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Webster RG, 1999, P NATL ACAD SCI USA, V96, P1164, DOI 10.1073/pnas.96.4.1164; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; WILEY DC, 1987, ANNU REV BIOCHEM, V56, P365, DOI 10.1146/annurev.biochem.56.1.365; Worobey M, 1999, P NATL ACAD SCI USA, V96, P7352, DOI 10.1073/pnas.96.13.7352	31	97	116	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2001	293	5536					1842	1845		10.1126/science.1061662	http://dx.doi.org/10.1126/science.1061662			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	470WN	11546876				2022-12-24	WOS:000170894400051
J	Xiang, JH; Wunschmann, S; Diekema, DJ; Klinzman, D; Patrick, KD; George, SL; Stapleton, JT				Xiang, JH; Wunschmann, S; Diekema, DJ; Klinzman, D; Patrick, KD; George, SL; Stapleton, JT			Effect of coinfection with GB virus C on survival among patients with HIV infection.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEPATITIS-G VIRUS; INTERFERON-ALPHA THERAPY; TYPE-1 REPLICATION; HIGH PREVALENCE; T-CELLS; PROGRESSION; DISEASE; RNA; ASSOCIATION; INHIBITION	Background: Previous studies have suggested that people with human immunodeficiency virus (HIV) infection who are coinfected with GB virus C (GBV-C, or hepatitis G virus) have delayed progression of HIV disease. GBV-C is related to hepatitis C virus but does not appear to cause liver disease. Methods: We examined the effect of coinfection with GBV-C on the survival of patients with HIV infection. We also evaluated cultures of peripheral-blood mononuclear cells infected with both viruses to determine whether GBV-C infection alters replication in vitro. Results: Of 362 HIV-infected patients, 144 (39.8 percent) had GBV-C viremia in two tests. Forty-one of the patients with GBV-C viremia (28.5 percent) died during the follow-up period, as compared with 123 of the 218 patients who tested negative for GBV-C RNA (56.4 percent; P<0.001). The mean duration of follow-up for the entire cohort was 4.1 years. In a Cox regression analysis adjusted for HIV treatment, base-line CD4+ T-cell count, age, sex, race, and mode of transmission of HIV, the mortality rate among the 218 HIV-infected patients without GBV-C coinfection was significantly higher than that among the 144 patients with GBV-C coinfection (relative risk, 3.7; 95 percent confidence interval, 2.5 to 5.4). HIV replication, as measured by the detection of p24 antigen in culture supernatants, was reproducibly inhibited in cultures of peripheral-blood mononuclear cells by GBV-C coinfection. Coinfection did not alter the surface expression of HIV cellular receptors on peripheral-blood mononuclear cells, as determined by flow cytometry. Conclusions: GBV-C infection is common in people with HIV infection and is associated with significantly improved survival.	Univ Iowa, Coll Med, Dept Internal Med, SW 54,GH UIHC, Iowa City, IA 52242 USA; Vet Affairs Med Ctr, Dept Internal Med, Iowa City, IA 52242 USA; Vet Affairs Med Ctr, Dept Res, Iowa City, IA 52242 USA; Helen C Levitt Ctr Viral Pathogenesis & Dis, Iowa City, IA USA	University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Stapleton, JT (corresponding author), Univ Iowa, Coll Med, Dept Internal Med, SW 54,GH UIHC, 200 Hawkins Dr, Iowa City, IA 52242 USA.			Diekema, Daniel/0000-0003-1273-0724; Stapleton, Jack/0000-0002-2302-9055; George, Sarah/0000-0002-9699-1042	NIAAA NIH HHS [R01 AA12671] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA012671] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Alter HJ, 1997, TRANSFUSION, V37, P569, DOI 10.1046/j.1537-2995.1997.37697335149.x; Alter HJ, 1997, NEW ENGL J MED, V336, P747, DOI 10.1056/NEJM199703133361102; Alter MJ, 1997, NEW ENGL J MED, V336, P741, DOI 10.1056/NEJM199703133361101; Asada H, 1999, J VIROL, V73, P4019, DOI 10.1128/JVI.73.5.4019-4028.1999; Cook RT, 1997, J INVEST MED, V45, P265; COX DR, 1972, J R STAT SOC B, V34, P187; Dawson GJ, 1996, J MED VIROL, V50, P97, DOI 10.1002/(SICI)1096-9071(199609)50:1&lt;97::AID-JMV16&gt;3.0.CO;2-V; Elvander M, 1998, ACTA VET SCAND, V39, P251; Fisher L, 1993, BIOSTATISTICS METHOD; Fogeda M, 1999, J VIROL, V73, P4052, DOI 10.1128/JVI.73.5.4052-4061.1999; Haas DW, 2000, AIDS RES HUM RETROV, V16, P183, DOI 10.1089/088922200309278; Heringlake S, 1998, J INFECT DIS, V177, P1723, DOI 10.1086/517431; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Lau DTY, 1999, J INFECT DIS, V180, P1334, DOI 10.1086/315031; Lefrere JJ, 1999, J INFECT DIS, V179, P783, DOI 10.1086/314671; Linnen J, 1996, SCIENCE, V271, P505, DOI 10.1126/science.271.5248.505; Nerurkar VR, 1998, J MED VIROL, V56, P123, DOI 10.1002/(SICI)1096-9071(199810)56:2&lt;123::AID-JMV4&gt;3.0.CO;2-A; Pessoa MG, 1998, HEPATOLOGY, V27, P877, DOI 10.1002/hep.510270335; Pinto LA, 2000, J VIROL, V74, P4505, DOI 10.1128/JVI.74.10.4505-4511.2000; Rey D, 2000, EUR J CLIN MICROBIOL, V19, P721, DOI 10.1007/s100960000352; RINALDO CR, 1976, INFECT IMMUN, V14, P660, DOI 10.1128/IAI.14.3.660-666.1976; Rowland-Jones S, 1999, J INFECTION, V38, P67, DOI 10.1016/S0163-4453(99)90070-1; SHIRAZI Y, 1993, VIROLOGY, V193, P303, DOI 10.1006/viro.1993.1126; SIMONS JN, 1995, NAT MED, V1, P564, DOI 10.1038/nm0695-564; Theodore D, 1997, HEPATOLOGY, V25, P1285, DOI 10.1002/hep.510250541; Thomas DL, 1998, J INFECT DIS, V177, P539, DOI 10.1086/514245; Toyoda H, 1998, J ACQ IMMUN DEF SYND, V17, P209, DOI 10.1097/00042560-199803010-00004; Wunschmann S, 2000, J CLIN MICROBIOL, V38, P3055; Wunschmann S, 2000, J VIROL, V74, P10055, DOI 10.1128/JVI.74.21.10055-10062.2000; XIANG J, 1999, J VIRAL HEPAT S1, V6, P6; Xiang JH, 1998, J VIROL, V72, P2738, DOI 10.1128/JVI.72.4.2738-2744.1998; Xiang JH, 2000, J VIROL, V74, P9125, DOI 10.1128/JVI.74.19.9125-9133.2000; Yeo AET, 2000, ANN INTERN MED, V132, P959, DOI 10.7326/0003-4819-132-12-200006200-00006; 1989, MMWR MORB MORTAL S5, V38, P1	34	289	305	0	3	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 6	2001	345	10					707	714		10.1056/NEJMoa003364	http://dx.doi.org/10.1056/NEJMoa003364			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	468RX	11547739				2022-12-24	WOS:000170772900001
J	Dinner, AR; Blackburn, GM; Karplus, M				Dinner, AR; Blackburn, GM; Karplus, M			Uracil-DNA glycosylase acts by substrate autocatalysis	NATURE			English	Article							HYDROGEN-BOND; ENERGY; MECHANISM; CATALYSIS; DYNAMICS; REPAIR; NMR; SIMULATION; ENZYME	In humans, uracil appears in DNA at the rate of several hundred bases per cell each day as a result of misincorporation of deoxyuridine (dU) or deamination of cytosine. Four enzymes that catalyse the hydrolysis of the glycosylic bond of dU in DNA to yield an apyridiminic site as the first step in base excision repair have been identified in the human genome(1). The most efficient and well characterized of these uracil-DNA glycosylases is UDG (also known as UNG and present in almost all known organisms)(2), which excises U from single- or double-stranded DNA and is associated with DNA replication forks(3). We used a hybrid quantum-mechanical/molecular-mechanical (QM/MM) approach(4) to determine the mechanism of catalysis by UDG. In contrast to the concerted associative mechanism proposed initially (5-10), we show here that the reaction proceeds in a stepwise dissociative manner(11,12). Cleavage of the glycosylic bond yields an intermediate comprising an oxocarbenium cation and a uracilate anion. Subsequent attack by a water molecule and transfer of a proton to D145 result in the products. Surprisingly, the primary contribution to lowering the activation energy comes from the substrate, rather than from the enzyme. This 'autocatalysis' derives from the burial and positioning of four phosphate groups that stabilize the rate-determining transition state. The importance of these phosphates explains the residual activity observed for mutants that lack key residues(6-9). A corresponding catalytic mechanism could apply to the DNA glycosylases TDG and SMUG1, which belong to the same structural superfamily as UDG(13,14).	Univ Oxford, Cent Chem Lab, Oxford OX1 3QH, England; Univ Sheffield, Krebs Inst, Dept Chem, Sheffield S3 7HF, S Yorkshire, England; Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA; Univ Strasbourg, ISIS, Lab Chim Biophys, F-67000 Strasbourg, France	University of Oxford; University of Sheffield; Harvard University; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Karplus, M (corresponding author), Univ Oxford, Cent Chem Lab, S Parks Rd, Oxford OX1 3QH, England.	marci@tammy.harvard.edu						BASH PA, 1991, BIOCHEMISTRY-US, V30, P5826, DOI 10.1021/bi00238a003; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Chen XY, 2000, J AM CHEM SOC, V122, P6527, DOI 10.1021/ja992751a; Desiraju GR, 1996, ACCOUNTS CHEM RES, V29, P441, DOI 10.1021/ar950135n; DEWAR MJS, 1985, J AM CHEM SOC, V107, P3902, DOI 10.1021/ja00299a024; Drohat AC, 2000, BIOCHEMISTRY-US, V39, P11865, DOI 10.1021/bi000922e; Drohat AC, 1999, BIOCHEMISTRY-US, V38, P11876, DOI 10.1021/bi9910880; Drohat AC, 1999, BIOCHEMISTRY-US, V38, P11866, DOI 10.1021/bi9910878; Drohat AC, 2000, J AM CHEM SOC, V122, P1840, DOI 10.1021/ja993254x; FIELD MJ, 1990, J COMPUT CHEM, V11, P700, DOI 10.1002/jcc.540110605; Haushalter KA, 1999, CURR BIOL, V9, P174, DOI 10.1016/S0960-9822(99)80087-6; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MACKERELL AD, 1995, J AM CHEM SOC, V117, P11946, DOI 10.1021/ja00153a017; Mol CD, 1999, ANNU REV BIOPH BIOM, V28, P101, DOI 10.1146/annurev.biophys.28.1.101; Nilsen H, 2000, MOL CELL, V5, P1059, DOI 10.1016/S1097-2765(00)80271-3; Parikh SS, 2000, P NATL ACAD SCI USA, V97, P5083, DOI 10.1073/pnas.97.10.5083; Pearl LH, 2000, MUTAT RES-DNA REPAIR, V460, P165, DOI 10.1016/S0921-8777(00)00025-2; Reuter N, 2000, J PHYS CHEM A, V104, P1720, DOI 10.1021/jp9924124; SAVVA R, 1995, NATURE, V373, P487, DOI 10.1038/373487a0; Schaefer M, 1997, J PHYS CHEM B, V101, P1663, DOI 10.1021/jp962972s; SHAPIRO R, 1969, BIOCHEMISTRY-US, V8, P1806, DOI 10.1021/bi00833a004; Shroyer MJN, 1999, BIOCHEMISTRY-US, V38, P4834, DOI 10.1021/bi982986j; Simonson T, 1997, J PHYS CHEM B, V101, P8349, DOI 10.1021/jp9711499; Slupphaug G, 1996, NATURE, V384, P87, DOI 10.1038/384087a0; SLUPPHAUG G, 1995, BIOCHEMISTRY-US, V34, P128, DOI 10.1021/bi00001a016; Weinhold F., 1998, ENCY COMPUTATIONAL C, P1792; Werner RM, 2000, BIOCHEMISTRY-US, V39, P14054, DOI 10.1021/bi0018178; Wood RD, 2001, SCIENCE, V291, P1284, DOI 10.1126/science.1056154; Wu N, 2000, P NATL ACAD SCI USA, V97, P2017, DOI 10.1073/pnas.050417797	30	201	202	0	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 18	2001	413	6857					752	755		10.1038/35099587	http://dx.doi.org/10.1038/35099587			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	482ZK	11607036				2022-12-24	WOS:000171608000048
J	Ferreira, FL; Bota, DP; Bross, A; Melot, C; Vincent, JL				Ferreira, FL; Bota, DP; Bross, A; Melot, C; Vincent, JL			Serial evaluation of the SOFA score to predict outcome in critically ill patients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INTENSIVE-CARE UNITS; MULTIPLE ORGAN FAILURE; ACUTE-PANCREATITIS; ACUTE PHYSIOLOGY; MULTICENTER; DYSFUNCTION/FAILURE; SEPSIS; MORTALITY; TRAUMA; APACHE	Context Evaluation of trends in organ dysfunction in critically ill patients may help predict outcome. Objective To determine the usefulness of repeated measurement the Sequential Organ Failure Assessment (SOFA) score for prediction of mortality in intensive care unit (ICU) patients. Design Prospective, observational cohort study conducted from April 1 to July 31, 1999. Setting A 31-bed medicosurgical ICU at a university hospital in Belgium. Patients Three hundred fifty-two consecutive patients (mean age, 59 years) admitted to the ICU for more than 24 hours for whom the SOFA score was calculated on admission and every 48 hours until discharge. Main Outcome Measures Initial SOFA score (0-24), Delta -SOFA scores (differences between subsequent scores), and the highest and mean SOFA scores obtained during the ICU stay and their correlations with mortality. Results The initial, highest, and mean SOFA scores correlated well with mortality. Initial and highest scores of more than 11 or mean scores of more than 5 corresponded to mortality of more than 80%. The predictive value of the mean score was independent of the length of ICU stay. In univariate analysis, mean and highest SOFA scores had the strongest correlation with mortality, followed by Delta-SOFA and initial SOFA scores. The area under the receiver operating characteristic curve was largest for highest scores (0.90; SE, 0.02; P<.001 vs initial score). When analyzing trends in the SOFA score during the first 96 hours, regardless of the initial score, the mortality rate was at least 50% when the score increased, 27% to 35% when it remained unchanged, and less than 27% when it decreased. Differences in mortality were better predicted in the first 48 hours than in the subsequent 48 hours. There was no significant difference in the length of stay among these groups. Except for initial scores of more than 11 (mortality rate >90%), a decreasing score during the first 48 hours was associated with a mortality rate of less than 6%, while an unchanged or increasing score was associated with a mortality rate of 37% when the initial score was 2 to 7 and 60% when the initial score was 8 to 11. Conclusions Sequential assessment of organ dysfunction during the first few days of ICU admission is a good indicator of prognosis. Both the mean and highest SOFA scores are particularly useful predictors of outcome. Independent of the initial score, an increase in SOFA score during the first 48 hours in the ICU predicts a mortality rate of at least 50%.	Free Univ Brussels, Erasme Univ Hosp, Dept Intens Care, B-1070 Brussels, Belgium	Universite Libre de Bruxelles; Vrije Universiteit Brussel	Vincent, JL (corresponding author), Free Univ Brussels, Erasme Univ Hosp, Dept Intens Care, Route de Lennik 808, B-1070 Brussels, Belgium.			Vincent, Jean-Louis/0000-0001-6011-6951; MELOT, Christian/0000-0002-6172-0330				Antonelli M, 1999, INTENS CARE MED, V25, P389, DOI 10.1007/s001340050863; BION JF, 1988, INTENS CARE MED, V14, P167; Cryer HG, 1999, J TRAUMA, V46, P597, DOI 10.1097/00005373-199904000-00007; CULLEN DJ, 1994, CRIT CARE MED, V22, P1345; DEITCH EA, 1992, ANN SURG, V216, P117, DOI 10.1097/00000658-199208000-00002; Di Filippo A, 1998, CHEMOTHERAPY, V44, P63, DOI 10.1159/000007092; Goldhill DR, 1998, CRIT CARE MED, V26, P1337, DOI 10.1097/00003246-199808000-00017; Hynninen M, 1999, J CRIT CARE, V14, P63, DOI 10.1016/S0883-9441(99)90015-1; KNAUS WA, 1981, CRIT CARE MED, V9, P591, DOI 10.1097/00003246-198108000-00008; LARVIN M, 1989, LANCET, V2, P201; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; LEMESHOW S, 1988, CRIT CARE MED, V16, P470, DOI 10.1097/00003246-198805000-00002; Moreno R, 1999, INTENS CARE MED, V25, P686, DOI 10.1007/s001340050931; Regel G, 1996, WORLD J SURG, V20, P422, DOI 10.1007/s002689900067; SAWYER RG, 1992, AM SURGEON, V58, P82; SHORTELL SM, 1994, MED CARE, V32, P508, DOI 10.1097/00005650-199405000-00009; TRAN DD, 1990, CRIT CARE MED, V18, P474, DOI 10.1097/00003246-199005000-00002; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; WAGNER DP, 1994, CRIT CARE MED, V22, P1359, DOI 10.1097/00003246-199409000-00004; ZWEIG MH, 1993, CLIN CHEM, V39, P561	21	1548	1625	1	38	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 10	2001	286	14					1754	1758		10.1001/jama.286.14.1754	http://dx.doi.org/10.1001/jama.286.14.1754			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	480NC	11594901	Bronze			2022-12-24	WOS:000171466800026
J	Steinmetz, EJ; Conrad, NK; Brow, DA; Corden, JL				Steinmetz, EJ; Conrad, NK; Brow, DA; Corden, JL			RNA-binding protein Nrd1 directs poly(A)-independent 3 '-end formation of RNA polymerase II transcripts	NATURE			English	Article							C-TERMINAL DOMAIN; SACCHAROMYCES-CEREVISIAE; SPLICING ENDONUCLEASE; YEAST; GENE; SNRNA; SEN1; ACCUMULATION; EXPRESSION; DELETION	A eukaryotic chromosome contains many genes, each transcribed separately by RNA polymerase (pol) I, II or III. Transcription termination between genes prevents the formation of polycistronic RNAs and anti-sense RNAs, which are generally detrimental to the correct expression of genes. Terminating the transcription of protein-coding genes by pol II requires a group of proteins that also direct cleavage and polyadenylation of the messenger RNA in response to a specific sequence element, and are associated with the carboxyl-terminal domain of the largest subunit of pol II (refs 1-6). By contrast, the cis-acting elements and trans-acting factors that direct termination of non-polyadenylated transcripts made by pol II, including small nucleolar and small nuclear RNAs, are not known. Here we show that read-through transcription from yeast small nucleolar RNA and small nuclear RNA genes into adjacent genes is prevented by a cis-acting element that is recognized, in part, by the essential RNA-binding protein Nrd1. The RNA-binding protein Nab3, the putative RNA helicase Sen1, and the intact C-terminal domain of pol II are also required for efficient response to the element. The same proteins are required for maintaining normal levels of Nrd1 mRNA, indicating that these proteins may control elongation of a subset of mRNA transcripts.	Univ Wisconsin, Sch Med, Dept Biomol Chem, Madison, WI 53706 USA; Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA	University of Wisconsin System; University of Wisconsin Madison; Johns Hopkins University	Brow, DA (corresponding author), Univ Wisconsin, Sch Med, Dept Biomol Chem, Madison, WI 53706 USA.	dabrow@facstaff.wisc.edu; jcorden@jhmi.edu						Allmang C, 1999, EMBO J, V18, P5399, DOI 10.1093/emboj/18.19.5399; Barilla D, 2001, P NATL ACAD SCI USA, V98, P445, DOI 10.1073/pnas.021545298; Birse CE, 1998, SCIENCE, V280, P298, DOI 10.1126/science.280.5361.298; Brachmann CB, 1998, YEAST, V14, P115; Chanfreau G, 1997, GENE DEV, V11, P2741, DOI 10.1101/gad.11.20.2741; Conrad NK, 2000, GENETICS, V154, P557; DEMARINI DJ, 1992, MOL CELL BIOL, V12, P2154, DOI 10.1128/MCB.12.5.2154; Elela SA, 1998, EMBO J, V17, P3738, DOI 10.1093/emboj/17.13.3738; Fatica A, 2000, EMBO J, V19, P6218, DOI 10.1093/emboj/19.22.6218; Greger IH, 2000, P NATL ACAD SCI USA, V97, P8415, DOI 10.1073/pnas.140217697; Hirose Y, 1998, NATURE, V395, P93, DOI 10.1038/25786; LEE JM, 1991, GENE EXPRESSION, V1, P149; LESSER CF, 1993, GENETICS, V133, P851; McCracken S, 1997, NATURE, V385, P357, DOI 10.1038/385357a0; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Osheim YN, 1999, MOL CELL, V3, P379, DOI 10.1016/S1097-2765(00)80465-7; Rasmussen TP, 1999, MOL CELL BIOL, V19, P5235; Rodriguez CR, 2000, MOL CELL BIOL, V20, P104, DOI 10.1128/MCB.20.1.104-112.2000; Sacher M, 2000, EUR J CELL BIOL, V79, P71, DOI 10.1078/S0171-9335(04)70009-6; Seipelt RL, 1999, NUCLEIC ACIDS RES, V27, P587, DOI 10.1093/nar/27.2.587; Steinmetz EJ, 1998, P NATL ACAD SCI USA, V95, P6699, DOI 10.1073/pnas.95.12.6699; Steinmetz EJ, 1996, MOL CELL BIOL, V16, P6993, DOI 10.1128/mcb.16.12.6993; Trotta CR, 1997, CELL, V89, P849, DOI 10.1016/S0092-8674(00)80270-6; Ursic D, 1997, NUCLEIC ACIDS RES, V25, P4778, DOI 10.1093/nar/25.23.4778; Van Hoof A, 2000, MOL CELL BIOL, V20, P441, DOI 10.1128/MCB.20.2.441-452.2000; WEST ML, 1995, GENETICS, V140, P1223; Yuryev A, 1996, P NATL ACAD SCI USA, V93, P6975, DOI 10.1073/pnas.93.14.6975	27	278	284	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 20	2001	413	6853					327	331		10.1038/35095090	http://dx.doi.org/10.1038/35095090			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473KB	11565036				2022-12-24	WOS:000171040500043
J	Dockray, GJ				Dockray, GJ			Gastrin-releasing peptide: an Identity crisis at 30?	LANCET			English	Editorial Material							BOMBESIN; SECRETION		Univ Liverpool, Physiol Lab, Liverpool L69 3BX, Merseyside, England	University of Liverpool	Dockray, GJ (corresponding author), Univ Liverpool, Physiol Lab, POB 147, Liverpool L69 3BX, Merseyside, England.							ANASTASI A, 1971, EXPERIENTIA, V27, P166, DOI 10.1007/BF02145873; Degen LP, 2001, GASTROENTEROLOGY, V120, P361, DOI 10.1053/gast.2001.21174; DOCKRAY GJ, 1979, NEUROSCIENCE, V4, P561; ELOMAR E, 1995, GUT, V36, P534, DOI 10.1136/gut.36.4.534; Gibbons AH, 1997, GASTROENTEROLOGY, V112, P1940, DOI 10.1053/gast.1997.v112.pm9178686; Hildebrand P, 2001, GUT, V49, P23, DOI 10.1136/gut.49.1.23; HOLST JJ, 1990, SCAND J GASTROENTERO, V25, P89, DOI 10.3109/00365529008999214; MCDONALD TJ, 1979, BIOCHEM BIOPH RES CO, V90, P227, DOI 10.1016/0006-291X(79)91614-0; Moore EDW, 1999, J BIOL CHEM, V274, P22493, DOI 10.1074/jbc.274.32.22493; Rozengurt E, 1998, AM J PHYSIOL-GASTR L, V275, pG177, DOI 10.1152/ajpgi.1998.275.2.G177; SCHUBERT ML, 1992, AM J PHYSIOL, V262, pG685, DOI 10.1152/ajpgi.1992.262.4.G685; Wada E, 1997, BIOCHEM BIOPH RES CO, V239, P28, DOI 10.1006/bbrc.1997.7418; WALSH JH, 1979, FED PROC, V38, P2315	13	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 8	2001	358	9284					778	779		10.1016/S0140-6736(01)06008-1	http://dx.doi.org/10.1016/S0140-6736(01)06008-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	472NA	11564479				2022-12-24	WOS:000170989300005
J	Martinez, E; Mocroft, A; Garcia-Viejo, MA; Perez-Cuevas, JB; Blanco, JL; Mallolas, J; Bianchi, L; Conget, I; Blanch, J; Phillips, A; Gatell, JM				Martinez, E; Mocroft, A; Garcia-Viejo, MA; Perez-Cuevas, JB; Blanco, JL; Mallolas, J; Bianchi, L; Conget, I; Blanch, J; Phillips, A; Gatell, JM			Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: a prospective cohort study	LANCET			English	Article							REVERSE-TRANSCRIPTASE INHIBITORS; NUCLEOSIDE ANALOG THERAPY; ANTIRETROVIRAL-THERAPY; BODY-COMPOSITION; METABOLIC ABNORMALITIES; FAT DISTRIBUTION; HIV-INFECTION; PERIPHERAL LIPODYSTROPHY; INSULIN-RESISTANCE; HYPERLIPIDEMIA	Background Risk factors for lipodystrophy in patients infected with HIV-1 treated with highly active antiretroviral therapy (HAART) containing HIV-1 protease inhibitors are poorly understood. We aimed to identify the risk factors for lipodystrophy in antiretroviral-naive HIV-1-infected adults on HAART. Methods Moderate or severe body-fat changes were clinically assessed and categorised as subcutaneous lipoatrophy, central obesity, or both, in all consecutive antiretroviral-naive HIV-1-infected adults who began HAART with two nucleoside reverse transcriptase inhibitors plus at least one protease inhibitor from October, 1996, to September, 1999. A person-years analysis was used to calculate the incidence of types of lipodystrophy, and Cox proportional hazards models were used to describe the univariate and multivariate factors associated with progression to any lipodystrophy. Findings After a median follow-up of 18 months, 85 (17%) of the 494 patients developed some type of lipodystrophy. The incidences of any lipodystrophy, lipodystrophy with subcutaneous lipoatrophy, and lipodystrophy with central obesity were 11.7 (95% CI 9.2-14.2), 9.2 (7.0-11.4), and 7.7 (5.7-9.7) per 100 patient-years. An increased risk for any lipodystrophy was found among women as compared with men (relative hazard 1.87 [1.07-3.28]), heterosexuals (2.86 [1.50-5.48]), and homosexuals (2.17 [1.07-4.42]) as compared with intravenous drug users, with increasing age (1.33 per 10 years older [1.08-1.62]), and with the duration of exposure to antiretroviral therapy (1.57 per 6 months extra [1.30-1.88]) but not with any individual antiretroviral agent. The factors associated with an increased risk for lipodystrophy with subcutaneous lipoatrophy or lipodystrophy with central obesity were very similar to those associated with any lipodystrophy. The duration of indinavir use may represent an additional contribution for the development of lipodystrophy with central obesity (1.26 per 6 months extra [0.99-1.60]); p=0.064). Interpretation Risk factors associated with development of any lipodystrophy, lipodystrophy with subcutaneous lipoatrophy, and tipodystrophy with central obesity in patients infected with HIV-1 who were receiving HAART containing protease inhibitors are multifactorial and overlapping, and cannot be exclusively ascribed to the duration of exposure to an particular antiretroviral agent.	August Pl I Sunyer Hosp Clin Barcelona, Inst Invest Biomed, Dept Infect Dis, Barcelona 08036, Spain; August Pl I Sunyer Hosp Clin Barcelona, Inst Invest Biomed, Dept Radiol, Barcelona 08036, Spain; August Pl I Sunyer Hosp Clin Barcelona, Inst Invest Biomed, Dept Endocrinol, Barcelona 08036, Spain; UCL, Royal Free & Univ Coll Med Sch, Dept Primary Care & Populat Sci, London NW3 2PF, England; UCL, Royal Free & Univ Coll Med Sch, Royal Free Ctr HIV Med, London NW3 2PF, England	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of London; University College London; University of London; University College London	Martinez, E (corresponding author), Hosp Clin Barcelona, Infect Dis Unit, C Villarroel 170, E-08036 Barcelona, Spain.	esteban@intercom.es	Blanch, Jordi/I-9022-2012; Phillips, Andrew N/B-4427-2008; Mocroft, Amanda/G-8748-2011; Mocroft, Amanda/C-1527-2008; Gatell, Jose M/ABC-3607-2020	Blanch, Jordi/0000-0003-2597-8454; Phillips, Andrew N/0000-0003-2384-4807; Mocroft, Amanda/0000-0001-8316-1122; Mallolas Masferrer, Josep/0000-0002-8365-141X				Brinkman K, 1999, LANCET, V354, P1112, DOI 10.1016/S0140-6736(99)06102-4; Carbonnel F, 1998, AIDS, V12, P1777, DOI 10.1097/00002030-199814000-00009; Carpenter CCJ, 1997, JAMA-J AM MED ASSOC, V277, P1962, DOI 10.1001/jama.277.24.1962; Carr A, 1999, LANCET, V353, P2093, DOI 10.1016/S0140-6736(98)08468-2; Carr A, 1998, AIDS, V12, pF51, DOI 10.1097/00002030-199807000-00003; Carr A, 2000, AIDS, V14, pF25, DOI 10.1097/00002030-200002180-00001; Carr A, 1998, LANCET, V351, P1881, DOI 10.1016/S0140-6736(98)03391-1; CARR A, 1997, 9 ANN C AUSTR SOC HI; DAUCOURT V, 1999, 1 INT WORKSH ADV DRU; Dong KL, 1999, J ACQ IMMUN DEF SYND, V21, P107; FALUTZ J, 1999, 1 INT WORKSH ADV DRU; FLYNN MA, 1989, AM J CLIN NUTR, V50, P713, DOI 10.1093/ajcn/50.4.713; GALLI M, 1990, 1 INT WORKSH ADV DRU; Gervasoni C, 1999, AIDS, V13, P465, DOI 10.1097/00002030-199903110-00004; Hadigan C, 1999, J CLIN ENDOCR METAB, V84, P1932, DOI 10.1210/jc.84.6.1932; Kirk O, 1998, AIDS, V12, P2031, DOI 10.1097/00002030-199815000-00015; Kotler DP, 1999, J ACQ IMMUN DEF SYND, V20, P228, DOI 10.1097/00042560-199903010-00003; Mallal SA, 2000, AIDS, V14, P1309, DOI 10.1097/00002030-200007070-00002; Martinez E, 2000, CLIN INFECT DIS, V31, P1266, DOI 10.1086/317426; Martinez E, 2000, LANCET, V356, P1412, DOI 10.1016/S0140-6736(00)02850-6; Martinez E, 1999, AIDS, V13, P805, DOI 10.1097/00002030-199905070-00009; Martinez E, 1999, CURR OPIN INFECT DIS, V12, P13, DOI 10.1097/00001432-199902000-00003; Miller KD, 1998, LANCET, V351, P871, DOI 10.1016/S0140-6736(97)11518-5; MUURAHAINEN N, 1999, 1 INT WORKSH ADV DRU; Pernerstorfer-Schoen H, 1999, AIDS, V13, P2389, DOI 10.1097/00002030-199912030-00010; Safrin S, 1999, AIDS, V13, P2493, DOI 10.1097/00002030-199912240-00002; Saint-Marc T, 1999, AIDS, V13, P1659, DOI 10.1097/00002030-199909100-00009; Saint-Marc T, 2000, AIDS, V14, P37, DOI 10.1097/00002030-200001070-00005; SCHWARTZ RS, 1990, J GERONTOL, V45, P181; SHIMOKATA H, 1989, J GERONTOL, V44, P66; Silva M, 1998, AIDS, V12, P1645, DOI 10.1097/00002030-199813000-00012; VIARD JP, 1999, 1 INT WORKSH ADV DRU; WARD DJ, 1999, 1 INT WORKSH ADV DRU	33	329	337	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 24	2001	357	9256					592	598		10.1016/S0140-6736(00)04056-3	http://dx.doi.org/10.1016/S0140-6736(00)04056-3			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	404UB	11558485				2022-12-24	WOS:000167119100011
J	Hines, PJ; Purnell, BA; Marx, J				Hines, PJ; Purnell, BA; Marx, J			Stem cells branch out	SCIENCE			English	Editorial Material																			0	10	12	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 25	2000	287	5457					1417	1417		10.1126/science.287.5457.1417	http://dx.doi.org/10.1126/science.287.5457.1417			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	287WZ	11645196				2022-12-24	WOS:000085531600028
J	Wootton, JT				Wootton, JT			Local interactions predict large-scale pattern in empirically derived cellular automata	NATURE			English	Article							FOREST-FIRES; DISTURBANCE; COMPETITION; SUCCESSION; COMMUNITY; DYNAMICS; ECOLOGY; MODELS; SIZE	An important unanswered question in ecology is whether processes such as species interactions that occur at a local scale can generate large-scale patterns seen in nature(1,2). Because of the complexity of natural ecosystems, developing an adequate theoretical framework to scale up local processes has been challenging. Models of complex systems can produce a wide array of outcomes; therefore, model parameter values must be constrained by empirical information to usefully narrow the range of predicted behaviour. Under some conditions, spatially explicit models of locally interacting objects (for example, cells, sand grains, car drivers, or organisms), variously termed cellular automata(3,4) or interacting particle models(5), can self-organize to develop complex spatial and temporal patterning at larger scales in the absence of any externally imposed pattern(1,6-8). When these models are based on transition probabilities of moving between ecological states at a local level, relatively complex versions of these models can be linked readily to empirical information on ecosystem dynamics. Here, I show that an empirically derived cellular automaton model of a rocky intertidal mussel bed based on local interactions correctly predicts large-scale spatial patterns observed in nature.	Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA	University of Chicago	Wootton, JT (corresponding author), Univ Chicago, Dept Ecol & Evolut, 940 E 57th St, Chicago, IL 60637 USA.		Wootton, J. Timothy/F-3191-2015	Wootton, J. Timothy/0000-0002-7715-0344				Bak P., 2013, NATURE WORKS SCI SEL; Clar S, 1996, J PHYS-CONDENS MAT, V8, P6803, DOI 10.1088/0953-8984/8/37/004; DAYTON PK, 1971, ECOL MONOGR, V41, P351, DOI 10.2307/1948498; DENNY MW, 1987, J EXP MAR BIOL ECOL, V113, P231, DOI 10.1016/0022-0981(87)90103-1; DURRETT R, 1994, PHILOS T ROY SOC B, V343, P329, DOI 10.1098/rstb.1994.0028; ERMENTROUT GB, 1993, J THEOR BIOL, V160, P97, DOI 10.1006/jtbi.1993.1007; Jensen J. H., 1998, SELF ORG CRITICALITY; JOHNSON LE, 1992, J EXP MAR BIOL ECOL, V160, P251, DOI 10.1016/0022-0981(92)90241-2; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; LEVIN SA, 1974, P NATL ACAD SCI USA, V71, P2744, DOI 10.1073/pnas.71.7.2744; Malamud BD, 1998, SCIENCE, V281, P1840, DOI 10.1126/science.281.5384.1840; Paine R. T., 1994, MARINE ROCKY SHORES; PAINE RT, 1981, ECOL MONOGR, V51, P145, DOI 10.2307/2937261; Sokal RR., 1995, BIOMETRY, V3; SOLE RV, 1995, J THEOR BIOL, V173, P31, DOI 10.1006/jtbi.1995.0040; SOUSA WP, 1984, ECOLOGY, V65, P1918, DOI 10.2307/1937789; Stephenson T.A., 1972, LIFE TIDEMARKS ROCKY; WIENS JA, 1993, OIKOS, V66, P369, DOI 10.2307/3544931; WOLFRAM S, 1984, NATURE, V311, P419, DOI 10.1038/311419a0; WOOTTON JT, 1993, ECOLOGY, V74, P195, DOI 10.2307/1939514; WOOTTON JT, 1992, ECOLOGY, V73, P981, DOI 10.2307/1940174; WOOTTON JT, 1994, ECOLOGY, V75, P151, DOI 10.2307/1939391; Wootton JT, 2001, ECOLOGY, V82, P580, DOI 10.2307/2679881	23	137	144	1	44	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 25	2001	413	6858					841	844		10.1038/35101595	http://dx.doi.org/10.1038/35101595			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	485JA	11677606				2022-12-24	WOS:000171750200045
J	Edmunds, L; Waters, E; Elliott, EJ				Edmunds, L; Waters, E; Elliott, EJ			Evidence based paediatrics - Evidence based management of childhood obesity	BMJ-BRITISH MEDICAL JOURNAL			English	Review							OVERWEIGHT; CHILDREN; ADOLESCENTS; RISK		Univ Oxford, Dept Publ Hlth, Oxford OX3 7LF, England; Univ Melbourne, Royal Childrens Hosp, Ctr Community Child Hlth, Parkville, Vic 3052, Australia; Univ Sydney, Sydney, NSW 2145, Australia; New Childrens Hosp, Sydney, NSW 2145, Australia	University of Oxford; Royal Children's Hospital Melbourne; University of Melbourne; University of Sydney; University of Sydney	Edmunds, L (corresponding author), Univ Oxford, Dept Publ Hlth, Oxford OX3 7LF, England.	laurel.edmunds@dphpc.ox.ac.uk		Edmunds, Laurel/0000-0001-9677-3742; Elliott, Elizabeth/0000-0002-6501-5487				[Anonymous], 1983, J ROY COLL PHYS LOND, V17, P5; Barlow SE, 1998, PEDIATRICS, V102, DOI 10.1542/peds.102.3.e29; BIDDLE SJH, 1994, PHYSICAL ACTIVITY PR; CAMPBELL K, 2001, COCHRANE DATABASE SY, V1; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Dietz WH, 1999, AM J CLIN NUTR, V70, p123S; Epstein LH, 1998, PEDIATRICS, V101, P554; Flegal KM, 1999, MED SCI SPORT EXER, V31, pS509, DOI 10.1097/00005768-199911001-00004; Freedman DS, 1999, PEDIATRICS, V103, P1175, DOI 10.1542/peds.103.6.1175; FRENCH SA, 1995, OBES RES, V3, P479, DOI 10.1002/j.1550-8528.1995.tb00179.x; Gill TP, 1997, BRIT MED BULL, V53, P359, DOI 10.1093/oxfordjournals.bmb.a011618; GLENNY AM, 1997, SYSTEMATIC REV INTER; Golan M, 1998, INT J OBESITY, V22, P1217, DOI 10.1038/sj.ijo.0800749; GORTMAKER SL, 1993, NEW ENGL J MED, V329, P1008, DOI 10.1056/NEJM199309303291406; Haddock C. Keith, 1994, Annals of Behavioral Medicine, V16, P235; Hughes JM, 1997, ARCH DIS CHILD, V76, P182, DOI 10.1136/adc.76.3.182; Lake JK, 1997, ARCH DIS CHILD, V77, P376, DOI 10.1136/adc.77.5.376; Owens S, 1999, MED SCI SPORT EXER, V31, P143, DOI 10.1097/00005768-199901000-00022; Parsons TJ, 1999, INT J OBESITY, V23, pS1; Story M, 1999, INT J OBESITY, V23, pS43, DOI 10.1038/sj.ijo.0800859; SUMMERBELL C, 2001, COCHRANE LIB; Wake M, 2000, PEDIATR RES, V47, p160A; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301; Whitaker RC, 1998, PEDIATRICS, V101, DOI 10.1542/peds.101.3.e5; WHO, 1998, WHO TECHN REP SER	25	77	81	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 20	2001	323	7318					916	919		10.1136/bmj.323.7318.916	http://dx.doi.org/10.1136/bmj.323.7318.916			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	486BH	11668139	Green Published			2022-12-24	WOS:000171798200025
J	Lammert, E; Cleaver, O; Melton, D				Lammert, E; Cleaver, O; Melton, D			Induction of pancreatic differentiation by signals from blood vessels	SCIENCE			English	Article							ENDOTHELIAL GROWTH-FACTOR; VASCULAR ENDOTHELIUM; XENOPUS; GENE; EXPRESSION; LETHALITY; ENDODERM; FLT-1; FLK-1; PDX-1	Blood vessels supply developing organs with metabolic sustenance. Here, we demonstrate a role for blood vessels as a source of developmental signals during pancreatic organogenesis. In vitro experiments with embryonic mouse tissues demonstrate that blood vessel endothelium induces insulin expression in isolated endoderm. Removal of the dorsal aorta in Xenopus laevis embryos results in the failure of insulin expression in vivo. Furthermore, using transgenic mice, we show that ectopic vascularization in the posterior foregut leads to ectopic insulin expression and islet hyperplasia. These results indicate that vessels not only provide metabolic sustenance, but also provide inductive signals for organ development.	Harvard Univ, Howard Hughes Med Inst, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University; Howard Hughes Medical Institute	Melton, D (corresponding author), Harvard Univ, Howard Hughes Med Inst, Dept Mol & Cellular Biol, 7 Divin Ave, Cambridge, MA 02138 USA.		Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647; Cleaver, Ondine/0000-0003-2454-6641				ALTABA ARI, 1993, P NATL ACAD SCI USA, V90, P8268, DOI 10.1073/pnas.90.17.8268; BANTING FG, 1990, J LAB CLIN MED, V115, P254; Brekken RA, 1998, CANCER RES, V58, P1952; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; CHRISTOFORI G, 1995, MOL ENDOCRINOL, V9, P1760, DOI 10.1210/me.9.12.1760; Cleaver O, 1998, DEVELOPMENT, V125, P3905; DUMONT DJ, 1995, DEV DYNAM, V203, P80, DOI 10.1002/aja.1002030109; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Ferrara N, 1999, J MOL MED, V77, P527, DOI 10.1007/s001099900019; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0; Hirsch N, 1997, J NEUROBIOL, V32, P45, DOI 10.1002/(SICI)1097-4695(199701)32:1<45::AID-NEU5>3.3.CO;2-V; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Kelly OG, 2000, DEV DYNAM, V218, P615, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1027>3.0.CO;2-8; Kim SK, 1997, DEVELOPMENT, V124, P4243; Lammert E, 2000, MECH DEVELOP, V94, P199, DOI 10.1016/S0925-4773(00)00317-8; LEE JE, 1995, SCIENCE, V268, P836, DOI 10.1126/science.7754368; Newman CS, 1997, MECH DEVELOP, V66, P83, DOI 10.1016/S0925-4773(97)00092-0; Offield MF, 1996, DEVELOPMENT, V122, P983; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; TEITELMAN G, 1987, DEV BIOL, V120, P425, DOI 10.1016/0012-1606(87)90246-6; Wells JM, 2000, DEVELOPMENT, V127, P1563; Wu KL, 1997, MOL CELL BIOL, V17, P6002, DOI 10.1128/MCB.17.10.6002	22	793	837	4	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2001	294	5542					564	567		10.1126/science.1064344	http://dx.doi.org/10.1126/science.1064344			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484NC	11577200				2022-12-24	WOS:000171695600038
J	Fonarow, GC				Fonarow, GC			Quality indicators for the management of heart failure in vulnerable elders	ANNALS OF INTERNAL MEDICINE			English	Article							CONVERTING ENZYME-INHIBITORS; LEFT-VENTRICULAR DYSFUNCTION; ACUTE MYOCARDIAL-INFARCTION; CALCIUM-CHANNEL BLOCKER; RANDOMIZED-TRIAL; DOUBLE-BLIND; MORTALITY; MORBIDITY; THERAPY; CAPTOPRIL		Univ Calif Los Angeles, Div Cardiol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Fonarow, GC (corresponding author), Univ Calif Los Angeles, Div Cardiol, 47-123 CHS,10833 Le Conte Ave, Los Angeles, CA 90095 USA.	gfonarow@mednet.ucla.edu	Fonarow, Gregg C/D-5988-2014	Fonarow, Gregg C/0000-0002-3192-8093				*AM HEART ASS, 1997, HEART STROK STAT UPD; Blackshear JL, 1996, LANCET, V348, P633; CAS LD, 1995, CLIN CARDIOL, V18, P370, DOI 10.1002/clc.4960180704; Cohn JN, 1997, CIRCULATION, V96, P856, DOI 10.1161/01.cir.96.3.856; Doughty RN, 1997, EUR HEART J, V18, P560; ELKAYAM U, 1985, AM J CARDIOL, V56, P560, DOI 10.1016/0002-9149(85)91185-3; ELKAYAM U, 1990, CIRCULATION, V82, P1954, DOI 10.1161/01.CIR.82.6.1954; Gambassi G, 2000, ARCH INTERN MED, V160, P53, DOI 10.1001/archinte.160.1.53; GARG R, 1995, JAMA-J AM MED ASSOC, V273, P1450, DOI 10.1001/jama.273.18.1450; GHALI JK, 1988, ARCH INTERN MED, V148, P2013, DOI 10.1001/archinte.148.9.2013; Gheorghiade M, 1998, CIRCULATION, V97, P282, DOI 10.1161/01.CIR.97.3.282; GOLDSTEIN RE, 1991, CIRCULATION, V83, P52, DOI 10.1161/01.CIR.83.1.52; Grossman E, 1996, ANN INTERN MED, V125, P304, DOI 10.7326/0003-4819-125-4-199608150-00009; Heidenreich PA, 1997, J AM COLL CARDIOL, V30, P27, DOI 10.1016/S0735-1097(97)00104-6; Hjalmarson A, 1999, LANCET, V353, P2001; KAHN KL, 1990, JAMA-J AM MED ASSOC, V264, P1969, DOI 10.1001/jama.264.15.1969; KOBER L, 1995, NEW ENGL J MED, V333, P1670, DOI 10.1056/NEJM199512213332503; KONSTAM MA, 1994, AHCPR PUBL; Kostis JB, 1997, AM HEART J, V133, P550, DOI 10.1016/S0002-8703(97)70150-9; Lechat P, 1999, LANCET, V353, P9; Lechat P, 1998, CIRCULATION, V98, P1184, DOI 10.1161/01.CIR.98.12.1184; Levine TB, 2000, CIRCULATION, V101, P758, DOI 10.1161/01.CIR.101.7.758; NICKLAS JM, 1992, NEW ENGL J MED, V327, P685; Packer M, 1996, NEW ENGL J MED, V335, P1107, DOI 10.1056/NEJM199610103351504; Packer M, 2001, NEW ENGL J MED, V344, P1651, DOI 10.1056/NEJM200105313442201; PARKER M, 1996, NEW ENGL J MED, V334, P1349; PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001; Philbin EF, 1998, ARCH INTERN MED, V158, P501, DOI 10.1001/archinte.158.5.501; Pitt B, 2000, LANCET, V355, P1582, DOI 10.1016/S0140-6736(00)02213-3; Pitt B, 1997, LANCET, V349, P747, DOI 10.1016/S0140-6736(97)01187-2; Prystowsky EN, 1996, CIRCULATION, V93, P1262, DOI 10.1161/01.CIR.93.6.1262; RICH MW, 1995, NEW ENGL J MED, V333, P1190, DOI 10.1056/NEJM199511023331806; RYMAN KS, 1986, AM J CARDIOL, V58, P583, DOI 10.1016/0002-9149(86)90280-8; Senni M, 1999, J AM COLL CARDIOL, V33, P164, DOI 10.1016/S0735-1097(98)00523-3; Shekelle PG, 2001, ANN INTERN MED, V135, P647, DOI 10.7326/0003-4819-135-8_Part_2-200110161-00003; STEVENSON WG, 1993, CIRCULATION, V88, P2953, DOI 10.1161/01.CIR.88.6.2953; SWEDBERG K, 1987, NEW ENGL J MED, V316, P1429; TEO KK, 1993, JAMA-J AM MED ASSOC, V270, P1589, DOI 10.1001/jama.270.13.1589; Thackray S, 2000, EUR J HEART FAIL, V2, P209, DOI 10.1016/S1388-9842(00)00080-5; Yusuf S, 2000, NEW ENGL J MED, V342, P145	40	15	15	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 16	2001	135	8	2				694	702		10.7326/0003-4819-135-8_Part_2-200110161-00008	http://dx.doi.org/10.7326/0003-4819-135-8_Part_2-200110161-00008			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	481WA	11601952				2022-12-24	WOS:000171542400008
J	Mutabingwa, T; Nzila, A; Mberu, E; Nduati, E; Winstanley, P; Hills, E; Watkins, W				Mutabingwa, T; Nzila, A; Mberu, E; Nduati, E; Winstanley, P; Hills, E; Watkins, W			Chlorproguanil-dapsone for treatment of drug-resistant falciparum malaria in Tanzania	LANCET			English	Article							PLASMODIUM-FALCIPARUM; DIHYDROPTEROATE SYNTHASE; DIHYDROFOLATE-REDUCTASE; SULFADOXINE-PYRIMETHAMINE; SELECTIVE PRESSURE; SYNTHETASE GENE; PARASITES; FANSIDAR; CHILDREN; AFRICA	Background Resistance to the affordable malaria treatments chloroquine and pyrimethamine-sulfadoxine is seriously impeding malaria control through treatment in east Africa. We did an open, alternate drug allocation study to assess the efficacy of chlorproguanil-dapsone in the treatment of falciparum malaria clinically resistant to pyrimethamine-sulfadoxine. Methods Children younger than 5 years with non-severe falciparum malaria, attending Muheza district hospital in Tanzania, were treated with the standard regimen of pyrimethamine-sulfadoxine. Patients whose clinical symptoms resolved but who remained parasitaemic 7 days after pyrimethamine-sulfadoxine were followed up for 1 month. Clinical malaria episodes were retreated with either single dose pyrimethamine-sulfadoxine or a 3-day regimen of chlorproguanil-dapsone. Those with parasitaemia after 7 days were treated with chlorproguanil-dapsone. Parasite DNA was collected on day 7 after first treatment with pyrimethamine-sulfadoxine and we looked for point mutations in the genes encoding dihydrofolate reductase (dhfr) and dyhydropteroate synthetase (dhps). Findings 360 children were enrolled and treated with pyrimethamine-sulfadoxine. On day 7, 192 (55%) of 348 had cleared parasitaemia. Of the remaining 156 parasitaemic children, 140 (90%) were followed up to day 28, and 92 (66%) of 140 developed clinical malaria. These 92 patients were alternately retreated with either pyrimethamine-sulfadoxine (46) or chlorproguanil-dapsone (46). 28 (61%) of 46 children retreated with pyrimethamine-sulfadoxine were still parasitaemic at day 7, compared with three (15%) of 46 children retreated with chlorproguanil-dapsone. Resistance to pyrimethamine-sulfadoxine increased from 45% (156/348) at the first treatment to 61% (28/46) after retreatment. 83 of 85 parasite isolates collected after the first pyrimethamine-sulfadoxine treatment, and before and after the second treatments with pyrimethamine-sulfadoxine and chlorproguanil-dapsone showed triple-mutant dhfr alleles, associated with a variety of dhps mutations. Interpretation Most patients treated with pyrimethamine-sulfadoxine, who remain parasitaemic at day 7, develop new malaria symptoms within 1 month. Chlorproguanil-dapsone was a practicable therapy under these circumstances. Analysis of parasite dhfr and dhps before and after treatment supports the view that pyrimethamine-sulfadoxine resistance in this part of Africa is primarily due to parasites with three mutations in the dhfr domain.	Amani Med Res Ctr, Natl Inst Med Res, Amani Tanga, Tanzania; Univ Liverpool, Dept Pharmacol & Therapeut, Liverpool L69 3BX, Merseyside, England; Kenya Govt Med Res Ctr, Wellcome Trust Collaborat Programme, Nairobi, Kenya; Muheza Designated Dist Hosp, Muheza Tanga, Tanzania	University of Liverpool; Kenya Medical Research Institute	Mutabingwa, T (corresponding author), Amani Med Res Ctr, Natl Inst Med Res, POB 4, Amani Tanga, Tanzania.							Amukoye E, 1997, ANTIMICROB AGENTS CH, V41, P2261, DOI 10.1128/AAC.41.10.2261; Basco LK, 2000, J INFECT DIS, V182, P624, DOI 10.1086/315731; BRANDLINGBENNETT AD, 1988, T ROY SOC TROP MED H, V82, P833, DOI 10.1016/0035-9203(88)90009-0; BROOKS DR, 1994, EUR J BIOCHEM, V224, P397, DOI 10.1111/j.1432-1033.1994.00397.x; BZIK DJ, 1987, P NATL ACAD SCI USA, V84, P8360, DOI 10.1073/pnas.84.23.8360; Clyde David F, 1967, MALARIA TANZANIA; Goodman CA, 1999, LANCET, V354, P378, DOI 10.1016/S0140-6736(99)02141-8; HYDE JE, 1990, PHARMACOL THERAPEUT, V48, P45, DOI 10.1016/0163-7258(90)90017-V; KILIMALI VAEB, 1985, T ROY SOC TROP MED H, V79, P482, DOI 10.1016/0035-9203(85)90071-9; Marsh VM, 1999, TROP MED INT HEALTH, V4, P383, DOI 10.1046/j.1365-3156.1999.00403.x; MSUYA FHM, 1991, ACTA TROP, V49, P165, DOI 10.1016/0001-706X(91)90035-I; MUTABINGWA TK, 1999, MAL OTHER INFECT DIS, V10, P28; Nzila AM, 2000, J INFECT DIS, V181, P2023, DOI 10.1086/315520; Nzila AM, 2000, ANTIMICROB AGENTS CH, V44, P991, DOI 10.1128/AAC.44.4.991-996.2000; Ronn AM, 1996, T ROY SOC TROP MED H, V90, P179, DOI 10.1016/S0035-9203(96)90129-7; STICH AHR, 1994, T ROY SOC TROP MED H, V88, P150, DOI 10.1016/0035-9203(94)90271-2; Trigg JK, 1997, ACTA TROP, V63, P185, DOI 10.1016/S0001-706X(96)00617-1; Triglia T, 1997, P NATL ACAD SCI USA, V94, P13944, DOI 10.1073/pnas.94.25.13944; Triglia T, 1998, EMBO J, V17, P3807, DOI 10.1093/emboj/17.14.3807; TRIGLIA T, 1994, P NATL ACAD SCI USA, V91, P7149, DOI 10.1073/pnas.91.15.7149; Wang P, 1997, PARASITOLOGY, V115, P223, DOI 10.1017/S0031182097001431; WATKINS WM, 1993, T ROY SOC TROP MED H, V87, P75, DOI 10.1016/0035-9203(93)90431-O; Watkins WM, 1997, PARASITOL TODAY, V13, P459, DOI 10.1016/S0169-4758(97)01124-1; White NJ, 1999, LANCET, V353, P1965, DOI 10.1016/S0140-6736(98)07367-X; WHO, 1996, WHOMAL961077; Winstanley P, 1997, T ROY SOC TROP MED H, V91, P322, DOI 10.1016/S0035-9203(97)90093-6	26	148	149	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 13	2001	358	9289					1218	1223		10.1016/S0140-6736(01)06344-9	http://dx.doi.org/10.1016/S0140-6736(01)06344-9			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	481NX	11675058				2022-12-24	WOS:000171527000010
J	Christian, CE				Christian, CE			Consequences of a biological invasion reveal the importance of mutualism for plant communities	NATURE			English	Article							ANT IRIDOMYRMEX-HUMILIS; ARGENTINE ANT; SEEDLING RECRUITMENT; ECOLOGY; MAYR	Seed-dispersal mutualisms have a fundamental role in regenerating natural communities(1,2). Interest in the importance of seed dispersal to plant communities has been heightened by worldwide declines in animal dispersers(3-5). One view, the 'keystone mutualist hypothesis', predicts that these human-caused losses will trigger a cascade of linked extinctions throughout the community(6). Implicitly, this view holds that mutualisms, such as seed dispersal, are crucial ecological interactions that maintain the structure and diversity of natural communities. Although many studies suggest the importance of mutualism(3,7), empirical evidence for community-level impacts of mutualists has remained anecdotal(8,9), and the central role of mutualism, relative to other species interactions, has long been debated in the theoretical literature(10,11). Here I report the community-level consequences of a biological invasion that disrupts important seed-dispersal mutualisms. I show that invasion of South African shrublands by the Argentine ant (Linepithema humile) leads to a shift in composition of the plant community, owing to a disproportionate reduction in the densities of large-seeded plants. This study suggests that the preservation of mutualistic interactions may be essential for maintaining natural communities.	Univ Calif Davis, Ctr Populat Biol, Davis, CA 95616 USA	University of California System; University of California Davis	Christian, CE (corresponding author), Univ Calif Davis, Ctr Populat Biol, 1 Shields Ave, Davis, CA 95616 USA.	cechristian@ucdavis.edu						Addicott J.F., 1984, P437; BOND W, 1984, ECOLOGY, V65, P1031, DOI 10.2307/1938311; BOND WJ, 1985, S AFR J ZOOL, V20, P150; BOND WJ, 1991, ANT - PLANT INTERACTIONS, P448; BOND WJ, 1994, PHILOS T R SOC B, V344, P83, DOI 10.1098/rstb.1994.0055; BROWN JH, 1990, SCIENCE, V250, P1705, DOI 10.1126/science.250.4988.1705; CHAPMAN CA, 1995, CONSERV BIOL, V9, P675, DOI 10.1046/j.1523-1739.1995.09030675.x; Chapman Colin A., 1995, Evolutionary Anthropology, V4, P74, DOI 10.1002/evan.1360040303; COLE FR, 1992, ECOLOGY, V73, P1313, DOI 10.2307/1940678; COX PA, 1991, CONSERV BIOL, V5, P448, DOI 10.1111/j.1523-1739.1991.tb00351.x; CUSHMAN JH, 1995, ISLANDS BIOL DIVERSI, P135; DEKOCK AE, 1989, J ENTOMOL SOC S AFR, V52, P157; DEKOCK AE, 1992, FIRE S AFRICAN MOUNT, P201; Gilbert L. E., 1980, Conservation biology. An evolutionary-ecological perspective., P11; Holldobler B., 1990, pi; HOWE HF, 1982, ANNU REV ECOL SYST, V13, P201, DOI 10.1146/annurev.es.13.110182.001221; HOWE HF, 1993, VEGETATIO, V108, P3; HUGHES L, 1994, J ECOL, V82, P933, DOI 10.2307/2261456; LAWTON JH, 1993, ECOL STU AN, V99, P255; Lopes MA, 2000, CONSERV BIOL, V14, P1658, DOI 10.1046/j.1523-1739.2000.98402.x; May R.M., 1976, P49; MILLS LS, 1993, BIOSCIENCE, V43, P219, DOI 10.2307/1312122; PASSERA L, 1994, WESTV STUD, P23; Power ME, 1996, BIOSCIENCE, V46, P609, DOI 10.2307/1312990; SLINGSBY P, 1985, S AFR J BOT, V51, P30, DOI 10.1016/S0254-6299(16)31698-2; Slingsby P., 1981, VELD FLORA, V67, P39, DOI [10.10520/AJA00423203\_1083, DOI 10.10520/AJA00423203]; Visser D, 1996, AFR ENTOMOL, V4, P285; WARD PS, 1987, HILGARDIA, V55, P1; Way MJ, 1997, INSECT SOC, V44, P415, DOI 10.1007/s000400050062; WITT ABR, 1993, FACTORS AFFECTING MY	30	278	315	10	168	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 11	2001	413	6856					635	639		10.1038/35098093	http://dx.doi.org/10.1038/35098093			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480WE	11675787				2022-12-24	WOS:000171485700050
J	Higgins, J; Wilson, S; Bridge, P; Cooke, MW				Higgins, J; Wilson, S; Bridge, P; Cooke, MW			Communication difficulties during 999 ambulance calls: observational study	BRITISH MEDICAL JOURNAL			English	Article									Univ Birmingham, Dept Primary Care & Gen Practice, Emergency Med Res Grp, Birmingham B15 2TT, W Midlands, England; Univ Warwick, Sch Hlth & Social Studies, Ctr Primary Hlth Care Studies, Emergency Med Res Grp, Coventry CV4 7AL, W Midlands, England	University of Birmingham; University of Warwick	Wilson, S (corresponding author), Univ Birmingham, Dept Primary Care & Gen Practice, Emergency Med Res Grp, Birmingham B15 2TT, W Midlands, England.							Cooke MW, 1998, PREHOSPITAL IMMEDIAT, V2, P193; Marsden A K, 1995, Accid Emerg Nurs, V3, P177, DOI 10.1016/0965-2302(95)90002-0; MCNAUGHTON GW, 1997, PREHOSP IMMED CARE, V1, P71; *MOB PHON HLTH IND, 2000, NAT RAD PROT BOARD; NICHOLL J, 1996, PREHOSP IMMED CARE, V3, P71	5	14	14	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 6	2001	323	7316					781	782		10.1136/bmj.323.7316.781	http://dx.doi.org/10.1136/bmj.323.7316.781			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	481LK	11588079	Bronze, Green Published			2022-12-24	WOS:000171520600028
J	Nicewarner-Pena, SR; Freeman, RG; Reiss, BD; He, L; Pena, DJ; Walton, ID; Cromer, R; Keating, CD; Natan, MJ				Nicewarner-Pena, SR; Freeman, RG; Reiss, BD; He, L; Pena, DJ; Walton, ID; Cromer, R; Keating, CD; Natan, MJ			Submicrometer metallic barcodes	SCIENCE			English	Article							GOLD; MONOLAYERS; ARRAYS	We synthesized multimetal microrods intrinsically encoded with submicrometer stripes. Complex striping patterns are readily prepared by sequential electrochemical deposition of metal ions into templates with uniformly sized pores. The differential reflectivity of adjacent stripes enables identification of the striping patterns by conventional tight microscopy. This readout mechanism does not interfere with the use of fluorescence for detection of analytes bound to particles by affinity capture, as demonstrated by DNA and protein bioassays.	Penn State Univ, Dept Chem, Davey Lab 152, University Pk, PA 16802 USA; SurroMed Inc, Mt View, CA 94043 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Keating, CD (corresponding author), Penn State Univ, Dept Chem, Davey Lab 152, University Pk, PA 16802 USA.			Keating, Christine/0000-0001-6039-1961	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002228] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG02228] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		ALMAWLAWI D, 1994, J MATER RES, V9, P1014, DOI 10.1557/JMR.1994.1014; Battersby BJ, 2000, J AM CHEM SOC, V122, P2138, DOI 10.1021/ja993634i; Bruchez M, 1998, SCIENCE, V281, P2013, DOI 10.1126/science.281.5385.2013; Chan WCW, 1998, SCIENCE, V281, P2016, DOI 10.1126/science.281.5385.2016; Cheung VG, 1999, NAT GENET, V21, P15, DOI 10.1038/4439; Dunbar SA, 2000, CLIN CHEM, V46, P1498; Grabar KC, 1997, ANAL CHEM, V69, P471, DOI 10.1021/ac9605962; Han MY, 2001, NAT BIOTECHNOL, V19, P631, DOI 10.1038/90228; Harder P, 1998, J PHYS CHEM B, V102, P426, DOI 10.1021/jp972635z; HARRISON DJ, 1993, SCIENCE, V261, P895, DOI 10.1126/science.261.5123.895; Henry MR, 1999, ANAL BIOCHEM, V276, P204, DOI 10.1006/abio.1999.4344; Hulteen JC, 1997, J MATER CHEM, V7, P1075, DOI 10.1039/a700027h; Inoue S., 1997, VIDEO MICROSCOPY; LIDE DR, 1990, CRC HDB CHEM PHYSICS; Martin BR, 1999, ADV MATER, V11, P1021, DOI 10.1002/(SICI)1521-4095(199908)11:12<1021::AID-ADMA1021>3.0.CO;2-S; Masuda H, 2001, ADV MATER, V13, P189, DOI 10.1002/1521-4095(200102)13:3<189::AID-ADMA189>3.0.CO;2-Z; Savas TA, 1996, J VAC SCI TECHNOL B, V14, P4167, DOI 10.1116/1.588613; SKOOG DA, 1992, FUNDAMENTALS ANAL CH, P42; Thurn-Albrecht T, 2000, SCIENCE, V290, P2126, DOI 10.1126/science.290.5499.2126; Ulman A., 1991, INTRO ULTRATHIN FILM; Walt DR, 2000, SCIENCE, V287, P451, DOI 10.1126/science.287.5452.451	21	1215	1318	8	287	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 5	2001	294	5540					137	141		10.1126/science.294.5540.137	http://dx.doi.org/10.1126/science.294.5540.137			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480EJ	11588257				2022-12-24	WOS:000171448800045
J	Park, HS; Himmelbach, A; Browning, KS; Hohn, T; Ryabova, LA				Park, HS; Himmelbach, A; Browning, KS; Hohn, T; Ryabova, LA			A plant viral "reinitiation" factor interacts with the host translational machinery	CELL			English	Article							CAULIFLOWER MOSAIC-VIRUS; OPEN READING FRAME; POLYCISTRONIC MESSENGER-RNA; FACTOR 3 EIF3; RIBOSOMAL-SUBUNIT; INITIATION-FACTORS; GENE-EXPRESSION; CROSS-LINKING; PROTEIN; YEAST	The cauliflower mosaic virus transactivator, TAV, controls translation reinitiation of major open reading frames on polycistronic RNA. We show here that TAV function depends on its association with polysomes and eukaryotic initiation factor eIF3 in vitro and in vivo. TAV physically interacts with eIF3 and the 60S ribosomal subunit. Two proteins mediating these interactions were identified: eIF3g and 60S ribosomal protein L24. Transient expression of eIF3g and L24 in plant protoplasts strongly affects TAV-mediated reinitiation activity. We demonstrate that TAV/eIF3/40S and eIF3/TAV160S ternary complexes form in vitro, and propose that TAV mediates efficient recruitment of eIF3 to polysomes, allowing translation of polycistronic mRNAs by reinitiation, overcoming the normal cell barriers to this process.	Friedrich Miescher Inst, CH-4002 Basel, Switzerland; Univ Texas, Dept Chem & Biochem, Austin, TX 78712 USA; Univ Texas, Inst Mol & Cellular Biol, Austin, TX 78712 USA	Friedrich Miescher Institute for Biomedical Research; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Hohn, T (corresponding author), Friedrich Miescher Inst, POB 2543, CH-4002 Basel, Switzerland.	hohn@fmi.ch; iryabova@fmi.ch		Ryabova, Lyubov/0000-0003-1989-203X; Himmelbach, Axel/0000-0001-7338-0946				Asano K, 2000, GENE DEV, V14, P2534, DOI 10.1101/gad.831800; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Bandyopadhyay A, 1999, NUCLEIC ACIDS RES, V27, P1331, DOI 10.1093/nar/27.5.1331; BARONASLOWELL DM, 1990, MOL CELL BIOL, V10, P5235, DOI 10.1128/MCB.10.10.5235; BONNEVILLE JM, 1989, CELL, V59, P1135, DOI 10.1016/0092-8674(89)90769-1; Burks EA, 2001, J BIOL CHEM, V276, P2122, DOI 10.1074/jbc.M007236200; Cerritelli SM, 1998, NUCLEIC ACIDS RES, V26, P1834, DOI 10.1093/nar/26.7.1834; DETAPIA M, 1993, EMBO J, V12, P3305, DOI 10.1002/j.1460-2075.1993.tb06000.x; DEVER TE, 1992, CELL, V68, P585, DOI 10.1016/0092-8674(92)90193-G; DEZOETEN GA, 1989, VIROLOGY, V172, P213, DOI 10.1016/0042-6822(89)90123-2; Dominguez DI, 1998, J BIOL CHEM, V273, P3669, DOI 10.1074/jbc.273.6.3669; Dresios J, 2000, BIOCHEMISTRY-US, V39, P7236, DOI 10.1021/bi9925266; FromontRacine M, 1997, NAT GENET, V16, P277, DOI 10.1038/ng0797-277; FUTTERER J, 1992, NUCLEIC ACIDS RES, V20, P3851, DOI 10.1093/nar/20.15.3851; FUTTERER J, 1991, EMBO J, V10, P3887, DOI 10.1002/j.1460-2075.1991.tb04958.x; FUTTERER J, 1990, POSTTRANSCRIPTIONAL, P347, DOI DOI 10.1007/978-3-642-75139-4_32; GIVORD L, 1984, EMBO J, V3, P1423, DOI 10.1002/j.1460-2075.1984.tb01987.x; GOWDA S, 1989, P NATL ACAD SCI USA, V86, P9203, DOI 10.1073/pnas.86.23.9203; HATAKEYAMA T, 1989, EUR J BIOCHEM, V185, P685, DOI 10.1111/j.1432-1033.1989.tb15166.x; Hershey JWB, 2000, COLD SPRING HARBOR M, V39, P33; Herzog E, 2000, J VIROL, V74, P2073, DOI 10.1128/JVI.74.5.2073-2083.2000; HEUFLER C, 1988, BIOCHIM BIOPHYS ACTA, V951, P182, DOI 10.1016/0167-4781(88)90039-5; Hinnebusch AG, 1997, J BIOL CHEM, V272, P21661, DOI 10.1074/jbc.272.35.21661; JACKSON AO, 1976, PLANT PHYSIOL, V57, P5, DOI 10.1104/pp.57.1.5; Jackson RJ, 2000, COLD SPRING HARBOR M, V39, P127; Kobayashi K, 1998, MICROBIOL IMMUNOL, V42, P377, DOI 10.1111/j.1348-0421.1998.tb02298.x; KOZAK M, 1987, MOL CELL BIOL, V7, P3438, DOI 10.1128/MCB.7.10.3438; Kumar KU, 1999, MOL CELL BIOL, V19, P1116; Leh V, 2000, VIROLOGY, V266, P1, DOI 10.1006/viro.1999.0073; Lin L, 2001, J CELL BIOCHEM, V80, P483, DOI 10.1002/1097-4644(20010315)80:4<483::AID-JCB1002>3.0.CO;2-B; LUUKKONEN BGM, 1995, J VIROL, V69, P4086, DOI 10.1128/JVI.69.7.4086-4094.1995; MARION MJ, 1987, BIOCHEM BIOPH RES CO, V149, P1077, DOI 10.1016/0006-291X(87)90518-3; MARTINEZIZQUIERDO JA, 1987, VIROLOGY, V160, P527, DOI 10.1016/0042-6822(87)90032-8; NAKAYASHIKI H, 1993, J GEN VIROL, V74, P2469, DOI 10.1099/0022-1317-74-11-2469; PEABODY DS, 1986, MOL CELL BIOL, V6, P2695, DOI 10.1128/MCB.6.7.2695; PEABODY DS, 1986, MOL CELL BIOL, V6, P2704, DOI 10.1128/MCB.6.7.2704; Pestova TV, 2000, NATURE, V403, P332, DOI 10.1038/35002118; Pestova TV, 1998, GENE DEV, V12, P67, DOI 10.1101/gad.12.1.67; Pestova TV, 1998, NATURE, V394, P854, DOI 10.1038/29703; Phan L, 1998, MOL CELL BIOL, V18, P4935, DOI 10.1128/MCB.18.8.4935; Pooggin MM, 2000, J BIOL CHEM, V275, P17288, DOI 10.1074/jbc.M001143200; Pooggin MM, 1998, J VIROL, V72, P4157, DOI 10.1128/JVI.72.5.4157-4169.1998; RAMAIAH KVA, 1992, P NATL ACAD SCI USA, V89, P12063, DOI 10.1073/pnas.89.24.12063; ROTHNIE HM, 1994, ADV VIRUS RES, V44, P1, DOI 10.1016/S0065-3527(08)60327-9; Ryabova LA, 2000, GENE DEV, V14, P817; SchmidtPuchta W, 1997, NUCLEIC ACIDS RES, V25, P2854, DOI 10.1093/nar/25.14.2854; SCHOLTHOF HB, 1992, J VIROL, V66, P3131, DOI 10.1128/JVI.66.5.3131-3139.1992; Shepherd R J, 1976, Adv Virus Res, V20, P305, DOI 10.1016/S0065-3527(08)60508-4; SRIVASTAVA S, 1992, J MOL BIOL, V226, P301, DOI 10.1016/0022-2836(92)90946-H; Tirode F, 1997, J BIOL CHEM, V272, P22995, DOI 10.1074/jbc.272.37.22995; UCHIUMI T, 1986, J BIOL CHEM, V261, P9663; Verlhac MH, 1997, EMBO J, V16, P6812, DOI 10.1093/emboj/16.22.6812; Vornlocher HP, 1999, J BIOL CHEM, V274, P16802, DOI 10.1074/jbc.274.24.16802; Wool IG, 1996, TRENDS BIOCHEM SCI, V21, P164, DOI 10.1016/S0968-0004(96)20011-8; Zhu SH, 1997, J BIOL CHEM, V272, P14434, DOI 10.1074/jbc.272.22.14434	55	123	127	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 21	2001	106	6					723	733		10.1016/S0092-8674(01)00487-1	http://dx.doi.org/10.1016/S0092-8674(01)00487-1			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	476EJ	11572778	Bronze			2022-12-24	WOS:000171213000009
J	Klarreich, E				Klarreich, E			Top researchers plan to snub fertility conference	NATURE			English	News Item																			0	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 20	2001	413	6853					241	241		10.1038/35095185	http://dx.doi.org/10.1038/35095185			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473KB	11564998	Bronze			2022-12-24	WOS:000171040500007
J	Thewissen, JGM; Williams, EM; Roe, LJ; Hussain, ST				Thewissen, JGM; Williams, EM; Roe, LJ; Hussain, ST			Skeletons of terrestrial cetaceans and the relationship of whales to artiodactyls	NATURE			English	Article							LOCOMOTOR EVOLUTION; EARLIEST CETACEANS; MIDDLE EOCENE; ORIGIN; MAMMALIA; PAKISTAN; INDIA; MODEL; TIME	Modern members of the mammalian order Cetacea (whales, dolphins and porpoises) are obligate aquatic swimmers that are highly distinctive in morphology, lacking hair and hind limbs, and having flippers, flukes, and a streamlined body. Eocene fossils document much of cetaceans' land-to-water transition, but, until now, the most primitive representative for which a skeleton was known was clearly amphibious and lived in coastal environments. Here we report on the skeletons of two early Eocene pakicetid cetaceans, the fox-sized Ichthyolestes pinfoldi, and the wolf-sized Pakicetus attocki. Their skeletons also elucidate the relationships of cetaceans to other mammals. Morphological cladistic analyses have shown cetaceans to be most closely related to one or more mesonychians, a group of extinct, archaic ungulates, but molecular analyses have indicated that they are the sister group to hippopotamids. Our cladistic analysis indicates that cetaceans are more closely related to artiodactyls than to any mesonychian. Cetaceans are not the sister group to (any) mesonychians, nor to hippopotamids. Our analysis stops short of identifying any particular artiodactyl family as the cetacean sister group and supports monophyly of artiodactyls.	Northeastern Ohio Univ Coll Med & Pharm, Coll Med, Dept Anat, Rootstown, OH 44272 USA; Univ Arizona, Dept Geosci, Tucson, AZ 85721 USA; Howard Univ, Coll Med, Dept Anat, Washington, DC 20059 USA	Northeast Ohio Medical University (NEOMED); University of Arizona; Howard University	Thewissen, JGM (corresponding author), Northeastern Ohio Univ Coll Med & Pharm, Coll Med, Dept Anat, Rootstown, OH 44272 USA.	thewisse@neoucom.edu		Thewissen, J. G. M./0000-0002-0973-4137				Bajpai S, 2000, CURR SCI INDIA, V79, P1478; Bajpai S, 1998, ADV VERT PALEOBIOL, P213; Bajpai S, 1998, P NATL ACAD SCI USA, V95, P15464, DOI 10.1073/pnas.95.26.15464; Gatesy J, 1998, ADV VERT PALEOBIOL, P63; Geisler JH, 1998, ADV VERT PALEOBIOL, P163; Gentry AW, 1988, PHYLOGENY CLASSIFICA, V35B, P235; GINGERICH PD, 1990, SCIENCE, V249, P154, DOI 10.1126/science.249.4965.154; GINGERICH PD, 1983, SCIENCE, V220, P403, DOI 10.1126/science.220.4595.403; GINGERICH PD, 1994, NATURE, V368, P844, DOI 10.1038/368844a0; GINGERICH PD, IN PRESS SCIENCE; Hemila S, 1999, HEARING RES, V133, P82, DOI 10.1016/S0378-5955(99)00055-6; Howell A.B., 1930, AQUAT MAMM; Howell AB, 1944, SPEED ANIMALS THEIR; Hulbert RC, 1998, J PALEONTOL, V72, P907, DOI 10.1017/S0022336000027232; Kellogg R, 1936, REV ARCHAEOCETI; King J. E., 1991, SEALS WORLD; LENHARDT M L, 1982, Journal of Auditory Research, V22, P153; Luckett W. Patrick, 1998, Journal of Mammalian Evolution, V5, P127, DOI 10.1023/A:1020501622015; Luo Z., 1999, U MICHIGAN PAPERS PA, V31, P1; Luo ZX, 2000, NATURE, V404, P235, DOI 10.1038/35005194; Luo ZX, 1998, ADV VERT PALEOBIOL, P269; MADAR SI, IN PRESS J VERTEBR P; Milinkovitch MC, 1998, ADV VERT PALEOBIOL, P113; Milinkovitch MC, 1997, NATURE, V388, P622, DOI 10.1038/41650; Naylor GJP, 2001, SYST BIOL, V50, P444, DOI 10.1080/106351501300318030; Nikaido M, 1999, P NATL ACAD SCI USA, V96, P10261, DOI 10.1073/pnas.96.18.10261; O'Leary MA, 1999, SYST BIOL, V48, P455, DOI 10.1080/106351599260102; O'Leary MA, 1998, ADV VERT PALEOBIOL, P133; O'Leary MA, 1999, PALEOBIOLOGY, V25, P534, DOI 10.1017/S0094837300020376; RADO R, 1989, HEARING RES, V41, P23, DOI 10.1016/0378-5955(89)90175-5; SHAEFFER B, 1947, AM MUS NOVIT, P1; Shimamura M, 1997, NATURE, V388, P666, DOI 10.1038/41759; SWOFFORD DL, 1998, PAUP 40B8 PHYLOGENET; Thewissen J.G.M., 1996, Courier Forschungsinstitut Senckenberg, V191, P1; Thewissen J.G.M., 1998, Bulletin of Carnegie Museum of Natural History, V34, P220; Thewissen J. G. M., 1994, Journal of Mammalian Evolution, V2, P157, DOI 10.1007/BF01473527; Thewissen JGM, 1997, PALEOBIOLOGY, V23, P482, DOI 10.1017/S0094837300019850; THEWISSEN JGM, 1994, SCIENCE, V263, P210, DOI 10.1126/science.263.5144.210; Thewissen JGM, 2001, J VERTEBR PALEONTOL, V21, P347, DOI 10.1671/0272-4634(2001)021[0347:EMFFNI]2.0.CO;2; THEWISSEN JGM, 1993, NATURE, V361, P444, DOI 10.1038/361444a0; THEWISSEN JGM, 1990, ANAT HISTOL EMBRYOL, V19, P37, DOI 10.1111/j.1439-0264.1990.tb00876.x; Thewissen JGM, 1998, NATURE, V395, P452, DOI 10.1038/26656; Thewissen JGM, 1999, SYST BIOL, V48, P21, DOI 10.1080/106351599260418; Uhen MD, 1998, ADV VERT PALEOBIOL, P29; Uhen MD, 1999, J PALEONTOL, V73, P512, DOI 10.1017/S002233600002802X; Vaughan TA, 1986, MAMMALOGY; Weber M, 1928, SAUGETIERE; Zhou Xiaoyuan, 1992, Contributions from the Museum of Paleontology University of Michigan, V28, P289	48	208	218	6	185	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 20	2001	413	6853					277	281		10.1038/35095005	http://dx.doi.org/10.1038/35095005			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473KB	11565023				2022-12-24	WOS:000171040500030
J	Uemura, N; Okamoto, S; Yamamoto, S; Matsumura, N; Yamaguchi, S; Yamakido, M; Taniyama, K; Sasaki, N; Schlemper, RJ				Uemura, N; Okamoto, S; Yamamoto, S; Matsumura, N; Yamaguchi, S; Yamakido, M; Taniyama, K; Sasaki, N; Schlemper, RJ			Helicobacter pylori infection and the development of gastric cancer.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	101st Annual Meeting of the American-Gastroenterological-Association	MAY 21-24, 2000	SAN DIEGO, CA	Amer Gastroenterol Assoc			DUODENAL-ULCER DISEASE; CARCINOMA; STOMACH; RISK; CLASSIFICATION; INFLAMMATION; EPIDEMIOLOGY; PREVALENCE; ANTIBODY; ATROPHY	Background: Although many studies have found an association between Helicobacter pylori infection and the development of gastric cancer, many aspects of this relation remain uncertain. Methods: We prospectively studied 1526 Japanese patients who had duodenal ulcers, gastric ulcers, gastric hyperplasia, or nonulcer dyspepsia at the time of enrollment; 1246 had H. pylori infection and 280 did not. The mean follow-up was 7.8 years (range, 1.0 to 10.6). Patients underwent endoscopy with biopsy at enrollment and then between one and three years after enrollment. H. pylori infection was assessed by histologic examination, serologic testing, and rapid urease tests and was defined by a positive result on any of these tests. Results: Gastric cancers developed in 36 (2.9 percent) of the infected and none of the uninfected patients. There were 23 intestinal-type and 13 diffuse-type cancers. Among the patients with H. pylori infection, those with severe gastric atrophy, corpus-predominant gastritis, and intestinal metaplasia were at significantly higher risk for gastric cancer. We detected gastric cancers in 21 (4.7 percent) of the 445 patients with nonulcer dyspepsia, 10 (3.4 percent) of the 297 with gastric ulcers, 5 (2.2 percent) of the 229 with gastric hyperplastic polyps, and none of the 275 with duodenal ulcers. Conclusions: Gastric cancer develops in persons infected with H. pylori but not in uninfected persons. Those with histologic findings of severe gastric atrophy, corpus-predominant gastritis, or intestinal metaplasia are at increased risk. Persons with H. pylori infection and nonulcer dyspepsia, gastric ulcers, or gastric hyperplastic polyps are also at risk, but those with duodenal ulcers are not. (N Engl J Med 2001;345:784-9.) Copyright (C) 2001 Massachusetts Medical Society.	Kure Kyosai Hosp, Dept Gastroenterol, Kure, Japan; Kure Kyosai Hosp, Dept Clin Pathol, Kure, Japan; Fukuoka Univ, Sch Med, Dept Internal Med, Fukuoka 81401, Japan	Fukuoka University	Uemura, N (corresponding author), Kure Kyosai Hosp, Dept Gastroenterol, 2-3-28 Nishi Chuo, Kure, Japan.	n-uemura@mua.biglobe.ne.jp						[Anonymous], 1983, LANCET, V1, P1273; ASAKA M, 1999, GASTRIC CANC HELICOB, P116; BLASER MJ, 1992, GASTROENTEROLOGY, V102, P720, DOI 10.1016/0016-5085(92)90126-J; CORREA P, 1990, CANCER-AM CANCER SOC, V66, P2569, DOI 10.1002/1097-0142(19901215)66:12<2569::AID-CNCR2820661220>3.0.CO;2-I; CORREA P, 1992, CANCER RES, V52, P6735; Danesh J, 1999, ALIMENT PHARM THERAP, V13, P851; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; Enomoto H, 1998, EUR J GASTROEN HEPAT, V10, P473, DOI 10.1097/00042737-199806000-00007; FORMAN D, 1991, BRIT MED J, V302, P1302, DOI 10.1136/bmj.302.6788.1302; GRAHAM DY, 1991, J GASTROEN HEPATOL, V6, P105, DOI 10.1111/j.1440-1746.1991.tb01448.x; Hansson LE, 1996, NEW ENGL J MED, V335, P242, DOI 10.1056/NEJM199607253350404; Huang JQ, 1998, GASTROENTEROLOGY, V114, P1169, DOI 10.1016/S0016-5085(98)70422-6; IARC, 1994, IARC MON EV CARC RIS, V61, P177; Ito S, 1996, GUT, V39, P800, DOI 10.1136/gut.39.6.800; KIKUCHI S, 1995, CANCER, V75, P2789, DOI 10.1002/1097-0142(19950615)75:12<2789::AID-CNCR2820751202>3.0.CO;2-4; Kimura K, 1969, ENDOSCOPY, V1, P1; Kokkola A, 1996, SCAND J GASTROENTERO, V31, P643, DOI 10.3109/00365529609009143; KUIPERS EJ, 1995, LANCET, V345, P1525, DOI 10.1016/S0140-6736(95)91084-0; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Meining A, 1997, VIRCHOWS ARCH, V431, P11, DOI 10.1007/s004280050063; Miwa H, 2000, DIAGN MICR INFEC DIS, V36, P95, DOI 10.1016/S0732-8893(99)00143-1; NOMURA A, 1991, NEW ENGL J MED, V325, P1132, DOI 10.1056/NEJM199110173251604; Ohara S, 1998, J GASTROENTEROL, V33, P6, DOI 10.1007/PL00009968; PARSONNET J, 1991, NEW ENGL J MED, V325, P1127, DOI 10.1056/NEJM199110173251603; SAS Institute, 1996, SAS STAT SOFTW CHANG; Satoh K, 1996, AM J GASTROENTEROL, V91, P963; Schlemper RJ, 2000, GUT, V47, P251, DOI 10.1136/gut.47.2.251; SIPPONEN P, 1992, J CLIN PATHOL, V45, P319, DOI 10.1136/jcp.45.4.319; SIPPONEN P, 1993, SCAND J GASTROENTERO, V28, P3, DOI 10.3109/00365529309098333; Solcia E, 1996, AM J SURG PATHOL, V20, pS8; STOLTE M, 1990, Z GASTROENTEROL, V28, P229; Tabata H, 1999, DIGEST DIS SCI, V44, P2027, DOI 10.1023/A:1026622418625; Uemura N, 1997, CANCER EPIDEM BIOMAR, V6, P639	33	3233	3391	6	345	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 13	2001	345	11					784	789		10.1056/NEJMoa001999	http://dx.doi.org/10.1056/NEJMoa001999			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	471BK	11556297				2022-12-24	WOS:000170906800002
J	Rose, NF; Marx, PA; Luckay, A; Nixon, DF; Moretto, WJ; Donahoe, SM; Montefiori, D; Roberts, A; Buonocore, L; Rose, JK				Rose, NF; Marx, PA; Luckay, A; Nixon, DF; Moretto, WJ; Donahoe, SM; Montefiori, D; Roberts, A; Buonocore, L; Rose, JK			An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants	CELL			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; T-CELL RESPONSES; RHESUS-MONKEYS; PRIMARY ISOLATE; NEUTRALIZING ANTIBODIES; LYMPHOCYTE DEPLETION; TYPE-1; ENVELOPE; GLYCOPROTEINS; INFECTION	We developed an AIDS vaccine based on attenuated VSV vectors expressing env and gag genes and tested it in rhesus monkeys. Boosting was accomplished using vectors with glycoproteins from different VSV serotypes. Animals were challenged with a pathogenic AIDS virus (SHIV89.6P). Control monkeys showed a severe loss of CD4(+) T cells and high viral loads, and 7/8 progressed to AIDS with an average time of 148 days. All seven vaccinees were initially infected with SHIV89.6P but have remained healthy for up to 14 months after challenge with low or undetectable viral loads. Protection from AIDS was highly significant (p=0.001). VSV vectors are promising candidates for human AIDS vaccine trials because they propagate to high titers and can be delivered without injection.	Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; Aaron Diamond AIDS Res Ctr, New York, NY 10016 USA; Tulane Univ, Hlth Sci Ctr, New Orleans, LA 70043 USA; Gladstone Inst Virol & Immunol, San Francisco, CA 94141 USA; Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA	Yale University; Yale University; Tulane University; University of California System; University of California San Francisco; The J David Gladstone Institutes; Duke University	Rose, JK (corresponding author), Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA.	john.rose@yale.edu	Nixon, Douglas/AAU-5734-2020	Nixon, Douglas/0000-0002-2801-1786	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI045510, R37AI040357, R01AI040357, R01AI045510, N01AI085343] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-45510, AI-40357, AI-85343] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Amara RR, 2001, SCIENCE, V292, P69, DOI 10.1126/science.1058915; Barouch DH, 2000, SCIENCE, V290, P486, DOI 10.1126/science.290.5491.486; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Bures R, 2000, AIDS RES HUM RETROV, V16, P2019, DOI 10.1089/088922200750054756; Burton DR, 1997, P NATL ACAD SCI USA, V94, P10018, DOI 10.1073/pnas.94.19.10018; CHEN ZW, 1995, J EXP MED, V182, P21, DOI 10.1084/jem.182.1.21; Crawford JM, 1999, J VIROL, V73, P10199, DOI 10.1128/JVI.73.12.10199-10207.1999; DANIEL MD, 1992, SCIENCE, V258, P1938, DOI 10.1126/science.1470917; Donahoe SM, 2000, VIROLOGY, V272, P347, DOI 10.1006/viro.2000.0404; FIELDS BN, 1967, NEW ENGL J MED, V277, P889, DOI 10.1056/NEJM196711092771901; Haglund K, 2000, VIROLOGY, V268, P112, DOI 10.1006/viro.1999.0120; Hinman A, 1999, ANNU REV PUBL HEALTH, V20, P211, DOI 10.1146/annurev.publhealth.20.1.211; Johnson JE, 1997, J VIROL, V71, P5060, DOI 10.1128/JVI.71.7.5060-5068.1997; JOHNSON KM, 1966, AM J TROP MED HYG, V15, P244, DOI 10.4269/ajtmh.1966.15.244; Karlsson GB, 1997, J VIROL, V71, P4218, DOI 10.1128/JVI.71.6.4218-4225.1997; Karlsson GB, 1998, J EXP MED, V188, P1159, DOI 10.1084/jem.188.6.1159; KESTLER H, 1990, SCIENCE, V248, P1109, DOI 10.1126/science.2160735; Kim SK, 1998, P NATL ACAD SCI USA, V95, P10814, DOI 10.1073/pnas.95.18.10814; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Kretzschmar E, 1997, J VIROL, V71, P5982, DOI 10.1128/JVI.71.8.5982-5989.1997; Kuroda MJ, 1998, J EXP MED, V187, P1373, DOI 10.1084/jem.187.9.1373; LAWSON ND, 1995, P NATL ACAD SCI USA, V92, P4477, DOI 10.1073/pnas.92.10.4477; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Montefiori DC, 1998, J VIROL, V72, P3427, DOI 10.1128/JVI.72.4.3427-3431.1998; Moretto WJ, 2000, AIDS, V14, P2625, DOI 10.1097/00002030-200011100-00034; Musey L, 1997, NEW ENGL J MED, V337, P1267, DOI 10.1056/NEJM199710303371803; Ogg GS, 1998, SCIENCE, V279, P2103, DOI 10.1126/science.279.5359.2103; PACHL C, 1995, J ACQ IMMUN DEF SYND, V8, P446, DOI 10.1097/00042560-199504120-00003; PANTALEO G, 1994, NATURE, V370, P463, DOI 10.1038/370463a0; REGIER DA, 1990, AIDS RES HUM RETROV, V6, P1221, DOI 10.1089/aid.1990.6.1221; Reimann KA, 1996, J VIROL, V70, P6922, DOI 10.1128/JVI.70.10.6922-6928.1996; Reiss CS, 1998, ANN NY ACAD SCI, V855, P751, DOI 10.1111/j.1749-6632.1998.tb10655.x; Richardson TM, 1996, J VIROL, V70, P753, DOI 10.1128/JVI.70.2.753-762.1996; Roberts A, 1998, J VIROL, V72, P4704, DOI 10.1128/JVI.72.6.4704-4711.1998; Roberts A, 1999, J VIROL, V73, P3723, DOI 10.1128/JVI.73.5.3723-3732.1999; Rose NF, 2000, J VIROL, V74, P10903, DOI 10.1128/JVI.74.23.10903-10910.2000; Rosenberg ES, 1997, SCIENCE, V278, P1447, DOI 10.1126/science.278.5342.1447; Schlereth B, 2000, J VIROL, V74, P4652, DOI 10.1128/JVI.74.10.4652-4657.2000; Schnell MJ, 1996, J VIROL, V70, P2318, DOI 10.1128/JVI.70.4.2318-2323.1996; Schnell MJ, 1996, P NATL ACAD SCI USA, V93, P11359, DOI 10.1073/pnas.93.21.11359; Schnell MJ, 1998, EMBO J, V17, P1289, DOI 10.1093/emboj/17.5.1289; TESH RB, 1969, AM J EPIDEMIOL, V90, P255, DOI 10.1093/oxfordjournals.aje.a121068; *UNAIDS, 2000, AIDS EP UPD; Wagner R.R., 1996, RHABDOVIRIDAE VIRUSE, P1121; ZINKERNAGEL RM, 1978, EXP CELL BIOL, V46, P53	45	380	404	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 7	2001	106	5					539	549		10.1016/S0092-8674(01)00482-2	http://dx.doi.org/10.1016/S0092-8674(01)00482-2			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	472FQ	11551502	Bronze			2022-12-24	WOS:000170973200005
J	Rogers, A				Rogers, A			Europe join debate on care for the terminally ill	LANCET			English	News Item																		1999, LANCET, V353, P2220	1	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 3	1999	354	9172					55	55		10.1016/S0140-6736(05)75326-5	http://dx.doi.org/10.1016/S0140-6736(05)75326-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	212XP	11657547				2022-12-24	WOS:000081243200035
J	Martin, W; Stoebe, B; Goremykin, V; Hansmann, S; Hasegawa, M; Kowallik, KV				Martin, W; Stoebe, B; Goremykin, V; Hansmann, S; Hasegawa, M; Kowallik, KV			Gene transfer to the nucleus and the evolution of chloroplasts	NATURE			English	Article							COMPLETE SEQUENCE; EUGLENA; PROCHLOROPHYTES; CHLOROPHYLL; ORIGINS; GENOME; ALGAE; TREES; MODEL; DNA	Photosynthetic eukaryotes, particularly unicellular forms, possess a fossil record that is either wrought with gaps or difficult to interpret, or both. Attempts to reconstruct their evolution have focused on plastid phylogeny, but were limited by the amount and type of phylogenetic information contained within single genes(1-5). Among the 210 different protein-coding genes contained in the completely sequenced chloroplast genomes from a glaucocystophyte, a rhodophyte, a diatom, a euglenophyte and five land plants, we have now identified the set of 45 common to each and to a cyanobacterial outgroup genome. Phylogenetic inference with an alignment of 11,039 amino-acid positions per genome indicates that this information is sufficient - but just barely so - to identify the rooted nine-taxon topology. We mapped the process of gene loss from chloroplast genomes across the inferred tree and found that, surprisingly, independent parallel gene losses in multiple lineages outnumber phylogenetically unique losses by more than 4:1. We identified homologues of 44 different plastid-encoded proteins as functional nuclear genes of chloroplast origin, providing evidence for endosymbiotic gene transfer to the nucleus in plants.	Tech Univ Carolo Wilhelmina Braunschweig, Inst Genet, D-38023 Braunschweig, Germany; Univ Dusseldorf, Inst Bot, D-40225 Dusseldorf, Germany; Inst Stat Math, Minato Ku, Tokyo 106, Japan	Braunschweig University of Technology; Heinrich Heine University Dusseldorf; Research Organization of Information & Systems (ROIS); Institute of Statistical Mathematics (ISM) - Japan	Martin, W (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Inst Genet, Spielmannstr 7, D-38023 Braunschweig, Germany.	w.martin@tu-bs.de	Martin, William/C-5680-2008; Martin, William F./O-5446-2015	Martin, William F./0000-0003-1478-6449				ACACHI J, 1996, COMPUT SCI MONOGRAPH, V28; Adachi J, 1996, J MOL EVOL, V42, P459; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; CAVALIERSMITH T, 1993, MICROBIOL REV, V57, P953, DOI 10.1128/MMBR.57.4.953-994.1993; CavalierSmith T, 1996, EUR J PHYCOL, V31, P315, DOI 10.1080/09670269600651541; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; GIBBS SP, 1978, CAN J BOT, V56, P2883, DOI 10.1139/b78-345; HALLICK RB, 1993, NUCLEIC ACIDS RES, V21, P3537, DOI 10.1093/nar/21.15.3537; Hedtke B, 1997, SCIENCE, V277, P809, DOI 10.1126/science.277.5327.809; HELMCHEN TA, 1995, J MOL EVOL, V41, P203; HENZE K, 1995, P NATL ACAD SCI USA, V92, P9122, DOI 10.1073/pnas.92.20.9122; Herrmann RG, 1997, EUKARYOTISM SYMBIOSI, P73, DOI [10.1007/978-3-642-60885-8_7, DOI 10.1007/978-3-642-60885-8_7]; Kaneko T, 1996, DNA Res, V3, P109; Kowallik KV, 1995, PLANT MOL BIOL REP, V13, P336, DOI 10.1007/BF02669188; Lockhart PJ, 1996, P NATL ACAD SCI USA, V93, P1930, DOI 10.1073/pnas.93.5.1930; LOCKHART PJ, 1994, MOL BIOL EVOL, V11, P605; LOFFELHARDT W, 1994, MOL BIOL CYANOBACTER, P56; Lynch M, 1996, MOL BIOL EVOL, V13, P209, DOI 10.1093/oxfordjournals.molbev.a025557; MAIER RM, 1995, J MOL BIOL, V251, P614, DOI 10.1006/jmbi.1995.0460; Martin W, 1997, CURR GENET, V32, P1, DOI 10.1007/s002940050241; Martin W, 1998, NATURE, V392, P37, DOI 10.1038/32096; Melkonian Michael, 1996, Progress in Botany, V57, P281; Moran NA, 1996, P NATL ACAD SCI USA, V93, P2873, DOI 10.1073/pnas.93.7.2873; Naylor GJP, 1997, NATURE, V388, P527, DOI 10.1038/41460; PALENIK B, 1992, NATURE, V355, P265, DOI 10.1038/355265a0; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; URBACH E, 1992, NATURE, V355, P267, DOI 10.1038/355267a0; VanDePeer Y, 1996, P NATL ACAD SCI USA, V93, P7732, DOI 10.1073/pnas.93.15.7732; WAKASUGI T, 1994, P NATL ACAD SCI USA, V91, P9794, DOI 10.1073/pnas.91.21.9794	30	572	604	2	98	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 14	1998	393	6681					162	165		10.1038/30234	http://dx.doi.org/10.1038/30234			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZN200	11560168				2022-12-24	WOS:000073619900046
J	Shoham, S; Halgren, E; Maynard, EM; Normann, RA				Shoham, S; Halgren, E; Maynard, EM; Normann, RA			Motor-cortical activity in tetraplegics	NATURE			English	Article							CORTEX; REORGANIZATION		Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA; Massachusetts Gen Hosp, Nucl Magnet Resonance Ctr, Charlestown, MA 02129 USA	Utah System of Higher Education; University of Utah; Harvard University; Massachusetts General Hospital	Shoham, S (corresponding author), Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA.			Shoham, Shy/0000-0003-0376-3495				Cheney PD, 2000, PROG BRAIN RES, V128, P135; Fink GR, 1997, J NEUROPHYSIOL, V77, P2164, DOI 10.1152/jn.1997.77.4.2164; Friston K.J., 1994, HUMAN BRAIN MAPPING, V2, P211, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Green JB, 1999, NEUROLOGY, V53, P736, DOI 10.1212/WNL.53.4.736; Kennedy PR, 2000, IEEE T REHABIL ENG, V8, P198, DOI 10.1109/86.847815; Lotze M, 1999, RESTOR NEUROL NEUROS, V14, P183; Nicolelis MAL, 2001, NATURE, V409, P403, DOI 10.1038/35053191; Nitschke MF, 1996, BRAIN, V119, P1023; Raineteau O, 2001, NAT REV NEUROSCI, V2, P263, DOI 10.1038/35067570; Sanes JN, 2000, ANNU REV NEUROSCI, V23, P393, DOI 10.1146/annurev.neuro.23.1.393; Turner JA, 2001, IEEE T NEUR SYS REH, V9, P154, DOI 10.1109/7333.928575; Wessberg J, 2000, NATURE, V408, P361, DOI 10.1038/35042582; Yousry TA, 1997, BRAIN, V120, P141, DOI 10.1093/brain/120.1.141	13	73	74	0	6	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 25	2001	413	6858					793	793		10.1038/35101651	http://dx.doi.org/10.1038/35101651			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	485JA	11677592	Bronze			2022-12-24	WOS:000171750200031
J	Marivaux, L; Welcomme, JL; Antoine, PO; Metais, G; Baloch, IM; Benammi, M; Chaimanee, Y; Ducrocq, S; Jaeger, JJ				Marivaux, L; Welcomme, JL; Antoine, PO; Metais, G; Baloch, IM; Benammi, M; Chaimanee, Y; Ducrocq, S; Jaeger, JJ			A fossil lemur from the Oligocene of Pakistan	SCIENCE			English	Article							MOLECULAR PHYLOGENY; SINGLE-ORIGIN; PRIMATE; CHEIROGALEIDAE; MADAGASCAR	In the absence of a comprehensive fossil record, the origin and early evolution of Malagasy lemurs have been subject to much uncertainty. We report here the discovery of a strepsirrhine fossil with strong cheirogaleid lemur affinities, Bugtilemur mathesoni gen. et sp. nov., from early Oligocene deposits of the Bugti Hills (Balochistan, Pakistan). Bugtilemur represents the earliest record of Lemuriformes, which hence appear to. have already diversified outside of Madagascar at least 30 million years ago. This fossil clearly enhances the critical role of the Indian subcontinent in the early diversification of lemurs and constrains paleobiogeographic models of strepsirrhine lemur evolution.	Univ Montpellier 2, CNRS, Inst Sci Evolut, Lab Paleontol,UMR 5554, F-34095 Montpellier 5, France; Univ Balochistan, Dept Geol, Quetta, Pakistan; Museum Natl Hist Nat, CNRS, Lab Paleontol, UMR 8569, F-75231 Paris 5, France; Univ Nacl Autonoma Mexico, Inst Geofis, Lab Paleomagnetismo, Mexico City 04510, DF, Mexico; Dept Mineral Resources, Geol Survey Div, Paleontol Sect, Bangkok 10400, Thailand	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; University of Balochistan; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); Universidad Nacional Autonoma de Mexico; Department of Mineral Resources - Thailand	Marivaux, L (corresponding author), Univ Montpellier 2, CNRS, Inst Sci Evolut, Lab Paleontol,UMR 5554, CC064,Pl E Bataillon, F-34095 Montpellier 5, France.	marivaux@isem.univ-montp2.fr; jaeger@isem.univ-montp2.fr	Métais, Grégoire/F-6916-2010	Benammi, Mouloud/0000-0003-4707-7518; chaimanee, yaowalak/0000-0002-8432-3880				BEARD KC, 1988, NATURE, V331, P712, DOI 10.1038/331712a0; Cartmill M., 1975, P313; CHARLESD.P, 1970, NATURE, V227, P257, DOI 10.1038/227257a0; CIOCHON RL, 1994, INTEGRATIVE PATHS PA, P37; DAGOSTO M, 1988, J HUM EVOL, V17, P35, DOI 10.1016/0047-2484(88)90048-6; Gheerbrant Emmanuel, 1993, Palaeovertebrata (Montpellier), V22, P141; Gingerich P.D., 1975, P65; Gingerich P. D., 1977, Geobios Lyon Memoire Special, VNo. 1, P165; GOODMAN M, 1994, AM J PHYS ANTHROPOL, V94, P3, DOI 10.1002/ajpa.1330940103; Gregory WK, 1915, BULL GEOL SOC AM, V26, P419; Jaeger JJ, 1999, SCIENCE, V286, P528, DOI 10.1126/science.286.5439.528; Jansa SA, 1999, CLADISTICS, V15, P253, DOI 10.1111/j.1096-0031.1999.tb00267.x; JODOT P, 1952, MEM I SCI MADAGASC D, V4, P131; Kappeler PM, 2000, FOLIA PRIMATOL, V71, P422, DOI 10.1159/000052741; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; MACPHEE RDE, 1986, VERTEBRATES PHYLOGEN, V3, P131; Martin R.D., 1990, PRIMATE ORIGINS EVOL; Martin RD, 2000, INT J PRIMATOL, V21, P1021, DOI 10.1023/A:1005563113546; McCall RA, 1997, P ROY SOC B-BIOL SCI, V264, P663, DOI 10.1098/rspb.1997.0094; Pastorini J, 2001, MOL PHYLOGENET EVOL, V19, P45, DOI 10.1006/mpev.2000.0904; Rage JC, 1996, COLLOQ SEMI, P27; Rasmussen DT, 1998, FOLIA PRIMATOL, V69, P250; ROSENBERGER AL, 1985, FOLIA PRIMATOL, V44, P15, DOI 10.1159/000156195; Ross C, 1998, J HUM EVOL, V35, P221, DOI 10.1006/jhev.1998.0254; SCHWARTZ J H, 1985, Anthropological Papers of the American Museum of Natural History, V60, P1; Simons EL, 1997, P NATL ACAD SCI USA, V94, P180, DOI 10.1073/pnas.94.1.180; STOREY M, 1995, SCIENCE, V267, P852, DOI 10.1126/science.267.5199.852; SZALAY FS, 1973, FOLIA PRIMATOL, V19, P88, DOI 10.1159/000155535; TATTERSALL I, 1974, ANTHROPOL PAP AM MUS, V52, P137; Welcomme JL, 2001, GEOL MAG, V138, P397, DOI 10.1017/S0016756801005428; Yoder AD, 1997, EVOL ANTHROPOL, V6, P11, DOI 10.1002/(SICI)1520-6505(1997)6:1<11::AID-EVAN6>3.0.CO;2-Z; YODER AD, 1994, AM J PHYS ANTHROPOL, V94, P25, DOI 10.1002/ajpa.1330940104; Yoder AD, 1996, P NATL ACAD SCI USA, V93, P5122, DOI 10.1073/pnas.93.10.5122	33	61	65	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2001	294	5542					587	591		10.1126/science.1065257	http://dx.doi.org/10.1126/science.1065257			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484NC	11641497				2022-12-24	WOS:000171695600045
J	Moreira-Leite, FF; Sherwin, T; Kohl, L; Gull, K				Moreira-Leite, FF; Sherwin, T; Kohl, L; Gull, K			A trypanosome structure involved in transmitting cytoplasmic information during cell division	SCIENCE			English	Article							DOUBLE-STRANDED-RNA; BRUCEI; CYCLE; INTERFERENCE; SEGREGATION; GLYCOPROTEIN; CYTOKINESIS; POLARITY; ADHESION; SYSTEM	African trypanosomes are protozoan parasites that cause sleeping sickness in humans through a tsetse fly vector. The procyclic form of Trypanosoma brucei has a single, attached flagellum that describes a helical path along the cell from posterior to anterior. During division, a specific flagellum-flagellum connection is elaborated between the new and old flagellum. This connector was present only during cell duplication and was found to be involved in the replication of the helical cell pattern and polarity. This finding implicates the concept of cytotaxis in cell morphogenesis in trypanosomes.	Univ Manchester, Sch Biol Sci, Manchester M13 9PT, Lancs, England	University of Manchester	Gull, K (corresponding author), Univ Manchester, Sch Biol Sci, 2-205 Stopford Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	k.gutt@man.ac.uk	Sherwin, Trevor/A-1217-2008	Sherwin, Trevor/0000-0002-9090-1034				Bastin P, 2000, J CELL SCI, V113, P3321; BASTIN P, 1996, PARASITOL TODAY, V12, P295; BEISSON J, 1965, P NATL ACAD SCI USA, V53, P275, DOI 10.1073/pnas.53.2.275; Chen T, 2000, SCIENCE, V290, P1975, DOI 10.1126/science.290.5498.1975; COOPER R, 1993, J CELL BIOL, V122, P149, DOI 10.1083/jcb.122.1.149; DOLAN MT, 1986, J CELL SCI, V80, P123; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; GRIMES GW, 1982, AM ZOOL, V22, P35; Gull K, 1999, ANNU REV MICROBIOL, V53, P629, DOI 10.1146/annurev.micro.53.1.629; Kohl L, 1999, J EUKARYOT MICROBIOL, V46, P105, DOI 10.1111/j.1550-7408.1999.tb04592.x; LaCount DJ, 2000, MOL BIOCHEM PARASIT, V111, P67, DOI 10.1016/S0166-6851(00)00300-5; Ngo H, 1998, P NATL ACAD SCI USA, V95, P14687, DOI 10.1073/pnas.95.25.14687; Nozaki T, 1996, MOL BIOCHEM PARASIT, V82, P245, DOI 10.1016/0166-6851(96)02741-7; Ploubidou A, 1999, J CELL SCI, V112, P4641; ROBINSON DR, 1995, J CELL BIOL, V128, P1163, DOI 10.1083/jcb.128.6.1163; ROBINSON DR, 1991, NATURE, V352, P731, DOI 10.1038/352731a0; SHERWIN T, 1989, PHILOS T R SOC B, V323, P573, DOI 10.1098/rstb.1989.0037; SONNEBORN TM, 1964, P NATL ACAD SCI USA, V51, P915, DOI 10.1073/pnas.51.5.915; Wang ZF, 2000, J BIOL CHEM, V275, P40174, DOI 10.1074/jbc.M008405200; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X	20	120	120	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2001	294	5542					610	612		10.1126/science.1063775	http://dx.doi.org/10.1126/science.1063775			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484NC	11641501				2022-12-24	WOS:000171695600051
J	Weimerskirch, H; Martin, J; Clerquin, Y; Alexandre, P; Jiraskova, S				Weimerskirch, H; Martin, J; Clerquin, Y; Alexandre, P; Jiraskova, S			Energy saving in flight formation - Pelicans flying in a 'V' can glide for extended periods using the other birds' air streams.	NATURE			English	Article							INDUCED DRAG		CNRS, Ctr Etud Biol Chize, F-79360 Villiers En Bois, France; Galatee Films, Peuple Migrateur Jacques Perrin, F-75017 Paris, France	Centre National de la Recherche Scientifique (CNRS)	Weimerskirch, H (corresponding author), CNRS, Ctr Etud Biol Chize, F-79360 Villiers En Bois, France.	henriw@cebc.cnrs.fr	Weimerskirch, Henri/K-7306-2019; Weimerskirch, Henri/F-5562-2013	Weimerskirch, Henri/0000-0002-0457-586X; Martin, Julien/0000-0002-7375-129X				BADGEROW JP, 1981, J THEOR BIOL, V93, P41, DOI 10.1016/0022-5193(81)90055-2; BADGEROW JP, 1988, AUK, V105, P749, DOI 10.1093/auk/105.4.749; CUTTS CJ, 1994, J EXP BIOL, V189, P251; GOULD LL, 1974, AUK, V91, P494; HAINSWORTH FR, 1988, J EXP BIOL, V135, P431; Hamilton WJ, 1967, ANIMAL ORIENTATION N, P57; HIGDON JJL, 1978, AM NAT, V112, P727, DOI 10.1086/283314; HUMMEL D, 1983, J THEOR BIOL, V104, P321, DOI 10.1016/0022-5193(83)90110-8; LISSAMAN PB, 1970, SCIENCE, V168, P1003, DOI 10.1126/science.168.3934.1003; OMALLEY JBE, 1982, CAN J ZOOL, V60, P1388, DOI 10.1139/z82-187; Weimerskirch H, 2000, P ROY SOC B-BIOL SCI, V267, P1869, DOI 10.1098/rspb.2000.1223	11	297	312	3	94	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 18	2001	413	6857					697	698		10.1038/35099670	http://dx.doi.org/10.1038/35099670			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	482ZK	11607019				2022-12-24	WOS:000171608000031
J	Grossman, JM; MacLean, CH				Grossman, JM; MacLean, CH			Quality indicators for the management of osteoporosis in vulnerable elders	ANNALS OF INTERNAL MEDICINE			English	Review							BONE-MINERAL DENSITY; HORMONE REPLACEMENT THERAPY; RANDOMIZED CONTROLLED TRIAL; FRACTURE INTERVENTION TRIAL; EARLY POSTMENOPAUSAL WOMEN; VITAMIN-D SUPPLEMENTATION; ESTROGEN PLUS PROGESTIN; POST-MENOPAUSAL WOMEN; BREAST-CANCER RISK; HIP FRACTURE		Univ Calif Los Angeles, Los Angeles, CA 90095 USA; RAND Corp, RAND Hlth, Santa Monica, CA 90406 USA	University of California System; University of California Los Angeles; RAND Corporation	Grossman, JM (corresponding author), Univ Calif Los Angeles, 1000 Vet Ave,Room 32-59, Los Angeles, CA 90095 USA.	jgrossman@mednet.ucla.edu						*AM ASS CLIN END, 2001, AM ASS CLIN END 2001; *AM ASS CLIN END, 1998, AM ASS CLIN END CLIN; Anderson FH, 1996, BONE, V18, P171, DOI 10.1016/8756-3282(95)00441-6; Bagur A, 1996, MEDICINA-BUENOS AIRE, V56, P247; BAUER DC, 1993, ANN INTERN MED, V118, P657, DOI 10.7326/0003-4819-118-9-199305010-00001; Behre HM, 1997, J CLIN ENDOCR METAB, V82, P2386, DOI 10.1210/jc.82.8.2386; Black DM, 1996, LANCET, V348, P1535, DOI 10.1016/S0140-6736(96)07088-2; BODY JJ, 1995, CLIN RHEUMATOL, V14, P18, DOI 10.1007/BF02210683; *CAN TASK FORC PRE, 1999, PHYS ACT COUNS; CANIGGIA A, 1984, Acta Vitaminologica et Enzymologica, V6, P117; Cardona JM, 1997, OSTEOPOROSIS INT, V7, P165, DOI 10.1007/BF01622285; CAULEY JA, 1995, ANN INTERN MED, V122, P9, DOI 10.7326/0003-4819-122-1-199501010-00002; CHAPUY MC, 1992, NEW ENGL J MED, V327, P1637, DOI 10.1056/NEJM199212033272305; Chen JT, 1997, BONE, V20, P557, DOI 10.1016/S8756-3282(97)00054-9; CHESTNUT CH, 2001, AM J MED, V109, P267; CHRISCHILLES EA, 1991, ARCH INTERN MED, V151, P2026, DOI 10.1001/archinte.151.10.2026; CHRISTIANSEN C, 1981, LANCET, V1, P459; CUMMING RG, 1990, CALCIFIED TISSUE INT, V47, P194; Cummings SR, 1998, JAMA-J AM MED ASSOC, V280, P2077, DOI 10.1001/jama.280.24.2077; CUMMINGS SR, 1995, NEW ENGL J MED, V332, P767, DOI 10.1056/NEJM199503233321202; Davies KM, 1996, OSTEOPOROSIS INT, V6, P160, DOI 10.1007/BF01623941; DawsonHughes B, 1997, NEW ENGL J MED, V337, P670, DOI 10.1056/NEJM199709043371003; DAWSONHUGHES B, 1990, NEW ENGL J MED, V323, P878, DOI 10.1056/NEJM199009273231305; Delmas PD, 1997, NEW ENGL J MED, V337, P1641, DOI 10.1056/NEJM199712043372301; Eiken P, 1996, BONE, V19, pS191, DOI 10.1016/S8756-3282(96)00266-9; Ensrud KE, 1997, ARCH INTERN MED, V157, P2617, DOI 10.1001/archinte.157.22.2617; ETTINGER B, 1985, ANN INTERN MED, V102, P319, DOI 10.7326/0003-4819-102-3-319; ETTINGER B, 1987, ANN INTERN MED, V106, P40, DOI 10.7326/0003-4819-106-1-40; Ettinger B, 1999, JAMA-J AM MED ASSOC, V282, P637, DOI 10.1001/jama.282.7.637; FELSON DT, 1993, NEW ENGL J MED, V329, P1141, DOI 10.1056/NEJM199310143291601; GALLAGHER JC, 1990, ANN INTERN MED, V113, P649, DOI 10.7326/0003-4819-113-9-649; GALLAGHER JC, 1989, P SOC EXP BIOL MED, V191, P287; Gillespie WJ, 2000, COCHRANE DATABASE SY; GRADY D, 1992, ANN INTERN MED, V117, P1016, DOI 10.7326/0003-4819-117-12-1016; HARRIS ST, 1993, AM J MED, V95, P557, DOI 10.1016/0002-9343(93)90350-X; Harris ST, 1999, JAMA-J AM MED ASSOC, V282, P1344, DOI 10.1001/jama.282.14.1344; HARRISON JE, 1993, OSTEOPOROSIS INT, V3, P13, DOI 10.1007/BF01623171; Herd RJM, 1997, AM J MED, V103, P92, DOI 10.1016/S0002-9343(97)00019-3; Hochberg MC, 1996, ARTHRITIS RHEUM-US, V39, P1791; HOMIK J, 1998, COCHRANE LIB; HORSMAN A, 1983, NEW ENGL J MED, V309, P1405, DOI 10.1056/NEJM198312083092301; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; HUTCHINSON TA, 1979, LANCET, V2, P705; JACKSON JA, 1987, J CLIN ENDOCR METAB, V65, P53, DOI 10.1210/jcem-65-1-53; JAGLAL SB, 1993, AM J EPIDEMIOL, V138, P107, DOI 10.1093/oxfordjournals.aje.a116833; JOHNSON RE, 1981, AM J PUBLIC HEALTH, V71, P138, DOI 10.2105/AJPH.71.2.138; Jones G, 1996, OSTEOPOROSIS INT, V6, P233, DOI 10.1007/BF01622740; Josse R, 1996, CAN MED ASSOC J, V155, P1113; Kanis JA, 1997, OSTEOPOROSIS INT, V7, P390, DOI 10.1007/BF01623782; Karpf DB, 1997, JAMA-J AM MED ASSOC, V277, P1159; Kaufman JM, 1997, CLIN RHEUMATOL, V16, P343, DOI 10.1007/BF02242449; KIEL DP, 1987, NEW ENGL J MED, V317, P1169, DOI 10.1056/NEJM198711053171901; KOHRT WM, 1995, J BONE MINER RES, V10, P1303, DOI 10.1002/jbmr.5650100906; Komulainen M, 1997, OSTEOPOROSIS INT, V7, P126, DOI 10.1007/BF01623687; KREIGER N, 1982, AM J EPIDEMIOL, V116, P141, DOI 10.1093/oxfordjournals.aje.a113388; LINDSAY R, 1980, LANCET, V2, P1151; LINDSAY R, 1976, LANCET, V1, P1038; LINDSAY R, 1984, OBSTET GYNECOL, V63, P759; LINDSAY R, 1992, OSTEOPOROSIS GUIDE D; Lips P, 1996, ANN INTERN MED, V124, P400, DOI 10.7326/0003-4819-124-4-199602150-00003; LUFKIN EG, 1992, ANN INTERN MED, V117, P1, DOI 10.7326/0003-4819-117-1-1; Lyritis GP, 1997, CLIN RHEUMATOL, V16, P354, DOI 10.1007/BF02242451; MAXIM P, 1995, OSTEOPOROSIS INT, V5, P23, DOI 10.1007/BF01623654; MENCZEL J, 1994, CLIN ORTHOP RELAT R, P241; Montessori MLM, 1997, OSTEOPOROSIS INT, V7, P52, DOI 10.1007/BF01623461; MUNKJENSEN N, 1988, BRIT MED J, V296, P1150, DOI 10.1136/bmj.296.6630.1150; Murray TM, 1996, CAN MED ASSOC J, V155, P935; NAESSEN T, 1990, ANN INTERN MED, V113, P95, DOI 10.7326/0003-4819-113-2-95; *NAT OST FDN, 2001, PHYS GUID PREV TREAT; National Osteoporosis Foundation, 1998, PHYS GUID PREV TREAT; NIELSEN SP, 1994, BRIT J OBSTET GYNAEC, V101, P319, DOI 10.1111/j.1471-0528.1994.tb13618.x; ORIMO H, 1994, CALCIFIED TISSUE INT, V54, P370, DOI 10.1007/BF00305521; Orwoll ES, 1996, ANN INTERN MED, V124, P187, DOI 10.7326/0003-4819-124-2-199601150-00001; OTT SM, 1989, ANN INTERN MED, V110, P267, DOI 10.7326/0003-4819-110-4-267; Paganini-Hill A, 1991, Epidemiology, V2, P16; PAGANINIHILL A, 1981, ANN INTERN MED, V95, P28, DOI 10.7326/0003-4819-95-1-28; PECK WA, 1993, AM J MED, V94, P646; PERIS P, 1995, BRIT J RHEUMATOL, V34, P936; PERIS P, 1996, CURR OPIN RHEUMATOL, P357; Preisinger E, 1996, BRIT J SPORT MED, V30, P209, DOI 10.1136/bjsm.30.3.209; PREISINGER E, 1995, AM J PHYS MED REHAB, V74, P120; Prior JC, 1996, CAN MED ASSOC J, V155, P940; QUIGLEY MET, 1987, AM J OBSTET GYNECOL, V156, P1516; Ray NF, 1997, J BONE MINER RES, V12, P24, DOI 10.1359/jbmr.1997.12.1.24; Reid IR, 1996, ARCH INTERN MED, V156, P1173, DOI 10.1001/archinte.156.11.1173; REID IR, 1995, AM J MED, V98, P331, DOI 10.1016/S0002-9343(99)80310-6; REID IR, 1993, NEW ENGL J MED, V328, P460, DOI 10.1056/NEJM199302183280702; Ross RK, 2000, JNCI-J NATL CANCER I, V92, P328, DOI 10.1093/jnci/92.4.328; Schairer C, 2000, JAMA-J AM MED ASSOC, V283, P485, DOI 10.1001/jama.283.4.485; Schneider DL, 1997, JAMA-J AM MED ASSOC, V277, P543, DOI 10.1001/jama.277.7.543; Shekelle PG, 2001, ANN INTERN MED, V135, P647, DOI 10.7326/0003-4819-135-8_Part_2-200110161-00003; Shiraki M, 1996, ENDOCR J, V43, P211, DOI 10.1507/endocrj.43.211; Siminoski K, 1996, CAN MED ASSOC J, V155, P962; Snyder PJ, 1999, J CLIN ENDOCR METAB, V84, P1966, DOI 10.1210/jc.84.6.1966; Storm T, 1996, J RHEUMATOL, V23, P1560; TILYARD MW, 1992, NEW ENGL J MED, V326, P357, DOI 10.1056/NEJM199202063260601; Tucci JR, 1996, AM J MED, V101, P488, DOI 10.1016/S0002-9343(96)00282-3; *US CONGR OFF TECH, 1994, OTABPH120 US CONGR O; US Preventive Services Task Force, 1996, GUID CLIN PREV SERV, P18; WEISS NS, 1980, NEW ENGL J MED, V303, P1195, DOI 10.1056/NEJM198011203032102; 1984, NIH CONS STAT 2 4 AP, V5, P1; 1998, OSTEOPOROOS INT S4, V8, pS7; 1989, J R COLL PHYSICIANS, V23, P8	103	10	10	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 16	2001	135	8	2				722	730		10.7326/0003-4819-135-8_Part_2-200110161-00011	http://dx.doi.org/10.7326/0003-4819-135-8_Part_2-200110161-00011			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	481WA	11601955				2022-12-24	WOS:000171542400011
J	Lohmann, KJ; Cain, SD; Dodge, SA; Lohmann, CMF				Lohmann, KJ; Cain, SD; Dodge, SA; Lohmann, CMF			Regional magnetic fields as navigational markers for sea turtles	SCIENCE			English	Article							LONG-DISTANCE NAVIGATION; MECHANISMS	Young loggerhead sea turtles (Caretta caretta) from eastern Florida undertake a transoceanic migration in which they gradually circle the north Atlantic Ocean before returning to the North American coast. Here we report that hatchling loggerheads, when exposed to magnetic fields replicating those found in three widely separated oceanic regions, responded by swimming in directions that would, in each case, help keep turtles within the currents of the North Atlantic gyre and facilitate movement along the migratory pathway. These results imply that young loggerheads have a guidance system in which regional magnetic fields function as navigational markers and elicit changes in swimming direction at crucial geographic boundaries.	Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Lohmann, KJ (corresponding author), Univ N Carolina, Dept Biol, CB 3280, Chapel Hill, NC 27599 USA.							Akesson S, 1996, TRENDS ECOL EVOL, V11, P398, DOI 10.1016/0169-5347(96)30040-2; BATSCHELET E, 1981, CIRCULAR STAT BIOL, P104; BEARMAN G, 1989, OCEAN CIRCULATION; BECK W, 1988, 19 C INT ORN, V2, P1955; Bolten AB, 1998, ECOL APPL, V8, P1; CARR A, 1986, BIOSCIENCE, V36, P92, DOI 10.2307/1310109; CARR A, 1987, Conservation Biology, V1, P103, DOI 10.1111/j.1523-1739.1987.tb00020.x; GOULD JL, 1982, NATURE, V296, P205, DOI 10.1038/296205a0; GOULD JL, 1985, MAGNETITE BIOMINERAL, P257; Hays GC, 1997, CAN J ZOOL, V75, P40, DOI 10.1139/z97-005; Jacobs JA, 1994, REVERSALS EARTHS MAG; KIRSCHVINK JL, 1992, BIOELECTROMAGNETICS, V13, P401, DOI 10.1002/bem.2250130507; Lohmann KJ, 1999, ETHOL ECOL EVOL, V11, P1, DOI 10.1080/08927014.1999.9522838; LOHMANN KJ, 1994, J EXP BIOL, V190, P1; Lohmann KJ, 1996, NATURE, V380, P59, DOI 10.1038/380059a0; LOHMANN KJ, 1994, J EXP BIOL, V194, P23; Lohmann KJ, 1998, J AVIAN BIOL, V29, P585, DOI 10.2307/3677179; LOHMANN KJ, BIOL CONSERVATION LO; MERRITT R, 1983, REV SCI INSTRUM, V54, P879, DOI 10.1063/1.1137480; Musick John A., 1997, P137; SALMON M, 1987, J EXP MAR BIOL ECOL, V109, P137, DOI 10.1016/0022-0981(87)90012-8; Schmitz W.J., 1996, WHOI9603; Skiles D.D., 1985, MAGNETITE BIOMINERAL, P43; SMITH FA, 1995, SCIENCE, V270, P2012, DOI 10.1126/science.270.5244.2012; Wehner R, 1998, J AVIAN BIOL, V29, P370, DOI 10.2307/3677156; WILTSCHKO R, 1995, MAGNETIC ORIENTATION, P177	26	188	202	6	116	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 12	2001	294	5541					364	366		10.1126/science.1064557	http://dx.doi.org/10.1126/science.1064557			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	482WZ	11598298				2022-12-24	WOS:000171601400041
J	Maira, SM; Galetic, I; Brazil, DP; Kaech, S; Ingley, E; Thelen, M; Hemmings, BA				Maira, SM; Galetic, I; Brazil, DP; Kaech, S; Ingley, E; Thelen, M; Hemmings, BA			Carboxyl-terminal modulator protein (CTMP), a negative regulator of PKB/Akt and v-Akt at the plasma membrane	SCIENCE			English	Article							KINASE-B; PHOSPHOINOSITIDE 3-KINASE; PHOSPHATASE INHIBITORS; MOLECULAR-CLONING; ACTIVATION; MECHANISM; INSULIN; TRANSLOCATION; LYMPHOMA	The PKB (protein kinase B, also called Akt) family of protein kinases plays a key role in insulin signaling, cellular survival, and transformation. PKB is activated by phosphorylation on residues threonine 308, by the protein kinase PDK1, and Serine 473, by a putative serine 473 kinase. Several protein binding partners for PKB have been identified. Here, we describe a protein partner for PKB alpha termed CTMP, or carboxyl-terminal modulator protein, that binds specifically to the carboxyl-terminal regulatory domain of PKB alpha at the plasma membrane. Binding of CTMP reduces the activity of PKB alpha by inhibiting phosphorylation on serine 473 and threonine 308. Moreover, CTMP expression reverts the phenotype of v-Akt-transformed cells examined under a number of criteria including cell morphology, growth rate, and in vivo tumorigenesis. These findings identify CTMP as a negative regulatory component of the pathway controlling PKB activity.	Friedrich Miescher Inst, CH-4002 Basel, Switzerland; Inst Biomed Res, CH-6500 Bellinzona, Switzerland	Friedrich Miescher Institute for Biomedical Research; Universita della Svizzera Italiana	Hemmings, BA (corresponding author), Friedrich Miescher Inst, POB 2543, CH-4002 Basel, Switzerland.		Ingley, Evan/C-2401-2013	Ingley, Evan/0000-0002-8112-9134; Brazil, Derek/0000-0003-1375-1076; Kaech Petrie, Stefanie/0000-0002-6246-6434				Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Andjelkovic M, 1996, P NATL ACAD SCI USA, V93, P5699, DOI 10.1073/pnas.93.12.5699; Andjelkovic M, 1999, MOL CELL BIOL, V19, P5061; Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; CHATTON B, 1995, BIOTECHNIQUES, V18, P142; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Galetic I, 1999, PHARMACOL THERAPEUT, V82, P409, DOI 10.1016/S0163-7258(98)00071-0; GALETIC I, UNPUB; Ishii N, 1999, BRAIN PATHOL, V9, P469, DOI 10.1111/j.1750-3639.1999.tb00536.x; JONES PF, 1991, CELL REGUL, V2, P1001, DOI 10.1091/mbc.2.12.1001; Koh H, 2000, J BIOL CHEM, V275, P34451, DOI 10.1074/jbc.M001753200; MAIRA SM, UNPUB; Mitsuuchi Y, 1999, ONCOGENE, V18, P4891, DOI 10.1038/sj.onc.1203080; Pekarsky Y, 2000, P NATL ACAD SCI USA, V97, P3028, DOI 10.1073/pnas.040557697; POSNER BI, 1994, J BIOL CHEM, V269, P4596; STAAL SP, 1987, P NATL ACAD SCI USA, V84, P5034, DOI 10.1073/pnas.84.14.5034; STAAL SP, 1988, J EXP MED, V167, P1259, DOI 10.1084/jem.167.3.1259; STAAL SP, 1977, P NATL ACAD SCI USA, V74, P3065, DOI 10.1073/pnas.74.7.3065; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; Vazquez F, 2000, BBA-REV CANCER, V1470, pM21, DOI 10.1016/S0304-419X(99)00032-3	26	203	223	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 12	2001	294	5541					374	380		10.1126/science.1062030	http://dx.doi.org/10.1126/science.1062030			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	482WZ	11598301				2022-12-24	WOS:000171601400044
J	Federman, AD; Adams, AS; Ross-Degnan, D; Soumerai, SB; Ayanian, JZ				Federman, AD; Adams, AS; Ross-Degnan, D; Soumerai, SB; Ayanian, JZ			Supplemental insurance and use of effective cardiovascular drugs among elderly Medicare beneficiaries with coronary heart disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BETA-BLOCKER USE; MYOCARDIAL-INFARCTION; PRESCRIPTION DRUGS; COST-EFFECTIVENESS; ADVERSE SELECTION; MEDIGAP INSURANCE; UNITED-STATES; COVERAGE; HEALTH; CHOLESTEROL	Context Cost-sharing in US prescription drug coverage plans for elderly persons varies widely. Evaluation of prescription drug use among elderly persons by type of health insurance could provide useful information for designing a Medicare drug program.. Objective To determine use of effective cardiovascular drugs among elderly per sons with coronary heart disease (CHD) by type of health insurance. Design, Setting, and Patients Cross-sectional evaluation of 1908 community-dwelling adults, aged 66 years or older, with a history of CHD or myocardial infarction from the 1997 Medicare Current Beneficiary Survey, a nationally representative sample of Medicare beneficiaries. Main Outcome Measures Use of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins), beta -blockers, and nitrates, and out-of-pocket expenditures for prescription drugs, stratified by type of health insurance: Medicare without drug coverage (Medicare only or self-purchased supplemental insurance) or with drug coverage (Medicaid, other public program, Medigap, health maintenance organization, or employer-sponsored plan). Results Statin use ranged from 4.1% in Medicare patients with no drug coverage to 27.4% in patients with employer-sponsored drug coverage (P<.001). Less variation between these 2 types occurred for <beta>-blockers (20.7% vs 36.1%; P=.003) and nitrates (20.4% vs 38.0%; P=.005). In multivariate analyses, statin use remained significantly lower for patients with Medicare only (odds ratio [OR], 0.16; 95% confidence interval [CI], 0.05-0.49) and beta -blocker use was lower for Medicaid patients (OR, 0.55; 95% Cl, 0.34-0.88) vs those with employer-sponsored coverage. Nitrate use occurred less frequently in persons lacking drug coverage (patients with Medicare only, P=.049; patients with supplemental insurance without drug coverage, P=.03). Patients with Medicare only spent a much larger fraction of income on prescription compared with those with employer-sponsored drug coverage (7.9% vs; 1.7%; adjusted P<.001). Conclusion Elderly Medicare beneficiaries with CHD who lack drug coverage have disproportionately large drug expenditures and lower use rates of statins, a class of relatively expensive drugs that improve survival.	Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Gen Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Ayanian, JZ (corresponding author), Harvard Univ, Sch Med, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA.	ayanian@hcp.med.harvard.edu			DIVISION OF MEDICINE, BUREAU HEALTH PROFESSIONS, HRSA [T32PE011001] Funding Source: NIH RePORTER; BHP HRSA HHS [5T32PE11001-13] Funding Source: Medline	DIVISION OF MEDICINE, BUREAU HEALTH PROFESSIONS, HRSA(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); BHP HRSA HHS		Adams AS, 2001, HEALTH AFFAIR, V20, P276, DOI 10.1377/hlthaff.20.1.276; Adams AS, 2001, ANNU REV PUBL HEALTH, V22, P49, DOI 10.1146/annurev.publhealth.22.1.49; Adler G S, 1994, Health Care Financ Rev, V15, P153; Alecxih L, 2001, HEALTH SERV RES, V35, P1365; Avorn J, 1998, JAMA-J AM MED ASSOC, V279, P1458, DOI 10.1001/jama.279.18.1458; BERK ML, 1990, HEALTH AFFAIR, V9, P146, DOI 10.1377/hlthaff.9.3.146; Blustein J, 2000, HEALTH AFFAIR, V19, P219, DOI 10.1377/hlthaff.19.2.219; BOWLIN SJ, 1993, J CLIN EPIDEMIOL, V46, P561, DOI 10.1016/0895-4356(93)90129-O; CASSIDY A, 2000, MEDICARE PLUS CHOICE; DAVIDSON BN, 1992, SOC SCI MED, V34, P1023, DOI 10.1016/0277-9536(92)90133-B; Davis M, 1999, HEALTH AFFAIR, V18, P231, DOI 10.1377/hlthaff.18.1.231; Ettner SL, 1997, J HEALTH ECON, V16, P543, DOI 10.1016/S0167-6296(97)00011-8; FURBERG CD, 1995, CIRCULATION, V92, P1326, DOI 10.1161/01.CIR.92.5.1326; Ganz DA, 2000, ANN INTERN MED, V132, P780, DOI 10.7326/0003-4819-132-10-200005160-00003; GOLDMAN L, 1988, NEW ENGL J MED, V319, P152, DOI 10.1056/NEJM198807213190306; GROSS D, 1999, STATE PHARM ASSISTAN; Harnick DJ, 1998, AM J CARDIOL, V81, P1416, DOI 10.1016/S0002-9149(98)00209-4; *HJ KAIS FAM FDN, 2000, HLTH POL ALT, V1; HJALMARSON A, 1988, AM J CARDIOL, V61, pB26; Hodgson TA, 1999, MED CARE, V37, P994, DOI 10.1097/00005650-199910000-00004; Hosmer D., 1989, APPL LOGISTIC REGRES, P82; Jackevicius CA, 2000, J AM COLL CARDIOL, V35, p314A; JENSEN GA, 1992, GERONTOLOGIST, V32, P693, DOI 10.1093/geront/32.5.693; Johnson RE, 1997, HEALTH SERV RES, V32, P103; LONG SH, 1994, HEALTH AFFAIR, V13, P157, DOI 10.1377/hlthaff.13.2.157; Majumdar SR, 1999, J GEN INTERN MED, V14, P711, DOI 10.1046/j.1525-1497.1999.02229.x; McClellan M, 2000, HEALTH AFFAIR, V19, P26, DOI 10.1377/hlthaff.19.2.26; *MED EC CO INC, 1997, DRUG TOP RED BOOK; Miller M, 2000, ARCH INTERN MED, V160, P343, DOI 10.1001/archinte.160.3.343; MOELLER JF, 1991, HEALTH AFFAIR, V10, P210, DOI 10.1377/hlthaff.10.1.210; Pear R., 2001, NY TIMES B      1025, P1; PEDERSEN TR, 1994, LANCET, V344, P1383; Pedersen TR, 2000, AM J CARDIOL, V86, P257, DOI 10.1016/S0002-9149(00)00910-3; Phillips KA, 2000, JAMA-J AM MED ASSOC, V284, P2748, DOI 10.1001/jama.284.21.2748; Poisal JA, 2000, HEALTH AFFAIR, V19, P248, DOI 10.1377/hlthaff.19.2.248; Poisal JA, 2001, HEALTH AFFAIR, V20, P74, DOI 10.1377/hlthaff.20.2.74; Prosser LA, 2000, ANN INTERN MED, V132, P769, DOI 10.7326/0003-4819-132-10-200005160-00002; *RES TRIANGL I, 1997, PROF SOFTW SURV DAT; RICE T, 1991, HEALTH SERV RES, V26, P223; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Schrott HG, 1997, JAMA-J AM MED ASSOC, V277, P1281, DOI 10.1001/jama.277.16.1281; Seddon ME, 2001, AM J MED, V111, P24, DOI 10.1016/S0002-9343(01)00741-0; SEMPOS CT, 1993, JAMA-J AM MED ASSOC, V269, P3009, DOI 10.1001/jama.269.23.3009; SOUMERAI SB, 1991, NEW ENGL J MED, V325, P1072, DOI 10.1056/NEJM199110103251505; SOUMERAI SB, 1994, NEW ENGL J MED, V331, P650, DOI 10.1056/NEJM199409083311006; Soumerai SB, 1999, NEW ENGL J MED, V340, P722, DOI 10.1056/NEJM199903043400909; SOUMERAI SB, 1987, NEW ENGL J MED, V317, P550, DOI 10.1056/NEJM198708273170906; Soumeral SB, 1997, JAMA-J AM MED ASSOC, V277, P115, DOI 10.1001/jama.277.2.115; Stuart B, 1998, MED CARE, V36, P202, DOI 10.1097/00005650-199802000-00009; Stuart B, 1999, HEALTH AFFAIR, V18, P201, DOI 10.1377/hlthaff.18.2.201; STUART B, 2001, DESIGNING MED DRUG B; Tamblyn R, 2001, JAMA-J AM MED ASSOC, V285, P421, DOI 10.1001/jama.285.4.421; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; VISCOLI CM, 1993, ANN INTERN MED, V118, P99, DOI 10.7326/0003-4819-118-2-199301150-00004; Vistnes JP, 1997, INQUIRY-J HEALTH CAR, V34, P311; Wang TJ, 1998, ARCH INTERN MED, V158, P1901, DOI 10.1001/archinte.158.17.1901; WOLFE JR, 1991, J HEALTH ECON, V10, P433, DOI 10.1016/0167-6296(91)90024-H	57	134	136	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 10	2001	286	14					1732	1739		10.1001/jama.286.14.1732	http://dx.doi.org/10.1001/jama.286.14.1732			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	480NC	11594898	Bronze, Green Published			2022-12-24	WOS:000171466800023
J	Dishy, V; Sofowora, GG; Xie, HG; Kim, RB; Byrne, DW; Stein, CM; Wood, AJJ				Dishy, V; Sofowora, GG; Xie, HG; Kim, RB; Byrne, DW; Stein, CM; Wood, AJJ			The effect of common polymorphisms of the beta(2)-adrenergic receptor on agonist-mediated vascular desensitization	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BETA-2-ADRENERGIC RECEPTOR; BLOOD-PRESSURE; HYPERTENSION; VASODILATION; GENOTYPES; ASTHMA	Background: With continuous exposure to beta (2)-adrenergic agonists, vascular tissue becomes desensitized to agonist-mediated vasodilatation. We studied the effects of two common polymorphisms of the beta (2)-adrenergic receptor, one at codon 16 and one at codon 27, on agonist-mediated vasodilatation and desensitization in the vascular bed. Methods: We studied 26 healthy subjects who were selected to represent three genotypes: 7 were homozygous for the alleles encoding Arg16 and GIn27, 8 were homozygous for the alleles encoding Gly16 and Gln27, and 11 were homozygous for the alleles encoding Gly16 and Glu27. Vascular responses were assessed by measuring changes in the diameter of a dorsal hand vein. A dose-response curve of the effect of the beta (2)-adrenergic-receptor agonist isoproterenol was constructed (dose range, 4 to 480 ng per minute). Desensitization was then induced by a 2-hour continuous infusion of isoproterenol, and venodilatation was measured 30, 60, 90, and 120 minutes after the start of the infusion. Results: Subjects who were homozygous for Arg16 had almost complete desensitization; venodilatation in response to isoproterenol in this group decreased from a mean (+/-SE) of 44+/-11 percent to 8+/-4 percent (P=0.006). In contrast, subjects who were homozygous for Gly16 did not have significant desensitization, irrespective of the amino acid encoded by codon 27. Subjects who were homozygous for Glu27 had higher maximal venodilatation in response to isoproterenol than those who were homozygous for Gln27 (86+/-13 percent vs. 54+/-8 percent, P=0.03). Conclusions: The Arg16 polymorphism of the beta (2)-adrenergic receptor is associated with enhanced agonist-mediated desensitization in the vasculature, and the Glu27 polymorphism is associated with increased agonist-mediated responsiveness. Therefore, polymorphisms of the beta (2)-adrenergic receptor are potentially important determinants of the vascular response to stress. (N Engl J Med 2001;345:1030-5.) Copyright (C) 2001 Massachusetts Medical Society.	Vanderbilt Univ, Sch Med, Div Clin Pharmacol, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Gen Clin Res Ctr, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Wood, AJJ (corresponding author), Vanderbilt Univ, Sch Med, Div Clin Pharmacol, Rm 550,Med Res Bldg 1, Nashville, TN 37232 USA.		Kim, Richard/D-6971-2011; Sofowora, Gbemiga/E-4118-2011; Byrne, Daniel/GRE-6302-2022	Kim, Richard/0000-0001-8148-1632; 	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056251] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-56251, HL-04012] Funding Source: Medline; NIGMS NIH HHS [GM-RR0095] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AELLIG WH, 1981, BRIT J CLIN PHARMACO, V11, P237, DOI 10.1111/j.1365-2125.1981.tb00527.x; [Anonymous], 1997, ARCH INTERN MED, V157, P2413; BRISTOW MR, 1989, MOL PHARMACOL, V35, P295; BURT VL, 1995, HYPERTENSION, V25, P305, DOI 10.1161/01.HYP.25.3.305; Chong LK, 2000, PHARMACOGENETICS, V10, P153, DOI 10.1097/00008571-200003000-00007; Cockcroft JR, 2000, HYPERTENSION, V36, P371, DOI 10.1161/01.HYP.36.3.371; Dewar JC, 1998, CLIN EXP ALLERGY, V28, P442; Drysdale CM, 2000, P NATL ACAD SCI USA, V97, P10483, DOI 10.1073/pnas.97.19.10483; FELDMAN RD, 1990, J CLIN INVEST, V85, P647, DOI 10.1172/JCI114487; Flier J, 1996, NEW ENGL J MED, V334, P580, DOI 10.1056/NEJM199602293340907; GOLDSTEIN DS, 1983, HYPERTENSION, V5, P86, DOI 10.1161/01.HYP.5.1.86; Gratze G, 1999, HYPERTENSION, V33, P1425, DOI 10.1161/01.HYP.33.6.1425; GREEN SA, 1993, J BIOL CHEM, V268, P23116; GREEN SA, 1995, AM J RESP CELL MOL, V13, P25, DOI 10.1165/ajrcmb.13.1.7598936; Hoit BD, 2000, AM HEART J, V139, P537, DOI 10.1016/S0002-8703(00)90099-1; Israel E, 2000, AM J RESP CRIT CARE, V162, P75, DOI 10.1164/ajrccm.162.1.9907092; Landau R, 2000, ANESTHESIOLOGY, V93, pU212; LANG CC, 1995, NEW ENGL J MED, V333, P155, DOI 10.1056/NEJM199507203330304; NASLUND T, 1990, CLIN PHARMACOL THER, V48, P87, DOI 10.1038/clpt.1990.121; REIHSAUS E, 1993, AM J RESP CELL MOL, V8, P334, DOI 10.1165/ajrcmb/8.3.334; Schobel HP, 1996, NEW ENGL J MED, V335, P1480, DOI 10.1056/NEJM199611143352002; STEIN CM, 1995, J CLIN INVEST, V96, P579, DOI 10.1172/JCI118070; Stein CM, 2001, PHARMACOGENETICS, V11, P95, DOI 10.1097/00008571-200103000-00001; STEIN M, 1993, CLIN PHARMACOL THER, V54, P187, DOI 10.1038/clpt.1993.130; Tan S, 1997, LANCET, V350, P995, DOI 10.1016/S0140-6736(97)03211-X; Taylor DR, 2000, THORAX, V55, P762, DOI 10.1136/thorax.55.9.762; VINCENT J, 1992, J CARDIOVASC PHARM, V19, P447, DOI 10.1097/00005344-199203000-00023; Xie HG, 1999, PHARMACOGENETICS, V9, P511	28	283	301	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 4	2001	345	14					1030	1035		10.1056/NEJMoa010819	http://dx.doi.org/10.1056/NEJMoa010819			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	478HF	11586955				2022-12-24	WOS:000171340400004
J	Pearson, PN; Ditchfield, PW; Singano, J; Harcourt-Brown, KG; Nicholas, CJ; Olsson, RK; Shackleton, NJ; Hall, MA				Pearson, PN; Ditchfield, PW; Singano, J; Harcourt-Brown, KG; Nicholas, CJ; Olsson, RK; Shackleton, NJ; Hall, MA			Warm tropical sea surface temperatures in the Late Cretaceous and Eocene epochs	NATURE			English	Article							ATMOSPHERIC CARBON-DIOXIDE; GLOBAL CLIMATE; MIDDLE EOCENE; OCEAN; OXYGEN; DIAGENESIS; EVOLUTION; ISOTOPES; RECORD; CO2	Climate models with increased levels of carbon dioxide predict that global warming causes heating in the tropics, but investigations of ancient climates based on palaeodata have generally indicated cool tropical temperatures during supposed greenhouse episodes. For example, in the Late Cretaceous and Eocene epochs there is abundant geological evidence for warm, mostly ice-free poles, but tropical sea surface temperatures are generally estimated to be only 15-23 degreesC, based on oxygen isotope palaeothermometry of surface-dwelling planktonic foraminifer shells. Here we question the validity of most such data on the grounds of poor preservation and diagenetic alteration. We present new data from exceptionally well preserved foraminifer shells extracted from impermeable clay-rich sediments, which indicate that for the intervals studied, tropical sea surface temperatures were at least 28-32 degreesC. These warm temperatures are more in line with our understanding of the geographical distributions of temperature-sensitive fossil organisms and the results of climate models with increased CO2 levels.	Univ Bristol, Dept Earth Sci, Bristol BS8 1RJ, Avon, England; Tanzania Petr Dev Corp, Dar Es Salaam, Tanzania; Univ Dublin Trinity Coll, Dept Geol, Dublin 2, Ireland; Rutgers State Univ, Dept Geol Sci, Piscataway, NJ 08855 USA; Univ Cambridge, Dept Earth Sci, Godwin Lab, Cambridge CB2 3SA, England	University of Bristol; Trinity College Dublin; Rutgers State University New Brunswick; University of Cambridge	Pearson, PN (corresponding author), Univ Bristol, Dept Earth Sci, Queens Rd, Bristol BS8 1RJ, Avon, England.	paul.pearson@bristol.ac.uk	Pearson, Paul N/B-2276-2009	Pearson, Paul N/0000-0003-4628-9818				ADAMS CG, 1990, PALAEOGEOGR PALAEOCL, V77, P289; Andreasson FP, 1998, PALEOCEANOGRAPHY, V13, P183, DOI 10.1029/98PA00120; BARRON EJ, 1995, EFFECTS PAST GLOBAL, P108; Barron EJ, 1987, PALEOCEANOGRAPHY, V2, P729, DOI 10.1029/PA002i006p00729; Bice KL, 2000, PALAEOGEOGR PALAEOCL, V161, P295, DOI 10.1016/S0031-0182(00)00072-9; Blow W.H., 1962, FUNDAMENTALS MIDTERT, P61; Blow WH, 1979, CAINOZOIC GLOBIGERIN, V1, pxv+752; Boersma A, 1987, PALEOCEANOGRAPHY, V2, P287, DOI 10.1029/PA002i003p00287; BRALOWER TJ, 1995, PALEOCEANOGRAPHY, V10, P841, DOI 10.1029/95PA01143; Bush ABG, 1997, PALEOCEANOGRAPHY, V12, P495, DOI 10.1029/97PA00721; Coxall HK, 2000, GEOLOGY, V28, P87, DOI 10.1130/0091-7613(2000)028<0087:HDAAEL>2.3.CO;2; Crowley TJ, 2001, SCIENCE, V292, P870, DOI 10.1126/science.1061664; Crowley TJ, 2000, WARM CLIMATES EARTH, P50, DOI DOI 10.1017/CBO9780511564512.004; DHONDT S, 1995, PALEOCEANOGRAPHY, V10, P123, DOI 10.1029/94PA02671; DHondt S, 1996, SCIENCE, V271, P1838, DOI 10.1126/science.271.5257.1838; EMILIANI C, 1954, AM J SCI, V252, P149, DOI 10.2475/ajs.252.3.149; EREZ J, 1983, GEOCHIM COSMOCHIM AC, V47, P1025, DOI 10.1016/0016-7037(83)90232-6; GRAHAM A, 1994, AM J BOT, V81, P301, DOI 10.2307/2445456; Hemleben C., 1989, MODERN PLANKTONIC FO, DOI [DOI 10.1016/S0016-6995(89)80108-1, DOI 10.1007/978-1-4612-3544-6_2]; Horrell MA, 1990, PALEOCEANOGRAPHY, V5, P339, DOI 10.1029/PA005i003p00339; Huber M, 2000, PALEOCEANOGRAPHY, V15, P443, DOI 10.1029/1999PA000455; Kent PE, 1971, 6 NAT ENV RES COUNC; KILLINGLEY JS, 1983, NATURE, V301, P594, DOI 10.1038/301594a0; KOLODNY Y, 1988, PALAEOGEOGR PALAEOCL, V64, P59, DOI 10.1016/0031-0182(88)90142-3; MANABE S, 1985, J GEOPHYS RES-OCEANS, V90, P1689, DOI 10.1029/JC090iC06p11689; Markwick PJ, 1998, PALAEOGEOGR PALAEOCL, V137, P205, DOI 10.1016/S0031-0182(97)00108-9; Norris RD, 1998, GEOLOGY, V26, P823, DOI 10.1130/0091-7613(1998)026<0823:LLSSTF>2.3.CO;2; Pearson PN, 2000, NATURE, V406, P695, DOI 10.1038/35021000; PEARSON PN, 1993, J FORAMIN RES, V23, P123, DOI 10.2113/gsjfr.23.2.123; RAMANATHAN V, 1991, NATURE, V351, P27, DOI 10.1038/351027a0; Retallack GJ, 2001, NATURE, V411, P287, DOI 10.1038/35077041; RIND D, 1991, J GEOPHYS RES-ATMOS, V96, P7437, DOI 10.1029/91JD00009; Rind D, 1998, J GEOPHYS RES-ATMOS, V103, P5943, DOI 10.1029/97JD03649; SAVIN SM, 1977, ANNU REV EARTH PL SC, V5, P319, DOI 10.1146/annurev.ea.05.050177.001535; SCHLUTER T, 1997, GEOLOGY E AFRICA, V239; SCHRAG DP, 1995, GEOCHIM COSMOCHIM AC, V59, P2265, DOI 10.1016/0016-7037(95)00105-9; Schrag DP, 1999, CHEM GEOL, V161, P215, DOI 10.1016/S0009-2541(99)00088-1; SHACKLETON N, 1981, J GEOL SOC LONDON, V138, P153, DOI 10.1144/gsjgs.138.2.0153; SHACKLETON NJ, 1984, FOSSILS CLIMATE, P27; Sloan LC, 1996, PALAEOGEOGR PALAEOCL, V119, P275, DOI 10.1016/0031-0182(95)00012-7; Spero HJ, 1997, NATURE, V390, P497, DOI 10.1038/37333; UREY HC, 1947, J CHEM SOC, P562, DOI 10.1039/jr9470000562; Veizer J, 2000, NATURE, V408, P698, DOI 10.1038/35047044; Wade BS, 2001, GEOL SOC SPEC PUBL, V183, P273, DOI 10.1144/GSL.SP.2001.183.01.13; Waliser DE, 1996, B AM METEOROL SOC, V77, P357; Wilson PA, 2001, NATURE, V412, P425, DOI 10.1038/35086553; Wilson PA, 1998, NATURE, V392, P889, DOI 10.1038/31865; Wilson PA, 1996, GEOLOGY, V24, P555, DOI 10.1130/0091-7613(1996)024<0555:ESSTFT>2.3.CO;2; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; ZACHOS JC, 1994, PALEOCEANOGRAPHY, V9, P353, DOI 10.1029/93PA03266	50	492	509	3	127	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 4	2001	413	6855					481	487		10.1038/35097000	http://dx.doi.org/10.1038/35097000			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	478HG	11586350				2022-12-24	WOS:000171340500037
J	Bailey, SM; Cornforth, MN; Kurimasa, A; Chen, DJ; Goodwin, EH				Bailey, SM; Cornforth, MN; Kurimasa, A; Chen, DJ; Goodwin, EH			Strand-specific postreplicative processing of mammalian telomeres	SCIENCE			English	Article							HUMAN-CHROMOSOMES; DNA; END; TRF2; FUSIONS; LENGTH	Telomeres are specialized nucleoprotein structures that stabilize the ends of linear eukaryotic chromosomes. In mammalian cells, abrogation of telomeric repeat binding factor TRF2 or DNA-dependent protein kinase (DNA-PK) activity causes end-to-end chromosomal fusion, thus establishing an essential role for these proteins in telomere function. Here we show that TRF2-mediated endcapping occurs after telomere replication. The postreplicative requirement for TRF2 and DNA-PKcs, the catalytic subunit of DNA-PK, is confined to only half of the telomeres, namely, those that were produced by leading-strand DNA synthesis. These results demonstrate a crucial difference in postrepticative processing of telomeres that is linked to their mode of replication.	Los Alamos Natl Lab, Biosci Div, Los Alamos, NM 87544 USA; Univ Texas, Med Branch, Dept Radiat Oncol, Galveston, TX 77550 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Cell & Mol Biol, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Los Alamos National Laboratory; University of Texas System; University of Texas Medical Branch Galveston; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Goodwin, EH (corresponding author), Los Alamos Natl Lab, Biosci Div, POB 1663, Los Alamos, NM 87544 USA.				NATIONAL CANCER INSTITUTE [R37CA050519, R01CA076260, R01CA050519] Funding Source: NIH RePORTER; NCI NIH HHS [CA76260, CA50519] Funding Source: Medline; NIA NIH HHS [AG-917709] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bailey SM, 1999, P NATL ACAD SCI USA, V96, P14899, DOI 10.1073/pnas.96.26.14899; BAILEY SM, 2001, DNA DAMAGE REPAIR, V3, pCH14; BLACKBURN EH, 1984, ANNU REV BIOCHEM, V53, P163, DOI 10.1146/annurev.bi.53.070184.001115; Cech TR, 2000, ANGEW CHEM INT EDIT, V39, P34, DOI 10.1002/(SICI)1521-3773(20000103)39:1<34::AID-ANIE34>3.0.CO;2-N; Cornforth MN, 2001, MUTAGENESIS, V16, P85, DOI 10.1093/mutage/16.1.85; GOODWIN EH, 1993, CYTOGENET CELL GENET, V63, P253; Goodwin EH, 1996, CHROMOSOMA, V104, P345, DOI 10.1007/BF00337223; Goytisolo FA, 2001, MOL CELL BIOL, V21, P3642, DOI 10.1128/MCB.21.11.3642-3651.2001; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P12454, DOI 10.1073/pnas.96.22.12454; Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321; Kurimasa A, 1999, P NATL ACAD SCI USA, V96, P1403, DOI 10.1073/pnas.96.4.1403; Makarov VL, 1997, CELL, V88, P657, DOI 10.1016/S0092-8674(00)81908-X; MEYNE J, 1995, CHROMOSOME RES, V3, P375, DOI 10.1007/BF00710019; Samper E, 2000, EMBO REP, V1, P244, DOI 10.1093/embo-reports/kvd051; Smogorzewska A, 2000, MOL CELL BIOL, V20, P1659, DOI 10.1128/MCB.20.5.1659-1668.2000; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; Wellinger RJ, 1996, CELL, V85, P423, DOI 10.1016/S0092-8674(00)81120-4; Wright WE, 1997, GENE DEV, V11, P2801, DOI 10.1101/gad.11.21.2801; ZAKIAN VA, 1989, ANNU REV GENET, V23, P579, DOI 10.1146/annurev.genet.23.1.579	20	217	224	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 28	2001	293	5539					2462	2465		10.1126/science.1062560	http://dx.doi.org/10.1126/science.1062560			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	476PD	11577237	Green Published			2022-12-24	WOS:000171237200050
J	Kawabata, H; Ueno, T				Kawabata, H; Ueno, T			Screening recommendation for women taking tamoxifen	LANCET			English	Letter							BREAST-CANCER; ADJUVANT TAMOXIFEN; ENDOMETRIUM		JR Tokyo Gen Hosp, Dept Surg, Tokyo 1510053, Japan		Kawabata, H (corresponding author), JR Tokyo Gen Hosp, Dept Surg, Tokyo 1510053, Japan.							Barakat RR, 2000, J CLIN ONCOL, V18, P3459, DOI 10.1200/JCO.2000.18.20.3459; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Gerber B, 2000, J CLIN ONCOL, V18, P3464, DOI 10.1200/JCO.2000.18.20.3464; Katase K, 1998, CANCER, V82, P1698, DOI 10.1002/(SICI)1097-0142(19980501)82:9<1698::AID-CNCR16>3.3.CO;2-K; *ONC COMM, 2001, NIPPON SANFUJINNKA G, V53, P788	5	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 22	2001	358	9286					1018	1018		10.1016/S0140-6736(01)06150-5	http://dx.doi.org/10.1016/S0140-6736(01)06150-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	474YR	11593503				2022-12-24	WOS:000171135300059
J	Katsanis, N; Ansley, SJ; Badano, JL; Eichers, ER; Lewis, RA; Hoskins, BE; Scambler, PJ; Davidson, WS; Beales, PL; Lupski, JR				Katsanis, N; Ansley, SJ; Badano, JL; Eichers, ER; Lewis, RA; Hoskins, BE; Scambler, PJ; Davidson, WS; Beales, PL; Lupski, JR			Triallelic inheritance in Bardet-Biedl syndrome, a Mendelian recessive disorder	SCIENCE			English	Article							MICE LACKING GDNF; RETINITIS-PIGMENTOSA; HIRSCHSPRUNG DISEASE; GERMLINE MUTATIONS; CHROMOSOME 16Q; SYNDROME LOCUS; LINKAGE; FORM; RET; FAMILIES	Bardet-Biedl syndrome (BBS) is a genetically heterogeneous disorder characterized by multiple clinical features that include pigmentary retinal dystrophy, polydactyly, obesity, developmental delay, and renal defects. BBS is considered an autosomal recessive disorder, and recent positional cloning efforts have identified two BBS genes (BBS2 and BBS6). We screened our cohort of 163 BBS families for, mutations in both BBS2 and BBS6 and report the presence of three mutant alleles in affected individuals in four pedigrees. In addition, we detected unaffected individuals in two pedigrees who carry two BBS2 mutations but not a BBS6 mutation. We therefore propose that BBS may not be a single-gene recessive disease but a complex trait requiring three mutant alleles to manifest the phenotype. This triallelic model of disease transmission may be important in the study of both Mendelian and multifactorial disorders.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Ophthalmol, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Baylor Coll Med, Dept Med, Houston, TX 77030 USA; Texas Childrens Hosp, Baylor Coll Med, Houston, TX 77030 USA; UCL, Inst Child Hlth, Mol Med Unit, London WC1N 1EH, England; Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of London; University College London; Simon Fraser University	Lupski, JR (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Plaza, Houston, TX 77030 USA.	jlupski@bcm.tmc.edu	Scambler, Peter/AAZ-6026-2020; Scambler, Peter J/C-4998-2008; Katsanis, Nicholas/E-1837-2012; Beales, Philip L/C-7367-2009	Scambler, Peter/0000-0002-1487-4628; Scambler, Peter J/0000-0002-1487-4628; Badano, Jose/0000-0002-0706-8652; Katsanis, Nicholas/0000-0002-2480-0171	NATIONAL EYE INSTITUTE [R01EY012666] Funding Source: NIH RePORTER; NEI NIH HHS [EY12666] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Angrist M, 1996, NAT GENET, V14, P341, DOI 10.1038/ng1196-341; Beales PL, 1997, J MED GENET, V34, P92, DOI 10.1136/jmg.34.2.92; Beales PL, 2001, AM J HUM GENET, V68, P606, DOI 10.1086/318794; Bruford EA, 1997, GENOMICS, V41, P93, DOI 10.1006/geno.1997.4613; CARMI R, 1995, HUM MOL GENET, V4, P9, DOI 10.1093/hmg/4.1.9; Floeth M, 1999, AM J HUM GENET, V65, P1530, DOI 10.1086/302672; Goldberg AFX, 1996, P NATL ACAD SCI USA, V93, P13726, DOI 10.1073/pnas.93.24.13726; GREEN JS, 1989, NEW ENGL J MED, V321, P1002, DOI 10.1056/NEJM198910123211503; HELWIG U, 1995, NAT GENET, V11, P60, DOI 10.1038/ng0995-60; KAJIWARA K, 1994, SCIENCE, V264, P1604, DOI 10.1126/science.8202715; Katsanis N, 1999, AM J HUM GENET, V65, P1672, DOI 10.1086/302684; Katsanis N, 2000, NAT GENET, V26, P67, DOI 10.1038/79201; KWITEKBLACK AE, 1993, NAT GENET, V5, P392, DOI 10.1038/ng1293-392; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; Morell R, 1997, HUM MOL GENET, V6, P659, DOI 10.1093/hmg/6.5.659; Nishimura DY, 2001, HUM MOL GENET, V10, P865, DOI 10.1093/hmg/10.8.865; Pichel JG, 1996, NATURE, V382, P73, DOI 10.1038/382073a0; Salomon R, 1996, NAT GENET, V14, P345, DOI 10.1038/ng1196-345; Sanchez MP, 1996, NATURE, V382, P70, DOI 10.1038/382070a0; SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0; SHEFFIELD VC, 1994, HUM MOL GENET, V3, P1331, DOI 10.1093/hmg/3.8.1331; Slavotinek AM, 2000, NAT GENET, V26, P15, DOI 10.1038/79116; Stone DL, 2000, NAT GENET, V25, P79, DOI 10.1038/75637; Todd JA, 1999, BIOESSAYS, V21, P164, DOI 10.1002/(SICI)1521-1878(199902)21:2<164::AID-BIES10>3.3.CO;2-W; Young TL, 1999, AM J HUM GENET, V64, P900, DOI 10.1086/302301	26	445	461	1	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 21	2001	293	5538					2256	2259		10.1126/science.1063525	http://dx.doi.org/10.1126/science.1063525			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475AL	11567139				2022-12-24	WOS:000171139400044
J	Flick, K; Scholander, C; Chen, QJ; Fernandez, V; Pouvelle, B; Gysin, J; Wahlgren, M				Flick, K; Scholander, C; Chen, QJ; Fernandez, V; Pouvelle, B; Gysin, J; Wahlgren, M			Rote of nonimmune IgG bound to PfEMP1 in placental malaria	SCIENCE			English	Article							PLASMODIUM-FALCIPARUM; PREGNANCY	Infections with Plasmodium falciparum during pregnancy lead to the accumulation of parasitized red blood cells (infected erythrocytes, IEs) in the placenta. IEs of A falciparum isolates that infect the human placenta were found to bind immunoglobulin G (IgG). A strain of P. falciparum cloned for IgG binding adhered massively to placental syncytiotrophoblasts in a pattern similar to that of natural infections. Adherence was inhibited by IgG-binding proteins, but not by glycosaminoglycans or enzymatic digestion of chondroitin sulfate A or hyaluronic acid. Normal, nonimmune IgG that is bound to a duffy binding-like domain beta of the P. falciparum erythrocyte membrane protein 1 (PfEMP1) might at the IE surface act as a bridge to neonatal Fc receptors of the placenta.	Karolinska Inst, Ctr Microbiol & Tumor Biol, S-17177 Stockholm, Sweden; Swedish Inst Infect Dis Control, S-17177 Stockholm, Sweden; Univ Aix Marseille 2, Fac Med, Unite Parasitol Expt, F-13385 Marseille 5, France	Karolinska Institutet; Swedish Institute for Infectious Disease Control; UDICE-French Research Universities; Aix-Marseille Universite	Wahlgren, M (corresponding author), Karolinska Inst, Ctr Microbiol & Tumor Biol, Box 280, S-17177 Stockholm, Sweden.	Mats.wahlgren@smi.ki.se	Pouvelle, Bruno/AAA-3968-2022					BEESON JG, 2000, NAT MED, V6, P1; BRABIN BJ, 1983, B WORLD HEALTH ORGAN, V61, P1005; Buffet PA, 1999, P NATL ACAD SCI USA, V96, P12743, DOI 10.1073/pnas.96.22.12743; BULMER JN, 1993, HISTOPATHOLOGY, V22, P3; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; Fried M, 1998, NATURE, V395, P851, DOI 10.1038/27570; GITLIN D, 1969, J CLIN INVEST, V48, P1433, DOI 10.1172/JCI106109; Gysin J, 1999, INFECT IMMUN, V67, P6596; McGregor I A, 1987, Parassitologia, V29, P153; MCGREGOR IA, 1984, AM J TROP MED HYG, V33, P517, DOI 10.4269/ajtmh.1984.33.517; MENENDEZ C, 1995, PARASITOL TODAY, V11, P178, DOI 10.1016/0169-4758(95)80151-0; Reeder JC, 1999, P NATL ACAD SCI USA, V96, P5198, DOI 10.1073/pnas.96.9.5198; Ricke CH, 2000, J IMMUNOL, V165, P3309, DOI 10.4049/jimmunol.165.6.3309; Robert C, 1995, RES IMMUNOL, V146, P383, DOI 10.1016/0923-2494(96)81042-X; ROGERSON SJ, 1995, J EXP MED, V182, P15, DOI 10.1084/jem.182.1.15; Scherf A, 1998, EMBO J, V17, P5418, DOI 10.1093/emboj/17.18.5418; SCHOLANDER C, 1996, NAT MED, V2, P2	17	121	121	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 14	2001	293	5537					2098	2100		10.1126/science.1062891	http://dx.doi.org/10.1126/science.1062891			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473FB	11557894				2022-12-24	WOS:000171028700076
J	Herzig, S; Long, FX; Jhala, US; Hedrick, S; Quinn, R; Bauer, A; Rudolph, D; Schutz, G; Yoon, C; Puigserver, P; Spiegelman, B; Montminy, M				Herzig, S; Long, FX; Jhala, US; Hedrick, S; Quinn, R; Bauer, A; Rudolph, D; Schutz, G; Yoon, C; Puigserver, P; Spiegelman, B; Montminy, M			CREB regulates hepatic gluconeogenesis through the coactivator PGC-1	NATURE			English	Article							PHOSPHOENOLPYRUVATE CARBOXYKINASE GENE; CAMP RESPONSE ELEMENT; GTP GENE; LEPTIN RECEPTOR; BINDING PROTEIN; TRANSCRIPTION; GLUCOCORTICOIDS; PROMOTER; MICE; IDENTIFICATION	When mammals fast, glucose homeostasis is achieved by triggering expression of gluconeogenic genes in response to glucagon and glucocorticoids. The pathways act synergistically to induce gluconeogenesis (glucose synthesis), although the underlying mechanism has not been determined(1-4). Here we show that mice carrying a targeted disruption of the cyclic AMP (cAMP) response element binding (CREB) protein gene, or overexpressing a dominant-negative CREB inhibitor, exhibit fasting hyperglycaemia and reduced expression of gluconeogenic enzymes. CREB was found to induce expression of the gluconeogenic programme through the nuclear receptor coactivator PGC-1, which is shown here to be a direct target for CREB regulation in vivo. Overexpression of PGC-1 in CREB-dercient mice restored glucose homeostasis and rescued expression of gluconeogenic genes. In transient assays, PGC-1 potentiated glucocorticoid induction of the gene for phosphoenolpyruvate carboxykinase (PEPCK), the rate-limiting enzyme in gluconeogenesis. PGC-1 promotes cooperativity between cyclic AMP and glucocorticoid signalling pathways during hepatic gluconeogenesis. Fasting hyperglycaemia is strongly correlated with type II diabetes, so our results suggest that the activation of PGC-1 by CREB in liver contributes importantly to the pathogenesis of this disease.	Salk Inst Biol Studies, Peptide Biol Labs, La Jolla, CA 92037 USA; Joslin Diabet Ctr, Boston, MA 02215 USA; Deutsch Krebsforschungszentrum, D-69120 Heidelberg, Germany; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Cell Biol, Boston, MA 02115 USA	Salk Institute; Harvard University; Joslin Diabetes Center, Inc.; Helmholtz Association; German Cancer Research Center (DKFZ); Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Montminy, M (corresponding author), Salk Inst Biol Studies, Peptide Biol Labs, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.			Herzig, Stephan/0000-0003-3950-3652				Ahn S, 1998, MOL CELL BIOL, V18, P967, DOI 10.1128/MCB.18.2.967; ANGRAND PO, 1994, CELL GROWTH DIFFER, V5, P957; BECKER TC, 1994, METHOD CELL BIOL, V43, P161; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; CONSOLI A, 1992, DIABETES CARE, V15, P430, DOI 10.2337/diacare.15.3.430; Friedman JE, 1997, J BIOL CHEM, V272, P31475, DOI 10.1074/jbc.272.50.31475; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Hanson RW, 1997, ANNU REV BIOCHEM, V66, P581, DOI 10.1146/annurev.biochem.66.1.581; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; IMAI E, 1993, J BIOL CHEM, V268, P5353; IMAI E, 1990, MOL CELL BIOL, V10, P4712, DOI 10.1128/MCB.10.9.4712; Jitrapakdee S, 1997, J BIOL CHEM, V272, P20522, DOI 10.1074/jbc.272.33.20522; Knutti D, 2000, MOL CELL BIOL, V20, P2411, DOI 10.1128/MCB.20.7.2411-2422.2000; Lee GH, 1996, NATURE, V379, P632, DOI 10.1038/379632a0; Lei KJ, 1996, NAT GENET, V13, P203, DOI 10.1038/ng0696-203; LEMAIGRE FP, 1994, BIOCHEM J, V303, P1; LIU JK, 1988, GENE DEV, V2, P528, DOI 10.1101/gad.2.5.528; LIU JS, 1991, J BIOL CHEM, V266, P19095; Long FX, 2001, DEVELOPMENT, V128, P541; Michael LF, 2000, MOL CELL BIOL, V20, P1596, DOI 10.1128/MCB.20.5.1596-1603.2000; Nakajima T, 1997, CELL, V90, P1107, DOI 10.1016/S0092-8674(00)80376-1; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; QUINN PG, 1990, MOL CELL BIOL, V10, P3357, DOI 10.1128/MCB.10.7.3357; Rudolph D, 1998, P NATL ACAD SCI USA, V95, P4481, DOI 10.1073/pnas.95.8.4481; Schmoll D, 1999, BIOCHEM J, V338, P457, DOI 10.1042/0264-6021:3380457; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; SHORT JM, 1986, J BIOL CHEM, V261, P9721; Wexler ID, 1998, PEDIATR RES, V43, P579, DOI 10.1203/00006450-199805000-00004; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050	29	1097	1137	6	103	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 13	2001	413	6852					179	183		10.1038/35093131	http://dx.doi.org/10.1038/35093131			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471FU	11557984				2022-12-24	WOS:000170918800050
J	Yoon, JC; Puigserver, P; Chen, GX; Donovan, J; Wu, ZD; Rhee, J; Adelmant, G; Stafford, J; Kahn, CR; Granner, DK; Newgard, CB; Spiegelman, BM				Yoon, JC; Puigserver, P; Chen, GX; Donovan, J; Wu, ZD; Rhee, J; Adelmant, G; Stafford, J; Kahn, CR; Granner, DK; Newgard, CB; Spiegelman, BM			Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1	NATURE			English	Article							PHOSPHOENOLPYRUVATE CARBOXYKINASE GENE; GLUCOSE-6-PHOSPHATASE CATALYTIC SUBUNIT; RECEPTOR-GAMMA COACTIVATOR-1; RESPONSE UNIT; GLUCOCORTICOID RESPONSE; NUCLEAR RECEPTORS; METABOLIC IMPACT; CAMP INDUCTION; BINDING-SITES; GTP GENE	Blood glucose levels are maintained by the balance between glucose uptake by peripheral tissues and glucose secretion by the liver. Gluconeogenesis is strongly stimulated during fasting and is aberrantly activated in diabetes mellitus. Here we show that the transcriptional coactivator PGC-1 is strongly induced in liver in fasting mice and in three mouse models of insulin action deficiency: streptozotocin-induced diabetes, ob/ob genotype and liver insulin-receptor knockout. PGC-1 is induced synergistically in primary liver cultures by cyclic AMP and glucocorticoids. Adenoviral-mediated expression of PGC-1 in hepatocytes in culture or in vivo strongly activates an entire programme of key gluconeogenic enzymes, including phosphoenolpyruvate carboxykinase (PEPCK) and glucose-6-phosphatase, leading to increased glucose output. Full transcriptional activation of the PEPCK promoter requires coactivation of the glucocorticoid receptor and the liver-enriched transcription factor HNF-4 alpha (hepatic nuclear factor-4 alpha) by PGC-1. These results implicate PGC-1 as a key modulator of hepatic gluconeogenesis and as a central target of the insulin-cAMP axis in liver.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Univ Texas, SW Med Ctr, Touchstone Ctr Diabet Res, Dept Biochem, Dallas, TX USA; Univ Texas, SW Med Ctr, Touchstone Ctr Diabet Res, Dept Internal Med, Dallas, TX USA; Vanderbilt Univ, Dept Mol Biol & Biophys, Sch Med, Nashville, TN 37232 USA; Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Vanderbilt University; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School	Spiegelman, BM (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, 44 Binney St, Boston, MA 02115 USA.		Kahn, Ronald/AAY-2435-2021; Rhee, James/V-9973-2019; Stafford, John/K-7763-2017	Kahn, Ronald/0000-0002-7583-9228; Wu, Zhidan/0000-0001-7289-9420; Stafford, John/0000-0001-6527-959X				Antinozzi PA, 1999, ANNU REV NUTR, V19, P511, DOI 10.1146/annurev.nutr.19.1.511; BECKER TC, 1994, METHOD CELL BIOL, V43, P161; Boss O, 1999, BIOCHEM BIOPH RES CO, V261, P870, DOI 10.1006/bbrc.1999.1145; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; DeFronzo RA, 1997, DIABETES REV, V5, P177; Glass CK, 2000, GENE DEV, V14, P121; Gomez-Ambrosi J, 2001, MOL CELL ENDOCRINOL, V176, P85, DOI 10.1016/S0303-7207(01)00451-8; HALL RK, 1995, P NATL ACAD SCI USA, V92, P412, DOI 10.1073/pnas.92.2.412; Hanson RW, 1997, ANNU REV BIOCHEM, V66, P581, DOI 10.1146/annurev.biochem.66.1.581; Knutti D, 2000, MOL CELL BIOL, V20, P2411, DOI 10.1128/MCB.20.7.2411-2422.2000; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; McNeill J. H, 1999, EXPT MODELS DIABETES; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; MITCHELL J, 1994, MOL ENDOCRINOL, V8, P585, DOI 10.1210/me.8.5.585; Nakae J, 2000, EMBO J, V19, P989, DOI 10.1093/emboj/19.5.989; Nordlie RC, 1999, ANNU REV NUTR, V19, P379, DOI 10.1146/annurev.nutr.19.1.379; O'Doherty RM, 1999, DIABETES, V48, P2022, DOI 10.2337/diabetes.48.10.2022; Park EA, 1999, J BIOL CHEM, V274, P211, DOI 10.1074/jbc.274.1.211; PILKIS SJ, 1992, ANNU REV PHYSIOL, V54, P885, DOI 10.1146/annurev.ph.54.030192.004321; Puigserver P, 1999, SCIENCE, V286, P1368, DOI 10.1126/science.286.5443.1368; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; ROESLER WJ, 1994, J BIOL CHEM, V269, P14276; Scott DK, 1996, J BIOL CHEM, V271, P31909, DOI 10.1074/jbc.271.50.31909; Seoane J, 1997, J BIOL CHEM, V272, P26972, DOI 10.1074/jbc.272.43.26972; Sugiyama T, 2000, J BIOL CHEM, V275, P3446, DOI 10.1074/jbc.275.5.3446; Tcherepanova I, 2000, J BIOL CHEM, V275, P16302, DOI 10.1074/jbc.M001364200; Trinh KY, 1998, J BIOL CHEM, V273, P31615, DOI 10.1074/jbc.273.47.31615; VALERA A, 1994, P NATL ACAD SCI USA, V91, P9151, DOI 10.1073/pnas.91.19.9151; Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000; Wang JC, 1999, MOL ENDOCRINOL, V13, P604, DOI 10.1210/me.13.4.604; Wiernsperger NF, 1999, DRUGS, V58, P31, DOI 10.2165/00003495-199958001-00009; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yeagley D, 1998, J BIOL CHEM, V273, P18743, DOI 10.1074/jbc.273.30.18743	33	1442	1523	4	143	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 13	2001	413	6852					131	138		10.1038/35093050	http://dx.doi.org/10.1038/35093050			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471FU	11557972				2022-12-24	WOS:000170918800038
J	Schwetz, BA				Schwetz, BA			Novel imaging device	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Off Commissioner Food & Drugs, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Schwetz, BA (corresponding author), US FDA, Off Commissioner Food & Drugs, HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	2	2	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 12	2001	286	10					1166	1166		10.1001/jama.286.10.1166	http://dx.doi.org/10.1001/jama.286.10.1166			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	471CR	11559244				2022-12-24	WOS:000170910400005
J	Dong, XZ; Han, SK; Zylka, MJ; Simon, MI; Anderson, DJ				Dong, XZ; Han, SK; Zylka, MJ; Simon, MI; Anderson, DJ			A diverse family of GPCRs expressed in specific subsets of nociceptive sensory neurons	CELL			English	Article							PROTEIN-COUPLED RECEPTORS; PUTATIVE PHEROMONE RECEPTORS; NEUROPEPTIDE FF RECEPTORS; LECTIN-BINDING ANALYSIS; DORSAL-ROOT; SPINAL-CORD; CAPSAICIN RECEPTOR; ODORANT RECEPTORS; TASTE RECEPTORS; COMPREHENSIVE IMMUNOFLUORESCENCE	In vertebrates, peripheral chemosensory neurons express large families of G protein-coupled receptors (GPCRs), reflecting the diversity and specificity of stimuli they detect. However, somatosensory neurons, which respond to chemical, thermal, or mechanical stimuli, are more broadly tuned. Here we describe a family of approximately 50 GPCRs related to Mas1, called mrgs, a subset of which is expressed in specific subpopulations of sensory neurons that detect painful stimuli. The expression patterns of mrgs thus reveal an unexpected degree of molecular diversity among nociceptive neurons. Some of these receptors can be specifically activated in heterologous cells by RFamide neuropeptides such as NPFF and NPAF, which are analgesic in vivo. Thus, mrgs may regulate nociceptor function and/or development, including the sensation or modulation of pain.	CALTECH, Div Biol 216 76, Pasadena, CA 91125 USA; CALTECH, Div Biol 147 75, Pasadena, CA 91125 USA; CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute	Anderson, DJ (corresponding author), CALTECH, Div Biol 216 76, Pasadena, CA 91125 USA.	wuwei@caltech.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM034236, R01GM034236] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-34236] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Akopian AN, 1996, TRENDS NEUROSCI, V19, P240, DOI 10.1016/0166-2236(96)10030-8; Akopian AN, 1996, NATURE, V379, P257, DOI 10.1038/379257a0; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; ANDERSON L, 1995, BIOCHEM J, V311, P385, DOI 10.1042/bj3110385; Askwith CC, 2000, NEURON, V26, P133, DOI 10.1016/S0896-6273(00)81144-7; Bennett DLH, 1998, J NEUROSCI, V18, P3059; Bonini JA, 2000, J BIOL CHEM, V275, P39324, DOI 10.1074/jbc.M004385200; Bradbury EJ, 1998, MOL CELL NEUROSCI, V12, P256, DOI 10.1006/mcne.1998.0719; Brosius J, 1999, TRENDS GENET, V15, P304, DOI 10.1016/S0168-9525(99)01783-7; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Caterina MJ, 1999, CURR OPIN NEUROBIOL, V9, P525, DOI 10.1016/S0959-4388(99)00009-4; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; CHENN A, 1995, CELL, V82, P631, DOI 10.1016/0092-8674(95)90035-7; DADO RJ, 1993, NEUROREPORT, V5, P341, DOI 10.1097/00001756-199312000-00041; Donaldson LF, 2001, PROSTAG OTH LIPID M, V63, P109, DOI 10.1016/S0090-6980(00)00101-5; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Elshourbagy NA, 2000, J BIOL CHEM, V275, P25965, DOI 10.1074/jbc.M004515200; Friedel RH, 2001, MOL CELL NEUROSCI, V17, P31, DOI 10.1006/mcne.2000.0912; Fundin BT, 1997, J COMP NEUROL, V385, P185, DOI 10.1002/(SICI)1096-9861(19970825)385:2<185::AID-CNE2>3.0.CO;2-Y; Glusman G, 2001, GENOME RES, V11, P685, DOI 10.1101/gr.171001; Goodier JL, 2000, HUM MOL GENET, V9, P653, DOI 10.1093/hmg/9.4.653; Gouarderes C, 2000, SYNAPSE, V35, P45, DOI 10.1002/(SICI)1098-2396(200001)35:1<45::AID-SYN6>3.0.CO;2-0; Gouarderes C, 1996, NEUROSCIENCE, V74, P21, DOI 10.1016/0306-4522(96)00122-4; Hinuma S, 1998, NATURE, V393, P272, DOI 10.1038/30515; Hinuma S, 2000, NAT CELL BIOL, V2, P703, DOI 10.1038/35036326; Hunt SP, 2001, NAT REV NEUROSCI, V2, P83, DOI 10.1038/35053509; Jackman A, 2000, J COMP NEUROL, V418, P281; JACKSON TR, 1988, NATURE, V335, P437, DOI 10.1038/335437a0; KOBILKA B, 1992, ANNU REV NEUROSCI, V15, P87, DOI 10.1146/annurev.ne.15.030192.000511; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li C, 1999, BRAIN RES, V848, P26, DOI 10.1016/S0006-8993(99)01972-1; Ma QF, 1996, CELL, V87, P43, DOI 10.1016/S0092-8674(00)81321-5; Ma QF, 1999, GENE DEV, V13, P1717, DOI 10.1101/gad.13.13.1717; Malmberg AB, 1997, SCIENCE, V278, P279, DOI 10.1126/science.278.5336.279; Matsunami H, 2000, NATURE, V404, P601, DOI 10.1038/35007072; Matsunami H, 1997, CELL, V90, P775, DOI 10.1016/S0092-8674(00)80537-1; MCMAHON SB, 1994, NEURON, V12, P1161, DOI 10.1016/0896-6273(94)90323-9; Michael GJ, 1999, J NEUROSCI, V19, P1844; Molliver DC, 1997, NEURON, V19, P849, DOI 10.1016/S0896-6273(00)80966-6; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Mombaerts P, 1999, ANNU REV NEUROSCI, V22, P487, DOI 10.1146/annurev.neuro.22.1.487; MONNOT C, 1991, MOL ENDOCRINOL, V5, P1477, DOI 10.1210/mend-5-10-1477; Nelson LS, 1998, SCIENCE, V281, P1686, DOI 10.1126/science.281.5383.1686; OFFERMANNS S, 1995, J BIOL CHEM, V270, P15175, DOI 10.1074/jbc.270.25.15175; Ohtaki T, 2001, NATURE, V411, P613, DOI 10.1038/35079135; Pantages E, 2000, NEURON, V28, P835, DOI 10.1016/S0896-6273(00)00157-4; Panula P, 1999, BRAIN RES, V848, P191, DOI 10.1016/S0006-8993(99)02044-2; Perez SE, 1999, DEVELOPMENT, V126, P1715; Perry SJ, 1997, FEBS LETT, V409, P426, DOI 10.1016/S0014-5793(97)00557-7; PRICE DA, 1977, SCIENCE, V197, P670, DOI 10.1126/science.877582; Rebeyrolles S, 1996, NEUROREPORT, V7, P2979, DOI 10.1097/00001756-199611250-00036; Rice FL, 1997, J COMP NEUROL, V385, P149; ROSS PC, 1990, P NATL ACAD SCI USA, V87, P3052, DOI 10.1073/pnas.87.8.3052; Scott SA, 1992, SENSORY NEURONS DIVE; Snider WD, 1996, PHILOS T ROY SOC B, V351, P395, DOI 10.1098/rstb.1996.0034; Snider WD, 1998, NEURON, V20, P629, DOI 10.1016/S0896-6273(00)81003-X; Stucky CL, 1999, J NEUROSCI, V19, P6497; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; TSIEN RY, 1985, CELL CALCIUM, V6, P145, DOI 10.1016/0143-4160(85)90041-7; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Vilim FS, 1999, MOL PHARMACOL, V55, P804; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Willis Jr W. D., 1991, SENSORY MECH SPINAL; Xie SY, 2000, MAMM GENOME, V11, P1070, DOI 10.1007/s003350010217; YOUNG D, 1986, CELL, V45, P711, DOI 10.1016/0092-8674(86)90785-3; Zhao HQ, 1998, SCIENCE, V279, P237, DOI 10.1126/science.279.5348.237	72	475	541	2	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 7	2001	106	5					619	632		10.1016/S0092-8674(01)00483-4	http://dx.doi.org/10.1016/S0092-8674(01)00483-4			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	472FQ	11551509	Bronze			2022-12-24	WOS:000170973200012
J	Tillmann, HL; Heiken, H; Knapik-Botor, A; Heringlake, S; Ockenga, J; Wilber, JC; Goergen, B; Detmer, J; McMorrow, M; Stoll, M; Schmidt, RE; Manns, MP				Tillmann, HL; Heiken, H; Knapik-Botor, A; Heringlake, S; Ockenga, J; Wilber, JC; Goergen, B; Detmer, J; McMorrow, M; Stoll, M; Schmidt, RE; Manns, MP			Infection with GB virus C and reduced mortality among HIV-infected patients.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HEPATITIS-G VIRUS; ANTIRETROVIRAL THERAPY; CLINICAL PROGRESSION; NATURAL-HISTORY; HOMOSEXUAL MEN; LIVER-DISEASE; COINFECTION; ANTIBODIES; COHORT	Background: The flavivirus GB virus C (GBV-C, also designated hepatitis G virus) was identified in a search for hepatitis viruses, but no disease is currently known to be associated with it. We investigated the relation between coinfection with GBV-C and the long-term outcome in patients infected with the human immunodeficiency virus (HIV). Methods: A total of 197 HIV-positive patients were followed prospectively beginning in 1993 or 1994. Of these patients, 33 (16.8 percent) tested positive for GBV-C RNA, 112 (56.9 percent) had detectable antibodies against the GBV-C envelope protein E2, and 52 (26.4 percent) had no marker of GBV-C infection and were considered unexposed. We assessed the relation between GBV-C infection and the progression of HIV disease. We also tested 169 GBV-C-positive plasma samples with a quantitative branched-chain DNA (bDNA) assay in order to investigate possible correlations between GBV-C viral load and both the CD4+ cell count and the HIV load. Results: Among the patients who tested positive for GBV-C RNA, survival was significantly longer, and there was a slower progression to the acquired immunodeficiency syndrome (AIDS) (P<0.001 for both comparisons). Survival after the development of AIDS was also better among the GBV-C-positive patients. The association of GBV-C viremia with reduced mortality remained significant in analyses stratified according to age and CD4+ cell count. In an analysis restricted to the years after highly active antiretroviral therapy became available, the presence of GBV-C RNA remained predictive of longer survival (P=0.02). The HIV load was lower in the GBV-C-positive patients than in the GBV-C-negative patients. The GBV-C load correlated inversely with the HIV load (r=-0.33, P<0.001) but did not correlate with the CD4+ cell count. Conclusions: Coinfection with GBV-C is associated with a reduced mortality rate in HIV-infected patients. GBV-C is not known to cause any disease, but it is possible that its presence leads to an inhibition of HIV replication. However, GBV-C infection could also be a marker for the presence of other factors that lead to a favorable HIV response.	Hannover Med Sch, Dept Gastroenterol & Hepatol, D-30623 Hannover, Germany; Hannover Med Sch, Dept Clin Immunol, D-30623 Hannover, Germany; Bayer Diagnost, Emeryville, CA USA	Hannover Medical School; Hannover Medical School; Bayer AG	Tillmann, HL (corresponding author), Hannover Med Sch, Dept Gastroenterol & Hepatol, Neuberg Str 1, D-30623 Hannover, Germany.							Alter HJ, 1996, NEW ENGL J MED, V334, P1536, DOI 10.1056/NEJM199606063342310; BARTHOLOMEW C, 1987, LANCET, V2, P1469; Carpenter CCJ, 1998, JAMA-J AM MED ASSOC, V280, P78, DOI 10.1001/jama.280.1.78; Casoli C, 2000, BLOOD, V95, P2760, DOI 10.1182/blood.V95.9.2760.009k04_2760_2769; Dille BJ, 1997, J INFECT DIS, V175, P458, DOI 10.1093/infdis/175.2.458; EYSTER ME, 1993, J ACQ IMMUN DEF SYND, V6, P602; Fischer HP, 1996, J HEPATOL, V24, P35; Greub G, 2000, LANCET, V356, P1800, DOI 10.1016/S0140-6736(00)03232-3; Heringlake S, 1998, J INFECT DIS, V177, P1723, DOI 10.1086/517431; Lefrere JJ, 1999, J INFECT DIS, V179, P783, DOI 10.1086/314671; Lesens O, 1999, J INFECT DIS, V179, P1254, DOI 10.1086/314720; Linnen J, 1996, SCIENCE, V271, P505, DOI 10.1126/science.271.5248.505; MARTIN P, 1989, GASTROENTEROLOGY, V97, P1559, DOI 10.1016/0016-5085(89)90405-8; MCNAIR ANB, 1992, SEMIN LIVER DIS, V12, P188, DOI 10.1055/s-2007-1007390; Ockenga J, 1997, J HEPATOL, V27, P18, DOI 10.1016/S0168-8278(97)80274-7; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Pol S, 1998, J HEPATOL, V29, P12, DOI 10.1016/S0168-8278(98)80173-6; Pol S, 1998, J HEPATOL, V28, P945, DOI 10.1016/S0168-8278(98)80341-3; Rambusch EG, 1998, Z GASTROENTEROL, V36, P41; Sabin CA, 1998, J ACQ IMMUN DEF SYND, V19, P546, DOI 10.1097/00042560-199812150-00016; Sagnelli E, 2000, HEPATOLOGY, V32, P1106, DOI 10.1053/jhep.2000.19288; Sherlock S, 1999, J VIRAL HEPATITIS, V6, P1, DOI 10.1046/j.1365-2893.1999.00007.x; SIMONS JN, 1995, NAT MED, V1, P564, DOI 10.1038/nm0695-564; Soto B, 1997, J HEPATOL, V26, P1, DOI 10.1016/S0168-8278(97)80001-3; TELFER P, 1994, BRIT J HAEMATOL, V87, P555, DOI 10.1111/j.1365-2141.1994.tb08312.x; Tillmann HL, 1998, HEPATOLOGY, V28, P379, DOI 10.1002/hep.510280213; TILLMANN HL, IN PRESS ANTIVIRAL R; Toyoda H, 1998, J ACQ IMMUN DEF SYND, V17, P209, DOI 10.1097/00042560-199803010-00004; Wachtler M, 2000, INFECTION, V28, P297, DOI 10.1007/s150100070022; Watt G, 2000, LANCET, V356, P475, DOI 10.1016/S0140-6736(00)02557-5; Xiang JH, 2001, NEW ENGL J MED, V345, P707, DOI 10.1056/NEJMoa003364; Yeo AET, 2000, ANN INTERN MED, V132, P959, DOI 10.7326/0003-4819-132-12-200006200-00006	32	300	323	1	7	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 6	2001	345	10					715	724		10.1056/NEJMoa010398	http://dx.doi.org/10.1056/NEJMoa010398			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	468RX	11547740	Bronze			2022-12-24	WOS:000170772900002
J	van den Ent, F; Amos, LA; Lowe, J				van den Ent, F; Amos, LA; Lowe, J			Prokaryotic origin of the actin cytoskeleton	NATURE			English	Article							F-ACTIN; CRYSTAL-STRUCTURE; ATPASE FRAGMENT; ATOMIC MODEL; CELL-SHAPE; PROTEINS; DOMAIN; REFINEMENT; PARAMETERS; SEQUENCE	It was thought until recently that bacteria lack the actin or tubulin filament networks that organize eukaryotic cytoplasm. However, we show here that the bacterial MreB protein assembles into filaments with a subunit repeat similar to that of F-actin-the physiological polymer of eukaryotic actin. By elucidating the MreB crystal structure we demonstrate that MreB and actin are very similar in three dimensions. Moreover, the crystals contain protofilaments, allowing visualization of actin-like strands at atomic resolution. The structure of the MreB protofilament is in remarkably good agreement with the model for F-actin, showing that the proteins assemble in identical orientations. The actin-like properties of MreB explain the finding that MreB forms large fibrous spirals under the cell membrane of rod-shaped cells, where they are involved in cell-shape determination. Thus, prokaryotes are now known to possess homologues both of tubulin, namely FtsZ, and of actin.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	van den Ent, F (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	fent@mrc-lmb.cam.ac.uk	Löwe, Jan/X-6998-2019; Löwe, Jan/B-3882-2011	Lowe, Jan/0000-0002-5218-6615; Amos, Linda/0000-0001-8305-5346				AEBI U, 1981, J CELL BIOL, V91, P340, DOI 10.1083/jcb.91.2.340; ANDERSON PK, 1978, AUST WILDLIFE RES, V5, P1; BARTON GJ, 1993, PROTEIN ENG, V6, P37, DOI 10.1093/protein/6.1.37; BORK P, 1992, P NATL ACAD SCI USA, V89, P7290, DOI 10.1073/pnas.89.16.7290; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chik JK, 1996, J MOL BIOL, V263, P607, DOI 10.1006/jmbi.1996.0602; Crowther RA, 1996, J STRUCT BIOL, V116, P9, DOI 10.1006/jsbi.1996.0003; DOI M, 1988, J BACTERIOL, V170, P4619, DOI 10.1128/jb.170.10.4619-4624.1988; EGELMAN EH, 1982, NATURE, V298, P131, DOI 10.1038/298131a0; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; FLAHERTY KM, 1991, P NATL ACAD SCI USA, V88, P5041, DOI 10.1073/pnas.88.11.5041; FLAHERTY KM, 1990, NATURE, V346, P623, DOI 10.1038/346623a0; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; HURLEY JH, 1993, SCIENCE, V259, P673, DOI 10.1126/science.8430315; Jones LJF, 2001, CELL, V104, P913, DOI 10.1016/S0092-8674(01)00287-2; KABSCH W, 1995, FASEB J, V9, P167, DOI 10.1096/fasebj.9.2.7781919; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LESLIE AGW, 1991, RECENT CHANGES MOSFL; LEVIN PA, 1992, J BACTERIOL, V174, P6717, DOI 10.1128/JB.174.21.6717-6728.1992; LORENZ M, 1993, J MOL BIOL, V234, P826, DOI 10.1006/jmbi.1993.1628; MCLAUGHLIN PJ, 1993, NATURE, V364, P685, DOI 10.1038/364685a0; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Nogales E, 1998, NAT STRUCT BIOL, V5, P451, DOI 10.1038/nsb0698-451; Page R, 1998, J MOL BIOL, V280, P463, DOI 10.1006/jmbi.1998.1879; Schmidt A, 1998, ANNU REV CELL DEV BI, V14, P305, DOI 10.1146/annurev.cellbio.14.1.305; SCHUTT CE, 1993, NATURE, V365, P810, DOI 10.1038/365810a0; Steinmetz MO, 1998, J MOL BIOL, V278, P703, DOI 10.1006/jmbi.1998.1717; Straub FB, 1942, STUD I MED CHEM U SZ, V2, P3; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; TIRION MM, 1995, BIOPHYS J, V68, P5, DOI 10.1016/S0006-3495(95)80156-6; TURK D, 1992, THESIS TU MUNCHEN; van den Ent F, 1999, STRUCTURE, V7, P1181, DOI 10.1016/S0969-2126(00)80052-0; van den Ent F, 2000, EMBO J, V19, P5300, DOI 10.1093/emboj/19.20.5300; WACHI M, 1987, J BACTERIOL, V169, P4935, DOI 10.1128/jb.169.11.4935-4940.1987	39	591	606	3	91	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 6	2001	413	6851					39	44		10.1038/35092500	http://dx.doi.org/10.1038/35092500			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469EG	11544518				2022-12-24	WOS:000170801200031
J	Kirkwood, TBL				Kirkwood, TBL			Where will it all end?	LANCET			English	Editorial Material									Univ Newcastle Upon Tyne, Newcastle Gen Hosp, Inst Hlth Elderly, Dept Gerontol, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England	Newcastle General Hospital; Newcastle University - UK	Kirkwood, TBL (corresponding author), Univ Newcastle Upon Tyne, Newcastle Gen Hosp, Inst Hlth Elderly, Dept Gerontol, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England.							Kirkwood TBL, 2000, NATURE, V408, P233, DOI 10.1038/35041682; Tuljapurkar S, 2000, NATURE, V405, P789, DOI 10.1038/35015561; Vaupel JW, 1997, PHILOS T ROY SOC B, V352, P1799, DOI 10.1098/rstb.1997.0164; Wilmoth JR, 2000, SCIENCE, V289, P2366, DOI 10.1126/science.289.5488.2366	4	4	5	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 24	2001	357	9256					576	576		10.1016/S0140-6736(00)04077-0	http://dx.doi.org/10.1016/S0140-6736(00)04077-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	404UB	11558481				2022-12-24	WOS:000167119100007
J	Nieman, K; Oudkerk, M; Rensing, BJ; van Ooijen, P; Munne, A; van Geuns, RJ; de Feyter, PJ				Nieman, K; Oudkerk, M; Rensing, BJ; van Ooijen, P; Munne, A; van Geuns, RJ; de Feyter, PJ			Coronary angiography with multi-slice computed tomography	LANCET			English	Article							ARTERY STENOSES	Background A new generation of subsecond multi-slice computed tomography (MSCT) scanners, which allow complete coronary coverage, are becoming widely available. We investigated the potential value of MSCT angiography in a range of coronary disorders. Methods We studied 35 patients, including 11 who had undergone percutaneous transluminal coronary angioplasty and four who had had coronary-artery bypass grafts, by both MSCT and conventional coronary angiography. After intravenous injection of a non-ionic contrast medium with high iodine content, the entire heart was scanned within a single breath-hold. The total examination time was no more than 20 min. The retrospective electrocardiographically gated reconstruction source images and three-dimensional reconstructed volumes were analysed by two investigators, unaware of the results of conventional angiography. Findings In the 31 patients without previous coronary surgery, 173 (73%) of the 237 proximal and middle coronary segments were assessable. In the assessable segments, 17 of 21 significant stenoses (>50% reduction of vessel diameter) were correctly diagnosed. The non-assessable segments included four lesions. Misinterpretations were mainly the result of severe calcification of the vessel wall. Segments with implanted stents were poorly visualised, but stent patency could be assessed in all cases. Of the 17 segments of bypass grafts, 15 were assessable and four of five graft lesions were detected. Two cases of anomalous coronary anatomy could be visualised well. Interpretation These preliminary data suggest that MSCT allows non-invasive imaging of coronary-artery stenoses and has potential to develop into a reliable clinical technique.	Univ Rotterdam Hosp, Thoraxctr BD 406, Dept Cardiol, Catheterizat Lab, NL-3000 CA Rotterdam, Netherlands; Univ Rotterdam Hosp, Daniel Den Hoed Klin, Dept Radiol, NL-3000 CA Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute	de Feyter, PJ (corresponding author), Univ Rotterdam Hosp, Thoraxctr BD 406, Dept Cardiol, Catheterizat Lab, POB 2040, NL-3000 CA Rotterdam, Netherlands.		van Geuns, Robert-Jan M/N-7976-2017; van Geuns, Robert/AAR-6386-2021; van Ooijen, Peter/B-9150-2008	van Geuns, Robert-Jan M/0000-0003-2943-5932; van Ooijen, Peter/0000-0002-8995-1210; Oudkerk, Matthijs/0000-0003-2800-4110				Achenbach S, 1998, NEW ENGL J MED, V339, P1964, DOI 10.1056/NEJM199812313392702; Austen W G, 1975, Circulation, V51, P5; Becker CR, 2000, RADIOLOGE, V40, P118, DOI 10.1007/s001170050019; Bielak LF, 2000, CIRCULATION, V102, P380; de Feyter PJ, 2000, HEART, V84, P442, DOI 10.1136/heart.84.4.442; Hu H, 2000, RADIOLOGY, V215, P55, DOI 10.1148/radiology.215.1.r00ap3755; Huber A, 1999, AM J ROENTGENOL, V173, P95, DOI 10.2214/ajr.173.1.10397107; Kachelriess M, 1998, MED PHYS, V25, P2417, DOI 10.1118/1.598453; Kessler W, 1997, AM J CARDIOL, V80, P989, DOI 10.1016/S0002-9149(97)00590-0; Klingenbeck-Regn K, 1999, EUR J RADIOL, V31, P110, DOI 10.1016/S0720-048X(99)00086-8; Leclerc X, 2000, AM J ROENTGENOL, V174, P820, DOI 10.2214/ajr.174.3.1740820; Ohnesorge B, 2000, RADIOLOGY, V217, P564, DOI 10.1148/radiology.217.2.r00nv30564; PATTYNAMA PMT, 1994, AM HEART J, V128, P595, DOI 10.1016/0002-8703(94)90636-X; Pennell DJ, 1996, HEART, V75, P127, DOI 10.1136/hrt.75.2.127; Post JC, 1996, AM J ROENTGENOL, V166, P1399, DOI 10.2214/ajr.166.6.8633453; Rensing BJ, 1998, CIRCULATION, V98, P2509, DOI 10.1161/01.CIR.98.23.2509; Sandstede JJW, 1999, AM J ROENTGENOL, V172, P135, DOI 10.2214/ajr.172.1.9888755; van Geuns RJM, 1999, HEART, V82, P515, DOI 10.1136/hrt.82.4.515; van Geuns RJM, 2000, RADIOLOGY, V217, P270, DOI 10.1148/radiology.217.1.r00oc01270; Wielopolski PA, 2000, EUR RADIOL, V10, P12, DOI 10.1007/s003300050004	20	522	576	0	10	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 24	2001	357	9256					599	603		10.1016/S0140-6736(00)04058-7	http://dx.doi.org/10.1016/S0140-6736(00)04058-7			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	404UB	11558487				2022-12-24	WOS:000167119100013
J	Bulford, R				Bulford, R			Personal view - Children have rights too	BRITISH MEDICAL JOURNAL			English	Editorial Material											Bulford, R (corresponding author), ARTICLE 12,8 WAKLEY ST,LONDON EC1V 7QE,ENGLAND.								0	1	1	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	MAY 10	1997	314	7091					1421	1422						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WZ169	11644928				2022-12-24	WOS:A1997WZ16900077
J	Elliott, C				Elliott, C			Philosopher assisted suicide and euthanasia	BRITISH MEDICAL JOURNAL			English	Editorial Material											Elliott, C (corresponding author), MCGILL UNIV,MONTREAL,PQ,CANADA.								0	9	9	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	OCT 26	1996	313	7064					1088	1089						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	VP742	11644845				2022-12-24	WOS:A1996VP74200083
J	VanCappellen, P; Ingall, ED				VanCappellen, P; Ingall, ED			Redox stabilization of the atmosphere and oceans by phosphorus-limited marine productivity	SCIENCE			English	Article							OXYGEN; CARBON; PRESERVATION; WATER; TIME	Data from modern and ancient marine sediments demonstrate that burial of the limiting nutrient phosphorus is less efficient when bottom waters are low in oxygen. Mass-balance calculations using a coupled model of the biogeochemical cycles of carbon, phosphorus, oxygen, and iran indicate that the redox dependence of phosphorus burial in the oceans provides a powerful forcing mechanism for balancing production and consumption of atmospheric oxygen over geologic time. The oxygen-phosphorus coupling further guards against runaway ocean anoxia. Phosphorus-mediated redox stabilization of the atmosphere and oceans may have been crucial to the radiation of higher life forms during the Phanerozoic.	UNIV TEXAS,INST MARINE SCI,PORT ARANSAS,TX 78373	University of Texas System	VanCappellen, P (corresponding author), GEORGIA INST TECHNOL,SCH EARTH & ATMOSPHER SCI,ATLANTA,GA 30332, USA.		Van Cappellen, Philippe/A-2906-2013; Ingall, Ellery/A-5447-2008	Van Cappellen, Philippe/0000-0001-5476-0820; Ingall, Ellery/0000-0003-1954-0317	NCIPC CDC HHS [OCE94-15563] Funding Source: Medline	NCIPC CDC HHS		BERKNER LV, 1965, J ATMOS SCI, V22, P225, DOI 10.1175/1520-0469(1965)022<0225:OTOARO>2.0.CO;2; BERNER RA, 1987, AM J SCI, V287, P177, DOI 10.2475/ajs.287.3.177; BERNER RA, 1989, AM J SCI, V289, P333, DOI 10.2475/ajs.289.4.333; BERNER RA, 1989, PALAEOGEOGR PALAEOCL, V75, P97, DOI DOI 10.1016/0031-0182(89)90186-7; BROECKER WS, 1982, GEOCHIM COSMOCHIM AC, V46, P1689, DOI 10.1016/0016-7037(82)90110-7; Broecker WS, 1982, TRACERS SEA; CANFIELD DE, 1989, DEEP-SEA RES, V36, P121, DOI 10.1016/0198-0149(89)90022-8; FILIPPELLI GM, 1994, PALEOCEANOGRAPHY, V9, P643, DOI 10.1029/94PA01453; FOLLMI KB, 1995, GEOLOGY, V23, P859, DOI 10.1130/0091-7613(1995)023<0859:MYROMS>2.3.CO;2; HERBERT TD, 1991, GEOLOGY, V19, P702, DOI 10.1130/0091-7613(1991)019<0702:ONDAOL>2.3.CO;2; Holland H. D., 1978, CHEM ATMOSPHERE OCEA; Holland H.D., 1984, CHEM EVOLUTION ATMOS; HOLLAND HD, 1990, NATURE, V347, P17, DOI 10.1038/347017a0; INGALL E, 1994, GEOCHIM COSMOCHIM AC, V58, P2571, DOI 10.1016/0016-7037(94)90033-7; INGALL E, IN PRESS MAR GEOL; INGALL ED, 1993, GEOCHIM COSMOCHIM AC, V57, P303, DOI 10.1016/0016-7037(93)90433-W; JONES TP, 1978, PALAEOGEOGR PALAEOCL, V77, P51; JONES TP, 1991, PALAEOGEOGR PALAEOCL, V77, P39; Kump L. R, 1993, INTERACTIONS C N P S, P475; KUMP LR, 1988, NATURE, V335, P152, DOI 10.1038/335152a0; KUMP LR, 1986, AM J SCI, V286, P337, DOI 10.2475/ajs.286.5.337; LASAGA AC, 1985, CARBON CYCLE ATMOSPH, P397; REDFIELD AC, 1958, AM SCI, V46, P205; Sarmiento JL, 1988, GLOBAL BIOGEOCHEM CY, V2, P115, DOI 10.1029/GB002i002p00115; TROMP TK, 1995, GEOCHIM COSMOCHIM AC, V59, P1259, DOI 10.1016/0016-7037(95)00042-X; VANCAPPELLEN P, 1994, PALEOCEANOGRAPHY, V9, P677, DOI 10.1029/94PA01455; WATSON A, 1978, BIOSYSTEMS, V10, P293, DOI 10.1016/0303-2647(78)90012-6	27	271	274	2	89	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JAN 26	1996	271	5248					493	496		10.1126/science.271.5248.493	http://dx.doi.org/10.1126/science.271.5248.493			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TR322	11541251				2022-12-24	WOS:A1996TR32200038
J	GIESEN, TF; VANORDEN, A; HWANG, HJ; FELLERS, RS; PROVENCAL, RA; SAYKALLY, RJ				GIESEN, TF; VANORDEN, A; HWANG, HJ; FELLERS, RS; PROVENCAL, RA; SAYKALLY, RJ			INFRARED-LASER SPECTROSCOPY OF THE LINEAR C-13 CARBON CLUSTER	SCIENCE			English	Article							MULTIREFERENCE CONFIGURATION-INTERACTION; ELECTRON-SPIN-RESONANCE; MOLECULAR-STRUCTURE; CHAIN MOLECULES; GAS-PHASE; ISOMERS; SPECTRA; C-6; FULLERENES; STABILITY	The infrared absorption spectrum of a linear, 13-atom carbon cluster (C-13) has been observed by the use of a supersonic cluster beam-diode laser spectrometer. Seventy-six rovibrational transitions were measured near 1809 wave numbers and assigned to an antisymmetric stretching fundamental in the (1) Sigma(g)(+) ground state of C-13. This definitive structural characterization of a carbon cluster in the intermediate size range between C-10 and C-20 is in apparent conflict with theoretical calculations, which predict that clusters of this size should exist as planar monocyclic rings.	UNIV CALIF BERKELEY,DEPT CHEM,BERKELEY,CA 94720	University of California System; University of California Berkeley			Giesen, Thomas/B-9476-2015; Van Orden, Alan K/N-4219-2015	Giesen, Thomas/0000-0002-2401-0049; SAYKALLY, RICHARD/0000-0001-8942-3656				ACHIBA Y, 1991, Z PHYS D ATOM MOL CL, V19, P427, DOI 10.1007/BF01448344; ARNOLD DW, 1991, J CHEM PHYS, V95, P8753, DOI 10.1063/1.461211; BAKOWIES D, 1991, J AM CHEM SOC, V113, P3704, DOI 10.1021/ja00010a012; BERNATH PF, 1989, SCIENCE, V244, P562, DOI 10.1126/science.244.4904.562; BERNHOLDT DE, 1988, J CHEM PHYS, V89, P3612, DOI 10.1063/1.454881; BOWERS MT, 1993, SCIENCE, V260, P1446, DOI 10.1126/science.260.5113.1446; CHELIKOWSKY JR, 1991, PHYS REV LETT, V67, P2970, DOI 10.1103/PhysRevLett.67.2970; FEYEREISEN M, 1992, J CHEM PHYS, V96, P2926, DOI 10.1063/1.461989; Guelachvili G, 1986, HDB INFRARED STANDAR; HEATH JR, 1987, J AM CHEM SOC, V109, P359, DOI 10.1021/ja00236a012; HEATH JR, 1993, CLUSTERS CLUSTERING, P7; HINKLE KW, 1988, SCIENCE, V241, P1319, DOI 10.1126/science.241.4871.1319; HOFFMANN R, 1966, TETRAHEDRON, V22, P521, DOI 10.1016/0040-4020(66)80020-0; HUTTER J, 1993, 93107 SWISS FED I TE; HWANG HJ, 1993, MOL PHYS, V79, P769, DOI 10.1080/00268979300101611; JIAO CQ, 1993, RAPID COMMUN MASS SP, V7, P404, DOI 10.1002/rcm.1290070518; KAWAGUCHI K, 1989, J CHEM PHYS, V91, P1953, DOI 10.1063/1.457054; KROTO HW, 1987, ASTROPHYS J, V314, P352, DOI 10.1086/165065; KURTZ J, 1991, ASTROPHYS J, V370, P784, DOI 10.1086/169862; LIANG CX, 1990, J CHEM PHYS, V93, P8844, DOI 10.1063/1.459223; MARTIN JML, 1991, CHEM PHYS LETT, V187, P367, DOI 10.1016/0009-2614(91)80267-2; MARTIN JML, 1991, J CHEM PHYS, V94, P3753, DOI 10.1063/1.459747; MARTIN JML, 1990, J CHEM PHYS, V93, P8850, DOI 10.1063/1.459224; MCELVANY SW, 1993, SCIENCE, V259, P1594, DOI 10.1126/science.259.5101.1594; MOAZZENAHMADI N, 1994, J CHEM PHYS, V100, P4033, DOI 10.1063/1.466340; MOAZZENAHMADI N, 1993, J CHEM PHYS, V98, P7757, DOI 10.1063/1.464583; MOAZZENAHMADI N, 1991, CHEM PHYS LETT, V186, P291, DOI 10.1016/S0009-2614(91)85144-L; NORTHRUP FJ, 1991, J MOL SPECTROSC, V145, P74, DOI 10.1016/0022-2852(91)90352-B; PARASUK V, 1991, J CHEM PHYS, V94, P8172, DOI 10.1063/1.460100; PARASUK V, 1989, J CHEM PHYS, V91, P1137, DOI 10.1063/1.457186; PITZER KS, 1959, J AM CHEM SOC, V81, P4477, DOI 10.1021/ja01526a010; RAGHAVACHARI K, 1993, CHEM PHYS LETT, V214, P357, DOI 10.1016/0009-2614(93)85650-D; RAGHAVACHARI K, 1987, J CHEM PHYS, V87, P2191, DOI 10.1063/1.453145; SLANINA Z, 1992, MOL PHYS, V76, P387, DOI 10.1080/00268979200101401; SOWA MB, 1992, J CHEM PHYS, V97, P8164, DOI 10.1063/1.463438; VANORDEN A, 1993, J CHEM PHYS, V98, P6678, DOI 10.1063/1.464785; VANZEE RJ, 1988, J CHEM PHYS, V88, P3465, DOI 10.1063/1.453895; VANZEE RJ, 1987, J CHEM PHYS, V86, P5212, DOI 10.1063/1.452643; VON HELDEN G, 1993, CHEM PHYS LETT, V212, P241, DOI 10.1016/0009-2614(93)89320-H; VON HELDEN G, 1993, CHEM PHYS LETT, V212, P247, DOI 10.1016/0009-2614(93)89321-8; VON HELDEN G, 1993, J PHYS CHEM-US, V97, P8182, DOI 10.1021/j100133a011; VON HELDEN G, 1993, CHEM PHYS LETT, V204, P15, DOI 10.1016/0009-2614(93)85599-J; VON HELDEN G, 1993, NATURE, V363, P60, DOI 10.1038/363060a0; VON HELDEN G, 1993, SCIENCE, V259, P1300, DOI 10.1126/science.259.5099.1300; WATTS JD, 1992, CHEM PHYS LETT, V190, P19, DOI 10.1016/0009-2614(92)86095-Y; WELTNER W, 1989, CHEM REV, V89, P1713, DOI 10.1021/cr00098a005; ZAJFMAN D, 1992, SCIENCE, V258, P1129, DOI 10.1126/science.258.5085.1129	47	106	106	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	AUG 5	1994	265	5173					756	759		10.1126/science.11539187	http://dx.doi.org/10.1126/science.11539187			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PA372	11539187				2022-12-24	WOS:A1994PA37200025
J	JENNISKENS, P; BLAKE, DF				JENNISKENS, P; BLAKE, DF			STRUCTURAL TRANSITIONS IN AMORPHOUS WATER ICE AND ASTROPHYSICAL IMPLICATIONS	SCIENCE			English	Article							SOLID WATER; INTERSTELLAR GRAINS; LIQUID WATER; VAPOR; PRESSURE; AMORPHIZATION; DIFFRACTION; BEHAVIOR; REGION; IH	Selected area electron diffraction is used to monitor structural changes of vapor-deposited water ice in vacuum during warm-up from 15 to 188 K. A progression of three amorphous forms of water ice is found with well-defined transitions. The formation of a high-density amorphous form (I(a)h) at 15 K is confirmed, and the transition to the more familiar low-density form (I(a)l) occurs gradually over the range 38 to 68 K. At 131 K, the ice transforms into a third amorphous form (I(a)r), which precedes the crystallization of cubic ice (I-c) and coexists metastably with I-c from 148 K until at least 188 K. These structural transformations of amorphous water ice can be used to explain hitherto anomalous properties of astrophysical ices. The structural transition from I(a)h to I(a)l is responsible for the diffusion and recombination of radicals in ultraviolet-photolyzed interstellar ices at low temperatures. The occurrence and persistence of I(a)r explains anomalous gas retention and gas release from water-rich ices at temperatures above 150 K.			JENNISKENS, P (corresponding author), NASA,AMES RES CTR,SPACE SCI MICROSCOPY LAB,MAIL STOP 239-4,MOFFETT FIELD,CA 94035, USA.							ALLEN LC, 1974, PHYSICS CHEM ICE, P13; BARATTA GA, 1990, ASTRON ASTROPHYS, V240, P429; BARNUN A, 1985, ICARUS, V63, P317, DOI 10.1016/0019-1035(85)90048-X; BIZID A, 1987, J CHEM PHYS, V87, P2225, DOI 10.1063/1.453149; BLAKE DF, 1991, MICROBEAM ANAL 1991, P293; DOWELL LG, 1960, NATURE, V188, P1144, DOI 10.1038/1881144a0; DUBOCHET J, 1982, ULTRAMICROSCOPY, V10, P55, DOI 10.1016/0304-3991(82)90187-5; DUNCAN M, 1987, ASTRON J, V94, P1330, DOI 10.1086/114571; FESTOU MC, 1993, ASTRON ASTROPHYS REV, V5, P37, DOI 10.1007/BF00872923; GHORMLEY JA, 1968, J CHEM PHYS, V48, P503, DOI 10.1063/1.1667954; GHORMLEY JA, 1967, J CHEM PHYS, V46, P1321, DOI 10.1063/1.1840851; GREENBERG JM, 1972, MEM SOC ROY SCI LI 6, V3, P425; GREENBERG JM, 1991, CHEM SPACE, P227; HAGEN W, 1979, ASTROPHYS SPACE SCI, V65, P215, DOI 10.1007/BF00643502; HAGEN W, 1981, CHEM PHYS, V56, P367, DOI 10.1016/0301-0104(81)80158-9; HALLBRUCKER A, 1989, J PHYS CHEM-US, V93, P7751, DOI 10.1021/j100360a003; HALLBRUCKER A, 1991, ICARUS, V90, P176, DOI 10.1016/0019-1035(91)90078-8; HANDA YP, 1986, J CHEM PHYS, V84, P2766, DOI 10.1063/1.450301; HEIDE HG, 1985, ULTRAMICROSCOPY, V16, P151, DOI 10.1016/0304-3991(85)90070-1; HEIDE HG, 1984, ULTRAMICROSCOPY, V14, P271, DOI 10.1016/0304-3991(84)90095-0; JENNISKENS P, 1993, ASTRON ASTROPHYS, V273, P583; Jichen Li, 1993, Nature, V365, P327, DOI 10.1038/365327a0; KAMB B, 1973, WATER AQUEOUS SOLUTI, P9; KOUCHI A, 1990, J CRYST GROWTH, V99, P1220, DOI 10.1016/S0022-0248(08)80112-1; KOUCHI A, 1990, NATURE, V344, P134, DOI 10.1038/344134a0; KOUCHI A, 1987, NATURE, V330, P550, DOI 10.1038/330550a0; KOUCHI A, 1990, SP315 EUR SPAC AG, P193; MISHIMA O, 1984, NATURE, V310, P393, DOI 10.1038/310393a0; Mumma M. J., 1993, PROTOSTARS PLANETS, P1177; NARTEN AH, 1976, J CHEM PHYS, V64, P1106, DOI 10.1063/1.432298; Pauling L., 1960, NATURE CHEM BOND, P449; POHORILLE A, 1987, J CHEM PHYS, V87, P6070, DOI 10.1063/1.453481; ROWLAND B, 1991, J CHEM PHYS, V95, P1378, DOI 10.1063/1.461119; SACK NJ, 1993, PHYS REV B, V48, P9973, DOI 10.1103/PhysRevB.48.9973; SANDFORD SA, 1988, ICARUS, V76, P201, DOI 10.1016/0019-1035(88)90069-3; Sceats M.G., 1982, WATER COMPREHENSIVE, V7, P83; SCHMITT B, 1989, ESASP302, P65; SCHUTTE WA, 1988, THESIS U LEIDEN LEID; SCIORTINO F, 1992, J CHEM PHYS, V96, P3857, DOI 10.1063/1.461890; SCIORTINO F, 1991, NATURE, V354, P218, DOI 10.1038/354218a0; SIVAKUMAR TC, 1978, J CHEM PHYS, V69, P3468, DOI 10.1063/1.437079; SPEEDY RJ, 1992, J PHYS CHEM-US, V96, P2322, DOI 10.1021/j100184a056; TIELENS AGG, 1988, INTERSTELLAR DUST, V135, P239; TIELENS AGGM, 1983, J PHYS CHEM-US, V87, P4220, DOI 10.1021/j100244a049; TSE JS, 1992, J CHEM PHYS, V96, P5482, DOI 10.1063/1.462732	45	389	388	0	104	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	AUG 5	1994	265	5173					753	756		10.1126/science.11539186	http://dx.doi.org/10.1126/science.11539186			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PA372	11539186	Green Submitted			2022-12-24	WOS:A1994PA37200024
J	DIBROZOLO, FR; BUNCH, TE; FLEMING, RH; MACKLIN, J				DIBROZOLO, FR; BUNCH, TE; FLEMING, RH; MACKLIN, J			FULLERENES IN AN IMPACT CRATER ON THE LDEF SPACECRAFT	NATURE			English	Article							ENVIRONMENT; C-60	THE fullerenes C-60 (ref. 1) and C-70 have been found to occur naturally on Earth(2,3), and have also been invoked to explain features in the absorption spectra of interstellar clouds(1,4). But no definitive spectroscopic evidence exists for fullerenes in space and attempts to find fullerenes in carbonaceous chondrites have been unsuccessful(5,6), Here we report the observation of fullerenes associated with carbonaceous impact residue in a crater on the Long Duration Exposure Facility (LDEF) spacecraft. Laser ionization mass spectrometry and Raman spectroscopy indicate the presence of fullerenes in the crater and in adjacent ejecta. Man-made fullerenes survive experimental hypervelocity (similar to 6.1 km s(-1)) impacts into aluminium targets, suggesting that space fullerenes contained in a carbonaceous micrometeorite could have survived the LDEF impact at velocities towards the lower end of the natural particle encounter range (<13 km s(-1)). We also demonstrate that the fullerenes were unlikely to have formed as instrumental artefacts, nor are they present as contaminants. Although we cannot specify the origin of the fullerenes with certainty, the most plausible source is the chondritic impactor. If, alternatively, the impact produced the fullerenes in situ on LDEF, then this suggests a viable mechanism for fullerene production in space.	NASA, AMES RES CTR, PLANETARY BIOL BRANCH, MOFFETT FIELD, CA 94035 USA; UNIV WASHINGTON, DEPT CHEM, SEATTLE, WA 98195 USA	National Aeronautics & Space Administration (NASA); NASA Ames Research Center; University of Washington; University of Washington Seattle	DIBROZOLO, FR (corresponding author), CHARLES EVANS & ASSOCIATES, REDWOOD CITY, CA 94063 USA.							BETHUNE DS, 1990, CHEM PHYS LETT, V174, P219, DOI 10.1016/0009-2614(90)85335-A; BROWNLEE DE, 1993, NASA CP3194 C P, P577; BUNCH TE, 1993, NASA CP3194 C P, P453; BUNCH TE, 1992, NASA CP3134 C P; BUSECK PR, 1992, SCIENCE, V257, P215, DOI 10.1126/science.257.5067.215; COOMBS CR, 1993, NASA CP3194 C P, P595; DALY CF, 1993, SCIENCE, V259, P1599; DEVRIES MS, 1993, GEOCHIM COSMOCHIM AC, V57, P933, DOI 10.1016/0016-7037(93)90179-Z; GILMOUR L, 1991, LUNAR PLANET SCI, V22, P445; HCELVANY SH, 1992, J AM SOC MASS SPECTR, V3, P268; HORZ F, 1992, NASA CP3134 C P, P487; KESSLER DJ, 1991, J SPACECRAFT ROCKETS, V28, P347, DOI 10.2514/3.26250; KRATSCHMER W, 1990, NATURE, V347, P354, DOI 10.1038/347354a0; KROTO HW, 1985, NATURE, V318, P33; ONEAL RL, 1992, NASA CP3134 C P, P3; WEEKS S, 1990, LASERS MASS SPECTROM, P510; [No title captured]	17	39	39	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	1994	369	6475					37	40		10.1038/369037a0	http://dx.doi.org/10.1038/369037a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NJ860	11541208				2022-12-24	WOS:A1994NJ86000044
J	SCHOPF, JW				SCHOPF, JW			MICROFOSSILS OF THE EARLY ARCHEAN APEX CHERT - NEW EVIDENCE OF THE ANTIQUITY OF LIFE	SCIENCE			English	Article							BARBERTON MOUNTAIN LAND; WESTERN-AUSTRALIA; SOUTH-AFRICA; STROMATOLITIC MICROBIOTAS; NORTH-POLE; OLD	Eleven taxa (including eight heretofore undescribed species) of cellularly preserved filamentous microbes, among the oldest fossils known, have been discovered in a bedded chert unit of the Early Archean Apex Basalt of northwestern Western Australia. This prokaryotic assemblage establishes that trichomic cyanobacterium-like microorganisms were extant and morphologically diverse at least as early as approximately 3465 million years ago and suggests that oxygen-producing photoautotrophy may have already evolved by this early stage in biotic history.	UNIV CALIF LOS ANGELES,INST GEOPHYS & PLANETARY PHYS,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,DEPT EARTH & SPACE SCI,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,INST MOLEC BIOL,LOS ANGELES,CA 90024	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	SCHOPF, JW (corresponding author), UNIV CALIF LOS ANGELES,CTR STUDY EVOLUT & ORIGIN LIFE,LOS ANGELES,CA 90024, USA.							AWRAMIK SM, 1983, PRECAMBRIAN RES, V20, P357, DOI 10.1016/0301-9268(83)90081-5; BARGHOOR.ES, 1966, SCIENCE, V152, P758, DOI 10.1126/science.152.3723.758; BARGHOORN ES, 1965, SCIENCE, V147, P563, DOI 10.1126/science.147.3658.563; BLAKE TS, 1984, U W AUST GEOL DEP U, V9, P1; Buchanan R.E, 1974, BERGEYS MANUAL DETER, V8th ed., DOI 10.1007/bergeysoutline200405; BUICK R, 1981, ALCHERINGA, V5, P161, DOI 10.1080/03115518108566999; BUICK R, 1991, PALAIOS, V5, P441; BYERLY GR, 1986, NATURE, V319, P489, DOI 10.1038/319489a0; CLOUD P, 1980, GEOMICROBIOL J, V2, P161, DOI 10.1080/01490458009377759; CLOUD PE, 1965, SCIENCE, V148, P27, DOI 10.1126/science.148.3666.27; Desikachary T. V., 1959, CYANOPHYTA DESIKACHA; Hayes J. M., 1983, EARTHS EARLIEST BIOS, P93; HICKMAN AH, 1983, AUST GEOL SURV B, V127, P1; HOFMANN HJ, 1976, J PALEONTOL, V50, P1040; HOFMANN HJ, 1991, ECON GEOL BULL SOC, V86, P1023, DOI 10.2113/gsecongeo.86.5.1023; Klein C, 1992, PROTEROZOIC BIOSPHER, P603; KNOLL AH, 1977, SCIENCE, V198, P396, DOI 10.1126/science.198.4315.396; KNOLL AH, 1988, PRECAMBRIAN RES, V38, P257, DOI 10.1016/0301-9268(88)90005-8; LOWE DR, 1980, NATURE, V284, P441, DOI 10.1038/284441a0; Mendelson C.V., 1992, PROTEROZOIC BIOSPHER, P865, DOI 10.1017/CBO9780511601064.024; MENDELSON CV, 1982, J PALEONTOL, V56, P42; Muir M.D., 1976, EARLY HIST EARTH, P595; NYBERG AV, 1981, PRECAMBRIAN RES, V16, P129, DOI 10.1016/0301-9268(81)90008-5; Oehler JH, 1977, ALCHERINGA, V1, P315, DOI 10.1080/03115517708527768; Pflug H.D., 1992, EARLY ORGANIC EVOLUT, P509; PFLUG HD, 1966, U WITWATERSRAND EC G, V28, P1; Schopf J.W., 1992, P583; SCHOPF J W, 1968, Journal of Paleontology, V42, P651; Schopf J.W., 1983, P214; Schopf J.W., 1992, P1055; Schopf J.W., 1992, PROTEROZOIC BIOSPHER, P195, DOI DOI 10.1017/CBO9780511601064; Schopf J. W., 1992, PROTEROZOIC BIOSPHER, P25; SCHOPF JW, 1987, SCIENCE, V237, P70, DOI 10.1126/science.11539686; SCHOPF JW, 1977, PRECAMBRIAN RES, V4, P269, DOI 10.1016/0301-9268(77)90017-1; SCHOPF JW, 1984, PRECAMBRIAN RES, V24, P335, DOI 10.1016/0301-9268(84)90064-0; SCHOPF JW, 1986, 5TH M INT SOC STUD O, P163; SCHOPF JW, IN PRESS EARLY LIFE; SCHOPF JW, 1992, PROTEROZOIC BIOSPHER, P179; SCHOPF JW, 1976, SCIENCE, V193, P43; Shukla M., 1986, PALAEOBOTANIST, V35, P347; Strauss H., 1992, PROTEROZOIC BIOSPHER, P709; THORPE RI, 1992, PRECAMBRIAN RES, V56, P169, DOI 10.1016/0301-9268(92)90100-3; Towe KM, 1991, PALAEOGEOGR PALAEOCL, V97, P113, DOI 10.1016/0031-0182(91)90187-V; TOWE KM, 1990, NATURE, V348, P54, DOI 10.1038/348054a0; WALSH MM, 1992, PRECAMBRIAN RES, V54, P271, DOI 10.1016/0301-9268(92)90074-X; WALSH MM, 1985, NATURE, V314, P530, DOI 10.1038/314530a0; Walter M.R., 1983, EARTHS EARLIEST BIOS, P187; WALTER MR, 1980, NATURE, V284, P443, DOI 10.1038/284443a0; WALTER MR, 1992, PROTEROZOIC BIOSPHER, P253; Ward D. M., 1992, PROTEROZOIC BIOSPHER, P309	50	861	916	4	197	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	APR 30	1993	260	5108					640	646		10.1126/science.260.5108.640	http://dx.doi.org/10.1126/science.260.5108.640			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KZ641	11539831				2022-12-24	WOS:A1993KZ64100022
J	Cheah, J				Cheah, J			Chronic disease management: a Singapore perspective	BRITISH MEDICAL JOURNAL			English	Article							CHRONIC ILLNESS; CARE		Natl Univ Singapore, Dept Community Occupat & Family Med, Singapore 119074, Singapore	National University of Singapore	Cheah, J (corresponding author), Natl Univ Singapore, Dept Community Occupat & Family Med, Singapore 119074, Singapore.							COUCH JB, 1997, PHYSICIANS GUIDE DIS; ELLRODT G, 1997, JAMA-J AM MED ASSOC, V278, P687; FRIEDMAN N, 1999, DIS MANAGEMENT HLTH, V6, P355; FULLER MG, 1999, DIS MANAG HEALTH OUT, V6, P29; Ketner L, 1999, Healthc Financ Manage, V53, P36; KONGSTVEDT PR, 1998, BEST PRACTICES MED M; Leider H.L, 1999, DIS MANAG HEALTH OUT, V6, P327, DOI [10.2165/00115677-199906060-00003, DOI 10.2165/00115677-199906060-00003]; *MIN COMM DEV MIN, 1999, REP INT COMM AG POP; *MIN HLTH, 2001, ANN REP 2000; STONE RE, 1999, DIS MANAGEMENT HLTH, V5, P145; TODD W, 1997, DIS MANAGEMENT SYSTE; Von Korff M, 1997, ANN INTERN MED, V127, P1097, DOI 10.7326/0003-4819-127-12-199712150-00008; Wagner EH, 1996, MILBANK Q, V74, P511, DOI 10.2307/3350391; Wagner EH, 2000, BMJ-BRIT MED J, V320, P569, DOI 10.1136/bmj.320.7234.569	14	36	38	6	19	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 27	2001	323	7319					990	993		10.1136/bmj.323.7319.990	http://dx.doi.org/10.1136/bmj.323.7319.990			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	488CU	11679392	Green Published			2022-12-24	WOS:000171918500023
J	Chaudhuri, TK; Farr, GW; Fenton, WA; Rospert, S; Horwich, AL				Chaudhuri, TK; Farr, GW; Fenton, WA; Rospert, S; Horwich, AL			GroEL/GroES-mediated folding of a protein too large to be encapsulated	CELL			English	Article							THERMODYNAMIC COUPLING MECHANISM; CHAPERONIN GROEL; MOLECULAR CHAPERONES; ESCHERICHIA-COLI; BINDING; SUBSTRATE; POLYPEPTIDE; ATP; INTERMEDIATE; ACONITASE	The chaperonin GroEL binds nonnative proteins too large to fit inside the productive GroEL-GroES cis cavity, but whether and how it assists their folding has remained unanswered. We have examined yeast mitochondrial aconitase, an 82 kDa monomeric Fe4S4 cluster-containing enzyme, observed to aggregate in chaperonin-deficient mitochondria. We observed that aconitase folding both in vivo and in vitro requires both GroEL and GroES, and proceeds via multiple rounds of binding and release. Unlike the folding of smaller substrates, however, this mechanism does not involve cis encapsulation but, rather, requires GroES binding to the trans ring to release nonnative substrate, which likely folds in solution. Following the phase of ATP/ GroES-dependent refolding, GroEL stably bound apoaconitase, releasing active holoenzyme upon Fe4S4 co-factor formation, independent of ATP and GroES.	Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; MPI Enxymol Prot Folding, D-06120 Halle Saale, Germany	Howard Hughes Medical Institute; Yale University; Yale University	Horwich, AL (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, 295 Congress Ave, New Haven, CT 06510 USA.			Rospert, Sabine/0000-0002-3089-9614				Bhutani N, 2000, J MOL BIOL, V297, P1037, DOI 10.1006/jmbi.2000.3648; BRUNSCHIER R, 1993, J BIOL CHEM, V268, P2767; Burston SG, 1996, NATURE, V383, P96, DOI 10.1038/383096a0; Chuang JL, 1999, J BIOL CHEM, V274, P10395, DOI 10.1074/jbc.274.15.10395; Clark AC, 1999, J MOL BIOL, V285, P1777, DOI 10.1006/jmbi.1998.2403; Coyle JE, 1999, NAT STRUCT BIOL, V6, P683; Dubaquie Y, 1998, EMBO J, V17, P5868, DOI 10.1093/emboj/17.20.5868; Ewalt KL, 1997, CELL, V90, P491, DOI 10.1016/S0092-8674(00)80509-7; Farr GW, 2000, CELL, V100, P561, DOI 10.1016/S0092-8674(00)80692-3; Feltham JL, 2000, CELL, V100, P193, DOI 10.1016/S0092-8674(00)81557-3; GOLOUBINOFF P, 1989, NATURE, V342, P884, DOI 10.1038/342884a0; GORDON CL, 1994, J BIOL CHEM, V269, P27941; Horovitz A, 1998, CURR OPIN STRUC BIOL, V8, P93, DOI 10.1016/S0959-440X(98)80015-8; Houry WA, 1999, NATURE, V402, P147, DOI 10.1038/45977; Huang YS, 1999, J BIOL CHEM, V274, P10405, DOI 10.1074/jbc.274.15.10405; Iametti S, 2001, EUR J BIOCHEM, V268, P2421, DOI 10.1046/j.1432-1327.2001.02130.x; KENNEDY MC, 1988, J BIOL CHEM, V263, P8194; KENT TA, 1985, J BIOL CHEM, V260, P6871; LAUBLE H, 1992, BIOCHEMISTRY-US, V31, P2735, DOI 10.1021/bi00125a014; MARTIN J, 1991, NATURE, V352, P36, DOI 10.1038/352036a0; MORRISON JF, 1954, BIOCHEM J, V58, P685, DOI 10.1042/bj0580685; RANSON NA, 1995, J MOL BIOL, V250, P581, DOI 10.1006/jmbi.1995.0399; Ranson NA, 1997, J MOL BIOL, V266, P656, DOI 10.1006/jmbi.1996.0815; Ribbe MW, 2001, P NATL ACAD SCI USA, V98, P5521, DOI 10.1073/pnas.101119498; Roseman AM, 1996, CELL, V87, P241, DOI 10.1016/S0092-8674(00)81342-2; Rye HS, 1999, CELL, V97, P325, DOI 10.1016/S0092-8674(00)80742-4; Rye HS, 1997, NATURE, V388, P792, DOI 10.1038/42047; Sigler PB, 1998, ANNU REV BIOCHEM, V67, P581, DOI 10.1146/annurev.biochem.67.1.581; Song JL, 2000, J BIOL CHEM, V275, P22305, DOI 10.1074/jbc.M002038200; VIITANEN PV, 1992, PROTEIN SCI, V1, P363; Walter S, 1996, P NATL ACAD SCI USA, V93, P9425, DOI 10.1073/pnas.93.18.9425; WEISSMAN JS, 1994, CELL, V78, P693, DOI 10.1016/0092-8674(94)90533-9; WEISSMAN JS, 1995, CELL, V83, P577, DOI 10.1016/0092-8674(95)90098-5; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; YIFRACH O, 1995, BIOCHEMISTRY-US, V34, P5303, DOI 10.1021/bi00016a001; Yifrach O, 1996, J MOL BIOL, V255, P356, DOI 10.1006/jmbi.1996.0028; Zahn R, 1996, SCIENCE, V271, P642, DOI 10.1126/science.271.5249.642; ZAHN R, 1994, J MOL BIOL, V242, P165, DOI 10.1006/jmbi.1994.1567	38	139	142	1	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 19	2001	107	2					235	246		10.1016/S0092-8674(01)00523-2	http://dx.doi.org/10.1016/S0092-8674(01)00523-2			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	484MU	11672530	Bronze			2022-12-24	WOS:000171694800012
J	Wild, K; Sinning, I; Cusack, S				Wild, K; Sinning, I; Cusack, S			Crystal structure of an early protein-RNA assembly complex of the signal recognition particle	SCIENCE			English	Article							SITE-DIRECTED MUTAGENESIS; RIBOSOMAL-RNA; BINDING; DOMAIN; SRP19; IDENTIFICATION; TRANSLOCATION; TETRALOOPS; SEQUENCE; LOOP	The signal recognition particle (SRP) is a universally conserved ribonucleoprotein complex that mediates the cotranslational targeting of secretory and membrane proteins to cellular membranes. A crucial early step in SRP assembly in archaea and eukarya is the binding of protein SRP19 to specific sites on SRP RNA. Here we report the 1.8 angstrom resolution crystal structure of human SRP19 in complex with its primary binding site on helix 6 of SRP RNA, which consists of a stem-loop structure closed by an unusual GGAG tetraloop. Protein-RNA interactions are mediated by the specific recognition of a widened major groove and the tetraloop without any direct protein-base contacts and include a complex network of highly ordered water molecules. A model of the assembly of the SRP core comprising SRP19, SRP54, and SRP RNA based on crystallographic and biochemical data is proposed.	Univ Heidelberg, Zentrum Biochem, D-69120 Heidelberg, Germany; European Mol Biol Lab, Grenoble Outstn, F-38042 Grenoble, France	Ruprecht Karls University Heidelberg; European Molecular Biology Laboratory (EMBL)	Wild, K (corresponding author), Univ Heidelberg, Zentrum Biochem, Neuenheimer Feld 328, D-69120 Heidelberg, Germany.	klemens.wild@bzh.uni-heidelberg.de	Sinning, Irmgard/A-2982-2010	Cusack, Stephen/0000-0002-9324-0796				Agalarov SC, 2000, SCIENCE, V288, P107, DOI 10.1126/science.288.5463.107; Batey RT, 2000, SCIENCE, V287, P1232, DOI 10.1126/science.287.5456.1232; Birse DEA, 1997, EMBO J, V16, P3757, DOI 10.1093/emboj/16.13.3757; Black SD, 1997, EUR J BIOCHEM, V245, P564, DOI 10.1111/j.1432-1033.1997.00564.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; CHITTENDEN K, 1994, J BIOL CHEM, V269, P20497; De Guzman RN, 1998, SCIENCE, V279, P384, DOI 10.1126/science.279.5349.384; Diener JL, 2000, BIOCHEMISTRY-US, V39, P12862, DOI 10.1021/bi001180s; Doherty EA, 2001, NAT STRUCT BIOL, V8, P339, DOI 10.1038/86221; Esnouf R. M., 1997, J MOL GRAPHICS, V15, P133; GLUCK A, 1992, J MOL BIOL, V226, P411, DOI 10.1016/0022-2836(92)90956-K; Gowda K, 1997, NUCLEIC ACIDS RES, V25, P2835, DOI 10.1093/nar/25.14.2835; HAUSER S, 1995, EMBO J, V14, P5485, DOI 10.1002/j.1460-2075.1995.tb00235.x; Jagath JR, 2001, RNA, V7, P293, DOI 10.1017/S1355838201002205; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jucker FM, 1996, J MOL BIOL, V264, P968, DOI 10.1006/jmbi.1996.0690; LUTCKE H, 1995, EUR J BIOCHEM, V228, P531, DOI 10.1111/j.1432-1033.1995.0531m.x; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perez-Canadillas JM, 2001, CURR OPIN STRUC BIOL, V11, P53, DOI 10.1016/S0959-440X(00)00164-0; PLEY HW, 1994, NATURE, V372, P111, DOI 10.1038/372111a0; Politz JC, 2000, P NATL ACAD SCI USA, V97, P55, DOI 10.1073/pnas.97.1.55; PRICE SR, 1995, J MOL BIOL, V249, P398, DOI 10.1006/jmbi.1995.0305; ROMISCH K, 1990, J CELL BIOL, V111, P1793, DOI 10.1083/jcb.111.5.1793; Rose MA, 2001, NAT STRUCT BIOL, V8, P515, DOI 10.1038/88577; UHLENBECK OC, 1990, NATURE, V346, P613, DOI 10.1038/346613a0; WALTER P, 1983, CELL, V34, P525, DOI 10.1016/0092-8674(83)90385-9; WALTER P, 1994, ANNU REV CELL BIOL, V10, P87, DOI 10.1146/annurev.cb.10.110194.000511; Wild K, 1999, STRUCTURE, V7, P1345, DOI 10.1016/S0969-2126(00)80024-6; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P8467, DOI 10.1073/pnas.87.21.8467; ZWIEB C, 1992, J BIOL CHEM, V267, P15650; Zwieb C, 1997, NUCLEIC ACIDS RES, V25, P107, DOI 10.1093/nar/25.1.107	34	65	68	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2001	294	5542					598	601		10.1126/science.1063839	http://dx.doi.org/10.1126/science.1063839			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484NC	11641499				2022-12-24	WOS:000171695600048
J	Knight, EL; Avorn, J				Knight, EL; Avorn, J			Quality indicators for appropriate medication use in vulnerable elders	ANNALS OF INTERNAL MEDICINE			English	Article							CONVERTING ENZYME-INHIBITOR; OVERACTIVE BLADDER; HEART-FAILURE; RISK-FACTORS; HYPOGLYCEMIA; HYPERTENSION; INTERVENTION; OUTPATIENTS; THERAPY; DRUGS		Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Avorn, J (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Pharmacoepidemiol & Pharmacoecon, 221 Londwood Ave, Boston, MA 02115 USA.							Abrams P, 1998, BRIT J UROL, V81, P801; *ABT ASS, 1998, EV DRUG US REV DEM P; Appell RA, 1997, UROLOGY, V50, P90, DOI 10.1016/S0090-4295(97)00599-2; ASPLUND K, 1983, DIABETOLOGIA, V24, P412; AVORN J, 2001, GERIATRIC MED; BEERS MH, 1991, ARCH INTERN MED, V151, P1825; BEERS MH, 1992, ANN INTERN MED, V117, P684, DOI 10.7326/0003-4819-117-8-684; Black HR, 1997, ARCH INTERN MED, V157, P2413; Chiquette E, 1998, ARCH INTERN MED, V158, P1641, DOI 10.1001/archinte.158.15.1641; CHRISCHILLES EA, 1992, J GERONTOL, V47, pM137, DOI 10.1093/geronj/47.5.M137; EISENDRATH SJ, 1987, AM J PSYCHIAT, V144, P1062; FERNER RE, 1988, BRIT MED J, V296, P949, DOI 10.1136/bmj.296.6627.949; GOETZ DW, 1989, J ALLERGY CLIN IMMUN, V84, P316, DOI 10.1016/0091-6749(89)90414-4; GONZALEZFERNANDEZ RA, 1990, AM J CARDIOL, V65, P1384, DOI 10.1016/0002-9149(90)91332-Z; GOODYER LI, 1995, BRIT J CLIN PRACT, V49, P173; GRISSO JA, 1991, NEW ENGL J MED, V324, P1326, DOI 10.1056/NEJM199105093241905; Hanlon JT, 1996, AM J MED, V100, P428, DOI 10.1016/S0002-9343(97)89519-8; HIRSH J, 1995, AM J CARDIOL, V75, pB39, DOI 10.1016/0002-9149(95)80009-H; Hirsh J, 1998, CHEST, V114, p445S, DOI 10.1378/chest.114.5_Supplement.445S; HYLEK EM, 1994, ANN INTERN MED, V120, P897, DOI 10.7326/0003-4819-120-11-199406010-00001; Hylek EM, 1996, NEW ENGL J MED, V335, P540, DOI 10.1056/NEJM199608223350802; Kalra PA, 1999, BMJ-BRIT MED J, V318, P234; Knight EL, 1999, AM HEART J, V138, P849, DOI 10.1016/S0002-8703(99)70009-8; Koenig K L, 1994, Acad Emerg Med, V1, P544; LOWE CJ, 1995, BRIT MED J, V310, P1229, DOI 10.1136/bmj.310.6989.1229; MACDONALD JB, 1977, BRIT MED J, V2, P483, DOI 10.1136/bmj.2.6085.483; MacDowall P, 1998, LANCET, V352, P13, DOI 10.1016/S0140-6736(97)11060-1; MARCANTONIO ER, 1994, JAMA-J AM MED ASSOC, V272, P1518, DOI 10.1001/jama.272.19.1518; MONANE M, 1993, ARCH INTERN MED, V153, P633, DOI 10.1001/archinte.153.5.633; Monane M, 1998, JAMA-J AM MED ASSOC, V280, P1249, DOI 10.1001/jama.280.14.1249; PAICE BJ, 1985, ADVERSE DRUG REACT T, V4, P23; POTAMIANOS G, 1982, BRIT J PSYCHIAT, V140, P470, DOI 10.1192/bjp.140.5.470; Psaty BM, 1997, JAMA-J AM MED ASSOC, V277, P739, DOI 10.1001/jama.277.9.739; Reardon LC, 1998, ARCH INTERN MED, V158, P26, DOI 10.1001/archinte.158.1.26; Rich MW, 1996, AM J MED, V101, P270, DOI 10.1016/S0002-9343(96)00172-6; Roter DL, 1998, MED CARE, V36, P1138, DOI 10.1097/00005650-199808000-00004; Sands L, 1997, AM J GERIAT PSYCHIAT, V5, P156; SELTZER HS, 1972, DIABETES, V21, P955, DOI 10.2337/diab.21.9.955; Shekelle PG, 2001, ANN INTERN MED, V135, P647, DOI 10.7326/0003-4819-135-8_Part_2-200110161-00003; SIEGEL D, 1992, JAMA-J AM MED ASSOC, V267, P1083, DOI 10.1001/jama.267.8.1083; SIMONS FER, 1994, NEW ENGL J MED, V330, P1663; SISCOVICK DS, 1994, NEW ENGL J MED, V330, P1852, DOI 10.1056/NEJM199406303302603; Staessen JA, 1997, LANCET, V350, P757, DOI 10.1016/S0140-6736(97)05381-6; WILLCOX SM, 1994, JAMA-J AM MED ASSOC, V272, P292, DOI 10.1001/jama.272.4.292; 1991, JAMA, V165, P3255	45	93	94	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 16	2001	135	8	2				703	710		10.7326/0003-4819-135-8_Part_2-200110161-00009	http://dx.doi.org/10.7326/0003-4819-135-8_Part_2-200110161-00009			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	481WA	11601953				2022-12-24	WOS:000171542400009
J	Bibby, TS; Nield, J; Partensky, F; Barber, J				Bibby, TS; Nield, J; Partensky, F; Barber, J			Oxyphotobacteria - Antenna ring around photosystem I	NATURE			English	Article							MARINE PROKARYOTE; PROCHLOROCOCCUS; LIGHT; PROCHLOROPHYTE		Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, Wolfson Labs, London SW7 2AY, England; CNRS, Observ Oceanol Roscoff, F-29682 Roscoff, France; Univ Paris 06, Biol Stn, F-29682 Roscoff, France	Imperial College London; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite	Bibby, TS (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, Wolfson Labs, London SW7 2AY, England.	j.barber@ic.ac.uk	Partensky, Frédéric/B-9194-2018; Partensky, Frédéric/AAH-1170-2021; Bibby, Thomas/C-9159-2014; Nield, Jon/C-5892-2013	Partensky, Frédéric/0000-0003-1274-4050; Partensky, Frédéric/0000-0003-1274-4050; Nield, Jon/0000-0001-9983-0239; Bibby, Thomas/0000-0003-1743-473X				Bibby TS, 2001, NATURE, V412, P743, DOI 10.1038/35089098; CHISHOLM SW, 1988, NATURE, V334, P340, DOI 10.1038/334340a0; CHISHOLM SW, 1992, ARCH MICROBIOL, V157, P297, DOI 10.1007/BF00245165; Garczarek L, 2000, P NATL ACAD SCI USA, V97, P4098, DOI 10.1073/pnas.070040897; Krauss N, 1996, NAT STRUCT BIOL, V3, P965, DOI 10.1038/nsb1196-965; LaRoche J, 1996, P NATL ACAD SCI USA, V93, P15244; LEWIN RA, 1976, NATURE, V261, P697, DOI 10.1038/261697b0; MOORE LR, 1995, MAR ECOL PROG SER, V116, P259, DOI 10.3354/meps116259; Partensky F, 1999, MICROBIOL MOL BIOL R, V63, P106, DOI 10.1128/MMBR.63.1.106-127.1999; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	10	81	92	2	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 11	2001	413	6856					590	590		10.1038/35098153	http://dx.doi.org/10.1038/35098153			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480WE	11595938	Bronze			2022-12-24	WOS:000171485700038
J	Parkhill, J; Wren, BW; Thomson, NR; Titball, RW; Holden, MTG; Prentice, MB; Sebaihia, M; James, KD; Churcher, C; Mungall, KL; Baker, S; Basham, D; Bentley, SD; Brooks, K; Cerdeno-Tarraga, AM; Chillingworth, T; Cronin, A; Davies, RM; Davis, P; Dougan, G; Feltwell, T; Hamlin, N; Holroyd, S; Jagels, K; Karlyshev, AV; Leather, S; Moule, S; Oyston, PCF; Quail, M; Rutherford, K; Simmonds, M; Skelton, J; Stevens, K; Whitehead, S; Barrell, BG				Parkhill, J; Wren, BW; Thomson, NR; Titball, RW; Holden, MTG; Prentice, MB; Sebaihia, M; James, KD; Churcher, C; Mungall, KL; Baker, S; Basham, D; Bentley, SD; Brooks, K; Cerdeno-Tarraga, AM; Chillingworth, T; Cronin, A; Davies, RM; Davis, P; Dougan, G; Feltwell, T; Hamlin, N; Holroyd, S; Jagels, K; Karlyshev, AV; Leather, S; Moule, S; Oyston, PCF; Quail, M; Rutherford, K; Simmonds, M; Skelton, J; Stevens, K; Whitehead, S; Barrell, BG			Genome sequence of Yersinia pestis, the causative agent of plague	NATURE			English	Article							DNA-SEQUENCE; PSEUDOTUBERCULOSIS; ENTEROCOLITICA; VIRULENCE; IDENTIFICATION; INVASION; PLASMID; LOCUS; CELLS; SHOWS	The Gram-negative bacterium Yersinia pestis is the causative agent of the systemic invasive infectious disease classically referred to as plague(1), and has been responsible for three human pandemics: the Justinian plague (sixth to eighth centuries), the Black Death (fourteenth to nineteenth centuries) and modern plague (nineteenth century to the present day). The recent identification of strains resistant to multiple drugs(2) and the potential use of Y. pestis as an agent of biological warfare mean that plague still poses a threat to human health. Here we report the complete genome sequence of Y. pestis strain CO92, consisting of a 4.65-megabase (Mb) chromosome and three plasmids of 96.2 kilobases (kb), 70.3 kb and 9.6 kb. The genome is unusually rich in insertion sequences and displays anomalies in GC base-composition bias, indicating frequent intragenomic recombination. Many genes seem to have been acquired from other bacteria and viruses (including adhesins, secretion systems and insecticidal toxins). The genome contains around 150 pseudogenes, many of which are remnants of a redundant enteropathogenic lifestyle. The evidence of ongoing genome fluidity, expansion and decay suggests Y. pestis is a pathogen that has undergone large-scale genetic flux and provides a unique insight into the ways in which new and highly virulent pathogens evolve.	Sanger Ctr, Cambridge CB10 1SA, England; Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1E 7HT, England; Chem & Biol Sci, Salisbury SP4 0JQ, Wilts, England; St Bartholomews & Royal London Sch Med & Dent, Dept Med Microbiol, London EC1A 7BE, England; Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, Ctr Mol Microbiol & Infect, London SW7 2AZ, England	Wellcome Trust Sanger Institute; University of London; London School of Hygiene & Tropical Medicine; University of London; Queen Mary University London; Imperial College London	Parkhill, J (corresponding author), Sanger Ctr, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.		Prentice, Michael/AAE-7246-2019; Quail, michael/ABE-6131-2020; Karlyshev, Andrey/D-2797-2011; Rutherford, Kim/Y-7995-2018; Sebaihia, Mohammed/AAF-6589-2019; Holden, Matthew TG/K-6449-2014; Parkhill, Julian/G-4703-2011; Thomson, Nicholas/P-5988-2014	Prentice, Michael/0000-0003-1117-2388; Karlyshev, Andrey/0000-0003-3124-019X; Rutherford, Kim/0000-0001-6277-726X; Sebaihia, Mohammed/0000-0002-3324-3346; Holden, Matthew TG/0000-0002-4958-2166; Parkhill, Julian/0000-0002-7069-5958; Davis, Paul/0000-0001-5545-0824; Thomson, Nicholas/0000-0002-4432-8505; Cerdeno-Tarraga, Ana M./0000-0001-6635-3237; Baker, Stephen/0000-0003-1308-5755; Davies, Robert/0000-0002-9983-1378				Achtman M, 1999, P NATL ACAD SCI USA, V96, P14043, DOI 10.1073/pnas.96.24.14043; Buchrieser C, 1999, INFECT IMMUN, V67, P4851, DOI 10.1128/IAI.67.9.4851-4861.1999; Cornelis GR, 1998, MICROBIOL MOL BIOL R, V62, P1315, DOI 10.1128/MMBR.62.4.1315-1352.1998; Cowan C, 2000, INFECT IMMUN, V68, P4523, DOI 10.1128/IAI.68.8.4523-4530.2000; Darwin AJ, 1999, MOL MICROBIOL, V32, P51, DOI 10.1046/j.1365-2958.1999.01324.x; DOLL JM, 1994, AM J TROP MED HYG, V51, P109, DOI 10.4269/ajtmh.1994.51.109; Galimand M, 1997, NEW ENGL J MED, V337, P677, DOI 10.1056/NEJM199709043371004; Guiyoule A, 1997, J CLIN MICROBIOL, V35, P2826, DOI 10.1128/JCM.35.11.2826-2833.1997; Haller JC, 2000, MOL MICROBIOL, V36, P1436, DOI 10.1046/j.1365-2958.2000.01964.x; Henderson IR, 1999, MOL MICROBIOL, V33, P919, DOI 10.1046/j.1365-2958.1999.01555.x; Hinnebusch J, 2000, INT J MED MICROBIOL, V290, P483, DOI 10.1016/S1438-4221(00)80070-3; Lerm M, 2000, FEMS MICROBIOL LETT, V188, P1; Lobry JR, 1996, MOL BIOL EVOL, V13, P660, DOI 10.1093/oxfordjournals.molbev.a025626; McDonough KA, 1997, J BACTERIOL, V179, P2081, DOI 10.1128/jb.179.6.2081-2085.1997; Mecsas J, 2001, INFECT IMMUN, V69, P2779, DOI 10.1128/IAI.67.5.2779-2787.2001; Nesper J, 2001, INFECT IMMUN, V69, P435, DOI 10.1128/IAI.69.1.435-445.2001; Odaert M, 1996, J CLIN MICROBIOL, V34, P2231, DOI 10.1128/JCM.34.9.2231-2235.1996; Parkhill J, 2000, NATURE, V404, P502, DOI 10.1038/35006655; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; PIERSON DE, 1994, J BACTERIOL, V176, P4043, DOI 10.1128/JB.176.13.4043-4051.1994; Prentice MB, 2001, J BACTERIOL, V183, P2586, DOI 10.1128/JB.183.8.2586-2594.2001; Sebbane F, 2001, INFECT IMMUN, V69, P170, DOI 10.1128/IAI.69.1.170-176.2001; Shea JE, 1996, P NATL ACAD SCI USA, V93, P2593, DOI 10.1073/pnas.93.6.2593; Skurnik M, 2000, MOL MICROBIOL, V37, P316, DOI 10.1046/j.1365-2958.2000.01993.x; TOROSIAN SD, 1996, 96 GEN M AM SOC MICR, P191; Townsend SM, 2001, INFECT IMMUN, V69, P2894, DOI 10.1128/IAI.69.5.2894-2901.2001; WACHTEL MR, 1995, INFECT IMMUN, V63, P2541, DOI 10.1128/IAI.63.7.2541-2548.1995; Wang P, 1997, P NATL ACAD SCI USA, V94, P6977, DOI 10.1073/pnas.94.13.6977; Waterfield NR, 2001, TRENDS MICROBIOL, V9, P185, DOI 10.1016/S0966-842X(01)01978-3; Young GM, 2000, INFECT IMMUN, V68, P4323, DOI 10.1128/IAI.68.7.4323-4326.2000	30	934	2060	4	145	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 4	2001	413	6855					523	527		10.1038/35097083	http://dx.doi.org/10.1038/35097083			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	478HG	11586360	Green Accepted, hybrid			2022-12-24	WOS:000171340500047
J	Schwetz, BA				Schwetz, BA			Hypercalcemia of malignancy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Off Commissioner Food & Drugs, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Schwetz, BA (corresponding author), US FDA, Off Commissioner Food & Drugs, HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	4	4	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 3	2001	286	13					1569	1569		10.1001/jama.286.13.1569-b	http://dx.doi.org/10.1001/jama.286.13.1569-b			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	478HH	11585463				2022-12-24	WOS:000171340600005
J	Deshpande, G; Swanhart, L; Chiang, P; Schedl, P				Deshpande, G; Swanhart, L; Chiang, P; Schedl, P			Hedgehog signaling in germ cell migration	CELL			English	Article							GONADAL MESODERM; CUBITUS-INTERRUPTUS; GENE-EXPRESSION; FAT-BODY; DROSOPHILA-MELANOGASTER; TRANSDUCING HEDGEHOG; MEMBRANE-PROTEIN; RECEPTOR COMPLEX; EMBRYONIC GONAD; NANOS	The primitive gonad of the Drosophila embryo is formed from two cell types, the somatic gonad precursor cells (SGPs) and the germ cells, which originate at distant sites. To reach the SGPs the germ cells must undergo a complex series of cell movements. While there is evidence that attractive and repulsive signals guide germ cell migration through the embryo, the molecular identity of these instructive molecules has remained elusive. Here, we present evidence suggesting that hedgehog (hh) may serve as such an attractive guidance cue. Misexpression of hh in the soma induces germ cells to migrate to inappropriate locations. Conversely, cell-autonomous components of the hh pathway appear to be required in the germline for proper germ cell migration.	Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University	Deshpande, G (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.							Alcedo J, 1997, BIOL CHEM, V378, P583; Alcedo J, 1996, CELL, V86, P221, DOI 10.1016/S0092-8674(00)80094-X; Asaoka-Taguchi M, 1999, NAT CELL BIOL, V1, P431, DOI 10.1038/15666; AzaBlanc P, 1997, CELL, V89, P1043, DOI 10.1016/S0092-8674(00)80292-5; AZPIAZU N, 1993, GENE DEV, V7, P1325, DOI 10.1101/gad.7.7b.1325; Azpiazu N, 1996, GENE DEV, V10, P3183, DOI 10.1101/gad.10.24.3183; Boyle M, 1997, DEVELOPMENT, V124, P971; BOYLE M, 1995, DEVELOPMENT, V121, P1815; BRAND AH, 1993, DEVELOPMENT, V118, P401; Broihier HT, 1998, DEVELOPMENT, V125, P655; BROOKMAN JJ, 1992, DEVELOPMENT, V116, P1185; Chen CH, 1999, CELL, V98, P305, DOI 10.1016/S0092-8674(00)81960-1; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; Chen Y, 1998, DEVELOPMENT, V125, P4943; CHOU TB, 1992, GENETICS, V131, P643; Chuang PT, 2000, CURR OPIN GENET DEV, V10, P515, DOI 10.1016/S0959-437X(00)00121-0; Denef N, 2000, CELL, V102, P521, DOI 10.1016/S0092-8674(00)00056-8; DESHPANDE G, 1995, MOL CELL BIOL, V15, P4430; Deshpande G, 1999, CELL, V99, P271, DOI 10.1016/S0092-8674(00)81658-X; EPHRUSSI A, 1992, NATURE, V358, P387, DOI 10.1038/358387a0; Forbes A, 1998, DEVELOPMENT, V125, P679; FRASCH M, 1995, NATURE, V374, P464, DOI 10.1038/374464a0; HEEMSKERK J, 1994, CELL, V76, P449, DOI 10.1016/0092-8674(94)90110-4; HOOPER JE, 1989, CELL, V59, P751, DOI 10.1016/0092-8674(89)90021-4; Howard K, 1998, NATURE, V396, P406, DOI 10.1038/24714; Ingham PW, 1998, EMBO J, V17, P3505, DOI 10.1093/emboj/17.13.3505; JAGLARZ MK, 1995, DEVELOPMENT, V121, P3495; Johnson RL, 1998, CURR OPIN GENET DEV, V8, P450, DOI 10.1016/S0959-437X(98)80117-2; Kalderon D, 2000, CELL, V103, P371, DOI 10.1016/S0092-8674(00)00129-X; Kobayashi S, 1996, NATURE, V380, P708, DOI 10.1038/380708a0; Kuwabara PE, 2000, GENE DEV, V14, P1933; LANE ME, 1995, MECH DEVELOP, V49, P191, DOI 10.1016/0925-4773(94)00317-G; Luer K, 1997, DEVELOPMENT, V124, P2681; Methot N, 2001, DEVELOPMENT, V128, P733; Moore LA, 1998, DEVELOPMENT, V125, P837; Moore LA, 1998, DEVELOPMENT, V125, P667; NAKANO Y, 1989, NATURE, V341, P508, DOI 10.1038/341508a0; Porter JA, 1996, SCIENCE, V274, P255, DOI 10.1126/science.274.5285.255; Porter JA, 1996, CELL, V86, P21, DOI 10.1016/S0092-8674(00)80074-4; PREAT T, 1990, NATURE, V347, P87, DOI 10.1038/347087a0; Ramirez-Weber FA, 2000, MOL CELL, V6, P479, DOI 10.1016/S1097-2765(00)00046-0; Riechmann V, 1998, DEVELOPMENT, V125, P713; Sam S, 1996, MECH DEVELOP, V60, P197, DOI 10.1016/S0925-4773(96)00615-6; Seydoux G, 1999, DEVELOPMENT, V126, P3275; SMITH JL, 1992, CELL, V70, P849, DOI 10.1016/0092-8674(92)90318-7; St Johnston Daniel, 1993, P325; STAEHLINGHAMPTON K, 1994, NATURE, V372, P783; Strigini M, 1997, DEVELOPMENT, V124, P4697; Struhl G, 1997, DEVELOPMENT, V124, P2155; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Van Doren M, 1998, NATURE, V396, P466, DOI 10.1038/24871; vandenHeuvel M, 1996, NATURE, V382, P547, DOI 10.1038/382547a0; Wang QT, 2000, DEVELOPMENT, V127, P3131; WARRIOR R, 1994, DEV BIOL, V166, P180, DOI 10.1006/dbio.1994.1306; Williamson A, 1996, ANNU REV CELL DEV BI, V12, P365, DOI 10.1146/annurev.cellbio.12.1.365; ZALOKAR M, 1976, J MICROSC BIOL CELL, V25, P97; Zhang N, 1997, NATURE, V385, P64, DOI 10.1038/385064a0; Zhang N, 1996, GENETICS, V143, P1231	58	67	70	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 21	2001	106	6					759	769		10.1016/S0092-8674(01)00488-3	http://dx.doi.org/10.1016/S0092-8674(01)00488-3			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	476EJ	11572781	Bronze			2022-12-24	WOS:000171213000012
J	Johnson, ES; Gupta, AA				Johnson, ES; Gupta, AA			An E3-like factor that promotes SUMO conjugation to the yeast septins	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; UBIQUITIN; PROTEIN; COMPLEX; ENZYME; HOMOLOG; GENE; ACTIVATION; COMPONENT; PATHWAY	Covalent attachment of the ubiquitin-related protein SUMO to other proteins participates in many processes including signal transduction, transcriptional regulation, and growth control. We report the characterization of Siz1 as an E3-like factor in the SUMO pathway. Siz1 is required for SUMO attachment to the S. cerevisiae septins in vivo and strongly stimulates septin sumoylation in vitro. Siz1 and the related protein Siz2 promote SUMO conjugation to different substrates at different stages of the cell cycle and, together, are required for most SUMO conjugation in yeast. Siz1, Siz2, and the PIAS (protein inhibitor of activated STAT) proteins form a conserved family defined by an unusual RING-related motif. Our results suggest that this family functions by promoting SUMO conjugation to specific substrates.	Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA	Jefferson University	Johnson, ES (corresponding author), Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062268] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM62268] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aravind L, 2000, TRENDS BIOCHEM SCI, V25, P112, DOI 10.1016/S0968-0004(99)01537-6; Betting J, 1996, J BIOL CHEM, V271, P25790, DOI 10.1074/jbc.271.42.25790; BUSCHMANN T, 2001, IN PRESS J BIOL CHEM; CHEN ZJ, 1991, J BIOL CHEM, V266, P15698; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Desterro JMP, 1997, FEBS LETT, V417, P297, DOI 10.1016/S0014-5793(97)01305-7; Desterro JMP, 1999, J BIOL CHEM, V274, P10618, DOI 10.1074/jbc.274.15.10618; DOHMEN RJ, 1995, J BIOL CHEM, V270, P18099, DOI 10.1074/jbc.270.30.18099; Field CM, 1996, J CELL BIOL, V133, P605, DOI 10.1083/jcb.133.3.605; FIELD J, 1988, MOL CELL BIOL, V8, P2159, DOI 10.1128/MCB.8.5.2159; Frazier JA, 1998, J CELL BIOL, V143, P737, DOI 10.1083/jcb.143.3.737; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P2563, DOI 10.1073/pnas.92.7.2563; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Johnson ES, 1999, J CELL BIOL, V147, P981, DOI 10.1083/jcb.147.5.981; Johnson ES, 1997, EMBO J, V16, P5509, DOI 10.1093/emboj/16.18.5509; Johnson EW, 1997, J BACK MUSCULOSKELET, V9, P3, DOI 10.3233/BMR-1997-9102; Kwon YT, 1998, P NATL ACAD SCI USA, V95, P7898, DOI 10.1073/pnas.95.14.7898; Li SJ, 2000, MOL CELL BIOL, V20, P2367, DOI 10.1128/MCB.20.7.2367-2377.2000; Li SJ, 1999, NATURE, V398, P246, DOI 10.1038/18457; Longtine MS, 1996, CURR OPIN CELL BIOL, V8, P106, DOI 10.1016/S0955-0674(96)80054-8; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Melchior F, 2000, ANNU REV CELL DEV BI, V16, P591, DOI 10.1146/annurev.cellbio.16.1.591; MELUH PB, 1995, MOL BIOL CELL, V6, P793, DOI 10.1091/mbc.6.7.793; Minty A, 2000, J BIOL CHEM, V275, P36316, DOI 10.1074/jbc.M004293200; Moilanen AM, 1999, J BIOL CHEM, V274, P3700, DOI 10.1074/jbc.274.6.3700; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Okuma T, 1999, BIOCHEM BIOPH RES CO, V254, P693, DOI 10.1006/bbrc.1998.9995; Page AM, 1999, ANNU REV BIOCHEM, V68, P583, DOI 10.1146/annurev.biochem.68.1.583; Poukka H, 2000, P NATL ACAD SCI USA, V97, P14145, DOI 10.1073/pnas.97.26.14145; PRINGLE J R, 1991, P565; Rosenblum JS, 1998, J CELL BIOL, V143, P887, DOI 10.1083/jcb.143.4.887; SAMPSON DA, 2001, J BIOL CHEM, V19, P19; Schwienhorst I, 2000, MOL GEN GENET, V263, P771, DOI 10.1007/s004380000254; SEUFERT W, 1995, NATURE, V373, P78, DOI 10.1038/373078a0; Sherman F., 1986, METHODS YEAST GENETI; Shuai K, 2000, ONCOGENE, V19, P2638, DOI 10.1038/sj.onc.1203522; Smith J.A., 2000, CURRENT PROTOCOLS MO; Strunnikov AV, 2001, GENETICS, V158, P95; Takahashi Y, 1999, BIOCHEM BIOPH RES CO, V259, P582, DOI 10.1006/bbrc.1999.0821; Tanaka K, 1999, MOL CELL BIOL, V19, P8660; TATHAM MH, 2001, IN PRESS J BIOL CHEM; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; WHITE HD, 1993, BIOCHEMISTRY-US, V32, P9859, DOI 10.1021/bi00088a042; YAFFE MP, 1984, P NATL ACAD SCI-BIOL, V81, P4819, DOI 10.1073/pnas.81.15.4819	46	517	540	0	12	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 21	2001	106	6					735	744		10.1016/S0092-8674(01)00491-3	http://dx.doi.org/10.1016/S0092-8674(01)00491-3			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	476EJ	11572779	Bronze			2022-12-24	WOS:000171213000010
J	Noonan, FP; Recio, JA; Takayama, H; Duray, P; Anver, MR; Rush, WL; De Fabo, EC; Merlino, G				Noonan, FP; Recio, JA; Takayama, H; Duray, P; Anver, MR; Rush, WL; De Fabo, EC; Merlino, G			Neonatal sunburn and melanoma in mice - Severe sunburn in newborn, but not adult, mice is linked with melanoma in later life.	NATURE			English	Article							FACTOR SCATTER FACTOR; MALIGNANT-MELANOMA		George Washington Univ, Sch Med, Dept Dermatol, Lab Photobiol & Photoimmunol, Washington, DC 20037 USA; George Washington Univ, Sch Med, Dept Immunol, Lab Photobiol & Photoimmunol, Washington, DC 20037 USA; NCI, Mol Biol Lab, Bethesda, MD 20892 USA; NCI, Pathol Lab, Bethesda, MD 20892 USA; NCI, Pathol Histotechnol Lab, Sci Applicat Int Corp, Frederick, MD 21702 USA; Armed Forces Inst Pathol, Dept Dermatopathol, Washington, DC 20306 USA	George Washington University; George Washington University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); United States Department of Defense	Noonan, FP (corresponding author), George Washington Univ, Sch Med, Dept Dermatol, Lab Photobiol & Photoimmunol, Washington, DC 20037 USA.			Recio, Juan Angel/0000-0002-7320-3832; Noonan, Frances/0000-0002-3302-7280	NATIONAL CANCER INSTITUTE [Z01BC008756] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Chin L, 1998, GENE DEV, V12, P3467, DOI 10.1101/gad.12.22.3467; DEFABO EC, 1990, PHOTOCHEM PHOTOBIOL, V52, P811; HIROBE T, 1988, DEVELOPMENT, V102, P567; HOLMAN CDJ, 1983, JNCI-J NATL CANCER I, V71, P651; International Agency for Research on Cancer IARC Monographs, 1992, IARC MON, V55; Jeffers M, 1996, J MOL MED-JMM, V74, P505, DOI 10.1007/BF00204976; NATALI PG, 1993, BRIT J CANCER, V68, P746, DOI 10.1038/bjc.1993.422; Noonan FP, 2000, CANCER RES, V60, P3738; NOONAN FP, 1990, PHOTOCHEM PHOTOBIOL, V52, P801, DOI 10.1111/j.1751-1097.1990.tb08685.x; Otsuka T, 1998, CANCER RES, V58, P5157; Takayama H, 1997, P NATL ACAD SCI USA, V94, P701, DOI 10.1073/pnas.94.2.701; Tietze MK, 2000, MOL MED TODAY, V6, P408, DOI 10.1016/S1357-4310(00)01781-0; Whiteman DC, 2001, CANCER CAUSE CONTROL, V12, P69, DOI 10.1023/A:1008980919928	13	285	289	0	11	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 20	2001	413	6853					271	272		10.1038/35095108	http://dx.doi.org/10.1038/35095108			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473KB	11565020				2022-12-24	WOS:000171040500027
J	Lipton, AJ; Johnson, MA; Macdonald, T; Lieberman, MW; Gozal, D; Gaston, B				Lipton, AJ; Johnson, MA; Macdonald, T; Lieberman, MW; Gozal, D; Gaston, B			S-nitrosothiols signal the ventilatory response to hypoxia	NATURE			English	Article							NUCLEUS-TRACTUS-SOLITARII; NITRIC-OXIDE SYNTHASE; RAT; NITROSOGLUTATHIONE	Increased ventilation in response to hypoxia has been appreciated for over a century(1), but the biochemistry underlying this response remains poorly understood. Here we define a pathway in which increased minute ventilation ((V)over dot(E)) is signalled by deoxyhaemoglobin-derived S-nitrosothiols (SNOs). Specifically, we demonstrate that S-nitrosocysteinyl glycine (CGSNO) and S-nitroso-L-cysteine (L-CSNO)-but not S-nitroso-D-cysteine (D-CSNO)-reproduce the ventilatory effects of hypoxia at the level of the nucleus tractus solitarius (NTS). We show that plasma from deoxygenated, but not from oxygenated, blood produces the ventilatory effect of both SNOs and hypoxia. Further, this activity is mediated by S-nitrosoglutathione (GSNO), and GSNO activation by gamma -glutamyl transpeptidase (gamma -GT) is required. The normal response to hypoxia is impaired in a knockout mouse lacking gamma GT. These observations suggest that S-nitrosothiol biochemistry is of central importance to the regulation of breathing.	Univ Virginia, Sch Med, Dept Pediat, Div Resp Med, Charlottesville, VA 22908 USA; Univ Louisville, Kosair Childrens Hosp Res Inst, Dept Pediat, Louisville, KY 40202 USA; Univ Louisville, Kosair Childrens Hosp Res Inst, Dept Pharmacol & Toxicol, Louisville, KY 40202 USA; Univ Virginia, Dept Chem, Charlottesville, VA 22906 USA; Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Univ Virginia, Sch Med, Dept Pediat, Div Resp Med, Charlottesville, VA 22908 USA	University of Virginia; University of Louisville; University of Louisville; University of Virginia; Baylor College of Medicine; Baylor College of Medicine; University of Virginia	Gaston, B (corresponding author), Univ Virginia, Sch Med, Dept Pediat, Div Resp Med, Charlottesville, VA 22908 USA.		Gozal, David/ABH-3805-2020; Gozal, David/M-9492-2017	Johnson, Michael/0000-0001-5078-9896				ANWAR M, 1990, CIRC RES, V67, P1365, DOI 10.1161/01.RES.67.6.1365; ASKEW SC, 1995, BIOORGAN MED CHEM, V3, P1, DOI 10.1016/0968-0896(94)00139-T; BISGARD GE, 1995, REGULATION BREATHING; Chiueh CC, 1999, FREE RADICAL RES, V31, P641, DOI 10.1080/10715769900301211; Choi YB, 2000, NAT NEUROSCI, V3, P15, DOI 10.1038/71090; Davisson RL, 1997, AM J PHYSIOL-HEART C, V272, pH2361, DOI 10.1152/ajpheart.1997.272.5.H2361; Fang KZ, 1998, BIOCHEM BIOPH RES CO, V252, P535, DOI 10.1006/bbrc.1998.9688; Gaston B, 1998, BIOCHEM BIOPH RES CO, V253, P899, DOI 10.1006/bbrc.1998.9865; Gozal D, 1996, J APPL PHYSIOL, V81, P2068, DOI 10.1152/jappl.1996.81.5.2068; Gozal D, 1997, AM J RESP CRIT CARE, V155, P1755, DOI 10.1164/ajrccm.155.5.9154888; Haldane J, 1892, J PATHOL BACTERIOL, V1, P168; Jia L, 1996, NATURE, V380, P221, DOI 10.1038/380221a0; Kline DD, 2000, J APPL PHYSIOL, V88, P1496, DOI 10.1152/jappl.2000.88.4.1496; Kluge I, 1997, J NEUROCHEM, V69, P2599; Lieberman MW, 1996, P NATL ACAD SCI USA, V93, P7923, DOI 10.1073/pnas.93.15.7923; Lin LH, 2000, NEUROSCIENCE, V96, P341, DOI 10.1016/S0306-4522(99)00560-6; LIPTON SA, 1993, NATURE, V364, P626, DOI 10.1038/364626a0; Menendez AA, 1999, J APPL PHYSIOL, V86, P1478, DOI 10.1152/jappl.1999.86.5.1478; Ohta H, 1997, BRAIN RES, V746, P98, DOI 10.1016/S0006-8993(96)01188-2; Palmer LA, 2000, MOL PHARMACOL, V58, P1197, DOI 10.1124/mol.58.6.1197; Pawloski JR, 2001, NATURE, V409, P622, DOI 10.1038/35054560; Paxinos G., 1986, RAT BRAIN STEREOTAXI, V2nd; Schmidt HHHW, 1996, P NATL ACAD SCI USA, V93, P14492, DOI 10.1073/pnas.93.25.14492; SMITH TK, 1995, P NATL ACAD SCI USA, V92, P2360, DOI 10.1073/pnas.92.6.2360; STAMLER JS, 1996, METHODS NITRIC OXIDE, P521; Torres JE, 1997, NEUROSCI LETT, V232, P175, DOI 10.1016/S0304-3940(97)00598-3	26	265	279	2	15	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 13	2001	413	6852					171	174		10.1038/35093117	http://dx.doi.org/10.1038/35093117			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471FU	11557982				2022-12-24	WOS:000170918800048
J	Knight, J				Knight, J			Celera and Motorola brought in to aid hunt for disease genes	NATURE			English	News Item																		2001, NATURE, V412, P105	1	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 6	2001	413	6851					9	9		10.1038/35092692	http://dx.doi.org/10.1038/35092692			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469EG	11544494	Bronze			2022-12-24	WOS:000170801200011
J	Sharpless, NE; Bardeesy, N; Lee, KH; Carrasco, D; Castrillon, DH; Aguirre, AJ; Wu, EA; Horner, JW; DePinho, RA				Sharpless, NE; Bardeesy, N; Lee, KH; Carrasco, D; Castrillon, DH; Aguirre, AJ; Wu, EA; Horner, JW; DePinho, RA			Loss of p16(Ink4a) with retention of p19(Arf) predisposes mice to tumorigenesis	NATURE			English	Article							PLASMACYTOMA SUSCEPTIBILITY; TUMOR SUPPRESSION; G(1) CONTROL; INK4A LOCUS; MOUSE SKIN; IN-VIVO; IMMORTALIZATION; CELLS; GENE; FIBROBLASTS	The cyclin-dependent kinase inhibitor p16(INK4a) can induce senescence of human cells, and its loss by deletion, mutation or epigenetic silencing is among the most frequently observed molecular lesions in human cancer(1,2). Overlapping reading frames in the INK4A/ARF gene encode p16(INK4a) and a distinct tumour-suppressor protein, p19(ARF) (ref. 3). Here we describe the generation and characterization of a p16(Ink4a)-specific knockout mouse that retains normal p19(Arf) function. Mice lacking p16(Ink4a) were born with the expected mendelian distribution and exhibited normal development except for thymic hyperplasia. T cells deficient in p16(Ink4a) exhibited enhanced mitogenic responsiveness, consistent with the established role of p16(Ink4a) in constraining cellular proliferation. In contrast to mouse embryo fibroblasts (MEFs) deficient in p19(Arf) (ref. 4), p16(Ink4a)-null MEFs possessed normal growth characteristics and remained susceptible to Ras-induced senescence. Compared with wild-type MEFs, p16(Ink4a) null MEFs exhibited an increased rate of immortalization, although this rate was less than that observed previously for cells null for Ink4a/Arf, p19(Arf) or p53 (refs 4, 5). Furthermore, p16(Ink4a) deficiency was associated with an increased incidence of spontaneous and carcinogen-induced cancers. These data establish that p16(Ink4a), along with p19(Arf), functions as a tumour suppressor in mice.	Harvard Univ, Sch Med, Dept Adult Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School	DePinho, RA (corresponding author), Harvard Univ, Sch Med, Dept Adult Oncol, Boston, MA 02115 USA.			Sharpless, Norman/0000-0001-7078-9455; DePinho, Ronald/0000-0002-5625-577X				Alcorta DA, 1996, P NATL ACAD SCI USA, V93, P13742, DOI 10.1073/pnas.93.24.13742; BUCHMANN A, 1991, CANCER RES, V51, P4097; Carnero A, 2000, NAT CELL BIOL, V2, P148, DOI 10.1038/35004020; Carrasco D, 1998, J EXP MED, V187, P973, DOI 10.1084/jem.187.7.973; Dannenberg JH, 2000, GENE DEV, V14, P3051, DOI 10.1101/gad.847700; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Groth A, 2000, J BIOL CHEM, V275, P27473; HERMAN JG, 1995, CANCER RES, V55, P4525; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Herzog CR, 1999, MOL CARCINOGEN, V25, P92, DOI 10.1002/(SICI)1098-2744(199906)25:2<92::AID-MC3>3.0.CO;2-2; Kamijo T, 1999, CANCER RES, V59, P2217; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; LINARDOPOULOS S, 1995, CANCER RES, V55, P5168; MATSUSHIME H, 1994, MOL CELL BIOL, V14, P2066, DOI 10.1128/MCB.14.3.2066; Naviaux RK, 1996, J VIROL, V70, P5701, DOI 10.1128/JVI.70.8.5701-5705.1996; Patel AC, 2000, CARCINOGENESIS, V21, P1691, DOI 10.1093/carcin/21.9.1691; Pham CTN, 1996, P NATL ACAD SCI USA, V93, P13090, DOI 10.1073/pnas.93.23.13090; QUELLE DE, 1995, CELL, V83, P993; Reznikoff CA, 1996, CANCER RES, V56, P2886; ROGAN EM, 1995, MOL CELL BIOL, V15, P4745; Ruas M, 1998, BIOCHIM BIOPHYS ACTA, V1378, P115, DOI 10.1016/s0304-419x(98)00017-1; Sage J, 2000, GENE DEV, V14, P3037, DOI 10.1101/gad.843200; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; Sharpless NE, 1999, CURR OPIN GENET DEV, V9, P22, DOI 10.1016/S0959-437X(99)80004-5; Swafford DS, 1997, MOL CELL BIOL, V17, P1366, DOI 10.1128/MCB.17.3.1366; Zhang SL, 1998, P NATL ACAD SCI USA, V95, P2429, DOI 10.1073/pnas.95.5.2429; Zhang SL, 2001, MOL CELL BIOL, V21, P310, DOI 10.1128/MCB.21.1.310-318.2001; Zindy F, 1997, ONCOGENE, V15, P203, DOI 10.1038/sj.onc.1201178	30	601	615	0	22	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 6	2001	413	6851					86	91		10.1038/35092592	http://dx.doi.org/10.1038/35092592			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469EG	11544531				2022-12-24	WOS:000170801200044
J	Matsumoto, K; Yoshitomi, H; Rossant, J; Zaret, KS				Matsumoto, K; Yoshitomi, H; Rossant, J; Zaret, KS			Liver organogenesis promoted by endothelial cells prior to vascular function	SCIENCE			English	Article							HEPATOCYTE GROWTH-FACTOR; TYROSINE KINASE; ANGIOGENESIS INHIBITOR; TIE2 RECEPTOR; ANGIOPOIETIN-1; VASCULOGENESIS; ANTAGONIST; HGF/NK4; LIGAND; FLK-1	The embryonic role of endothelial cells and nascent vessels in promoting organogenesis, prior to vascular function, is unclear. We find that early endothelial cells in mouse embryos surround newly specified hepatic endoderm and delimit the mesenchymal domain into which the Liver bud grows. In flk-1 mutant embryos, which lack endothelial cells, hepatic specification occurs, but liver morphogenesis fails prior to mesenchyme invasion. We developed an embryo tissue explant system that permits liver bud vasculogenesis and show that in the absence of endothelial cells, or when the latter are inhibited, there is a selective defect in hepatic outgrowth. We conclude that vasculogenic endothelial cells and nascent vessels are critical for the earliest stages of organogenesis, prior to blood vessel function.	Fox Chase Canc Ctr, Program Cell & Dev Biol, Philadelphia, PA 19111 USA; Osaka Univ, Grad Sch Med, Course Adv Med, Div Mol Regenerat Med, Osaka 5650871, Japan; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5T 1K5, Canada	Fox Chase Cancer Center; Osaka University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Zaret, KS (corresponding author), Fox Chase Canc Ctr, Program Cell & Dev Biol, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	zaret@fccc.edu	Matsumoto, Kunio/D-8441-2015; Yoshitomi, Hideyuki/AAN-8812-2020	Matsumoto, Kunio/0000-0002-6532-4482; Yoshitomi, Hideyuki/0000-0003-2911-8056	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036477, R37GM036477] Funding Source: NIH RePORTER; NCI NIH HHS [CA06297] Funding Source: Medline; NIGMS NIH HHS [GM36477] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barbera JPM, 2000, DEVELOPMENT, V127, P2433; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Date K, 1997, FEBS LETT, V420, P1, DOI 10.1016/S0014-5793(97)01475-0; Davis S, 1996, CELL, V87, P1161, DOI 10.1016/S0092-8674(00)81812-7; Folkman J, 1996, CELL, V87, P1153, DOI 10.1016/S0092-8674(00)81810-3; Gale NW, 1999, GENE DEV, V13, P1055, DOI 10.1101/gad.13.9.1055; Gualdi R, 1996, GENE DEV, V10, P1670, DOI 10.1101/gad.10.13.1670; Jung JN, 1999, SCIENCE, V284, P1998, DOI 10.1126/science.284.5422.1998; KINGSBURY JW, 1956, ANAT RECORD, V124, P165, DOI 10.1002/ar.1091240204; Kuba K, 2000, CANCER RES, V60, P6737; LEDOUARIN NM, 1975, MED BIOL, V53, P427; MILLAUER B, 1993, CELL, V72, P835, DOI 10.1016/0092-8674(93)90573-9; OELRICHS RB, 1993, ONCOGENE, V8, P11; Ohmichi H, 1998, DEVELOPMENT, V125, P1315; OREILLY MS, 1994, CELL, V79, P315, DOI 10.1016/0092-8674(94)90200-3; PAUL J, 1969, CELL TISSUE KINET, V2, P283, DOI 10.1111/j.1365-2184.1969.tb00238.x; QUINN TP, 1993, P NATL ACAD SCI USA, V90, P7533, DOI 10.1073/pnas.90.16.7533; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; ROSS MA, IN PRESS HEPATOLOGY; Rossi JM, 2001, GENE DEV, V15, P1998, DOI 10.1101/gad.904601; SCHMIDT C, 1995, NATURE, V373, P699, DOI 10.1038/373699a0; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; SHERER GK, 1975, DEV BIOL, V46, P281, DOI 10.1016/0012-1606(75)90105-0; SHERER GK, 1991, DEV VASCULAR SYSTEM, V14, P37; Sosa-Pineda B, 2000, NAT GENET, V25, P254, DOI 10.1038/76996; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Takebayashi-Suzuki K, 2000, DEVELOPMENT, V127, P3523; VECCHI A, 1994, EUR J CELL BIOL, V63, P247; WIDMANN JJ, 1975, AM J PATHOL, V80, P349; YAMAGUCHI TP, 1993, DEVELOPMENT, V118, P489; YAMANE A, 1994, ONCOGENE, V9, P2683	31	611	646	4	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2001	294	5542					559	563		10.1126/science.1063889	http://dx.doi.org/10.1126/science.1063889			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484NC	11577199				2022-12-24	WOS:000171695600037
J	Wang, YQ; Hu, YM; Meng, J; Li, C				Wang, YQ; Hu, YM; Meng, J; Li, C			An ossified Meckel's cartilage in two cretaceous mammals and origin of the mammalian middle ear	SCIENCE			English	Article							EVOLUTION; MORGANUCODON	An ossified Meckel's cartilage has been recovered from two early Cretaceous mammals from China. This element is similar to Meckel's cartilage in prenatal and some postnatal extant mammals and indicates the relationship of Meckel's cartilage with the middle ear in early mammals, The evidence shows that brain expansion may not be the initial factor that caused the separation of postdentary bones from the dentary as middle ear ossicles during mammalian evolution. The failure of the dentary to seize reduced postdentary elements during ontogeny of early mammals is postulated as an alternative mechanism for the separation. Modifications of both feeding and hearing apparatuses in early mammals may have led to the development of the definitive mammalian middle ear.	Chinese Acad Sci, IVPP, Beijing 100044, Peoples R China; Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA; CUNY City Coll, New York, NY 10016 USA; CUNY, Grad Sch, Biol Program Ecol Evolutionary Biol & Behav, New York, NY 10016 USA	Chinese Academy of Sciences; American Museum of Natural History (AMNH); City University of New York (CUNY) System; City College of New York (CUNY); City University of New York (CUNY) System	Wang, YQ (corresponding author), Chinese Acad Sci, IVPP, POB 643, Beijing 100044, Peoples R China.	wang.yuanqing@pa.ivpp.ac.cn; jmeng@amnh.org						ALLIN EF, 1992, EVOLUTIONARY BIOLOGY OF HEARING, P587; ALLIN EF, 1975, J MORPHOL, V147, P403, DOI 10.1002/jmor.1051470404; BARGHUSEN HR, 1970, SCIENCE, V168, P573, DOI 10.1126/science.168.3931.573; CLARK CT, 1993, J MORPHOL, V215, P119, DOI 10.1002/jmor.1052150203; CROMPTON A. W., 1963, PROC ZOOL SOC LONDON, V140, P697; CROMPTON AW, 1985, ZOOL J LINN SOC-LOND, V85, P99, DOI 10.1111/j.1096-3642.1985.tb01500.x; Crompton AW, 1993, MAMMAL PHYLOGENY, V1, P30, DOI DOI 10.1007/978-1-4613-9249-1; Gambaryan Petr P., 1995, Acta Palaeontologica Polonica, V40, P45; Gaupp EWT, 1913, REICHERTSCHE THEORIE; Goodrich ES., 1930, STUDIES STRUCTURE DE, DOI [DOI 10.5962/BHL.TITLE.82144, 10.5962/bhl.title.82144]; HOPSON JA, 1966, AM ZOOL, V6, P437; Hu YM, 1997, NATURE, V390, P137, DOI 10.1038/36505; Jenkins F.A. Jr, 1988, Journal of Vertebrate Paleontology, V8, P1; Ji Q, 1999, NATURE, V398, P326; KERMACK KA, 1981, ZOOL J LINN SOC-LOND, V71, P1, DOI 10.1111/j.1096-3642.1981.tb01127.x; KERMACK KA, 1973, ZOOL J LINN SOC-LOND, V53, P87, DOI 10.1111/j.1096-3642.1973.tb00786.x; Kielan-Jaworowska Z, 1998, ACTA PALAEONTOL POL, V43, P413; KUHN HJ, 1971, ABH SENCKENB NAT, V28, P1; KUHN HJ, 1987, MORPHOGENESIS MAMMAL, P1; Li J-L, 2000, CHINESE SCI BULL, V45, P2545; LUO ZX, 1994, J VERTEBR PALEONTOL, V14, P341, DOI 10.1080/02724634.1994.10011564; Luo ZX, 2001, SCIENCE, V292, P1535, DOI 10.1126/science.1058476; MAIER W, 1990, NETH J ZOOL, V40, P55, DOI 10.1163/156854289X00183; McKenna MC, 1997, CLASSIFICATION MAMMA; Owen R., 1871, MONOGRAPH FOSSIL MAM; ROUGIER GW, 1966, AM MUS NOVIT, P1; Rowe T., 1988, Journal of Vertebrate Paleontology, V8, P241; Rowe Timothy, 1996, Memoirs of the California Academy of Sciences, V20, P71; Sanchez-Villagra Marcelo R., 1997, Journal of Mammalian Evolution, V4, P119, DOI 10.1023/A:1027318213347; SIMPSON G. G., 1928, CATALOGUE MESOZOIC M; Wang Xiaolin, 1998, Vertebrata Palasiatica, V36, P81; Zeller U., 1987, Mammalia Depicta, P17; ZELLER U, 1993, MAMMAL PHYLOGENY, P95	33	105	122	1	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 12	2001	294	5541					357	361		10.1126/science.1063830	http://dx.doi.org/10.1126/science.1063830			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	482WZ	11598297				2022-12-24	WOS:000171601400039
J	Mansley, EC; McKenna, MT				Mansley, EC; McKenna, MT			Importance of perspective in economic analyses of cancer screening decisions	LANCET			English	Article							RECOMMENDATIONS; KNOWLEDGE; BREAST	As the fifth, and final, report in this Lancet series on health economics, we discuss how economic analyses in public health, with cancer screening as the example, differ depending on the perspective taken. We identify nine different, but related, decision makers at various levels, from the individual patient to society as a whole, and discuss how their different viewpoints affect their ultimate decisions. Central to our discussion Is the identification of seven distinct components of perspective, each potentially important in the screening decision. In many fields of healthcare, decisions about the use of resources, such as time, wealth, or energy, are made by weighing up the positive and negative consequences of the alternatives under consideration and are thus based on an economic analysis of the situation (although sometimes this process is subconscious). For simplicity, we restrict our report to the effect of perspective on cancer screening decisions and show how the costs (negative consequences) and benefits (positive consequences) vary depending on the decision maker.	Ctr Dis Control & Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Div Canc Prevent & Control, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Mansley, EC (corresponding author), Merck & Co Inc, Outcomes Res & Management, POB 4,WP39-160, West Point, PA 19486 USA.	edward_mansley@merck.com						*AG HEALTHC RES QU, 2000, AHRQ RES ACTIVITIES, V239, P5; *AG HEALTHC RES QU, 2000, AHRQ RES ACTIVITIES, V239, P4; [Anonymous], 1996, COST EFFECTIVENESS H; Breslow RA, 1997, PREV MED, V26, P170, DOI 10.1006/pmed.1996.0136; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P162; Drummond MF, 1997, METHODS EC EVALUATIO, P52; Dugan E, 2000, J AM GERIATR SOC, V48, P413, DOI 10.1111/j.1532-5415.2000.tb04699.x; ELMORE JG, 1998, NEW ENGL J MED, V338, P1145; Farnham P. G., 1996, PREVENTION EFFECTIVE, P12; Fletcher SW, 1997, NEW ENGL J MED, V336, P1180, DOI 10.1056/NEJM199704173361612; Fowler FJ, 2000, JAMA-J AM MED ASSOC, V283, P3217, DOI 10.1001/jama.283.24.3217; Gold MR, 1996, COST EFFECTIVENESS H; Hurley J, 2000, HANDB ECON, V17, P55; Lee MR, 1999, EXPERT SYST APPL, V17, P315, DOI 10.1016/S0957-4174(99)00043-3; MANSLEY EC, 1997, NBCCEDP DIAGNOSIS TR; May DS, 1998, AM J ROENTGENOL, V170, P97, DOI 10.2214/ajr.170.1.9423608; Meltzer MI, 2001, LANCET, V358, P993, DOI 10.1016/S0140-6736(01)06107-4; *NIH, 1997, NIH CONS DEV C BREAS; O'Dell KJ, 1999, J FAM PRACTICE, V48, P682; Ries L, 2000, SEER CANC STAT REV 1; Torrance GW., 1996, COST EFFECTIVENESS H, P54; Torrance GW, 1996, COST EFFECTIVENESS H, P276; US Preventive Services Task Force, 1996, GUID CLIN PREV SERV, P18; Weeks JC, 1998, JAMA-J AM MED ASSOC, V279, P1709, DOI 10.1001/jama.279.21.1709; Woloshin S, 1999, NEW ENGL J MED, V340, P884, DOI 10.1056/NEJM199903183401112	25	8	9	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 6	2001	358	9288					1169	1173		10.1016/S0140-6736(01)06258-4	http://dx.doi.org/10.1016/S0140-6736(01)06258-4			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	479HM	11597692				2022-12-24	WOS:000171399000034
J	Garrus, JE; von Schwedler, UK; Pornillos, OW; Morham, SG; Zavitz, KH; Wang, HE; Wettstein, DA; Stray, KM; Cote, M; Rich, RL; Myszka, DG; Sundquist, WI				Garrus, JE; von Schwedler, UK; Pornillos, OW; Morham, SG; Zavitz, KH; Wang, HE; Wettstein, DA; Stray, KM; Cote, M; Rich, RL; Myszka, DG; Sundquist, WI			Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding	CELL			English	Article							VESICULAR STOMATITIS-VIRUS; PLASMA-MEMBRANE PROTEINS; GAG PROTEINS; UBIQUITIN LIGASE; MATRIX PROTEIN; LIFE-CYCLE; WW DOMAINS; RELEASE; YEAST; MOTIF	Like other enveloped viruses, HIV-1 uses cellular machinery to bud from infected cells. We now show that Tsg101 protein, which functions in vacuolar protein sorting (Vps), is required for HIV-1 budding. The UEV domain of Tsg101 binds to an essential tetrapeptide (PTAP) motif within the p6 domain of the structural Gag protein and also to ubiquitin. Depletion of cellular Tsg101 by small interfering RNA arrests HIV-1 budding at a late stage, and budding is rescued by reintroduction of Tsg101. Dominant negative mutant Vps4 proteins that inhibit vacuolar protein sorting also arrest HIV-1 and MLV budding. These observations suggest that retroviruses bud by appropriating cellular machinery normally used in the Vps pathway to form multivesicular bodies.	Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84132 USA; Univ Utah, Sch Med, Ctr Biomol Interact Anal, Salt Lake City, UT 84132 USA; Myriad Genet, Salt Lake City, UT 84108 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Myriad Genetics, Inc	Sundquist, WI (corresponding author), Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84132 USA.				NIGMS NIH HHS [P32 GM07464] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amerik AY, 2000, MOL BIOL CELL, V11, P3365, DOI 10.1091/mbc.11.10.3365; Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982; Babst M, 2000, TRAFFIC, V1, P248, DOI 10.1034/j.1600-0854.2000.010307.x; BARTEL PL, 1997, YEAST 2 HYBRID SCREE; Berthoud VM, 2000, METHODS, V20, P180, DOI 10.1006/meth.1999.0935; Bishop N, 2000, MOL BIOL CELL, V11, P227, DOI 10.1091/mbc.11.1.227; Bishop N, 2001, J BIOL CHEM, V276, P11735, DOI 10.1074/jbc.M009863200; Chin LS, 2001, J BIOL CHEM, V276, P7069, DOI 10.1074/jbc.M004129200; Craven RC, 1999, J VIROL, V73, P3359, DOI 10.1128/JVI.73.4.3359-3365.1999; Dunn R, 2001, MOL BIOL CELL, V12, P421, DOI 10.1091/mbc.12.2.421; Dupre S, 2001, MOL CELL BIOL, V21, P4482, DOI 10.1128/MCB.21.14.4482-4494.2001; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Freed EO, 1998, VIROLOGY, V251, P1, DOI 10.1006/viro.1998.9398; Galan JM, 2001, MOL CELL BIOL, V21, P3105, DOI 10.1128/MCB.21.9.3105-3117.2001; Gamier L, 1996, NATURE, V381, P744, DOI 10.1038/381744a0; GOTTLINGER HG, 1991, P NATL ACAD SCI USA, V88, P3195, DOI 10.1073/pnas.88.8.3195; Harty RN, 2000, P NATL ACAD SCI USA, V97, P13871, DOI 10.1073/pnas.250277297; Harty RN, 1999, J VIROL, V73, P2921, DOI 10.1128/JVI.73.4.2921-2929.1999; Harvey KF, 1999, TRENDS CELL BIOL, V9, P166, DOI 10.1016/S0962-8924(99)01541-X; Hermida-Matsumoto L, 2000, J VIROL, V74, P8670, DOI 10.1128/JVI.74.18.8670-8679.2000; Hicke L, 1999, TRENDS CELL BIOL, V9, P107, DOI 10.1016/S0962-8924(98)01491-3; HUANG MJ, 1995, J VIROL, V69, P6810, DOI 10.1128/JVI.69.11.6810-6818.1995; James P, 1996, GENETICS, V144, P1425; Jayakar HR, 2000, J VIROL, V74, P9818, DOI 10.1128/JVI.74.21.9818-9827.2000; JENKINS Y, 2001, IN PRESS J VIROL; JOHNSSON B, 1991, ANAL BIOCHEM, V198, P268, DOI 10.1016/0003-2697(91)90424-R; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Komada M, 2001, BIOCHEM BIOPH RES CO, V281, P1065, DOI 10.1006/bbrc.2001.4441; Koonin EV, 1997, NAT GENET, V16, P330, DOI 10.1038/ng0897-330; Lemmon SK, 2000, CURR OPIN CELL BIOL, V12, P457, DOI 10.1016/S0955-0674(00)00117-4; Li LM, 1996, CELL, V85, P319, DOI 10.1016/S0092-8674(00)81111-3; Li LM, 2001, P NATL ACAD SCI USA, V98, P1619, DOI 10.1073/pnas.98.4.1619; Li Y, 1999, MOL CELL BIOL, V19, P3588; Losko S, 2001, MOL BIOL CELL, V12, P1047, DOI 10.1091/mbc.12.4.1047; Myszyka DG, 1999, J MOL RECOGNIT, V12, P279, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<279::AID-JMR473>3.0.CO;2-3; Naviaux RK, 1996, J VIROL, V70, P5701, DOI 10.1128/JVI.70.8.5701-5705.1996; Ott DE, 2000, VIROLOGY, V278, P111, DOI 10.1006/viro.2000.0648; Owen DJ, 2000, CURR OPIN CELL BIOL, V12, P467, DOI 10.1016/S0955-0674(00)00118-6; PARENT LJ, 1995, J VIROL, V69, P5455, DOI 10.1128/JVI.69.9.5455-5460.1995; Patnaik A, 2000, P NATL ACAD SCI USA, V97, P13069, DOI 10.1073/pnas.97.24.13069; Ponting CP, 1997, J MOL MED-JMM, V75, P467; Puffer BA, 1998, J VIROL, V72, P10218, DOI 10.1128/JVI.72.12.10218-10221.1998; Puffer BA, 1997, J VIROL, V71, P6541, DOI 10.1128/JVI.71.9.6541-6546.1997; Rotin D, 2000, J MEMBRANE BIOL, V176, P1; Ruland J, 2001, P NATL ACAD SCI USA, V98, P1859, DOI 10.1073/pnas.98.4.1859; Schubert U, 2000, P NATL ACAD SCI USA, V97, P13057, DOI 10.1073/pnas.97.24.13057; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; Shih SC, 2000, EMBO J, V19, P187, DOI 10.1093/emboj/19.2.187; Strack B, 2000, P NATL ACAD SCI USA, V97, P13063, DOI 10.1073/pnas.97.24.13063; VanDemark AP, 2001, CELL, V105, P711, DOI 10.1016/S0092-8674(01)00387-7; VerPlank L, 2001, P NATL ACAD SCI USA, V98, P7724, DOI 10.1073/pnas.131059198; Vogt VM, 2000, P NATL ACAD SCI USA, V97, P12945, DOI 10.1073/pnas.97.24.12945; von Schwedler UK, 1998, EMBO J, V17, P1555, DOI 10.1093/emboj/17.6.1555; Wang GL, 2001, MOL CELL BIOL, V21, P3564, DOI 10.1128/MCB.21.10.3564-3575.2001; WILLS JW, 1991, AIDS, V5, P639, DOI 10.1097/00002030-199106000-00002; Xie WQ, 1998, P NATL ACAD SCI USA, V95, P1595, DOI 10.1073/pnas.95.4.1595; Yuan B, 1999, EMBO J, V18, P4700, DOI 10.1093/emboj/18.17.4700; Yuan B, 2000, J VIROL, V74, P7250, DOI 10.1128/JVI.74.16.7250-7260.2000; Zhong Q, 1998, CANCER RES, V58, P2699	59	1103	1160	0	35	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 5	2001	107	1					55	65		10.1016/S0092-8674(01)00506-2	http://dx.doi.org/10.1016/S0092-8674(01)00506-2			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	480GF	11595185	Bronze			2022-12-24	WOS:000171453100009
J	Sanchez, AM; Schreiber, GB; Bethel, J; McCurdy, PR; Glynn, SA; Williams, AE; Gilcher, R				Sanchez, AM; Schreiber, GB; Bethel, J; McCurdy, PR; Glynn, SA; Williams, AE; Gilcher, R		Retrovirus Epidemiology Donor Stud	Prevalence, donation practices, and risk assessment of blood donors with hemochromatosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HEPATITIS-B ANTIGEN; HEREDITARY HEMOCHROMATOSIS; UNITED-STATES; TRANSFUSION; EXCLUSION; ANTIBODY; IMPACT	Context Despite changes in eligibility policies, practical barriers limit blood donations from individuals with hemochromatosis. Increased knowledge of hemochromatosis donor characteristics may help foster further changes that will promote more donations. Objectives To estimate the prevalence of donors diagnosed as having hemochromatosis and to compare rates of unreported deferrable risks for transfusion-transmissible viral infections (TTVIs), positive screening test results for TTVIs, and donation patterns between hemochromatosis patient donors and donors reporting no medical conditions necessitating phlebotomy (non-health-related donors). Design An anonymous mail survey conducted in 1998 as part of the ongoing Retrovirus Epidemiology Donor Study. Setting and Participants Among a stratified probability sample of 92581 blood donors from 8 geographically diverse US blood centers, 52650 (57%) responded. Main Outcome Measures Prevalence of hemochromatosis among blood donors; prevalence of unreported deferrable risks and positive screening test results for TTVIs among hemochromatosis patient donors vs non-health-related donors. Results One hundred ninety-seven respondents (0.4%) identified themselves as hemochromatosis patients and 50079 (95.1%) as non-health-related donors. An estimated 0.8% of all donations were from hemochromatosis patients, 45.8% of whom reported that they had donated blood to treat their illness. The proportion of repeat donors was higher in hemochromatosis patients than in non-health-related donors (83.5% vs 76.5%; P = .03). Among repeat donors, 68.7% of hemochromatosis patients reported donating at least 3 times in the past year compared with 49.1% of non-health-related donors (P<.001). The prevalence of unreported deferrable risks for TTVIs was similar in hemochromatosis patients (2.0%) and non-health-related donors (3.1%) as was the overall prevalence of positive screening test results (1.3% of hemochromatosis patients vs 1.6% of non-health-related donors). Conclusions Although significant numbers of hemochromatosis patients reported donating blood for therapeutic reasons, our findings suggest that this population does not present a greater risk to blood safety than other donors.	WESTAT Corp, Rockville, MD 20850 USA; Amer Red Cross, Jerome H Holland Lab, Rockville, MD USA; NHLBI, Bethesda, MD 20892 USA; Oklahoma Blood Inst, Sylvan N Goldman Ctr, Oklahoma City, OK USA	Westat; American Red Cross; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Sanchez, AM (corresponding author), WESTAT Corp, WB 266,1650 Res Blvd, Rockville, MD 20850 USA.				NHLBI NIH HHS [N01-HB-97079, N01-HB-97081, N01-HB-97082, N01-HB-97078, N01-HB-97077, N01-HB-47114, N01-HB-97080] Funding Source: Medline; DIVISION OF BLOOD DISEASES AND RESOURCES [N01HB097078, N01HB097082, N01HB097081, N01HB097080, N01HB097077, N01HB047114, N01HB097079] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF BLOOD DISEASES AND RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AACH RD, 1980, ANN INTERN MED, V92, P539, DOI 10.7326/0003-4819-92-4-539; ALTER HJ, 1972, ANN INTERN MED, V77, P691, DOI 10.7326/0003-4819-77-5-691; Bartolotta A, 1999, POLYM ENG SCI, V39, P549, DOI 10.1002/pen.11445; Barton JC, 1998, ANN INTERN MED, V129, P932, DOI 10.7326/0003-4819-129-11_Part_2-199812011-00003; Bothwell TH, 1998, SEMIN HEMATOL, V35, P55; CHERUBIN CE, 1971, TRANSFUSION, V11, P25, DOI 10.1111/j.1537-2995.1971.tb04370.x; Conry-Cantilena C, 2000, HEMOCHROMATOSIS: GENETICS, PATHOPHYSIOLOGY, DIAGNOSIS AND TREATMENT, P564; *CTR BIOL EV RES, 2001, GUID IND VAR BLOOD C; CUMMING PD, 1989, NEW ENGL J MED, V321, P941, DOI 10.1056/NEJM198910053211405; *CYT SOFTW CO, 1999, STATXACT 4 SOFTW PRO; DOMEN RE, 1995, TRANSFUS MED REV, V9, P53, DOI 10.1016/S0887-7963(05)80030-6; Eastlund T, 1998, TRANSFUSION, V38, P874, DOI 10.1046/j.1537-2995.1998.38998409009.x; EDWARDS CQ, 1993, NEW ENGL J MED, V328, P1616; EDWARDS CQ, 1988, NEW ENGL J MED, V318, P1355, DOI 10.1056/NEJM198805263182103; Glynn SA, 2000, JAMA-J AM MED ASSOC, V284, P229, DOI 10.1001/jama.284.2.229; GRINDON AJ, 1993, JAMA-J AM MED ASSOC, V270, P880; Jeffrey G, 1999, TRANSFUSION, V39, P549, DOI 10.1046/j.1537-2995.1999.39060549.x; JOHNSON ES, 1994, TRANSFUSION, V34, P769, DOI 10.1046/j.1537-2995.1994.34994378277.x; LEGGETT BA, 1990, BRIT J HAEMATOL, V74, P525, DOI 10.1111/j.1365-2141.1990.tb06345.x; Levstik M, 1998, CAN J GASTROENTEROL, V12, P61, DOI 10.1155/1998/590428; McCullough J, 2000, TRANSFUSION, V40, P143; McDonnell SM, 1999, TRANSFUSION, V39, P651, DOI 10.1046/j.1537-2995.1999.39060651.x; MCLAREN CE, 1995, BLOOD, V86, P2021, DOI 10.1182/blood.V86.5.2021.bloodjournal8652021; Mitka M, 2001, JAMA-J AM MED ASSOC, V285, P1694, DOI 10.1001/jama.285.13.1694; Munsterman KA, 1998, TRANSFUSION, V38, P45, DOI 10.1046/j.1537-2995.1998.38198141497.x; Niederau C, 1996, GASTROENTEROLOGY, V110, P1107, DOI 10.1053/gast.1996.v110.pm8613000; PILIAVIN JA, 1990, TRANSFUSION, V30, P444, DOI 10.1046/j.1537-2995.1990.30590296381.x; Powell LW, 1996, GASTROENTEROLOGY, V110, P1304, DOI 10.1053/gast.1996.v110.agast961304; Sacher RA, 1999, TRANSFUSION, V39, P551, DOI 10.1046/j.1537-2995.1999.39060551.x; Seeff L B, 1988, Transfus Med Rev, V2, P204, DOI 10.1016/S0887-7963(88)70046-2; SZMUNESS W, 1973, J INFECT DIS, V127, P17, DOI 10.1093/infdis/127.1.17; Tan L, 1999, TRANSFUSION, V39, P1018, DOI 10.1046/j.1537-2995.1999.39091018.x; THOMAS DG, 1971, APPLIED STATISTICS, V20, P105, DOI DOI 10.2307/2346643; Walker EM, 1998, ANN CLIN LAB SCI, V28, P300; *WEST INC, 1994, WESVAR SAS PROC; Williams AE, 1997, JAMA-J AM MED ASSOC, V277, P967, DOI 10.1001/jama.277.12.967; Witte DL, 1996, CLIN CHIM ACTA, V245, P139, DOI 10.1016/0009-8981(95)06212-2; Zuck TF, 1995, TRANSFUSION, V35, P944, DOI 10.1046/j.1537-2995.1995.351196110900.x; 1997, P 146 ANN M HOUS DEL	39	22	22	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 26	2001	286	12					1475	1481		10.1001/jama.286.12.1475	http://dx.doi.org/10.1001/jama.286.12.1475			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	475UX	11572740	Bronze			2022-12-24	WOS:000171188600025
J	Nielsen, EE; Hansen, MM; Schmidt, C; Meldrup, D; Gronkjaer, P				Nielsen, EE; Hansen, MM; Schmidt, C; Meldrup, D; Gronkjaer, P			Fisheries - Population of origin of Atlantic cod	NATURE			English	Article									Danish Inst Fisheries Res, Dept Inland Fisheries, DK-8600 Silkeborg, Denmark; Univ Aarhus, Dept Marine Ecol, DK-8200 Aarhus, Denmark	Aarhus University	Nielsen, EE (corresponding author), Danish Inst Fisheries Res, Dept Inland Fisheries, DK-8600 Silkeborg, Denmark.		Nielsen, Einar/AAT-1737-2021; Hansen, Michael/I-5979-2013; Hansen, Michael M./Z-5047-2019; Grønkjær, Peter/A-3697-2008; Hansen, Michael/C-3336-2008	Nielsen, Einar/0000-0002-7009-9814; Hansen, Michael/0000-0001-5372-4828; Hansen, Michael M./0000-0001-5372-4828; Grønkjær, Peter/0000-0003-1337-4661; 				BAKER CS, 1994, SCIENCE, V265, P1538, DOI 10.1126/science.265.5178.1538; *INT COUNC EXPL SE, 200 AFCM INT COUNC E; Pritchard JK, 2000, GENETICS, V155, P945; WARD RD, 1994, J FISH BIOL, V44, P213, DOI 10.1111/j.1095-8649.1994.tb01200.x; Ward RD, 2000, HYDROBIOLOGIA, V420, P191, DOI 10.1023/A:1003928327503	5	108	112	0	30	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 20	2001	413	6853					272	272		10.1038/35095112	http://dx.doi.org/10.1038/35095112			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473KB	11565021				2022-12-24	WOS:000171040500028
J	Freiman, RN; Albright, SR; Zheng, S; Sha, WC; Hammer, RE; Tjian, R				Freiman, RN; Albright, SR; Zheng, S; Sha, WC; Hammer, RE; Tjian, R			Requirement of tissue-selective TBP-associated factor TAF(II)105 in ovarian development	SCIENCE			English	Article							POLYMERASE-II TRANSCRIPTION; MOLECULAR-CLONING; TFIID COMPLEX; C-ELEGANS; ACTIVATION; SUBUNITS; DNA	Transcription factor TFIID, composed of TBP and TAF(11) subunits, is a central component of the RNA polymerase II machinery. Here, we report that the tissue-selective TAF(11)105 subunit of TFIID is essential for proper development and function of the mouse ovary. Female mice lacking TAF(11)105 are viable but infertile because of a defect in folliculogenesis correlating with restricted expression of TAF(11)105 in the granulosa cells of the ovarian follicle. Gene expression profiling has uncovered a defective inhibin-activin signaling pathway in TAF(11)105-deficient ovaries. Together, these studies suggest that TAF(11)105 mediates the transcription of a subset of genes required for proper folliculogenesis in the ovary and establishes TAF(11)105 as a cell type-specific component of the mammalian transcriptional machinery.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Green Ctr Reprod Biol Sci, Dallas, TX 75390 USA	University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Tjian, R (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.			Hammer, Robert E./0000-0001-5487-7551				BRINSTER RL, 1985, P NATL ACAD SCI USA, V82, P4438, DOI 10.1073/pnas.82.13.4438; Dantonel JC, 2000, MOL CELL, V6, P715, DOI 10.1016/S1097-2765(00)00069-1; Dikstein R, 1996, CELL, V87, P137, DOI 10.1016/S0092-8674(00)81330-6; Elvin JA, 1998, REV REPROD, V3, P183, DOI 10.1530/ror.0.0030183; FREIMAN RN, UNPUB; GOODRICH JA, 1993, CELL, V75, P519, DOI 10.1016/0092-8674(93)90386-5; Gross CA, 1998, COLD SPRING HARB SYM, V63, P141, DOI 10.1101/sqb.1998.63.141; Hiller MA, 2001, GENE DEV, V15, P1021, DOI 10.1101/gad.869101; HOEY T, 1993, CELL, V72, P247, DOI 10.1016/0092-8674(93)90664-C; Kaltenbach L, 2000, MOL CELL, V6, P705, DOI 10.1016/S1097-2765(00)00068-X; Martianov I, 2001, MOL CELL, V7, P509, DOI 10.1016/S1097-2765(01)00198-8; Mengus G, 1997, GENE DEV, V11, P1381, DOI 10.1101/gad.11.11.1381; Sanders SL, 2000, J BIOL CHEM, V275, P13895, DOI 10.1074/jbc.275.18.13895; Tanese N, 1996, P NATL ACAD SCI USA, V93, P13611, DOI 10.1073/pnas.93.24.13611; Veenstra GJC, 2000, SCIENCE, V290, P2312, DOI 10.1126/science.290.5500.2312; VERRIJZER CP, 1994, SCIENCE, V264, P933, DOI 10.1126/science.8178153; Wolstein O, 2000, J BIOL CHEM, V275, P16459, DOI 10.1074/jbc.275.22.16459; Yamit-Hezi A, 1998, EMBO J, V17, P5161, DOI 10.1093/emboj/17.17.5161; Zhang D, 2001, SCIENCE, V292, P1153, DOI 10.1126/science.1059188	19	158	162	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 14	2001	293	5537					2084	2087		10.1126/science.1061935	http://dx.doi.org/10.1126/science.1061935			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473FB	11557891				2022-12-24	WOS:000171028700073
J	Gifford, DK				Gifford, DK			Blazing pathways through genetic mountains	SCIENCE			English	Editorial Material								It is now widely accepted that high-throughput data sources will shed essential understanding on the inner workings of cellular and organism function. One key challenge is to distill the results of such experiments into an interpretable computational form that will be the basis of a predictive model. A predictive model represents the gold standard in understanding a biological system and will permit us to investigate the underlying cause of diseases and help us to develop therapeutics. Here I explore how discoveries can be based on high-throughput data sources and discuss how independent discoveries can be assembled into a comprehensive picture of cellular function.	MIT, Dept Comp Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Gifford, DK (corresponding author), MIT, Dept Comp Sci, 200 Technol Sq, Cambridge, MA 02139 USA.		Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647				HARTEMINK A, 2000, PAC S BIOC 2000 OAH; Hartemink A.J., 2001, THESIS MIT CAMBRIDGE; Kim SK, 2001, SCIENCE, V293, P2087, DOI 10.1126/science.1061603; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; PEER D, 2001, 9 C INT SYST MOL BIO	5	18	21	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 14	2001	293	5537					2049	2051		10.1126/science.1065113	http://dx.doi.org/10.1126/science.1065113			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473FB	11557882				2022-12-24	WOS:000171028700063
J	Krimpenfort, P; Quon, KC; Mooi, WJ; Loonstra, A; Berns, A				Krimpenfort, P; Quon, KC; Mooi, WJ; Loonstra, A; Berns, A			Loss of p16(Ink4a) confers susceptibility to metastatic melanoma in mice	NATURE			English	Article							TUMOR SUPPRESSION; G(1) CONTROL; INK4A LOCUS; IN-VITRO; SENESCENCE; MUTATIONS; GROWTH; DISRUPTION; P14(ARF); DELETION	CDKN2A (INK4a/ARF) is frequently disrupted in various types of human cancer, and germline mutations of this locus can confer susceptibility to melanoma and other tumours(1). However, because CDKN2A encodes two distinct cell cycle inhibitory proteins, p16(INK4a) and p14(ARF) (p19(Arf) in mice)(2), the mechanism of tumour suppression by CDKN2A has remained controversial. Genetic disruption of Cdkn2a(p19(Arf)) (hereafter Arf) alone predisposes mice to tumorigenesis(3), demonstrating that Arf is a tumour-suppressor gene in mice. We mutated mice specifically in Cdkn2a(p16(Ink4a)) (hereafter Ink4a). Here we demonstrate that these mice, designated Ink4a*/*, do not show a significant predisposition to spontaneous tumour formation within 17 months. Embryo fibroblasts derived from them proliferate normally, are mortal, and are not transformed by oncogenic HRAS. The very mild phenotype of the Ink4a*/* mice implies that the very strong phenotypes of the original Ink4a/Arf(Delta2,3) mice were primarily or solely due to loss of Arf. However, Ink4a*(/2 Delta ,3) mice that are deficient for Ink4a and heterozygous for Arf spontaneously develop a wide spectrum of tumours, including melanoma. Treatment of these mice with the carcinogen 7,12-dimethylbenzanthracene (DMBA) results in an increased incidence of melanoma, with frequent metastases. Our results show that, in the mouse, Ink4a is a tumour-suppressor gene that, when lost, can recapitulate the tumour predisposition seen in humans.	Netherlands Canc Inst, Div Mol Genet, NL-1066 CX Amsterdam, Netherlands; Netherlands Canc Inst, Ctr Biomed Genet, NL-1066 CX Amsterdam, Netherlands; Netherlands Canc Inst, Dept Pathol, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute	Berns, A (corresponding author), Netherlands Canc Inst, Div Mol Genet, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	tberns@nki.nl						Arap W, 1997, ONCOGENE, V14, P603, DOI 10.1038/sj.onc.1200870; Burri N, 2001, LAB INVEST, V81, P217, DOI 10.1038/labinvest.3780230; Carnero A, 2000, NAT CELL BIOL, V2, P148, DOI 10.1038/35004020; Dannenberg JH, 2000, GENE DEV, V14, P3051, DOI 10.1101/gad.847700; Eischen CM, 1999, GENE DEV, V13, P2658, DOI 10.1101/gad.13.20.2658; HARVEY M, 1993, ONCOGENE, V8, P2457; Jacobs JJL, 1999, GENE DEV, V13, P2678, DOI 10.1101/gad.13.20.2678; Kamijo T, 1999, CANCER RES, V59, P2217; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Kiyono T, 1998, NATURE, V396, P84, DOI 10.1038/23962; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Peeper DS, 2001, NAT CELL BIOL, V3, P198, DOI 10.1038/35055110; Randerson-Moor JA, 2001, HUM MOL GENET, V10, P55, DOI 10.1093/hmg/10.1.55; Rizos H, 1997, ONCOGENE, V15, P515, DOI 10.1038/sj.onc.1201217; Robanus-Maandag E, 1998, GENE DEV, V12, P1599, DOI 10.1101/gad.12.11.1599; Ruas M, 1998, BBA-REV CANCER, V1378, pF115, DOI 10.1016/S0304-419X(98)00017-1; Sage J, 2000, GENE DEV, V14, P3037, DOI 10.1101/gad.843200; Schmitt CA, 1999, GENE DEV, V13, P2670, DOI 10.1101/gad.13.20.2670; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; Sharpless NE, 1999, CURR OPIN GENET DEV, V9, P22, DOI 10.1016/S0959-437X(99)80004-5; Sherr CJ, 1998, GENE DEV, V12, P2984, DOI 10.1101/gad.12.19.2984; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Wright WE, 2001, CURR OPIN GENET DEV, V11, P98, DOI 10.1016/S0959-437X(00)00163-5; Zhu JY, 1998, GENE DEV, V12, P2997, DOI 10.1101/gad.12.19.2997	27	427	436	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 6	2001	413	6851					83	86		10.1038/35092584	http://dx.doi.org/10.1038/35092584			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469EG	11544530				2022-12-24	WOS:000170801200043
J	Owen-Davies, J				Owen-Davies, J			North Korea's public health tragedy	LANCET			English	Article											Owen-Davies, J (corresponding author), 9 Cleveland Rd, London SW13 0AA, England.								0	6	6	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 24	2001	357	9256					628	630		10.1016/S0140-6736(00)04062-9	http://dx.doi.org/10.1016/S0140-6736(00)04062-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	404UB	11558502				2022-12-24	WOS:000167119100036
J	GEHRING, CA; WILLIAMS, DA; CODY, SH; PARISH, RW				GEHRING, CA; WILLIAMS, DA; CODY, SH; PARISH, RW			PHOTOTROPISM AND GEOTROPISM IN MAIZE COLEOPTILES ARE SPATIALLY CORRELATED WITH INCREASES IN CYTOSOLIC FREE CALCIUM	NATURE			English	Article									LA TROBE UNIV, CTR PROT & ENZYME TECHNOL, BUNDOORA, VIC 3083, AUSTRALIA; UNIV MELBOURNE, DEPT PHYSIOL, PARKVILLE, VIC 3052, AUSTRALIA	La Trobe University; University of Melbourne	GEHRING, CA (corresponding author), LA TROBE UNIV, DEPT BOT, BUNDOORA, VIC 3083, AUSTRALIA.			Gehring, Christoph/0000-0003-4355-4591				BASKIN TI, 1986, PLANT PHYSIOL, V81, P306, DOI 10.1104/pp.81.1.306; BLOWERS DP, 1988, 2ND MESSENGERS PLANT, P1; BRIGGS WR, 1963, ANNU REV PLANT PHYS, V14, P311, DOI 10.1146/annurev.pp.14.060163.001523; BRUMMER B, 1985, FEBS LETT, V189, P109, DOI 10.1016/0014-5793(85)80852-8; Darwin C, 1880, POWER MOVEMENT PLANT; ETTLINGER C, 1988, NATURE, V331, P176, DOI 10.1038/331176a0; FELLE H, 1988, PLANTA, V174, P495, DOI 10.1007/BF00634478; FELLE H, 1986, P NATL ACAD SCI USA, V83, P8992, DOI 10.1073/pnas.83.23.8992; FILNER B, 1970, PLANTA, V94, P333, DOI 10.1007/BF00385765; GILLESPIE B, 1963, PLANT PHYSIOL, V38, P214, DOI 10.1104/pp.38.2.214; HEPLER PK, 1985, ANNU REV PLANT PHYS, V36, P397, DOI 10.1146/annurev.pp.36.060185.002145; HILD V, 1972, PLANTA, V108, P245, DOI 10.1007/BF00384112; IINO M, 1984, PLANT CELL ENVIRON, V7, P97, DOI 10.1111/j.1365-3040.1984.tb01562.x; MARME D, 1988, 2ND MESSENGERS PLANT, P57; MCCLURE BA, 1989, SCIENCE, V243, P91, DOI 10.1126/science.11540631; RINK TJ, 1982, J CELL BIOL, V95, P189, DOI 10.1083/jcb.95.1.189; SCANLON M, 1987, J BIOL CHEM, V262, P6308; TREWAVAS A, 1981, PLANT CELL ENVIRON, V4, P203, DOI 10.1111/j.1365-3040.1981.tb01048.x; Went F.W., 1937, PHYTOHORMONES; WILLIAMS DA, IN PRESS CELL CALCIU	20	129	137	2	13	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 7	1990	345	6275					528	530		10.1038/345528a0	http://dx.doi.org/10.1038/345528a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH143	11540625				2022-12-24	WOS:A1990DH14300061
J	Capewell, S; MacIntyre, K; Stewart, S; Chalmers, JWT; Boyd, J; Finlayson, A; Redpath, A; Pell, JP; McMurray, JJV				Capewell, S; MacIntyre, K; Stewart, S; Chalmers, JWT; Boyd, J; Finlayson, A; Redpath, A; Pell, JP; McMurray, JJV			Age, sex, and social trends in out-of-hospital cardiac deaths in Scotland 1986-95: a retrospective cohort study	LANCET			English	Article							ACUTE MYOCARDIAL-INFARCTION; CORONARY HEART-DISEASE; MONICA PROJECT POPULATIONS; CASE-FATALITY; RISK-FACTORS; MORTALITY-RATES; EVENT RATES; REGISTER; SURVIVAL; CARDIOLOGY	Background Most deaths from coronary heart disease occur out of hospital. Hospital patients face social, age, and sex inequalities. Our aim was to examine inequalities and trends in out-of-hospital cardiac deaths. Methods We used the Scottish record linked database to identify all deaths from acute myocardial infarction that occurred in Scotland (population 5.1 million), in 1986-95. We have compared population-based death rates for men and women across age and social groups. Findings Between 1986 and 1995, 83 365 people died from acute myocardial infarction, out of hospital and without previous hospital admission (44 655 men, 38 710 women); and 117 749 were admitted with a first acute myocardial infarction, of whom 37 020 died within 1 year. Thus, out-of-hospital deaths accounted for 69.2% (95% CI 69.0-69.5) of all 120 385 deaths. Out-of-hospital deaths, measured as a proportion of all acute myocardial infarction events (deaths plus first hospital admissions), increased with age, from 20.1% (19.2-21.0) in people younger than 55 years, to 62.1% (61.3-62.9) in those older than 85 years. Population-based out-of-hospital mortality rates fell by a third in men and by a quarter in women. Mean yearly falls were larger in people aged 55-64 years (5.6% per year in men, 3.7% in women), than in those older than 85 years (2.5% in men and women), Mortality rates were substantially higher in deprived socioeconomic groups than in affluent groups, especially in people younger than 65 years. Interpretation These inequalities in age, sex, and socioeconomic class should be actively addressed by prevention strategies for coronary heart disease.	Univ Glasgow, Dept Publ Hlth, Glasgow, Lanark, Scotland; Common Serv Agcy NHS Scotland, Informat & Stat Div, Edinburgh, Midlothian, Scotland; Greater Glasgow Hlth Board, Glasgow, Lanark, Scotland; Glasgow Western Infirm, Dept Cardiol, Glasgow, Lanark, Scotland	University of Glasgow	Capewell, S (corresponding author), Univ Liverpool, Dept Publ Hlth, Liverpool L69 3GB, Merseyside, England.		Macintyre, Kate/J-7174-2014; mcmurray, John/B-2467-2013; Stewart, Simon/M-3316-2016	Macintyre, Kate/0000-0003-2741-0467; mcmurray, John/0000-0002-6317-3975; Boyd, James/0000-0002-8925-8811; Stewart, Simon/0000-0001-9032-8998; Pell, Jill/0000-0002-8898-7035				Blane D, 1998, BRIT MED J, V317, P255, DOI 10.1136/bmj.317.7153.255; Bowling A, 1999, BRIT MED J, V319, P1353, DOI 10.1136/bmj.319.7221.1353; Brophy JM, 1997, CAN J CARDIOL, V13, P474; Brown N, 1997, BMJ-BRIT MED J, V315, P159, DOI 10.1136/bmj.315.7101.159; Capewell S, 1999, BRIT MED J, V318, P1072, DOI 10.1136/bmj.318.7190.1072; Capewell S, 1999, HEART, V81, P380, DOI 10.1136/hrt.81.4.380; Capewell S, 1996, HEART, V76, P70, DOI 10.1136/hrt.76.1.70; Capewell S, 2000, EUR HEART J, V21, P1833, DOI 10.1053/euhj.2000.2318; Capewell S, 2000, CIRCULATION, V102, P1511, DOI 10.1161/01.CIR.102.13.1511; Carstairs V., 1991, DEPRIVATION HLTH SCO; CRITCHLEY JA, 2000, J EPIDEMIOL COMMUNIT, V54, P774; Dobson AJ, 1999, J CLIN EPIDEMIOL, V52, P761, DOI 10.1016/S0895-4356(99)00052-9; Hallqvist J, 1998, INT J EPIDEMIOL, V27, P410, DOI 10.1093/ije/27.3.410; Harley K, 1996, Health Bull (Edinb), V54, P410; Kendrick Stephen, 1993, Health Bulletin (Edinburgh), V51, P72; Kuulasmaa K, 2000, LANCET, V355, P675, DOI 10.1016/S0140-6736(99)11180-2; Macintyre K, 2001, BRIT MED J, V322, P1152, DOI 10.1136/bmj.322.7295.1152; MARMOT M, 1999, INEQUALITIES CORONAR; McGovern PG, 1996, NEW ENGL J MED, V334, P884, DOI 10.1056/NEJM199604043341403; MCMURRAY J, 1994, BMJ-BRIT MED J, V309, P1343, DOI 10.1136/bmj.309.6965.1343; Morrison C, 1997, BMJ-BRIT MED J, V314, P541, DOI 10.1136/bmj.314.7080.541; *NAT SERV, 2000, NAT SERV FRAM COR HE; NAYHA S, 1992, INT J EPIDEMIOL, V21, P30, DOI 10.1093/ije/21.1.30; NAYLOR CD, 1994, J AM COLL CARDIOL, V24, P1431, DOI 10.1016/0735-1097(94)90136-8; Rathore SS, 2000, CIRCULATION, V102, P642, DOI 10.1161/01.CIR.102.6.642; *REG GEN SCOTL, 1998, ANN REP; Rosamond WD, 1998, NEW ENGL J MED, V339, P861, DOI 10.1056/NEJM199809243391301; Rosen M, 2000, J INTERN MED, V248, P159, DOI 10.1046/j.1365-2796.2000.00716.x; Salomaa V, 2000, CIRCULATION, V101, P1913, DOI 10.1161/01.CIR.101.16.1913; Smith GD, 1998, J EPIDEMIOL COMMUN H, V52, P399, DOI 10.1136/jech.52.6.399; Tunstall-Pedoe H, 1999, LANCET, V353, P1547, DOI 10.1016/S0140-6736(99)04021-0; Volmink JA, 1998, HEART, V80, P40, DOI 10.1136/hrt.80.1.40; Woodward M, 1996, J EPIDEMIOL COMMUN H, V50, P570, DOI 10.1136/jech.50.5.570	33	79	80	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 13	2001	358	9289					1213	1217		10.1016/S0140-6736(01)06343-7	http://dx.doi.org/10.1016/S0140-6736(01)06343-7			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	481NX	11675057				2022-12-24	WOS:000171527000009
J	Mahal, LK; Charter, NW; Angata, K; Fukuda, M; Koshland, DE; Bertozzi, CR				Mahal, LK; Charter, NW; Angata, K; Fukuda, M; Koshland, DE; Bertozzi, CR			A small-molecule modulator of poly-alpha 2,8-sialic acid expression on cultured neurons and tumor cells	SCIENCE			English	Article							ADHESION MOLECULE; POLYSIALIC ACID; 2 POLYSIALYLTRANSFERASES; SIALIC ACIDS; STX; SURFACE; PST; POLYSIALYLATION; PLASTICITY; PATTERN	Poly-alpha2,8-sialic acid (PSA) has been implicated in numerous normal and pathological processes, including development, neuronal plasticity, and tumor metastasis. We report that cell surface PSA expression can be reversibly inhibited by a small molecule, N-butanoylmannosamine (ManBut). Inhibition occurs through a metabolic mechanism in which ManBut is converted to unnatural sialic acid derivatives that effectively act as chain terminators during cellular PSA biosynthesis. N-Propanoylmannosamine (ManProp), which differs from ManBut by a single methylene group, did not inhibit PSA biosynthesis. Modulation of PSA expression by chemical means has a rote complementary to genetic and biochemical approaches in the study of complex PSA-mediated events.	Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; Burnham Inst, Ctr Canc Res, Glycobiol Program, La Jolla, CA 92037 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; Sanford Burnham Prebys Medical Discovery Institute	Bertozzi, CR (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.		Mahal, Lara/GRY-7287-2022; Angata, Kiyohiko/M-2749-2018	Angata, Kiyohiko/0000-0001-5561-1368; Mahal, Lara/0000-0003-4791-8524	NATIONAL CANCER INSTITUTE [R01CA033895] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK009765, R37DK009765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058867, R37GM058867] Funding Source: NIH RePORTER; NCI NIH HHS [CA33895] Funding Source: Medline; NIDDK NIH HHS [DK09765] Funding Source: Medline; NIGMS NIH HHS [GM58867-01] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Angata K, 1998, J BIOL CHEM, V273, P28524, DOI 10.1074/jbc.273.43.28524; Angata K, 1997, J BIOL CHEM, V272, P7182, DOI 10.1074/jbc.272.11.7182; Bertozzi CR, 2001, SCIENCE, V291, P2357, DOI 10.1126/science.1059820; BERTOZZI CR, 1995, CHEM BIOL, V2, P703, DOI 10.1016/1074-5521(95)90096-9; Chappell MD, 1997, TETRAHEDRON, V53, P11109, DOI 10.1016/S0040-4020(97)00370-0; Charter NW, 2000, GLYCOBIOLOGY, V10, P1049, DOI 10.1093/glycob/10.10.1049; ECKHARDT M, 1995, NATURE, V373, P715, DOI 10.1038/373715a0; Eckhardt M, 2000, J NEUROSCI, V20, P5234, DOI 10.1523/JNEUROSCI.20-14-05234.2000; Fukuda M, 1996, CANCER RES, V56, P2237; Hildebrandt H, 1998, CANCER RES, V58, P779; JORGENSEN OS, 1995, NEUROCHEM RES, V20, P533, DOI 10.1007/BF01694535; JOURDIAN GW, 1971, J BIOL CHEM, V246, P430; Keppler OT, 2001, GLYCOBIOLOGY, V11, p11R, DOI 10.1093/glycob/11.2.11R; Liu TM, 2000, J BIOL CHEM, V275, P32832, DOI 10.1074/jbc.C000573200; Mahal LK, 1997, SCIENCE, V276, P1125, DOI 10.1126/science.276.5315.1125; NAKAYAMA J, 1995, P NATL ACAD SCI USA, V92, P7031, DOI 10.1073/pnas.92.15.7031; Ong E, 1998, GLYCOBIOLOGY, V8, P415, DOI 10.1093/glycob/8.4.415; PLEASURE SJ, 1992, J NEUROSCI, V12, P1802; PROBSTMEIER R, 1994, J NEUROSCI RES, V37, P324, DOI 10.1002/jnr.490370305; Rutishauser U, 1998, J CELL BIOCHEM, V70, P304, DOI 10.1002/(SICI)1097-4644(19980901)70:3<304::AID-JCB3>3.0.CO;2-R; SCHEIDEGGER EP, 1995, J BIOL CHEM, V270, P22685, DOI 10.1074/jbc.270.39.22685; SCHEIDEGGER EP, 1994, LAB INVEST, V70, P95; Schumacher U, 1996, HISTOCHEM CELL BIOL, V106, P599; SZELE FG, 1994, NEUROSCIENCE, V60, P133, DOI 10.1016/0306-4522(94)90209-7; TROY FA, 1992, GLYCOBIOLOGY, V2, P5, DOI 10.1093/glycob/2.1.5; Yarema KJ, 1998, J BIOL CHEM, V273, P31168, DOI 10.1074/jbc.273.47.31168	26	90	91	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 12	2001	294	5541					380	382		10.1126/science.1062192	http://dx.doi.org/10.1126/science.1062192			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	482WZ	11598302				2022-12-24	WOS:000171601400045
J	Reid, G; Flonta, ML				Reid, G; Flonta, ML			Physiology - Cold current in thermoreceptive neurons	NATURE			English	Article							MENTHOL; RAT		Univ Bucharest, Fac Biol, Dept Anim Physiol & Biophys, Bucharest 76201, Romania	University of Bucharest	Reid, G (corresponding author), Univ Bucharest, Fac Biol, Dept Anim Physiol & Biophys, Splaiul Independentei 91-95, Bucharest 76201, Romania.							Gee MD, 1999, NEUROSCIENCE, V90, P509, DOI 10.1016/S0306-4522(98)00454-0; HENSEL H, 1951, ACTA PHYSIOL SCAND, V24, P27, DOI 10.1111/j.1748-1716.1951.tb00824.x; HENSEL H, 1974, PFLUG ARCH EUR J PHY, V352, P87, DOI 10.1007/BF01061953; Hensel H, 1981, THERMORECEPTION TEMP; KENSHALO DR, 1977, J NEUROPHYSIOL, V40, P319, DOI 10.1152/jn.1977.40.2.319; LEEM JW, 1993, J NEUROPHYSIOL, V69, P1684, DOI 10.1152/jn.1993.69.5.1684; Okazawa M, 2000, NEUROREPORT, V11, P2151, DOI 10.1097/00001756-200007140-00018; PIERAU FK, 1974, BRAIN RES, V73, P156, DOI 10.1016/0006-8993(74)91015-4; Reid G, 2001, J NEUROSCI METH, V111, P1, DOI 10.1016/S0165-0270(01)00416-2; Reid G, 2001, NEUROSCI LETT, V297, P171, DOI 10.1016/S0304-3940(00)01694-3; SCHAFER K, 1986, J GEN PHYSIOL, V88, P757, DOI 10.1085/jgp.88.6.757; Suto K, 1999, NEUROSCIENCE, V92, P1131, DOI 10.1016/S0306-4522(99)00063-9	12	129	138	0	15	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 4	2001	413	6855					480	480		10.1038/35097164	http://dx.doi.org/10.1038/35097164			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	478HG	11586349				2022-12-24	WOS:000171340500036
J	McDermott, MM; Greenland, P; Liu, K; Guralnik, JM; Criqui, MH; Dolan, NC; Chan, CL; Celic, L; Pearce, WH; Schneider, JR; Sharma, L; Clark, E; Gibson, D; Martin, GJ				McDermott, MM; Greenland, P; Liu, K; Guralnik, JM; Criqui, MH; Dolan, NC; Chan, CL; Celic, L; Pearce, WH; Schneider, JR; Sharma, L; Clark, E; Gibson, D; Martin, GJ			Leg symptoms in peripheral arterial disease - Associated clinical characteristics and functional impairment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LOWER-EXTREMITY FUNCTION; INTERMITTENT CLAUDICATION; CARDIOVASCULAR HEALTH; PHYSICAL-DISABILITY; WOMENS HEALTH; 6-MINUTE WALK; ACCELEROMETER; PREDICTOR; MORTALITY; CRITERIA	Context Persons with lower-extremity peripheral arterial disease (PAD) are often asymptomatic or have leg symptoms other than intermittent claudication (IC). Objective To identify clinical characteristics and functional limitations associated with a broad range of leg symptoms identified among patients with PAD. Design, Setting, and Participants Cross-sectional study of 460 men and women with PAD and 130 without PAD, who were identified consecutively, conducted between October 1998 and January 2000 at 3 Chicago-area medical centers. Main Outcome Measures Ankle-brachial index score of less than 0.90; scores from 6-minute walk, accelerometer-measured physical activity over 7 days, repeated chair raises, standing balance (full tandem stand), 4-m walking velocity, San Diego claudication questionnaire, Geriatric Depression Score Short-Form, and the Walking Impairment Questionnaire. Results All groups with PAD had poorer functioning than participants without PAD. The following values are for patients without IC vs those with IC. Participants in the group with leg pain on exertion and rest (n=88) had a higher (poorer) score for neuropathy (5.6 vs 3.5; P<.001), prevalence of diabetes mellitus (48.9% vs 26.7%; P<.001), and spinal stenosis (20.8% vs 7.2%; P=.002). The atypical exertional leg pain/carry on group (exertional leg pain other than IC associated with walking through leg pain [n=41]) and the atypical exertional leg pain/stop group (exertional leg pain other than IC that causes one to stop walking [n=90]) had better functioning than the IC group. The group without exertional leg pain/inactive (no exertional leg pain in individual who walks less than or equal to6 blocks per week [n=28]) and the leg pain on exertion and rest group had poorer functioning than those with IC. Adjusting for age, sex, race, and comorbidities and compared with IC, participants with atypical exertional leg pain/carry on achieved a greater distance on the 6-minute walk (404.3 vs 328.5 m; P<.001) and were less likely to stop during the 6-minute walk (6.8% vs 36%; P=.002). The group with pain on exertion and rest had a slower time for completing 5 chair raises (13.5 vs 11.9 seconds; P=.009), completed the tandem stand less frequently (37.5% vs 60.0%; P=.004), and had a slower 4-m walking velocity (0.80 vs 0.90 m/s; P<.001). Conclusions There is a wide range of leg symptoms in persons with PAD beyond that of classic IC. Comorbid disease may contribute to these symptoms in PAD. Functional impairments are found in every PAD symptom group, and the degree of functional limitation varies depending on the type of leg symptom.	Northwestern Univ, Sch Med, Dept Med, Chicago, IL 60611 USA; Northwestern Univ, Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; Northwestern Univ, Sch Med, Dept Surg, Chicago, IL 60611 USA; Evanston Northwestern Hosp, Dept Surg, Div Vasc Surg, Evanston, IL USA; Univ Calif San Diego, Dept Family & Prevent Med, San Diego, CA 92103 USA; NIA, Epidemiol Demog & Biometry Program, Bethesda, MD 20892 USA; Catholic Hlth Partners, Dept Surg, Div Vasc Surg, Chicago, IL USA	Northwestern University; Northwestern University; Northwestern University; NorthShore University Health System; University of California System; University of California San Diego; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	McDermott, MM (corresponding author), 675 N St Clair,Suite 18-200, Chicago, IL 60611 USA.		Greenland, Philip/ABD-5528-2021	Sharma, Leena/0000-0002-5571-1622	NCRR NIH HHS [RR-00048] Funding Source: Medline; PHS HHS [R01-58099] Funding Source: Medline	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ALTMAN R, 1991, ARTHRITIS RHEUM, V34, P505, DOI 10.1002/art.1780340502; ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; BERNSTEIN EF, 1982, SURG CLIN N AM, V62, P473; BIRKE JA, 1986, LEPROSY REV, V57, P261; Criqui M H, 1996, Vasc Med, V1, P65; ETTINGER WH, 1994, J AM GERIATR SOC, V42, P1035, DOI 10.1111/j.1532-5415.1994.tb06206.x; Feinglass J, 2000, J VASC SURG, V31, P93, DOI 10.1016/S0741-5214(00)70071-1; FRIED LP, 1994, J CLIN EPIDEMIOL, V47, P747, DOI 10.1016/0895-4356(94)90172-4; Fried LP, 1999, J CLIN EPIDEMIOL, V52, P27, DOI 10.1016/S0895-4356(98)00124-3; Gardner AW, 1998, ANGIOLOGY, V49, P327, DOI 10.1177/000331979804900501; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Guralnik JM, 1995, NIH PUBLICATION, V95-4009; GUYATT GH, 1985, CAN MED ASSOC J, V132, P919; HIATT WR, 1995, CIRCULATION, V91, P1472, DOI 10.1161/01.CIR.91.5.1472; Hirsch AT, 2001, JAMA-J AM MED ASSOC, V286, P1317, DOI 10.1001/jama.286.11.1317; Lyness JM, 1997, ARCH INTERN MED, V157, P449, DOI 10.1001/archinte.157.4.449; McDermott MM, 1998, J AM GERIATR SOC, V46, P1355, DOI 10.1111/j.1532-5415.1998.tb06001.x; McDermott MM, 2000, J VASC SURG, V32, P1164, DOI 10.1067/mva.2000.108640; McDermott MM, 1999, ARCH INTERN MED, V159, P387; McDermott MM, 2000, CIRCULATION, V101, P1007, DOI 10.1161/01.CIR.101.9.1007; McDermott MM, 2001, J AM GERIATR SOC, V49, P747, DOI 10.1046/j.1532-5415.2001.49151.x; McDermott MM, 2001, J GEN INTERN MED, V16, P384, DOI 10.1046/j.1525-1497.2001.016006384.x; McDermott MM, 2000, ANGIOLOGY, V51, P91, DOI 10.1177/000331970005100201; MCKENNA M, 1991, ATHEROSCLEROSIS, V87, P119, DOI 10.1016/0021-9150(91)90014-T; MILLER DJ, 1994, MED SCI SPORT EXER, V26, P376; Montgomery PS, 1998, J AM GERIATR SOC, V46, P706, DOI 10.1111/j.1532-5415.1998.tb03804.x; NEWMAN AB, 1993, CIRCULATION, V88, P837, DOI 10.1161/01.CIR.88.3.837; OGREN M, 1995, BMJ-BRIT MED J, V310, P1294, DOI 10.1136/bmj.310.6990.1294; OLIN JW, 1998, AM J MED CONTINUING, P10; OLMOS PR, 1995, AM J MED SCI, V309, P76, DOI 10.1097/00000441-199502000-00004; Regensteiner JG, 1990, J VASC MED BIOL, V2, P142; Richardson M T, 1995, J Cardiopulm Rehabil, V15, P107, DOI 10.1097/00008483-199503000-00003; ROSE GA, 1962, B WORLD HEALTH ORGAN, V27, P645; Swan PD, 1997, BRIT J SPORT MED, V31, P235, DOI 10.1136/bjsm.31.3.235; Weitz JI, 1996, CIRCULATION, V94, P3026, DOI 10.1161/01.CIR.94.11.3026; [No title captured]	37	561	573	2	24	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 3	2001	286	13					1599	1606						8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	478HH	11585483				2022-12-24	WOS:000171340600027
J	Korevaar, JC; Jansen, MAM; Dekker, FW; Jager, KJ; Boeschoten, EW; Krediet, RT; Bossuyt, PMM				Korevaar, JC; Jansen, MAM; Dekker, FW; Jager, KJ; Boeschoten, EW; Krediet, RT; Bossuyt, PMM		Netherlands Cooperative Study Adeq	When to initiate dialysis: effect of proposed US guidelines on survival	LANCET			English	Article							RESIDUAL RENAL-FUNCTION; PERITONEAL-DIALYSIS; CONTROLLED TRIALS; DISEASE; STAGE; PROGRESSION; PREDICTORS; PROTEIN; THERAPY	Background Recent guidelines from the US National Kidney Foundation Dialysis Outcomes Quality Initiative recommend an earlier start of dialysis treatment than has been common practice. Their implementation would have a substantial effect on patients' daily lives and would increase costs. The guidelines are largely opinion-based, because evidence is still lacking. Methods As part of a prospective multicentre study in the Netherlands, we included, between January, 1997, and May, 1999, all new patients with end-stage renal disease, for whom data were available on residual renal function 0-4 weeks before the start of dialysis. We recorded date of death or censoring until August, 2000. Findings 94 (37%) of 253 patients started dialysis treatment later than recommended by the US guideline. There was an increased mortality risk for these patients compared with those who started dialysis on time, although it was not significant (adjusted hazard ratio 1.66 [95% Cl 0.95-2-89]). The adjusted difference in estimated survival time after 3 years on dialysis treatment was 2.5 months (1.1-4.0) in favour of timely starters. Conversely, the average delay in dialysis initiation for late starters, the extra time free of dialysis, was at least 4.1 months. Interpretation Although we observed a gain in survival time with a timely start of dialysis, it is probably a reflection of initiating dialysis earlier in the disease. We question the benefit of putting this guideline into daily practice, given the current clinical evidence and the effects it would have on patients and dialysis resources.	Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol & Biostat, NL-1100 DD Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dianet Dialysis Ctr, NL-1100 DD Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Nephrol, NL-1100 DD Amsterdam, Netherlands; Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Korevaar, JC (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol & Biostat, POB 22660, NL-1100 DD Amsterdam, Netherlands.		Bossuyt, Patrick M/AAR-1183-2021; Bossuyt, Patrick M./B-4557-2016; Jager, Kitty J/C-3887-2008; Dekker, Friedo W/B-6452-2011; Krediet, Raymond/GLT-2390-2022; Krediet, Raymond/AAP-3291-2021	Bossuyt, Patrick M/0000-0003-4427-0128; Bossuyt, Patrick M./0000-0003-4427-0128; Dekker, Friedo W/0000-0002-2433-2494; Krediet, Raymond/0000-0002-9851-8507; 				Benson K, 2000, NEW ENGL J MED, V342, P1878, DOI 10.1056/NEJM200006223422506; BERGSTROM J, 1993, KIDNEY INT, V44, P1048, DOI 10.1038/ki.1993.347; Bergstrom J, 1998, PERITON DIALYSIS INT, V18, P467; BONOMINI V, 1985, KIDNEY INT, V28, P57; Concato J, 2000, NEW ENGL J MED, V342, P1887, DOI 10.1056/NEJM200006223422507; Davies SJ, 1998, NEPHROL DIAL TRANSPL, V13, P962, DOI 10.1093/ndt/13.4.962; Fink JC, 1999, AM J KIDNEY DIS, V34, P694, DOI 10.1016/S0272-6386(99)70395-1; Gokal R, 2000, PERITON DIALYSIS INT, V20, P386; HAKIM RM, 1995, J AM SOC NEPHROL, V6, P1319; Hunsicker LG, 1997, KIDNEY INT, V51, P1908, DOI 10.1038/ki.1997.260; Ifudu O, 1998, AM J NEPHROL, V18, P193, DOI 10.1159/000013336; Jacobs C, 2000, NEPHROL DIAL TRANSPL, V15, P305, DOI 10.1093/ndt/15.3.305; KHAN IH, 1993, LANCET, V341, P415, DOI 10.1016/0140-6736(93)93003-J; Moist LM, 2000, J AM SOC NEPHROL, V11, P556, DOI 10.1681/ASN.V113556; *NAT KIDN FDN, 1997, AM J KIDNEY DIS S, V30, pS1; National Kidney Foundation, 1997, AM J KIDNEY DIS, V30, pS67; Obrador GT, 1999, KIDNEY INT, V56, P2227, DOI 10.1046/j.1523-1755.1999.00779.x; Samuelsson O, 1998, J AM SOC NEPHROL, V9, P1482; TATTERSALL J, 1995, AM J NEPHROL, V15, P283, DOI 10.1159/000168850; Tonelli M., 1998, Journal of the American Society of Nephrology, V9, p80A; Van Biesen W, 1999, PERITON DIALYSIS INT, V19, pS273; WATSON PE, 1980, AM J CLIN NUTR, V33, P27, DOI 10.1093/ajcn/33.1.27	22	158	165	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 29	2001	358	9287					1046	1050		10.1016/S0140-6736(01)06180-3	http://dx.doi.org/10.1016/S0140-6736(01)06180-3			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	479EY	11589934				2022-12-24	WOS:000171393100009
J	Richardson, JE; Pennington, RT; Pennington, TD; Hollingsworth, PM				Richardson, JE; Pennington, RT; Pennington, TD; Hollingsworth, PM			Rapid diversification of a species-rich genus of neotropical rain forest trees	SCIENCE			English	Article							RIBOSOMAL DNA; SEQUENCES; CHLOROPLAST; DIVERGENCE; PHYLOGENY; DIVERSITY; FABACEAE; REGIONS	Species richness in the tropics has been attributed to the gradual accumulation of species over a long geological period in stable equatorial climates or, conversely, to speciation in response to late Tertiary geological events and unstable Pleistocene climates. DNA sequence data are consistent with recent diversification in Inga, a species-rich neotropical tree genus. We estimate that speciation was concentrated in the past 10 million years, with many species arising as recently as 2 million years ago. This coincides with the more recent major uplifts of the Andes, the bridging of the Isthmus of Panama, and Quaternary glacial cycles. Inga may be representative of other species-rich neotropical genera with rapid growth and reproduction, which contribute substantially to species numbers in the world's most diverse flora.	Royal Bot Garden Edinburgh, Edinburgh EH3 5LR, Midlothian, Scotland; Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; Royal Bot Gardens, Richmond TW9 3AB, Surrey, England	University of California System; University of California Santa Cruz; Royal Botanic Gardens, Kew	Pennington, RT (corresponding author), Royal Bot Garden Edinburgh, 20A Inverleith Row, Edinburgh EH3 5LR, Midlothian, Scotland.	t.pennington@rbge.org.uk	Richardson, James-Edward/L-2768-2016	Richardson, James-Edward/0000-0001-9014-4865; Hollingsworth, Peter/0000-0003-0602-0654; Pennington, Toby/0000-0002-8196-288X				Baldwin BG, 1998, P NATL ACAD SCI USA, V95, P9402, DOI 10.1073/pnas.95.16.9402; Burnham RJ, 1999, ANN MO BOT GARD, V86, P546, DOI 10.2307/2666185; BUSH MB, 1994, J BIOGEOGR, V21, P5, DOI 10.2307/2845600; Coates Anthony G., 1996, P21; Comes HP, 1999, SYST ASSOC SPEC VOL, V57, P171; De Oliveira AA, 1999, BIODIVERS CONSERV, V8, P1219, DOI 10.1023/A:1008908615271; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Gentry A., 1989, TROPICAL FORESTS BOT, P113; GENTRY AH, 1982, ANN MO BOT GARD, V69, P557, DOI 10.2307/2399084; Haffer J., 1982, P6; Kass E, 1997, PLANT SYST EVOL, V208, P139, DOI 10.1007/BF00985439; KOPTUR S, 1984, EVOLUTION, V38, P1130, DOI 10.1111/j.1558-5646.1984.tb00381.x; LI WH, 1987, J MOL EVOL, V25, P330, DOI 10.1007/BF02603118; Mes THM, 1996, BOT ACTA, V109, P477, DOI 10.1111/j.1438-8677.1996.tb00601.x; Moritz C, 2000, ANNU REV ECOL SYST, V31, P533, DOI 10.1146/annurev.ecolsys.31.1.533; Pennington RT, 1996, SYST BIOL, V45, P496, DOI 10.2307/2413527; Pennington T.D., 1997, GENUS INGA BOT; PENNINGTON TD, 1998, GENUS INGA UTILIZATI, P159; Pennington TD, 1998, GENUS INGA UTILIZATI; RAMBAUT A, 2000, TREEEDIT VERSION 1 0; Richardson JE, 2001, TAXON, V50, P405, DOI 10.2307/1223889; Sanderson MJ, 1997, MOL BIOL EVOL, V14, P1218, DOI 10.1093/oxfordjournals.molbev.a025731; SANG T, 1994, AM J BOT, V81, P1494, DOI 10.2307/2445322; SANG T, 1995, SYST BOT, V20, P55, DOI 10.2307/2419632; Stebbins G. L., 1974, EVOLUTION SPECIES LE; SUH YB, 1993, AM J BOT, V80, P1042, DOI 10.2307/2445752; Swofford D.L., 1998, PAUP 4 0B2 PHYLOGENE; Thomas WW, 1999, BIODIVERS CONSERV, V8, P1007, DOI 10.1023/A:1008857429787; VALENCIA R, 1994, BIODIVERS CONSERV, V3, P21, DOI 10.1007/BF00115330; Vargas P, 1999, AM J BOT, V86, P724, DOI 10.2307/2656582; WENDEL JF, 1995, MOL PHYLOGENET EVOL, V4, P298, DOI 10.1006/mpev.1995.1027; WHITEMORE TC, 1987, BIOGEOGRAPHY QUATERN; WHITEMORE TC, 1998, INTRO TROPICAL RAINF; Wojciechowski MF, 1999, SYST BOT, V24, P409, DOI 10.2307/2419698; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; ZURAWSKI G, 1984, GENETICS, V106, P735	36	584	607	4	138	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 21	2001	293	5538					2242	2245		10.1126/science.1061421	http://dx.doi.org/10.1126/science.1061421			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475AL	11567135				2022-12-24	WOS:000171139400040
J	Linder, JA; Stafford, RS				Linder, JA; Stafford, RS			Antibiotic treatment of adults with sore throat by community primary care physicians - A national survey, 1989-1999	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	24th Annual Meeting of the Society-of-General-Internal-Medicine	MAY   04, 2001	SAN DIEGO, CALIFORNIA	Soc Gen Internal Med			RESPIRATORY-TRACT INFECTIONS; GROUP-A STREPTOCOCCI; ERYTHROMYCIN RESISTANCE; PHARYNGITIS; SUSCEPTIBILITY; MANAGEMENT; BRONCHITIS; PENICILLIN; DIAGNOSIS; PYOGENES	Context Most sore throats are due to viral upper respiratory tract infections. Group A beta -hemolytic streptococci (GABHS), the only common cause of sore throat warranting antibiotics, is cultured in 5% to 17% of adults with sore throat. The frequency of antibiotic use for pharyngitis has greatly exceeded the prevalence of GABHS, but less is known about specific classes of antibiotics used. Only penicillin and erythromycin are recommended as first-line antibiotics against GABHS. Objectives To measure trends in antibiotic use for adults with sore throat and to determine predictors of antibiotic use and nonrecommended antibiotic use. Design, Setting, and Subjects Retrospective analysis of 2244 visits to primary care physicians in off ice-based practices in the National Ambulatory Medical Care Survey, 1989-1999, by adults with a chief complaint of sore throat. Main Outcome Measures Treatment with antibiotics and treatment with nonrecommended antibiotics, extrapolated to US annual national rates. Results There were an estimated 6.7 million annual visits in the United States by adults with sore throat between 1989 and 1999. Antibiotics were used in 73% (95% confidence interval [CI] 70%-76%) of visits. Patients treated with antibiotics were given nonrecommended antibiotics in 68% (95% CI, 64%-72%) of visits. From 1989 to 1999, there was a significant decrease in use of penicillin and erythromycin and an increase in use of nonrecommended antibiotics, especially extended-spectrum macrolides and extended-spectrum fluoroquinolones (P<.001 for all trends). In multivariable modeling, increasing patient age (odds ratio [OR], 0.86 per decade; 95% CI, 0.79-0.94) and general practice specialty (OR, 1.54 compared with family practice specialty; 95% CI, 1.10-2.14) were independent predictors of antibiotic use. Among patients receiving antibiotics, nonrecommended antibiotic use became more frequent over time (OR, 1.17 per year; 95% CI, 1.11-1.24). Conclusions More than half of adults are treated with antibiotics for sore throat by community primary care physicians. Use of nonrecommended, more expensive, broader-spectrum antibiotics is frequent.	Massachusetts Gen Hosp, Div Gen Med, Boston, MA 02114 USA; Stanford Univ, Sch Med, Stanford Ctr Res Dis Prevent, Palo Alto, CA 94304 USA	Harvard University; Massachusetts General Hospital; Stanford University	Linder, JA (corresponding author), Massachusetts Gen Hosp, Div Gen Med, 50 Staniford St,9th Floor, Boston, MA 02114 USA.		Linder, Jeffrey/AAF-3424-2021; Stafford, Randall/F-3974-2017	Linder, Jeffrey/0000-0003-2217-184X; Stafford, Randall/0000-0003-1805-1271	DIVISION OF MEDICINE, BUREAU HEALTH PROFESSIONS, HRSA [T32PE011001] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL003548] Funding Source: NIH RePORTER; NHLBI NIH HHS [K08-HL03548] Funding Source: Medline; BHP HRSA HHS [5T32PE11001-12] Funding Source: Medline	DIVISION OF MEDICINE, BUREAU HEALTH PROFESSIONS, HRSA(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); BHP HRSA HHS		Betriu C, 1999, DIAGN MICR INFEC DIS, V33, P255, DOI 10.1016/S0732-8893(98)00155-2; Bisno AL, 2001, NEW ENGL J MED, V344, P205, DOI 10.1056/NEJM200101183440308; Bisno AL, 1997, CLIN INFECT DIS, V25, P574, DOI 10.1086/513768; Boos M, 2001, ANTIMICROB AGENTS CH, V45, P938, DOI 10.1128/AAC.45.3.938-942.2001; Cooper RJ, 2001, ANN INTERN MED, V134, P509, DOI 10.7326/0003-4819-134-6-200103200-00019; DELMAR CB, 2001, COCHRANE LIB; DENNY FW, 1950, JAMA-J AM MED ASSOC, V143, P151, DOI 10.1001/jama.1950.02910370001001; *FDA, 1995, NAT DRUG COD DIR 199; Gonzales R, 1997, JAMA-J AM MED ASSOC, V278, P901, DOI 10.1001/jama.278.11.901; GWALTNEY JM, 2000, MANDELL DOUGLAS BENN, P656; HOOTON TM, 1991, AM J MED S3A, V91, P23; KAPLAN EL, 1971, J INFECT DIS, V123, P490, DOI 10.1093/infdis/123.5.490; Kaplan EL, 1999, PEDIATR INFECT DIS J, V18, P1069, DOI 10.1097/00006454-199912000-00008; KLJAKOVIC M, 1993, NEW ZEAL MED J, V106, P381; KOMAROFF AL, 1986, J GEN INTERN MED, V1, P1, DOI 10.1007/BF02596317; Macris MH, 1998, PEDIATR INFECT DIS J, V17, P377, DOI 10.1097/00006454-199805000-00006; McIsaac WJ, 2000, CAN MED ASSOC J, V163, P811; McIsaac WJ, 1998, CAN MED ASSOC J, V158, P75; *MED EC DAT, 1999, DRUG TOP RED BOOK; *NAT CTR HLTH STAT, 1999, PUBL US MICR DOC; Nyquist AC, 1998, JAMA-J AM MED ASSOC, V279, P875, DOI 10.1001/jama.279.11.875; PASKO T, 2000, PHYSICIAN CHARACTERI; PICHICHERO ME, 1991, PEDIATR INFECT DIS J, V10, P275, DOI 10.1097/00006454-199104000-00002; POSES RM, 1985, JAMA-J AM MED ASSOC, V254, P925, DOI 10.1001/jama.254.7.925; POTTHOFF RF, 1992, J AM STAT ASSOC, V87, P383, DOI 10.2307/2290269; SCHATZ RT, 1992, POLIT PSYCHOL, V13, P1, DOI 10.2307/3791421; Seppala H, 1997, NEW ENGL J MED, V337, P441, DOI 10.1056/NEJM199708143370701; Seppala H, 1995, CLIN INFECT DIS, V21, P1378, DOI 10.1093/clinids/21.6.1378; Snow V, 2001, ANN INTERN MED, V134, P506, DOI 10.7326/0003-4819-134-6-200103200-00018; WALSH BT, 1975, ARCH INTERN MED, V135, P1493, DOI 10.1001/archinte.135.11.1493; WANNAMAKER LW, 1951, AM J MED, V10, P673, DOI 10.1016/0002-9343(51)90336-1; WOODWELL DA, 2000, VITAL HLTH STAT, V315; York MK, 1999, J CLIN MICROBIOL, V37, P1727, DOI 10.1128/JCM.37.6.1727-1731.1999; Zwart S, 2000, BRIT MED J, V320, P150, DOI 10.1136/bmj.320.7228.150	34	143	157	5	11	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 12	2001	286	10					1181	1186		10.1001/jama.286.10.1181	http://dx.doi.org/10.1001/jama.286.10.1181			6	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	471CR	11559262	Bronze			2022-12-24	WOS:000170910400027
J	Bista, MB; Banerjee, MK; Shin, SH; Tandan, JB; Kim, MH; Sohn, YM; Ohrr, HC; Tang, JL; Halstead, SB				Bista, MB; Banerjee, MK; Shin, SH; Tandan, JB; Kim, MH; Sohn, YM; Ohrr, HC; Tang, JL; Halstead, SB			Efficacy of single-dose SA 14-14-2 vaccine against Japanese encephalitis: a case control study	LANCET			English	Article							SA14-14-2; TRIAL	Background: In China, since 1989, an estimated 120 million children have been immunised with the SA 14-14-2 live-attenuated Japanese encephalitis (JE) vaccine at ages 1, 2, and 6 years. A case-control study of licensed vaccine found two doses to be 98% effective. Subsequently, researchers found that single-dose vaccine efficacy was high; we aimed to confirm this result. Methods: During July 11-24, 1999, 160 000 doses of JE vaccine were given to children aged 1-15 years, resident in three districts of Nepal. Several cases of JE were admitted to hospital from early August. We obtained names and addresses of cases with serological evidence of a recent infection from Bheri Zonal Hospital, Nepalgunj. We did a matched case-control study and calculated the odds ratio of vaccination among JE cases and age-sex matched village controls. Findings: 20 children, aged 1-15 years, were identified whose illness conformed with the JE case definition and were resident in villages receiving the vaccine. None of 20 JE cases had received JE vaccine compared with 326 of 557 age-sex matched village controls. The efficacy of a single dose of JE vaccine was 99.3% (CI 94.9-100%). Interpretation: A single dose of JE vaccine is highly efficacious in preventing Japanese encephalitis when administered only days or weeks before exposure to infection.	Glovax Co Ltd, Kyryo Academytel, Seoul, South Korea; Minist Hlth, Epidemiol & Dis Control Div, Kathmandu, Nepal; Sch Hlth Sci, Bharatpur, Nepal; Yonsei Univ, Coll Med, Dept Pediat, Seoul, South Korea; Yonsei Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; Chinese Univ Hong Kong, Dept Community & Family Med, Shatin, Hong Kong, Peoples R China; Uniformed Serv Univ Hlth Sci, Dept Prevent Med & Biostat, Bethesda, MD 20814 USA	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Chinese University of Hong Kong; Uniformed Services University of the Health Sciences - USA	Shin, SH (corresponding author), Glovax Co Ltd, Kyryo Academytel, 437-3 Ahyun Dong, Seoul, South Korea.	sunheang@soback.kornet2l.net	Tang, JL/G-1759-2013; Tang, Jin-Ling/AAJ-4090-2021					AO J, 1983, CHIN J MICROBIOL IMM, V3, P245; FLANDERS WD, 1986, AM J EPIDEMIOL, V124, P684, DOI 10.1093/oxfordjournals.aje.a114442; Hennessy S, 1996, LANCET, V347, P1583, DOI 10.1016/S0140-6736(96)91075-2; HIRJI KF, 1988, BIOMETRICS, V44, P803, DOI 10.2307/2531592; HOKE CH, 1988, NEW ENGL J MED, V319, P608, DOI 10.1056/NEJM198809083191004; INNIS BL, 1989, AM J TROP MED HYG, V40, P418, DOI 10.4269/ajtmh.1989.40.418; Liu ZL, 1997, J INFECT DIS, V176, P1366, DOI 10.1086/517323; MA W X, 1993, CHINESE J BIOL, V6, P188; ORENSTEIN WA, 1985, B WORLD HEALTH ORGAN, V63, P1055; Rodrigues LC, 1999, EPIDEMIOL REV, V21, P56, DOI 10.1093/oxfordjournals.epirev.a017988; ROTHMAN KJ, 1986, MODERN EPIDEMIOLOGY, P297; Shepard D.S., 1993, DIS CONTROL PRIORITI, P303; Sohn YM, 1999, VACCINE, V17, P2259, DOI 10.1016/S0264-410X(99)00006-7; SOKHEY J, 1998, INVESTIGATION CONTRO; Takahashi H, 2000, VACCINE, V18, P2963, DOI 10.1016/S0264-410X(00)00111-0; Tsai TF, 1998, J INFECT DIS, V177, P221, DOI 10.1086/517358; TSAI TF, 1999, VACCINES, P672; UNICEF, 1994, STAT WORLDS CHILDR, P82; VAUGHN DW, 1992, EPIDEMIOL REV, V14, P197, DOI 10.1093/oxfordjournals.epirev.a036087; WERZBERGER A, 1992, NEW ENGL J MED, V327, P453, DOI 10.1056/NEJM199208133270702; YU YX, 1988, AM J TROP MED HYG, V39, P214, DOI 10.4269/ajtmh.1988.39.214; 1993, MMWR, V42, P1	22	117	128	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 8	2001	358	9284					791	795		10.1016/S0140-6736(01)05967-0	http://dx.doi.org/10.1016/S0140-6736(01)05967-0			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	472NA	11564484				2022-12-24	WOS:000170989300010
J	Cohen, J				Cohen, J			TREM-1 in sepsis	LANCET			English	Editorial Material							INNATE IMMUNITY; LIPOPOLYSACCHARIDE; ENDOTOXIN; STIMULATION; ACTIVATION; RESPONSES; MONOCYTES; SHOCK		Hammersmith Hosp, Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Infect Dis & Microbiol, London W12 0NN, England	Imperial College London	Cohen, J (corresponding author), Hammersmith Hosp, Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Infect Dis & Microbiol, London W12 0NN, England.							Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Blunck R, 2001, J IMMUNOL, V166, P1009, DOI 10.4049/jimmunol.166.2.1009; Bouchon A, 2000, J IMMUNOL, V164, P4991, DOI 10.4049/jimmunol.164.10.4991; Bouchon A, 2001, NATURE, V410, P1103, DOI 10.1038/35074114; Bunnell E, 2000, CRIT CARE MED, V28, P2713, DOI 10.1097/00003246-200008000-00005; Cauwels A, 1997, INFECT IMMUN, V65, P3255, DOI 10.1128/IAI.65.8.3255-3260.1997; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; Daws MR, 2001, EUR J IMMUNOL, V31, P783, DOI 10.1002/1521-4141(200103)31:3<783::AID-IMMU783>3.0.CO;2-U; DINARELLO CA, 1997, CHEST S, V112, P321, DOI DOI 10.1378/CHEST.112.6_SUPPLEMENT.321S; Haworth R, 1997, J EXP MED, V186, P1431, DOI 10.1084/jem.186.9.1431; Inohara N, 2001, J BIOL CHEM, V276, P2551, DOI 10.1074/jbc.M009728200; Lanier LL, 1998, NATURE, V391, P703, DOI 10.1038/35642; LYNN WA, 1993, INFECT IMMUN, V61, P4452, DOI 10.1128/IAI.61.10.4452-4461.1993; Modlin RL, 1999, NEW ENGL J MED, V340, P1834, DOI 10.1056/NEJM199906103402312; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Perera PY, 2001, J IMMUNOL, V166, P574, DOI 10.4049/jimmunol.166.1.574; SRISKANDAN S, 1995, J INFECTION, V30, P201, DOI 10.1016/S0163-4453(95)90647-9; Ulevitch RJ, 1999, NAT MED, V5, P144, DOI 10.1038/5504; ULEVITCH RJ, 1995, ANNU REV IMMUNOL, V13, P437, DOI 10.1146/annurev.iy.13.040195.002253; Wurfel MM, 1997, J EXP MED, V186, P2051, DOI 10.1084/jem.186.12.2051	20	48	66	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 8	2001	358	9284					776	778		10.1016/S0140-6736(01)06007-X	http://dx.doi.org/10.1016/S0140-6736(01)06007-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	472NA	11564478				2022-12-24	WOS:000170989300004
J	Kachroo, A; Schopfer, CR; Nasrallah, ME; Nasrallah, JB				Kachroo, A; Schopfer, CR; Nasrallah, ME; Nasrallah, JB			Allele-specific receptor-ligand interactions in Brassica self-incompatibility	SCIENCE			English	Article							S-LOCUS; TRANSGENIC TOBACCO; MALE DETERMINANT; SLG ALLELES; OLERACEA; KINASE; CAMPESTRIS; GENE; GLYCOPROTEINS; HAPLOTYPES	Genetic self-incompatibility in Brassica is determined by alleles of the transmembrane serine-threonine kinase SRK, which functions in the stigma epidermis, and of the cysteine-rich peptide SCR, which functions in pollen. Using tagged versions of SRK and SCR as well as endogenous stigma and pollen proteins, we show that SCR binds the SRK ectodomain and that this binding is allele,specific. Thus, SRK and SCR function as a receptor-Ligand pair in the recognition of self pollen. Specificity in the self-incompatibility response derives from allele-specific formation of SRK-SCR complexes at the pollen-stigma interface.	Cornell Univ, Dept Plant Biol, Ithaca, NY 14853 USA	Cornell University	Nasrallah, JB (corresponding author), Cornell Univ, Dept Plant Biol, Ithaca, NY 14853 USA.	jnb2@cornell.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057527] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM57527] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAULCOMBE DC, 1995, PLANT J, V7, P1045, DOI 10.1046/j.1365-313X.1995.07061045.x; Cabrillac D, 2001, NATURE, V410, P220, DOI 10.1038/35065626; Conner JA, 1997, PLANT J, V11, P809, DOI 10.1046/j.1365-313X.1997.11040809.x; Dixit R, 2000, PLANT PHYSIOL, V124, P297, DOI 10.1104/pp.124.1.297; DOUGHTY J, 1993, P NATL ACAD SCI USA, V90, P467, DOI 10.1073/pnas.90.2.467; Kusaba M, 1999, PLANT J, V17, P83, DOI 10.1046/j.1365-313X.1999.00355.x; Kusaba M, 1997, P NATL ACAD SCI USA, V94, P7673, DOI 10.1073/pnas.94.14.7673; Lu YB, 1996, P NATL ACAD SCI USA, V93, P12902, DOI 10.1073/pnas.93.23.12902; Nasrallah JB, 2000, CURR OPIN PLANT BIOL, V3, P368, DOI 10.1016/S1369-5266(00)00098-4; NASRALLAH JB, 1987, NATURE, V326, P617, DOI 10.1038/326617a0; Schopfer CR, 2000, PLANT PHYSIOL, V124, P935, DOI 10.1104/pp.124.3.935; Schopfer CR, 1999, SCIENCE, V286, P1697, DOI 10.1126/science.286.5445.1697; Shiba H, 2001, PLANT PHYSIOL, V125, P2095, DOI 10.1104/pp.125.4.2095; Stein JC, 1996, PLANT CELL, V8, P429, DOI 10.1105/tpc.8.3.429; STEIN JC, 1991, P NATL ACAD SCI USA, V88, P8816, DOI 10.1073/pnas.88.19.8816; Stephenson AG, 1997, PLANT J, V12, P1351, DOI 10.1046/j.1365-313x.1997.12061351.x; Takasaki T, 2000, NATURE, V403, P913, DOI 10.1038/35002628; Takayama S, 2000, P NATL ACAD SCI USA, V97, P1920, DOI 10.1073/pnas.040556397; Tantikanjana T, 1996, SEX PLANT REPROD, V9, P107; Trotochaud AE, 2000, SCIENCE, V289, P613, DOI 10.1126/science.289.5479.613; UMBACH AL, 1990, PLANT PHYSIOL, V93, P739, DOI 10.1104/pp.93.2.739; Watanabe M, 2000, FEBS LETT, V473, P139, DOI 10.1016/S0014-5793(00)01514-3	22	228	264	1	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2001	293	5536					1824	1826		10.1126/science.1062509	http://dx.doi.org/10.1126/science.1062509			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	470WN	11546871				2022-12-24	WOS:000170894400045
J	Bengel, FM; Ueberfuhr, P; Schiepel, N; Nekolla, SG; Reichart, B; Schwaiger, M				Bengel, FM; Ueberfuhr, P; Schiepel, N; Nekolla, SG; Reichart, B; Schwaiger, M			Effect of sympathetic reinnervation on cardiac performance after heart transplantation.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; EXERCISE CAPACITY; SERIAL ASSESSMENT; RECIPIENTS; HUMANS; INNERVATION	Background: Late after cardiac transplantation, limited reinnervation of the transplanted heart may occur, but little is known about the effect of reinnervation on cardiac function and exercise performance. Methods: We quantified the extent of myocardial reinnervation noninvasively in 29 cardiac-transplant recipients, using positron-emission tomography and the catecholamine analogue [C-11]hydroxyephedrine. Global and regional ventricular function at rest and during standardized exercise testing was measured with the use of radionuclide angiography, and the results were compared with those in 10 healthy controls. Results: Sympathetic reinnervation, mainly in the anteroseptal wall, was present in 16 of the 29 transplant recipients. At rest, hemodynamic differences were not observed between the patients with reinnervation and those with denervation. However, the latter group had a shorter mean (+/-SD) exercise time (6.1+/-1.5 minutes, vs. 8.2+/-1.2 in the group with reinnervation; P<0.01) and a lower peak heart rate (121+/-13 vs. 143+/-15 beats per minute, P<0.01). The contractile response to exercise was significantly enhanced in transplant recipients with reinnervation and similar to that of normal controls. In a multivariate analysis, hydroxyephedrine retention was the only independent determinant of the exercise-induced increase in the ejection fraction. Conclusions: In heart-transplant recipients, the restoration of sympathetic innervation is associated with improved responses of the heart rate and contractile function to exercise. These results support the functional importance of reinnervation in transplanted hearts.	Tech Univ Munich, Nukl Med Klin & Poliklin, D-8000 Munich, Germany; Univ Munich, Herzchirurg Klin, Munich, Germany	Technical University of Munich; University of Munich	Bengel, FM (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Nukl Med Klin & Poliklin, Ismaninger Str 22, D-81675 Munich, Germany.		Bengel, Frank/AAR-7353-2020; Nekolla, Stephan G/L-1857-2013	Nekolla, Stephan G/0000-0002-8817-1482; schwaiger, markus/0000-0002-2305-7144				American Society of Nuclear Cardiology, 1996, J NUCL CARDIOL, V3, pG26; Bengel FM, 2000, EUR J NUCL MED, V27, P1650, DOI 10.1007/s002590000366; Bengel FM, 1999, CIRCULATION, V99, P1866, DOI 10.1161/01.CIR.99.14.1866; Bengel FM, 2001, CIRCULATION, V103, P1881; BURKE MN, 1995, CIRCULATION, V91, P72, DOI 10.1161/01.CIR.91.1.72; COOPER T, 1962, SCIENCE, V138, P40, DOI 10.1126/science.138.3536.40; DEMARCO T, 1995, J AM COLL CARDIOL, V25, P927, DOI 10.1016/0735-1097(94)00463-Z; DiCarli MF, 1997, NEW ENGL J MED, V336, P1208, DOI 10.1056/NEJM199704243361703; GILBERT EM, 1989, CIRCULATION, V79, P344, DOI 10.1161/01.CIR.79.2.344; Givertz MM, 1997, CIRCULATION, V96, P232; KAO AC, 1994, CIRCULATION, V89, P2605, DOI 10.1161/01.CIR.89.6.2605; KAYE DM, 1993, CIRCULATION, V88, P1110, DOI 10.1161/01.CIR.88.3.1110; LEENEN FHH, 1995, CIRCULATION, V91, P685, DOI 10.1161/01.CIR.91.3.685; Mancini D, 1997, CIRCULATION, V96, P6; MANDAK JS, 1995, J HEART LUNG TRANSPL, V14, P468; MARTI V, 1992, TRANSPLANT P, V24, P16; Nekolla SG, 1998, EUR J NUCL MED, V25, P1313, DOI 10.1007/s002590050301; Odaka K, 2001, J NUCL MED, V42, P1011; OPIE LH, 1998, HEART PHYSL CELL CIR, P193; OSTLE B, 1975, STAT RES BASIC CONCE, P321; OYER PE, 1983, TRANSPLANT P, V15, P2546; PAFFENBARGER RS, 1978, AM J EPIDEMIOL, V108, P161, DOI 10.1093/oxfordjournals.aje.a112608; PAULUS WJ, 1992, CIRCULATION, V86, P1175, DOI 10.1161/01.CIR.86.4.1175; QUIGG RJ, 1989, J AM COLL CARDIOL, V14, P338, DOI 10.1016/0735-1097(89)90183-6; ROSENSPIRE KC, 1990, J NUCL MED, V31, P1328; Schwaiblmair M, 1999, J HEART LUNG TRANSPL, V18, P838, DOI 10.1016/S1053-2498(99)00048-0; SCHWAIGER M, 1991, J CLIN INVEST, V87, P1681, DOI 10.1172/JCI115185; STARK RP, 1991, NEW ENGL J MED, V324, P1791, DOI 10.1056/NEJM199106203242507; STEVENSON LW, 1990, CIRCULATION, V81, P78, DOI 10.1161/01.CIR.81.1.78; STRANG KT, 1994, CIRC RES, V74, P542, DOI 10.1161/01.RES.74.3.542; VERANI MS, 1994, J HEART LUNG TRANSPL, V13, P181; WILSON RF, 1993, CIRCULATION, V88, P165, DOI 10.1161/01.CIR.88.1.165; WILSON RF, 1991, CIRCULATION, V83, P1210, DOI 10.1161/01.CIR.83.4.1210; Wilson RF, 2000, CIRCULATION, V101, P2727, DOI 10.1161/01.CIR.101.23.2727	34	184	189	0	8	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 6	2001	345	10					731	738		10.1056/NEJMoa010519	http://dx.doi.org/10.1056/NEJMoa010519			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	468RX	11547742	Bronze			2022-12-24	WOS:000170772900004
J	SCHUTTE, WA; ALLAMANDOLA, LJ; SANDFORD, SA				SCHUTTE, WA; ALLAMANDOLA, LJ; SANDFORD, SA			FORMALDEHYDE AND ORGANIC-MOLECULE PRODUCTION IN ASTROPHYSICAL ICES AT CRYOGENIC TEMPERATURES	SCIENCE			English	Article							MU-M; COMET; EMISSION	Thermally promoted formaldehyde (H2CO) reactions in cryogenic ices have been studied to test their importance as a source of organic molecules in comets and interstellar ices. Ices containing H2CO, H2O, CH3OH, CO, and NH3 were investigated by using infrared spectroscopy. Small traces of NH3 (NH3/H2CO greater-than-or-equal-to 0.005) are sufficient to convert significant fractions (greater-than-or-equal-to 40%) of the H2CO into more complex organics. However, H2CO reactions do not proceed without NH3. Spectral evidence for reaction onset appeared between 40 and 80 kelvin, depending on the ice. Five distinct products were formed. These principally consist of polyoxymethylene and related derivatives. Polyoxymethylene itself was not made in significant amounts in cometary analogs. These products differ from those produced by ultraviolet and particle irradiation. The nature and relative amounts of the products depend on the initial composition, making these materials excellent tracers of a comet's history. About 3% of the organics in p-Halley's coma could have been produced by thermal H2CO reactions.			SCHUTTE, WA (corresponding author), NASA,AMES RES CTR,MS 245-6,MOFFETT FIELD,CA 94035, USA.							AGARWAL VK, 1985, ORIGINS LIFE EVOL B, V16, P21, DOI 10.1007/BF01808047; ALLAMANDOLA LJ, 1988, ICARUS, V76, P225, DOI 10.1016/0019-1035(88)90070-X; ALLAMANDOLA LJ, 1992, ASTROCHEMISTRY COSMI, P65; BROOKE TY, 1991, ASTRON J, V101, P268, DOI 10.1086/115686; DANKS AC, 1987, ASTRON ASTROPHYS, V184, P329; MUMMA MJ, 1989, ASTROPHYS J, V344, P940, DOI 10.1086/167862; SANDFORD SA, IN PRESS ASTRONOMICA; SCHUTTE W, UNPUB; SCHUTTE WA, 1988, THESIS U LEIDEN LEID; SNYDER LE, 1989, ASTRON J, V97, P246, DOI 10.1086/114976; TADOKORO H, 1963, J CHEM PHYS, V38, P703, DOI 10.1063/1.1733727; TIELENS AGGM, 1982, ASTRON ASTROPHYS, V114, P245; Walker J. F., 1964, FORMALDEHYDE; WALSMLEY C, 1989, INTERSTELLAR DUST, P263; ZHAO NS, 1990, THESIS U LEIDEN LEID	15	75	75	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	FEB 19	1993	259	5098					1143	1145		10.1126/science.11540093	http://dx.doi.org/10.1126/science.11540093			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KM917	11540093				2022-12-24	WOS:A1993KM91700033
J	MCKAY, CP; POLLACK, JB; COURTIN, R				MCKAY, CP; POLLACK, JB; COURTIN, R			THE GREENHOUSE AND ANTIGREENHOUSE EFFECTS ON TITAN	SCIENCE			English	Article							ATMOSPHERE; OCEAN	There are many parallels between the atmospheric thermal structure of the Saturnian satellite Titan and the terrestrial greenhouse effect; these parallels provide a comparison for theories of the heat balance of Earth. Titan's atmosphere has a greenhouse effect caused primarily by pressure-induced opacity of N2, CH4, and H-2. H-2 is a key absorber because it is primarily responsible for the absorption in the wave number 400 to 600 cm-1 "window" region of Titan's infrared spectrum. The concentration of CH4, also an important absorber, is set by the saturation vapor pressure and hence is dependent on temperature. In this respect there is a similarity between the role of H-2 and CH4 on Titan and that of CO2 and H2O on Earth. Titan also has an antigreenhouse effect that results from the presence of a high-altitude haze layer that is absorbing at solar wavelengths but transparent in the thermal infrared. The antigreenhouse effect on Titan reduces the surface temperature by 9 K whereas the greenhouse effect increases it by 21 K. The net effect is that the surface temperature (94 K) is 12 K warmer than the effective temperature (82 K). If the haze layer were removed, the antigreenhouse effect would be greatly reduced, the greenhouse effect would become even stronger, and the surface temperature would rise by over 20 K.	OBSERV PARIS,RECH SPATIALE LAB,F-92195 MEUDON,FRANCE	UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris	MCKAY, CP (corresponding author), NASA,AMES RES CTR,DIV SPACE SCI,MOFFETT FIELD,CA 94035, USA.							DANIELSON RE, 1973, ICARUS, V20, P437, DOI 10.1016/0019-1035(73)90016-X; Hunten D.M, 1984, SATURN, P671; KHARE BN, 1984, ICARUS, V60, P127, DOI 10.1016/0019-1035(84)90142-8; LELLOUCH E, 1989, ICARUS, V79, P328, DOI 10.1016/0019-1035(89)90081-X; LUNINE JI, 1983, SCIENCE, V222, P1229, DOI 10.1126/science.222.4629.1229; MCKAY CP, 1989, ICARUS, V80, P23, DOI 10.1016/0019-1035(89)90160-7; MUHLEMAN DO, 1990, SCIENCE, V248, P975, DOI 10.1126/science.248.4958.975; POLLACK JB, 1991, ICARUS, V91, P173, DOI 10.1016/0019-1035(91)90017-N; POLLACK JB, 1983, SCIENCE, V219, P287, DOI 10.1126/science.219.4582.287; RAGES K, 1983, ICARUS, V55, P50, DOI 10.1016/0019-1035(83)90049-0; RAGES K, 1979, ICARUS, V41, P119; SAGAN C, 1984, ICARUS, V59, P133, DOI 10.1016/0019-1035(84)90018-6; SAMUELSON RE, 1981, NATURE, V292, P688, DOI 10.1038/292688a0; SAMUELSON RE, 1983, ICARUS, V53, P364, DOI 10.1016/0019-1035(83)90156-2; TOON OB, 1988, ICARUS, V75, P255, DOI 10.1016/0019-1035(88)90005-X; TOON OB, 1982, P C LARGE BODY IMPAC, P187; TURCO RP, 1983, SCIENCE, V222, P1283, DOI 10.1126/science.222.4630.1283; WEST RA, 1983, J GEOPHYS RES-SPACE, V88, P8699, DOI 10.1029/JA088iA11p08699	18	157	160	1	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	SEP 6	1991	253	5024					1118	1121		10.1126/science.11538492	http://dx.doi.org/10.1126/science.11538492			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD808	11538492				2022-12-24	WOS:A1991GD80800025
J	Wolpert, HA; Anderson, BJ				Wolpert, HA; Anderson, BJ			Management of diabetes: are doctors framing the benefits from the wrong perspective?	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Joslin Diabet Ctr, Sect Adult Diabet, Boston, MA 02215 USA; Joslin Diabet Ctr, Behav & Mental Hlth Res Unit, Boston, MA 02215 USA	Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Joslin Diabetes Center, Inc.	Wolpert, HA (corresponding author), Joslin Diabet Ctr, Sect Adult Diabet, 1 Joslin Pl, Boston, MA 02215 USA.	howard.wolpert@joslin.harvard.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046887] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK046887, DK-46887] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		*AM DIAB ASS, 2001, DIABETES CARE S1, V24, pS33; *AM DIAB ASS, 1999, AM DIAB ASS COMPL GU; ANDERSON BJ, 1995, DIABETES SPECTRUM, V8, P69; ANDERSON RM, 1995, DIABETES CARE, V18, P943, DOI 10.2337/diacare.18.7.943; Bott S, 1997, DIABETOLOGIA, V40, P926, DOI 10.1007/s001250050769; CLEMENT S, 1995, DIABETES CARE, V18, P1204, DOI 10.2337/diacare.18.8.1204; COYNE JC, 1988, MARSHALLING SOCIAL S, P309; *DAFNE STUD GROUP, 2001, DIABETIC MED S2, V18, P325; *DIAB UK, 2000, REC MAN DIAB PRIM CA; GALAZKA SS, 1984, FAMILY SYSTEMS MED, V2, P28; Gray A, 2000, BMJ-BRIT MED J, V320, P1373, DOI 10.1136/bmj.320.7246.1373; GREENFIELD S, 1988, J GEN INTERN MED, V3, P448, DOI 10.1007/BF02595921; Howorka K, 2000, J PSYCHOSOM RES, V48, P37, DOI 10.1016/S0022-3999(99)00074-4; Miller W.R., 2013, MOTIVATIONAL INTERVI, V3rd ed.; Nathan DM, 1996, JAMA-J AM MED ASSOC, V276, P1409; ROLLNICK S, 1993, BRIT MED J, V307, P188, DOI 10.1136/bmj.307.6897.188; Rollnick S., 1999, HLTH BEHAV CHANGE GU, V1st; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Shannon H, 2000, NEW ENGL J MED, V342, P381; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Von Korff M, 1997, ANN INTERN MED, V127, P1097, DOI 10.7326/0003-4819-127-12-199712150-00008; Williams GC, 1998, DIABETES CARE, V21, P1644, DOI 10.2337/diacare.21.10.1644; Wolpert HA, 2001, DIABETES CARE, V24, P1301, DOI 10.2337/diacare.24.7.1301-a	23	76	76	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 27	2001	323	7319					994	996		10.1136/bmj.323.7319.994	http://dx.doi.org/10.1136/bmj.323.7319.994			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	488CU	11679393	Green Published			2022-12-24	WOS:000171918500027
J	Luna, B; Feinglos, MN				Luna, B; Feinglos, MN			Drug-induced hyperglycemia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ONSET DIABETES-MELLITUS; IMPAIRED GLUCOSE-TOLERANCE; BETA-BLOCKING-AGENTS; INSULIN SENSITIVITY; PROTEASE INHIBITORS; THIAZIDE DIURETICS; INDUCED DISORDERS; CLOZAPINE; KETOACIDOSIS; HYPERTENSION		Duke Univ, Med Ctr, Div Metab Endocrinol & Nutr, Dept Internal Med, Durham, NC 27710 USA; Campbell Univ, Sch Pharm, Dept Internal Med, Buies Creek, NC 27506 USA; Duke Univ Hlth Syst, Durham, NC USA	Duke University; Campbell University; Duke University	Feinglos, MN (corresponding author), Duke Univ, Med Ctr, Div Metab Endocrinol & Nutr, Dept Internal Med, Box 3921, Durham, NC 27710 USA.	feing002@mc.duke.edu						*AM DIAB ASS, 2001, DIABETES CARE, V24, pS 21; BAGDADE JD, 1978, DIABETES, V27, P677, DOI 10.2337/diabetes.27.6.677; Balkau B, 1998, DIABETES CARE, V21, P360, DOI 10.2337/diacare.21.3.360; Behrens G, 1999, AIDS, V13, pF63, DOI 10.1097/00002030-199907090-00001; Bettinger TL, 2000, ANN PHARMACOTHER, V34, P865, DOI 10.1345/aph.19327; Blake M, 2000, CLIN INFECT DIS, V30, pS96, DOI 10.1086/313859; Chan JCN, 1996, DRUG SAFETY, V15, P135, DOI 10.2165/00002018-199615020-00005; COARKIN PE, 2000, PSYCHOSOMATICS, V41, P369; Conley RR, 2000, J CLIN PSYCHIAT, V61, P26; Coutinho M, 1999, DIABETES CARE, V22, P233, DOI 10.2337/diacare.22.2.233; Curran P, 2000, SIGHT SOUND, V10, P62; Fertig MK, 1998, J CLIN PSYCHIAT, V59, P687, DOI 10.4088/JCP.v59n1208c; Gatta B, 1999, DIABETES CARE, V22, P1002, DOI 10.2337/diacare.22.6.1002; Giugliano D, 1997, ANN INTERN MED, V126, P955, DOI 10.7326/0003-4819-126-12-199706150-00004; GOLDSTEIN L, 2000, PRIMARY PSYCHIAT, V7, P65; Goldstein LE, 1999, PSYCHOSOMATICS, V40, P438, DOI 10.1016/S0033-3182(99)71210-7; Gress TW, 2000, NEW ENGL J MED, V342, P905, DOI 10.1056/NEJM200003303421301; GRINSPOON SK, 1992, NEW ENGL J MED, V327, P1360, DOI 10.1056/NEJM199211053271906; GURWITZ JH, 1993, ANN INTERN MED, V118, P273, DOI 10.7326/0003-4819-118-4-199302150-00005; Hadigan C, 2000, JAMA-J AM MED ASSOC, V284, P472, DOI 10.1001/jama.284.4.472; Hagg S, 1998, J CLIN PSYCHIAT, V59, P294, DOI 10.4088/JCP.v59n0604; HELDERMAN JH, 1983, DIABETES, V32, P106, DOI 10.2337/diabetes.32.2.106; Henderson DC, 2000, AM J PSYCHIAT, V157, P975, DOI 10.1176/appi.ajp.157.6.975; Isakov I, 2000, PSYCHOSOMATICS, V41, P373, DOI 10.1176/appi.psy.41.4.373; Jacob S, 1996, J HYPERTENS, V14, P489; KAMRAN A, 1994, AM J PSYCHIAT, V151, P1395; Kilby JM, 1998, J ACQ IMMUN DEF SYND, V17, P46, DOI 10.1097/00042560-199801010-00007; Kingsbury SJ, 2001, J CLIN PSYCHIAT, V62, P347, DOI 10.4088/JCP.v62n0507; Kostakoglu AE, 1996, ACTA PSYCHIAT SCAND, V93, P217, DOI 10.1111/j.1600-0447.1996.tb10635.x; KOVAL MS, 1994, AM J PSYCHIAT, V151, P1520; Lindenmayer JP, 1999, AM J PSYCHIAT, V156, P1471; MCMURRY JF, 1984, SURG CLIN N AM, V64, P769; Mukherjee S, 1996, COMPR PSYCHIAT, V37, P68, DOI 10.1016/S0010-440X(96)90054-1; Mulligan K, 2000, J ACQ IMMUN DEF SYND, V23, P35, DOI 10.1097/00042560-200001010-00005; Ober SK, 1999, AM J PSYCHIAT, V156, P970, DOI 10.1176/ajp.156.6.970; PANDIT MK, 1993, ANN INTERN MED, V118, P529, DOI 10.7326/0003-4819-118-7-199304010-00008; PETERS A, 1995, EXP CLIN ENDOCR DIAB, V103, P213, DOI 10.1055/s-0029-1211353; Peterson GA, 1996, AM J PSYCHIAT, V153, P737; Popli AP, 1997, J CLIN PSYCHIAT, V58, P108, DOI 10.4088/JCP.v58n0304; Procyshyn RM, 2000, CAN J PSYCHIAT, V45, P668; RAMIREZ EA, 1985, HYPERTENSION, V7, P1008; RAYFIELD EJ, 1982, AM J MED, V72, P439, DOI 10.1016/0002-9343(82)90511-3; Rigalleau V, 2000, DIABETIC MED, V17, P484, DOI 10.1046/j.1464-5491.2000.00296.x; Saint-Marc T, 1999, AIDS, V13, P1000, DOI 10.1097/00002030-199905280-00023; SAMUELSSON O, 1994, J HUM HYPERTENS, V8, P257; Sobel M, 1999, J CLIN PSYCHIAT, V60, P556, DOI 10.4088/JCP.v60n0809f; Tsiodras S, 2000, ARCH INTERN MED, V160, P2050, DOI 10.1001/archinte.160.13.2050; US Department of Health and Human Services, 2001, GUID US ANT AG HIV I; Walli R, 2000, RES EXP MED, V199, P253, DOI 10.1007/s004330050123; Walli R, 1998, AIDS, V12, pF167, DOI 10.1097/00002030-199815000-00001; White WB, 2000, AM J MED, V108, P238, DOI 10.1016/S0002-9343(99)00444-1; WICKLMAYR M, 1990, HORM METAB RES, V22, P29; WILSON PWF, 1991, AM HEART J, V121, P586, DOI 10.1016/0002-8703(91)90729-2; Wirshing DA, 1998, BIOL PSYCHIAT, V44, P778, DOI 10.1016/S0006-3223(98)00100-0; Yazici KM, 1998, EXP CLIN ENDOCR DIAB, V106, P475, DOI 10.1055/s-0029-1212019	55	110	113	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 24	2001	286	16					1945	1948		10.1001/jama.286.16.1945	http://dx.doi.org/10.1001/jama.286.16.1945			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	485JD	11667913				2022-12-24	WOS:000171750500001
J	Lumaret, R; Ouazzani, N				Lumaret, R; Ouazzani, N			Plant genetics - Ancient wild olives in Mediterranean forests	NATURE			English	Article							OLEA-EUROPAEA L		CNRS, Ctr Ecol Fonct & Evolut, F-34293 Montpellier 5, France; Ecole Natl Agr, Meknes, Morocco	UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; Moulay Ismail University of Meknes	Lumaret, R (corresponding author), CNRS, Ctr Ecol Fonct & Evolut, 1919 Route de Mende, F-34293 Montpellier 5, France.							LUMARET R, 1997, BOCCONEA, V7, P39; Ouazzani N, 1996, EUPHYTICA, V91, P9, DOI 10.1007/BF00035271; OUAZZANI N, 1993, J HERED, V84, P34, DOI 10.1093/oxfordjournals.jhered.a111274; OUAZZANI N, 1995, AGRONOMIE, V15, P31, DOI 10.1051/agro:19950104; Terral JF, 1999, PALAEOGEOGR PALAEOCL, V153, P71, DOI 10.1016/S0031-0182(99)00079-6; TRUJILLO T, 1995, J AM SOC HORTIC SCI, V120, P318; TURRILL WB, 1951, KEW B, V3, P439; ZOHARY D, 1975, SCIENCE, V187, P319, DOI 10.1126/science.187.4174.319	8	76	77	0	12	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 18	2001	413	6857					700	700		10.1038/35099680	http://dx.doi.org/10.1038/35099680			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	482ZK	11607022				2022-12-24	WOS:000171608000034
J	McDonald, LC; Rossiter, S; Mackinson, C; Wang, YY; Johnson, S; Sullivan, M; Sokolow, R; DeBess, E; Gilbert, L; Benson, JA; Hill, B; Angulo, FJ				McDonald, LC; Rossiter, S; Mackinson, C; Wang, YY; Johnson, S; Sullivan, M; Sokolow, R; DeBess, E; Gilbert, L; Benson, JA; Hill, B; Angulo, FJ			Quinupristin-dalfopristin-resistant Enterococcus faecium on chicken and in human stool specimens.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GASTROINTESTINAL-TRACT COLONIZATION; GLYCOPEPTIDE RESISTANCE; ANTIMICROBIAL RESISTANCE; HIGH PREVALENCE; FECAL CARRIAGE; UNITED-STATES; POULTRY MEAT; SATA GENE; VANCOMYCIN; ANIMALS	Background: The combination of the streptogramins quinupristin and dalfopristin was approved in the United States in late 1999 for the treatment of vancomycin-resistant Enterococcus faecium infections. Since 1974, another streptogramin, virginiamycin, has been used at subtherapeutic concentrations to promote the growth of farm animals, including chickens. Methods: To determine the frequency of quinupristin-dalfopristin-resistant E. faecium, we used selective medium to culture samples from chickens purchased in supermarkets in Georgia, Maryland, Minnesota, and Oregon and stool samples from outpatients. Results: Between July 1998 and June 1999, samples from 407 chickens from 26 stores in four states were cultured, as were 334 stool samples from outpatients. Quinupristin-dalfopristin-resistant E. faecium was isolated from 237 chicken carcasses and 3 stool specimens. The resistant isolates from stool had low-level resistance (minimal inhibitory concentration [MIC], 4 mug per milliliter; resistance was defined as a MIC of at least 4 mug per milliliter). The resistant isolates from chickens in general had higher levels of resistance (MICs ranging from 4 to 32 microg per milliliter; MIC required to inhibit 50 percent of isolates, 8 mug per milliliter). Conclusions: Quinupristin-dalfopristin - resistant E. faecium contaminates a large proportion of chickens sold in U.S. supermarkets. However, the low prevalence and low level of resistance of these strains in human stool specimens suggest that the use of virginiamycin in animals has not yet had a substantial influence. Foodborne dissemination of resistance may increase, however, as the clinical use of quinupristin-dalfopristin increases. (N Engl J Med 2001;345:1155-60.) Copyright (C) 2001 Massachusetts Medical Society.	CDCP, Foodborne & Diarrheal Dis Branch, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; CDCP, Hosp Infect Program, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; Univ Maryland, Baltimore, MD 21201 USA; Minnesota Dept Hlth, Minneapolis, MN USA; Oregon Hlth Div, Portland, OR USA; Georgia Div Publ Hlth, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; University System of Maryland; University of Maryland Baltimore; Minnesota Department of Health (MHD); Oregon Health & Science University	Angulo, FJ (corresponding author), CDCP, Foodborne & Diarrheal Dis Branch, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, 1600 Clifton Rd,MS A38, Atlanta, GA 30333 USA.	fangulo@cdc.gov						Aarestrup FM, 1995, MICROB DRUG RESIST, V1, P255, DOI 10.1089/mdr.1995.1.255; [Anonymous], 1997, M7A4 NCCLS; BATES J, 1994, J ANTIMICROB CHEMOTH, V34, P507, DOI 10.1093/jac/34.4.507; Bergeron M, 1997, J ANTIMICROB CHEMOTH, V39, P129, DOI 10.1093/jac/39.suppl_1.129; Borgen K, 2000, J APPL MICROBIOL, V89, P478, DOI 10.1046/j.1365-2672.2000.01137.x; *CDCP, 1999, MMWR-MORBID MORTAL W, V47, P1; *COMM DRUG US FOOD, 1999, US DRUG FOOD AN BEN; Dever LL, 1996, MICROB DRUG RESIST, V2, P415, DOI 10.1089/mdr.1996.2.415; Donskey CJ, 1999, J INFECT DIS, V180, P384, DOI 10.1086/314874; Eliopoulos GM, 1998, ANTIMICROB AGENTS CH, V42, P1088, DOI 10.1128/AAC.42.5.1088; Endtz HP, 1997, J CLIN MICROBIOL, V35, P3026, DOI 10.1128/JCM.35.12.3026-3031.1997; FORD M, 1994, J CLIN MICROBIOL, V32, P2999, DOI 10.1128/JCM.32.12.2999-3001.1994; GORDTS B, 1995, J CLIN MICROBIOL, V33, P2842, DOI 10.1128/JCM.33.11.2842-2846.1995; Hammerum AM, 1998, FEMS MICROBIOL LETT, V168, P145, DOI [10.1111/j.1574-6968.1998.tb13267.x, 10.1016/S0378-1097(98)00433-9]; Jacobsen B. L., 1999, Microbial Ecology in Health and Disease, V11, P241, DOI 10.1080/08910609908540834; Jensen LB, 1998, ANTIMICROB AGENTS CH, V42, P3330, DOI 10.1128/AAC.42.12.3330; JONES RN, 1995, DIAGN MICR INFEC DIS, V21, P85, DOI 10.1016/0732-8893(94)00147-O; Jones RN, 1998, DIAGN MICR INFEC DIS, V31, P437, DOI 10.1016/S0732-8893(98)80002-3; JORDENS JZ, 1994, J ANTIMICROB CHEMOTH, V34, P515, DOI 10.1093/jac/34.4.515; Klare I, 1999, MICROB DRUG RESIST, V5, P45, DOI 10.1089/mdr.1999.5.45; KLARE I, 1995, FEMS MICROBIOL LETT, V125, P165, DOI 10.1111/j.1574-6968.1995.tb07353.x; Mellon M., 2001, HOGGING IT ESTIMATES; Moller FM, 1998, APMIS, V106, P606, DOI 10.1111/j.1699-0463.1998.tb01391.x; National Committee for Clinical Laboratory Standards, 1999, PERF STAND ANT SUSC; Pantosti A, 1999, LANCET, V354, P741, DOI 10.1016/S0140-6736(99)02395-8; RENDEFOURNIER R, 1993, ANTIMICROB AGENTS CH, V37, P2119, DOI 10.1128/AAC.37.10.2119; Sahm DF, 1999, CLIN INFECT DIS, V29, P259, DOI 10.1086/520195; Schouten MA, 1999, ANTIMICROB AGENTS CH, V43, P2542, DOI 10.1128/AAC.43.10.2542; Schouten MA, 1997, LANCET, V349, P1258, DOI 10.1016/S0140-6736(05)62461-0; Soltani M, 2000, ANTIMICROB AGENTS CH, V44, P433, DOI 10.1128/AAC.44.2.433-436.2000; Stobberingh E, 1999, ANTIMICROB AGENTS CH, V43, P2215, DOI 10.1128/AAC.43.9.2215; Teixeira, 1999, MANUAL CLIN MICROBIO, P297; vandenBogaard AE, 1997, J ANTIMICROB CHEMOTH, V40, P454, DOI 10.1093/jac/40.3.454; VanderAuwera P, 1996, J INFECT DIS, V173, P1129, DOI 10.1093/infdis/173.5.1129; Wegener HC, 1999, EMERG INFECT DIS, V5, P329, DOI 10.3201/eid0503.990303; Welton LA, 1998, ANTIMICROB AGENTS CH, V42, P705, DOI 10.1128/AAC.42.3.705; Whitman MS, 1996, ANTIMICROB AGENTS CH, V40, P1526, DOI 10.1128/AAC.40.6.1526; 2000, FED REG, V65, P20992	38	72	78	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 18	2001	345	16					1155	1160		10.1056/NEJMoa010805	http://dx.doi.org/10.1056/NEJMoa010805			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	482YX	11642231				2022-12-24	WOS:000171605800002
J	MacLehose, L; Brand, H; Camaroni, I; Fulop, N; Gill, ON; Reintjes, R; Schaefer, O; McKee, M; Weinberg, J				MacLehose, L; Brand, H; Camaroni, I; Fulop, N; Gill, ON; Reintjes, R; Schaefer, O; McKee, M; Weinberg, J			Communicable disease outbreaks involving more than one country: systems approach to evaluating the response	BRITISH MEDICAL JOURNAL			English	Article							SURVEILLANCE; ENGLAND		Publ Hlth Lab Serv, Ctr Communicable Dis Surveillance, London NW9 5EQ, England; PHLS, Ctr Communicable Dis Surveillance, Cardiff CF4 3QX, S Glam, Wales; Inst Publ Hlth N Rhine Westfalia, Munster, Germany; Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England	Public Health England; University of London; London School of Hygiene & Tropical Medicine	Weinberg, J (corresponding author), City Univ London, London EC1 0HV, England.		McKee, Marc D/E-2187-2011; Mckee, Martin/E-6673-2018; Brand, Helmut/F-6368-2013	McKee, Marc D/0000-0001-8349-965X; Mckee, Martin/0000-0002-0121-9683; Fulop, Naomi/0000-0001-5306-6140; Weinberg, Julius/0000-0001-5973-359X; Brand, Helmut/0000-0002-2755-0673				[Anonymous], 1997, Commun Dis Rep CDR Wkly, V7, P36; Burgess R., 1982, FIELD RES SOURCEBOOK; CHECKLAND P, 1994, AM BEHAV SCI, V38, P75, DOI 10.1177/0002764294038001007; DESENCLOS JC, 1993, LANCET, V341, P1003, DOI 10.1016/0140-6736(93)91084-Y; FISHER I, 1994, PHLS MICROBIOL DIGES, V9, P107; Giesecke J, 1998, LANCET, V352, P1308, DOI 10.1016/S0140-6736(98)00042-7; Joseph C, 1996, EUR J EPIDEMIOL, V12, P215, DOI 10.1007/BF00145408; Killalea D, 1996, BMJ-BRIT MED J, V313, P1105, DOI 10.1136/bmj.313.7065.1105; Lavanchy D, 1998, Euro Surveill, V3, P23; Mounts AW, 1999, J INFECT DIS, V180, P505, DOI 10.1086/314903; *NAT ADV COMM MICR, 1998, J FOOD PROTECT, V61, P1246; SAMUELSSON S, 1999, THESIS U SO DENMARK; Sorensen H T, 1995, Int J Risk Saf Med, V7, P179, DOI 10.3233/JRS-1995-7303; Threlfall EJ, 1998, EPIDEMIOL INFECT, V121, P289, DOI 10.1017/S0950268898001149; Van Steenbergen J.E., 1999, Euro Surveill, V4, P18; VANLOOCK F, 1997, EUROSURVEILLANCE JUN; Wheeler JG, 1999, BMJ-BRIT MED J, V318, P1046, DOI 10.1136/bmj.318.7190.1046; Yin R.K., 1994, CASE STUDY RES; 1996, COMMUN DIS REP CDR W, V6, P355	19	19	19	0	6	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 13	2001	323	7317					861	863		10.1136/bmj.323.7317.861	http://dx.doi.org/10.1136/bmj.323.7317.861			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	483RW	11597974	Green Accepted, Green Published			2022-12-24	WOS:000171650500036
J	Schueler, MG; Higgins, AW; Rudd, MK; Gustashaw, K; Willard, HF				Schueler, MG; Higgins, AW; Rudd, MK; Gustashaw, K; Willard, HF			Genomic and genetic definition of a functional human centromere	SCIENCE			English	Article							ALPHA-SATELLITE DNA; HUMAN X-CHROMOSOME; SEQUENCE-ANALYSIS; EVOLUTION; INACTIVATION; ISOCHROMOSOMES; RECOMBINATION; ORGANIZATION; HYPOTHESIS; PRIMATES	The definition of centromeres of human chromosomes requires a complete genomic understanding of these regions. Toward this end, we report integration of physical mapping, genetic, and functional approaches, together with sequencing of selected regions, to define the centromere of the human X chromosome and to explore the evolution of sequences responsible for chromosome segregation. The transitional region between expressed sequences on the short arm of the X and the chromosome-specific alpha satellite array DXZ1 spans about 450 kilobases and is satellite-rich. At the junction between this satellite region and canonical DXZ1 repeats, diverged repeat units provide direct evidence of unequal crossover as the homogenizing force of these arrays. Results from deletion analysis of mitotically stable chromosome rearrangements and from a human artificial chromosome assay demonstrate that DXZ1 DNA is sufficient for centromere function. Evolutionary studies indicate that, white alpha satellite DNA present throughout the pericentromeric region of the X chromosome appears to be a descendant of an ancestral primate centromere, the current functional centromere based on DXZ1 sequences is the product of the much more recent concerted evolution of this satellite DNA.	Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA; Univ Hosp Cleveland, Res Inst, Cleveland, OH 44106 USA; Univ Hosp Cleveland, Ctr Human Genet, Cleveland, OH 44106 USA	Case Western Reserve University; University Hospitals of Cleveland; University Hospitals of Cleveland	Willard, HF (corresponding author), Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA.	willard@uhri.org			NHGRI NIH HHS [HG00107] Funding Source: Medline; NICHD NIH HHS [HD07518, HD32111] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD032111] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Alexandrov I, 2001, CHROMOSOMA, V110, P253, DOI 10.1007/s004120100146; ALEXANDROV IA, 1993, NUCLEIC ACIDS RES, V21, P2209; Bailey JA, 2000, P NATL ACAD SCI USA, V97, P6634, DOI 10.1073/pnas.97.12.6634; Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; Choo KHA, 2000, TRENDS CELL BIOL, V10, P182, DOI 10.1016/S0962-8924(00)01739-6; Copenhaver GP, 1999, SCIENCE, V286, P2468, DOI 10.1126/science.286.5449.2468; Darlington CD, 1939, J GENET, V37, P341, DOI 10.1007/BF02982733; DONEHOWER L, 1979, J MOL BIOL, V134, P805, DOI 10.1016/0022-2836(79)90487-X; DURFY SJ, 1989, GENOMICS, V5, P810, DOI 10.1016/0888-7543(89)90123-7; Ebersole TA, 2000, HUM MOL GENET, V9, P1623, DOI 10.1093/hmg/9.11.1623; Goldberg IG, 1996, MOL CELL BIOL, V16, P5156; GREIG GM, 1993, HUM MOL GENET, V2, P1611; Harrington JJ, 1997, NAT GENET, V15, P345, DOI 10.1038/ng0497-345; Henikoff S, 2001, SCIENCE, V293, P1098, DOI 10.1126/science.1062939; Higgins AW, 1999, CHROMOSOMA, V108, P256, DOI 10.1007/s004120050376; Horvath JE, 2000, HUM MOL GENET, V9, P113, DOI 10.1093/hmg/9.1.113; Horvath JE, 2000, GENOME RES, V10, P839, DOI 10.1101/gr.10.6.839; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Laurent AM, 1997, GENOMICS, V46, P127, DOI 10.1006/geno.1997.4987; Laurent AM, 1999, CHROMOSOME RES, V7, P305, DOI 10.1023/A:1009283015738; Lee C, 2000, CHROMOSOMA, V109, P381, DOI 10.1007/s004120000095; Mahtani MM, 1998, GENOME RES, V8, P100, DOI 10.1101/gr.8.2.100; MILLER AP, 1995, HUM MOL GENET, V4, P731, DOI 10.1093/hmg/4.4.731; Montefalcone G, 1999, GENOME RES, V9, P1184, DOI 10.1101/gr.9.12.1184; MURPHY TD, 1995, CELL, V82, P599, DOI 10.1016/0092-8674(95)90032-2; O'Brien SJ, 1999, SCIENCE, V286, P458, DOI 10.1126/science.286.5439.458; OHNO S, 1973, NATURE, V244, P259, DOI 10.1038/244259a0; Puechberty J, 1999, GENOMICS, V56, P274, DOI 10.1006/geno.1999.5742; ROSENBERG H, 1978, SCIENCE, V200, P394, DOI 10.1126/science.205944; Schueler MG, 2000, GENOMICS, V66, P104, DOI 10.1006/geno.2000.6180; SMIT AFA, 1995, J MOL BIOL, V246, P401, DOI 10.1006/jmbi.1994.0095; SMITH GP, 1976, SCIENCE, V191, P528, DOI 10.1126/science.1251186; SULLIVAN BA, 1995, HUM MOL GENET, V4, P2189, DOI 10.1093/hmg/4.12.2189; Sullivan BA, 2001, NAT REV GENET, V2, P584, DOI 10.1038/35084512; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Ventura M, 2001, GENOME RES, V11, P595, DOI 10.1101/gr.152101; Warburton PE, 2001, TRENDS GENET, V17, P243, DOI 10.1016/S0168-9525(01)02283-1; WARBURTON PE, 1991, GENOMICS, V11, P324, DOI 10.1016/0888-7543(91)90139-6; Warburton PE, 1996, HUMAN GENOME EVOLUTI, P121; WAYE JS, 1985, NUCLEIC ACIDS RES, V13, P2731, DOI 10.1093/nar/13.8.2731; WILLARD HF, 1987, TRENDS GENET, V3, P192, DOI 10.1016/0168-9525(87)90232-0; Willard HF, 1998, CURR OPIN GENET DEV, V8, P219, DOI 10.1016/S0959-437X(98)80144-5; Wolff DJ, 1996, AM J HUM GENET, V58, P154	43	360	375	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 5	2001	294	5540					109	115		10.1126/science.1065042	http://dx.doi.org/10.1126/science.1065042			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480EJ	11588252				2022-12-24	WOS:000171448800040
J	Harvey, J				Harvey, J			The natural economy	NATURE			English	Article									NIOO NAW, Netherlands Institute of Ecology, Ctr Terr Ecol, Dept Multitroph Interact, NL-6666 ZG Heteren, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW)	Harvey, J (corresponding author), NIOO NAW, Netherlands Institute of Ecology, Ctr Terr Ecol, Dept Multitroph Interact, POB 40, NL-6666 ZG Heteren, Netherlands.		Harvey, Jeffrey A/B-7439-2008	Harvey, Jeffrey A/0000-0002-4227-7935				BASKIN Y, 1997, WORK NATURE; Jones C. G., 1995, LINKING SPECIES ECOS; LEVIN SA, 1999, FRAGILE DOMINION COR; Maurer BA, 1999, UNTANGLING ECOLOGICA; Pimm S. L., 1991, BALANCE NATURE ECOLO	5	6	7	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 4	2001	413	6855					463	463		10.1038/35097209	http://dx.doi.org/10.1038/35097209			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	478HG	11586335	Bronze			2022-12-24	WOS:000171340500024
J	Barbeau, K; Rue, EL; Bruland, KW; Butler, A				Barbeau, K; Rue, EL; Bruland, KW; Butler, A			Photochemical cycling of iron in the surface ocean mediated by microbial iron(III)-binding ligands	NATURE			English	Article							EQUATORIAL PACIFIC-OCEAN; CATHODIC STRIPPING VOLTAMMETRY; MARINE-BACTERIA; SIDEROPHORE PRODUCTION; PHYTOPLANKTON BLOOM; COMPLEXATION; CHEMISTRY; SEAWATER; FERTILIZATION; CYANOBACTERIA	Iron is a limiting nutrient for primary production in large areas of the oceans(1-4). Dissolved iron(III) in the upper oceans occurs almost entirely in the form of complexes with strong organic ligands(5-7) presumed to be of biological origin(8,9). Although the importance of organic ligands to aquatic iron cycling is becoming clear, the mechanism by which they are involved in this process remains uncertain. Here we report observations of photochemical reactions involving Fe(III) bound to siderophores-high-affinity iron(III) ligands produced by bacteria to facilitate iron acquisition(10-12). We show that photolysis of Fe(III)-siderophore complexes leads to the formation of lower-affinity Fe(III) ligands and the reduction of Fe(III), increasing the availability of siderophore-bound iron for uptake by planktonic assemblages. These photochemical reactions are mediated by the alpha -hydroxy acid moiety, a group which has generally been found to be present in the marine siderophores that have been characterized(13-15). We suggest that Fe(III)-binding ligands can enhance the photolytic production of reactive iron species in the euphotic zone and so influence iron availability in aquatic systems.	Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA; Univ Calif Santa Cruz, Inst Marine Sci, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Cruz	Butler, A (corresponding author), Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA.		Butler, Alison/D-5094-2015	Butler, Alison/0000-0002-3525-7864; Barbeau, Katherine/0000-0002-2132-7219				Albrecht-Gary AM, 1998, MET IONS BIOL SYST, V35, P239; Archer DE, 2000, GLOBAL BIOGEOCHEM CY, V14, P269, DOI 10.1029/1999GB900053; Boyd PW, 2000, NATURE, V407, P695, DOI 10.1038/35037500; Coale KH, 1996, NATURE, V383, P495, DOI 10.1038/383495a0; DONAT JR, 1988, ANAL CHEM, V60, P240, DOI 10.1021/ac00154a011; Emmenegger L, 1998, ENVIRON SCI TECHNOL, V32, P2990, DOI 10.1021/es980207g; FAUST BC, 1993, ENVIRON SCI TECHNOL, V27, P2517, DOI 10.1021/es00048a032; GLEDHILL M, 1994, MAR CHEM, V47, P41, DOI 10.1016/0304-4203(94)90012-4; Granger J, 1999, LIMNOL OCEANOGR, V44, P541, DOI 10.4319/lo.1999.44.3.0541; HAYGOOD MG, 1993, LIMNOL OCEANOGR, V38, P1091, DOI 10.4319/lo.1993.38.5.1091; HUDSON RJM, 1989, LIMNOL OCEANOGR, V34, P1113, DOI 10.4319/lo.1989.34.6.1113; Hutchins DA, 1999, NATURE, V400, P858, DOI 10.1038/23680; Hutchins DA, 1998, NATURE, V393, P561, DOI 10.1038/31203; Johnson KS, 1997, MAR CHEM, V57, P137, DOI 10.1016/S0304-4203(97)00043-1; JOHNSON KS, 1994, MAR CHEM, V46, P319, DOI 10.1016/0304-4203(94)90029-9; LEWIS BL, 1995, MAR CHEM, V50, P179, DOI 10.1016/0304-4203(95)00034-O; MACRELLIS HM, IN PRESS MAR CHEM; MARFEY P, 1984, CARLSBERG RES COMMUN, V49, P591, DOI 10.1007/BF02908688; MARTIN JH, 1994, NATURE, V371, P123, DOI 10.1038/371123a0; Martinez JS, 2000, SCIENCE, V287, P1245, DOI 10.1126/science.287.5456.1245; OSULLIVAN DW, 1991, LIMNOL OCEANOGR, V36, P1727, DOI 10.4319/lo.1991.36.8.1727; REID RT, 1993, NATURE, V366, P455, DOI 10.1038/366455a0; RUE EL, 1995, MAR CHEM, V50, P117, DOI 10.1016/0304-4203(95)00031-L; Rue EL, 1997, LIMNOL OCEANOGR, V42, P901, DOI 10.4319/lo.1997.42.5.0901; TRICK CG, 1989, CURR MICROBIOL, V18, P375, DOI 10.1007/BF01571131; WAITE TD, 1995, MAR CHEM, V50, P79, DOI 10.1016/0304-4203(95)00028-P; WELLS ML, 1991, NATURE, V353, P248, DOI 10.1038/353248a0; WILHELM SW, 1994, LIMNOL OCEANOGR, V39, P1979, DOI 10.4319/lo.1994.39.8.1979; WU JF, 1995, MAR CHEM, V50, P159, DOI 10.1016/0304-4203(95)00033-N; ZUO YG, 1992, ENVIRON SCI TECHNOL, V26, P1014, DOI 10.1021/es00029a022	30	389	401	5	188	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 27	2001	413	6854					409	413		10.1038/35096545	http://dx.doi.org/10.1038/35096545			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475UY	11574885				2022-12-24	WOS:000171188700051
J	Wei, DS; Mei, YA; Bagal, A; Kao, JPY; Thompson, SM; Tang, CM				Wei, DS; Mei, YA; Bagal, A; Kao, JPY; Thompson, SM; Tang, CM			Compartmentalized and binary behavior of terminal dendrites in hippocampal pyramidal neurons	SCIENCE			English	Article							CELLS; SPINES	The dendritic arbor of pyramidal neurons is not a monolithic structure. We show here that the excitability of terminal apical, dendrites differs from that of the apical trunk. in response to fluorescence-guided focal photolysis of caged glutamate, individual terminal apical dendrites generated cadmium-sensitive all-or-none responses that were subthreshold for somatic action potentials. Calcium transients produced by all-or-none responses were not restricted to the sites of photolysis, but occurred throughout individual distal dendritic compartments, indicating that electrogenesis is mediated primarily by voltage-gated calcium channels. Compartmentalized and binary behavior of parallel-connected terminal dendrites can greatly expand the computational power of a single neuron.	Univ Maryland, Sch Med, Dept Neurol, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; Univ Maryland, Inst Biotechnol, Ctr Med Biotechnol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Tang, CM (corresponding author), Univ Maryland, Sch Med, Dept Neurol, Baltimore, MD 21201 USA.		Thompson, Scott M/K-8921-2015	Kao, Joseph/0000-0002-8875-2180				BANNISTER NJ, 1995, J COMP NEUROL, V360, P150, DOI 10.1002/cne.903600111; GAHWILER BH, 1991, CULTURING NERVE CELL, P379; Golding NL, 1999, J NEUROSCI, V19, P8789, DOI 10.1523/JNEUROSCI.19-20-08789.1999; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; HESTRIN S, 1990, COLD SH Q B, V55, P87; Johnston D, 1996, ANNU REV NEUROSCI, V19, P165, DOI 10.1146/annurev.ne.19.030196.001121; MACCAFERRI G, 1993, J NEUROPHYSIOL, V69, P2129, DOI 10.1152/jn.1993.69.6.2129; Magee J. C., 1999, DENDRITES, P139; MCALLISTER AK, 2000, BIOLISTIC TRANSFECTI; Mel B. W., 1999, DENDRITES, P271; NEHER E, 1992, J PHYSIOL-LONDON, V450, P273, DOI 10.1113/jphysiol.1992.sp019127; RHODES PA, 1999, CEREBRAL CORTEX, V13, pCH3; Rossi FM, 1997, J BIOL CHEM, V272, P32933, DOI 10.1074/jbc.272.52.32933; Schiller J, 2000, NATURE, V404, P285, DOI 10.1038/35005094; Segev I, 2000, SCIENCE, V290, P744, DOI 10.1126/science.290.5492.744; Segev I, 1998, TRENDS NEUROSCI, V21, P453, DOI 10.1016/S0166-2236(98)01327-7; SPRUSTON N, 1995, SCIENCE, V268, P297, DOI 10.1126/science.7716524; TANG CM, IN PRESS CURR PROTOC; TROMMALD M, 1995, J COMP NEUROL, V353, P260, DOI 10.1002/cne.903530208; YLINEN A, 1995, J NEUROSCI, V15, P30; Yuste R, 1996, NEURON, V16, P701, DOI 10.1016/S0896-6273(00)80091-4	21	156	160	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 21	2001	293	5538					2272	2275		10.1126/science.1061198	http://dx.doi.org/10.1126/science.1061198			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475AL	11567143				2022-12-24	WOS:000171139400049
J	Volpi, E; Sheffield-Moore, M; Rasmussen, BB; Wolfe, RR				Volpi, E; Sheffield-Moore, M; Rasmussen, BB; Wolfe, RR			Basal muscle amino acid kinetics and protein synthesis in healthy young and older men	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RESISTANCE EXERCISE; SKELETAL-MUSCLE; METABOLISM; SARCOPENIA; RATES	Context Sarcopenia is associated with loss of strength and function, eventually leading to loss of independence. Some studies suggest that basal muscle protein turnover is reduced with aging, but other studies do not confirm this finding. Objective To determine if aging per se affects basal muscle protein turnover in men. Design and Setting Cross-sectional study conducted from June 1997 to July 2000 in a general US community. Participants Twenty-six young (mean [SE] age, 28 [2] years) and 22 older (mean [SE] age, 70 [1] years) men, who were healthy and independent based on activities of daily living, physical examinations, and screening tests. Subjects were excluded if they had cardiac, pulmonary, liver, or kidney disease; any impairment in activities of daily living; or steroid use. Main Outcome Measures We measured basal muscle protein and amino acid kinetics, based on stable isotope techniques with femoral arteriovenous catheterization and muscle biopsies. Three models (arteriovenous balance, three-pool, and fractional synthesis rate) were used to estimate the metabolic parameters. Results Mean (SE) total leg volume was 9.60 (0.32) L in older men vs 10.83 (0.43) L in younger men, which suggests muscle loss in the older men. Net muscle protein balance was similar in both groups (older men, -19 [2] nmol/min per 100 mL of leg volume vs younger men, -21 [2] nmol/min per 100 ml. of leg volume; P = .51). Small differences were found in mean (SE) muscle protein synthesis in comparisons of older vs younger men: arteriovenous balance, 48 (5) nmol/min per 100 mL of leg volume vs 32 (3) nmol/min per 100 mL of leg volume; P = .004; three-pool, 58 (5) nmol/min per 100 mL of leg volume vs 43 (4) nmol/min per 100 mL of leg volume; P = .04; and fractional synthesis rate, 0.0601 (0.0046) %/h vs 0.0578 (0.0047) %/h; P = .73. Small differences were also found in mean (SE) muscle protein breakdown: arteriovenous balance, 66 (5) nmol/min per 100 mL of leg volume in older vs 53 (4) nmol/min per 100 mL of leg volume in younger men, P = .045; and three-pool, 76 (6) nmol/min per 100 mL of leg volume vs 64 (5) nmol/min per 100 mL of leg volume, P = .14. Conclusion Differences in basal muscle protein turnover between older and younger men do not appear to explain muscle loss that occurs with age.	Univ So Calif, Div Endocrinol & Diabet, Dept Med, 1333 San Pablo St,BMT-B11, Los Angeles, CA 90033 USA; Univ Texas, Med Branch, Dept Internal Med, Galveston, TX 77550 USA; Univ Texas, Med Branch, Dept Surg, Galveston, TX 77550 USA; Univ Texas, Med Branch, Dept Anesthesiol, Galveston, TX 77550 USA; Shriners Hosp Children, Galveston, TX 77550 USA; Univ So Calif, Dept Kinesiol, Los Angeles, CA 90033 USA	University of Southern California; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Southern California	Volpi, E (corresponding author), Univ So Calif, Div Endocrinol & Diabet, Dept Med, 1333 San Pablo St,BMT-B11, Los Angeles, CA 90033 USA.	volpi@usc.edu	Sheffield-Moore, Melinda/A-9794-2016; Volpi, Elena/I-4459-2012	Sheffield-Moore, Melinda/0000-0001-6579-4655; Volpi, Elena/0000-0001-8776-0384; Rasmussen, Blake/0000-0001-7854-5375	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG024832, R01AG015780, R01AG018311, P60AG017231] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR00073, M01 RR000073] Funding Source: Medline; NIA NIH HHS [P60 AG017231, P30 AG024832, R01 AG018311, P60 AG17231, R01 AG018311-01, R01 AG18311, R01 AG015780, R01 AG15780] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Balagopal P, 1997, AM J PHYSIOL-ENDOC M, V273, pE790, DOI 10.1152/ajpendo.1997.273.4.E790; Barazzoni R, 2000, J BIOL CHEM, V275, P3343, DOI 10.1074/jbc.275.5.3343; BIOLO G, 1995, AM J PHYSIOL-ENDOC M, V268, pE75, DOI 10.1152/ajpendo.1995.268.1.E75; Bonnefoy M, 2001, J AM GERIATR SOC, V49, P28, DOI 10.1046/j.1532-5415.2001.49006.x; Bross R, 1999, J CLIN ENDOCR METAB, V84, P3420, DOI 10.1210/jc.84.10.3420; CALDER AG, 1992, RAPID COMMUN MASS SP, V6, P421, DOI 10.1002/rcm.1290060704; Campbell WW, 1996, EUR J CLIN NUTR, V50, pS180; CHINKES DL, 1993, CLIN SCI, V84, P177, DOI 10.1042/cs0840177; Dionne I J, 2000, J Nutr Health Aging, V4, P156; DUTTA C, 1995, J GERONTOL A-BIOL, V50, P1, DOI 10.1093/gerona/50A.Special_Issue.1; EVANS WJ, 1995, J GERONTOL A-BIOL, V50, P147; EVANS WJ, 1995, J GERONTOL A-BIOL, V50, P5, DOI 10.1093/gerona/50A.Special_Issue.5; FIATARONE MA, 1994, NEW ENGL J MED, V330, P1769, DOI 10.1056/NEJM199406233302501; Gavin JR, 1999, DIABETES CARE, V22, pS5; Hasten DL, 2000, AM J PHYSIOL-ENDOC M, V278, pE620, DOI 10.1152/ajpendo.2000.278.4.E620; JACOBS DR, 1993, MED SCI SPORT EXER, V25, P81, DOI 10.1249/00005768-199301000-00012; JORFELDT L, 1978, METABOLISM, V27, P97, DOI 10.1016/0026-0495(78)90128-2; JORFELDT L, 1971, CLIN SCI, V41, P459, DOI 10.1042/cs0410459; KATCH V, 1975, HUM BIOL, V47, P203; LEXELL J, 1995, J GERONTOL, V50; Pannemans DLE, 1998, AM J CLIN NUTR, V68, P1228, DOI 10.1093/ajcn/68.6.1228; Patterson BW, 1997, METABOLISM, V46, P943, DOI 10.1016/S0026-0495(97)90084-6; Proctor DN, 1998, J NUTR, V128, p351S, DOI 10.1093/jn/128.2.351S; ROBERTS SB, 1995, J GERONTOL A-BIOL, V50, P101; Roubenoff R, 2000, J Nutr Health Aging, V4, P140; SHETTY KR, 1995, ENDOCRIN METAB CLIN, V24, P213, DOI 10.1016/S0889-8529(18)30039-2; Tinetti ME, 1997, NEW ENGL J MED, V337, P1279, DOI 10.1056/NEJM199710303371806; Volpi E, 2000, J CLIN ENDOCR METAB, V85, P4481, DOI 10.1210/jc.85.12.4481; Volpi E, 1999, AM J PHYSIOL-ENDOC M, V277, pE513, DOI 10.1152/ajpendo.1999.277.3.E513; WELLE S, 1993, AM J PHYSIOL, V264, pE693, DOI 10.1152/ajpendo.1993.264.5.E693; WELLE S, 1995, AM J PHYSIOL-ENDOC M, V268, pE422, DOI 10.1152/ajpendo.1995.268.3.E422; WOLFE RR, 1992, RADIOACTIVE STABLE I, P167; WOLFE RR, 1992, RADIOACTIVE STABLE I, P417; WOLFE RR, 1992, RADIOACTIVE STABLE I, P119; WOLFSON L, 1995, J GERONTOL A-BIOL, V50, P64; Yarasheski KE, 1999, AM J PHYSIOL-ENDOC M, V277, pE118, DOI 10.1152/ajpendo.1999.277.1.E118; YARASHESKI KE, 1993, AM J PHYSIOL, V265, pE210, DOI 10.1152/ajpendo.1993.265.2.E210	37	302	307	0	22	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 12	2001	286	10					1206	1212		10.1001/jama.286.10.1206	http://dx.doi.org/10.1001/jama.286.10.1206			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	471CR	11559266	Green Accepted, Bronze			2022-12-24	WOS:000170910400031
J	Doherty, M				Doherty, M			Risk factors for progression of knee osteoarthritis	LANCET			English	Editorial Material							ALIGNMENT		City Hosp, Acad Dept Rheumatol, Nottingham NG5 1PB, England	University of Nottingham	Doherty, M (corresponding author), City Hosp, Acad Dept Rheumatol, Clin Sci Bldg, Nottingham NG5 1PB, England.	Michael.Doherty@nottingham.ac.uk		Doherty, Michael/0000-0002-5763-8326				Brandt KD, 1998, OSTEOARTHRITIS, P70; Creamer P, 2000, RHEUMATOLOGY, V39, P490, DOI 10.1093/rheumatology/39.5.490; DOHERTY M, 1983, LANCET, V2, P8; Elahi S, 2000, ARTHRITIS RHEUM, V43, P1874, DOI 10.1002/1529-0131(200008)43:8<1874::AID-ANR25>3.0.CO;2-2; Felson DT, 2000, ANN INTERN MED, V133, P635, DOI 10.7326/0003-4819-133-8-200010170-00016; GUCCIONE AA, 1994, AM J PUBLIC HEALTH, V84, P351, DOI 10.2105/AJPH.84.3.351; HUSKISSON EC, 1995, J RHEUMATOL, V22, P1941; LEDINGHAM J, 1995, ANN RHEUM DIS, V54, P53, DOI 10.1136/ard.54.1.53; Loughlin J, 2001, CURR OPIN RHEUMATOL, V13, P111, DOI 10.1097/00002281-200103000-00004; Ogata K, 1997, INT ORTHOP, V21, P308, DOI 10.1007/s002640050174; Peat G, 2001, ANN RHEUM DIS, V60, P91, DOI 10.1136/ard.60.2.91; Sharma L, 2001, JAMA-J AM MED ASSOC, V286, P188, DOI 10.1001/jama.286.2.188; Sharma L, 2000, ARTHRITIS RHEUM, V43, P568, DOI 10.1002/1529-0131(200003)43:3<568::AID-ANR13>3.0.CO;2-E	13	64	66	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 8	2001	358	9284					775	776		10.1016/S0140-6736(01)06006-8	http://dx.doi.org/10.1016/S0140-6736(01)06006-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	472NA	11564477				2022-12-24	WOS:000170989300003
J	Sambrano, GR; Weiss, EJ; Zheng, YW; Huang, W; Coughlin, SR				Sambrano, GR; Weiss, EJ; Zheng, YW; Huang, W; Coughlin, SR			Role of thrombin signalling in platelets in haemostasis and thrombosis	NATURE			English	Article							GLYCOPROTEIN IB-ALPHA; COLLAGEN RECEPTOR; ACTIVATION; MODEL; GENE; ANTIBODY; IIB/IIIA; FAMILY; DEATH; MICE	Platelets are critical in haemostasis and in arterial thrombosis, which causes heart attacks and other events triggered by abnormal clotting(1-5). The coagulation protease thrombin is a potent activator of platelets ex vivo(6). However, because thrombin also mediates fibrin deposition and because multiple agonists can trigger platelet activation(7), the relative importance of platelet activation by thrombin in haemostasis and thrombosis is unknown. Thrombin triggers cellular responses at least in part through protease-activated receptors (PARs)(8). Mouse platelets express PAR3 and PAR4 (ref. 9). Here we show that platelets from PAR4-deficient mice failed to change shape, mobilize calcium, secrete ATP or aggregate in response to thrombin. This result demonstrates that PAR signalling is necessary for mouse platelet activation by thrombin and supports the model that mouse PAR3 (mPAR3) does not by itself mediate transmembrane signalling but instead acts as a cofactor for thrombin cleavage and activation of mPAR4 (ref. 10). Importantly, PAR4-deficient mice had markedly prolonged bleeding times and were protected in a model of arteriolar thrombosis. Thus platelet activation by thrombin is necessary for normal haemostasis and may be an important target in the treatment of thrombosis.	Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Coughlin, SR (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, 513 Parnassus Ave, San Francisco, CA 94143 USA.							Andrews RK, 1999, THROMB HAEMOSTASIS, V82, P357, DOI 10.1055/s-0037-1615854; COLLER BS, 1986, BLOOD, V68, P783; Colman RW, 1994, HEMOSTASIS THROMBOSI, P3; COOK JJ, 1995, CIRCULATION, V91, P2961, DOI 10.1161/01.CIR.91.12.2961; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; DAVEY MG, 1967, NATURE, V216, P857, DOI 10.1038/216857a0; DAVIES MJ, 1989, EUR HEART J, V10, P203, DOI 10.1093/oxfordjournals.eurheartj.a059467; DEMARCO L, 1991, J BIOL CHEM, V266, P23776; Denis C, 1998, P NATL ACAD SCI USA, V95, P9524, DOI 10.1073/pnas.95.16.9524; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; Giesen PLA, 1999, P NATL ACAD SCI USA, V96, P2311, DOI 10.1073/pnas.96.5.2311; Ishihara H, 1998, BLOOD, V91, P4152, DOI 10.1182/blood.V91.11.4152.411k22_4152_4157; Ishihara H, 1997, NATURE, V386, P502, DOI 10.1038/386502a0; Kahn ML, 1998, J BIOL CHEM, V273, P23290, DOI 10.1074/jbc.273.36.23290; Kahn ML, 1998, NATURE, V394, P690, DOI 10.1038/29325; Kehrel B, 1998, BLOOD, V91, P491; Lewandoski M, 1997, COLD SPRING HARB SYM, V62, P159; LEWIS HD, 1983, NEW ENGL J MED, V309, P396, DOI 10.1056/NEJM198308183090703; Mann KG, 1999, THROMB HAEMOSTASIS, V82, P165; Meiner VL, 1996, P NATL ACAD SCI USA, V93, P14041, DOI 10.1073/pnas.93.24.14041; MORTENSEN R, 1993, CURRENT PROTOCOLS S, V23; Nakanishi-Matsui M, 2000, NATURE, V404, P609, DOI 10.1038/35007085; Offermanns S, 2000, BIOL CHEM, V381, P389, DOI 10.1515/BC.2000.051; Ramakrishnan V, 2001, P NATL ACAD SCI USA, V98, P1823, DOI 10.1073/pnas.98.4.1823; SAUER B, 1993, GUIDE TECHNIQUES MOU, P890; SCHLAEGER TM, 1995, DEVELOPMENT, V121, P1089; Schwartz MA, 2000, TRENDS BIOCHEM SCI, V25, P388, DOI 10.1016/S0968-0004(00)01605-4; Topol E, 1998, NEW ENGL J MED, V339, P436; WARE J, 1990, P NATL ACAD SCI USA, V87, P2026, DOI 10.1073/pnas.87.5.2026; Watson S, 2000, PLATELETS, V11, P252	30	407	424	1	49	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 6	2001	413	6851					74	78		10.1038/35092573	http://dx.doi.org/10.1038/35092573			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469EG	11544528				2022-12-24	WOS:000170801200041
J	Lu, Z; Klem, AM; Ramu, Y				Lu, Z; Klem, AM; Ramu, Y			Ion conduction pore is conserved among potassium channels	NATURE			English	Article							RECTIFIER K+ CHANNEL; VOLTAGE-SENSING RESIDUES; INWARD-RECTIFIER; STREPTOMYCES-LIVIDANS; FUNCTIONAL EXPRESSION; MOLECULAR-BASIS; GATING CHARGE; C-TERMINUS; RECTIFICATION; INACTIVATION	Potassium channels, a group of specialized membrane proteins, enable K+ ions to flow selectively across cell membranes. Transmembrane K+ currents underlie electrical signalling in neurons and other excitable cells. The atomic structure of a bacterial K+ channel pore has been solved by means of X-ray crystallography. To the extent that the prokaryotic pore is representative of other K+ channels, this landmark achievement has profound implications for our general understanding of K+ channels. But serious doubts have been raised concerning whether the prokaryotic K+ channel pore does actually represent those of eukaryotes. Here we have addressed this fundamental issue by substituting the prokaryotic pore into eukaryotic voltage-gated and inward-rectifier K+ channels. The resulting chimaeras retain the respective functional hallmarks of the eukaryotic channels, which indicates that the ion conduction pore is indeed conserved among K+ channels.	Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA	University of Pennsylvania	Lu, Z (corresponding author), Univ Penn, Dept Physiol, 3700 Hamilton Walk, Philadelphia, PA 19104 USA.							Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; ARMSTRONG CM, 1971, J GEN PHYSIOL, V58, P413, DOI 10.1085/jgp.58.4.413; BOND CT, 1994, RECEPTOR CHANNEL, V2, P183; BUTLER A, 1989, SCIENCE, V243, P943, DOI 10.1126/science.2493160; Caprini M, 2001, J BIOL CHEM, V276, P21070, DOI 10.1074/jbc.M100487200; Chen GQ, 1999, NATURE, V402, P817, DOI 10.1038/45568; DASCAL N, 1993, P NATL ACAD SCI USA, V90, P10235, DOI 10.1073/pnas.90.21.10235; del Camino D, 2000, NATURE, V403, P321, DOI 10.1038/35002099; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; FAKLER B, 1995, CELL, V80, P149, DOI 10.1016/0092-8674(95)90459-X; FICKER E, 1994, SCIENCE, V266, P1068, DOI 10.1126/science.7973666; GARCIA ML, 1994, BIOCHEMISTRY-US, V33, P6834, DOI 10.1021/bi00188a012; Guo DL, 2000, J GEN PHYSIOL, V116, P561, DOI 10.1085/jgp.116.4.561; Hackos DH, 2001, BIOPHYS J, V80, p182A; Heginbotham L, 1999, J GEN PHYSIOL, V114, P551, DOI 10.1085/jgp.114.4.551; HO K, 1993, NATURE, V362, P31, DOI 10.1038/362031a0; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; HOSHI T, 1991, NEURON, V7, P547, DOI 10.1016/0896-6273(91)90367-9; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; KAMB A, 1988, NEURON, V1, P421, DOI 10.1016/0896-6273(88)90192-4; KRAPIVINSKY G, 1995, NATURE, V374, P135, DOI 10.1038/374135a0; KUBO Y, 1993, NATURE, V362, P127, DOI 10.1038/362127a0; KUBO Y, 1993, NATURE, V364, P802, DOI 10.1038/364802a0; Larsson HP, 1996, NEURON, V16, P387, DOI 10.1016/S0896-6273(00)80056-2; Li-Smerin Y, 1998, P NATL ACAD SCI USA, V95, P8585, DOI 10.1073/pnas.95.15.8585; Li-Smerin YY, 2000, NEURON, V25, P411, DOI 10.1016/S0896-6273(00)80904-6; LIMAN ER, 1991, NATURE, V353, P752, DOI 10.1038/353752a0; Liu Y, 1997, NEURON, V19, P175, DOI 10.1016/S0896-6273(00)80357-8; LOPATIN AN, 1994, NATURE, V372, P366, DOI 10.1038/372366a0; LOPEZBARNEO J, 1993, RECEPTOR CHANNEL, V1, P61; LU Z, 1994, NATURE, V371, P243, DOI 10.1038/371243a0; Lu Z, 1997, BIOCHEMISTRY-US, V36, P6936, DOI 10.1021/bi9702849; MacKinnon R, 1998, SCIENCE, V280, P106, DOI 10.1126/science.280.5360.106; Minor DL, 1999, CELL, V96, P879, DOI 10.1016/S0092-8674(00)80597-8; PAPAZIAN DM, 1991, NATURE, V349, P305, DOI 10.1038/349305a0; PARDO LA, 1992, P NATL ACAD SCI USA, V89, P2466, DOI 10.1073/pnas.89.6.2466; Perozo E, 1999, SCIENCE, V285, P73, DOI 10.1126/science.285.5424.73; PONGS O, 1988, EMBO J, V7, P1087, DOI 10.1002/j.1460-2075.1988.tb02917.x; SCHOPPA NE, 1992, SCIENCE, V255, P1712, DOI 10.1126/science.1553560; SCHREMPF H, 1995, EMBO J, V14, P5170, DOI 10.1002/j.1460-2075.1995.tb00201.x; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; Spassova MA, 1998, J GEN PHYSIOL, V112, P211, DOI 10.1085/jgp.112.2.211; STANFIELD PR, 1994, J PHYSIOL-LONDON, V478, P1; TAGLIALATELA M, 1995, EMBO J, V14, P5532, DOI 10.1002/j.1460-2075.1995.tb00240.x; TEMPEL BL, 1987, SCIENCE, V237, P770, DOI 10.1126/science.2441471; VANDONGEN AMJ, 1990, NEURON, V5, P433, DOI 10.1016/0896-6273(90)90082-Q; WIBLE BA, 1994, NATURE, V371, P246, DOI 10.1038/371246a0; YANG J, 1995, NEURON, V14, P1047, DOI 10.1016/0896-6273(95)90343-7; Yang NB, 1996, NEURON, V16, P113, DOI 10.1016/S0896-6273(00)80028-8; YELLEN G, 1994, BIOPHYS J, V66, P1068, DOI 10.1016/S0006-3495(94)80888-4	50	266	273	1	26	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 25	2001	413	6858					809	813		10.1038/35101535	http://dx.doi.org/10.1038/35101535			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	485JA	11677598				2022-12-24	WOS:000171750200037
J	Wong, K; Ren, XR; Huang, YZ; Xie, Y; Liu, GF; Saito, H; Tang, H; Wen, L; Brady-Kalnay, SM; Mei, L; Wu, JY; Xiong, WC; Rao, Y				Wong, K; Ren, XR; Huang, YZ; Xie, Y; Liu, GF; Saito, H; Tang, H; Wen, L; Brady-Kalnay, SM; Mei, L; Wu, JY; Xiong, WC; Rao, Y			Signal transduction in neuronal migration: Roles of GTPase activating proteins and the small GTPase Cdc42 in the Slit-Robo pathway	CELL			English	Article							ACTIN-DEPOLYMERIZING PROTEIN; PHOTORECEPTOR AXON GUIDANCE; ALDRICH-SYNDROME PROTEIN; GROWTH-CONE COLLAPSE; ARP2/3 COMPLEX; N-WASP; DROSOPHILA-MELANOGASTER; CELL-ADHESION; RHO GTPASES; REPELLENT	The Slit protein guides neuronal and leukocyte migration through the transmembrane receptor Roundabout (Robo). We report here that the intracellular domain of Robo interacts with a novel family of Rho GTPase activating proteins (GAPs). Two of the Slit-Robo GAPs (srGAPs) are expressed in regions responsive to Slit. Slit increased srGAP1-Robo1 interaction and inactivated Cdc42. A dominant negative srGAP1 blocked Slit inactivation of Cdc42 and Slit repulsion of migratory cells from the anterior subventricular zone (SVZa) of the forebrain. A constitutively active Cdc42 blocked the repulsive effect of Slit. These results have demonstrated important roles for GAPs and Cdc42 in neuronal migration. We propose a signal transduction pathway from the extracellular guidance cue to intracellular actin polymerization.	Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; Univ Alabama Birmingham, Sch Med, Dept Pathol, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Sch Med, Dept Neurobiol, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Sch Med, Dept Phys Med & Rehabil, Birmingham, AL 35294 USA; Case Western Reserve Univ, Sch Med, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Case Western Reserve University	Rao, Y (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, 660 S Euclid Ave, St Louis, MO 63110 USA.	wxiong@path.uab.edu; raoyi@thalamus.wustl.edu	Tang, Hao/G-9841-2011; Mei, Lin/G-8755-2012		NCI NIH HHS [R01 CA114197-01A2] Funding Source: Medline; NEI NIH HHS [R01 EY014576-03] Funding Source: Medline; NIGMS NIH HHS [R01 GM070967-02] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA114197] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY014576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070967] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ba-Charvet KTN, 2001, J NEUROSCI, V21, P4281; Ba-Charvet KTN, 1999, NEURON, V22, P463, DOI 10.1016/S0896-6273(00)80702-3; Bashaw GJ, 2000, CELL, V101, P703, DOI 10.1016/S0092-8674(00)80883-1; Battye R, 1999, DEVELOPMENT, V126, P2475; Blanchoin L, 2000, NATURE, V404, P1007, DOI 10.1038/35010008; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Burden-Gulley SM, 1999, J CELL BIOL, V144, P1323, DOI 10.1083/jcb.144.6.1323; Chen JH, 2001, J NEUROSCI, V21, P1548, DOI 10.1523/JNEUROSCI.21-05-01548.2001; DEVREOTES PN, 1988, ANNU REV CELL BIOL, V4, P649, DOI 10.1146/annurev.cb.04.110188.003245; Driessens MHE, 2001, CURR BIOL, V11, P339, DOI 10.1016/S0960-9822(01)00092-6; Erskine L, 2000, J NEUROSCI, V20, P4975; Garrity PA, 1996, CELL, V85, P639, DOI 10.1016/S0092-8674(00)81231-3; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Higgs HN, 2000, J CELL BIOL, V150, P1311, DOI 10.1083/jcb.150.6.1311; Hildebrand JD, 1996, MOL CELL BIOL, V16, P3169; Hing H, 1999, CELL, V97, P853, DOI 10.1016/S0092-8674(00)80798-9; Hu HY, 1999, NEURON, V23, P703, DOI 10.1016/S0896-6273(01)80029-5; Huang YZ, 2000, NEURON, V26, P443, DOI 10.1016/S0896-6273(00)81176-9; Jin Z, 1997, J NEUROSCI, V17, P6256; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Kuhn TB, 1999, J NEUROSCI, V19, P1965; LAMARCHE N, 1994, TRENDS GENET, V10, P436, DOI 10.1016/0168-9525(94)90114-7; Li HS, 1999, CELL, V96, P807, DOI 10.1016/S0092-8674(00)80591-7; Lin MZ, 2000, CELL, V101, P239, DOI 10.1016/S0092-8674(00)80833-8; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Ma L, 1998, P NATL ACAD SCI USA, V95, P15362, DOI 10.1073/pnas.95.26.15362; Machesky LM, 1999, J CELL BIOL, V146, P267, DOI 10.1083/jcb.146.2.267; Miki H, 1998, NATURE, V391, P93, DOI 10.1038/34208; Miki H, 1996, EMBO J, V15, P5326, DOI 10.1002/j.1460-2075.1996.tb00917.x; Mueller BK, 1999, ANNU REV NEUROSCI, V22, P351, DOI 10.1146/annurev.neuro.22.1.351; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; Mullins RD, 1999, CURR BIOL, V9, P405, DOI 10.1016/S0960-9822(99)80187-0; Niclou SP, 2000, J NEUROSCI, V20, P4962; NUSSLEINVOLHARD C, 1984, ROUX ARCH DEV BIOL, V193, P267, DOI 10.1007/BF00848156; O'Brien SP, 2000, P NATL ACAD SCI USA, V97, P12074, DOI 10.1073/pnas.97.22.12074; Paulus W, 1996, J VIROL, V70, P62, DOI 10.1128/JVI.70.1.62-67.1996; Pear Warren S., 1997, P41; Prehoda KE, 2000, SCIENCE, V290, P801, DOI 10.1126/science.290.5492.801; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Ren XR, 2001, J CELL BIOL, V152, P971, DOI 10.1083/jcb.152.5.971; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Ringstedt T, 2000, J NEUROSCI, V20, P4983; Rohatgi R, 2000, J CELL BIOL, V150, P1299, DOI 10.1083/jcb.150.6.1299; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; ROTHBERG JM, 1988, CELL, V55, P1047, DOI 10.1016/0092-8674(88)90249-8; Ruan WJ, 1999, NEURON, V24, P595, DOI 10.1016/S0896-6273(00)81115-0; Sander EE, 1998, J CELL BIOL, V143, P1385, DOI 10.1083/jcb.143.5.1385; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; SWIFT S, 1999, CURRENT PROTOCOL S31, V28; Symons M, 1996, CELL, V84, P723, DOI 10.1016/S0092-8674(00)81050-8; Vastrik I, 1999, CURR BIOL, V9, P991, DOI 10.1016/S0960-9822(99)80447-3; Vikis HG, 2000, P NATL ACAD SCI USA, V97, P12457, DOI 10.1073/pnas.220421797; Wahl S, 2000, J CELL BIOL, V149, P263, DOI 10.1083/jcb.149.2.263; Wang KH, 1999, CELL, V96, P771, DOI 10.1016/S0092-8674(00)80588-7; Wu JY, 2001, NATURE, V410, P948, DOI 10.1038/35073616; Wu W, 1999, NATURE, V400, P331, DOI 10.1038/22477; Yuan WL, 1999, DEV BIOL, V212, P290, DOI 10.1006/dbio.1999.9371; Zallen JA, 1998, CELL, V92, P217, DOI 10.1016/S0092-8674(00)80916-2; Zhu Y, 1999, NEURON, V23, P473, DOI 10.1016/S0896-6273(00)80801-6; Zigmond SH, 1997, J CELL BIOL, V138, P363, DOI 10.1083/jcb.138.2.363	61	429	459	1	53	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 19	2001	107	2					209	221		10.1016/S0092-8674(01)00530-X	http://dx.doi.org/10.1016/S0092-8674(01)00530-X			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	484MU	11672528	Bronze			2022-12-24	WOS:000171694800010
J	Heine, A; DeSantis, G; Luz, JG; Mitchell, M; Wong, CH; Wilson, IA				Heine, A; DeSantis, G; Luz, JG; Mitchell, M; Wong, CH; Wilson, IA			Observation of covalent intermediates in an enzyme mechanism at atomic resolution	SCIENCE			English	Article							FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE; CRYSTAL-STRUCTURE; MUSCLE ALDOLASE; DEOXYRIBOSE-5-PHOSPHATE ALDOLASE; BINDING; CONDENSATION; ANTIBODIES; CATALYST; CLEAVAGE; ANGSTROM	In classical enzymology, intermediates and transition states in a catalytic mechanism are usually inferred from a series of biochemical experiments. Here, we derive an enzyme mechanism from true atomic-resolution x-ray structures of reaction intermediates. Two ultra-high resolution structures of wild-type and mutant D-2-deoxyribose-5-phosphate (DRP) aldolase complexes with DRP at 1.05 and 1.10 angstroms unambiguously identify the postulated covalent carbinolamine and Schiff base intermediates in the aldolase mechanism. In combination with site-directed mutagenesis and H-1 nuclear magnetic resonance, we can now propose how the heretofore elusive C-2 proton abstraction step and the overall stereochemical course are accomplished. A proton relay system appears to activate a conserved active-site water that functions as the critical mediator for proton transfer.	Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Wong, CH (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.				NIGMS NIH HHS [GM44154] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044154, R37GM044154] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allard J, 2001, P NATL ACAD SCI USA, V98, P3679, DOI 10.1073/pnas.071380898; Barbas CF, 1997, SCIENCE, V278, P2085, DOI 10.1126/science.278.5346.2085; BARBAS CF, 1990, J AM CHEM SOC, V112, P2013, DOI 10.1021/ja00161a064; BARBAS CF, 1989, THESIS TEXAS A M U C; Blom N, 1997, NAT STRUCT BIOL, V4, P36, DOI 10.1038/nsb0197-36; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHEN LR, 1992, J AM CHEM SOC, V114, P741, DOI 10.1021/ja00028a050; Choi KH, 1999, BIOCHEMISTRY-US, V38, P12655, DOI 10.1021/bi9828371; CONNOLLY ML, 1983, J APPL CRYSTALLOGR, V16, P439; COPLEY RR, 1994, J MOL BIOL, V242, P321; Dalby A, 1999, PROTEIN SCI, V8, P291; DeSantis G, 1998, J AM CHEM SOC, V120, P8582, DOI 10.1021/ja980072e; Fong S, 2000, CHEM BIOL, V7, P873, DOI 10.1016/S1074-5521(00)00035-1; GREEN MM, 1974, J ORG CHEM, V39, P2166, DOI 10.1021/jo00929a006; HEINE A, UNPUB; HOFFEE P, 1974, ARCH BIOCHEM BIOPHYS, V164, P736, DOI 10.1016/0003-9861(74)90087-3; Jia J, 1997, PROTEIN SCI, V6, P119; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Karlstrom A, 2000, P NATL ACAD SCI USA, V97, P3878, DOI 10.1073/pnas.97.8.3878; Kim H, 1998, BIOCHEMISTRY-US, V37, P4388, DOI 10.1021/bi972233h; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KRISHNAN G, 1991, EUR J BIOCHEM, V195, P343, DOI 10.1111/j.1432-1033.1991.tb15712.x; Larsen TM, 1998, BIOCHEMISTRY-US, V37, P6247, DOI 10.1021/bi980243s; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LITTLECHILD JA, 1993, TRENDS BIOCHEM SCI, V18, P36, DOI 10.1016/0968-0004(93)90048-R; Machajewski TD, 2000, ANGEW CHEM INT EDIT, V39, P1352, DOI 10.1002/(SICI)1521-3773(20000417)39:8<1352::AID-ANIE1352>3.0.CO;2-J; MELOCHE HP, 1973, SCIENCE, V181, P350, DOI 10.1126/science.181.4097.350; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; MORRIS AJ, 1994, BIOCHEMISTRY-US, V33, P12291, DOI 10.1021/bi00206a036; Morris AJ, 1996, PROTEIN ENG, V9, P61, DOI 10.1093/protein/9.1.61; NICHOLAS PC, 1988, BIOCHEM SOC T, V16, P752, DOI 10.1042/bst0160752; NICHOLAS PC, 1988, BIOCHEM SOC T, V76, P752; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PRICER WE, 1960, J BIOL CHEM, V5, P1292; ROSE IA, 1967, ARCH BIOCHEM BIOPHYS, V118, P758, DOI 10.1016/0003-9861(67)90414-6; SCHMIDT DE, 1971, BIOCHEMISTRY-US, V10, P1249; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; SHERIFF S, 1993, IMMUNOMETHODS, V3, P191; SILVESTRI M, IN PRESS TOPICS STER; SYGUSCH J, 1987, P NATL ACAD SCI USA, V84, P7846, DOI 10.1073/pnas.84.22.7846; VALENTINHANSEN P, 1982, EUR J BIOCHEM, V125, P561, DOI 10.1111/j.1432-1033.1982.tb06719.x; Verlinde CLMJ, 1999, J MOL MODEL, V5, P37, DOI 10.1007/s008940050103; WAGNER J, 1995, SCIENCE, V270, P1797, DOI 10.1126/science.270.5243.1797; WESTHEIMER FH, 1995, TETRAHEDRON, V51, P3, DOI 10.1016/0040-4020(94)00865-R; Wymer N, 2001, STRUCTURE, V9, P1, DOI 10.1016/S0969-2126(00)00555-4; Zhong GF, 1999, ANGEW CHEM INT EDIT, V38, P3738, DOI 10.1002/(SICI)1521-3773(19991216)38:24<3738::AID-ANIE3738>3.0.CO;2-2; Zhong GF, 1998, ANGEW CHEM INT EDIT, V37, P2481, DOI 10.1002/(SICI)1521-3773(19981002)37:18<2481::AID-ANIE2481>3.0.CO;2-T	47	252	258	3	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 12	2001	294	5541					369	374		10.1126/science.1063601	http://dx.doi.org/10.1126/science.1063601			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	482WZ	11598300				2022-12-24	WOS:000171601400043
J	Seibel, BA; Walsh, PJ				Seibel, BA; Walsh, PJ			Carbon cycle - Potential, impacts of CO2 injection on deep-sea biota	SCIENCE			English	Editorial Material							ANIMALS; METABOLISM; DEPTH; ADAPTATIONS; HABITAT; FISHES; LIFE		Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA; Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Div Marine Biol & Fisheries, NIEHS,Marine & Freshwater Biomed Sci Ctr, Miami, FL 33149 USA	Monterey Bay Aquarium Research Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Miami	Seibel, BA (corresponding author), Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA.							ARP AJ, 1985, PHYSIOL ZOOL, V58, P38, DOI 10.1086/physzool.58.1.30161218; AUERBACH D, 1996, OCEAN STORAGE CARBON, P41; BARRY JJA, UNPUB; Brewer P. G., 2000, OCEANOGRAPHY, V13, P84, DOI [DOI 10.5670/OCEANOG.2000.38, 10.5670/oceanog.2000.38]; CHILDRESS JJ, 1995, TRENDS ECOL EVOL, V10, P30, DOI 10.1016/S0169-5347(00)88957-0; Childress JJ, 1998, J EXP BIOL, V201, P1223; Drange H, 2001, GEOPHYS RES LETT, V28, P2637, DOI 10.1029/2000GL012609; Gage JD, 1991, DEEP SEA BIOL NATURA; GIBBS A, 1990, MAR BIOL, V106, P315, DOI 10.1007/BF01344307; Goffredi SK, 2001, MAR BIOL, V138, P259, DOI 10.1007/s002270000462; Guppy M, 1999, BIOL REV, V74, P1, DOI 10.1017/S0006323198005258; Haedrich RL, 1996, J FISH BIOL, V49, P40, DOI 10.1111/j.1095-8649.1996.tb06066.x; HEISLER N, 1989, CAN J ZOOL, V67, P2923, DOI 10.1139/z89-415; HENRY RP, 1990, J CRUSTACEAN BIOL, V10, P413, DOI 10.2307/1548331; Hunt JC, 2000, MAR BIOL, V136, P543, DOI 10.1007/s002270050714; Kerr RA, 2001, SCIENCE, V292, P1978, DOI 10.1126/science.292.5524.1978; Kochevar RE, 1996, MAR BIOL, V125, P375, DOI 10.1007/BF00346318; MARCHETTI C, 1977, CLIMATIC CHANGE, V1, P59, DOI 10.1007/BF00162777; MICKEL TJ, 1978, BIOL BULL, V154, P138, DOI 10.2307/1540779; Morgan IJ, 2001, GLOBAL CHANGE BIOL, V7, P345, DOI 10.1046/j.1365-2486.2001.00424.x; NOBLE RW, 1986, BIOCHIM BIOPHYS ACTA, V870, P552, DOI 10.1016/0167-4838(86)90265-7; Reipschloger A., 1996, OCEAN STORAGE CARBON, P57; Seibel BA, 1997, BIOL BULL, V192, P262, DOI 10.2307/1542720; SMITH KL, 1982, MAR BIOL, V68, P287, DOI 10.1007/BF00409595; Somero G.N., 1985, P454; Tamburri MN, 2000, MAR CHEM, V72, P95, DOI 10.1016/S0304-4203(00)00075-X; WALSH PJ, 1989, CAN J ZOOL, V67, P2994, DOI 10.1139/z89-422; White D., 2012, PHYSL BIOCH PROKARYO	28	154	163	5	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 12	2001	294	5541					319	320		10.1126/science.1065301	http://dx.doi.org/10.1126/science.1065301			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	482WZ	11598290				2022-12-24	WOS:000171601400030
J	Yokoyama, T; Yokoyama, S; Kamikado, T; Okuno, Y; Mashiko, S				Yokoyama, T; Yokoyama, S; Kamikado, T; Okuno, Y; Mashiko, S			Selective assembly on a surface of supramolecular aggregates with controlled size and shape	NATURE			English	Article							MOLECULES; AU(111); NANOSTRUCTURES; MANIPULATION; DEVICES	The realization of molecule-based miniature devices with advanced functions requires the development of new and efficient approaches for combining molecular building blocks into desired functional structures, ideally with these structures supported on suitable substrates(1-4). Supramolecular aggregation occurs spontaneously and can lead to controlled structures if selective and directional non-covalent interactions are exploited. But such selective supramolecular assembly has yielded almost exclusively crystals or dissolved structures(5); the self-assembly of absorbed molecules into larger structures(6-8), in contrast, has not yet been directed by controlling selective intermolecular interactions. Here we report the formation of surface-supported supramolecular structures whose size and aggregation pattern are rationally controlled by tuning the non-covalent interactions between individual absorbed molecules. Using low-temperature scanning tunnelling microscopy, we show that substituted porphyrin molecules adsorbed on a gold surface form monomers, trimers, tetramers or extended wire-like structures. We rnd that each structure corresponds in a predictable fashion to the geometric and chemical nature of the porphyrin substituents that mediate the interactions between individual adsorbed molecules. Our findings suggest that careful placement of functional groups that are able to participate in directed noncovalent interactions will allow the rational design and construction of a wide range of supramolecular architectures absorbed to surfaces.	Natl Inst Mat Sci, Moriyama Ku, Nagoya, Aichi 4630003, Japan; Commun Res Labs, Nishi Ku, Kobe, Hyogo 6512401, Japan	National Institute for Materials Science; National Institute of Information & Communications Technology (NICT) - Japan	Yokoyama, T (corresponding author), Natl Inst Mat Sci, Moriyama Ku, 2268-1 Shimo Shidami, Nagoya, Aichi 4630003, Japan.	Yokoyama.takashi@nims.go.jp	Yokoyama, Takashi/B-9845-2011					BARTH JV, 1990, PHYS REV B, V42, P9307, DOI 10.1103/PhysRevB.42.9307; Barth JV, 2000, ANGEW CHEM INT EDIT, V39, P1230, DOI 10.1002/(SICI)1521-3773(20000403)39:7<1230::AID-ANIE1230>3.0.CO;2-I; Bohringer M, 1999, PHYS REV LETT, V83, P324, DOI 10.1103/PhysRevLett.83.324; Cai LT, 2000, APPL PHYS LETT, V77, P3105, DOI 10.1063/1.1323546; CHAMBLISS DD, 1991, PHYS REV LETT, V66, P1721, DOI 10.1103/PhysRevLett.66.1721; Collier CP, 1999, SCIENCE, V285, P391, DOI 10.1126/science.285.5426.391; DEREGE PJF, 1995, SCIENCE, V269, P1409, DOI 10.1126/science.7660123; FIND HW, 1999, NATURE, V398, P407; Furukawa M, 2000, SURF SCI, V445, pL58, DOI 10.1016/S0039-6028(99)01068-7; Joachim C, 2000, NATURE, V408, P541, DOI 10.1038/35046000; Jung TA, 1996, SCIENCE, V271, P181, DOI 10.1126/science.271.5246.181; Jung TA, 1997, NATURE, V386, P696, DOI 10.1038/386696a0; Lehn J. M., 1995, SUPRAMOLECULAR CHEM; Lopinski GP, 2000, NATURE, V406, P48, DOI 10.1038/35017519; Moresco F, 2001, PHYS REV LETT, V86, P672, DOI 10.1103/PhysRevLett.86.672; Moresco F, 2001, APPL PHYS LETT, V78, P306, DOI 10.1063/1.1339251; Sugiura K, 1999, CHEM LETT, P841, DOI 10.1246/cl.1999.841; Wada Y, 2000, JPN J APPL PHYS 1, V39, P3835, DOI 10.1143/JJAP.39.3835; Yokoyama T, 2001, J CHEM PHYS, V115, P3814, DOI 10.1063/1.1389276; Yokoyama T, 1999, PHYS REV B, V59, P12232, DOI 10.1103/PhysRevB.59.12232	20	742	749	7	297	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 11	2001	413	6856					619	621		10.1038/35098059	http://dx.doi.org/10.1038/35098059			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480WE	11675782				2022-12-24	WOS:000171485700045
J	Lai, CSL; Fisher, SE; Hurst, JA; Vargha-Khadem, F; Monaco, AP				Lai, CSL; Fisher, SE; Hurst, JA; Vargha-Khadem, F; Monaco, AP			A forkhead-domain gene is mutated in a severe speech and language disorder	NATURE			English	Article							TRANSCRIPTION FACTORS; CLEFT-PALATE; HEAD; FAMILY; LOCALIZATION; MUTATIONS; GLAUCOMA; MODEL; FOXC1; FKHL7	Individuals affected with developmental disorders of speech and language have substantial difficulty acquiring expressive and/or receptive language in the absence of any profound sensory or neurological impairment and despite adequate intelligence and opportunity(1). Although studies of twins consistently indicate that a significant genetic component is involved(1-3), most families segregating speech and language deficits show complex patterns of inheritance, and a gene that predisposes individuals to such disorders has not been identified. We have studied a unique three-generation pedigree, KE, in which a severe speech and language disorder is transmitted as an autosomal-dominant monogenic trait(4). Our previous work mapped the locus responsible, SPCH1, to a 5.6-cM interval of region 7q31 on chromosome 7 (ref. 5). We also identified an unrelated individual, CS, in whom speech and language impairment is associated with a chromosomal translocation involving the SPCH1 interval(6). Here we show that the gene FOXP2, which encodes a putative transcription factor containing a polyglutamine tract and a forkhead DNA-binding domain, is directly disrupted by the translocation breakpoint in CS. In addition, we identify a point mutation in affected members of the KE family that alters an invariant amino-acid residue in the forkhead domain. Our findings suggest that FOXP2 is involved in the developmental process that culminates in speech and language.	Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Oxford Radcliffe Hosp, Dept Clin Genet, Oxford OX3 7LJ, England; Inst Child Hlth, Dev Cognit Neurosci Unit, London WC1N 2AP, England	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; University of London; University College London	Monaco, AP (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England.		Monaco, Anthony P/A-4495-2010; Fisher, Simon E./E-9130-2012; Vargha-Khadem, Faraneh/C-2558-2008	Monaco, Anthony P/0000-0001-7480-3197; Fisher, Simon E./0000-0002-3132-1996; vargha-khadem, faraneh/0000-0003-4890-8379				Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; BISHOP DVM, 1995, DEV MED CHILD NEUROL, V37, P56; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; CLARK KL, 1993, NATURE, V364, P412, DOI 10.1038/364412a0; Clifton-Bligh RJ, 1998, NAT GENET, V19, P399, DOI 10.1038/1294; Crisponi L, 2001, NAT GENET, V27, P159, DOI 10.1038/84781; Cummings CJ, 2000, HUM MOL GENET, V9, P909, DOI 10.1093/hmg/9.6.909; Dale PS, 1998, NAT NEUROSCI, V1, P324, DOI 10.1038/1142; De Felice M, 1998, NAT GENET, V19, P395, DOI 10.1038/1289; Fang JM, 2000, AM J HUM GENET, V67, P1382, DOI 10.1086/316915; Fisher SE, 1998, NAT GENET, V18, P168, DOI 10.1038/ng0298-168; GOPNIK M, 1991, COGNITION, V39, P1, DOI 10.1016/0010-0277(91)90058-C; Kaestner KH, 2000, GENE DEV, V14, P142; Kaufmann E, 1996, MECH DEVELOP, V57, P3, DOI 10.1016/0925-4773(96)00539-4; Lai CSL, 2000, AM J HUM GENET, V67, P357, DOI 10.1086/303011; LAI E, 1993, P NATL ACAD SCI USA, V90, P10421, DOI 10.1073/pnas.90.22.10421; Lehmann OJ, 2000, AM J HUM GENET, V67, P1129; LI C, 1993, P NATL ACAD SCI USA, V90, P11583, DOI 10.1073/pnas.90.24.11583; Margolis RL, 1997, HUM GENET, V100, P114, DOI 10.1007/s004390050476; Mears AJ, 1998, AM J HUM GENET, V63, P1316, DOI 10.1086/302109; Nishimura DY, 1998, NAT GENET, V19, P140, DOI 10.1038/493; Nishimura DY, 2001, AM J HUM GENET, V68, P364, DOI 10.1086/318183; Semina EV, 2001, HUM MOL GENET, V10, P231, DOI 10.1093/hmg/10.3.231; Shu WG, 2001, J BIOL CHEM, V276, P27488, DOI 10.1074/jbc.M100636200; Smith RS, 2000, HUM MOL GENET, V9, P1021, DOI 10.1093/hmg/9.7.1021; Tomblin JB, 1998, J SPEECH LANG HEAR R, V41, P188, DOI 10.1044/jslhr.4101.188; Vargha-Khadem F, 1998, P NATL ACAD SCI USA, V95, P12695, DOI 10.1073/pnas.95.21.12695; VARGHAKHADEM F, 1995, P NATL ACAD SCI USA, V92, P930, DOI 10.1073/pnas.92.3.930; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; [No title captured]	30	1296	1341	2	221	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 4	2001	413	6855					519	523		10.1038/35097076	http://dx.doi.org/10.1038/35097076			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	478HG	11586359	Green Published			2022-12-24	WOS:000171340500046
J	Falkenburger, BH; Barstow, KL; Mintz, IM				Falkenburger, BH; Barstow, KL; Mintz, IM			Dendrodendritic inhibition through reversal of dopamine transport	SCIENCE			English	Article							RAT SUBSTANTIA NIGRA; VENTRAL TEGMENTAL AREA; DENDRITIC RELEASE; PARS RETICULATA; IN-VITRO; NEURONS; SLICES; ELECTROPHYSIOLOGY; STIMULATION; CHANNELS	Synapses in the central nervous system are usually defined by presynaptic exocytotic release sites and postsynaptic differentiations. We report here a demonstration of dendrodendritic inhibition that does not engage a conventional synapse. Using amperometric and patch-clamp recordings in rat brain slices of the substantia nigra, we found that blockade of the dopamine transporter abolished the dendritic release of dopamine and the resulting self-inhibition. These findings demonstrate that dendrodendritic autoinhibition entails the carrier-mediated release of dopamine rather than conventional exocytosis. This suggests that some widely used antidepressants that inhibit the dopamine transporter may benefit patients in the early stages of Parkinson's disease.	Boston Univ, Med Ctr, Dept Pharmacol & Expt Therapeut, Boston, MA 02118 USA	Boston University	Mintz, IM (corresponding author), Boston Univ, Med Ctr, Dept Pharmacol & Expt Therapeut, Boston, MA 02118 USA.	imintz@bu.edu		Falkenburger, Bjoern/0000-0002-2387-526X	PHS HHS [R01-3445] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ARANEDA R, 1989, J NEUROCHEM, V52, P962, DOI 10.1111/j.1471-4159.1989.tb02548.x; BARSTOW KL, 2001, THESIS BOSTON U SCH; Bjorklund A., 1984, HDB CHEM NEUROANAT 1, V2, P55; BUDA M, 1981, EUR J PHARMACOL, V73, P61, DOI 10.1016/0014-2999(81)90145-X; CHERAMY A, 1981, NATURE, V16, P415; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; COLLINGRIDGE GL, 1979, J PHYSIOL-LONDON, V290, pP44; DRAY A, 1976, BRAIN RES, V113, P45, DOI 10.1016/0006-8993(76)90005-6; Elverfors A, 1997, SYNAPSE, V26, P359, DOI 10.1002/(SICI)1098-2396(199708)26:4<359::AID-SYN4>3.0.CO;2-5; ESHLEMAN AJ, 1994, MOL PHARMACOL, V45, P312; GEFFEN LB, 1976, NATURE, V260, P258, DOI 10.1038/260258a0; GIROS B, 1993, TRENDS PHARMACOL SCI, V14, P43, DOI 10.1016/0165-6147(93)90029-J; GRAYBIEL AM, 1994, SCIENCE, V265, P1826, DOI 10.1126/science.8091209; GROVES PM, 1975, SCIENCE, V190, P522, DOI 10.1126/science.242074; HAUSSER M, 1995, NEURON, V15, P637, DOI 10.1016/0896-6273(95)90152-3; Hoffman AF, 1998, J PHARMACOL EXP THER, V287, P487; Hoffman AF, 1999, J PHARMACOL EXP THER, V289, P455; Iribe Y, 1999, J NEUROPHYSIOL, V82, P925, DOI 10.1152/jn.1999.82.2.925; Jaffe EH, 1998, J NEUROSCI, V18, P3548; JOHNSON SW, 1992, J PHYSIOL-LONDON, V450, P455, DOI 10.1113/jphysiol.1992.sp019136; Lai CT, 1997, BIOCHEM PHARMACOL, V53, P363, DOI 10.1016/S0006-2952(96)00731-9; LLINAS R, 1984, BRAIN RES, V294, P127, DOI 10.1016/0006-8993(84)91316-7; Lozano AM, 1998, CURR OPIN NEUROBIOL, V8, P783, DOI 10.1016/S0959-4388(98)80122-0; MINTZ I, 1986, BRAIN RES, V376, P406, DOI 10.1016/0006-8993(86)90209-X; Nirenberg MJ, 1996, J NEUROSCI, V16, P436; PUCAK ML, 1995, CRIT REV NEUROBIOL, V9, P67; Rice ME, 1997, J NEUROPHYSIOL, V77, P853, DOI 10.1152/jn.1997.77.2.853; ROSALES MG, 1994, BRAIN RES, V645, P335, DOI 10.1016/0006-8993(94)91669-1; ROTHMAN RB, 1993, SYNAPSE, V14, P34, DOI 10.1002/syn.890140106; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; SHARIF NA, 1992, NEUROCHEM INT, V21, P69, DOI 10.1016/0197-0186(92)90068-3; Sonders MS, 1996, CURR OPIN NEUROBIOL, V6, P294, DOI 10.1016/S0959-4388(96)80111-5; WASSEF M, 1981, NEUROSCIENCE, V6, P2125, DOI 10.1016/0306-4522(81)90003-8; YUNG WH, 1991, J PHYSIOL-LONDON, V436, P643, DOI 10.1113/jphysiol.1991.sp018571	34	163	165	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 28	2001	293	5539					2465	2470		10.1126/science.1060645	http://dx.doi.org/10.1126/science.1060645			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	476PD	11577238				2022-12-24	WOS:000171237200051
J	Garcia-Pichel, F; Pringault, O				Garcia-Pichel, F; Pringault, O			Microbiology - Cyanobacteria track water in desert soils	NATURE			English	Article							CHEMOTAXIS; MIGRATIONS		Arizona State Univ, Dept Microbiol, Tempe, AZ 85287 USA; Univ Bordeaux 1, Lab Oceanog Biol, CNRS, UMR EPOC 5805, F-33120 Arcachon, France	Arizona State University; Arizona State University-Tempe; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite de Bordeaux	Garcia-Pichel, F (corresponding author), Arizona State Univ, Dept Microbiol, Tempe, AZ 85287 USA.	ferran@asu.edu	Pringault, Olivier/P-2495-2019; Pringault, Olivier/A-7399-2008	Pringault, Olivier/0000-0003-2363-8376; Pringault, Olivier/0000-0003-2363-8376				Armitage JP, 1999, ADV MICROB PHYSIOL, V41, P229, DOI 10.1016/S0065-2911(08)60168-X; BEBOUT BM, 1995, APPL ENVIRON MICROB, V61, P4215, DOI 10.1128/AEM.61.12.4215-4222.1995; BELNAP J, 1993, GREAT BASIN NAT, V53, P40; Garcia-Pichel F, 2001, APPL ENVIRON MICROB, V67, P1902, DOI 10.1128/AEM.67.4.1902-1910.2001; GarciaPichel F, 1996, J PHYCOL, V32, P774, DOI 10.1111/j.0022-3646.1996.00774.x; GARCIAPICHEL F, 1994, APPL ENVIRON MICROB, V60, P1500, DOI 10.1128/AEM.60.5.1500-1511.1994; LI CY, 1988, P NATL ACAD SCI USA, V85, P9451, DOI 10.1073/pnas.85.24.9451; MALIN G, 1985, J GEN MICROBIOL, V131, P2643; MARTINAC B, 1990, NATURE, V348, P261, DOI 10.1038/348261a0; Wilkinson PC, 1997, AUTOIMMUNITY, V26, P55, DOI 10.3109/08916939709009550	10	147	155	3	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 27	2001	413	6854					380	381		10.1038/35096640	http://dx.doi.org/10.1038/35096640			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475UY	11574875				2022-12-24	WOS:000171188700041
J	Milan, M; Weihe, U; Perez, L; Cohen, SM				Milan, M; Weihe, U; Perez, L; Cohen, SM			The LRR proteins Capricious and Tartan mediate cell interactions during DV boundary formation in the Drosophila wing	CELL			English	Article							LIM-HOMEODOMAIN ACTIVITY; APICAL ECTODERMAL RIDGE; VENTRAL CELLS; EPH RECEPTORS; DORSOVENTRAL COMPARTMENTALIZATION; LINEAGE RESTRICTION; GRADIENT FORMATION; ADHESION MOLECULE; GENE-EXPRESSION; RADICAL FRINGE	Mechanisms to segregate cell populations play important roles in tissue patterning during animal development. Rhombomeres and compartments in the ectoderm and imaginal discs of Drosophila are examples in which initially homogenous populations of cells come to be separated by boundaries of lineage restriction. Boundary formation depends in part on signaling between the distinctly specified cell populations that comprise compartments and in part on formation of affinity boundaries that prevent intermingling of these cell populations. Here, we present evidence that two transmembrane proteins with leucine-rich repeats, known as Capricious and Tartan, contribute to formation of the affinity boundary between dorsal and ventral compartments during Drosophila wing development.	European Mol Biol Lab, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Cohen, SM (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.	cohen@embl-heidelberg.de	Milan, Marco/H-1450-2015; Cohen, Stephen M/G-9930-2011; Perez, Lidia/F-7695-2016	Milan, Marco/0000-0002-7111-6444; Cohen, Stephen M/0000-0003-2858-9163; Perez, Lidia/0000-0002-8821-1202				BASLER K, 1994, NATURE, V368, P208, DOI 10.1038/368208a0; BLAIR SS, 1994, DEVELOPMENT, V120, P1805; Blair SS, 1997, DEVELOPMENT, V124, P4053; Brook WJ, 1996, SCIENCE, V273, P1373, DOI 10.1126/science.273.5280.1373; Bruckner K, 2000, NATURE, V406, P411, DOI 10.1038/35019075; Bruckner K, 1998, CURR OPIN NEUROBIOL, V8, P375, DOI 10.1016/S0959-4388(98)80064-0; Calleja M, 1996, SCIENCE, V274, P252, DOI 10.1126/science.274.5285.252; CHANG Z, 1993, DEV BIOL, V160, P315, DOI 10.1006/dbio.1993.1310; Cho KO, 2000, CELL, V103, P331, DOI 10.1016/S0092-8674(00)00124-0; COHEN B, 1992, GENE DEV, V6, P715, DOI 10.1101/gad.6.5.715; Dahmann C, 1999, TRENDS GENET, V15, P320, DOI 10.1016/S0168-9525(99)01774-6; Dahmann C, 2000, CELL, V100, P411, DOI 10.1016/S0092-8674(00)80677-7; deCelis JF, 1996, DEVELOPMENT, V122, P359; DiazBenjumea FJ, 1995, DEVELOPMENT, V121, P4215; DIAZBENJUMEA FJ, 1993, CELL, V75, P741, DOI 10.1016/0092-8674(93)90494-B; Doherty D, 1996, GENE DEV, V10, P421, DOI 10.1101/gad.10.4.421; Dominguez M, 1996, SCIENCE, V272, P1621, DOI 10.1126/science.272.5268.1621; Entchev EV, 2000, CELL, V103, P981, DOI 10.1016/S0092-8674(00)00200-2; Fernandez-Funez P, 1998, EMBO J, V17, P6846, DOI 10.1093/emboj/17.23.6846; Fleming RJ, 1997, DEVELOPMENT, V124, P2973; GARCIABELLIDO A, 1973, NATURE-NEW BIOL, V245, P251, DOI 10.1038/newbio245251a0; GARCIABELLIDO A, 1972, GENETICS, V72, P87; HAY BA, 1994, DEVELOPMENT, V120, P2121; Hynes RO, 1999, TRENDS CELL BIOL, V9, pM33, DOI 10.1016/S0962-8924(99)01667-0; IRVINE KD, 1994, CELL, V79, P595, DOI 10.1016/0092-8674(94)90545-2; Laufer E, 1997, NATURE, V386, P366, DOI 10.1038/386366a0; Martin-Blanco E, 2000, P NATL ACAD SCI USA, V97, P7888, DOI 10.1073/pnas.97.14.7888; MEADOWS LA, 1994, J CELL SCI, V107, P321; Mellitzer G, 1999, NATURE, V400, P77, DOI 10.1038/21907; Micchelli CA, 1999, NATURE, V401, P473, DOI 10.1038/46779; Milan M, 1999, MOL CELL, V4, P267, DOI 10.1016/S1097-2765(00)80374-3; Milan M, 1998, GENE DEV, V12, P2912, DOI 10.1101/gad.12.18.2912; Milan M, 1999, MOL CELL, V4, P1073, DOI 10.1016/S1097-2765(00)80235-X; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; MORATA G, 1975, NATURE, V255, P614, DOI 10.1038/255614a0; Morcillo P, 1997, GENE DEV, V11, P2729, DOI 10.1101/gad.11.20.2729; NOSE A, 1992, CELL, V70, P553, DOI 10.1016/0092-8674(92)90426-D; Panin VM, 1997, NATURE, V387, P908, DOI 10.1038/43191; Raghavan S, 1997, NEURON, V18, P873, DOI 10.1016/S0896-6273(00)80327-X; Raich WB, 1999, CURR BIOL, V9, P1139, DOI 10.1016/S0960-9822(00)80015-9; Ramirez-Weber FA, 2000, MOL CELL, V6, P479, DOI 10.1016/S1097-2765(00)00046-0; Ramirez-Weber FA, 1999, CELL, V97, P599, DOI 10.1016/S0092-8674(00)80771-0; Rauskolb C, 1999, NATURE, V401, P476, DOI 10.1038/46786; Rodriguez I, 1997, NATURE, V389, P614, DOI 10.1038/39343; RodriguezEsteban C, 1997, NATURE, V386, P360, DOI 10.1038/386360a0; ROTHBERG JM, 1990, GENE DEV, V4, P2169, DOI 10.1101/gad.4.12a.2169; Salzberg A, 1997, GENETICS, V147, P1723; Shishido E, 1998, SCIENCE, V280, P2118, DOI 10.1126/science.280.5372.2118; STEINBERG MS, 1994, P NATL ACAD SCI USA, V91, P206, DOI 10.1073/pnas.91.1.206; Strigini M, 2000, CURR BIOL, V10, P293, DOI 10.1016/S0960-9822(00)00378-X; TABATA T, 1995, DEVELOPMENT, V121, P3359; TABATA T, 1994, CELL, V76, P89, DOI 10.1016/0092-8674(94)90175-9; van Meyel DJ, 1999, MOL CELL, V4, P259, DOI 10.1016/S1097-2765(00)80373-1; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Vasioukhin V, 2001, CURR OPIN CELL BIOL, V13, P76, DOI 10.1016/S0955-0674(00)00177-0; Vleminckx K, 1999, BIOESSAYS, V21, P211, DOI 10.1002/(SICI)1521-1878(199903)21:3<211::AID-BIES5>3.3.CO;2-G; Xu QL, 1999, NATURE, V399, P267, DOI 10.1038/20452; ZECCA M, 1995, DEVELOPMENT, V121, P2265	58	106	107	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 21	2001	106	6					785	794		10.1016/S0092-8674(01)00489-5	http://dx.doi.org/10.1016/S0092-8674(01)00489-5			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	476EJ	11572783	Bronze			2022-12-24	WOS:000171213000014
J	Fox, JE; Starcevic, M; Kow, KY; Burow, ME; McLachlan, JA				Fox, JE; Starcevic, M; Kow, KY; Burow, ME; McLachlan, JA			Nitrogen fixation - Endocrine disrupters and flavonoid signalling	NATURE			English	Article							MELILOTI NODULATION GENES; RHIZOBIUM-MELILOTI; EXPRESSION; INDUCTION; PROTEIN; NODD		Tulane Univ, Environm Endocrinol Lab, Ctr Bioenvironm Res, Sch Med, New Orleans, LA 70112 USA; Xavier Univ, Environm Endocrinol Lab, Ctr Bioenvironm Res, Cincinnati, OH 45207 USA; Tulane Univ, Mol & Cellular Biol Program, Sch Med, New Orleans, LA 70112 USA; Tulane Univ, Dept Pharmacol, Sch Med, New Orleans, LA 70112 USA	Tulane University; Xavier University; Tulane University; Tulane University	McLachlan, JA (corresponding author), Tulane Univ, Environm Endocrinol Lab, Ctr Bioenvironm Res, Sch Med, New Orleans, LA 70112 USA.		Burow, Matthew/D-6351-2013	Burow, Matthew/0000-0002-0642-6630				Baker ME, 1998, ADV EXP MED BIOL, V439, P249; Collins-Burow BM, 2000, NUTR CANCER, V38, P229, DOI 10.1207/S15327914NC382_13; DJORDJEVIC MA, 1987, EMBO J, V6, P1173, DOI 10.1002/j.1460-2075.1987.tb02351.x; FIRMIN JL, 1986, NATURE, V324, P90, DOI 10.1038/324090a0; Gage DJ, 1996, J BACTERIOL, V178, P7159, DOI 10.1128/jb.178.24.7159-7166.1996; GYORGYPAL Z, 1991, MOL GEN GENET, V226, P337, DOI 10.1007/BF00273624; McLachlan JA, 2001, ENDOCR REV, V22, P319, DOI 10.1210/er.22.3.319; MULLIGAN JT, 1985, P NATL ACAD SCI USA, V82, P6609, DOI 10.1073/pnas.82.19.6609; PETERS NK, 1986, SCIENCE, V233, P977, DOI 10.1126/science.3738520; PETERS NK, 1988, PLANT PHYSIOL, V88, P396, DOI 10.1104/pp.88.2.396; REDMOND JW, 1986, NATURE, V323, P632, DOI 10.1038/323632a0; Schultze M, 1998, ANNU REV GENET, V32, P33, DOI 10.1146/annurev.genet.32.1.33; Tham DM, 1998, J CLIN ENDOCR METAB, V83, P2223, DOI 10.1210/jc.83.7.2223	13	49	51	3	38	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 13	2001	413	6852					128	129		10.1038/35093163	http://dx.doi.org/10.1038/35093163			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471FU	11557969				2022-12-24	WOS:000170918800035
J	Gum, PA; Thamilarasan, M; Watanabe, J; Blackstone, EH; Lauer, MS				Gum, PA; Thamilarasan, M; Watanabe, J; Blackstone, EH; Lauer, MS			Aspirin use and all-cause mortality among patients being evaluated for known or suspected coronary artery disease - A propensity analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CHRONIC STABLE ANGINA; HEART-RATE RECOVERY; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; PRIMARY PREVENTION; RANDOMIZED-TRIALS; UNSTABLE ANGINA; EXERCISE; ASSOCIATION; PREDICTOR	Context Although aspirin has been shown to reduce cardiovascular morbidity and short-term mortality following acute myocardial infarction, the association between its use and long-term all-cause mortality has not been well defined. Objectives To determine whether aspirin is associated with a mortality benefit in stable patients with known or suspected coronary disease and to identify patient characteristics that predict the maximum absolute mortality benefit from aspirin. Design and Setting Prospective, nonrandomized, observational cohort study conducted between 1990 and 1998 at an academic medical institution, with a median follow-up of 3.1 years. Patients Of 6174 consecutive adults undergoing stress echocardiography for evaluation of known or suspected coronary disease, 2310 (37%) were taking aspirin. Patients with significant valvular disease or documented contraindication to aspirin use, including peptic ulcer disease, renal insufficiency, and use of nonsteroidal antiinflammatory drugs, were excluded. Main Outcome Measure All-cause mortality according to aspirin use. Results During 3.1 years of follow-up, 276 patients (4.5%) died. In a simple univariable analysis, there was no association between aspirin use and mortality(4.5% vs 4.5%). However, after adjustment for age, sex, standard cardiovascular risk factors, use of other medications, coronary disease history, ejection fraction, exercise capacity, heart rate recovery, and echocardiographic ischemia, aspirin use was associated with reduced mortality (hazard ratio [HR], 0.67; 95% confidence interval [CI], 0.51-0.87; P = .002). In further analysis using matching by propensity score, 1351 patients who were taking aspirin were at lower risk for death than 1351 patients not using aspirin (4% vs 8%, respectively; HR, 0.53; 95% Cl, 0.38-0.74; P = .002). After adjusting for the propensity for using aspirin, as well as other possible confounders and interactions, aspirin use remained associated with a lower risk for death (adjusted HR, 0.56; 95% Cl, 0.40-0.78; P<.001). The patient characteristics associated with the most aspirin-related reductions in mortality were older age, known coronary artery disease, and impaired exercise capacity. Conclusion Aspirin use among patients undergoing stress echocardiography was independently associated with reduced long-term all-cause mortality, particularly among older patients, those with known coronary artery disease, and those with impaired exercise capacity.	Cleveland Clin Fdn, Dept Cardiol, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Dept Thorac & Cardiovasc Surg, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Dept Biostat & Epidemiol, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Lauer, MS (corresponding author), Cleveland Clin Fdn, Dept Cardiol, Desk F25,9500 Euclid Ave, Cleveland, OH 44195 USA.	lauerm@ccf.org	Lauer, Michael S/L-9656-2013	Lauer, Michael S/0000-0002-9217-8177	NHLBI NIH HHS [HL 66004-01] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066004] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALTMAN R, 1994, BMJ-BRIT MED J, V308, P81, DOI 10.1136/bmj.308.6921.81; [Anonymous], 1988, LANCET, V2, P349; [Anonymous], 1993, ARCH INTERN MED, V153, P154, DOI DOI 10.1001/archinte.1993.00410020010002; BASTYR EJ, 1990, AM J MED, V88, P601, DOI 10.1016/0002-9343(90)90525-I; Benson K, 2000, NEW ENGL J MED, V342, P1878, DOI 10.1056/NEJM200006223422506; BLACKSTONE EH, 1986, J AM STAT ASSOC, V81, P615, DOI 10.2307/2288989; BOYLE CA, 1990, AM J EPIDEMIOL, V131, P160, DOI 10.1093/oxfordjournals.aje.a115470; Buffon A, 1999, J AM COLL CARDIOL, V34, P1512, DOI 10.1016/S0735-1097(99)00348-4; CAIRNS JA, 1985, NEW ENGL J MED, V313, P1369, DOI 10.1056/NEJM198511283132201; CAIRNS P, 1987, ARCH PATHOL LAB MED, V111, P80; Cole CR, 1999, NEW ENGL J MED, V341, P1351, DOI 10.1056/NEJM199910283411804; Concato J, 2000, NEW ENGL J MED, V342, P1887, DOI 10.1056/NEJM200006223422507; Cook NR, 2000, ARCH INTERN MED, V160, P921, DOI 10.1001/archinte.160.7.921; COX DR, 1972, J R STAT SOC B, V34, P187; Gibbons RJ, 1997, J AM COLL CARDIOL, V30, P260; Harpaz D, 1998, AM J MED, V105, P494, DOI 10.1016/S0002-9343(98)00328-3; HENNEKENS CH, 1989, NEW ENGL J MED, V321, P129, DOI 10.1056/nejm198907203210301; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Hosmer D.W., 2004, APPL LOGISTIC REGRES, VSecond; HUBBARD BL, 1992, ARCH INTERN MED, V152, P309, DOI 10.1001/archinte.152.2.309; Ikonomidis I, 1999, CIRCULATION, V100, P793, DOI 10.1161/01.CIR.100.8.793; Joffe MM, 1999, AM J EPIDEMIOL, V150, P327; JUULMOLLER S, 1992, LANCET, V340, P1421, DOI 10.1016/0140-6736(92)92619-Q; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KESTIN AS, 1993, CIRCULATION, V88, P1502, DOI 10.1161/01.CIR.88.4.1502; Krumholz HM, 2001, ARCH INTERN MED, V161, P577, DOI 10.1001/archinte.161.4.577; Lauer MS, 1999, J AM COLL CARDIOL, V34, P618, DOI 10.1016/S0735-1097(99)00250-8; Lauer MS, 1999, JAMA-J AM MED ASSOC, V281, P524, DOI 10.1001/jama.281.6.524; Lauer MS, 2000, JAMA-J AM MED ASSOC, V283, P2988, DOI 10.1001/jama.283.22.2988; Lauer MS, 1998, J AM COLL CARDIOL, V32, P1280, DOI 10.1016/S0735-1097(98)00377-5; Leor J, 1999, J AM COLL CARDIOL, V33, P1920, DOI 10.1016/S0735-1097(99)00129-1; LEWIS HD, 1983, NEW ENGL J MED, V309, P396, DOI 10.1056/NEJM198308183090703; Lytle BW, 1999, J THORAC CARDIOV SUR, V117, P855, DOI 10.1016/S0022-5223(99)70365-X; MANSON JE, 1991, JAMA-J AM MED ASSOC, V266, P521, DOI 10.1001/jama.266.4.521; Meade TW, 1998, LANCET, V351, P233; MOSES LE, 1995, MED CARE, V33, pAS8; Newman TB, 1997, J AM MED INFORM ASSN, V4, P233, DOI 10.1136/jamia.1997.0040233; Nishime EO, 2000, JAMA-J AM MED ASSOC, V284, P1392, DOI 10.1001/jama.284.11.1392; PETO R, 1988, BRIT MED J, V296, P313, DOI 10.1136/bmj.296.6618.313; Pocock SJ, 2000, NEW ENGL J MED, V342, P1907, DOI 10.1056/NEJM200006223422511; RIDKER PM, 1991, ANN INTERN MED, V114, P835, DOI 10.7326/0003-4819-114-10-835; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Snader CE, 1997, J AM COLL CARDIOL, V30, P641, DOI 10.1016/S0735-1097(97)00217-9; THEROUX P, 1988, NEW ENGL J MED, V319, P1105, DOI 10.1056/NEJM198810273191701; Tognoni G, 2001, LANCET, V357, P89, DOI 10.1016/S0140-6736(00)03539-X; TOHGI H, 1992, STROKE, V23, P1400, DOI 10.1161/01.STR.23.10.1400; TRIP MD, 1990, NEW ENGL J MED, V322, P1549, DOI 10.1056/NEJM199005313222201; TSCHOEPE D, 1993, CIRCULATION, V88, P37, DOI 10.1161/01.CIR.88.1.37; WALLENTIN L, 1990, LANCET, V336, P827	49	183	190	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 12	2001	286	10					1187	1194		10.1001/jama.286.10.1187	http://dx.doi.org/10.1001/jama.286.10.1187			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	471CR	11559263				2022-12-24	WOS:000170910400028
J	Nardi, M; Tomlinson, S; Greco, MA; Karpatkin, S				Nardi, M; Tomlinson, S; Greco, MA; Karpatkin, S			Complement-independent, peroxide-induced antibody lysis of platelets in HIV-1-related immune thrombocytopenia	CELL			English	Article							HEPARIN-INDUCED THROMBOCYTOPENIA; CHRONIC GRANULOMATOUS-DISEASE; MICROPARTICLE FORMATION; PLASMA-MEMBRANE; PROCOAGULANT ACTIVITY; ANTIPLATETLET GPIIIA; ACTIVATED PLATELETS; HIV-1 INFECTION; HOMOSEXUAL MEN; PURPURA	Immunologic thrombocytopenia is seen commonly in HIV-1 infection. The pathogenesis of this problem has been unclear, but it is associated with circulating immune complexes that contain platelet membrane, components and anti-platelet membrane GPIIIa49-66 IgG antibodies. These antibodies cause acute thrombocytopenia when injected into mice. We now show, that purified anti-GPIIIa49-66 causes platelet fragmentation, in vitro in the absence of complement, and in vivo in wild-type and C3-deficient mice. The mechanism of complement-independent platelet lysis; is shown to be caused by the antibody-induced generation of H2O2, as indicated by in vitro experiments with inhibitors of reactive oxygen species, and in vivo studies carried out with p47phox-deficient mice. Thus, a novel mechanism of immunologic platelet clearance is described in which an anti-platelet IgG causes platelet fragmentation via the induction of reactive oxygen species.	NYU, Sch Med, Dept Med, New York, NY 10016 USA; NYU, Sch Med, Dept Pediat, New York, NY 10016 USA; NYU, Sch Med, Dept Pathol, New York, NY 10016 USA	New York University; New York University; New York University	Karpatkin, S (corresponding author), NYU, Sch Med, Dept Med, 550 1st Ave, New York, NY 10016 USA.			Nardi, Michael/0000-0002-3276-3198	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL013336] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA004315] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-13336] Funding Source: Medline; NIDA NIH HHS [DA-04315] Funding Source: Medline; PHS HHS [A134451] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ABRAMS CS, 1990, BLOOD, V75, P128; ARMSTRONG MJ, 1988, BIOCHIM BIOPHYS ACTA, V946, P106, DOI 10.1016/0005-2736(88)90462-2; Aupeix K, 1997, J CLIN INVEST, V99, P1546, DOI 10.1172/JCI119317; Barry OP, 1998, J CLIN INVEST, V102, P136, DOI 10.1172/JCI2592; BASS DA, 1983, J IMMUNOL, V130, P1910; BEAUDOIN AR, 1991, BIOCHIM BIOPHYS ACTA, V1071, P203, DOI 10.1016/0304-4157(91)90014-N; Circolo A, 1999, IMMUNOPHARMACOLOGY, V42, P135, DOI 10.1016/S0162-3109(99)00021-1; FADOK VA, 1992, J IMMUNOL, V149, P4029; FOX JEB, 1991, J BIOL CHEM, V266, P13289; GEMMELL CH, 1993, J BIOL CHEM, V268, P14586; GEORGE JN, 1986, J CLIN INVEST, V78, P340, DOI 10.1172/JCI112582; HOLME PA, 1994, THROMB HAEMOSTASIS, V72, P666; Holme PA, 1998, FASEB J, V12, P79, DOI 10.1096/fasebj.12.1.79; Holme PA, 1998, THROMB HAEMOSTASIS, V79, P389; Holme PA, 1997, ARTERIOSCL THROM VAS, V17, P646, DOI 10.1161/01.ATV.17.4.646; Hughes M, 2000, BLOOD, V96, P188, DOI 10.1182/blood.V96.1.188.013k12_188_194; Inngjerdingen M, 1999, THROMB RES, V95, P215, DOI 10.1016/S0049-3848(99)00035-3; JACKSON SH, 1995, J EXP MED, V182, P751, DOI 10.1084/jem.182.3.751; JOST J, 1988, SCHWEIZ MED WSCHR, V118, P206; JY W, 1992, J LAB CLIN MED, V119, P119; KARPATKI.S, 1969, J CLIN INVEST, V48, P1073, DOI 10.1172/JCI106063; Karpatkin S, 1997, LANCET, V349, P1531, DOI 10.1016/S0140-6736(96)12118-8; KARPATKIN S, 1988, P NATL ACAD SCI USA, V85, P9763, DOI 10.1073/pnas.85.24.9763; KARPATKIN S, 1995, P NATL ACAD SCI USA, V92, P2263, DOI 10.1073/pnas.92.6.2263; KARPATKIN S, 1992, P NATL ACAD SCI USA, V89, P1487, DOI 10.1073/pnas.89.4.1487; KARPATKIN S, 1992, BLOOD, V80, P3164; Kelton JG, 1996, BRIT J HAEMATOL, V93, P421, DOI 10.1046/j.1365-2141.1996.4891031.x; KHAN I, 1975, BRIT J HAEMATOL, V31, P449, DOI 10.1111/j.1365-2141.1975.tb00880.x; LEAF AN, 1988, ANN INTERN MED, V109, P194, DOI 10.7326/0003-4819-109-3-194; LEE YJ, 1993, THROMB RES, V72, P295, DOI 10.1016/0049-3848(93)90138-E; LIU LX, 1995, BRIT J HAEMATOL, V91, P976; Mallat Z, 1999, CIRCULATION, V99, P348, DOI 10.1161/01.CIR.99.3.348; Miyamoto S, 1998, THROMB HAEMOSTASIS, V80, P225, DOI 10.1055/s-0037-1615177; MORRIS L, 1982, ANN INTERN MED, V96, P714, DOI 10.7326/0003-4819-96-6-714; MURPHY MF, 1987, BRIT J HAEMATOL, V66, P337, DOI 10.1111/j.1365-2141.1987.tb06920.x; NAJEAN Y, 1994, J LAB CLIN MED, V123, P415; Nardi M, 2000, J EXP MED, V191, P2093, DOI 10.1084/jem.191.12.2093; Nardi MA, 1997, P NATL ACAD SCI USA, V94, P7589, DOI 10.1073/pnas.94.14.7589; Nieuwland R, 2000, BLOOD, V95, P930, DOI 10.1182/blood.V95.3.930.003k46_930_935; Nieuwland R, 1997, CIRCULATION, V96, P3534; NOMURA S, 1995, ATHEROSCLEROSIS, V116, P235, DOI 10.1016/0021-9150(95)05551-7; OWENS MR, 1992, THROMB RES, V66, P247, DOI 10.1016/0049-3848(92)90195-G; RATNOFF OD, 1983, NEW ENGL J MED, V308, P439, DOI 10.1056/NEJM198302243080808; SAVONA S, 1985, ANN INTERN MED, V102, P737, DOI 10.7326/0003-4819-102-6-737; Segal BH, 2000, MEDICINE, V79, P170, DOI 10.1097/00005792-200005000-00004; Segundo C, 1999, BLOOD, V94, P1012, DOI 10.1182/blood.V94.3.1012.415k05_1012_1020; Shcherbina A, 1999, BLOOD, V93, P4222, DOI 10.1182/blood.V93.12.4222.412k34_4222_4231; SIMS PJ, 1989, J BIOL CHEM, V264, P17049; SIMS PJ, 1988, J BIOL CHEM, V263, P18205; Tait JF, 1999, J BIOL CHEM, V274, P3048, DOI 10.1074/jbc.274.5.3048; VARON D, 1983, P NATL ACAD SCI-BIOL, V80, P6992, DOI 10.1073/pnas.80.22.6992; WALSH CM, 1984, NEW ENGL J MED, V311, P635, DOI 10.1056/NEJM198409063111004; WARKENTIN TE, 1994, BLOOD, V84, P3691, DOI 10.1182/blood.V84.11.3691.bloodjournal84113691; WEIDMER T, 1990, BIOCHEMISTRY-US, V29, P623; Wentworth AD, 2000, P NATL ACAD SCI USA, V97, P10930, DOI 10.1073/pnas.97.20.10930; Wolf BB, 1999, BLOOD, V94, P1683, DOI 10.1182/blood.V94.5.1683.417k37_1683_1692; YANO Y, 1993, THROMB RES, V71, P385, DOI 10.1016/0049-3848(93)90163-I; YU JR, 1986, J CLIN INVEST, V77, P1756, DOI 10.1172/JCI112498; ZUCKERFRANKLIN D, 1977, NEW ENGL J MED, V297, P517, DOI 10.1056/NEJM197709082971001	59	110	110	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 7	2001	106	5					551	561		10.1016/S0092-8674(01)00477-9	http://dx.doi.org/10.1016/S0092-8674(01)00477-9			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	472FQ	11551503	Bronze			2022-12-24	WOS:000170973200006
J	Fitzgerald, KA; Palsson-McDermott, EM; Bowie, AG; Jefferies, CA; Mansell, AS; Brady, G; Brint, E; Dunne, A; Gray, P; Harte, MT; McMurray, D; Smith, DE; Sims, JE; Bird, TA; O'Neill, LAJ				Fitzgerald, KA; Palsson-McDermott, EM; Bowie, AG; Jefferies, CA; Mansell, AS; Brady, G; Brint, E; Dunne, A; Gray, P; Harte, MT; McMurray, D; Smith, DE; Sims, JE; Bird, TA; O'Neill, LAJ			Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction	NATURE			English	Article							DROSOPHILA TOLL; MYD88; ACTIVATION; FAMILY; IL-1; LIPOPROTEINS; RECOGNITION; PATHOGENS; ADAPTER; MEMBER	The recognition of microbial pathogens by the innate immune system involves Toll-like receptors (TLRs), which recognize pathogen-associated molecular patterns (1-9). Different TLRs recognize different pathogen-associated molecular patterns, with TLR-4 mediating the response to lipopolysaccharide from Gram-negative bacteria(5-7). All TLRs have a Toll/IL-1 receptor (TIR) domain, which is responsible for signal transduction(1,2). MyD88 is one such protein that contains a TIR domain(10,11). It acts as an adapter, being involved in TLR-2, TLR-4 and TLR-9 signalling(12-15); however, our understanding of how TLR-4 signals is incomplete(15,16). Here we describe a protein, Mal (MyD88-adapter-like), which joins MyD88 as a cytoplasmic TIR-domain-containing protein in the human genome. Mal activates NF-kappaB, Jun amino-terminal kinase and extracellular signal-regulated kinase-1 and -2. Mal can form homodimers and can also form heterodimers with MyD88. Activation of NF-kappaB by Mal requires IRAK-2, but not IRAK, whereas MyD88 requires both IRAKs. Mal associates with IRAK-2 by means of its TIR domain. A dominant negative form of Mal inhibits NF-kappaB, which is activated by TLR-4 or lipopolysaccharide, but it does not inhibit NF-kappaB activation by IL-1RI or IL-18R. Mal associates with TLR-4. Mal is therefore an adapter in TLR-4 signal transduction.	Univ Dublin Trinity Coll, Dept Biochem, Dublin 2, Ireland; Immunex Res & Dev Corp, Seattle, WA 98101 USA	Trinity College Dublin	O'Neill, LAJ (corresponding author), Univ Dublin Trinity Coll, Dept Biochem, Dublin 2, Ireland.		Mansell, Ashley/B-9553-2008; Jefferies, Caroline/AAI-1543-2021; Fitzgerald, Katherine/ABE-6317-2020	Mansell, Ashley/0000-0002-6540-1281; Jefferies, Caroline/0000-0002-8879-6722; dunne, aisling/0000-0002-2342-9518; Brint, Elizabeth/0000-0001-9214-149X; Sims, John/0000-0002-5667-9185; Fitzgerald, Kate/0000-0003-3175-609X; Brady, Gareth/0000-0001-5376-0060; O'Neill, Luke/0000-0002-4333-2748; Bowie, Andrew/0000-0001-5316-4373				Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Aliprantis AO, 1999, SCIENCE, V285, P736, DOI 10.1126/science.285.5428.736; Bowie A, 2000, P NATL ACAD SCI USA, V97, P10162, DOI 10.1073/pnas.160027697; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; COSMAN D, 1984, NATURE, V312, P768, DOI 10.1038/312768a0; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Jefferies C, 2001, MOL CELL BIOL, V21, P4544, DOI 10.1128/MCB.21.14.4544-4552.2001; Kaisho T, 2001, J IMMUNOL, V166, P5688, DOI 10.4049/jimmunol.166.9.5688; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kirschning CJ, 1998, J EXP MED, V188, P2091, DOI 10.1084/jem.188.11.2091; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Muzio M, 1998, J EXP MED, V187, P2097, DOI 10.1084/jem.187.12.2097; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Rock FL, 1998, P NATL ACAD SCI USA, V95, P588, DOI 10.1073/pnas.95.2.588; Schnare M, 2000, CURR BIOL, V10, P1139, DOI 10.1016/S0960-9822(00)00700-4; Schwandner R, 2000, J EXP MED, V191, P1233, DOI 10.1084/jem.191.7.1233; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; Wesche H, 1997, IMMUNITY, V7, P837, DOI 10.1016/S1074-7613(00)80402-1; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008	23	945	1004	0	73	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 6	2001	413	6851					78	83		10.1038/35092578	http://dx.doi.org/10.1038/35092578			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469EG	11544529				2022-12-24	WOS:000170801200042
J	Zwart, F				Zwart, F			A very special day	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	2	2	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUL 26	1997	315	7102					260	260		10.1136/bmj.315.7102.260	http://dx.doi.org/10.1136/bmj.315.7102.260			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XN517	11644985	Green Published			2022-12-24	WOS:A1997XN51700077
J	Rabinowitz, B				Rabinowitz, B			The great hijack	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	4	4	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	SEP 28	1996	313	7060					826	826						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	VK566	11644828				2022-12-24	WOS:A1996VK56600087
J	DUNEA, G				DUNEA, G			EDITORS IN DISTRESS	BRITISH MEDICAL JOURNAL			English	Editorial Material																		1988, BR MED J, V296, P307; 1988, JAMA            0108, P272	2	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	AUG 6	1988	297	6645					430	430		10.1136/bmj.297.6645.430	http://dx.doi.org/10.1136/bmj.297.6645.430			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	P5450	11644468	Green Published, Bronze			2022-12-24	WOS:A1988P545000065
J	Alvarez, B; Martinez, C; Burgering, BMT; Carrera, AC				Alvarez, B; Martinez, C; Burgering, BMT; Carrera, AC			Forkhead transcription factors contribute to execution of the mitotic programme in mammals	NATURE			English	Article							CELL-CYCLE; PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHOINOSITIDE 3-KINASE; REGULATORY SUBUNIT; FACTOR FKHR; KINASE; MITOSIS; PROGRESSION; PROTEIN; GROWTH	Cell cycle progression is a process that is tightly controlled by internal and external signals. Environmental cues, such as those provided by growth factors, activate early signals that promote cell cycle entry(1-3). Cells that have progressed past the restriction point become independent of growth factors, and cell cycle progression is then controlled endogenously. The phosphatidylinositol 3OH kinase (PI(3)K)/protein kinase B (PKB) pathway must be activated in G1 to inactivate forkhead transcription factors (FKH-TFs)(4,5) and allow cell cycle entry(2,3). Here we show that subsequent attenuation of the PI(3)K/PKB pathway is required to allow transcriptional activation of FKH-TF in G2. FKH-TF activity in G2 controls mammalian cell cycle termination, as interference with FKH transcriptional activation by disrupting PI(3)K/PKB downregulation, or by expressing a transcriptionally inactive FKH mutant, induces cell accumulation in G2/M, defective cytokinesis, and delayed transition from M to G1 of the cell cycle. We demonstrate that FKH-TFs regulate expression of mitotic genes such as cyclin B and polo-like kinase (Plk). Our results support the important role of forkhead in the control of mammalian cell cycle completion, and suggest that efficient execution of the mitotic programme depends on downregulation of PI(3)K/PKB and consequent induction of FKH transcriptional activity.	Univ Autonoma Madrid, CSIC, Ctr Nacl Biotecnol, Dept Immunol & Oncol, E-28049 Madrid, Spain; Univ Med Ctr, Dept Hematol, NL-3584 CG Utrecht, Netherlands	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Utrecht University; Utrecht University Medical Center	Carrera, AC (corresponding author), Univ Autonoma Madrid, CSIC, Ctr Nacl Biotecnol, Dept Immunol & Oncol, E-28049 Madrid, Spain.	acarrera@cnb.uam.es		Carrera, Ana/0000-0002-3999-5434				Borlado LR, 2000, FASEB J, V14, P895; Boyd KE, 1998, P NATL ACAD SCI USA, V95, P13887, DOI 10.1073/pnas.95.23.13887; BRAUNINGER A, 1995, ONCOGENE, V11, P1793; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; Carmena M, 1998, J CELL BIOL, V143, P659, DOI 10.1083/jcb.143.3.659; COGSWELL JP, 1995, MOL CELL BIOL, V15, P2782; del Peso L, 1999, ONCOGENE, V18, P7328, DOI 10.1038/sj.onc.1203159; Dijkers PF, 2000, CURR BIOL, V10, P1201, DOI 10.1016/S0960-9822(00)00728-4; Glover DM, 1998, GENE DEV, V12, P3777, DOI 10.1101/gad.12.24.3777; Jackson JG, 2000, ONCOGENE, V19, P4574, DOI 10.1038/sj.onc.1203825; Jimenez C, 2000, J CELL BIOL, V151, P249, DOI 10.1083/jcb.151.2.249; Jimenez C, 1998, EMBO J, V17, P743, DOI 10.1093/emboj/17.3.743; Jones SM, 1999, CURR BIOL, V9, P512, DOI 10.1016/S0960-9822(99)80235-8; Klippel A, 1998, MOL CELL BIOL, V18, P5699, DOI 10.1128/MCB.18.10.5699; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Kotani S, 1998, MOL CELL, V1, P371, DOI 10.1016/S1097-2765(00)80037-4; Kotani S, 1999, J CELL BIOL, V146, P791, DOI 10.1083/jcb.146.4.791; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Morgan DO, 1999, NAT CELL BIOL, V1, pE47, DOI 10.1038/10039; MURRAY AW, 1989, NATURE, V339, P280, DOI 10.1038/339280a0; PARDEE AB, 1989, SCIENCE, V246, P603, DOI 10.1126/science.2683075; Pic A, 2000, EMBO J, V19, P3750, DOI 10.1093/emboj/19.14.3750; Reif K, 1996, CURR BIOL, V6, P1445, DOI 10.1016/S0960-9822(96)00749-X; SURANA U, 1993, EMBO J, V12, P1969, DOI 10.1002/j.1460-2075.1993.tb05846.x; Takeshita T, 1997, IMMUNITY, V6, P449, DOI 10.1016/S1074-7613(00)80288-5; Tatsumoto T, 1999, J CELL BIOL, V147, P921, DOI 10.1083/jcb.147.5.921; Zachariae W, 1999, CURR OPIN CELL BIOL, V11, P708, DOI 10.1016/S0955-0674(99)00041-1; Zhu GF, 2000, NATURE, V406, P90, DOI 10.1038/35017581	29	232	235	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 18	2001	413	6857					744	747		10.1038/35099574	http://dx.doi.org/10.1038/35099574			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	482ZK	11607034				2022-12-24	WOS:000171608000046
J	White, DG; Zhao, S; Sudler, R; Ayers, S; Friedman, S; Chen, S; McDermott, PF; McDermott, S; Wagner, DD; Meng, JH				White, DG; Zhao, S; Sudler, R; Ayers, S; Friedman, S; Chen, S; McDermott, PF; McDermott, S; Wagner, DD; Meng, JH			The isolation of antibiotic-resistant Salmonella from retail ground meats.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TYPHIMURIUM DT104 INFECTIONS; FIELD GEL-ELECTROPHORESIS; PHAGE TYPE DT104; RAW-MILK CHEESE; MULTIDRUG-RESISTANT; UNITED-STATES; ANTIMICROBIAL RESISTANCE; INTEGRONS; GENES; CONSEQUENCES	Background: Salmonella is a leading cause of food-borne illness. The emergence of antimicrobial-resistant salmonella is associated with the use of antibiotics in animals raised for food; resistant bacteria can be transmitted to humans through foods, particularly those of animal origin. We identified and characterized strains of salmonella isolated from ground meats purchased in the Washington, D.C., area. Methods: Salmonella was isolated from samples of ground chicken, beef, turkey, and pork purchased at three supermarkets. The isolates were characterized by serotyping, antimicrobial-susceptibility testing, phage typing, and pulsed-field gel electrophoresis. The polymerase chain reaction and DNA sequencing were used to identify resistance integrons and extended spectrum beta -lactamase genes. Results: Of 200 meat samples, 41 (20 percent) contained salmonella, with a total of 13 serotypes. Eighty-four percent of the isolates were resistant to at least one antibiotic, and 53 percent were resistant to at least three antibiotics. Sixteen percent of the isolates were resistant to ceftriaxone, the drug of choice for treating salmonellosis in children. Bacteriophage typing identified four isolates of Salmonella enterica serotype typhimurium definitive type 104 (DT104), one of DT104b, and two of DT208. Five isolates of S. enterica serotype agona had resistance to 9 antibiotics, and the two isolates of serotype typhimurium DT208 were resistant to 12 antibiotics. Electrophoretic patterns of DNA that were indistinguishable from one another were repeatedly found in isolates from different meat samples and different stores. Eighteen isolates, representing four serotypes, had integrons with genes conferring resistance to aminoglycosides, sulfonamides, trimethoprim, and beta -lactams. Conclusions: Resistant strains of salmonella are common in retail ground meats. These findings provide support for the adoption of guidelines for the prudent use of antibiotics in food animals and for a reduction in the number of pathogens present on farms and in slaughterhouses. National surveillance for antimicrobial-resistant salmonella should be extended to include retail meats. (N Engl J Med 2001;345:1147-54.) Copyright (C) 2001 Massachusetts Medical Society.	Univ Maryland, Dept Nutr & Food Sci, College Pk, MD 20742 USA; US FDA, Ctr Vet Med, Div Anim & Food Microbiol Off Res, Laurel, MD USA	University System of Maryland; University of Maryland College Park; US Food & Drug Administration (FDA)	Meng, JH (corresponding author), Univ Maryland, Dept Nutr & Food Sci, College Pk, MD 20742 USA.	jm332@umail.umd.edu	McDermott, Patrick F./ABE-4374-2021	McDermott, Patrick F./0000-0003-1868-8096; Chen, Sheng/0000-0003-3526-7808				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Angulo FJ, 2000, MICROB DRUG RESIST, V6, P77, DOI 10.1089/mdr.2000.6.77; *AOAC INT, 1998, BACT AN MAN; Baggesen DL, 2000, J CLIN MICROBIOL, V38, P1581, DOI 10.1128/JCM.38.4.1581-1586.2000; BANNERMAN TL, 1995, J CLIN MICROBIOL, V33, P551, DOI 10.1128/JCM.33.3.551-555.1995; Calvert N, 1998, VET REC, V143, P351, DOI 10.1136/vr.143.13.351; *CDCP, 1998, STAND MOL SUBT FOODB; Cloeckaert A, 2000, ANTIMICROB AGENTS CH, V44, P1359, DOI 10.1128/AAC.44.5.1359-1361.2000; Cody SH, 1999, JAMA-J AM MED ASSOC, V281, P1805, DOI 10.1001/jama.281.19.1805; Davies A, 1996, Commun Dis Rep CDR Rev, V6, pR159; Davis MA, 1999, EMERG INFECT DIS, V5, P802, DOI 10.3201/eid0506.990610; Dunne EF, 2000, JAMA-J AM MED ASSOC, V284, P3151, DOI 10.1001/jama.284.24.3151; Fey PD, 2000, NEW ENGL J MED, V342, P1242, DOI 10.1056/NEJM200004273421703; Glynn MK, 1998, NEW ENGL J MED, V338, P1333, DOI 10.1056/NEJM199805073381901; Gomez Thomas M., 1997, World Health Statistics Quarterly, V50, P81; Grein T, 1999, IRISH MED J, V92, P238; Guerra B, 2000, ANTIMICROB AGENTS CH, V44, P2166, DOI 10.1128/AAC.44.8.2166-2169.2000; Hall RM, 1997, CIBA F SYMP, V207, P192; HALL RM, 1993, GENETICA, V90, P115, DOI 10.1007/BF01435034; Hohmann EL, 2001, CLIN INFECT DIS, V32, P263, DOI 10.1086/318457; Izumiya H, 1999, JPN J INFECT DIS, V52, P133; Markogiannakis A, 2000, J CLIN MICROBIOL, V38, P1269, DOI 10.1128/JCM.38.3.1269-1271.2000; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; *NAT COMM CLIN LAB, 1999, M31A NCCLS; National Committee for Clinical Laboratory Standards, 2000, M7A5 NCCLS; Ridley A, 1998, MICROB DRUG RESIST, V4, P113, DOI 10.1089/mdr.1998.4.113; Sandvang D, 1998, FEMS MICROBIOL LETT, V160, P37, DOI 10.1016/S0378-1097(98)00006-8; Synnott M B, 1998, Commun Dis Public Health, V1, P176; Taylor JP, 1998, J CLIN MICROBIOL, V36, P2861, DOI 10.1128/JCM.36.10.2861-2864.1998; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Tollefson L, 1997, REV SCI TECH OIE, V16, P709, DOI 10.20506/rst.16.2.1054; Tollefson L, 1998, VET CLIN N AM-FOOD A, V14, P141, DOI 10.1016/S0749-0720(15)30285-1; Villar RG, 1999, JAMA-J AM MED ASSOC, V281, P1811, DOI 10.1001/jama.281.19.1811; WHO, 2000, OV ANT RES; Winokur PL, 2000, ANTIMICROB AGENTS CH, V44, P2777, DOI 10.1128/AAC.44.10.2777-2783.2000; Witte W, 1998, SCIENCE, V279, P996, DOI 10.1126/science.279.5353.996; 1999, WKLY EPIDEMIOL REC, V74, P345; 1998, MMWR MORB MORTAL WKL, V47, P462	38	363	385	3	78	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 18	2001	345	16					1147	1154		10.1056/NEJMoa010315	http://dx.doi.org/10.1056/NEJMoa010315			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	482YX	11642230	Bronze			2022-12-24	WOS:000171605800001
J	Riedler, J; Braun-Fahrlander, C; Eder, W; Schreuer, M; Waser, M; Maisch, S; Carr, D; Schierl, R; Nowak, D; von Mutius, E				Riedler, J; Braun-Fahrlander, C; Eder, W; Schreuer, M; Waser, M; Maisch, S; Carr, D; Schierl, R; Nowak, D; von Mutius, E		ALEX Study Team	Exposure to farming in early life and development of asthma and allergy: a cross-sectional survey	LANCET			English	Article							HAY-FEVER; AUSTRIAN CHILDREN; IGE PRODUCTION; CHILDHOOD; SENSITIZATION; PREVALENCE; ATOPY; RISK; STIMULATION; CHALLENGE	Background A farming environment protects against development of asthma, hay fever, and atopic sensitisation in children. We aimed to establish whether increased exposure to microbial compounds has to occur early in life to affect maturation of the immune system and thereby reduces risk for development of allergic diseases. Methods We did a cross-sectional survey in rural areas of Austria, Germany, and Switzerland. 2618 (75%) of 3504 parents of 6-13-year-old children completed a standardised questionnaire on asthma, hay fever, and atopic eczema. Children from farming families, and a random sample of non-farmers' children, who gave consent for blood samples to be obtained for measurements of specific serum IgE antibodies to common allergens were invited to participate (n = 901). Findings Exposure of children younger than 1 year, compared with those aged 1-5 years, to stables and consumption of farm milk was associated with lower frequencies of asthma (1% [3/218] vs 11% [15/138]), hay fever (3% [7] vs 13% [18]), and atopic sensitisation (12% [27] vs 29% [40]). Protection against development of asthma was independent from effect on atopic sensitisation. Continual long-term exposure to stables until age 5 years was associated with the lowest frequencies of asthma (0.8% [1/122]), hay fever (0.8% [1]), and atopic sensitisation (8.2% [10]). Interpretation Long-term and early-life exposure to stables and farm milk induces a strong protective effect against development of asthma, hay fever, and atopic sensitisation.	Childrens Hosp, A-5020 Salzburg, Austria; Univ Basel, Inst Social & Prevent Med, Basel, Switzerland; Salzburg Univ, Dept Sociol, A-5020 Salzburg, Austria; Univ Munich, Dr von Hauner Childrens Hosp, Munich, Germany; Univ Munich, Inst Occupat & Environm Med, Munich, Germany	University of Basel; Salzburg University; University of Munich; University of Munich	Riedler, J (corresponding author), Childrens Hosp, Muellner Hauptstr 48, A-5020 Salzburg, Austria.		riedler, josef/AAQ-4666-2020					Baldini M, 1999, AM J RESP CELL MOL, V20, P976, DOI 10.1165/ajrcmb.20.5.3494; Ball TM, 2000, NEW ENGL J MED, V343, P538, DOI 10.1056/NEJM200008243430803; Beasley R, 1998, LANCET, V351, P1225, DOI 10.1016/S0140-6736(97)07302-9; Braun-Fahrlander C, 1999, CLIN EXP ALLERGY, V29, P28, DOI 10.1046/j.1365-2222.1999.00479.x; Ernst P, 2000, AM J RESP CRIT CARE, V161, P1563, DOI 10.1164/ajrccm.161.5.9908119; Holt PG, 1996, J EXP MED, V183, P1297, DOI 10.1084/jem.183.4.1297; Kilewein G, 1994, LEITFADEN MILCHKUNDE, P83; Kilpelainen M, 2000, CLIN EXP ALLERGY, V30, P201, DOI 10.1046/j.1365-2222.2000.00800.x; Klinman DM, 1999, VACCINE, V17, P19, DOI 10.1016/S0264-410X(98)00151-0; Kramer U, 1999, LANCET, V353, P450, DOI 10.1016/S0140-6736(98)06329-6; Lewis SA, 2000, CLIN EXP ALLERGY, V30, P153; MACATONIA SE, 1995, J IMMUNOL, V154, P5071; Murosaki S, 1998, J ALLERGY CLIN IMMUN, V102, P57, DOI 10.1016/S0091-6749(98)70055-7; Prescott SL, 1999, LANCET, V353, P196, DOI 10.1016/S0140-6736(98)05104-6; RIEDLER J, 1994, AM J RESP CRIT CARE, V150, P1632, DOI 10.1164/ajrccm.150.6.7952626; Riedler J, 2000, CLIN EXP ALLERGY, V30, P194, DOI 10.1046/j.1365-2222.2000.00799.x; Riedler J, 1998, EUR RESPIR J, V11, P355, DOI 10.1183/09031936.98.11020355; Sudo N, 1997, J IMMUNOL, V159, P1739; SUHREN G, 1986, MILCHWISSENSCHAFT, V41, P156; Tariq SM, 1998, J ALLERGY CLIN IMMUN, V101, P587, DOI 10.1016/S0091-6749(98)70164-2; Tulic MK, 2000, AM J RESP CELL MOL, V22, P604; ULEVITCH RJ, 1995, ANNU REV IMMUNOL, V13, P437, DOI 10.1146/annurev.iy.13.040195.002253; Von Ehrenstein OS, 2000, CLIN EXP ALLERGY, V30, P187, DOI 10.1046/j.1365-2222.2000.00801.x; von Mutius E, 2000, CLIN EXP ALLERGY, V30, P1230	24	1064	1094	0	148	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 6	2001	358	9288					1129	1133		10.1016/S0140-6736(01)06252-3	http://dx.doi.org/10.1016/S0140-6736(01)06252-3			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	479HM	11597666				2022-12-24	WOS:000171399000009
J	LaRiviere, FJ; Wolfson, AD; Uhlenbeck, OC				LaRiviere, FJ; Wolfson, AD; Uhlenbeck, OC			Uniform binding of aminoacyl-tRNAs to elongation factor Tu by thermodynamic compensation	SCIENCE			English	Article							TRANSFER RNA-SYNTHETASES; INDIRECT READOUT; TERNARY COMPLEX; EF-TU; GTP; ASSOCIATION; DISCRIMINATION; AFFINITIES; PROTEINS; ACIDS	Elongation factor Tu (EF-Tu) binds all elongator aminoacyl-transfer RNAs (aa-tRNAs) for delivery to the ribosome during protein synthesis. Here, we show that EF-Tu binds misacylated tRNAs over a much wider range of affinities than it binds the corresponding correctly acylated tRNAs, suggesting that the protein exhibits considerable specificity for both the amino acid side chain and the tRNA body. The thermodynamic contributions of the amino acid and the tRNA body to the overall binding affinity are independent of each other and compensate for one another when the tRNAs are correctly acylated. Because certain misacylated tRNAs bind EF-Tu significantly more strongly or weakly than cognate aa-tRNAs, EF-Tu may contribute to translational accuracy.	Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Uhlenbeck, OC (corresponding author), Univ Colorado, Dept Chem & Biochem, Campus Box 215, Boulder, CO 80309 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037552] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-37552] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bareket-Samish A, 1998, J MOL BIOL, V277, P1071, DOI 10.1006/jmbi.1998.1638; Becker HD, 1998, P NATL ACAD SCI USA, V95, P12832, DOI 10.1073/pnas.95.22.12832; BRUCE AG, 1982, BIOCHEMISTRY-US, V21, P855, DOI 10.1021/bi00534a007; CHAPEVILLE F, 1962, P NATL ACAD SCI USA, V48, P1086, DOI 10.1073/pnas.48.6.1086; CRICK F H, 1958, Symp Soc Exp Biol, V12, P138; Doring V, 2001, SCIENCE, V292, P501, DOI 10.1126/science.1057718; FERSHT AR, 1979, BIOCHEMISTRY-US, V18, P2627, DOI 10.1021/bi00579a030; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; JAKUBOWSKI H, 1988, J THEOR BIOL, V133, P363, DOI 10.1016/S0022-5193(88)80327-8; JANIAK F, 1990, BIOCHEMISTRY-US, V29, P4268, DOI 10.1021/bi00470a002; KNOWLTON RG, 1980, J MOL BIOL, V139, P721, DOI 10.1016/0022-2836(80)90057-1; Leonard DA, 1998, NAT STRUCT BIOL, V5, P877, DOI 10.1038/2316; Liu JCH, 1998, RNA, V4, P639, DOI 10.1017/S1355838298980013; LOUIE A, 1985, BIOCHEMISTRY-US, V24, P6433, DOI 10.1021/bi00344a019; LOUIE A, 1984, J BIOL CHEM, V259, P5010; Martin AM, 1999, NAT STRUCT BIOL, V6, P269; MCCLAIN WH, 1988, SCIENCE, V242, P1681, DOI 10.1126/science.2462282; NAZARENKO IA, 1994, EMBO J, V13, P2464, DOI 10.1002/j.1460-2075.1994.tb06531.x; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Nissen P, 1999, STRUCTURE, V7, P143, DOI 10.1016/S0969-2126(99)80021-5; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; NOREN CJ, 1989, SCIENCE, V244, P182, DOI 10.1126/science.2649980; NORMANLY J, 1990, J MOL BIOL, V213, P719, DOI 10.1016/S0022-2836(05)80258-X; NORMANLY J, 1986, NATURE, V321, P2163; OTT G, 1990, BIOCHIM BIOPHYS ACTA, V1050, P222, DOI 10.1016/0167-4781(90)90170-7; Pleiss JA, 2001, J MOL BIOL, V308, P895, DOI 10.1006/jmbi.2001.4612; RECORD MT, 1978, Q REV BIOPHYS, V11, P103, DOI 10.1017/S003358350000202X; SHERMAN JM, 1992, NUCLEIC ACIDS RES, V20, P2847, DOI 10.1093/nar/20.11.2847; STANZEL M, 1994, EUR J BIOCHEM, V219, P435, DOI 10.1111/j.1432-1033.1994.tb19956.x; Wang L, 2001, SCIENCE, V292, P498, DOI 10.1126/science.1060077; YARUS M, 1972, NATURE-NEW BIOL, V239, P106, DOI 10.1038/newbio239106a0	31	260	267	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 5	2001	294	5540					165	168		10.1126/science.1064242	http://dx.doi.org/10.1126/science.1064242			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480EJ	11588263				2022-12-24	WOS:000171448800053
J	Zavialov, AV; Buckingham, RH; Ehrenberg, M				Zavialov, AV; Buckingham, RH; Ehrenberg, M			A posttermination ribosomal complex is the guanine nucleotide exchange factor for peptide release factor RF3	CELL			English	Article							ELONGATION-FACTOR TU; ESCHERICHIA-COLI; TRANSLATION TERMINATION; POLYPEPTIDE-SYNTHESIS; MESSENGER-RNA; FACTOR RF-3; BINDING; ERF3; INITIATION; MECHANISM	The mechanism by which peptide release factor RF3 recycles RF1 and RF2 has been clarified and incorporated in a complete scheme for translation termination. Free RF3 is in vivo stably bound to GDP, and ribosomes in complex with RF1 or RF2 act as guanine nucleotide exchange factors (GEF). Hydrolysis of peptldyl-tRNA by RF1 or RF2 allows GTP binding to RF3 on the ribosome. This induces an RF3 conformation with high affinity for ribosomes and leads to rapid dissociation of RF1 or RF2. Dissociation of RF3 from the ribosome requires GTP hydrolysis. Our data suggest that RF3 and its eukaryotic counterpart, eRF3, have mechanistic principles in common.	Uppsala Univ, BMC, Dept Cell & Mol Biol, S-75124 Uppsala, Sweden; Inst Biol Physicochim, CNRS, UPR 9073, F-75005 Paris, France	Uppsala University; Centre National de la Recherche Scientifique (CNRS)	Zavialov, AV (corresponding author), Uppsala Univ, BMC, Dept Cell & Mol Biol, Box 596, S-75124 Uppsala, Sweden.		Zavialov, Anton V./C-7664-2015	Zavialov, Anton V./0000-0001-6191-5931; Zavialov, Andrey/0000-0001-6420-0368; Buckingham, Richard/0000-0002-8567-4500				ADAMSKI FM, 1994, J MOL BIOL, V238, P302, DOI 10.1006/jmbi.1994.1293; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN CM, 1994, J BIOL CHEM, V269, P33164; BRUNEL C, 1993, BIOCHIMIE, V75, P1167, DOI 10.1016/0300-9084(93)90016-L; Ehrenberg M, 1990, RIBOSOMES PROTEIN SY, P101; Freistroffer DV, 2000, P NATL ACAD SCI USA, V97, P2046, DOI 10.1073/pnas.030541097; Freistroffer DV, 1997, EMBO J, V16, P4126, DOI 10.1093/emboj/16.13.4126; Frolova L, 1996, RNA, V2, P334; FROLOVA L, 1994, NATURE, V372, P701, DOI 10.1038/372701a0; GOLDSTEIN JL, 1970, P NATL ACAD SCI USA, V67, P537, DOI 10.1073/pnas.67.2.537; GOODY RS, 1991, TRENDS BIOCHEM SCI, V16, P327, DOI 10.1016/0968-0004(91)90134-H; GRENTZMANN G, 1994, P NATL ACAD SCI USA, V91, P5848, DOI 10.1073/pnas.91.13.5848; Grentzmann G, 1998, RNA, V4, P973, DOI 10.1017/S1355838298971576; Holst-Hansen P, 1997, BIOCHIMIE, V79, P725, DOI 10.1016/S0300-9084(97)86930-1; Ito K, 2000, NATURE, V403, P680, DOI 10.1038/35001115; Ito K, 1998, RNA, V4, P958, DOI 10.1017/S1355838298971874; JELENC PC, 1979, P NATL ACAD SCI USA, V76, P3174, DOI 10.1073/pnas.76.7.3174; Karimi R, 1999, MOL CELL, V3, P601, DOI 10.1016/S1097-2765(00)80353-6; Kisselev LL, 2000, TRENDS BIOCHEM SCI, V25, P561, DOI 10.1016/S0968-0004(00)01669-8; Merkulova TI, 1999, FEBS LETT, V443, P41, DOI 10.1016/S0014-5793(98)01669-X; MIKUNI O, 1994, P NATL ACAD SCI USA, V91, P5798, DOI 10.1073/pnas.91.13.5798; MILMAN G, 1969, P NATL ACAD SCI USA, V63, P183, DOI 10.1073/pnas.63.1.183; Mortensen KK, 1995, EUR J BIOCHEM, V234, P732, DOI 10.1111/j.1432-1033.1995.732_a.x; Nakamura Y, 2000, CELL, V101, P349, DOI 10.1016/S0092-8674(00)80845-4; Nakamura Y, 1996, CELL, V87, P147, DOI 10.1016/S0092-8674(00)81331-8; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; Pape T, 1998, EMBO J, V17, P7490, DOI 10.1093/emboj/17.24.7490; Pavlov MY, 1997, EMBO J, V16, P4134, DOI 10.1093/emboj/16.13.4134; Pel HJ, 1998, RNA, V4, P47; RODNINA MV, 1995, P NATL ACAD SCI USA, V92, P1945, DOI 10.1073/pnas.92.6.1945; RUUSALA T, 1982, EMBO J, V1, P741, DOI 10.1002/j.1460-2075.1982.tb01240.x; RUUSALA T, 1982, EMBO J, V1, P75, DOI 10.1002/j.1460-2075.1982.tb01127.x; SCOLNICK E, 1968, P NATL ACAD SCI USA, V61, P768, DOI 10.1073/pnas.61.2.768; SOFFIENTINI A, 1994, PROTEIN EXPRES PURIF, V5, P118, DOI 10.1006/prep.1994.1018; Song HW, 2000, CELL, V100, P311, DOI 10.1016/S0092-8674(00)80667-4; Sprang SR, 1998, CELL, V95, P155, DOI 10.1016/S0092-8674(00)81746-8; Tomsic J, 2000, EMBO J, V19, P2127, DOI 10.1093/emboj/19.9.2127; ZHOURAVLEVA G, 1995, EMBO J, V14, P4065, DOI 10.1002/j.1460-2075.1995.tb00078.x	39	161	170	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 5	2001	107	1					115	124		10.1016/S0092-8674(01)00508-6	http://dx.doi.org/10.1016/S0092-8674(01)00508-6			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	480GF	11595190	Bronze			2022-12-24	WOS:000171453100014
J	Marcil, I; Stern, RS				Marcil, I; Stern, RS			Squamous-cell cancer of the skin in patients given PUVA and ciclosporin: nested cohort crossover study	LANCET			English	Article							SEVERE PSORIASIS; TRANSPLANT RECIPIENTS; RISK; CYCLOSPORINE; CARCINOMA; PHOTOCHEMOTHERAPY; THERAPY	Background Immunosuppressive treatments have been associated with an increased risk of skin cancer, especially in patients who have had organ transplants. We aimed to assess the risk of skin cancer in patients taking the ciclosporin who had been exposed to psoralen and ultraviolet-A light (PUVA) and other treatments for severe psoriasis. Methods We did a nested cohort crossover study of 28 participants in the PUVA follow-up study who were on ciclosporin to compare the frequency of squamous-cell carcinoma before and after first use of ciclosporin. We also analysed the entire PUVA study cohort (1380) to assess the relation between use of this drug and frequency of squamous-cell carcinoma. Findings In the 5 years before first use, six of 28 (21%) ciclosporin users developed a total of 20 squamous cell cancers. After ciclosporin use (average follow-up 6 years), 13 (46%) developed a total of 169 squamous-cell carcinomas. In the nested cohort, after adjustment for amount of exposure to PUVA and methotrexate, incidence of tumours was seven times higher after first ciclosporin use than in the previous 5 years (incidence rate ratio 6.9 [95% CI 4.3-11]). Multivariate, analysis of the entire cohort showed that risk of squamous-cell carcinoma after any use of ciclosporin is close to that recorded for at least 200 PUVA treatments (3.1 [2.6-3.7] and 2.8 [2.6-3.2], respectively). Interpretation The risk of squamous cell cancer of the skin is increased by ciclosporin in patients with psoriasis who have been exposed to PUVA. Such risks should be balanced against the effectiveness of the drug and possible newer immunosuppressive agents.	Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Dermatol, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Stern, RS (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Dermatol, 330 Brookline Ave, Boston, MA 02215 USA.	rstern@caregroup.harvard.edu			NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [N01AR002246, N01AR042214] Funding Source: NIH RePORTER; NIAMS NIH HHS [N01-AR-0-2246, N01-AR-4-2214] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Abrams JR, 2000, J EXP MED, V192, P681, DOI 10.1084/jem.192.5.681; Bavinck JNB, 1996, TRANSPLANTATION, V61, P715, DOI 10.1097/00007890-199603150-00008; BIRKELAND SA, 1995, INT J CANCER, V60, P183, DOI 10.1002/ijc.2910600209; Cribier B, 1999, DERMATOLOGY, V199, P208, DOI 10.1159/000018276; Grundmann-Kollmann M, 2000, J AM ACAD DERMATOL, V42, P835, DOI 10.1067/mjd.2000.104890; HENSELER T, 1987, J AM ACAD DERMATOL, V16, P108, DOI 10.1016/S0190-9622(87)70010-3; Ho VC, 1999, BRIT J DERMATOL, V141, P283; Hojo M, 1999, NATURE, V397, P530, DOI 10.1038/17401; Jensen P, 1999, J AM ACAD DERMATOL, V40, P177, DOI 10.1016/S0190-9622(99)70185-4; Koo J, 1998, BRIT J DERMATOL, V139, P88; LINDELOF B, 1991, LANCET, V338, P91, DOI 10.1016/0140-6736(91)90083-2; Lindelof B, 2000, BRIT J DERMATOL, V143, P513, DOI 10.1111/j.1365-2133.2000.03703.x; LONDON NJ, 1995, LANCET, V346, P403, DOI 10.1016/S0140-6736(95)92780-8; Nabel GJ, 1999, NATURE, V397, P471, DOI 10.1038/17207; Owen CM, 2000, CLIN EXP DERMATOL, V25, P195, DOI 10.1046/j.1365-2230.2000.00612.x; Ramsay HM, 2000, AM J KIDNEY DIS, V36, P167, DOI 10.1053/ajkd.2000.8290; SCOTTO J, 1983, PUBLICATION NIH; STERN RS, 1984, NEW ENGL J MED, V310, P1156, DOI 10.1056/NEJM198405033101805; Stern RS, 1998, JNCI-J NATL CANCER I, V90, P1278, DOI 10.1093/jnci/90.17.1278; STERN RS, 1994, CANCER-AM CANCER SOC, V73, P2759, DOI 10.1002/1097-0142(19940601)73:11<2759::AID-CNCR2820731118>3.0.CO;2-C; STERN RS, 1979, NEW ENGL J MED, V300, P809, DOI 10.1056/NEJM197904123001501; VandeKerkhof PCM, 1997, BRIT J DERMATOL, V136, P275, DOI 10.1046/j.1365-2133.1997.d01-1187.x	22	164	169	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 29	2001	358	9287					1042	1045		10.1016/S0140-6736(01)06179-7	http://dx.doi.org/10.1016/S0140-6736(01)06179-7			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	479EY	11589933				2022-12-24	WOS:000171393100008
J	Klein, G; Klein, E				Klein, G; Klein, E			Bridge or ravine?	NATURE			English	Article									Karolinska Inst, Ctr Microbiol & Tumor Biol, S-17177 Stockholm, Sweden	Karolinska Institutet	Klein, G (corresponding author), Karolinska Inst, Ctr Microbiol & Tumor Biol, S-17177 Stockholm, Sweden.								0	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 27	2001	413	6854					365	365						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475UY	11574864				2022-12-24	WOS:000171188700032
J	Zhu, RX; Hoffman, KA; Potts, R; Deng, CL; Pan, YX; Guo, B; Shi, CD; Guo, ZT; Yuan, BY; Hou, YM; Huang, WW				Zhu, RX; Hoffman, KA; Potts, R; Deng, CL; Pan, YX; Guo, B; Shi, CD; Guo, ZT; Yuan, BY; Hou, YM; Huang, WW			Earliest presence of humans in northeast Asia	NATURE			English	Article							MAGNETIC-SUSCEPTIBILITY; BASIN; CHINA; HOMO	The timing of the earliest habitation and oldest stone technologies in different regions of the world remains a contentious topic in the study of human evolution(1-4). Here we contribute to this debate with detailed magnetostratigraphic results on two exposed parallel sections of lacustrine sediments at Xiaochangliang in the Nihewan Basin, north China; these results place stringent controls on the age of Palaeolithic stone artifacts that were originally reported over two decades ago(5). Our palaeomagnetic findings indicate that the artifact layer resides in a reverse polarity magnetozone bounded by the Olduvai and Jaramillo subchrons. Coupled with an estimated rate of sedimentation, these findings constrain the layer's age to roughly 1.36 million years ago. This result represents the age of the oldest known stone assemblage comprising recognizable types of Palaeolithic tool in east Asia, and the earliest definite occupation in this region as far north as 40 degrees N.	Chinese Acad Sci, Inst Geol & Geophys, Beijing 100101, Peoples R China; Calif Polytech State Univ San Luis Obispo, Dept Phys, San Luis Obispo, CA 93410 USA; Smithsonian Inst, Natl Museum Nat Hist, Human Origins Program, Washington, DC 20560 USA; Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Beijing 100044, Peoples R China	Chinese Academy of Sciences; Institute of Geology & Geophysics, CAS; California State University System; California Polytechnic State University San Luis Obispo; Smithsonian Institution; Smithsonian National Museum of Natural History; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS	Zhu, RX (corresponding author), Chinese Acad Sci, Inst Geol & Geophys, Beijing 100101, Peoples R China.		Huang, WW/GXH-0977-2022; Deng, Chenglong/B-8871-2009; Zhu, Rixiang/F-2126-2018; huang, wen/GXW-0661-2022; Deng, Chenglong/B-8881-2009; Pan, Yongxin/B-4302-2008; Guo, Zhengtang/B-6854-2008	Deng, Chenglong/0000-0003-1848-3170; Zhu, Rixiang/0000-0002-4985-925X; Pan, Yongxin/0000-0002-4227-3061; Guo, Zhengtang/0000-0003-2259-9715				Ambrose SH, 2001, SCIENCE, V291, P1748, DOI 10.1126/science.1059487; AN ZH, 1989, QUATERNARY RES, V32, P213, DOI 10.1016/0033-5894(89)90077-X; Barbour G.B., 1925, B GEOLOGICAL SOC CHI, V4, P53; Berggren WA, 1995, GEOCHRONOLOGY TIME S, V54, P129, DOI DOI 10.2110/PEC.95.04.0129; CHEN C, IN PRESS ACTA ANTHR; Chen IM, 1999, INT J ROBOT RES, V18, P225; DAY R, 1977, PHYS EARTH PLANET IN, V13, P260, DOI 10.1016/0031-9201(77)90108-X; Gabunia L, 2000, SCIENCE, V288, P1019, DOI 10.1126/science.288.5468.1019; Hou YM, 2000, SCIENCE, V287, P1622, DOI 10.1126/science.287.5458.1622; Huang Weiwen, 1985, Acta Anthropologica Sinica, V4, P301; HUANG WP, 1995, NATURE, V378, P275; HUANG WP, 1991, WUSHAN HOMINID SITE, P105; JELINEK V, 1978, STUD GEOPHYS GEOD, V22, P50, DOI 10.1007/BF01613632; JIA LP, 1980, QUAT SINICA, V5, P12; Keates SG, 2000, BAR INT SERIES, V863, P107; Li YX, 1999, ACTA ANTHR SINICA, V18, P241; LIU TS, 1999, QUAT SCI, V4, P289; Morwood MJ, 1998, NATURE, V392, P173, DOI 10.1038/32401; PEI WZ, 1980, QUAT SINICA, V5, P11; Qiu Z.X., 2000, QUATERNARY SCI, V20, P142; ROCHETTE P, 1992, REV GEOPHYS, V30, P209, DOI 10.1029/92RG00733; Rutherford S, 2000, NATURE, V408, P72, DOI 10.1038/35040533; SCHICK K, 1991, J HUM EVOL, V21, P13, DOI 10.1016/0047-2484(91)90033-R; Tang Yingjun, 1995, Vertebrata Palasiatica, V33, P74; Teilhard de Chardin P., 1930, ANN PALEONTOL, V19, P1; Wei Q., 1997, EVIDENCE EVOLUTION E, P193; Wei Qi, 1985, Acta Anthropologica Sinica, V4, P223; You Y.Z., 1980, QUATERNARIA SINICA, V5, P1	28	164	261	4	57	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 27	2001	413	6854					413	417		10.1038/35096551	http://dx.doi.org/10.1038/35096551			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475UY	11574886				2022-12-24	WOS:000171188700052
J	Bruneau, BG; Nemer, G; Schmitt, JP; Charron, F; Robitaille, L; Caron, S; Conner, DA; Gessler, M; Nemer, M; Seidman, CE; Seidman, JG				Bruneau, BG; Nemer, G; Schmitt, JP; Charron, F; Robitaille, L; Caron, S; Conner, DA; Gessler, M; Nemer, M; Seidman, CE; Seidman, JG			A murine model of Holt-Oram syndrome defines roles of the T-box transcription factor Tbx5 in cardiogenesis and disease	CELL			English	Article							ULNAR-MAMMARY SYNDROME; CARDIAC CONDUCTION; MICE LACKING; CONNEXIN40-DEFICIENT MICE; GENE FAMILY; HEART; EXPRESSION; MUTATIONS; MOUSE; NKX2-5	Heterozygous Tbx5(del/+) mice were generated to study the mechanisms by which TBX5 haploinsufficiency causes cardiac and forelimb abnormalities seen in Holt-Oram syndrome. Tbx5 deficiency in homozygous mice (Tbx5(del/del)) decreased expression of multiple genes and caused severe hypoplasia of posterior domains in the developing heart. Surprisingly, Tbx5 haploinsufficiency also markedly decreased atrial natriuretic factor (ANF) and connexin 40 (cx40) transcription, implicating these as Tbx5 target genes and providing a mechanism by which 50% reduction of T-box transcription factors cause disease. Direct and cooperative transactivation of the ANF and cx40 promoters by Tbx5 and the homeodomain transcription factor Nkx2-5 was also demonstrated. These studies provide one potential explanation for Holt-Oram syndrome conduction system defects, suggest mechanisms for intrafamilial phenotypic variability, and account for related cardiac malformations caused by other transcription factor mutations.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; Inst Rech Clin Montreal, Lab Dev & Differenciat Cardiaques, Montreal, PQ H2W 1R7, Canada; Univ Wurzburg, Biozentrum, D-97074 Wurzburg, Germany; Brigham & Womens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; University of Wurzburg; Harvard University; Brigham & Women's Hospital; Howard Hughes Medical Institute; Harvard University; Brigham & Women's Hospital	Nemer, M (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.		Charron, Frederic/O-8017-2019; Nemer, Georges/ABB-5117-2020; Schmitt, Joachim/GQP-7068-2022; Nemer, Georges/H-7801-2014	Charron, Frederic/0000-0003-3483-8672; Nemer, Georges/0000-0003-2157-5279; Gessler, Manfred/0000-0002-7915-6045; Bruneau, Benoit/0000-0002-0804-7597	NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR014792] Funding Source: NIH RePORTER; NCRR NIH HHS [S10 RR14792] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ARGENTIN S, 1994, MOL CELL BIOL, V14, P777, DOI 10.1128/MCB.14.1.777; Bamshad M, 1997, NAT GENET, V16, P311, DOI 10.1038/ng0797-311; BASSON CT, 1994, NEW ENGL J MED, V330, P885, DOI 10.1056/NEJM199403313301302; Basson CT, 1999, P NATL ACAD SCI USA, V96, P2919, DOI 10.1073/pnas.96.6.2919; Basson CT, 1997, NAT GENET, V15, P30, DOI 10.1038/ng0197-30; Benson DW, 1999, J CLIN INVEST, V104, P1567, DOI 10.1172/JCI8154; Bevilacqua LM, 2000, J INTERV CARD ELECTR, V4, P459, DOI 10.1023/A:1009800328836; Bruneau BG, 1999, DEV BIOL, V211, P100, DOI 10.1006/dbio.1999.9298; Bruneau BG, 2000, DEV BIOL, V217, P266, DOI 10.1006/dbio.1999.9548; Bruneau BG, 2001, MOL CELL BIOL, V21, P1730, DOI 10.1128/MCB.21.5.1730-1736.2001; Carreira S, 1998, MOL CELL BIOL, V18, P5099, DOI 10.1128/MCB.18.9.5099; Chapman DL, 1996, DEV DYNAM, V206, P379, DOI 10.1002/(SICI)1097-0177(199608)206:4<379::AID-AJA4>3.0.CO;2-F; Durocher D, 1997, EMBO J, V16, P5687, DOI 10.1093/emboj/16.18.5687; Erives A, 2000, DEV BIOL, V225, P169, DOI 10.1006/dbio.2000.9815; GREPIN C, 1995, MOL CELL BIOL, V15, P4095; Gutstein DE, 2001, CIRC RES, V88, P333, DOI 10.1161/01.RES.88.3.333; HAEFLIGER JA, 1992, J BIOL CHEM, V267, P2057; Hagendorff A, 1999, CIRCULATION, V99, P1508, DOI 10.1161/01.CIR.99.11.1508; He ML, 1999, P NATL ACAD SCI USA, V96, P10212, DOI 10.1073/pnas.96.18.10212; HENDRICKSON BA, 1995, J EXP MED, V182, P1905, DOI 10.1084/jem.182.6.1905; HERRMANN BG, 1990, NATURE, V343, P617, DOI 10.1038/343617a0; Hiroi Y, 2001, NAT GENET, V28, P276, DOI 10.1038/90123; Horb ME, 1999, DEVELOPMENT, V126, P1739; Kirchhoff S, 2000, CIRC RES, V87, P399; Kirchhoff S, 1998, CURR BIOL, V8, P299, DOI 10.1016/S0960-9822(98)70114-9; KISPERT A, 1993, EMBO J, V12, P4898, DOI 10.1002/j.1460-2075.1993.tb06179.x; KNOWLTON KU, 1995, J CLIN INVEST, V96, P1311, DOI 10.1172/JCI118166; KOMURO I, 1993, P NATL ACAD SCI USA, V90, P8145, DOI 10.1073/pnas.90.17.8145; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Leimeister C, 1999, MECH DEVELOP, V85, P173, DOI 10.1016/S0925-4773(99)00080-5; Li QY, 1997, NAT GENET, V15, P21; LYONS GE, 1990, J CELL BIOL, V111, P2427, DOI 10.1083/jcb.111.6.2427; MARRIOTT HJL, 1983, PRACTICAL ELECTROCAR; Merscher S, 2001, CELL, V104, P619, DOI 10.1016/S0092-8674(01)00247-1; Molkentin JD, 1997, GENE DEV, V11, P1061, DOI 10.1101/gad.11.8.1061; Muller CW, 1997, NATURE, V389, P884, DOI 10.1038/39929; NewburyEcob RA, 1996, J MED GENET, V33, P300, DOI 10.1136/jmg.33.4.300; Papaioannou VE, 1998, BIOESSAYS, V20, P9, DOI 10.1002/(SICI)1521-1878(199801)20:1<9::AID-BIES4>3.0.CO;2-Q; Platzer J, 2000, CELL, V102, P89, DOI 10.1016/S0092-8674(00)00013-1; Schott JJ, 1998, SCIENCE, V281, P108, DOI 10.1126/science.281.5373.108; Seul KH, 1997, GENOMICS, V46, P120, DOI 10.1006/geno.1997.5025; Simon AM, 1998, CURR BIOL, V8, P295, DOI 10.1016/S0960-9822(98)70113-7; Srivastava D, 2000, NATURE, V407, P221, DOI 10.1038/35025190; Srivastava D, 1997, NAT GENET, V16, P154, DOI 10.1038/ng0697-154; Tada M, 2001, DEV GROWTH DIFFER, V43, P1	45	758	786	1	42	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 21	2001	106	6					709	721		10.1016/S0092-8674(01)00493-7	http://dx.doi.org/10.1016/S0092-8674(01)00493-7			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	476EJ	11572777	Bronze			2022-12-24	WOS:000171213000008
J	Hylek, EM; Regan, S; Go, AS; Hughes, RA; Singer, DE; Skates, SJ				Hylek, EM; Regan, S; Go, AS; Hughes, RA; Singer, DE; Skates, SJ			Clinical predictors of prolonged delay in return of the international normalized ratio to within the therapeutic range after excessive anticoagulation with warfarin	ANNALS OF INTERNAL MEDICINE			English	Article							RISK-FACTORS; BLEEDING COMPLICATIONS; DRUG-METABOLISM; PROTEIN-BINDING; AGING LIVER; AGE; DISCONTINUATION; OUTPATIENTS; CLEARANCE	Background: An elevated international normalized ratio (INR) increases the risk for major hemorrhage during warfarin therapy. Optimal management of patients with asymptomatic elevations in INR is hampered by the lack of understanding of the time course of INR decay after cessation of warfarin therapy. Objective: To identify predictors of the rate of INR normalization after excessive anticoagulation. Design: Retrospective cohort study. Setting: Outpatient anticoagulant therapy unit. Patients: Outpatients with an INR greater than 6.0 were identified from August 1993 to September 1998. Patients in whom two doses of warfarin were withheld and a follow-up INR was obtained on the second calendar day were enrolled. No patient received vitamin K-tau. Measurements: The INR was measured 2 days after an INR greater than 6.0 was recorded. Results: Of 633 study patients with an initial INR greater than 6.0, 232 (37%) still had an INR of 4.0 or greater after two doses of warfarin were withheld. Patients who required larger weekly maintenance doses of warfarin were less likely to have an INR of 4.0 or greater on day 2 (adjusted odds ratio per 10 mg of warfarin, 0.87 [95% Cl, 0.79 to 0.97]). Other risk factors for having an INR of 4.0 or greater on day 2 included age (odds ratio per decade of life, 1.18 [Cl, 1.01 to 1.38]), index INR (odds ratio per unit, 1.25 [Cl, 1.14 to 1.37]), decompensated congestive heart failure (odds ratio, 2.79 [Cl, 1.30 to 5.98]), and active cancer (odds ratio, 2.48 [Cl, 1.11 to 5.57]). Conclusions: Steady-state warfarin dose, advanced age, and extreme elevation in INR are risk factors for prolonged delay in return of the INR to within the therapeutic range. Decompensated congestive heart failure and active cancer greatly increase this risk.	Massachusetts Gen Hosp, Clin Epidemiol Unit, Div Gen Med, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA; Kaiser Permanente Med Care Program, Oakland, CA USA; Univ Calif San Francisco, San Francisco, CA 94143 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Kaiser Permanente; University of California System; University of California San Francisco	Hylek, EM (corresponding author), Massachusetts Gen Hosp, Clin Epidemiol Unit, Div Gen Med, 50 Staniford St,9th Floor, Boston, MA 02114 USA.		Go, Alan S./AAE-7745-2019	Hylek, Elaine/0000-0001-8263-8304	NATIONAL INSTITUTE ON AGING [R01AG015478] Funding Source: NIH RePORTER; NIA NIH HHS [AG15478] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		[Anonymous], 1998, Br J Haematol, V101, P374; Ansell J, 2001, CHEST, V119, p22S, DOI 10.1378/chest.119.1_suppl.22S; Bonow RO, 1998, CIRCULATION, V98, P1949, DOI 10.1161/01.CIR.98.18.1949; BRADBURY H, 1994, BRIT J PHARMACOL, V37, P563; CHAN E, 1994, BRIT J CLIN PHARMACO, V37, P563, DOI 10.1111/j.1365-2125.1994.tb04305.x; Chesebro JH, 1996, ARCH INTERN MED, V156, P409; Crowther MA, 1998, THROMB HAEMOSTASIS, V79, P1116; DURNAS C, 1990, CLIN PHARMACOKINET, V19, P359, DOI 10.2165/00003088-199019050-00002; FIHN SD, 1993, ANN INTERN MED, V118, P511, DOI 10.7326/0003-4819-118-7-199304010-00005; Grandison MK, 2000, CLIN PHARMACOKINET, V38, P271, DOI 10.2165/00003088-200038030-00005; Hammerlein A, 1998, CLIN PHARMACOKINET, V35, P49; Hirsh J, 1998, CHEST, V114, p445S, DOI 10.1378/chest.114.5_Supplement.445S; HIRSH J, 1995, CHEST, V108, pS231, DOI 10.1378/chest.108.4_Supplement.231S; Hosmer DW, 1989, APPL LOGISTIC REGRES, P140; Hylek E. M., 1999, JGIM, V14, P42; HYLEK EM, 1994, ANN INTERN MED, V120, P897, DOI 10.7326/0003-4819-120-11-199406010-00001; Hylek EM, 1998, JAMA-J AM MED ASSOC, V279, P657, DOI 10.1001/jama.279.9.657; JAMES OFW, 1985, J HEPATOL, V1, P431, DOI 10.1016/S0168-8278(85)80780-7; KLEINBAUM DG, 1982, EPIDEMIOLOGIC RES PR, P299; LANDEFELD CS, 1989, AM J MED, V87, P144; Le Couteur DG, 1998, CLIN PHARMACOKINET, V34, P359, DOI 10.2165/00003088-199834050-00003; Levine MN, 2001, CHEST, V119, p108S, DOI 10.1378/chest.119.1_suppl.108S; Lousberg TR, 1998, ARCH INTERN MED, V158, P528, DOI 10.1001/archinte.158.5.528; NOTARI RE, 1987, BIOPHARMACEUTICS CLI, P7; Palareti G, 2000, ARCH INTERN MED, V160, P470, DOI 10.1001/archinte.160.4.470; Palareti G, 1996, LANCET, V348, P423, DOI 10.1016/S0140-6736(96)01109-9; PENGO V, 1993, BLOOD COAGUL FIBRIN, V4, P739, DOI 10.1097/00001721-199304050-00010; ROUTLEDGE PA, 1979, BRIT J CLIN PHARMACO, V8, P243, DOI 10.1111/j.1365-2125.1979.tb01009.x; SCHOFIELD KP, 1987, CLIN LAB HAEMATOL, V9, P255, DOI 10.1111/j.1365-2257.1987.tb00089.x; SHEPHERD AM, 1979, DRUGS ELDERLY PERSPE; SHEPHERD AMM, 1977, BRIT J CLIN PHARMACO, V4, P315, DOI 10.1111/j.1365-2125.1977.tb00719.x; VANDERMEER FJM, 1993, ARCH INTERN MED, V153, P1557, DOI 10.1001/archinte.153.13.1557; VESTAL RE, 1989, HEPATOLOGY, V9, P331, DOI 10.1002/hep.1840090228; WALLACE SM, 1987, CLIN PHARMACOKINET, V12, P41, DOI 10.2165/00003088-198712010-00004; Weibert RT, 1997, ANN INTERN MED, V126, P959, DOI 10.7326/0003-4819-126-12-199706150-00005; WELLS PS, 1994, ANN INTERN MED, V121, P676, DOI 10.7326/0003-4819-121-9-199411010-00009; WHITE RH, 1995, ANN INTERN MED, V122, P40, DOI 10.7326/0003-4819-122-1-199501010-00006; WOODHOUSE KW, 1984, AGE AGEING, V13, P328, DOI 10.1093/ageing/13.6.328; WYNNE HA, 1989, HEPATOLOGY, V9, P297, DOI 10.1002/hep.1840090222	39	138	142	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 18	2001	135	6					393	400		10.7326/0003-4819-135-6-200109180-00008	http://dx.doi.org/10.7326/0003-4819-135-6-200109180-00008			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	472FH	11560452				2022-12-24	WOS:000170972500001
J	Giribet, G; Edgecombe, GD; Wheeler, WC				Giribet, G; Edgecombe, GD; Wheeler, WC			Arthropod phylogeny based on eight molecular loci and morphology	NATURE			English	Article							SEQUENCE ALIGNMENT; DNA-SEQUENCES; HISTONE H3; CRUSTACEANS; INSECTS; ORIGIN; HYPOTHESIS; PATTERN	The interrelationships of major clades within the Arthropoda remain one of the most contentious issues in systematics, which has traditionally been the domain of morphologists(1,2). A growing body of DNA sequences and other types of molecular data has revitalized study of arthropod phylogeny(3-7) and has inspired new considerations of character evolution(8,9). Novel hypotheses such as a crustacean-hexapod affinity(4,10-12) were based on analyses of single or few genes and limited taxon sampling, but have received recent support from mitochondrial gene order(13), and eye and brain ultrastructure and neurogenesis(14,15). Here we assess relationships within Arthropoda based on a synthesis of all well sampled molecular loci together with a comprehensive data set of morphological, developmental, ultrastructural and gene-order characters. The molecular data include sequences of three nuclear ribosomal genes, three nuclear protein-coding genes, and two mitochondrial genes (one protein coding, one ribosomal). We devised new optimization procedures(16,17) and constructed a parallel computer cluster with 256 central processing units(18) to analyse molecular data on a scale not previously possible. The optimal 'total evidence' cladogram supports the crustacean-hexapod clade, recognizes pycnogonids as sister to other euarthropods, and indicates monophyly of Myriapoda and Mandibulata.	Harvard Univ, Dept Organism & Evolut Biol, Cambridge, MA 02138 USA; Australian Museum, Sydney, NSW 2010, Australia; Amer Museum Nat Hist, Div Invertebrate Zool, New York, NY 10024 USA	Harvard University; Australian Museum; American Museum of Natural History (AMNH)	Giribet, G (corresponding author), Harvard Univ, Dept Organism & Evolut Biol, 16 Divin Ave, Cambridge, MA 02138 USA.	ggiribet@oeb.harvard.edu	Giribet, Gonzalo/P-1086-2015	Giribet, Gonzalo/0000-0002-5467-8429; Edgecombe, Gregory/0000-0002-9591-8011				Boore JL, 1998, NATURE, V392, P667, DOI 10.1038/33577; BREMER K, 1988, EVOLUTION, V42, P795, DOI [10.2307/2408870, 10.1111/j.1558-5646.1988.tb02497.x]; Colgan DJ, 1998, AUST J ZOOL, V46, P419, DOI 10.1071/ZO98048; Dohle W, 2001, ANN SOC ENTOMOL FR, V37, P85; Edgecombe GD, 2000, CLADISTICS, V16, P155, DOI 10.1111/j.1096-0031.2000.tb00352.x; Farris JS, 1995, SYST BIOL, V44, P570, DOI 10.2307/2413663; FRIEDRICH M, 1995, NATURE, V376, P165, DOI 10.1038/376165a0; Gee H, 2000, NATURE, V404, P214, DOI 10.1038/35005235; Giribet G, 2000, CLADISTICS, V16, P204, DOI 10.1111/j.1096-0031.2000.tb00353.x; Giribet G, 1996, MOL BIOL EVOL, V13, P76, DOI 10.1093/oxfordjournals.molbev.a025573; Goloboff PA, 1999, CLADISTICS, V15, P415, DOI 10.1111/j.1096-0031.1999.tb00278.x; GOLOBOFF PA, 1998, NONA V 2 0; KLUGE AG, 1989, SYST ZOOL, V38, P7, DOI 10.2307/2992432; Popadic A, 1998, DEV GENES EVOL, V208, P142, DOI 10.1007/s004270050165; Regier JC, 1998, AM ZOOL, V38, P918; Regier JC, 1997, MOL BIOL EVOL, V14, P902, DOI 10.1093/oxfordjournals.molbev.a025833; Scholtz G, 1998, INT J DEV BIOL, V42, P801; Shultz JW, 2000, P ROY SOC B-BIOL SCI, V267, P1011, DOI 10.1098/rspb.2000.1104; SNODGRASS R. E., 1938, SMITHSONIAN MISC COLL, V97, P1; Spears T., 1998, Systematics Association Special Volume Series, V55, P169; Strausfeld NJ, 1998, BRAIN BEHAV EVOLUT, V52, P186, DOI 10.1159/000006563; Wahlberg N, 2000, CLADISTICS, V16, P347, DOI 10.1111/j.1096-0031.2000.tb00355.x; Wheeler W, 1996, CLADISTICS, V12, P1, DOI 10.1111/j.1096-0031.1996.tb00189.x; Wheeler W, 1998, ARTHROPOD FOSSILS AND PHYLOGENY, P9; WHEELER WC, 1993, CLADISTICS, V9, P1, DOI 10.1111/j.1096-0031.1993.tb00207.x; WHEELER WC, 1995, SYST BIOL, V44, P321, DOI 10.2307/2413595; Wills MA, 1998, ARTHROPOD FOSSILS AND PHYLOGENY, P33; Zrzavy J., 1998, Arthropod relationships., P97; Zrzavy J, 1997, J EVOLUTION BIOL, V10, P353, DOI 10.1007/s000360050029	29	437	469	4	129	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 13	2001	413	6852					157	161		10.1038/35093097	http://dx.doi.org/10.1038/35093097			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471FU	11557979				2022-12-24	WOS:000170918800045
J	Antonova, I; Arancio, O; Trillat, AC; Wang, HG; Zablow, L; Udo, H; Kandel, ER; Hawkins, RD				Antonova, I; Arancio, O; Trillat, AC; Wang, HG; Zablow, L; Udo, H; Kandel, ER; Hawkins, RD			Rapid increase in clusters of presynaptic proteins at onset of long-lasting potentiation	SCIENCE			English	Article							TERM POTENTIATION; GLUTAMATE RECEPTORS; TRANSMITTER RELEASE; REDISTRIBUTION; EXPRESSION; LTP	A change in the efficiency of synaptic communication between neurons is thought to underlie learning. Consistent with recent studies of such changes, we find that long-tasting potentiation of synaptic transmission between cultured hippocampal neurons is accompanied by an increase in the number of clusters of postsynaptic glutamate receptors containing the subunit GLuR1. In addition, potentiation is accompanied by a rapid and long-tasting increase in the number of clusters of the presynaptic protein synaptophysin and the number of sites at which synaptophysin and GLuR1 are colocalized. These results suggest that potentiation involves rapid coordinate changes in the distribution of proteins in the presynaptic neuron as well as the postsynaptic neuron.	Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, New York, NY 10032 USA; Howard Hughes Med Inst, New York, NY 10032 USA; New York State Psychiat Inst & Hosp, New York, NY 10032 USA; SUNY Hlth Sci Ctr, Dept Anat & Cell Biol, Brooklyn, NY 11203 USA	Columbia University; Howard Hughes Medical Institute; New York State Psychiatry Institute; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Hawkins, RD (corresponding author), Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, 722 W 168th St, New York, NY 10032 USA.	rdh1@columbia.edu	arancio, ottavio/AAB-7959-2019	arancio, ottavio/0000-0001-6335-164X	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH026212] Funding Source: NIH RePORTER; NIMH NIH HHS [MH26212] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; ARANCIO O, 1995, NATURE, V376, P74, DOI 10.1038/376074a0; BATTAGLIA F, 2000, SOC NEUR ABSTR, V26, P879; BEKKERS JM, 1990, NATURE, V346, P724, DOI 10.1038/346724a0; BI QQ, 1998, J NEUROSCI, V18, P10469; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bozdagi O, 2000, NEURON, V28, P245, DOI 10.1016/S0896-6273(00)00100-8; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; DELSSEROTH K, 1996, NEURON, V16, P89; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; HAWKINS RD, 1993, ANNU REV NEUROSCI, V16, P625, DOI 10.1146/annurev.ne.16.030193.003205; Huang Y Y, 1994, Learn Mem, V1, P74; Kim CH, 1999, J NEUROSCI, V19, P4314; Krucker T, 2000, P NATL ACAD SCI USA, V97, P6856, DOI 10.1073/pnas.100139797; KULLMANN DM, 1995, NEURON, V15, P997, DOI 10.1016/0896-6273(95)90089-6; Lissin DV, 1999, J NEUROSCI, V19, P1263; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; Ma L, 1999, NAT NEUROSCI, V2, P24, DOI 10.1038/4525; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; MALGAROLI A, 1995, SCIENCE, V268, P1624, DOI 10.1126/science.7777862; MALGAROLI A, 1992, NATURE, V357, P134, DOI 10.1038/357134a0; Morales M, 2000, NEURON, V27, P539, DOI 10.1016/S0896-6273(00)00064-7; ODELL TJ, 1991, P NATL ACAD SCI USA, V88, P11285, DOI 10.1073/pnas.88.24.11285; Ryan TA, 1996, NEURON, V17, P125, DOI 10.1016/S0896-6273(00)80286-X; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Shen L, 2000, J NEUROSCI, V20, P7932; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Zakharenko SS, 2001, NAT NEUROSCI, V4, P711, DOI 10.1038/89498	28	138	143	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 16	2001	294	5546					1547	1550		10.1126/science.1066273	http://dx.doi.org/10.1126/science.1066273			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	493TX	11641465				2022-12-24	WOS:000172240500055
J	Whiteley, M; Bangera, MG; Bumgarner, RE; Parsek, MR; Teitzel, GM; Lory, S; Greenberg, EP				Whiteley, M; Bangera, MG; Bumgarner, RE; Parsek, MR; Teitzel, GM; Lory, S; Greenberg, EP			Gene expression in Pseudomonas aeruginosa biofilms	NATURE			English	Article							MICROBIAL BIOFILMS; BACTERIAL BIOFILMS; RESISTANCE; ANTIBIOTICS; GENTAMICIN; MUTATION; SEQUENCE; BINDING; SIGNALS; FLOW	Bacteria often adopt a sessile biofilm lifestyle that is resistant to antimicrobial treatment(1-5). Opportunistic pathogenic bacteria like Pseudomonas aeruginosa can develop persistent infections(1-3). To gain insights into the differences between free-living P. aeruginosa cells and those in biofilms, and into the mechanisms underlying the resistance of biofilms to antibiotics, we used DNA microarrays. Here we show that, despite the striking differences in lifestyles, only about 1% of genes showed differential expression in the two growth modes; about 0.5% of genes were activated and about 0.5% were repressed in biofilms. Some of the regulated genes are known to affect antibiotic sensitivity of free-living P. aeruginosa. Exposure of biofilms to high levels of the antibiotic tobramycin caused differential expression of 20 genes. We propose that this response is critical for the development of biofilm resistance to tobramycin. Our results show that gene expression in biofilm cells is similar to that in free-living cells but there are a small number of significant differences. Our identification of biofilm-regulated genes points to mechanisms of biofilm resistance to antibiotics.	Univ Iowa, Coll Med, Dept Microbiol, Iowa City, IA 52242 USA; Harvard Univ, Dept Microbiol & Mol Genet, Boston, MA 02115 USA; Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; Northwestern Univ, Dept Civil Engn, Evanston, IL 60208 USA	University of Iowa; Harvard University; University of Washington; University of Washington Seattle; Northwestern University	Greenberg, EP (corresponding author), Univ Iowa, Coll Med, Dept Microbiol, Iowa City, IA 52242 USA.		Bumgarner, Roger/AAA-6846-2020; Bumgarner, Roger E/K-3531-2015	Bumgarner, Roger E/0000-0002-8168-6985; Greenberg, Everett/0000-0001-9474-8041				BANGERA MG, 2000, AM SOC MICR 100 GEN; BRYAN LE, 1976, J ANTIBIOT, V29, P743, DOI 10.7164/antibiotics.29.743; BRYAN LE, 1980, ANTIMICROB AGENTS CH, V17, P71, DOI 10.1128/AAC.17.1.71; BRYAN LE, 1983, ANTIMICROB AGENTS CH, V23, P835, DOI 10.1128/AAC.23.6.835; Burns J L, 1993, Adv Pediatr Infect Dis, V8, P53; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; COSTERTON JW, 1994, J BACTERIOL, V176, P2137, DOI 10.1128/JB.176.8.2137-2142.1994; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; DAMPER PD, 1981, ANTIMICROB AGENTS CH, V20, P803, DOI 10.1128/AAC.20.6.803; Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295; DEBEER D, 1994, BIOTECHNOL BIOENG, V44, P636, DOI 10.1002/bit.260440510; Greenberg EP, 2000, NATURE, V406, P947, DOI 10.1038/35023203; HANCOCK REW, 1984, ANNU REV MICROBIOL, V38, P237, DOI 10.1146/annurev.mi.38.100184.001321; Hentzer M, 2001, J BACTERIOL, V183, P5395, DOI 10.1128/JB.183.18.5395-5401.2001; Heydorn A, 2000, MICROBIOL-UK, V146, P2409, DOI 10.1099/00221287-146-10-2409; HILL DF, 1991, J MOL BIOL, V218, P349, DOI 10.1016/0022-2836(91)90717-K; HOIBY N, 1993, ANNU REV MED, V44, P1, DOI 10.1146/annurev.me.44.020193.000245; HOIBY N, 1998, PSEUDOMONAS CYSTIC F, P1; Ichikawa JK, 2000, P NATL ACAD SCI USA, V97, P9659, DOI 10.1073/pnas.160140297; JOHNSON JA, 1993, J CLIN MICROBIOL, V31, P732, DOI 10.1128/JCM.31.3.732-733.1993; LAWRENCE JR, 1991, J BACTERIOL, V173, P6558, DOI 10.1128/jb.173.20.6558-6567.1991; MacLeod DL, 2000, J INFECT DIS, V181, P1180, DOI 10.1086/315312; NIKAIDO H, 1985, MICROBIOL REV, V49, P872; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; RIVERA M, 1988, ANTIMICROB AGENTS CH, V32, P649, DOI 10.1128/AAC.32.5.649; Singh PK, 2000, NATURE, V407, P762, DOI 10.1038/35037627; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Suh SJ, 1999, J BACTERIOL, V181, P3890, DOI 10.1128/JB.181.13.3890-3897.1999; Whiteley M, 2000, J BACTERIOL, V182, P4356, DOI 10.1128/JB.182.15.4356-4360.2000; ZABRISKIE JB, 1966, ANNU REV MED, V17, P337, DOI 10.1146/annurev.me.17.020166.002005	30	797	852	3	151	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 25	2001	413	6858					860	864		10.1038/35101627	http://dx.doi.org/10.1038/35101627			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	485JA	11677611				2022-12-24	WOS:000171750200050
J	Lawton, RO; Nair, US; Pielke, RA; Welch, RM				Lawton, RO; Nair, US; Pielke, RA; Welch, RM			Climatic impact of tropical lowland deforestation on nearby montane cloud forests	SCIENCE			English	Article							COSTA-RICA; CUMULUS; VARIABILITY; VEGETATION; PASTURES; MOISTURE; TRENDS	Tropical montane cloud forests (TMCFs) depend on predictable, frequent, and prolonged immersion in cloud. Clearing upwind lowland forest alters surface energy budgets in ways that influence dry season cloud fields and thus the TMCF environment. Landsat and Geostationary Operational Environmental Satellite imagery show that deforested areas of Costa Rica's Caribbean lowlands remain relatively cloud-free when forested regions have well-developed dry season cumulus cloud fields. Further, regional atmospheric simulations show that cloud base heights are higher over pasture than over tropical forest areas under reasonable dry season conditions. These results suggest that [and use in tropical lowlands has serious impacts on ecosystems in adjacent mountains.	Univ Alabama, Dept Biol Sci, Huntsville, AL 35899 USA; Univ Alabama, Nat Sci Technol Ctr, Dept Atmospher Sci, Huntsville, AL 35806 USA; Colorado State Univ, Dept Atmospher Sci, Ft Collins, CO 80523 USA	University of Alabama System; University of Alabama Huntsville; University of Alabama System; University of Alabama Huntsville; Colorado State University	Lawton, RO (corresponding author), Univ Alabama, Dept Biol Sci, Huntsville, AL 35899 USA.	lawtonr@email.uah.edu	Pielke, Roger A/A-5015-2009					BASTABLE HG, 1993, INT J CLIMATOL, V13, P783, DOI 10.1002/joc.3370130706; BERENDES T, 1992, IEEE T GEOSCI REMOTE, V30, P430, DOI 10.1109/36.142921; BRUIJNZEEL LA, 1995, ECOL STU AN, V110, P38; CHEN F, 1994, J APPL METEOROL, V33, P1382, DOI 10.1175/1520-0450(1994)033<1382:IOLSMV>2.0.CO;2; Dietrich W.E., 1982, ECOLOGY TROPICAL FOR, P21; Haber W. A., 2000, MONTEVERDE ECOLOGY C, P39; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Lawton R. O., 1980, BRENESIA, V8, P101; Longman K. A., 1987, TROPICAL FOREST ITS; MEHERHOMJI VM, 1991, CLIMATIC CHANGE, V19, P163, DOI 10.1007/BF00142223; Nadkarni N. M., 2000, MONTEVERDE ECOLOGY C, P303; Nadkarni NM., 2000, MONTEVERDE ECOLOGY C, P15; Nair US, 1999, P SOC PHOTO-OPT INS, V3750, P345, DOI 10.1117/12.363530; NEPSTAD DC, 1994, NATURE, V372, P666, DOI 10.1038/372666a0; NOBRE CA, 1991, J CLIMATE, V4, P957, DOI 10.1175/1520-0442(1991)004<0957:ADARCC>2.0.CO;2; PIELKE RA, 1992, METEOROL ATMOS PHYS, V49, P69, DOI 10.1007/BF01025401; Pounds JA, 1999, NATURE, V398, P611, DOI 10.1038/19297; SADER SA, 1988, BIOTROPICA, V20, P11, DOI 10.2307/2388421; SCHLESINGER WH, 1990, SCIENCE, V247, P1043, DOI 10.1126/science.247.4946.1043; SHUKLA J, 1990, SCIENCE, V247, P1322, DOI 10.1126/science.247.4948.1322; Still CJ, 1999, NATURE, V398, P608, DOI 10.1038/19293; SUD YC, 1993, J ARID ENVIRON, V25, P5, DOI 10.1006/jare.1993.1038; UHL C, 1988, J ECOL, V76, P663, DOI 10.2307/2260566; Vaughan C., 1983, REPORT DENSE FOREST; Veldkamp E., 1992, Land Degradation & Rehabilitation, V3, P71, DOI 10.1002/ldr.3400030202; Weitz AM, 2001, SOIL BIOL BIOCHEM, V33, P1077, DOI 10.1016/S0038-0717(01)00013-X; Wheelwight Nathaniel T., 2000, P419; WRIGHT IR, 1992, Q J ROY METEOR SOC, V118, P1083, DOI 10.1002/qj.49711850804; Zeng N, 1999, SCIENCE, V286, P1537, DOI 10.1126/science.286.5444.1537	29	235	254	6	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2001	294	5542					584	587						4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484NC	11641496				2022-12-24	WOS:000171695600044
J	Kvist, A; Lindstrom, A; Green, M; Piersma, T; Visser, GH				Kvist, A; Lindstrom, A; Green, M; Piersma, T; Visser, GH			Carrying large fuel loads during sustained bird flight is cheaper than expected	NATURE			English	Article							DISTANCE MIGRANT SHOREBIRD; BASAL METABOLIC-RATE; CALIDRIS-CANUTUS; WIND-TUNNEL; KNOT; MIGRATION	Birds on migration alternate between consuming fuel stores during flights and accumulating fuel stores during stopovers. The optimal timing and length of flights and stopovers for successful migration depend heavily on the extra metabolic power input (fuel use) required to carry the fuel stores during flight(1,2). The effect of large fuel loads on metabolic power input has never been empirically determined. We measured the total metabolic power input of a long-distance migrant, the red knot (Calidris canutus), flying for 6 to 10 h in a wind tunnel, using the doubly labelled water technique(3). Here we show that total metabolic power input increased with fuel load, but proportionally less than the predicted mechanical power output from the flight muscles. The most likely explanation is that the efficiency with which metabolic power input is converted into mechanical output by the flight muscles increases with fuel load. This will influence current models of bird flight and bird migration. It may also help to explain why some shorebirds, despite the high metabolic power input required to fly, routinely make nonstop flights of 4,000 km longer(4).	Lund Univ, Dept Anim Ecol, S-22362 Lund, Sweden; Netherlands Inst Sea Res, NL-1790 AB Den Burg, Netherlands; Univ Groningen, Ctr Ecol & Evolutionary Studies, NL-9750 AA Haren, Netherlands; Ctr Isotope Res, NL-9747 AG Groningen, Netherlands	Lund University; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); University of Groningen; University of Groningen	Kvist, A (corresponding author), Lund Univ, Dept Anim Ecol, Ecol Bldg, S-22362 Lund, Sweden.		Piersma, Theunis/D-1871-2012	Piersma, Theunis/0000-0001-9668-466X; Kvist, Anders/0000-0002-1358-0695				Alerstam T, 1998, J AVIAN BIOL, V29, P343, DOI 10.2307/3677155; Alerstam T., 1990, P331; Ancel A, 1997, NATURE, V385, P304, DOI 10.1038/385304a0; Battley PF, 2000, P ROY SOC B-BIOL SCI, V267, P191, DOI 10.1098/rspb.2000.0986; Duke, 1997, ANIMAL PHYSL ADAPTAT, P169, DOI DOI 10.2307/2403350; GUDMUNDSSON GA, 1994, J AVIAN BIOL, V25, P15, DOI 10.2307/3677290; HEDENSTROM A, 1995, PHILOS T ROY SOC B, V348, P471, DOI 10.1098/rstb.1995.0082; Kullberg C, 1996, P ROY SOC B-BIOL SCI, V263, P1671, DOI 10.1098/rspb.1996.0244; Lindstrom A, 2000, J EXP BIOL, V203, P913; METCALFE NB, 1995, P ROY SOC B-BIOL SCI, V261, P395, DOI 10.1098/rspb.1995.0165; NOER H, 1979, Dansk Ornitologisk Forenings Tidsskrift, V73, P215; Pennycuick C.J., 1975, AVIAN BIOL, P1, DOI DOI 10.1016/B978-0-12-249405-5.50009-4; PENNYCUICK CJ, 1995, ISRAEL J ZOOL, V41, P307; Pennycuick CJ, 1997, J EXP BIOL, V200, P1441; Pennycuick CJ, 1996, J EXP BIOL, V199, P2757; PIERSMA T, 1995, J COMP PHYSIOL B, V165, P37, DOI 10.1007/BF00264684; Piersma T, 1996, PHYSIOL ZOOL, V69, P191, DOI 10.1086/physzool.69.1.30164207; RAYNER JMV, 1985, J THEOR BIOL, V117, P47, DOI 10.1016/S0022-5193(85)80164-8; RAYNER JMV, 1979, J EXP BIOL, V80, P17; Rayner JMV, 1999, P 22 INT ORN C DURB, P1786; Speakman J.R., 1997, DOUBLY LABELLED WATE; TUCKER VA, 1973, J EXP BIOL, V58, P689; Visser GH, 2000, J COMP PHYSIOL B, V170, P365, DOI 10.1007/s003600000112; VISSER GH, 2000, AM J PHYSIOL, V209, pR1795; [No title captured]	25	138	140	3	52	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 18	2001	413	6857					730	732		10.1038/35099556	http://dx.doi.org/10.1038/35099556			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	482ZK	11607031	Green Published			2022-12-24	WOS:000171608000043
J	Wenger, NS; Rosenfeld, K				Wenger, NS; Rosenfeld, K			Quality indicators for end-of-life care in vulnerable elders	ANNALS OF INTERNAL MEDICINE			English	Article							NURSING-HOME RESIDENTS; ADVANCE DIRECTIVES; RESUSCITATION PREFERENCES; SUSTAINING TREATMENT; DYING PATIENTS; ILL; PHYSICIANS; DISCUSSIONS; MANAGEMENT; INSIGHTS		Univ Calif Los Angeles, Dept Med, Div Gen Internal Med, Los Angeles, CA 90095 USA; Vet Affairs Greater Los Angeles Health Care Syst, Los Angeles, CA USA	University of California System; University of California Los Angeles; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	Wenger, NS (corresponding author), Univ Calif Los Angeles, Dept Med, Div Gen Internal Med, 911 Broxton Plaza, Los Angeles, CA 90095 USA.	nwenger@mednet.ucla.edu						ADAMOWSKI K, 1994, CAN MED ASSOC J, V150, P326; *AM MED ASS, 1991, COD MED ETH REP AMA; [Anonymous], 1992, ANN INTERN MED, V117, P947; APPELBAUM PS, 1988, NEW ENGL J MED, V319, P1635, DOI 10.1056/NEJM198812223192504; *APS, 1997, APS B, V7, P1; BLACKHALL LJ, 1989, J GEN INTERN MED, V4, P399, DOI 10.1007/BF02599689; BLANCHARD CG, 1988, SOC SCI MED, V27, P1139, DOI 10.1016/0277-9536(88)90343-7; Brody H, 1997, NEW ENGL J MED, V336, P652, DOI 10.1056/NEJM199702273360910; CAMPBELL ML, 1998, AACN CRITICAL CARE P, P61; Canadian Palliative Care Association, 1995, PALL CAR CONS STAND; DANIS M, 1991, NEW ENGL J MED, V324, P882, DOI 10.1056/NEJM199103283241304; DENNIS C, 1998, VACCOS COMMISSION QU; Desbiens NA, 1998, PAIN, V75, P237, DOI 10.1016/S0304-3959(97)00225-X; DRANE JF, 1984, JAMA-J AM MED ASSOC, V252, P925, DOI 10.1001/jama.252.7.925; Ehman JW, 1999, ARCH INTERN MED, V159, P1803, DOI 10.1001/archinte.159.15.1803; Emanuel EJ, 1998, LANCET, V351, P21, DOI 10.1016/S0140-6736(98)90329-4; Faber-Langendoen K, 2000, ANN INTERN MED, V133, P886, DOI 10.7326/0003-4819-133-11-200012050-00013; FABERLANGENDOEN K, 1994, CHEST, V106, P880, DOI 10.1378/chest.106.3.880; Field MJ, 1997, APPROACHING DEATH IM; Fischer GS, 1998, J GEN INTERN MED, V13, P447, DOI 10.1046/j.1525-1497.1998.00133.x; Fox E, 1999, JAMA-J AM MED ASSOC, V282, P1638, DOI 10.1001/jama.282.17.1638; GERETY MB, 1993, J AM GERIATR SOC, V41, P953, DOI 10.1111/j.1532-5415.1993.tb06761.x; Goodman MD, 1998, CRIT CARE MED, V26, P701, DOI 10.1097/00003246-199804000-00018; Gregory J J, 1995, N J Med, V92, P438; Hammes BJ, 1998, ARCH INTERN MED, V158, P383, DOI 10.1001/archinte.158.4.383; Hanson LC, 1997, ANN INTERN MED, V126, P381, DOI 10.7326/0003-4819-126-5-199703010-00007; *HAST CTR, 1987, GUID TERM LIF SUST T; Hofmann JC, 1997, ANN INTERN MED, V127, P1, DOI 10.7326/0003-4819-127-1-199707010-00001; KEAY TJ, 1994, J AM GERIATR SOC, V42, P853, DOI 10.1111/j.1532-5415.1994.tb06557.x; KNAUS WA, 1995, JAMA-J AM MED ASSOC, V274, P1591, DOI 10.1001/jama.1995.03530200027032; LANKEN PN, 1991, AM REV RESPIR DIS, V144, P726, DOI 10.1164/ajrccm/144.3_Pt_1.726; Levin JR, 1999, J AM GERIATR SOC, V47, P82, DOI 10.1111/j.1532-5415.1999.tb01905.x; LO B, 1986, ARCH INTERN MED, V146, P1613, DOI 10.1001/archinte.146.8.1613; LUCHINS DJ, 1993, J AM GERIATR SOC, V41, P25; Lynn J, 1997, ANN INTERN MED, V126, P97, DOI 10.7326/0003-4819-126-2-199701150-00001; Martin DK, 1999, ARCH INTERN MED, V159, P86, DOI 10.1001/archinte.159.1.86; MORRISON RS, 1995, JAMA-J AM MED ASSOC, V274, P478, DOI 10.1001/jama.274.6.478; MOWER WR, 1993, ARCH INTERN MED, V153, P375, DOI 10.1001/archinte.153.3.375; PEARLMAN RA, 1993, J CLIN ETHIC, V4, P33; ROBINSON L, 1994, BRIT J GEN PRACT, V44, P461; SCHNEIDERMAN L, 1995, WRONG MED; SCHNEIDERMAN LJ, 1992, ANN INTERN MED, V117, P599, DOI 10.7326/0003-4819-117-7-599; SECKLER AB, 1991, ANN INTERN MED, V115, P92, DOI 10.7326/0003-4819-115-2-92; Shekelle PG, 2001, ANN INTERN MED, V135, P647, DOI 10.7326/0003-4819-135-8_Part_2-200110161-00003; Singer PA, 1999, JAMA-J AM MED ASSOC, V281, P163, DOI 10.1001/jama.281.2.163; Steinhauser KE, 2000, ANN INTERN MED, V132, P825, DOI 10.7326/0003-4819-132-10-200005160-00011; Sulmasy DP, 1996, J MED ETHICS, V22, P344, DOI 10.1136/jme.22.6.344; SULMASY DP, 1992, JAMA-J AM MED ASSOC, V267, P682; SWARTZ RD, 1993, J AM SOC NEPHROL, V3, P1623; Taylor RM, 1996, NEUROLOGY, V46, P870; TENO JM, 1995, J GEN INTERN MED, V10, P179, DOI 10.1007/BF02600252; TENO JM, 1994, HASTINGS CENT REP, V24, pS32, DOI 10.2307/3563482; Tolle SW, 2000, WESTERN J MED, V172, P374, DOI 10.1136/ewjm.172.6.374; *U CAL, 1998, TERM WEAN MECH VENT; UHLMANN RF, 1989, WESTERN J MED, V150, P705; VIRMANI J, 1994, ARCH INTERN MED, V154, P909, DOI 10.1001/archinte.154.8.909; Wenger N. S., 1997, JGIM, V12, P105; Wenger N. S., 1994, Journal of the American Geriatrics Society, V42, pSA67; Wenger NS, 2000, J AM GERIATR SOC, V48, pS44, DOI 10.1111/j.1532-5415.2000.tb03140.x; Wenger NS, 1996, J CLIN ETHIC, V7, P48; Wenger NS, 2001, JAMA-J AM MED ASSOC, V285, P2880, DOI 10.1001/jama.285.22.2880; 1983, PRESIDENTS COMM STUD; 1996, JAMA, V274, P474; 1995, J AM GERIATR SOC, V43, P577	64	54	54	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 16	2001	135	8	2				677	685		10.7326/0003-4819-135-8_Part_2-200110161-00006	http://dx.doi.org/10.7326/0003-4819-135-8_Part_2-200110161-00006			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	481WA	11601950				2022-12-24	WOS:000171542400006
J	Nemec, P; Altmann, J; Marhold, S; Burda, H; Oelschlager, HHA				Nemec, P; Altmann, J; Marhold, S; Burda, H; Oelschlager, HHA			Neuroanatomy of magnetoreception: The superior colliculus involved in magnetic orientation in a mammal	SCIENCE			English	Article							VISUAL-SYSTEM; C-FOS; COMPASS; ARCHITECTURE; RESPONSES; BOBOLINK; CELLS	The neural substrate subserving magnetic orientation is largely unknown in vertebrates and unstudied in mammals, We combined a behavioral test for magnetic compass orientation in mole rats and immunocytochemical visualization of the transcription factor c-Fos as a marker of neuronal activity. We found that the superior colliculus of the Zambian mote rat (Cryptomys anselli) contains neurons that are responsive to magnetic stimuli. These neurons are directionally selective and organized within a discrete sublayer. Our results constitute evidence for the involvement of a specific mammalian brain structure in magnetoreception.	Charles Univ, Dept Zool, CZ-12844 Prague, Czech Republic; Univ Frankfurt, Dept Anat 3, D-60590 Frankfurt, Germany; Univ Frankfurt, Inst Zool, D-60323 Frankfurt, Germany; Univ Essen Gesamthsch, Dept Gen Zool, D-45117 Essen, Germany	Charles University Prague; Goethe University Frankfurt; Goethe University Frankfurt; University of Duisburg Essen	Nemec, P (corresponding author), Charles Univ, Dept Zool, CZ-12844 Prague, Czech Republic.		Nemec, Pavel/K-1163-2012	Nemec, Pavel/0000-0003-0277-0239				BEASON RC, 1987, NEUROSCI LETT, V80, P229, DOI 10.1016/0304-3940(87)90659-8; BURDA H, 1990, EXPERIENTIA, V46, P528, DOI 10.1007/BF01954256; Chevalier G, 2000, J COMP NEUROL, V419, P137, DOI 10.1002/(SICI)1096-9861(20000403)419:2<137::AID-CNE1>3.0.CO;2-6; DEAN P, 1989, TRENDS NEUROSCI, V12, P137, DOI 10.1016/0166-2236(89)90052-0; DEMAINE C, 1985, NEUROSCI LETT, V62, P119, DOI 10.1016/0304-3940(85)90294-0; DRAGUNOW M, 1989, J NEUROSCI METH, V29, P261, DOI 10.1016/0165-0270(89)90150-7; Herdegen T, 1998, BRAIN RES REV, V28, P370, DOI 10.1016/S0165-0173(98)00018-6; Huerta M.F., 1984, P687; HUERTA MF, 1984, TRENDS NEUROSCI, V7, P286, DOI 10.1016/S0166-2236(84)80197-6; ILLING RB, 1992, P NATL ACAD SCI USA, V89, P10900, DOI 10.1073/pnas.89.22.10900; Illing RB, 1996, PROG BRAIN RES, V112, P17; Lohmann KJ, 2000, TRENDS NEUROSCI, V23, P153, DOI 10.1016/S0166-2236(99)01542-8; Marhold S, 1997, NATURWISSENSCHAFTEN, V84, P421, DOI 10.1007/s001140050422; Morgan Marcyliena., 1991, PRAGMATICS, V1, P421; Oelschlager HHA, 2000, BRAIN BEHAV EVOLUT, V55, P209, DOI 10.1159/000006653; SEMM P, 1990, BRAIN RES BULL, V25, P735, DOI 10.1016/0361-9230(90)90051-Z; SEMM P, 1986, J COMP PHYSIOL A, V159, P619, DOI 10.1007/BF00612035; SEMM P, 1984, J COMP PHYSIOL, V155, P283, DOI 10.1007/BF00610581; SEMM P, 1980, NATURE, V288, P607, DOI 10.1038/288607a0; SPARKS DL, 1988, BRAIN BEHAV EVOLUT, V31, P49, DOI 10.1159/000116575; Stein BE, 1998, EXP BRAIN RES, V123, P124, DOI 10.1007/s002210050553; Stein BE., 1993, MERGING SENSES; Walker MM, 1997, NATURE, V390, P371, DOI 10.1038/37057; Wiltschko R., 1995, TIEROSYCHOL	24	93	100	1	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 12	2001	294	5541					366	368		10.1126/science.1063351	http://dx.doi.org/10.1126/science.1063351			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	482WZ	11598299				2022-12-24	WOS:000171601400042
J	Flum, DR; Morris, A; Koepsell, T; Dellinger, EP				Flum, DR; Morris, A; Koepsell, T; Dellinger, EP			Has misdiagnosis of appendicitis decreased over time? A population-based analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COMPUTED-TOMOGRAPHY; NEGATIVE APPENDECTOMY; DIAGNOSIS; IMPACT; CT	Context Misdiagnosis of presumed appendicitis is an adverse outcome that leads to unnecessary surgery. Computed tomography, ultrasonography, and laparoscopy have been suggested for use in patients with equivocal signs of appendicitis to decrease unnecessary surgery. Objective To determine if frequency of misdiagnosis preceding appendectomy has decreased with increased availability of computed tomography, ultrasonography, and laparoscopy. Design, Setting, and Patients Retrospective, population-based cohort study of data from a Washington State hospital discharge database for 85790 residents assigned International Classification of Diseases, Ninth Revision procedure codes for appendectomy, and United States Census Bureau data for 1987-1998. Main Outcome Measure Population-based age- and sex-standardized incidence of appendectomy with acute appendicitis (perforated or not) or with a normal appendix. Results Among 63707 nonincidental appendectomy patients, 84.5% had appendicitis (25.8% with perforation) and 15.5% had no associated diagnosis of appendicitis. After adjusting for age and sex, the population-based incidence of unnecessary appendectomy and of appendicitis with perforation did not change significantly over time. Among women of reproductive age, the population-based incidence of misdiagnosis increased 1% per year (P =.005). The incidence of misdiagnosis increased 8% yearly in patients older than 65 years (P<.001) but did not change significantly in children younger than 5 years (P =.17). The proportion of patients undergoing laparoscopic appendectomy who were misdiagnosed was significantly higher than that of open appendectomy patients (19.6% vs 15.5%; P<.001). Conclusion Contrary to expectation, the frequency of misdiagnosis leading to unnecessary appendectomy has not changed with the introduction of computed tomography, ultrasonography, and laparoscopy, nor has the frequency of perforation decreased. These data suggest that on a population level, diagnosis of appendicitis has not improved with the availability of advanced diagnostic testing.	Univ Washington, Hlth Sci Ctr H220, Robert Wood Johnson Clin Scholars Program, Dept Surg, Seattle, WA 98195 USA; Univ Washington, Dept Epidemiol & Hlth Serv, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Flum, DR (corresponding author), Univ Washington, Hlth Sci Ctr H220, Robert Wood Johnson Clin Scholars Program, Dept Surg, Box 357183, Seattle, WA 98195 USA.	daveflum@u.washington.edu	Flum, David/GPX-7976-2022	Morris, Arden/0000-0001-5795-2940				ADDISS DG, 1990, AM J EPIDEMIOL, V132, P910, DOI 10.1093/oxfordjournals.aje.a115734; Balthazar EJ, 1998, AM J GASTROENTEROL, V93, P768; Barrat C, 1999, SURG LAPAROSC ENDOSC, V9, P27, DOI 10.1097/00019509-199901000-00005; Birnbaum BA, 2000, RADIOLOGY, V215, P337, DOI 10.1148/radiology.215.2.r00ma24337; Borgstein PJ, 1997, SURG ENDOSC-ULTRAS, V11, P923, DOI 10.1007/s004649900488; DETMER DE, 1981, JAMA-J AM MED ASSOC, V246, P1318, DOI 10.1001/jama.246.12.1318; Firilas AM, 1999, AM SURGEON, V65, P769; Franke C, 1999, WORLD J SURG, V23, P141, DOI 10.1007/PL00013165; Grunewald B, 1993, J R Coll Surg Edinb, V38, P158; JADALLAH FA, 1994, EUR J SURG, V160, P41; Korner H, 1998, BRIT J SURG, V85, P341; Korner H, 1997, WORLD J SURG, V21, P313, DOI 10.1007/s002689900235; Pittman-Waller VA, 2000, AM SURGEON, V66, P548; Rao PM, 1999, ANN SURG, V229, P344, DOI 10.1097/00000658-199903000-00007; Rao PM, 1997, J COMPUT ASSIST TOMO, V21, P686, DOI 10.1097/00004728-199709000-00002; Rao PM, 1998, NEW ENGL J MED, V338, P141, DOI 10.1056/NEJM199801153380301; STRINGEL G, 1987, AM J SURG, V154, P631, DOI 10.1016/0002-9610(87)90231-5; Styrud J, 1999, DIGEST SURG, V16, P39, DOI 10.1159/000018692; Velanovich V, 1998, AM SURGEON, V64, P7; Weyant MJ, 2000, SURGERY, V128, P145, DOI 10.1067/msy.2000.107422; Wong SW, 1999, AUST NZ J SURG, V69, P31, DOI 10.1046/j.1440-1622.1999.01482.x	21	326	337	2	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 10	2001	286	14					1748	1753		10.1001/jama.286.14.1748	http://dx.doi.org/10.1001/jama.286.14.1748			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	480NC	11594900	Bronze			2022-12-24	WOS:000171466800025
J	Wilcox, AJ; Baird, DD; Dunson, D; McChesney, R; Weinberg, CR				Wilcox, AJ; Baird, DD; Dunson, D; McChesney, R; Weinberg, CR			Natural limits of pregnancy testing in relation to the expected menstrual period	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HUMAN CHORIONIC-GONADOTROPIN; URINE; SERUM; CYCLE	Context Pregnancy test kits routinely recommend testing "as early as the first day of the missed period." However, a pregnancy cannot be detected before the blastocyst implants. Due to natural variability in the timing of ovulation, implantation does not necessarily occur before the expected onset of next menses. Objective To estimate the maximum screening sensitivity of pregnancy tests when used on the first day of the expected period, taking into account the natural variability of ovulation and implantation. Design and Setting Community-based prospective cohort study conducted in North Carolina between 1982 and 1986. Participants Two hundred twenty-one healthy women 21 to 42 years of age who were planning to conceive. Main Outcome Measures Day of implantation, defined by the serial assay of first morning urine samples using an extremely sensitive immunoradiometric assay for human chorionic gonadotropin (hCG), relative to the first day of the missed period, defined as the day on which women expected their next menses to begin, based on self-reported usual cycle length. Results Data were available for 136 clinical pregnancies conceived during the study, 14 (10%) of which had not yet implanted by the first day of the missed period. The highest possible screening sensitivity for an hCG-based pregnancy test therefore is estimated to be 90% (95% confidence interval [CI], 84%-94%) on the first day of the missed period. By 1 week after the first day of the missed period, the highest possible screening sensitivity is estimated to be 97% (95% Cl, 94%-99%). Conclusions In this study, using an extremely sensitive assay for hCG, 10% of clinical pregnancies were undetectable on the first day of missed menses. fn practice, an even larger percentage of clinical pregnancies may be undetected by current test kits on this day, given their reported assay properties and other practical limitations.	NIEHS, Epidemiol Branch, Durham, NC USA; NIEHS, Biostat Branch, Durham, NC USA; Columbia Univ Barnard Coll, Dept Biol Sci, New York, NY USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Columbia University	Wilcox, AJ (corresponding author), NIEHS, Epidemiol Branch, MD A3-05, Res Triangle Pk, NC 27709 USA.		Wilcox, Allen J/C-7723-2019; Baird, Donna D/D-5214-2017	Wilcox, Allen J/0000-0002-3376-1311; Baird, Donna D/0000-0002-5544-2653; Weinberg, Clarice/0000-0002-7713-8556	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES049003, Z01ES044003, ZIAES044003, Z01ES049003] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ALFTHAN H, 1993, SCAND J CLIN LAB INV, V53, P105, DOI 10.3109/00365519309086911; ARMSTRONG EG, 1984, J CLIN ENDOCR METAB, V59, P867, DOI 10.1210/jcem-59-5-867; Bastian LA, 1998, ARCH FAM MED, V7, P465, DOI 10.1001/archfami.7.5.465; CHARD T, 1992, HUM REPROD, V7, P701, DOI 10.1093/oxfordjournals.humrep.a137722; COLE LA, 1993, AM J OBSTET GYNECOL, V168, P1580, DOI 10.1016/S0002-9378(11)90802-3; Harlow SD, 2000, J CLIN EPIDEMIOL, V53, P722, DOI 10.1016/S0895-4356(99)00202-4; Ikomi A, 1998, BRIT J OBSTET GYNAEC, V105, P462, DOI 10.1111/j.1471-0528.1998.tb10135.x; LENTON EA, 1984, BRIT J OBSTET GYNAEC, V91, P681, DOI 10.1111/j.1471-0528.1984.tb04830.x; LIPSITZ R, 2000, SCI AM, V283, P110; MISHALANI SH, 1994, CLIN CHEM, V40, P1944; Shew ML, 2000, AM J PUBLIC HEALTH, V90, P974, DOI 10.2105/AJPH.90.6.974; WILCOX AJ, 1988, NEW ENGL J MED, V319, P189, DOI 10.1056/NEJM198807283190401; Wilcox AJ, 1999, NEW ENGL J MED, V340, P1796, DOI 10.1056/NEJM199906103402304; Wilcox AJ, 2000, BRIT MED J, V321, P1259, DOI 10.1136/bmj.321.7271.1259	14	62	62	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 10	2001	286	14					1759	1761		10.1001/jama.286.14.1759	http://dx.doi.org/10.1001/jama.286.14.1759			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	480NC	11594902	Bronze			2022-12-24	WOS:000171466800027
J	Baker, D; Sali, A				Baker, D; Sali, A			Protein structure prediction and structural genomics	SCIENCE			English	Editorial Material							PROTEASES; DATABASE; BINDING; TOOL	Genome sequencing projects are producing linear amino acid sequences, but full understanding of the biological role of these proteins will require knowledge of their structure and function. Although experimental structure determination methods are providing high-resolution structure information about a subset of the proteins, computational structure prediction methods will provide valuable information for the large fraction of sequences whose structures will not be determined experimentally. The first class of protein structure prediction methods, including threading and comparative modeling, rely on detectable similarity spanning most of the modeled sequence and at least one known structure. The second class of methods, de novo or ab initio methods, predict the structure from sequence alone, without relying on similarity at the fold level between the modeled sequence and any of the known structures. In this Viewpoint, we begin by describing the essential features of the methods, the accuracy of the models, and their application to the prediction and understanding of protein function, both for single proteins and on the scale of whole genomes. We then discuss the important role that protein structure prediction methods play in the growing worldwide effort in structural genomics.	Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; Rockefeller Univ, Pels Family Ctr Biochem & Struct Biol, Lab Mol Biophys, New York, NY 10021 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Rockefeller University	Baker, D (corresponding author), Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA.	dabaker@u.washington.edu; sail@rockefeller.edu	Baker, David/K-8941-2012	Baker, David/0000-0001-7896-6217	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054762, R29GM054762] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 54762] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aloy P, 2001, J MOL BIOL, V311, P395, DOI 10.1006/jmbi.2001.4870; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BLUNDELL TL, 1987, NATURE, V326, P347, DOI 10.1038/326347a0; Bonneau R, 2001, ANNU REV BIOPH BIOM, V30, P173, DOI 10.1146/annurev.biophys.30.1.173; Bonneau R, 2001, J STRUCT BIOL, V134, P186, DOI 10.1006/jsbi.2000.4370; BONNEAU R, IN PRESS PROTEINS ST; Bower MJ, 1997, J MOL BIOL, V267, P1268, DOI 10.1006/jmbi.1997.0926; Brenner SE, 2000, NAT STRUCT BIOL, V7, P967, DOI 10.1038/80747; BROWNE WJ, 1969, J MOL BIOL, V42, P65, DOI 10.1016/0022-2836(69)90487-2; Burley SK, 1999, NAT GENET, V23, P151, DOI 10.1038/13783; Dann CE, 2001, NATURE, V412, P86, DOI 10.1038/35083601; Fischer D, 1997, P NATL ACAD SCI USA, V94, P11929, DOI 10.1073/pnas.94.22.11929; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Gonzalez C, 2000, P NATL ACAD SCI USA, V97, P11221, DOI 10.1073/pnas.210301097; GREER J, 1981, J MOL BIOL, V153, P1027, DOI 10.1016/0022-2836(81)90465-4; Guex N, 1999, TRENDS BIOCHEM SCI, V24, P364, DOI 10.1016/S0968-0004(99)01427-9; HAVEL TF, 1991, J MOL BIOL, V217, P1, DOI 10.1016/0022-2836(91)90603-4; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Jones DT, 1997, PROTEINS, P185; Koehl Patrice, 1999, Nature Structural Biology, V6, P108, DOI 10.1038/5794; Kolinski A, 2001, PROTEINS, V44, P133, DOI 10.1002/prot.1080; LEVITT M, 1992, J MOL BIOL, V226, P507, DOI 10.1016/0022-2836(92)90964-L; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; MARTIRENOM MA, IN PRESS STRUCTURE; MATSUMOTO R, 1995, J BIOL CHEM, V270, P19524, DOI 10.1074/jbc.270.33.19524; Obmolova G, 2000, NATURE, V407, P703, DOI 10.1038/35037509; Ortiz AR, 1999, PROTEINS, P177; Pillardy A, 2001, P NATL ACAD SCI USA, V98, P2329, DOI 10.1073/pnas.041609598; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sali Andrej, 1998, Nature Structural Biology, V5, P1029, DOI 10.1038/4136; SAMUDRALA R, 1999, PROTEINS, V3, P197; Sanchez R, 2000, NUCLEIC ACIDS RES, V28, P250, DOI 10.1093/nar/28.1.250; Sanchez R, 1998, P NATL ACAD SCI USA, V95, P13597, DOI 10.1073/pnas.95.23.13597; Sanchez R, 2000, NAT STRUCT BIOL, V7, P986, DOI 10.1038/80776; Simons KT, 2001, J MOL BIOL, V306, P1191, DOI 10.1006/jmbi.2000.4459; SPAHN CMT, IN PRESS CELL; Torda AE, 1997, CURR OPIN STRUC BIOL, V7, P200, DOI 10.1016/S0959-440X(97)80026-7; Vitkup D, 2001, NAT STRUCT BIOL, V8, P559, DOI 10.1038/88640; Wallace AC, 1997, PROTEIN SCI, V6, P2308; Xu LZ, 1996, J BIOL CHEM, V271, P24711; Zhang BH, 1999, PROTEIN SCI, V8, P1104, DOI 10.1110/ps.8.5.1104	41	1164	1306	8	170	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 5	2001	294	5540					93	96		10.1126/science.1065659	http://dx.doi.org/10.1126/science.1065659			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480EJ	11588250				2022-12-24	WOS:000171448800038
J	Hilleren, P; McCarthy, T; Rosbash, M; Parker, R; Jensen, TH				Hilleren, P; McCarthy, T; Rosbash, M; Parker, R; Jensen, TH			Quality control of mRNA 3 '-end processing is linked to the nuclear exosome	NATURE			English	Article							MESSENGER-RNA; SACCHAROMYCES-CEREVISIAE; POLY(A) POLYMERASE; RIBOSOMAL-RNA; EXPORT; YEAST; POLYADENYLATION; MUTATIONS; TURNOVER; PATHWAY	An emerging theme in messenger RNA metabolism is the coupling of nuclear pre-mRNA processing events, which contributes to mRNA quality control(1). Most eukaryotic mRNAs acquire a poly(A) tail during 3'-end processing within the nucleus, and this is coupled to efficient export of mRNAs to the cytoplasm(2,3). In the yeast Saccharomyces cerevisiae, a common consequence of defective nuclear export of mRNA is the hyperadenylation of nascent transcripts(4,5), which are sequestered at or near their sites of transcription(5). This implies that polyadenylation and nuclear export are coupled in a step that involves the release of mRNA from transcription site foci. Here we demonstrate that transcripts which fail to acquire a poly(A) tail are also retained at or near transcription sites. Surprisingly, this retention mechanism requires the protein Rrp6p and the nuclear exosome, a large complex of exonucleolytic enzymes(6,7). In exosome mutants, hypo- as well as hyperadenylated mRNAs are released and translated. These observations suggest that the exosome contributes to a checkpoint that monitors proper 3'-end formation of mRNA.	Univ Arizona, Howard Hughes Med Inst, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA; Brandeis Univ, Howard Hughes Med Inst, Dept Biol, Waltham, MA 02454 USA	Howard Hughes Medical Institute; University of Arizona; Brandeis University; Howard Hughes Medical Institute	Hilleren, P (corresponding author), Univ Arizona, Howard Hughes Med Inst, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA.		Jensen, Torben H/G-2954-2017					Allmang C, 1999, EMBO J, V18, P5399, DOI 10.1093/emboj/18.19.5399; Amrani N, 1996, MOL GEN GENET, V252, P552, DOI 10.1007/BF02172401; Bousquet-Antonelli C, 2000, CELL, V102, P765, DOI 10.1016/S0092-8674(00)00065-9; Briggs MW, 1998, J BIOL CHEM, V273, P13255, DOI 10.1074/jbc.273.21.13255; Burkard KTD, 2000, MOL CELL BIOL, V20, P604, DOI 10.1128/MCB.20.2.604-616.2000; DECKER CJ, 1993, GENE DEV, V7, P1632, DOI 10.1101/gad.7.8.1632; ECKNER R, 1991, EMBO J, V10, P3513, DOI 10.1002/j.1460-2075.1991.tb04915.x; GORSCH LC, 1995, J CELL BIOL, V129, P939, DOI 10.1083/jcb.129.4.939; Hilleren P, 2001, RNA, V7, P753, DOI 10.1017/S1355838201010147; Huang YQ, 1996, MOL CELL BIOL, V16, P1534; Jensen TH, 2001, MOL CELL, V7, P887, DOI 10.1016/S1097-2765(01)00232-5; Lee MS, 1996, GENE DEV, V10, P1233, DOI 10.1101/gad.10.10.1233; MANDART E, 1995, MOL CELL BIOL, V15, P6979; Maquat LE, 2001, CELL, V104, P173, DOI 10.1016/S0092-8674(01)00202-1; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; PATEL D, 1992, MOL CELL BIOL, V12, P3297, DOI 10.1128/MCB.12.7.3297; Vainberg IE, 2000, MOL CELL BIOL, V20, P3996, DOI 10.1128/MCB.20.11.3996-4005.2000; Van Hoof A, 2000, MOL CELL BIOL, V20, P441, DOI 10.1128/MCB.20.2.441-452.2000	18	284	288	0	24	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 4	2001	413	6855					538	542		10.1038/35097110	http://dx.doi.org/10.1038/35097110			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	478HG	11586364				2022-12-24	WOS:000171340500051
J	Goldie, SJ; Levin, AR				Goldie, SJ; Levin, AR			Genomics in medicine and public health: Role of cost-effectiveness analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review									Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; Brown Univ, Providence, RI 02912 USA	Harvard University; Harvard T.H. Chan School of Public Health; Brown University	Goldie, SJ (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA.			Levin, April/0000-0003-4192-4720				BROWN ML, 1995, J NATL CANCER I, V87, P1131, DOI 10.1093/jnci/87.15.1131; Collins FS, 1999, NEW ENGL J MED, V341, P28, DOI 10.1056/NEJM199907013410106; Emery J, 2001, LANCET, V358, P56, DOI 10.1016/S0140-6736(00)05257-0; Gold MR, 1996, COST EFFECTIVENESS H; Holtzman NA, 2000, NEW ENGL J MED, V343, P141, DOI 10.1056/NEJM200007133430213; Motulsky AG, 1999, LANCET, V354, pSI35; Veenstra DL, 2000, AAPS PHARMSCI, V2, part. no.; Weinstein MC, 2001, ANN INTERN MED, V134, P440, DOI 10.7326/0003-4819-134-6-200103200-00008	8	4	5	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 3	2001	286	13					1637	1638		10.1001/jama.286.13.1637	http://dx.doi.org/10.1001/jama.286.13.1637			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	478HH	11585493	hybrid			2022-12-24	WOS:000171340600036
J	Clutton-Brock, TH; Russell, AF; Sharpe, LL; Brotherton, PNM; McIlrath, GM; White, S; Cameron, EZ				Clutton-Brock, TH; Russell, AF; Sharpe, LL; Brotherton, PNM; McIlrath, GM; White, S; Cameron, EZ			Effects of helpers on juvenile development and survival in meerkats	SCIENCE			English	Article							COOPERATIVE MONGOOSE; FOOD ALLOCATION; GROUP-SIZE; BEHAVIOR; DYNAMICS	Although breeding success is known to increase with group size in several cooperative mammals, the mechanisms underlying these relationships are uncertain. We show that in wild groups of cooperative meerkats, Suricata suricatta, reductions in the ratio of helpers to pups depress the daily weight gain and growth of pups and the daily weight gain of helpers. Increases in the daily weight gain of pups are associated with heavier weights at independence and at 1 year of age, as well as with improved foraging success as juveniles and higher survival rates through the first year of life. These results suggest that the effects of helpers on the fitness of pups extend beyond weaning and that helpers may gain direct as well as indirect benefits by feeding pups.	Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; Univ Stellenbosch, Dept Zool, ZA-7602 Matieland, South Africa; Univ Pretoria, Mammal Res Inst, ZA-0002 Pretoria, South Africa	University of Cambridge; Stellenbosch University; University of Pretoria	Clutton-Brock, TH (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.	thcb@hermes.cam.ac.uk	Cameron, Elissa/B-8053-2014; Cameron, Elissa Z/E-4280-2010	Cameron, Elissa/0000-0002-9243-0547; 				Brotherton PNM, 2001, BEHAV ECOL, V12, P590, DOI 10.1093/beheco/12.5.590; Brown J.L., 1987, HELPING COMMUNAL BRE; Clutton-Brock TH, 1998, P ROY SOC B-BIOL SCI, V265, P185, DOI 10.1098/rspb.1998.0281; Clutton-Brock TH, 2000, P ROY SOC B-BIOL SCI, V267, P301, DOI 10.1098/rspb.2000.1000; Clutton-Brock TH, 2001, SCIENCE, V291, P478, DOI 10.1126/science.291.5503.478; Clutton-Brock TH, 2001, ANIM BEHAV, V61, P705, DOI 10.1006/anbe.2000.1631; Clutton-Brock TH, 1999, J ANIM ECOL, V68, P672, DOI 10.1046/j.1365-2656.1999.00317.x; Clutton-Brock TH, 1999, SCIENCE, V284, P1640, DOI 10.1126/science.284.5420.1640; CLUTTONBROCK TH, 1982, NATURE, V300, P178, DOI 10.1038/300178a0; Cockburn A, 1998, ANNU REV ECOL SYST, V29, P141, DOI 10.1146/annurev.ecolsys.29.1.141; Courchamp F, 1999, P ROY SOC B-BIOL SCI, V266, P557, DOI 10.1098/rspb.1999.0672; Courchamp F, 2000, ANIM CONSERV, V3, P277, DOI 10.1017/S1367943000001001; CREEL S, IN PRESS AFRICAN WIL; GRIFFIN AS, 1999, THESIS U EDINBURGH; JENNIONS MD, 1994, TRENDS ECOL EVOL, V9, P89, DOI 10.1016/0169-5347(94)90202-X; *LAW AGR TRUST ROT, 1998, GENSTAT 5 4 1; Lindstrom J, 1999, TRENDS ECOL EVOL, V14, P343, DOI 10.1016/S0169-5347(99)01639-0; MALCOLM JR, 1982, BEHAV ECOL SOCIOBIOL, V10, P1, DOI 10.1007/BF00296390; Manser MB, 2000, BEHAV ECOL SOCIOBIOL, V48, P429, DOI 10.1007/s002650000248; Moehlman P.D., 1989, P143; ROOD JP, 1990, ANIM BEHAV, V39, P566, DOI 10.1016/S0003-3472(05)80423-3; Solomon N. G., 1997, COOPERATIVE BREEDING; VANSCHAIK CP, 1983, BEHAVIOUR, V87, P120, DOI 10.1163/156853983X00147; Woodroffe R, 2000, J ZOOL, V250, P113, DOI 10.1017/S0952836900001102	24	168	169	1	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 28	2001	293	5539					2446	2449		10.1126/science.1061274	http://dx.doi.org/10.1126/science.1061274			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	476PD	11577235				2022-12-24	WOS:000171237200045
J	Lawrence, JM; Bennett, P; Young, A; Robinson, AM				Lawrence, JM; Bennett, P; Young, A; Robinson, AM			Screening for diabetes in general practice: cross sectional population study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CARDIOVASCULAR-DISEASE; OLDER-ADULTS; MELLITUS; GLUCOSE; PREVENTION; CRITERIA	Objective To assess the policy proposed by the American Diabetes Association of universal screening in general practice of all patients aged over 45 years for diabetes. Design Cross sectional Population study. Setting Local general practice in die United Kingdom. Participants All patients aged over 45 not known to have diabetes. Main outcome measures Prevalence of diabetes in the screened population, cardiovascular risk profile of patients diagnosed as having diabetes after screening. Results Of 2481 patients aged over 45 and not known to have diabetes, 876 attended for screening. There were no significant demographic differences between the screened and unscreened patients. Prevalence of diabetes in patients with age as a sole risk factor was 0.2% (95% confidence interval 0% to 1.4%). Prevalence of diabetes in patients with age and one or more other risk factors (hypertension, obesity, or a family history of diabetes) was 2.8% (1.6% to 4.7%). Four hours a week for a year would be needed to screen all people over 45 in the practice's population, about half this time would be needed to screen patients with risk factors other than age. More than 80% of patients newly diagnosed as having diabetes had a 10 year risk of coronary heart disease >15%. 73%) (45% to 92% were hypertensive, and 73% (45% to 92%) had a cholesterol concentration >5 mmol/l. Conclusions Screening for diabetes in general practice by measuring fasting blood glucose is feasible but has a very low yield in patients whose sole risk factor For diabetes is age over 45. Screening in a low risk population would best be targeted at patients with multiple risk factors.	Royal United Hosp, Dept Endocrinol & Diabet, Bath BA1 3NG, Avon, England; Batheaston Med Ctr, Bath BA1 7NP, Avon, England		Lawrence, JM (corresponding author), Royal United Hosp, Dept Endocrinol & Diabet, Bath BA1 3NG, Avon, England.	mpsjml@bath.ac.uk						Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; [Anonymous], 1999, Diabetologia, V42, P647; Balkau B, 1998, DIABETES CARE, V21, P360, DOI 10.2337/diacare.21.3.360; Barzilay JI, 1999, LANCET, V354, P622, DOI 10.1016/S0140-6736(98)12030-5; BLUNT BA, 1991, DIABETES CARE, V14, P989, DOI 10.2337/diacare.14.11.989; Borch-Johnsen K, 1999, LANCET, V354, P617; *DIAB UK, 2001, NEW DIAGN CRIT DIAB; GATLING W, 1985, J ROY COLL PHYS LOND, V19, P248; Gavin JR, 1997, DIABETES CARE, V20, P1183; Harris MI, 1998, DIABETES CARE, V21, P518, DOI 10.2337/diacare.21.4.518; Majumdar SR, 1999, J GEN INTERN MED, V14, P711, DOI 10.1046/j.1525-1497.1999.02229.x; Resnick HE, 2000, DIABETES CARE, V23, P176, DOI 10.2337/diacare.23.2.176; Wareham NJ, 2001, BMJ-BRIT MED J, V322, P986, DOI 10.1136/bmj.322.7292.986; Wood D, 1998, HEART, V80, pS1	14	77	81	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 8	2001	323	7312					548	551		10.1136/bmj.323.7312.548	http://dx.doi.org/10.1136/bmj.323.7312.548			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	471NC	11546702	Green Published, Bronze			2022-12-24	WOS:000170934600023
J	Clark, I; Whitten, R; Molyneux, M; Taylor, L				Clark, I; Whitten, R; Molyneux, M; Taylor, L			Salicylates, nitric oxide, malaria, and Reye's syndrome	LANCET			English	Article							TUMOR-NECROSIS-FACTOR; SMOOTH-MUSCLE CELLS; PLASMODIUM-FALCIPARUM MALARIA; ACTIVATED PROTEIN-KINASE; SYNTHASE EXPRESSION; CEREBRAL MALARIA; CHILDREN; ASPIRIN; INTOXICATION; INDUCTION	Reye's syndrome virtually disappeared from much of the world after the use of salicylate in febrile children was successfully discouraged. This severe sepsis-like disease was thought tot be caused by a hypersensitivity to salicylates in children with mild viral infections, although mo mechanism consistent with this proposal was ever established. Salicylate toxicity in African children has been noted to have many clinical features in common with severe falciparum malaria, including acidosis, altered consciousness, convulsions, and hypoglycaemia. Salicylates are widely available in various formulations in many African countries, and are commonly used for initial treatment of the symptoms that malaria shares with other diseases. There is now experimental evidence that salicylate increases and prolongs the activity of key elements along the signalling pathway through which interferon gamma generates inducible nitric oxide synthase (iNOS), and we have shown that INOS is strongly expressed in fatal malaria and other acute fevers in African children. We further propose that, in areas where salicyaltes are still used to treat the symptoms of febrile illnesses in children, this mechanism could exacerbate potentially serious infectious diseases, including falciparum malaria. In contrast, the absence of salicylate use in children in some Pacific islands could contribute to the milder outcome of falciparum malaria than is observed in Africa. Widespread expression of iNOS has also been seen in the tissues of a patient with fatal clinically defined Reye's syndrome. This finding suggests that Reye's syndrome can be mediated through salicylate enhancement of iNOS expression, the initial trigger in this instance usually being a viral infection.	Australian Natl Univ, Sch Life Sci, Div Biochem & Mol Biol, Canberra, ACT 0200, Australia; Black Hills Pathol, Olympia, WA USA; Univ Malawi, Coll Med, Wellcome Trust Res Labs, Zomba, Malawi; Univ Liverpool, Sch Trop Med, Liverpool L69 3BX, Merseyside, England; Univ Malawi, Coll Med, Malaria Project, Zomba, Malawi; Michigan State Univ, E Lansing, MI 48824 USA	Australian National University; University of Malawi; Liverpool School of Tropical Medicine; University of Liverpool; University of Malawi; Michigan State University	Clark, I (corresponding author), Australian Natl Univ, Sch Life Sci, Div Biochem & Mol Biol, Canberra, ACT 0200, Australia.							Chalasani N, 1996, SOUTHERN MED J, V89, P479, DOI 10.1097/00007611-199605000-00005; CHENLC, 1999, BIOCH J, V432, P503; CLARK IA, 1994, PARASITOL TODAY, V10, P410, DOI 10.1016/0169-4758(94)90237-2; CLARK IA, 1992, LANCET, V340, P894, DOI 10.1016/0140-6736(92)93295-X; CLARK IA, 1981, INFECT IMMUN, V32, P1058, DOI 10.1128/IAI.32.3.1058-1066.1981; Crocker JFS, 1998, CLIN INVEST MED, V21, P192; de Miguel LS, 1999, EUR J CLIN INVEST, V29, P93, DOI 10.1046/j.1365-2362.1999.00425.x; Durak I, 1999, CLIN CHIM ACTA, V288, P169, DOI 10.1016/S0009-8981(99)00134-5; English M, 1996, LANCET, V347, P1736, DOI 10.1016/S0140-6736(96)90809-0; Faure V, 1999, J BIOL CHEM, V274, P4794, DOI 10.1074/jbc.274.8.4794; GILES HM, 1965, LANCET, V1, P1075; Guan ZH, 1999, J BIOL CHEM, V274, P36200, DOI 10.1074/jbc.274.51.36200; HEMMER CJ, 1991, AM J TROP MED HYG, V45, P608, DOI 10.4269/ajtmh.1991.45.608; HURWITZ ES, 1987, JAMA-J AM MED ASSOC, V257, P1905, DOI 10.1001/jama.257.14.1905; KWIATKOWSKI D, 1990, LANCET, V336, P1201, DOI 10.1016/0140-6736(90)92827-5; LARRICK JW, 1986, LANCET, V2, P132; Maitland K, 1996, T ROY SOC TROP MED H, V90, P614, DOI 10.1016/S0035-9203(96)90406-X; Marsh K, 1996, ANN TROP MED PARASIT, V90, P395, DOI 10.1080/00034983.1996.11813068; Melillo G, 1996, J IMMUNOL, V157, P2638; Nishio E, 1998, LIFE SCI, V63, P429, DOI 10.1016/S0024-3205(98)00292-6; PARTIN JS, 1984, HEPATOLOGY, V4, P687, DOI 10.1002/hep.1840040421; PARTIN JS, 1982, LANCET, V1, P191; REYE RDK, 1963, LANCET, V2, P749; Roczniak A, 1996, AM J PHYSIOL-RENAL, V270, pF106, DOI 10.1152/ajprenal.1996.270.1.F106; ROWE PC, 1988, JAMA-J AM MED ASSOC, V260, P3167, DOI 10.1001/jama.260.21.3167; Ruetten H, 1996, BRIT J PHARMACOL, V118, P261, DOI 10.1111/j.1476-5381.1996.tb15397.x; Schwenger P, 1997, P NATL ACAD SCI USA, V94, P2869, DOI 10.1073/pnas.94.7.2869; STARKO KM, 1980, PEDIATRICS, V66, P859; Yan ZQ, 1999, ARTERIOSCL THROM VAS, V19, P2854, DOI 10.1161/01.ATV.19.12.2854; Ye ZC, 1996, NEUROREPORT, V7, P2181, DOI 10.1097/00001756-199609020-00025; 1965, LANCET, V1, P941	32	25	26	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 24	2001	357	9256					625	627		10.1016/S0140-6736(00)04061-7	http://dx.doi.org/10.1016/S0140-6736(00)04061-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	404UB	11558501				2022-12-24	WOS:000167119100035
J	SMITH, T				SMITH, T			CHEAP, MANAGED DEATH	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	2	2	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	MAR 18	1995	310	6981					744	744		10.1136/bmj.310.6981.744	http://dx.doi.org/10.1136/bmj.310.6981.744			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QN461	11644673	Green Published			2022-12-24	WOS:A1995QN46100079
J	PALMER, K				PALMER, K			PEACE AND PAIN	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUL 23	1994	309	6949					279	279		10.1136/bmj.309.6949.279	http://dx.doi.org/10.1136/bmj.309.6949.279			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NZ180	11644574	Green Published			2022-12-24	WOS:A1994NZ18000070
J	OTT, U; BEGEMANN, F; YANG, JM; EPSTEIN, S				OTT, U; BEGEMANN, F; YANG, JM; EPSTEIN, S			S-PROCESS KRYPTON OF VARIABLE ISOTOPIC COMPOSITION IN THE MURCHISON METEORITE	NATURE			English	Article									CALTECH,DIV GEOL & PLANETARY SCI,PASADENA,CA 91125	California Institute of Technology	OTT, U (corresponding author), MAX PLANCK INST CHEM,SAARSTR 23,D-6500 MAINZ 1,FED REP GER.		Ott, Ulrich/ABH-2337-2020	Ulrich, Ott/0000-0003-3574-9591				ALAERTS L, 1980, GEOCHIM COSMOCHIM AC, V44, P189, DOI 10.1016/0016-7037(80)90131-3; BAO ZY, 1987, ATOM DATA NUCL DATA, V36, P411, DOI 10.1016/0092-640X(87)90011-8; BEER H, 1986, NUCLEOSYNTHESIS ITS, P263; BURBIDGE EM, 1957, REV MOD PHYS, V29, P547, DOI 10.1103/RevModPhys.29.547; CLAYTON DD, 1978, ASTROPHYS J, V244, P1000; FOWLER WA, 1984, SCIENCE, V226, P922, DOI 10.1126/science.226.4677.922; KAPPELER F, 1982, ASTROPHYS J, V257, P821, DOI 10.1086/160033; MARTI K, 1967, EARTH PLANET SC LETT, V3, P243, DOI 10.1016/0012-821X(67)90044-1; MATHEWS GJ, 1985, REP PROG PHYS, V48, P1371, DOI 10.1088/0034-4885/48/10/002; MATSUDA J, 1980, ASTROPHYS J, V237, pL21, DOI 10.1086/183226; OTT U, 1985, METEORITICS, V20, P722; SRINIVASAN B, 1978, SCIENCE, V201, P51, DOI 10.1126/science.201.4350.51; TANG M, 1987, METEORITICS, V22, P462; WALTER G, 1986, ASTRON ASTROPHYS, V155, P247; WALTER G, 1986, ASTRON ASTROPHYS, V167, P186; WARD RA, 1976, ASTROPHYS J SUPPL S, V31, P33, DOI 10.1086/190373; YANG JM, 1984, NATURE, V311, P544, DOI 10.1038/311544a0	17	53	54	0	2	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	APR 21	1988	332	6166					700	702		10.1038/332700a0	http://dx.doi.org/10.1038/332700a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	N0293	11542152				2022-12-24	WOS:A1988N029300046
J	Sereno, PC; Larsson, HCE; Sidor, CA; Gado, B				Sereno, PC; Larsson, HCE; Sidor, CA; Gado, B			The giant crocodyliform Sarcosuchus from the Cretaceous of Africa	SCIENCE			English	Article								New fossils of the giant African crocodyliform Sarcosuchus imperator clarify its skeletal anatomy, growth patterns, size, longevity, and phylogenetic position. The skull has an expansive narial bulla and elongate jaws studded with stout, smooth crowns that do not interlock. The jaw form suggests a generalized diet of large vertebrates, including fish and dinosaurs. S. imperator is estimated to have grown to a maximum body length of at least 11 to 12 meters and body weight of about 8 metric tons over a life-span of 50 to 60 years. Unlike its closest relatives, which lived as specialized piscivores in marginal marine habitats, S. imperator thrived in fluvial environments.	Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA; Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06511 USA; New York Coll Osteopath Med, Dept Anat, Old Westbury, NY 11568 USA; Inst Rech Sci Humaines, Niamey, Niger	University of Chicago; Yale University; New York Institute Technology	Sereno, PC (corresponding author), Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA.		Larsson, Hans/AAD-4579-2019	Larsson, Hans/0000-0002-6377-4770				Andrews C. W., 1913, Annals & Magazine of Natural History, V11; Buffetau E., 1981, MEMOIRES SOC GEOLOGI, V60, P1; BUFFETAUT E, 1977, Palaeontology (Oxford), V20, P203; Erickson GM, 1999, NATURE, V398, P205, DOI 10.1038/18343; Greer A.E., 1974, Journal Herpet, V8, P381, DOI 10.2307/1562913; Grenard S., 1991, HDB ALLIGATORS CROCO; Headden Jaime A., 2001, Journal of Vertebrate Paleontology, V21, p59A; HOOLEY RW, 1907, J GEOL SOC LONDON, V63, P50; LARSSON HC, 2000, THESIS U CHICAGO; Maisey J.G., 1991, SANTANA FOSSILS ILLU, P342; Pooley A.C., 1989, P76; Ross F.D., 1983, P305; Schwimmer David R., 1999, Journal of Vertebrate Paleontology, V19, p74A; Sereno PC, 1999, SYST BIOL, V48, P329, DOI 10.1080/106351599260328; Singh L.A.K., 1982, British Journal of Herpetology, V6, P253; Smith A.G., 1994, ATLAS MESOZOIC CENOZ; SWOFFORD DL, 1993, PAUP 3 1; TAQUET P, 1975, CAH PALEONTOL, V1, P1; Taquet P., 1966, CR HEBD ACAD SCI, V262, P2326; WEBB GJW, 1983, AUST WILDLIFE RES, V10, P383, DOI 10.1071/WR9830383; WEBB GJW, 1978, AUST J ZOOL, V26, P1; WERMUTH HEINZ, 1964, SENCKENBERG BIOL, V45, P369; Woodward AR, 1995, J HERPETOL, V29, P507, DOI 10.2307/1564733; Wu XC, 2001, J VERTEBR PALEONTOL, V21, P492, DOI 10.1671/0272-4634(2001)021[0492:TACNMF]2.0.CO;2; Wu XC, 1996, CAN J EARTH SCI, V33, P606, DOI 10.1139/e96-045	25	215	225	1	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 16	2001	294	5546					1516	1519		10.1126/science.1066521	http://dx.doi.org/10.1126/science.1066521			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	493TX	11679634				2022-12-24	WOS:000172240500045
J	Attaran, A; Gillespie-White, L				Attaran, A; Gillespie-White, L			Do patents for antiretroviral drugs constrain access to AIDS treatment in Africa?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COMBINATION THERAPY; LAMIVUDINE; STAVUDINE; ZIDOVUDINE; NEVIRAPINE; EFFICACY; REGIMEN; SAFETY; INDIVIDUALS; DIDANOSINE	Public attention and debate recently have focused on access to treatment of acquired immunodeficiency syndrome (AIDS) in poor, severely affected countries, such as those in Africa. Whether patents on antiretroviral drugs In Africa are impeding access to lifesaving treatment for the 25 million Africans with human immunodeficiency virus infection is unknown. We studied the patent statuses of 15 antiretroviral drugs in 53 African countries. Using a survey method, we found that these antiretroviral drugs are patented in few African countries (median, 3; mode, 0) and that in countries where antiretroviral drug patents exist, generally only a small subset of antiretroviral drugs are patented (median and mode, 4). The observed scarcity of patents cannot be simply explained by a lack of patent laws because most African countries have offered patent protection for pharmaceuticals for many years. Furthermore, in this particular case, geographic patent coverage does not appear to correlate with antiretroviral treatment access in Africa, suggesting that patents and patent law are not a major barrier to treatment access in and of themselves. We conclude that a variety of de facto barriers are more responsible for impeding access to antiretroviral treatment, including but not limited to the poverty of African countries, the high cost of antiretroviral treatment, national regulatory requirements for medicines, tariffs and sales taxes, and, above all, a lack of sufficient international financial aid to fund anti-retroviral treatment. We consider these findings in light of policies for enhancing antiretroviral treatment access in poor countries.	Harvard Univ, Ctr Int Dev, Cambridge, MA 02138 USA; Harvard Univ, John F Kennedy Sch Govt, Cambridge, MA 02138 USA; Int Intellectual Property Inst, Washington, DC USA	Harvard University; Harvard University	Attaran, A (corresponding author), Harvard Univ, Ctr Int Dev, 79 JFK St, Cambridge, MA 02138 USA.	amir_attaran@harvard.edu						[Anonymous], PATENT POLICY PROPOS; Attaran A, 2001, LANCET, V357, P57, DOI 10.1016/S0140-6736(00)03576-5; ATTARAN A, 1999, MED SANS FRONT WHO W; ATTARAN A, 1999, HLTH HUM RIGHTS, V4, P28; BALA K, 2001, HLTH ACTION INT  APR; Bale H., 1998, J INT ECON LAW, V1, P637, DOI DOI 10.1093/JIEL/1.4.637; BALE HE, 2001, CONSUMPTION TRADE OF; BOULET P, 2000, DRUG PATENTS FRENCHS; BOULET P, 2000, PATENT PROTECTION ME; *CA DEP TRANSP, 1999, EST COST VFAR FREEW; CORREA C, 2001, INTELLECTUAL PROPERT; CORREA C, 2001, INTEGRATING PUBLIC H; *DEP HLTH HUM SERV, 2001, GUID US ANT AG HIV I; Eron JJ, 2000, AIDS, V14, P1601, DOI 10.1097/00002030-200007280-00016; Ford S., 2000, AM U INT L REV, V15, P941; Gartland M, 2001, ANTIVIR THER, V6, P127; Gupta R, 2001, SCIENCE, V293, P1049, DOI 10.1126/science.1061861; JOHNSON V, 2001, 8 C RETR OPP INF FEB; *JOINT UN PROGR HI, 2000, PAT SIT HIV AIDS REL; Laing RO, 2000, INT J TUBERC LUNG D, V4, pS194; Marseille E, 1999, LANCET, V354, P803, DOI 10.1016/S0140-6736(99)80009-9; McKee RL, 2001, PEOPLE EYE STORIES D, V1st; *PAN I, 2001, OUR MEANS COST TREAT; Pecoul B, 1999, JAMA-J AM MED ASSOC, V281, P361, DOI 10.1001/jama.281.4.361; Raffi F, 2000, ANTIVIR THER, V5, P267; Rockstroh JK, 2000, AIDS, V14, P1181, DOI 10.1097/00002030-200006160-00015; Shalit P, 2001, AIDS, V15, P804, DOI 10.1097/00002030-200104130-00020; Squires KE, 2000, AIDS, V14, P1591, DOI 10.1097/00002030-200007280-00015; Stephenson J, 2001, JAMA-J AM MED ASSOC, V286, P405, DOI 10.1001/jama.286.4.405; SWAMS RL, 2001, NY TIMES        0308, pA1; *WHO, 2001, WHO INT CONS M HIV A; 1883, PAR CONVENTION PROTE; 2000, MANUAL HANDLING APPL; 2000, FED REG, V65, P30521; 2001, TOP HIV MED, V9, P14; 2001, AGREEMENT TRADE RELA	36	105	106	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 17	2001	286	15					1886	1892		10.1001/jama.286.15.1886	http://dx.doi.org/10.1001/jama.286.15.1886			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	482UH	11597292				2022-12-24	WOS:000171595300031
J	Domning, DP				Domning, DP			The earliest known fully quadrupedal sirenian	NATURE			English	Article							EOCENE; JAMAICA; ORIGIN	Modern seacows (manatees and dugongs; Mammalia, Sirenia) are completely aquatic, with flipperlike forelimbs and no hindlimbs(1,2). Here I describe Eocene fossils from Jamaica that represent nearly the entire skeleton of a new genus and species of sirenian-the most primitive for which extensive postcranial remains are known. This animal was fully capable of locomotion on land, with four well-developed legs, a multivertebral sacrum, and a strong sacroiliac articulation that could support the weight of the body out of water as in land mammals. Aquatic adaptations show, however, that it probably spent most of its time in the water. Its intermediate form thus illustrates the evolutionary transition between terrestrial and aquatic life. Similar to contemporary primitive cetaceans(3), it probably swam by spinal extension with simultaneous pelvic paddling, unlike later sirenians and cetaceans, which lost the hindlimbs and enlarged the tail to serve as the main propulsive organ. Together with fossils of later sirenians elsewhere in the world(1,4-7), these new specimens document one of the most marked examples of morphological evolution in the vertebrate fossil record.	Howard Univ, Dept Anat, Washington, DC 20059 USA	Howard University	Domning, DP (corresponding author), Howard Univ, Dept Anat, Washington, DC 20059 USA.	ddomning@fac.howard.edu						Abel O, 1904, ABHANDLUNGEN KAISERL, V19, P1; Domning Daryl P., 2000, Historical Biology, V14, P115; Domning Daryl P., 2001, P151; Domning Daryl P., 1994, Contributions from the Museum of Paleontology University of Michigan, V29, P69; Domning Daryl P., 1994, Proceedings of the San Diego Society of Natural History, V29, P177; DOMNING DP, 1991, MAR MAMMAL SCI, V7, P331, DOI 10.1111/j.1748-7692.1991.tb00111.x; Domning DP, 1997, J VERTEBR PALEONTOL, V17, P638, DOI 10.1080/02724634.1997.10011013; DOMNING DP, 1982, SMITHSONIAN CONTRIBU, V52, P1; DOMNING DP, 2001, B ASHORO MUS PALEONT, V2, P39; Fish FE, 1996, AM ZOOL, V36, P628, DOI 10.1093/icb/36.6.628; GINGERICH PD, 1994, NATURE, V368, P844, DOI 10.1038/368844a0; Lepsius G.R., 1882, ABHANDLUNGEN MITTELR, V1, P1; Liu FGR, 1999, SYST BIOL, V48, P54, DOI 10.1080/106351599260436; MacPhee R. D. E., 1999, Journal of Vertebrate Paleontology, V19, p61A; Matthew W. D., 1937, Transactions of the American Philosophical Society Philadelphia NS, V30, P1; Pregill GK, 1999, HERPETOLOGICA, V55, P157; SAVAGE RJG, 1994, J VERTEBR PALEONTOL, V14, P427, DOI 10.1080/02724634.1994.10011569; Siegfried P., 1967, Palaeontologische Zeitschrift, V41, P165; Taylor Michael A., 2000, Historical Biology, V14, P15; Thewissen J.G.M., 1996, Courier Forschungsinstitut Senckenberg, V191, P1; Thewissen J.G.M., 1992, Journal of Vertebrate Paleontology, V12, P494; THEWISSEN JGM, 1994, SCIENCE, V263, P210, DOI 10.1126/science.263.5144.210	22	114	121	0	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 11	2001	413	6856					625	627		10.1038/35098072	http://dx.doi.org/10.1038/35098072			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480WE	11675784				2022-12-24	WOS:000171485700047
J	Ferguson, NM; Donnelly, CA; Anderson, RM				Ferguson, NM; Donnelly, CA; Anderson, RM			Transmission intensity and impact of control policies on the foot and mouth epidemic in Great Britain	NATURE			English	Article							DISEASE; SPREAD	The foot and mouth disease (FMD) epidemic in British livestock remains an ongoing cause for concern, with new cases still arising in previously unaffected areas. Epidemiological analyses(1-3) have been vital in delivering scientific advice to government on effective control measures. Using disease, culling and census data on all livestock farms in Great Britain, we analysed the risk factors determining the spatiotemporal evolution of the epidemic and of the impact of control policies on FMD incidence. Here we show that the species mix, animal numbers and the number of distinct land parcels in a farm are central to explaining regional variation in transmission intensity. We use the parameter estimates thus obtained in a dynamical model of disease spread to show that extended culling programmes were essential for controlling the epidemic to the extent achieved, but demonstrate that the epidemic could have been substantially reduced in scale had the most efficient control measures been rigorously applied earlier.	Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Infect Dis Epidemiol, London W2 1PG, England	Imperial College London	Ferguson, NM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Infect Dis Epidemiol, St Mary Campus,Norfolk Pl, London W2 1PG, England.	neil.ferguson@ic.ac.uk	Ferguson, Neil/B-8578-2008	Ferguson, Neil/0000-0002-1154-8093; Donnelly, Christl/0000-0002-0195-2463; Anderson, Roy/0000-0002-9528-3175				ANDERSON R M, 1991; [Anonymous], 2001, NATURE, V411, P977; Barber CB, 1996, ACM T MATH SOFTWARE, V22, P469, DOI 10.1145/235815.235821; Donaldson AI, 2001, VET REC, V148, P602, DOI 10.1136/vr.148.19.602; Ferguson NM, 2001, SCIENCE, V292, P1155, DOI 10.1126/science.1061020; HIGHFIELD R, 2001, TELEGRAPH       0702; HMSO (Her Majesty's Stationery Office), 1968, NORTHUMBERLAND REPOR; Kao RR, 2001, VET REC, V148, P746, DOI 10.1136/vr.148.24.746; MCCOLL KA, 1995, AUST VET J, V72, P286, DOI 10.1111/j.1751-0813.1995.tb03556.x; *UK MIN AGR FISH F, 2001, JUN 2000 AGR HORT CE; Woolhouse M, 2001, NATURE, V411, P258, DOI 10.1038/35077149; 2001, VET REC, V148, P550; 2001, GUARDIAN UNLIMI 0320	13	319	322	3	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 4	2001	413	6855					542	548		10.1038/35097116	http://dx.doi.org/10.1038/35097116			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	478HG	11586365				2022-12-24	WOS:000171340500052
J	Thompson, PM; Ollason, JC				Thompson, PM; Ollason, JC			Lagged effects of ocean climate change on fulmar population dynamics	NATURE			English	Article							NORTH-ATLANTIC; CONSEQUENCES; VARIABILITY; GLACIALIS; FISHERIES; SURVIVAL; ORKNEY; TRENDS	Environmental variation reflected by the North Atlantic Oscillation affects breeding and survival in terrestrial vertebrates(1,2), and climate change is predicted to have an impact on population dynamics by influencing food quality or availability(3). The North Atlantic Oscillation also affects the abundance of marine fish and zooplankton(4,5), but it is unclear whether this filters up trophic levels to long-lived marine top predators. Here we show by analysis of data from a 50-year study of the fulmar that two different indices of ocean climate variation may have lagged effects on population dynamics in this procellariiform seabird.	Univ Aberdeen, Dept Zool, Lighthouse Field Stn, Cromarty IV11 8YJ, Ross Shire, Scotland; Univ Aberdeen, Dept Zool, Culterty Field Stn, Ellon AB41 6AA, Aberdeen, Scotland	University of Aberdeen; University of Aberdeen	Thompson, PM (corresponding author), Univ Aberdeen, Dept Zool, Lighthouse Field Stn, Cromarty IV11 8YJ, Ross Shire, Scotland.		Thompson, Paul Michael/AGR-6267-2022; Thompson, Paul M/B-6742-2009	Thompson, Paul Michael/0000-0001-6195-3284; Thompson, Paul M/0000-0001-6195-3284				Bradley JS, 2000, J ANIM ECOL, V69, P639, DOI 10.1046/j.1365-2656.2000.00422.x; Briffa KR, 1998, NATURE, V393, P450, DOI 10.1038/30943; BROWN RGB, 1970, IBIS, V112, P44, DOI 10.1111/j.1474-919X.1970.tb00074.x; COOPER CF, 1983, SCIENCE, V219, P969, DOI 10.1126/science.219.4587.969; DUNNET GM, 1991, IBIS, V133, P24, DOI 10.1111/j.1474-919X.1991.tb07665.x; DUNNET GM, 1979, IBIS, V121, P293, DOI 10.1111/j.1474-919X.1979.tb06846.x; DUNNET GM, 1961, BIRD STUDY, V8, P119; FISHER J, 1952, FULMAR; Furness RW, 1996, ECOLOGY, V77, P1181, DOI 10.2307/2265587; Gaillard JM, 1998, TRENDS ECOL EVOL, V13, P58, DOI 10.1016/S0169-5347(97)01237-8; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; Kitaysky AS, 2000, J ANIM ECOL, V69, P248, DOI 10.1046/j.1365-2656.2000.00392.x; Lloyd C, 1991, STATUS SEABIRDS BRIT; Milner JM, 1999, J ANIM ECOL, V68, P1235, DOI 10.1046/j.1365-2656.1999.00366.x; Mougin JL, 1997, IBIS, V139, P40, DOI 10.1111/j.1474-919X.1997.tb04502.x; O'Brien CM, 2000, NATURE, V404, P142, DOI 10.1038/35004654; Ollason J.C., 1988, P263; OLLASON JC, 1980, J FIELD ORNITHOL, V51, P39; Phillips RA, 1999, MAR BIOL, V135, P159, DOI 10.1007/s002270050613; Planque B, 1998, ICES J MAR SCI, V55, P644, DOI 10.1006/jmsc.1998.0390; Pomeroy PP, 2000, J ZOOL, V250, P1; Post E, 1999, NATURE, V401, P905, DOI 10.1038/44814; Post E, 1999, ECOLOGY, V80, P1322, DOI 10.1890/0012-9658(1999)080[1322:CVPPAN]2.0.CO;2; Saether BE, 2000, SCIENCE, V287, P854, DOI 10.1126/science.287.5454.854; SALOMONS.F, 1965, AUK, V82, P327, DOI 10.2307/4083117; Wilby RL, 1997, WEATHER, V52, P266, DOI [10.1002/j.1477-8696.1997.tb06323.x, DOI 10.1002/J.1477-8696.1997.TB06323.X]; Wynne-Edwards V. C., 1962, pUnpaginated	27	188	191	0	83	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 27	2001	413	6854					417	420		10.1038/35096558	http://dx.doi.org/10.1038/35096558			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475UY	11574887				2022-12-24	WOS:000171188700053
J	Vulliamy, T; Marrone, A; Goldman, F; Dearlove, A; Bessler, M; Mason, PJ; Dokal, I				Vulliamy, T; Marrone, A; Goldman, F; Dearlove, A; Bessler, M; Mason, PJ; Dokal, I			The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita	NATURE			English	Article							MICE; CELLS	Dyskeratosis congenita is a progressive bone-marrow failure syndrome that is characterized by abnormal skin pigmentation, leukoplakia and nail dystrophy(1,2). X-linked, autosomal recessive and autosomal dominant inheritance have been found in different pedigrees. The X-linked form of the disease is due to mutations in the gene DKC1 in band 2, sub-band 8 of the long arm of the X chromosome (ref. 3). The affected protein, dyskerin, is a nucleolar protein that is found associated with the H/ACA class of small nucleolar RNAs and is involved in pseudo-uridylation of specific residues of ribosomal RNA(4). Dyskerin is also associated with telomerase RNA (hTR)(5), which contains a H/ACA consensus sequence(6,7). Here we map the gene responsible for dyskeratosis congenita in a large pedigree with autosomal dominant inheritance. Affected members of this family have an 821-base-pair deletion on chromosome 3q that removes the 3' 74 bases of hTR. Mutations in hTR were found in two other families with autosomal dominant dyskeratosis congenita.	Hammersmith Hosp, Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Haematol,Div Invest Sci, London W12 0NN, England; Univ Iowa Hosp & Clin, Dept Pediat, Iowa City, IA 52242 USA; MRC UK, HGMP Resource Ctr, Cambridge CB10 1SB, England; Washington Univ, Sch Med, Div Hematol, St Louis, MO 63110 USA	Imperial College London; University of Iowa; Washington University (WUSTL)	Mason, PJ (corresponding author), Hammersmith Hosp, Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Haematol,Div Invest Sci, Ducane Rd, London W12 0NN, England.		Mason, Philip J/B-1087-2008	Dokal, Inderjeet/0000-0003-4462-4782				Alter BP, 2000, J PEDIATR-US, V136, P275, DOI 10.1067/mpd.2000.104285; Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592; Artandi SE, 2000, CURR OPIN GENET DEV, V10, P39, DOI 10.1016/S0959-437X(99)00047-7; Bachand F, 2001, MOL CELL BIOL, V21, P1888, DOI 10.1128/MCB.21.5.1888-1897.2001; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; BROWN WRA, 1990, CELL, V63, P119, DOI 10.1016/0092-8674(90)90293-N; Chen JL, 2000, CELL, V100, P503, DOI 10.1016/S0092-8674(00)80687-X; Collins K, 2000, CURR OPIN CELL BIOL, V12, P378, DOI 10.1016/S0955-0674(00)00103-4; Dokal I, 2000, BRIT J HAEMATOL, V110, P768, DOI 10.1046/j.1365-2141.2000.02109.x; DRACHTMAN RA, 1992, AM J PEDIAT HEMATOL, V14, P297; Dragon F, 2000, MOL CELL BIOL, V20, P3037, DOI 10.1128/MCB.20.9.3037-3048.2000; FENG JL, 1995, SCIENCE, V269, P1236, DOI 10.1126/science.7544491; Heiss NS, 1998, NAT GENET, V19, P32, DOI 10.1038/ng0598-32; Hemann MT, 2000, NUCLEIC ACIDS RES, V28, P4474, DOI 10.1093/nar/28.22.4474; Herrera E, 1999, EMBO J, V18, P2950, DOI 10.1093/emboj/18.11.2950; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Marciniak RA, 2000, TRENDS GENET, V16, P193, DOI 10.1016/S0168-9525(00)01984-3; Martin-Rivera L, 2001, J BIOL CHEM, V276, P5856, DOI 10.1074/jbc.M008419200; Mitchell JR, 1999, MOL CELL BIOL, V19, P567; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; Notaro R, 1997, P NATL ACAD SCI USA, V94, P13782, DOI 10.1073/pnas.94.25.13782; Pogacic V, 2000, MOL CELL BIOL, V20, P9028, DOI 10.1128/MCB.20.23.9028-9040.2000; Prescott JC, 1999, CURR OPIN GENET DEV, V9, P368, DOI 10.1016/S0959-437X(99)80055-0; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Sambrook J, 1989, MOL CLONING LAB MANU, V2nd; Tollervey D, 1997, CURR OPIN CELL BIOL, V9, P337, DOI 10.1016/S0955-0674(97)80005-1; Vulliamy TJ, 2001, BLOOD CELL MOL DIS, V27, P353, DOI 10.1006/bcmd.2001.0389; Vulliamy TJ, 1997, BLOOD, V90, P2213	29	707	736	1	31	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 27	2001	413	6854					432	435		10.1038/35096585	http://dx.doi.org/10.1038/35096585			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475UY	11574891				2022-12-24	WOS:000171188700057
J	Peterson, EJ; Woods, ML; Dmowski, SA; Derimanov, G; Jordan, MS; Wu, JN; Myung, PS; Liu, QH; Pribila, JT; Freedman, BD; Shimizu, Y; Koretzky, GA				Peterson, EJ; Woods, ML; Dmowski, SA; Derimanov, G; Jordan, MS; Wu, JN; Myung, PS; Liu, QH; Pribila, JT; Freedman, BD; Shimizu, Y; Koretzky, GA			Coupling of the TCR to integrin activation by SLAP-130/Fyb	SCIENCE			English	Article							T-CELL RECEPTOR; ADAPTER PROTEIN SLP-76; LYMPHOCYTE MIGRATION; TYROSINE KINASES; ADHESION; MICE; LFA-1; SUBSTRATE; CLONING; ZAP-70	SLAP-130/Fyb (SLP-76-associated phosphoprotein or Fyn-binding protein; also known as Fyb/Slap) is a hematopoietic-specific adapter, which associates with and modulates function of SH2-containing leukocyte phosphoprotein of 76 kilodaltons (SLP-76). T cells from mice lacking SLAP-130/Fyb show markedly impaired proliferation following CD3 engagement. In addition, the T cell receptor (TCR) in SLAP-130/Fyb mutant cells fails to enhance integrin-dependent adhesion. Although TCR-induced actin polymerization is normal, TCR-stimulated clustering of the integrin LFA-1 is defective in SLAP-130/Fyb-deficient cells. These data indicate that SLAP-130/Fyb is important for coupling TCR-mediated actin cytoskeletal rearrangement with activation of integrin function, and for T cells to respond fully to activating signals.	Univ Penn, Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA; Univ Minnesota, Sch Med, Ctr Canc, Ctr Immunol,Dept Pathol & Lab Med, Minneapolis, MN 55455 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Minnesota System; University of Minnesota Twin Cities	Koretzky, GA (corresponding author), Univ Penn, Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA.	koretzky@mail.med.upenn.edu	Koretzky, Gary/AAU-5381-2021; Peterson, Erik/M-9365-2013	Shimizu, Yoji/0000-0001-9760-0288	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060921] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI060921] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Berlin-Rufenach C, 1999, J EXP MED, V189, P1467, DOI 10.1084/jem.189.9.1467; Clements JL, 1998, SCIENCE, V281, P416, DOI 10.1126/science.281.5375.416; DaSilva AJ, 1997, P NATL ACAD SCI USA, V94, P7493, DOI 10.1073/pnas.94.14.7493; DRANSFIELD I, 1992, J CELL BIOL, V116, P219, DOI 10.1083/jcb.116.1.219; DUSTIN ML, 1989, NATURE, V341, P619, DOI 10.1038/341619a0; Epler JA, 2000, J IMMUNOL, V165, P4941, DOI 10.4049/jimmunol.165.9.4941; Freedman BD, 1999, J EXP MED, V190, P943, DOI 10.1084/jem.190.7.943; GENG L, IN PRESS NATL ACAD S; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Hunter AJ, 2000, J IMMUNOL, V164, P1143, DOI 10.4049/jimmunol.164.3.1143; Krause M, 2000, J CELL BIOL, V149, P181, DOI 10.1083/jcb.149.1.181; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Musci MA, 1997, J BIOL CHEM, V272, P11674, DOI 10.1074/jbc.272.18.11674; PETERSON ET, UNPUB; Pivniouk V, 1998, CELL, V94, P229, DOI 10.1016/S0092-8674(00)81422-1; Reichert P, 2001, J IMMUNOL, V166, P4278, DOI 10.4049/jimmunol.166.7.4278; Samelson LE, 1999, PROG BIOPHYS MOL BIO, V71, P393, DOI 10.1016/S0079-6107(98)00050-9; Scharffetter-Kochanek K, 1998, J EXP MED, V188, P119, DOI 10.1084/jem.188.1.119; Schmits R, 1996, J EXP MED, V183, P1415, DOI 10.1084/jem.183.4.1415; Stewart MP, 1996, J IMMUNOL, V156, P1810; Stewart MP, 1998, J CELL BIOL, V140, P699, DOI 10.1083/jcb.140.3.699; VAN SG, 1990, J IMMUNOL, V144, P4579; VANKOOYK Y, 1994, J CELL BIOL, V124, P1061, DOI 10.1083/jcb.124.6.1061; VANKOOYK Y, 1989, NATURE, V342, P811, DOI 10.1038/342811a0; Yablonski D, 1998, SCIENCE, V281, P413, DOI 10.1126/science.281.5375.413; Zell T, 1999, IMMUNOL RES, V20, P127; Zhang J, 1999, J EXP MED, V190, P1329, DOI 10.1084/jem.190.9.1329; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0	28	259	273	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 21	2001	293	5538					2263	2265		10.1126/science.1063486	http://dx.doi.org/10.1126/science.1063486			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475AL	11567141				2022-12-24	WOS:000171139400046
J	Harden, PN; Reece, SM; Fryer, AA; Smith, AG; Ramsay, HM				Harden, PN; Reece, SM; Fryer, AA; Smith, AG; Ramsay, HM			Skin cancer surveillance in renal transplant recipients: questionnaire survey of current UK practice	BRITISH MEDICAL JOURNAL			English	Article									N Staffordshire Hosp, Dept Nephrol, Stoke On Trent ST4 7LN, Staffs, England; N Staffordshire Hosp, Dept Biochem, Stoke On Trent ST4 7LN, Staffs, England; N Staffordshire Hosp, Dept Dermatol, Stoke On Trent ST4 7LN, Staffs, England	Keele University; University Hospital of North Staffordshire NHS Trust; Keele University; University Hospital of North Staffordshire NHS Trust; Keele University; University Hospital of North Staffordshire NHS Trust	Harden, PN (corresponding author), N Staffordshire Hosp, Dept Nephrol, Stoke On Trent ST4 7LN, Staffs, England.			Fryer, Anthony/0000-0001-8678-0404				Harden PN, 2001, TRANSPLANT P, V33, P1302, DOI 10.1016/S0041-1345(00)02486-6; Kasiske BL, 2000, J AM SOC NEPHROL, V11, pS1; Ramsay HM, 2000, AM J KIDNEY DIS, V36, P167, DOI 10.1053/ajkd.2000.8290; Seukeran DC, 1998, BRIT J DERMATOL, V138, P301; SLADE J, 1995, J AM ACAD DERMATOL, V32, P479, DOI 10.1016/0190-9622(95)90073-X	5	17	18	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 15	2001	323	7313					600	601		10.1136/bmj.323.7313.600	http://dx.doi.org/10.1136/bmj.323.7313.600			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	474CT	11557706	Bronze, Green Published			2022-12-24	WOS:000171087300017
J	Abbott, A				Abbott, A			WHO plans study of Gulf War fallout	NATURE			English	News Item																			0	1	1	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 13	2001	413	6852					97	97		10.1038/35093231	http://dx.doi.org/10.1038/35093231			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471FU	11557937	Bronze			2022-12-24	WOS:000170918800008
J	Diefenbach, A; Jensen, ER; Jamieson, AM; Raulet, DH				Diefenbach, A; Jensen, ER; Jamieson, AM; Raulet, DH			Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity	NATURE			English	Article							NATURAL-KILLER-CELLS; NK CELLS; T-CELLS; DEFICIENT MICE; COMMON ORIGIN; MURINE NKG2D; ACTIVATION; SURVEILLANCE; EXPRESSION; FAMILY	Natural killer (NK) cells attack many tumour cell lines, and are thought to have a critical role in anti-tumour immunity(1-7); however, the interaction between NK cells and tumour targets is poorly understood. The stimulatory lectin-like NKG2D receptor(8-13) is expressed by NK cells, activated CD8(+) T cells and by activated macrophages in mice(11). Several distinct cell-surface ligands that are related to class I major histocompatibility complex molecules have been identified(11-14), some of which are expressed at high levels by tumour cells but not by normal cells in adults(11,13,15,16). However, no direct evidence links the expression of these 'induced self' ligands with tumour cell rejection. Here we demonstrate that ectopic expression of the murine NKG2D ligands Rae1 beta or H60 in several tumour cell lines results in potent rejection of the tumour cells by syngeneic mice. Rejection is mediated by NK cells and/or CD8(+) T cells. The ligand-expressing tumour cells induce potent priming of cytotoxic T cells and sensitization of NK cells in vivo. Mice that are exposed to live or irradiated tumour cells expressing Rae1 beta or H60 are specifically immune to subsequent challenge with tumour cells that lack NKG2D ligands, suggesting application of the ligands in the design of tumour vaccines.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Canc Res Lab, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Raulet, DH (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 485 Life Sci Addit, Berkeley, CA 94720 USA.	raulet@uclink4.berkeley.edu	Jamieson, Amanda/U-7169-2019; Diefenbach, Andreas/T-2589-2018	Jamieson, Amanda/0000-0002-5781-9231; Diefenbach, Andreas/0000-0002-9176-9530; Raulet, David/0000-0002-1257-8649	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039642] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI039642] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Cerwenka A, 2000, IMMUNITY, V12, P721, DOI 10.1016/S1074-7613(00)80222-8; Cosman D, 2001, IMMUNITY, V14, P123, DOI 10.1016/S1074-7613(09)00098-3; Diefenbach A, 2000, NAT IMMUNOL, V1, P119, DOI 10.1038/77793; DRANOFF G, 1993, P NATL ACAD SCI USA, V90, P3539, DOI 10.1073/pnas.90.8.3539; Gays F, 2000, J IMMUNOL, V164, P5094, DOI 10.4049/jimmunol.164.10.5094; Glas R, 2000, J EXP MED, V191, P129, DOI 10.1084/jem.191.1.129; Groh V, 1999, P NATL ACAD SCI USA, V96, P6879, DOI 10.1073/pnas.96.12.6879; Groh V, 2001, NAT IMMUNOL, V2, P255, DOI 10.1038/85321; Grufman P, 2000, EUR J IMMUNOL, V30, P1088, DOI 10.1002/(SICI)1521-4141(200004)30:4<1088::AID-IMMU1088>3.0.CO;2-O; HART IR, 1979, AM J PATHOL, V97, P587; Ho EL, 1998, P NATL ACAD SCI USA, V95, P6320, DOI 10.1073/pnas.95.11.6320; HUANG AYC, 1994, SCIENCE, V264, P961, DOI 10.1126/science.7513904; Kaplan DH, 1998, P NATL ACAD SCI USA, V95, P7556, DOI 10.1073/pnas.95.13.7556; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; Kim S, 2000, P NATL ACAD SCI USA, V97, P2731, DOI 10.1073/pnas.050588297; LIAO NS, 1991, SCIENCE, V253, P199, DOI 10.1126/science.1853205; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Moretta A, 2001, ANNU REV IMMUNOL, V19, P197, DOI 10.1146/annurev.immunol.19.1.197; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Nomura M, 1996, J BIOCHEM-TOKYO, V120, P987; Pende D, 1999, J EXP MED, V190, P1505, DOI 10.1084/jem.190.10.1505; SEAMAN WE, 1987, J IMMUNOL, V138, P4539; Smyth MJ, 2000, J EXP MED, V192, P755, DOI 10.1084/jem.192.5.755; TRINCHIERI G, 1989, ADV IMMUNOL, V47, P187, DOI 10.1016/S0065-2776(08)60664-1; van Elsas A, 1999, J EXP MED, V190, P355, DOI 10.1084/jem.190.3.355; van Hall T, 2000, J IMMUNOL, V165, P869, DOI 10.4049/jimmunol.165.2.869; Vance RE, 1997, EUR J IMMUNOL, V27, P3236, DOI 10.1002/eji.1830271222; vandenBroek MF, 1996, J EXP MED, V184, P1781, DOI 10.1084/jem.184.5.1781; Wu J, 1999, SCIENCE, V285, P730, DOI 10.1126/science.285.5428.730	30	788	833	2	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 13	2001	413	6852					165	171		10.1038/35093109	http://dx.doi.org/10.1038/35093109			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471FU	11557981	Green Accepted			2022-12-24	WOS:000170918800047
J	Greco, V; Hannus, M; Eaton, S				Greco, V; Hannus, M; Eaton, S			Argosomes: A potential vehicle for the spread of morphogens through epithelia	CELL			English	Article							GRADIENT FORMATION; TRANSMEMBRANE LIGAND; LYMPHOCYTES-T; CELL-SURFACE; DROSOPHILA; HEDGEHOG; PROTEIN; NOTCH; GLYCOSAMINOGLYCANS; ENDOCYTOSIS	The formation of morphogen gradients is essential for tissue patterning. Morphogens are released from producing cells and spread through adjacent tissue; paradoxically, however, many morphogens, including Wingless, associate tightly with the cell membrane. Here, we describe a novel cell biological mechanism that disperses membrane fragments over large distances through the Drosophila imaginal disc epithelium. We call these membrane exovesicles argosomes. Argosomes are derived from basolateral membranes and are produced by many different regions of the disc. They travel through adjacent tissue where they are found predominantly in endosomes. Wingless protein colocalizes with argosomes derived from Wingless-producing cells. The properties of argosomes are consistent with their being a vehicle for the spread of Wingless protein.	Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	Max Planck Society	Eaton, S (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr-108, D-01307 Dresden, Germany.		Eaton, Suzanne/D-7698-2017	Eaton, Suzanne/0000-0002-8319-284X	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR063663] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR063663] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Baeg GH, 2001, DEVELOPMENT, V128, P87; BELLAICHE Y, 1998, IN PRESS NATURE; Binari RC, 1997, DEVELOPMENT, V124, P2623; BRADLEY RS, 1990, EMBO J, V9, P1569, DOI 10.1002/j.1460-2075.1990.tb08276.x; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cadigan KM, 1998, CELL, V93, P767, DOI 10.1016/S0092-8674(00)81438-5; CAGAN RL, 1992, CELL, V69, P393, DOI 10.1016/0092-8674(92)90442-F; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; Christian JL, 2000, CURR OPIN CELL BIOL, V12, P244, DOI 10.1016/S0955-0674(99)00082-4; Denzer K, 2000, J IMMUNOL, V165, P1259, DOI 10.4049/jimmunol.165.3.1259; Denzer K, 2000, J CELL SCI, V113, P3365; Entchev EV, 2000, CELL, V103, P981, DOI 10.1016/S0092-8674(00)00200-2; Keller P, 2001, NAT CELL BIOL, V3, P140, DOI 10.1038/35055042; Klueg KM, 1999, J CELL SCI, V112, P3289; Klueg KM, 1998, MOL BIOL CELL, V9, P1709, DOI 10.1091/mbc.9.7.1709; Lawrence PA, 1996, CELL, V85, P951, DOI 10.1016/S0092-8674(00)81297-0; Lin XH, 2000, MATRIX BIOL, V19, P303, DOI 10.1016/S0945-053X(00)00073-1; Lin XH, 1999, NATURE, V400, P281, DOI 10.1038/22343; Neumann C, 1997, BIOESSAYS, V19, P721, DOI 10.1002/bies.950190813; PAPKOFF J, 1990, MOL CELL BIOL, V10, P2723, DOI 10.1128/MCB.10.6.2723; Parks AL, 2000, DEVELOPMENT, V127, P1373; Pepinsky RB, 1998, J BIOL CHEM, V273, P14037, DOI 10.1074/jbc.273.22.14037; PETERS PJ, 1990, IMMUNOL TODAY, V11, P28; PETERS PJ, 1989, EUR J IMMUNOL, V19, P1469, DOI 10.1002/eji.1830190819; Porter JA, 1996, SCIENCE, V274, P255, DOI 10.1126/science.274.5285.255; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Reichsman F, 1996, J CELL BIOL, V135, P819, DOI 10.1083/jcb.135.3.819; Robbins JR, 1999, J CELL BIOL, V146, P1333, DOI 10.1083/jcb.146.6.1333; Strigini M, 2000, CURR BIOL, V10, P293, DOI 10.1016/S0960-9822(00)00378-X; Teleman AA, 2000, CELL, V103, P971, DOI 10.1016/S0092-8674(00)00199-9; Tsuda M, 1999, NATURE, V400, P276, DOI 10.1038/22336; VANDENHEUVEL M, 1989, CELL, V59, P739, DOI 10.1016/0092-8674(89)90020-2; Zecca M, 1996, CELL, V87, P833, DOI 10.1016/S0092-8674(00)81991-1; Zitvogel L, 1998, NAT MED, V4, P594, DOI 10.1038/nm0598-594	34	331	341	0	16	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 7	2001	106	5					633	645		10.1016/S0092-8674(01)00484-6	http://dx.doi.org/10.1016/S0092-8674(01)00484-6			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	472FQ	11551510	Bronze			2022-12-24	WOS:000170973200013
J	Sleigh, AC; Jackson, S				Sleigh, AC; Jackson, S			Dams, development, and health: a missed opportunity	LANCET			English	Editorial Material									Univ Queensland, Sch Populat Hlth, Brisbane, Qld 4006, Australia; Univ Queensland, Sch Econ, St Lucia, Qld, Australia	University of Queensland; University of Queensland	Sleigh, AC (corresponding author), Univ Queensland, Sch Populat Hlth, Brisbane, Qld 4006, Australia.		sleigh, adrian/J-4540-2019	sleigh, adrian/0000-0001-8443-7864				[Anonymous], 1993, PARASITIC DIS WATER; BRODY H, 2001, ADDRESSING PROJECT S; Jackson S, 2000, COMMUNIS POST-COMMUN, V33, P223, DOI 10.1016/S0967-067X(00)00005-2; MUSHKIN SJ, 1962, J POLIT ECON, V70, P129, DOI 10.1086/258730; Pearson Lestor B., 1969, PARTNERS DEV REPORT; Sleigh A, 1998, LANCET, V351, P1449, DOI 10.1016/S0140-6736(05)78866-8; Strauss J, 1998, J ECON LIT, V36, P766; *WORLD COMM DAMS, 2000, DAMS DEV NEW FRAM DE	8	15	15	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 24	2001	357	9256					570	571		10.1016/S0140-6736(00)04072-1	http://dx.doi.org/10.1016/S0140-6736(00)04072-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	404UB	11558476				2022-12-24	WOS:000167119100002
J	Watson, SA				Watson, SA			Oncogenic targets of beta-catenin-mediated transcription in molecular pathogenesis of intestinal polyposis	LANCET			English	Editorial Material							COLORECTAL-CANCER; COLON-CARCINOMA; ACTIVATION; PATHWAY; GASTRIN; COMPLEX; GENE		Univ Nottingham, Acad Unit Canc Studies, Nottingham NG7 2UH, England	University of Nottingham	Watson, SA (corresponding author), Univ Nottingham, Acad Unit Canc Studies, Nottingham NG7 2UH, England.	sue.watson@nottingham.ac.uk						Barker N, 2000, ADV CANCER RES, V77, P1; GOYETTE MC, 1992, MOL CELL BIOL, V12, P1387, DOI 10.1128/MCB.12.3.1387; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; He TC, 1999, CELL, V99, P335, DOI 10.1016/S0092-8674(00)81664-5; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Koh TJ, 2000, J CLIN INVEST, V106, P533, DOI 10.1172/JCI9476; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; POLAKIS P, 1997, BIOCHIM BIOPHYS ACTA, V1332, P127; Smith AM, 2000, GUT, V47, P820, DOI 10.1136/gut.47.6.820; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Watson SA, 1998, GASTROENTEROLOGY, V114, pA701; WATSON SA, 1999, DIGESTION, V60, P600; Yamada T, 2000, CANCER RES, V60, P4761	14	17	18	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 24	2001	357	9256					572	573		10.1016/S0140-6736(00)04074-5	http://dx.doi.org/10.1016/S0140-6736(00)04074-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	404UB	11558478				2022-12-24	WOS:000167119100004
J	Saha, S; Bardelli, A; Buckhaults, P; Velculescu, VE; Rago, C; St Croix, B; Romans, KE; Choti, MA; Lengauer, C; Kinzler, KW; Vogelstein, B				Saha, S; Bardelli, A; Buckhaults, P; Velculescu, VE; Rago, C; St Croix, B; Romans, KE; Choti, MA; Lengauer, C; Kinzler, KW; Vogelstein, B			A phosphatase associated with metastasis of colorectal cancer	SCIENCE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; PROTEIN-TYROSINE PHOSPHATASES; TUMOR-SUPPRESSOR GENES; PROSTATE-CANCER; AMPLIFICATION; TRANSCRIPTOMES; PRENYLATION; EXPRESSION; BREAST	To gain insights into the molecular basis for metastasis, we compared the global gene expression profile of metastatic colorectal cancer with that of primary cancers, benign colorectal tumors, and normal colorectal epithelium. Among the genes identified, the PRL-3 protein tyrosine phosphatase gene was of particular interest. It was expressed at high levels in each of 18 cancer metastases studied but at lower levels in nonmetastatic tumors and normal colorectal epithelium. In 3 of 12 metastases examined, multiple copies of the PRL-3 gene were found within a small amplicon located at chromosome 8q24.3. These data suggest that the PRL-3 gene is important for colorectal cancer metastasis and provide a new therapeutic target for these intractable lesions.	Johns Hopkins Med Inst, Howard Hughes Med Inst, Ctr Oncol, Dept Surg, Baltimore, MD 21231 USA; Johns Hopkins Med Inst, Program Cellular & Mol Med, Baltimore, MD 21231 USA	Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Kinzler, KW (corresponding author), Johns Hopkins Med Inst, Howard Hughes Med Inst, Ctr Oncol, Dept Surg, Baltimore, MD 21231 USA.	kinzlke@jhmi.edu; vogelbe@welch.jhu.edu	Velculescu, Victor/ABF-4846-2020; BARDELLI, Alberto/J-9721-2018	Velculescu, Victor/0000-0003-1195-438X; BARDELLI, Alberto/0000-0003-1647-5070	NATIONAL CANCER INSTITUTE [R37CA043460, R01CA057345, P50CA062924, R01CA043460, R37CA057345] Funding Source: NIH RePORTER; NCI NIH HHS [CA57345, CA43460, CA 62924] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alers JC, 1997, LAB INVEST, V77, P437; BRODEUR GM, 1998, GENETIC BASIS HUMAN, V1, P161; Cates CA, 1996, CANCER LETT, V110, P49, DOI 10.1016/S0304-3835(96)04459-X; DIAMOND RH, 1994, MOL CELL BIOL, V14, P3752, DOI 10.1128/MCB.14.6.3752; El Gedaily A, 2001, PROSTATE, V46, P184; Fidler I J, 2001, Surg Oncol Clin N Am, V10, P257; Haber D, 1997, NAT GENET, V16, P320, DOI 10.1038/ng0897-320; Heiskanen MA, 2000, CANCER RES, V60, P799; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Matter WF, 2001, BIOCHEM BIOPH RES CO, V283, P1061, DOI 10.1006/bbrc.2001.4881; Nupponen NN, 2000, GENE CHROMOSOME CANC, V28, P203; Paredes-Zaglul A, 1998, CLIN CANCER RES, V4, P879; Pegram M D, 2000, Cancer Treat Res, V103, P57; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Ridley A, 2000, NATURE, V406, P466, DOI 10.1038/35020170; Velculescu VE, 2000, TRENDS GENET, V16, P423, DOI 10.1016/S0168-9525(00)02114-4; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; Velculescu VE, 1999, NAT GENET, V23, P387, DOI 10.1038/70487; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Weiss L, 2000, CANCER METAST REV, V19, P193, DOI 10.1023/A:1010646304844; Zeng Q, 2000, J BIOL CHEM, V275, P21444, DOI 10.1074/jbc.M000453200; Zhang L, 1997, SCIENCE, V276, P1268, DOI 10.1126/science.276.5316.1268	24	548	618	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 9	2001	294	5545					1343	1346		10.1126/science.1065817	http://dx.doi.org/10.1126/science.1065817			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	491VF	11598267				2022-12-24	WOS:000172130200050
J	Vrijhoef, HJM; Spreeuwenberg, C; Eijkelberg, IMJG; Wolffenbuttel, BHR; van Merode, GG				Vrijhoef, HJM; Spreeuwenberg, C; Eijkelberg, IMJG; Wolffenbuttel, BHR; van Merode, GG			Adoption of disease management model for diabetes in region of Maastricht	BRITISH MEDICAL JOURNAL			English	Article							CARE; TECHNOLOGY; QUALITY		Univ Maastricht, Fac Hlth Sci, Dept Hlth Care Studies, NL-6200 MD Maastricht, Netherlands; Univ Maastricht, Fac Hlth Sci, Dept Hlth Org Policy & Econ, NL-6200 MD Maastricht, Netherlands; Univ Hosp Maastricht, Dept Endocrinol, NL-6202 AZ Maastricht, Netherlands	Maastricht University; Maastricht University; Maastricht University; Maastricht University Medical Centre (MUMC)	Vrijhoef, HJM (corresponding author), Univ Maastricht, Fac Hlth Sci, Dept Hlth Care Studies, POB 616, NL-6200 MD Maastricht, Netherlands.		Wolffenbuttel, Bruce/A-8419-2011; Vrijhoef, Hubertus/AAR-2387-2020	Wolffenbuttel, Bruce/0000-0001-9262-6921; Vrijhoef, Hubertus/0000-0002-5539-4671				Davis RM, 1999, BRIT MED J, V318, P1090, DOI 10.1136/bmj.318.7191.1090; Drummond M, 2000, INT J TECHNOL ASSESS, V16, P1, DOI 10.1017/S0266462300016111; EIJKELBERG I, 2000, HDB TRANSMURALE ZORG, P37; EIJKELBERG IMJ, 2001, INT J INTEGRATED CAR, V1; Eisenberg JM, 1999, JAMA-J AM MED ASSOC, V282, P1865, DOI 10.1001/jama.282.19.1865; Ellrodt G, 1997, JAMA-J AM MED ASSOC, V278, P1687, DOI 10.1001/jama.278.20.1687; Epstein RS, 1996, ANN INTERN MED, V124, P832, DOI 10.7326/0003-4819-124-9-199605010-00008; Grol R, 2000, INT J QUAL HEALTH C, V12, P297, DOI 10.1093/intqhc/12.4.297; Hampson JP, 1996, FAM PRACT, V13, P264, DOI 10.1093/fampra/13.3.264; Hunter DJ, 1997, BRIT MED J, V315, P50, DOI 10.1136/bmj.315.7099.50; Hunter DJ, 2000, BRIT MED J, V320, P530, DOI 10.1136/bmj.320.7234.530; Kesteloot K, 1999, INT J TECHNOL ASSESS, V15, P506, DOI 10.1017/S0266462399015366; Richards T, 1998, BRIT MED J, V317, P426; Vrijhoef HJM, 2000, PATIENT EDUC COUNS, V41, P243, DOI 10.1016/S0738-3991(99)00104-4; VRIJHOEF HJM, IN PRESS J ADV NURS; Wagner EH, 1996, MILBANK Q, V74, P511, DOI 10.2307/3350391; Yin R.K., 1994, CASE STUDY RES	17	35	36	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 27	2001	323	7319					983	985		10.1136/bmj.323.7319.983	http://dx.doi.org/10.1136/bmj.323.7319.983			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	488CU	11679390	Green Published			2022-12-24	WOS:000171918500021
J	Brinker, A; Pfeifer, G; Kerner, MJ; Naylor, DJ; Hartl, FU; Hayer-Hartl, M				Brinker, A; Pfeifer, G; Kerner, MJ; Naylor, DJ; Hartl, FU; Hayer-Hartl, M			Dual function of protein confinement in chaperonin-assisted protein folding	CELL			English	Article							RIBULOSEBISPHOSPHATE CARBOXYLASE; MOLECULAR CHAPERONES; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; ATPASE CYCLE; IN-VIVO; RHODOSPIRILLUM-RUBRUM; NONNATIVE FORMS; CENTRAL CAVITY; GROEL	The GroEL/GroES chaperonin system mediates the folding of a range of newly synthesized polypeptides in the bacterial cytosol. Using a rapid biotin-streptavidin-based inhibition of chaperonin function, we show that the cage formed by GroEL and its cofactor GroES can have a dual role in promoting folding. First, enclosure of nonnative protein in the GroEL:GroES complex is essential for folding to proceed unimpaired by aggregation. Second, folding inside the cage can be significantly faster than folding in free solution, independently of ATP-driven cycles of GroES binding and release. This suggests that confinement of unfolded protein in the narrow hydrophilic space of the chaperonin cage smoothes the energy landscape for the folding of some proteins, increasing the flux of folding intermediates toward the native state.	Max Planck Inst Biochem, Dept Cellular Biochem, D-82152 Martinsried, Germany; Max Planck Inst Biochem, Dept Mol Struct Biol, D-82152 Martinsried, Germany	Max Planck Society; Max Planck Society	Hayer-Hartl, M (corresponding author), Max Planck Inst Biochem, Dept Cellular Biochem, Klopferspitz 18A, D-82152 Martinsried, Germany.		Hartl, F. Ulrich/Y-8206-2019; Hayer-Hartl, Manajit/V-8078-2017	Hayer-Hartl, Manajit/0000-0001-8213-6742				AGARD DA, 1993, SCIENCE, V260, P1903, DOI 10.1126/science.8100365; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; Chen JW, 2001, NAT STRUCT BIOL, V8, P721, DOI 10.1038/90443; CORRALES FJ, 1995, P NATL ACAD SCI USA, V92, P5326, DOI 10.1073/pnas.92.12.5326; Corrales FJ, 1996, P NATL ACAD SCI USA, V93, P4509, DOI 10.1073/pnas.93.9.4509; Coyle JE, 1999, NAT STRUCT BIOL, V6, P683; COYLE JE, 1997, FOLD DES, V2, P93; Dobson CM, 1998, ANGEW CHEM INT EDIT, V37, P868, DOI 10.1002/(SICI)1521-3773(19980420)37:7<868::AID-ANIE868>3.0.CO;2-H; Ellis R. John, 1999, Current Opinion in Structural Biology, V9, P102, DOI 10.1016/S0959-440X(99)80013-X; Ellis RJ, 1996, FASEB J, V10, P20, DOI 10.1096/fasebj.10.1.8566542; ELLIS RJ, 1994, CURR BIOL, V4, P633; ENGEL A, 1995, SCIENCE, V269, P832, DOI 10.1126/science.7638600; Ewalt KL, 1997, CELL, V90, P491, DOI 10.1016/S0092-8674(00)80509-7; Farr GW, 1997, CELL, V89, P927, DOI 10.1016/S0092-8674(00)80278-0; Farr GW, 2000, CELL, V100, P561, DOI 10.1016/S0092-8674(00)80692-3; FAYET O, 1989, J BACTERIOL, V171, P1379, DOI 10.1128/JB.171.3.1379-1385.1989; Feltham JL, 2000, CELL, V100, P193, DOI 10.1016/S0092-8674(00)81557-3; FENTON WA, 1994, NATURE, V371, P614, DOI 10.1038/371614a0; GOLOUBINOFF P, 1989, NATURE, V337, P44, DOI 10.1038/337044a0; GREEN NM, 1990, METHOD ENZYMOL, V184, P51; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; HAYERHARTL MK, 1995, SCIENCE, V269, P836, DOI 10.1126/science.7638601; HAYERHARTL MK, 1994, EMBO J, V13, P3192, DOI 10.1002/j.1460-2075.1994.tb06618.x; HayerHartl MK, 1996, EMBO J, V15, P6111, DOI 10.1002/j.1460-2075.1996.tb00999.x; HORWICH AL, 1993, CELL, V74, P909, DOI 10.1016/0092-8674(93)90470-B; Houry WA, 1999, NATURE, V402, P147, DOI 10.1038/45977; Hunt JF, 1996, NATURE, V379, P37, DOI 10.1038/379037a0; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LANGER T, 1992, EMBO J, V11, P4757, DOI 10.1002/j.1460-2075.1992.tb05581.x; Luo S, 2001, J BIOL CHEM, V276, P7023, DOI 10.1074/jbc.M006838200; MARTIN J, 1991, NATURE, V352, P36, DOI 10.1038/352036a0; Martin J, 1997, P NATL ACAD SCI USA, V94, P1107, DOI 10.1073/pnas.94.4.1107; Mayhew M, 1996, NATURE, V379, P420, DOI 10.1038/379420a0; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; MINTON AP, 1992, BIOPHYS J, V63, P1090, DOI 10.1016/S0006-3495(92)81663-6; MURAL RJ, 1990, J BIOL CHEM, V265, P6501; Ranson NA, 1997, J MOL BIOL, V266, P656, DOI 10.1006/jmbi.1996.0815; Richardson A, 1998, TRENDS BIOCHEM SCI, V23, P138, DOI 10.1016/S0968-0004(98)01193-1; Roseman AM, 1996, CELL, V87, P241, DOI 10.1016/S0092-8674(00)81342-2; Rye HS, 1999, CELL, V97, P325, DOI 10.1016/S0092-8674(00)80742-4; Rye HS, 1997, NATURE, V388, P792, DOI 10.1038/42047; Saibil H, 2000, CURR OPIN STRUC BIOL, V10, P251, DOI 10.1016/S0959-440X(00)00074-9; SCHLOSS JV, 1979, J BACTERIOL, V137, P490, DOI 10.1128/JB.137.1.490-501.1979; SCHMIDT M, 1994, J BIOL CHEM, V269, P10304; Shtilerman M, 1999, SCIENCE, V284, P822, DOI 10.1126/science.284.5415.822; SOMERVILLE CR, 1984, MOL GEN GENET, V193, P214, DOI 10.1007/BF00330670; Sparrer H, 1997, P NATL ACAD SCI USA, V94, P1096, DOI 10.1073/pnas.94.4.1096; TODD MJ, 1994, SCIENCE, V265, P659, DOI 10.1126/science.7913555; Todd MJ, 1996, P NATL ACAD SCI USA, V93, P4030, DOI 10.1073/pnas.93.9.4030; van den Berg B, 1999, EMBO J, V18, P6927, DOI 10.1093/emboj/18.24.6927; VANDERVIES SM, 1992, BIOCHEMISTRY-US, V31, P3635, DOI 10.1021/bi00129a012; VIITANEN PV, 1990, BIOCHEMISTRY-US, V29, P5665, DOI 10.1021/bi00476a003; Wang JD, 1999, NAT STRUCT BIOL, V6, P597; Weber F, 1998, NAT STRUCT BIOL, V5, P977, DOI 10.1038/2952; WEISSMAN JS, 1994, CELL, V78, P693, DOI 10.1016/0092-8674(94)90533-9; Weissman JS, 1996, CELL, V84, P481, DOI 10.1016/S0092-8674(00)81293-3; WEISSMAN JS, 1995, CELL, V83, P577, DOI 10.1016/0092-8674(95)90098-5; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944	58	238	241	0	26	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 19	2001	107	2					223	233		10.1016/S0092-8674(01)00517-7	http://dx.doi.org/10.1016/S0092-8674(01)00517-7			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	484MU	11672529	Bronze			2022-12-24	WOS:000171694800011
J	Richter, C; Wunsch, M; Rasheed, M; Kotter, I; Badran, MI				Richter, C; Wunsch, M; Rasheed, M; Kotter, I; Badran, MI			Endoscopic exploration of Red Sea coral reefs reveals dense populations of cavity-dwelling sponges	NATURE			English	Article							PHYTOPLANKTON; ABUNDANCE; DEPLETION; PLANKTON	Framework cavities are the largest but least explored coral reef habitat(1). Previous dive studies of caverns, spaces below plate corals, rubble and artificial cavities(1-3) suggest that cavity-dwelling (coelobite) filter-feeders are important in the trophodynamics of reefs(2,4,5). Quantitative community data are lacking, however, as the bulk of the narrow crevices interlacing the reef framework are inaccessible to conventional analysis methods(6). Here we have developed endoscopic techniques to explore Red Sea framework crevices up to 4 m into the carbonate rock, revealing a large internal surface (2.5-7.4 m(2) per projected m(2) reef) dominated by encrusting filter-feeders. Sponges alone provided up to 60% of coelobite cover, outweighing epi-reefal filter-feeder biomass by two orders of magnitude. Coelobite community filtration removed more than 60% of the phytoplankton in the course of its less than 5-minute passage through the crevices, corresponding to an uptake of roughly 0.9 g carbon m(-2) d(-1). Mineralization of the largely allochthonous organic material is a principal source of nutrients supporting coral and algal growth. The supply of new material by coelobites may provide a key to understanding the 'coral reef paradox'-a rich ecosystem thriving in nutrient-poor water.	Zentrum Marine Trop Okol, D-28359 Bremen, Germany; Univ Jordan, Marine Sci Stn, Aqaba, Jordan; Yarmouk Univ, Aqaba, Jordan; Max Planck Inst Marien Mikrobiol, D-28359 Bremen, Germany	Leibniz Zentrum fur Marine Tropenforschung (ZMT); University of Bremen; University of Jordan; Yarmouk University; Max Planck Society	Richter, C (corresponding author), Zentrum Marine Trop Okol, Fahrenheitstr 6, D-28359 Bremen, Germany.	crichter@uni-bremen.de	Koetter, Ina/O-3121-2019; Richter, Claudio/AAT-1212-2020	Koetter, Ina/0000-0002-9262-005X; Richter, Claudio/0000-0002-8182-6896; Rasheed, Mohammed/0000-0002-6131-368X				ANDREWS JC, 1983, LIMNOL OCEANOGR, V28, P215, DOI 10.4319/lo.1983.28.2.0215; ATKINSON MJ, 1983, LIMNOL OCEANOGR, V28, P568, DOI 10.4319/lo.1983.28.3.0568; AYUKAI T, 1995, CORAL REEFS, V14, P141, DOI 10.1007/BF00367231; BUSS LW, 1981, J EXP MAR BIOL ECOL, V49, P151, DOI 10.1016/0022-0981(81)90067-8; D'Elia CF, 1988, CONCEPTS ECOSYSTEM E, P195; Darwin C., 1842, STRUCTURE DISTRIBUTI; Ferrier-Pages C, 1998, MICROBIAL ECOL, V35, P46, DOI 10.1007/s002489900059; Gast GJ, 1998, MAR ECOL PROG SER, V167, P37, DOI 10.3354/meps167037; Ginsburg R.N, 1983, PERSPECTIVES CORAL R, P148; GLYNN PW, 1973, MAR BIOL, V22, P1, DOI 10.1007/BF00388905; JACKSON JBC, 1971, SCIENCE, V173, P623, DOI 10.1126/science.173.3997.623; JOKIEL PL, 1993, MAR ECOL PROG SER, V93, P175, DOI 10.3354/meps093175; KOBLUK D R, 1988, Palaios, V3, P379, DOI 10.2307/3514784; Mergner H., 1985, P 5 INT COR REEF C, V6, P243; MERGNER H, 1980, P S COAST MAR ENV RE, P39; MEYER JL, 1983, SCIENCE, V220, P1047, DOI 10.1126/science.220.4601.1047; Parsons T.R., 1984, MANUAL BIOL CHEM MET; Pawlik JR, 1998, LIMNOL OCEANOGR, V43, P1396, DOI 10.4319/lo.1998.43.6.1396; Pile AJ, 1997, LIMNOL OCEANOGR, V42, P178, DOI 10.4319/lo.1997.42.1.0178; REISWIG HM, 1971, BIOL BULL, V141, P568, DOI 10.2307/1540270; Richter C, 1999, MAR ECOL PROG SER, V188, P105, DOI 10.3354/meps188105; ROUGERIE F, 1995, OCEANOL ACTA, V18, P61; SHASHAR N, 1994, CORAL REEFS, V13, P171, DOI 10.1007/BF00301195; Sorokin Y. I., 1995, CORAL REEF ECOLOGY; Tribble G.W., 1988, P 6 INT CORAL REEF S, P577; Wulff JL, 1997, MAR BIOL, V129, P41, DOI 10.1007/s002270050144; Wunsch M, 1998, MAR ECOL PROG SER, V169, P277, DOI 10.3354/meps169277; Yahel G, 1998, LIMNOL OCEANOGR, V43, P551, DOI 10.4319/lo.1998.43.4.0551; [No title captured]; [No title captured]	30	159	163	0	32	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 18	2001	413	6857					726	730		10.1038/35099547	http://dx.doi.org/10.1038/35099547			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	482ZK	11607030				2022-12-24	WOS:000171608000042
J	Singleton, MR; Scaife, S; Wigley, DB				Singleton, MR; Scaife, S; Wigley, DB			Structural analysis of DNA replication fork reversal by RecG	CELL			English	Article							SINGLE-STRANDED-DNA; CRYSTAL-STRUCTURE; HOLLIDAY JUNCTION; BRANCH MIGRATION; PCRA HELICASE; PROTEIN; RECOMBINATION; MECHANISM; RUVA; TRANSLOCATION	The stalling of DNA replication forks that occurs as a consequence of encountering DNA damage is a critical problem for cells. RecG protein is involved in the processing of stalled replication forks, and acts by reversing the fork past the damage to create a four-way junction that allows template switching and lesion bypass. We have determined the crystal structure of RecG bound to a DNA substrate that mimics a stalled replication fork. The structure not only reveals the elegant mechanism used by the protein to recognize junctions but has also trapped the protein in the initial stage of fork reversal. We propose a mechanism for how forks are processed by RecG to facilitate replication fork restart. In addition, this structure suggests that the mechanism and function of the two largest helicase superfamilies are distinct.	Imperial Canc Res Fund, Clare Hall Labs, Potters Bar EN6 3LD, Herts, England		Wigley, DB (corresponding author), Imperial Canc Res Fund, Clare Hall Labs, Blanche Lane, Potters Bar EN6 3LD, Herts, England.	d.wigley@icrf.icnet.uk		Singleton, Martin/0000-0001-5716-7715				Ariyoshi M, 2000, P NATL ACAD SCI USA, V97, P8257, DOI 10.1073/pnas.140212997; ASAI T, 1993, EMBO J, V12, P3287, DOI 10.1002/j.1460-2075.1993.tb05998.x; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bird LE, 1998, NUCLEIC ACIDS RES, V26, P2686, DOI 10.1093/nar/26.11.2686; Bird LE, 1998, CURR OPIN STRUC BIOL, V8, P14, DOI 10.1016/S0959-440X(98)80004-3; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CAIRNS J, 1963, J MOL BIOL, V6, P208, DOI 10.1016/S0022-2836(63)80070-4; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; Caruthers JM, 2000, P NATL ACAD SCI USA, V97, P13080, DOI 10.1073/pnas.97.24.13080; Chen Y, 2000, MOL CELL, V6, P885, DOI 10.1016/S1097-2765(05)00088-2; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DELTITO BJD, 1995, J BACTERIOL, V177, P7086, DOI 10.1128/jb.177.24.7086-7091.1995; Dillingham MS, 2000, BIOCHEMISTRY-US, V39, P205, DOI 10.1021/bi992105o; DUCKETT DR, 1990, EMBO J, V9, P583, DOI 10.1002/j.1460-2075.1990.tb08146.x; Dudas KC, 2001, MOL CELL BIOL, V21, P2706, DOI 10.1128/MCB.21.8.2706-2715.2001; Frei C, 2000, J CELL SCI, V113, P2641; GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2; Guo F, 1997, NATURE, V389, P40, DOI 10.1038/37925; Hargreaves D, 1998, NAT STRUCT BIOL, V5, P441, DOI 10.1038/nsb0698-441; HIGGINS NP, 1976, J MOL BIOL, V101, P417, DOI 10.1016/0022-2836(76)90156-X; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; HONG XK, 1995, EMBO J, V14, P2385, DOI 10.1002/j.1460-2075.1995.tb07233.x; Kim JL, 1998, STRUCTURE, V6, P89, DOI 10.1016/S0969-2126(98)00010-0; Kornberg A., 1992, DNA REPLICATION; Korolev S, 1997, CELL, V90, P635, DOI 10.1016/S0092-8674(00)80525-5; Kowalczykowski SC, 2000, TRENDS BIOCHEM SCI, V25, P156, DOI 10.1016/S0968-0004(00)01569-3; KUZMINOV A, 1995, MOL MICROBIOL, V16, P373, DOI 10.1111/j.1365-2958.1995.tb02403.x; LLOYD RG, 1991, J BACTERIOL, V173, P5414, DOI 10.1128/jb.173.17.5414-5418.1991; Machius M, 1999, P NATL ACAD SCI USA, V96, P11717, DOI 10.1073/pnas.96.21.11717; Mahdi AA, 1997, NUCLEIC ACIDS RES, V25, P3875, DOI 10.1093/nar/25.19.3875; Marians KJ, 2000, TRENDS BIOCHEM SCI, V25, P185, DOI 10.1016/S0968-0004(00)01565-6; McGlynn P, 2000, NUCLEIC ACIDS RES, V28, P2324, DOI 10.1093/nar/28.12.2324; McGlynn P, 2000, CELL, V101, P35, DOI 10.1016/S0092-8674(00)80621-2; McGlynn P, 2001, P NATL ACAD SCI USA, V98, P8227, DOI 10.1073/pnas.111008698; McGlynn P, 2001, P NATL ACAD SCI USA, V98, P8235, DOI 10.1073/pnas.121007798; MOSIG G, 1987, ANNU REV GENET, V21, P347, DOI 10.1146/annurev.ge.21.120187.002023; Neuwald AF, 1999, GENOME RES, V9, P27; NICHOLLS A, 1991, J COMPUT CHEM, V12, P435, DOI 10.1002/jcc.540120405; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651; Postow L, 2001, J BIOL CHEM, V276, P2790, DOI 10.1074/jbc.M006736200; Preugschat F, 1996, J BIOL CHEM, V271, P24449, DOI 10.1074/jbc.271.40.24449; Putnam CD, 2001, J MOL BIOL, V311, P297, DOI 10.1006/jmbi.2001.4852; Rafferty JB, 1996, SCIENCE, V274, P415, DOI 10.1126/science.274.5286.415; Roe SM, 1998, MOL CELL, V2, P361, DOI 10.1016/S1097-2765(00)80280-4; ROUSSEL A, 1989, SILICON GRAPHICS GEO, P77; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; Skalka A., 1974, MECH RECOMBINATION, P421, DOI [10.1007/978-1-4684-2133-0_37, DOI 10.1007/978-1-4684-2133-0_37]; Soultanas P, 2000, EMBO J, V19, P3799, DOI 10.1093/emboj/19.14.3799; Story RM, 2001, P NATL ACAD SCI USA, V98, P1465, DOI 10.1073/pnas.98.4.1465; Subramanya HS, 1996, NATURE, V384, P379, DOI 10.1038/384379a0; Theis K, 1999, EMBO J, V18, P6899, DOI 10.1093/emboj/18.24.6899; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; Vincent SD, 1996, J MOL BIOL, V264, P713, DOI 10.1006/jmbi.1996.0671; West SC, 1996, J BACTERIOL, V178, P1237, DOI 10.1128/jb.178.5.1237-1241.1996; Whitby MC, 1998, J BIOL CHEM, V273, P19729, DOI 10.1074/jbc.273.31.19729; WHITBY MC, 1993, CELL, V75, P341, DOI 10.1016/0092-8674(93)80075-P; Yamada K, 2001, P NATL ACAD SCI USA, V98, P1442, DOI 10.1073/pnas.031470598; Yao NH, 1997, NAT STRUCT BIOL, V4, P463, DOI 10.1038/nsb0697-463; YARRANTON GT, 1979, P NATL ACAD SCI USA, V76, P1658, DOI 10.1073/pnas.76.4.1658	61	233	246	3	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 5	2001	107	1					79	89		10.1016/S0092-8674(01)00501-3	http://dx.doi.org/10.1016/S0092-8674(01)00501-3			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	480GF	11595187	Bronze			2022-12-24	WOS:000171453100011
J	Lendon, C; Craddock, N				Lendon, C; Craddock, N			Is LBP-1c/CP2/LSF a disease-modifying gene for Alzheimer's disease?	LANCET			English	Editorial Material							CHROMOSOME-12; LOCUS; HETEROGENEITY		Univ Birmingham, Queen Elizabeth Psychiat Hosp, Dept Psychiat, Div Neurosci, Birmingham B15 2QZ, W Midlands, England	University of Birmingham	Lendon, C (corresponding author), Univ Birmingham, Queen Elizabeth Psychiat Hosp, Dept Psychiat, Div Neurosci, Birmingham B15 2QZ, W Midlands, England.							Blacker D, 1998, NAT GENET, V19, P357, DOI 10.1038/1243; Craddock N, 1998, LANCET, V352, P1720, DOI 10.1016/S0140-6736(98)00075-0; Kehoe P, 1999, HUM MOL GENET, V8, P237, DOI 10.1093/hmg/8.2.237; Lambert JC, 2000, HUM MOL GENET, V9, P2275, DOI 10.1093/oxfordjournals.hmg.a018918; Lendon CL, 1997, NEUROSCI LETT, V222, P187, DOI 10.1016/S0304-3940(97)13381-X; Martin ES, 1998, JAMA-J AM MED ASSOC, V279, P433, DOI 10.1001/jama.279.6.433; PericakVance MA, 1997, JAMA-J AM MED ASSOC, V278, P1237, DOI 10.1001/jama.278.15.1237; Rogaeva E, 1998, JAMA-J AM MED ASSOC, V280, P614, DOI 10.1001/jama.280.7.614; Schellenberg G D, 2000, Curr Psychiatry Rep, V2, P158, DOI 10.1007/s11920-000-0061-z; Scott WK, 2000, AM J HUM GENET, V66, P922, DOI 10.1086/302828; Taylor AE, 2001, J MED GENET, V38, P232, DOI 10.1136/jmg.38.4.232; Wu WS, 1998, JAMA-J AM MED ASSOC, V280, P619, DOI 10.1001/jama.280.7.619	12	10	10	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 29	2001	358	9287					1029	1030		10.1016/S0140-6736(01)06228-6	http://dx.doi.org/10.1016/S0140-6736(01)06228-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	479EY	11589929				2022-12-24	WOS:000171393100004
J	Chiappe, LM; Salgado, L; Coria, RA				Chiappe, LM; Salgado, L; Coria, RA			Embryonic skulls of titanosaur sauropod dinosaurs	SCIENCE			English	Article								Little is known about the cranial anatomy of the taxonomically diverse and geographically widespread titanosaurs, a paucity that has hindered inferences about the genealogical history and evolutionary development of the latest sauropod dinosaurs. Newly discovered fossil eggs containing embryonic remains from the Late Cretaceous of Argentina provide the first articulated skulls of titanosaur dinosaurs. The nearly complete fetal skulls shed light on the evolution of some of the most notable cranial features of sauropod dinosaurs, including the retraction of the external nares, the forward rotation of the braincase, and the abbreviation of the infraorbital region.	Nat Hist Museum Los Angeles, Dept Vertebrate Paleontol, Los Angeles, CA 90007 USA; Univ Nacl Comahue, Museo Geol & Paleontol, RA-8300 Neuquen, Argentina; Museo Carmen Funes, RA-8318 Plaza Huincul, Neuquen, Argentina	Universidad Nacional del Comahue	Chiappe, LM (corresponding author), Nat Hist Museum Los Angeles, Dept Vertebrate Paleontol, 900 Exposit Blvd, Los Angeles, CA 90007 USA.	lchiappe@nhm.org		Chiappe, Luis/0000-0001-9661-0601				Calvo Jorge O., 1994, Gaia, V10, P183; Chiappe L. M., 2001, WALKING EGGS; Chiappe L.M., 2000, 1 INT S DIN EGGS BAB, P23; Chiappe LM, 1998, NATURE, V396, P258, DOI 10.1038/24370; Coria RA, 1999, AMEGHINIANA, V36, P98; Dingus Lowell, 2000, American Museum Novitates, V3290, P1, DOI 10.1206/0003-0082(2000)290<0001:SAMFCF>2.0.CO;2; JACOBS LL, 1993, PALAEONTOLOGY, V36, P523; McIntosh J.S., 1990, P345; MCINTOSH JS, 1997, ENCY DINOSAURS, P664; Powell JE., 1986, THESIS U NACL TUCUMA; Rogers KC, 2001, NATURE, V412, P530, DOI 10.1038/35087566; Salgado Leonardo, 1997, Ameghiniana, V34, P33; Shubin Neil H., 1994, P249; Upchurch P, 1999, J VERTEBR PALEONTOL, V19, P106, DOI 10.1080/02724634.1999.10011127; Wilson JA, 1998, J VERTEBR PALEONTOL, V18, P1, DOI 10.1080/02724634.1998.10011115	15	103	111	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 28	2001	293	5539					2444	2446		10.1126/science.1063723	http://dx.doi.org/10.1126/science.1063723			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	476PD	11577234				2022-12-24	WOS:000171237200044
J	Isozaki, Y				Isozaki, Y			An extraterrestrial impact at the Permian-Triassic boundary?	SCIENCE			English	Editorial Material									Univ Tokyo, Dept Earth Sci & Astron, Tokyo 1538902, Japan	University of Tokyo	Isozaki, Y (corresponding author), Univ Tokyo, Dept Earth Sci & Astron, Tokyo 1538902, Japan.		Isozaki, Yukio/A-1806-2009	Isozaki, Yukio/0000-0002-3596-581X				Becker L, 2001, SCIENCE, V291, P1530, DOI 10.1126/science.1057243; Isozaki Y, 1997, SCIENCE, V276, P235, DOI 10.1126/science.276.5310.235; Kakuwa Y, 1996, PALAEOGEOGR PALAEOCL, V121, P35, DOI 10.1016/0031-0182(95)00070-4; Kuwahara K., 1991, Journal of the Geological Society of Japan, V97, P1005	4	35	35	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 28	2001	293	5539					2343	2343						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	476PD	11579934				2022-12-24	WOS:000171237200002
J	Macfarlane, GJ; McBeth, J; Silman, AJ				Macfarlane, GJ; McBeth, J; Silman, AJ			Widespread body pain and mortality: prospective population based study	BRITISH MEDICAL JOURNAL			English	Article							LOW-BACK-PAIN; GENERAL-POPULATION; FIBROMYALGIA SYNDROME; PREVALENCE; CANCER	Objective To determine whether there is excess mortality in groups of people who report widespread body pain, and if so to establish the nature and extent of any excess. Design Prospective follow up study over eight years. Mortality rate ratios were adjusted for age group, sex, and study location. Setting North west England. Participants 6569 people who took part in two pain surveys during 1991-2. Main outcome measures Pain status at baseline and subsequent mortality. Results 1005 (15%) participants had widespread pain, 3176 (48%) had regional pain, and 2388 (36%) had no pain. During follow up mortality was higher in people with regional pain (mortality rate ratio 1.21, 95% confidence interval 1.01 to 1.44) and widespread pain (1.31, 1.05 to 1.65) than in those who reported no pain. The excess mortality among people with regional and widespread pain was almost entirely related to deaths from cancer (1.55 (1.09 to 2.19) for regional pain and 2.07 (1.37 to 3.13) for widespread pain). The excess cancer mortality remained after exclusion of people in whom cancer had been diagnosed before the original survey and after adjustment for potential confounding factors. There were also more deaths from causes other than disease (for example, accidents, suicide, violence) among people with widespread pain (5.21, 0.94 to 28.78). Conclusion There is an intriguing association between the report of widespread pain and subsequent death from cancer in the medium and long term. This may have implications for the long term follow up of patients with "unexplained widespread pain symptoms, such as those with fibromyalgia.	Univ Manchester, Sch Med, Unit Chron Dis Epidemiol, Manchester M13 9PT, Lancs, England; Univ Manchester, Sch Med, Arthrit Res Campaign Epidemiol Unit, Manchester M13 9PT, Lancs, England	University of Manchester; University of Manchester	Macfarlane, GJ (corresponding author), Univ Manchester, Sch Med, Unit Chron Dis Epidemiol, Manchester M13 9PT, Lancs, England.		McBeth, John/AAG-1954-2019; Macfarlane, Gary J/I-9521-2014	Macfarlane, Gary J/0000-0003-2322-3314; McBeth, John/0000-0001-7047-2183				Andersson HI, 1996, SCAND J RHEUMATOL, V25, P146, DOI 10.3109/03009749609080005; BOISSETPIORO MH, 1995, ARTHRITIS RHEUM, V38, P235, DOI 10.1002/art.1780380212; COX T, 1982, SOC SCI MED, V16, P381, DOI 10.1016/0277-9536(82)90048-X; CROFT P, 1993, J RHEUMATOL, V20, P710; Goldberg D.P., 1988, USERS GUIDE GEN HLTH; HAWLEY DJ, 1988, J RHEUMATOL, V15, P1551; Hunt IM, 1999, RHEUMATOLOGY, V38, P275, DOI 10.1093/rheumatology/38.3.275; International Association for the Study of Pain, 1986, PAIN S, V3, P1; McBeth J, 2001, RHEUMATOLOGY, V40, P95, DOI 10.1093/rheumatology/40.1.95; McBeth J, 2001, ARTHRITIS RHEUM, V44, P940, DOI 10.1002/1529-0131(200104)44:4<940::AID-ANR151>3.3.CO;2-J; MCBETH J, IN PRESS J RHEUMATOL; *OFF NAT STAT, 1998, SER DH1, V31; PAPAGEORGIOU AC, 1995, SPINE, V20, P1889, DOI 10.1097/00007632-199509000-00009; PAPAGEORGIOUS AC, 1997, SPINE, V22, P137; SHEKELLE RB, 1981, PSYCHOSOM MED, V43, P117, DOI 10.1097/00006842-198104000-00003; Spiegel D, 1998, ANN NY ACAD SCI, V840, P674, DOI 10.1111/j.1749-6632.1998.tb09606.x; Spiegel D, 1996, BRIT J PSYCHIAT, V168, P109, DOI 10.1192/S0007125000298486; WALSH K, 1992, J EPIDEMIOL COMMUN H, V46, P227, DOI 10.1136/jech.46.3.227; White KP, 1999, J RHEUMATOL, V26, P1570; WOLFE F, 1995, ARTHRITIS RHEUM-US, V38, P19, DOI 10.1002/art.1780380104; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203	21	149	150	0	7	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 22	2001	323	7314					662	664B		10.1136/bmj.323.7314.662	http://dx.doi.org/10.1136/bmj.323.7314.662			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	476LP	11566829	Green Published, Bronze			2022-12-24	WOS:000171228800016
J	Williams, JA; Su, HS; Bernards, A; Field, J; Sehgal, A				Williams, JA; Su, HS; Bernards, A; Field, J; Sehgal, A			A circadian output in Drosophila mediated by neurofibromatosis-1 and Ras/MAPK	SCIENCE			English	Article							ACTIVATED PROTEIN-KINASE; PATHWAY; CLOCK; RAS; SEVENLESS; RHYTHMS; SON; PHOSPHORYLATION; MELANOGASTER; GENES	Output from the circadian clock controls rhythmic behavior through poorly understood mechanisms. In Drosophila, null mutations of the neurofibromatosis-1 (Nf1) gene produce abnormalities of circadian rhythms in locomotor activity. Mutant flies show normal oscillations of the clock genes period (per) and timeless (tim) and of their corresponding proteins, but altered oscillations and levels of a clock-controlled reporter. Mitogen-activated protein kinase (MAPK) activity is increased in Nf1 mutants, and the circadian phenotype is rescued by loss-of-function mutations in the Ras/MAPK pathway. Thus, Nf1 signals through Ras/MAPK in Drosophila. Immunohistochemical staining revealed a circadian oscillation of phospho-MAPK in the vicinity of nerve terminals containing pigment-dispersing factor (PDF), a secreted output from clock cells, suggesting a coupling of PDF to Ras/MAPK signaling.	Univ Penn, Sch Med, Howard Hughes Med Inst, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Ctr Sleep & Resp Neurobiol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA; Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA	Howard Hughes Medical Institute; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Harvard University; Massachusetts General Hospital	Sehgal, A (corresponding author), Univ Penn, Sch Med, Howard Hughes Med Inst, Philadelphia, PA 19104 USA.							Akashi M, 2000, GENE DEV, V14, P645; Belvin MP, 1999, NEURON, V22, P777, DOI 10.1016/S0896-6273(00)80736-9; BONFINI L, 1992, SCIENCE, V255, P603, DOI 10.1126/science.1736363; CHERNIACK AD, 1994, J BIOL CHEM, V269, P4717; CorbalanGarcia S, 1996, MOL CELL BIOL, V16, P5674; Guo HF, 2000, NATURE, V403, P895, DOI 10.1038/35002593; Harada Y, 2000, J BIOL CHEM, V275, P37078, DOI 10.1074/jbc.M004706200; Helfrich-Forster C, 2000, J NEUROSCI, V20, P3339, DOI 10.1523/JNEUROSCI.20-09-03339.2000; HICKMAN L, UNPUB; Howe AK, 2000, NAT CELL BIOL, V2, P593, DOI 10.1038/35023536; Huang AM, 2000, GENETICS, V156, P1219; Ko GYP, 2001, NEURON, V29, P255, DOI 10.1016/S0896-6273(01)00195-7; Krishnan B, 2001, NATURE, V411, P313, DOI 10.1038/35077094; LEVINE JD, 1994, NEURON, V13, P967, DOI 10.1016/0896-6273(94)90262-3; MAJORCAK J, 1997, MOL CELL BIOL, V17, P5915; MCCORMICK F, 1995, CURR OPIN GENET DEV, V5, P51, DOI 10.1016/S0959-437X(95)90053-5; Obrietan K, 1998, NAT NEUROSCI, V1, P693, DOI 10.1038/3695; Park JH, 2000, P NATL ACAD SCI USA, V97, P3608, DOI 10.1073/pnas.070036197; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; ROGGE RD, 1991, CELL, V64, P39, DOI 10.1016/0092-8674(91)90207-F; Sanada K, 2000, J NEUROSCI, V20, P986, DOI 10.1523/JNEUROSCI.20-03-00986.2000; Silva AJ, 1997, NAT GENET, V15, P281, DOI 10.1038/ng0397-281; The I, 1997, SCIENCE, V276, P791, DOI 10.1126/science.276.5313.791; VISCKOCHIL D, 1993, ANNU REV NEUROSCI, V16, P183; Williams JA, 2001, ANNU REV PHYSIOL, V63, P729, DOI 10.1146/annurev.physiol.63.1.729; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959	26	168	174	2	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 21	2001	293	5538					2251	2256		10.1126/science.1063097	http://dx.doi.org/10.1126/science.1063097			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475AL	11567138				2022-12-24	WOS:000171139400043
J	Kim, SK; Lund, J; Kiraly, M; Duke, K; Jiang, M; Stuart, JM; Eizinger, A; Wylie, BN; Davidson, GS				Kim, SK; Lund, J; Kiraly, M; Duke, K; Jiang, M; Stuart, JM; Eizinger, A; Wylie, BN; Davidson, GS			A gene expression map for Caenorhabditis elegans	SCIENCE			English	Article							FUNCTIONAL GENOMIC ANALYSIS; PROTEIN; ORGANIZATION; MICROARRAY; MUTATIONS; DISCOVERY; PATTERNS; RNAI	We have assembled data from Caenorhabditis elegans DNA microarray experiments involving many growth conditions, developmental stages, and varieties of mutants. Co-regulated genes were grouped together and visualized in a three-dimensional expression map that displays correlations of gene expression profiles as distances in two dimensions and gene density in the third dimension. The gene expression map can be used as a gene discovery toot to identify genes that are co-regulated with known sets of genes (such as heat shock, growth control genes, germ line genes, and so forth) or to uncover previously unknown genetic functions (such as genomic instability in mates and sperm caused by specific transposons).	Stanford Univ, Sch Med, Dept Dev Biol & Genet, Stanford, CA 94305 USA; Stanford Med Informat, Stanford, CA 94305 USA; Sandia Natl Labs, Computat Comp & Math Ctr, Albuquerque, NM 87185 USA	Stanford University; Stanford University; United States Department of Energy (DOE); Sandia National Laboratories	Kim, SK (corresponding author), Stanford Univ, Sch Med, Dept Dev Biol & Genet, Stanford, CA 94305 USA.	kim@cmgm.stanford.edu		Stuart, Joshua/0000-0002-2171-565X; Lund, Jim/0000-0002-1437-8448				Brundage L, 1996, NEURON, V16, P999, DOI 10.1016/S0896-6273(00)80123-3; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Chen SH, 1999, J BIOL CHEM, V274, P288, DOI 10.1074/jbc.274.1.288; Costanzo MC, 2000, NUCLEIC ACIDS RES, V28, P73, DOI 10.1093/nar/28.1.73; Davidson GS, 1998, J INTELL INF SYST, V11, P259, DOI 10.1023/A:1008690008856; DAVIDSON GS, IN PRESS IEEE S INF; DeRisi J, 1996, NAT GENET, V14, P457; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; EDGAR LG, 1986, DEV BIOL, V114, P109, DOI 10.1016/0012-1606(86)90387-8; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; FERGUSON EL, 1989, GENETICS, V123, P109; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; FREEDMAN JH, 1993, J BIOL CHEM, V268, P2554; Gonczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526; Hill AA, 2000, SCIENCE, V290, P809, DOI 10.1126/science.290.5492.809; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Jiang M, 2001, P NATL ACAD SCI USA, V98, P218, DOI 10.1073/pnas.011520898; Kim S.O., UNPUB; Kim SK, 1997, CURR OPIN CELL BIOL, V9, P853, DOI 10.1016/S0955-0674(97)80088-9; Lee RYN, 1997, EMBO J, V16, P6066, DOI 10.1093/emboj/16.20.6066; LHernault SW, 1995, METHOD CELL BIOL, V48, P273; Lu XW, 1998, CELL, V95, P981, DOI 10.1016/S0092-8674(00)81722-5; Lyon CJ, 2000, GENE, V252, P147, DOI 10.1016/S0378-1119(00)00213-4; Maeda I, 2001, CURR BIOL, V11, P171, DOI 10.1016/S0960-9822(01)00052-5; Piano F, 2000, CURR BIOL, V10, P1619, DOI 10.1016/S0960-9822(00)00869-1; Reinke V, 2000, MOL CELL, V6, P605, DOI 10.1016/S1097-2765(00)00059-9; ROGALSKI TM, 1993, GENE DEV, V7, P1471, DOI 10.1101/gad.7.8.1471; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Shalon D, 1996, GENOME RES, V6, P639, DOI 10.1101/gr.6.7.639; VILLENEUVE AM, COMMUNICATION; Walhout AJM, 2000, SCIENCE, V287, P116, DOI 10.1126/science.287.5450.116	31	510	526	1	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 14	2001	293	5537					2087	2092		10.1126/science.1061603	http://dx.doi.org/10.1126/science.1061603			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473FB	11557892				2022-12-24	WOS:000171028700074
J	Hu, FB; Manson, JE; Stampfer, MJ; Colditz, G; Liu, S; Solomon, CG; Willett, WC				Hu, FB; Manson, JE; Stampfer, MJ; Colditz, G; Liu, S; Solomon, CG; Willett, WC			Diet, lifestyle, and the risk of type 2 diabetes mellitus in women.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY-HEART-DISEASE; PHYSICAL-ACTIVITY; CIGARETTE-SMOKING; GLYCEMIC LOAD; FAT INTAKE; WEIGHT; PREVENTION; FIBER; HEALTH; NIDDM	Background: Previous studies have examined individual dietary and lifestyle factors in relation to type 2 diabetes, but the combined effects of these factors are largely unknown. Methods: We followed 84,941 female nurses from 1980 to 1996; these women were free of diagnosed cardiovascular disease, diabetes, and cancer at base line. Information about their diet and lifestyle was updated periodically. A low-risk group was defined according to a combination of five variables: a body-mass index (the weight in kilograms divided by the square of the height in meters) of less than 25; a diet high in cereal fiber and polyunsaturated fat and low in trans fat and glycemic load (which reflects the effect of diet on the blood glucose level); engagement in moderate-to-vigorous physical activity for at least half an hour per day; no current smoking; and the consumption of an average of at least half a drink of an alcoholic beverage per day. Results: During 16 years of follow-up, we documented 3300 new cases of type 2 diabetes. Overweight or obesity was the single most important predictor of diabetes. Lack of exercise, a poor diet, current smoking, and abstinence from alcohol use were all associated with a significantly increased risk of diabetes, even after adjustment for the body-mass index. As compared with the rest of the cohort, women in the low-risk group (3.4 percent of the women) had a relative risk of diabetes of 0.09 (95 percent confidence interval, 0.05 to 0.17). A total of 91 percent of the cases of diabetes in this cohort (95 percent confidence interval, 83 to 95 percent) could be attributed to habits and forms of behavior that did not conform to the low-risk pattern. Conclusions: Our findings support the hypothesis that the majority of cases of type 2 diabetes could be prevented by the adoption of a healthier lifestyle. (N Engl J Med 2001;345:790-7.) Copyright (C) 2001 Massachusetts Medical Society.	Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; Brigham & Womens Hosp, Dept Med, Div Prevent Med, Boston, MA USA; Brigham & Womens Hosp, Dept Med, Div Gen Med, Boston, MA USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Hu, FB (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, 665 Huntington Ave, Boston, MA 02115 USA.	frank.hu@channing.harvard.edu	Liu, Simin/GSN-4159-2022; Robles-Sardin, Alma E/M-7714-2015; Liu, Simin/I-3689-2014; Hu, Frank/C-1919-2013; Colditz, Graham/A-3963-2009	Robles-Sardin, Alma E/0000-0003-2044-7793; Liu, Simin/0000-0003-2098-3844; Colditz, Graham/0000-0002-7307-0291	NATIONAL CANCER INSTITUTE [P01CA087969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK036798] Funding Source: NIH RePORTER; NCI NIH HHS [CA87969] Funding Source: Medline; NIDDK NIH HHS [DK36798] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ajani UA, 2000, ARCH INTERN MED, V160, P1025, DOI 10.1001/archinte.160.7.1025; [Anonymous], 1996, JAMA, V276, P241; Carey VJ, 1997, AM J EPIDEMIOL, V145, P614, DOI 10.1093/oxfordjournals.aje.a009158; Colditz GA, 1997, J WOMENS HEALTH, V6, P49, DOI 10.1089/jwh.1997.6.49; COLDITZ GA, 1995, ANN INTERN MED, V122, P481, DOI 10.7326/0003-4819-122-7-199504010-00001; COLDITZ GA, 1990, AM J EPIDEMIOL, V132, P501, DOI 10.1093/oxfordjournals.aje.a115686; DAGOSTINO RB, 1990, STAT MED, V9, P1501, DOI 10.1002/sim.4780091214; Gavin JR, 1997, DIABETES CARE, V20, P1183; HARRIS M, 1979, DIABETES, V28, P1039; HELMRICH SP, 1991, NEW ENGL J MED, V325, P147, DOI 10.1056/NEJM199107183250302; Hu FB, 1999, AM J EPIDEMIOL, V149, P531, DOI 10.1093/oxfordjournals.aje.a009849; Hu FB, 1997, NEW ENGL J MED, V337, P1491, DOI 10.1056/NEJM199711203372102; Hu FB, 1999, JAMA-J AM MED ASSOC, V282, P1433, DOI 10.1001/jama.282.15.1433; Hu FB, 2001, DIABETOLOGIA, V44, P805, DOI 10.1007/s001250100547; Jeffery RW, 2000, HEALTH PSYCHOL, V19, P5, DOI 10.1037/0278-6133.19.Suppl1.5; Liu SM, 2001, AM J CLIN NUTR, V73, P560; Liu SM, 2000, AM J PUBLIC HEALTH, V90, P1409, DOI 10.2105/AJPH.90.9.1409; Lynch J, 1996, ARCH INTERN MED, V156, P1307, DOI 10.1001/archinte.156.12.1307; MANNING A, 2001, US TODAY        0108, pD7; Manson JE, 2000, AM J MED, V109, P538, DOI 10.1016/S0002-9343(00)00568-4; MANSON JE, 1991, LANCET, V338, P774, DOI 10.1016/0140-6736(91)90664-B; Meyer KA, 2000, AM J CLIN NUTR, V71, P921; Mokdad AH, 1999, JAMA-J AM MED ASSOC, V282, P1519, DOI 10.1001/jama.282.16.1519; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; RIMM EB, 1995, BRIT MED J, V310, P555, DOI 10.1136/bmj.310.6979.555; Rothman K. J., 2008, MODERN EPIDEMIOLOGY; Salmeron J, 1997, JAMA-J AM MED ASSOC, V277, P472, DOI 10.1001/jama.277.6.472; Salmeron J, 1997, DIABETES CARE, V20, P545, DOI 10.2337/diacare.20.4.545; Salmeron J, 2001, AM J CLIN NUTR, V73, P1019; Stampfer MJ, 2000, NEW ENGL J MED, V343, P16, DOI 10.1056/NEJM200007063430103; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Vessby B, 2000, BRIT J NUTR, V83, pS91; WACHOLDER S, 1994, AM J EPIDEMIOL, V140, P668; Wei M, 2000, DIABETES CARE, V23, P18, DOI 10.2337/diacare.23.1.18; WHO, 1998, WHO TECHN REP SER; Willet W., 1998, NUTR EPIDEMIOLOGY, P74, DOI DOI 10.1093/ACPROF:OSO/9780195122978.001.0001; WILLETT W, 1983, AM J EPIDEMIOL, V117, P651, DOI 10.1093/oxfordjournals.aje.a113598; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086	39	1869	1935	7	342	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 13	2001	345	11					790	797		10.1056/NEJMoa010492	http://dx.doi.org/10.1056/NEJMoa010492			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	471BK	11556298				2022-12-24	WOS:000170906800003
J	Schwetz, BA				Schwetz, BA			New FDA Web sites	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Off Commissioner Food & Drugs, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Schwetz, BA (corresponding author), US FDA, Off Commissioner Food & Drugs, HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	2	2	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 12	2001	286	10					1166	1166		10.1001/jama.286.10.1166	http://dx.doi.org/10.1001/jama.286.10.1166			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	471CR	11559244				2022-12-24	WOS:000170910400007
J	Wentworth, P; Jones, LH; Wentworth, AD; Zhu, XY; Larsen, NA; Wilson, IA; Xu, X; Goddard, WA; Janda, KD; Eschenmoser, A; Lerner, RA				Wentworth, P; Jones, LH; Wentworth, AD; Zhu, XY; Larsen, NA; Wilson, IA; Xu, X; Goddard, WA; Janda, KD; Eschenmoser, A; Lerner, RA			Antibody catalysis of the oxidation of water	SCIENCE			English	Article							HYDROGEN TRIOXIDE HOOOH; LOW-TEMPERATURE OZONATION; MOLECULAR-OXYGEN; SINGLET OXYGEN; PEROXIDE; PHOTOOXIDATION; DECOMPOSITION; TRYPTOPHAN; MECHANISM; SEQUENCE	Recently we reported that antibodies can generate hydrogen peroxide (H2O2) from singlet molecular oxygen (O-1(2)*), We now show that this process is catalytic, and we identify the electron source for a quasi-unlimited generation of H2O2. Antibodies produce up to 500 mote equivalents of H2O2 from O-1(2)*, without a reduction in rate, and we have excluded metals or Cl- as the electron source. On the basis of isotope incorporation experiments and kinetic data, we propose that antibodies use H2O as an electron source, facilitating its addition to O-1(2)* to form H2O3 as the first intermediate in a reaction cascade that eventually leads to H2O2. X-ray crystallographic studies with xenon point to putative conserved oxygen binding sites within the antibody fold where this chemistry could be initiated. Our findings suggest a protective function of immunoglobulins against O-1(2)* and raise the question of whether the need to detoxify O-1(2)* has played a decisive role in the evolution of the immunoglobulin fold.	Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; CALTECH, Div Chem & Chem Engn, Mat & Proc Simulat Ctr, Pasadena, CA 91125 USA; ETH Zurich, Organ Chem Lab, CH-8092 Zurich, Switzerland	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; California Institute of Technology; Swiss Federal Institutes of Technology Domain; ETH Zurich	Wentworth, P (corresponding author), Scripps Res Inst, Dept Chem, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Zhu, Xueyong/ABE-3068-2021	Jones, Lyn/0000-0002-8388-5865; Xu, Xin/0000-0002-5247-2937	NCI NIH HHS [CA27489] Funding Source: Medline; NICHD NIH HHS [HD 36385] Funding Source: Medline; NIGMS NIH HHS [GM43858] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD036385] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA027489] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM043858, R01GM043858] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Cacace F, 1999, SCIENCE, V285, P81, DOI 10.1126/science.285.5424.81; Cannac-Caffrey V, 1998, BIOCHIMIE, V80, P1003, DOI 10.1016/S0300-9084(99)80005-4; CERKOVNIK J, 1993, J AM CHEM SOC, V115, P12169, DOI 10.1021/ja00078a067; COREY EJ, 1986, J AM CHEM SOC, V108, P2472, DOI 10.1021/ja00269a070; Datta D., UNPUB; DEBY C, 1991, RECHERCHE, V228, P378; DETTY MR, 1990, J AM CHEM SOC, V112, P4086, DOI 10.1021/ja00166a083; FOOTE CS, 1968, ACCOUNTS CHEM RES, V1, P104, DOI 10.1021/ar50004a002; FOWLER AV, 1978, J BIOL CHEM, V253, P5521; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; Han J, 1996, ANAL BIOCHEM, V234, P107, DOI 10.1006/abio.1996.0059; KANOFSKY JR, 1989, CHEM-BIOL INTERACT, V70, P1, DOI 10.1016/0009-2797(89)90059-8; Koller J, 1996, J AM CHEM SOC, V118, P2470, DOI 10.1021/ja9503387; LI TY, 1995, J AM CHEM SOC, V117, P3308, DOI 10.1021/ja00116a050; LIDE DR, 1992, HDB CHEM PHYSICS, P73; MCCORMICK JP, 1978, J AM CHEM SOC, V100, P312, DOI 10.1021/ja00469a068; Plesnicar B, 2000, CHEM-EUR J, V6, P809; Prange T, 1998, PROTEINS, V30, P61, DOI 10.1002/(SICI)1097-0134(19980101)30:1<61::AID-PROT6>3.0.CO;2-N; Sawyer D. T, 1991, OXYGEN CHEM; SCHARF HD, 1979, CATAL CHEM BIOCH THE, V12, P355; SCHOENBORN BP, 1965, NATURE, V207, P28, DOI 10.1038/207028a0; Scott EE, 1997, BIOCHEMISTRY-US, V36, P11909, DOI 10.1021/bi970719s; TILSON RF, 1988, J MOL BIOL, V199, P195; VINCENT MA, 1995, J PHYS CHEM-US, V99, P3109, DOI 10.1021/j100010a021; WALRANT P, 1974, PHOTOCHEM PHOTOBIOL, V19, P411, DOI 10.1111/j.1751-1097.1974.tb06533.x; WELINDER KG, 1991, MOL IMMUNOL, V28, P177, DOI 10.1016/0161-5890(91)90102-P; Wentworth AD, 2000, P NATL ACAD SCI USA, V97, P10930, DOI 10.1073/pnas.97.20.10930; WILKINSON F, 1993, J PHYS CHEM REF DATA, V22, P113, DOI 10.1063/1.555934; Zhou MJ, 1997, ANAL BIOCHEM, V253, P162, DOI 10.1006/abio.1997.2391	29	242	259	9	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2001	293	5536					1806	1811		10.1126/science.1062722	http://dx.doi.org/10.1126/science.1062722			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	470WN	11546867				2022-12-24	WOS:000170894400040
J	Reynolds, JNJ; Hyland, BI; Wickens, JR				Reynolds, JNJ; Hyland, BI; Wickens, JR			A cellular mechanism of reward-related learning	NATURE			English	Article							MEMBRANE-POTENTIAL FLUCTUATIONS; NIGROSTRIATAL DOPAMINE SYSTEM; VENTRAL TEGMENTAL AREA; SELF-STIMULATION; SPINY NEURONS; IN-VIVO; BRAIN-STIMULATION; RAT NEOSTRIATUM; NEURAL-NETWORK; BASAL GANGLIA	Positive reinforcement helps to control the acquisition of learned behaviours. Here we report a cellular mechanism in the brain that may underlie the behavioural effects of positive reinforcement. We used intracranial self-stimulation (ICSS) as a model of reinforcement learning(1), in which each rat learns to press a lever that applies reinforcing electrical stimulation to its own substantia nigra(2,3). The outputs from neurons of the substantia nigra terminate on neurons in the striatum in close proximity to inputs from the cerebral cortex on the same striatal neurons(4). We measured the effect of substantia nigra stimulation on these inputs from the cortex to striatal neurons and also on how quickly the rats learned to press the lever. We found that stimulation of the substantia nigra (with the optimal parameters for lever-pressing behaviour) induced potentiation of synapses between the cortex and the striatum, which required activation of dopamine receptors. The degree of potentiation within ten minutes of the ICSS trains was correlated with the time taken by the rats to learn ICSS behaviour.	Univ Otago, Sch Med Sci, Neurosci Res Ctr, Dunedin, New Zealand; Univ Otago, Sch Med Sci, Dept Anat & Struct Biol, Dunedin, New Zealand; Univ Otago, Sch Med Sci, Dept Physiol, Dunedin, New Zealand	University of Otago; University of Otago; University of Otago	Wickens, JR (corresponding author), Univ Otago, Sch Med Sci, Neurosci Res Ctr, Dunedin, New Zealand.		Hyland, Brian I/F-7840-2012; Reynolds, John/C-5636-2009; Wickens, Jeffery R/N-6055-2014	Hyland, Brian I/0000-0001-7593-4885; Wickens, Jeffery R/0000-0002-8795-1209				ALEXANDER GE, 1990, J NEUROPHYSIOL, V64, P133, DOI 10.1152/jn.1990.64.1.133; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; [Anonymous], [No title captured]; AOSAKI T, 1994, SCIENCE, V265, P412, DOI 10.1126/science.8023166; BENINGER RJ, 1977, SCIENCE, V196, P547, DOI 10.1126/science.850798; BIELAJEW C, 1986, J NEUROSCI, V6, P919; Charpier S, 1997, P NATL ACAD SCI USA, V94, P7036, DOI 10.1073/pnas.94.13.7036; CORBETT D, 1980, BRAIN RES, V185, P1, DOI 10.1016/0006-8993(80)90666-6; FIBIGER HC, 1987, J NEUROSCI, V7, P3888; HODOS W, 1962, J COMP PHYSIOL PSYCH, V55, P80, DOI 10.1037/h0047681; HUNT GE, 1994, PHARMACOL BIOCHEM BE, V48, P853, DOI 10.1016/0091-3057(94)90192-9; KIMURA M, 1990, J NEUROPHYSIOL, V63, P1277, DOI 10.1152/jn.1990.63.6.1277; MAJOR R, 1978, PHYSIOL BEHAV, V20, P723, DOI 10.1016/0031-9384(78)90298-6; Matsumoto N, 1999, J NEUROPHYSIOL, V82, P978, DOI 10.1152/jn.1999.82.2.978; MILLER RM, 1981, MEANING PURPOSE INTA, P62; Mirenowicz J, 1996, NATURE, V379, P449, DOI 10.1038/379449a0; MIRENOWICZ J, 1994, J NEUROPHYSIOL, V72, P1024, DOI 10.1152/jn.1994.72.2.1024; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; OLDS J, 1954, J COMP PHYSIOL PSYCH, V47, P419, DOI 10.1037/h0058775; Reynolds JNJ, 2000, NEUROSCIENCE, V99, P199, DOI 10.1016/S0306-4522(00)00273-6; REYNOLDS RW, 1958, J COMP PHYSIOL PSYCH, V51, P193, DOI 10.1037/h0048362; Schultz W, 2000, NAT REV NEUROSCI, V1, P199, DOI 10.1038/35044563; SMITH AD, 1990, TRENDS NEUROSCI, V13, P259; Stern EA, 1998, NATURE, V394, P475, DOI 10.1038/28848; Suri RE, 1999, NEUROSCIENCE, V91, P871, DOI 10.1016/S0306-4522(98)00697-6; SWANSON LW, 1982, BRAIN RES BULL, V9, P321, DOI 10.1016/0361-9230(82)90145-9; WILSON CJ, 1981, BRAIN RES, V220, P67, DOI 10.1016/0006-8993(81)90211-0; WILSON CJ, 1986, BRAIN RES, V367, P201, DOI 10.1016/0006-8993(86)91593-3; Wilson CJ, 1996, J NEUROSCI, V16, P2397; Wise RA, 1996, ANNU REV NEUROSCI, V19, P319, DOI 10.1146/annurev.ne.19.030196.001535	30	559	572	0	38	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 6	2001	413	6851					67	70		10.1038/35092560	http://dx.doi.org/10.1038/35092560			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469EG	11544526				2022-12-24	WOS:000170801200039
J	Benhamou, Y; Bochet, M; Thibault, V; Calvez, V; Fievet, MH; Vig, P; Gibbs, CS; Brosgart, C; Fry, J; Namini, H; Katiama, C; Poynard, T				Benhamou, Y; Bochet, M; Thibault, V; Calvez, V; Fievet, MH; Vig, P; Gibbs, CS; Brosgart, C; Fry, J; Namini, H; Katiama, C; Poynard, T			Safety and efficacy of adefovir dipivoxil in patients co-infected with HIV-1 and lamivudine-resistant hepatitis B virus: an open-label pilot study	LANCET			English	Article							MUTATIONS; IDENTIFICATION; REINFECTION; FAMCICLOVIR; THERAPY; TRIAL	Background Lamivudine-resistant hepatitis B virus (HBV) is found in about 15-32% of infected patients with or without co-infection with HIV-1 after 1 year of lamivudine therapy. Adefovir dipivoxil is active in vivo and in vitro against wild-type and lamivudine-resistant HBV. We assessed the safety and efficacy of a once daily dose of adefovir dipivoxil in an open-label trial for the treatment of lamivudine-resistant HBV infection in HIV-1-infected patients. Methods 35 HIV-1/HBV co-infected patients receiving lamivudine therapy (150 mg twice daily) as part of their current HIV-1 antiretroviral regimen were enrolled. Patients received a 10 mg once-daily dose of adefovir dipivoxil for 48 weeks while maintaining their existing anti-HIV-1 therapy, including lamivudine. Patients were assessed every 4 weeks for safety and efficacy. Findings Four patients withdrew from the study (two because of adverse events), leaving 31 patients who received adefovir dipivoxil for a median of 48 weeks (range 44-48). Mean decreases in serum HBV DNA concentrations from baseline (log 8.64 copies/mL [SE log 0.08]) were -log 3.40 copies/mL [log 0.12] at week 24 (n=31) and -log 4.01 copies/mL [log 0.17] at week 48 (n=29; p<0.0001). Two patients underwent hepatitis B e antigen seroconversion-one at week 32 and one at week 36. Adefovir dipivoxil was generally well tolerated, but was associated with a transient increase in serum alanine aminotransferase concentrations in 15 patients. We found no significant changes in either HIV-1 RNA or CD4 cell count. Interpretation These results indicate that 48 weeks of 10 mg daily adefovir dipivoxil is well tolerated and active against lamivudine-resistant HBV in HIV-1/HBV co-infected patients.	Grp Hosp Pitie Salpetriere, Serv Hepatogastroenterol, F-75651 Paris 13, France; Grp Hosp Pitie Salpetriere, Serv Malad Infect, F-75651 Paris 13, France; Grp Hosp Pitie Salpetriere, Virol Lab, F-75651 Paris 13, France; Grp Hosp Pitie Salpetriere, Serv Pharm, F-75651 Paris 13, France; Univ Paris 06, CNRS, UPRESA 8087, Paris, France; Gilead Sci Inc, Foster City, CA 94404 USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Gilead Sciences	Benhamou, Y (corresponding author), Grp Hosp Pitie Salpetriere, Serv Hepatogastroenterol, 27 Blvd Hop, F-75651 Paris 13, France.	ybenhamou@teaser.fr	THIBAULT, Vincent/AAB-5241-2020; Poynard, Thierry/C-1355-2010; THIBAULT, Vincent/J-7193-2015	THIBAULT, Vincent/0000-0001-6517-2901; Poynard, Thierry/0000-0002-3726-7230; THIBAULT, Vincent/0000-0001-6517-2901; Poynard, Thierry/0000-0002-2050-640X				Allen MI, 1998, HEPATOLOGY, V27, P1670, DOI 10.1002/hep.510270628; Atkins M, 1998, HEPATOLOGY, V28, p319A; Bartholomew MM, 1997, LANCET, V349, P20, DOI 10.1016/S0140-6736(96)02266-0; BEDOSSA P, 1994, HEPATOLOGY, V20, P15; Benhamou Y, 1996, ANN INTERN MED, V125, P705, DOI 10.7326/0003-4819-125-9-199611010-00001; Benhamou Y, 1999, HEPATOLOGY, V30, P1302, DOI 10.1002/hep.510300525; CHANG TT, 2000, ANTIVIR THER S, V5, P44; Colin JF, 1999, HEPATOLOGY, V29, P1306, DOI 10.1002/hep.510290447; DIENSTAG JL, 1995, NEW ENGL J MED, V333, P1657, DOI 10.1056/NEJM199512213332501; Gilson RJC, 1999, J VIRAL HEPATITIS, V6, P387, DOI 10.1046/j.1365-2893.1999.00182.x; Hardy H, 2001, ANN PHARMACOTHER, V35, P343, DOI 10.1345/aph.10044; Heathcote EJ, 1998, HEPATOLOGY, V28, p317A; Kahn J, 1999, JAMA-J AM MED ASSOC, V282, P2305, DOI 10.1001/jama.282.24.2305; KANE MA, 1993, GUT, V34, pS10, DOI 10.1136/gut.34.2_Suppl.S10; Lai CL, 1998, NEW ENGL J MED, V339, P61, DOI 10.1056/NEJM199807093390201; Leung N.W.Y., 1999, Journal of Hepatology, V30, P59; Liaw YF, 1998, GASTROENTEROLOGY, V114, pA1289, DOI 10.1016/S0016-5085(98)85233-5; Nicoll AJ, 1998, ANTIMICROB AGENTS CH, V42, P3130, DOI 10.1128/AAC.42.12.3130; Niesters HGM, 1998, J INFECT DIS, V177, P1382, DOI 10.1086/517819; Perrillo R, 2000, HEPATOLOGY, V32, P129, DOI 10.1053/jhep.2000.8626; Pillay D., 1998, International Antiviral News, V6, P167; RUSTGI VK, 1984, ANN INTERN MED, V101, P795, DOI 10.7326/0003-4819-101-6-795; SCHINAZI R, 2000, ANTIVIRAL NEWS, P8; Schuhbauer H, 1999, WIRTSCHAFTSINF, V41, P58, DOI 10.1007/BF03250636; Thibault V, 1999, J CLIN MICROBIOL, V37, P3013, DOI 10.1128/JCM.37.9.3013-3016.1999; Tillmann HL, 1999, HEPATOLOGY, V30, P244, DOI 10.1002/hep.510300141; Xiong XF, 1998, HEPATOLOGY, V28, P1669, DOI 10.1002/hep.510280629; Xiong XF, 2000, HEPATOLOGY, V31, P219, DOI 10.1002/hep.510310132; Xiong XF, 1997, ANTIVIR RES, V36, P131, DOI 10.1016/S0166-3542(97)00050-8; Yoshida EM, 1998, CAN J GASTROENTEROL, V12, P125, DOI 10.1155/1998/617039	30	241	261	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 1	2001	358	9283					718	723		10.1016/S0140-6736(01)05840-8	http://dx.doi.org/10.1016/S0140-6736(01)05840-8			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	467XR	11551579				2022-12-24	WOS:000170729500012
J	Kinghorn, W				Kinghorn, W			Indecision	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Harvard Univ, Sch Med, Cambridge, MA 02138 USA	Harvard University	Kinghorn, W (corresponding author), Harvard Univ, Sch Med, Cambridge, MA 02138 USA.								0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 4	1998	280	17					1538	1538		10.1001/jama.280.17.1538	http://dx.doi.org/10.1001/jama.280.17.1538			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	134RR	11645112	hybrid			2022-12-24	WOS:000076757200034
J	BRAHAMS, D				BRAHAMS, D			FRAUD IN DRUG RESEARCH	LANCET			English	Editorial Material																			0	0	0	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	AUG 22	1992	340	8817					477	478		10.1016/0140-6736(92)91788-A	http://dx.doi.org/10.1016/0140-6736(92)91788-A			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JJ877	11643085				2022-12-24	WOS:A1992JJ87700018
J	[Anonymous]				[Anonymous]			EUTHANASIA - CONCLUSIONS OF A BMA WORKING PARTY SET UP TO REVIEW THE ASSOCIATIONS GUIDANCE ON EUTHANASIA	BRITISH MEDICAL JOURNAL			English	Editorial Material																		1988, EUTHANASIA REPORT	1	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	MAY 14	1988	296	6633					1376	1377						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	N4544	11652526				2022-12-24	WOS:A1988N454400020
J	Cheng, E; Myers, L; Wolf, S; Shatin, D; Cui, XP; Ellison, G; Belin, T; Vickrey, B				Cheng, E; Myers, L; Wolf, S; Shatin, D; Cui, XP; Ellison, G; Belin, T; Vickrey, B			Mobility impairments and use of preventive services in women with multiple sclerosis: observational study	BRITISH MEDICAL JOURNAL			English	Article									Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90095 USA; Ctr Hlth Care Policy & Evaluat, Minnetonka, MN USA; Univ Calif Los Angeles, Dept Biostat, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Cheng, E (corresponding author), Univ Calif Los Angeles, Dept Neurol, 650 Charles Young Dr S, Los Angeles, CA 90095 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS081764] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Becker H, 1997, ARCH PHYS MED REHAB, V78, pS26, DOI 10.1016/S0003-9993(97)90218-5; FRAME PS, 1992, AM FAM PHYSICIAN, V45, P1192; Iezzoni LI, 2000, AM J PUBLIC HEALTH, V90, P955, DOI 10.2105/AJPH.90.6.955; US Department of Health and Human Services, 1995, HLTH PEOPL 2000 NAT; Vickrey BG, 2000, NEUROLOGY, V55, P1341, DOI 10.1212/WNL.55.9.1341	5	36	37	0	5	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 27	2001	323	7319					968	969		10.1136/bmj.323.7319.968	http://dx.doi.org/10.1136/bmj.323.7319.968			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	488CU	11679386	Green Published, Bronze			2022-12-24	WOS:000171918500017
J	Griffiths, C; Kaur, G; Gantley, M; Feder, G; Hillier, S; Goddard, J; Packe, G				Griffiths, C; Kaur, G; Gantley, M; Feder, G; Hillier, S; Goddard, J; Packe, G			Influences on hospital admission for asthma in south Asian and white adults: qualitative interview study	BRITISH MEDICAL JOURNAL			English	Article							SOCIOECONOMICALLY DEPRIVED AREAS; SUBCONTINENT ETHNIC-GROUPS; OUTCOMES; RATES; POPULATION; BIRMINGHAM; EDUCATION; IMPACT; CITY; UK	Objective To explore reasons for increased risk of hospital admission among south Asian patients with asthma. Design Qualitative interview study using modified critical incident technique and framework analysis. Setting Newham, east London, a deprived area with a large mixed south Asian population. Participants 58 south Asian and white adults With asthma (49 admitted to hospital with asthma, 9 not admitted); 17 general practitioners; 5 accident and emergency doctors; 2 out of hours general practitioners; 1 asthma specialist nurse. Main outcome measures Patients' and health professionals' views on influences on admission, events leading to admission, general practices' organisation and asthma strategies, doctor-patient relationship, and cultural attitudes to asthma. Results South Asian and white patients admitted to hospital coped differently with asthma. South Asians described less confidence in controlling their asthma, were unfamiliar with the concept of preventive medication, and often expressed less confidence in their general practitioner. South Asians managed asthma exacerbations with family advocacy, without systematic changes in prophylaxis, and without systemic corticosteroids. Patients describing difficulty accessing primary care during asthma exacerbations were registered with practices with weak strategies for asthma care and were often south Asian. Patients with easy access described care suggesting partnerships with their general practitioner, had better confidence to control asthma, and were registered with practices with Well developed asthma strategies that included policies low avoiding hospital admission. Conclusions The different ways of coping with asd)ina exacerbations and accessing care may partly explain the increased risk of hospital admission in south Asian patients. Interventions that increase confidence to control asthma, confidence in the general practitioner, understanding of preventive treatment, and use of systemic corticosteroids in exacerbations may reduce hospital admissions. Development of more sophisticated asthma strategies by practices with better access and partnerships with patients tray also achieve this.	Queen Marys Sch Med & Dent, St Bartholomews & Royal London Sch Med & Dent, Dept Gen Practice & Primary Care, London E1 4NS, England; Royal London Hosp, Dept Human Sci & Med Eth, London E1 2AD, England; Newham Dist Gen Hosp, London, England	University of London; Queen Mary University London; Barts Health NHS Trust; Royal London Hospital	Griffiths, C (corresponding author), Queen Marys Sch Med & Dent, St Bartholomews & Royal London Sch Med & Dent, Dept Gen Practice & Primary Care, London E1 4NS, England.			Feder, Gene/0000-0002-7890-3926				[Anonymous], 1997, SELF EFFICACY; AYRES JG, 1986, BRIT J DIS CHEST, V80, P242, DOI 10.1016/0007-0971(86)90059-8; BINDMAN AB, 1995, JAMA-J AM MED ASSOC, V274, P305, DOI 10.1001/jama.274.4.305; BRADLEY CP, 1992, FAM PRACT, V9, P98, DOI 10.1093/fampra/9.1.98; Clark NM, 1998, PEDIATRICS, V101, P831, DOI 10.1542/peds.101.5.831; *COMM HLTH SCI RES, 2000, SYST REV ACC TREATM; DEPALO VA, 1994, CHEST, V106, P447, DOI 10.1378/chest.106.2.447; *E LOND CIT HLTH A, 2000, HLTH E END ANN PUBL; GIBSON PG, 2000, COCHRANE DATABASE SY; Gilthorpe MS, 1998, RESP MED, V92, P642, DOI 10.1016/S0954-6111(98)90511-X; Green J, 1998, BMJ-BRIT MED J, V316, P1064; Howie JGR, 1999, BMJ-BRIT MED J, V319, P738, DOI 10.1136/bmj.319.7212.738; KELSO TM, 1995, AM J EMERG MED, V13, P632, DOI 10.1016/0735-6757(95)90046-2; Moudgil H, 1998, THORAX, V53, P490, DOI 10.1136/thx.53.6.490; Moudgil H, 2000, THORAX, V55, P177, DOI 10.1136/thorax.55.3.177; MYERS P, 1992, RESP MED, V86, P297, DOI 10.1016/S0954-6111(06)80027-2; Norman P., 1996, PREDICTING HLTH BEHA, P197; ORMEROD LP, 1995, RESP MED, V89, P415, DOI 10.1016/0954-6111(95)90209-0; ORMEROD LP, 1995, RESP MED, V89, P115; Partridge MR, 2000, THORAX, V55, P175, DOI 10.1136/thorax.55.3.175; PATTEN MQ, 1990, QUALITATIVE EVALUATI; Ritchie J, 2002, ANAL QUALITATIVE DAT, P187; Rona RJ, 2000, THORAX, V55, P239, DOI 10.1136/thorax.55.3.239; ROWE BH, 1992, AM J EMERG MED, V10, P301, DOI 10.1016/0735-6757(92)90007-K; SPERBER K, 1995, J ASTHMA, V32, P335, DOI 10.3109/02770909509082758; [No title captured], DOI DOI 10.1136/THX.52.2008.S1]	26	55	55	0	7	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 27	2001	323	7319					962	966A		10.1136/bmj.323.7319.962	http://dx.doi.org/10.1136/bmj.323.7319.962			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	488CU	11679384	Bronze, Green Published			2022-12-24	WOS:000171918500015
J	Van Dover, CL; Humphris, SE; Fornari, D; Cavanaugh, CM; Collier, R; Goffredi, SK; Hashimoto, J; Lilley, MD; Reysenbach, AL; Shank, TM; Von Damm, KL; Banta, A; Gallant, RM; Gotz, D; Green, D; Hall, J; Harmer, TL; Hurtado, LA; Johnson, P; McKiness, ZP; Meredith, C; Olson, E; Pan, IL; Turnipseed, M; Won, Y; Young, CR; Vrijenhoek, RC				Van Dover, CL; Humphris, SE; Fornari, D; Cavanaugh, CM; Collier, R; Goffredi, SK; Hashimoto, J; Lilley, MD; Reysenbach, AL; Shank, TM; Von Damm, KL; Banta, A; Gallant, RM; Gotz, D; Green, D; Hall, J; Harmer, TL; Hurtado, LA; Johnson, P; McKiness, ZP; Meredith, C; Olson, E; Pan, IL; Turnipseed, M; Won, Y; Young, CR; Vrijenhoek, RC			Biogeography and ecological setting of Indian Ocean hydrothermal vents	SCIENCE			English	Article							MID-ATLANTIC RIDGE; SHRIMP; FLUIDS; BRESILIIDAE; DISPERSAL; PRIMERS; FAUNA	Within the endemic invertebrate faunas of hydrothermal vents, five biogeographic provinces are recognized. Invertebrates at two Indian Ocean vent fields (Kairei and Edmond) belong to a sixth province, despite ecological settings and invertebrate-bacterial symbioses similar to those of both western Pacific and Atlantic vents. Most organisms found at these Indian Ocean vent fields have evolutionary affinities with western Pacific vent faunas, but a shrimp that ecologically dominates Indian Ocean vents closely resembles its Mid-Atlantic counterpart. These findings contribute to a global assessment of the biogeography of chemosynthetic faunas and indicate that the Indian Ocean vent community follows asymmetric assembly rules biased toward Pacific evolutionary alliances.	Coll William & Mary, Dept Biol, Williamsburg, VA 23187 USA; Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA; Harvard Univ, Cambridge, MA 02138 USA; Oregon State Univ, Coll Ocean & Atmospher Sci, Corvallis, OR 97331 USA; Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA; Japan Marine Sci & Technol Ctr, Kanagawa 2370061, Japan; Univ Washington, Sch Oceanog, Seattle, WA 98195 USA; Portland State Univ, Dept Biol, Portland, OR 97201 USA; Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; Univ New Hampshire, Inst Study Earth Oceans & Space, Durham, NH 03824 USA; Univ Southampton, Southampton Oceanog Ctr, Southampton, Hants, England; Louisiana State Univ, Baton Rouge, LA 70803 USA; Univ Hawaii Manoa, Honolulu, HI 96822 USA	William & Mary; Woods Hole Oceanographic Institution; Harvard University; Oregon State University; Monterey Bay Aquarium Research Institute; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); University of Washington; University of Washington Seattle; Portland State University; Woods Hole Oceanographic Institution; University System Of New Hampshire; University of New Hampshire; NERC National Oceanography Centre; University of Southampton; Louisiana State University System; Louisiana State University; University of Hawaii System; University of Hawaii Manoa	Van Dover, CL (corresponding author), Coll William & Mary, Dept Biol, Williamsburg, VA 23187 USA.	cindy_vandover@wm.edu	Hurtado, Luis A/B-5953-2008; Luke, Tara Harmer/S-5923-2019; Harmer Luke, Tara/R-6816-2018	Hurtado, Luis A/0000-0002-9773-4996; Luke, Tara Harmer/0000-0003-2529-1708; Harmer Luke, Tara/0000-0003-2529-1708; Banta, Amy/0000-0002-1843-5059; Van Dover, Cindy/0000-0001-9845-8391				AREVALO E, 1994, SYST BIOL, V43, P387, DOI 10.2307/2413675; Bielawski JP, 1996, MOL BIOL EVOL, V13, P889, DOI 10.1093/oxfordjournals.molbev.a025649; BRIAIS A, 1995, MAR GEOPHYS RES, V17, P431, DOI 10.1007/BF01371787; CAVANAUGH CM, 1983, NATURE, V302, P58, DOI 10.1038/302058a0; Chevaldonne P, 1998, CAH BIOL MAR, V39, P347; Craig H., 1980, EOS, V61, P992; DEMETS C, 1988, J GEOPHYS RES-SOLID, V93, P11877, DOI 10.1029/JB093iB10p11877; Donval J.P., 1997, EOS T AM GEOPHYS UNI, V78, pF832; EVANS WC, 1988, J GEOPHYS RES-SOLID, V93, P15305, DOI 10.1029/JB093iB12p15305; Fisher C.R., 1995, SEAFLOOR HYDROTHERMA, V91, P297; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; FOUQUET Y, 1993, ECON GEOL BULL SOC, V88, P2018, DOI 10.2113/gsecongeo.88.8.2018; GRASSLE JF, 1985, SCIENCE, V229, P713, DOI 10.1126/science.229.4715.713; Hashimoto J, 2001, ZOOL SCI, V18, P717, DOI 10.2108/zsj.18.717; Herring PJ, 1998, DEEP-SEA RES PT I, V45, P2105, DOI 10.1016/S0967-0637(98)00050-8; HERZIG PM, 1988, CAN MINERAL, V26, P721; HESSLER RR, 1991, DEEP-SEA RES, V38, P185, DOI 10.1016/0198-0149(91)90079-U; HUBER R, 1992, SYST APPL MICROBIOL, V15, P340, DOI 10.1016/S0723-2020(11)80206-7; Kleinrock MC, 1996, NATURE, V382, P149, DOI 10.1038/382149a0; LILLEY M, UNPUB; LUTZ RA, 1979, AM ZOOL, V19, P927; Maas PAY, 1999, BIOL BULL, V196, P265, DOI 10.2307/1542951; Merritt TJS, 1998, MOL MAR BIOL BIOTECH, V7, P7; Mironov AN, 1998, CAH BIOL MAR, V39, P367; Palumbi Stephen R., 1996, P205; PLUGER WL, 1990, MAR MINING, V9, P73; Polz MF, 1998, LIMNOL OCEANOGR, V43, P1631, DOI 10.4319/lo.1998.43.7.1631; Pond DW, 2000, MAR ECOL PROG SER, V198, P171, DOI 10.3354/meps198171; Reysenbach AL, 2000, NATURE, V404, P835, DOI 10.1038/35009029; Reysenbach AL, 2000, APPL ENVIRON MICROB, V66, P3798, DOI 10.1128/AEM.66.9.3798-3806.2000; Robinson JL, 1995, LIMNOL OCEANOGR, V40, P1496, DOI 10.4319/lo.1995.40.8.1496; Shank TM, 1998, MOL MAR BIOL BIOTECH, V7, P88; Shank TM, 1999, MOL PHYLOGENET EVOL, V13, P244, DOI 10.1006/mpev.1999.0642; TUNNICLIFFE V, 1988, PROC R SOC SER B-BIO, V233, P347, DOI 10.1098/rspb.1988.0025; Tunnicliffe V, 1996, NATURE, V379, P531, DOI 10.1038/379531a0; TUNNICLIFFE V, 1998, GEOLOGICAL SOC SPEC, V118, P225; Van Dover C., 2000, ECOLOGY DEEP SEA HYD; Van Dover Cindy Lee, 1995, Geological Society Special Publication, V87, P257; Van Dover CL, 2000, MAR ECOL PROG SER, V195, P169, DOI 10.3354/meps195169; VANDOVER CL, 1989, MAR BIOL, V102, P257, DOI 10.1007/BF00428287; VANDOVER CL, 1994, LIMNOL OCEANOGR, V39, P51, DOI 10.4319/lo.1994.39.1.0051; VANDOVER CL, 1990, GORDA RIDGE, P253; VANDOVER CL, IN PRESS MAR ECOL PR; Von Damm KL, 1998, EARTH PLANET SC LETT, V160, P521, DOI 10.1016/S0012-821X(98)00108-3; Von Damm KL, 2000, J GEOPHYS RES-SOL EA, V105, P11203, DOI 10.1029/1999JB900414; Vrijenhoek RC, 1997, J HERED, V88, P285, DOI 10.1093/oxfordjournals.jhered.a023106; VRIJENHOEK RC, 1997, JAMSTEC DEEP SEA RES, V111; White SN, 1998, MAR GEOPHYS RES, V20, P41, DOI 10.1023/A:1004376229719; AF393376 GENB; AF393378 GENB; AF393377 GENB; AF393379 GENB	52	261	262	0	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 26	2001	294	5543					818	823		10.1126/science.1064574	http://dx.doi.org/10.1126/science.1064574			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487AP	11557843				2022-12-24	WOS:000171851800037
J	Derry, WB; Putzke, AP; Rothman, JH				Derry, WB; Putzke, AP; Rothman, JH			Caenorhabditis elegans p53: Role in apoptosis, meiosis, and stress resistance	SCIENCE			English	Article							PROGRAMMED CELL-DEATH; TRANSCRIPTIONAL ACTIVATION; GENETIC-CONTROL; DROSOPHILA P53; TUMOR-ANTIGEN; C-ELEGANS; PROTEIN; EMBRYOGENESIS; ACCUMULATION; CHECKPOINT	We have identified a homolog of the mammalian p53 tumor suppressor protein in the nematode Caenorhabditis elegans that is expressed ubiquitously in embryos. The gene encoding this protein, cep-1, promotes DNA damage-induced apoptosis and is required for normal meiotic chromosome segregation in the germ line. Moreover, although somatic apoptosis is unaffected, cep-1 mutants show hypersensitivity to hypoxia-induced lethality and decreased longevity in response to starvation-induced stress. Overexpression of cep-1 promotes widespread caspase-independent cell death, demonstrating the critical importance of regulating p53 function at appropriate levels. These findings show that C. elegans p53 mediates multiple stress responses in the soma, and mediates apoptosis and meiotic chromosome segregation in the germ line.	Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Derry, WB (corresponding author), Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA.	derry@lifesci.ucsb.edu	Derry, Brent/CAF-4503-2022	Derry, Brent/0000-0002-1977-8475	NATIONAL INSTITUTE ON AGING [R01AG013736] Funding Source: NIH RePORTER; NIA NIH HHS [AG13736] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ABRAMS JM, 1993, DEVELOPMENT, V117, P29; Alarcon R, 1999, CANCER RES, V59, P6046; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BIENZ B, 1984, EMBO J, V3, P2179, DOI 10.1002/j.1460-2075.1984.tb02110.x; Brodsky MH, 2000, CELL, V101, P103, DOI 10.1016/S0092-8674(00)80627-3; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; DERRY WB, UNPUB; ELLIS HM, 1986, CELL, V44, P817, DOI 10.1016/0092-8674(86)90004-8; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gartner A, 2000, MOL CELL, V5, P435, DOI 10.1016/S1097-2765(00)80438-4; Gengyo-Ando K, 2000, BIOCHEM BIOPH RES CO, V269, P64, DOI 10.1006/bbrc.2000.2260; GRAEBER TG, 1994, MOL CELL BIOL, V14, P6264, DOI 10.1128/MCB.14.9.6264; Gumienny TL, 1999, DEVELOPMENT, V126, P1011; HENIKOFF S, 1995, GENE, V163, P17; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jansen G, 1997, NAT GENET, V17, P119, DOI 10.1038/ng0997-119; Jin SK, 2000, P NATL ACAD SCI USA, V97, P7301, DOI 10.1073/pnas.97.13.7301; Kitanaka C, 1999, CELL DEATH DIFFER, V6, P508, DOI 10.1038/sj.cdd.4400526; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; LAMB P, 1986, MOL CELL BIOL, V6, P1379, DOI 10.1128/MCB.6.5.1379; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; LIN JY, 1994, GENE DEV, V8, P1235, DOI 10.1101/gad.8.10.1235; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Ollmann M, 2000, CELL, V101, P91, DOI 10.1016/S0092-8674(00)80626-1; Riddle D. L, 1997, C ELEGANS, P47; ROGEL A, 1985, MOL CELL BIOL, V5, P2851, DOI 10.1128/MCB.5.10.2851; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SCHMID P, 1991, DEVELOPMENT, V113, P857; STRINGHAM EG, 1992, MOL BIOL CELL, V3, P221, DOI 10.1091/mbc.3.2.221; THUT CJ, 1995, SCIENCE, V267, P100, DOI 10.1126/science.7809597; Wallingford JB, 1997, CURR BIOL, V7, P747, DOI 10.1016/S0960-9822(06)00333-2	32	371	398	0	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2001	294	5542					591	595		10.1126/science.1065486	http://dx.doi.org/10.1126/science.1065486			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484NC	11557844				2022-12-24	WOS:000171695600046
J	Schiermeier, Q				Schiermeier, Q			Bid to end EU's transgenic impasse	NATURE			English	News Item																		2001, NATURE, V409, P967	1	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 18	2001	413	6857					661	661		10.1038/35099712	http://dx.doi.org/10.1038/35099712			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	482ZK	11606987	Bronze			2022-12-24	WOS:000171608000012
J	Raedle, J; Trojan, J; Brieger, A; Weber, N; Schafer, D; Plotz, G; Staib-Sebler, E; Kriener, S; Lorenz, M; Zeuzem, S				Raedle, J; Trojan, J; Brieger, A; Weber, N; Schafer, D; Plotz, G; Staib-Sebler, E; Kriener, S; Lorenz, M; Zeuzem, S			Bethesda guidelines: Relation to microsatellite instability and MLH1 promoter methylation in patients with colorectal cancer	ANNALS OF INTERNAL MEDICINE			English	Article							MISMATCH REPAIR GENES; REPLICATION ERRORS; GERMLINE MUTATIONS; DNA METHYLATION; HMLH1 PROMOTER; COLON-CANCER; HYPERMETHYLATION; TUMORS; HMSH2; EPIGENETICS	Background: Microsatellite instability is a hallmark of mismatch repair deficiency in hereditary nonpolyposis colorectal cancer and results from mutations in the mismatch repair genes MLH1 or MSH2 or from gene inactivation associated with DNA methylation. The Bethesda guidelines were established to identify patients with colorectal cancer who should be tested for microsatellite instability. Objective: To assess the Bethesda guidelines for detection, of microsatellite instability and to determine the role of MLH1 promoter methylation in colorectal cancer. Design: Prospective cohort study. Setting: Tertiary care referral center in Frankfurt, Germany. Patients: 125 consecutive patients with colorectal cancer. Measurements, Patients were assessed according to the Bethesda guidelines, and tumor specimens were analyzed for micro-satellite instability. Patients with microsatellite Instability were tested for MLH1 promoter methylation and MLH1 and MSH2 germline mutations. Results: Microsatellite instability was detected in 17 of 58 patients who fulfilled and 5 of 67 patients who did not fulfill criteria of the Bethesda guidelines. In I I of 17 patients with microsatellite instability who fulfilled Bethesda guidelines, an MLH1 (n = 3), MSH2 (n = 7), or combined MLH1 and MSH2 (n = 1) mutation was found. Among the patients with microsatellite instability who did not fulfill Bethesda guidelines, no mutations were observed; MLH1 promoter methylation was observed in 6 of 11 patients with an MLH1 or MSH2 mutation and 5 of 11 patients without an MLH1 or MSH2 mutation. Conclusions: The Bethesda guidelines are useful for selecting patients for microsatellite instability testing. MLH1 and MSH2 testing should be recommended in all patients with colorectal cancer and microsatellite instability who fulfill at least one Bethesda criterion. MLH1 promoter methylation may accompany rather than initiate carcinogenesis in patients with colorectal cancer who have mismatch repair gene defects.	Goethe Univ Frankfurt, Dept Internal Med 2, D-60590 Frankfurt, Germany; Goethe Univ Frankfurt, Inst Human Genet, D-60590 Frankfurt, Germany; Goethe Univ Frankfurt, Dept Gen & Vasc Surg, D-60590 Frankfurt, Germany; Goethe Univ Frankfurt, Dept Pathol, D-60590 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt	Raedle, J (corresponding author), Goethe Univ Frankfurt, Dept Internal Med 2, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	Raedle@em.uni-frankfurt.de	Zeuzem, Stefan/AAE-7435-2019	Plotz, Guido/0000-0001-5314-9739				AALTONEN LA, 1994, CANCER RES, V54, P1645; Aaltonen LA, 1998, NEW ENGL J MED, V338, P1481, DOI 10.1056/NEJM199805213382101; Basik M, 1997, GENE CHROMOSOME CANC, V18, P19, DOI 10.1002/(SICI)1098-2264(199701)18:1<19::AID-GCC3>3.0.CO;2-4; Baylin SB, 2000, TRENDS GENET, V16, P168, DOI 10.1016/S0168-9525(99)01971-X; Bocker T, 1997, CANCER RES, V57, P4739; Boland CR, 1998, CANCER RES, V58, P5248; Brieger A, 1999, CLIN CHEM, V45, P1564; Canzian F, 1996, CANCER RES, V56, P3331; CAWKWELL L, 1995, GASTROENTEROLOGY, V109, P465, DOI 10.1016/0016-5085(95)90334-8; Cravo ML, 1999, CANCER, V85, P779, DOI 10.1002/(SICI)1097-0142(19990215)85:4<779::AID-CNCR4>3.0.CO;2-C; Cunningham JM, 1998, CANCER RES, V58, P3455; Dietmaier W, 1997, CANCER RES, V57, P4749; Farrington SM, 1998, AM J HUM GENET, V63, P749, DOI 10.1086/301996; Fleisher AS, 1999, CANCER RES, V59, P1090; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; *INT COLL GROUP HE, 2001, MUT DAT PATH MUT MSH; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; Jarvinen HJ, 2000, GASTROENTEROLOGY, V118, P829, DOI 10.1016/S0016-5085(00)70168-5; Jass JR, 1998, GUT, V42, P673, DOI 10.1136/gut.42.5.673; Jones PA, 1999, NAT GENET, V21, P163, DOI 10.1038/5947; Kane MF, 1997, CANCER RES, V57, P808; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; KOLODNER RD, 1995, CANCER RES, V55, P242; Kuismanen SA, 2000, AM J PATHOL, V156, P1773, DOI 10.1016/S0002-9440(10)65048-1; Lamberti C, 1999, GUT, V44, P839, DOI 10.1136/gut.44.6.839; Lengauer C, 1997, P NATL ACAD SCI USA, V94, P2545, DOI 10.1073/pnas.94.6.2545; LIU B, 1995, NAT GENET, V9, P48, DOI 10.1038/ng0195-48; Liu B, 1996, NAT MED, V2, P169, DOI 10.1038/nm0296-169; LIU B, 1994, CANCER RES, V54, P4590; LIU B, 1995, NAT MED, V1, P348, DOI 10.1038/nm0495-348; Lynch HT, 1996, CANCER, V78, P1149, DOI 10.1002/(SICI)1097-0142(19960915)78:6<1149::AID-CNCR1>3.3.CO;2-Q; Lynch HT, 1998, NEW ENGL J MED, V338, P1537, DOI 10.1056/NEJM199805213382109; Momparler RL, 2000, J CELL PHYSIOL, V183, P145, DOI 10.1002/(SICI)1097-4652(200005)183:2<145::AID-JCP1>3.0.CO;2-V; Oda S, 1997, NUCLEIC ACIDS RES, V25, P3415, DOI 10.1093/nar/25.17.3415; Peltomaki P, 1997, ADV CANCER RES, V71, P93, DOI 10.1016/S0065-230X(08)60097-4; Raedle J, 1999, MODERN PATHOL, V12, P485; RodriguezBigas MA, 1997, J NATL CANCER I, V89, P1758, DOI 10.1093/jnci/89.23.1758; Salovaara R, 2000, J CLIN ONCOL, V18, P2193, DOI 10.1200/JCO.2000.18.11.2193; Sambrook J, 1989, MOL CLONING LAB MANU, V2; Syngal S, 1999, JAMA-J AM MED ASSOC, V282, P247, DOI 10.1001/jama.282.3.247; Syngal S, 2000, J MED GENET, V37, P641, DOI 10.1136/jmg.37.9.641; Terdiman JP, 2001, GASTROENTEROLOGY, V120, P21, DOI 10.1053/gast.2001.20874; Trojan J, 2000, GUT, V47, P272, DOI 10.1136/gut.47.2.272; Vasen HFA, 1999, GASTROENTEROLOGY, V116, P1453, DOI 10.1016/S0016-5085(99)70510-X; VASEN HFA, 1991, DIS COLON RECTUM, V34, P424, DOI 10.1007/BF02053699; Wang Q, 1999, HUM GENET, V105, P79, DOI 10.1007/s004390051067; Wheeler JMD, 2000, GUT, V47, P148, DOI 10.1136/gut.47.1.148; Wijnen JT, 1998, NEW ENGL J MED, V339, P511, DOI 10.1056/NEJM199808203390804	48	58	59	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 16	2001	135	8	1				566	576		10.7326/0003-4819-135-8_Part_1-200110160-00007	http://dx.doi.org/10.7326/0003-4819-135-8_Part_1-200110160-00007			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	481VY	11601928				2022-12-24	WOS:000171542200002
J	Xiong, JP; Stehle, T; Diefenbach, B; Zhang, RG; Dunker, R; Scott, DL; Joachimiak, A; Goodman, SL; Arnaout, MA				Xiong, JP; Stehle, T; Diefenbach, B; Zhang, RG; Dunker, R; Scott, DL; Joachimiak, A; Goodman, SL; Arnaout, MA			Crystal structure of the extracellular segment of integrin alpha V beta 3	SCIENCE			English	Article							IIB-IIIA COMPLEX; LIGAND-BINDING; A-DOMAIN; CELL-ADHESION; CONFORMATIONAL-CHANGES; PROTEIN; AFFINITY; SITES; FIBRINOGEN; INSIGHTS	Integrins are alpha beta heterodimeric receptors that mediate divalent cation-dependent cell-cell and cell-matrix adhesion through tightly regulated interactions with ligands. We have solved the crystal structure of the extracellular portion of integrin alphaV beta3 at 3.1 Angstrom resolution. Its 12 domains assemble into an ovoid "head" and two "tails." In the crystal, alphaV beta3 is severely bent at a defined region in its tails, reflecting an unusual flexibility that may be linked to integrin regulation. The main intersubunit interface ties within the head, between a seven-bladed beta -propeller from alphaV and an A domain from beta3, and bears a striking resemblance to the G alpha /G beta interface in G proteins. A metal ion-dependent adhesion site (MIDAS) in the betaA domain is positioned to participate in a ligand-binding interface formed of loops from the propeller and betaA domains. MIDAS ties adjacent to a calcium-binding site with a potential regulatory function.	Massachusetts Gen Hosp, Struct Biol Program, Leukocyte Biol & Inflammat Program, Renal Unit, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Charlestown, MA 02129 USA; Massachusetts Gen Hosp, Lab Dev Immunol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA; Merck KGaA, Dept Biotechnol, D-64271 Darmstadt, Germany; Merck KGaA, Dept Biomed Res Immunol Oncol, D-64271 Darmstadt, Germany; Argonne Natl Lab, Biosci Div, Argonne, IL 60439 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Merck KGaA; Merck KGaA; United States Department of Energy (DOE); Argonne National Laboratory	Arnaout, MA (corresponding author), Massachusetts Gen Hosp, Struct Biol Program, Leukocyte Biol & Inflammat Program, Renal Unit, 149 13th St, Charlestown, MA 02129 USA.	arnaout@receptor.mgh.harvard.edu		Goodman, Simon L./0000-0002-3480-1346	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054227] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045716] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048549, P01DK050305] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM062414] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bork P, 1999, TRENDS BIOCHEM SCI, V24, P261, DOI 10.1016/S0968-0004(99)01416-4; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Calvete JJ, 1999, P SOC EXP BIOL MED, V222, P29, DOI 10.1111/j.1525-1373.1999.09993.x; CARSON M, 1987, J MOL GRAPHICS, V5, P103, DOI 10.1016/0263-7855(87)80010-3; Chothia C, 1997, ANNU REV BIOCHEM, V66, P823, DOI 10.1146/annurev.biochem.66.1.823; DANA N, 1991, P NATL ACAD SCI USA, V88, P3106, DOI 10.1073/pnas.88.8.3106; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Downing AK, 1996, CELL, V85, P597, DOI 10.1016/S0092-8674(00)81259-3; DU XP, 1993, J BIOL CHEM, V268, P23087; Eliceiri BP, 1999, J CLIN INVEST, V103, P1227, DOI 10.1172/JCI6869; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; Erb EM, 1997, BIOCHEMISTRY-US, V36, P7395, DOI 10.1021/bi9702187; FITZGERALD LA, 1985, J BIOL CHEM, V260, P1366; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; Hantgan RR, 1999, BIOCHEMISTRY-US, V38, P14461, DOI 10.1021/bi9907680; Hemler ME, 1998, CURR OPIN CELL BIOL, V10, P578, DOI 10.1016/S0955-0674(98)80032-X; Hogg N, 2000, MATRIX BIOL, V19, P211, DOI 10.1016/S0945-053X(00)00066-4; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Hu DD, 1996, J BIOL CHEM, V271, P21745, DOI 10.1074/jbc.271.36.21745; Hughes PE, 1996, J BIOL CHEM, V271, P6571, DOI 10.1074/jbc.271.12.6571; Humphries MJ, 2000, BIOCHEM SOC T, V28, P311, DOI 10.1042/0300-5127:0280311; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Janowski R, 2001, NAT STRUCT BIOL, V8, P316, DOI 10.1038/86188; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; LEE JO, 1995, CELL, V80, P631, DOI 10.1016/0092-8674(95)90517-0; Lee JO, 1995, STRUCTURE, V3, P1333, DOI 10.1016/S0969-2126(01)00271-4; Li R, 1998, J CELL BIOL, V143, P1523, DOI 10.1083/jcb.143.6.1523; Mehta RJ, 1998, BIOCHEM J, V330, P861; MICHISHITA M, 1993, CELL, V72, P857, DOI 10.1016/0092-8674(93)90575-B; MOULD AP, 1995, J BIOL CHEM, V270, P26270, DOI 10.1074/jbc.270.44.26270; Mould AP, 1998, BIOCHEM J, V331, P821, DOI 10.1042/bj3310821; NERMUT MV, 1988, EMBO J, V7, P4093, DOI 10.1002/j.1460-2075.1988.tb03303.x; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PARISE LV, 1985, J BIOL CHEM, V260, P1750; Plow EF, 2000, J BIOL CHEM, V275, P21785, DOI 10.1074/jbc.R000003200; Pujades C, 1997, MOL BIOL CELL, V8, P2647, DOI 10.1091/mbc.8.12.2647; SIMS PJ, 1991, J BIOL CHEM, V266, P7345; van Kooyk Y, 1999, J BIOL CHEM, V274, P26869, DOI 10.1074/jbc.274.38.26869; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; WEISEL JW, 1992, J BIOL CHEM, V267, P16637; Xiong JP, 2000, J BIOL CHEM, V275, P38762, DOI 10.1074/jbc.C000563200; Yamada KM, 1997, CURR OPIN CELL BIOL, V9, P76, DOI 10.1016/S0955-0674(97)80155-X; [No title captured]	45	1043	1097	4	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 12	2001	294	5541					339	345		10.1126/science.1064535	http://dx.doi.org/10.1126/science.1064535			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	482WZ	11546839	Green Accepted			2022-12-24	WOS:000171601400034
J	Thompson, WT; Cupples, ME; Sibbett, CH; Skan, DI; Bradley, T				Thompson, WT; Cupples, ME; Sibbett, CH; Skan, DI; Bradley, T			Challenge of culture, conscience, and contract to general practitioners' care of their own health: qualitative study	BRITISH MEDICAL JOURNAL			English	Article							DOCTORS; ILLNESS; SICKNESS; STRESS; JOB	Objective To explore general practitioners' perceptions of the effects of their profession and training on their attitudes to illness in themselves and colleagues. Design Qualitative study using focus groups and indepth interviews. Setting Primary care in Northern Ireland. Participants 27 general practitioners, including six recently appointed principals and six who also practised occupational medicine part time. Main outcome measures Participants' views about their own and colleagues' health. Results Participants were concerned about the current level of illness within the profession. They described their need to portray a healthy image to both patients and colleagues. This hindered acknowledgement of personal illness and engaging in health screening. Embarrassment in adopting the role of a patient and concerns about confidentiality also influenced their reactions to personal illness. Doctors' attitudes can impede their access to appropriate health care for themselves, their families, and their colleagues. A sense of conscience towards patients and colleagues and the working arrangements of the practice were cited as reasons for working through illness and expecting colleagues to do likewise. Conclusions General practitioners perceive that their professional position and training adversely influence their attitudes to illness in themselves and their colleagues. Organisational changes within general practice, including revalidation, must take account of barriers experienced by general practitioners in accessing health care. Medical education and culture should strive to promote appropriate self care among doctors.	Queens Univ Belfast, Sch Med, Dept Gen Practice, Belfast BT9 7HR, Antrim, North Ireland; Queens Univ Belfast, Grad Sch Educ, Belfast BT7 1HL, Antrim, North Ireland; Hlth & Safety Execut No Ireland, Employment Med Advisory Serv, Belfast BT6 9FR, Antrim, North Ireland; No Ireland Council Postgrad Med & Dent Educ, Belfast BT7 3JH, Antrim, North Ireland	Queens University Belfast; Queens University Belfast	Cupples, ME (corresponding author), Queens Univ Belfast, Sch Med, Dept Gen Practice, Belfast BT9 7HR, Antrim, North Ireland.			Cupples, Margaret/0000-0002-4248-9700				Appleton K, 1998, BRIT J GEN PRACT, V48, P1059; *BMA BOARD SCI ED, 1993, MORB MORT MED PROF; BRANDON S, 1997, BRIT MED J, V314, P2; Chambers R, 1996, BRIT MED J, V312, P722; CHAMBERS R, 1992, BRIT J GEN PRACT, V42, P153; Clarke J, 1998, IRISH MED J, V91, P175; Forsythe M, 1999, BRIT MED J, V319, P605, DOI 10.1136/bmj.319.7210.605; *GEN MED COUNC, 1998, GOOD MED PRACT; *GEN MED COUNC, 2000, REV DOCT ENS STAND; Gilliland AEV, 1998, BRIT J GEN PRACT, V48, P1663; Glaser B. G., 1978, AWARENESS DYING; *HLTH POL EC RES U, 2000, WORK REL STRESS SEN; KING MB, 1992, J ROY SOC MED, V85, P605; McKevitt C, 1997, J PUBLIC HEALTH MED, V19, P295, DOI 10.1093/oxfordjournals.pubmed.a024633; McKevitt C, 1997, SOCIOL HEALTH ILL, V19, P644, DOI 10.1111/1467-9566.ep10935530; McKevitt C, 1996, DOCTORS HLTH NEEDS S; MILLAR RL, 2000, RES LIFE STORIES FAM; MORTONWILLIAMS J, 1988, APPL QUALITATIVE RES, P27; PILOWSKI L, 1989, BRIT MED J, V298, P269, DOI 10.1136/bmj.298.6669.269; Schneck SA, 1998, JAMA-J AM MED ASSOC, V280, P2039, DOI 10.1001/jama.280.23.2039; Waldron HA, 1996, ANN OCCUP HYG, V40, P391, DOI 10.1093/annhyg/40.4.391; Wall TD, 1997, BRIT J PSYCHIAT, V171, P519, DOI 10.1192/bjp.171.6.519; Williams S, 1998, IMPROVING HLTH NHS W; 1994, LANCET, V344, P1583	24	107	109	0	18	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 29	2001	323	7315					728	731		10.1136/bmj.323.7315.728	http://dx.doi.org/10.1136/bmj.323.7315.728			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	478HJ	11576981	Green Published			2022-12-24	WOS:000171340700021
J	Nash, MS; Young, KW; Challiss, RAJ; Nahorski, SR				Nash, MS; Young, KW; Challiss, RAJ; Nahorski, SR			Intracellular signalling - Receptor-specific messenger oscillations	NATURE			English	Article							CALCIUM OSCILLATIONS; FEEDBACK		Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England	University of Leicester	Nash, MS (corresponding author), Univ Leicester, Dept Cell Physiol & Pharmacol, Med Sci Bldg,Univ Rd, Leicester LE1 9HN, Leics, England.		Challiss, R.A. John/A-9412-2008	Challiss, John/0000-0001-5506-2848				Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; BIRD GSJ, 1993, J BIOL CHEM, V268, P8425; De Koninck P, 1998, SCIENCE, V279, P227, DOI 10.1126/science.279.5348.227; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; HAROOTUNIAN AT, 1991, SCIENCE, V251, P75, DOI 10.1126/science.1986413; Hirose K, 1999, SCIENCE, V284, P1527, DOI 10.1126/science.284.5419.1527; Kawabata S, 1996, NATURE, V383, P89, DOI 10.1038/383089a0; Nash MS, 2001, BIOCHEM J, V356, P137, DOI 10.1042/0264-6021:3560137; Petersen OH, 1999, TRENDS NEUROSCI, V22, P488, DOI 10.1016/S0166-2236(99)01456-3; Taylor CW, 2001, CURR BIOL, V11, pR352, DOI 10.1016/S0960-9822(01)00192-0; Thomas AP, 1996, FASEB J, V10, P1505, DOI 10.1096/fasebj.10.13.8940296; van der Wal J, 2001, J BIOL CHEM, V276, P15337, DOI 10.1074/jbc.M007194200	12	114	115	0	7	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 27	2001	413	6854					381	382		10.1038/35096643	http://dx.doi.org/10.1038/35096643			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475UY	11574876				2022-12-24	WOS:000171188700042
J	Strohmaier, H; Spruck, CH; Kaiser, P; Won, KA; Sangfelt, O; Reed, SI				Strohmaier, H; Spruck, CH; Kaiser, P; Won, KA; Sangfelt, O; Reed, SI			Human F-box protein hCdc4 targets cyclin E for proteolysis and is mutated in a breast cancer cell line	NATURE			English	Article								Cyclin E, one of the activators of the cyclin-dependent kinase Cdk2, is expressed near the G(1)-S phase transition and is thought to be critical for the initiation of DNA replication and other S-phase functions(1-3). Accumulation of cyclin E at the G(1)-S boundary is achieved by periodic transcription coupled with regulated proteolysis linked to autophosphorylation of cyclin E-4. The proper timing and amplitude of cyclin E expression seem to be important, because elevated levels of cyclin E have been associated with a variety of malignancies(5,6) and constitutive expression of cyclin E leads to genomic instability(7). Here we show that turnover of phosphorylated cyclin E depends on an SCF-type protein-ubiquitin ligase that contains the human homologue of yeast Cdc4, which is an F-box protein containing repeated sequences of WD40 (a unit containing about 40 residues with tryptophan (W) and aspartic acid (D) at defined positions). The gene encoding hCdc4 was found to be mutated in a cell line derived from breast cancer that expressed extremely high levels of cyclin E.	Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Karolinska Hosp, Dept Oncol Pathol, S-17176 Stockholm, Sweden	Scripps Research Institute; Karolinska Institutet; Karolinska University Hospital	Reed, SI (corresponding author), Scripps Res Inst, Dept Mol Biol, MB-7,10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	sreed@scripps.edu						BETT AJ, 1994, P NATL ACAD SCI USA, V91, P8802, DOI 10.1073/pnas.91.19.8802; Bortner DM, 1997, MOL CELL BIOL, V17, P453, DOI 10.1128/MCB.17.1.453; Clurman BE, 1996, GENE DEV, V10, P1979, DOI 10.1101/gad.10.16.1979; Dealy MJ, 1999, NAT GENET, V23, P245, DOI 10.1038/13886; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Donnellan R, 1999, FASEB J, V13, P773, DOI 10.1096/fasebj.13.8.773; Ekholm SV, 2000, CURR OPIN CELL BIOL, V12, P676, DOI 10.1016/S0955-0674(00)00151-4; KEYOMARSI K, 1993, P NATL ACAD SCI USA, V90, P1112, DOI 10.1073/pnas.90.3.1112; Koepp DM, 1999, CELL, V97, P431, DOI 10.1016/S0092-8674(00)80753-9; Moberg KH, 2001, NATURE, V413, P311, DOI 10.1038/35095068; MUHLRAD D, 1992, YEAST, V8, P79, DOI 10.1002/yea.320080202; Nakayama K, 2000, EMBO J, V19, P2069, DOI 10.1093/emboj/19.9.2069; Patton EE, 1998, TRENDS GENET, V14, P236, DOI 10.1016/S0168-9525(98)01473-5; REED SI, 1985, P NATL ACAD SCI USA, V82, P4055, DOI 10.1073/pnas.82.12.4055; Reed SI, 1996, BBA-REV CANCER, V1287, P151, DOI 10.1016/0304-419X(96)00006-6; Reed SI, 1997, CANCER SURV, V29, P7; Sambrook JFE, 1989, MOL CLONING LAB MANU; Sandhu C, 2000, CANCER DETECT PREV, V24, P107; Sauer K, 1995, Prog Cell Cycle Res, V1, P125; Spruck C, 2001, MOL CELL, V7, P639, DOI 10.1016/S1097-2765(01)00210-6; Spruck CH, 1999, NATURE, V401, P297, DOI 10.1038/45836; Tyers M, 2000, CURR OPIN GENET DEV, V10, P54, DOI 10.1016/S0959-437X(99)00049-0; WALEN KH, 1989, CANCER GENET CYTOGEN, V37, P249, DOI 10.1016/0165-4608(89)90056-3; Wang YS, 1999, CURR BIOL, V9, P1191, DOI 10.1016/S0960-9822(00)80024-X; Won KA, 1996, EMBO J, V15, P4182, DOI 10.1002/j.1460-2075.1996.tb00793.x; Yeh KH, 2001, BIOCHEM BIOPH RES CO, V281, P884, DOI 10.1006/bbrc.2001.4442	26	498	512	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 20	2001	413	6853					316	322		10.1038/35095076	http://dx.doi.org/10.1038/35095076			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473KB	11565034				2022-12-24	WOS:000171040500041
J	Greene, JD; Sommerville, RB; Nystrom, LE; Darley, JM; Cohen, JD				Greene, JD; Sommerville, RB; Nystrom, LE; Darley, JM; Cohen, JD			An fMRI investigation of emotional engagement in moral judgment	SCIENCE			English	Article							WORKING-MEMORY; BRAIN	The long-standing rationalist tradition in moral psychology emphasizes the rote of reason in moral judgment. A more recent trend places increased emphasis on emotion. Although both reason and emotion are likely to play important roles in moral judgment, relatively tittle is known about their neural correlates, the nature of their interaction, and the factors that modulate their respective behavioral influences in the context of moral judgment. In two functional magnetic resonance imaging (fMRI) studies using moral dilemmas as probes, we apply the methods of cognitive neuroscience to the study of moral judgment. We argue that moral dilemmas vary systematically in the extent to which they engage emotional processing and that these variations in emotional engagement influence moral judgment. These results may shed light on some puzzling patterns in moral judgment observed by contemporary philosophers.	Princeton Univ, Ctr Study Brain Mind & Behav, Princeton, NJ 08544 USA; Princeton Univ, Dept Philosophy, Princeton, NJ 08544 USA; Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA; Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA 15260 USA	Princeton University; Princeton University; Princeton University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Greene, JD (corresponding author), Princeton Univ, Ctr Study Brain Mind & Behav, Princeton, NJ 08544 USA.							Cohen JD, 1997, NATURE, V386, P604, DOI 10.1038/386604a0; DAMASIO AR, 1994, DESCARTES ERROR; Davidson RJ, 1999, TRENDS COGN SCI, V3, P11, DOI 10.1016/S1364-6613(98)01265-0; Drevets WC, 1998, COGNITION EMOTION, V12, P353, DOI 10.1080/026999398379646; HAIDT JD, IN PRESS PSYCH REV; Isenberg N, 1999, P NATL ACAD SCI USA, V96, P10456, DOI 10.1073/pnas.96.18.10456; Kosslyn SM, 1996, NEUROREPORT, V7, P1569, DOI 10.1097/00001756-199607080-00007; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Maddock RJ, 1999, TRENDS NEUROSCI, V22, P310, DOI 10.1016/S0166-2236(98)01374-5; Reiman EM, 1997, J CLIN PSYCHIAT, V58, P4; Reiman EM, 1997, AM J PSYCHIAT, V154, P918; Smith EE, 1997, COGNITIVE PSYCHOL, V33, P5, DOI 10.1006/cogp.1997.0658; STROOP JR, 1935, J EXP PSYCHOL, V72, P219; Talairach J., 1988, COPLANAR STEREOTAXIC; Thomson J.J., 1986, RIGHTS RESTITUTION R, P94	15	2521	2591	45	665	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 14	2001	293	5537					2105	2108		10.1126/science.1062872	http://dx.doi.org/10.1126/science.1062872			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	473FB	11557895				2022-12-24	WOS:000171028700078
J	Hwang, UW; Friedrich, M; Tautz, D; Park, CJ; Kim, W				Hwang, UW; Friedrich, M; Tautz, D; Park, CJ; Kim, W			Mitochondrial protein phylogeny joins myriapods with chelicerates	NATURE			English	Article							ARTHROPOD PHYLOGENY; HOX GENES; SEQUENCE; EXPRESSION; EVOLUTION; POSITION; INSECTS; PATTERN; MODEL	The animal phylum Arthropoda is very useful for the study of body plan evolution given its abundance of morphologically diverse species and our profound understanding of Drosophila development(1). However, there is a lack of consistently resolved phylogenetic relationships between the four extant arthropod subphyla, Hexapoda, Myriapoda, Chelicerata and Crustacea. Recent molecular studies(2-4) have strongly supported a sister group relationship between Hexapoda and Crustacea, but have not resolved the phylogenetic position of Chelicerata and Myriapoda. Here we sequence the mitochondrial genome of the centipede species Lithobius forficatus and investigate its phylogenetic information content. Molecular phylogenetic analysis of conserved regions from the arthropod mitochondrial proteome yields highly resolved and congruent trees. We also rnd that a sister group relationship between Myriapoda and Chelicerata is strongly supported. We propose a model to explain the apparently parallel evolution of similar head morphologies in insects and myriapods.	Kyungpook Natl Univ, Dept Biol, Teachers Coll, Taegu 702701, South Korea; Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea; Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA; Univ Cologne, Abt Evolut Genet, Inst Genet, D-50931 Cologne, Germany	Kyungpook National University; Seoul National University (SNU); Wayne State University; University of Cologne	Friedrich, M (corresponding author), Kyungpook Natl Univ, Dept Biol, Teachers Coll, Taegu 702701, South Korea.	mf@biology.biosci.wayne.edu	Tautz, Diethard/H-8436-2014; Tautz, Diethard/D-4304-2011	Tautz, Diethard/0000-0002-0460-5344; 				Adachi J, 1996, J MOL EVOL, V42, P459; Aguinaldo AMA, 1997, NATURE, V387, P489, DOI 10.1038/387489a0; Akam M, 2000, P NATL ACAD SCI USA, V97, P4438, DOI 10.1073/pnas.97.9.4438; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Boore JL, 1998, NATURE, V392, P667, DOI 10.1038/33577; BOORE JL, 1995, NATURE, V376, P163, DOI 10.1038/376163a0; Casares F, 1998, NATURE, V392, P723, DOI 10.1038/33706; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; CISNE JL, 1974, SCIENCE, V186, P13, DOI 10.1126/science.186.4158.13; Cook CE, 2001, CURR BIOL, V11, P759, DOI 10.1016/S0960-9822(01)00222-6; Curole JP, 1999, TRENDS ECOL EVOL, V14, P394, DOI 10.1016/S0169-5347(99)01660-2; Damen WGM, 1998, P NATL ACAD SCI USA, V95, P10665, DOI 10.1073/pnas.95.18.10665; delle Cave L., 1991, P189; FELSENSTEIN J, 1995, PHYLIP PHYLOGENY INF; Foster PG, 1999, J MOL EVOL, V48, P284, DOI 10.1007/PL00006471; FRIEDRICH M, 1995, NATURE, V376, P165, DOI 10.1038/376165a0; Garcia-Machado E, 1999, J MOL EVOL, V49, P142, DOI 10.1007/PL00006527; Giribet G, 2000, CLADISTICS, V16, P204, DOI 10.1111/j.1096-0031.2000.tb00353.x; Hausdorf B, 2000, SYST BIOL, V49, P130, DOI 10.1080/10635150050207438; Kusche K, 2001, MOL BIOL EVOL, V18, P1566, DOI 10.1093/oxfordjournals.molbev.a003943; MUSE SV, 2000, HY PHY 0 7 BETA; Peterson KJ, 2001, EVOL DEV, V3, P170, DOI 10.1046/j.1525-142x.2001.003003170.x; Shultz JW, 2000, P ROY SOC B-BIOL SCI, V267, P1011, DOI 10.1098/rspb.2000.1104; SIDOW A, 1994, CURR BIOL, V4, P596, DOI 10.1016/S0960-9822(00)00131-7; SNODGRASS RE, 1938, SMITHSON MISC COLLEC, V138, P1; Strimmer K, 1996, MOL BIOL EVOL, V13, P964, DOI 10.1093/oxfordjournals.molbev.a025664; Strimmer K, 1997, P NATL ACAD SCI USA, V94, P6815, DOI 10.1073/pnas.94.13.6815; Telford MJ, 1998, P NATL ACAD SCI USA, V95, P10671, DOI 10.1073/pnas.95.18.10671; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wilson K, 2000, MOL BIOL EVOL, V17, P863, DOI 10.1093/oxfordjournals.molbev.a026366	30	212	220	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 13	2001	413	6852					154	157		10.1038/35093090	http://dx.doi.org/10.1038/35093090			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471FU	11557978				2022-12-24	WOS:000170918800044
J	Dowey, JA				Dowey, JA			Child B: A personal view	BRITISH MEDICAL JOURNAL			English	Article																			0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JAN 18	1997	314	7075					200	200						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WD911	11644899				2022-12-24	WOS:A1997WD91100034
J	CANFIELD, DE; THAMDRUP, B				CANFIELD, DE; THAMDRUP, B			THE PRODUCTION OF S-34-DEPLETED SULFIDE DURING BACTERIAL DISPROPORTIONATION OF ELEMENTAL SULFUR	SCIENCE			English	Article							SULFATE REDUCTION RATES; MARINE-SEDIMENTS; BLACK-SEA; MANGANESE REDUCTION; COASTAL SEDIMENTS; ORGANIC-MATTER; IRON; ISOTOPE; OXIDATION; KINETICS	Bacteria that disproportionate elemental sulfur fractionate sulfur isotopes such that sulfate is enriched in sulfur-34 by 12.6 to 15.3 per mil and sulfide is depleted in sulfur-34 by 7.3 to 8.6 per mil. Through a repeated cycle of sulfide oxidation to S-0 and subsequent disproportionation, these bacteria can deplete sedimentary sulfides in sulfur-34. A prediction, borne out by observation, is that more extensive sulfide oxidation will lead to sulfides that are more depleted in sulfur-34. Thus, the oxidative part of the sulfur cycle creates circumstances by which sulfides become more depleted in sulfur-34 than would be possible with sulfate-reducing bacteria alone.	GEORGIA INST TECHNOL,SCH EARTH & ATMOSPHER SCI,ATLANTA,GA 30332	University System of Georgia; Georgia Institute of Technology	CANFIELD, DE (corresponding author), MAX PLANCK INST MARINE MICROBIOL,FAHRENHEITSTR 1,D-28359 BREMEN,GERMANY.		Canfield, Don/C-1735-2012; Thamdrup, Bo/F-3889-2016	Canfield, Don/0000-0001-7602-8366; Thamdrup, Bo/0000-0002-1221-7077				BEMER RA, 1964, MAR GEOL, V1, P117; BEMER RA, 1985, AM J SCI, V285, P193; BURDIGE DJ, 1986, GEOMICROBIOL J, V4, P361, DOI 10.1080/01490458609385944; CANFIELD DE, 1993, GEOCHIM COSMOCHIM AC, V57, P3867, DOI 10.1016/0016-7037(93)90340-3; CANFIELD DE, 1992, AM J SCI, V292, P659, DOI 10.2475/ajs.292.9.659; CANFIELD DE, UNPUB; CHAMBERS LA, 1975, CAN J MICROBIOL, V21, P1602, DOI 10.1139/m75-234; CHAMBERS LA, 1982, GEOCHIM COSMOCHIM AC, V46, P721, DOI 10.1016/0016-7037(82)90023-0; CHANTON JP, 1985, THESIS U N CAROLINA; CHEN KY, 1972, ENVIRON SCI TECHNOL, V6, P529, DOI 10.1021/es60065a008; CRILL PM, 1987, GEOCHIM COSMOCHIM AC, V51, P1175, DOI 10.1016/0016-7037(87)90210-9; FRY B, 1991, DEEP-SEA RES, V38, pS1003, DOI 10.1016/S0198-0149(10)80021-4; GOLDHABER MB, 1975, SOIL SCI, V119, P42, DOI 10.1097/00010694-197501000-00008; GOLDHABER MB, 1974, SEA, P569; HARRISON A, 1958, T FARADAY SOC, V53, P84; JORGENSEN BB, 1982, NATURE, V296, P643, DOI 10.1038/296643a0; JORGENSEN BB, 1991, DEEP-SEA RES, V38, pS1083; JORGENSEN BB, 1990, SCIENCE, V249, P152, DOI 10.1126/science.249.4965.152; JORGENSEN BB, 1979, GEOCHIM COSMOCHIM AC, V43, P363, DOI 10.1016/0016-7037(79)90201-1; KAPLAN IR, 1964, J GEN MICROBIOL, V34, P195, DOI 10.1099/00221287-34-2-195; KEMP ALW, 1968, GEOCHIM COSMOCHIM AC, V32, P71, DOI 10.1016/0016-7037(68)90088-4; LUTHER GW, 1991, DEEP-SEA RES, V38, pS1121, DOI 10.1016/S0198-0149(10)80027-5; MURAMOTO JA, 1991, DEEP-SEA RES, V38, pS1151, DOI 10.1016/S0198-0149(10)80029-9; Ohmoto H., 1992, STABLE ISOT STABLE I, V23, P70; PYZIK AJ, 1981, GEOCHIM COSMOCHIM AC, V45, P687, DOI 10.1016/0016-7037(81)90042-9; THAMDRUP B, 1993, APPL ENVIRON MICROB, V59, P101, DOI 10.1128/AEM.59.1.101-108.1993; THODEANDERSEN S, 1989, LIMNOL OCEANOGR, V34, P793, DOI 10.4319/lo.1989.34.5.0793; TROELSEN H, 1982, ESTUAR COAST SHELF S, V15, P255, DOI 10.1016/0272-7714(82)90062-2; UYAMA F, 1985, GEOCHEM J, V19, P301, DOI 10.2343/geochemj.19.301; WESTRICH J, UNPUB; Westrich J.T., 1983, THESIS YALE U, pYale	31	461	488	4	102	AMER ASSOC ADVAN SCIENCE	WASHINGTON	1333 H ST NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	DEC 23	1994	266	5193					1973	1975		10.1126/science.11540246	http://dx.doi.org/10.1126/science.11540246			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ267	11540246				2022-12-24	WOS:A1994PZ26700024
J	HARTGERS, WA; DAMSTE, JSS; REQUEJO, AG; ALLAN, J; HAYES, JM; DELEEUW, JW				HARTGERS, WA; DAMSTE, JSS; REQUEJO, AG; ALLAN, J; HAYES, JM; DELEEUW, JW			EVIDENCE FOR ONLY MINOR CONTRIBUTIONS FROM BACTERIA SEDIMENTARY ORGANIC-CARBON	NATURE			English	Article							BASIN; PHOTOSYNTHESIS; DISTRIBUTIONS; HYDROCARBONS; ORIGINS; SULFUR; SHALE	BECAUSE their molecular signatures are often prominent in extracts of sediments, bacteria are thought to be important contributors to petroleum source beds(1). It has been shown recently(2,3), however, that abundances of biomarkers do not always reflect relative contributions to sedimentary organic carbon (C-org). The contribution of photosynthetic green sulphur bacteria to sediments can be assessed effectively because the diagenetic products of distinctive carotenoids from these organisms occur widely(4-11) and their biomass is isotopically labelled, being enriched in C-13 (refs 11, 13). We show here that, although sediments and oils from the Western Canada and Williston basins contain prominent biomarkers of photosynthetic bacteria, the absence of C-13 enrichment in the total C-org requires that the bacterial contribution is in fact minimal. Although the importance of bacterial reworking of sedimentary debris cannot be doubted(14), we argue that our findings, when considered in conjunction with those from other settings, suggest that bacterial biomass may commonly represent only a minor component of total C-org in carbonaceous rocks.	TEXAS A&M UNIV,GEOCHEM & ENVIRONV RES GRP,COLLEGE STN,TX 77845; ESSO RESOURCES CANADA LTD,CALGARY T2P 0H6,AB,CANADA; INDIANA UNIV,DEPT CHEM,BIOGEOCHEM LABS,BLOOMINGTON,IN 47405; INDIANA UNIV,DEPT GEOL SCI,BIOGEOCHEM LABS,BLOOMINGTON,IN 47405	Texas A&M University System; Texas A&M University College Station; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	HARTGERS, WA (corresponding author), NETHERLANDS INST SEA RES,DIV MARINE BIOGEOCHEM,POB 59,1790 AB DEN BURG,NETHERLANDS.		de Leeuw, Jan W/F-6471-2011; Damste, Jaap S Sinninghe/F-6128-2011	Damste, Jaap S Sinninghe/0000-0002-8683-1854				ALLAN J, 1991, B CAN PETROL GEOL, V39, P107; COLLISTER JW, 1992, ORG GEOCHEM, V19, P265, DOI 10.1016/0146-6380(92)90042-V; DAMSTE JSS, 1993, NATURE, V362, P827, DOI 10.1038/362827a0; DAMSTE JSS, 1993, GEOCHIM COSMOCHIM AC, V57, P389; DERENNE S, 1991, ORGANIC GEOCHEMISTRY, P408; DOUGLAS AG, 1991, GEOCHIM COSMOCHIM AC, V55, P275, DOI 10.1016/0016-7037(91)90417-4; EDLINGTON TI, IN PRESS ORG GEOCHEM; EGLINTON TI, 1991, ORGANIC GEOCHEMISTRY, P411; FREEMAN KH, 1990, NATURE, V343, P254, DOI 10.1038/343254a0; GOTH K, 1988, NATURE, V336, P759, DOI 10.1038/336759a0; HARTGERS WA, 1991, ORGANIC GEOCHEMISTRY, P420; HARTGERS WA, 1993, J CHEM SOC CHEM COMM, V23, P1715; HAYES JM, 1987, NATURE, V329, P48, DOI 10.1038/329048a0; KOHNEN MEL, 1992, SCIENCE, V256, P358, DOI 10.1126/science.256.5055.358; KOHNEN MEL, 1991, NATURE, V349, P775, DOI 10.1038/349775a0; Liaaen-Jensen S., 1978, PHOTOSYNTHETIC BACTE, P233; Ostroukhov S. B., 1982, PETROL CHEM-USSR+, V22, P723; OURLSSON G, 1984, SCI AM, V251, P34; PARKES RJ, 1993, MAR GEOL, V113, P55, DOI 10.1016/0025-3227(93)90149-P; QUANDT L, 1977, FEMS MICROBIOL LETT, V1, P125, DOI 10.1016/0378-1097(77)90140-9; REPETA DJ, 1989, NATURE, V342, P69, DOI 10.1038/342069a0; REPETA DJ, 1993, GEOCHIM COSMOCHIM AC, V57, P4337, DOI 10.1016/0016-7037(93)90334-S; REQUEJO AG, 1992, ORG GEOCHEM, V19, P245, DOI 10.1016/0146-6380(92)90041-U; Schaefle J., 1977, TETRAHEDRON LETT, V18, P3673, DOI [DOI 10.1016/S0040-4039(01)83324-4, 10.1016/S0040-4039(01)83324-4]; SCHOELL M, 1994, SCIENCE, V263, P1122, DOI 10.1126/science.263.5150.1122; SCHWARK L, 1990, ORG GEOCHEM, V16, P749, DOI 10.1016/0146-6380(90)90114-F; SIREVAG R, 1977, ARCH MICROBIOL, V112, P35, DOI 10.1007/BF00446651; SUMMONS RE, 1986, NATURE, V319, P763, DOI 10.1038/319763a0; XINKE Y, 1990, ORG GEOCHEM, V15, P433, DOI 10.1016/0146-6380(90)90170-5; [No title captured]	30	70	75	0	7	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	MAY 19	1994	369	6477					224	227		10.1038/369224a0	http://dx.doi.org/10.1038/369224a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NM067	11539490				2022-12-24	WOS:A1994NM06700053
J	DOROZYNSKI, A				DOROZYNSKI, A			FRENCH DOCTORS PUZZLE OVER GENE OWNERSHIP	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	APR 2	1994	308	6933					873	874		10.1136/bmj.308.6933.873a	http://dx.doi.org/10.1136/bmj.308.6933.873a			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NE600	11644527	Green Published			2022-12-24	WOS:A1994NE60000008
J	WARD, E				WARD, E			A TRAGIC AND WICKED WASTE OF LIFE	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	1	1	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JAN 5	1991	302	6767					57	57		10.1136/bmj.302.6767.57	http://dx.doi.org/10.1136/bmj.302.6767.57			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ER372	11642869	Green Published, Bronze			2022-12-24	WOS:A1991ER37200061
J	BUTTERFIELD, NJ; KNOLL, AH; SWETT, K				BUTTERFIELD, NJ; KNOLL, AH; SWETT, K			EXCEPTIONAL PRESERVATION OF FOSSILS IN AN UPPER PROTEROZOIC SHALE	NATURE			English	Article									UNIV IOWA,DEPT GEOL,IOWA CITY,IA 52242	University of Iowa	BUTTERFIELD, NJ (corresponding author), HARVARD UNIV,BOT MUSEUM,CAMBRIDGE,MA 02138, USA.			Butterfield, Nicholas/0000-0002-3046-7520				AWRAMIK SM, NATURE, V315, P655; CHRISTIEBLICK N, 1988, GEOLOGY, V16, P100, DOI 10.1130/0091-7613(1988)016<0100:SSIPS>2.3.CO;2; HORODYSKI RJ, 1978, SCIENCE, V199, P682, DOI 10.1126/science.199.4329.682; Jankauskas T.V, 1982, STRATOTYPE RIPHEAN P, P84; KIRSCHVINK JL, 1978, GEOL MAG, V115, P139, DOI 10.1017/S0016756800041200; KNOLL AH, 1985, PHILOS T R SOC B, V311, P111, DOI 10.1098/rstb.1985.0143; KNOLL AH, 1986, NATURE, V321, P832, DOI 10.1038/321832a0; LANIER WP, 1988, J SEDIMENT PETROL, V58, P89; MAGARITZ M, 1986, NATURE, V320, P258, DOI 10.1038/320258a0; RAABEN ME, 1972, T GEOL I AKAD NAUK S, V217, P1; Round F.E., 1981, ECOLOGY ALGAE; SOUTHGATE PN, 1986, GEOLOGY, V14, P683, DOI 10.1130/0091-7613(1986)14<683:DEAMOP>2.0.CO;2; VEIZER J, 1983, GEOCHIM COSMOCHIM AC, V47, P295, DOI 10.1016/0016-7037(83)90142-4; VIDAL G, 1983, GEOL SOC AM MEM, V161, P265; Wilson C.B., 1961, GEOL MAG, V98, P89; YIN L, 1984, PALAEONT CATHAYANA, V2, P229	16	71	72	0	18	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	AUG 4	1988	334	6181					424	427		10.1038/334424a0	http://dx.doi.org/10.1038/334424a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	P5292	11542151				2022-12-24	WOS:A1988P529200055
J	Begbie, J; Graham, A				Begbie, J; Graham, A			Integration between the epibranchial placodes and the hindbrain	SCIENCE			English	Article							NEURAL CREST CELLS; CHICK HINDBRAIN; MIGRATION; GANGLIA; EMBRYO; INDUCTION; ENDODERM; MESODERM; ABSENCE; REGION	Developmental integration results from coordination among components of different embryonic fields to realize the later anatomical and functional relationships. We demonstrate that in the chick head, integration between the epibranchial placodes and the hindbrain is achieved as the neuroglial hindbrain crest cells guide the epibranchial neuronal. cells inward to establish their central connections. This work defines a role for the neuroglial hindbrain crest in organizing the afferent innervation of the hindbrain.	UCL, MRC, Ctr Dev Neurobiol, London SE1 9RT, England	University of London; University College London	Graham, A (corresponding author), UCL, MRC, Ctr Dev Neurobiol, 4th Floor,New Hunts House,Guys Campus, London SE1 9RT, England.	anthony.graham@kcl.ac.uk	graham, anthony/B-1864-2008	graham, anthony/0000-0003-2011-7188				Ariens Kappers C. N., 1960, COMP ANATOMY NERVOUS; AYERLELIEVRE CS, 1982, DEV BIOL, V94, P291, DOI 10.1016/0012-1606(82)90349-9; Baker CVH, 1997, DEVELOPMENT, V124, P3077; Barlow LA, 1997, DEVELOPMENT, V124, P949; Begbie J, 1999, DEVELOPMENT, V126, P895; BIRTSCH S, 2001, GENE DEV, V15, P66; DAMICOMARTEL A, 1983, AM J ANAT, V166, P445, DOI 10.1002/aja.1001660406; GRAHAM A, 1993, DEVELOPMENT, V119, P233; Graham A, 2001, BIOESSAYS, V23, P54, DOI 10.1002/1521-1878(200101)23:1<54::AID-BIES1007>3.0.CO;2-5; Horigome N, 1999, DEV BIOL, V207, P287, DOI 10.1006/dbio.1998.9175; LUMSDEN A, 1989, NATURE, V337, P424, DOI 10.1038/337424a0; LUMSDEN A, 1991, DEVELOPMENT, V113, P1281; Morin X, 1997, NEURON, V18, P411, DOI 10.1016/S0896-6273(00)81242-8; NODEN DM, 1983, DEV BIOL, V96, P144, DOI 10.1016/0012-1606(83)90318-4; Pattyn A, 1999, NATURE, V399, P366, DOI 10.1038/20700; Piotrowski T, 2000, DEV BIOL, V225, P339, DOI 10.1006/dbio.2000.9842; SIMON H, 1994, J NEUROBIOL, V25, P1129, DOI 10.1002/neu.480250908; TOSNEY KW, 1982, DEV BIOL, V89, P13, DOI 10.1016/0012-1606(82)90289-5; Trainor P, 2000, NAT CELL BIOL, V2, P96, DOI 10.1038/35000051; Veitch E, 1999, CURR BIOL, V9, P1481, DOI 10.1016/S0960-9822(00)80118-9	20	77	78	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2001	294	5542					595	598		10.1126/science.1062028	http://dx.doi.org/10.1126/science.1062028			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484NC	11641498				2022-12-24	WOS:000171695600047
J	Urban, S; Lee, JR; Freeman, M				Urban, S; Lee, JR; Freeman, M			Drosophila Rhomboid-1 defines a family of putative intramembrane serine proteases	CELL			English	Article							EGF RECEPTOR; SIGNALING PATHWAY; ALZHEIMERS-DISEASE; GXXXG MOTIF; GENE; STAR; PROTEINS; SPITZ; PROVIDENCIA; ASSOCIATION	The polytopic membrane protein Rhomboid-1 promotes the cleavage of the membrane-anchored TGF alpha -like growth factor Spitz, allowing it to activate the Drosophila EGF receptor. Until now, the mechanism of this key signaling regulator has been obscure, but our analysis suggests that Rhomboid-1 is a novel intramembrane serine protease that directly cleaves Spitz. In accordance with the putative Rhomboid active site being in the membrane bilayer, Spitz is cleaved within its transmembrane domain, and thus is, to our knowledge, the first example of a growth factor activated by regulated intramembrane proteolysis. Rhomboid-1 is conserved throughout evolution from archaea to humans, and our results show that a human Rhomboid promotes Spitz cleavage by a similar mechanism. This growth factor activation mechanism may therefore be widespread.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Freeman, M (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.			Freeman, Matthew/0000-0003-0410-5451				Arribas J, 1997, J BIOL CHEM, V272, P17160, DOI 10.1074/jbc.272.27.17160; Bang AG, 2000, GENE DEV, V14, P177; BIER E, 1990, GENE DEV, V4, P190, DOI 10.1101/gad.4.2.190; BLOW DM, 1969, NATURE, V221, P337, DOI 10.1038/221337a0; BOEL E, 1988, LIPIDS, V23, P701, DOI 10.1007/BF02535672; BRENNER S, 1988, NATURE, V334, P528, DOI 10.1038/334528a0; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; CARTER P, 1988, NATURE, V332, P564, DOI 10.1038/332564a0; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; DATTA S, 1988, J BIOL CHEM, V263, P1107; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Fersht A. R., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; FERSHT AR, 1973, BIOCHEMISTRY-US, V12, P2035, DOI 10.1021/bi00735a002; FREEMAN M, 1992, DEVELOPMENT, V116, P335; Gallio M, 2000, CURR BIOL, V10, pR693, DOI 10.1016/S0960-9822(00)00722-3; GOLEMBO M, 1996, DEVELOPMENT, V122, P3360; Gratkowski H, 2001, P NATL ACAD SCI USA, V98, P880, DOI 10.1073/pnas.98.3.880; Guichard A, 2000, DEV BIOL, V226, P255, DOI 10.1006/dbio.2000.9851; Guichard A, 1999, DEVELOPMENT, V126, P2663; HARTLEY BS, 1960, ANNU REV BIOCHEM, V29, P45, DOI 10.1146/annurev.bi.29.070160.000401; Hartmann T, 1997, NAT MED, V3, P1016, DOI 10.1038/nm0997-1016; HEBERLEIN U, 1993, DEV BIOL, V160, P51, DOI 10.1006/dbio.1993.1285; Hooper NM, 1997, BIOCHEM J, V321, P265, DOI 10.1042/bj3210265; KOLODKIN AL, 1994, DEVELOPMENT, V120, P1731; Kopan R, 2000, GENE DEV, V14, P2799, DOI 10.1101/gad.836900; Lee JR, 2001, CELL, V107, P161, DOI 10.1016/S0092-8674(01)00526-8; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; Paetzel M, 1997, TRENDS BIOCHEM SCI, V22, P28, DOI 10.1016/S0968-0004(96)10065-7; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Pickup AT, 1999, DEV BIOL, V205, P254, DOI 10.1006/dbio.1998.9119; Primakoff P, 2000, TRENDS GENET, V16, P83, DOI 10.1016/S0168-9525(99)01926-5; Rather PN, 1999, J BACTERIOL, V181, P7185, DOI 10.1128/JB.181.23.7185-7191.1999; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; RUTLEDGE BJ, 1992, GENE DEV, V6, P1503, DOI 10.1101/gad.6.8.1503; Salvesen G.S., 2001, PROTEOLYTIC ENZYMES; Schauder S, 2001, GENE DEV, V15, P1468, DOI 10.1101/gad.899601; Schweitzer R, 1997, TRENDS GENET, V13, P191, DOI 10.1016/S0168-9525(97)01091-3; SCHWEITZER R, 1995, GENE DEV, V9, P1518, DOI 10.1101/gad.9.12.1518; Senes A, 2000, J MOL BIOL, V296, P921, DOI 10.1006/jmbi.1999.3488; Struhl G, 2000, MOL CELL, V6, P625, DOI 10.1016/S1097-2765(00)00061-7; STURTEVANT MA, 1993, GENE DEV, V7, P961, DOI 10.1101/gad.7.6.961; VERNET T, 1995, J BIOL CHEM, V270, P16645, DOI 10.1074/jbc.270.28.16645; Wang KKW, 1996, P NATL ACAD SCI USA, V93, P6687, DOI 10.1073/pnas.93.13.6687; Wasserman JD, 2000, GENE DEV, V14, P1651; Wasserman JD, 1997, TRENDS CELL BIOL, V7, P431, DOI 10.1016/S0962-8924(97)01143-4; zurLage P, 1997, CURR BIOL, V7, P166, DOI 10.1016/S0960-9822(97)70087-3	46	462	484	0	24	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 19	2001	107	2					173	182		10.1016/S0092-8674(01)00525-6	http://dx.doi.org/10.1016/S0092-8674(01)00525-6			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	484MU	11672525	Bronze			2022-12-24	WOS:000171694800007
J	Pradillon, F; Shillito, B; Young, CM; Gaill, F				Pradillon, F; Shillito, B; Young, CM; Gaill, F			Deep-seaecology - Developmental arrest in vent worm embryos	NATURE			English	Article							LARVAL DISPERSAL; HOT		Univ Paris 06, Unite Mixte Rech, F-75252 Paris 05, France; Harbor Branch Oceanog Inst Inc, Div Marine Sci, Ft Pierce, FL 34946 USA	UDICE-French Research Universities; Sorbonne Universite; Harbor Branch Oceanographic Institute Foundation	Pradillon, F (corresponding author), Univ Paris 06, Unite Mixte Rech, 7 Quai St Bernard, F-75252 Paris 05, France.	francoise.gaill@snv.jussieu.fr	Pradillon, Florence/AAM-2992-2020	Pradillon, Florence/0000-0002-6473-6290				Cary SC, 1998, NATURE, V391, P545, DOI 10.1038/35286; CHEVALDONNE P, 1992, NATURE, V359, P593, DOI 10.1038/359593b0; EDMOND JM, 1982, NATURE, V297, P187, DOI 10.1038/297187a0; LUTZ RA, 1980, MAR BIOL, V57, P127, DOI 10.1007/BF00387378; Marsh AG, 2001, NATURE, V411, P77, DOI 10.1038/35075063; MULLINEAUX LS, 1995, SEAFLOOR HYDROTHERMA, P408; YOUNG CM, 1989, OLSEN INT S, P225; YOUNG CM, 1993, LIMNOL OCEANOGR, V38, P178; ZOTTOLI R, 1983, Proceedings of the Biological Society of Washington, V96, P379	9	80	88	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 18	2001	413	6857					698	699		10.1038/35099674	http://dx.doi.org/10.1038/35099674			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	482ZK	11607020				2022-12-24	WOS:000171608000032
J	West, GB; Brown, JH; Enquist, BJ				West, GB; Brown, JH; Enquist, BJ			A general model for ontogenetic growth	NATURE			English	Article							BODY-SIZE; LIFE; LAWS	Several equations have been proposed to describe ontogenetic growth trajectories for organisms justified primarily on the goodness of rt rather than on any biological mechanism(1-6). Here, we derive a general quantitative model based on fundamental principles(7-9) for the allocation of metabolic energy between maintenance of existing tissue and the production of new biomass. We thus predict the parameters governing growth curves from basic cellular properties(10) and derive a single parameterless universal curve that describes the growth of many diverse species. The model provides the basis for deriving allometric relationships for growth rates and the timing of life history events(2,11,12).	Los Alamos Natl Lab, Div Theoret, Los Alamos, NM 87545 USA; Santa Fe Inst, Santa Fe, NM 87501 USA; Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA	United States Department of Energy (DOE); Los Alamos National Laboratory; The Santa Fe Institute; University of New Mexico; University of Arizona	West, GB (corresponding author), Los Alamos Natl Lab, Div Theoret, MS B285, Los Alamos, NM 87545 USA.	gbw@lanl.gov	Enquist, Brian J/B-6436-2008	Enquist, Brian J/0000-0002-6124-7096				ALBERTS M, 1994, MOL BIOL CELL; BLUEWEISS L, 1978, OECOLOGIA, V37, P257, DOI 10.1007/BF00344996; Brett JR., 1979, FISH PHYSIOL, P677, DOI [10.1016/S1546-5098(08)60034-5, DOI 10.1016/S1546-5098(08)60034-5]; BRETT JR, 1989, J FISH RES BOARD CAN, V22, P1491; Brody S, 1964, BIOENERGETICS GROWTH; Brown J., 2000, SCALING BIOL; Calder WA., 1984, SIZE FUNCTION LIFE H; Charnov Eric L., 1993, P1; Cummins K. W, 1971, Mitt int Verein theor angew Limnol, VNo. 18, P1; Day T, 1997, AM NAT, V149, P381, DOI 10.1086/285995; Enquist BJ, 1998, NATURE, V395, P163, DOI 10.1038/25977; Enquist BJ, 1999, NATURE, V401, P907, DOI 10.1038/44819; HAMBURGER K, 1983, MAR BIOL, V75, P303, DOI 10.1007/BF00406016; KOHLER AC, 1964, J FISH RES BOARD CAN, V21, P57, DOI 10.1139/f64-007; Kozlowski J, 1996, P ROY SOC B-BIOL SCI, V263, P559, DOI 10.1098/rspb.1996.0084; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Reiss M.J., 1989, ALLOMETRY GROWTH REP; ROGERS DM, 1995, J APPL PHYSIOL, V79, P958, DOI 10.1152/jappl.1995.79.3.958; Stearns S.C., 1992, pi; VONBERTALANFFY L, 1957, Q REV BIOL, V32, P217, DOI 10.1086/401873; WEATHERS WW, 1995, IBIS, V137, P532, DOI 10.1111/j.1474-919X.1995.tb03263.x; West GB, 1999, SCIENCE, V284, P1677, DOI 10.1126/science.284.5420.1677; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; XIAOJUN X, 1990, Physiological Zoology, V63, P1181	24	770	807	10	212	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 11	2001	413	6856					628	631		10.1038/35098076	http://dx.doi.org/10.1038/35098076			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480WE	11675785				2022-12-24	WOS:000171485700048
J	Etterson, JR; Shaw, RG				Etterson, JR; Shaw, RG			Constraint to adaptive evolution in response to global warming	SCIENCE			English	Article							CHAMAECRISTA-FASCICULATA; QUANTITATIVE GENETICS; NATURAL-SELECTION; SIZE	We characterized the genetic architecture of three populations of a native North American prairie plant in field conditions that simulate the warmer and more and climates predicted by global climate models. Despite genetic variance for traits under selection, among-trait genetic correlations that are antagonistic to the direction of selection limit adaptive evolution within these populations. Predicted rates of evolutionary response are much slower than the predicted rate of climate change.	Univ Minnesota, Dept Ecol Evolut & Behav, Minnesota Ctr Community Genet, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	Etterson, JR (corresponding author), Univ Virginia, Dept Biol, Gilmer Hall, Charlottesville, VA 22903 USA.			Etterson, Julie/0000-0001-6657-0610				ANTONOVICS J, 1976, ANN MO BOT GARD, V63, P224, DOI 10.2307/2395303; BARTON NH, 1989, ANNU REV GENET, V23, P337, DOI 10.1146/annurev.ge.23.120189.002005; Davis MB, 2001, SCIENCE, V292, P673, DOI 10.1126/science.292.5517.673; ETTERSON JR, 2000, THESIS U MINNESOTA S; FENSTER CB, 1991, EVOLUTION, V45, P398, DOI 10.1111/j.1558-5646.1991.tb04413.x; GROOM MJ, 1993, BIOTIC INTERACTIONS; HUNTLY B, 1997, PAST FUTURE RAPID EN; KALISZ S, 1986, EVOLUTION, V40, P470; KELLY CA, 1992, EVOLUTION, V46, P1658, DOI 10.2307/2410022; LANDE R, 1979, EVOLUTION, V33, P402, DOI 10.1111/j.1558-5646.1979.tb04694.x; LANDE R, 1983, EVOLUTION, V37, P1210, DOI 10.1111/j.1558-5646.1983.tb00236.x; MITCHELLOLDS T, 1987, EVOLUTION, V41, P1149, DOI 10.1111/j.1558-5646.1987.tb02457.x; PRICE GR, 1970, NATURE, V227, P520, DOI 10.1038/227520a0; ROBERTSON A, 1966, ANIM PROD, V8, P95, DOI 10.1017/S0003356100037752; SHAW RG, 1987, EVOLUTION, V41, P812, DOI 10.1111/j.1558-5646.1987.tb05855.x; SHAW RG, 1994, QUERCUS PROGRAMS; Shigesada N, 1997, BIOL INVASIONS THEOR; THOMPSON RS, 2000, 1650 AB US GEOL SURV; WALKER KV, COMMUNICATION	19	611	622	7	332	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 5	2001	294	5540					151	154		10.1126/science.1063656	http://dx.doi.org/10.1126/science.1063656			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480EJ	11588260				2022-12-24	WOS:000171448800049
J	Schwetz, BA				Schwetz, BA			Congestive heart failure treatment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Off Commissioner Food & Drug, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Schwetz, BA (corresponding author), US FDA, Off Commissioner Food & Drug, HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	4	4	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 3	2001	286	13					1569	1569		10.1001/jama.286.13.1569-b	http://dx.doi.org/10.1001/jama.286.13.1569-b			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	478HH	11585463				2022-12-24	WOS:000171340600006
J	Rahman, M; DaVanzo, J; Razzaque, A				Rahman, M; DaVanzo, J; Razzaque, A			Do better family planning services reduce abortion in Bangladesh?	LANCET			English	Article							MATERNAL MORTALITY; RURAL BANGLADESH; PROGRAMS; MATLAB; DECLINE; TRENDS; AREA	Background Fertility decline is often associated with an increase in contraception and abortion, but the causal relations are difficult to examine with non-experimental data. We aimed to assess the effects of family planning services on abortion rates in two similar areas. Methods We examined trends in overall abortion rates and rates for intended and unintended pregnancies in two similar areas typical of rural Bangladesh. We analysed Matlab Demographic Surveillance System (DSS) data on pregnancy outcomes between 1979 and 1998 in these areas, matching them to survey data on fertility preferences, which enabled us to identify pregnancies as intended or unintended. Findings Abortion rates were significantly lower in the area with better family planning services compared with the comparison area (1984-86, 2.2 vs 5.2; 1996-98, 2.3 vs 6.8). Abortion of unintended pregnancies is similar in both areas, but the higher levels of contraceptive use in the treatment area have led to lower levels of unintended pregnancy and abortion. The likelihood that an unintended pregnancy will be aborted has increased in both areas but the decrease in unintended pregnancies was sufficiently large in the treatment area to offset this increase. Interpretations Abortion may increase during the fertility transition in less-developed countries as the desire to limit family size increases unless there is widespread availability of quality family planning services.	Pathfinder Int, Watertown, MA 02472 USA; RAND Corp, Santa Monica, CA 90401 USA; Int Ctr Diarrhoeal Dis Res, Ctr Hlth & Populat Res B, Dhaka 1000, Bangladesh	RAND Corporation; International Centre for Diarrhoeal Disease Research (ICDDR)	Rahman, M (corresponding author), Pathfinder Int, 9 Galen St,Ste 217, Watertown, MA 02472 USA.	MRahman@pathfind.org						Ahmed K., 1996, DEMOGRAPHY INDIA, V25, P105; Ahmed MK, 1998, INT FAM PLAN PERSPEC, V24, P128, DOI 10.2307/3038209; ALAUDDIN M, 1986, STUD FAMILY PLANN, V17, P13, DOI 10.2307/1966951; BAIRAGI R, 2000, MCH FP PROGRAM BRING; BHATIA S, 1980, J BIOSOC SCI, V12, P31, DOI 10.1017/S0021932000012669; Bulatao R., 1998, VALUE FAMILY PLANNIN; Caldwell B, 2000, STUD FAMILY PLANN, V31, P239, DOI 10.1111/j.1728-4465.2000.00239.x; CHEN LC, 1974, STUD FAMILY PLANN, V5, P334, DOI 10.2307/1965185; DIXONMUELLER R, 1988, STUD FAMILY PLANN, V19, P129, DOI 10.2307/1966749; FAUVEAU V, 1989, SOC SCI MED, V29, P1121, DOI 10.1016/0277-9536(89)90025-7; Henshaw SK, 1999, INT FAM PLAN PERSPEC, V25, pS30, DOI 10.2307/2991869; *ICDDR B CTR HLTH, 2000, 87 ICDDR B CTR HLTH; KHAN AR, 1986, STUD FAMILY PLANN, V17, P95, DOI 10.2307/1967069; KOENIG MA, 1992, STUD FAMILY PLANN, V23, P352, DOI 10.2307/1966893; KOENIG MA, 1988, STUD FAMILY PLANN, V19, P69, DOI 10.2307/1966492; Maine D, 1996, STUD FAMILY PLANN, V27, P179, DOI 10.2307/2137952; MITRA S, 1997, BANGLADESH DEMOGRAPH; MITRA SNA, 1994, BANGLADESH DEMOGRAPH; *NAT I POP RES TRA, 2000, BANGL DEM HLTH SURV; POTTS M, 1977, ABORTION; REQUENA MB, 1968, MILBANK FUND Q, V46, P191; ROSS J, 1999, PROFILES FAMILY PLAN; SIMMONS GB, 1991, STUD FAMILY PLANN, V22, P83, DOI 10.2307/1966779; VANDERTAK J, 1974, ABORTION FERTILITY C; *WHO DIV REPR HLTH, 1998, UNS AB GLOB REG EST	25	40	40	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 29	2001	358	9287					1051	1056		10.1016/S0140-6736(01)06182-7	http://dx.doi.org/10.1016/S0140-6736(01)06182-7			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	479EY	11589936				2022-12-24	WOS:000171393100011
J	Jackson, JBC; Johnson, KG				Jackson, JBC; Johnson, KG			Paleoecology - Measuring past biodiversity	SCIENCE			English	Editorial Material							EXTINCTION; PATTERNS; DIVERSITY		Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; Smithsonian Trop Res Inst, Balboa, Panama; Nat Hist Museum Los Agneles Cty, Los Angeles, CA 90007 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; Smithsonian Institution; Smithsonian Tropical Research Institute	Jackson, JBC (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA.							Adrain JM, 2000, PALEOBIOLOGY, V26, P625, DOI 10.1666/0094-8373(2000)026<0625:STADAT>2.0.CO;2; ALLISON PA, 1993, GEOLOGY, V21, P65, DOI 10.1130/0091-7613(1993)021<0065:PSBPSD>2.3.CO;2; Alroy J, 2001, P NATL ACAD SCI USA, V98, P6261, DOI 10.1073/pnas.111144698; Behrensmeyer AK, 2000, PALEOBIOLOGY, V26, P103, DOI 10.1666/0094-8373(2000)26[103:TAP]2.0.CO;2; BUDD AF, 1994, J PALEONTOL, V68, P951, DOI 10.1017/S0022336000026585; Cheetham Alan H., 1999, Bulletins of American Paleontology, V357, P159; Collins Laurel S., 1999, Bulletins of American Paleontology, V357, P1; Conway Morris S., 1998, CRUCIBLE CREATION BU; Foote M, 1996, EVOLUTION, V50, P1, DOI 10.1111/j.1558-5646.1996.tb04467.x; FOOTE M, COMMUNICATION; JACKSON JBC, 1994, PALEOBIOLOGY, V20, P407, DOI 10.1017/S0094837300012902; Jackson JBC, 2000, PALEOBIOLOGY, V26, P221, DOI 10.1666/0094-8373(2000)26[221:LITLFM]2.0.CO;2; Jackson JCB., 1996, EVOLUTION ENV TROPIC; Jackson Jeremy B.C., 1999, Bulletins of American Paleontology, V357, P193; Jin YG, 2000, SCIENCE, V289, P432, DOI 10.1126/science.289.5478.432; Kestenbaum D, 1998, SCIENCE, V279, P798, DOI 10.1126/science.279.5352.798; Khain V.Y., 1981, INT GEOL REV, V23, P426, DOI [DOI 10.1080/00206818109455078, 10.1080/00206818109455078]; MAY RM, 1994, PHILOS T R SOC B, V343, P105, DOI 10.1098/rstb.1994.0014; MAY RM, 1990, PHILOS T R SOC B, V330, P171; Newman M, 2001, P NATL ACAD SCI USA, V98, P5955, DOI 10.1073/pnas.121190498; Pennisi E, 2000, SCIENCE, V289, P2306, DOI 10.1126/science.289.5488.2306; RAUP D M, 1976, Paleobiology, V2, P289; RAUP DM, 1994, P NATL ACAD SCI USA, V91, P6758, DOI 10.1073/pnas.91.15.6758; RAUP DM, 1991, PALEOBIOLOGY, V17, P37, DOI 10.1017/S0094837300010332; Roy K, 1996, PHILOS T R SOC B, V351, P1605, DOI 10.1098/rstb.1996.0144; SEPKOSKI JJ, 1993, PALEOBIOLOGY, V19, P43, DOI 10.1017/S0094837300012306; Smith AB, 2001, PHILOS T R SOC B, V356, P351, DOI 10.1098/rstb.2000.0768; Stokstad E, 2001, SCIENCE, V291, P232, DOI 10.1126/science.291.5502.232; VALENTINE J W, 1970, Journal of Paleontology, V44, P410; VALENTINE JW, 1973, SCIENCE, V180, P1078, DOI 10.1126/science.180.4090.1078; Vermeij G.J., 1987, EVOLUTION ESCALATION; Wilson Moyra E. J., 1998, P165	32	92	98	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 28	2001	293	5539					2401	+		10.1126/science.1063789	http://dx.doi.org/10.1126/science.1063789			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	476PD	11577222				2022-12-24	WOS:000171237200031
J	Ludwig, DS; Ebbeling, CB				Ludwig, DS; Ebbeling, CB			Type 2 diabetes mellitus in children - Primary care and public health considerations	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							POSTPRANDIAL STATE; INSULIN-RESISTANCE; PHYSICAL-ACTIVITY; GLYCEMIC INDEX; BIRTH-WEIGHT; RISK-FACTOR; SYNDROME-X; CHILDHOOD; ADOLESCENTS; OBESITY		Childrens Hosp, Dept Med, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital	Ludwig, DS (corresponding author), Childrens Hosp, Dept Med, 300 Longwood Ave, Boston, MA 02115 USA.	david.ludwig@tch.harvard.edu		Ludwig, David/0000-0003-3307-8544	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007699, K08DK002440] Funding Source: NIH RePORTER; NIDDK NIH HHS [5T32DK07699-18, 1K08DK02440] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		[Anonymous], 2000, Pediatrics, V105, P671; Arslanian S, 1996, J CLIN ENDOCR METAB, V81, P1058, DOI 10.1210/jc.81.3.1058; Bar-Or O, 1998, MED SCI SPORT EXER, V30, P2, DOI 10.1097/00005768-199801000-00002; BECKNIELSEN H, 1994, J CLIN INVEST, V94, P1714, DOI 10.1172/JCI117518; Blair SN, 1999, MED SCI SPORT EXER, V31, pS646, DOI 10.1097/00005768-199911001-00025; BROWNLEE M, 1995, ANNU REV MED, V46, P223, DOI 10.1146/annurev.med.46.1.223; Ceriello A, 2000, DIABETES-METAB RES, V16, P125, DOI 10.1002/(SICI)1520-7560(200003/04)16:2<125::AID-DMRR90>3.0.CO;2-4; Dabelea D, 1999, DIABETES CARE, V22, P944, DOI 10.2337/diacare.22.6.944; Dabelea D, 2000, J Matern Fetal Med, V9, P83, DOI 10.1002/(SICI)1520-6661(200001/02)9:1<83::AID-MFM17>3.0.CO;2-O; Despres JP, 1996, NEW ENGL J MED, V334, P952, DOI 10.1056/NEJM199604113341504; Eckel RH, 1998, CIRCULATION, V97, P2099, DOI 10.1161/01.CIR.97.21.2099; Epstein LH, 2000, ARCH PEDIAT ADOL MED, V154, P220, DOI 10.1001/archpedi.154.3.220; Fagot-Campagna A, 2000, J PEDIATR-US, V136, P664, DOI 10.1067/mpd.2000.105141; FLETCHER SW, 1993, ANN INTERN MED, V119, P764, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00026; Forsen T, 2000, ANN INTERN MED, V133, P176, DOI 10.7326/0003-4819-133-3-200008010-00008; Freemark M, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.4.e55; Glaser NS, 1998, WESTERN J MED, V168, P11; Glaser NS, 1997, PEDIATR CLIN N AM, V44, P307, DOI 10.1016/S0031-3955(05)70479-X; Gortmaker SL, 1996, ARCH PEDIAT ADOL MED, V150, P356, DOI 10.1001/archpedi.1996.02170290022003; Hu FB, 1999, JAMA-J AM MED ASSOC, V282, P1433, DOI 10.1001/jama.282.15.1433; Lefebvre P, 1998, DIABETIC MED, V15, pS63, DOI 10.1002/(SICI)1096-9136(1998120)15:4+<S63::AID-DIA737>3.3.CO;2-Z; Ludwig DS, 2000, J NUTR, V130, p280S, DOI 10.1093/jn/130.2.280S; MILLER JCB, 1994, AM J CLIN NUTR, V59, p747S, DOI 10.1093/ajcn/59.3.747S; Phillips DIW, 1998, DIABETES CARE, V21, pB150; PinhasHamiel O, 1996, J PEDIATR-US, V128, P608, DOI 10.1016/S0022-3476(96)80124-7; PiSunyer FX, 1996, CLIN THER, V18, P1006, DOI 10.1016/S0149-2918(96)80057-9; REAVEN GM, 1995, PHYSIOL REV, V75, P473, DOI 10.1152/physrev.1995.75.3.473; Reaven GM, 1997, CURR OPIN LIPIDOL, V8, P23, DOI 10.1097/00041433-199702000-00006; Salmeron J, 1997, JAMA-J AM MED ASSOC, V277, P472, DOI 10.1001/jama.277.6.472; Salmeron J, 2001, AM J CLIN NUTR, V73, P1019; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Trent Maria E., 1999, Current Opinion in Pediatrics, V11, P297, DOI 10.1097/00008480-199908000-00005; Troiano RP, 1998, PEDIATRICS, V101, P497; Turner RC, 1999, JAMA-J AM MED ASSOC, V281, P2005, DOI 10.1001/jama.281.21.2005; Whitaker RC, 1998, J PEDIATR-US, V132, P768, DOI 10.1016/S0022-3476(98)70302-6; Willi SM, 1998, DIABETES, V47, pA306; WING RR, 1995, J AM DIET ASSOC, V95, P569, DOI 10.1016/S0002-8223(95)00155-7	37	121	125	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 26	2001	286	12					1427	1430		10.1001/jama.286.12.1427	http://dx.doi.org/10.1001/jama.286.12.1427			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	475UX	11572718				2022-12-24	WOS:000171188600002
J	Vaughan, DG; Marshall, GJ; Connolley, WM; King, JC; Mulvaney, R				Vaughan, DG; Marshall, GJ; Connolley, WM; King, JC; Mulvaney, R			Climate change - Devil in the detail	SCIENCE			English	Editorial Material							SEA-ICE-EXTENT; ANTARCTIC PENINSULA; TEMPERATURE; INCREASES; SHELF; OCEAN		British Antarctic Survey, NERC, Cambridge CB3 0ET, England	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Vaughan, DG (corresponding author), British Antarctic Survey, NERC, Madingley Rd, Cambridge CB3 0ET, England.	d.vaughan@bas.ac.uk	Mulvaney, Robert/K-3929-2012; Vaughan, David/C-8348-2011	Mulvaney, Robert/0000-0002-5372-8148; Vaughan, David/0000-0002-9065-0570				Cai WJ, 1999, J CLIMATE, V12, P132, DOI 10.1175/1520-0442(1999)012<3087:SMTHLV>2.0.CO;2; Connolley WM, 1998, ANN GLACIOL, V27, P565; delaMare WK, 1997, NATURE, V389, P57, DOI 10.1038/37956; Domack E. A., 2001, EOS, V82, P13, DOI [DOI 10.1029/01EO00009, DOI 10.1029/01E000009]; DOMACK EW, 1995, ANTARCT SCI, V7, P159, DOI 10.1017/S0954102095000228; FOWBERT JA, 1994, ARCTIC ALPINE RES, V26, P290, DOI 10.2307/1551941; Fox AJ, 1998, ANN GLACIOL, V27, P636; FRASER WR, 1992, POLAR BIOL, V11, P525; Hansen J, 1999, J GEOPHYS RES-ATMOS, V104, P30997, DOI 10.1029/1999JD900835; Hofmann EE., 1996, FDN ECOLOGICAL RES W, V70, P61, DOI 10.1029/AR070p0061; Houghton JT, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P1; Jacka TH, 1998, ANN GLACIOL, V27, P553; KING JC, 1994, INT J CLIMATOL, V14, P357, DOI 10.1002/joc.3370140402; King JC, 1998, ANN GLACIOL, V27, P571; MERCER JH, 1978, NATURE, V271, P321, DOI 10.1038/271321a0; PARKINSON C, IN PRESS ANN GLACIOL; Pudsey CJ, 2001, GEOLOGY, V29, P787, DOI 10.1130/0091-7613(2001)029<0787:FSOASI>2.0.CO;2; SHUMAN CA, 1993, GEOPHYS RES LETT, V20, P2643, DOI 10.1029/93GL02810; Smith AM, 1998, ANN GLACIOL, V27, P113; THOMPSON LG, 1994, ANN GLACIOL, V20, P420, DOI 10.3189/172756494794587438; Vaughan DG, 1996, NATURE, V379, P328, DOI 10.1038/379328a0; WEATHERLY JW, 1991, J GEOPHYS RES-OCEANS, V96, P15119, DOI 10.1029/91JC01432	22	224	232	2	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2001	293	5536					1777	1779		10.1126/science.1065116	http://dx.doi.org/10.1126/science.1065116			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	470WN	11546858				2022-12-24	WOS:000170894400031
J	Bessereau, JL; Wright, A; Williams, DC; Schuske, K; Davis, MW; Jorgensen, EM				Bessereau, JL; Wright, A; Williams, DC; Schuske, K; Davis, MW; Jorgensen, EM			Mobilization of a Drosophila transposon in the Caenorhabditis elegans germ line	NATURE			English	Article							C-ELEGANS; MARINER; EXPRESSION; ELEMENT; GENE; SEQUENCE; ENCODES; MOS1; TC3	Transposons have been enormously useful for genetic analysis in both Drosophila and bacteria. Mutagenic insertions constitute molecular tags that are used to rapidly clone the mutated gene. Such techniques would be especially advantageous in the nematode Caenorhabditis elegans, as the entire sequence of the genome has been determined. Several different types of endogenous transposons are present in C. elegans, and these can be mobilized in mutator strains (reviewed in ref. 1). Unfortunately, use of these native transposons for regulated transposition in C. elegans is limited. First, all strains contain multiple copies of these transposons and thus new insertions do not provide unique tags. Second, mutator strains tend to activate the transposition of several classes of transposons, so that the type of transposon associated with a particular mutation is not known. Here we demonstrate that the Drosophila mariner element Mos1 can be mobilized in C. elegans. First, efficient mobilization of Mos1 is possible in somatic cells. Second, heritable insertions of the transposon can be generated in the germ line. Third, genes that have been mutated by insertion can be rapidly identified using inverse polymerase chain reaction. Fourth, these insertions can subsequently be remobilized to generate deletion and frameshift mutations by imperfect excision.	Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Jorgensen, EM (corresponding author), Univ Utah, Dept Biol, 257 S 1400 E, Salt Lake City, UT 84112 USA.	jorgensen@biology.utah.edu	Bessereau, Jean-Louis/M-2988-2017	Bessereau, Jean-Louis/0000-0002-3088-7621; Davis, Mikel/0000-0003-1867-1593				BRYAN G, 1990, GENETICS, V125, P103; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; CANDIDO EPM, 1989, GENOME, V31, P690, DOI 10.1139/g89-126; CLARK SG, 1994, GENETICS, V137, P987; Coates CJ, 1998, P NATL ACAD SCI USA, V95, P3748, DOI 10.1073/pnas.95.7.3748; FIRE A, 1990, GENE, V93, P189, DOI 10.1016/0378-1119(90)90224-F; Gruidl ME, 1996, P NATL ACAD SCI USA, V93, P13837, DOI 10.1073/pnas.93.24.13837; Gueiros FJ, 1997, SCIENCE, V276, P1716, DOI 10.1126/science.276.5319.1716; Hart DL, 1997, ANNU REV GENET, V31, P337, DOI 10.1146/annurev.genet.31.1.337; JACOBSON JW, 1986, P NATL ACAD SCI USA, V83, P8684, DOI 10.1073/pnas.83.22.8684; Kelly WG, 1997, GENETICS, V146, P227; KRAMER JM, 1990, MOL CELL BIOL, V10, P2081, DOI 10.1128/MCB.10.5.2081; Lohe AR, 2000, GENETICS, V154, P647; MEDHORA M, 1991, GENETICS, V128, P311; Plasterk RHA, 1999, TRENDS GENET, V15, P326, DOI 10.1016/S0168-9525(99)01777-1; Plasterk Ronald H.A., 1997, Cold Spring Harbor Monograph Series, V33, P97; ROBERTSON HM, 1995, MOL BIOL EVOL, V12, P850; SEDENSKY MM, 1994, NUCLEIC ACIDS RES, V22, P1719, DOI 10.1093/nar/22.9.1719; SULSTON JE, 1974, GENETICS, V77, P95; Tosi LRO, 2000, NUCLEIC ACIDS RES, V28, P784, DOI 10.1093/nar/28.3.784; VANLUENEN HGAM, 1994, CELL, V79, P293, DOI 10.1016/0092-8674(94)90198-8; VANLUENEN HGAM, 1993, EMBO J, V12, P2513, DOI 10.1002/j.1460-2075.1993.tb05906.x; Waterston Robert H., 1997, Cold Spring Harbor Monograph Series, V33, P23; WILLIAMS BD, 1992, GENETICS, V131, P609	24	106	114	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 6	2001	413	6851					70	74		10.1038/35092567	http://dx.doi.org/10.1038/35092567			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469EG	11544527				2022-12-24	WOS:000170801200040
J	Greig-Midlane, H				Greig-Midlane, H			The parents' perspective on withdrawing treatment	BRITISH MEDICAL JOURNAL			English	Article											Greig-Midlane, H (corresponding author), 32 Littleheath, London SE7 8HU, England.								0	2	2	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 18	2001	323	7309					390	390						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	465GN	11548687				2022-12-24	WOS:000170581400029
J	[Anonymous]				[Anonymous]			THE RIGHT-TO-DIE	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JAN 1	1994	308	6920					66	66						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MQ096	11644505				2022-12-24	WOS:A1994MQ09600081
J	BURKHART, J				BURKHART, J			AMA POLICY FOR TESTING HIV	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material											BURKHART, J (corresponding author), AMER MED ASSOC,DEPT RESIDENT PHYSICIAN SERV,515 N STATE ST,CHICAGO,IL 60610, USA.								0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 12	1992	267	6					792	792						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HC484	11642977				2022-12-24	WOS:A1992HC48400008
J	d'Aignaux, JNH; Cousens, SN; Smith, PG				d'Aignaux, JNH; Cousens, SN; Smith, PG			Predictability of the UK variant Creutzfeldt-Jakob disease epidemic	SCIENCE			English	Article							VCJD MORTALITY; AIDS EPIDEMIC; UNITED-STATES; GREAT-BRITAIN; SCRAPIE; GENOTYPE	Back-calculation analysis of the variant Creutzfeldt-Jakob disease epidemic in the United Kingdom is used to estimate the number of infected individuals and future disease incidence. The model assumes a hazard of infection proportional to the incidence of bovine spongiform encephalopathy in the United Kingdom and accounts for precautionary control measures and very wide ranges of incubation periods. The model indicates that current case data are compatible with numbers of infections ranging from a few hundred to several millions. In the tatter case, the model suggests that the mean incubation period must be well beyond the human life-span, resulting in disease epidemics of at most several thousand cases.	Univ London London Sch Hyg & Trop Med, Infect Dis Epidemiol Unit, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	d'Aignaux, JNH (corresponding author), Univ London London Sch Hyg & Trop Med, Infect Dis Epidemiol Unit, Keppel St, London WC1E 7HT, England.		smith, peter/ABH-9627-2020	smith, peter/0000-0003-0080-7560				ANDERSON RM, 1996, NATURE, V382, P943; Balter M, 2000, SCIENCE, V289, P1663; Bonn D, 2000, LANCET, V356, P570; Bossers A, 1996, J GEN VIROL, V77, P2669, DOI 10.1099/0022-1317-77-10-2669; BROOKMEYER R, 1991, SCIENCE, V253, P37, DOI 10.1126/science.2063206; BROOKMEYER R, 1986, LANCET, V2, P1320; CARP RI, 1987, J GEN VIROL, V68, P401, DOI 10.1099/0022-1317-68-2-401; Cervenakova L, 1998, P NATL ACAD SCI USA, V95, P13239, DOI 10.1073/pnas.95.22.13239; Cooper J D, 2000, J Epidemiol Biostat, V5, P209; Cousens SN, 1997, NATURE, V385, P197, DOI 10.1038/385197a0; Frosh A, 2001, BRIT MED J, V322, P1558, DOI 10.1136/bmj.322.7302.1558; Ghani AC, 2000, NATURE, V406, P583, DOI 10.1038/35020688; Ghani AC, 1998, P ROY SOC B-BIOL SCI, V265, P2443, DOI 10.1098/rspb.1998.0596; JONES J, 2000, BRIT MED J, V321, pB469; Lasmezas CI, 2001, P NATL ACAD SCI USA, V98, P4142, DOI 10.1073/pnas.041490898; Lloyd SE, 2001, P NATL ACAD SCI USA, V98, P6279, DOI 10.1073/pnas.101130398; Manolakou K, 2001, P NATL ACAD SCI USA, V98, P7402, DOI 10.1073/pnas.121172098; McLean AR, 2000, PHILOS T ROY SOC B, V355, P1043, DOI 10.1098/rstb.2000.0641	18	72	74	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 23	2001	294	5547					1729	1731		10.1126/science.1064748	http://dx.doi.org/10.1126/science.1064748			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494VW	11679631				2022-12-24	WOS:000172307400048
J	Bruick, RK; McKnight, SL				Bruick, RK; McKnight, SL			A conserved family of prolyl-4-hydroxylases that modify HIF	SCIENCE			English	Article							INDUCIBLE FACTOR 1-ALPHA; TUMOR-SUPPRESSOR PROTEIN; UBIQUITIN-PROTEASOME PATHWAY; DROSOPHILA-MELANOGASTER; TRANSGENIC MICE; O-2 HOMEOSTASIS; HYPOXIA; HIF-1-ALPHA; EXPRESSION; BINDING	Mammalian cells respond to changes in oxygen availability through a conserved pathway that is regulated by the hypoxia-inducible factor (HIF). The alpha subunit of HIF is targeted for degradation under normoxic conditions by a ubiquitin-ligase complex that recognizes a hydroxylated proline residue in HIF. We identified a conserved family of HIF prolyl hydoxylase (HPH) enzymes that appear to be responsible for this posttranslational modification. In cultured mammalian cells, inappropriate accumulation of HIF caused by forced expression of the HIF-1 alpha subunit under normoxic conditions was attenuated by coexpression of HPH. Suppression of HPH in cultured Drosophila melanogaster cells by RNA interference resulted in elevated expression of a hypoxia-inducible gene (LDH, encoding lactate dehydrogenase) under normoxic conditions. These findings indicate that HPH is an essential component of the pathway through which cells sense oxygen.	Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	McKnight, SL (corresponding author), Univ Texas, SW Med Ctr, Dept Biochem, 5323 Harry Hines Blvd L3-124, Dallas, TX 75390 USA.							Adryan B, 2000, ONCOGENE, V19, P2803, DOI 10.1038/sj.onc.1203611; Bacon NCM, 1998, BIOCHEM BIOPH RES CO, V249, P811, DOI 10.1006/bbrc.1998.9234; Bruick RK, 2000, P NATL ACAD SCI USA, V97, P9082, DOI 10.1073/pnas.97.16.9082; Bruick RK, 2001, GENE DEV, V15, P2497, DOI 10.1101/gad.931601; Cockman ME, 2000, J BIOL CHEM, V275, P25733, DOI 10.1074/jbc.M002740200; Detmar M, 1998, J INVEST DERMATOL, V111, P1, DOI 10.1046/j.1523-1747.1998.00262.x; Elson DA, 2001, GENE DEV, V15, P2520, DOI 10.1101/gad.914801; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jiang HQ, 2001, P NATL ACAD SCI USA, V98, P7916, DOI 10.1073/pnas.141234698; Kallio PJ, 1999, J BIOL CHEM, V274, P6519, DOI 10.1074/jbc.274.10.6519; Kivirikko KI, 1998, ADV ENZYMOL RAMB, V72, P325; Larcher F, 1998, ONCOGENE, V17, P303, DOI 10.1038/sj.onc.1201928; Lipscomb EA, 2001, J BIOL CHEM, V276, P5085, DOI 10.1074/jbc.M008407200; Ma E, 1999, MOL BRAIN RES, V73, P11, DOI 10.1016/S0169-328X(99)00224-7; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Nambu JR, 1996, GENE, V172, P249, DOI 10.1016/0378-1119(96)00060-1; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; Semenza GL, 2000, GENE DEV, V14, P1983; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Tanimoto K, 2000, EMBO J, V19, P4298, DOI 10.1093/emboj/19.16.4298; Thurston G, 1999, SCIENCE, V286, P2511, DOI 10.1126/science.286.5449.2511; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Yu F, 2001, P NATL ACAD SCI USA, V98, P9630, DOI 10.1073/pnas.181341498	29	2017	2113	4	196	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 9	2001	294	5545					1337	1340		10.1126/science.1066373	http://dx.doi.org/10.1126/science.1066373			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	491VF	11598268				2022-12-24	WOS:000172130200048
J	Schlunzen, F; Zarivach, R; Harms, J; Bashan, A; Tocilj, A; Albrecht, R; Yonath, A; Franceschi, F				Schlunzen, F; Zarivach, R; Harms, J; Bashan, A; Tocilj, A; Albrecht, R; Yonath, A; Franceschi, F			Structural basis for the interaction of antibiotics with the peptidyl transferase centre in eubacteria	NATURE			English	Article							23S RIBOSOMAL-RNA; ESCHERICHIA-COLI; BINDING-SITE; ERYTHROMYCIN RESISTANCE; CRYSTAL-STRUCTURES; CHLORAMPHENICOL; MUTATIONS; SUBUNIT; CONFORMATION; RECOGNITION	Ribosomes, the site of protein synthesis, are a major target for natural and synthetic antibiotics. Detailed knowledge of antibiotic binding sites is central to understanding the mechanisms of drug action. Conversely, drugs are excellent tools for studying the ribosome function. To elucidate the structural basis of ribosome-antibiotic interactions, we determined the high-resolution X-ray structures of the 50S ribosomal subunit of the eubacterium Deinococcus radiodurans, complexed with the clinically relevant antibiotics chloramphenicol, clindamycin and the three macrolides erythromycin, clarithromycin and roxithromycin. We found that antibiotic binding sites are composed exclusively of segments of 23S ribosomal RNA at the peptidyl transferase cavity and do not involve any interaction of the drugs with ribosomal proteins. Here we report the details fo antibiotic interactions with the components of their binding sites. Our results also show the importance of putative Mg+2 ions for the binding of some drugs. This structural analysis should facilitate rational drug design.	Max Planck Inst Mol Genet, D-14195 Berlin, Germany; Max Planck Res, Unit Ribosomal Struct, D-22603 Hamburg, Germany; Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel	Max Planck Society; Max Planck Society; Weizmann Institute of Science	Franceschi, F (corresponding author), Max Planck Inst Mol Genet, Ihnestr 73, D-14195 Berlin, Germany.	Franceschi@molgen.mpg.de	ZARIVACH, RAZ/F-1671-2012; Schluenzen, Frank/P-9177-2019; Franceschi, Francois/AAF-5860-2021; Schluenzen, Frank/H-6274-2014; Harms, Joerg/K-8786-2012	ZARIVACH, RAZ/0000-0001-6543-0296; Schluenzen, Frank/0000-0003-2849-0542; Schluenzen, Frank/0000-0003-2849-0542; Harms, Joerg/0000-0002-9442-8264; Franceschi, Francois/0000-0002-1554-7944				Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Barta A., 2001, SCIENCE, V291, p203a, DOI [10.1126/science.291.5502.203a, DOI 10.1126/SCIENCE.291.5502.203A]; Bottger EC, 2001, EMBO REP, V2, P318, DOI 10.1093/embo-reports/kve062; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; CUNDLIFFE E, 1990, RIBOSOME, P479; DOUTHWAITE S, 1992, NUCLEIC ACIDS RES, V20, P4717, DOI 10.1093/nar/20.18.4717; GASC JC, 1991, J ANTIBIOT, V44, P313, DOI 10.7164/antibiotics.44.313; GOLDMAN RC, 1990, ANTIMICROB AGENTS CH, V34, P426, DOI 10.1128/AAC.34.3.426; Gregory ST, 1999, J MOL BIOL, V289, P827, DOI 10.1006/jmbi.1999.2839; Hansen LH, 1999, MOL MICROBIOL, V31, P623, DOI 10.1046/j.1365-2958.1999.01202.x; HARMS J, IN PRESS CELL; Izard T, 2000, EMBO J, V19, P2690, DOI 10.1093/emboj/19.11.2690; KALLIARAFTOPOULOS S, 1994, MOL PHARMACOL, V46, P1009; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; MANKIN AS, 1991, J BACTERIOL, V173, P3559, DOI 10.1128/jb.173.11.3559-3563.1991; MAO JCH, 1969, J MOL BIOL, V44, P347, DOI 10.1016/0022-2836(69)90180-6; MILLER KD, 1993, J AM HIST, V80, P319, DOI 10.2307/2079816; MOAZED D, 1991, P NATL ACAD SCI USA, V88, P3725, DOI 10.1073/pnas.88.9.3725; MOAZED D, 1987, BIOCHIMIE, V69, P879, DOI 10.1016/0300-9084(87)90215-X; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; NOLL M, 1973, J MOL BIOL, V75, P281, DOI 10.1016/0022-2836(73)90021-1; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pioletti M, 2001, EMBO J, V20, P1829, DOI 10.1093/emboj/20.8.1829; Polacek N, 2001, NATURE, V411, P498, DOI 10.1038/35078113; POLACEK N, 2000, RNA BINDING ANTIBIOT, P1; Poulsen SM, 2000, J MOL BIOL, V304, P471, DOI 10.1006/jmbi.2000.4229; RODRIGUEZFONSECA C, 1995, J MOL BIOL, V247, P224, DOI 10.1006/jmbi.1994.0135; Ross JI, 1997, ANTIMICROB AGENTS CH, V41, P1162, DOI 10.1128/AAC.41.5.1162; Saarma U, 1998, RNA, V4, P189; Schluenzen F, 2000, CELL, V102, P615, DOI 10.1016/S0092-8674(00)00084-2; SHAW WV, 1991, ANNU REV BIOPHYS BIO, V20, P363, DOI 10.1146/annurev.biophys.20.1.363; SIGMUND CD, 1984, NUCLEIC ACIDS RES, V12, P4653, DOI 10.1093/nar/12.11.4653; Spahn CMT, 1996, J MOL MED, V74, P423, DOI 10.1007/s001090050044; STEINER G, 1988, EMBO J, V7, P3949, DOI 10.1002/j.1460-2075.1988.tb03281.x; STEINMETZ WE, 1992, J MED CHEM, V35, P4842, DOI 10.1021/jm00104a009; Tenson T, 1996, P NATL ACAD SCI USA, V93, P5641, DOI 10.1073/pnas.93.11.5641; Thompson J, 2001, P NATL ACAD SCI USA, V98, P9002, DOI 10.1073/pnas.151257098; VAZQUEZ D, 1975, INHIBITORS PROTEIN S; VESTER B, 1988, EMBO J, V7, P3577, DOI 10.1002/j.1460-2075.1988.tb03235.x; VESTER B, 1995, RNA, V1, P501; Vester B, 2001, ANTIMICROB AGENTS CH, V45, P1, DOI 10.1128/AAC.45.1.1-12.2001; VINCE R, 1975, ANTIMICROB AGENTS CH, V8, P439, DOI 10.1128/AAC.8.4.439; WEISBLUM B, 1995, ANTIMICROB AGENTS CH, V39, P577, DOI 10.1128/AAC.39.3.577; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; WITTMANN HG, 1973, MOL GEN GENET, V127, P175, DOI 10.1007/BF00333665; Xiong LQ, 1999, MOL MICROBIOL, V31, P633, DOI 10.1046/j.1365-2958.1999.01203.x; YONATH A, 1987, SCIENCE, V236, P813, DOI 10.1126/science.3576200; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089	51	806	873	7	154	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 25	2001	413	6858					814	821		10.1038/35101544	http://dx.doi.org/10.1038/35101544			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	485JA	11677599				2022-12-24	WOS:000171750200038
J	Luo, JY; Nikolaev, AY; Imai, S; Chen, DL; Su, F; Shiloh, A; Guarente, L; Gu, W				Luo, JY; Nikolaev, AY; Imai, S; Chen, DL; Su, F; Shiloh, A; Guarente, L; Gu, W			Negative control of p53 by Sir2 alpha promotes cell survival under stress	CELL			English	Article							DNA-DAMAGE; HISTONE DEACETYLASE; SIR2-LIKE PROTEINS; P53-DEPENDENT APOPTOSIS; PREMATURE SENESCENCE; OXIDATIVE STRESS; ONCOGENIC RAS; LIFE-SPAN; SIR2; ACETYLATION	The NAD-dependent histone deacetylation of Sir2 connects cellular metabolism with gene silencing as well as aging in yeast. Here, we show that mammalian Sir2 alpha physically interacts with p53 and attenuates p53-mediated functions. Nicotinamide (Vitamin B3) inhibits an NAD-dependent p53 deacetylation induced by Sir2 alpha, and also enhances the p53 acetylation levels in vivo. Furthermore, Sir2 alpha represses p53-dependent apoptosis in response to DNA damage and oxidative stress, whereas expression of a Sir2 alpha point mutant increases the sensitivity of cells in the stress response. Thus, our findings implicate a p53 regulatory pathway mediated by mammalian Sir2 alpha. These results have significant implications regarding an important role for Sir2 alpha in modulating the sensitivity of cells in p53-dependent apoptotic response and the possible effect in cancer therapy.	Columbia Univ Coll Phys & Surg, Inst Canc Genet, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Pathol, New York, NY 10032 USA; MIT, Dept Biol, Cambridge, MA 02139 USA	Columbia University; Columbia University; Massachusetts Institute of Technology (MIT)	Gu, W (corresponding author), Columbia Univ Coll Phys & Surg, Inst Canc Genet, 1150 St Nicholas Ave, New York, NY 10032 USA.		Luo, Jianyuan/ABI-7585-2020	Luo, Jianyuan/0000-0001-6057-2914; Nikolaev, Anatoly/0000-0003-2818-5839	NCI NIH HHS [R01CA85533] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA085533] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Appella E, 2000, PATHOL BIOL, V48, P227; Avantaggiati ML, 1997, CELL, V89, P1175, DOI 10.1016/S0092-8674(00)80304-9; Bernstein BE, 2000, P NATL ACAD SCI USA, V97, P13708, DOI 10.1073/pnas.250477697; Butler LM, 2000, CANCER RES, V60, P5165; Campisi J, 2000, SCIENCE, V289, P2062, DOI 10.1126/science.289.5487.2062; Chao C, 2000, EMBO J, V19, P4967, DOI 10.1093/emboj/19.18.4967; Chen QM, 2000, BIOCHEM J, V347, P543, DOI 10.1042/0264-6021:3470543; Chresta CM, 1996, NAT MED, V2, P745, DOI 10.1038/nm0796-745; Di Cristofano A, 1999, SCIENCE, V285, P2122, DOI 10.1126/science.285.5436.2122; Ferbeyre G, 2000, GENE DEV, V14, P2015; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Frye RA, 1999, BIOCHEM BIOPH RES CO, V260, P273, DOI 10.1006/bbrc.1999.0897; Gu W, 1999, MOL CELL, V3, P97, DOI 10.1016/S1097-2765(00)80178-1; Gu W, 1997, NATURE, V387, P819, DOI 10.1038/42972; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Guarente L, 2000, GENE DEV, V14, P1021; Guo A, 2000, NAT CELL BIOL, V2, P730, DOI 10.1038/35036365; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Ito A, 2001, EMBO J, V20, P1331, DOI 10.1093/emboj/20.6.1331; Jimenez GS, 2000, NAT GENET, V26, P37, DOI 10.1038/79152; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; Landry J, 2000, BIOCHEM BIOPH RES CO, V278, P685, DOI 10.1006/bbrc.2000.3854; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Lill NL, 1997, NATURE, V387, P823, DOI 10.1038/42981; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Luo JY, 2000, NATURE, V408, P377, DOI 10.1038/35042612; Lutzker SG, 1996, NAT MED, V2, P804, DOI 10.1038/nm0796-804; Marks PA, 2001, CLIN CANCER RES, V7, P759; Maya R, 2001, GENE DEV, V15, P1067, DOI 10.1101/gad.886901; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Nakamura S, 2000, MOL CELL BIOL, V20, P9391, DOI 10.1128/MCB.20.24.9391-9398.2000; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Pearson M, 2000, NATURE, V406, P207, DOI 10.1038/35018127; Prives C, 1999, J PATHOL, V187, P112; Rodriguez MS, 2000, MOL CELL BIOL, V20, P8458, DOI 10.1128/MCB.20.22.8458-8467.2000; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Shore D, 2000, P NATL ACAD SCI USA, V97, P14030, DOI 10.1073/pnas.011506198; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Tanner KG, 2000, P NATL ACAD SCI USA, V97, P14178, DOI 10.1073/pnas.250422697; Tanny JC, 2001, P NATL ACAD SCI USA, V98, P415, DOI 10.1073/pnas.031563798; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Vaziri H, 1997, EMBO J, V16, P6018, DOI 10.1093/emboj/16.19.6018; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Yin YX, 1998, NATURE, V391, P707, DOI 10.1038/35648; YOSHIDA M, 1995, BIOESSAYS, V17, P423, DOI 10.1002/bies.950170510; Yu AD, 2000, MOL CELL, V5, P801, DOI 10.1016/S1097-2765(00)80320-2; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1	50	1771	1885	1	124	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 19	2001	107	2					137	148		10.1016/S0092-8674(01)00524-4	http://dx.doi.org/10.1016/S0092-8674(01)00524-4			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	484MU	11672522	Bronze			2022-12-24	WOS:000171694800004
J	Simonsen, L; Morens, DM; Elixhauser, A; Gerber, M; Van Raden, M; Blackwelder, WC				Simonsen, L; Morens, DM; Elixhauser, A; Gerber, M; Van Raden, M; Blackwelder, WC			Effect of rotavirus vaccination programme on trends in admission of infants to hospital for intussusception	LANCET			English	Article							DEVELOPING-COUNTRIES; UNITED-STATES; IMMUNIZATION; INFECTION; CHILDREN; FUTURE	Background Studies have reported a temporal association between a first dose of rotavirus vaccine (Rotashield) and infant intussusception. We investigated the effect of Rotashield vaccination use on intussusception admissions in ten US states. Methods We analysed electronic databases containing 100% hospital discharge records for 1993-99 from ten US states, where an estimated 28% of the birth cohort had received Rotashield (based on manufacturer's net sales data). We examined records of infants admitted to hospital (<365 days old) with any mention of intussusception (international Classification of Diseases, ninth revision. clinical modification code 560.0). Excess admissions for intussusception during the period of Rotashield availability (October 1998 to June 1999) were estimated by direct comparison with the corresponding period of October 1997 to June 1998 (before Rotashield was available) and with adjustment for secular trends during 1993-98 by Poisson regression. Findings Hospital admission for intussusception among infants younger than 365 days of age during the Rotashield period compared with previously was 4% lower (10 cases) by direct comparison and 10% lower (27 cases) by trend comparison, corresponding to a negative population attributable risk. Among infants aged 45-210 days (target age range for a first Rotashield dose), we estimated an increase in intussusception admissions of 1% (one excess admission) by direct comparison and 4% (4.6 excess admissions) by trend comparison, corresponding to a population attributable risk range of one excess admission in 66 000-302 000. Interpretation We found no evidence of increased infant intussusception admissions during the period of Rotashield availability. The total intussusception admission risk attributable to Rotashield was substantially lower than previous estimates based on studies focusing on the immediate postvaccination weeks.	NIAID, NIH, Bethesda, MD 20892 USA; Agcy Healthcare Res & Qual, Rockville, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Agency for Healthcare Research & Quality	Simonsen, L (corresponding author), 6700-B Rockledge Dr,Room 3153, Bethesda, MD 20892 USA.		Simonsen, Lone/K-4531-2014	Simonsen, Lone/0000-0003-1535-8526				*ADV COMM IMM PRAC, 1999, ACIP C ATL OCT 22 19, P1; [Anonymous], M FUT DIR ROT VACC R; Bresee JS, 1999, VACCINE, V17, P2207, DOI 10.1016/S0264-410X(98)00376-4; *CDCP, 1999, MMWR MORB MORTAL WKL, V48; CHANG HGH, IN PRESS PEDIATRICS; DEZOYSA I, 1985, B WORLD HEALTH ORGAN, V63, P569; Ehresman K., 1999, Morbidity and Mortality Weekly Report, V48, P577; Emanuel EJ, 2000, JAMA-J AM MED ASSOC, V283, P2701, DOI 10.1001/jama.283.20.2701; Gay N, 1999, LANCET, V354, P956, DOI 10.1016/S0140-6736(05)75710-X; Glass RI, 1996, J INFECT DIS, V174, pS5, DOI 10.1093/infdis/174.Supplement_1.S5; *I MED, 1986, NEW VACC DEV DIS IMP, V2; Kramarz P, 2001, PEDIATR INFECT DIS J, V20, P410, DOI 10.1097/00006454-200104000-00008; Levin A, 2000, ANN INTERN MED, V133, P661, DOI 10.7326/0003-4819-133-8-200010170-00102; Melton L, 2000, LANCET, V356, P318, DOI 10.1016/S0140-6736(05)73604-7; Murphy TV, 2001, NEW ENGL J MED, V344, P564, DOI 10.1056/NEJM200102223440804; Nakagomi T, 2000, MICROBIOL IMMUNOL, V44, P619, DOI 10.1111/j.1348-0421.2000.tb02542.x; Parashar UD, 2000, PEDIATRICS, V106, P1413, DOI 10.1542/peds.106.6.1413; Rennels MB, 1998, PEDIATR INFECT DIS J, V17, P924, DOI 10.1097/00006454-199810000-00018; Tucker AW, 1998, JAMA-J AM MED ASSOC, V279, P1371, DOI 10.1001/jama.279.17.1371; Weijer C, 2000, BRIT MED J, V321, P525, DOI 10.1136/bmj.321.7260.525	20	92	94	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 13	2001	358	9289					1224	1229		10.1016/S0140-6736(01)06346-2	http://dx.doi.org/10.1016/S0140-6736(01)06346-2			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	481NX	11675060				2022-12-24	WOS:000171527000012
J	Ren, DJ; Navarro, B; Perez, G; Jackson, AC; Hsu, SF; Shi, Q; Tilly, JL; Clapham, DE				Ren, DJ; Navarro, B; Perez, G; Jackson, AC; Hsu, SF; Shi, Q; Tilly, JL; Clapham, DE			A sperm ion channel required for sperm motility and male fertility	NATURE			English	Article							MOUSE SPERM; ACROSOME REACTION; CALCIUM CHANNELS; ZONA-PELLUCIDA; CA2+ CHANNELS; ENTRY; SPERMATOZOA; EXPRESSION; INCREASE	Calcium and cyclic nucleotides have crucial roles in mammalian fertilization, but the molecules comprising the Ca2+-permeation pathway in sperm motility are poorly understood. Here we describe a putative sperm cation channel, CatSper, whose amino-acid sequence most closely resembles a single, six-transmembrane-spanning repeat of the voltage-dependent Ca2+-channel four-repeat structure. CatSper is located specifically in the principal piece of the sperm tail. Targeted disruption of the gene results in male sterility in otherwise normal mice. Sperm motility is decreased markedly in CatSper(-/-) mice, and CatSper(-/-) sperm are unable to fertilize intact eggs. In addition, the cyclic-AMP-induced Ca2+ influx is abolished in the sperm of mutant mice. CatSper is thus vital to cAMP-mediated Ca2+ influx in sperm, sperm motility and fertilization. CatSper represents an excellent target for non-hormonal contraceptives for both men and women.	Harvard Univ, Childrens Hosp, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; Massachusetts Gen Hosp, Vincent Ctr Reprod Biol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Obstet Gynecol & Reprod Biol, Boston, MA 02114 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Clapham, DE (corresponding author), Harvard Univ, Childrens Hosp, Sch Med, Howard Hughes Med Inst, Enders 1309,320 Longwood Ave, Boston, MA 02115 USA.	dclapham@rascal.med.harvard.edu	Clapham, David/S-1123-2019; Oka, Yoshitaka/C-9670-2010; Clapham, David/R-5974-2019	Clapham, David/0000-0002-4459-9428; Oka, Yoshitaka/0000-0002-3482-3051; 	Howard Hughes Medical Institute Funding Source: Medline; NICHD NIH HHS [R01 HD045339] Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Aoki F, 1999, MOL REPROD DEV, V53, P77, DOI 10.1002/(SICI)1098-2795(199905)53:1&lt;77::AID-MRD9&gt;3.0.CO;2-C; Arnoult C, 1996, P NATL ACAD SCI USA, V93, P13004, DOI 10.1073/pnas.93.23.13004; Arnoult C, 1997, EMBO J, V16, P1593, DOI 10.1093/emboj/16.7.1593; Bedford JM, 1998, BIOL REPROD, V59, P1275, DOI 10.1095/biolreprod59.6.1275; Darszon A, 1999, PHYSIOL REV, V79, P481, DOI 10.1152/physrev.1999.79.2.481; ELLINOR PT, 1995, NEURON, V15, P1121, DOI 10.1016/0896-6273(95)90100-0; Ertel EA, 2000, NEURON, V25, P533, DOI 10.1016/S0896-6273(00)81057-0; Espinosa F, 1998, FEBS LETT, V426, P47, DOI 10.1016/S0014-5793(98)00305-6; HYNE RV, 1979, P NATL ACAD SCI USA, V76, P5699, DOI 10.1073/pnas.76.11.5699; Jungnickel MK, 2001, NAT CELL BIOL, V3, P499, DOI 10.1038/35074570; Kobori H, 2000, BIOL REPROD, V63, P113, DOI 10.1095/biolreprod63.1.113; O'Toole CMB, 2000, MOL BIOL CELL, V11, P1571, DOI 10.1091/mbc.11.5.1571; Perez GI, 1999, NAT GENET, V21, P200, DOI 10.1038/5985; Santi CM, 1996, AM J PHYSIOL-CELL PH, V271, pC1583, DOI 10.1152/ajpcell.1996.271.5.C1583; Serrano CJ, 1999, FEBS LETT, V462, P171, DOI 10.1016/S0014-5793(99)01518-5; Tash J.S., 1990, P229; Wassarman PM, 2001, NAT CELL BIOL, V3, pE59, DOI 10.1038/35055178; Wennemuth G, 2000, J BIOL CHEM, V275, P21210, DOI 10.1074/jbc.M002068200; WEYAND I, 1994, NATURE, V368, P859, DOI 10.1038/368859a0; Wiesner B, 1998, J CELL BIOL, V142, P473, DOI 10.1083/jcb.142.2.473; Yanagimachi R., 1994, P189	21	667	698	0	83	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 11	2001	413	6856					603	609		10.1038/35098027	http://dx.doi.org/10.1038/35098027			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480WE	11595941	Green Accepted			2022-12-24	WOS:000171485700041
J	Stevenson, DJ				Stevenson, DJ			Planetary science - Jupiter and its moons	SCIENCE			English	Editorial Material									CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA	California Institute of Technology	Stevenson, DJ (corresponding author), CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA.							Anderson JD, 1998, SCIENCE, V280, P1573, DOI 10.1126/science.280.5369.1573; CANUP RM, 2000, ORIGIN EARTH MOON; Showman AP, 1999, SCIENCE, V286, P77, DOI 10.1126/science.286.5437.77; Wuchterl G., 2000, Protostars and planets 4, P1081	4	15	15	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 5	2001	294	5540					71	72		10.1126/science.1065306	http://dx.doi.org/10.1126/science.1065306			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480EJ	11588243				2022-12-24	WOS:000171448800031
J	Panikashvili, D; Simeonidou, C; Ben-Shabat, S; Hanus, L; Breuer, A; Mechoulam, R; Shohami, E				Panikashvili, D; Simeonidou, C; Ben-Shabat, S; Hanus, L; Breuer, A; Mechoulam, R; Shohami, E			An endogenous cannabinoid (2-AG) is neuroprotective after brain injury	NATURE			English	Article							CLOSED-HEAD-INJURY; NECROSIS-FACTOR-ALPHA; RECEPTOR-LIGAND; RAT-BRAIN; ANANDAMIDE; MICE; SYSTEM; 2-ARACHIDONOYLGLYCEROL; ENDOCANNABINOIDS; AMIDOHYDROLASE	Traumatic brain injury triggers the accumulation of harmful mediators that may lead to secondary damage(1,2). Protective mechanisms to attenuate damage are also set in motion(2). 2-Arachidonoyl glycerol (2-AG) is an endogenous cannabinoid, identified both in the periphery(3) and in the brain(4), but its physiological roles have been only partially clarified(5-7). Here we show that, after injury to the mouse brain, 2-AG may have a neuroprotective role in which the cannabinoid system is involved. After closed head injury (CHI) in mice, the level of endogenous 2-AG was significantly elevated. We administered synthetic 2-AG to mice after CHI and found significant reduction of brain oedema, better clinical recovery, reduced infarct volume and reduced hippocampal cell death compared with controls. When 2-AG was administered together with additional inactive 2-acyl-glycerols that are normally present in the brain, functional recovery was significantly enhanced. The beneficial effect of 2-AG was dose-dependently attenuated by SR-141761A, an antagonist of the CB1 cannabinoid receptor.	Hebrew Univ Jerusalem, Fac Med, Dept Pharmacol, IL-91120 Jerusalem, Israel; Hebrew Univ Jerusalem, Fac Med, Dept Med Chem & Nat Prod, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Shohami, E (corresponding author), Hebrew Univ Jerusalem, Fac Med, Dept Pharmacol, IL-91120 Jerusalem, Israel.							Adams IB, 1998, J PHARMACOL EXP THER, V284, P1209; Axelrod J, 1998, NEUROCHEM RES, V23, P575, DOI 10.1023/A:1022418217479; Ben-Shabat S, 1998, EUR J PHARMACOL, V353, P23, DOI 10.1016/S0014-2999(98)00392-6; Beni-Adani L, 2001, J PHARMACOL EXP THER, V296, P57; Chan PH, 2001, J CEREBR BLOOD F MET, V21, P2, DOI 10.1097/00004647-200101000-00002; CHEN DS, 1987, J GASTROEN HEPATOL, V2, P1, DOI 10.1111/j.1440-1746.1987.tb00142.x; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Gallily R, 2000, EUR J PHARMACOL, V406, pR5, DOI 10.1016/S0014-2999(00)00653-1; Goparaju SK, 1998, FEBS LETT, V422, P69, DOI 10.1016/S0014-5793(97)01603-7; Hansen HS, 2000, CHEM PHYS LIPIDS, V108, P135, DOI 10.1016/S0009-3084(00)00192-4; Klein TW, 2000, P SOC EXP BIOL MED, V225, P1, DOI 10.1046/j.1525-1373.2000.22501.x; Kochanek Patrick M., 2000, Pediatr Crit Care Med, V1, P4, DOI 10.1097/00130478-200007000-00003; Mathews KS, 2000, J NEUROSCI METH, V102, P43, DOI 10.1016/S0165-0270(00)00277-6; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; MECHOULAM R, 1995, BIOCHEM PHARMACOL, V50, P83, DOI 10.1016/0006-2952(95)00109-D; Mechoulam R, 1998, EUR J PHARMACOL, V359, P1, DOI 10.1016/S0014-2999(98)00649-9; NADLER V, 1995, BRAIN RES, V685, P1, DOI 10.1016/0006-8993(95)00367-Y; Nagayama T, 1999, J NEUROSCI, V19, P2987; OVADIA H, 1995, NEUROPHARMACOLOGY, V34, P175, DOI 10.1016/0028-3908(94)00133-D; Piomelli D, 2000, TRENDS PHARMACOL SCI, V21, P218, DOI 10.1016/S0165-6147(00)01482-6; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Reggio PH, 2000, CHEM PHYS LIPIDS, V108, P15, DOI 10.1016/S0009-3084(00)00185-7; Shen MX, 1998, MOL PHARMACOL, V54, P459, DOI 10.1124/mol.54.3.459; Shohami E, 1999, CYTOKINE GROWTH F R, V10, P119, DOI 10.1016/S1359-6101(99)00008-8; Shohami E, 2000, DRUG DEVELOP RES, V50, P211, DOI 10.1002/1098-2299(200007/08)50:3/4<211::AID-DDR3>3.0.CO;2-G; SHOHAMI E, 1989, J NEUROCHEM, V53, P1541, DOI 10.1111/j.1471-4159.1989.tb08550.x; Sinor AD, 2000, NEUROSCI LETT, V278, P157, DOI 10.1016/S0304-3940(99)00922-2; Smith SR, 2000, J PHARMACOL EXP THER, V293, P136; Sugiura T, 2000, BIOCHEM BIOPH RES CO, V271, P654, DOI 10.1006/bbrc.2000.2686; SUGIURA T, 1995, BIOCHEM BIOPH RES CO, V215, P89, DOI 10.1006/bbrc.1995.2437; van der Stelt M, 2001, J NEUROSCI, V21, P6475, DOI 10.1523/JNEUROSCI.21-17-06475.2001	31	573	602	1	30	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 4	2001	413	6855					527	531		10.1038/35097089	http://dx.doi.org/10.1038/35097089			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	478HG	11586361				2022-12-24	WOS:000171340500048
J	Takayama, S; Shimosato, H; Shiba, H; Funato, M; Che, FS; Watanabe, M; Iwano, M; Isogai, A				Takayama, S; Shimosato, H; Shiba, H; Funato, M; Che, FS; Watanabe, M; Iwano, M; Isogai, A			Direct ligand-receptor complex interaction controls Brassica self-incompatibility	NATURE			English	Article							S-LOCUS GLYCOPROTEIN; CAMPESTRIS SYN. RAPA; TRANSGENIC TOBACCO; MALE DETERMINANT; KINASE; GENE; OLERACEA; STIGMA; EXPRESSION; HAPLOTYPES	Many higher plants have evolved self-incompatibility mechanisms to prevent self-fertilization(1). In Brassica self-incompatibility, recognition between pollen and the stigma is controlled by the S locus, which contains three highly polymorphic genes: S-receptor kinase (SRK)(2), S-locus protein 11 (SP11)(3) (also called S-locus cysteine-rich protein; SCR)(4) and S-locus glycoprotein (SLG)(5). SRK encodes a membrane-spanning serine/threonine kinase that determines the S-haplotype specificity of the stigma(6), and SP11 encodes a small cysteine-rich protein that determines the S-haplotype specificity of pollen(4,7,8). SP11 is localized in the pollen coat(8). It is thought that, during self-pollination, SP11 is secreted from the pollen coat and interacts with its cognate SRK in the papilla cell of the stigma to elicit the self-incompatibility response. SLG is a secreted stigma protein(9) that is highly homologous to the SRK extracellular domain. Although it is not required for S-haplotype specificity of the stigma, SLG enhances the self-incompatibility response(6); however, how this is accomplished remains controversial(10-12). Here we show that a single form of SP11 of the S-8 haplotype (S-8-SP11) stabilized with four intramolecular disulphide bonds specifically binds the stigma membrane of the S-8 haplotype to induce autophosphorylation of SRK8, and that SRK8 and SLG(8) together form a high-affinity receptor complex for S-8-SP11 on the stigma membrane.	Nara Inst Sci & Technol, Grad Sch Biol Sci, Ikoma 6300101, Japan; Iwate Univ, Fac Agr, Morioka, Iwate 0208550, Japan	Nara Institute of Science & Technology; Iwate University	Isogai, A (corresponding author), Nara Inst Sci & Technol, Grad Sch Biol Sci, 8916-5 Takayama, Ikoma 6300101, Japan.	isogai@bs.aist-nara.ac.jp	Isogai, Akira/O-8897-2017; Watanabe, Masao/N-1465-2019; Watanabe, Masao/E-6300-2011	Isogai, Akira/0000-0001-8095-0441; Watanabe, Masao/0000-0002-9419-5149; Watanabe, Masao/0000-0002-9419-5149				BROEKAERT WF, 1995, PLANT PHYSIOL, V108, P1353, DOI [10.1104/pp.108.4.1353, 10.1016/j.chiabu.2021.105188]; Brugiere N, 2000, TRENDS PLANT SCI, V5, P432, DOI 10.1016/S1360-1385(00)01759-3; BRUIX M, 1993, BIOCHEMISTRY-US, V32, P715, DOI 10.1021/bi00053a041; Cabrillac D, 2001, NATURE, V410, P220, DOI 10.1038/35065626; Dickinson HG, 2000, TRENDS GENET, V16, P373, DOI 10.1016/S0168-9525(00)02083-7; Dixit R, 2000, PLANT PHYSIOL, V124, P297, DOI 10.1104/pp.124.1.297; Doughty J, 1998, PLANT CELL, V10, P1333, DOI 10.1105/tpc.10.8.1333; Giranton JL, 1995, PLANT J, V8, P827, DOI 10.1046/j.1365-313X.1995.8060827.x; Giranton JL, 2000, P NATL ACAD SCI USA, V97, P3759, DOI 10.1073/pnas.070025097; Gomez-Gomez L, 2001, PLANT CELL, V13, P1155, DOI 10.1105/tpc.13.5.1155; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; LARSSON C, 1987, METHOD ENZYMOL, V148, P558; McCubbin AG, 2000, ANNU REV CELL DEV BI, V16, P333, DOI 10.1146/annurev.cellbio.16.1.333; NASRALLAH JB, 1987, NATURE, V326, P617, DOI 10.1038/326617a0; Schopfer CR, 1999, SCIENCE, V286, P1697, DOI 10.1126/science.286.5445.1697; Shiba H, 2000, BIOSCI BIOTECH BIOCH, V64, P1016, DOI 10.1271/bbb.64.1016; Shiba H, 2001, PLANT PHYSIOL, V125, P2095, DOI 10.1104/pp.125.4.2095; STEIN JC, 1991, P NATL ACAD SCI USA, V88, P8816, DOI 10.1073/pnas.88.19.8816; Stephenson AG, 1997, PLANT J, V12, P1351, DOI 10.1046/j.1365-313x.1997.12061351.x; Suzuki G, 1996, PLANT CELL PHYSIOL, V37, P866, DOI 10.1093/oxfordjournals.pcp.a029024; Suzuki G, 1999, GENETICS, V153, P391; Suzuki T, 2000, FEBS LETT, V482, P102, DOI 10.1016/S0014-5793(00)02048-2; Takasaki T, 2000, NATURE, V403, P913, DOI 10.1038/35002628; Takayama S, 2000, P NATL ACAD SCI USA, V97, P3765, DOI 10.1073/pnas.040580797; TAKAYAMA S, 1987, NATURE, V326, P102, DOI 10.1038/326102a0; Takayama S, 2000, P NATL ACAD SCI USA, V97, P1920, DOI 10.1073/pnas.040556397; Torii KU, 2000, CURR OPIN PLANT BIOL, V3, P361, DOI 10.1016/S1369-5266(00)00097-2; Trotochaud AE, 2000, SCIENCE, V289, P613, DOI 10.1126/science.289.5479.613; Wang ZY, 2001, NATURE, V410, P380, DOI 10.1038/35066597; Watanabe M, 2000, FEBS LETT, V473, P139, DOI 10.1016/S0014-5793(00)01514-3	30	319	361	2	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 4	2001	413	6855					534	538		10.1038/35097104	http://dx.doi.org/10.1038/35097104			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	478HG	11586363				2022-12-24	WOS:000171340500050
J	Schwetz, BA				Schwetz, BA			Reprocessing of single-use devices	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Off Commissioner Food & Drugs, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Schwetz, BA (corresponding author), US FDA, Off Commissioner Food & Drugs, HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	4	4	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 3	2001	286	13					1569	1569		10.1001/jama.286.13.1569-b	http://dx.doi.org/10.1001/jama.286.13.1569-b			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	478HH	11585463				2022-12-24	WOS:000171340600007
J	Mondal, N; Parvin, JD				Mondal, N; Parvin, JD			DNA topoisomerase IIa is required for RNA polymerase II transcription on chromatin templates	NATURE			English	Article							IN-VITRO; RIBOSOMAL-RNA; HOLOENZYME; PURIFICATION; ACTIVATION; YEAST; BRCA1; INVITRO; ELUTION; COMPLEX	In the nucleus of the cell, core RNA polymerase II (pol II) is associated with a large complex called the pol II holoenzyme (holo-pol)(1,2). Transcription by core pol II in vitro on nucleosomal templates is repressed compared with that on templates of histone-free naked DNA(3-5). We found that the transcriptional activity of holo-pol, in contrast to that of core pol II, is not markedly repressed on chromatin templates. We refer to this property of holo-pol as chromatin-dependent coactivation (CDC). Here we show that DNA topoisomerase II alpha is associated with the holo-pol and is a required component of CDC. Etoposide and ICRF-193, specific inhibitors of topoisomerase II, blocked transcription on chromatin templates, but did not affect transcription on naked templates. Addition of purified topoisomerase IIa reconstituted CDC activity in reactions with core pol II. These findings suggest that transcription on chromatin templates results in the accumulation of superhelical tension, making the relaxation activity of topoisomerase II essential for productive RNA synthesis on nucleosomal DNA.	Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Parvin, JD (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA.	jparvin@rics.bwh.harvard.edu	Parvin, Jeffrey D/C-8955-2009					BRILL SJ, 1987, NATURE, V326, P414, DOI 10.1038/326414a0; Chao DM, 1996, NATURE, V380, P82, DOI 10.1038/380082a0; CHASMAN DI, 1989, MOL CELL BIOL, V9, P4746, DOI 10.1128/MCB.9.11.4746; CHIANG CM, 1993, PEPTIDE RES, V6, P62; Cho H, 1998, MOL CELL BIOL, V18, P5355, DOI 10.1128/MCB.18.9.5355; Cho H, 1997, J BIOL CHEM, V272, P11495; Cramer P, 2000, SCIENCE, V288, P640, DOI 10.1126/science.288.5466.640; GARTENBERG MR, 1992, P NATL ACAD SCI USA, V89, P11461, DOI 10.1073/pnas.89.23.11461; Haile DT, 1999, J BIOL CHEM, V274, P2113, DOI 10.1074/jbc.274.4.2113; ISHIDA R, 1995, CANCER RES, V55, P2299; KIM YJ, 1994, CELL, V77, P599, DOI 10.1016/0092-8674(94)90221-6; KOLESKE AJ, 1994, NATURE, V368, P466, DOI 10.1038/368466a0; LAYBOURN PJ, 1991, SCIENCE, V254, P238, DOI 10.1126/science.1718039; LeRoy G, 1998, SCIENCE, V282, P1900, DOI 10.1126/science.282.5395.1900; LIU LF, 1989, ANNU REV BIOCHEM, V58, P351, DOI 10.1146/annurev.bi.58.070189.002031; MANLEY JL, 1983, METHOD ENZYMOL, V101, P568; Neish AS, 1998, NUCLEIC ACIDS RES, V26, P847, DOI 10.1093/nar/26.3.847; Parvin JD, 1998, CURR OPIN GENET DEV, V8, P565, DOI 10.1016/S0959-437X(98)80012-9; Sandbrink R, 1994, Neurobiol Dis, V1, P13, DOI 10.1006/nbdi.1994.0003; Schlegel BP, 2000, P NATL ACAD SCI USA, V97, P3148, DOI 10.1073/pnas.070452397; SCHULTZ MC, 1992, GENE DEV, V6, P1332, DOI 10.1101/gad.6.7.1332; Scully R, 1997, P NATL ACAD SCI USA, V94, P5605, DOI 10.1073/pnas.94.11.5605; THOMPSON NE, 1990, J BIOL CHEM, V265, P7069; WANG JC, 1993, CURR OPIN GENET DEV, V3, P764, DOI 10.1016/S0959-437X(05)80096-6; WORKMAN JL, 1991, METHOD CELL BIOL, V35, P419	25	100	100	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 27	2001	413	6854					435	438		10.1038/35096590	http://dx.doi.org/10.1038/35096590			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475UY	11574892				2022-12-24	WOS:000171188700058
J	Groeneveld, PW; Kwong, JL; Liu, YY; Rodriguez, AJ; Jones, MP; Sanders, GD; Garber, AM				Groeneveld, PW; Kwong, JL; Liu, YY; Rodriguez, AJ; Jones, MP; Sanders, GD; Garber, AM			Cost-effectiveness of automated external defibrillators on airlines	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							EMERGENCY MEDICAL-SERVICES; HOSPITAL CARDIAC-ARREST; RAPID DEFIBRILLATION; SURVIVORS; QUALITY; LIFE; ANTIARRHYTHMICS; OUTCOMES; VICTIMS; STATES	Context Installation of automated external defibrillators (AEDs) on passenger aircraft has been shown to improve survival of cardiac arrest in that setting, but the cost-effectiveness of such measures has not been proven. Objective To examine the costs and effectiveness of several different options for AED deployment in the US commercial air transportation system. Design, Setting, and Subjects Decision and cost-effectiveness analysis of a strategy of full deployment on all aircraft as well as several strategies of partial deployment only on larger aircraft, compared with a baseline strategy of no AEDs on aircraft (but training flight attendants in basic life support) for a hypothetical cohort of persons experiencing cardiac arrest aboard US commercial aircraft. Estimates for costs and outcomes were obtained from the medical literature, the Federal Aviation Administration, the Air Transport Association of America, a population-based cohort of Medicare patients, AED manufacturers, and the Bureau of Labor Statistics. Main Outcome Measures Quality-adjusted survival after cardiac arrest; costs of AED deployment on aircraft and of medical care for cardiac arrest survivors. Results Adding AEDs on passenger aircraft with more than 200 passengers would cost $35300 per quality-adjusted life-year (QALY) gained. Additional AEDs on aircraft with capacities between 100 and 200 persons would cost an additional $40800 per added QALY compared with deployment on large-capacity aircraft only, and full deployment on all passenger aircraft would cost an additional $94700 per QALY gained compared with limited deployment on aircraft with capacity greater than 100. Sensitivity analyses indicated that the quality of life, annual mortality rate, and the effectiveness of AEDs in improving survival were the most influential factors in the model. In 85% of Monte Carlo simulations, AED placement on large-capacity aircraft produced cost-effectiveness ratios of less than $50000 per QALY. Conclusion The cost-effectiveness of placing AEDs on commercial aircraft compares favorably with the cost-effectiveness of widely accepted medical interventions and health policy regulations, but is critically dependent on the passenger capacity of the aircraft. Placing AEDs on most US commercial aircraft would meet conventional standards of cost-effectiveness.	Stanford Univ, Ctr Primary Care & Outcomes Res, Stanford, CA 94305 USA; Stanford Univ, Grad Sch Business, Stanford, CA 94305 USA; Stanford Univ, Stanford Biomed Informat, Stanford, CA 94305 USA; Front Line Strateg Management Consulting, Foster City, CA USA; Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA	Stanford University; Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Groeneveld, PW (corresponding author), Stanford Univ, Ctr Primary Care & Outcomes Res, 179 Encina Commons,MC 6019, Stanford, CA 94305 USA.	petegro@healthpolicy.stanford.edu	Garber, Alan M/F-1476-2010	Groeneveld, Peter/0000-0002-7374-4292	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [F32HS000028, T32HS000028] Funding Source: NIH RePORTER; AHRQ HHS [HS00028-15] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		*AIR TRANSP ASS AM, 2000, IND ANN REP 2000; AUBLE TE, 1995, ANN EMERG MED, V25, P642, DOI 10.1016/S0196-0644(95)70178-8; BANTA HD, 1990, JAMA-J AM MED ASSOC, V264, P235, DOI 10.1001/jama.264.2.235; Berek K, 1997, J NEUROL, V244, P556, DOI 10.1007/s004150050143; *BUR LAB STAT, 2000, OCC OUTL HDB; CREWDSON J, 1996, CHICAGO TRIBUNE 0630, P1; de Vos R, 1999, ARCH INTERN MED, V159, P249, DOI 10.1001/archinte.159.3.249; Doubilet P, 1985, Med Decis Making, V5, P157, DOI 10.1177/0272989X8500500205; EISENBERG MS, 1984, JAMA-J AM MED ASSOC, V251, P1723, DOI 10.1001/jama.251.13.1723; EISENBERG MS, 1980, NEW ENGL J MED, V302, P1379, DOI 10.1056/NEJM198006193022502; EISENBERG MS, 1984, AM J EMERG MED, V2, P189, DOI 10.1016/0735-6757(84)90001-9; EVERY N, 1994, DEFIBRILLATION HEART, P182; Ewy GA, 2000, J AM COLL CARDIOL, V35, P830; Federal Aviation Administration, 2001, FED REGISTER, V66, P19028; FLINT P, 1998, INT AIR TRANSP ASS A; Foutz R A, 2000, Prehosp Emerg Care, V4, P314, DOI 10.1080/10903120090941010; FREEMAN KD, 2001, ACAD EMERG MED, V8, P431; Gage BF, 1996, ARCH INTERN MED, V156, P1829, DOI 10.1001/archinte.156.16.1829; GILLUM RF, 1989, CIRCULATION, V79, P756, DOI 10.1161/01.CIR.79.4.756; Gold MR, 1996, COST EFFECTIVENESS H; Graham JD, 1997, JAMA-J AM MED ASSOC, V278, P1418, DOI 10.1001/jama.278.17.1418; Gratton M, 1999, Prehosp Emerg Care, V3, P303, DOI 10.1080/10903129908958958; Graves JR, 1997, RESUSCITATION, V35, P117; HOFER S, 1998, PUBLICATION FEDERAL; *INT AIR TRANSP AS, 2000, CORP AIR TRAV SURV 1; Jermyn B D, 2000, Prehosp Emerg Care, V4, P43, DOI 10.1080/10903120090941632; KELLERMANN AL, 1993, JAMA-J AM MED ASSOC, V270, P1708, DOI 10.1001/jama.270.14.1708; Kim SG, 1997, AM J CARDIOL, V80, P454, DOI 10.1016/S0002-9149(97)00394-9; Marenco JP, 2001, JAMA-J AM MED ASSOC, V285, P1193, DOI 10.1001/jama.285.9.1193; McAnulty J, 1997, NEW ENGL J MED, V337, P1576; *NAT HEART LUNG BL, 2001, STUD LAUNCH TEST PUB; National Center for Health Statistics, 2000, HLTH US 2000; Nichol G, 1999, ANN EMERG MED, V34, P517, DOI 10.1016/S0196-0644(99)80054-7; Nichol G, 1999, ACAD EMERG MED, V6, P95, DOI 10.1111/j.1553-2712.1999.tb01044.x; Nichol G, 1998, CIRCULATION, V97, P1315, DOI 10.1161/01.CIR.97.13.1315; Nichol G, 1996, ANN EMERG MED, V27, P711, DOI 10.1016/S0196-0644(96)70188-9; ORourke MF, 1997, CIRCULATION, V96, P2849, DOI 10.1161/01.CIR.96.9.2849; Owens DK, 1997, ANN INTERN MED, V126, P1, DOI 10.7326/0003-4819-126-1-199701010-00001; Page RL, 1998, CIRCULATION, V97, P1429; Page RL, 2000, NEW ENGL J MED, V343, P1210, DOI 10.1056/NEJM200010263431702; Pasta DJ, 1999, MED DECIS MAKING, V19, P353, DOI 10.1177/0272989X9901900314; Pinski SL, 2000, AM HEART J, V139, P804, DOI 10.1016/S0002-8703(00)90011-5; RAYMAN RB, 1994, JAMA-J AM MED ASSOC, V271, P1657, DOI 10.1001/jama.271.21.1657; Riegel B, 1998, Am J Crit Care, V7, P402; ROINE RO, 1993, JAMA-J AM MED ASSOC, V269, P237, DOI 10.1001/jama.269.2.237; SAPP F, 2001, PUBLICATION FEDERAL; SEDGWICK ML, 1993, RESUSCITATION, V26, P75, DOI 10.1016/0300-9572(93)90166-N; Skogvoll E, 1999, ANN EMERG MED, V33, P409, DOI 10.1016/S0196-0644(99)70305-7; SoRelle R, 1999, CIRCULATION, V99, P2606, DOI 10.1161/01.CIR.99.20.2606; STULTS KR, 1984, NEW ENGL J MED, V310, P219, DOI 10.1056/NEJM198401263100403; Thompson RJ, 1998, AM J CARDIOL, V81, P17, DOI 10.1016/S0002-9149(97)00798-4; TORRANCE GW, 1995, PHARMACOECONOMICS, V7, P503, DOI 10.2165/00019053-199507060-00005; Valenzuela TD, 2000, NEW ENGL J MED, V343, P1206, DOI 10.1056/NEJM200010263431701; Valenzuela TD, 1997, CIRCULATION, V96, P3308; Varon J, 1999, RESUSCITATION, V41, P219, DOI 10.1016/S0300-9572(99)00064-7; VUKOV LF, 1988, ANN EMERG MED, V17, P318, DOI 10.1016/S0196-0644(88)80771-6; WEAVER WD, 1988, NEW ENGL J MED, V319, P661, DOI 10.1056/NEJM198809153191101; Weiss JP, 2000, CIRCULATION, V102, P395; Zipes DP, 1998, CIRCULATION, V98, P2334, DOI 10.1161/01.CIR.98.21.2334	59	71	72	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 26	2001	286	12					1482	1489		10.1001/jama.286.12.1482	http://dx.doi.org/10.1001/jama.286.12.1482			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	475UX	11572741	Bronze			2022-12-24	WOS:000171188600026
J	Nakajima, K; Sena, G; Nawy, T; Benfey, PN				Nakajima, K; Sena, G; Nawy, T; Benfey, PN			Intercellular movement of the putative transcription factor SHR in root patterning	NATURE			English	Article							ARABIDOPSIS ROOT; CELL-DIFFERENTIATION; THALIANA; ORGANIZATION; MERISTEM; MORPHOGENESIS; TRAFFICKING; EXPRESSION; POSITION; PROTEINS	Positional information is pivotal for establishing developmental patterning in plants(1-3), but little is known about the underlying signalling mechanisms. The Arabidopsis root radial pattern is generated through stereotyped division of initial cells and the subsequent acquisition of cell fate(4). short-root (shr) mutants do not undergo the longitudinal cell division of the cortex/endodermis initial daughter cell, resulting in a single cell layer with only cortex attributes(5,6). Thus, SHR is necessary for both cell division and endodermis specification(5,6). SHR messenger RNA is found exclusively in the stele cells internal to the endodermis and cortex, indicating that it has a non-cell-autonomous mode of action(6). Here we show that the SHR protein, a putative transcription factor, moves from the stele to a single layer of adjacent cells, where it enters the nucleus. Ectopic expression of SHR driven by the promoter of the downstream gene SCARECROW(SCR) results in autocatalytic reinforcement of SHR signalling, producing altered cell fates and multiplication of cell layers. These results support a model in which SHR protein acts both as a signal from the stele and as an activator of endodermal cell fate and SCR-mediated cell division.	NYU, Dept Biol, New York, NY 10003 USA	New York University	Benfey, PN (corresponding author), NYU, Dept Biol, 1009 Main Bldg,100 Washington Sq E, New York, NY 10003 USA.		Sena, Giovanni/C-3297-2012	Sena, Giovanni/0000-0003-3626-5038; Nawy, Tal/0000-0003-3720-3699; Nakajima, Keiji/0000-0002-1580-3354				BENFEY PN, 1993, DEVELOPMENT, V119, P57; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; DiLaurenzio L, 1996, CELL, V86, P423, DOI 10.1016/S0092-8674(00)80115-4; DOLAN L, 1993, DEVELOPMENT, V119, P71; Esau K., 1977, ANATOMY SEED PLANTS, V2nd Edn., P215; Freshour G, 1996, PLANT PHYSIOL, V110, P1413, DOI 10.1104/pp.110.4.1413; Helariutta Y, 2000, CELL, V101, P555, DOI 10.1016/S0092-8674(00)80865-X; JACKSON D, 1994, DEVELOPMENT, V120, P405; Kidner C, 2000, PLANTA, V211, P191, DOI 10.1007/s004250000284; KNOX JP, 1990, PLANTA, V181, P512, DOI 10.1007/BF00193004; LUCAS WJ, 1995, SCIENCE, V270, P1980, DOI 10.1126/science.270.5244.1980; Malamy JE, 1997, DEVELOPMENT, V124, P33; Masucci JD, 1996, DEVELOPMENT, V122, P1253; Perbal MC, 1996, DEVELOPMENT, V122, P3433; Sabatini S, 1999, CELL, V99, P463, DOI 10.1016/S0092-8674(00)81535-4; SESSIONS A, 2000, SCIENCE, V287, P419; vandenBerg C, 1997, NATURE, V390, P287, DOI 10.1038/36856; VANDENBERG C, 1995, NATURE, V378, P62, DOI 10.1038/378062a0; von Arnim AG, 1998, GENE, V221, P35, DOI 10.1016/S0378-1119(98)00433-8; Wysocka-Diller JW, 2000, DEVELOPMENT, V127, P595	20	588	627	3	104	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 20	2001	413	6853					307	311		10.1038/35095061	http://dx.doi.org/10.1038/35095061			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473KB	11565032	Green Submitted			2022-12-24	WOS:000171040500039
J	Radman, M				Radman, M			Fidelity and infidelity	NATURE			English	Editorial Material									Univ Paris 05, Lab Evolut & Med Mol Genet, INSERM, E9916, F-75730 Paris 15, France; Univ Paris 05, Dept Cell Biol, F-75730 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Radman, M (corresponding author), Univ Paris 05, Lab Evolut & Med Mol Genet, INSERM, E9916, F-75730 Paris 15, France.		; Radman, Miroslav/HDM-5955-2022	Radman, Miroslav/0000-0002-7034-4365; Radman, Miroslav/0000-0003-0216-3148				CAPORALE LH, 1999, MOL STRATEGIES BIOL; Freidberg E. C., 1997, CORRECTING BLUEPRINT; Keller Evelyn Fox, 2000, CENTURY GENE	3	24	26	0	5	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 13	2001	413	6852					115	115		10.1038/35093178	http://dx.doi.org/10.1038/35093178			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471FU	11557959	Bronze			2022-12-24	WOS:000170918800027
J	Gindler, J; Li, Z; Berry, RJ; Zheng, JC; Correa, A; Sun, XM; Wong, LY; Cheng, LC; Erickson, JD; Wang, Y; Tong, QL				Gindler, J; Li, Z; Berry, RJ; Zheng, JC; Correa, A; Sun, XM; Wong, LY; Cheng, LC; Erickson, JD; Wang, Y; Tong, QL		Jiaxing City Collaborative Project	Folic acid supplements during pregnancy and risk of miscarriage	LANCET			English	Article							NEURAL-TUBE DEFECTS; METHYLENETETRAHYDROFOLATE REDUCTASE; PREVENTION	Background Although taking supplements that contain 400 mug of folic acid before and during early pregnancy reduces a woman's risk for having a baby with a neural-tube defect (NTD), the effects of such supplements on other pregnancy outcomes remain unclear. We examined whether the use of such supplements affects the occurrence of miscarriage. Methods Participants were women in China who had taken part in a recent folic acid campaign to prevent NTDs and who had registered in this campaign before they became pregnant for the first time. We examined the risk for miscarriage among women who had confirmed pregnancies and who had or had not taken pills containing only 400 mug of folic acid before and during early pregnancy. Results The overall rate of miscarriage was 9.1% (2155/23 806). The rates of miscarriage among women who had and had not taken folic acid pills before and during the first trimester were 9.0% and 9.3%, respectively (risk ratio 0.97 [95% Cl 0.84-1.12]). The distributions of gestational age at pregnancy diagnosis and at miscarriage were similar for both groups of women. Interpretation In this population-based study of a cohort of women whose use of folic acid supplements while pregnant had been previously documented and who had been pregnant for the first time, we found no evidence that daily consumption of 400 pg of folic acid before and during early pregnancy influenced their risk for miscarriage.	Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30341 USA; Beijing Univ, Hlth Sci Ctr, Natl Ctr Maternal Hlth & Infant Hlth, Beijing 100871, Peoples R China; Jiaxing City Collaborat Project Neural Tube Defec, Jiaxing, Zhejiang Provin, Peoples R China	Centers for Disease Control & Prevention - USA; Peking University	Berry, RJ (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, 4770 Buford Highway,MS F-45, Atlanta, GA 30341 USA.	rjb1@cdc.gov		Berry, Robert/0000-0002-7162-5046				[Anonymous], 1991, Lancet, V338, P131, DOI 10.1016/0140-6736(91)90133-A; BENDICH A, 1991, MICRONUTRIENTS HLTH, P251; Berry RJ, 1999, NEW ENGL J MED, V341, P1485, DOI 10.1056/NEJM199911113412001; Berry RJ, 2000, NEW ENGL J MED, V342, P1136; Botto LD, 1998, CLIN GENET, V53, P456; Christensen B, 1999, AM J MED GENET, V84, P151, DOI 10.1002/(SICI)1096-8628(19990521)84:2<151::AID-AJMG12>3.3.CO;2-K; CZEIZEL AE, 1992, NEW ENGL J MED, V327, P1832, DOI 10.1056/NEJM199212243272602; FRENCH FE, 1962, PUBLIC HEALTH REP, V77, P835, DOI 10.2307/4591645; Hook EB, 2000, NEW ENGL J MED, V342, P1136; Hook EB, 1997, LANCET, V350, P513, DOI 10.1016/S0140-6736(97)01342-1; Ou CY, 1996, AM J MED GENET, V63, P610, DOI 10.1002/(SICI)1096-8628(19960628)63:4<610::AID-AJMG15>3.0.CO;2-L; Ray JG, 1999, PLACENTA, V20, P519, DOI 10.1053/plac.1999.0417; THIERSCH JB, 1952, AM J OBSTET GYNECOL, V63, P1298; VANDERPUT NMJ, 1995, LANCET, V346, P1070, DOI 10.1016/S0140-6736(95)91743-8; Wald N, 1997, LANCET, V350, P665, DOI 10.1016/S0140-6736(05)63358-2; WILCOX AJ, 1988, NEW ENGL J MED, V319, P189, DOI 10.1056/NEJM198807283190401; Windham GC, 2000, AM J MED GENET, V90, P261, DOI 10.1002/(SICI)1096-8628(20000131)90:3<261::AID-AJMG18>3.0.CO;2-L; Xu Z., 1992, CHUNG HUA HSUEH TSA, V72, P216	18	73	79	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 8	2001	358	9284					796	800		10.1016/S0140-6736(01)05969-4	http://dx.doi.org/10.1016/S0140-6736(01)05969-4			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	472NA	11564486				2022-12-24	WOS:000170989300012
J	Winther, JF; Sankila, R; Boice, JD; Tulinius, H; Bautz, A; Barlow, L; Glattre, E; Langmark, F; Moller, TR; Mulvihill, JJ; Olafsdottir, GH; Ritvanen, A; Olsen, JH				Winther, JF; Sankila, R; Boice, JD; Tulinius, H; Bautz, A; Barlow, L; Glattre, E; Langmark, F; Moller, TR; Mulvihill, JJ; Olafsdottir, GH; Ritvanen, A; Olsen, JH			Cancer in siblings of children with cancer in the Nordic countries: a population-based cohort study	LANCET			English	Article							CHILDHOOD-CANCER; HEREDITARY RETINOBLASTOMA; RELATIVES; FAMILIES; RISK; TUMORS; SIBS; EPIDEMIOLOGY; SURVIVORS; NEOPLASMS	Background In some rare inherited disorders such as Li-Fraumeni syndrome, relatives of children with cancer are at increased risk of cancer. We aimed to assess relations between childhood cancer and sibling risk, and evaluate the influence of recessive conditions in cancer causation. Methods We did a population-based cohort study in the Nordic countries of 42 277 siblings of 25 605 children with cancer. Children with cancer were identified from records in the five Nordic cancer registries, and their siblings from nationwide population registries. Cancers in siblings were documented through record linkage with cancer registries and compared with national incidence rates. We also assessed cancer incidence in parents to identify familial cancer syndromes. Findings 284.2 cancers were expected in siblings, whereas 353 were diagnosed (standardised incidence ratio 1.24 95% CI 1.12-1.38). Risk ratios for siblings were highest in the first decade of life (2.59, 1.89-3.46). We excluded 56 families with genetic syndromes linked to cancer, which reduced this ratio from 1.7 to 1.0 (0.7-1.3) for siblings younger than 20 years, and from 1.3 to 1.0 (0.8-1.3) for those aged 20-29 years. We found no new patterns of familial cancer that indicated inherited susceptibility, or evidence that recessive conditions might contribute to cancers not explained by syndromes. 40% of cancers in siblings that occurred before age 20 years could be attributed to known genetic factors, whereas 60% remained unexplained. Interpretation Apart from rare cancer syndromes, paediatric cancer is not an indicator of increased cancer risk in siblings.	Finnish Canc Registry, FIN-00170 Helsinki, Finland; Natl Res & Dev Ctr Welf & Hlth, Finnish Register Congenital Malformat, Helsinki, Finland; Int Epidemiol Inst, Rockville, MD USA; Vanderbilt Univ, Dept Med, Nashville, TN USA; Vanderbilt Ingram Canc Ctr, Nashville, TN USA; Univ Oklahoma, Oklahoma City, OK USA; Iceland Canc Registry, Reykjavik, Iceland; Natl Board Hlth & Welf, Ctr Epidemiol, Stockholm, Sweden; So Swedish Reg Registry, Lund, Sweden; Canc Registry Norway, Oslo, Norway	Finnish Cancer Registry; Vanderbilt University; Vanderbilt University; University of Oklahoma System; University of Oklahoma Health Sciences Center; National Board of Health & Welfare; University of Oslo	Winther, JF (corresponding author), Danish Canc Soc, Inst Canc Epidemiol, Strandblvd 49,Box 839, DK-2100 Copenhagen, Denmark.		Winther, Jeanette Falck/AAS-2754-2020	Winther, Jeanette Falck/0000-0002-3440-5108; Olsen, Jorgen Helge/0000-0001-9633-5662				BIRCH JM, 1987, INT J CANCER, V40, P620, DOI 10.1002/ijc.2910400508; BIRCH JM, 1990, CANCER-AM CANCER SOC, V66, P2239, DOI 10.1002/1097-0142(19901115)66:10<2239::AID-CNCR2820661034>3.0.CO;2-Q; BONDY ML, 1991, GENET EPIDEMIOL, V8, P253, DOI 10.1002/gepi.1370080406; BRESLOW NE, 1987, IARC SCI PUBLICATION, V82; BURKE E, 1991, CANCER-AM CANCER SOC, V67, P1467, DOI 10.1002/1097-0142(19910301)67:5<1467::AID-CNCR2820670535>3.0.CO;2-4; *DAN NAT BOARD HLT, 1999, CANC INC DENM 1996; DERKINDEREN DJ, 1988, INT J CANCER, V41, P499, DOI 10.1002/ijc.2910410405; DRAPER GJ, 1992, BRIT J CANCER, V66, P211, DOI 10.1038/bjc.1992.244; Draper GJ, 1996, BRIT J CANCER, V74, P152, DOI 10.1038/bjc.1996.331; DRAPER GJ, 1977, J MED GENET, V14, P81, DOI 10.1136/jmg.14.2.81; FARWELL J, 1984, NEW ENGL J MED, V311, P749, DOI 10.1056/NEJM198409203111201; HARTLEY AL, 1991, J NATL CANCER I, V83, P955, DOI 10.1093/jnci/83.13.955; Hoover RN, 2000, NEW ENGL J MED, V343, P135, DOI 10.1056/NEJM200007133430210; JONES SM, 1995, J MED GENET, V32, P627, DOI 10.1136/jmg.32.8.627; LI FP, 1995, CANCER EPIDEM BIOMAR, V4, P579; LI FP, 1976, J PEDIATR-US, V88, P419, DOI 10.1016/S0022-3476(76)80256-9; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Lindor NM, 1998, JNCI-J NATL CANCER I, V90, P1039, DOI 10.1093/jnci/90.14.1039; MILLER RW, 1971, J NATL CANCER I, V46, P203; MOUTOU C, 1994, J MED GENET, V31, P429, DOI 10.1136/jmg.31.6.429; MULVIHILL JJ, 1999, CATALOG HUMAN CANC G, P1; *NORD MED STAT COM, 1991, NOMESCO PUBL, V36; OLSEN JH, 1990, HUM GENET, V85, P283; OLSEN JH, 1995, NEW ENGL J MED, V333, P1594, DOI 10.1056/NEJM199512143332403; OLSEN JH, 1993, BRIT MED J, V307, P1030, DOI 10.1136/bmj.307.6911.1030; PASTORE G, 1985, FAM CANCER, P146; PERKKIO M, 1990, PEDIATR HEMAT ONCOL, V7, P159, DOI 10.3109/08880019009033386; Sankila R, 1998, NEW ENGL J MED, V338, P1339, DOI 10.1056/NEJM199805073381902; SCHULL WJ, 1977, GENETICS HUMAN CANC, P15; STEINBERG AG, 1960, CANCER, V13, P985, DOI 10.1002/1097-0142(196009/10)13:5<985::AID-CNCR2820130520>3.0.CO;2-J; STROM SS, 1991, AM J EPIDEMIOL, V134, P766; STRONG LC, 1984, J NATL CANCER I, V73, P303, DOI 10.1093/jnci/73.2.303; Tulinius H, 1992, APMIS Suppl, V31, P1	33	54	56	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 1	2001	358	9283					711	717		10.1016/S0140-6736(01)05838-X	http://dx.doi.org/10.1016/S0140-6736(01)05838-X			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	467XR	11551577				2022-12-24	WOS:000170729500010
J	Klaassen, M; Lindstrom, A; Meltofte, H; Piersma, T				Klaassen, M; Lindstrom, A; Meltofte, H; Piersma, T			Ornithology - Arctic waders are not capital breeders	NATURE			English	Article							STABLE ISOTOPES		Netherlands Inst Ecol, Ctr Limnol, NL-3600 BG Maarssen, Netherlands; Lund Univ, Dept Anim Ecol, S-22362 Lund, Sweden; Netherlands Inst Sea Res, NL-1790 AB Den Burg, Netherlands; Univ Groningen, Ctr Ecol & Evolutionary Studies, NL-9750 AA Haren, Netherlands; Natl Environm Res Inst, Dept Arctic Environm, DK-4000 Roskilde, Denmark	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Lund University; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); University of Groningen; Aarhus University	Klaassen, M (corresponding author), Netherlands Inst Ecol, Ctr Limnol, POB 1299, NL-3600 BG Maarssen, Netherlands.		Piersma, Theunis/D-1871-2012; Bond, Alexander L/A-3786-2010; Klaassen, Marcel/B-4325-2008	Klaassen, Marcel/0000-0003-3907-9599				Cramp S., 1980, BIRDS W PALEARCTIC, V2; Davidson N.C., 1988, P342; DRENT RH, 1980, ARDEA, V68, P225; Hobson KA, 1999, OECOLOGIA, V120, P314, DOI 10.1007/s004420050865; Newton I., 1977, P113; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Stettenheim P., 1972, AVIAN BIOL, V2, P1; WITTER MS, 1993, PHILOS T R SOC B, V340, P73, DOI 10.1098/rstb.1993.0050	8	169	179	0	33	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 25	2001	413	6858					794	794		10.1038/35101654	http://dx.doi.org/10.1038/35101654			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	485JA	11677593	Green Published			2022-12-24	WOS:000171750200032
J	Barnett, RN; Cleveland, CL; Joy, A; Landman, U; Schuster, GB				Barnett, RN; Cleveland, CL; Joy, A; Landman, U; Schuster, GB			Charge migration in DNA: Ion-gated transport	SCIENCE			English	Article							HOLE TRANSPORT; POTENTIALS; DYNAMICS; BASES	Electron hole (radical cation) migration in DNA, where the quantum transport of an injected charge is gated in a correlated manner by the thermal motions of the hydrated counterions, is described here. Classical molecular dynamics simulations in conjunction with large-scale first-principles electronic structure calculations reveal that different counterion configurations Lead to formation of states characterized by varying spatial distributions and degrees of charge localization. Stochastic dynamic fluctuations between such ionic configurations can induce correlated changes in the spatial distribution of the hole, with concomitant transport along the DNA double helix. Comparative ultraviolet tight-induced cleavage experiments on native B DNA oligomers and on ones modified to contain counterion (Na+)-starved bridges between damage-susceptible hole-trapping sites called GG steps show in the Latter a reduction in damage at the distal step. This reduction indicates a reduced mobility of the hole across the modified bridge as predicted theoretically.	Georgia Inst Technol, Sch Phys, Atlanta, GA 30332 USA; Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Landman, U (corresponding author), Georgia Inst Technol, Sch Phys, Atlanta, GA 30332 USA.	gary.schuster@cos.gatech.edu						ARNOTT S, 1977, HDB BIOCH MOL BIOL, P411; BARNETT RN, 1993, PHYS REV B, V48, P2081, DOI 10.1103/PhysRevB.48.2081; Berlin YA, 2001, J AM CHEM SOC, V123, P260, DOI 10.1021/ja001496n; Beveridge DL, 2000, CURR OPIN STRUC BIOL, V10, P182, DOI 10.1016/S0959-440X(00)00076-2; Boudaiffa B, 2000, SCIENCE, V287, P1658, DOI 10.1126/science.287.5458.1658; Fink HW, 2001, CELL MOL LIFE SCI, V58, P1, DOI 10.1007/PL00000770; Giese B, 2000, ACCOUNTS CHEM RES, V33, P631, DOI 10.1021/ar990040b; Grozema FC, 2000, J AM CHEM SOC, V122, P10903, DOI 10.1021/ja001497f; Heller A, 2000, FARADAY DISCUSS, V116, P1, DOI 10.1039/b006196o; Henderson PT, 1999, P NATL ACAD SCI USA, V96, P8353, DOI 10.1073/pnas.96.15.8353; Hud NV, 2001, CURR OPIN STRUC BIOL, V11, P293, DOI 10.1016/S0959-440X(00)00205-0; HUSH NS, 1975, CHEM PHYS LETT, V34, P11, DOI 10.1016/0009-2614(75)80190-4; Jackson NM, 2001, CURR OPIN CHEM BIOL, V5, P209, DOI 10.1016/S1367-5931(00)00192-7; Jortner J, 1998, P NATL ACAD SCI USA, V95, P12759, DOI 10.1073/pnas.95.22.12759; Lewis FD, 2001, ACCOUNTS CHEM RES, V34, P159, DOI 10.1021/ar0000197; LIAS SG, 1988, J PHYS CHEM REF DATA, V17, P1; Marcus RA, 1998, J PHYS CHEM B, V102, P10071, DOI 10.1021/jp9834457; McFail-Isom L, 1999, CURR OPIN STRUC BIOL, V9, P298, DOI 10.1016/S0959-440X(99)80040-2; Meggers E, 1998, J AM CHEM SOC, V120, P12950, DOI 10.1021/ja983092p; ORLOV VM, 1976, TETRAHEDRON LETT, P4377; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Ratner MA, 2001, P NATL ACAD SCI USA, V98, P387, DOI 10.1073/pnas.98.2.387; Schuster GB, 2000, ACCOUNTS CHEM RES, V33, P253, DOI 10.1021/ar980059z; Steenken S, 1997, J AM CHEM SOC, V119, P617, DOI 10.1021/ja962255b; TCHOU J, 1991, P NATL ACAD SCI USA, V88, P4690, DOI 10.1073/pnas.88.11.4690; TROULLIER N, 1991, PHYS REV B, V43, P1993, DOI 10.1103/PhysRevB.43.1993; Wan CZ, 2000, P NATL ACAD SCI USA, V97, P14052, DOI 10.1073/pnas.250483297; Wang D, 1998, MUTAT RES-FUND MOL M, V400, P99, DOI 10.1016/S0027-5107(98)00066-9; [No title captured]	29	338	347	1	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2001	294	5542					567	571		10.1126/science.1062864	http://dx.doi.org/10.1126/science.1062864			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484NC	11641491				2022-12-24	WOS:000171695600039
J	Murphy, DJ; Liebling, RE; Verity, L; Swingler, R; Patel, R				Murphy, DJ; Liebling, RE; Verity, L; Swingler, R; Patel, R			Early maternal and neonatal morbidity associated with operative delivery in second stage of labour: a cohort study	LANCET			English	Article							CESAREAN-SECTION; VAGINAL DELIVERY; TRIAL; MIDFORCEPS; FORCEPS	Background A frequent dilemma for obstetricians is how to keep morbidity to a minimum when faced with arrested progress at full dilatation of the cervix. Our aim was to examine maternal and neonatal morbidity associated with vaginal instrumental delivery in theatre and caesarean section, at full dilatation. Methods We did a prospective cohort study of 393 women, who had term, singleton, liveborn, cephalic pregnancies requiring operative delivery in theatre at full dilatation for 1 year. Findings Factors increasing the likelihood of caesarean section included maternal body-mass index greater than 30 (adjusted odds ratio 2.4, 95% CI 1.2-4.9), neonatal birthweight greater than 4.0 kg (2.3, 1.3-3.8), and occipitoposterior position (2.5, 1.6-3.9). Women undergoing caesarean section were more likely to have a major haemorrhage (>1 L; 2.8, 1.1-7.6) and extended hospital stay (greater than or equal to6 days; 3.5, 1.6-7.6) than those with vaginal delivery. Babies delivered by caesarean section were more likely to require admission for intensive care (2.6, 1.2-6.0) but less likely to have trauma (0.4, 0.2-0.7) than babies delivered by forceps. Overall neonatal morbidity was low, but a few babies in each group had serious complications (serious trauma, eight vs three; sepsis, six vs 13; and jaundice, ten vs 12 after vaginal delivery and caesarean section, respectively). Major haemorrhage was less likely after delivery by a skilled obstetrician (0.5, 0.3-0.9). Interpretation The data lend support to an aim to deliver women vaginally, unless there are clear signs of cephalopelvic disproportion, and underline the importance of skilled obstetricians supervising complex operative deliveries.	Univ Bristol, St Michaels Hosp, Div Obstet & Gynecol, Bristol BS2 8EG, Avon, England; Southmead Gen Hosp, N Bristol NHS Trust, Bristol, Avon, England	University of Bristol; North Bristol NHS Trust; Southmead Hospital	Murphy, DJ (corresponding author), Univ Bristol, St Michaels Hosp, Div Obstet & Gynecol, Southwell St, Bristol BS2 8EG, Avon, England.			Patel, Roshni/0000-0002-1399-3131; Murphy, Deirdre/0000-0001-6074-6718				AlMufti R, 1996, LANCET, V347, P544, DOI 10.1016/S0140-6736(96)91176-9; *ASS IMPR MAT SERV, 1997, CHART ETH RES MAT CA; BASHORE RA, 1990, AM J OBSTET GYNECOL, V162, P1428, DOI 10.1016/0002-9378(90)90902-J; CHISWICK ML, 1979, BRIT MED J, V1, P7, DOI 10.1136/bmj.1.6155.7; CIBILS LA, 1990, J PERINAT MED, V18, P5, DOI 10.1515/jpme.1990.18.1.5; CLARK SL, 1984, OBSTET GYNECOL, V64, P376; DIERKER LJ, 1985, AM J OBSTET GYNECOL, V152, P176, DOI 10.1016/S0002-9378(85)80019-3; *EXP MAT GROUP, 1993, CHANG CHILDB 1; Fynes M, 1999, LANCET, V354, P983, DOI 10.1016/S0140-6736(98)11205-9; Fynes M, 1998, OBSTET GYNECOL, V92, P496, DOI 10.1016/S0029-7844(98)00256-7; Hannah ME, 2000, LANCET, V356, P1375, DOI 10.1016/S0140-6736(00)02840-3; Johanson RB, 1999, BRIT J OBSTET GYNAEC, V106, P544, DOI 10.1111/j.1471-0528.1999.tb08322.x; LOMAS J, 1989, EFFECTIVE CARE PREGN, P1189; LOWE B, 1987, BRIT J OBSTET GYNAEC, V94, P60, DOI 10.1111/j.1471-0528.1987.tb02254.x; Penn ZJ, 1996, BRIT J OBSTET GYNAEC, V103, P684, DOI 10.1111/j.1471-0528.1996.tb09838.x; REPKE JT, 1984, SURG GYNECOL OBSTET, V158, P112; Revah A, 1997, AM J OBSTET GYNECOL, V176, P200, DOI 10.1016/S0002-9378(97)80036-1; ROBERTSON PA, 1990, AM J OBSTET GYNECOL, V162, P1436, DOI 10.1016/0002-9378(90)90903-K; RODRIGUEZ AI, 1994, AM J OBSTET GYNECOL, V171, P1022, DOI 10.1016/0002-9378(94)90026-4; Sachs BP, 1999, NEW ENGL J MED, V340, P54, DOI 10.1056/NEJM199901073400112; Wagner M, 2000, LANCET, V356, P1677, DOI 10.1016/S0140-6736(00)03169-X	21	216	224	0	8	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 13	2001	358	9289					1203	1207		10.1016/S0140-6736(01)06341-3	http://dx.doi.org/10.1016/S0140-6736(01)06341-3			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	481NX	11675055				2022-12-24	WOS:000171527000007
J	Bayes-Genis, A; Conover, CA; Overgaard, MT; Bailey, KR; Christiansen, M; Holmes, DR; Virmani, R; Oxvig, C; Schwartz, RS				Bayes-Genis, A; Conover, CA; Overgaard, MT; Bailey, KR; Christiansen, M; Holmes, DR; Virmani, R; Oxvig, C; Schwartz, RS			Pregnancy-associated plasma protein a as a marker of acute coronary syndromes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MAJOR BASIC-PROTEIN; GROWTH-FACTOR-I; ACUTE MYOCARDIAL-INFARCTION; CARDIAC TROPONIN-T; EMERGENCY ROOM; CHEST PAIN; ATHEROSCLEROSIS; SERUM; RISK; EXPRESSION	Background: Circulating markers indicating the instability of atherosclerotic plaques could have diagnostic value in unstable angina or acute myocardial infarction. We evaluated pregnancy-associated plasma protein A (PAPP-A), a potentially proatherosclerotic metalloproteinase, as a marker of acute coronary syndromes. Methods: We examined the level of expression of PAPP-A in eight culprit unstable coronary plaques and four stable plaques from eight patients who had died suddenly of cardiac causes. We also measured circulating levels of PAPP-A, C-reactive protein, and insulin-like growth factor I (IGF-I) in 17 patients with acute myocardial infarction, 20 with unstable angina, 19 with stable angina, and 13 controls without atherosclerosis. Results: PAPP-A was abundantly expressed in plaque cells and extracellular matrix of ruptured and eroded unstable plaques, but not in stable plaques. Circulating PAPP-A levels were significantly higher in patients with unstable angina or acute myocardial infarction than in patients with stable angina and controls (P<0.001). A PAPP-A threshold value of 10 mIU per liter identified patients who had acute coronary syndromes with a sensitivity of 89.2 percent and a specificity of 81.3 percent. PAPP-A levels correlated with levels of C-reactive protein and free IGF-I, but not with markers of myocardial injury (troponin I and the MB isoform of creatine kinase). Conclusions: PAPP-A is present in unstable plaques, and circulating levels are elevated in acute coronary syndromes; these increased levels may reflect the instability of atherosclerotic plaques. PAPP-A is a new candidate marker of unstable angina and acute myocardial infarction. (N Engl J Med 2001;345:1022-9.) Copyright (C) 2001 Massachusetts Medical Society.	Mayo Clin & Mayo Fdn, Div Cardiovasc Dis, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Endocrine Res Unit, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Stat, Rochester, MN 55905 USA; Univ Aarhus, Dept Biol Mol & Struct, Aarhus, Denmark; Statens Serum Inst, Dept Clin Biochem, DK-2300 Copenhagen, Denmark; Armed Forces Inst Pathol, Dept Cardiovasc Pathol, Washington, DC 20306 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Aarhus University; Statens Serum Institut; United States Department of Defense	Schwartz, RS (corresponding author), Mayo Clin & Mayo Fdn, Div Cardiovasc Dis, 200 1st St SW, Rochester, MN 55905 USA.		Bayes-Genis, Antoni/C-4002-2015; Bayes-Genis, Antonio/AAV-9422-2021; Christiansen, Michael/B-4588-2009; Overgaard, Michael Toft/E-1354-2011	Bayes-Genis, Antoni/0000-0002-3044-197X; Bayes-Genis, Antonio/0000-0002-3044-197X; Christiansen, Michael/0000-0003-4713-755X; Overgaard, Michael Toft/0000-0002-1423-2481; Oxvig, Claus/0000-0002-4715-9719				Antman EM, 1996, NEW ENGL J MED, V335, P1342, DOI 10.1056/NEJM199610313351802; Bayes-Genis A, 2001, ARTERIOSCL THROM VAS, V21, P335, DOI 10.1161/01.ATV.21.3.335; Bayes-Genis A, 2000, CIRC RES, V86, P125, DOI 10.1161/01.RES.86.2.125; Burke AP, 1997, NEW ENGL J MED, V336, P1276, DOI 10.1056/NEJM199705013361802; Christiansen M, 2000, CLIN CHEM, V46, P1099; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; DEWINTER RJ, 1995, CIRCULATION, V92, P3401, DOI 10.1161/01.CIR.92.12.3401; DU J, 1995, CIRC RES, V76, P963, DOI 10.1161/01.RES.76.6.963; GALIS ZS, 1994, J CLIN INVEST, V94, P2493, DOI 10.1172/JCI117619; GALIS ZS, 1995, P NATL ACAD SCI USA, V92, P402, DOI 10.1073/pnas.92.2.402; Hamm CW, 1997, NEW ENGL J MED, V337, P1648, DOI 10.1056/NEJM199712043372302; JENKINS PJ, 1978, BMJ-BRIT MED J, V2, P388, DOI 10.1136/bmj.2.6134.388; Jones JI, 1996, P NATL ACAD SCI USA, V93, P2482, DOI 10.1073/pnas.93.6.2482; Kontos MC, 1997, J AM COLL CARDIOL, V30, P976, DOI 10.1016/S0735-1097(97)00264-7; Lawrence JB, 1999, P NATL ACAD SCI USA, V96, P3149, DOI 10.1073/pnas.96.6.3149; LIN TM, 1974, AM J OBSTET GYNECOL, V118, P223, DOI 10.1016/0002-9378(74)90553-5; LIUZZO G, 1994, NEW ENGL J MED, V331, P417, DOI 10.1056/NEJM199408183310701; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Newby LK, 2000, AM HEART J, V140, P351, DOI 10.1067/mhj.2000.108824; Nichols TC, 1999, CIRC RES, V85, P1040; NIKKARI ST, 1995, CIRCULATION, V92, P1393, DOI 10.1161/01.CIR.92.6.1393; Ohman EM, 1996, NEW ENGL J MED, V335, P1333, DOI 10.1056/NEJM199610313351801; Overgaard MT, 1999, BIOL REPROD, V61, P1083, DOI 10.1095/biolreprod61.4.1083; OXVIG C, 1995, J BIOL CHEM, V270, P13645, DOI 10.1074/jbc.270.23.13645; OXVIG C, 1994, BBA-GEN SUBJECTS, V1201, P415, DOI 10.1016/0304-4165(94)90071-X; PULEO PR, 1994, NEW ENGL J MED, V331, P561, DOI 10.1056/NEJM199409013310901; Qin QP, 1997, CLIN CHEM, V43, P2323; Renier G, 1996, ENDOCRINOLOGY, V137, P4611, DOI 10.1210/en.137.11.4611; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; SABIA P, 1991, CIRCULATION, V84, pI85; Wald NJ, 1999, NEW ENGL J MED, V341, P461, DOI 10.1056/NEJM199908123410701	32	463	561	0	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 4	2001	345	14					1022	1029		10.1056/NEJMoa003147	http://dx.doi.org/10.1056/NEJMoa003147			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	478HF	11586954	Bronze			2022-12-24	WOS:000171340400003
J	Ramsey, JD; Butcher, MA; Murphy, MF; Lee, T; Johnston, A; Holt, DW				Ramsey, JD; Butcher, MA; Murphy, MF; Lee, T; Johnston, A; Holt, DW			A new method to monitor drugs at dance venues	BRITISH MEDICAL JOURNAL			English	Article							ECSTASY		Univ London St Georges Hosp, Sch Med, London SW17 0RE, England; Univ London Kings Coll, London SE1 8WA, England; St Bartholomews & Royal London Sch Med & Dent, London EC1M 6BQ, England	St Georges University London; University of London; King's College London; University of London; Queen Mary University London	Holt, DW (corresponding author), Univ London St Georges Hosp, Sch Med, London SW17 0RE, England.			Johnston, Atholl/0000-0001-5787-2270				MOFFAT AC, 1986, CLARKES ISOLATION ID, P139; Ramsey JD, 1999, LANCET, V354, P2166, DOI 10.1016/S0140-6736(05)77071-9; RAMSEY JD, 1999, TICTAC VERSION 4 4; Sherlock K, 1999, J ACCID EMERG MED, V16, P194	4	30	30	1	6	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 15	2001	323	7313					603	603		10.1136/bmj.323.7313.603	http://dx.doi.org/10.1136/bmj.323.7313.603			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	474CT	11557708	Green Published, Bronze			2022-12-24	WOS:000171087300019
J	Uplekar, M; Pathania, V; Raviglione, M				Uplekar, M; Pathania, V; Raviglione, M			Private practitioners and public health: weak links in tuberculosis control	LANCET			English	Editorial Material							GENERAL-PRACTITIONERS; INDIA; CLINICS		WHO, Stop TB Dept, CH-1211 Geneva, Switzerland	World Health Organization	Uplekar, M (corresponding author), WHO, Stop TB Dept, CH-1211 Geneva, Switzerland.			RAVIGLIONE, Mario/0000-0002-9331-2067				FUJIWARA PI, 1996, TUBERCLE LUNG DIS S2, V77, P72; GRIFFIN C, 1989, 4 IFC WORLD BANK; Hong YP, 1999, INT J TUBERC LUNG D, V3, P695; Kamat V. R., 1997, PRIVATE HLTH PROVIDE, P124; LONROTH K, 2000, PUBLIC HLTH PRIVATE; LONROTH K, IN PRESS HLTH POL PL; *NAT COUNC APPL EC, 1995, 53 NCAER; Pathania V, 1997, WHOTB972231997; Reich MR, 2000, NAT MED, V6, P617, DOI 10.1038/76176; Singla N, 1998, INT J TUBERC LUNG D, V2, P384; TAYLOR E, 1999, TUBERCULOSIS AN INTE; Uplekar M, 1998, INT J TUBERC LUNG D, V2, P324; UPLEKAR M, 1996, SEARCH SOLUTIONS; UPLEKAR MW, 1991, TUBERCLE, V72, P284, DOI 10.1016/0041-3879(91)90055-W; Weil DEC, 2000, INT J TUBERC LUNG D, V4, P597; *WHO, 1995, WHOTB96202; *WHO, 2000, WHOCDSTB2000282; *WHO, 2000, WHOCDSTB2000	18	197	198	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 15	2001	358	9285					912	916		10.1016/S0140-6736(01)06076-7	http://dx.doi.org/10.1016/S0140-6736(01)06076-7			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	474CP	11567729				2022-12-24	WOS:000171087000030
J	Mokdad, AH; Bowman, BA; Ford, ES; Vinicor, F; Marks, JS; Koplan, JP				Mokdad, AH; Bowman, BA; Ford, ES; Vinicor, F; Marks, JS; Koplan, JP			The continuing epidemics of obesity and diabetes in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IMPAIRED GLUCOSE-TOLERANCE; RISK FACTOR SURVEILLANCE; WEIGHT-GAIN; HEALTH; MELLITUS; US; PREVENTION; PREVALENCE; OVERWEIGHT; EXERCISE	Context Recent reports show that obesity and diabetes have increased in the United States in the past decade. Objective To estimate the prevalence of obesity, diabetes, and use of weight control strategies among US adults in 2000. Design, Setting, and Participants The Behavioral Risk Factor Surveillance System, a random-digit telephone survey conducted in all states in 2000, with 184450 adults aged 18 years or older. Main Outcome Measures Body mass index (BMI), calculated from self-reported weight and height; self-reported diabetes; prevalence of weight loss or maintenance attempts; and weight control strategies used. Results In 2000, the prevalence of obesity (BMI greater than or equal to 30 kg/m(2)) was 19.8%, the prevalence of diabetes was 7.3% and the prevalence of both combined was 2.9%. Mississippi had the highest rates of obesity (24.3%) and of diabetes (8.8%); Colorado had the lowest rate of obesity (13.8%); and Alaska had the lowest rate of diabetes (4.4%). Twenty-seven percent of US adults did not engage in any physical activity, and another 28.2% were not regularly active. Only 24.4% of US adults consumed fruits and vegetables 5 or more times daily. Among obese participants who had had a routine checkup during the past year, 42.8% had been advised by a health care professional to lose weight. Among participants trying to lose or maintain weight, 17.5% were following recommendations to eat fewer calories and increase physical activity to more than 150 min/wk. Conclusions The prevalence of obesity and diabetes continues to increase among US adults. Interventions are needed to improve physical activity and diet in communities nationwide.	Ctr Dis Control & Prevent, Data Management Div, Natl Immunizat Program, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Div Diabet Translat, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Div Nutr & Phys Activ, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Off Director, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Mokdad, AH (corresponding author), Ctr Dis Control & Prevent, Data Management Div, Natl Immunizat Program, MS E62,1600 Clifton Rd NE, Atlanta, GA 30333 USA.	ahm1@cdc.gov						ADAY LA, 1989, DESIGNING CONDUCTING, P79; Allison DB, 1999, JAMA-J AM MED ASSOC, V282, P1530, DOI 10.1001/jama.282.16.1530; *AM DIAB ASS, 1997, DIAB FACTS FIG; CASPERSEN CJ, 1987, DHHS PUBLICATION PHS; CHAN JM, 1994, DIABETES CARE, V17, P961, DOI 10.2337/diacare.17.9.961; Colditz GA, 1999, MED SCI SPORT EXER, V31, pS663, DOI 10.1097/00005768-199911001-00026; COLDITZ GA, 1995, ANN INTERN MED, V122, P481, DOI 10.7326/0003-4819-122-7-199504010-00001; Department of Health and Human Services. National Heart Lung and Blood Institute, 1998, CLIN GUID ID EV TREA; ERIKSSON KF, 1991, DIABETOLOGIA, V34, P891, DOI 10.1007/BF00400196; Fontaine K., 1998, DIS MANAG HLTH OUT, V3, P61; Fontanarosa PB, 1999, JAMA-J AM MED ASSOC, V282, P1581, DOI 10.1001/jama.282.16.1581; Ford ES, 2001, OBES RES, V9, P21, DOI 10.1038/oby.2001.4; Ford ES, 1997, AM J EPIDEMIOL, V146, P214, DOI 10.1093/oxfordjournals.aje.a009256; Ford ES, 1998, J CLIN EPIDEMIOL, V51, P55, DOI 10.1016/S0895-4356(97)00225-4; Galuska DA, 1999, JAMA-J AM MED ASSOC, V282, P1576, DOI 10.1001/jama.282.16.1576; HANSEN RG, 1995, J IND ECON, V43, P261, DOI 10.2307/2950579; Harris MI, 1998, DIABETES CARE, V21, pC11, DOI 10.2337/diacare.21.3.C11; Harris MI, 1998, DIABETES CARE, V21, P518, DOI 10.2337/diacare.21.4.518; HOLBROOK TL, 1989, INT J OBESITY, V13, P723; Koplan JP, 1999, JAMA-J AM MED ASSOC, V282, P1579, DOI 10.1001/jama.282.16.1579; Li RW, 2000, AM J PUBLIC HEALTH, V90, P777, DOI 10.2105/AJPH.90.5.777; Mokdad AH, 2000, JAMA-J AM MED ASSOC, V284, P1650, DOI 10.1001/jama.284.13.1650; Mokdad AH, 2000, DIABETES CARE, V23, P1278, DOI 10.2337/diacare.23.9.1278; Mokdad AH, 2001, DIABETES CARE, V24, P412, DOI 10.2337/diacare.24.2.412; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; NELSON DE, 1998, P SECT SURV METH AM; PALTA M, 1982, AM J EPIDEMIOL, V115, P223, DOI 10.1093/oxfordjournals.aje.a113294; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; PISUNYER FX, 1991, AM J CLIN NUTR, V53, pS1595; PISUNYER FX, 1993, ANN INTERN MED, V119, P655, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00006; Ray NF, 1998, DIABETES CARE, V21, P296; REMINGTON PL, 1988, PUBLIC HEALTH REP, V103, P366; Resnick HE, 2000, J EPIDEMIOL COMMUN H, V54, P596, DOI 10.1136/jech.54.8.596; ROWLAND ML, 1990, AM J CLIN NUTR, V52, P1125, DOI 10.1093/ajcn/52.6.1125; *SAS I INC, 1998, SAS VERS 6; Serdula MK, 1999, JAMA-J AM MED ASSOC, V282, P1353, DOI 10.1001/jama.282.14.1353; Shah BV, 1997, SUDAAN USERS MANUAL; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; World Health Organization Expert Committee on Physical Status, 1995, WHO TECHN REP SER, V854	39	1884	1942	1	138	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 12	2001	286	10					1195	1200		10.1001/jama.286.10.1195	http://dx.doi.org/10.1001/jama.286.10.1195			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	471CR	11559264	Bronze			2022-12-24	WOS:000170910400029
J	Schwetz, BA				Schwetz, BA			Treatment for hepatitis C	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									US FDA, Off Commissioner Food & Drugs, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Schwetz, BA (corresponding author), US FDA, Off Commissioner Food & Drugs, HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	2	2	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 12	2001	286	10					1166	1166		10.1001/jama.286.10.1166	http://dx.doi.org/10.1001/jama.286.10.1166			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	471CR	11559244				2022-12-24	WOS:000170910400006
J	Ishigaki, Y; Li, XJ; Serin, G; Maquat, LE				Ishigaki, Y; Li, XJ; Serin, G; Maquat, LE			Evidence for a pioneer round of mRNA translation: mRNAs subject to nonsense-mediated decay in mammalian cells are bound by CBP80 and CBP20	CELL			English	Article							CAP-BINDING PROTEIN; GLUTATHIONE-PEROXIDASE 1; INITIATION-FACTOR 4E; POLY(A)-BINDING PROTEIN; RIBONUCLEOPROTEIN PARTICLE; UPF PROTEINS; FACTOR 4G; NUCLEAR; COMPLEX; YEAST	Nonsense-mediated decay (NMD) eliminates mRNAs that prematurely terminate translation. We used antibody to the nuclear cap binding protein CBP80 or its cytoplasmic counterpart eIF4E to immunopurify RNP containing nonsense-free or nonsense-containing transcripts. Data indicate that NMD takes place in association with CBP80. We defined other components of NMD-susceptible mRNP as CBP20, PABP2, eIF4G, and the NMD factors Upf2 and Upf3. Consistent with the dependence of NMD on translation, the NMD of CBP80-bound mRNA is blocked by cycloheximide or suppressor tRNA. These findings provide evidence that translation can take place in association with CBP80. They also indicate that CBP80-bound mRNA undergoes a "pioneer" round of translation, before CBP80-CBP20 are replaced by eIF4E, and Upf2 and Upf3 proteins dissociate from upstream of exon-exon junctions.	Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA	University of Rochester	Maquat, LE (corresponding author), Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, 601 Elmwood Ave,Box 712, Rochester, NY 14642 USA.	lynne_maquat@urmc.rochester.edu		Maquat, Lynne/0000-0002-2789-2075	NIDDK NIH HHS [DK 33938] Funding Source: Medline; NIGMS NIH HHS [GM 59614] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033938] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059614] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BELGRADER P, 1994, MOL CELL BIOL, V14, P6326, DOI 10.1128/MCB.14.9.6326; BELGRADER P, 1993, P NATL ACAD SCI USA, V90, P482, DOI 10.1073/pnas.90.2.482; BELGRADER P, 1994, MOL CELL BIOL, V14, P8219, DOI 10.1128/MCB.14.12.8219; Bhattacharya A, 2000, RNA, V6, P1226, DOI 10.1017/S1355838200000546; BIENROTH S, 1993, EMBO J, V12, P585, DOI 10.1002/j.1460-2075.1993.tb05690.x; Carter MS, 1996, EMBO J, V15, P5965, DOI 10.1002/j.1460-2075.1996.tb00983.x; Chu E, 1999, METH MOL B, V118, P265; Czaplinski K, 1998, GENE DEV, V12, P1665, DOI 10.1101/gad.12.11.1665; Das B, 2000, MOL CELL BIOL, V20, P2827, DOI 10.1128/MCB.20.8.2827-2838.2000; Dostie J, 2000, J CELL BIOL, V148, P239, DOI 10.1083/jcb.148.2.239; Fortes P, 2000, MOL CELL, V6, P191, DOI 10.1016/S1097-2765(00)00020-4; Frischmeyer PA, 1999, HUM MOL GENET, V8, P1893, DOI 10.1093/hmg/8.10.1893; HARLOW E, 1999, USING ANTIBODIES LAB, P74; Hentze MW, 1999, CELL, V96, P307, DOI 10.1016/S0092-8674(00)80542-5; Hentze MW, 1997, SCIENCE, V275, P500, DOI 10.1126/science.275.5299.500; Imataka H, 1998, EMBO J, V17, P7480, DOI 10.1093/emboj/17.24.7480; IZAURRALDE E, 1994, CELL, V78, P657, DOI 10.1016/0092-8674(94)90530-4; IZAURRALDE E, 1995, NATURE, V376, P709, DOI 10.1038/376709a0; Kessler SH, 1998, MOL CELL BIOL, V18, P51, DOI 10.1128/MCB.18.1.51; KRAUSE S, 1994, EXP CELL RES, V214, P75, DOI 10.1006/excr.1994.1235; KUGLER W, 1995, NUCLEIC ACIDS RES, V23, P413, DOI 10.1093/nar/23.3.413; Le Hir H, 2000, EMBO J, V19, P6860, DOI 10.1093/emboj/19.24.6860; Le Hir H, 2000, GENE DEV, V14, P1098; LEJBKOWICZ F, 1992, P NATL ACAD SCI USA, V89, P9612, DOI 10.1073/pnas.89.20.9612; Lewis JD, 1997, EUR J BIOCHEM, V247, P461, DOI 10.1111/j.1432-1033.1997.00461.x; Lykke-Andersen J, 2000, CELL, V103, P1121, DOI 10.1016/S0092-8674(00)00214-2; Maquat LE, 2000, COLD SPRING HARBOR M, V39, P849; Maquat LE, 2001, CELL, V104, P173, DOI 10.1016/S0092-8674(01)00202-1; MAQUAT LE, 1995, RNA, V1, P453; MAQUAT LE, 2001, IN PRESS COLD SPRING; Marcotrigiano J, 1999, MOL CELL, V3, P707, DOI 10.1016/S1097-2765(01)80003-4; McKendrick L, 2001, MOL CELL BIOL, V21, P3632, DOI 10.1128/MCB.21.11.3632-3641.2001; MEHLIN H, 1992, CELL, V69, P605, DOI 10.1016/0092-8674(92)90224-Z; Mendell JT, 2000, MOL CELL BIOL, V20, P8944, DOI 10.1128/MCB.20.23.8944-8957.2000; Moriarty PM, 1998, MOL CELL BIOL, V18, P2932, DOI 10.1128/MCB.18.5.2932; Morley SJ, 1997, J BIOL CHEM, V272, P17887, DOI 10.1074/jbc.272.28.17887; NEMETH A, 1995, NUCLEIC ACIDS RES, V23, P4034, DOI 10.1093/nar/23.20.4034; Orphanides G, 2000, NATURE, V407, P471, DOI 10.1038/35035000; Pal M, 2001, RNA, V7, P5, DOI 10.1017/S1355838201000127; Ptushkina M, 1998, EMBO J, V17, P4798, DOI 10.1093/emboj/17.16.4798; Pyronnet S, 1999, EMBO J, V18, P270, DOI 10.1093/emboj/18.1.270; Rajavel KS, 2001, MOL CELL BIOL, V21, P5512, DOI 10.1128/MCB.21.16.5512-5519.2001; Sachs AB, 2000, NAT STRUCT BIOL, V7, P356, DOI 10.1038/75120; Serin G, 2001, MOL CELL BIOL, V21, P209, DOI 10.1128/MCB.21.1.209-223.2001; Shen EC, 2000, J BIOL CHEM, V275, P23718, DOI 10.1074/jbc.M002312200; Sun XL, 2000, EMBO J, V19, P4734, DOI 10.1093/emboj/19.17.4734; Sun XL, 1998, P NATL ACAD SCI USA, V95, P10009, DOI 10.1073/pnas.95.17.10009; Thermann R, 1998, EMBO J, V17, P3484, DOI 10.1093/emboj/17.12.3484; Visa N, 1996, J CELL BIOL, V133, P5, DOI 10.1083/jcb.133.1.5; WAHLE E, 1993, J BIOL CHEM, V268, P2937; WAHLE E, 1991, CELL, V66, P759, DOI 10.1016/0092-8674(91)90119-J; Wang WR, 2001, EMBO J, V20, P880, DOI 10.1093/emboj/20.4.880; WIGLER M, 1979, CELL, V16, P777, DOI 10.1016/0092-8674(79)90093-X; Zhang J, 1998, MOL CELL BIOL, V18, P5272, DOI 10.1128/MCB.18.9.5272; Zhang J, 1998, RNA, V4, P801, DOI 10.1017/S1355838298971849	55	445	457	1	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 7	2001	106	5					607	617		10.1016/S0092-8674(01)00475-5	http://dx.doi.org/10.1016/S0092-8674(01)00475-5			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	472FQ	11551508	Bronze			2022-12-24	WOS:000170973200011
J	Kielkopf, CL; Rodionova, NA; Green, MR; Burley, SK				Kielkopf, CL; Rodionova, NA; Green, MR; Burley, SK			A novel peptide recognition mode revealed by the X-ray structure of a core U2AF-(35)/U2AF(65) heterodimer	CELL			English	Article							SPLICING FACTOR U2AF(35); PRE-MESSENGER-RNA; RIBONUCLEOPROTEIN AUXILIARY FACTOR; PROLINE-RICH LIGANDS; BINDING PROTEINS; SMALL-SUBUNIT; SH3 DOMAINS; WW DOMAIN; U2 SNRNP; SITE AG	U2 auxiliary factor (U2AF) is an essential splicing factor that recognizes the 3' splice site and recruits the U2 snRNP to the branch point. The X-ray structure of the human core U2AF heterodimer, consisting of the U2AF(35) central domain and a proline-rich region of U2AF(65), has been determined at 2.2 Angstrom resolution. The structure reveals a novel protein-protein recognition strategy, in which an atypical RNA recognition motif (RRM) of U2AF(35) and the U2AF(65) polyproline segment interact via reciprocal "tongue-in-groove" tryptophan residues. Complementary biochemical experiments demonstrate that the core U2AF heterodimer binds RNA, and that the interacting tryptophan side chains are essential for U2AF dimerization. Atypical RRMs in other splicing factors may serve as protein-protein interaction motifs elsewhere during spliceosome assembly.	Rockefeller Univ, Lab Mol Biophys, New York, NY 10021 USA; Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Programs Gene Funct & Express, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Program Mol Med, Worcester, MA 01605 USA	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester	Burley, SK (corresponding author), Rockefeller Univ, Lab Mol Biophys, 1230 York Ave, New York, NY 10021 USA.	burley@rockvax.rockefeller.edu		Kielkopf, Clara/0000-0002-7648-8271; Burley, Stephen K./0000-0002-2487-9713				ALEXANDROPOULOS K, 1995, P NATL ACAD SCI USA, V92, P3110, DOI 10.1073/pnas.92.8.3110; Antson AA, 2000, CURR OPIN STRUC BIOL, V10, P87, DOI 10.1016/S0959-440X(99)00054-8; Bedford MT, 1997, EMBO J, V16, P2376, DOI 10.1093/emboj/16.9.2376; Berglund JA, 1998, GENE DEV, V12, P858, DOI 10.1101/gad.12.6.858; BIRNEY E, 1993, NUCLEIC ACIDS RES, V21, P5803, DOI 10.1093/nar/21.25.5803; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BURLEY SK, 1988, ADV PROTEIN CHEM, V39, P125; CHEN HI, 1995, P NATL ACAD SCI USA, V92, P7819, DOI 10.1073/pnas.92.17.7819; Creighton T. E., 1993, PROTEINS STRUCTURES; Deo RC, 1999, CELL, V98, P835, DOI 10.1016/S0092-8674(00)81517-2; Dodson EJ, 1997, METHOD ENZYMOL, V277, P620, DOI 10.1016/S0076-6879(97)77034-4; Fleckner J, 1997, GENE DEV, V11, P1864, DOI 10.1101/gad.11.14.1864; Gozani O, 1998, MOL CELL BIOL, V18, P4752, DOI 10.1128/MCB.18.8.4752; Handa N, 1999, NATURE, V398, P579, DOI 10.1038/19242; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; Hertel KJ, 1997, CURR OPIN CELL BIOL, V9, P350, DOI 10.1016/S0955-0674(97)80007-5; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Huang X, 2000, NAT STRUCT BIOL, V7, P634, DOI 10.1038/77923; JOHNSON ML, 1981, BIOPHYS J, V36, P575, DOI 10.1016/S0006-3495(81)84753-4; KANAAR R, 1993, SCIENCE, V262, P569, DOI 10.1126/science.7692602; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee CH, 1998, METH MOL B, V84, P3; LIM WA, 1994, NATURE, V372, P375, DOI 10.1038/372375a0; Mahoney NM, 1999, NAT STRUCT BIOL, V6, P666, DOI 10.1038/10722; McKinney R, 1997, CURR GENET, V32, P323, DOI 10.1007/s002940050284; Merendino L, 1999, NATURE, V402, P838, DOI 10.1038/45602; MUSACCHIO A, 1994, NAT STRUCT BIOL, V1, P546, DOI 10.1038/nsb0894-546; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Page-McCaw PS, 1999, RNA, V5, P1548, DOI 10.1017/S1355838299991938; POTASHKIN J, 1993, SCIENCE, V262, P573, DOI 10.1126/science.8211184; Price SR, 1998, NATURE, V394, P645, DOI 10.1038/29234; Reed R, 2000, CURR OPIN CELL BIOL, V12, P340, DOI 10.1016/S0955-0674(00)00097-1; Rudner DZ, 1998, MOL CELL BIOL, V18, P1765, DOI 10.1128/MCB.18.4.1765; Rudner DZ, 1996, P NATL ACAD SCI USA, V93, P10333, DOI 10.1073/pnas.93.19.10333; Rudner DZ, 1998, MOL CELL BIOL, V18, P4004, DOI 10.1128/MCB.18.7.4004; Sanchez R, 2000, METH MOL B, V143, P97; Simpson GG, 1996, PLANT MOL BIOL, V32, P1, DOI 10.1007/BF00039375; SINGH R, 1995, SCIENCE, V268, P1173, DOI 10.1126/science.7761834; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Tronchere H, 1997, NATURE, V388, P397, DOI 10.1038/41137; Tupler R, 2001, NATURE, V409, P832, DOI 10.1038/35057011; Verdecia MA, 2000, NAT STRUCT BIOL, V7, P639, DOI 10.1038/77929; Wang XQ, 2001, NAT STRUCT BIOL, V8, P141, DOI 10.1038/84131; WU JY, 1993, CELL, V75, P1061, DOI 10.1016/0092-8674(93)90316-I; Wu SP, 1999, NATURE, V402, P832, DOI 10.1038/45590; Yan D, 1998, MOL CELL BIOL, V18, P5000, DOI 10.1128/MCB.18.9.5000; ZAMORE PD, 1992, NATURE, V355, P609, DOI 10.1038/355609a0; ZAMORE PD, 1989, P NATL ACAD SCI USA, V86, P9243, DOI 10.1073/pnas.86.23.9243; ZHANG M, 1992, P NATL ACAD SCI USA, V89, P8769, DOI 10.1073/pnas.89.18.8769; Zorio DAR, 1999, NATURE, V402, P835, DOI 10.1038/45597; Zorio DAR, 1999, RNA, V5, P487, DOI 10.1017/S1355838299982225; Zuo P, 1996, GENE DEV, V10, P1356, DOI 10.1101/gad.10.11.1356	52	167	169	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 7	2001	106	5					595	605		10.1016/S0092-8674(01)00480-9	http://dx.doi.org/10.1016/S0092-8674(01)00480-9			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	472FQ	11551507	Bronze			2022-12-24	WOS:000170973200010
J	Kim, VN; Kataoka, N; Dreyfuss, G				Kim, VN; Kataoka, N; Dreyfuss, G			Role of the nonsense-mediated decay factor hUpf3 in the splicing-dependent exon-exon junction complex	SCIENCE			English	Article							PRE-MESSENGER-RNA; TRANSLATIONAL TERMINATION CODON; OPEN READING FRAME; NUCLEAR EXPORT; BINDING-PROTEINS; HNRNP PROTEINS; K-PROTEIN; SURVEILLANCE; YEAST; IDENTIFICATION	Nonsense-mediated messenger RNA (mRNA) decay, or NMD, is a critical process of selective degradation of mRNAs that contain premature stop codons. NMD depends on both pre-mRNA splicing and translation, and it requires recognition of the position of stop codons relative to exon-exon junctions. A key factor in NMD is hUpf3, a mostly nuclear protein that shuttles between the nucleus and cytoplasm and interacts specifically with spliced mRNAs. We found that hUpf3 interacts with Y14, a component of post-splicing mRNA-protein (mRNP) complexes, and that hUpf3 is enriched in Y14-containing mRNP complexes. The mRNA export factors Aly/REF and TAP are also associated with nuclear hUpf3, indicating that hUpf3 is in mRNP complexes that are poised for nuclear export. Like Y14 and Aly/REF, hUpf3 binds to spliced mRNAs specifically (similar to 20 nucleotides) upstream of exon-exon junctions. The splicing-dependent binding of hUpf3 to mRNAs before export, as part of the complex that assembles near exon-exon junctions, allows it to serve as a link between splicing and NMD in the cytoplasm.	Univ Penn, Sch Med, Howard Hughes Med Inst, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA	Howard Hughes Medical Institute; University of Pennsylvania; University of Pennsylvania	Dreyfuss, G (corresponding author), Univ Penn, Sch Med, Howard Hughes Med Inst, Philadelphia, PA 19104 USA.	gdreyfuss@hhmi.upenn.edu	Kataoka, Naoyuki/H-6298-2019; Dreyfuss, Gideon/D-1218-2013	Kataoka, Naoyuki/0000-0002-4498-7420; Dreyfuss, Gideon/0000-0001-8129-8774	NIGMS NIH HHS [5 R01 GM37125.14] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037125] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aoufouchi S, 1996, CELL, V85, P415, DOI 10.1016/S0092-8674(00)81119-8; Applequist SE, 1997, NUCLEIC ACIDS RES, V25, P814, DOI 10.1093/nar/25.4.814; Atkin AL, 1997, J BIOL CHEM, V272, P22163, DOI 10.1074/jbc.272.35.22163; Blencowe BJ, 1998, GENE DEV, V12, P996, DOI 10.1101/gad.12.7.996; BOCHNIG P, 1987, EUR J BIOCHEM, V168, P461, DOI 10.1111/j.1432-1033.1987.tb13439.x; Brogna S, 1999, RNA, V5, P562, DOI 10.1017/S1355838299981359; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; CHOI YD, 1984, P NATL ACAD SCI-BIOL, V81, P7471, DOI 10.1073/pnas.81.23.7471; CUI Y, 1995, GENE DEV, V9, P423, DOI 10.1101/gad.9.4.423; Czaplinski K, 1998, GENE DEV, V12, P1665, DOI 10.1101/gad.12.11.1665; DIETZ HC, 1994, NAT GENET, V8, P183, DOI 10.1038/ng1094-183; DREYFUSS G, 1993, ANNU REV BIOCHEM, V62, P289, DOI 10.1146/annurev.bi.62.070193.001445; Gersappe A, 1999, MOL CELL BIOL, V19, P1640; He F, 1996, RNA, V2, P153; HE F, 1995, GENE DEV, V9, P437, DOI 10.1101/gad.9.4.437; Hentze MW, 1999, CELL, V96, P307, DOI 10.1016/S0092-8674(00)80542-5; Kataoka N, 2000, MOL CELL, V6, P673, DOI 10.1016/S1097-2765(00)00065-4; Kim VN, 2001, EMBO J, V20, P2062, DOI 10.1093/emboj/20.8.2062; Le Hir H, 2000, EMBO J, V19, P6860, DOI 10.1093/emboj/19.24.6860; Le Hir H, 2000, GENE DEV, V14, P1098; LEEDS P, 1991, GENE DEV, V5, P2303, DOI 10.1101/gad.5.12a.2303; Li SL, 1998, IMMUNITY, V8, P135, DOI 10.1016/S1074-7613(00)80466-5; Luo MJ, 1999, P NATL ACAD SCI USA, V96, P14937, DOI 10.1073/pnas.96.26.14937; Lykke-Andersen J, 2001, CURR BIOL, V11, pR88, DOI 10.1016/S0960-9822(01)00036-7; Lykke-Andersen J, 2000, CELL, V103, P1121, DOI 10.1016/S0092-8674(00)00214-2; Maquat LE, 2001, CELL, V104, P173, DOI 10.1016/S0092-8674(01)00202-1; Matsumoto K, 1998, EMBO J, V17, P2107, DOI 10.1093/emboj/17.7.2107; MATUNIS EL, 1993, J CELL BIOL, V121, P219, DOI 10.1083/jcb.121.2.219; Mayeda A, 1999, EMBO J, V18, P4560, DOI 10.1093/emboj/18.16.4560; McGarvey T, 2000, J CELL BIOL, V150, P309, DOI 10.1083/jcb.150.2.309; Mendell JT, 2000, MOL CELL BIOL, V20, P8944, DOI 10.1128/MCB.20.23.8944-8957.2000; Michael WM, 1997, EMBO J, V16, P3587, DOI 10.1093/emboj/16.12.3587; MICHAEL WM, 1995, CELL, V83, P415; Moriarty PM, 1998, MOL CELL BIOL, V18, P2932, DOI 10.1128/MCB.18.5.2932; Ohno M, 1996, GENE DEV, V10, P997, DOI 10.1101/gad.10.8.997; Pellizzoni L, 1998, CELL, V95, P615, DOI 10.1016/S0092-8674(00)81632-3; Perlick HA, 1996, P NATL ACAD SCI USA, V93, P10928, DOI 10.1073/pnas.93.20.10928; PULAK R, 1993, GENE DEV, V7, P1885, DOI 10.1101/gad.7.10.1885; Rodrigues JP, 2001, P NATL ACAD SCI USA, V98, P1030, DOI 10.1073/pnas.98.3.1030; Serin G, 2001, MOL CELL BIOL, V21, P209, DOI 10.1128/MCB.21.1.209-223.2001; Shyu AB, 2000, CELL, V102, P135, DOI 10.1016/S0092-8674(00)00018-0; SIOMI H, 1993, NUCLEIC ACIDS RES, V21, P1193, DOI 10.1093/nar/21.5.1193; Siomi MC, 1997, J CELL BIOL, V138, P1181, DOI 10.1083/jcb.138.6.1181; Thermann R, 1998, EMBO J, V17, P3484, DOI 10.1093/emboj/17.12.3484; Wang WR, 2001, EMBO J, V20, P880, DOI 10.1093/emboj/20.4.880; Zhou ZL, 2000, NATURE, V407, P401, DOI 10.1038/35030160	46	236	249	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2001	293	5536					1832	1836		10.1126/science.1062829	http://dx.doi.org/10.1126/science.1062829			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	470WN	11546873				2022-12-24	WOS:000170894400048
J	Ni, CY; Murphy, MP; Golde, TE; Carpenter, G				Ni, CY; Murphy, MP; Golde, TE; Carpenter, G			gamma-Secretase cleavage and nuclear localization of ErbB-4 receptor tyrosine kinase	SCIENCE			English	Article							INTRAMEMBRANE PROTEOLYSIS; MECHANISM	ErbB-4 is a transmembrane receptor tyrosine kinase that regulates cell proliferation and differentiation. After binding of its ligand heregulin (HRG) or activation of protein kinase C (PKC) by 12-O-tetradecanoylphorbol-13-acetate (TPA), the ErbB-4 ectodomain is cleaved by a metalloprotease. We now report a subsequent cleavage by gamma -secretase that releases the ErbB-4 intracellular domain from the membrane and facilitates its translocation to the nucleus. gamma -Secretase cleavage was prevented by chemical inhibitors or a dominant negative presenilin. Inhibition of gamma -secretase also prevented growth inhibition by HRG. gamma -Secretase cleavage of ErbB-4 may represent another mechanism for receptor tyrosine kinase-mediated signaling.	Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37232 USA; Mayo Clin Jacksonville, Dept Neurosci & Pharmacol, Jacksonville, FL 32224 USA	Vanderbilt University; Vanderbilt University; Mayo Clinic	Carpenter, G (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 221 Kirkland Hall, Nashville, TN 37232 USA.				NCI NIH HHS [CA68485, CA24071] Funding Source: Medline; NIDDK NIH HHS [DK20593] Funding Source: Medline; NINDS NIH HHS [NS39072] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA068485, R01CA024071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020593, P30DK020593] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039072] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bae SS, 2001, FEBS LETT, V491, P16, DOI 10.1016/S0014-5793(01)02167-6; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Hoppe T, 2000, CELL, V102, P577, DOI 10.1016/S0092-8674(00)00080-5; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; McLendon C, 2000, FASEB J, V14, P2383; Murphy MP, 2000, J BIOL CHEM, V275, P26277, DOI 10.1074/jbc.M002812200; NI CB, UNPUB; PELES E, 1992, CELL, V69, P205, DOI 10.1016/0092-8674(92)90131-U; Rio C, 2000, J BIOL CHEM, V275, P10379, DOI 10.1074/jbc.275.14.10379; Sartor CI, 2001, MOL CELL BIOL, V21, P4265, DOI 10.1128/MCB.21.13.4265-4275.2001; Seiffert D, 2000, J BIOL CHEM, V275, P34086, DOI 10.1074/jbc.M005430200; Shearman MS, 2000, BIOCHEMISTRY-US, V39, P8698, DOI 10.1021/bi0005456; Srinivasan R, 2000, CANCER RES, V60, P1483; Steiner H, 2000, NAT REV MOL CELL BIO, V1, P217, DOI 10.1038/35043065; Vecchi M, 1997, J CELL BIOL, V139, P995, DOI 10.1083/jcb.139.4.995; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zhou WL, 2000, J BIOL CHEM, V275, P34737, DOI 10.1074/jbc.M003756200	18	713	731	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 7	2001	294	5549					2179	2181		10.1126/science.1065412	http://dx.doi.org/10.1126/science.1065412			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500VQ	11679632				2022-12-24	WOS:000172647700055
J	Fukuchi-Shimogori, T; Grove, EA				Fukuchi-Shimogori, T; Grove, EA			Neocortex patterning by the secreted signaling molecule FGF8	SCIENCE			English	Article							CEREBRAL-CORTEX; SOMATOSENSORY CORTEX; REGIONAL DIFFERENCES; AREA IDENTITY; SPECIFICATION; EXPRESSION; MIDBRAIN; DIFFERENTIATION; HIPPOCAMPUS; FOREBRAIN	A classic model proposes that the mammalian neocortex is divided into areas early in neurogenesis, but the molecular mechanisms that generate the area map have been elusive. Here we provide evidence that FGF8 regulates development of the map from a source in the anterior telencephalon. Using electroporation-mediated gene transfer in mouse embryos, we show that augmenting the endogenous anterior FGF8 signal shifts area boundaries posteriorly, reducing the signal shifts them anteriorly, and introducing a posterior source of FGF8 elicits partial area duplications, revealed by ectopic somatosensory barrel fields. These findings support a rote for FGF signaling in specifying positional identity in the neocortex.	Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA	University of Chicago	Grove, EA (corresponding author), Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA.		Shimogori, Tomomi/L-2893-2013	Shimogori, Tomomi/0000-0002-6931-5401				Agarwala S, 2001, SCIENCE, V291, P2147, DOI 10.1126/science.1058624; BARBE MF, 1991, J NEUROSCI, V11, P519; Bishop KM, 2000, SCIENCE, V288, P344, DOI 10.1126/science.288.5464.344; Chellaiah A, 1999, J BIOL CHEM, V274, P34785, DOI 10.1074/jbc.274.49.34785; Crossley PH, 1996, NATURE, V380, P66, DOI 10.1038/380066a0; CROSSLEY PH, 1995, DEVELOPMENT, V121, P439; FERRI RT, 1995, DEVELOPMENT, V121, P1151; FUKUCHISHIMOGOR.T, UNPUB; Furuta Y, 1997, DEVELOPMENT, V124, P2203; Galceran J, 2000, DEVELOPMENT, V127, P469; Gitton Y, 1999, J NEUROSCI, V19, P4889; Grove EA, 1998, DEVELOPMENT, V125, P2315; HEIKINHEIMO M, 1994, MECH DEVELOP, V48, P129, DOI 10.1016/0925-4773(94)90022-1; Huffman KJ, 1999, J NEUROSCI, V19, P9939; JENSEN KF, 1987, J NEUROSCI, V7, P3529; Lee SMK, 2000, DEVELOPMENT, V127, P457; Lee SMK, 1997, DEVELOPMENT, V124, P959; Levitt P, 1997, ANNU REV NEUROSCI, V20, P1, DOI 10.1146/annurev.neuro.20.1.1; MACARTHUR CA, 1995, DEVELOPMENT, V121, P3603; MACARTHUR CA, 1995, CELL GROWTH DIFFER, V6, P817; Mackarehtschian K, 1999, CEREB CORTEX, V9, P601, DOI 10.1093/cercor/9.6.601; Minowada G, 1999, DEVELOPMENT, V126, P4465; Miyashita-Lin EM, 1999, SCIENCE, V285, P906, DOI 10.1126/science.285.5429.906; Nauta W., 1986, FUNDAMENTAL NEUROANA; Neubuser A, 1997, CELL, V90, P247, DOI 10.1016/S0092-8674(00)80333-5; Ragsdale CW, 2001, CURR OPIN NEUROBIOL, V11, P50, DOI 10.1016/S0959-4388(00)00173-2; RAGSDALE CW, UNPUB; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; Rubenstein JLR, 1999, CEREB CORTEX, V9, P524, DOI 10.1093/cercor/9.6.524; Shamim H, 1999, DEVELOPMENT, V126, P945; Shimamura K, 1997, DEVELOPMENT, V124, P2709; Suzuki SC, 1997, MOL CELL NEUROSCI, V9, P433, DOI 10.1006/mcne.1997.0626; Tucker AS, 1999, DEVELOPMENT, V126, P51; VANDERLO.H, 1973, SCIENCE, V179, P395, DOI 10.1126/science.179.4071.395; WONGRILEY MTT, 1980, P NATL ACAD SCI-BIOL, V77, P2333, DOI 10.1073/pnas.77.4.2333; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X; Xu JS, 2000, DEVELOPMENT, V127, P1833; Yasuda K, 2000, DEV GROWTH DIFFER, V42, P203; Ye WL, 1998, CELL, V93, P755, DOI 10.1016/S0092-8674(00)81437-3	39	506	520	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 2	2001	294	5544					1071	1074		10.1126/science.1064252	http://dx.doi.org/10.1126/science.1064252			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	489VU	11567107				2022-12-24	WOS:000172013800041
J	Lee, JR; Urban, S; Garvey, CF; Freeman, M				Lee, JR; Urban, S; Garvey, CF; Freeman, M			Regulated intracellular ligand transport and proteolysis control EGF signal activation in Drosophila	CELL			English	Article							ALPHA HOMOLOG SPITZ; DORSAL-VENTRAL AXIS; GROWTH-FACTOR-ALPHA; CELL-SURFACE; EYE DEVELOPMENT; PROTGF-ALPHA; RECEPTOR; PROTEIN; PATHWAY; GENE	The membrane proteins Star and Rhomboid-1 have been genetically defined as the primary regulators of EGF receptor activation in Drosophila, but their molecular mechanisms have been elusive. Both Star and Rhomboid-1 have been assumed to work at the cell surface to control ligand activation. Here, we demonstrate that they control receptor signaling by regulating intracellular trafficking and proteolysis of the ligand Spitz. Star is present throughout the secretory pathway and is required to export Spitz from the endoplasmic reticulum to the Golgi apparatus. Rhomboid-1 is localized in the Golgi, where it promotes the cleavage of Spitz. This defines a novel growth factor release mechanism that is distinct from metalloprotease-dependent shedding from the cell surface.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Freeman, M (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.			Freeman, Matthew/0000-0003-0410-5451				Arribas J, 1996, J BIOL CHEM, V271, P11376, DOI 10.1074/jbc.271.19.11376; Bang AG, 2000, GENE DEV, V14, P177; BIER E, 1990, GENE DEV, V4, P190, DOI 10.1101/gad.4.2.190; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; CAPDEVILA J, 1994, EMBO J, V13, P4459, DOI 10.1002/j.1460-2075.1994.tb06768.x; Casci T, 1999, CANCER METAST REV, V18, P181, DOI 10.1023/A:1006313122373; Dominguez M, 1998, CURR BIOL, V8, P1039, DOI 10.1016/S0960-9822(98)70441-5; Fernandez-Larrea J, 1999, MOL CELL, V3, P423, DOI 10.1016/S1097-2765(00)80470-0; FREEMAN M, 1992, DEVELOPMENT, V116, P335; FREEMAN M, 1994, MECH DEVELOP, V48, P25, DOI 10.1016/0925-4773(94)90003-5; Gabay L, 1997, SCIENCE, V277, P1103, DOI 10.1126/science.277.5329.1103; Golembo M, 1996, DEVELOPMENT, V122, P3363; Guichard A, 1999, DEVELOPMENT, V126, P2663; HEBERLEIN U, 1993, DEV BIOL, V160, P51, DOI 10.1006/dbio.1993.1285; Kennerdell JR, 1998, CELL, V95, P1017, DOI 10.1016/S0092-8674(00)81725-0; Klambt C, 2000, CURR BIOL, V10, pR388, DOI 10.1016/S0960-9822(00)00485-1; KOLODKIN AL, 1994, DEVELOPMENT, V120, P1731; Kuo A, 2000, EMBO J, V19, P6427, DOI 10.1093/emboj/19.23.6427; Munro S, 2000, CURR BIOL, V10, P813, DOI 10.1016/S0960-9822(00)00578-9; PANDIELLA A, 1992, J BIOL CHEM, V267, P24028; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Pickup AT, 1999, DEV BIOL, V205, P254, DOI 10.1006/dbio.1998.9119; RUOHOLABAKER H, 1993, CELL, V73, P953, DOI 10.1016/0092-8674(93)90273-S; RUTLEDGE BJ, 1992, GENE DEV, V6, P1503, DOI 10.1101/gad.6.8.1503; Schlondorff J, 2000, BIOCHEM J, V347, P131, DOI 10.1042/0264-6021:3470131; Schweitzer R, 1997, TRENDS GENET, V13, P191, DOI 10.1016/S0168-9525(97)01091-3; SCHWEITZER R, 1995, GENE DEV, V9, P1518, DOI 10.1101/gad.9.12.1518; SEELIG HP, 1994, J AUTOIMMUN, V7, P67, DOI 10.1006/jaut.1994.1006; Sturtevant MA, 1996, DEV BIOL, V174, P298, DOI 10.1006/dbio.1996.0075; STURTEVANT MA, 1993, GENE DEV, V7, P961, DOI 10.1101/gad.7.6.961; TEIXIDO J, 1990, J BIOL CHEM, V265, P6410; Tio M, 1997, DEVELOPMENT, V124, P343; Urban S, 2001, CELL, V107, P173, DOI 10.1016/S0092-8674(01)00525-6; Urena JM, 1999, J CELL SCI, V112, P773; VANDERBLIEK AM, 1991, NATURE, V351, P411, DOI 10.1038/351411a0; Wasserman JD, 2000, GENE DEV, V14, P1651; Wasserman JD, 1997, TRENDS CELL BIOL, V7, P431, DOI 10.1016/S0962-8924(97)01143-4; Wasserman JD, 1998, CELL, V95, P355, DOI 10.1016/S0092-8674(00)81767-5; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; zurLage P, 1997, CURR BIOL, V7, P166, DOI 10.1016/S0960-9822(97)70087-3	40	309	319	0	11	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 19	2001	107	2					161	171		10.1016/S0092-8674(01)00526-8	http://dx.doi.org/10.1016/S0092-8674(01)00526-8			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	484MU	11672524	Bronze			2022-12-24	WOS:000171694800006
J	Smith, DE; Tans, SJ; Smith, SB; Grimes, S; Anderson, DL; Bustamante, C				Smith, DE; Tans, SJ; Smith, SB; Grimes, S; Anderson, DL; Bustamante, C			The bacteriophage phi 29 portal motor can package DNA against a large internal force	NATURE			English	Article							BACILLUS-SUBTILIS; ESCHERICHIA-COLI; MOLECULES; PROTEIN-GP3; PROHEAD	As part of the viral infection cycle, viruses must package their newly replicated genomes for delivery to other host cells. Bacteriophage phi 29 packages its 6.6-mum long, double-stranded DNA into a 42x54 nm capsid(1) by means of a portal complex that hydrolyses ATP(2). This process is remarkable because entropic, electrostatic and bending energies of the DNA must be overcome to package the DNA to near-crystalline density. Here we use optical tweezers to pull on single DNA molecules as they are packaged, thus demonstrating that the portal complex is a force-generating motor. This motor can work against loads of up to 57 pN on average, making it one of the strongest molecular motors reported to date. Movements of over 5 mum are observed, indicating high processivity. Pauses and slips also occur, particularly at higher forces. We establish the force-velocity relationship of the motor and find that the rate-limiting step of the motor's cycle is force dependent even at low loads. Notably, the packaging rate decreases as the prohead is filled, indicating that an internal force builds up to similar to 50 pN owing to DNA confinement. Our data suggest that this force may be available for initiating the ejection of the DNA from the capsid during infection.	Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA; Univ Minnesota, Dept Microbiol, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Oral Sci, Minneapolis, MN 55455 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Bustamante, C (corresponding author), Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.		Tans, Sander/AAS-2901-2020; Smith, Douglas E/A-3131-2017	Smith, Douglas E/0000-0002-8206-3632; Bustamante, Carlos/0000-0002-2970-0073				Anderson Dwight, 1993, P859; BARLOW R, 1989, STAT GUIDE USE STAT, P15; Baumann CG, 1997, P NATL ACAD SCI USA, V94, P6185, DOI 10.1073/pnas.94.12.6185; BERG HC, 1993, BIOPHYS J, V65, P2201, DOI 10.1016/S0006-3495(93)81278-5; BJORNSTI MA, 1983, J VIROL, V45, P383, DOI 10.1128/JVI.45.1.383-396.1983; Coppin CM, 1997, P NATL ACAD SCI USA, V94, P8539, DOI 10.1073/pnas.94.16.8539; EARNSHAW WC, 1980, CELL, V21, P319, DOI 10.1016/0092-8674(80)90468-7; FINER JT, 1994, NATURE, V368, P113, DOI 10.1038/368113a0; Garcia LR, 1996, J BACTERIOL, V178, P6921, DOI 10.1128/jb.178.23.6921-6929.1996; GRIMES S, 1989, J MOL BIOL, V209, P91, DOI 10.1016/0022-2836(89)90172-1; Grimes S, 1997, J MOL BIOL, V266, P901, DOI 10.1006/jmbi.1996.0843; GUO PX, 1987, J MOL BIOL, V197, P229, DOI 10.1016/0022-2836(87)90121-5; GUO PX, 1986, P NATL ACAD SCI USA, V83, P3505, DOI 10.1073/pnas.83.10.3505; Ibarra B, 2000, J MOL BIOL, V298, P807, DOI 10.1006/jmbi.2000.3712; Kramers HA, 1940, PHYSICA, V7, P284, DOI 10.1016/S0031-8914(40)90098-2; LEHNINGER AL, 1993, PRINCIPLES BIOCH, P375; NOVICK SL, 1988, BIOCHEMISTRY-US, V27, P7919, DOI 10.1021/bi00420a050; Odijk T, 1998, BIOPHYS J, V75, P1223, DOI 10.1016/S0006-3495(98)74041-X; RAU DC, 1984, P NATL ACAD SCI-BIOL, V81, P2621, DOI 10.1073/pnas.81.9.2621; RIEMER SC, 1978, BIOPOLYMERS, V17, P785, DOI 10.1002/bip.1978.360170317; Simpson AA, 2000, NATURE, V408, P745, DOI 10.1038/35047129; Smith SB, 1996, SCIENCE, V271, P795, DOI 10.1126/science.271.5250.795; SVOBODA K, 1994, CELL, V77, P773, DOI 10.1016/0092-8674(94)90060-4; Tao YZ, 1998, CELL, V95, P431, DOI 10.1016/S0092-8674(00)81773-0; Wang MD, 1998, SCIENCE, V282, P902, DOI 10.1126/science.282.5390.902	25	829	851	1	118	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 18	2001	413	6857					748	752		10.1038/35099581	http://dx.doi.org/10.1038/35099581			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	482ZK	11607035				2022-12-24	WOS:000171608000047
J	Breedveld, FC				Breedveld, FC			Is there a place for leflunomide in the treatment of rheumatoid arthritis?	LANCET			English	Editorial Material							METHOTREXATE; SAFETY; EFFICACY; SULFASALAZINE		Leiden Univ, Med Ctr, Dept Rheumatol, NL-2300 RC Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Breedveld, FC (corresponding author), Leiden Univ, Med Ctr, Dept Rheumatol, NL-2300 RC Leiden, Netherlands.							Boers M, 1997, LANCET, V350, P309, DOI 10.1016/S0140-6736(97)01300-7; Drossaers-Bakker KW, 1999, ARTHRITIS RHEUM, V42, P1854, DOI 10.1002/1529-0131(199909)42:9<1854::AID-ANR9>3.0.CO;2-F; Emery P, 2000, RHEUMATOLOGY, V39, P655, DOI 10.1093/rheumatology/39.6.655; FRIES JF, 1993, ARTHRITIS RHEUM, V36, P297, DOI 10.1002/art.1780360303; Herrmann ML, 2000, IMMUNOPHARMACOLOGY, V47, P273, DOI 10.1016/S0162-3109(00)00191-0; MLADENOVIC V, 1995, ARTHRITIS RHEUM-US, V38, P1595, DOI 10.1002/art.1780381111; Smolen JS, 1999, LANCET, V353, P259, DOI 10.1016/S0140-6736(98)09403-3; Strand V, 1999, ARCH INTERN MED, V159, P2542, DOI 10.1001/archinte.159.21.2542; Weinblatt ME, 1999, ARTHRITIS RHEUM-US, V42, P1322, DOI 10.1002/1529-0131(199907)42:7<1322::AID-ANR4>3.0.CO;2-P	9	10	10	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 13	2001	358	9289					1198	1200		10.1016/S0140-6736(01)06338-3	http://dx.doi.org/10.1016/S0140-6736(01)06338-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	481NX	11675052				2022-12-24	WOS:000171527000004
J	Brundtland, GH				Brundtland, GH			Health professionals must confront HIV/AIDS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									WHO, CH-1211 Geneva, Switzerland	World Health Organization	Brundtland, GH (corresponding author), WHO, CH-1211 Geneva, Switzerland.								0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 26	2001	286	12					1444	1444		10.1001/jama.286.12.1444	http://dx.doi.org/10.1001/jama.286.12.1444			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	475UX	11572726				2022-12-24	WOS:000171188600010
J	Malek, NP; Sundberg, H; McGrew, S; Nakayama, K; Kyriakidis, TR; Roberts, JM				Malek, NP; Sundberg, H; McGrew, S; Nakayama, K; Kyriakidis, TR; Roberts, JM			A mouse knock-in model exposes sequential proteolytic pathways that regulate p27(Kip1) in G1 and S phase	NATURE			English	Article							KINASE INHIBITOR P27(KIP1); CELL-CYCLE; F-BOX; P27; MYC; ACCUMULATION; DEGRADATION; COMPLEX; UBIQUITINATION; PROGRESSION	The protein p27(Kip1) is an inhibitor of cell division(1). An increase in p27 causes proliferating cells to exit from the cell cycle, and a decrease in p27 is necessary for quiescent cells to resume division(2,3). Abnormally low amounts of p27 are associated with pathological states of excessive cell proliferation, especially cancers(4-8). In normal and tumour cells, p27 is regulated primarily at the level of translation(9-11) and protein turnover. Phosphorylation of p27 on threonine 187 (T187) by cyclin-dependent kinase 2 (Cdk2) is thought to initiate the major pathway for p27 proteolysis(12-15). To critically test the importance of this pathway in vivo, we replaced the murine p27 gene with one that encoded alanine instead of threonine at position 187 (p27(T187A)). Here we show that cells expressing p27(T187A) were unable to downregulate p27 during the S and G2 phases of the cell cycle, but that this had a surprisingly modest effect on cell proliferation both in vitro and in vivo. Our efforts to explain this unexpected result led to the discovery of a second proteolytic pathway for controlling p27, one that is activated by mitogens and degrades p27 exclusively during G1.	Fred Hutchinson Canc Res Ctr, Howard Hughes Med Inst, Seattle, WA 98104 USA; Fred Hutchinson Canc Res Ctr, Dept Basic Sci, Seattle, WA 98104 USA; Kyushu Univ, Med Inst Bioregulat, Lab Embryon & Genet Engn, Fukuoka 8128582, Japan; Univ Washington, Dept Biochem, Seattle, WA 98104 USA	Fred Hutchinson Cancer Center; Howard Hughes Medical Institute; Fred Hutchinson Cancer Center; Kyushu University; University of Washington; University of Washington Seattle	Roberts, JM (corresponding author), Fred Hutchinson Canc Res Ctr, Howard Hughes Med Inst, Seattle, WA 98104 USA.		高, 雨莉/HGU-8187-2022					Agrawal D, 1996, MOL CELL BIOL, V16, P4327; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Catzavelos C, 1997, NAT MED, V3, P227, DOI 10.1038/nm0297-227; Coats S, 1999, CURR BIOL, V9, P163, DOI 10.1016/S0960-9822(99)80086-4; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; Fero ML, 1998, NATURE, V396, P177, DOI 10.1038/24179; HATAKEYAMA M, 1994, COLD SPRING HARB SYM, V59, P1; Hengst L, 1996, SCIENCE, V271, P1861, DOI 10.1126/science.271.5257.1861; Kyriakides TR, 1999, J INVEST DERMATOL, V113, P782, DOI 10.1046/j.1523-1747.1999.00755.x; Leone G, 1997, NATURE, V387, P422, DOI 10.1038/387422a0; Millard SS, 2000, MOL CELL BIOL, V20, P5947, DOI 10.1128/MCB.20.16.5947-5959.2000; Muller D, 1997, ONCOGENE, V15, P2561, DOI 10.1038/sj.onc.1201440; Nagy A, 1998, CURR BIOL, V8, P661, DOI 10.1016/S0960-9822(98)70254-4; Nakayama K, 2000, EMBO J, V19, P2069, DOI 10.1093/emboj/19.9.2069; O'Hagan RC, 2000, GENE DEV, V14, P2185, DOI 10.1101/gad.827200; Ophascharoensuk V, 1998, NAT MED, V4, P575, DOI 10.1038/nm0598-575; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; PARDEE AB, 1974, P NATL ACAD SCI USA, V71, P1286, DOI 10.1073/pnas.71.4.1286; PORTENOY RK, 1997, T PALLIAT CARE, V1, P3; Rolfe M, 1997, J MOL MED-JMM, V75, P5, DOI 10.1007/s001090050081; Sheaff RJ, 1997, GENE DEV, V11, P1464, DOI 10.1101/gad.11.11.1464; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Sutterluty H, 1999, NAT CELL BIOL, V1, P207, DOI 10.1038/12027; Tan P, 1997, CANCER RES, V57, P1259; Tsvetkov LM, 1999, CURR BIOL, V9, P661, DOI 10.1016/S0960-9822(99)80290-5; Vlach J, 1996, EMBO J, V15, P6595, DOI 10.1002/j.1460-2075.1996.tb01050.x	30	222	232	0	6	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 20	2001	413	6853					323	327		10.1038/35095083	http://dx.doi.org/10.1038/35095083			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473KB	11565035				2022-12-24	WOS:000171040500042
J	Poliakoff, M; Anastas, P				Poliakoff, M; Anastas, P			A principled stance	NATURE			English	Article									Univ Nottingham, Sch Chem, Nottingham NG7 2RD, England	University of Nottingham	Poliakoff, M (corresponding author), Univ Nottingham, Sch Chem, Univ Pk, Nottingham NG7 2RD, England.		Anastas, Paul/L-3258-2013	Anastas, Paul/0000-0003-4777-5172				Anastas P, 2001, CHEM BRIT, V37, P26; Anastas P. T., 1998, GREEN CHEM THEORY PR; HAMLEY PA, 2001, CHEM ENG, V72, P24; Ritter SK, 2001, CHEM ENG NEWS, V79, P24, DOI 10.1021/cen-v079n027.p024	4	135	136	0	24	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 20	2001	413	6853					257	257		10.1038/35095133	http://dx.doi.org/10.1038/35095133			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473KB	11565009	Bronze			2022-12-24	WOS:000171040500018
J	Petitto, LA; Holowka, S; Sergio, LE; Ostry, D				Petitto, LA; Holowka, S; Sergio, LE; Ostry, D			Language rhythms in baby hand movements	NATURE			English	Article									York Univ, Dept Kinesiol & Hlth Sci, N York, ON M3J 1P3, Canada; Haskins Labs Inc, New Haven, CT 06511 USA; McGill Univ, Dept Psychol, Montreal, PQ H3A 1B1, Canada	York University - Canada; Yale University; Haskins Laboratories; McGill University	Petitto, LA (corresponding author), Dartmouth Coll, Dept Psychol, 302 Silsby Hall, Hanover, NH 03755 USA.		Sergio, Lauren/AAK-3274-2020; Galantucci, Bruno/E-5770-2010					Jusczyk P., 1997, DISCOVERY SPOKEN LAN; Lieberman Philip, 2000, HUMAN LANGUAGE OUR R; Locke J.L., 1993, CHILDS PATH SPOKEN L; Locke JL, 2000, SCIENCE, V288, P449, DOI 10.1126/science.288.5465.449; MacNeilage PF, 2000, SCIENCE, V288, P527, DOI 10.1126/science.288.5465.527; MEIER RP, 1995, LANGUAGE, GESTURE, AND SPACE, P391; Petitto LA, 2000, P NATL ACAD SCI USA, V97, P13961, DOI 10.1073/pnas.97.25.13961; PETITTO LA, 1991, SCIENCE, V251, P1493, DOI 10.1126/science.2006424; Pinker S, 1992, ADAPTED MIND EVOLUTI, P451; STUDDERTKENNEDY MG, 1991, COGNITION SYMBOLIC P, P38; van der Stelt J. M., 1986, WENNER GREN CTR IN B, P163; Vihman M. M., 1996, PHONOLOGICAL DEV ORI	12	69	71	0	16	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 6	2001	413	6851					35	36		10.1038/35092613	http://dx.doi.org/10.1038/35092613			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469EG	11544514				2022-12-24	WOS:000170801200027
J	DeWildt, G; Sweeney, H				DeWildt, G; Sweeney, H			Moving away from rational medicine?	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	2	2	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	MAY 25	1996	312	7042					1367	1367		10.1136/bmj.312.7042.1367	http://dx.doi.org/10.1136/bmj.312.7042.1367			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UN476	11644783	Green Published			2022-12-24	WOS:A1996UN47600079
J	LYONS, JR; YUNG, YL; ALLEN, M				LYONS, JR; YUNG, YL; ALLEN, M			SOLAR CONTROL OF THE UPPER-ATMOSPHERE OF TRITON	SCIENCE			English	Article							IONOSPHERE; PHOTOCHEMISTRY; CHEMISTRY; NEPTUNE; METHANE; CARBON; TITAN; MODEL	If the upper atmosphere and ionosphere of Triton are controlled by precipitation of electrons from Neptune's magnetosphere as previously proposed, Triton could have the only ionosphere in the solar system not controlled by solar radiation. However, a new model of Triton's atmosphere, in which only solar radiation is present, predicts a large column of carbon atoms. With an assumed, but reasonable, rate of charge transfer between N2+ and C, a peak C+ abundance results that is close to the peak electron densities measured by Voyager in Triton's ionosphere. These results suggest that Triton's upper atmospheric chemistry may thus be solar-controlled. Measurement of key reaction rate constants, currently unknown or highly uncertain at Triton's low temperatures, would help to clarify the chemical and physical processes occurring in Triton's atmosphere.	CALTECH,JET PROP LAB,DIV EARTH & SPACE SCI,PASADENA,CA 91109	California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	LYONS, JR (corresponding author), CALTECH,DIV GEOL & PLANETARY SCI,PASADENA,CA 91125, USA.		Yung, Yuk/AAM-4850-2021	Yung, Yuk/0000-0002-4263-2562				ANICICH VG, 1986, ASTROPHYS J SUPPL S, V62, P553, DOI 10.1086/191151; BRAUN W, 1969, PROC R SOC LON SER-A, V312, P417, DOI 10.1098/rspa.1969.0168; BROADFOOT AL, 1989, SCIENCE, V246, P1459, DOI 10.1126/science.246.4936.1459; CANTU AM, 1981, PHYS REV A, V23, P1223, DOI 10.1103/PhysRevA.23.1223; CRUIKSHANK DP, 1991, B AM ASTRON SOC, V23, P1208; DELITSKY ML, 1990, GEOPHYS RES LETT, V17, P1725, DOI 10.1029/GL017i010p01725; HERBERT F, 1991, J GEOPHYS RES-PLANET, V96, P19241, DOI 10.1029/91JA01821; HUSAIN D, 1971, T FARADAY SOC, V67, P2025, DOI 10.1039/tf9716702025; IP WH, 1990, GEOPHYS RES LETT, V17, P1713, DOI 10.1029/GL017i010p01713; LINDAL GF, 1983, ICARUS, V53, P348, DOI 10.1016/0019-1035(83)90155-0; Lyons J. L., UNPUB; MAJEED T, 1990, GEOPHYS RES LETT, V17, P1721, DOI 10.1029/GL017i010p01721; Rebbert R. E., 1972, J PHOTOCHEM, V1, P171; REES MH, 1989, PHYSICS CHEM UPPER A; RICHARDSON JD, 1990, GEOPHYS RES LETT, V17, P1673, DOI 10.1029/GL017i010p01673; SCHRODER K, 1991, J PHYS B-AT MOL OPT, V24, P2487, DOI 10.1088/0953-4075/24/10/007; SMITH GR, 1982, J GEOPHYS RES-SPACE, V87, P1351, DOI 10.1029/JA087iA03p01351; SPENCER JR, 1990, GEOPHYS RES LETT, V17, P1769, DOI 10.1029/GL017i010p01769; STROBEL DF, 1990, GEOPHYS RES LETT, V17, P1729, DOI 10.1029/GL017i010p01729; STROBEL DF, 1990, GEOPHYS RES LETT, V17, P1661, DOI 10.1029/GL017i010p01661; SUMMERS ME, 1989, ASTROPHYS J, V346, P495, DOI 10.1086/168031; SUMMERS ME, 1991, GEOPHYS RES LETT, V18, P2309, DOI 10.1029/91GL01334; THOMPSON WR, 1990, SCIENCE, V250, P415, DOI 10.1126/science.11538073; TORR MR, 1985, J GEOPHYS RES-SPACE, V90, P6675, DOI 10.1029/JA090iA07p06675; TRAFTON L, 1984, ICARUS, V58, P312, DOI 10.1016/0019-1035(84)90048-4; TYLER GL, 1989, SCIENCE, V246, P1466, DOI 10.1126/science.246.4936.1466; VANDISHOECK E, IN PRESS PROTOSTARS, V3; WHYTE AR, 1983, CHEM PHYS LETT, V98, P590, DOI 10.1016/0009-2614(83)80248-6; YELLE RV, 1989, NATURE, V339, P288, DOI 10.1038/339288a0; YELLE RV, 1991, ICARUS, V89, P347, DOI 10.1016/0019-1035(91)90182-S; YUNG YL, 1984, ASTROPHYS J SUPPL S, V55, P465, DOI 10.1086/190963; YUNG YL, 1990, GEOPHYS RES LETT, V17, P1717, DOI 10.1029/GL017i010p01717	32	14	14	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	APR 10	1992	256	5054					204	206						3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM896	11540928				2022-12-24	WOS:A1992HM89600023
J	CARVEL, J				CARVEL, J			EMBRYO RESEARCH	LANCET			English	Editorial Material																			0	0	0	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	FEB 13	1988	1	8581					368	369						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	M0211	11644347				2022-12-24	WOS:A1988M021100063
J	Sorensen, HT; Pedersen, L; Nogard, L; Fonager, K; Rothman, KJ				Sorensen, HT; Pedersen, L; Nogard, L; Fonager, K; Rothman, KJ			Does month of birth affect risk of Crohn's disease in childhood and adolescence?	BRITISH MEDICAL JOURNAL			English	Article							IN-UTERO; MEASLES; EXPOSURE		Aarhus Univ Hosp, Dept Clin Epidemiol, DK-8000 Aarhus C, Denmark; Aalborg Univ Hosp, Dept Clin Epidemiol, DK-8000 Aarhus, Denmark; Aarhus Univ, Inst Epidemiol & Social Med, DK-8000 Aarhus C, Denmark; Boston Univ, Sch Med, Prevent Med & Epidemiol Sect, Boston, MA 02118 USA	Aarhus University; Aalborg University; Aalborg University Hospital; Aarhus University; Aarhus University; Boston University	Sorensen, HT (corresponding author), Aarhus Univ Hosp, Dept Clin Epidemiol, Vennelyst Blvd 6, DK-8000 Aarhus C, Denmark.		Sorensen, Henrik Toft/Z-6181-2019; Nørgård, Bente M/F-9563-2013	Sorensen, Henrik Toft/0000-0003-4299-7040; Nørgård, Bente M/0000-0002-9514-3033; Rothman, Kenneth/0000-0003-2398-1705; Fonager, Kirsten/0000-0001-9641-992X				Ekbom A, 1996, LANCET, V348, P515, DOI 10.1016/S0140-6736(96)04429-7; Haslam N, 2000, GUT, V47, P801, DOI 10.1136/gut.47.6.801; Nielsen LLW, 1998, BRIT MED J, V316, P196, DOI 10.1136/bmj.316.7126.196	3	24	24	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 20	2001	323	7318					907	907		10.1136/bmj.323.7318.907	http://dx.doi.org/10.1136/bmj.323.7318.907			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	486BH	11668136	Bronze, Green Published			2022-12-24	WOS:000171798200022
J	Cui, XD; Primak, A; Zarate, X; Tomfohr, J; Sankey, OF; Moore, AL; Moore, TA; Gust, D; Harris, G; Lindsay, SM				Cui, XD; Primak, A; Zarate, X; Tomfohr, J; Sankey, OF; Moore, AL; Moore, TA; Gust, D; Harris, G; Lindsay, SM			Reproducible measurement of single-molecule conductivity	SCIENCE			English	Article							ASSEMBLED ALKANETHIOL MONOLAYERS; METAL JUNCTIONS; TRANSPORT	A reliable method has been developed for making through-bond electrical contacts to molecules. Current-voltage curves are quantized as integer multiples of one fundamental curve, an observation used to identify single-molecule contacts. The resistance of a single octanedithiol molecule was 900 +/- 50 megohms, based on measurements on more than 1000 single molecules. In contrast, nonbonded contacts to octanethiol monolayers were at least four orders of magnitude more resistive, less reproducible, and had a different voltage dependence, demonstrating that the measurement of intrinsic molecular properties requires chemically bonded contacts.	Arizona State Univ, Dept Phys & Astron, Tempe, AZ 85287 USA; Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA; Motorola Inc, Tempe, AZ 85284 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Cui, XD (corresponding author), Arizona State Univ, Dept Phys & Astron, Tempe, AZ 85287 USA.		Zarate, Xristo/AAH-1463-2020; Cui, Xiaodong/C-2023-2009	Zarate, Xristo/0000-0002-9824-3961; Cui, Xiaodong/0000-0002-2013-8336				Cygan MT, 1998, J AM CHEM SOC, V120, P2721, DOI 10.1021/ja973448h; Datta S, 1997, PHYS REV LETT, V79, P2530, DOI 10.1103/PhysRevLett.79.2530; DEMKOV AA, 1995, PHYS REV B, V52, P1618, DOI 10.1103/PhysRevB.52.1618; DEROSE JA, 1991, SURF SCI, V256, P102, DOI 10.1016/0039-6028(91)91204-B; Di Ventra M, 2000, PHYS REV LETT, V84, P979, DOI 10.1103/PhysRevLett.84.979; DOROGI M, 1995, PHYS REV B, V52, P9071, DOI 10.1103/PhysRevB.52.9071; Fink HW, 1999, NATURE, V398, P407, DOI 10.1038/18855; Frank S, 1998, SCIENCE, V280, P1744, DOI 10.1126/science.280.5370.1744; Gittins DI, 2000, NATURE, V408, P67, DOI 10.1038/35040518; Holmlin RE, 2001, J AM CHEM SOC, V123, P5075, DOI 10.1021/ja004055c; Leatherman G, 1999, J PHYS CHEM B, V103, P4006, DOI 10.1021/jp9831278; MUJICA V, 1994, J CHEM PHYS, V101, P6849, DOI 10.1063/1.468314; Porath D, 2000, NATURE, V403, P635, DOI 10.1038/35001029; Reed MA, 1997, SCIENCE, V278, P252, DOI 10.1126/science.278.5336.252; Schlenoff JB, 1995, J AM CHEM SOC, V117, P12528, DOI 10.1021/ja00155a016; SIEPMANN JI, 1993, PHYS REV LETT, V70, P453, DOI 10.1103/PhysRevLett.70.453; Son KA, 2001, PHYS REV LETT, V86, P5357, DOI 10.1103/PhysRevLett.86.5357; Weare WW, 2000, J AM CHEM SOC, V122, P12890, DOI 10.1021/ja002673n; Wold DJ, 2001, J AM CHEM SOC, V123, P5549, DOI 10.1021/ja0101532; Yang JS, 2000, J ORG CHEM, V65, P871, DOI 10.1021/jo991339a	20	1194	1224	13	258	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2001	294	5542					571	574		10.1126/science.1064354	http://dx.doi.org/10.1126/science.1064354			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484NC	11641492				2022-12-24	WOS:000171695600040
J	Girardi, M; Oppenheim, DE; Steele, CR; Lewis, JM; Glusac, E; Filler, R; Hobby, P; Sutton, B; Tigelaar, RE; Hayday, AC				Girardi, M; Oppenheim, DE; Steele, CR; Lewis, JM; Glusac, E; Filler, R; Hobby, P; Sutton, B; Tigelaar, RE; Hayday, AC			Regulation of cutaneous malignancy by gamma delta T cells	SCIENCE			English	Article							EPIDERMAL-CELLS; NATURAL-KILLER; EXPRESSION; RECEPTOR; ANTIGEN; LIGAND; FAMILY; GENES; NKG2D; MICE	The localization of gamma delta T cells within epithelia suggests that these cells may contribute to the down-regulation of epithelial malignancies. We report that mice lacking gamma delta cells are highly susceptible to multiple regimens of cutaneous carcinogenesis. After exposure to carcinogens, skin cells expressed Rae-1 and H60, major histocompatibility complex-related molecules structurally resembling human MICA. Each of these is a ligand for NKG2d, a receptor expressed by cytolytic T cells and natural killer(NK) cells. In vitro, skin-associated NKG2d(+) gamma delta cells killed skin carcinoma cells by a mechanism that was sensitive to blocking NKG2d engagement. Thus, local T cells may use evolutionarily conserved proteins to negatively regulate malignancy.	Guys Kings St Thomas Med Sch, Peter Gorer Dept Immunobiol, London SE1 9RT, England; Guys Kings St Thomas Med Sch, Dept Dermatol, London SE1 9RT, England; Guys Kings St Thomas Med Sch, Yale Skin Dis Res Core Ctr, London SE1 9RT, England; Kings Coll London, Guys Hosp, Randall Ctr Mol Med, London SE1 9RT, England	University of London; King's College London; University of London; King's College London; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Hayday, AC (corresponding author), Guys Kings St Thomas Med Sch, Peter Gorer Dept Immunobiol, London SE1 9RT, England.	adrian.hayday@kcl.ac.uk		HAYDAY, ADRIAN/0000-0002-9495-5793; Girardi, Michael/0000-0003-1887-9343	NIAID NIH HHS [AI 27855] Funding Source: Medline; PHS HHS [KO8] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI027855] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ASARNOW DM, 1988, CELL, V55, P837, DOI 10.1016/0092-8674(88)90139-0; Brown MH, 1998, J EXP MED, V188, P2083, DOI 10.1084/jem.188.11.2083; Cerwenka A, 2000, IMMUNITY, V12, P721, DOI 10.1016/S1074-7613(00)80222-8; Coligan JKA, 1991, CURRENT PROTOCOLS IM; Cosman D, 2001, IMMUNITY, V14, P123, DOI 10.1016/S1074-7613(09)00098-3; Coussens LM, 2001, J EXP MED, V193, pF23, DOI 10.1084/jem.193.6.F23; Diefenbach A, 2000, NAT IMMUNOL, V1, P119, DOI 10.1038/77793; FUSENIG NE, 1978, B CANCER, V65, P271; Girardi M., UNPUB; Groh V, 1999, P NATL ACAD SCI USA, V96, P6879, DOI 10.1073/pnas.96.12.6879; Groh V, 2001, NAT IMMUNOL, V2, P255, DOI 10.1038/85321; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Ho EL, 1998, P NATL ACAD SCI USA, V95, P6320, DOI 10.1073/pnas.95.11.6320; Holtmeier V, 2001, J INVEST DERMATOL, V116, P275, DOI 10.1046/j.1523-1747.2001.01250.x; JANEWAY CA, 1988, IMMUNOL TODAY, V9, P73, DOI 10.1016/0167-5699(88)91267-4; Kaplan DH, 1998, P NATL ACAD SCI USA, V95, P7556, DOI 10.1073/pnas.95.13.7556; Lewis J M, UNPUB; Li PW, 2001, NAT IMMUNOL, V2, P443, DOI 10.1038/87757; Malarkannan S, 1998, J IMMUNOL, V161, P3501; MARSHALL V, 1974, TRANSPLANTATION, V17, P272, DOI 10.1097/00007890-197403000-00006; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; MOMBAERTS P, 1993, NATURE, V365, P53, DOI 10.1038/365053a0; Nomura M, 1996, J BIOCHEM-TOKYO, V120, P987; Owens DM, 1999, CARCINOGENESIS, V20, P1837, DOI 10.1093/carcin/20.9.1837; Sanchez LM, 1999, SCIENCE, V283, P1914, DOI 10.1126/science.283.5409.1914; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Wolan DW, 2001, NAT IMMUNOL, V2, P248, DOI 10.1038/85311	27	747	776	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2001	294	5542					605	609		10.1126/science.1063916	http://dx.doi.org/10.1126/science.1063916			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484NC	11567106				2022-12-24	WOS:000171695600050
J	Valadkhan, S; Manley, JL				Valadkhan, S; Manley, JL			Splicing-related catalysis by protein-free snRNAs	NATURE			English	Article							SMALL NUCLEAR-RNA; METAL-ION CATALYSIS; U6 SNRNA; TERTIARY INTERACTION; IN-VITRO; SPLICEOSOME; SELECTION; STEP; DNA; SEQUENCE	Removal of intervening sequences from eukaryotic messenger RNA precursors is carried out by the spliceosome, a complex assembly of five small nuclear RNAs (snRNAs) and a large number of proteins. Although it has been suggested that the spliceosome might be an RNA enzyme, direct evidence for this has been lacking, and the identity of the catalytic domain of the spliceosome is unknown. Here we show that a protein-free complex of two snRNAs, U2 and U6, can bind and position a small RNA containing the sequence of the intron branch site, and activate the branch adenosine to attack a catalytically critical domain of U6 in a reaction that is related to the first step of splicing. Our data provide direct evidence for the catalytic potential of spliceosomal snRNAs.	Columbia Univ, Sherman Fairchild Ctr Life Sci, Dept Biol Sci, New York, NY 10027 USA	Columbia University	Manley, JL (corresponding author), Columbia Univ, Sherman Fairchild Ctr Life Sci, Dept Biol Sci, New York, NY 10027 USA.	jlm2@columbia.edu	Valadkhan, Saba/G-5561-2010; Valadkhan, Saba/G-7271-2012	Manley, James/0000-0002-8341-1459				Boudvillain M, 1998, EMBO J, V17, P7091, DOI 10.1093/emboj/17.23.7091; BURGE CB, 1998, RNA WORLD, V2, P525; BURN AJ, 1961, J CHEM SOC, P5532, DOI 10.1039/jr9610005532; Collins CA, 2000, NAT STRUCT BIOL, V7, P850; Collins CA, 1999, GENE DEV, V13, P1970, DOI 10.1101/gad.13.15.1970; DATTA B, 1993, MOL CELL BIOL, V13, P5377, DOI 10.1128/MCB.13.9.5377; FABRIZIO P, 1992, NUCLEIC ACIDS RES, V20, P3659, DOI 10.1093/nar/20.14.3659; FABRIZIO P, 1990, SCIENCE, V250, P404, DOI 10.1126/science.2145630; GISH G, 1988, SCIENCE, V240, P1520, DOI 10.1126/science.2453926; Gordon PM, 2000, RNA, V6, P199, DOI 10.1017/S1355838200992069; Hetzer M, 1997, NATURE, V386, P417, DOI 10.1038/386417a0; Huang Z, 1996, NUCLEIC ACIDS RES, V24, P4360, DOI 10.1093/nar/24.21.4360; KOOLE LH, 1991, TETRAHEDRON, V47, P3183, DOI 10.1016/S0040-4020(01)96043-0; LEHMAN IR, 1974, SCIENCE, V186, P790; MADHANI HD, 1994, GENE DEV, V8, P1071, DOI 10.1101/gad.8.9.1071; MADHANI HD, 1990, GENE DEV, V4, P2264, DOI 10.1101/gad.4.12b.2264; Newman A, 1997, CURR BIOL, V7, pR418, DOI 10.1016/S0960-9822(06)00206-5; Nilsen TW, 1998, COLD SPRING HARBOR M, P279; OKeefe RT, 1996, CELL, V86, P679, DOI 10.1016/S0092-8674(00)80140-3; QUERY CC, 1994, GENE DEV, V8, P587, DOI 10.1101/gad.8.5.587; Query CC, 1996, EMBO J, V15, P1392, DOI 10.1002/j.1460-2075.1996.tb00481.x; Saenger W., 1984, PRINCIPLES NUCL ACID, P116, DOI DOI 10.1007/978-1-4612-5190-3_6; Santoro SW, 1997, P NATL ACAD SCI USA, V94, P4262, DOI 10.1073/pnas.94.9.4262; Segault V, 1999, MOL CELL BIOL, V19, P2782; Siatecka M, 1999, GENE DEV, V13, P1983, DOI 10.1101/gad.13.15.1983; Sontheimer EJ, 1997, NATURE, V388, P801, DOI 10.1038/42068; SUN JS, 1995, GENE DEV, V9, P843, DOI 10.1101/gad.9.7.843; TANI T, 1991, GENE DEV, V5, P1022, DOI 10.1101/gad.5.6.1022; Tarn WY, 1996, SCIENCE, V273, P1824, DOI 10.1126/science.273.5283.1824; Tarn WY, 1997, TRENDS BIOCHEM SCI, V22, P132, DOI 10.1016/S0968-0004(97)01018-9; Tuschl T, 2001, RNA, V7, P29, DOI 10.1017/S1355838201001510; Tuschl T, 1998, EMBO J, V17, P2637, DOI 10.1093/emboj/17.9.2637; Valadkhan S, 2000, RNA, V6, P206, DOI 10.1017/S1355838200992197; WOLFF T, 1994, P NATL ACAD SCI USA, V91, P903, DOI 10.1073/pnas.91.3.903; Yean SL, 2000, NATURE, V408, P881, DOI 10.1038/35048617; YU YT, 1995, RNA, V1, P46; YU YT, 1993, CELL, V75, P1049, DOI 10.1016/0092-8674(93)90315-H	37	170	185	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 18	2001	413	6857					701	707		10.1038/35099500	http://dx.doi.org/10.1038/35099500			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	482ZK	11607023				2022-12-24	WOS:000171608000035
J	Chodosh, J; Ferrell, BA; Shekelle, PG; Wenger, NS				Chodosh, J; Ferrell, BA; Shekelle, PG; Wenger, NS			Quality indicators for pain management in vulnerable elders	ANNALS OF INTERNAL MEDICINE			English	Article							CHRONIC MUSCULOSKELETAL PAIN; PLACEBO-CONTROLLED TRIAL; GENERAL-POPULATION; NUTRITION EXAMINATION; DEPRESSIVE SYMPTOMS; DIABETIC NEUROPATHY; RANDOMIZED TRIAL; NATIONAL-HEALTH; PEPTIC-ULCER; DRUG-USE		Univ Calif Los Angeles, Div Geriatr, Dept Med, Los Angeles, CA 90095 USA; RAND Corp, Hlth, Santa Monica, CA 90406 USA; Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA USA	University of California System; University of California Los Angeles; RAND Corporation; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	Chodosh, J (corresponding author), Univ Calif Los Angeles, Div Geriatr, Dept Med, Los Angeles, CA 90095 USA.	jchodosh@mednet.ucla.edu		Chodosh, Joshua/0000-0001-7784-4306				ANDERSEN S, 1987, PAIN S, V4, P332; [Anonymous], [No title captured]; Becker N, 1997, PAIN, V73, P393, DOI 10.1016/S0304-3959(97)00126-7; Bernabei R, 1998, JAMA-J AM MED ASSOC, V279, P1877, DOI 10.1001/jama.279.23.1877; BRATTBERG G, 1989, PAIN, V37, P215, DOI 10.1016/0304-3959(89)90133-4; Brochet B, 1998, AGE AGEING, V27, P279, DOI 10.1093/ageing/27.3.279; CLEELAND CS, 1994, NEW ENGL J MED, V330, P592, DOI 10.1056/NEJM199403033300902; COONER E, 1997, 628200 NATL COUNC AG; CROOK J, 1984, PAIN, V18, P299, DOI 10.1016/0304-3959(84)90824-8; Davis M A, 1988, Clin Geriatr Med, V4, P241; DIETRICH AJ, 1982, J FAM PRACTICE, V15, P929; Ellison Neil M., 1993, P185; Ettinger WH, 1997, JAMA-J AM MED ASSOC, V277, P25, DOI 10.1001/jama.277.1.25; Ferrell BA, 1997, AGING-CLIN EXP RES, V9, P99, DOI 10.1007/BF03340134; Ferrell BA, 1998, J AM GERIATR SOC, V46, P635, DOI 10.1111/j.1532-5415.1998.tb01084.x; FERRELL BA, 1990, J AM GERIATR SOC, V38, P409, DOI 10.1111/j.1532-5415.1990.tb03538.x; Foley K, 1994, PRINCIPLES GERIATRIC, P317; GLARE P, 1992, J PAIN SYMPTOM MANAG, V7, P369, DOI 10.1016/0885-3924(92)90092-V; GRIFFIN MR, 1988, ANN INTERN MED, V109, P359, DOI 10.7326/0003-4819-109-5-359; GRIFFIN MR, 1991, ANN INTERN MED, V114, P257, DOI 10.7326/0003-4819-114-4-257; GURWITZ JH, 1990, JAMA-J AM MED ASSOC, V264, P471, DOI 10.1001/jama.264.4.471; HAMEROFF SR, 1984, J CLIN PSYCHIAT, V45, P47; LAVSKYSHULAN M, 1985, J AM GERIATR SOC, V33, P23, DOI 10.1111/j.1532-5415.1985.tb02855.x; MAGNI G, 1993, PAIN, V53, P163, DOI 10.1016/0304-3959(93)90076-2; MAGNI G, 1990, PAIN, V43, P299, DOI 10.1016/0304-3959(90)90027-B; MAX MB, 1991, PAIN, V45, P3, DOI 10.1016/0304-3959(91)90157-S; MAX MB, 1992, NEW ENGL J MED, V326, P1250, DOI 10.1056/NEJM199205073261904; Mobily P., 1994, J AGING HEALTH, V6, P139, DOI DOI 10.1177/089826439400600201; PANERAI AE, 1990, ACTA NEUROL SCAND, V82, P34; PARMELEE PA, 1991, J GERONTOL, V46, pP15, DOI 10.1093/geronj/46.1.P15; PFEIFER MA, 1993, DIABETES CARE, V16, P1103, DOI 10.2337/diacare.16.8.1103; POPP B, 1996, PAIN ELDERLY, P21; RODRIGUEZ LAG, 1994, LANCET, V343, P769, DOI 10.1016/S0140-6736(94)91843-0; ROGERS M, 1989, J CLIN GASTROENTEROL, V11, P132; ROY R, 1986, CAN FAM PHYSICIAN, V32, P513; Shekelle PG, 2001, ANN INTERN MED, V135, P647, DOI 10.7326/0003-4819-135-8_Part_2-200110161-00003; *US AG HLTH CAR PO, 1994, AHCPR PUBL; Wilson PR, 1997, ANESTHESIOLOGY, V86, P995	38	26	26	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 16	2001	135	8	2				731	735		10.7326/0003-4819-135-8_Part_2-200110161-00012	http://dx.doi.org/10.7326/0003-4819-135-8_Part_2-200110161-00012			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	481WA	11601956				2022-12-24	WOS:000171542400012
J	Bay-Nielsen, M; Kehlet, H; Strand, L; Malmstrom, J; Andersen, FH; Wara, P; Juul, P; Callesen, T				Bay-Nielsen, M; Kehlet, H; Strand, L; Malmstrom, J; Andersen, FH; Wara, P; Juul, P; Callesen, T		Danish Hernia Database Collaborat	Quality assessment of 26,304 herniorrhaphies in Denmark: a prospective nationwide study	LANCET			English	Article							INGUINAL HERNIORRHAPHY; HERNIA SURGERY	Background Groin hernia repair is one of the most frequent operations, but there is no consensus about surgical or anaesthetic technique. Furthermore, no nationwide studies have been done. Our aim was to investigate outcome results of groin hernia surgery to improve quality of treatment. Methods We prospectively recorded 26 304 groin hernia repairs done in Denmark from Jan 1, 1998, to June 30, 2000, in a nationwide Danish hernia database. Findings 93% of all groin herniorrhaphies done in Denmark in the 30 months of the study were recorded in the database. Kaplan-Meier estimates of reoperation rates 30 months after anterior mesh repair and laparoscopic repair were significantly lower than after sutured posterior wall repairs in primary inguinal hernia (2.2% and 2.6% vs 4.4%; p < 0.0001). Reoperation rates were also lower with anterior mesh repair (6.1%; p < 0.0001) and laparoscopic repair (3.4%; p < 0.0001) than with sutured posterior wall repair (10.6%) after recurrent hernia. Use of Lichtenstein mesh repair increased from 33% in January, 1998, to 62% in June, 2000, whereas use of laparoscopic repair remained constant at about 5%. Kaplan-Meier estimates of reoperation rates were 2.8% in the first 15 months and 1.6% in the second (p = 0.03). For elective repairs, only 59% of patients were treated on an outpatient basis, and only 18% had local anaesthesia. Interpretation Mesh repairs have a lower reoperation rate than conventional open repairs. Systematic prospective recording of treatment and outcome variables in a national clinical database improved the overall quality of surgical care. However, there is a large potential for cost savings and more efficient patient care with extended use of mesh techniques, outpatient surgery, and local anaesthesia.	Hvidovre Univ Hosp, Dept Surg Gastroenterol 435, DK-2650 Hvidovre, Denmark	University of Copenhagen	Bay-Nielsen, M (corresponding author), Hvidovre Univ Hosp, Dept Surg Gastroenterol 435, Kettegaard Alle 30, DK-2650 Hvidovre, Denmark.	morten.bay.nielsen@hh.hosp.dk						Amid PK, 1998, HERNIA, V22, P89, DOI [DOI 10.1007/BF01207492, 10.1007/BF01207492]; [Anonymous], 1926, REP PUBLIC HLTH MED; Bay-Nielsen M, 2001, ANN SURG, V233, P1, DOI 10.1097/00000658-200101000-00001; Bay-Nielsen M, 1999, HERNIA, V3, P81; Black N, 1999, LANCET, V353, P1205, DOI 10.1016/S0140-6736(99)00108-7; Callesen T, 1997, ANESTHESIOLOGY, V87, P1219, DOI 10.1097/00000542-199711000-00027; Callesen T, 1998, ANAESTHESIA, V53, P31, DOI 10.1111/j.1365-2044.1998.00244.x; Callesen T, 1999, EUR J SURG, V165, P236; DEYSINE M, 1991, ARCH SURG-CHICAGO, V126, P628; Grant A, 2000, BRIT J SURG, V87, P854, DOI 10.1046/j.1365-2168.2000.01539.x; Grant A, 2000, BRIT J SURG, V87, P860, DOI 10.1046/j.1365-2168.2000.01540.x; Kald A, 1998, EUR J SURG, V164, P45; Kark AE, 1998, J AM COLL SURGEONS, V186, P447, DOI 10.1016/S1072-7515(98)00057-X; Kingsnorth AN, 2000, HERNIA, V4, P1; MAJEED AW, 1995, BRIT MED J, V311, P296, DOI 10.1136/bmj.311.7000.296; Nilsson E, 1998, SURG CLIN N AM, V78, P1141, DOI 10.1016/S0039-6109(05)70375-3; Nilsson E, 1997, EUR J SURG, V163, P823; O'Riordan DC, 1998, SURG CLIN N AM, V78, P1129, DOI 10.1016/S0039-6109(05)70374-1; WELSH DRJ, 1993, SURG CLIN N AM, V73, P451	19	311	327	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 6	2001	358	9288					1124	1128		10.1016/S0140-6736(01)06251-1	http://dx.doi.org/10.1016/S0140-6736(01)06251-1			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	479HM	11597665				2022-12-24	WOS:000171399000008
J	Heppner, FL; Musahl, C; Arrighi, I; Klein, MA; Rulicke, T; Oesch, B; Zinkernagel, RM; Kalinke, U; Aguzzi, A				Heppner, FL; Musahl, C; Arrighi, I; Klein, MA; Rulicke, T; Oesch, B; Zinkernagel, RM; Kalinke, U; Aguzzi, A			Prevention of scrapie pathogenesis by transgenic expression of anti-prion protein antibodies	SCIENCE			English	Article							FOLLICULAR DENDRITIC CELLS; PRP KNOCKOUT MICE; B-CELLS; VARIANT CJD; PURIFICATION; LYMPHOCYTES; REPLICATION; RESISTANT; LACKING; AGENT	Variant Creutzfeldt-Jakob disease and bovine spongiform encephalopathy are initiated by extracerebral exposure to prions. Although prion transmission from extracerebral sites to the brain represents a potential target for prophylaxis, attempts at vaccination have been limited by the poor immunogenicity of prion proteins. To circumvent this, we expressed an anti-prion protein (anti-PrP) mu chain in Prnp(o/o) mice. Transgenic mice developed sustained anti-PrP titers, which were not suppressed by introduction of Prnp(+) alleles. Transgene expression prevented pathogenesis of prions introduced by intraperitoneal injection in the spleen and brain. Expression of endogenous PrP (PrPC) in the spleen and brain was unaffected, suggesting that immunity was responsible for protection. This indicates the feasibility of immunological inhibition of prion disease in vivo.	Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland; Univ Zurich Hosp, Inst Lab Anim Sci, CH-8091 Zurich, Switzerland; Univ Zurich Hosp, Inst Expt Immunol, CH-8091 Zurich, Switzerland; Prion AG, CH-8057 Zurich, Switzerland; European Mol Biol Lab, Mouse Biol Programme, I-00016 Monterotondo, Rome, Italy	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; European Molecular Biology Laboratory (EMBL)	Aguzzi, A (corresponding author), Univ Zurich Hosp, Inst Neuropathol, Schmelzbergstr 12, CH-8091 Zurich, Switzerland.		Aguzzi, Adriano/A-3351-2008; Heppner, Frank/ABH-8393-2020	Heppner, Frank/0000-0001-9816-8917; Kalinke, Ulrich/0000-0003-0503-9564; Aguzzi, Adriano/0000-0002-0344-6708				ADELSTEIN S, 1991, SCIENCE, V251, P1223, DOI 10.1126/science.1900950; Aguzzi A, 2001, NAT REV MOL CELL BIO, V2, P118, DOI 10.1038/35052063; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; Forster I, 1989, Int Immunol, V1, P321, DOI 10.1093/intimm/1.4.321; GABIZON R, 1988, P NATL ACAD SCI USA, V85, P6617, DOI 10.1073/pnas.85.18.6617; HEPPNER FL, UNPUB; Horiuchi M, 1999, EMBO J, V18, P3193, DOI 10.1093/emboj/18.12.3193; Hornemann S, 1997, FEBS LETT, V413, P277, DOI 10.1016/S0014-5793(97)00921-6; KITAMOTO T, 1991, J VIROL, V65, P6292, DOI 10.1128/JVI.65.11.6292-6295.1991; Klein MA, 2001, NAT MED, V7, P488, DOI 10.1038/86567; Klein MA, 1998, NAT MED, V4, P1429, DOI 10.1038/4022; Klein MA, 1997, NATURE, V390, P687, DOI 10.1038/37789; Korth C, 1997, NATURE, V390, P74, DOI 10.1038/36337; KOSCO MH, 1992, J IMMUNOL, V148, P2331; Loder F, 1999, J EXP MED, V190, P75, DOI 10.1084/jem.190.1.75; Montrasio F, 2000, SCIENCE, V288, P1257, DOI 10.1126/science.288.5469.1257; PRUSINER SB, 1982, ANN NEUROL, V11, P353, DOI 10.1002/ana.410110406; PRUSINER SB, 1993, P NATL ACAD SCI USA, V90, P10608, DOI 10.1073/pnas.90.22.10608; Raeber AJ, 1999, P NATL ACAD SCI USA, V96, P3987, DOI 10.1073/pnas.96.7.3987; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; SAILER A, 1994, CELL, V77, P967, DOI 10.1016/0092-8674(94)90436-7; TARABOULOS A, 1992, P NATL ACAD SCI USA, V89, P7620, DOI 10.1073/pnas.89.16.7620; TIEGS SL, 1993, J EXP MED, V177, P1009, DOI 10.1084/jem.177.4.1009; ZINKERNAGEL RM, 1990, NATURE, V345, P68, DOI 10.1038/345068a0	28	274	298	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 5	2001	294	5540					178	182		10.1126/science.1063093	http://dx.doi.org/10.1126/science.1063093			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480EJ	11546838				2022-12-24	WOS:000171448800056
J	Hammarstrom, P; Schneider, F; Kelly, JW				Hammarstrom, P; Schneider, F; Kelly, JW			Trans-suppression of misfolding in an amyloid disease	SCIENCE			English	Article							POLYNEUROPATHY; STABILITY; HOMOZYGOSITY; TRANSTHYRETIN-MET30-GENE; PROTEIN	The transthyretin (TTR) amyloid diseases, representative of numerous misfolding disorders, are of considerable interest because there are mutations that cause or suppress disease. The Val(30) --> Met(30) (V30M) TTR mutation is the most prevalent cause of familial amyloid polyneuropathy in heterozygotes, whereas a Thr(119) ---> Met(119) (T119M) mutation on the second TTR allele protects V30M carriers from disease. Here, we show that the incorporation of one or more T119M TTR subunits into a predominantly V30M tetramer strongly stabilized the! mixed tetramer against dissociation. Dissociation is required for amyloid formation, so these findings provide a molecular explanation for intragenic trans-suppression of amyloidosis. The data also suggest a potential therapeutic strategy, provide insight into tissue-specific deposition and amyloid composition, and support the validity of the amyloid hypothesis in human disease.	Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Kelly, JW (corresponding author), Scripps Res Inst, Dept Chem, 10550 N Torrey Pines Rd BCC265, La Jolla, CA 92037 USA.	jkelly@scripps.edu		Hammarstrom, Per/0000-0001-5827-3587	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK046335, R01DK046335, R29DK046335] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK46335-09] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alves IL, 1997, EUR J BIOCHEM, V249, P662, DOI 10.1111/j.1432-1033.1997.00662.x; Ando Y, 1999, AMYLOID, V6, P119, DOI 10.3109/13506129909007312; Coehlo T., 1996, NEUROMUSCUL DISORD, V6, P27; Coelho Teresa, 1993, Journal of Rheumatology, V20, P179; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; DWULET FE, 1984, P NATL ACAD SCI-BIOL, V81, P694, DOI 10.1073/pnas.81.3.694; Fink AL, 1998, FOLD DES, V3, pR9, DOI 10.1016/S1359-0278(98)00002-9; Hammarstrom P, 2001, BIOCHEMISTRY-US, V40, P11453, DOI 10.1021/bi010673+; HOLMGREN G, 1992, CLIN GENET, V41, P39; HOLMGREN G, 1988, CLIN GENET, V34, P333; IKEDA S, 1992, EUR NEUROL, V32, P308, DOI 10.1159/000116850; Kelly JW, 1996, CURR OPIN STRUC BIOL, V6, P11, DOI 10.1016/S0959-440X(96)80089-3; MCCUTCHEN SL, 1995, BIOCHEMISTRY-US, V34, P13527, DOI 10.1021/bi00041a032; Nikolova PV, 2000, EMBO J, V19, P370, DOI 10.1093/emboj/19.3.370; SANDGREN O, 1990, ARCH OPHTHALMOL-CHIC, V108, P1584, DOI 10.1001/archopht.1990.01070130086036; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; SARAIVA MJM, 1984, J CLIN INVEST, V74, P104, DOI 10.1172/JCI111390; Schneider F, 2001, PROTEIN SCI, V10, P1606, DOI 10.1110/ps.8901; Schuler B, 1998, J MOL BIOL, V281, P227, DOI 10.1006/jmbi.1998.1944; Sebastiao MP, 2001, J MOL BIOL, V306, P733, DOI 10.1006/jmbi.2000.4415; SUHR OB, 1995, TRANSPLANTATION, V60, P933, DOI 10.1097/00007890-199511150-00009; Yazaki M, 2000, BIOCHEM BIOPH RES CO, V274, P702, DOI 10.1006/bbrc.2000.3203	22	233	240	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 28	2001	293	5539					2459	2462		10.1126/science.1062245	http://dx.doi.org/10.1126/science.1062245			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	476PD	11577236				2022-12-24	WOS:000171237200049
J	Hwang, I; Sheen, J				Hwang, I; Sheen, J			Two-component circuitry in Arabidopsis cytokinin signal transduction	NATURE			English	Article							2-COMPONENT RESPONSE REGULATOR; MAP KINASE CASCADE; HISTIDINE KINASE; ASP PHOSPHORELAY; LEAF SENESCENCE; PROTEIN-KINASES; PLANTS; THALIANA; YEAST; TRANSFORMATION	Cytokinins are essential plant hormones that are involved in shoot meristem and leaf formation, cell division, chloroplast biogenesis and senescence. Although hybrid histidine protein kinases have been implicated in cytokinin perception in Arabidopsis, the action of histidine protein kinase receptors and the downstream signalling pathway has not been elucidated to date. Here we identify a eukaryotic two-component signalling circuit that initiates cytokinin signalling through distinct hybrid histidine protein kinase activities at the plasma membrane. Histidine phosphotransmitters act as signalling shuttles between the cytoplasm and nucleus in a cytokinin-dependent manner. The short signalling circuit reaches the nuclear target genes by enabling nuclear response regulators ARR1, ARR2 and ARR10 as transcription activators. The cytokinin-inducible ARR4, ARR5, ARR6 and ARR7 genes encode transcription repressors that mediate a negative feedback loop in cytokinin signalling. Ectopic expression in transgenic Arabidopsis of ARR2, the rate-limiting factor in the response to cytokinin, is sufficient to mimic cytokinin in promoting shoot meristem proliferation and leaf differentiation, and in delaying leaf senescence.	Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Sheen, J (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.		Ding, Cheng-Qiang/B-6287-2011					[Anonymous], 1995, PLANT HORMONES PHYSL, DOI DOI 10.1007/978-94-011-0473-9; Bleecker AB, 2000, ANNU REV CELL DEV BI, V16, P1, DOI 10.1146/annurev.cellbio.16.1.1; CLARKE FH, 1995, J DYN CONTROL SYST, V1, P1, DOI DOI 10.1007/BF02254655; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; D'Agostino IB, 2000, PLANT PHYSIOL, V124, P1706, DOI 10.1104/pp.124.4.1706; D'Agostino IB, 1999, TRENDS BIOCHEM SCI, V24, P452, DOI 10.1016/S0968-0004(99)01465-6; ELBEIN AD, 1984, CRC CR REV BIOCH MOL, V16, P21, DOI 10.3109/10409238409102805; Frank M, 2000, PLANT PHYSIOL, V122, P721, DOI 10.1104/pp.122.3.721; Gamble RL, 1998, P NATL ACAD SCI USA, V95, P7825, DOI 10.1073/pnas.95.13.7825; GAN SS, 1995, SCIENCE, V270, P1986, DOI 10.1126/science.270.5244.1986; Haseloff J, 1997, P NATL ACAD SCI USA, V94, P2122, DOI 10.1073/pnas.94.6.2122; Imamura A, 1999, PLANT CELL PHYSIOL, V40, P733, DOI 10.1093/oxfordjournals.pcp.a029600; Inoue T, 2001, NATURE, V409, P1060, DOI 10.1038/35059117; Kakimoto T, 1996, SCIENCE, V274, P982, DOI 10.1126/science.274.5289.982; Kiba T, 1999, PLANT CELL PHYSIOL, V40, P767, DOI 10.1093/oxfordjournals.pcp.a029604; Kovtun Y, 2000, P NATL ACAD SCI USA, V97, P2940, DOI 10.1073/pnas.97.6.2940; Lohrmann J, 2001, MOL GENET GENOMICS, V265, P2, DOI 10.1007/s004380000400; MAEDA T, 1994, NATURE, V369, P242, DOI 10.1038/369242a0; Mahonen AP, 2000, GENE DEV, V14, P2938, DOI 10.1101/gad.189200; Meijer M, 2001, CURR OPIN PLANT BIOL, V4, P44, DOI 10.1016/S1369-5266(00)00134-5; Mok DWS, 2001, ANNU REV PLANT PHYS, V52, P89, DOI 10.1146/annurev.arplant.52.1.89; Nakamura A, 1999, BIOSCI BIOTECH BIOCH, V63, P1627, DOI 10.1271/bbb.63.1627; Ori N, 1999, PLANT CELL, V11, P1073, DOI 10.1105/tpc.11.6.1073; Posas F, 1996, CELL, V86, P865, DOI 10.1016/S0092-8674(00)80162-2; Posas F, 1998, EMBO J, V17, P1385, DOI 10.1093/emboj/17.5.1385; Quirino BF, 2000, TRENDS PLANT SCI, V5, P278, DOI 10.1016/S1360-1385(00)01655-1; Riou-Khamlichi C, 1999, SCIENCE, V283, P1541, DOI 10.1126/science.283.5407.1541; Sakai H, 1998, PLANT CELL PHYSIOL, V39, P1232, DOI 10.1093/oxfordjournals.pcp.a029325; Sakai H, 2000, PLANT J, V24, P703, DOI 10.1046/j.1365-313x.2000.00909.x; Sakakibara H, 2000, PLANT MOL BIOL, V42, P273, DOI 10.1023/A:1006334926388; Sheen J, 1996, SCIENCE, V274, P1900, DOI 10.1126/science.274.5294.1900; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Sussman MR, 2000, PLANT PHYSIOL, V124, P1465, DOI 10.1104/pp.124.4.1465; Suzuki T, 2001, PLANT CELL PHYSIOL, V42, P107, DOI 10.1093/pcp/pce037; Suzuki T, 1998, PLANT CELL PHYSIOL, V39, P1258, DOI 10.1093/oxfordjournals.pcp.a029329; Suzuki T, 2001, PLANT CELL PHYSIOL, V42, P37, DOI 10.1093/pcp/pce011; Suzuki T, 2000, BIOSCI BIOTECH BIOCH, V64, P2486, DOI 10.1271/bbb.64.2486; Thomason P, 2000, J CELL SCI, V113, P3141; Tsiantis M, 2001, PLANT CELL, V13, P733, DOI 10.1105/tpc.13.4.733; Ueguchi C, 2001, PLANT CELL PHYSIOL, V42, P231, DOI 10.1093/pcp/pce015; Urao T, 2000, TRENDS PLANT SCI, V5, P67, DOI 10.1016/S1360-1385(99)01542-3; Urao T, 2000, FEBS LETT, V478, P227, DOI 10.1016/S0014-5793(00)01860-3; Urao T, 1998, FEBS LETT, V427, P175, DOI 10.1016/S0014-5793(98)00418-9; Urao T, 1999, PLANT CELL, V11, P1743, DOI 10.1105/tpc.11.9.1743; WurglerMurphy SM, 1997, TRENDS BIOCHEM SCI, V22, P172, DOI 10.1016/S0968-0004(97)01036-0; Xiang CB, 1999, PLANT MOL BIOL, V40, P711, DOI 10.1023/A:1006201910593; Yanagisawa S, 1998, PLANT CELL, V10, P75, DOI 10.1105/tpc.10.1.75; Yeh KC, 1998, P NATL ACAD SCI USA, V95, P13976, DOI 10.1073/pnas.95.23.13976	48	682	749	4	111	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 27	2001	413	6854					383	389		10.1038/35096500	http://dx.doi.org/10.1038/35096500			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475UY	11574878				2022-12-24	WOS:000171188700044
J	Moberg, KH; Bell, DW; Wahrer, DCR; Haber, DA; Hariharan, IK				Moberg, KH; Bell, DW; Wahrer, DCR; Haber, DA; Hariharan, IK			Archipelago regulates Cyclin E levels in Drosophila and is mutated in human cancer cell lines	NATURE			English	Article							EYE IMAGINAL DISC; CONTROLS S-PHASE; F-BOX; PROLIFERATION; EXPRESSION; PROTEINS; ELEGANS; BREAST; ARREST; FAMILY	During Drosophila development and mammalian embryogenesis, exit from the cell cycle is contingent on tightly controlled downregulation of the activity of Cyclin E-Cdk2 complexes that normally promote the transition from G1 to S phase(1,2). Although protein degradation has a crucial role in downregulating levels of Cyclin E, many of the proteins that function in degradation of Cyclin E have not been identified. In a screen for Drosophila mutants that display increased cell proliferation, we identified archipelago, a gene encoding a protein with an F-box and seven tandem WD (tryptophan-aspartic acid) repeats. Here we show that archipelago mutant cells have persistently elevated levels of Cyclin E protein without increased levels of cyclin E RNA. They are under-represented in G1 fractions and continue to proliferate when their wild-type neighbours become quiescent. The Archipelago protein binds directly to Cyclin E and probably targets it for ubiquitin-mediated degradation. A highly conserved human homologue is present and is mutated in four cancer cell lines including three of ten derived from ovarian carcinomas. These findings implicate archipelago in developmentally regulated degradation of Cyclin E and potentially in the pathogenesis of human cancers.	Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital	Hariharan, IK (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Bldg 149,13th St, Charlestown, MA 02129 USA.		Moberg, Ken/J-4849-2017	Moberg, Ken/0000-0002-9820-5543				Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Courjal F, 1996, INT J CANCER, V69, P247; Dealy MJ, 1999, NAT GENET, V23, P245, DOI 10.1038/13886; FitzGerald MG, 1997, NAT GENET, V15, P307, DOI 10.1038/ng0397-307; HAY BA, 1994, DEVELOPMENT, V120, P2121; Horsfield J, 1998, DEVELOPMENT, V125, P5069; Hubbard EJA, 1997, GENE DEV, V11, P3182, DOI 10.1101/gad.11.23.3182; Keyomarsi K, 1997, Prog Cell Cycle Res, V3, P171; Kipreos ET, 2000, DEVELOPMENT, V127, P5071; Kipreos ET, 1996, CELL, V85, P829, DOI 10.1016/S0092-8674(00)81267-2; Kiyokawa H, 1998, CURR TOP MICROBIOL, V227, P105; KNOBLICH JA, 1994, CELL, V77, P107, DOI 10.1016/0092-8674(94)90239-9; Neufeld TP, 1998, CELL, V93, P1183, DOI 10.1016/S0092-8674(00)81462-2; PERRY MM, 1968, J MORPHOL, V124, P249, DOI 10.1002/jmor.1051240209; RICHARDSON H, 1995, DEVELOPMENT, V121, P3371; Secombe J, 1998, GENETICS, V149, P1867; Singer JD, 1999, GENE DEV, V13, P2375, DOI 10.1101/gad.13.18.2375; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; Tapon N, 2001, CELL, V105, P345, DOI 10.1016/S0092-8674(01)00332-4; Wang YS, 1999, CURR BIOL, V9, P1191, DOI 10.1016/S0960-9822(00)80024-X	22	375	390	0	8	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 20	2001	413	6853					311	316		10.1038/35095068	http://dx.doi.org/10.1038/35095068			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473KB	11565033				2022-12-24	WOS:000171040500040
J	Rioual, P; Andrieu-Ponel, V; Rietti-Shati, M; Battarbee, RW; de Beaulieu, JL; Cheddadi, R; Reille, M; Svobodova, H; Shemesh, A				Rioual, P; Andrieu-Ponel, V; Rietti-Shati, M; Battarbee, RW; de Beaulieu, JL; Cheddadi, R; Reille, M; Svobodova, H; Shemesh, A			High-resolution record of climate stability in France during the last interglacial period	NATURE			English	Article							EUROPEAN POLLEN RECORDS; LAKE DEVELOPMENT; OXYGEN ISOTOPES; BIOGENIC SILICA; NORTH-ATLANTIC; OCEAN; RECONSTRUCTION; VARIABILITY; TEMPERATURE; REGION	The last interglacial period (127-110 kyr ago) has been considered to be an analogue to the present interglacial period, the Holocene, which may help us to understand present climate evolution. But whereas Holocene climate has been essentially stable in Europe, variability in climate during the last interglacial period has remained unresolved, because climate reconstructions from ice cores(1,2), continental records(3,4) and marine sediment cores(5,6) give conflicting results for this period(7). Here we present a high-resolution multi-proxy lacustrine record of climate change during the last interglacial period, based on oxygen isotopes in diatom silica, diatom assemblages and pollen-climate transfer functions from the Ribains maar in France. Contrary to a previous study(8), our data do not show a cold event interrupting the warm interglacial climate. Instead, we rnd an early temperature maximum with a transition to a colder climate about halfway through the sequence. The end of the interglacial period is clearly marked by an abrupt change in all proxy records. Our study confirms that in southwestern Europe the last interglacial period was a time of climatic stability and is therefore still likely to represent a useful analogue for the present climate.	UCL, Environm Change Res Ctr, London WC1H 0AP, England; Fac Sci & Tech St Jerome, UDESAM, Inst Mediterraneen Ecol & Paleoecol, CNRS,UMR 6116, F-13397 Marseille 20, France; Weizmann Inst Sci, Dept Environm Sci & Energy Res, IL-76100 Rehovot, Israel; Inst Bot, CZ-25243 Prague, Czech Republic	University of London; University College London; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Weizmann Institute of Science; Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences	Rioual, P (corresponding author), UCL, Environm Change Res Ctr, 26 Bedford Way, London WC1H 0AP, England.	prioual@geog.ucl.ac.uk	ANDRIEU-PONEL, Valerie/J-2818-2014; Rioual, Patrick/H-5140-2018; Svitavska, Helena Svobodova/D-4161-2013	ANDRIEU-PONEL, Valerie/0000-0001-7044-967X; Rioual, Patrick/0000-0001-9491-9197; Svitavska Svobodova, Helena/0000-0001-6092-4588				Aalbersberg G, 1998, J QUATERNARY SCI, V13, P367, DOI 10.1002/(SICI)1099-1417(1998090)13:5<367::AID-JQS400>3.3.CO;2-9; ANKLIN M, 1993, NATURE, V364, P203, DOI 10.1038/364203a0; BATTARBEE RW, 1982, LIMNOL OCEANOGR, V27, P184, DOI 10.4319/lo.1982.27.1.0184; Beyerle U, 1998, SCIENCE, V282, P731, DOI 10.1126/science.282.5389.731; Bjorck S, 2000, QUATERNARY SCI REV, V19, P509, DOI 10.1016/S0277-3791(99)00025-6; Cheddadi R, 1998, PALAEOGEOGR PALAEOCL, V143, P73, DOI 10.1016/S0031-0182(98)00067-4; Cortijo E, 2000, QUATERNARY SCI REV, V19, P227, DOI 10.1016/S0277-3791(99)00063-3; de Beaulieu J.L., 1992, VEG HIST ARCHAEOBOT, V1, P233, DOI DOI 10.1007/BF00189500; Frogley MR, 1999, SCIENCE, V285, P1886, DOI 10.1126/science.285.5435.1886; Fronval T, 1996, NATURE, V383, P806, DOI 10.1038/383806a0; GROOTES PM, 1993, NATURE, V366, P552, DOI 10.1038/366552a0; GUIOT J, 1989, NATURE, V338, P309, DOI 10.1038/338309a0; JUILLETLECLERC A, 1987, EARTH PLANET SCI NEW, V84, P69, DOI DOI 10.1016/0012-821X(87)90177-4; Kukla G, 1997, QUATERNARY SCI REV, V16, P605, DOI 10.1016/S0277-3791(96)00114-X; Kukla GJ, 2000, SCIENCE, V287, P987, DOI 10.1126/science.287.5455.987; Litt T, 1996, VEG HIST ARCHAEOBOT, V5, P247, DOI 10.1007/BF00217502; MABERLY SC, 1994, FRESHWATER BIOL, V31, P19, DOI 10.1111/j.1365-2427.1994.tb00835.x; McManus JF, 1999, SCIENCE, V283, P971, DOI 10.1126/science.283.5404.971; Reille M, 2000, J QUATERNARY SCI, V15, P665, DOI 10.1002/1099-1417(200010)15:7<665::AID-JQS560>3.0.CO;2-G; Rosqvist GC, 1999, GEOLOGY, V27, P967, DOI 10.1130/0091-7613(1999)027<0967:LGTMHC>2.3.CO;2; Rozanski K., 1993, CLIMATE CHANGE CONTI, V78, P1, DOI DOI 10.1029/GM078P0001; SHEMESH A, 1992, SCIENCE, V256, P1434, DOI 10.1126/science.256.5062.1434; Shemesh A, 2001, GEOPHYS RES LETT, V28, P2305, DOI 10.1029/2000GL012720; SMOL JP, 1985, HYDROBIOLOGIA, V123, P199, DOI 10.1007/BF00034378; Stockhausen H, 1999, EARTH PLANET SC LETT, V173, P299, DOI 10.1016/S0012-821X(99)00237-X; Stoermer Eugene F., 1993, Journal of Paleolimnology, V8, P71; THOUVENY N, 1994, NATURE, V371, P503, DOI 10.1038/371503a0; Weckstrom J, 1997, ARCTIC ALPINE RES, V29, P75, DOI 10.2307/1551838; WOILLARD G, 1979, NATURE, V281, P558, DOI 10.1038/281558a0; Wolin JA, 1996, J PALEOLIMNOL, V15, P19; Zagwijn WH, 1996, QUATERNARY SCI REV, V15, P451, DOI 10.1016/0277-3791(96)00011-X	31	92	97	2	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 20	2001	413	6853					293	296		10.1038/35095037	http://dx.doi.org/10.1038/35095037			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473KB	11565028				2022-12-24	WOS:000171040500035
J	Levinsky, NG; Yu, W; Ash, A; Moskowitz, M; Gazelle, G; Saynina, O; Emanuel, EJ				Levinsky, NG; Yu, W; Ash, A; Moskowitz, M; Gazelle, G; Saynina, O; Emanuel, EJ			Influence of age on medicare expenditures and medical care in the last year of life	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ILL HOSPITALIZED ADULTS; SERIOUSLY ILL; DEATH; MORBIDITY; DECISIONS	Context Expenditures for Medicare beneficiaries in the last year of life decrease with increasing age. The cause of this phenomenon is uncertain. Objectives To examine this pattern in detail and evaluate whether decreases in aggressiveness of medical care explain the phenomenon. Design, Setting, and Patients Analysis of sample Medicare data for beneficiaries aged 65 years or older from Massachusetts (n=34131) and California (n=19064) who died in 1996. Main Outcome Measure Medical expenditures during the last year of life, analyzed by age group, sex, race, place and cause of death, comorbidity, and use of hospital services. Results For Massachusetts and California, respectively, Medicare expenditures per beneficiary were $35300 and $27800 among those aged 65 through 74 years vs $22000 and $21600 for those aged 85 years or older. The pattern of decreasing Medicare expenditures with age is pervasive, persisting throughout the last year of life in both states for both sexes, for black and white beneficiaries, for persons with varying levels of comorbidity, and for those receiving hospice vs conventional care, regardless of cause and site of death. The aggressiveness of medical care in both Massachusetts and California also decreased with age, as judged by less frequent hospital and intensive care unit admissions and by markedly decreasing use of cardiac catheterization, dialysis, ventilators, and pulmonary artery monitors, regardless of cause of death. Decrease in the cost of hospital services accounts for approximately 80% of the decrease in Medicare expenditures with age in both states. Conclusions Medicare expenditures in the last year of life decrease with age, especially for those aged 85 years or older. This is in large part because the aggressiveness of medical care in the last year of life decreases with increasing age.	Boston Univ, Med Ctr, Sch Med, Dept Med,Sect Gen Internal Med,Hlth Care Res Unit, Boston, MA 02118 USA; US Dept Vet Affairs, Hlth Econ Resource Ctr Hlth Sci, Res Serv, Menlo Pk, CA USA; US Dept Vet Affairs, Hlth Econ Resource Ctr Hlth Sci, Dev Serv, Menlo Pk, CA USA; US Dept Vet Affairs, Ctr Cooperat Studies Hlth Serv, Menlo Pk, CA USA; Harvard Vanguard Med Associates, Palliat & Support Med Program, Boston, MA USA; Natl Bur Econ Res, Palo Alto, CA USA; NIH, Dept Clin Bioeth, Bethesda, MD 20892 USA	Boston University; US Department of Veterans Affairs; US Department of Veterans Affairs; US Department of Veterans Affairs; Harvard Vanguard Medical Associates; National Bureau of Economic Research; National Institutes of Health (NIH) - USA	Levinsky, NG (corresponding author), Boston Univ, Med Ctr, Sch Med, Dept Med,Sect Gen Internal Med,Hlth Care Res Unit, 715 Albany St, Boston, MA 02118 USA.		Ash, Arlene/AAG-2914-2019	Ash, Arlene/0000-0002-8448-0253	CLINICAL CENTER [Z01CL010508] Funding Source: NIH RePORTER	CLINICAL CENTER		Callahan D, 2000, NEW ENGL J MED, V342, P654, DOI 10.1056/NEJM200003023420910; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; FRIES JF, 1980, NEW ENGL J MED, V303, P130, DOI 10.1056/NEJM198007173030304; Hamel MB, 1999, ANN INTERN MED, V131, P721, DOI 10.7326/0003-4819-131-10-199911160-00002; Hamel MB, 2000, J AM GERIATR SOC, V48, pS176, DOI 10.1111/j.1532-5415.2000.tb03129.x; Hamel MB, 1996, J AM GERIATR SOC, V44, P1043, DOI 10.1111/j.1532-5415.1996.tb02935.x; Hamel MB, 1999, ANN INTERN MED, V130, P116, DOI 10.7326/0003-4819-130-2-199901190-00005; Johnson MF, 2000, J CLIN ETHIC, V11, P323; Levinsky NG, 1999, J AM GERIATR SOC, V47, P553, DOI 10.1111/j.1532-5415.1999.tb02569.x; Lubitz J, 1984, Health Care Financ Rev, V5, P117; LUBITZ JD, 1993, NEW ENGL J MED, V328, P1092, DOI 10.1056/NEJM199304153281506; PICKLE LW, 1996, ATLAS US MORTALITY, P4; RILEY G, 1987, INQUIRY-J HEALTH CAR, V24, P233; Yu W, 2000, J GEN INTERN MED, V15, P97, DOI 10.1046/j.1525-1497.2000.02349.x	14	148	148	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 19	2001	286	11					1349	1355		10.1001/jama.286.11.1349	http://dx.doi.org/10.1001/jama.286.11.1349			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	473DJ	11560540	Green Published, Bronze			2022-12-24	WOS:000171024500028
J	Valbuzzi, A; Yanofsky, C				Valbuzzi, A; Yanofsky, C			Inhibition of the B-subtilis regulatory protein TRAP by the TRAP-inhibitory protein, AT	SCIENCE			English	Article							BINDING ATTENUATION PROTEIN; BACILLUS-SUBTILIS; LEADER RNA; EXPRESSION; OPERON; GENES; BIOSYNTHESIS; TRANSCRIPTS; REPEATS; DOMAIN	An anti-TRAP (AT) protein, a factor of previously unknown function, conveys the metabolic signal that the cellular transfer RNA for tryptophan (tRNA(Trp)) is predominantly uncharged. Expression of the operon encoding AT is induced by uncharged tRNA(Trp). AT associates with TRAP, the trp operon attenuation protein, and inhibits its binding to its target RNA sequences. This relieves TRAP-mediated transcription termination and translation inhibition, increasing the rate of tryptophan biosynthesis. AT binds to TRAP primarily when it is in the tryptophan-activated state. The 53-residue AT polypeptide is homologous to the zinc-binding domain of DnaJ. The mechanisms regulating tryptophan biosynthesis in Bacillus subtilis differ from those used by Escherichia coli.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	Stanford University	Yanofsky, C (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.							Antson AA, 1999, NATURE, V401, P235, DOI 10.1038/45730; ANTSON AA, 1995, NATURE, V374, P693, DOI 10.1038/374693a0; BABITZKE P, 1995, P NATL ACAD SCI USA, V92, P7916, DOI 10.1073/pnas.92.17.7916; BABITZKE P, 1993, P NATL ACAD SCI USA, V90, P133, DOI 10.1073/pnas.90.1.133; BABITZKE P, 1994, J BIOL CHEM, V269, P16597; Du HS, 1997, J BACTERIOL, V179, P2582, DOI 10.1128/jb.179.8.2582-2586.1997; GOLLNICK P, IN PRESS BACILLUS SU; GRUNDY FJ, 1994, J MOL BIOL, V235, P798, DOI 10.1006/jmbi.1994.1038; HALL CV, 1982, J BACTERIOL, V151, P918, DOI 10.1128/JB.151.2.918-923.1982; Henner Dennis, 1993, P269; Martinez-Yamout M, 2000, J MOL BIOL, V300, P805, DOI 10.1006/jmbi.2000.3923; MERINO E, 1995, J BACTERIOL, V177, P6362, DOI 10.1128/jb.177.22.6362-6370.1995; Miller JH, 1972, EXPT MOL GENETICS; OTRIDGE J, 1993, P NATL ACAD SCI USA, V90, P128, DOI 10.1073/pnas.90.1.128; Sarsero JP, 2000, P NATL ACAD SCI USA, V97, P2656, DOI 10.1073/pnas.050578997; SHIMOTSU H, 1986, J BACTERIOL, V166, P461, DOI 10.1128/jb.166.2.461-471.1986; STEINBERG W, 1974, J BACTERIOL, V117, P1023, DOI 10.1128/JB.117.3.1023-1034.1974; STRAGIER P, 1988, CELL, V52, P697, DOI 10.1016/0092-8674(88)90407-2; Szabo A, 1996, EMBO J, V15, P408, DOI 10.1002/j.1460-2075.1996.tb00371.x; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; VALBUZZI A, UNPUB; YANOFSKY C, 1999, ENCY MOL BIOL, V4, P2676	22	61	64	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 14	2001	293	5537					2057	2059		10.1126/science.1062187	http://dx.doi.org/10.1126/science.1062187			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473FB	11557884				2022-12-24	WOS:000171028700065
J	Ghavidel, A; Schultz, MC				Ghavidel, A; Schultz, MC			TATA binding protein-associated CK2 transduces DNA damage, signals to the RNA polymerase III transcriptional machinery	CELL			English	Article							CASEIN KINASE-II; SACCHAROMYCES-CEREVISIAE; CELL-CYCLE; BETA-SUBUNIT; GENE; YEAST; CHECKPOINT; PROMOTERS; CKII; TBP	Here we report that RNA polymerase (pol) III transcription is repressed in response to DNA damage by downregulation of TFIIIB, the core component of the pol III transcriptional machinery. Protein kinase CK2 transduces this stress signal to TFIIIB. CK2 associates with and normally activates the TATA binding protein (TBP) subunit of TFIIIB. The beta regulatory subunit of CK2 binds to TBP and is required for high TBP-associated CK2 activity and pol III transcription in unstressed cells. Transcriptional repression induced by DNA damage requires CK2 and coincides with downregulation of TBP-associated CK2 and dissociation of catalytic subunits from TBP-CK2 complexes. Therefore, CK2 is the terminal effector in a signaling pathway that represses pol III transcription when genome integrity is compromised.	Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada	University of Alberta	Schultz, MC (corresponding author), Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada.							Aboussekhra A, 1998, GENE DEV, V12, P411, DOI 10.1101/gad.12.3.411; Aboussekhra A, 1996, EMBO J, V15, P3912, DOI 10.1002/j.1460-2075.1996.tb00765.x; ALLENDE JE, 1995, FASEB J, V9, P313, DOI 10.1096/fasebj.9.5.7896000; BIDWAI AP, 1995, J BIOL CHEM, V270, P10395, DOI 10.1074/jbc.270.18.10395; BRAUN BR, 1989, P NATL ACAD SCI USA, V86, P2530, DOI 10.1073/pnas.86.8.2530; Chantalat L, 1999, EMBO J, V18, P2930, DOI 10.1093/emboj/18.11.2930; Cho H, 1999, GENE DEV, V13, P1540, DOI 10.1101/gad.13.12.1540; CORMACK BP, 1993, SCIENCE, V262, P244, DOI 10.1126/science.8211143; Dobrowolska G, 1999, MOL CELL BIOCHEM, V191, P3, DOI 10.1023/A:1006882910351; Fan HY, 1996, GENETICS, V142, P749; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Fritz G, 1999, ONCOGENE, V18, P1033, DOI 10.1038/sj.onc.1202394; Ghavidel A, 1999, MOL CELL BIOCHEM, V191, P143, DOI 10.1023/A:1006885522221; Ghavidel A, 1997, GENE DEV, V11, P2780, DOI 10.1101/gad.11.21.2780; Glover CVC, 1998, PROG NUCLEIC ACID RE, V59, P95; Guerra B, 1999, ELECTROPHORESIS, V20, P391, DOI 10.1002/(SICI)1522-2683(19990201)20:2<391::AID-ELPS391>3.0.CO;2-N; HANNA DE, 1995, J BIOL CHEM, V270, P25905, DOI 10.1074/jbc.270.43.25905; Heriche JK, 1997, SCIENCE, V276, P952, DOI 10.1126/science.276.5314.952; Hockman DJ, 1996, MOL CELL BIOL, V16, P892; *IARC, 1999, IARC MON EV CARC R 3, V71, P1059; Jelinsky SA, 1999, P NATL ACAD SCI USA, V96, P1486, DOI 10.1073/pnas.96.4.1486; KASSAVETIS GA, 1989, MOL CELL BIOL, V9, P2551, DOI 10.1128/MCB.9.6.2551; Kelliher MA, 1996, EMBO J, V15, P5160, DOI 10.1002/j.1460-2075.1996.tb00900.x; KOCH H, 1976, BIOCHIM BIOPHYS ACTA, V454, P436, DOI 10.1016/0005-2787(76)90270-7; Landesman-Bollag E, 1998, ONCOGENE, V16, P2965, DOI 10.1038/sj.onc.1201854; Lee TI, 1998, GENE DEV, V12, P1398, DOI 10.1101/gad.12.10.1398; Maldonado E, 1999, FEBS LETT, V443, P256, DOI 10.1016/S0014-5793(98)01734-7; Martzen MR, 1999, SCIENCE, V286, P1153, DOI 10.1126/science.286.5442.1153; McCulloch V, 2000, EMBO J, V19, P4134, DOI 10.1093/emboj/19.15.4134; MIYATA Y, 1992, J BIOL CHEM, V267, P7042; Moore DD, 1995, GLOB MOB SURV; Neufeld TP, 1998, CURR OPIN CELL BIOL, V10, P784, DOI 10.1016/S0955-0674(98)80122-1; NIKOLOV DB, 1994, NAT STRUCT BIOL, V1, P621, DOI 10.1038/nsb0994-621; Orlandini M, 1998, J BIOL CHEM, V273, P21291, DOI 10.1074/jbc.273.33.21291; PEPPERKOK R, 1994, J BIOL CHEM, V269, P6986; Pinna L A, 1997, Prog Cell Cycle Res, V3, P77; Polymenis M, 1999, CURR OPIN GENET DEV, V9, P76, DOI 10.1016/S0959-437X(99)80011-2; Raman C, 1998, J IMMUNOL, V161, P5817; Sayed M, 2000, J BIOL CHEM, V275, P16569, DOI 10.1074/jbc.M000312200; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; Schramm L, 2000, GENE DEV, V14, P2650, DOI 10.1101/gad.836400; SCHULTZ MC, 1992, CELL, V69, P697, DOI 10.1016/0092-8674(92)90233-3; SELDIN DC, 1995, SCIENCE, V267, P894, DOI 10.1126/science.7846532; SETHY I, 1995, J BIOL CHEM, V270, P28463; SIEDE W, 1993, P NATL ACAD SCI USA, V90, P7985, DOI 10.1073/pnas.90.17.7985; SMITH GJ, 1983, MUTAT RES, V111, P405, DOI 10.1016/0027-5107(83)90036-2; TEITZ T, 1990, MUTAT RES, V236, P85, DOI 10.1016/0921-8777(90)90036-5; Toczyski DP, 1997, CELL, V90, P1097, DOI 10.1016/S0092-8674(00)80375-X; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; WHITE RJ, 1998, RNA POLYM 3 TRANSCRI; ZANDOMENI R, 1986, J BIOL CHEM, V261, P3414; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	52	112	118	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 7	2001	106	5					575	584		10.1016/S0092-8674(01)00473-1	http://dx.doi.org/10.1016/S0092-8674(01)00473-1			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	472FQ	11551505	Bronze			2022-12-24	WOS:000170973200008
J	Berlin, S; Ellegren, H				Berlin, S; Ellegren, H			Evolutionary genetics - Clonal inheritance of avian mitochondrial DNA	NATURE			English	Article							MODERN HUMANS; ORIGIN		Uppsala Univ, Dept Evolutionary Biol, Evolutionary Biol Ctr, SE-75236 Uppsala, Sweden	Uppsala University	Berlin, S (corresponding author), Uppsala Univ, Dept Evolutionary Biol, Evolutionary Biol Ctr, Norbyvagen 18D, SE-75236 Uppsala, Sweden.	hans.ellegren@ebc.uu.se						Awadalla P, 1999, SCIENCE, V286, P2524, DOI 10.1126/science.286.5449.2524; Cramp S., 1980, HDB BIRDS EUROPE MID, VII; Ellegren H, 2000, TRENDS ECOL EVOL, V15, P188, DOI 10.1016/S0169-5347(00)01821-8; Ellegren H, 2000, TRENDS GENET, V16, P551, DOI 10.1016/S0168-9525(00)02139-9; Elson JL, 2001, AM J HUM GENET, V68, P145, DOI 10.1086/316938; Eyre-Walker A, 1999, P ROY SOC B-BIOL SCI, V266, P477, DOI 10.1098/rspb.1999.0662; Fridolfsson AK, 2000, GENETICS, V155, P1903; Garcia-Moreno J, 2000, MOL BIOL EVOL, V17, P1826, DOI 10.1093/oxfordjournals.molbev.a026283; GOLDSTEIN DB, 1995, P NATL ACAD SCI USA, V92, P6723, DOI 10.1073/pnas.92.15.6723; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Klicka J, 1997, SCIENCE, V277, P1666, DOI 10.1126/science.277.5332.1666; MONTELL H, IN PRESS MOL BIOL EV; Nesje M, 2000, HEREDITAS, V132, P261, DOI 10.1111/j.1601-5223.2000.00261.x; Sharma A, 2000, SCIENCE, V288, P977	14	35	37	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 6	2001	413	6851					37	38		10.1038/35092623	http://dx.doi.org/10.1038/35092623			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469EG	11544517				2022-12-24	WOS:000170801200030
J	Mumby, PJ; Chisholm, JRM; Clark, CD; Hedley, JD; Jaubert, J				Mumby, PJ; Chisholm, JRM; Clark, CD; Hedley, JD; Jaubert, J			Spectrographic imaging - A bird's-eye view of the health of coral reefs	NATURE			English	Article							SPECTRAL DISCRIMINATION		Univ Newcastle Upon Tyne, Dept Marine Sci & Coastal Management, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Observ Oceanol Europeen, Ctr Sci Monaco, MC-98000 Monaco, Monaco; Univ Sheffield, Dept Geog, Sheffield S10 2TN, S Yorkshire, England; Univ Sheffield, Ctr Earth Observat Sci, Sheffield S10 2TN, S Yorkshire, England; Khaled Bin Sultan Living Oceans Fdn, E Lansing, MI 48823 USA	Newcastle University - UK; University of Sheffield; University of Sheffield	Mumby, PJ (corresponding author), Univ Newcastle Upon Tyne, Dept Marine Sci & Coastal Management, Ridley Bldg, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.		Mumby, Peter/F-9914-2010; Clark, Chris/C-3830-2009	Mumby, Peter/0000-0002-6297-9053; Clark, Chris/0000-0002-1021-6679				CARLETON JH, 1995, CORAL REEFS, V14, P35, DOI 10.1007/BF00304070; Clark CD, 2000, INT J REMOTE SENS, V21, P2321, DOI 10.1080/01431160050029602; English S., 1997, SURVEY MANUAL TROPIC; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Hochberg EJ, 2000, CORAL REEFS, V19, P164, DOI 10.1007/s003380000087; Holden H, 1998, REMOTE SENS ENVIRON, V65, P217, DOI 10.1016/S0034-4257(98)00029-7; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Kleypas JA, 1999, SCIENCE, V284, P118, DOI 10.1126/science.284.5411.118; Lubin D, 2001, REMOTE SENS ENVIRON, V75, P127, DOI 10.1016/S0034-4257(00)00161-9; Mumby PJ, 2001, MAR BIOL, V139, P183; Myers MR, 1999, CORAL REEFS, V18, P179, DOI 10.1007/s003380050177; Pittock AB, 1999, AM ZOOL, V39, P10; Tsai F, 1998, REMOTE SENS ENVIRON, V66, P41, DOI 10.1016/S0034-4257(98)00032-7	13	51	53	0	10	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 6	2001	413	6851					36	36		10.1038/35092617	http://dx.doi.org/10.1038/35092617			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469EG	11544515				2022-12-24	WOS:000170801200028
J	Lam, RW				Lam, RW			Patients' preferences and counselling for depression in primary care	LANCET			English	Editorial Material							CONTROLLED TRIALS; MAJOR DEPRESSION		Univ British Columbia, Dept Psychiat, UBC Hosp, Vancouver, BC V6T 2A1, Canada	University of British Columbia	Lam, RW (corresponding author), Univ British Columbia, Dept Psychiat, UBC Hosp, 2255 Wesbrook Mall, Vancouver, BC V6T 2A1, Canada.		Lam, Raymond W/D-2529-2013	Lam, Raymond W/0000-0001-7142-4669				Bedi N, 2000, BRIT J PSYCHIAT, V175, P217; Bower P, 2000, BMJ-BRIT MED J, V321, P1389, DOI 10.1136/bmj.321.7273.1389; Churchill R, 1999, BRIT J GEN PRACT, V49, P738; Hotopf M, 1999, BRIT J PSYCHIAT, V175, P217, DOI 10.1192/bjp.175.3.217; Katon W, 1999, ARCH GEN PSYCHIAT, V56, P1109, DOI 10.1001/archpsyc.56.12.1109; Mynors-Wallis LM, 2000, BMJ-BRIT MED J, V320, P26, DOI 10.1136/bmj.320.7226.26; Priest RG, 1996, BRIT MED J, V313, P858; Schulberg HC, 1997, ARCH FAM MED, V6, P334, DOI 10.1001/archfami.6.4.334; Scott C, 1997, BRIT J PSYCHIAT, V171, P131, DOI 10.1192/bjp.171.2.131; SIBBALD B, 1993, BMJ-BRIT MED J, V306, P29, DOI 10.1136/bmj.306.6869.29; Silverman WA, 1996, LANCET, V347, P171, DOI 10.1016/S0140-6736(96)90347-5; Simon GE, 2000, BRIT MED J, V320, P550, DOI 10.1136/bmj.320.7234.550; Torgerson DJ, 1998, BRIT MED J, V316, P360, DOI 10.1136/bmj.316.7128.360; Ward E, 2000, BRIT MED J, V321, P1383, DOI 10.1136/bmj.321.7273.1383	14	4	4	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 24	2001	357	9256					575	576		10.1016/S0140-6736(00)04076-9	http://dx.doi.org/10.1016/S0140-6736(00)04076-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	404UB	11558480				2022-12-24	WOS:000167119100006
J	HEATH, JR; COOKSY, AL; GRUEBELE, MHW; SCHMUTTENMAER, CA; SAYKALLY, RJ				HEATH, JR; COOKSY, AL; GRUEBELE, MHW; SCHMUTTENMAER, CA; SAYKALLY, RJ			DIODE-LASER ABSORPTION-SPECTROSCOPY OF SUPERSONIC CARBON CLUSTER BEAMS - THE V3 SPECTRUM OF C-5	SCIENCE			English	Article											HEATH, JR (corresponding author), UNIV CALIF BERKELEY,DEPT CHEM,BERKELEY,CA 94720, USA.			Cooksy, Andrew/0000-0002-2794-4269; SAYKALLY, RICHARD/0000-0001-8942-3656				BERNATH PF, 1989, SCIENCE, V244, P562, DOI 10.1126/science.244.4904.562; DOUGLAS AE, 1951, ASTROPHYS J, V114, P466, DOI 10.1086/145486; DROWART J, 1959, J CHEM PHYS, V31, P1131, DOI 10.1063/1.1730519; EWING DW, 1987, CHEM PHYS LETT, V134, P413, DOI 10.1016/0009-2614(87)87164-6; FUSINA L, 1980, J MOL SPECTROSC, V79, P101, DOI 10.1016/0022-2852(80)90296-9; GERHARDT P, 1987, CHEM PHYS LETT, V137, P306, DOI 10.1016/0009-2614(87)80889-8; HEATH JR, 1987, J AM CHEM SOC, V109, P359, DOI 10.1021/ja00236a012; HEATH JR, UNPUB; HEATH JR, 1987, ASTROPHYS J, V314, P352; Herzberg G, 1942, ASTROPHYS J, V96, P314, DOI 10.1086/144464; HINKLE KW, 1988, SCIENCE, V241, P1319, DOI 10.1126/science.241.4871.1319; HOFFMANN R, 1966, TETRAHEDRON, V22, P521, DOI 10.1016/0040-4020(66)80020-0; Huggins W., 1882, P R SOC LONDON, V33, P1; KRISHNAN R, 1986, J CHEM PHYS, V85, P6623; KROTO HW, 1985, NATURE, V318, P162, DOI 10.1038/318162a0; MAGERS DH, 1986, J CHEM PHYS, V84, P3284, DOI 10.1063/1.450259; MATSUMURA K, 1988, J CHEM PHYS, V89, P3491, DOI 10.1063/1.454919; MCKELLAR ARW, IN PRESS CHEM PHYS L; PITZER KS, 1959, J AM CHEM SOC, V81, P4477, DOI 10.1021/ja01526a010; RAGHAVACHARI K, 1987, J CHEM PHYS, V87, P2191, DOI 10.1063/1.453145; RITCHIE JP, 1986, J CHEM PHYS, V85, P5175, DOI 10.1063/1.451711; ROHLFING EA, 1984, J CHEM PHYS, V81, P3322, DOI 10.1063/1.447994; VALA M, 1989, J CHEM PHYS, V90, P595, DOI 10.1063/1.456458; VANZEE RJ, 1988, J CHEM PHYS, V88, P3465, DOI 10.1063/1.453895; WHITESIDE RA, 1981, CHEM PHYS LETT, V78, P538, DOI 10.1016/0009-2614(81)85253-0	25	89	89	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAY 5	1989	244	4904					564	566						3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	U4450	11539817				2022-12-24	WOS:A1989U445000023
J	Weiss, HB; Songer, TJ; Fabio, A				Weiss, HB; Songer, TJ; Fabio, A			Fetal deaths related to maternal injury	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TRAUMA; PREGNANCY; MORTALITY; HOMICIDE; ACCIDENTS; WOMEN	Context Maternal and fetal trauma is an important cause of adverse fetal outcomes. However, systematic exclusion from US injury surveillance programs of even the most severe outcome, fetal/neonatal death, has led to a lack of understanding about frequency, causes, and prevention. Objective To determine the rate of traumatic fetal deaths reported instate fetal death registries and the types of trauma and physiologic diagnoses associated with these deaths. Design and Setting Retrospective descriptive study of fetal death certificates from 1995 through 1997 obtained from 16 states, which accounted for 55% of US live births and approximately 15000 fetal death registrations per year. Main Outcome Measure Rate of fetal injury deaths, based on fetal death certificates coded with an underlying cause of death due to maternal injury at 20 weeks' gestation or later, by cause. Results During the 3-year study period, 240 traumatic fetal injury deaths were identified (3.7 fetal deaths per 100000 live births). Motor vehicle crashes were the leading trauma mechanism (82% of cases; 2.3 fetal deaths per 100000 live births), followed by firearm injuries (6% of cases) and falls (3% of cases). In 3 states, reported crash-related fetal deaths exceeded that of crash-related infant deaths. Placental injury was mentioned in 100 cases (42%) and maternal death was noted in 27 cases (11%). A peak rate of 9.3 fetal deaths per 100000 live births was observed among 15- to 19-year-old women. Conclusions Motor vehicle crashes are the leading cause of fetal deaths related to maternal trauma. improved tracking of traumatic fetal injury deaths is important to stimulate and guide research and efforts to reduce the risks to women and fetuses from injury during pregnancy.	Univ Pittsburgh, Ctr Injury Res & Control, Dept Neurosurg, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Weiss, HB (corresponding author), Univ Pittsburgh, Ctr Injury Res & Control, Dept Neurosurg, 200 Lothrop St,Suite B400, Pittsburgh, PA 15213 USA.		Weiss, Hank/D-1052-2010	Fabio, Anthony/0000-0002-6808-4939; Songer, Thomas/0000-0002-5253-2514				AGRAN PF, 1987, ANN EMERG MED, V16, P1355, DOI 10.1016/S0196-0644(87)80418-3; *AM AC PED AM COLL, 1988, STAND TERM REP REPR, P308; Bausch L C, 1996, Nebr Med J, V81, P120; Brinton JH, 1884, T AM SURG ASS, V2, P425; Buchsbaum H J, 1976, Med Times, V104, P134; BUCHSBAUM HJ, 1968, AM J OBSTET GYNECOL, V102, P752, DOI 10.1016/0002-9378(68)90390-6; CROSBY WM, 1971, NEW ENGL J MED, V284, P632, DOI 10.1056/NEJM197103252841203; DANNENBERG AL, 1995, AM J OBSTET GYNECOL, V172, P1557, DOI 10.1016/0002-9378(95)90496-4; Dietz PM, 1998, AM J PUBLIC HEALTH, V88, P641, DOI 10.2105/AJPH.88.4.641; Elliott M, 1966, Aust N Z J Obstet Gynaecol, V6, P279, DOI 10.1111/j.1479-828X.1966.tb00389.x; ESPOSITO TJ, 1989, J TRAUMA, V29, P1628, DOI 10.1097/00005373-198912000-00006; FILDES J, 1992, J TRAUMA, V32, P643, DOI 10.1097/00005373-199205000-00017; Gaudino JA, 1997, AM J PUBLIC HEALTH, V87, P1323, DOI 10.2105/AJPH.87.8.1323; GREB AE, 1987, AM J PUBLIC HEALTH, V77, P1202, DOI 10.2105/AJPH.77.9.1202; HANSEN G, 1990, J MED SOC N J, V87, P995; Harper M, 1997, OBSTET GYNECOL, V90, P920, DOI 10.1016/S0029-7844(97)00485-7; HERSCHEL M, 1995, AM J PREV MED, V11, P185, DOI 10.1016/S0749-3797(18)30471-9; Horon IL, 2001, JAMA-J AM MED ASSOC, V285, P1455, DOI 10.1001/jama.285.11.1455; Jacob S, 1998, OBSTET GYNECOL, V91, P187, DOI 10.1016/S0029-7844(97)00664-9; KAUNITZ AM, 1985, OBSTET GYNECOL, V65, P605; KIRBY RS, 1993, AM J PUBLIC HEALTH, V83, P1088, DOI 10.2105/AJPH.83.8.1088; KISSINGER DP, 1991, ARCH SURG-CHICAGO, V126, P1079; KLINICH KD, 1998, ANN C ASS ADV AUT ME; KOWALSKI J, 1997, STATE DEFINITIONS RE, P3; Krulewitch CJ, 2001, J MIDWIFERY WOM HEAL, V46, P4, DOI 10.1016/S1526-9523(00)00096-9; LANE P L, 1989, Journal of Emergency Medicine, V7, P433, DOI 10.1016/0736-4679(89)90135-2; *MOD STAT VIT STAT, 1992, DHHS PUBL; *NAT CTR HLTH STAT, 1998, 1995 PER MORT DAT FI; *NAT CTR INF PREV, 2001, LEAD CAUS DEATH REP; ONI OOA, 1984, INJURY, V15, P376, DOI 10.1016/0020-1383(84)90199-2; PEARLMAN MD, 1990, AM J OBSTET GYNECOL, V162, P1502, DOI 10.1016/0002-9378(90)90913-R; PEARLMAN MD, 1990, NEW ENGL J MED, V323, P1609; PEPPERELL RJ, 1977, MED J AUSTRALIA, V1, P203, DOI 10.5694/j.1326-5377.1977.tb130630.x; Rasmussen S, 1996, ACTA OBSTET GYN SCAN, V75, P229, DOI 10.3109/00016349609047092; ROSE PG, 1985, AM J OBSTET GYNECOL, V153, P844, DOI 10.1016/0002-9378(85)90687-8; Rosner B, 1994, FUNDAMENTALS BIOSTAT, V4th; ROTHENBERGER D, 1978, J TRAUMA, V18, P173, DOI 10.1097/00005373-197803000-00004; Rumbolz W L, 1991, Nebr Med J, V76, P31; Schiff M, 1997, WESTERN J MED, V167, P19; SEEAR T, 1953, AM J OBSTET GYNECOL, V65, P450, DOI 10.1016/0002-9378(53)90459-1; Theodorou DA, 2000, AM SURGEON, V66, P809; TIMBERLAKE GA, 1989, AM SURGEON, V55, P151; VENTURA S, 1998, REPORT FINAL NATALIT, P32; VFAMER MW, 1987, SURG GYNECOL OBSTET, V168, P555; Weiss H, 2001, JAMA-J AM MED ASSOC, V285, P2854, DOI 10.1001/jama.285.22.2854; WEISS H, 1999, EPIDEMIOLOGY PERINAT, P32; Weiss HB, 2001, ACCIDENT ANAL PREV, V33, P449, DOI 10.1016/S0001-4575(00)00058-0; Woodhull RB, 1942, SURGERY, V12, P615	48	135	137	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 17	2001	286	15					1863	1868		10.1001/jama.286.15.1863	http://dx.doi.org/10.1001/jama.286.15.1863			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	482UH	11597288				2022-12-24	WOS:000171595300027
J	Luo, MJ; Zhou, ZL; Magni, K; Christoforides, C; Rappsilber, J; Mann, M; Reed, R				Luo, MJ; Zhou, ZL; Magni, K; Christoforides, C; Rappsilber, J; Mann, M; Reed, R			Pre-mRNA splicing and mRNA export linked by direct interactions between UAP56 and Aly	NATURE			English	Article							MESSENGER-RNA EXPORT; BINDING PROTEIN; U2 SNRNP; NUCLEUS; METAZOANS; COMPLEX	Recent studies indicate that splicing of pre-messenger RNA and export of mRNA are normally coupled in vivo(1-6). During splicing, the conserved mRNA export factor Aly is recruited to the spliced mRNA-protein complex (mRNP), which targets the mRNA for export. At present, it is not known how Aly is recruited to the spliced mRNP. Here we show that the conserved DEAD-box helicase UAP56, which functions during spliceosome assembly(7-10), interacts directly and highly specifically with Aly. Moreover, UAP56 is present together with Aly in the spliced mRNP. Significantly, excess UAP56 is a potent dominant negative inhibitor of mRNA export. Excess UAP56 also inhibits the recruitment of Aly to the spliced mRNP. Furthermore, a mutation in Aly that blocks its interaction with UAP56 prevents recruitment of Aly to the spliced mRNP. These data suggest that the splicing factor UAP56 functions in coupling the splicing and export machineries by recruiting Aly to the spliced mRNP.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Univ So Denmark, Prot Interact Lab, Ctr Expt Bioinformat, Dept Biochem & Mol Biol, DK-5230 Odense M, Denmark	Harvard University; Harvard Medical School; University of Southern Denmark	Reed, R (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	rreed@hms.harvard.edu	Rappsilber, Juri/B-7265-2015; Mann, Matthias/A-3454-2013; Rappsilber, Juri/ABF-3328-2020	Rappsilber, Juri/0000-0001-5999-1310; Mann, Matthias/0000-0003-1292-4799; 				Bruhn L, 1997, GENE DEV, V11, P640, DOI 10.1101/gad.11.5.640; Conti E, 2001, CURR OPIN CELL BIOL, V13, P310, DOI 10.1016/S0955-0674(00)00213-1; Das R, 2000, MOL CELL, V5, P779, DOI 10.1016/S1097-2765(00)80318-4; Fleckner J, 1997, GENE DEV, V11, P1864, DOI 10.1101/gad.11.14.1864; HAMM J, 1990, CELL, V63, P109, DOI 10.1016/0092-8674(90)90292-M; Huang YQ, 2001, MOL CELL, V7, P899, DOI 10.1016/S1097-2765(01)00233-7; Izaurralde E, 1997, EMBO J, V16, P6535, DOI 10.1093/emboj/16.21.6535; Kataoka N, 2000, MOL CELL, V6, P673, DOI 10.1016/S1097-2765(00)00065-4; Kim VN, 2001, EMBO J, V20, P2062, DOI 10.1093/emboj/20.8.2062; Kistler AL, 2001, GENE DEV, V15, P42, DOI 10.1101/gad.851301; Le Hir H, 2000, EMBO J, V19, P6860, DOI 10.1093/emboj/19.24.6860; Libri D, 2001, GENE DEV, V15, P36, DOI 10.1101/gad.852101; Luo MJ, 1999, P NATL ACAD SCI USA, V96, P14937, DOI 10.1073/pnas.96.26.14937; Moazed D, 1997, P NATL ACAD SCI USA, V94, P2186, DOI 10.1073/pnas.94.6.2186; Rodrigues JP, 2001, P NATL ACAD SCI USA, V98, P1030, DOI 10.1073/pnas.98.3.1030; Staley JP, 1998, CELL, V92, P315, DOI 10.1016/S0092-8674(00)80925-3; Strasser K, 2001, NATURE, V413, P648, DOI 10.1038/35098113; Strasser K, 2000, EMBO J, V19, P410, DOI 10.1093/emboj/19.3.410; Virbasius CMA, 1999, MOL CELL, V4, P219, DOI 10.1016/S1097-2765(00)80369-X; VORM O, 1994, ANAL CHEM, V66, P3281, DOI 10.1021/ac00091a044; Wichmann I, 1999, HUM IMMUNOL, V60, P57, DOI 10.1016/S0198-8859(98)00085-8; Zhang M, 2001, GENE DEV, V15, P30, DOI 10.1101/gad.851701; Zhou ZL, 2000, NATURE, V407, P401, DOI 10.1038/35030160	23	298	304	3	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 11	2001	413	6856					644	647		10.1038/35098106	http://dx.doi.org/10.1038/35098106			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480WE	11675789				2022-12-24	WOS:000171485700052
J	Luo, YQ; Wan, SQ; Hui, DF; Wallace, LL				Luo, YQ; Wan, SQ; Hui, DF; Wallace, LL			Acclimatization of soil respiration to warming in a tall grass prairie	NATURE			English	Article							TRACE GAS FLUXES; TEMPERATURE-DEPENDENCE; ORGANIC-CARBON; CO2 EMISSIONS; DECOMPOSITION; CLIMATE; FEEDBACKS; FOREST; MATTER; CH4	The latest report by the Intergovernmental Panel on Climate Change (IPCC) predicts a 1.4-5.8 degreesC average increase in the global surface temperature over the period 1990 to 2100 (ref. 1). These estimates of future warming are greater than earlier projections, which is partly due to incorporation of a positive feedback. This feedback results from further release of greenhouse gases from terrestrial ecosystems in response to climatic warming(2-4). The feedback mechanism is usually based on the assumption that observed sensitivity of soil respiration to temperature under current climate conditions would hold in a warmer climate(5). However, this assumption has not been carefully examined. We have therefore conducted an experiment in a tall grass prairie ecosystem in the US Great Plains to study the response of soil respiration (the sum of root and heterotrophic respiration) to artificial warming of about 2 degreesC. Our observations indicate that the temperature sensitivity of soil respiration decreases-or acclimatizes-under warming and that the acclimatization is greater at high temperatures. This acclimatization of soil respiration to warming may therefore weaken the positive feedback between the terrestrial carbon cycle and climate.	Univ Oklahoma, Dept Bot & Microbiol, Norman, OK 73019 USA	University of Oklahoma System; University of Oklahoma - Norman	Luo, YQ (corresponding author), Univ Oklahoma, Dept Bot & Microbiol, Norman, OK 73019 USA.	yluo@ou.edu	Wan, Shiqiang/B-5799-2009; Wan, Shiqiang/L-9166-2019	Wan, Shiqiang/0000-0003-0631-1232; Wan, Shiqiang/0000-0003-0631-1232; Hui, Dafeng/0000-0002-5284-2897				Atkin OK, 2000, NEW PHYTOL, V147, P141, DOI 10.1046/j.1469-8137.2000.00683.x; Cheng WX, 1996, SOIL BIOL BIOCHEM, V28, P1283, DOI 10.1016/S0038-0717(96)00138-1; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; Giardina CP, 2000, NATURE, V404, P858, DOI 10.1038/35009076; *IPCC, 2001, CLIM CHANG 2001 SYNT; JENKINSON DS, 1991, NATURE, V351, P304, DOI 10.1038/351304a0; KIRSCHBAUM MUF, 1995, SOIL BIOL BIOCHEM, V27, P753, DOI 10.1016/0038-0717(94)00242-S; Kirschbaum MUF, 2000, BIOGEOCHEMISTRY, V48, P21, DOI 10.1023/A:1006238902976; Lenton TM, 2000, TELLUS B, V52, P1159, DOI 10.1034/j.1600-0889.2000.01104.x; Lin GH, 1999, GLOB CHANGE BIOL, V5, P157, DOI 10.1046/j.1365-2486.1999.00211.x; Liski J, 1999, AMBIO, V28, P171; LLOYD J, 1994, FUNCT ECOL, V8, P315, DOI 10.2307/2389824; McHale PJ, 1998, CAN J FOREST RES, V28, P1365, DOI 10.1139/cjfr-28-9-1365; Oechel WC, 2000, NATURE, V406, P978, DOI 10.1038/35023137; PETERJOHN WT, 1994, ECOL APPL, V4, P617, DOI 10.2307/1941962; RAICH JW, 1995, GLOBAL BIOGEOCHEM CY, V9, P23, DOI 10.1029/94GB02723; Rustad LE, 2001, OECOLOGIA, V126, P543, DOI 10.1007/s004420000544; Rustad LE, 1998, GLOB CHANGE BIOL, V4, P597, DOI 10.1046/j.1365-2486.1998.00169.x; Saleska SR, 1999, GLOB CHANGE BIOL, V5, P125, DOI 10.1046/j.1365-2486.1999.00216.x; Sarmiento J, 2000, NATURE, V408, P155, DOI 10.1038/35041676; Schimel DS, 1996, GLOBAL BIOGEOCHEM CY, V10, P677, DOI 10.1029/96GB01524; Shaver GR, 2000, BIOSCIENCE, V50, P871, DOI 10.1641/0006-3568(2000)050[0871:GWATEA]2.0.CO;2; Striegl RG, 1998, CAN J FOREST RES, V28, P534, DOI 10.1139/cjfr-28-4-534; TARR J, 1980, Proceedings of the Oklahoma Academy of Science, V60, P39; *USDA, 1963, NAT COOP SOIL SURV, P1; Verville JH, 1998, BIOGEOCHEMISTRY, V41, P215, DOI 10.1023/A:1005984701775; Woodwell GM, 1998, CLIMATIC CHANGE, V40, P495, DOI 10.1023/A:1005345429236; Zogg GP, 1997, SOIL SCI SOC AM J, V61, P475, DOI 10.2136/sssaj1997.03615995006100020015x	28	892	1218	28	647	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 11	2001	413	6856					622	625		10.1038/35098065	http://dx.doi.org/10.1038/35098065			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480WE	11675783				2022-12-24	WOS:000171485700046
J	Scheffer, M; Carpenter, S; Foley, JA; Folke, C; Walker, B				Scheffer, M; Carpenter, S; Foley, JA; Folke, C; Walker, B			Catastrophic shifts in ecosystems	NATURE			English	Review							MULTIPLE STABLE STATES; ARABIAN PENINSULA; GRAZING SYSTEMS; SHALLOW LAKES; PHASE-SHIFTS; VEGETATION; DYNAMICS; CLIMATE; SAHEL; MANAGEMENT	All ecosystems are exposed to gradual changes in climate, nutrient loading, habitat fragmentation or biotic exploitation. Nature is usually assumed to respond to gradual change in a smooth way. However, studies on lakes, coral reefs, oceans, forests and arid lands have shown that smooth change can be interrupted by sudden drastic switches to a contrasting state. Although diverse events can trigger such shifts, recent studies show that a loss of resilience usually paves the way for a switch to an alternative state. This suggests that strategies for sustainable management of such ecosystems should focus on maintaining resilience.	Wageningen Univ, Dept Aquat Ecol & Water Qual Management, NL-6700 DD Wageningen, Netherlands; Univ Wisconsin, Ctr Limnol, Madison, WI 53706 USA; Univ Wisconsin, Ctr Sustainabil & Global Environm, Inst Environm Studies, Madison, WI 53706 USA; Stockholm Univ, Dept Syst Ecol, S-10691 Stockholm, Sweden; Stockholm Univ, Ctr Res Nat Resources & Environm CNM, S-10691 Stockholm, Sweden; CSIRO Sustainable Ecosyst, Canberra, ACT 2601, Australia	Wageningen University & Research; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Stockholm University; Stockholm University; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Scheffer, M (corresponding author), Wageningen Univ, Dept Aquat Ecol & Water Qual Management, POB 8080, NL-6700 DD Wageningen, Netherlands.	marten.scheffer@aqec.wkao.wau.nl	Foley, Jonathan A/GRS-5522-2022; Scheffer, Marten/C-1852-2012; Carpenter, Stephen/AAQ-6404-2020; Folke, Carl/Z-1545-2019; Walker, Brian H/F-2386-2011	Carpenter, Stephen/0000-0001-8097-8700; Folke, Carl/0000-0002-4050-3281				[Anonymous], LANDSCAPE ECOLOGY FU; Brovkin V, 1998, J GEOPHYS RES-ATMOS, V103, P31613, DOI 10.1029/1998JD200006; Carpenter SR, 1999, ECOL APPL, V9, P751, DOI 10.1890/1051-0761(1999)009[0751:MOEFLS]2.0.CO;2; Carpenter SR, 1997, OIKOS, V78, P3, DOI 10.2307/3545794; CARPENTER SR, 2001, ECOLOGY ACHIEVEMENT; CHARNEY JG, 1975, Q J ROY METEOR SOC, V101, P193, DOI 10.1002/qj.49710142802; Claussen M, 1999, GEOPHYS RES LETT, V26, P2037, DOI 10.1029/1999GL900494; CONNELL JH, 1983, AM NAT, V121, P789, DOI 10.1086/284105; Cury P, 2000, ICES J MAR SCI, V57, P603, DOI 10.1006/jmsc.2000.0712; deMenocal P, 2000, QUATERNARY SCI REV, V19, P347, DOI 10.1016/S0277-3791(99)00081-5; DONE TJ, 1992, HYDROBIOLOGIA, V247, P121, DOI 10.1007/BF00008211; DUBLIN HT, 1990, J ANIM ECOL, V59, P1147, DOI 10.2307/5037; ELLNER S, 1995, AM NAT, V145, P343, DOI 10.1086/285744; HALL CAS, 1992, OIKOS, V65, P377, DOI 10.2307/3545553; Hare SR, 2000, PROG OCEANOGR, V47, P103, DOI 10.1016/S0079-6611(00)00033-1; Hoelzmann P, 1998, GLOBAL BIOGEOCHEM CY, V12, P35, DOI 10.1029/97GB02733; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; Holling CS, 1996, CONSERV BIOL, V10, P328, DOI 10.1046/j.1523-1739.1996.10020328.x; Holmgren M, 2001, ECOSYSTEMS, V4, P151, DOI 10.1007/s100210000065; Ives AR, 1998, ECOLOGY, V79, P1039, DOI 10.1890/0012-9658(1998)079[1039:CDISTM]2.0.CO;2; Jeppesen E, 1999, HYDROBIOLOGIA, V395, P419, DOI 10.1023/A:1017071602549; Jolly D, 1998, J BIOGEOGR, V25, P1007, DOI 10.1046/j.1365-2699.1998.00238.x; KASSAS M, 1995, J ARID ENVIRON, V30, P115, DOI 10.1016/S0140-1963(05)80063-1; KNOWLTON N, 1992, AM ZOOL, V32, P674; Kuznetsov Y.A., 1997, ELEMENTS APPL BIFURC; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; LUDWIG D, 1997, CONSERV ECOL    0801; Maler KG, 2000, EUR ECON REV, V44, P645, DOI 10.1016/S0014-2921(00)00043-X; MAY RM, 1977, NATURE, V269, P471, DOI 10.1038/269471a0; McCook LJ, 1999, CORAL REEFS, V18, P357, DOI 10.1007/s003380050213; Meijer M.-L., 2000, BIOMANIPULATION NETH, P1, DOI [10.1109/48.820749, DOI 10.1109/48.820749]; MEIJER ML, 1994, HYDROBIOLOGIA, V276, P457; Nicholson S, 2000, REV GEOPHYS, V38, P117, DOI 10.1029/1999RG900014; Nystrom M, 2000, TRENDS ECOL EVOL, V15, P413, DOI 10.1016/S0169-5347(00)01948-0; Paine RT, 1998, ECOSYSTEMS, V1, P535, DOI 10.1007/s100219900049; RAHMSTORF S, 1995, NATURE, V378, P145, DOI 10.1038/378145a0; Reid PC, 1998, NATURE, V391, P546, DOI 10.1038/35290; Reid PC, 2000, ICES J MAR SCI, V57, P495, DOI 10.1006/jmsc.2000.0740; Rietkerk M, 1997, OIKOS, V80, P241, DOI 10.2307/3546592; Rinaldi S, 2000, ECOSYSTEMS, V3, P507, DOI 10.1007/s100210000045; SCHEFFER M, 1990, HYDROBIOLOGIA, V200, P475, DOI 10.1007/BF02530365; SCHEFFER M, 1993, TRENDS ECOL EVOL, V8, P275, DOI 10.1016/0169-5347(93)90254-M; Scheffer M, 1997, ECOLOGY, V78, P272; Scheffer M, 2000, ECOSYSTEMS, V3, P451, DOI 10.1007/s100210000040; Scheffer M., 1998, ECOLOGY SHALLOW LAKE; Schelske Claire L., 1999, P367; Schelske Claire L., 1992, P393; Shiomoto A, 1997, MAR ECOL PROG SER, V150, P75, DOI 10.3354/meps150075; Taylor K, 1999, AM SCI, V87, P320, DOI 10.1511/1999.4.320; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Tucker CJ, 1999, AMBIO, V28, P587; vandeKoppel J, 1997, TRENDS ECOL EVOL, V12, P352, DOI 10.1016/S0169-5347(97)01133-6; Vandermeer J, 1999, ECOLOGY, V80, P1817, DOI 10.1890/0012-9658(1999)080[1817:BBCAAM]2.0.CO;2; Verity PG, 1996, MAR ECOL PROG SER, V130, P277, DOI 10.3354/meps130277; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Walker B., 1989, P121; WALKER BH, 1993, AMBIO, V22, P2; Wang GL, 2000, GEOPHYS RES LETT, V27, P795, DOI 10.1029/1999GL011089; Wang GL, 2000, WATER RESOUR RES, V36, P1013, DOI 10.1029/1999WR900361; WILSON JB, 1992, ADV ECOL RES, V23, P263, DOI 10.1016/S0065-2504(08)60149-X; Zeng N, 1999, SCIENCE, V286, P1537, DOI 10.1126/science.286.5444.1537	61	4463	4698	121	3071	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 11	2001	413	6856					591	596		10.1038/35098000	http://dx.doi.org/10.1038/35098000			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480WE	11595939				2022-12-24	WOS:000171485700039
J	Grigg, ME; Bonnefoy, S; Hehl, AB; Suzuki, Y; Boothroyd, JC				Grigg, ME; Bonnefoy, S; Hehl, AB; Suzuki, Y; Boothroyd, JC			Success and virulence in toxoplasma as the result of sexual recombination between two distinct ancestries	SCIENCE			English	Article							GONDII STRAINS; INTRAGENIC RECOMBINATION; GENE; PLASMODIUM; ANTIGEN; POLYMORPHISM; MICE; PATHOGENICITY; TRYPANOSOMA; ALLELES	Toxoplasma gondii is a common human pathogen causing serious, even fatal, disease in the developing fetus and in immunocompromised patients. Despite its ability to reproduce sexually and its broad geographic and host range, Toxoplasma has a clonal population structure comprised principally of three lines. We have analyzed 15 polymorphic loci in the archetypal type I, II, and III strains and found that polymorphism was limited to, at most, two rather than three allelic classes and no polymorphism was detected between alleles in strains of a given type. Multilocus analysis of 10 nonarchetypal isolates likewise clustered the vast majority of alleles into the same two distinct ancestries. These data strongly suggest that the currently predominant genotypes exist as a pandemic outbreak from a genetic mixing of two discrete ancestral lines. To determine if such mixing could lead to the extreme virulence observed for some strains, we examined the F-1 progeny of a cross between a type II and III strain, both of which are relatively avirulent in mice. Among the progeny were recombinants that were at least 3 logs more virulent than either parent. Thus, sexual recombination, by combining polymorphisms in two distinct and competing clonal lines, can be a powerful force driving the natural evolution of virulence in this highly successful pathogen.	Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; Palo Alto Med Fdn, Res Inst, Dept Immunol & Infect Dis, Palo Alto, CA 94301 USA; Stanford Univ, Sch Med, Dept Med, Div Infect Dis & Geog Med, Stanford, CA 94305 USA	Stanford University; Palo Alto Medical Foundation Research Institute; Stanford University	Suzuki, Y (corresponding author), Virginia Polytech Inst & State Univ, Dept Biomed Sci & Pathobiol, Blacksburg, VA 24061 USA.	ysuzuki@vt.edu; John.Boothroyd@stanford.edu	Bonnefoy, Serge/B-2466-2014	Bonnefoy, Serge/0000-0001-9148-0123; Boothroyd, John C./0000-0001-9719-745X; Hehl, Adrian/0000-0002-2110-4445	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI004717, R01AI041014, R37AI021423, R01AI021423, R37AI004717] Funding Source: NIH RePORTER; NIAID NIH HHS [AI04717, AI21423, AI41014] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ayala FJ, 1998, P NATL ACAD SCI USA, V95, P3346, DOI 10.1073/pnas.95.7.3346; Binas M, 1998, INT J PARASITOL, V28, P1033, DOI 10.1016/S0020-7519(98)00052-6; BOOTHROYD JC, 1993, INFECT AGENT DIS, V2, P100; BOOTHROYD JC, 1993, TOXIPLASMOSIS, P63; BULOW R, 1991, J IMMUNOL, V147, P3496; CONWAY DJ, 1991, EXP PARASITOL, V73, P469, DOI 10.1016/0014-4894(91)90071-4; COUVREUR G, 1988, PARASITOLOGY, V97, P1, DOI 10.1017/S0031182000066695; Darde ML, 1998, J CLIN MICROBIOL, V36, P324; Darde ML, 1996, CURR TOP MICROBIOL, V219, P27; Fazaeli A, 2000, J PARASITOL, V86, P716, DOI 10.1645/0022-3395(2000)086[0716:ISIPAN]2.0.CO;2; Fazaeli A, 2000, INT J PARASITOL, V30, P637, DOI 10.1016/S0020-7519(00)00036-9; Grigg ME, 2001, J INFECT DIS, V184, P633, DOI 10.1086/322800; Homan WL, 1997, PARASITOL RES, V83, P285, DOI 10.1007/s004360050248; HOWE DK, 1995, J INFECT DIS, V172, P1561, DOI 10.1093/infdis/172.6.1561; Howe DK, 1997, J CLIN MICROBIOL, V35, P1411, DOI 10.1128/JCM.35.6.1411-1414.1997; HOWE DK, 1994, EXP PARASITOL, V78, P242, DOI 10.1006/expr.1994.1024; Howe DK, 1996, INFECT IMMUN, V64, P5193, DOI 10.1128/IAI.64.12.5193-5198.1996; KERR PJ, 1994, MOL BIOCHEM PARASIT, V66, P241, DOI 10.1016/0166-6851(94)90151-1; Lehmann T, 2000, J PARASITOL, V86, P960, DOI 10.1645/0022-3395(2000)086[0960:STOTGC]2.0.CO;2; LUTON K, 1995, PARASITOL RES, V81, P310, DOI 10.1007/BF00931536; MacLeod A, 2000, P NATL ACAD SCI USA, V97, P13442, DOI 10.1073/pnas.230434097; Meisel R, 1996, MOL BIOCHEM PARASIT, V81, P259, DOI 10.1016/0166-6851(96)02719-3; PARMLEY SF, 1994, J PARASITOL, V80, P293, DOI 10.2307/3283761; PFEFFERKORN LC, 1980, EXP PARASITOL, V50, P305, DOI 10.1016/0014-4894(80)90034-X; RINDER H, 1995, MOL BIOCHEM PARASIT, V69, P123, DOI 10.1016/0166-6851(94)00211-5; SCHOLTISSEK C, 1979, VIROLOGY, V95, P492, DOI 10.1016/0042-6822(79)90503-8; SIBLEY LD, 1992, GENETICS, V132, P1003; SIBLEY LD, 1992, NATURE, V359, P82, DOI 10.1038/359082a0; Sibley LD, 1996, CURR TOP MICROBIOL, V219, P3; SMITH JM, 1993, P NATL ACAD SCI USA, V90, P4384, DOI 10.1073/pnas.90.10.4384; TANABE K, 1987, J MOL BIOL, V195, P273, DOI 10.1016/0022-2836(87)90649-8; TIBAYRENC M, 1990, P NATL ACAD SCI USA, V87, P2414, DOI 10.1073/pnas.87.7.2414; TIBAYRENC M, 1991, P NATL ACAD SCI USA, V88, P5129, DOI 10.1073/pnas.88.12.5129; TOMAVO S, 1991, INFECT IMMUN, V59, P3750, DOI 10.1128/IAI.59.10.3750-3753.1991	34	231	243	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 5	2001	294	5540					161	165		10.1126/science.1061888	http://dx.doi.org/10.1126/science.1061888			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480EJ	11588262				2022-12-24	WOS:000171448800052
J	Lohse, D; Schmitz, B; Versluis, M				Lohse, D; Schmitz, B; Versluis, M			Snapping shrimp make flashing bubbles	NATURE			English	Article							SONOLUMINESCENCE		Univ Twente, Res Ctr Fluid Dynam, NL-7500 AE Enschede, Netherlands; Tech Univ Munich, Lehrstuhl Zool, D-85747 Garching, Germany	University of Twente; Technical University of Munich	Lohse, D (corresponding author), Univ Twente, Res Ctr Fluid Dynam, POB 217, NL-7500 AE Enschede, Netherlands.		Lohse, Detlef/B-4915-2013; Versluis, Michel/F-3541-2011	Lohse, Detlef/0000-0003-4138-2255; Versluis, Michel/0000-0002-2296-1860				Baghdassarian O, 1999, PHYS REV LETT, V83, P2437, DOI 10.1103/PhysRevLett.83.2437; Brennen C.E., 1995, CAVITATION BUBBLE DY; CRUM LA, 1994, PHYS TODAY, V47, P22, DOI 10.1063/1.881402; EVEREST FA, 1948, J ACOUST SOC AM, V20, P137, DOI 10.1121/1.1906355; McNamara WB, 1999, NATURE, V401, P772, DOI 10.1038/44536; OHL CD, 1999, THESIS G AUGUST U GO; SCHMITZ B, 2001, PHYSL CRUSTACEAN NER, P521; Versluis M, 2000, SCIENCE, V289, P2114, DOI 10.1126/science.289.5487.2114	8	67	72	5	110	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 4	2001	413	6855					477	478		10.1038/35097152	http://dx.doi.org/10.1038/35097152			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	478HG	11586346				2022-12-24	WOS:000171340500033
J	Dalton, R				Dalton, R			Transgenic corn found growing in Mexico	NATURE			English	News Item																			0	17	26	1	7	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 27	2001	413	6854					337	337		10.1038/35096714	http://dx.doi.org/10.1038/35096714			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475UY	11574839	Bronze			2022-12-24	WOS:000171188700007
J	van Walraven, C; Mamdani, MM; Wells, PS; Williams, JI				van Walraven, C; Mamdani, MM; Wells, PS; Williams, JI			Inhibition of serotonin reuptake by antidepressants and upper gastrointestinal bleeding in elderly patients: retrospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							FLUOXETINE; HEMORRHAGE; RISK; ASSOCIATION; DRUGS; TIME	Objectives To determine the association between inhibition of serotonin reuptake by antidepressants and upper gastrointestinal bleeding. Design Retrospective cohort study from population based databases. Setting Ontario, Canada. Participants 317 824 elderly people observed for more than 130 000 person years. The patients started taking an antidepressant between 1992 and 1998 and were grouped by how much the drug inhibited serotonin reuptake. Patients were observed until they stopped the drug, had an upper gastrointestinal bleed, or died or the study ended. Main outcome measure Admission to hospital for acute upper gastrointestinal bleeding. Results Overall, 974 bleeds were observed, with an overall bleeding rate of 7.3 per 1000 person years. After controlling for age or previous gastrointestinal bleeding, the risk of bleeding significantly increased by 10.7% and 9.8%, respectively, with increasing inhibition of serotonin reuptake. Absolute differences in bleeding between antidepressant groups were greatest for octogenarians (low inhibition of serotonin reuptake, 10.6 bleeds/1000 person years v high inhibition of serotonin reuptake, 14.7 bleeds/1000 person years; number needed to harm 244) and those with previous upper gastrointestinal bleeding (low, 28.6 bleeds/1000 person years v high, 40.3 bleeds/1000 person years; number needed to harm 85). Conclusions After age or previous upper gastrointestinal bleeding were controlled for, antidepressants with high inhibition of serotonin reuptake increased the risk of upper gastrointestinal bleeding. These increases are clinically important for elderly patients and those with previous gastrointestinal bleeding.	Ottawa Hosp, Ottawa Hlth Res Inst, Clin Epidemiol Unit, Ottawa, ON K1Y 4E9, Canada; Inst Clin Evaluat Sci, Toronto, ON M4N 3M5, Canada; Toronto Rehabil Inst, Toronto, ON M5G 2A2, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto Rehabilitation Institute	van Walraven, C (corresponding author), Ottawa Hosp, Ottawa Hlth Res Inst, Clin Epidemiol Unit, Civ Campus, Ottawa, ON K1Y 4E9, Canada.	carlv@ohri.ca						ALDERMAN CP, 1992, ANN PHARMACOTHER, V26, P1517, DOI 10.1177/106002809202601205; ARANTH J, 1992, AM J PSYCHIAT, V149, P412; Blatchford O, 1997, BMJ-BRIT MED J, V315, P510, DOI 10.1136/bmj.315.7107.510; Calhoun JW, 1996, AM J PSYCHIAT, V153, P443; de Abajo FJ, 1999, BRIT MED J, V319, P1106, DOI 10.1136/bmj.319.7217.1106; Dickinson T, 2000, BRIT MED J, V320, P1406; Dunn NR, 2000, BRIT MED J, V320, P1405; Grymonpre RE, 1998, ANN PHARMACOTHER, V32, P749, DOI 10.1345/aph.17423; GUNZBERGER DW, 1992, AM J PSYCHIAT, V149, P1751; HENNEKENS CH, 1987, EPIDEMIOLOGY MED, P153; HUMPHRIES JE, 1990, ARCH PATHOL LAB MED, V114, P727; Leung M, 1996, CAN J PSYCHIAT, V41, P604, DOI 10.1177/070674379604100919; Li N, 1997, BLOOD COAGUL FIBRIN, V8, P517, DOI 10.1097/00001721-199711000-00006; OTTERVANGER JD, 1994, AM J PSYCHIAT, V151, P781; Pahor M, 1996, LANCET, V347, P1061, DOI 10.1016/S0140-6736(96)90276-7; PAHOR M, 1994, JAMA-J AM MED ASSOC, V272, P595, DOI 10.1001/jama.272.8.595; Po ALW, 1999, BMJ-BRIT MED J, V319, P1081, DOI 10.1136/bmj.319.7217.1081; Raiford DS, 1996, EPIDEMIOLOGY, V7, P101, DOI 10.1097/00001648-199601000-00018; RODRIGUEZ LAG, 1994, LANCET, V343, P769, DOI 10.1016/S0140-6736(94)91843-0; ROSS SB, 1980, PSYCHOPHARMACOLOGY, V67, P1, DOI 10.1007/BF00427588; Tatsumi M, 1997, EUR J PHARMACOL, V340, P249, DOI 10.1016/S0014-2999(97)01393-9; Weil J, 2000, GUT, V46, P27, DOI 10.1136/gut.46.1.27; Williams D, 2000, BRIT MED J, V320, P1405, DOI 10.1136/bmj.320.7246.1405; Wilmshurst PT, 1996, EYE, V10, P141, DOI 10.1038/eye.1996.26	24	167	167	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 22	2001	323	7314					655	658		10.1136/bmj.323.7314.655	http://dx.doi.org/10.1136/bmj.323.7314.655			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	476LP	11566827	Bronze, Green Published			2022-12-24	WOS:000171228800014
J	Parle, JV; Maisonneuve, P; Sheppard, MC; Boyle, P; Franklyn, JA				Parle, JV; Maisonneuve, P; Sheppard, MC; Boyle, P; Franklyn, JA			Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study	LANCET			English	Article							SUPPRESSIVE THERAPY; FOLLOW-UP; THYROTOXICOSIS; LEVOTHYROXINE; ASSAY; TSH; HYPERTHYROIDISM; THYROXINE; HEART	Background Low serum thyrotropin, in combination with normal concentrations of circulating thyroid hormones, is common, especially in elderly people and in individuals with a history of thyroid disease. We aimed to assess the long-term effects of subclinical hyperthyroidism on mortality. Methods We did a population-based study of mortality in a cohort of 1191 individuals not on thyroxine or antithyroid medication. All participants were aged 60 years or older. We measured concentration of thyrotropin in serum at baseline in 1988-89. We recorded vital status on June 1, 1999, and ascertained causes of death for those who had died. We compared data for causes of death with age-specific, sex-specific, and year-specific data for England and Wales. We also compared mortality within the cohort according to initial thyrotropin measurement. Results During 9733 person-years of follow-up, 509 of 1191 people died, the expected number of deaths being 496 (standardised mortality ratio [SMR] 1.0, 95% CI 0.9-1.1). Mortality from all causes was significantly increased at 2 (SMR 2.1), 3 (2.1), 4 (1.7), and 5 (1.8) years after first measurement in those with low serum thyrotropin (n=71). These increases were largely accounted for by significant increases in mortality due to circulatory diseases (SMR 2.1, 2.2, 1.9, 2.0, at years 2, 3, 4, and 5 respectively). Increases in mortality from all causes in years 2-5 were higher in patients with low serum thyrotropin than in the rest of the cohort (hazard ratios for years 2, 3, 4, and 5 were 2.1, 2.2, 1.8, and 1.8, respectively). This result reflects an increase in mortality from circulatory diseases (hazard ratios at years 2, 3, 4, and 5 were 2.3, 2.6, 2.3, 2.3), and specifically from cardiovascular diseases (hazard ratios at years 2, 3, 4, and 5 were 3.3, 3.0, 2.3, 2.2). Interpretation A single measurement of low serum thyrotropin in individuals aged 60 years or older is associated with increased mortality from all causes, and in particular mortality due to circulatory and cardiovascular diseases.	Univ Birmingham, Div Primary Care Publ & Occupat Hlth, Birmingham, W Midlands, England; Univ Birmingham, Div Med Sci, Birmingham, W Midlands, England; European Inst Oncol, Div Epidemiol & Biostat, Milan, Italy	University of Birmingham; University of Birmingham; IRCCS European Institute of Oncology (IEO)	Franklyn, JA (corresponding author), Univ Birmingham, Queen Elizabeth Hosp, Dept Med, Birmingham B15 2TH, W Midlands, England.		Maisonneuve, Patrick/U-9789-2018; Boyle, Peter/A-4380-2014	Maisonneuve, Patrick/0000-0002-5309-4704; Boyle, Peter/0000-0001-6251-0610				Biondi B, 1996, J CLIN ENDOCR METAB, V81, P4224, DOI 10.1210/jc.81.12.4224; BIONDI B, 1994, J CLIN ENDOCR METAB, V78, P1028, DOI 10.1210/jc.78.5.1028; BIONDI B, 1993, J CLIN ENDOCR METAB, V77, P334, DOI 10.1210/jc.77.2.334; Ching GW, 1996, HEART, V75, P363, DOI 10.1136/hrt.75.4.363; DAVIES PH, 1992, J CLIN ENDOCR METAB, V74, P1189, DOI 10.1210/jc.74.5.1189; EGGERTSEN R, 1988, BRIT MED J, V297, P1586, DOI 10.1136/bmj.297.6663.1586; Franklyn JA, 1998, NEW ENGL J MED, V338, P712, DOI 10.1056/NEJM199803123381103; LADENSON PW, 1993, J CLIN ENDOCR METAB, V77, P332, DOI 10.1210/jc.77.2.332; LEESE GP, 1992, CLIN ENDOCRINOL, V37, P500, DOI 10.1111/j.1365-2265.1992.tb01480.x; PARLE JV, 1991, CLIN ENDOCRINOL, V34, P77; PRESTI CF, 1989, AM HEART J, V117, P967; SANDLER G, 1958, Q J MED, V111, P347; SAWIN CT, 1994, NEW ENGL J MED, V331, P1249, DOI 10.1056/NEJM199411103311901; SPENCER CA, 1990, J CLIN ENDOCR METAB, V70, P453, DOI 10.1210/jcem-70-2-453; UTIGER RD, 1994, NEW ENGL J MED, V331, P1302, DOI 10.1056/NEJM199411103311909; Uzzan B, 1996, J CLIN ENDOCR METAB, V81, P4278, DOI 10.1210/jc.81.12.4278; WOEBER KA, 1992, NEW ENGL J MED, V327, P94	17	499	522	0	9	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 15	2001	358	9285					861	865		10.1016/S0140-6736(01)06067-6	http://dx.doi.org/10.1016/S0140-6736(01)06067-6			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	474CP	11567699				2022-12-24	WOS:000171087000006
J	SQUYRES, SW; KASTING, JF				SQUYRES, SW; KASTING, JF			EARLY MARS - HOW WARM AND HOW WET	SCIENCE			English	Article							SMALL MARTIAN VALLEYS; TERRESTRIAL PLANETS; CHAOTIC OBLIQUITY; CLIMATIC CHANGE; MASS-LOSS; EVOLUTION; EARTH; ORIGIN; ATMOSPHERE; SURFACE	Early in its history, Mars underwent fluvial erosion that has been interpreted as evidence for a warmer, wetter climate. However, no atmosphere composed of only CO2 and H2O appears capable of producing mean planetary temperatures even close to 0 degrees C. Rather than by precipitation, aquifer recharge and ground water seepage may have been enabled by hydrothermal convection driven by geothermal heat and heat associated with impacts. Some climatic warming was probably necessary to allow water to flow for long distances across the surface. Modest warming could be provided by even a low-pressure CO2 atmosphere if it was supplemented with small amounts of CH4, NH3, or SO2. Episodic excursions to high obliquities may also have raised temperatures over some portions of the planet's surface.	PENN STATE UNIV,DEPT GEOSCI,STATE COLL,PA 16802	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	SQUYRES, SW (corresponding author), CORNELL UNIV,CTR RADIOPHYS & SPACE RES,ITHACA,NY 14853, USA.		Kasting, James/AAF-6851-2020					ANDERS E, 1977, SCIENCE, V198, P453, DOI 10.1126/science.198.4316.453; Baker V.R., 1992, CHANNELS VALLEY NETW, P493; BAROSS JA, 1985, ORIGINS LIFE EVOL B, V15, P327, DOI 10.1007/BF01808177; Biemann K., 1977, Journal of Geophysical Research, V82, P4641, DOI 10.1029/JS082i028p04641; BOGARD DD, 1983, SCIENCE, V221, P651, DOI 10.1126/science.221.4611.651; BOOTHROYD AI, 1991, ASTROPHYS J, V377, P318, DOI 10.1086/170361; BRAKENRIDGE GR, 1985, GEOLOGY, V13, P859, DOI 10.1130/0091-7613(1985)13<859:AHSOMO>2.0.CO;2; Brown L.L., 1993, WORKSHOP EARLY MARS, P3; Brutsaert W., 2013, EVAPORATION ATMOSPHE; CARR MH, 1983, ICARUS, V56, P476, DOI 10.1016/0019-1035(83)90168-9; CARR MH, 1981, ICARUS, V48, P91, DOI 10.1016/0019-1035(81)90156-1; CARR MH, 1979, J GEOPHYS RES, V84, P2995, DOI 10.1029/JB084iB06p02995; CHAPMAN CR, 1977, ANNU REV EARTH PL SC, V5, P515, DOI 10.1146/annurev.ea.05.050177.002503; CHEN JH, 1986, GEOCHIM COSMOCHIM AC, V50, P955, DOI 10.1016/0016-7037(86)90376-5; CLIFFORD SM, 1981, CONTRIBUTION LUNAR P, V441, P46; CLIFFORD SM, 1985, J GEOPHYS RES S, V90, pD144; CORADINI A, 1983, PHYS EARTH PLANET IN, V31, P145, DOI 10.1016/0031-9201(83)90106-1; CRADDOCK RA, 1990, J GEOPHYS RES-SOLID, V95, P14265, DOI 10.1029/JB095iB09p14265; GIERASCH PJ, 1973, J ATMOS SCI, V30, P1502, DOI 10.1175/1520-0469(1973)030<1502:APVATC>2.0.CO;2; GOLDREICH P, 1969, J GEOPHYS RES, V74, P2555, DOI 10.1029/JB074i010p02555; GOLDSPIEL JM, 1993, ICARUS, V105, P479, DOI 10.1006/icar.1993.1143; GOLDSPIEL JM, 1991, ICARUS, V89, P392, DOI 10.1016/0019-1035(91)90186-W; GOLDSPIEL JM, 1993, ICARUS, V106, P346, DOI 10.1006/icar.1993.1177; GOLDSPIEL JM, 1994, THESIS CORNELL U ITH; GOUGH DO, 1981, SOL PHYS, V74, P21, DOI 10.1007/BF00151270; GRAEDEL TE, 1991, GEOPHYS RES LETT, V18, P1881, DOI 10.1029/91GL02314; GULICK VC, 1990, J GEOPHYS RES-SOLID, V95, P14325, DOI 10.1029/JB095iB09p14325; GULICK VC, 1993, WORKSHOP EARLY MARS, P12; GULICK VC, 1992, LUNAR PLANET SCI, V22, P509; HARTMANN WK, 1970, ICARUS, V12, P131, DOI 10.1016/0019-1035(70)90039-4; HIGGINS CG, 1982, GEOLOGY, V10, P147, DOI 10.1130/0091-7613(1982)10<147:DSDBSO>2.0.CO;2; HUNTEN DM, 1987, ICARUS, V69, P532, DOI 10.1016/0019-1035(87)90022-4; HUNTEN DM, 1993, SCIENCE, V259, P915, DOI 10.1126/science.259.5097.915; KASTING JF, 1991, ICARUS, V94, P1, DOI 10.1016/0019-1035(91)90137-I; KOCHEL RC, 1985, J GEOPHYS RES S, V91, pE175; LAITY JE, 1985, GEOL SOC AM BULL, V96, P203, DOI 10.1130/0016-7606(1985)96<203:SPATDO>2.0.CO;2; LASKAR J, 1993, NATURE, V361, P608, DOI 10.1038/361608a0; LEWIS JS, 1972, ICARUS, V16, P241, DOI 10.1016/0019-1035(72)90071-1; MATSUI T, 1986, NATURE, V319, P303, DOI 10.1038/319303a0; MCKAY CP, 1991, NATURE, V352, P489, DOI 10.1038/352489a0; MCSWEEN HY, 1985, REV GEOPHYS, V23, P391, DOI 10.1029/RG023i004p00391; MELOSH HJ, 1989, NATURE, V338, P487, DOI 10.1038/338487a0; NEWMAN MJ, 1977, SCIENCE, V198, P1035, DOI 10.1126/science.198.4321.1035; NEWSOM HE, 1980, ICARUS, V44, P207, DOI 10.1016/0019-1035(80)90066-4; OWEN T, 1979, NATURE, V277, P640, DOI 10.1038/277640a0; PIERI D, 1976, ICARUS, V27, P25, DOI 10.1016/0019-1035(76)90182-2; PIERI DC, 1980, SCIENCE, V210, P895, DOI 10.1126/science.210.4472.895; PLAUT JJ, 1988, ICARUS, V75, P357; POLLACK JB, 1987, ICARUS, V71, P203, DOI 10.1016/0019-1035(87)90147-3; POLLACK JB, 1979, ICARUS, V37, P479, DOI 10.1016/0019-1035(79)90012-5; POSTAWKO SE, 1986, J GEOPHYS RES-SOLID, V91, pD431, DOI 10.1029/JB091iB04p0D431; SAGAN C, 1973, SCIENCE, V181, P1045, DOI 10.1126/science.181.4104.1045; SAGAN C, 1972, SCIENCE, V177, P52, DOI 10.1126/science.177.4043.52; SAGAN C, 1991, B AM ASTRON SOC, V23, P1211; Schubert G., 1992, MARS, P147, DOI [10.2307/j.ctt207g59v.9, DOI 10.2307/J.CTT207G59V.9]; SHIH CY, 1982, GEOCHIM COSMOCHIM AC, V46, P2323, DOI 10.1016/0016-7037(82)90205-8; SLOAN CE, 1976, 979 US GEOL SURV PRO; TOUMA J, 1993, SCIENCE, V259, P1294, DOI 10.1126/science.259.5099.1294; WALKER JCG, 1981, J GEOPHYS RES-OCEANS, V86, P9776, DOI 10.1029/JC086iC10p09776; WALLACE D, 1979, ICARUS, V39, P385, DOI 10.1016/0019-1035(79)90148-9; WARD WR, 1974, J GEOPHYS RES, V79, P3375, DOI 10.1029/JC079i024p03375; Wasson J.T., 1979, ASTEROIDS, P926; Wetherill G. W, 1986, ORIGIN MOON, P519; WETHERILL GW, 1985, SCIENCE, V228, P877, DOI 10.1126/science.228.4701.877; Wood C.A., 1981, P LUNAR PLANET SCI C, V12B, P1359	65	207	208	1	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	AUG 5	1994	265	5173					744	749		10.1126/science.265.5173.744	http://dx.doi.org/10.1126/science.265.5173.744			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PA372	11539185				2022-12-24	WOS:A1994PA37200022
J	OHMOTO, H; KAKEGAWA, T; LOWE, DR				OHMOTO, H; KAKEGAWA, T; LOWE, DR			3.4-BILLION-YEAR-OLD BIOGENIC PYRITES FROM BARBERTON, SOUTH-AFRICA - SULFUR ISOTOPE EVIDENCE	SCIENCE			English	Article							BEARING	Laser ablation mass spectroscopy analyses of sulfur isotopic compositions of microscopic-sized grains of pyrite that formed about 3.4 billion years ago in the Barberton Greenstone Belt, South Africa, show that the pyrite formed by bacterial reduction of seawater sulfate. These data imply that by about 3.4 billion years ago sulfate-reducing bacteria had become active, the oceans were rich in sulfate, and the atmosphere contained appreciable amounts (>>10(-13) of the present atmospheric level) of free oxygen.	STANFORD UNIV,DEPT GEOL,STANFORD,CA 94305; TOHOKU UNIV,INST MINERAL PETROL & ECON GEOL,SENDAI,MIYAGI 980,JAPAN	Stanford University; Tohoku University	OHMOTO, H (corresponding author), PENN STATE UNIV,DEPT GEOSCI,UNIV PK,PA 16802, USA.				NCI NIH HHS [NCA2-332] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AULT WV, 1963, BIOGEOCHEMISTRY SULF, P16; CROWE DE, 1990, GEOCHIM COSMOCHIM AC, V54, P2075, DOI 10.1016/0016-7037(90)90272-M; Jones L. M., 1986, TERRA COGNITA, V6, P263; JORGENSEN BB, 1977, LIMNOL OCEANOGR, V22, P657, DOI 10.4319/lo.1977.22.4.0657; KELLEY SP, 1990, GEOCHIM COSMOCHIM AC, V54, P883, DOI 10.1016/0016-7037(90)90381-T; LOWE DR, 1977, J GEOL, V85, P699, DOI 10.1086/628358; OHMOTO H, 1987, NATURE, V328, P244, DOI 10.1038/328244a0; Ohmoto H., 1979, GEOCHEMISTRY HYDROTH, P509; OHMOTO H, 1990, STABLE ISOTOPES FLUI, P70; Ohmoto H, 1992, EARLY ORGANIC EVOLUT, P378, DOI DOI 10.1007/978-3-642-76884-2_29; WALKER JCG, 1985, PRECAMBRIAN RES, V28, P205, DOI 10.1016/0301-9268(85)90031-2	11	126	132	1	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 22	1993	262	5133					555	557		10.1126/science.11539502	http://dx.doi.org/10.1126/science.11539502			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC935	11539502				2022-12-24	WOS:A1993MC93500036
J	TONKS, A				TONKS, A			INTUBATION PRACTICE ON CADAVERS SHOULD STOP	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	15	14	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	AUG 8	1992	305	6849					332	332						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JJ032	11643027				2022-12-24	WOS:A1992JJ03200014
J	LEWIS, J				LEWIS, J			A COMMONS SUBCOMMITTEE ON MEDICAL-ETHICS	LANCET			English	Editorial Material																			0	2	2	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	APR 30	1988	1	8592					1005	1005						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	N1366	11644348				2022-12-24	WOS:A1988N136600056
J	Shenoy, SK; McDonald, PH; Kohout, TA; Lefkowitz, RJ				Shenoy, SK; McDonald, PH; Kohout, TA; Lefkowitz, RJ			Regulation of receptor fate by ubiquitination of activated beta(2)-adrenergic receptor and beta-arrestin	SCIENCE			English	Article							ADRENERGIC-RECEPTOR; CLATHRIN ADAPTER; PROTEIN LIGASE; ENDOCYTOSIS; P53; SYSTEM; MDM2; COMPLEX	Although trafficking and degradation of several membrane proteins are regulated by ubiquitination catalyzed by E3 ubiquitin ligases, there has been little evidence connecting ubiquitination with regulation of mammalian G protein (heterotrimeric guanine nucleotide-binding protein)-coupled receptor (GPCR) function. Agonist stimulation of endogenous or transfected beta (2)-adrenergic receptors (beta (2)ARs) led to rapid ubiquitination of both the receptors and the receptor regulatory protein, beta -arrestin. Moreover, proteasome inhibitors reduced receptor internalization and degradation, thus implicating a role for the ubiquitination machinery in the trafficking of the beta (2)AR. Receptor ubiquitination required beta -arrestin, which bound to the E3 ubiquitin ligase Mdm2. Abrogation of beta -arrestin ubiquitination, either by expression in Mdm2-null cells or by dominant-negative forms of Mdm2 lacking E3 ligase activity, inhibited receptor internalization with marginal effects on receptor degradation. However, a beta (2)AR mutant tacking lysine residues, which was not ubiquitinated, was internalized normally but was degraded ineffectively. These findings delineate an adapter role of beta -arrestin in mediating the ubiquitination of the beta (2)AR and indicate that ubiquitination of the receptor and of beta -arrestin have distinct and obligatory roles in the trafficking and degradation of this prototypic GPCR.	Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Cardiol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	Duke University; Howard Hughes Medical Institute; Duke University; Duke University; Duke University	Lefkowitz, RJ (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst, Box 3821, Durham, NC 27710 USA.		Lefkowitz, Robert/AAW-2649-2021; Shenoy, Sudha/AAN-4075-2021	Shenoy, Sudha/0000-0002-2565-4663	NHLBI NIH HHS [HL16037] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL016037, R01HL016037] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bonifacino JS, 1998, ANNU REV CELL DEV BI, V14, P19, DOI 10.1146/annurev.cellbio.14.1.19; BOUVIER M, 1988, MOL PHARMACOL, V33, P133; Buschmann T, 2000, CELL, V101, P753, DOI 10.1016/S0092-8674(00)80887-9; Chaturvedi K, 2001, J BIOL CHEM, V276, P12345, DOI 10.1074/jbc.M008054200; CHEN JD, 1993, MOL CELL BIOL, V13, P4107, DOI 10.1128/MCB.13.7.4107; CHIEN CT, 1991, P NATL ACAD SCI USA, V88, P9578, DOI 10.1073/pnas.88.21.9578; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; HAUSDORFF WP, 1991, P NATL ACAD SCI USA, V88, P2979, DOI 10.1073/pnas.88.8.2979; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 1996, CELL, V84, P277, DOI 10.1016/S0092-8674(00)80982-4; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Laporte SA, 1999, P NATL ACAD SCI USA, V96, P3712, DOI 10.1073/pnas.96.7.3712; Mori S, 1997, EUR J BIOCHEM, V247, P1190, DOI 10.1111/j.1432-1033.1997.01190.x; Nakamura K, 1999, MOL ENDOCRINOL, V13, P1295, DOI 10.1210/me.13.8.1295; Oakley RH, 1999, J BIOL CHEM, V274, P32248, DOI 10.1074/jbc.274.45.32248; Obin MS, 1996, J BIOL CHEM, V271, P14473, DOI 10.1074/jbc.271.24.14473; Parola AL, 1997, ANAL BIOCHEM, V254, P88, DOI 10.1006/abio.1997.2361; Roth AF, 2000, J BIOL CHEM, V275, P8143, DOI 10.1074/jbc.275.11.8143; SHENOY SR, UNPUB; Tsao P, 2001, TRENDS PHARMACOL SCI, V22, P91, DOI 10.1016/S0165-6147(00)01620-5; van Kerkhof P, 2000, J BIOL CHEM, V275, P1575, DOI 10.1074/jbc.275.3.1575; van Kerkhof P, 2001, J BIOL CHEM, V276, P3778, DOI 10.1074/jbc.M007326200; Yu AX, 2001, J BIOL CHEM, V276, P381, DOI 10.1074/jbc.M007991200	25	669	689	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 9	2001	294	5545					1307	1313		10.1126/science.1063866	http://dx.doi.org/10.1126/science.1063866			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	491VF	11588219				2022-12-24	WOS:000172130200039
J	Niswender, KD; Morton, GJ; Stearns, WH; Rhodes, CJ; Myers, MG; Schwartz, MW				Niswender, KD; Morton, GJ; Stearns, WH; Rhodes, CJ; Myers, MG; Schwartz, MW			Intracellular signalling - Key enzyme in leptin-induced anorexia	NATURE			English	Article							ACTIVATION; 3-KINASE; OBESE; MICE		Univ Washington, Sch Med, Div Metab Endocrinol & Nutr, Seattle, WA 98104 USA; Univ Washington, Harborview Med Ctr, Seattle, WA 98104 USA; Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02215 USA; Pacific NW Res Inst, Seattle, WA 98122 USA	University of Washington; University of Washington Seattle; Harborview Medical Center; University of Washington; University of Washington Seattle; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.	Niswender, KD (corresponding author), Univ Washington, Sch Med, Div Metab Endocrinol & Nutr, Seattle, WA 98104 USA.	mschwart@u.washington.edu	Schwartz, Michael W/H-9950-2012					Cone RD, 1996, RECENT PROG HORM RES, V51, P287; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; El-Haschimi K, 2000, J CLIN INVEST, V105, P1827, DOI 10.1172/JCI9842; Harvey J, 2000, J BIOL CHEM, V275, P4660, DOI 10.1074/jbc.275.7.4660; Heymsfield SB, 1999, JAMA-J AM MED ASSOC, V282, P1568, DOI 10.1001/jama.282.16.1568; McMinn JE, 2000, AM J PHYSIOL-REG I, V279, pR695, DOI 10.1152/ajpregu.2000.279.2.R695; MYERS MG, 1992, P NATL ACAD SCI USA, V89, P10350, DOI 10.1073/pnas.89.21.10350; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Spanswick D, 2000, NAT NEUROSCI, V3, P757, DOI 10.1038/77660; Vaisse C, 1996, NAT GENET, V14, P95, DOI 10.1038/ng0996-95; Woods SC, 1998, SCIENCE, V280, P1378, DOI 10.1126/science.280.5368.1378; Zhao AZ, 2000, J BIOL CHEM, V275, P11348, DOI 10.1074/jbc.275.15.11348	12	473	488	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 25	2001	413	6858					794	795		10.1038/35101657	http://dx.doi.org/10.1038/35101657			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	485JA	11677594				2022-12-24	WOS:000171750200033
J	Bates-Jensen, BM				Bates-Jensen, BM			Quality indicators for prevention and management of pressure ulcers in vulnerable elders	ANNALS OF INTERNAL MEDICINE			English	Article							PREDICTIVE-VALIDITY; COST-EFFECTIVENESS; RANDOMIZED TRIAL; WOUND CLEANSERS; BRADEN-SCALE; SORE RISK; INTERVENTIONS; DEBRIDEMENT; MULTISITE; DRESSINGS		Univ Calif Los Angeles, Borun Ctr Gerontol Res, Reseda, CA 91335 USA	University of California System; University of California Los Angeles	Bates-Jensen, BM (corresponding author), Univ Calif Los Angeles, Borun Ctr Gerontol Res, 7150 Tampa Ave, Reseda, CA 91335 USA.		Bates-Jensen, Barbara/ABA-3726-2020					ALLMAN RM, 1987, ANN INTERN MED, V107, P641, DOI 10.7326/0003-4819-107-5-641; ALLMAN RM, 1986, ANN INTERN MED, V105, P337, DOI 10.7326/0003-4819-105-3-337; *AM MED DIR ASS, 1996, PRESS ULC CLIN PRACT; AMLUNG S, 2000, 14 ANN CLIN S WOUND, P234; Bale S, 1998, J Wound Care, V7, P65; Bates-Jensen B M, 1992, Decubitus, V5, P20; Bates-Jensen B M, 1997, Adv Wound Care, V10, P65; BATESJENSEN BM, 1999, WOUND CARE COLLABORA, P139; BATESJENSEN BM, 1999, THESIS LOS ANGELES U, V59; BATESJENSEN BM, 1998, WOUND CARE COLLABORA, P235; Bergstrom N, 1996, J AM GERIATR SOC, V44, P22, DOI 10.1111/j.1532-5415.1996.tb05633.x; Bergstrom N, 1998, NURS RES, V47, P261, DOI 10.1097/00006199-199809000-00005; BERGSTROM N, 1992, J AM GERIATR SOC, V40, P747, DOI 10.1111/j.1532-5415.1992.tb01845.x; BERLOWITZ DR, 1989, J AM GERIATR SOC, V37, P1043, DOI 10.1111/j.1532-5415.1989.tb06918.x; BERLOWITZ DR, 1990, J AM GERIATR SOC, V38, P748, DOI 10.1111/j.1532-5415.1990.tb01464.x; BRADEN BJ, 1994, RES NURS HEALTH, V17, P459, DOI 10.1002/nur.4770170609; BRANDEIS GH, 1990, JAMA-J AM MED ASSOC, V264, P2905, DOI 10.1001/jama.264.22.2905; BRENNAN SS, 1988, ANN EMERG MED, V17, P1274; Colin D, 1996, J Wound Care, V5, P444; *DESCR NPUAP, 1995, ADV WOUND CAR S, V8, P93; FERRELL BA, 1993, JAMA-J AM MED ASSOC, V269, P494, DOI 10.1001/jama.269.4.494; Flanagan M, 1995, J Wound Care, V4, P264; FORESMAN PA, 1993, WOUNDS, V5, P226; GORSE GJ, 1987, ARCH DERMATOL, V123, P766, DOI 10.1001/archderm.123.6.766; Hellewell TB, 1997, WOUNDS, V9, P15; LAZARUS GS, 1994, ARCH DERMATOL, V130, P489, DOI 10.1001/archderm.130.4.489; LEVINE NS, 1976, J TRAUMA, V16, P89, DOI 10.1097/00005373-197602000-00002; LINEAWEAVER W, 1985, ARCH SURG-CHICAGO, V120, P267; Martin S J, 1996, J Wound Care, V5, P310; MOOLTEN SE, 1972, ARCH PHYS MED REHAB, V53, P430; Mulder G D, 1995, Ostomy Wound Manage, V41, P62; MULDER GD, 1993, WOUNDS, V5, P112; *NAT PRESS ULC ADV, 2001, STAT PRESS ULC PREV; *NPUAP STAT REV ST, 1995, NPUAP REP NEWSL NAT, V4, P1; PINCHCOFSKYDEVIN GD, 1986, J AM GERIATR SOC, V34, P435, DOI 10.1111/j.1532-5415.1986.tb03411.x; *PRESS ULC AD PREV, 1992, AHCPR PUBL; ROBSON MC, 1988, ANN EMERG MED, V17, P1274, DOI 10.1016/S0196-0644(88)80352-4; ROBSON MC, 1990, CLIN PLAST SURG, V17, P485; ROUSSEAU P, 1989, WOUNDS, V1, P135; SAPICO FL, 1986, DIAGN MICR INFEC DIS, V5, P31, DOI 10.1016/0732-8893(86)90089-1; Saydak S J, 1990, J Enterostomal Ther, V17, P139; SEBERN MD, 1986, ARCH PHYS MED REHAB, V67, P726, DOI 10.1016/0003-9993(86)90004-3; Shekelle PG, 2001, ANN INTERN MED, V135, P647, DOI 10.7326/0003-4819-135-8_Part_2-200110161-00003; Steed DL, 1996, J AM COLL SURGEONS, V183, P61; Stotts N A, 1995, Adv Wound Care, V8, P46; Thomas D R, 1997, Adv Wound Care, V10, P96; Thomas DR, 1997, CLIN GERIATR MED, V13, P497; THOMAS DR, 1997, GERIATRIC MED, P767; *TREATM PRESS ULC, 1994, AHCPR PUBL; *US DEP HHS, 2000, HLTH PEOP 2010; van Rijswijk L, 1993, Decubitus, V6, P16; van Rijswijk L, 1994, Ostomy Wound Manage, V40, P40; van Rijswijk L, 1999, Ostomy Wound Manage, V45, p56S; VANRIJSWIJK L, 1997, CHRONIC WOUND CARE C; Whittington K, 2000, J Wound Ostomy Continence Nurs, V27, P209, DOI 10.1067/mjw.2000.107879; XAKELLIS GC, 1992, J AM GERIATR SOC, V40, P1250, DOI 10.1111/j.1532-5415.1992.tb03651.x; XAKELLIS GC, 1992, ARCH PHYS MED REHAB, V73, P463	57	40	42	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 16	2001	135	8	2				744	751		10.7326/0003-4819-135-8_Part_2-200110161-00014	http://dx.doi.org/10.7326/0003-4819-135-8_Part_2-200110161-00014			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	481WA	11601958				2022-12-24	WOS:000171542400014
J	MacLean, CH				MacLean, CH			Quality indicators for the management of osteoarthritis in vulnerable elders	ANNALS OF INTERNAL MEDICINE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; ARTHRITIS SELF-MANAGEMENT; SERIOUS GASTROINTESTINAL COMPLICATIONS; TOTAL HIP-ARTHROPLASTY; RHEUMATOID-ARTHRITIS; PATIENT EDUCATION; DOUBLE-BLIND; KNEE OSTEOARTHRITIS; MEDICAL-MANAGEMENT; FUNCTIONAL STATUS		RAND Corp, RAND Hlth, Santa Monica, CA 90407 USA; Univ Calif Los Angeles, Los Angeles, CA 90024 USA	RAND Corporation; University of California System; University of California Los Angeles	MacLean, CH (corresponding author), RAND Corp, RAND Hlth, 1700 Main St,M-23C, Santa Monica, CA 90407 USA.							*AM AC ORTH SURG, 1991, OST HIP CLIN POL; [Anonymous], 1994, NIH Consens Statement, V12, P1; Bautch JC, 1997, ARTHRIT CARE RES, V10, P48, DOI 10.1002/art.1790100108; BECKENBAUGH RD, 1978, J BONE JOINT SURG AM, V60, P306, DOI 10.2106/00004623-197860030-00005; Bensen WG, 1999, MAYO CLIN PROC, V74, P1095, DOI 10.4065/74.11.1095; BOLLINI P, 1992, ARCH INTERN MED, V152, P1289, DOI 10.1001/archinte.152.6.1289; Bombardier C, 2000, NEW ENGL J MED, V343, P1520, DOI 10.1056/NEJM200011233432103; Borjesson M, 1996, Physiother Res Int, V1, P89; BRADLEY JD, 1991, NEW ENGL J MED, V325, P87, DOI 10.1056/NEJM199107113250203; *CADM J SERV, 1998, 18 AM BOARD FAM PRAC; CALLAGHAN MJ, 1995, CLIN REHABIL, V9, P213, DOI DOI 10.1177/026921559500900306; CALLAHAN CM, 1994, JAMA-J AM MED ASSOC, V271, P1349, DOI 10.1001/jama.271.17.1349; Chamberlain M A, 1982, Int Rehabil Med, V4, P101; COVENTRY MB, 1974, J BONE JOINT SURG AM, VA 56, P273, DOI 10.2106/00004623-197456020-00005; DALTROY LH, 1993, HEALTH EDUC QUART, V20, P3, DOI 10.1177/109019819302000103; Deyle GD, 2000, ANN INTERN MED, V132, P173, DOI 10.7326/0003-4819-132-3-200002010-00002; Ettinger WH, 1997, JAMA-J AM MED ASSOC, V277, P25, DOI 10.1001/jama.277.1.25; FELSON DT, 1990, SEMIN ARTHRITIS RHEU, V20, P42, DOI 10.1016/0049-0172(90)90046-I; FREUND D, 1995, ASSESSING IMPROVING; GABRIEL SE, 1991, ANN INTERN MED, V115, P787, DOI 10.7326/0003-4819-115-10-787; GOEPPINGER J, 1989, ARTHRITIS RHEUM, V32, P706, DOI 10.1002/anr.1780320608; GRIFFIN MR, 1991, ANN INTERN MED, V114, P257, DOI 10.7326/0003-4819-114-4-257; Hawkey CJ, 1998, NEW ENGL J MED, V338, P727, DOI 10.1056/NEJM199803123381105; HIRANO PC, 1994, PATIENT EDUC COUNS, V24, P9, DOI 10.1016/0738-3991(94)90024-8; Hochberg M C, 1996, Arthritis Care Res, V9, P170, DOI 10.1002/1529-0131(199606)9:3<170::AID-ANR1790090304>3.0.CO;2-K; HOCHBERG MC, 1995, ARTHRITIS RHEUM, V38, P1541, DOI 10.1002/art.1780381104; HOCHBERG MC, 1995, ARTHRITIS RHEUM, V38, P1535, DOI 10.1002/art.1780381103; Holman HR, 1997, WESTERN J MED, V167, P265; Hughes SL, 1995, ARTHRIT CARE RES, V8, P257, DOI 10.1002/art.1790080409; HUGHES SL, 1991, ARTHRITIS RHEUM-US, V34, P856, DOI 10.1002/art.1780340711; Jan M H, 1991, J Formos Med Assoc, V90, P1008; Katz BP, 1996, HEALTH SERV RES, V31, P125; KAVANAGH BF, 1989, J BONE JOINT SURG AM, V71A, P1496, DOI 10.2106/00004623-198971100-00007; KEEFE FJ, 1990, BEHAV THER, V21, P435, DOI 10.1016/S0005-7894(05)80357-0; KJAERSGAARDANDERSEN P, 1990, PAIN, V43, P309, DOI 10.1016/0304-3959(90)90028-C; KNETTNER KE, 1995, OSTEOARTHRITIC DISOR, pR21; Koch M, 1996, ARCH INTERN MED, V156, P2321, DOI 10.1001/archinte.156.20.2321; KOVAR PA, 1992, ANN INTERN MED, V116, P529, DOI 10.7326/0003-4819-116-7-529; LABORDE JM, 1989, MULTIPLE LINEAR REGR, V12, P12; Langman MJ, 1999, JAMA-J AM MED ASSOC, V282, P1929, DOI 10.1001/jama.282.20.1929; Lanza FL, 1998, AM J GASTROENTEROL, V93, P2037; LORIG K, 1992, HEALTH EDUC QUART, V19, P355, DOI 10.1177/109019819201900307; LORIG K, 1989, ARTHRITIS RHEUM, V32, P91, DOI 10.1002/anr.1780320116; LORIG K, 1986, J RHEUMATOL, V13, P763; LORIG K, 1989, SOC SCI MED, V29, P221, DOI 10.1016/0277-9536(89)90170-6; LORIG K, 1987, PATIENT EDUC COUNS, V10, P207, DOI 10.1016/0738-3991(87)90126-1; LORIG K, 1993, HEALTH EDUC QUART, V20, P17, DOI 10.1177/109019819302000104; LORIG K, 1985, ARTHRITIS RHEUM, V28, P680, DOI 10.1002/art.1780280612; MCCUNE WJ, 1997, TXB RHEUMATOLOGY, P378; MINOR MA, 1989, ARTHRITIS RHEUM, V32, P1396, DOI 10.1002/anr.1780321108; MULLEN PD, 1987, J RHEUMATOL, V14, P33; *OST ARTHR KNEE DE, 1996, CLIN POL AM AC ORTH; Pincus T, 2001, ARTHRITIS RHEUM-US, V44, P1587, DOI 10.1002/1529-0131(200107)44:7<1587::AID-ART282>3.0.CO;2-X; Schilke JM, 1996, NURS RES, V45, P68, DOI 10.1097/00006199-199603000-00002; Shekelle PG, 2001, ANN INTERN MED, V135, P647, DOI 10.7326/0003-4819-135-8_Part_2-200110161-00003; Shmerling RH, 1996, ARTHRITIS RHEUM, V39, P1; SILVERSTEIN FE, 1995, ANN INTERN MED, V123, P241, DOI 10.7326/0003-4819-123-4-199508150-00001; Silverstein FE, 2000, JAMA-J AM MED ASSOC, V284, P1247, DOI 10.1001/jama.284.10.1247; Simon LS, 1999, JAMA-J AM MED ASSOC, V282, P1921, DOI 10.1001/jama.282.20.1921; SuperioCabuslay E, 1996, ARTHRIT CARE RES, V9, P292, DOI 10.1002/1529-0131(199608)9:4<292::AID-ANR1790090414>3.0.CO;2-4; Taal E, 1997, SEMIN ARTHRITIS RHEU, V26, P805, DOI 10.1016/S0049-0172(97)80024-8; Taal E, 1996, ARTHRIT CARE RES, V9, P229, DOI 10.1002/1529-0131(199606)9:3<229::AID-ANR1790090312>3.0.CO;2-U; TOWHEED T, 2001, OSTEOARTHRITIS SYSTE, P2; Towheed TE, 1996, SEMIN ARTHRITIS RHEU, V26, P483, DOI 10.1016/S0049-0172(96)80029-1; Van Baar ME, 1998, J RHEUMATOL, V25, P2432; Van Baar ME, 1999, ARTHRITIS RHEUM-US, V42, P1361, DOI 10.1002/1529-0131(199907)42:7<1361::AID-ANR9>3.0.CO;2-9; VERBRUGGE LM, 1991, J GERONTOL, V46, pS71, DOI 10.1093/geronj/46.2.S71; WATSON MC, 2001, OSTEOARTHRITIS COMP, P2; WEINBERGER M, 1989, ARTHRITIS RHEUM, V32, P1577, DOI 10.1002/anr.1780321212; WHITE RH, 1990, J GEN INTERN MED, V5, P304, DOI 10.1007/BF02600396; WILLIAMS HJ, 1993, ARTHRITIS RHEUM-US, V36, P1196, DOI 10.1002/art.1780360904; YELIN EH, 1990, ARTHRITIS RHEUM, V33, P1205; Yeomans ND, 1998, NEW ENGL J MED, V338, P719, DOI 10.1056/NEJM199803123381104; Zicat B, 1993, J Arthroplasty, V8, P395, DOI 10.1016/S0883-5403(06)80038-0	74	49	51	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 16	2001	135	8	2				711	721		10.7326/0003-4819-135-8_Part_2-200110161-00010	http://dx.doi.org/10.7326/0003-4819-135-8_Part_2-200110161-00010			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	481WA	11601954				2022-12-24	WOS:000171542400010
J	Schnelle, JF; Smith, RL				Schnelle, JF; Smith, RL			Quality indicators for the management of urinary incontinence in vulnerable community-dwelling elders	ANNALS OF INTERNAL MEDICINE			English	Article							INTRINSIC SPHINCTERIC DEFICIENCY; GENUINE STRESS-INCONTINENCE; RANDOMIZED CONTROLLED TRIAL; MUSCLE EXERCISE TREATMENT; DETRUSOR INSTABILITY; OLDER WOMEN; OXYBUTYNIN CHLORIDE; SURGICAL-TREATMENT; FOLLOW-UP; FEMALE		Anna & Harry Borun Ctr Gerontol Res, Reseda, CA 91335 USA; Univ Calif Los Angeles, Los Angeles, CA 90024 USA; Los Angeles Jewish Home Aging, Los Angeles, CA USA; Ctr Geriatr Res Educ & Clin, Sepulveda, CA USA; Vet Affairs Greater Los Angeles Healthcare Syst, Sepulveda, CA USA	University of California System; University of California Los Angeles; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	Schnelle, JF (corresponding author), Anna & Harry Borun Ctr Gerontol Res, 7150 Tampa Ave, Reseda, CA 91335 USA.	lcarmona@ucla.edu						BENT AE, 1983, AM J OBSTET GYNECOL, V145, P218, DOI 10.1016/0002-9378(83)90495-7; Berghmans LCM, 1996, NEUROUROL URODYNAM, V15, P37, DOI 10.1002/(SICI)1520-6777(1996)15:1<37::AID-NAU4>3.0.CO;2-G; Blowman C, 1991, PHYSIOTHERAPY, V77, P661; Brown JS, 2000, J AM GERIATR SOC, V48, P721, DOI 10.1111/j.1532-5415.2000.tb04744.x; Burgio KL, 2000, J AM GERIATR SOC, V48, P370, DOI 10.1111/j.1532-5415.2000.tb04692.x; BURGIO KL, 1986, AM J OBSTET GYNECOL, V154, P58; Burgio KL, 1998, JAMA-J AM MED ASSOC, V280, P1995, DOI 10.1001/jama.280.23.1995; BURNS PA, 1993, J GERONTOL, V48, pM167; Chang PL, 1998, J UROLOGY, V160, P402, DOI 10.1016/S0022-5347(01)62908-2; Cohen SJ, 1999, J GERONTOL A-BIOL, V54, pM34, DOI 10.1093/gerona/54.1.M34; COUILLARD DR, 1994, UROLOGY, V43, P203, DOI 10.1016/0090-4295(94)90045-0; Demarco Eileen, 1994, Journal of Urology, V151, p420A; DIOKNO A, 1995, J UROLOGY, V154, P1727, DOI 10.1016/S0022-5347(01)66768-5; DIOKNO AC, 1988, J UROLOGY, V140, P567, DOI 10.1016/S0022-5347(17)41720-4; Dugan E, 2000, J AM GERIATR SOC, V48, P413, DOI 10.1111/j.1532-5415.2000.tb04699.x; EASTWOOD HDH, 1984, AGE AGEING, V13, P230, DOI 10.1093/ageing/13.4.230; FANTL JA, 1991, JAMA-J AM MED ASSOC, V265, P609, DOI 10.1001/jama.265.5.609; Galloway NTM, 1997, AM J MED SCI, V314, P268, DOI 10.1097/00000441-199710000-00011; Haab F, 1997, J UROLOGY, V158, P1738, DOI 10.1016/S0022-5347(01)64114-4; HILTON P, 1981, BRIT MED J, V282, P940, DOI 10.1136/bmj.282.6268.940; HOLMES DM, 1989, BRIT J OBSTET GYNAEC, V96, P607, DOI 10.1111/j.1471-0528.1989.tb03263.x; JENSEN JK, 1994, OBSTET GYNECOL, V83, P904; Johnson TM, 1997, AM J MED SCI, V314, P250, DOI 10.1097/00000441-199710000-00008; JUMA S, 1992, UROLOGY, V39, P424, DOI 10.1016/0090-4295(92)90238-R; Kaplan SA, 1996, UROLOGY, V47, P885, DOI 10.1016/S0090-4295(96)00062-3; Kinn AC, 1995, SCAND J UROL NEPHROL, V29, P449, DOI 10.3109/00365599509180026; Kondo A, 1998, J UROLOGY, V160, P756, DOI 10.1016/S0022-5347(01)62778-2; KOONINGS PP, 1990, UROLOGY, V36, P245, DOI 10.1016/0090-4295(90)80265-O; Leach GE, 1997, J UROLOGY, V158, P875, DOI 10.1016/S0022-5347(01)64346-5; Litwiller SE, 1997, J UROLOGY, V157, P1279, DOI 10.1016/S0022-5347(01)64950-4; Mason RC, 1996, J UROLOGY, V156, P1991, DOI 10.1016/S0022-5347(01)65412-0; MCGUIRE EJ, 1995, UROL CLIN N AM, V22, P657; Miller JM, 1998, J AM GERIATR SOC, V46, P870, DOI 10.1111/j.1532-5415.1998.tb02721.x; Mostwin JL, 1996, J ENDOUROL, V10, P207, DOI 10.1089/end.1996.10.207; NORTON PA, 1994, OBSTET GYNECOL, V84, P770; OUSLANDER J, 1988, J UROLOGY, V140, P1482, DOI 10.1016/S0022-5347(17)42080-5; OUSLANDER J, 1989, J AM GERIATR SOC, V37, P715, DOI 10.1111/j.1532-5415.1989.tb02232.x; OUSLANDER JG, 1986, J AM GERIATR SOC, V34, P507, DOI 10.1111/j.1532-5415.1986.tb04242.x; PANNILL FC, 1988, J AM GERIATR SOC, V36, P902, DOI 10.1111/j.1532-5415.1988.tb05783.x; Pfister S M, 1994, J Community Health Nurs, V11, P155, DOI 10.1207/s15327655jchn1103_4; RESNICK NM, 1987, JAMA-J AM MED ASSOC, V257, P3076, DOI 10.1001/jama.257.22.3076; RESNICK NM, 1995, LANCET, V346, P94, DOI 10.1016/S0140-6736(95)92117-6; RESNICK NM, 1989, NEW ENGL J MED, V320, P1, DOI 10.1056/NEJM198901053200101; Resnick NM, 1995, NEUROUROL URODYNAM, V14, P577; SAND PK, 1995, AM J OBSTET GYNECOL, V173, P72, DOI 10.1016/0002-9378(95)90172-8; SAND PK, 1987, OBSTET GYNECOL, V69, P399; SCHNELLE JF, 1990, J AM GERIATR SOC, V38, P356, DOI 10.1111/j.1532-5415.1990.tb03521.x; Shekelle PG, 2001, ANN INTERN MED, V135, P647, DOI 10.7326/0003-4819-135-8_Part_2-200110161-00003; Smith JJ, 1996, J UROLOGY, V155, P127, DOI 10.1016/S0022-5347(01)66567-4; SUMMITT RL, 1990, J REPROD MED, V35, P877; Swierzewski Stanley J. Iii, 1994, Journal of Urology, V151, p419A; SWIFT SE, 1996, UROGYNECOLOGY URODYN; SZONYI G, 1995, AGE AGEING, V24, P287, DOI 10.1093/ageing/24.4.287; TAPP AJS, 1990, BRIT J OBSTET GYNAEC, V97, P521, DOI 10.1111/j.1471-0528.1990.tb02523.x; *UR INC AD AC CHRO, 1996, 2 CLIN PRACT GUID UR; WELLS TJ, 1991, J AM GERIATR SOC, V39, P785, DOI 10.1111/j.1532-5415.1991.tb02701.x; WISKIND AK, 1994, OBSTET GYNECOL, V83, P108; Wright EJ, 1998, J UROLOGY, V160, P759, DOI 10.1016/S0022-5347(01)62779-4; Wyman JF, 1998, AM J OBSTET GYNECOL, V179, P999, DOI 10.1016/S0002-9378(98)70206-6; Yamada T, 1998, J UROLOGY, V160, P746, DOI 10.1016/S0022-5347(01)62774-5; ZORZITTO ML, 1989, AGE AGEING, V18, P195, DOI 10.1093/ageing/18.3.195	61	26	26	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 16	2001	135	8	2				752	758		10.7326/0003-4819-135-8_Part_2-200110161-00015	http://dx.doi.org/10.7326/0003-4819-135-8_Part_2-200110161-00015			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	481WA	11601959				2022-12-24	WOS:000171542400015
J	Chisholm, SW; Falkowski, PG; Cullen, JJ				Chisholm, SW; Falkowski, PG; Cullen, JJ			Oceans - Dis-crediting ocean fertilization	SCIENCE			English	Editorial Material							PHYTOPLANKTON BLOOM; CARBON-CYCLE; CO2		MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA; Rutgers State Univ, Dept Geol, New Brunswick, NJ 08901 USA; Dalhousie Univ, Dept Oceanog, Halifax, NS B3H 4J1, Canada	Massachusetts Institute of Technology (MIT); Rutgers State University New Brunswick; Dalhousie University	Chisholm, SW (corresponding author), MIT, Dept Civil & Environm Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	chisholm@mit.edu	Cuillen, John/AAE-1371-2019; Cullen, John J/B-6105-2008	Cuillen, John/0000-0002-7740-0999; Cullen, John J/0000-0002-7740-0999; Chisholm, Sallie/0000-0003-1480-2445				BERNER RA, 1990, SCIENCE, V249, P1382, DOI 10.1126/science.249.4975.1382; Boyd PW, 2000, NATURE, V407, P695, DOI 10.1038/35037500; Carson Rachel, 1951, SEA US; CHISHOLM SW, 1991, LIMNOL OCEANOGR, V36, pU1507; Coale KH, 1996, NATURE, V383, P495, DOI 10.1038/383495a0; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Falkowski P, 2000, SCIENCE, V290, P291, DOI 10.1126/science.290.5490.291; FUHRMAN JA, 1991, LIMNOL OCEANOGR, V36, P1951, DOI 10.4319/lo.1991.36.8.1951; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Jones RR, 1997, ADV ATOM MOL OPT PHY, V38, P1; MARTIN JH, 1994, NATURE, V371, P123, DOI 10.1038/371123a0; MARTIN JH, 1988, NATURE, V331, P341, DOI 10.1038/331341a0; MARTIN JH, 1992, ENVIR SCI R, V43, P123; Ney RA, 2000, ENVIRON SCI TECHNOL, V34, p176A, DOI 10.1021/es003230m; PEARCE F, 2000, NEW SCI         0408, P18; RAWLS R, 2000, CHEM ENG NEWS   0918, P66; SARMIENTO JL, 1991, LIMNOL OCEANOGR, V36, P1928, DOI 10.4319/lo.1991.36.8.1928; Seibel BA, 2001, SCIENCE, V294, P319, DOI 10.1126/science.1065301; Sigman DM, 2000, NATURE, V407, P859, DOI 10.1038/35038000; Smetacek V., 2001, US JGOFS NEWS, V11, P11; 5965117; 5992089; 5535701; 6200530; 20010002983; 5967087; 55433173; 6056919	28	121	124	3	78	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 12	2001	294	5541					309	310		10.1126/science.1065349	http://dx.doi.org/10.1126/science.1065349			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	482WZ	11598285				2022-12-24	WOS:000171601400023
J	Stevens, DR; Seifert, R; Bufe, B; Muller, F; Kremmer, E; Gauss, R; Meyerhof, W; Kaupp, UB; Lindemann, B				Stevens, DR; Seifert, R; Bufe, B; Muller, F; Kremmer, E; Gauss, R; Meyerhof, W; Kaupp, UB; Lindemann, B			Hyperpolarization-activated channels HCN1 and HCN4 mediate responses to sour stimuli	NATURE			English	Article							TASTE CELLS; PACEMAKER CHANNELS; INTRACELLULAR PH; CHORDA TYMPANI; CATION CURRENT; TRANSDUCTION; RAT; HAMSTER; NEURONS; FAMILY	Sour taste is initiated by protons acting at receptor proteins or channels. In vertebrates, transduction of this taste quality involves several parallel pathways(1-5). Here we examine the effects of sour stimuli on taste cells in slices of vallate papilla from rat. From a subset of cells, we identified a hyperpolarization-activated current that was enhanced by sour stimulation at the taste pore. This current resembled Ih found in neurons and cardio-myocytes(6,7), a current carried by members of the family of hyperpolarization-activated and cyclic-nucleotide-gated (HCN) channels(8-13). We show by in situ hybridization and immunohistochemistry that HCN1 and HCN4 are expressed in a subset of taste cells. By contrast, gustducin, the G-protein involved in bitter and sweet taste(14), is not expressed in these cells. Lowering extracellular pH causes a dose-dependent flattening of the activation curve of HCN channels and a shift in the voltage of half-maximal activation to more positive voltages. Our results indicate that HCN channels are gated by extracellular protons and may act as receptors for sour taste.	Univ Saarland, Dept Physiol, D-66421 Homburg, Germany; Forschungszentrum Julich, Inst Biol Informat Proc, D-52425 Julich, Germany; Deutsch Inst Ernahrungsforsch, Dept Mol Genet, D-14558 Potsdam, Germany; GSF, Inst Mol Immunol, D-81377 Munich, Germany	Saarland University; Helmholtz Association; Research Center Julich; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Lindemann, B (corresponding author), Univ Saarland, Dept Physiol, D-66421 Homburg, Germany.	phblin@uniklinik-saarland.de	Mueller, Frank/I-7196-2013; Bufe, Bernd/N-6685-2018	Mueller, Frank/0000-0001-7264-1227; Stevens, David/0000-0003-4651-1706; Bufe, Bernd/0000-0003-1610-0658				Boughter JD, 1997, J NEUROSCI, V17, P2852; DESIMONE JA, 1995, AM J PHYSIOL-CELL PH, V268, pC1295, DOI 10.1152/ajpcell.1995.268.5.C1295; Gauss R, 1998, NATURE, V393, P583, DOI 10.1038/31248; GILBERTSON TA, 1992, J GEN PHYSIOL, V100, P803, DOI 10.1085/jgp.100.5.803; Kaupp UB, 2001, ANNU REV PHYSIOL, V63, P235, DOI 10.1146/annurev.physiol.63.1.235; KINNAMON SC, 1988, P NATL ACAD SCI USA, V85, P7023, DOI 10.1073/pnas.85.18.7023; Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255; Miyamoto T, 1998, J NEUROPHYSIOL, V80, P1852, DOI 10.1152/jn.1998.80.4.1852; Monteggia LM, 2000, MOL BRAIN RES, V81, P129, DOI 10.1016/S0169-328X(00)00155-8; Muller F, 2001, J PHYSIOL-LONDON, V532, P399, DOI 10.1111/j.1469-7793.2001.0399f.x; Munsch T, 1999, J PHYSIOL-LONDON, V519, P493, DOI 10.1111/j.1469-7793.1999.0493m.x; Pape HC, 1996, ANNU REV PHYSIOL, V58, P299, DOI 10.1146/annurev.ph.58.030196.001503; Pittman DW, 1998, BRAIN RES, V790, P224, DOI 10.1016/S0006-8993(98)00059-6; Santoro B, 1999, ANN NY ACAD SCI, V868, P741, DOI 10.1111/j.1749-6632.1999.tb11353.x; Santoro B, 1998, CELL, V93, P717, DOI 10.1016/S0092-8674(00)81434-8; Santoro B, 2000, J NEUROSCI, V20, P5264, DOI 10.1523/JNEUROSCI.20-14-05264.2000; Seifert R, 1999, P NATL ACAD SCI USA, V96, P9391, DOI 10.1073/pnas.96.16.9391; Stewart RE, 1998, AM J PHYSIOL-CELL PH, V275, pC227, DOI 10.1152/ajpcell.1998.275.1.C227; STRIEM B J, 1991, Cellular Physiology and Biochemistry, V1, P46, DOI 10.1159/000154592; Trotier D, 1996, J PHYSIOL-LONDON, V490, P611, DOI 10.1113/jphysiol.1996.sp021171; Ugawa S, 1998, NATURE, V395, P555, DOI 10.1038/26882; Wong GT, 1996, NATURE, V381, P796, DOI 10.1038/381796a0; Zong XG, 2001, J BIOL CHEM, V276, P6313, DOI 10.1074/jbc.M010326200	23	165	177	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 11	2001	413	6856					631	635		10.1038/35098087	http://dx.doi.org/10.1038/35098087			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480WE	11675786				2022-12-24	WOS:000171485700049
J	Epstein, ACR; Gleadle, JM; McNeill, LA; Hewitson, KS; O'Rourke, J; Mole, DR; Mukherji, M; Metzen, E; Wilson, MI; Dhanda, A; Tian, YM; Masson, N; Hamilton, DL; Jaakkola, P; Barstead, R; Hodgkin, J; Maxwell, PH; Pugh, CW; Schofield, CJ; Ratcliffe, PJ				Epstein, ACR; Gleadle, JM; McNeill, LA; Hewitson, KS; O'Rourke, J; Mole, DR; Mukherji, M; Metzen, E; Wilson, MI; Dhanda, A; Tian, YM; Masson, N; Hamilton, DL; Jaakkola, P; Barstead, R; Hodgkin, J; Maxwell, PH; Pugh, CW; Schofield, CJ; Ratcliffe, PJ			C-elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation	CELL			English	Article							INDUCIBLE FACTOR 1-ALPHA; CAENORHABDITIS-ELEGANS; FACTOR-I; ALPHA; PROTEIN; GENE; UBIQUITINATION; EXPRESSION; MECHANISM; BINDING	HIF is a transcriptional complex that plays a central role in mammalian oxygen homeostasis. Recent studies have defined posttranslational modification by prolyl hydroxylation as a key regulatory event that targets HIF-alpha. subunits for proteasomal destruction via the von Hippel-Lindau ubiquitylation complex. Here, we define a conserved HIF-VHL-prolyl hydroxylase pathway in C. elegans, and use a genetic approach to identify EGL-9 as a dioxygenase that regulates HIF by prolyl hydroxylation. In mammalian cells, we show that the HIF-prolyl hydroxylases are represented by a series of isoforms bearing a conserved 2-histidine-1-carboxylate iron coordination motif at the catalytic site. Direct modulation of recombinant enzyme activity by graded hypoxia, iron chelation, and cobaltous ions mirrors the characteristics of HIF induction in vivo, fulfilling requirements for these enzymes being oxygen sensors that regulate HIF.	Oxford Ctr Mol Sci, Oxford OX1 3QY, England; Dyson Perrins Lab, Oxford OX1 3QY, England; Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA; Univ Oxford, Dept Biochem, Genet Unit, Oxford OX1 3QU, England	University of Oxford; University of Oxford; Oklahoma Medical Research Foundation; University of Oxford	Ratcliffe, PJ (corresponding author), Henry Wellcome Bldg Genom Med,Roosevelt Dr, Oxford OX3 7BN, England.	peter.ratcliffe@imm.ox.ac.uk	Knowles, Helen/F-3857-2018; Jaakkola, Panu M/B-4355-2012; Gleadle, Jonathan M/K-4188-2012; Maxwell, Patrick H/C-5557-2008	Knowles, Helen/0000-0002-9575-6067; Gleadle, Jonathan M/0000-0002-5215-7208; Maxwell, Patrick H/0000-0002-0338-2679; Mole, David/0000-0002-0984-300X; Pugh, Chris/0000-0002-5170-1662; Jaakkola, Panu/0000-0002-2365-4985; Schofield, Christopher/0000-0002-0290-6565; Ratcliffe, Peter/0000-0002-2853-806X				BARTON GJ, 1993, PROTEIN ENG, V6, P37, DOI 10.1093/protein/6.1.37; Berra E, 2001, FEBS LETT, V491, P85, DOI 10.1016/S0014-5793(01)02159-7; Cockman ME, 2000, J BIOL CHEM, V275, P25733, DOI 10.1074/jbc.M002740200; Darby C, 1999, P NATL ACAD SCI USA, V96, P15202, DOI 10.1073/pnas.96.26.15202; Dupuy D, 2000, GENOMICS, V69, P348, DOI 10.1006/geno.2000.6343; Hegg EL, 1997, EUR J BIOCHEM, V250, P625, DOI 10.1111/j.1432-1033.1997.t01-1-00625.x; Huang LE, 1999, J BIOL CHEM, V274, P9038, DOI 10.1074/jbc.274.13.9038; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jiang BH, 1996, AM J PHYSIOL-CELL PH, V271, pC1172, DOI 10.1152/ajpcell.1996.271.4.C1172; Jiang HQ, 2001, P NATL ACAD SCI USA, V98, P7916, DOI 10.1073/pnas.141234698; Kamura T, 2000, P NATL ACAD SCI USA, V97, P10430, DOI 10.1073/pnas.190332597; Kivirikko KI, 1998, MATRIX BIOL, V16, P357, DOI 10.1016/S0945-053X(98)90009-9; Lipscomb EA, 2001, J BIOL CHEM, V276, P5085, DOI 10.1074/jbc.M008407200; Lloyd MD, 1999, J MOL BIOL, V287, P943, DOI 10.1006/jmbi.1999.2594; Madden SL, 1996, CANCER RES, V56, P5384; Masson N, 2001, EMBO J, V20, P5197, DOI 10.1093/emboj/20.18.5197; Maxwell PH, 2001, CURR OPIN GENET DEV, V11, P293, DOI 10.1016/S0959-437X(00)00193-3; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Mukherji M, 2001, CHEM COMMUN, P972, DOI 10.1039/b101039p; O'Rourke JF, 1999, J BIOL CHEM, V274, P2060, DOI 10.1074/jbc.274.4.2060; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Palmer LA, 2000, MOL PHARMACOL, V58, P1197, DOI 10.1124/mol.58.6.1197; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; Schofield CJ, 1999, CURR OPIN STRUC BIOL, V9, P722, DOI 10.1016/S0959-440X(99)00036-6; Semenza GL, 2000, GENE DEV, V14, P1983; Semenza GL, 1999, CELL, V98, P281, DOI 10.1016/S0092-8674(00)81957-1; Semenza GL, 2000, J APPL PHYSIOL, V88, P1474, DOI 10.1152/jappl.2000.88.4.1474; Sutter CH, 2000, P NATL ACAD SCI USA, V97, P4748, DOI 10.1073/pnas.080072497; Tanimoto K, 2000, EMBO J, V19, P4298, DOI 10.1093/emboj/19.16.4298; TRENT C, 1983, GENETICS, V104, P619; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; WAX SD, 1994, J BIOL CHEM, V269, P13041; Wenger RH, 2000, J EXP BIOL, V203, P1253; Woodward ER, 2000, GENOMICS, V65, P253, DOI 10.1006/geno.2000.6144; Wu M, 1999, J AM CHEM SOC, V121, P587, DOI 10.1021/ja981193h; Zhang ZH, 2000, NAT STRUCT BIOL, V7, P127; Zhou J, 1998, J AM CHEM SOC, V120, P13539, DOI 10.1021/ja983534x; Zhu H, 2001, SCIENCE, V292, P449, DOI 10.1126/science.1060849	40	2610	2729	3	162	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 5	2001	107	1					43	54		10.1016/S0092-8674(01)00507-4	http://dx.doi.org/10.1016/S0092-8674(01)00507-4			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	480GF	11595184	Bronze			2022-12-24	WOS:000171453100008
J	Ritz, D; Lim, J; Reynolds, CM; Poole, LB; Beckwith, J				Ritz, D; Lim, J; Reynolds, CM; Poole, LB; Beckwith, J			Conversion of a peroxiredoxin into a disulfide reductase by a triplet repeat expansion	SCIENCE			English	Article							ALKYL HYDROPEROXIDE REDUCTASE; ESCHERICHIA-COLI CYTOPLASM; OXIDATIVE STRESS; SALMONELLA-TYPHIMURIUM; FRAMESHIFT MUTATION; PEROXIDE REDUCTION; PHASE VARIATION; HYDROGEN DONOR; BOND FORMATION; THIOREDOXIN	Pathways for the reduction of protein disulfide bonds are found in all organisms and are required for the reductive recycling of certain enzymes including the essential protein ribonucleotide reductase. An Escherichia coli strain that lacks both thioredoxin reductase and glutathione reductase grows extremely poorly. Here, we show that a mutation occurring at high frequencies in the gene ahpC, encoding a peroxiredoxin, restores normal growth to this strain. This mutation is the result of a reversible expansion of a triplet nucleotide repeat sequence, leading to the addition of one amino acid that converts the AhpC protein from a peroxidase to a disulfide reductase. The ready mutational interconversion between the two activities could provide an evolutionary advantage to E. coli.	Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA; Wake Forest Univ, Bowman Gray Sch Med, Dept Biochem, Winston Salem, NC 27157 USA	Harvard University; Harvard Medical School; Wake Forest University; Wake Forest Baptist Medical Center	Beckwith, J (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, 200 Longwood Ave, Boston, MA 02115 USA.			Poole, Leslie/0000-0003-0334-7328	NIGMS NIH HHS [R01 GM050389, R001 GM55090, R01 GM50389] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055090, R01GM050389] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aslund F, 1999, P NATL ACAD SCI USA, V96, P6161, DOI 10.1073/pnas.96.11.6161; Aslund F, 1999, CELL, V96, P751, DOI 10.1016/S0092-8674(00)80584-X; ASLUND F, 1994, P NATL ACAD SCI USA, V91, P9813, DOI 10.1073/pnas.91.21.9813; Bessette PH, 1999, P NATL ACAD SCI USA, V96, P13703, DOI 10.1073/pnas.96.24.13703; Calzi ML, 1997, BIOCHEMISTRY-US, V36, P13357, DOI 10.1021/bi9713660; Carmel-Harel O, 2000, ANNU REV MICROBIOL, V54, P439, DOI 10.1146/annurev.micro.54.1.439; Carroll PA, 1997, MOL MICROBIOL, V25, P1099, DOI 10.1046/j.1365-2958.1997.5371901.x; Ellis HR, 1997, BIOCHEMISTRY-US, V36, P13349, DOI 10.1021/bi9713658; Hardy J, 1998, SCIENCE, V282, P1075, DOI 10.1126/science.282.5391.1075; Harvey SC, 1997, BIOCHEMISTRY-US, V36, P3047, DOI 10.1021/bi962771e; HOLMGREN A, 1989, J BIOL CHEM, V264, P13963; Lillig CH, 1999, J BIOL CHEM, V274, P7695, DOI 10.1074/jbc.274.12.7695; Lowther WT, 2000, P NATL ACAD SCI USA, V97, P6463, DOI 10.1073/pnas.97.12.6463; Park SF, 2000, J BACTERIOL, V182, P207, DOI 10.1128/JB.182.1.207-210.2000; Poole LB, 2000, BIOCHEMISTRY-US, V39, P6602, DOI 10.1021/bi000405w; Poole LB, 2000, FREE RADICAL BIO MED, V28, P108, DOI 10.1016/S0891-5849(99)00218-X; Prinz WA, 1997, J BIOL CHEM, V272, P15661, DOI 10.1074/jbc.272.25.15661; REYNOLDS AE, 1981, NATURE, V293, P625, DOI 10.1038/293625a0; Ritz D, 2000, J BIOL CHEM, V275, P2505, DOI 10.1074/jbc.275.4.2505; RUSSEL M, 1990, J BACTERIOL, V172, P1923, DOI 10.1128/jb.172.4.1923-1929.1990; Shi J, 1999, J BIOL CHEM, V274, P36039, DOI 10.1074/jbc.274.51.36039; Stewart EJ, 1998, EMBO J, V17, P5543, DOI 10.1093/emboj/17.19.5543; STORZ G, 1989, J BACTERIOL, V171, P2049, DOI 10.1128/jb.171.4.2049-2055.1989; Theiss P, 1997, J BACTERIOL, V179, P4013, DOI 10.1128/jb.179.12.4013-4022.1997; Warren ST, 1996, SCIENCE, V271, P1374, DOI 10.1126/science.271.5254.1374; Wood ZA, 2001, BIOCHEMISTRY-US, V40, P3900, DOI 10.1021/bi002765p	26	98	101	2	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 5	2001	294	5540					158	160		10.1126/science.1063143	http://dx.doi.org/10.1126/science.1063143			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480EJ	11588261				2022-12-24	WOS:000171448800051
J	Beaufort, L; de Garidel-Thoron, T; Mix, AC; Pisias, NG				Beaufort, L; de Garidel-Thoron, T; Mix, AC; Pisias, NG			ENSO-like forcing on oceanic primary production during the Late Pleistocene	SCIENCE			English	Article							INDIAN-OCEAN; EQUATORIAL PACIFIC; TROPICAL CLIMATE; VARIABILITY; DYNAMICS; ATLANTIC; MONSOON; AGE	Late Pleistocene changes in oceanic primary productivity along the equator in the Indian and Pacific oceans are revealed by quantitative changes in nanoplankton communities preserved in nine deep-sea cores. We show that variations in equatorial productivity are primarily caused by glacial-interglacial variability and by precession-controlled changes in the east-west thermodine slope of the Indo-Pacific. The precession-controlled variations in productivity are linked to processes similar to the Southern Oscillation phenomenon, and they precede changes in the oxygen isotopic ratio, which indicates that they are not the result of ice sheet fluctuations. The 30,000-year spectral peak in the tropical Indo-Pacific Ocean productivity records is also present in the Antarctica atmospheric CO2 record, suggesting an important rote for equatorial biological productivity in modifying atmospheric CO2.	CNRS, CEREGE, F-13545 Aix En Provence 04, France; Oregon State Univ, Coll Oceanog & Atmospher Sci, Corvallis, OR 97331 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Oregon State University	Beaufort, L (corresponding author), CNRS, CEREGE, BP 80, F-13545 Aix En Provence 04, France.		Beaufort, Luc/ABG-2289-2021; de Garidel-Thoron, Thibault/B-1204-2008; Beaufort, Luc/AAH-5305-2021	Beaufort, Luc/0000-0001-6055-9373; de Garidel-Thoron, Thibault/0000-0001-8983-9571; 				Bard E, 1997, NATURE, V385, P707, DOI 10.1038/385707a0; BASSINOT FC, 1994, EARTH PLANET SC LETT, V126, P91, DOI 10.1016/0012-821X(94)90244-5; Beaufort L, 1997, SCIENCE, V278, P1451, DOI 10.1126/science.278.5342.1451; Charles CD, 1997, SCIENCE, V277, P925, DOI 10.1126/science.277.5328.925; CLEMENS S, 1991, NATURE, V353, P720, DOI 10.1038/353720a0; Clement AC, 1999, PALEOCEANOGRAPHY, V14, P441, DOI 10.1029/1999PA900013; Cole JE, 2000, SCIENCE, V287, P617, DOI 10.1126/science.287.5453.617; Dollfus D, 1999, NEURAL NETWORKS, V12, P553, DOI 10.1016/S0893-6080(99)00011-8; EDWARDS RL, 1987, SCIENCE, V236, P1547, DOI 10.1126/science.236.4808.1547; Fedorov AV, 2000, SCIENCE, V288, P1997, DOI 10.1126/science.288.5473.1997; Flenley JR, 1998, CLIMATIC CHANGE, V39, P177, DOI 10.1023/A:1005367822750; GALLUP CD, 1994, SCIENCE, V263, P796, DOI 10.1126/science.263.5148.796; Harris SE, 1999, QUATERNARY RES, V51, P14, DOI 10.1006/qres.1998.2008; Henderson GM, 2000, NATURE, V404, P61, DOI 10.1038/35003541; Lea DW, 2000, SCIENCE, V289, P1719, DOI 10.1126/science.289.5485.1719; LEWIS MR, 1986, SCIENCE, V234, P870, DOI 10.1126/science.234.4778.870; MEEHL GA, 1993, J CLIMATE, V6, P31, DOI 10.1175/1520-0442(1993)006<0031:ACASBM>2.0.CO;2; Mix AC, 1999, PALEOCEANOGRAPHY, V14, P350, DOI 10.1029/1999PA900012; Mix AC, 1986, PALEOCEANOGRAPHY, V1, P43, DOI 10.1029/PA001i001p00043; MOLFINO B, 1990, SCIENCE, V249, P766, DOI 10.1126/science.249.4970.766; OKADA H, 1973, DEEP-SEA RES, V20, P355, DOI 10.1016/0011-7471(73)90059-4; Paillard D., 1996, EOS T AM GEOPHYS UN, V77, P379, DOI 10.1029/96EO00259; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Pisias NG, 1997, PALEOCEANOGRAPHY, V12, P381, DOI 10.1029/97PA00583; POKRAS EM, 1987, NATURE, V326, P486, DOI 10.1038/326486a0; PRELL WL, 1984, MILANKOVITCH CLIMATE, V1, P349; Reichart GJ, 1998, PALEOCEANOGRAPHY, V13, P607, DOI 10.1029/98PA02203; Rich JJ, 1999, GLOBAL BIOGEOCHEM CY, V13, P531, DOI 10.1029/1998GB900023; Saji NH, 1999, NATURE, V401, P360, DOI 10.1038/43854; Tudhope AW, 2001, SCIENCE, V291, P1511, DOI 10.1126/science.1057969; Turk D, 2001, SCIENCE, V293, P471, DOI 10.1126/science.1056449; Villanueva J, 1998, PALEOCEANOGRAPHY, V13, P561, DOI 10.1029/98PA02318; Webster PJ, 1999, NATURE, V401, P356, DOI 10.1038/43848; [No title captured]	34	228	269	2	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 28	2001	293	5539					2440	2444		10.1126/science.293.5539.2440	http://dx.doi.org/10.1126/science.293.5539.2440			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	476PD	11577233				2022-12-24	WOS:000171237200043
J	Zhang, PC; Keleshian, AM; Sachs, F				Zhang, PC; Keleshian, AM; Sachs, F			Voltage-induced membrane movement	NATURE			English	Article							OUTER HAIR CELL; ATOMIC-FORCE MICROSCOPY; LIPID BILAYER; ION CHANNELS; SALICYLATE; MOTILITY; MODEL; ELECTROMOTILITY; CAPACITANCE; POTENTIALS	Thermodynamics predicts that transmembrane voltage modulates membrane tension(1) and that this will cause movement. The magnitude and polarity of movement is governed by cell stiffness and surface potentials. Here we confirm these predictions using the atomic force microscope to dynamically follow the movement of voltage-clamped HEK293 cells(2) in different ionic-strength solutions. In normal saline, depolarization caused an outward movement, and at low ionic strength an inward movement. The amplitude was proportional to voltage (about 1 nm per 100 mV) and increased with indentation depth. A simple physical model of the membrane and tip provided an estimate of the external and internal surface charge densities (-5 x10(-3) C m(-2) and -18x10(-3) C m(-2), respectively). Salicylate (a negative amphiphile(3)) inhibited electromotility by increasing the external charge density by -15x10(-3) C m(-2). As salicylate blocks electromotility in cochlear outer hair cells at the same concentration(4,5), the role of prestin as a motor protein(6) may need to be reassessed.	SUNY Buffalo, HHMI Ctr Single Mol Biophys, Buffalo, NY 14214 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Sachs, F (corresponding author), SUNY Buffalo, HHMI Ctr Single Mol Biophys, Buffalo, NY 14214 USA.		Zhang, Ping-Cheng/G-7862-2011					Akinlaja J, 1998, BIOPHYS J, V75, P247, DOI 10.1016/S0006-3495(98)77511-3; Bockris J. O. M., 1973, MODERN ELECTROCHEMIS, V2; CARNIE S, 1983, BIOPHYS J, V44, P325, DOI 10.1016/S0006-3495(83)84306-9; Carslaw H.S., 1986, CONDUCTION HEAT SOLI; Chou T, 1997, BIOPHYS J, V72, P2042, DOI 10.1016/S0006-3495(97)78848-9; GUTKNECHT J, 1973, SCIENCE, V182, P1258, DOI 10.1126/science.182.4118.1258; Hille B., 1992, IONIC CHANNELS EXCIT; Hwang WC, 1997, BIOPHYS J, V72, P2669, DOI 10.1016/S0006-3495(97)78910-0; IWASA K, 1980, SCIENCE, V210, P338, DOI 10.1126/science.7423196; Iwasa KH, 1997, BIOPHYS J, V73, P546, DOI 10.1016/S0006-3495(97)78092-5; Kakehata S, 1996, J NEUROSCI, V16, P4881; KRAAYENHOF R, 1993, BIOCHEMISTRY-US, V32, P10057, DOI 10.1021/bi00089a022; Lue AJC, 1999, HEARING RES, V135, P163, DOI 10.1016/S0378-5955(99)00102-1; Maingret F, 1999, J BIOL CHEM, V274, P1381, DOI 10.1074/jbc.274.3.1381; MARKIN VS, 1991, BIOPHYS J, V60, P1120, DOI 10.1016/S0006-3495(91)82147-6; MCLAUGHLIN S, 1973, NATURE, V203, P234; Mosbacher J, 1998, J GEN PHYSIOL, V111, P65, DOI 10.1085/jgp.111.1.65; Oliver D, 2001, SCIENCE, V292, P2340, DOI 10.1126/science.1060939; PETROV AG, 1993, EUR BIOPHYS J BIOPHY, V22, P289, DOI 10.1007/BF00180263; Raphael RM, 2000, BIOPHYS J, V78, P2844, DOI 10.1016/S0006-3495(00)76827-5; SANTOS-SACCHI J, 1991, J NEUROSCI, V11, P3096, DOI 10.1523/jneurosci.11-10-03096.1991; SHEHATA WE, 1991, ACTA OTO-LARYNGOL, V111, P707, DOI 10.3109/00016489109138403; SHIH CW, 1992, J MATER RES, V7, P1011, DOI 10.1557/JMR.1992.1011; SINGH AK, 1992, BIOCHIM BIOPHYS ACTA, V1120, P337, DOI 10.1016/0167-4838(92)90257-E; TODOROV AT, 1994, LANGMUIR, V10, P2344, DOI 10.1021/la00019a053; WINISKI AP, 1986, BIOCHEMISTRY-US, V25, P8206, DOI 10.1021/bi00373a013; Wu HW, 1998, SCANNING, V20, P389; Wu M, 1998, J MEMBRANE BIOL, V166, P111, DOI 10.1007/s002329900453; Yamaguchi T, 1997, COLLOID SURFACE B, V9, P275, DOI 10.1016/S0927-7765(97)00033-7; Zheng J, 2000, NATURE, V405, P149, DOI 10.1038/35012009	30	172	177	3	48	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 27	2001	413	6854					428	432		10.1038/35096578	http://dx.doi.org/10.1038/35096578			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475UY	11574890				2022-12-24	WOS:000171188700056
J	Gingerich, PD; ul Haq, M; Zalmout, IS; Khan, IH; Malkani, MS				Gingerich, PD; ul Haq, M; Zalmout, IS; Khan, IH; Malkani, MS			Origin of whales from early artiodactyls: Hands and feet of eocene Protocetidae from Pakistan	SCIENCE			English	Article							PHYLOGENETIC-RELATIONSHIPS; EARLIEST CETACEANS; MOLECULAR EVIDENCE; PRINCIPLES; DIACODEXIS; INCLUSION; RELATIVES; EVOLUTION	Partial skeletons of two new fossil whales, Artiocetus clavis and Rodhocetus balochistanensis, are among the oldest known protocetid archaeocetes. These came from early Lutetian age (47 million years ago) strata in eastern Balochistan Province, Pakistan. Both have an astragalus and cuboid in the ankle with characteristics diagnostic of artiodactyls; R. balochistanensis has virtually complete fore- and hind limbs. The new skeletons are important in augmenting the diversity of early Protocetidae, clarifying that Cetacea evolved from early Artiodactyla rather than Mesonychia and showing how early protocetids swam.	Univ Michigan, Dept Geol Sci, Ann Arbor, MI 48109 USA; Univ Michigan, Museum Paleontol, Ann Arbor, MI 48109 USA; Geol Survey Pakistan, Quetta, Pakistan; Univ New Hampshire, Dept Earth Sci, Durham, NH 03824 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University System Of New Hampshire; University of New Hampshire	Gingerich, PD (corresponding author), Univ Michigan, Dept Geol Sci, 1006 CC Little Bldg, Ann Arbor, MI 48109 USA.	girigeric@umich.edu	Gingerich, Philip D/A-6903-2008	Gingerich, Philip D/0000-0002-1550-2674				Arnason U, 2000, J MOL EVOL, V50, P569, DOI 10.1007/s002390010060; Bajpai S, 1998, P NATL ACAD SCI USA, V95, P15464, DOI 10.1073/pnas.95.26.15464; Berggren WA, 1995, GEOCHRONOLOGY TIME S, V54, P129, DOI DOI 10.2110/PEC.95.04.0129; BOYDEN ALAN, 1950, ZOOL [NEW YORK], V35, P145; Colbert E.H., 1935, AM MUS NOVIT, V799, P1; FORDYCE RE, 1994, ANNU REV EARTH PL SC, V22, P419, DOI 10.1146/annurev.ea.22.050194.002223; Gatesy J, 1996, MOL BIOL EVOL, V13, P954, DOI 10.1093/oxfordjournals.molbev.a025663; Gatesy J, 1999, SYST BIOL, V48, P6, DOI 10.1080/106351599260409; GINGERICH PD, 1990, SCIENCE, V249, P154, DOI 10.1126/science.249.4965.154; Gingerich PD, 1998, ADV VERT PALEOBIOL, P423; GINGERICH PD, 1983, SCIENCE, V220, P403, DOI 10.1126/science.220.4595.403; GINGERICH PD, 1994, NATURE, V368, P844, DOI 10.1038/368844a0; Gingerich Philip D., 1995, Contributions from the Museum of Paleontology University of Michigan, V29, P291; GRAUR D, 1994, MOL BIOL EVOL, V11, P357; Hardenbol J., 1998, SEPM SPEC PUBL, V60, P3, DOI DOI 10.2110/PEC.98.02.0003; Irwin David M., 1994, Journal of Mammalian Evolution, V2, P37, DOI 10.1007/BF01464349; Kleineidam RG, 1999, J MOL EVOL, V48, P360, DOI 10.1007/PL00006480; Kowalevsky W., 1873, PHILOS T ROY SOC LON, V163, P19; Liu FGR, 1999, SYST BIOL, V48, P54, DOI 10.1080/106351599260436; Luckett W. Patrick, 1998, Journal of Mammalian Evolution, V5, P127, DOI 10.1023/A:1020501622015; Lum JK, 2000, MOL BIOL EVOL, V17, P1417, DOI 10.1093/oxfordjournals.molbev.a026242; Luo Z., 1999, U MICHIGAN PAPERS PA, V31, P1; MCKENNA MC, 1997, CLASSIFICATION MAMMA, P366; Montgelard C, 1997, MOL BIOL EVOL, V14, P550, DOI 10.1093/oxfordjournals.molbev.a025792; Naylor GJP, 2001, SYST BIOL, V50, P444, DOI 10.1080/106351501300318030; Nikaido M, 1999, P NATL ACAD SCI USA, V96, P10261, DOI 10.1073/pnas.96.18.10261; O'Leary MA, 1999, SYST BIOL, V48, P455, DOI 10.1080/106351599260102; ROSE KD, 1982, SCIENCE, V216, P621, DOI 10.1126/science.216.4546.621; Rose KD, 1996, P NATL ACAD SCI USA, V93, P1705, DOI 10.1073/pnas.93.4.1705; SARICH VM, 1993, MAMMAL PHYLOGENY : PLACENTALS, P103; Schaeffer Bobb, 1947, AMER MUS NOVITATES, V1356, P1; Scott W. B., 1940, Transactions of the American Philosophical Society Philadelphia, V28, P363, DOI 10.2307/1005504; SCOTT WB, 1894, J ACAD NAT SCI-PHILA, V9, P461; Shimamura M, 1997, NATURE, V388, P666, DOI 10.1038/41759; SIMPSON GG, 1945, B AM MUS NAT HIST, V85, P1; SZALAY FS, 1969, EVOLUTION, V23, P703, DOI 10.1111/j.1558-5646.1969.tb03552.x; Thewissen J.G.M., 1996, Courier Forschungsinstitut Senckenberg, V191, P1; Thewissen J. G. M., 1994, Journal of Mammalian Evolution, V2, P157, DOI 10.1007/BF01473527; Thewissen JGM, 1997, PALEOBIOLOGY, V23, P482, DOI 10.1017/S0094837300019850; THEWISSEN JGM, 1994, SCIENCE, V263, P210, DOI 10.1126/science.263.5144.210; THEWISSEN JGM, 1990, ANAT HISTOL EMBRYOL, V19, P37, DOI 10.1111/j.1439-0264.1990.tb00876.x; Thewissen JGM, 1998, NATURE, V395, P452, DOI 10.1038/26656; Thewissen JGM, 1999, SYST BIOL, V48, P21, DOI 10.1080/106351599260418; Ursing BM, 1998, P ROY SOC B-BIOL SCI, V265, P2251, DOI 10.1098/rspb.1998.0567; VAN VALEN LEIGH, 1966, BULL AMER MUS NATUR HIST, V132, P1; WEBB PW, 1988, AM ZOOL, V28, P709	46	229	247	5	101	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 21	2001	293	5538					2239	2242		10.1126/science.1063902	http://dx.doi.org/10.1126/science.1063902			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475AL	11567134				2022-12-24	WOS:000171139400039
J	Griffiths, EK; Krawczyk, C; Kong, YY; Raab, M; Hyduk, SJ; Bouchard, D; Chan, VS; Kozieradzki, I; Oliveira-Dos-Santos, AJ; Wakeham, A; Ohashi, PS; Cybulsky, MI; Rudd, CE; Penninger, JM				Griffiths, EK; Krawczyk, C; Kong, YY; Raab, M; Hyduk, SJ; Bouchard, D; Chan, VS; Kozieradzki, I; Oliveira-Dos-Santos, AJ; Wakeham, A; Ohashi, PS; Cybulsky, MI; Rudd, CE; Penninger, JM			Positive regulation of T cell activation and integrin adhesion by the adapter Fyb/Slap	SCIENCE			English	Article							INTERLEUKIN-2 PRODUCTION; ENA/VASP PROTEINS; TYROSINE KINASES; IMMUNE-SYSTEM; DRIVING-FORCE; RECEPTOR; SLP-76; FYN; SLAP-130; CLONING	The molecular adapter Fyb/Slap regulates signaling downstream of the T cell receptor (TCR), but whether it plays a positive or negative role is controversial. We demonstrate that Fyb/Slap-deficient T cells exhibit defective proliferation and cytokine production in response to TCR stimulation. Fyb/Slap is also required in vivo for T cell-dependent immune responses. Functionally, Fyb/Slap has no apparent role in the activation of known TCR signaling pathways, F-actin polymerization, or TCR clustering. Rather, Fyb/Slap regulates TCR-induced integrin clustering and adhesion. Thus, Fyb/Slap is the first molecular adapter to be identified that couples TCR stimulation to the avidity modulation of integrins governing T cell adhesion.	Amgen Inst, Toronto, ON M5G 2C1, Canada; Univ Hlth Network, Ontario Canc Inst, Toronto, ON M5G 2M9, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada; Univ Toronto, Dept Immunol, Toronto, ON M5G 2M9, Canada; Dana Farber Canc Inst, Div Tumor Immunol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Univ Toronto, Toronto Gen Hosp, Res Inst, Dept Lab Med & Pathobiol, Toronto, ON M5G 1L7, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Penninger, JM (corresponding author), Amgen Inst, 620 Univ Ave, Toronto, ON M5G 2C1, Canada.		Rudd, Christopher E/ABF-7259-2021; Cybulsky, Myron I./AAD-6539-2019; Penninger, Josef M/I-6860-2013; Rudd, Christopher E/GOH-2021-2022; Chan, Vera Sau Fong/B-3419-2011	Penninger, Josef M/0000-0002-8194-3777; Rudd, Christopher E/0000-0001-5295-9019; Hyduk, Sharon J./0000-0003-2862-0300; Cybulsky, Myron/0000-0002-1696-2867; Ohashi, Pamela S./0000-0003-2915-9317				Bachmann MF, 1999, J IMMUNOL, V163, P137; Bear JE, 2000, CELL, V101, P717, DOI 10.1016/S0092-8674(00)80884-3; Boerth NJ, 2000, J BIOL CHEM, V275, P5143, DOI 10.1074/jbc.275.7.5143; Chan JR, 2000, J IMMUNOL, V164, P746, DOI 10.4049/jimmunol.164.2.746; Clements JL, 1999, ANNU REV IMMUNOL, V17, P89, DOI 10.1146/annurev.immunol.17.1.89; Clements JL, 1998, SCIENCE, V281, P416, DOI 10.1126/science.281.5375.416; DaSilva AJ, 1997, P NATL ACAD SCI USA, V94, P7493, DOI 10.1073/pnas.94.14.7493; Dustin ML, 2000, CELL, V103, P283, DOI 10.1016/S0092-8674(00)00120-3; DUSTIN ML, 1989, NATURE, V341, P619, DOI 10.1038/341619a0; Fischer KD, 1998, CURR BIOL, V8, P554, DOI 10.1016/S0960-9822(98)70224-6; GENG L, IN PRESS P NATL ACAD; Kolanus W, 1997, CURR OPIN CELL BIOL, V9, P725, DOI 10.1016/S0955-0674(97)80127-5; Krause M, 2000, J CELL BIOL, V149, P181, DOI 10.1083/jcb.149.1.181; Krawczyk C, 2000, IMMUNITY, V13, P463, DOI 10.1016/S1074-7613(00)00046-7; Machesky LM, 2000, CELL, V101, P685, DOI 10.1016/S0092-8674(00)80879-X; Musci MA, 1997, J BIOL CHEM, V272, P11674, DOI 10.1074/jbc.272.18.11674; Pivniouk V, 1998, CELL, V94, P229, DOI 10.1016/S0092-8674(00)81422-1; Raab M, 1999, J BIOL CHEM, V274, P21170, DOI 10.1074/jbc.274.30.21170; Rudd CE, 1999, CELL, V96, P5, DOI 10.1016/S0092-8674(00)80953-8; Shimizu Y, 1999, ADV IMMUNOL, V72, P325, DOI 10.1016/S0065-2776(08)60024-3; van Kooyk Y, 2000, CURR OPIN CELL BIOL, V12, P542, DOI 10.1016/S0955-0674(00)00129-0; VAN SG, 1990, J IMMUNOL, V144, P4579; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Veale M, 1999, J BIOL CHEM, V274, P28427, DOI 10.1074/jbc.274.40.28427; Wange RL, 1996, IMMUNITY, V5, P197, DOI 10.1016/S1074-7613(00)80315-5; Yablonski D, 1998, SCIENCE, V281, P413, DOI 10.1126/science.281.5375.413	26	240	246	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 21	2001	293	5538					2260	2263		10.1126/science.1063397	http://dx.doi.org/10.1126/science.1063397			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475AL	11567140				2022-12-24	WOS:000171139400045
J	Losick, R; Sonenshein, AL				Losick, R; Sonenshein, AL			Molecular biology - Turning gene regulation on its head	SCIENCE			English	Editorial Material							BIOSYNTHESIS		Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Tufts Univ, Sch Med, Dept Mol Biol & Microbiol, Boston, MA 02111 USA	Harvard University; Tufts University	Losick, R (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.							ANSTON AA, 1999, NATURE, V401, P235; GOLLNICK P, IN PRESS BACILLUS SU; GRUNDY FJ, 1994, J MOL BIOL, V235, P798, DOI 10.1006/jmbi.1994.1038; Sarsero JP, 2000, P NATL ACAD SCI USA, V97, P2656, DOI 10.1073/pnas.050578997; STEINBERG W, 1974, J BACTERIOL, V117, P1023, DOI 10.1128/JB.117.3.1023-1034.1974; Valbuzzi A, 2001, SCIENCE, V293, P2057, DOI 10.1126/science.1062187; YANOFSKY C, 1987, ESCHERICHIA COLI SAL, V2, P1453	7	3	3	1	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 14	2001	293	5537					2018	2019		10.1126/science.1064982	http://dx.doi.org/10.1126/science.1064982			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473FB	11557871				2022-12-24	WOS:000171028700052
J	Lawlor, DA; Ebrahim, S; Smith, GD				Lawlor, DA; Ebrahim, S; Smith, GD			Sex matters: secular and geographical trends in sex differences in coronary heart disease mortality	BRITISH MEDICAL JOURNAL			English	Article							DIETARY-FAT; CARDIOVASCULAR-DISEASE; RISK-FACTORS; CHOLESTEROL; CONSUMPTION; WOMEN; RATES; MEN	Objective To examine secular trends and geographical variations in sex differences in mortality from coronary heart disease and investigate how these relate to distributions in risk factors. Design National and international data were used to examine secular trends and geographical variations in sex differences in mortality from coronary heart disease and risk factors. Setting England and Wales, 1921-98; Australia, France,japan, Sweden, and the United States, 1947-97; 50 countries, 1992-6. Data sources Office for National Statistics, World Health Organization, and Food and Agriculture Organization of the United Nations. Results The 20th century epidemic of coronary heart disease affected only men in most industrialised countries and had a very rapid onset in England and Wales, which has been examined in detail. If this male only epidemic had not occurred there would have been 1.2 million fewer deaths from coronary heart disease in men in England and Wales over the past 50 years. Secular trends in mean per capita fat consumption show a similar pattern to secular trends in coronary heart disease mortality in mn. Fat consumption is positively correlated with coronary heart disease mortality in men (r,=0.79; 95% confidence interval 0.70 to 0.86) and inversely associated with coronary heart disease mortality in women (-0.30; -0.49 to -0.08) over this time. Although sex ratios for mortality from coronary heart disease show a clear period effect, those for lung cancer show a cohort effect. Sex ratios for stroke mortality were constant and close to unity for the entire period. Geographical variations in the sex ratio for coronary heart disease were associated with mean per capita fat consumption (0.64; 0.44 to 0.78) but were not associated with the sex ratio for smoking. Conclusion Sex differences are largely the result of environmental factors and hence not inevitable. Understanding the factors that determine sex differences has important implications for public health, particularly for countries and parts of countries where the death rates for coronary heart disease are currently increasing.	Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England	University of Bristol	Lawlor, DA (corresponding author), Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England.		Davey Smith, George/A-7407-2013	Davey Smith, George/0000-0002-1407-8314; Lawlor, Debbie A/0000-0002-6793-2262				*ADV PAN DIET REL, 1974, DIET COR HEART DIS; ANDERSON TW, 1973, JAMA-J AM MED ASSOC, V224, P336; Britton A, 2000, J EPIDEMIOL COMMUN H, V54, P328, DOI 10.1136/jech.54.5.328; CHARLES N, 1997, WOMEN FOOD FAMILIES; CHARLTON J, 1997, HLTH ADULT BRITAIN 1, P17; Charlton J, 1997, HLTH ADULT BRITAIN 1; CLIFTON PM, 1992, ARTERIOSCLER THROMB, V12, P955, DOI 10.1161/01.ATV.12.8.955; COOPER S, 1986, AGE AUSTERITY 1945 5, P34; Feinleib M, 1995, AM J MED SCI, V310, pS8, DOI 10.1097/00000441-199512000-00003; Hart CL, 2000, J EPIDEMIOL COMMUN H, V54, P874, DOI 10.1136/jech.54.11.874; Hemingway H, 1999, BMJ-BRIT MED J, V318, P1460, DOI 10.1136/bmj.318.7196.1460; ISLES CG, 1992, LANCET, V339, P702, DOI 10.1016/0140-6736(92)90599-X; Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.3.CO;2-Q; Kuulasmaa K, 2000, LANCET, V355, P675, DOI 10.1016/S0140-6736(99)11180-2; OREN L, 1974, CLIOS CONSCIOUSNESS, P226; PETERSEN S, 1999, CORONARY HEART DIS S; PLANT M, 1997, HLTH ADULT BRITAIN 1, P114; POSNER BM, 1995, J AM DIET ASSOC, V95, P171, DOI 10.1016/S0002-8223(95)00043-7; SASAKI S, 1992, AM J CLIN NUTR, V56, P716, DOI 10.1093/ajcn/56.4.716; STAMLER J, 1989, INT J EPIDEMIOL, V18, pS3; STEHBENS WE, 1987, LANCET, V1, P606; STEPHEN AM, 1994, BRIT J NUTR, V71, P775, DOI 10.1079/BJN19940183; STEPHEN AM, 1990, AM J CLIN NUTR, V52, P457, DOI 10.1093/ajcn/52.3.457; The Coronary Drug Project, 1973, JAMA-J AM MED ASSOC, V226, P652; UEMURA K, 1988, World Health Statistics Quarterly, V41, P155; Walden CE, 1997, ARTERIOSCL THROM VAS, V17, P375, DOI 10.1161/01.ATV.17.2.375; WALDRON I, 1993, SOC SCI MED, V36, P451, DOI 10.1016/0277-9536(93)90407-U; ZHANG XH, 1995, INT J EPIDEMIOL, V24, P720, DOI 10.1093/ije/24.4.720	28	141	143	0	11	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 8	2001	323	7312					541	545		10.1136/bmj.323.7312.541	http://dx.doi.org/10.1136/bmj.323.7312.541			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	471NC	11546699	Green Accepted, Green Published, Bronze			2022-12-24	WOS:000170934600020
J	Hatta, M; Gao, P; Halfmann, P; Kawaoka, Y				Hatta, M; Gao, P; Halfmann, P; Kawaoka, Y			Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses	SCIENCE			English	Article							A VIRUSES; HOST RANGE; HEMAGGLUTININ; HUMANS; GENE; PATHOGENICITY; PATHOGENESIS; ATTENUATION; MONKEYS; CELLS	In 1997, an H5N1 influenza A virus was transmitted from birds to humans in Hong Kong, killing 6 of the 18 people infected. When mice were infected with the human isolates, two virulence groups became apparent. Using reverse genetics, we showed that a mutation at position 627 in the PB2 protein influenced the outcome of infection in mice. Moreover, high cleavability of the hemagglutinin glycoprotein was an essential requirement for lethal infection.	Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA; Univ Tokyo, Inst Med Sci, Minato Ku, Tokyo 1088639, Japan	University of Wisconsin System; University of Wisconsin Madison; University of Tokyo	Kawaoka, Y (corresponding author), Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, 2015 Linden Dr, Madison, WI 53706 USA.	kawaokay@svm.vetmed.wisc.edu	Halfmann, Peter/W-8084-2019					ALMOND JW, 1977, NATURE, V270, P617, DOI 10.1038/270617a0; Claas ECJ, 1998, LANCET, V351, P472, DOI 10.1016/S0140-6736(97)11212-0; CLEMENTS ML, 1992, J CLIN MICROBIOL, V30, P655, DOI 10.1128/JCM.30.3.655-662.1992; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Gao P, 1999, J VIROL, V73, P3184, DOI 10.1128/JVI.73.4.3184-3189.1999; Katz JM, 2000, J VIROL, V74, P10807, DOI 10.1128/JVI.74.22.10807-10810.2000; KATZ JM, 1990, J VIROL, V64, P1808, DOI 10.1128/JVI.64.4.1808-1811.1990; KAWAOKA Y, 1988, P NATL ACAD SCI USA, V85, P324, DOI 10.1073/pnas.85.2.324; Kuechler E., 1982, NUCLEIC ACIDS RES, V10, P4803; Lu XH, 1999, J VIROL, V73, P5903, DOI 10.1128/JVI.73.7.5903-5911.1999; MURPHY BR, 1982, SCIENCE, V218, P1330, DOI 10.1126/science.6183749; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; ROTT R, 1976, J VIROL, V19, P54, DOI 10.1128/JVI.19.1.54-60.1976; SAUTER NK, 1992, BIOCHEMISTRY-US, V31, P9609, DOI 10.1021/bi00155a013; Suarez DL, 1998, J VIROL, V72, P6678, DOI 10.1128/JVI.72.8.6678-6688.1998; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Subbarao K, 1998, SCIENCE, V279, P393, DOI 10.1126/science.279.5349.393; ULMANEN I, 1981, P NATL ACAD SCI-BIOL, V78, P7355, DOI 10.1073/pnas.78.12.7355; WEBSTER RG, 1987, CELL, V50, P665, DOI 10.1016/0092-8674(87)90321-7; 1997, MORBID MORTAL WKLY R, V46, P1204	20	1065	1205	0	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2001	293	5536					1840	1842		10.1126/science.1062882	http://dx.doi.org/10.1126/science.1062882			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	470WN	11546875				2022-12-24	WOS:000170894400050
J	Sumbre, G; Gutfreund, Y; Fiorito, G; Flash, T; Hochner, B				Sumbre, G; Gutfreund, Y; Fiorito, G; Flash, T; Hochner, B			Control of octopus arm extension by a peripheral motor program	SCIENCE			English	Article							SYSTEM; MOVEMENTS; BEHAVIOR	For goal-directed arm movements, the nervous system generates a sequence of motor commands that bring the arm toward the target. Control of the octopus arm is especially complex because the arm can be moved in any direction, with a virtually infinite number of degrees of freedom. Here we show that arm extensions can be evoked mechanically or electrically in arms whose connection with the brain has been severed. These extensions show kinematic features that are almost identical to normal behavior, suggesting that the basic motor program for voluntary movement is embedded within the neural circuitry of the arm itself. Such peripheral motor programs represent considerable simplification in the motor control of this highly redundant appendage.	Hebrew Univ Jerusalem, Inst Life Sci, Dept Neurobiol & Interdisciplinary, Ctr Neuronal Computat, IL-91904 Jerusalem, Israel; Staz Zool Anton Dohrn, Neurobiol Lab, I-80121 Naples, Italy; Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel	Hebrew University of Jerusalem; Stazione Zoologica Anton Dohrn di Napoli; Weizmann Institute of Science	Hochner, B (corresponding author), Hebrew Univ Jerusalem, Inst Life Sci, Dept Neurobiol & Interdisciplinary, Ctr Neuronal Computat, IL-91904 Jerusalem, Israel.	bennyh@lobster.ls.huji.ac.il	Sumbre, German/K-7538-2017	Sumbre, German/0000-0003-4436-6840				ALTMAN JS, 1971, NATURE, V229, P204, DOI 10.1038/229204a0; Arshavsky YI, 1997, CURR OPIN NEUROBIOL, V7, P781, DOI 10.1016/S0959-4388(97)80136-5; Bizzi E, 2000, NAT REV NEUROSCI, V1, P101, DOI 10.1038/35039000; BOYCOTT BB, 1950, SYM SOC EXP BIOL, V4, P432; Chiel HJ, 1997, TRENDS NEUROSCI, V20, P553, DOI 10.1016/S0166-2236(97)01149-1; DELCOMYN F, 1980, SCIENCE, V210, P492, DOI 10.1126/science.7423199; FLASH T, 1985, J NEUROSCI, V5, P1688, DOI 10.1523/jneurosci.05-07-01688.1985; FLASH T, 1991, J COGNITIVE NEUROSCI, V3, P220, DOI 10.1162/jocn.1991.3.3.220; Graziadei P., 1971, ANATOMY NERVOUS SYST, P45; Gutfreund Y, 1998, J NEUROSCI, V18, P5976; Gutfreund Y, 1996, J NEUROSCI, V16, P7297; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; HOLLAND JJ, 1990, VIROLOGY, P151; KIER WM, 1985, ZOOL J LINN SOC-LOND, V83, P307, DOI 10.1111/j.1096-3642.1985.tb01178.x; Kristan WB, 2000, BIOMECHANICS AND NEURAL CONTROL OF POSTURE AND MOVEMENT, P206; Matzner H, 2000, J NEUROPHYSIOL, V83, P1315, DOI 10.1152/jn.2000.83.3.1315; Mussa-Ivaldi FA, 1999, CURR OPIN NEUROBIOL, V9, P713, DOI 10.1016/S0959-4388(99)00029-X; ROWELL CHF, 1963, J EXP BIOL, V40, P257; SHIK ML, 1976, PHYSIOL REV, V56, P465, DOI 10.1152/physrev.1976.56.3.465; WELLS MJ, 1959, J EXP BIOL, V36, P590; YOUNG JZ, 1965, PROC R SOC SER B-BIO, V162, P47, DOI 10.1098/rspb.1965.0025	21	182	184	1	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2001	293	5536					1845	1848		10.1126/science.1060976	http://dx.doi.org/10.1126/science.1060976			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	470WN	11546877				2022-12-24	WOS:000170894400052
J	Emery, J				Emery, J			Silent suffering	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	4	4	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	DEC 16	1995	311	7020					1647	1647		10.1136/bmj.311.7020.1647	http://dx.doi.org/10.1136/bmj.311.7020.1647			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TL422	11644742	Green Published			2022-12-24	WOS:A1995TL42200080
J	KOHNEN, MEL; SCHOUTEN, S; DAMSTE, JSS; DELEEUW, JW; MERRITT, DA; HAYES, JM				KOHNEN, MEL; SCHOUTEN, S; DAMSTE, JSS; DELEEUW, JW; MERRITT, DA; HAYES, JM			RECOGNITION OF PALEOBIOCHEMICALS BY A COMBINED MOLECULAR SULFUR AND ISOTOPE GEOCHEMICAL APPROACH	SCIENCE			English	Article							IMMATURE CRUDE OILS; BIOLOGICAL MARKERS; BOTRYOCOCCUS-BRAUNII; BLACK-SEA; SEDIMENTS; BACTERIA; LIPIDS; HYDROCARBONS; CARBON; IDENTIFICATION	Study of organic matter in immature sediments from a Messinian evaporitic basin shows that consideration of structures, modes of occurrence, and carbon isotopic compositions of free and sulfur-bound carbon skeletons allow identification of biochemical precursors. Detailed information concerning biotic communities present during deposition of sediments can be retrieved in this way. Moreover, unprecedented biochemicals were recognized; these extend the horizon of biomarker geochemistry.	DELFT UNIV TECHNOL,FAC CHEM TECHNOL & MAT SCI,ORGAN GEOCHEM UNIT,DE VRIES VAN HEYSTPLANTSOEN 2,2628 RZ DELFT,NETHERLANDS; INDIANA UNIV,DEPT CHEM,BIOGEOCHEM LAB,BLOOMINGTON,IN 47405; INDIANA UNIV,DEPT GEOL,BIOGEOCHEM LAB,BLOOMINGTON,IN 47405	Delft University of Technology; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington			de Leeuw, Jan W/F-6471-2011; Damste, Jaap S Sinninghe/F-6128-2011	Damste, Jaap S Sinninghe/0000-0002-8683-1854				BOON JJ, 1979, NATURE, V277, P125, DOI 10.1038/277125a0; BRASSELL SC, 1981, NATURE, V290, P693, DOI 10.1038/290693a0; BRAY EE, 1961, GEOCHIM COSMOCHIM AC, V22, P2, DOI 10.1016/0016-7037(61)90069-2; DAMSTE JSS, 1989, ORG GEOCHEM, V14, P555; DAMSTE JSS, 1990, ORG GEOCHEM, V16, P1077; DAMSTE JSS, 1988, ORG GEOCHEM, V13, P593; DAMSTE JSS, 1989, GEOCHIM COSMOCHIM AC, V53, P1343; DAMSTE JSS, 1990, NATURE, V345, P609, DOI 10.1038/345609a0; DEEVEY ES, 1964, LIMNOL OCEANOGR, V9, P1, DOI 10.4319/lo.1964.9.1.0001; Deines P, 1980, HDB ENV ISOTOPE GEOC, DOI DOI 10.1016/B978-0-444-41780-0.50015-8; DEROSA M, 1986, BIOCHIM BIOPHYS ACTA, V875, P487, DOI 10.1016/0005-2760(86)90068-8; DEROSA M, 1988, PROG LIPID RES, V27, P153, DOI 10.1016/0163-7827(88)90011-2; DEUSER WG, 1970, NATURE, V225, P1069, DOI 10.1038/2251069a0; Eglinton G., 1963, CHEM PLANT TAXONOMY, P87, DOI DOI 10.1016/B978-0-12-395540-1.50012-9; FREEMAN KH, 1990, NATURE, V343, P254, DOI 10.1038/343254a0; HAYES JM, 1990, ORG GEOCHEM, V16, P1115, DOI 10.1016/0146-6380(90)90147-R; HOLZER G, 1979, J CHROMATOGR, V186, P795, DOI 10.1016/S0021-9673(00)95296-8; JOHNSON JE, 1948, J AM CHEM SOC, V70, P3664, DOI 10.1021/ja01191a035; KOHNEN MEL, 1990, GEOCHIM COSMOCHIM AC, V54, P3053, DOI 10.1016/0016-7037(90)90121-Z; KOHNEN MEL, 1991, GEOCHIM COSMOCHIM AC, V55, P1375, DOI 10.1016/0016-7037(91)90315-V; KOHNEN MEL, 1990, ACS SYM SER, V429, P444; Liaaen-Jensen S., 1978, PHOTOSYNTHETIC BACTE, P233; Liaaen-Jensen S., 1978, MARINE NATURAL PRODU, V2, P1; METZGER P, 1987, TETRAHEDRON LETT, V28, P3931, DOI 10.1016/S0040-4039(00)96423-2; METZGER P, 1985, PHYTOCHEMISTRY, V24, P2305, DOI 10.1016/S0031-9422(00)83032-0; NICHOLS PD, 1988, J PHYCOL, V24, P90; OREMLAND RS, 1982, NATURE, V296, P143, DOI 10.1038/296143a0; OURISSON G, 1979, PURE APPL CHEM, V51, P709, DOI 10.1351/pac197951040709; OURISSON G, 1982, TRENDS BIOCHEM SCI, V7, P236, DOI 10.1016/0968-0004(82)90028-7; PANGANAMALA RV, 1971, CHEM PHYS LIPIDS, V7, P336, DOI 10.1016/0009-3084(71)90011-9; POPP BN, 1989, AM J SCI, V289, P436, DOI 10.2475/ajs.289.4.436; QUANDT L, 1977, FEMS MICROBIOL LETT, V1, P125, DOI 10.1016/0378-1097(77)90140-9; Risatti J.B., 1984, ORG GEOCHEM, V6, P93, DOI DOI 10.1016/0146-6380(84)90030-5; ROWLAND SJ, 1985, ORG GEOCHEM, V8, P207, DOI 10.1016/0146-6380(85)90028-2; SIREVAG R, 1977, ARCH MICROBIOL, V112, P35, DOI 10.1007/BF00446651; SUMMONS RE, 1986, NATURE, V319, P763, DOI 10.1038/319763a0; SUMMONS RE, 1987, GEOCHIM COSMOCHIM AC, V51, P557, DOI 10.1016/0016-7037(87)90069-X; TORGERSEN T, 1981, LIMNOL OCEANOGR, V26, P110, DOI 10.4319/lo.1981.26.1.0110; VAI G B, 1977, Sedimentology, V24, P211, DOI 10.1111/j.1365-3091.1977.tb00255.x; VOLKMAN JK, 1980, PHYTOCHEMISTRY, V19, P2619, DOI 10.1016/S0031-9422(00)83930-8; WAKEHAM SG, 1990, GEOCHIM COSMOCHIM AC, V54, P1325, DOI 10.1016/0016-7037(90)90157-G; [No title captured]; [No title captured]; [No title captured]; [No title captured]	45	141	144	2	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	APR 17	1992	256	5055					358	362		10.1126/science.256.5055.358	http://dx.doi.org/10.1126/science.256.5055.358			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HP032	11540057				2022-12-24	WOS:A1992HP03200030
J	Brock, J; Sauaia, T; Ahnen, D; Marine, W; Schluter, W; Stevens, BR; Scinto, JD; Karp, H; Bratzler, D				Brock, J; Sauaia, T; Ahnen, D; Marine, W; Schluter, W; Stevens, BR; Scinto, JD; Karp, H; Bratzler, D			Process of care and outcomes for elderly patients hospitalized with peptic ulcer disease - Results from a quality improvement project	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SERIOUS GASTROINTESTINAL COMPLICATIONS; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; HELICOBACTER-PYLORI; DUODENAL-ULCER; DOUBLE-BLIND; ERADICATION; RANITIDINE; RECURRENCE; ARTHRITIS; RISK	Context Since publication in 1994 of guidelines for management of peptic ulcer disease (PUD), trends in physician practice and outcomes related to guideline application have not been evaluated. Objectives To describe changes in process of care that occurred in a quality improvement program for patients hospitalized with PUD and to evaluate associations between in-hospital treatment of PUD and 1-year rehospitalization for PUD and mortality in a subset of these patients. Design, Setting, and Patients Cohort study of 4292 sequential Medicare beneficiaries hospitalized at acute care hospitals with a principal diagnosis of PUD in 5 states (Colorado, Georgia, Connecticut, Oklahoma, and Virginia) in 1995 (baseline) and 1997 (remeasurement); outcomes were evaluated for 752 patients in Colorado. Main Outcome Measures Changes in rates of screening for Helicobacter pylori infection, treatment for H pylori infection, screening for nonsteroidal anti-inflammatory drug (NSAID) use, counseling about NSAID use; outcomes included rehospitalization for PUD and all-cause mortality within 1 year of discharge in Colorado. Results Screening for H pylori infection increased significantly (12%-19% increase; P<.001) in each of the 5 states. Treatment of H pylori infection increased in each state and was significantly increased for the entire group of hospitalizations examined (8% increase overalls P=.001). Despite increased screening, detection of H pylori infection was less frequent than expected in every state, (13%-24%) and did not increase in any state. Screening for and counseling about NSAIDs did not significantly increase overall or in any state. In the Colorado cohort, the proportion of patients rehospitalized was unchanged in 1995 (8.9%) and 1997 (6.8%), and 124 patients (16%) in the combined 1995 and 1997 cohorts died within 1 year, Treatment for H pylori was not associated with a reduction in rehospitalization within 1 year (adjusted odds ratio [OR], 1.24; 95% confidence interval [CI], 0.65-2.36) or with a reduction in mortality (adjusted OR, 1.08; 95% Cl, 0.68-1.71). Counseling about NSAID use was associated with a decrease in risk of 1-year rehospitalization for PUD (adjusted OR, 0.47; 95% CI, 0.22-0.99) and risk of all-cause mortality (adjusted OR, 0.44; 95% CI, 0.26-0.75). Conclusions This quality improvement program for elderly patients with PUD resulted in increased screening for H pylori and increased treatment of H pylori Infection but no change in counseling about NSAID use. However, with the low prevalence of H pylori detected, treatment of H pylori infection was not associated with a reduction in repeat hospitalization for PUD or subsequent mortality, whereas counseling about the risks of using NSAIDs was associated with a reduction in the risk of both outcomes.	Colorado Fdn Med Care, Aurora, CO 80014 USA; Univ Colorado, Sch Med, Dept Prevent Med, Denver, CO USA; Denver Vet Adm Hosp, Dept Gastroenterol, Denver, CO USA; Qualidigm, Middletown, CT USA; Univ Connecticut, Ctr Hlth, Sch Med, Farmington, CT USA; Georgia Med Care Fdn, Atlanta, GA USA; Oklahoma Fdn Med Qual, Oklahoma City, OK USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Connecticut	Brock, J (corresponding author), Colorado Fdn Med Care, 2851 S Parker Rd,Suite 1000, Aurora, CO 80014 USA.	jbrockp@yahoo.com			PHS HHS [5D33HP10030-03] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Bero LA, 1998, BMJ-BRIT MED J, V317, P465; Berwick DM, 1998, ANN INTERN MED, V128, P651, DOI 10.7326/0003-4819-128-8-199804150-00009; BROWN DM, 1994, PUBLICATION NIH, P55; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; COGHLAN JG, 1987, LANCET, V2, P1109; DAVIES J, 1986, BRIT J RHEUMATOL, V25, P54; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; DICKER RC, 1998, QUALITY CARE SURVEIL; GABRIEL SE, 1991, ANN INTERN MED, V115, P787, DOI 10.7326/0003-4819-115-10-787; GRAHAM DY, 1991, GASTROENTEROLOGY, V100, P1653, DOI 10.1016/0016-5085(91)90665-8; GRAHAM DY, 1992, ANN INTERN MED, V116, P705, DOI 10.7326/0003-4819-116-9-705; GRAHAM DY, 1993, SCAND J GASTROENTERO, V28, P939, DOI 10.3109/00365529309098288; GREENE JM, 1992, ARCH INTERN MED, V152, P1995, DOI 10.1001/archinte.152.10.1995; Haddix A, 1996, PREVENTION EFFECTIVE; HENTSCHEL E, 1993, NEW ENGL J MED, V328, P308, DOI 10.1056/NEJM199302043280503; HOSKING SW, 1992, GASTROENTEROLOGY, V102, P85; HOSMER DW, 1989, APPL LOGISTIC REGRES, P86; JASPERSEN D, 1995, GASTROINTEST ENDOSC, V41, P5, DOI 10.1016/S0016-5107(95)70267-9; JENCKS SF, 1992, JAMA-J AM MED ASSOC, V268, P900, DOI 10.1001/jama.268.7.900; JENSEN D M, 1992, Gastroenterology, V102, pA90; LABENZ J, 1994, DIGESTION, V55, P19, DOI 10.1159/000201117; LAINE L, 1998, SLEISENGER FORDTRANS, P205; LANAS AI, 1995, GASTROENTEROLOGY, V109, P1124, DOI 10.1016/0016-5085(95)90570-7; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; LOEB DS, 1992, GASTROENTEROLOGY, V102, P1899, DOI 10.1016/0016-5085(92)90311-L; Malfertheiner P, 1997, GUT, V41, P8; MARSHALL BJ, 1988, LANCET, V2, P1437; Ofman JJ, 2000, AM J GASTROENTEROL, V95, P106; PAULUS HE, 1998, ARTHRITIS RHEUM, V31, P1450; *PEER REV ORG QUAL, 2001, PILL QUAL; RAUWS EAJ, 1990, LANCET, V335, P1233, DOI 10.1016/0140-6736(90)91301-P; ROKKAS T, 1995, GASTROINTEST ENDOSC, V41, P1, DOI 10.1016/S0016-5107(95)70266-0; SILVERSTEIN FE, 1995, ANN INTERN MED, V123, P241, DOI 10.7326/0003-4819-123-4-199508150-00001; Smith WR, 2000, CHEST, V118, p8S, DOI 10.1378/chest.118.2_suppl.8S; Soll AH, 1996, JAMA-J AM MED ASSOC, V275, P622; Sonnenberg A, 1996, AM J PUBLIC HEALTH, V86, P200, DOI 10.2105/AJPH.86.2.200; SONNENBERG A, 1994, PUBLICATION NIH, P359; *US DEP HHS, 1988, INT CLASS DIS 9 REV; WILSON MC, 1995, JAMA-J AM MED ASSOC, V274, P1630, DOI 10.1001/jama.274.20.1630; YAMADA T, 1994, JAMA-J AM MED ASSOC, V272, P65, DOI 10.1001/jama.272.1.65; Yeomans ND, 1998, NEW ENGL J MED, V338, P719, DOI 10.1056/NEJM199803123381104; 2000, MEDICARE PROVIDER AN	42	24	24	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 24	2001	286	16					1985	+		10.1001/jama.286.16.1985	http://dx.doi.org/10.1001/jama.286.16.1985			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	485JD	11667935				2022-12-24	WOS:000171750500022
J	Alexopoulou, L; Holt, AC; Medzhitov, R; Flavell, RA				Alexopoulou, L; Holt, AC; Medzhitov, R; Flavell, RA			Recognition of double-stranded RNA and activation of NF-kappa B by Toll-like receptor 3	NATURE			English	Article							DEPENDENT PROTEIN-KINASE; SIGNALING PATHWAYS; ADAPTER PROTEIN; CPG-DNA; MICE; PKR; FAMILY; CELLS; TLR4; ENDOTOXIN	Toll-like receptors (TLRs) are a family of innate immune-recognition receptors that recognize molecular patterns associated with microbial pathogens, and induce antimicrobial immune responses(1,2). Double-stranded RNA (dsRNA) is a molecular pattern associated with viral infection, because it is produced by most viruses at some point during their replication(3). Here we show that mammalian TLR3 recognizes dsRNA, and that activation of the receptor induces the activation of NF-kappaB and the production of type I interferons (IFNs). TLR3-deficient (TLR3(-/-)) mice showed reduced responses to polyinosine-polycytidylic acid (poly(I:C)), resistance to the lethal effect of poly(I:C) when sensitized with D-galactosamine (D-GalN), and reduced production of inflammatory cytokines. MyD88 is an adaptor protein that is shared by all the known TLRs(1). When activated by poly(I:C), TLR3 induces cytokine production through a signalling pathway dependent on MyD88. Moreover, poly(I:C) can induce activation of NF-kappaB and mitogen-activated protein (MAP) kinases independently of MyD88, and cause dendritic cells to mature.	Immunobiol Sect, New Haven, CT 06520 USA; Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; Howard Hughes Med Inst, New Haven, CT 06520 USA; Yale Univ, Sch Med, New Haven, CT 06520 USA	Howard Hughes Medical Institute; Yale University	Flavell, RA (corresponding author), Immunobiol Sect, New Haven, CT 06520 USA.		Alexopoulou, Lena/A-5041-2017	Alexopoulou, Lena/0000-0003-4619-697X				Abraham N, 1999, J BIOL CHEM, V274, P5953, DOI 10.1074/jbc.274.9.5953; Akira S, 2001, ADV IMMUNOL, V78, P1, DOI 10.1016/S0065-2776(01)78001-7; Akira S, 2000, BIOCHEM SOC T, V28, P551, DOI 10.1042/bst0280551; Burns K, 2000, NAT CELL BIOL, V2, P346, DOI 10.1038/35014038; Chu WM, 1999, IMMUNITY, V11, P721, DOI 10.1016/S1074-7613(00)80146-6; Clemens MJ, 1997, J INTERF CYTOK RES, V17, P503, DOI 10.1089/jir.1997.17.503; Goh KC, 2000, EMBO J, V19, P4292, DOI 10.1093/emboj/19.16.4292; Guidotti LG, 2001, ANNU REV IMMUNOL, V19, P65, DOI 10.1146/annurev.immunol.19.1.65; Hacker H, 2000, J EXP MED, V192, P595, DOI 10.1084/jem.192.4.595; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hoshino K, 1999, J IMMUNOL, V162, P3749; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Jacobs BL, 1996, VIROLOGY, V219, P339, DOI 10.1006/viro.1996.0259; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; KIMURA M, 1994, AM J PHYSIOL-REG I, V267, pR1596, DOI 10.1152/ajpregu.1994.267.6.R1596; Kopp EB, 1999, CURR OPIN IMMUNOL, V11, P13, DOI 10.1016/S0952-7915(99)80003-X; Kumar M, 1998, MICROBIOL MOL BIOL R, V62, P1415, DOI 10.1128/MMBR.62.4.1415-1434.1998; Maggi LB, 2000, EMBO J, V19, P3630, DOI 10.1093/emboj/19.14.3630; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Medzhitov R, 2000, IMMUNOL REV, V173, P89, DOI 10.1034/j.1600-065X.2000.917309.x; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Schnare M, 2000, CURR BIOL, V10, P1139, DOI 10.1016/S0960-9822(00)00700-4; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Takeuchi O, 1999, GENE, V231, P59, DOI 10.1016/S0378-1119(99)00098-0; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Yang YL, 1995, EMBO J, V14, P6095, DOI 10.1002/j.1460-2075.1995.tb00300.x; Zhou AM, 1999, VIROLOGY, V258, P435, DOI 10.1006/viro.1999.9738	29	4619	4965	9	449	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 18	2001	413	6857					732	738		10.1038/35099560	http://dx.doi.org/10.1038/35099560			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	482ZK	11607032				2022-12-24	WOS:000171608000044
J	Kleijn, D; Berendse, F; Smit, R; Gilissen, N				Kleijn, D; Berendse, F; Smit, R; Gilissen, N			Agri-environment schemes do not effectively protect biodiversity in Dutch agricultural landscapes	NATURE			English	Article							CONSERVATION; GRASSLAND; DIVERSITY; ABUNDANCE; FARMLAND; EUROPE; POLICY; AREAS	Roughly 20% of the European Union's farmland is under some form of agri-environment scheme to counteract the negative impacts of modern agriculture on the environment 1. The associated costs represent about 4% (1.7 billion euros) of the European Union's total expenditure on the Common Agricultural Policy and are expected to rise to 10% in the near future(2). Although agri-environment schemes have been implemented in various countries for well over a decade, to date no reliable, sufficiently replicated studies have been performed to test whether such measures have the presumed positive effects on biodiversity(1,3,4). Here we present the results of a study evaluating the contribution of agri-environment schemes to the protection of biodiversity in intensively used Dutch agricultural landscapes. We surveyed plants, birds, hover flies and bees on 78 paired fields that either had agri-environment schemes in the form of management agreements or were managed conventionally. Management agreements were not effective in protecting the species richness of the investigated species groups: no positive effects on plant and bird species diversity were found. The four most common wader species were observed even less frequently on fields with management agreements. By contrast, hover flies and bees showed modest increases in species richness on fields with management agreements. Our results indicate that there is a pressing need for a scientifically sound evaluation of agri-environment schemes.	Univ Wageningen & Res Ctr, Nat Conservat & Plant Ecol Grp, NL-6708 PD Wageningen, Netherlands	Wageningen University & Research	Kleijn, D (corresponding author), Univ Wageningen & Res Ctr, Nat Conservat & Plant Ecol Grp, Bornsesteeg 69, NL-6708 PD Wageningen, Netherlands.	David.Kleijn@staf.ton.wau.nl	Kleijn, David/HCH-3477-2022	Kleijn, David/0000-0003-2500-7164				Bakker JP, 1999, TRENDS ECOL EVOL, V14, P63, DOI 10.1016/S0169-5347(98)01544-4; BANASZAK J, 1983, Polish Ecological Studies, V9, P421; BEINTEMA AJ, 1987, J APPL ECOL, V24, P743, DOI 10.2307/2403978; Beintema Albert J., 1997, P269; Berendse F., 1993, LANDSCAPE ECOLOGY ST, P104, DOI [10. 1007/978-94-011-2318-1, DOI 10.1007/978-94-011-2318-1]; Bignal EM, 1998, J APPL ECOL, V35, P949, DOI 10.1111/j.1365-2664.1998.tb00013.x; Branquart E, 2000, ECOGRAPHY, V23, P732, DOI 10.1034/j.1600-0587.2000.230610.x; Chamberlain DE, 1999, J APPL ECOL, V36, P856, DOI 10.1046/j.1365-2664.1999.00453.x; *COMM STAT DEP, 1993, GENST 5 REL 3 REF MA; Donald PF, 2001, P ROY SOC B-BIOL SCI, V268, P25, DOI 10.1098/rspb.2000.1325; European Commission, 1997, AG 2000, VI; Evans Andy, 1997, P331; Hagemeijer W., 1997, EBCC ATLAS EUROPEAN; Henderson IG, 2000, ECOGRAPHY, V23, P50, DOI 10.1034/j.1600-0587.2000.230106.x; Kokko H, 2001, EVOL ECOL RES, V3, P537; Krebs JR, 1999, NATURE, V400, P611, DOI 10.1038/23127; MacDonald D, 2000, J ENVIRON MANAGE, V59, P47, DOI 10.1006/jema.1999.0335; Milsom TP, 1998, BIOL CONSERV, V84, P119, DOI 10.1016/S0006-3207(97)00111-0; Ovenden GN, 1998, J APPL ECOL, V35, P955, DOI 10.1111/j.1365-2664.1998.tb00014.x; PATTERSON HD, 1971, BIOMETRIKA, V58, P545, DOI 10.2307/2334389; Schekkerman Hans, 2000, Limosa, V73, P121; STANDEN V, 1984, J APPL ECOL, V21, P293, DOI 10.2307/2403055; VANDIJK AJ, 1996, SURVEYING BREEDING B	23	468	494	3	163	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 18	2001	413	6857					723	725		10.1038/35099540	http://dx.doi.org/10.1038/35099540			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	482ZK	11607029				2022-12-24	WOS:000171608000041
J	Ramsey, SD; Clarke, L; Etzioni, R; Higashi, M; Berry, K; Urban, N				Ramsey, SD; Clarke, L; Etzioni, R; Higashi, M; Berry, K; Urban, N			Cost-effectiveness of microsatellite instability screening as a method for detecting hereditary nonpolyposis colorectal cancer	ANNALS OF INTERNAL MEDICINE			English	Article							INSTITUTE WORKSHOP; FAMILIES; COLON; PREDISPOSITION; RISK; SUSCEPTIBILITY; SURVEILLANCE; COLONOSCOPY; MANAGEMENT; CARCINOMA	Background: The National Cancer Institute has published consensus guidelines for universal screening for hereditary nonpolyposis colorectal cancer (HNPCC) in patients with newly diagnosed colorectal cancer. Objective: To determine the cost-effectiveness of screening compared with standard care in eligible patients with colorectal cancer and their siblings and children. Design: Cost-effectiveness analysis. Data Sources: National colorectal cancer registry data, the Creighton International Hereditary Colorectal Cancer Registry, Medicare claims records, and published literature. Target Population: Patients with newly diagnosed colorectal cancer and their siblings and children. Time Horizon: Lifetime (varies depending on age at screening). Perspective: societal. Interventions: initial office-based screening to determine eligibility (based on personal and family cancer history), followed by tumor testing for microsatellite instability, Those with microsatellite instability were offered genetic testing for HNPCC. Siblings and children of patients with cancer and the HNPCC mutation were offered genetic testing, and those who were found to carry the mutation received lifelong colorectal cancer screening. Measurements: Life-years gained. Results of Base-Case Analysis: When only the patients with cancer were considered, cost-effectiveness of screening was $42 210 per life-year gained. When patients with cancer and their siblings and children were considered together, cost-effectiveness increased to $7556 per life-year gained. Results of Sensitivity Analysis: The model was most sensitive to the estimated survival gain from screening siblings and children, to the prevalence of HNPCC mutations among patients with newly diagnosed cancer, and to the discount rate. In probabilistic analysis, the 90% CI for the cost-effectiveness of screening patients with cancer plus their relatives was $4874 to $21 576 per life-year gained. Conclusion: Screening patients with newly diagnosed colorectal cancer for HNPCC is cost-effective, especially if the benefits to their immediate relatives are considered.				sramsey@fhcrc.org			NATIONAL CANCER INSTITUTE [U01CA074794] Funding Source: NIH RePORTER; NCI NIH HHS [U01 CA074794] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AALTONEN LA, 1994, CANCER RES, V54, P1645; AALTONEN LA, 1994, CANCER DETECT PREV, V18, P57; Aarnio M, 1999, INT J CANCER, V81, P214, DOI 10.1002/(SICI)1097-0215(19990412)81:2<214::AID-IJC8>3.3.CO;2-C; Aarnio M, 1995, INT J CANCER, V64, P430, DOI 10.1002/ijc.2910640613; American Cancer Society, 1999, CANC FACTS FIG 1999; Benson AB, 2000, J CLIN ONCOL, V18, P3586, DOI 10.1200/JCO.2000.18.20.3586; Bernhardt B A, 1998, J Genet Couns, V7, P317, DOI 10.1023/A:1022067916528; BIESECKER BB, 1993, JAMA-J AM MED ASSOC, V269, P1970, DOI 10.1001/jama.269.15.1970; Boland CR, 1998, CANCER RES, V58, P5248; BOLAND CR, 1998, GENETIC BASIS HUMAN; BROWN ML, 1995, J NATL CANCER I, V87, P1131, DOI 10.1093/jnci/87.15.1131; Bubb VJ, 1996, ONCOGENE, V12, P2641; Burke W, 1997, JAMA-J AM MED ASSOC, V277, P915, DOI 10.1001/jama.277.11.915; CORAN AG, 1990, ANN SURG, V212, P242, DOI 10.1097/00000658-199009000-00002; CROYLE RT, 1993, PREV MED, V22, P284, DOI 10.1006/pmed.1993.1023; Deftos L J, 1998, Spec Law Dig Health Care Law, P9; deLeon MP, 1996, TUMORI, V82, P102, DOI 10.1177/030089169608200202; Etzioni R, 1996, J CLIN EPIDEMIOL, V49, P95, DOI 10.1016/0895-4356(96)89259-6; Freyer G, 1999, ANN ONCOL, V10, P87, DOI 10.1023/A:1008349318728; GOLD MR, 1996, COST EFFECTIVENESS H, P214; Gonzalez-Garcia I, 2000, JNCI-J NATL CANCER I, V92, P544, DOI 10.1093/jnci/92.7.544; Gryfe R, 2000, NEW ENGL J MED, V342, P69, DOI 10.1056/NEJM200001133420201; *HLTH CAR FIN ADM, 2001, MED PROV AN REV MEDP; HOULSTON RS, 1992, ANN HUM GENET, V56, P99, DOI 10.1111/j.1469-1809.1992.tb01136.x; Jarvinen HJ, 2000, GASTROENTEROLOGY, V118, P829, DOI 10.1016/S0016-5085(00)70168-5; JENTSCHURA D, 1994, SURG ENDOSC, V8, P472; Kalbfleisch JD, 1980, STAT ANAL FAILURE TI; Kinney AY, 2000, AM J PREV MED, V18, P249, DOI 10.1016/S0749-3797(99)00162-2; KOLATA G, 1998, NY TIMES        0327; LERMAN C, 1994, ARCH INTERN MED, V154, P609, DOI 10.1001/archinte.154.6.609; Lerman C, 1999, JAMA-J AM MED ASSOC, V281, P1618, DOI 10.1001/jama.281.17.1618; Lieberman DA, 2000, NEW ENGL J MED, V343, P162, DOI 10.1056/NEJM200007203430301; LO AY, 1994, J AM COLL SURGEONS, V179, P333; LOTHE RA, 1993, CANCER RES, V53, P5849; Lynch HT, 1999, CANCER, V86, P2449, DOI 10.1002/(SICI)1097-0142(19991201)86:11+<2449::AID-CNCR1>3.0.CO;2-M; Lynch HT, 1999, SEMIN ONCOL, V26, P478; MACRAE FA, 1983, GUT, V24, P376, DOI 10.1136/gut.24.5.376; Marta M R, 1999, J Healthc Risk Manag, V19, P26; Myrhoj T, 1997, SCAND J GASTROENTERO, V32, P572, DOI 10.3109/00365529709025102; Nakahara M, 1997, CANCER EPIDEM BIOMAR, V6, P1057; *NAT CANC I DIV CA, 2000, SURV EP END RES SEER; Offit K, 1996, J CLIN ONCOL, V14, P1730, DOI 10.1200/JCO.1996.14.5.1730; Olick R S, 2000, N J Med, V97, P43; PEDERSEN T, 1990, ACTA ANAESTH SCAND, V34, P176, DOI 10.1111/j.1399-6576.1990.tb03066.x; Peltomaki P, 1999, ADV EXP MED BIOL, V470, P95; Percesepe A, 1997, INT J CANCER, V71, P373, DOI 10.1002/(SICI)1097-0215(19970502)71:3<373::AID-IJC12>3.0.CO;2-H; POTOSKY AL, 1993, MED CARE, V31, P732; RodriguezBigas MA, 1997, J NATL CANCER I, V89, P1758, DOI 10.1093/jnci/89.23.1758; ROUFFET F, 1994, DIS COLON RECTUM, V37, P651, DOI 10.1007/BF02054407; Salovaara R, 2000, J CLIN ONCOL, V18, P2193, DOI 10.1200/JCO.2000.18.11.2193; STELZNER M, 1989, SURG GYNECOL OBSTET, V169, P187; STEVENSON G, 1989, COLON CANC DIAGNOSIS; SUTER SM, 1993, MICH LAW REV, V91, P1854, DOI 10.2307/1289655; Syngal S, 1999, JAMA-J AM MED ASSOC, V282, P247, DOI 10.1001/jama.282.3.247; *US C OFF TECHN AS, 1992, GEN TESTS HLTH INS R; *US CENS BUR, 2000, STAT ABSTR US 1999; *US CENS BUR, 2000, STAT ABSTR US; VASEN HF, 1993, DIS COLON RECTUM, V36, P1, DOI 10.1007/BF02050292; Wijnen JT, 1998, NEW ENGL J MED, V339, P511, DOI 10.1056/NEJM199808203390804; 2000, FERTILITY AM WOMEN	60	99	100	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 16	2001	135	8	1				577	588		10.7326/0003-4819-135-8_Part_1-200110160-00008	http://dx.doi.org/10.7326/0003-4819-135-8_Part_1-200110160-00008			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	481VY	11601929				2022-12-24	WOS:000171542200003
J	Wiechert, U; Halliday, AN; Lee, DC; Snyder, GA; Taylor, LA; Rumble, D				Wiechert, U; Halliday, AN; Lee, DC; Snyder, GA; Taylor, LA; Rumble, D			Oxygen isotopes and the moon-forming giant impact	SCIENCE			English	Article							ORIGIN; RATIOS; EARTH; GAS	We have determined the abundances of O-16, O-17, and O-18 in 31 lunar samples from Apollo missions 11, 12, 15, 16, and 17 using a high-precision laser fluorination technique. All oxygen isotope compositions plot within +/-0.016 per mit (2 standard deviations) on a single mass-dependent fractionation line that is identical to the terrestrial fractionation tine within uncertainties. This observation is consistent with the Giant Impact model, provided that the proto-Earth and the smaller impactor planet (named Theia) formed from an identical mix of components. The similarity between the proto-Earth and Theia is consistent with formation at about the same heliocentric distance. The three oxygen isotopes (Delta O-17) provide no evidence that isotopic heterogeneity on the Moon was created by lunar impacts.	ETH Zentrum, Dept Earth Sci, Inst Isotope Geol & Mineral Resources, CH-8092 Zurich, Switzerland; Univ Tennessee, Dept Geol Sci, Planetary Geosci Inst, Knoxville, TN 37996 USA; Carnegie Inst Sci, Geophys Lab, Washington, DC 20015 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Tennessee System; University of Tennessee Knoxville; Carnegie Institution for Science	Wiechert, U (corresponding author), ETH Zentrum, Dept Earth Sci, Inst Isotope Geol & Mineral Resources, Sonneggstr 5, CH-8092 Zurich, Switzerland.	wiechert@erdw.ethz.ch	Lee, Der-Chuen/N-9225-2013; Rumble, Douglas/AAU-3930-2020	Rumble, Douglas/0000-0002-7440-9189; Lee, Der-Chuen/0000-0001-8855-9594				BENZ W, COMMUNICATION; CAMERON AGW, 1991, ICARUS, V92, P204, DOI 10.1016/0019-1035(91)90046-V; Cameron AGW, 2001, METEORIT PLANET SCI, V36, P9, DOI 10.1111/j.1945-5100.2001.tb01806.x; CAMERON AGW, 1998, LUNAR PLANET SCI, V29, P1062; Canup RM, 2001, NATURE, V412, P708, DOI 10.1038/35089010; CLAYTON RN, 1977, EARTH PLANET SC LETT, V34, P209, DOI 10.1016/0012-821X(77)90005-X; CLAYTON RN, 1993, ANNU REV EARTH PL SC, V21, P115, DOI 10.1146/annurev.earth.21.1.115; CLAYTON RN, 1973, SCIENCE, V182, P485, DOI 10.1126/science.182.4111.485; Clayton RN, 1996, GEOCHIM COSMOCHIM AC, V60, P1999, DOI 10.1016/0016-7037(96)00074-9; CLAYTON RN, 1984, P LUNAR PLANET SCI C, V15, pC245; CLAYTON RN, 1975, P LUNAR PLANET SCI C, V11, P1761; Eiler JM, 2000, NATURE, V403, P530, DOI 10.1038/35000553; Franchi IA, 1999, METEORIT PLANET SCI, V34, P657, DOI 10.1111/j.1945-5100.1999.tb01371.x; Halliday AN, 2000, EARTH PLANET SC LETT, V176, P17, DOI 10.1016/S0012-821X(99)00317-9; HALLIDAY AN, IN PRESS EARTH PLANE; Lugmair GW, 1998, GEOCHIM COSMOCHIM AC, V62, P2863, DOI 10.1016/S0016-7037(98)00189-6; Newton J, 2000, METEORIT PLANET SCI, V35, P689, DOI 10.1111/j.1945-5100.2000.tb01452.x; Rumble D, 1997, GEOCHIM COSMOCHIM AC, V61, P4229, DOI 10.1016/S0016-7037(97)00232-9; SHARP ZD, 1990, GEOCHIM COSMOCHIM AC, V54, P1353, DOI 10.1016/0016-7037(90)90160-M; Valley JW, 1995, GEOCHIM COSMOCHIM AC, V59, P5223, DOI 10.1016/0016-7037(95)00386-X; WETHERILL GW, 1994, GEOCHIM COSMOCHIM AC, V58, P4513, DOI 10.1016/0016-7037(94)90352-2; Yi W, 2000, J GEOPHYS RES-SOL EA, V105, P18927, DOI 10.1029/2000JB900152; Young ED, 1999, SCIENCE, V286, P1331, DOI 10.1126/science.286.5443.1331	23	265	268	2	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 12	2001	294	5541					345	348		10.1126/science.1063037	http://dx.doi.org/10.1126/science.1063037			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	482WZ	11598294				2022-12-24	WOS:000171601400035
J	Gumienny, TL; Brugnera, E; Tosello-Trampont, AC; Kinchen, JM; Haney, LB; Nishiwaki, K; Walk, SF; Nemergut, ME; Macara, IG; Francis, R; Schedl, T; Qin, Y; Van Aelst, L; Hengartner, MO; Ravichandran, KS				Gumienny, TL; Brugnera, E; Tosello-Trampont, AC; Kinchen, JM; Haney, LB; Nishiwaki, K; Walk, SF; Nemergut, ME; Macara, IG; Francis, R; Schedl, T; Qin, Y; Van Aelst, L; Hengartner, MO; Ravichandran, KS			CED-12/ELMO, a novel member of the crkII/dock180/rac pathway, is required for phagocytosis and cell migration	CELL			English	Article							CORPSE ENGULFMENT; BINDING PROTEIN; MYOBLAST CITY; RHO GTPASES; NEMATODE; ENCODES; GENES; DEATH; MECHANISMS; EXPRESSION	The C. elegans genes ced-2, ced-5, and ced-10, and their mammalian homologs crkII, dock180, and rac1, mediate cytoskeletal rearrangements during phagocytosis of apoptotic cells and cell motility. Here, we describe an additional member of this signaling pathway, ced-12, and its mammalian homologs, elmo1 and elmo2. In C. elegans, CED-12 is required for engulfment of dying cells and for cell migrations. In mammalian cells, ELMO1 functionally cooperates with CrkII and Dock180 to promote phagocytosis and cell shape changes. CED-12/ELMO-1 binds directly to CED-5/ Dock180; this evolutionarily conserved complex stimulates a Rac-GEF, leading to Rac1 activation and cytoskeletal rearrangements. These studies identify CED-12/ELMO as an upstream regulator of Rac1 that affects engulfment and cell migration from C. elegans to mammals.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11743 USA; SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA; Univ Virginia, Beirne B Carter Ctr Immunol Res, Charlottesville, VA 22908 USA; Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA; Japan Sci & Technol Corp, PRESTO, Tsukuba, Ibaraki 3058501, Japan; NEC Corp Ltd, Fundamental Res Labs, Tsukuba, Ibaraki 3058501, Japan; Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA; Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA	Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Virginia; University of Virginia; Japan Science & Technology Agency (JST); NEC Corporation; University of Virginia; Washington University (WUSTL)	Hengartner, MO (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11743 USA.	michael.hengartner@molbio.unizh.ch; ravi@virginia.edu	Hengartner, Michael O/E-6235-2011; Hengartner, Michael O/A-7058-2008; Kinchen, Jason/ABC-5663-2021; Gumienny, Tina/AAJ-5273-2020	Nemergut, Michael/0000-0002-6803-1765; Gumienny, Tina/0000-0002-3932-7815; Kinchen, Jason/0000-0001-8430-2265; Hengartner, Michael/0000-0002-7584-596X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052540, R01GM063310] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM063310, GM63310, GM52540] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Albert ML, 2000, NAT CELL BIOL, V2, P899, DOI 10.1038/35046549; AVERY L, 1987, CELL, V51, P1071, DOI 10.1016/0092-8674(87)90593-9; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Caron E, 1998, SCIENCE, V282, P1717, DOI 10.1126/science.282.5394.1717; Cheresh DA, 1999, J CELL BIOL, V146, P1107, DOI 10.1083/jcb.146.5.1107; Chimini G, 2000, NAT CELL BIOL, V2, pE191, DOI 10.1038/35036454; Chung SB, 2000, NAT CELL BIOL, V2, P931, DOI 10.1038/35046585; ELLIS RE, 1991, GENETICS, V129, P79; Erickson MRS, 1997, J CELL BIOL, V138, P589, DOI 10.1083/jcb.138.3.589; Hasegawa H, 1996, MOL CELL BIOL, V16, P1770; HEDGECOCK EM, 1983, SCIENCE, V220, P1277, DOI 10.1126/science.6857247; Hengartner MO, 1999, RECENT PROG HORM RES, V54, P213; HENGARTNER MO, 1994, CELL, V76, P665, DOI 10.1016/0092-8674(94)90506-1; Hengartner MO, 2001, CELL, V104, P325, DOI 10.1016/S0092-8674(01)00219-7; Hilleren P, 1999, ANNU REV GENET, V33, P229, DOI 10.1146/annurev.genet.33.1.229; HODGKIN J, 1988, NEMATODE CAENORHABDI, P502; Hubbard EJA, 2000, DEV DYNAM, V218, P2, DOI 10.1002/(SICI)1097-0177(200005)218:1<2::AID-DVDY2>3.0.CO;2-W; Kiyokawa E, 1997, CRIT REV ONCOGENESIS, V8, P329, DOI 10.1615/CritRevOncog.v8.i4.30; Kiyokawa E, 1998, J BIOL CHEM, V273, P24479, DOI 10.1074/jbc.273.38.24479; Kiyokawa E, 1998, GENE DEV, V12, P3331, DOI 10.1101/gad.12.21.3331; KLASS M, 1976, DEV BIOL, V52, P1, DOI 10.1016/0012-1606(76)90002-6; Klemke RL, 1998, J CELL BIOL, V140, P961, DOI 10.1083/jcb.140.4.961; Leverrier Y, 2001, CURR BIOL, V11, P195, DOI 10.1016/S0960-9822(01)00047-1; Liu QA, 1998, CELL, V93, P961, DOI 10.1016/S0092-8674(00)81202-7; Luciani MF, 1996, EMBO J, V15, P226, DOI 10.1002/j.1460-2075.1996.tb00353.x; Massol P, 1998, EMBO J, V17, P6219, DOI 10.1093/emboj/17.21.6219; MAYER BJ, 1988, NATURE, V332, P272, DOI 10.1038/332272a0; Mello C, 1995, METHOD CELL BIOL, V48, P451; Montell DJ, 1999, DEVELOPMENT, V126, P3035; Nemergut ME, 2001, SCIENCE, V292, P1540, DOI 10.1126/science.292.5521.1540; Nishihara H, 1999, BBA-MOL CELL RES, V1452, P179, DOI 10.1016/S0167-4889(99)00133-0; Nishiwaki K, 1999, GENETICS, V152, P985; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; Nolan KM, 1998, GENE DEV, V12, P3337, DOI 10.1101/gad.12.21.3337; Reddien PW, 2000, NAT CELL BIOL, V2, P131, DOI 10.1038/35004000; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; ROBERTSON AMG, 1982, J EMBRYOL EXP MORPH, V67, P89; Savill J, 2000, NATURE, V407, P784, DOI 10.1038/35037722; STRINGHAM EG, 1992, MOL BIOL CELL, V3, P221, DOI 10.1091/mbc.3.2.221; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; TANAKA M, 1995, MOL CELL BIOL, V15, P6829; TOSELLOTRAMPONT A, 2001, IN PRESS J BIOL CHEM; VAN AL, 1997, GENE DEV, V11, P2295; Wu YC, 1998, NATURE, V392, P501, DOI 10.1038/33163; Wu YC, 1998, CELL, V93, P951, DOI 10.1016/S0092-8674(00)81201-5; Zhou Z, 2001, CELL, V104, P43, DOI 10.1016/S0092-8674(01)00190-8	46	430	458	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 5	2001	107	1					27	41		10.1016/S0092-8674(01)00520-7	http://dx.doi.org/10.1016/S0092-8674(01)00520-7			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	480GF	11595183	Green Accepted, Bronze			2022-12-24	WOS:000171453100007
J	Hippisley-Cox, J; Pringle, M; Hammersley, V; Crown, N; Wynn, A; Meal, A; Coupland, C				Hippisley-Cox, J; Pringle, M; Hammersley, V; Crown, N; Wynn, A; Meal, A; Coupland, C			Antidepressants as risk factor for ischaemic heart disease: case-control study in primary care	BRITISH MEDICAL JOURNAL			English	Article							MYOCARDIAL-INFARCTION; TRICYCLIC ANTIDEPRESSANTS; PSYCHOTROPIC-DRUGS; DEPRESSION	Objectives To determine whether antidepressants are a risk factor for ischaemic heart disease and tp compare the risk for different subgroups of antidepressants and individual antidepressants. Design Case-control study. Setting Nine general practices recruited from the Trent Focus Collaborative Research Network, Participants 933 men and women with ischaemic heart disease matched by age, sex, and practice to 5516 controls. Main outcome measure Adjusted odds ratio for ischaemic heart disease calculated by logistic regression. Results Odds ratios for ischaemic heart disease were significantly raised for patients who had ever received a prescription for tricyclic antidepressants even after diabetes, hypertension, smoking, body mass index, and use of selective serotonin reuptake inhibitors had been adjusted for (1.56; 95% confidence interval 1.18 to 2.05). Patients who had ever taken dosulepin (dothiepin) had a significantly raised odds ratio for ischaemic heart disease after adjustment for confounding factors and use of other antidepressants (1.67, 1.17 to 2.36), There was no significant increase in the odds ratios for amitriptyline, lofepramine, and selective serotonin reuptake inhibitors in multivariate analysis. Increasing maximum doses of dosulepin were associated with increasing odds ratios for ischaemic heart disease. Similarly, there was a significant positive trend associated with increasing numbers of prescriptions of dosulepin (adjusted odds ratio 1.52 for 1 prescription, 1.39 for 2-3, and 1.96 for greater than or equal to4,P<0.002). Conclusion There is good evidence for an association between dosulepin and subsequent ischaemic heart disease and for a dose-response relation.	Univ Nottingham, Div Gen Practice, Nottingham NG7 2RD, England; Collingham Med Ctr, Collingham NG23 7LB, Notts, England; Queens Med Ctr, Sch Med, Sch Nursing, Nottingham NG7 2UH, England	University of Nottingham; University of Nottingham	Hippisley-Cox, J (corresponding author), Univ Nottingham, Div Gen Practice, Nottingham NG7 2RD, England.		Hippisley-Cox, Julia/AAY-2788-2020; Meal, Andy/B-9083-2008	Hippisley-Cox, Julia/0000-0002-2479-7283; Coupland, Carol/0000-0002-2327-3306				*AG HLTH CAR POL R, 1999, TREATM DEPR NEW PHAR; Breslow NE, 1987, STAT METHODS CANC RE; BUCKLEY NA, 1994, LANCET, V343, P159, DOI 10.1016/S0140-6736(94)90940-7; Campbell NC, 1998, BMJ-BRIT MED J, V316, P1430, DOI 10.1136/bmj.316.7142.1430; CARNEY RM, 1988, PSYCHOSOM MED, V50, P627, DOI 10.1097/00006842-198811000-00009; Cohen HW, 2000, AM J MED, V108, P2, DOI 10.1016/S0002-9343(99)00301-0; FRASURESMITH N, 1995, CIRCULATION, V91, P999, DOI 10.1161/01.CIR.91.4.999; GLASSMAN AH, 1994, GERONTOLOGY, V40, P15, DOI 10.1159/000213616; Glassman AH, 1998, J CLIN PSYCHIAT, V59, P13; HAMMERSLEY V, 1998, J INF PRIMARY CARE, V1, P3; HARRIS M, 1992, CLASSIFICATION DIABE; Hippisley-Cox J, 1998, BMJ-BRIT MED J, V316, P1714, DOI 10.1136/bmj.316.7146.1714; LADWIG KH, 1994, LANCET, V343, P20, DOI 10.1016/S0140-6736(94)90877-X; LAPANE KL, 1995, EPIDEMIOLOGY, V6, P376, DOI 10.1097/00001648-199507000-00008; Penttinen J, 1996, INT J EPIDEMIOL, V25, P760, DOI 10.1093/ije/25.4.760; PRATT L, 1996, CIRCULATION, V94, P123; ROOSE SP, 1994, J CLIN PSYCHIAT, V55, P83; Royal College of General Practitioners Office of Population Consensus & Survey. Department of Health, 1995, MORB STAT GEN PRACT; SCHLEIFER SJ, 1989, ARCH INTERN MED, V149, P1785, DOI 10.1001/archinte.149.8.1785; Sheline YI, 1997, AM J MED, V102, P54, DOI 10.1016/S0002-9343(96)00374-9	20	76	76	0	5	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 22	2001	323	7314					666	669		10.1136/bmj.323.7314.666	http://dx.doi.org/10.1136/bmj.323.7314.666			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	476LP	11566831	Bronze, Green Published			2022-12-24	WOS:000171228800019
J	Lomvardas, S; Thanos, D				Lomvardas, S; Thanos, D			Nucleosome sliding via TBP DNA binding in vivo	CELL			English	Article							REMODELING COMPLEX; TRANSCRIPTION FACTORS; CHROMATIN STRUCTURE; HISTONE OCTAMER; ARCHITECTURAL SPECIFICITY; POSITIONED NUCLEOSOMES; ORDERED RECRUITMENT; CRYSTAL-STRUCTURE; GENE-EXPRESSION; HMG I(Y)	Here, we show that a nucleosome obstructing transcription from the IFN-beta promoter slides in vivo in response to virus infection, thus exposing the previously masked TATA box and the initiation site, a requirement for transcriptional activation. Our experiments also revealed that this mode of chromatin remodeling is a two-step reaction. First, the enhanceosome recruits the SWI/SNF chromatin-remodeling complex that modifies the nucleosome to allow binding of TBP. Second, DNA bending is induced by TBP binding, and the nucleosome slides to a new position. Experiments with other DNA binding proteins demonstrated a strong correlation between the ability to bend DNA and nucleosome sliding, suggesting that the sliding is induced by the bend.	Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Columbia University	Thanos, D (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, 630 W 168th St, New York, NY 10032 USA.		Thanos, Dimitris/AAE-5720-2019	Lomvardas, Stavros/0000-0002-7668-3026	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054605] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-54605] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aalfs JD, 2000, TRENDS BIOCHEM SCI, V25, P548, DOI 10.1016/S0968-0004(00)01689-3; Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; ALMER A, 1986, EMBO J, V5, P2689, DOI 10.1002/j.1460-2075.1986.tb04552.x; ARCHER TK, 1991, MOL CELL BIOL, V11, P688, DOI 10.1128/MCB.11.2.688; Biggar SR, 1999, EMBO J, V18, P2254, DOI 10.1093/emboj/18.8.2254; Burke TW, 1997, GENE DEV, V11, P3020, DOI 10.1101/gad.11.22.3020; Cosma MP, 1999, CELL, V97, P299, DOI 10.1016/S0092-8674(00)80740-0; Dilworth FJ, 2000, MOL CELL, V6, P1049, DOI 10.1016/S1097-2765(00)00103-9; Falvo JV, 1995, CELL, V83, P1101, DOI 10.1016/0092-8674(95)90137-X; Fry CJ, 2001, CURR BIOL, V11, pR185, DOI 10.1016/S0960-9822(01)00090-2; Gavin I, 2001, MOL CELL, V7, P97, DOI 10.1016/S1097-2765(01)00158-7; GIESE K, 1992, CELL, V69, P185, DOI 10.1016/0092-8674(92)90129-Z; Goldmark JP, 2000, CELL, V103, P423, DOI 10.1016/S0092-8674(00)00134-3; Hamiche A, 1999, CELL, V97, P833, DOI 10.1016/S0092-8674(00)80796-5; Hassan AH, 2001, CELL, V104, P817, DOI 10.1016/S0092-8674(01)00279-3; Havas K, 2000, CELL, V103, P1133, DOI 10.1016/S0092-8674(00)00215-4; HONG L, 1993, J BIOL CHEM, V268, P305; IMBALZANO AN, 1994, NATURE, V370, P481, DOI 10.1038/370481a0; Jaskelioff M, 2000, MOL CELL BIOL, V20, P3058, DOI 10.1128/MCB.20.9.3058-3068.2000; KIM JL, 1993, NATURE, V365, P520, DOI 10.1038/365520a0; Kim JS, 1996, NUCLEIC ACIDS RES, V24, P4341, DOI 10.1093/nar/24.21.4341; KIM YC, 1993, NATURE, V365, P512, DOI 10.1038/365512a0; KORNBERG RD, 1974, SCIENCE, V184, P868, DOI 10.1126/science.184.4139.868; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Krebs JE, 2000, CELL, V102, P587, DOI 10.1016/S0092-8674(00)00081-7; Krebs JE, 1999, GENE DEV, V13, P1412, DOI 10.1101/gad.13.11.1412; Langst G, 1999, CELL, V97, P843, DOI 10.1016/S0092-8674(00)80797-7; Lemon B, 2000, GENE DEV, V14, P2551, DOI 10.1101/gad.831000; Li GF, 1998, P NATL ACAD SCI USA, V95, P4772, DOI 10.1073/pnas.95.8.4772; Lohr D, 1997, J BIOL CHEM, V272, P26795, DOI 10.1074/jbc.272.43.26795; LORCH Y, 1987, CELL, V49, P203, DOI 10.1016/0092-8674(87)90561-7; Lorch Y, 2001, MOL CELL, V7, P89, DOI 10.1016/S1097-2765(01)00157-5; LOVE JJ, 1995, NATURE, V376, P791, DOI 10.1038/376791a0; Maniatis T, 1998, COLD SPRING HARB SYM, V63, P609, DOI 10.1101/sqb.1998.63.609; MARMORSTEIN R, 1992, NATURE, V356, P408, DOI 10.1038/356408a0; Merika M, 2001, CURR OPIN GENET DEV, V11, P205, DOI 10.1016/S0959-437X(00)00180-5; Moreira JMA, 1999, EMBO J, V18, P2836, DOI 10.1093/emboj/18.10.2836; Munshi N, 1999, COLD SPRING HARB SYM, V64, P149, DOI 10.1101/sqb.1999.64.149; Munshi N, 1998, MOL CELL, V2, P457, DOI 10.1016/S1097-2765(00)80145-8; Munshi N, 2001, SCIENCE, V293, P1133, DOI 10.1126/science.293.5532.1133; Mutskov V, 1998, MOL CELL BIOL, V18, P6293, DOI 10.1128/MCB.18.11.6293; Peterson CL, 2000, FEBS LETT, V476, P68, DOI 10.1016/S0014-5793(00)01673-2; Reeves R, 2000, MOL CELL BIOL, V20, P4666, DOI 10.1128/MCB.20.13.4666-4679.2000; Reinke H, 2001, MOL CELL, V7, P529, DOI 10.1016/S1097-2765(01)00200-3; Roychoudhury M, 2000, P NATL ACAD SCI USA, V97, P13608, DOI 10.1073/pnas.250476297; Rubbi L, 1997, BIOCHEM J, V328, P401, DOI 10.1042/bj3280401; Schnitzler G, 1998, CELL, V94, P17, DOI 10.1016/S0092-8674(00)81217-9; Senger K, 2000, MOL CELL, V6, P931, DOI 10.1016/S1097-2765(05)00081-X; Sewack GF, 1997, J BIOL CHEM, V272, P31118, DOI 10.1074/jbc.272.49.31118; Shen CH, 2001, MOL CELL BIOL, V21, P534, DOI 10.1128/MCB.21.2.534-547.2001; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Sudarsanam P, 1999, EMBO J, V18, P3101, DOI 10.1093/emboj/18.11.3101; Syntichaki P, 2000, NATURE, V404, P414, DOI 10.1038/35006136; VERDIN E, 1993, EMBO J, V12, P3249, DOI 10.1002/j.1460-2075.1993.tb05994.x; Verdone L, 1996, MOL CELL BIOL, V16, P1978; Vignali M, 2000, MOL CELL BIOL, V20, P1899, DOI 10.1128/MCB.20.6.1899-1910.2000; Weinmann AS, 1999, IMMUNITY, V11, P665, DOI 10.1016/S1074-7613(00)80141-7; Weinmann AS, 2001, NAT IMMUNOL, V2, P51, DOI 10.1038/83168; Whitehouse I, 1999, NATURE, V400, P784, DOI 10.1038/23506; Wolffe A., 1995, CHROMATIN STRUCTURE; XIAO H, 2001, IN PRESS MOL CELL	61	161	164	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 21	2001	106	6					685	696		10.1016/S0092-8674(01)00490-1	http://dx.doi.org/10.1016/S0092-8674(01)00490-1			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	476EJ	11572775	Bronze			2022-12-24	WOS:000171213000006
J	Simon, I; Barnett, J; Hannett, N; Harbison, CT; Rinaldi, NJ; Volkert, TL; Wyrick, JJ; Zeitlinger, J; Gifford, DK; Jaakkola, TS; Young, RA				Simon, I; Barnett, J; Hannett, N; Harbison, CT; Rinaldi, NJ; Volkert, TL; Wyrick, JJ; Zeitlinger, J; Gifford, DK; Jaakkola, TS; Young, RA			Serial regulation of transcriptional regulators in the yeast cell cycle	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; S-PHASE; SWI5 TRANSCRIPTION; GENE-EXPRESSION; DNA-REPLICATION; FORKHEAD GENES; G1 CYCLINS; PROTEIN; IDENTIFICATION	Genome-wide location analysis was used to determine how the yeast cell cycle gene expression program is regulated by each of the nine known cell cycle transcriptional activators. We found that cell cycle transcriptional activators that function during one stage of the cell cycle regulate transcriptional activators that function during the next stage. This serial regulation of transcriptional activators forms a connected regulatory network that is itself a cycle. Our results also reveal how the nine transcriptional regulators coordinately regulate global gene expression and diverse stage-specific functions to produce a continuous cycle of cellular events. This information forms the foundation for a complete map of the transcriptional regulatory network that controls the cell cycle.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; MIT, Artificial Intelligence Lab, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Young, RA (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.		Young, Richard A/F-6495-2012; Rinaldi, Nicola J/J-5858-2017	Young, Richard A/0000-0001-8855-8647; Rinaldi, Nicola J/0000-0002-0358-0747; Simon, Itamar/0000-0002-8517-1903				ALTHOEFER H, 1995, MOL CELL BIOL, V15, P5917; AMON A, 1993, CELL, V74, P993, DOI 10.1016/0092-8674(93)90722-3; Breeden LL, 2000, CURR BIOL, V10, pR586, DOI 10.1016/S0960-9822(00)00634-5; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Cosma MP, 1999, CELL, V97, P299, DOI 10.1016/S0092-8674(00)80740-0; DIRICK L, 1992, NATURE, V357, P508, DOI 10.1038/357508a0; DIRICK L, 1995, EMBO J, V14, P4803, DOI 10.1002/j.1460-2075.1995.tb00162.x; FOSTER R, 1993, MOL CELL BIOL, V13, P3792, DOI 10.1128/MCB.13.6.3792; GORDON CB, 1991, P NATL ACAD SCI USA, V88, P6058, DOI 10.1073/pnas.88.14.6058; Grether ME, 1999, MOL BIOL CELL, V10, P3689, DOI 10.1091/mbc.10.11.3689; Hollenhorst PC, 2000, GENETICS, V154, P1533; Igual JC, 1996, EMBO J, V15, P5001, DOI 10.1002/j.1460-2075.1996.tb00880.x; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; Jaspersen SL, 1998, MOL BIOL CELL, V9, P2803, DOI 10.1091/mbc.9.10.2803; Knapp D, 1996, MOL CELL BIOL, V16, P5701; KOCH C, 1994, CURR OPIN CELL BIOL, V6, P451, DOI 10.1016/0955-0674(94)90039-6; KOCH C, 1993, SCIENCE, V261, P1551, DOI 10.1126/science.8372350; Koch C, 1996, GENE DEV, V10, P129, DOI 10.1101/gad.10.2.129; Koranda M, 2000, NATURE, V406, P94, DOI 10.1038/35017589; Kumar R, 2000, CURR BIOL, V10, P896, DOI 10.1016/S0960-9822(00)00618-7; KUO MH, 1994, MOL CELL BIOL, V14, P348, DOI 10.1128/MCB.14.1.348; LOWNDES NF, 1991, NATURE, V350, P247, DOI 10.1038/350247a0; Loy CJ, 1999, MOL CELL BIOL, V19, P3312; LYDALL D, 1991, GENE DEV, V5, P2405, DOI 10.1101/gad.5.12b.2405; MacKay VL, 2001, MOL CELL BIOL, V21, P4140, DOI 10.1128/MCB.21.13.4140-4148.2001; McBride HJ, 1999, J BIOL CHEM, V274, P21029, DOI 10.1074/jbc.274.30.21029; McInerny CJ, 1997, GENE DEV, V11, P1277, DOI 10.1101/gad.11.10.1277; Mendenhall MD, 1998, MICROBIOL MOL BIOL R, V62, P1191, DOI 10.1128/MMBR.62.4.1191-1243.1998; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Nasmyth K, 1996, TRENDS GENET, V12, P405, DOI 10.1016/0168-9525(96)10041-X; NASMYTH K, 1990, CELL, V62, P631, DOI 10.1016/0092-8674(90)90110-Z; NASMYTH K, 1991, CELL, V66, P995, DOI 10.1016/0092-8674(91)90444-4; Nurse P, 2000, CELL, V100, P71, DOI 10.1016/S0092-8674(00)81684-0; Oehlen LJWM, 1996, MOL CELL BIOL, V16, P2830; OGAS J, 1991, CELL, V66, P1015, DOI 10.1016/0092-8674(91)90445-5; Partridge JF, 1997, J BIOL CHEM, V272, P9071; PIATTI S, 1995, EMBO J, V14, P3788, DOI 10.1002/j.1460-2075.1995.tb00048.x; Pic A, 2000, EMBO J, V19, P3750, DOI 10.1093/emboj/19.14.3750; PIZZAGALLI A, 1988, P NATL ACAD SCI USA, V85, P3772, DOI 10.1073/pnas.85.11.3772; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Ross-Macdonald P, 1999, NATURE, V402, P413, DOI 10.1038/46558; SCHWOB E, 1993, GENE DEV, V7, P1160, DOI 10.1101/gad.7.7a.1160; Shirayama M, 1999, NATURE, V402, P203, DOI 10.1038/46080; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; SURANA U, 1991, CELL, V65, P145, DOI 10.1016/0092-8674(91)90416-V; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; TOONE WM, 1995, EMBO J, V14, P5824, DOI 10.1002/j.1460-2075.1995.tb00270.x; Toyn JH, 1997, GENETICS, V145, P85; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; VERMA R, 1991, P NATL ACAD SCI USA, V88, P7155, DOI 10.1073/pnas.88.16.7155; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460; Zhu GF, 2000, NATURE, V406, P90, DOI 10.1038/35017581	53	482	498	0	18	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	SEP 21	2001	106	6					697	708		10.1016/S0092-8674(01)00494-9	http://dx.doi.org/10.1016/S0092-8674(01)00494-9			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	476EJ	11572776	Bronze			2022-12-24	WOS:000171213000007
J	Gerrish, P				Gerrish, P			The rhythm of microbial adaptation	NATURE			English	Article							DIMINISHING RETURNS; EVOLUTION; POPULATION; LIMITS; INTERFERENCE; MUTATIONS; LINKAGE	The evolutionary biologist "studies the steps by which the miraculous adaptations so characteristic of every aspect of the organic world have evolved''(1). But the general nature of such adaptive steps is still unclear. Evolution is often thought to be random and dependent on unpredictable events(2). In this light, one might expect the steps taken by adaptation to be completely random, both biologically and temporally. Here I present a mathematical derivation to show that, on the contrary, adaptive steps can have fairly strong rhythm. I find that the strength of the adaptive rhythm, that is its relative temporal regularity, is equal to a constant that is the same for all microbial populations. As a consequence, numbers of accumulated adaptations are predicted to have a universal variance/mean ratio. The theory derived here is potentially applicable to the study of molecular evolution.	Los Alamos Natl Lab, Los Alamos, NM 87545 USA	United States Department of Energy (DOE); Los Alamos National Laboratory	Gerrish, P (corresponding author), Los Alamos Natl Lab, T-10,Mailstop K710, Los Alamos, NM 87545 USA.	gerrish@lanl.gov	Gerrish, Philip/AAE-7346-2019	Gerrish, Philip/0000-0001-6393-0553				BARTON NH, 1995, GENETICS, V140, P821; BARTON NH, 1994, GENET RES, V64, P199, DOI 10.1017/S0016672300032857; de Visser JAGM, 1999, SCIENCE, V283, P404, DOI 10.1126/science.283.5400.404; FELLER W, 1968, INTRO PROBABILITY TH, V2, P346; FELSENSTEIN J, 1974, GENETICS, V78, P737; Felsenstein J, 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fisher R., 1930, GENETICAL THEORY NAT, P102; Gerrish PJ, 1998, GENETICA, V102-3, P127, DOI 10.1023/A:1017067816551; GILLESPIE JH, 1998, POPULATION GENETICS, P77; Gould S.J, 1989, WONDERFUL LIFE BURGE; HAIGH J, 1978, THEOR POPUL BIOL, V14, P251, DOI 10.1016/0040-5809(78)90027-8; Haldane JBS, 1927, P CAMB PHILOS SOC, V23, P838, DOI 10.1017/S0305004100015644; HILL WG, 1966, GENET RES, V8, P269, DOI 10.1017/S0016672300010156; HOGG RV, 1995, INTRO MATH STAT, P59; KORBER BT, 1998, SNAP SYNONYMOUS NONS; MAYR E, 1988, NEW PHILOS BIOL, P26; McVean GAT, 2000, GENETICS, V155, P929; Miralles R, 1999, SCIENCE, V285, P1745, DOI 10.1126/science.285.5434.1745; Miralles R, 2000, J VIROL, V74, P3566, DOI 10.1128/JVI.74.8.3566-3571.2000; Morgan T.H., 1913, HEREDITY SEX; Muller HJ, 1932, AM NAT, V66, P118, DOI 10.1086/280418; Orr HA, 2000, GENETICS, V155, P961; Orr HA, 1998, EVOLUTION, V52, P935, DOI [10.1111/j.1558-5646.1998.tb01823.x, 10.2307/2411226]; OSMANOV S, 1994, AIDS RES HUM RETROV, V10, P1327, DOI 10.1089/aid.1994.10.1327; Ota T, 1971, J Mol Evol, V1, P18, DOI 10.1007/BF01659391; Otto SP, 1997, GENETICS, V147, P879; ROBERTSON A, 1970, MATH TOPICS POPULATI, P246; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wahl LM, 2000, GENETICS, V156, P1437	29	57	58	1	6	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 20	2001	413	6853					299	302		10.1038/35095046	http://dx.doi.org/10.1038/35095046			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473KB	11565030				2022-12-24	WOS:000171040500037
J	Karp, PD				Karp, PD			Pathway databases: A case study in computational symbolic theories	SCIENCE			English	Editorial Material							GENOME SEQUENCE	A pathway database (DB) is a DB that describes biochemical pathways, reactions, and enzymes. The EcoCyc pathway DB (see http://ecocyc.org) describes the metabolic, transport, and genetic-regulatory networks of Escherichia coli. EcoCyc is an example of a computational symbolic theory, which is a DB that structures a scientific theory within a formal ontology so that it is available for computational analysis. it is argued that by encoding scientific theories in symbolic form, we open new realms of analysis and understanding for theories that would otherwise be too large and complex for scientists to reason with effectively.	SRI Int, Bioinformat Res Grp, Menlo Pk, CA 94025 USA	SRI International	Karp, PD (corresponding author), SRI Int, Bioinformat Res Grp, EK223,333 Ravenswood Ave, Menlo Pk, CA 94025 USA.	pkarp@ai.sri.com	Karp, Peter/C-3514-2012	Karp, Peter/0000-0002-5876-6418	NCRR NIH HHS [1-R01-RR07861-01] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR007861] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Edwards JS, 2000, P NATL ACAD SCI USA, V97, P5528, DOI 10.1073/pnas.97.10.5528; Ellis LBM, 2000, NUCLEIC ACIDS RES, V28, P377, DOI 10.1093/nar/28.1.377; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; KARP P, 1996, P 4 INT C INT SYST M; KARP P, 1999, NUCL ACID PROTEIN DA, P269; Karp PD, 2000, BIOINFORMATICS, V16, P269, DOI 10.1093/bioinformatics/16.3.269; Karp PD, 1998, TRENDS BIOCHEM SCI, V23, P114, DOI 10.1016/S0968-0004(98)01184-0; Karp PD, 2000, NUCLEIC ACIDS RES, V28, P56, DOI 10.1093/nar/28.1.56; Karp PP, 1999, TRENDS BIOTECHNOL, V17, P275, DOI 10.1016/S0167-7799(99)01316-5; Ouzounis CA, 2000, GENOME RES, V10, P568, DOI 10.1101/gr.10.4.568; Overbeek R, 2000, NUCLEIC ACIDS RES, V28, P123, DOI 10.1093/nar/28.1.123; Romero P R, 2001, Pac Symp Biocomput, P471; SCHILLING C, 1988, P NATL ACAD SCI USA, V95, P4193; Stewart G., 1975, TOPICS NUMERICAL ANA, VII, P185, DOI [DOI 10.1016/B978-0-12-108550-6.50012-4, 10.1016/B978-0-12-496952-0.50023-4, DOI 10.1016/B978-0-12-496952-0.50023-4]	16	148	158	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 14	2001	293	5537					2040	2044		10.1126/science.1064621	http://dx.doi.org/10.1126/science.1064621			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473FB	11557880				2022-12-24	WOS:000171028700061
J	Luo, Y; Pfuetzner, RA; Mosimann, S; Paetzel, M; Frey, EA; Cherney, M; Kim, B; Little, JW; Strynadka, NCJ				Luo, Y; Pfuetzner, RA; Mosimann, S; Paetzel, M; Frey, EA; Cherney, M; Kim, B; Little, JW; Strynadka, NCJ			Crystal structure of LexA: A conformational switch for regulation of self-cleavage	CELL			English	Article							ESCHERICHIA-COLI; UMUD PROTEIN; INTERMOLECULAR CLEAVAGE; REPRESSOR; AUTODIGESTION; DNA; IDENTIFICATION; MECHANISM; PURIFICATION; PROGRAM	LexA repressor undergoes a self-cleavage reaction. In vivo, this reaction requires an activated form of RecA, but it occurs spontaneously in vitro at high pH. Accordingly, LexA must both allow self-cleavage and yet prevent this reaction in the absence of a stimulus. We have solved the crystal structures of several mutant forms of LexA. Strikingly, two distinct conformations are observed, one compatible with cleavage, and the other in which the cleavage site is similar to 20 Angstrom from the catalytic center. Our analysis provides insight into the structural and energetic features that modulate the interconversion between these two forms and hence the rate of the self-cleavage reaction. We suggest RecA activates the self-cleavage of LexA and related proteins through selective stabilization of the cleavable conformation.	Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada; Univ Arizona, Dept Biochem & Mol Biophys, Tucson, AZ 85721 USA; Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA	University of British Columbia; University of Alberta; University of Arizona; University of Arizona	Strynadka, NCJ (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, 2146 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	natalie@byron.biochem.ubc.ca		Paetzel, Mark/0000-0002-7408-5487	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM024178] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM24178] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BACON D, 1988, J MOL GRAPHICS, V6, P219, DOI 10.1016/S0263-7855(98)80030-1; BARTON GJ, 1993, PROTEIN ENG, V6, P37, DOI 10.1093/protein/6.1.37; Bell CE, 2000, CELL, V101, P801, DOI 10.1016/S0092-8674(00)80891-0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BURCKHARDT SE, 1988, P NATL ACAD SCI USA, V85, P1811, DOI 10.1073/pnas.85.6.1811; CHAN AWE, 1993, PROTEIN SCI, V2, P1574, DOI 10.1002/pro.5560021004; DAOPIN S, 1991, BIOCHEMISTRY-US, V30, P11521, DOI 10.1021/bi00113a006; DEANDA J, 1983, J BIOL CHEM, V258, P536; Ferentz AE, 1997, NAT STRUCT BIOL, V4, P979, DOI 10.1038/nsb1297-979; FOGH RH, 1994, EMBO J, V13, P3936, DOI 10.1002/j.1460-2075.1994.tb06709.x; Friedberg E.C., 2016, DNA REPAIR MUTAGENES, V33, P35; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; GIMBLE FS, 1986, J MOL BIOL, V192, P39, DOI 10.1016/0022-2836(86)90462-6; HONIG B, 1995, SCIENCE, V268, P1144, DOI 10.1126/science.7761829; HURSTEL S, 1986, EMBO J, V5, P793, DOI 10.1002/j.1460-2075.1986.tb04283.x; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KIM B, 1993, CELL, V73, P1165, DOI 10.1016/0092-8674(93)90645-7; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KRAUT J, 1977, ANNU REV BIOCHEM, V46, P331, DOI 10.1146/annurev.bi.46.070177.001555; Lamzin VS, 1997, METHOD ENZYMOL, V277, P269, DOI 10.1016/S0076-6879(97)77016-2; Laskowski M, 2000, BBA-PROTEIN STRUCT M, V1477, P324, DOI 10.1016/S0167-4838(99)00284-8; Lejal N, 2000, J GEN VIROL, V81, P983, DOI 10.1099/0022-1317-81-4-983; Liao DI, 2000, NAT STRUCT BIOL, V7, P749, DOI 10.1038/78973; LIN LL, 1988, J BACTERIOL, V170, P2163, DOI 10.1128/jb.170.5.2163-2173.1988; LIN LL, 1989, J MOL BIOL, V210, P439, DOI 10.1016/0022-2836(89)90121-6; LITTLE JW, 1984, P NATL ACAD SCI-BIOL, V81, P1375, DOI 10.1073/pnas.81.5.1375; LITTLE JW, 1991, BIOCHIMIE, V73, P411, DOI 10.1016/0300-9084(91)90108-D; LITTLE JW, 1994, METHOD ENZYMOL, V244, P266; LITTLE JW, 1980, P NATL ACAD SCI-BIOL, V77, P3225, DOI 10.1073/pnas.77.6.3225; LITTLE JW, 1982, CELL, V29, P11, DOI 10.1016/0092-8674(82)90085-X; LITTLE JW, 1993, J BACTERIOL, V175, P4943, DOI 10.1128/JB.175.16.4943-4950.1993; McDonald JP, 1998, P NATL ACAD SCI USA, V95, P1478, DOI 10.1073/pnas.95.4.1478; McDonald JP, 1999, J MOL BIOL, V285, P2199, DOI 10.1006/jmbi.1998.2433; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Opperman T, 1999, P NATL ACAD SCI USA, V96, P9218, DOI 10.1073/pnas.96.16.9218; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paetzel M, 1998, NATURE, V396, P186, DOI 10.1038/24196; Patricelli MP, 1999, BIOCHEMISTRY-US, V38, P9804, DOI 10.1021/bi990637z; Peat TS, 1996, STRUCTURE, V4, P1401, DOI 10.1016/S0969-2126(96)00148-7; Peat TS, 1996, NATURE, V380, P727, DOI 10.1038/380727a0; Ptashne M, 1992, GENETIC SWITCH PHAGE; ROBERTS JW, 1978, P NATL ACAD SCI USA, V75, P4714, DOI 10.1073/pnas.75.10.4714; ROLAND KL, 1990, J BIOL CHEM, V265, P12828; ROLAND KL, 1992, J MOL BIOL, V228, P395, DOI 10.1016/0022-2836(92)90829-9; SCHNARR M, 1985, BIOCHEMISTRY-US, V24, P2812, DOI 10.1021/bi00332a032; Shepley DP, 1996, P NATL ACAD SCI USA, V93, P11528, DOI 10.1073/pnas.93.21.11528; SLILATY SN, 1987, P NATL ACAD SCI USA, V84, P3987, DOI 10.1073/pnas.84.12.3987; SLILATY SN, 1991, PROTEIN ENG, V4, P919, DOI 10.1093/protein/4.8.919; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Volkman BF, 2001, SCIENCE, V291, P2429, DOI 10.1126/science.291.5512.2429	51	172	175	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 7	2001	106	5					585	594		10.1016/S0092-8674(01)00479-2	http://dx.doi.org/10.1016/S0092-8674(01)00479-2			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	472FQ	11551506	Bronze			2022-12-24	WOS:000170973200009
J	Brown, GD; Gordon, S				Brown, GD; Gordon, S			Immune recognition - A new receptor for beta-glucans	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; PHAGOCYTOSIS; BINDING		Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Oxford	Brown, GD (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	gbrown@molbiol.ox.ac.uk	brown, gordon/B-4249-2012	brown, gordon/0000-0002-0287-5383				Ariizumi K, 2000, J BIOL CHEM, V275, P20157, DOI 10.1074/jbc.M909512199; BARTNICK.S, 1968, ANNU REV MICROBIOL, V22, P87, DOI 10.1146/annurev.mi.22.100168.000511; CZOP JK, 1986, PATHOL IMMUNOPATH R, V5, P286, DOI 10.1159/000157022; DICARLO FJ, 1958, SCIENCE, V127, P756, DOI 10.1126/science.127.3301.756-a; GIAIMIS J, 1993, J LEUKOCYTE BIOL, V54, P564, DOI 10.1002/jlb.54.6.564; JANUSZ MJ, 1988, IMMUNOLOGY, V65, P181; Mueller A, 2000, GLYCOBIOLOGY, V10, P339, DOI 10.1093/glycob/10.4.339; Muller A, 1996, J IMMUNOL, V156, P3418; ROSS GD, 1985, J IMMUNOL, V134, P3307; Weis WI, 1998, IMMUNOL REV, V163, P19, DOI 10.1111/j.1600-065X.1998.tb01185.x; WILLIAMS DL, 1991, CARBOHYD RES, V219, P203, DOI 10.1016/0008-6215(91)89052-H	11	1166	1234	3	126	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 6	2001	413	6851					36	37		10.1038/35092620	http://dx.doi.org/10.1038/35092620			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469EG	11544516				2022-12-24	WOS:000170801200029
J	Pavlov, P; Svendsen, JI; Indrelid, S				Pavlov, P; Svendsen, JI; Indrelid, S			Human presence in the European Arctic nearly 40,000 years ago	NATURE			English	Article							ICE SHEETS; BARENTS; KARA; COLONIZATION; RUSSIA; EXTENT	The transition from the Middle to the Upper Palaeolithic, approximately 40,000-35,000 radiocarbon years ago, marks a turning point in the history of human evolution in Europe. Many changes in the archaeological and fossil record at this time have been associated with the appearance of anatomically modern humans(1,2). Before this transition, the Neanderthals roamed the continent, but their remains have not been found in the northernmost part of Eurasia. It is generally believed that this vast region was not colonized by humans until the final stage of the last Ice Age some 13,000-14,000 years ago(3,4). Here we report the discovery of traces of human occupation nearly 40,000 years old at Mamontovaya Kurya, a Palaeolithic site situated in the European part of the Russian Arctic. At this site we have uncovered stone artefacts, animal bones and a mammoth tusk with human-made marks from strata covered by thick Quaternary deposits. This is the oldest documented evidence for human presence at this high latitude; it implies that either the Neanderthals expanded much further north than previously thought or that modern humans were present in the Arctic only a few thousand years after their first appearance in Europe.	Univ Bergen, Ctr Studies Environm & Resources, N-5020 Bergen, Norway; Russian Acad Sci, Inst Language Literature & Hist, Komi Sci Ctr, Ural Div, Syktyvkar 167000, Russia; Univ Bergen, Bergen Museum, N-5020 Bergen, Norway	University of Bergen; Russian Academy of Sciences; Institute of Language, Literature & History, Komi Scientific Centre of the RAS; Komi Science Centre of the Ural Branch of the Russian Academy of Sciences; University of Bergen	Svendsen, JI (corresponding author), Univ Bergen, Ctr Studies Environm & Resources, N-5020 Bergen, Norway.	john.svendsen@smr.uib.no	Pavlov, Pavel Yu/S-3823-2016	Pavlov, Pavel Yu/0000-0001-8827-5719				ALLSWORTHJONES P, 1986, SZELETIAN, P83; ANIKOVICH MV, 1991, EARLY UPPER PALAEOLI; Astakhov VI, 1999, BOREAS, V28, P23, DOI 10.1111/j.1502-3885.1999.tb00205.x; Bader O.N., 1978, SUNGIR UPPER PALAEOL; Bar-Yosef O, 1998, NEANDERTALS AND MODERN HUMANS IN WESTERN ASIA, P39; Bocquet-Appel JP, 2000, ANTIQUITY, V74, P544, DOI 10.1017/S0003598X00059901; DERICCO F, 1998, CURR ANTHROPOL S, V39, P1; GAMBLE C, 1999, PALAEOLITHIC SOC EUR, P268; Halvorsen L. S., 2000, THESIS U BERGEN; HOFFECKER JF, 1993, SCIENCE, V259, P46, DOI 10.1126/science.259.5091.46; Kanivets V.I., 1976, PALEOLITHIC EXTREME; Kolosov YG, 1983, MOUSTERIAN SITES BEL; Mangerud J, 1999, BOREAS, V28, P46, DOI 10.1111/j.1502-3885.1999.tb00206.x; MOCHANOV YA, 1977, INITIAL SETTLING TER; Ovchinnikov IV, 2000, NATURE, V404, P490, DOI 10.1038/35006625; PAVLOV PY, 1999, B I BIOL SYKTYVKAR, V2, P24; PAVLOV PY, 1986, PAMIATNIKI MAT KULTY, P7; PAVLOV PY, 1996, PALAEOLITHIC ARCHAEO, P44; Powers WR, 1996, INTERD CONT, P229; PRASLOV ND, 1982, PALEOLIT KOSTENKOVSK, P16; SINITSYN AA, 1997, RADIOUGLERODNAYA KHR, P21; Smith NP, 1999, COMPUT SCI ENG, V1, P96; Straus LG, 2000, ANTIQUITY, V74, P553; STRAUS LG, 1989, NATURE, V342, P476; STRINGER CB, 1996, AFRICAN EXODUS ORIGI, P84; Svendsen JI, 1999, BOREAS, V28, P234, DOI 10.1111/j.1502-3885.1999.tb00217.x; VanAndel TH, 1996, QUATERNARY SCI REV, V15, P481, DOI 10.1016/0277-3791(96)00028-5	27	104	109	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 6	2001	413	6851					64	67		10.1038/35092552	http://dx.doi.org/10.1038/35092552			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469EG	11544525				2022-12-24	WOS:000170801200038
J	CRISP, D; ALLEN, DA; GRINSPOON, DH; POLLACK, JB				CRISP, D; ALLEN, DA; GRINSPOON, DH; POLLACK, JB			THE DARK SIDE OF VENUS - NEAR-INFRARED IMAGES AND SPECTRA FROM THE ANGLO-AUSTRALIAN-OBSERVATORY	SCIENCE			English	Article							HEATING RATES; NIGHT-SIDE; RADIATIVE-TRANSFER; LINE PARAMETERS; ENERGY-LEVELS; SOLAR FLUXES; ATMOSPHERE; INTENSITIES; GREENHOUSE; MESOSPHERE	Near-infrared images and spectra of the night side of Venus taken at the Anglo-Australian Telescope during February 1990 reveal four new thermal emission windows at 1.10, 1.18, 1.27, and 1.31 micrometers (mu-m), in addition to the previously discovered windows at 1.74 and 2.3-mu-m. Images of the Venus night side show similar bright and dark markings in all windows, but their contrast is much lower at short wavelengths. The 1.27-mu-m window includes a bright, high-altitude O2 airglow feature in addition to a thermal contribution from the deep atmosphere. Simulations of the 1.27- and 2.3-mu-m spectra indicate water vapor mixing ratios near 40 +/- 20 parts per million by volume between the surface and the cloud base. No large horizontal gradients in the water vapor mixing ratios were detected at these altitudes.	ANGLO AUSTRALIAN OBSERV,EPPING,NSW 2121,AUSTRALIA; NASA,AMES RES CTR,MOFFETT FIELD,CA 94035	National Aeronautics & Space Administration (NASA); NASA Ames Research Center	CRISP, D (corresponding author), CALTECH,JET PROP LAB,MS 169-237,4800 OAK GROVE DR,PASADENA,CA 91109, USA.		Crisp, David/F-6642-2017	Crisp, David/0000-0002-4573-9998				ALLEN D, 1990, 4962 INT ASTR UN CIR; ALLEN DA, 1984, NATURE, V307, P222, DOI 10.1038/307222a0; ALLEN DA, 1986, ICARUS, V69, P221; BAILEY J, 1988, PUBL ASTRON SOC PAC, V100, P1178, DOI 10.1086/132286; BELL JF, 1991, SCIENCE, V252, P1293, DOI 10.1126/science.252.5010.1293; BELL JF, 1990, B AM ASTRON SOC, V22, P1052; BEZARD B, 1990, NATURE, V345, P508, DOI 10.1038/345508a0; BROWN LR, 1987, APPL OPTICS, V26, P5154, DOI 10.1364/AO.26.005154; CLOUGH SA, 1981, P SOC PHOTO-OPT INST, V277, P152; CONNES P, 1979, ASTROPHYS J, V233, pL29, DOI 10.1086/183070; CRISP D, 1986, ICARUS, V67, P484, DOI 10.1016/0019-1035(86)90126-0; CRISP D, 1989, SCIENCE, V246, P506, DOI 10.1126/science.246.4929.506; CRISP D, 1990, J GEOPHYS RES-SOLID, V95, P14577, DOI 10.1029/JB095iB09p14577; DEBERGH C, 1991, SCIENCE, V21, P547; GRINSPOON DH, 1987, SCIENCE, V238, P1702, DOI 10.1126/science.238.4834.1702; Hoffman JH, 1980, J GEOPHYS RES-SPACE, V85, P7882, DOI 10.1029/JA085iA13p07882; HUSSON N, 1986, ANN GEOPHYS A-UPPER, V4, P185; INGERSOLL AP, 1969, J ATMOS SCI, V26, P1191, DOI 10.1175/1520-0469(1969)026<1191:TRGAHO>2.0.CO;2; KAMP LW, 1988, NATURE, V336, P360, DOI 10.1038/336360a0; KAMP LW, 1990, ICARUS, V86, P510, DOI 10.1016/0019-1035(90)90231-W; KASTING JF, 1988, ICARUS, V74, P472, DOI 10.1016/0019-1035(88)90116-9; Knollenberg RG, 1980, J GEOPHYS RES-SPACE, V85, P8039, DOI 10.1029/JA085iA13p08039; Moore JF, 1971, X6307248 NASA GODD S; Moroz V. I., 1983, Venus, P45; Oyama VI, 1980, J GEOPHYS RES-SPACE, V85, P7891, DOI 10.1029/JA085iA13p07891; PALMER KF, 1975, APPL OPTICS, V14, P208, DOI 10.1364/AO.14.000208; PARISOT JP, 1980, ICARUS, V42, P46, DOI 10.1016/0019-1035(80)90241-9; Pollack JB, 1980, J GEOPHYS RES-SPACE, V85, P8141, DOI 10.1029/JA085iA13p08141; Pollack JB, 1980, J GEOPHYS RES-SPACE, V85, P8223, DOI 10.1029/JA085iA13p08223; POLLACK JB, 1971, ICARUS, V14, P295, DOI 10.1016/0019-1035(71)90001-7; ROTHMAN LS, 1986, APPL OPTICS, V25, P1795, DOI 10.1364/AO.25.001795; ROTHMAN LS, 1987, APPL OPTICS, V26, P4085; Seiff A., 1983, Venus, P215; TOON OB, 1977, ICARUS, V30, P663, DOI 10.1016/0019-1035(77)90088-4; TOON OB, 1989, J GEOPHYS RES-ATMOS, V94, P16287, DOI 10.1029/JD094iD13p16287; WATTSON RB, 1986, J MOL SPECTROSC, V119, P83, DOI 10.1016/0022-2852(86)90203-1; YUNG YL, 1982, ICARUS, V51, P199, DOI 10.1016/0019-1035(82)90080-X	37	70	71	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	SEP 13	1991	253	5025					1263	1266		10.1126/science.11538493	http://dx.doi.org/10.1126/science.11538493			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE689	11538493				2022-12-24	WOS:A1991GE68900035
J	ZHANG, YX; STOLPER, EM				ZHANG, YX; STOLPER, EM			WATER DIFFUSION IN A BASALTIC MELT	NATURE			English	Article							ION MICRO-PROBE; ELEVATED-TEMPERATURES; SUBMARINE BASALTS; SILICATE MELTS; GLASSES; CARBON; H2O; CO2; PRESSURES; ABUNDANCE	WATER is the most abundant volatile component in terrestrial basalts and is a significant constituent of the gases that escape from basaltic magmas. Knowledge of the diffusivity of water (and other volatiles) in basaltic melts is important for understanding the degassing of basaltic magma and for assessing the fractionation of volatiles during degassing. We report here measurements of water diffusivity in a basaltic liquid. The water concentration profiles through the samples, determined by Fourier-transform infrared spectroscopy, cannot be modelled adequately on the basis of a constant water diffusivity 1-7, but instead can be fitted by assuming that only molecular H2O is diffusing and that there is a local equilibrium between H2O molecules and OH groups 7-13. The concentration-dependent total water diffusivities in the basaltic melt at 1,300-1,500-degrees-C are 30-50 times as large as those in rhyolitic melts 4-7, and are greater than the total CO2 diffusivity in basaltic melts, contrary to previous expectations 14. These results suggest that diffusive fractionation would increase the ratio of water to carbon dioxide in growing bubbles relative to equilibrium partitioning, and decrease the ratio in interface melts near an advancing anhydrous phenocryst.			ZHANG, YX (corresponding author), CALTECH,DEPT GEOL & PLANETARY SCI,17025,PASADENA,CA 91125, USA.		Zhang, Youxue/D-2922-2011					BURN I, 1970, PHYS CHEM GLASSES, V11, P106; CABLE M, 1987, J MATER SCI, V22, P919, DOI 10.1007/BF01103530; CARROLL MR, 1990, EOS, V71, P1664; CHEKHMIR AS, 1988, GEOKHIMIYA+, V10, P303; Crank J., 1975, MATH DIFFUSION; DELANEY JR, 1978, GEOCHIM COSMOCHIM AC, V42, P581, DOI 10.1016/0016-7037(78)90003-0; DELANEY JR, 1981, EARTH PLANET SC LETT, V52, P191, DOI 10.1016/0012-821X(81)90220-X; DIXON JE, 1988, EARTH PLANET SC LETT, V90, P87, DOI 10.1016/0012-821X(88)90114-8; Doremus RH., 1969, REACT SOLIDS, P667; DUNN T, 1983, GEOCHIM COSMOCHIM AC, V47, P1923, DOI 10.1016/0016-7037(83)90209-0; ERNSBERGER FM, 1980, PHYS CHEM GLASSES, V21, P146; HARRIS DM, 1981, J GEOL, V89, P689, DOI 10.1086/628636; HARRIS DM, 1983, GEOCHIM COSMOCHIM AC, V47, P1139, DOI 10.1016/0016-7037(83)90244-2; JAMBON A, 1987, CHEM GEOL, V62, P177, DOI 10.1016/0009-2541(87)90084-2; KARSTEN JL, 1982, EARTH PLANET SC LETT, V59, P420, DOI 10.1016/0012-821X(82)90143-1; KYSER TK, 1984, GEOCHIM COSMOCHIM AC, V48, P2123, DOI 10.1016/0016-7037(84)90392-2; LAPHAM KE, 1984, J NON-CRYST SOLIDS, V67, P179, DOI 10.1016/0022-3093(84)90148-0; LUX G, 1987, GEOCHIM COSMOCHIM AC, V51, P1549, DOI 10.1016/0016-7037(87)90336-X; MOORE JG, 1977, J VOLCANOL GEOTH RES, V2, P309, DOI 10.1016/0377-0273(77)90018-X; MUENOW DW, 1979, EARTH PLANET SC LETT, V42, P71, DOI 10.1016/0012-821X(79)90191-2; PINEAU F, 1983, EARTH PLANET SC LETT, V62, P239, DOI 10.1016/0012-821X(83)90087-0; Roberts GJ, 1964, PHYS CHEM GLASSES-B, V5, P26; SMETS BM, 1983, PHYS CHEM GLASSES, V24, P635; STANTON TR, 1985, EOS, V66, P1131; STOLPER E, 1988, EARTH PLANET SC LETT, V87, P397, DOI 10.1016/0012-821X(88)90004-0; STOLPER E, 1982, CONTRIB MINERAL PETR, V81, P1, DOI 10.1007/BF00371154; WAKABAYASHI H, 1989, J AM CERAM SOC, V72, P1850, DOI 10.1111/j.1151-2916.1989.tb05990.x; WASSERBERG GJ, 1988, J GEOL, V65, P15; WATSON EB, 1982, EARTH PLANET SC LETT, V61, P346, DOI 10.1016/0012-821X(82)90065-6; ZHANG Y, 1990, GEOCHEM SOC GOLDSCHM, P94; ZHANG Y, IN PRESS EARTH PLANE; ZHANG YX, 1991, GEOCHIM COSMOCHIM AC, V55, P441, DOI 10.1016/0016-7037(91)90003-N; ZHANG YX, 1989, CONTRIB MINERAL PETR, V102, P492, DOI 10.1007/BF00371090	33	151	156	1	31	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	MAY 23	1991	351	6324					306	309		10.1038/351306a0	http://dx.doi.org/10.1038/351306a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM976	11538704				2022-12-24	WOS:A1991FM97600056
J	McClelland, M; Sanderson, KE; Spieth, J; Clifton, SW; Latreille, P; Courtney, L; Porwollik, S; Ali, J; Dante, M; Du, FY; Hou, SF; Layman, D; Leonard, S; Nguyen, C; Scott, K; Holmes, A; Grewal, N; Mulvaney, E; Ryan, E; Sun, H; Florea, L; Miller, W; Stoneking, T; Nhan, M; Waterston, R; Wilson, RK				McClelland, M; Sanderson, KE; Spieth, J; Clifton, SW; Latreille, P; Courtney, L; Porwollik, S; Ali, J; Dante, M; Du, FY; Hou, SF; Layman, D; Leonard, S; Nguyen, C; Scott, K; Holmes, A; Grewal, N; Mulvaney, E; Ryan, E; Sun, H; Florea, L; Miller, W; Stoneking, T; Nhan, M; Waterston, R; Wilson, RK			Complete genome sequence of Salmonella enterica serovar typhimurium LT2	NATURE			English	Article							ESCHERICHIA-COLI; FOODBORNE ILLNESS; GENE-TRANSFER; IDENTIFICATION; EPIDEMIOLOGY; MALTOSE; SYSTEM	Salmonella enterica subspecies I, serovar Typhimurium (S. typhimurium), is a leading cause of human gastroenteritis, and is used as a mouse model of human typhoid fever(1). The incidence of non-typhoid salmonellosis is increasing worldwide(2-4), causing millions of infections and many deaths in the human population each year. Here we sequenced the 4,857-kilobase (kb) chromosome and 94-kb virulence plasmid of S. typhimurium strain LT2. The distribution of close homologues of S. typhimurium LT2 genes in eight related enterobacteria was determined using previously completed genomes of three related bacteria, sample sequencing of both S. enterica serovar Paratyphi A (S. paratyphi A) and Klebsiella pneumoniae, and hybridization of three unsequenced genomes to a microarray of S. typhimurium LT2 genes. Lateral transfer of genes is frequent, with 11% of the S. typhimurium LT2 genes missing from S. enterica serovar Typhi (S. typhi), and 29% missing from Escherichia coli K12. The 352 gene homologues of S. typhimurium LT2 confined to subspecies I of S. enterica- containing most mammalian and bird pathogens(5)- are useful for studies of epidemiology, host specificity and pathogenesis. Most of these homologues were previously unknown, and 50 may be exported to the periplasm or outer membrane, rendering them accessible as therapeutic or vaccine targets.	Sidney Kimmel Canc Ctr, San Diego, CA 92121 USA; Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; Washington Univ, Sch Med, Genome Sequencing Ctr, St Louis, MO 63108 USA; Penn State Univ, Dept Comp Sci & Engn, University Pk, PA 16802 USA	University of Calgary; Washington University (WUSTL); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	McClelland, M (corresponding author), Sidney Kimmel Canc Ctr, 10835 Altman Row, San Diego, CA 92121 USA.		McClelland, Michael/A-8583-2011; Wilson, Richard K./AAF-4139-2019	Wilson, Richard K./0000-0002-1992-1358; McClelland, Michael/0000-0003-1788-9347				Ahmer BMM, 1999, J BACTERIOL, V181, P1364, DOI 10.1128/JB.181.4.1364-1368.1999; Bermudes D, 2000, ADV EXP MED BIOL, V465, P57; Blanc-Potard AB, 1999, J BACTERIOL, V181, P998, DOI 10.1128/JB.181.3.998-1004.1999; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Bumann D, 2000, FEMS IMMUNOL MED MIC, V27, P357, DOI 10.1111/j.1574-695X.2000.tb01450.x; CHALKER RB, 1988, REV INFECT DIS, V10, P111; COOKE EM, 1990, LANCET, V336, P790, DOI 10.1016/0140-6736(90)93251-J; Decker K, 1999, MOL MICROBIOL, V32, P777, DOI 10.1046/j.1365-2958.1999.01395.x; Figueroa-Bossi N, 2001, MOL MICROBIOL, V39, P260, DOI 10.1046/j.1365-2958.2001.02234.x; Florea L, 2000, NUCLEIC ACIDS RES, V28, P3486, DOI 10.1093/nar/28.18.3486; GUPTA SD, 1995, J BACTERIOL, V177, P4207, DOI 10.1128/jb.177.15.4207-4215.1995; Lan RT, 1996, MOL BIOL EVOL, V13, P47, DOI 10.1093/oxfordjournals.molbev.a025569; LIU SL, 1993, J BACTERIOL, V175, P4104, DOI 10.1128/JB.175.13.4104-4120.1993; Liu SL, 1996, P NATL ACAD SCI USA, V93, P10303, DOI 10.1073/pnas.93.19.10303; Matsui H, 2001, J BACTERIOL, V183, P4652, DOI 10.1128/JB.183.15.4652-4658.2001; McClelland M, 2000, NUCLEIC ACIDS RES, V28, P4974, DOI 10.1093/nar/28.24.4974; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; NEIDHARDT FC, 1996, CELLULAR MOL BIOL; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816; Popoff MY, 2000, RES MICROBIOL, V151, P893, DOI 10.1016/S0923-2508(00)01157-8; Porwollik S, 2001, MUTAT RES-FUND MOL M, V483, P1, DOI 10.1016/S0027-5107(01)00239-1; REIDL J, 1991, J BACTERIOL, V173, P4862, DOI 10.1128/jb.173.15.4862-4876.1991; SELANDER RK, 1996, CELLULAR MOL BIOL, P2691; Stanley TL, 2000, J BACTERIOL, V182, P4406, DOI 10.1128/JB.182.16.4406-4413.2000; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; TODD E, 1990, LANCET, V336, P788, DOI 10.1016/0140-6736(90)93250-S; Townsend SM, 2001, INFECT IMMUN, V69, P2894, DOI 10.1128/IAI.69.5.2894-2901.2001	30	1450	3345	7	171	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 25	2001	413	6858					852	856		10.1038/35101614	http://dx.doi.org/10.1038/35101614			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	485JA	11677609	Bronze			2022-12-24	WOS:000171750200048
J	Parkhill, J; Dougan, G; James, KD; Thomson, NR; Pickard, D; Wain, J; Churcher, C; Mungall, KL; Bentley, SD; Holden, MTG; Sebaihia, M; Baker, S; Basham, D; Brooks, K; Chillingworth, T; Connerton, P; Cronin, A; Davis, P; Davies, RM; Dowd, L; White, N; Farrar, J; Feltwell, T; Hamlin, N; Haque, A; Hien, TT; Holroyd, S; Jagels, K; Krogh, A; Larsen, TS; Leather, S; Moule, S; O'Gaora, P; Parry, C; Quail, M; Rutherford, K; Simmonds, M; Skelton, J; Stevens, K; Whitehead, S; Barrell, BG				Parkhill, J; Dougan, G; James, KD; Thomson, NR; Pickard, D; Wain, J; Churcher, C; Mungall, KL; Bentley, SD; Holden, MTG; Sebaihia, M; Baker, S; Basham, D; Brooks, K; Chillingworth, T; Connerton, P; Cronin, A; Davis, P; Davies, RM; Dowd, L; White, N; Farrar, J; Feltwell, T; Hamlin, N; Haque, A; Hien, TT; Holroyd, S; Jagels, K; Krogh, A; Larsen, TS; Leather, S; Moule, S; O'Gaora, P; Parry, C; Quail, M; Rutherford, K; Simmonds, M; Skelton, J; Stevens, K; Whitehead, S; Barrell, BG			Complete genome sequence of a multiple drug resistant Salmonella enterica serovar Typhi CT18	NATURE			English	Article							COMPLETE DNA-SEQUENCE; YERSINIA-PESTIS; EPITHELIAL-CELLS; TYPHIMURIUM; IDENTIFICATION; PROTEIN; VIRULENCE; BACTERIA; PLASMID; STRAIN	Salmonella enterica serovar Typhi (S. typhi) is the aetiological agent of typhoid fever, a serious invasive bacterial disease of humans with an annual global burden of approximately 16 million cases, leading to 600,000 fatalities(1). Many S. enterica serovars actively invade the mucosal surface of the intestine but are normally contained in healthy individuals by the local immune defence mechanisms. However, S. typhi has evolved the ability to spread to the deeper tissues of humans, including liver, spleen and bone marrow. Here we have sequenced the 4,809,037-base pair (bp) genome of a S. typhi (CT18) that is resistant to multiple drugs, revealing the presence of hundreds of insertions and deletions compared with the Escherichia coli genome, ranging in size from single genes to large islands. Notably, the genome sequence identifies over two hundred pseudogenes, several corresponding to genes that are known to contribute to virulence in Salmonella typhimurium. This genetic degradation may contribute to the human-restricted host range for S. typhi. CT18 harbours a 218,150-bp multiple-drug-resistance incH1 plasmid (pHCM1), and a 106,516-bp cryptic plasmid (pHCM2), which shows recent common ancestry with a virulence plasmid of Yersinia pestis.	Sanger Ctr, Cambridge CB10 1SA, England; Univ London Imperial Coll Sci Technol & Med, Dept Sci Biol, Ctr Mol Microbiol & Infect, London SW7 2AZ, England; Univ Oxford, Ctr Trop Med, Oxford OX3 9DU, England; Univ Oxford, Wellcome Trust Clin Res Unit, Ctr Trop Dis, Ho Chi Minh City, Vietnam; Tech Univ Denmark, Biocentrum DTU, CTr Biol Sequence Anal, DK-2800 Lyngby, Denmark	Wellcome Trust Sanger Institute; Imperial College London; University of Oxford; University of Oxford; Technical University of Denmark	Parkhill, J (corresponding author), Sanger Ctr, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	parkhill@sanger.ac.uk; g.dougan@ic.ac.uk	Quail, michael/ABE-6131-2020; Holden, Matthew TG/K-6449-2014; Rutherford, Kim/Y-7995-2018; Connerton, Phillippa/K-2479-2019; Parkhill, Julian/G-4703-2011; Haque, Ashraful/H-8697-2014; White, Nicholas J/I-4629-2012; O'Gaora, Peadar/F-9400-2011; Sebaihia, Mohammed/AAF-6589-2019; Wain, John/B-3446-2013; White, Nick/AAC-6527-2019; Farrar, Jeremy J./HGA-7610-2022; Thomson, Nicholas/P-5988-2014; Krogh, Anders/M-1541-2014	Holden, Matthew TG/0000-0002-4958-2166; Rutherford, Kim/0000-0001-6277-726X; Parkhill, Julian/0000-0002-7069-5958; Haque, Ashraful/0000-0003-2260-0026; O'Gaora, Peadar/0000-0002-6417-7054; Sebaihia, Mohammed/0000-0002-3324-3346; Wain, John/0000-0002-1257-1148; White, Nick/0000-0002-1897-1978; Baker, Stephen/0000-0003-1308-5755; Davies, Robert/0000-0002-9983-1378; Farrar, Jeremy/0000-0002-2700-623X; Thomson, Nicholas/0000-0002-4432-8505; Krogh, Anders/0000-0002-5147-6282; Connerton, Phillippa/0000-0002-7686-5700; Davis, Paul/0000-0001-5545-0824				Bakshi CS, 2000, J BACTERIOL, V182, P2341, DOI 10.1128/JB.182.8.2341-2344.2000; Blanc-Potard AB, 1999, J BACTERIOL, V181, P998, DOI 10.1128/JB.181.3.998-1004.1999; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Doolittle RF, 1996, SCIENCE, V271, P470, DOI 10.1126/science.271.5248.470; HASHIMOTO Y, 1993, J BACTERIOL, V175, P4456, DOI 10.1128/JB.175.14.4456-4465.1993; Hensel M, 1999, MOL MICROBIOL, V32, P275, DOI 10.1046/j.1365-2958.1999.01345.x; Hu P, 1998, J BACTERIOL, V180, P5192, DOI 10.1128/JB.180.19.5192-5202.1998; IVANOV V, 1995, ELEMENTA, V2, P1; Jing DH, 1999, J BIOL CHEM, V274, P27287, DOI 10.1074/jbc.274.38.27287; Kadner R. J., 1996, ESCHERICHIA COLI SAL, V2nd; Kingsley RA, 2000, MOL MICROBIOL, V36, P1006, DOI 10.1046/j.1365-2958.2000.01907.x; Marcus SL, 2000, MICROBES INFECT, V2, P145, DOI 10.1016/S1286-4579(00)00273-2; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; Miao EA, 2000, P NATL ACAD SCI USA, V97, P7539, DOI 10.1073/pnas.97.13.7539; Mirold S, 1999, P NATL ACAD SCI USA, V96, P9845, DOI 10.1073/pnas.96.17.9845; Parkhill J, 2000, NATURE, V404, P502, DOI 10.1038/35006655; Parry C, 1998, LANCET, V351, P1289, DOI 10.1016/S0140-6736(05)79356-9; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; Prentice MB, 2001, J BACTERIOL, V183, P2586, DOI 10.1128/JB.183.8.2586-2594.2001; REEVES MW, 1989, J CLIN MICROBIOL, V27, P313, DOI 10.1128/JCM.27.2.313-320.1989; ROSENBERG SM, 1994, SCIENCE, V265, P405, DOI 10.1126/science.8023163; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sanderson KE, 1998, ELECTROPHORESIS, V19, P569, DOI 10.1002/elps.1150190417; Sherburne CK, 2000, NUCLEIC ACIDS RES, V28, P2177, DOI 10.1093/nar/28.10.2177; Townsend SM, 2001, INFECT IMMUN, V69, P2894, DOI 10.1128/IAI.69.5.2894-2901.2001; Tsolis RM, 1999, INFECT IMMUN, V67, P6385; Wain J, 1998, J CLIN MICROBIOL, V36, P1683, DOI 10.1128/JCM.36.6.1683-1687.1998; Wong KK, 1998, INFECT IMMUN, V66, P3365, DOI 10.1128/IAI.66.7.3365-3371.1998; Zhang XL, 2000, INFECT IMMUN, V68, P3067, DOI 10.1128/IAI.68.6.3067-3073.2000	30	932	2322	6	101	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 25	2001	413	6858					848	852		10.1038/35101607	http://dx.doi.org/10.1038/35101607			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	485JA	11677608	Bronze			2022-12-24	WOS:000171750200047
J	Henson, SM; Costantino, RF; Cushing, JM; Desharnais, RA; Dennis, B; King, AA				Henson, SM; Costantino, RF; Cushing, JM; Desharnais, RA; Dennis, B; King, AA			Lattice effects observed in chaotic dynamics of experimental populations	SCIENCE			English	Article							INSECT POPULATION; CYCLES; MODELS; TRANSITIONS; COMPLEXITY; HABITATS	Animals and many plants are counted in discrete units. The collection of possible values (state space) of population numbers is thus a nonnegative integer lattice. Despite this fact, many mathematical population models assume a continuum of system states. The complex dynamics, such as chaos, often displayed by such continuous-state models have stimulated much ecological research; yet discrete-state models with bounded population size can display only cyclic behavior. Motivated by data from a population experiment, we compared the predictions of discrete-state and continuous-state population models. Neither the discrete- nor continuous-state models completely account for the data. Rather, the observed dynamics are explained by a stochastic blending of the chaotic dynamics predicted by the continuous-state model and the cyclic dynamics predicted by the discrete-state models. We suggest that such lattice effects could be an important component of natural population fluctuations.	Andrews Univ, Dept Math, Berrien Springs, MI 49104 USA; Univ Rhode Isl, Dept Biol Sci, Kingston, RI 02881 USA; Univ Arizona, Dept Math, Interdisciplinary Program Appl Math, Tucson, AZ 85721 USA; Calif State Univ Los Angeles, Dept Biol & Microbiol, Los Angeles, CA 90032 USA; Univ Idaho, Dept Fish & Wildlife Resources, Moscow, ID 83844 USA; Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA 95616 USA	Andrews University; University of Rhode Island; University of Arizona; California State University System; California State University Los Angeles; Idaho; University of Idaho; University of California System; University of California Davis	Henson, SM (corresponding author), Andrews Univ, Dept Math, Berrien Springs, MI 49104 USA.	henson@andrews.edu	King, Aaron A/B-8092-2012	King, Aaron A/0000-0001-6159-3207; Cushing, Jim/0000-0003-1844-661X; Desharnais, Robert/0000-0003-2874-6835				BEDDINGTON JR, 1975, NATURE, V255, P58, DOI 10.1038/255058a0; Briggs CJ, 2000, J ANIM ECOL, V69, P352, DOI 10.1046/j.1365-2656.2000.00398.x; Chapman RN, 1928, ECOLOGY, V9, P111, DOI 10.2307/1929348; Costantino R. F., 1991, POPULATION DYNAMICS; COSTANTINO RF, 1995, NATURE, V375, P227, DOI 10.1038/375227a0; Costantino RF, 1997, SCIENCE, V275, P389, DOI 10.1126/science.275.5298.389; Costantino RF, 1998, B MATH BIOL, V60, P247, DOI 10.1006/bulm.1997.0017; CROMBIE AC, 1946, PROC R SOC SER B-BIO, V133, P76, DOI 10.1098/rspb.1946.0004; Cushing JM, 2001, CHAOS SOLITON FRACT, V12, P219, DOI 10.1016/S0960-0779(00)00109-0; Cushing JM, 1996, ECOL MODEL, V92, P111, DOI 10.1016/0304-3800(95)00170-0; Cushing JM, 1998, J ANIM ECOL, V67, P298, DOI 10.1046/j.1365-2656.1998.00194.x; Dennis B, 2001, ECOL MONOGR, V71, P277, DOI 10.1890/0012-9615(2001)071[0277:ECACDI]2.0.CO;2; Dennis B, 1997, J ANIM ECOL, V66, P704, DOI 10.2307/5923; DENNIS B, 1995, ECOL MONOGR, V65, P261, DOI 10.2307/2937060; Desharnais RA, 1997, SCIENCE, V276, P1881; Desharnais RA, 2001, ECOL LETT, V4, P229, DOI 10.1046/j.1461-0248.2001.00223.x; Hassell MP, 2000, J ANIM ECOL, V69, P543, DOI 10.1046/j.1365-2656.2000.00445.x; HASTINGS A, 1993, ANN REV ECOL SYST, V24; Henson SM, 1998, P ROY SOC B-BIOL SCI, V265, P2229, DOI 10.1098/rspb.1998.0564; Henson SM, 1999, B MATH BIOL, V61, P1121, DOI 10.1006/bulm.1999.0136; JACKSON EA, 1989, PERSPECTIVES NONLINE, V1, P216; May R.M., 1974, STABILITY COMPLEXITY; MAY RM, 1974, SCIENCE, V186, P645, DOI 10.1126/science.186.4164.645; MAY RM, 1976, AM NAT, V110, P573, DOI 10.1086/283092; MORAN PAP, 1950, BIOMETRICS, V6, P250, DOI 10.2307/3001822; Nicholson AJ, 1933, J ANIM ECOL, V2, P132, DOI 10.2307/954; NICHOLSON AJ, 1935, P ZOOL SOC LOND, V3, P551, DOI DOI 10.1111/J.1096-3642.1935.TB01680.X; RICKER W. E., 1954, JOUR FISH RES BD CANADA, V11, P559; Wilson HB, 1997, P ROY SOC B-BIOL SCI, V264, P1189, DOI 10.1098/rspb.1997.0164	29	67	70	1	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2001	294	5542					602	605		10.1126/science.1063358	http://dx.doi.org/10.1126/science.1063358			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484NC	11641500	Green Submitted			2022-12-24	WOS:000171695600049
J	Chow, TW; MacLean, CH				Chow, TW; MacLean, CH			Quality indicators for dementia in vulnerable community-dwelling and hospitalized elders	ANNALS OF INTERNAL MEDICINE			English	Article							NURSING-HOME PLACEMENT; MENTAL-STATE-EXAMINATION; ALZHEIMERS-DISEASE; CONTROLLED TRIAL; DOUBLE-BLIND; PHYSICAL RESTRAINTS; REVERSIBLE DEMENTIA; COGNITIVE DECLINE; AMERICAN-ACADEMY; SENILE DEMENTIA		Univ So Calif, Rancho Los Amigos Natl Rehabil Ctr, Alzheimers Dis Ctr, Downey, CA 90242 USA; Univ Calif Los Angeles, Los Angeles, CA 90024 USA; RAND Corp, Hlth, Santa Monica, CA 90406 USA	University of Southern California; University of California System; University of California Los Angeles; RAND Corporation	Chow, TW (corresponding author), Univ So Calif, Rancho Los Amigos Natl Rehabil Ctr, Alzheimers Dis Ctr, 7601 E Imperial Highway,800,W Annex, Downey, CA 90242 USA.	tchow@usc.edu						Aevarsson O, 1998, ARCH NEUROL-CHICAGO, V55, P1226, DOI 10.1001/archneur.55.9.1226; ALEXANDER EM, 1995, J AM GERIATR SOC, V43, P138, DOI 10.1111/j.1532-5415.1995.tb06378.x; *AM MED DIR ASS, 1998, CLIN PRACT GIUD 1998; American Psychiatric Association, 1997, PRACT GUID TREATM PA; Bellini M, 1998, ARCH GERONTOL GERIAT, P33; Bowen JD, 1996, NEUROLOGY, V47, P433, DOI 10.1212/WNL.47.2.433; BRADSHAW JR, 1983, BRIT MED J, V286, P277, DOI 10.1136/bmj.286.6361.277; Brodaty H, 1991, Int Psychogeriatr, V3, P11, DOI 10.1017/S1041610291000479; BURDZ MP, 1988, PSYCHOL AGING, V3, P38; BURTON LC, 1992, J AM GERIATR SOC, V40, P811, DOI 10.1111/j.1532-5415.1992.tb01854.x; CAIN ED, 2000, KAPLAN SADOCKS COMPR, P892; CAINE E, 1996, AM J GERIAT PSYCHI S, V4, pS56; Castle NG, 1998, MED CARE RES REV, V55, P139, DOI 10.1177/107755879805500201; CHIVERTON P, 1989, J AM GERIATR SOC, V37, P593, DOI 10.1111/j.1532-5415.1989.tb01248.x; Chow TW, 2000, INT J GERIATR PSYCH, V15, P838, DOI 10.1002/1099-1166(200009)15:9<838::AID-GPS209>3.0.CO;2-U; Chui H, 1997, NEUROLOGY, V49, P925, DOI 10.1212/WNL.49.4.925; CLARFIELD AM, 1988, ANN INTERN MED, V109, P476, DOI 10.7326/0003-4819-109-6-476; COREYBLOOM J, 1995, NEUROLOGY, V45, P211, DOI 10.1212/WNL.45.2.211; COSTA PT, 1996, AHCPR PUBL; COYNE AC, 1995, AM J ALZHEIMER DIS, P27; CRUM RM, 1993, JAMA-J AM MED ASSOC, V269, P2386, DOI 10.1001/jama.269.18.2386; CUMMINGS J, 1983, DEMENTIA CLIN APPROA; DIETCH JT, 1983, WESTERN J MED, V138, P835; DRACHMAN DA, 1993, NEUROLOGY, V43, P2448, DOI 10.1212/WNL.43.12.2448; Draper B, 1998, AGE AGEING, V27, P503, DOI 10.1093/ageing/27.4.503; Dubinsky RM, 2000, NEUROLOGY, V54, P2205, DOI 10.1212/WNL.54.12.2205; Eccles M, 1998, BMJ-BRIT MED J, V317, P802, DOI 10.1136/bmj.317.7161.802; Fillenbaum GG, 1996, AGING-CLIN EXP RES, V8, P379, DOI 10.1007/BF03339599; FRIEDLAND RP, 1988, ANN NEUROL, V24, P782, DOI 10.1002/ana.410240613; GAUTHIER S, 1990, NEW ENGL J MED, V322, P1272, DOI 10.1056/NEJM199005033221804; GRAFSTROM M, 1993, SCAND J SOC MED, V21, P247, DOI 10.1177/140349489302100404; Grasel E, 1997, Int Psychogeriatr, V9, P437; Gurian B, 1997, J GERIATR PSYCHIAT, V30, P211; HALL GR, 1996, RES BASES PROTOCOL A; Hendrie HC, 1998, AM J GERIAT PSYCHIAT, V6, pS3, DOI 10.1097/00019442-199821001-00002; HUNT L, 1993, J AM GERIATR SOC, V41, P747, DOI 10.1111/j.1532-5415.1993.tb07465.x; Innes E M, 1983, QRB Qual Rev Bull, V9, P30; JARVIK LF, 1991, GERIATRICS, V46, P31; Johansson K, 1996, J AM GERIATR SOC, V44, P1198, DOI 10.1111/j.1532-5415.1996.tb01369.x; Kapust L R, 1992, J Geriatr Psychiatry Neurol, V5, P210; Kaufer DI, 1996, J GERIATR PSYCH NEUR, V9, P1, DOI 10.1177/089198879600900101; Keady J, 1995, J Psychiatr Ment Health Nurs, V2, P33, DOI 10.1111/j.1365-2850.1995.tb00163.x; KENT DL, 1994, ANN INTERN MED, V120, P872; KITANO H, 1969, CROSS CULTURAL COUNS, P228; KNIGHT BG, 1993, GERONTOLOGIST, V33, P240, DOI 10.1093/geront/33.2.240; Knopman D, 1996, NEUROLOGY, V47, P166, DOI 10.1212/WNL.47.1.166; Knopman DS, 2001, NEUROLOGY, V56, P1143, DOI 10.1212/WNL.56.9.1143; KOENIG HG, 1989, J AM GERIATR SOC, V37, P599, DOI 10.1111/j.1532-5415.1989.tb01249.x; Kunik ME, 1998, J NERV MENT DIS, V186, P299, DOI 10.1097/00005053-199805000-00006; Launer LJ, 1999, NEUROLOGY, V52, P78, DOI 10.1212/WNL.52.1.78; LEDFORD L, 1996, RES BASES PROTOCOL; LIN KM, 1997, DSM IV 4 SOURCE BOOK, V3, P885; MAHLER ME, 1987, WESTERN J MED, V146, P705; MARAE TD, 1999, REICHELS CARE ELDERL, P200; MARTIN DC, 1987, ARCH INTERN MED, V147, P77, DOI 10.1001/archinte.147.1.77; McCurry SM, 1999, INT J GERIATR PSYCH, V14, P882, DOI 10.1002/(SICI)1099-1166(199910)14:10<882::AID-GPS42>3.0.CO;2-D; McHutchion E, 1989, J Gerontol Nurs, V15, P16; MILES SH, 1992, GERONTOLOGIST, V32, P762, DOI 10.1093/geront/32.6.762; Mittelman MS, 1996, JAMA-J AM MED ASSOC, V276, P1725, DOI 10.1001/jama.276.21.1725; MOHIDE EA, 1990, J AM GERIATR SOC, V38, P446, DOI 10.1111/j.1532-5415.1990.tb03544.x; MOSCA LJ, 1992, CLIN RES, V40, pA561; Mungas D, 1996, NEUROLOGY, V46, P700, DOI 10.1212/WNL.46.3.700; *OFF GER EXT CAR D, 1989, DEM GUID DIAGN TREAT; OKAGAKI JF, 1994, NEUROLOGY, V44, P2203; Penninx BWJH, 1998, JAMA-J AM MED ASSOC, V279, P1720, DOI 10.1001/jama.279.21.1720; Perryman KM, 1996, J GERIATR PSYCH NEUR, V9, P136, DOI 10.1177/089198879600900306; Rao R, 1997, INT J GERIATR PSYCH, V12, P337, DOI 10.1002/(SICI)1099-1166(199703)12:3<337::AID-GPS498>3.0.CO;2-T; ROCCA WA, 1986, ANN NEUROL, V19, P415, DOI 10.1002/ana.410190502; Rogers SL, 1998, NEUROLOGY, V50, P136, DOI 10.1212/WNL.50.1.136; Rogers SL, 1998, ARCH INTERN MED, V158, P1021, DOI 10.1001/archinte.158.9.1021; Ross GW, 1997, JAMA-J AM MED ASSOC, V277, P800, DOI 10.1001/jama.277.10.800; SCHNELLE JF, 1992, GERONTOLOGIST, V32, P767, DOI 10.1093/geront/32.6.767; SCHULZ B M, 1991, Clinical Gerontologist, V11, P80; Shekelle PG, 2001, ANN INTERN MED, V135, P647, DOI 10.7326/0003-4819-135-8_Part_2-200110161-00003; SMALL G, 1995, COMPREHENSIVE TXB PS, V2, P2562; Small GW, 1997, JAMA-J AM MED ASSOC, V278, P1363, DOI 10.1001/jama.278.16.1363; Small GW, 1998, CLIN THER, V20, P838, DOI 10.1016/S0149-2918(98)80145-8; Snowdon DA, 1997, JAMA-J AM MED ASSOC, V277, P813, DOI 10.1001/jama.277.10.813; Swan GE, 1998, NEUROLOGY, V51, P986, DOI 10.1212/WNL.51.4.986; Teunisse S, 1996, J NEUROL, V243, P522, DOI 10.1007/BF00886874; Thal LJ, 1997, NEUROLOGY, V49, P897, DOI 10.1212/WNL.49.3.897-b; THOMPSON P, 1987, BRIT J PSYCHIAT, V151, P206, DOI 10.1192/bjp.151.2.206; *UCLA MED CTR STAN, 1998, INV PHYS RESTR POL 0; *US BUR CENS, 1996, US BUR CENS PUBL; *VET HLTH ADM US D, 1997, DEM ID ASS GUID PRIM, P1; Walstra GJM, 1997, J NEUROL, V244, P17; WEYTINGH MD, 1995, J NEUROL, V242, P466, DOI 10.1007/BF00873551; 1986, JAMA, V256, P2234	88	23	23	1	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 16	2001	135	8	2				668	676		10.7326/0003-4819-135-8_Part_2-200110161-00005	http://dx.doi.org/10.7326/0003-4819-135-8_Part_2-200110161-00005			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	481WA	11601949				2022-12-24	WOS:000171542400005
J	Kampe, KKW; Frith, CD; Dolan, RJ; Frith, U				Kampe, KKW; Frith, CD; Dolan, RJ; Frith, U			Reward value of attractiveness and gaze - Making eye contact enhances the appeal of a pleasing face, irrespective of gender.	NATURE			English	Article									UCL, Inst Cognit Neurosci, London WC1N 3AR, England; Wellcome Dept Cognit Neurol, London WC1N 3BG, England	University of London; University College London; University of London; University College London	Kampe, KKW (corresponding author), UCL, Inst Cognit Neurosci, 17 Queen Sq, London WC1N 3AR, England.	k.kampe@ucl.ac.uk	Frith, Uta/C-1757-2008; Frith, Chris D/A-2171-2009	Frith, Uta/0000-0002-9063-4466; Frith, Chris D/0000-0002-8665-0690; Dolan, Ray/0000-0001-9356-761X				Berridge KC, 1996, NEUROSCI BIOBEHAV R, V20, P1, DOI 10.1016/0149-7634(95)00033-B; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; Emery NJ, 2000, NEUROSCI BIOBEHAV R, V24, P581, DOI 10.1016/S0149-7634(00)00025-7; KLEINKE CL, 1986, PSYCHOL BULL, V100, P78, DOI 10.1037/0033-2909.100.1.78; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1	6	329	335	1	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 11	2001	413	6856					589	589		10.1038/35098149	http://dx.doi.org/10.1038/35098149			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	480WE	11595937	Green Published, Bronze			2022-12-24	WOS:000171485700037
J	Nott, J; Hayne, M				Nott, J; Hayne, M			High frequency of 'super-cyclones' along the Great Barrier Reef over the past 5,000 years	NATURE			English	Article							CORAL-REEFS; RECRUITMENT; DISTURBANCE; COMMUNITY; DIVERSITY; ATOLL; BEBE	Understanding long-term variability in the occurrence of tropical cyclones that are of extreme intensity is important for determining their role in ecological disturbances(1-5), for predicting present and future community vulnerability and economic loss(6) and for assessing whether changes in the variability of such cyclones are induced by climate change(7). Our ability to accurately make these assessments has been limited by the short (less than 100 years) instrumented record of cyclone intensity. Here we determine the intensity of prehistoric tropical cyclones over the past 5,000 years from ridges of detrital coral and shell deposited above highest tide and terraces that have been eroded into coarse-grained alluvial fan deposits. These features occur along 1,500 km of the Great Barrier Reef and also the Gulf of Carpentaria, Australia. We infer that the deposits were formed by storms with recurrence intervals of two to three centuries(8-11), and we show that the cyclones responsible must have been of extreme intensity (central pressures less than 920 hPa). Our estimate of the frequency of such 'super-cyclones' is an order of magnitude higher than that previously estimated (which was once every several millennia(12-14)), and is sufficiently high to suggest that the character of rainforests and coral reef communities were probably shaped by these events.	James Cook Univ N Queensland, Sch Trop Environm Studies & Geog, Cairns, Qld 4870, Australia; Australial Geol Survey Org, Canberra, ACT 2601, Australia	James Cook University	Nott, J (corresponding author), James Cook Univ N Queensland, Sch Trop Environm Studies & Geog, POB 6811, Cairns, Qld 4870, Australia.	Jonathan.Nott@jcu.edu.au	Nott, Jonathan/H-5156-2011	Nott, Jonathan/0000-0001-7258-017X				BLUMENSTOCK DI, 1958, NATURE, V182, P1267, DOI 10.1038/1821267a0; Bryant E. A., 1991, NATURAL HAZARDS; CHAPPELL J, 1983, BMR J AUST GEOL GEOP, V8, P223; CHAPPELL J, 1984, COASTAL GEOMORPHOLOG, P197; CHIVAS A, 1986, MAR GEOL, V69, P273, DOI 10.1016/0025-3227(86)90043-5; Connell JH, 1997, ECOL MONOGR, V67, P461, DOI 10.1890/0012-9615(1997)067[0461:AYSOCA]2.0.CO;2; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Everham EM, 1996, BOT REV, V62, P113, DOI 10.1007/BF02857920; Fitchett K, 1987, AUST GEOGR, V18, P1, DOI 10.1080/00049188708702920; HARPER B, 1998, 10 QUEENSL DEP ENV H; Hayne M, 2001, PALAEOGEOGR PALAEOCL, V168, P207, DOI 10.1016/S0031-0182(00)00217-0; HAYNE M, IN PRESS PALAEOGEOGR; Henderson-Sellers A, 1998, B AM METEOROL SOC, V79, P19, DOI 10.1175/1520-0477(1998)079<0019:TCAGCC>2.0.CO;2; Hubbell SP, 1999, SCIENCE, V283, P554, DOI 10.1126/science.283.5401.554; Hubbert GD, 1999, J COASTAL RES, V15, P168; HUGHES TP, 1989, ECOLOGY, V70, P275, DOI 10.2307/1938434; Hughes TP, 1999, LIMNOL OCEANOGR, V44, P932, DOI 10.4319/lo.1999.44.3_part_2.0932; LIRMAN D, 1997, P 8 INT COR REEF S P, V1, P561; LOURENSZ H, 1981, TROPICAL CYCLONES AU; MARAGOS JE, 1973, SCIENCE, V181, P1161, DOI 10.1126/science.181.4105.1161; MCINNES K, 2000, CYCLONES IMPACTS TOU; OLIVER J, 1989, NATURAL HAZARDS REIN; POTTS DC, 1985, MAR ECOL PROG SER, V23, P79, DOI 10.3354/meps023079; SANDERSON B, 1995, 9528 MON U DEP MATH; SCOFFIN TP, 1993, CORAL REEFS, V12, P203, DOI 10.1007/BF00334480; SOUSA WP, 1984, ANNU REV ECOL SYST, V15, P353, DOI 10.1146/annurev.es.15.110184.002033; Tanner JE, 1996, ECOLOGY, V77, P108, DOI 10.2307/2265660; *USA CORPS ENG, 1986, SHOR PROT MAN; Walsh K., 2001, CLIMATE CHANGE QUEEN	29	155	162	3	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 4	2001	413	6855					508	512		10.1038/35097055	http://dx.doi.org/10.1038/35097055			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	478HG	11586356				2022-12-24	WOS:000171340500043
J	Hollander, E; Evers, M				Hollander, E; Evers, M			New developments in impulsivity	LANCET			English	Editorial Material							VENTROMEDIAL PREFRONTAL CORTEX; DECISION-MAKING; DEFICIT; BLIND		Mt Sinai Sch Med, Dept Psychiat, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Hollander, E (corresponding author), Mt Sinai Sch Med, Dept Psychiat, Box 1230, New York, NY 10029 USA.	eric.hollander@mssm.edu						Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Bechara A, 2000, BRAIN, V123, P2189, DOI 10.1093/brain/123.11.2189; Bechara A, 1999, J NEUROSCI, V19, P5473; Brunner D, 1997, ANN NY ACAD SCI, V836, P81, DOI 10.1111/j.1749-6632.1997.tb52356.x; Cardinal RN, 2001, SCIENCE, V292, P2499, DOI 10.1126/science.1060818; Ernst M, 1998, J NEUROSCI, V18, P5901; Hollander E, 1998, AM J PSYCHIAT, V155, P1781, DOI 10.1176/ajp.155.12.1781; Hollander E, 1998, BRIT J PSYCHIAT, V173, P7, DOI 10.1192/S0007125000297845; Hollander E, 2001, J CLIN PSYCHIAT, V62, P199, DOI 10.4088/JCP.v62n0311; Hollander E, 2000, PSYCHIAT CLIN N AM, V23, P629, DOI 10.1016/S0193-953X(05)70185-4; HOLLANDER E, IN PRESS AM PSYCHIAT; Luria A. R., 2012, HIGHER CORTICAL FUNC; New AS, 1998, AM J MED GENET, V81, P13, DOI 10.1002/(SICI)1096-8628(19980207)81:1<13::AID-AJMG3>3.0.CO;2-O; Rogers RD, 1999, NEUROPSYCHOPHARMACOL, V20, P322, DOI 10.1016/S0893-133X(98)00091-8; Siever LJ, 1999, NEUROPSYCHOPHARMACOL, V20, P413, DOI 10.1016/S0893-133X(98)00111-0	15	41	44	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 22	2001	358	9286					949	950		10.1016/S0140-6736(01)06114-1	http://dx.doi.org/10.1016/S0140-6736(01)06114-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	474YR	11583745				2022-12-24	WOS:000171135300012
J	Hale, ML; Lurz, PWW; Shirley, MDF; Rushton, S; Fuller, RM; Wolff, K				Hale, ML; Lurz, PWW; Shirley, MDF; Rushton, S; Fuller, RM; Wolff, K			Impact of landscape management on the genetic structure of red squirrel populations	SCIENCE			English	Article							MICROSATELLITE DATA; DISPERSAL; DISTANCE; FOREST; MAP	Landscape management practices that alter the degree of habitat fragmentation can significantly affect the genetic structure of animal populations. British red squirrels use "stepping stone" patches of habitat to move considerable distances through a fragmented habitat. Over the past few decades, the planting of a large conifer forest has connected groups of forest fragments in the north of England with those in southern Scotland. This "defragmentation" of the landscape has resulted in substantial genetic mixing of Scottish and Cumbrian genes in squirrel populations up to 100 kilometers from the site of the new forest. These results have implications for the conservation management of animal and plant species in fragmented landscapes such as those found in Britain.	Univ Newcastle Upon Tyne, Dept Agr & Environm Sci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Univ Newcastle Upon Tyne, Ctr Life Sci Modelling, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Ctr Ecol & Hydrol, Huntingdon PE28 2LS, England	Newcastle University - UK; Newcastle University - UK; UK Centre for Ecology & Hydrology (UKCEH)	Hale, ML (corresponding author), Univ Newcastle Upon Tyne, Dept Agr & Environm Sci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.		Lurz, Peter/O-5108-2019; Wolff, Kirsten/E-7961-2012	Wolff, Kirsten/0000-0002-6050-8493; Shirley, Mark/0000-0002-6220-2578				[Anonymous], 1997, ECOL SOC, DOI DOI 10.5751/ES-00015-010104; Beier P, 1998, CONSERV BIOL, V12, P1241, DOI 10.1046/j.1523-1739.1998.98036.x; Bevers M, 1999, THEOR POPUL BIOL, V55, P61, DOI 10.1006/tpbi.1998.1392; CARO TM, 1994, SCIENCE, V263, P485, DOI 10.1126/science.8290956; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; FULLER RM, 1994, PHOTOGRAMM ENG REM S, V60, P553; Gaggiotti OE, 1999, MOL ECOL, V8, P1513, DOI 10.1046/j.1365-294x.1999.00730.x; Gurnell J, 1997, CONSERVATION RED SQU; Haddad N, 2000, CONSERV BIOL, V14, P738, DOI 10.1046/j.1523-1739.2000.99041.x; Hale ML, 2001, MOL ECOL NOTES, V1, P47, DOI 10.1046/j.1471-8278 .2000.00020.x; Lande R, 1996, EVOLUTION, V50, P434, DOI [10.2307/2410812, 10.1111/j.1558-5646.1996.tb04504.x]; Lurz, 1997, CONSERVATION RED SQU, P5; Lurz P.W.W., 1995, THESIS U NEWCASTLE N; Lurz PWW, 1995, FOREST ECOL MANAG, V79, P79, DOI 10.1016/0378-1127(95)03617-2; Matthews J. D., 1955, Report on forest research by the Forestry Commission for the year ending March, 1954., P64; McIntosh R, 1995, FOREST ECOL MANAG, V79, P1, DOI 10.1016/0378-1127(95)03628-8; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Paetkau D, 1997, GENETICS, V147, P1943; PAETKAU D, 1995, MOL ECOL, V4, P347, DOI 10.1111/j.1365-294X.1995.tb00227.x; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; REYNOLDS JC, 1985, J ANIM ECOL, V54, P149, DOI 10.2307/4627; Schneider S., 2000, ARLEQUIN VERSION 200; Shorten M, 1954, SQUIRRELS; TONKIN JM, 1983, THESIS U BRADFORD BR; Waser PM, 1998, TRENDS ECOL EVOL, V13, P43, DOI 10.1016/S0169-5347(97)01255-X; WAUTERS L, 1994, OIKOS, V69, P140, DOI 10.2307/3545294	26	98	110	1	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 21	2001	293	5538					2246	2248		10.1126/science.1062574	http://dx.doi.org/10.1126/science.1062574			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475AL	11567136				2022-12-24	WOS:000171139400041
J	Ji, YD; Zhang, B; Van Horn, SF; Warren, P; Woodnutt, G; Burnham, MKR; Rosenberg, M				Ji, YD; Zhang, B; Van Horn, SF; Warren, P; Woodnutt, G; Burnham, MKR; Rosenberg, M			Identification of critical staphylococcal genes using conditional phenotypes generated by antisense RNA	SCIENCE			English	Article							IN-VITRO; REGULATED EXPRESSION; BACILLUS-SUBTILIS; AUREUS; VIRULENCE; OLIGONUCLEOTIDES; INACTIVATION; MUTAGENESIS; PLASMIDS; SYSTEM	Comprehensive genomic analysis of the important human pathogen Staphylococcus aureus was achieved by a strategy involving antisense technology in a regulatable gene expression system. In addition to known essential genes, many genes of unknown or poorly defined biological function were identified. This methodology allowed gene function to be characterized in a comprehensive, defined set of conditionally growth-defective/lethal isogenic strains. Quantitative titration of the conditional growth effect was performed either in bacterial culture or in an animal model of infection. This genomic strategy offers an approach to the identification of staphylococcal gene products that could serve as targets for antibiotic discovery.	GlaxoSmithKline Pharmaceut Res & Dev, Dept Microbiol, Collegeville, PA 19426 USA; GlaxoSmithKline Pharmaceut Res & Dev, Genet Res, Collegeville, PA 19426 USA	GlaxoSmithKline; GlaxoSmithKline	Ji, YD (corresponding author), 1250 S Collegeville Rd,UP1345, Collegeville, PA 19426 USA.							Agrawal S, 1997, P NATL ACAD SCI USA, V94, P2620, DOI 10.1073/pnas.94.6.2620; Akerley BJ, 1998, P NATL ACAD SCI USA, V95, P8927, DOI 10.1073/pnas.95.15.8927; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arigoni F, 1998, NAT BIOTECHNOL, V16, P851, DOI 10.1038/nbt0998-851; Brantl S, 2000, MOL MICROBIOL, V35, P1469, DOI 10.1046/j.1365-2958.2000.01813.x; CHEUNG AL, 1995, J BACTERIOL, V177, P3220, DOI 10.1128/jb.177.11.3220-3226.1995; De Backer MD, 2001, NAT BIOTECHNOL, V19, P235, DOI 10.1038/85677; DEBEAUREGARD MAC, 1995, EMBO J, V14, P409, DOI 10.1002/j.1460-2075.1995.tb07017.x; DELORENZO V, 1993, GENE, V123, P17, DOI 10.1016/0378-1119(93)90533-9; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; GEISSENDORFER M, 1990, APPL MICROBIOL BIOT, V33, P657, DOI 10.1007/BF00604933; Good L, 1998, NAT BIOTECHNOL, V16, P355, DOI 10.1038/nbt0498-355; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HENSEL M, 1995, SCIENCE, V269, P400, DOI 10.1126/science.7618105; Ji YD, 1999, J BACTERIOL, V181, P6585, DOI 10.1128/JB.181.21.6585-6590.1999; Martin PK, 1999, J BACTERIOL, V181, P3666, DOI 10.1128/JB.181.12.3666-3673.1999; Mizuta T, 1999, NAT BIOTECHNOL, V17, P583, DOI 10.1038/9893; Parish T, 1997, FEMS MICROBIOL LETT, V154, P151, DOI 10.1016/S0378-1097(97)00317-0; Rappleye CA, 1997, J BACTERIOL, V179, P5827, DOI 10.1128/jb.179.18.5827-5834.1997; SCHMID MB, 1989, GENETICS, V123, P625; Stieger M, 1999, GENE, V226, P243, DOI 10.1016/S0378-1119(98)00561-7; Vagner V, 1998, MICROBIOL-SGM, V144, P3097, DOI 10.1099/00221287-144-11-3097; WAGNER EGH, 1994, ANNU REV MICROBIOL, V48, P717; Zhang L, 2000, GENE, V255, P297, DOI 10.1016/S0378-1119(00)00325-5	24	328	2946	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 21	2001	293	5538					2266	2269		10.1126/science.1063566	http://dx.doi.org/10.1126/science.1063566			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475AL	11567142				2022-12-24	WOS:000171139400047
J	Hodge, A; Campbell, CD; Fitter, AH				Hodge, A; Campbell, CD; Fitter, AH			An arbuscular mycorrhizal fungus accelerates decomposition and acquires nitrogen directly from organic material	NATURE			English	Article							ROOT PROLIFERATION; SOIL; BIODIVERSITY; ACQUISITION; ASSOCIATION; DIVERSITY; HYPHAE; INFLOW	Arbuscular mycorrhizal fungi (order Glomales), which form mycorrhizal symbioses with two out of three of all plant species(1), are believed to be obligate biotrophs that are wholly dependent on the plant partner for their carbon supply(2). It is thought that they possess no degradative capability and that they are unable to decompose complex organic molecules, the form in which most soil nutrients occur. Earlier suggestions that they could exist saprotrophically were based on observation of hyphal proliferation on organic materials(3,4). In contrast, other mycorrhizal types have been shown to acquire nitrogen directly from organic sources(5-7). Here we show that the arbuscular mycorrhizal symbiosis can both enhance decomposition of and increase nitrogen capture from complex organic material (grass leaves) in soil. Hyphal growth of the fungal partner was increased in the presence of the organic material, independently of the host plant.	Univ York, Dept Biol, York YO10 5YW, N Yorkshire, England; Macaulay Land Use Res Inst, Aberdeen AB15 8QH, Scotland	University of York - UK; James Hutton Institute	Hodge, A (corresponding author), Univ York, Dept Biol, POB 373, York YO10 5YW, N Yorkshire, England.		Campbell, Colin D/B-3944-2010	Campbell, Colin D/0000-0002-5163-7656	Biotechnology and Biological Sciences Research Council [JF13140] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		ABUZINADAH RA, 1989, NEW PHYTOL, V112, P55, DOI 10.1111/j.1469-8137.1989.tb00308.x; [Anonymous], 1982, METHODS PRINCIPLES M; Bever JD, 1999, ECOL LETT, V2, P52, DOI 10.1046/j.1461-0248.1999.21050.x; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; CHAPIN FS, 1993, NATURE, V361, P150, DOI 10.1038/361150a0; Fransen B, 1998, OECOLOGIA, V115, P351, DOI 10.1007/s004420050527; Frostegard A, 1996, SOIL BIOL BIOCHEM, V28, P55, DOI 10.1016/0038-0717(95)00100-X; Hodge A, 1998, NEW PHYTOL, V139, P479, DOI 10.1046/j.1469-8137.1998.00216.x; HODGE A, 1995, MYCOL RES, V99, P935, DOI 10.1016/S0953-7562(09)80752-1; JONES DL, 1992, PLANT SOIL, V143, P259, DOI 10.1007/BF00007881; KOIDE RT, 1989, NEW PHYTOL, V111, P35, DOI 10.1111/j.1469-8137.1989.tb04215.x; LEAKE JR, 1990, NEW PHYTOL, V116, P123, DOI 10.1111/j.1469-8137.1990.tb00517.x; Mader P, 2000, NEW PHYTOL, V146, P155, DOI 10.1046/j.1469-8137.2000.00615.x; MOSSE BARBARA, 1959, TRANS BRIT MYOL SOC, V42, P439; NEWSHAM KK, 1995, TRENDS ECOL EVOL, V10, P407, DOI 10.1016/S0169-5347(00)89157-0; READ DJ, 1991, EXPERIENTIA, V47, P376, DOI 10.1007/BF01972080; SANDERS FE, 1971, NATURE, V233, P278, DOI 10.1038/233278c0; Smith SE., 1996, MYCORRHIZAL SYMBIOSI; Staddon PL, 1999, GLOBAL CHANGE BIOL, V5, P347, DOI 10.1046/j.1365-2486.1999.00230.x; Stark JM, 1994, EXPLOITATION ENV HET, P255; STJOHN TV, 1983, ECOLOGY, V64, P957, DOI 10.2307/1937216; Tinker PBH., 2000, SOLUTE TRANSPORT RHI; TOBAR RM, 1994, MYCORRHIZA, V4, P105, DOI 10.1007/BF00203769; Trappe JM, 1987, ECOPHYSIOLOGY VA MYC, P5; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; vanVuuren MMI, 1996, PLANT SOIL, V178, P185, DOI 10.1007/BF00011582; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87	27	675	775	27	545	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 20	2001	413	6853					297	299		10.1038/35095041	http://dx.doi.org/10.1038/35095041			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473KB	11565029	Green Accepted			2022-12-24	WOS:000171040500036
J	Giles, J				Giles, J			Relaxed restrictions blamed for rise in foot and mouth	NATURE			English	News Item																		Woolhouse M, 2001, NATURE, V411, P258, DOI 10.1038/35077149	1	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 13	2001	413	6852					98	98		10.1038/35093234	http://dx.doi.org/10.1038/35093234			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471FU	11557938	Bronze			2022-12-24	WOS:000170918800009
J	Glynn, I				Glynn, I			An intriguing door	NATURE			English	Editorial Material									Univ Cambridge, Trinity Coll, Cambridge CB2 1QT, England	University of Cambridge	Glynn, I (corresponding author), Univ Cambridge, Trinity Coll, Cambridge CB2 1QT, England.							Glynn I., 1999, ANATOMY THOUGHT ORIG; Holifield Robert J., 1987, DARWIN EMERGENCE EVO, P418; LOGOTHETIS NK, 1999, SCI AM           NOV, P44; ORICK F, 1994, ASTONISHING HYPOTHES	4	0	0	0	0	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 18	2001	413	6857					683	683		10.1038/35099639	http://dx.doi.org/10.1038/35099639			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	482ZK	11607008	Bronze			2022-12-24	WOS:000171608000022
J	Steffan, JS; Bodai, L; Pallos, J; Poelman, M; McCampbell, A; Apostol, BL; Kazantsev, A; Schmidt, E; Zhu, YZ; Greenwald, M; Kurokawa, R; Housman, DE; Jackson, GR; Marsh, JL; Thompson, LM				Steffan, JS; Bodai, L; Pallos, J; Poelman, M; McCampbell, A; Apostol, BL; Kazantsev, A; Schmidt, E; Zhu, YZ; Greenwald, M; Kurokawa, R; Housman, DE; Jackson, GR; Marsh, JL; Thompson, LM			Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila	NATURE			English	Article							CREB-BINDING PROTEIN; HUNTINGTONS-DISEASE; EXPANDED POLYGLUTAMINE; MAMMALIAN-CELLS; TRANSGENIC MICE; LOCALIZATION; AGGREGATION; EXPRESSION; APOPTOSIS; GROWTH	Proteins with expanded polyglutamine repeats cause Huntington's disease and other neurodegenerative diseases. Transcriptional dysregulation and loss of function of transcriptional coactivator proteins have been implicated in the pathogenesis of these diseases(1). Huntington's disease is caused by expansion of a repeated sequence of the amino acid glutamine in the abnormal protein huntingtin (Htt). Here we show that the polyglutamine-containing domain of Htt, Htt exon 1 protein (Httex1p), directly binds the acetyltransferase domains of two distinct proteins: CREB-binding protein (CBP) and p300/CBP-associated factor (P/CAF). In cell-free assays, Httex1p also inhibits the acetyltransferase activity of at least three enzymes: p300, P/CAF and CBP. Expression of Httex1p in cultured cells reduces the level of the acetylated histones H3 and H4, and this reduction can be reversed by administering inhibitors of histone deacetylase (HDAC). In vivo, HDAC inhibitors arrest ongoing progressive neuronal degeneration induced by polyglutamine repeat expansion, and they reduce lethality in two Drosophila models of polyglutamine disease. These findings raise the possibility that therapy with HDAC inhibitors may slow or prevent the progressive neurodegeneration seen in Huntington's disease and other polyglutamine-repeat diseases, even after the onset of symptoms.	Univ Calif Irvine, Dept Psychiat & Human Behav, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA; NINCDS, Neurogenet Branch, NIH, Bethesda, MD 20892 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90095 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Massachusetts Institute of Technology (MIT); University of California System; University of California San Diego; University of California System; University of California Los Angeles	Thompson, LM (corresponding author), Univ Calif Irvine, Dept Psychiat & Human Behav, Gillespie 2121, Irvine, CA 92697 USA.		Bodai, Laszlo/A-9764-2012; Pallos, Judit/AAE-6833-2020	Bodai, Laszlo/0000-0001-8411-626X; 	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002974, Z01NS002974] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AILSIALI S, 1998, NUCLEIC ACIDS RES, V26, P3869; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cha JHJ, 2000, TRENDS NEUROSCI, V23, P387, DOI 10.1016/S0166-2236(00)01609-X; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; Franceschini N., 1972, INFORMATION PROCESSI, P75; Giordano A, 1999, J CELL PHYSIOL, V181, P218, DOI 10.1002/(SICI)1097-4652(199911)181:2<218::AID-JCP4>3.0.CO;2-5; Goodman RH, 2000, GENE DEV, V14, P1553; Kazantsev A, 1999, P NATL ACAD SCI USA, V96, P11404, DOI 10.1073/pnas.96.20.11404; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Marks PA, 2000, JNCI-J NATL CANCER I, V92, P1210, DOI 10.1093/jnci/92.15.1210; Marsh JL, 2000, HUM MOL GENET, V9, P13, DOI 10.1093/hmg/9.1.13; McCampbell A, 2000, HUM MOL GENET, V9, P2197, DOI 10.1093/hmg/9.14.2197; Neufeld TP, 1998, GENETICS, V148, P277; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; Paulson HL, 1999, AM J HUM GENET, V64, P339, DOI 10.1086/302269; REUTER G, 1982, MOL GEN GENET, V188, P480, DOI 10.1007/BF00330052; Sapp E, 1997, ANN NEUROL, V42, P604, DOI 10.1002/ana.410420411; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; Steffan JS, 2000, P NATL ACAD SCI USA, V97, P6763, DOI 10.1073/pnas.100110097; Suhr ST, 1998, P NATL ACAD SCI USA, V95, P7999, DOI 10.1073/pnas.95.14.7999; Wanker EE, 2000, BIOL CHEM, V381, P937, DOI 10.1515/BC.2000.114; Yang XJ, 1996, NATURE, V382, P319, DOI 10.1038/382319a0; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	27	944	1002	2	57	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 18	2001	413	6857					739	743		10.1038/35099568	http://dx.doi.org/10.1038/35099568			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	482ZK	11607033	Green Published			2022-12-24	WOS:000171608000045
J	Moss, J; DeCastro, R; Patronas, NJ; Taveira-DeSilva, A				Moss, J; DeCastro, R; Patronas, NJ; Taveira-DeSilva, A			Meningiomas in lymphangioleiomyomatosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TUBEROUS SCLEROSIS COMPLEX; PULMONARY LYMPHANGIOLEIOMYOMATOSIS; PROGESTERONE-RECEPTORS; TSC2; MUTATIONS; WOMEN; LYMPHANGIOMYOMATOSIS; EPIDEMIOLOGY; GROWTH; GENES	Context Lymphangioleiomyomatosis (LAM), a cystic lung disease associated with progressive respiratory failure, is found predominantly in women of childbearing age and therefore has been treated with progesterone and other hormonal agents. However, meningiomas have progesterone receptors, and progesterone is believed to be a mitogen for meningioma cells in culture. Since 30% to 40% of patients with tuberous sclerosis complex (TSC) have LAM, we routinely screen patients with LAM for brain lesions found in TSC. Objective To determine the prevalence of meningiomas in women with LAM. Design and Setting Analysis of results from ongoing routine screening protocols initiated in December 1995 at the National Heart, Lung, and Blood Institute. Patients Two hundred fifty women with sporadic LAM who were referred for screening by magnetic resonance imaging (MRI) and/or computed tomography (CT) of the brain. Main Outcome Measures Presence of meningiomas on MRI and/or CT scans. Results Eight women with LAM (3 with and 5 without a diagnosis of TSC) had lesions on MRI scans compatible with meningiomas. Five of the patients had been treated with progesterone. Multiple meningiomas were observed in 2 patients. Conclusions Women with LAM appear to have a high prevalence of meningiomas. We recommend that patients with LAM be screened for meningiomas regardless of diagnosis of TSC. In view of the lack of a documented effect of progesterone on progression of lung disease in LAM and the reported mitogenic response of meningiomas to progesterone, we recommend that the drug not be given to LAM patients with an MRI result consistent with diagnosis of meningioma.	NHLBI, Pulm Crit Care Med Branch, NIH, Bethesda, MD 20892 USA; NIH, Dept Diagnost Radiol, Ctr Clin, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Moss, J (corresponding author), NHLBI, Pulm Crit Care Med Branch, NIH, Room 6D05,Bldg 10,MSC 1590, Bethesda, MD 20892 USA.	mossj@nhlbi.nih.gov						Avila NA, 2000, RADIOLOGY, V214, P441, DOI 10.1148/radiology.214.2.r00fe41441; Blankenstein MA, 2000, STEROIDS, V65, P795, DOI 10.1016/S0039-128X(00)00193-8; Boehler A, 1996, NEW ENGL J MED, V335, P1275, DOI 10.1056/NEJM199610243351704; Bondy M, 1996, J NEURO-ONCOL, V29, P197, DOI 10.1007/BF00165649; BONETTI F, 1993, AM J SURG PATHOL, V17, P1092, DOI 10.1097/00000478-199311000-00002; CARROLL RS, 1993, CANCER RES, V53, P1312; Carsillo T, 2000, P NATL ACAD SCI USA, V97, P6085, DOI 10.1073/pnas.97.11.6085; Chu SC, 1999, CHEST, V115, P1041, DOI 10.1378/chest.115.4.1041; Cordier JF, 1999, LUNG BIOL HEALTH DIS, V131, P9; Costello LC, 2000, MAYO CLIN PROC, V75, P591, DOI 10.4065/75.6.591; Gomez MR, 1988, TUBEROUS SCLEROSIS, P9; GRUNBERG SM, 1994, HUM REPROD, V9, P202, DOI 10.1093/humrep/9.suppl_1.202; Hewitt S, 1999, AM J RESP CRIT CARE, V159, pA531; Izumi T, 1999, LUNG BIOL HEALTH DIS, V131, P1; JAY JR, 1985, J NEUROSURG, V62, P757, DOI 10.3171/jns.1985.62.5.0757; KALASSIAN GK, 1999, LAM OTHER DIS CHARAC, P45; Kalassian KG, 1997, AM J RESP CRIT CARE, V155, P1183, DOI 10.1164/ajrccm.155.4.9105053; Lie J. T., 1999, TUBEROUS SCLEROSIS C, P207; MAXWELL M, 1990, INT J CANCER, V46, P16, DOI 10.1002/ijc.2910460106; Moss J, 2001, AM J RESP CRIT CARE, V164, P669, DOI 10.1164/ajrccm.164.4.2101154; NELLIST M, 1993, CELL, V75, P1305; Roach ES, 1999, J CHILD NEUROL, V14, P401, DOI 10.1177/088307389901400610; Short MP, 1999, LUNG BIOL HEALTH DIS, V131, P387; Smolarek TA, 1998, AM J HUM GENET, V62, P810, DOI 10.1086/301804; Strizheva GD, 2001, AM J RESP CRIT CARE, V163, P253, DOI 10.1164/ajrccm.163.1.2005004; SUTHERLAND GR, 1987, CAN J NEUROL SCI, V14, P586; TAYLOR JR, 1990, NEW ENGL J MED, V323, P1254, DOI 10.1056/NEJM199011013231807; TONN JC, 1994, ANTICANCER RES, V14, P2453; Trulock EP, 1999, LUNG BIOL HEALTH DIS, V131, P65; VALENCIA JC, 2000, AM J RESP CRIT CARE, V161, pA15; vanSlegtenhorst M, 1997, SCIENCE, V277, P805, DOI 10.1126/science.277.5327.805; Weiner DM, 1998, J AM COLL SURGEONS, V187, P548, DOI 10.1016/S1072-7515(98)00239-7; Zhang H, 1999, J HUM GENET, V44, P391, DOI 10.1007/s100380050185	33	36	37	1	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 17	2001	286	15					1879	1881		10.1001/jama.286.15.1879	http://dx.doi.org/10.1001/jama.286.15.1879			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	482UH	11597290	Bronze			2022-12-24	WOS:000171595300029
J	Fagarasan, S; Kinoshita, K; Muramatsu, M; Ikuta, K; Honjo, T				Fagarasan, S; Kinoshita, K; Muramatsu, M; Ikuta, K; Honjo, T			In situ class switching and differentiation to IgA-producing cells in the gut lamina propria	NATURE			English	Article							CYTIDINE DEAMINASE AID; B-CELLS; SURFACE-RECEPTORS; MARGINAL ZONE; PLASMA-CELLS; CD40 LIGAND; FC RECEPTOR; MICE; ACTIVATION; EXPRESSION	One of the front lines of the immune defence is the gut mucosa, where immunoglobulin-alpha (IgA) is continuously produced to react with commensal bacteria and dietary antigens. It is generally accepted that, after antigenic stimulation in the Peyer's patches, IgA(+) lymphoblasts (B220(+)IgA(+)) migrate through the lymph and blood circulation, and eventually home to the lamina propria of the intestine(1,2). Mice that lack activation-induced cytidine deaminase (AID) are defective in class switch recombination (CSR) and somatic hypermutation(3). CSR changes the immunoglobulin heavy chain constant region (CH) gene being expressed from C mu to other CH genes, resulting in a switch of the immunoglobulin isotype from IgM to IgG, IgE or IgA. AID(-/-) mice also secrete large amounts of immunoglobulin-m (IgM) into faeces, and accumulate B220(-)IgM(+) plasma cells as well as B220(+)IgM(+) cells in the gut. Here we show that lamina propria B220(+)IgA(+) cells have just completed CSR, as they still express both AID and transcripts from circular DNA that has been 'looped-out' during CSR. Lamina propria IgM(+) B cells seem to be pre-committed to switching to IgA(+) in vitro as well as in vivo. Culturing lamina propria IgM(+) B cells together with lamina propria stromal cells enhances preferential switching and differentiation of B cells to IgA(+) plasma cells. We conclude that IgA(+) cells in the gut lamina propria are generated in situ from B220(+)IgM(+) lymphocytes.	Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan	Kyoto University	Honjo, T (corresponding author), Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan.	honjo@mfour.med.kyoto-u.ac.jp	Fagarasan, Sidonia/A-5258-2016; Muramatsu, Masamichi/C-4339-2015; Honjo, Tasuku/N-4470-2016	Fagarasan, Sidonia/0000-0003-2086-6402; Muramatsu, Masamichi/0000-0002-0153-3533; Ikuta, Koichi/0000-0003-1319-1021				COFFMAN RL, 1989, J EXP MED, V170, P1039, DOI 10.1084/jem.170.3.1039; CRAIG SW, 1971, J EXP MED, V134, P188, DOI 10.1084/jem.134.1.188; Fagarasan S, 2000, J EXP MED, V191, P1477, DOI 10.1084/jem.191.9.1477; Fagarasan S, 2000, IMMUNOL REV, V176, P205; Fagarasan S, 2000, SCIENCE, V290, P89, DOI 10.1126/science.290.5489.89; IKUTA K, 1990, CELL, V62, P863, DOI 10.1016/0092-8674(90)90262-D; IWASATO T, 1990, CELL, V62, P143, DOI 10.1016/0092-8674(90)90248-D; Kamata T, 2000, J IMMUNOL, V165, P1387, DOI 10.4049/jimmunol.165.3.1387; KINOSHITA K, IN PRESS P NATL ACAD; Kroese FGM, 1989, INT IMMUNOL, V1, P75, DOI 10.1093/intimm/1.1.75; LEBMAN DA, 1987, J EXP MED, V166, P1405, DOI 10.1084/jem.166.5.1405; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Martin F, 1999, CURR TOP MICROBIOL, V246, P45; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nakamura M, 1996, INT IMMUNOL, V8, P193, DOI 10.1093/intimm/8.2.193; Oliver AM, 1997, EUR J IMMUNOL, V27, P2366, DOI 10.1002/eji.1830270935; RAMSAY AJ, 1994, SCIENCE, V264, P561, DOI 10.1126/science.8160012; RENSHAW BR, 1994, J EXP MED, V180, P1889, DOI 10.1084/jem.180.5.1889; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Shparago N, 1996, INT IMMUNOL, V8, P781, DOI 10.1093/intimm/8.5.781; SONODA E, 1989, J EXP MED, V170, P1415, DOI 10.1084/jem.170.4.1415; STAVNEZERNORDGREN J, 1986, EMBO J, V5, P95, DOI 10.1002/j.1460-2075.1986.tb04182.x; TSENG J, 1981, J IMMUNOL, V127, P2039; WALDSCHMIDT TJ, 1988, J IMMUNOL, V140, P2148; WALDSCHMIDT TJ, 1991, INT IMMUNOL, V3, P305, DOI 10.1093/intimm/3.4.305; Watanabe N, 2000, J EXP MED, V192, P1577, DOI 10.1084/jem.192.11.1577; WHITLOCK CA, 1987, CELL, V48, P1009, DOI 10.1016/0092-8674(87)90709-4; XU JC, 1994, IMMUNITY, V1, P423, DOI 10.1016/1074-7613(94)90073-6; Ye SK, 1999, IMMUNITY, V11, P213, DOI 10.1016/S1074-7613(00)80096-5	31	325	338	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 11	2001	413	6856					639	643		10.1038/35098100	http://dx.doi.org/10.1038/35098100			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480WE	11675788				2022-12-24	WOS:000171485700051
J	Avise, JC				Avise, JC			Evolving genomic metaphors: A new look at the language of DNA	SCIENCE			English	Editorial Material								Recent genome-sequencing efforts have confirmed that traditional "good-citizen" genes (those that encode functional RNA and protein molecules of obvious benefit to the organism) constitute only a small fraction of the genomic populace in humans and other multicellular creatures. The rest of the DNA sequence includes an astonishing collection of noncoding regions, regulatory modules, deadbeat pseudogenes, legions of repetitive elements, and hosts of oft-shifty, self-interested nomads, renegades, and immigrants. To help visualize functional operations in such intracellular genomic societies and to better encapsulate the evolutionary origins of complex genomes, new and evocative metaphors may be both entertaining and research-stimulating.	Univ Georgia, Dept Genet, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Avise, JC (corresponding author), Univ Georgia, Dept Genet, Athens, GA 30602 USA.	avise@arches.uga.edu						AVISE J, 1998, GENETIC GODS EVOLUTI; CONDIT CM, 1999, MEANING GENE; Dawkins R, 1976, SELFISH GENE; Kidwell MG, 2001, EVOLUTION, V55, P1, DOI 10.1111/j.0014-3820.2001.tb01268.x; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040	6	52	53	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 5	2001	294	5540					86	87		10.1126/science.294.5540.86	http://dx.doi.org/10.1126/science.294.5540.86			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480EJ	11588247	Green Submitted			2022-12-24	WOS:000171448800035
J	Hemann, MT; Strong, MA; Hao, LY; Greider, CW				Hemann, MT; Strong, MA; Hao, LY; Greider, CW			The shortest telomere, not average telomere length, is critical for cell viability and chromosome stability	CELL			English	Article							MINOR SATELLITE DNA; REPLICATIVE SENESCENCE; SACCHAROMYCES-CEREVISIAE; IONIZING-RADIATION; HUMAN FIBROBLASTS; PROTEIN; REPAIR; RNA; IDENTIFICATION; RECOMBINATION	Loss of telomere function can induce cell cycle arrest and apoptosis. To investigate the processes that trigger cellular responses to telomere dysfunction, we crossed mTR-/- G6 mice that have short telomeres with mice heterozygous for telomerase (mTR+/-) that have long telomeres. The phenotype of the telomerase null offspring was similar to that of the late generation parent, although only half of the chromosomes were short. Strikingly, spectra[ karyotyping (SKY) analysis revealed that loss of telomere function occurred preferentially on chromosomes with critically short telomeres. Our data indicate that, while average telomere length is measured in most studies, it is not the average but rather the shortest telomeres that constitute telomere dysfunction and limit cellular survival in the absence of telomerase.	Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Grad Training Program Human Genet, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Greider, CW (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.			Strong, Margaret/0000-0002-0055-6573; Greider, Carol/0000-0002-5494-8126	NCI NIH HHS [P01 CA16519] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA016519] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALLSOPP RC, 1992, P NATL ACAD SCI USA, V89, P10114, DOI 10.1073/pnas.89.21.10114; Blackburn E, 1999, MT SINAI J MED, V66, P292; Blackburn EH, 2000, NATURE, V408, P53, DOI 10.1038/35040500; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Broccoli D, 1997, NAT GENET, V17, P231, DOI 10.1038/ng1097-231; Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X; Chiu CP, 1997, P SOC EXP BIOL MED, V214, P99; Cooper JP, 1998, NATURE, V392, P828, DOI 10.1038/33947; DELANGE T, 1994, P NATL ACAD SCI USA, V91, P2882, DOI 10.1073/pnas.91.8.2882; Feldmann E, 2000, NUCLEIC ACIDS RES, V28, P2585, DOI 10.1093/nar/28.13.2585; GARAGNA S, 1995, CHROMOSOMA, V103, P685, DOI 10.1007/BF00344229; Garagna S, 2001, P NATL ACAD SCI USA, V98, P171, DOI 10.1073/pnas.98.1.171; Goytisolo FA, 2000, J EXP MED, V192, P1625, DOI 10.1084/jem.192.11.1625; Greider CW, 1996, ANNU REV BIOCHEM, V65, P337, DOI 10.1146/annurev.bi.65.070196.002005; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Guiducci C, 2001, ONCOGENE, V20, P714, DOI 10.1038/sj.onc.1204145; Hackett JA, 2001, CELL, V106, P275, DOI 10.1016/S0092-8674(01)00457-3; Hande MP, 1999, J CELL BIOL, V144, P589, DOI 10.1083/jcb.144.4.589; Hemann MT, 2001, MOL BIOL CELL, V12, P2023, DOI 10.1091/mbc.12.7.2023; HEMANN MT, 2001, COLD SPRING HARB S Q; Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321; Kim MM, 2001, P NATL ACAD SCI USA, V98, P7982, DOI 10.1073/pnas.131211098; KIPLING D, 1991, GENOMICS, V11, P235, DOI 10.1016/0888-7543(91)90128-2; Kirk KE, 1997, SCIENCE, V275, P1478, DOI 10.1126/science.275.5305.1478; KRAMER KM, 1994, MOL CELL BIOL, V14, P1293, DOI 10.1128/MCB.14.2.1293; LANGER PR, 1981, P NATL ACAD SCI-BIOL, V78, P6633, DOI 10.1073/pnas.78.11.6633; Lansdorp PM, 2000, MECH AGEING DEV, V118, P23, DOI 10.1016/S0047-6374(00)00151-2; Lansdorp PM, 1996, HUM MOL GENET, V5, P685, DOI 10.1093/hmg/5.5.685; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Liyanage M, 1996, NAT GENET, V14, P312, DOI 10.1038/ng1196-312; LUSTIG AJ, 1990, SCIENCE, V250, P549, DOI 10.1126/science.2237406; Martens UM, 2000, EXP CELL RES, V256, P291, DOI 10.1006/excr.2000.4823; Martens UM, 1998, NAT GENET, V18, P76, DOI 10.1038/ng0198-018; Marusic L, 1997, MOL CELL BIOL, V17, P6394, DOI 10.1128/MCB.17.11.6394; McClintock B, 1942, P NATL ACAD SCI USA, V28, P458, DOI 10.1073/pnas.28.11.458; McClintock B, 1939, P NATL ACAD SCI USA, V25, P405, DOI 10.1073/pnas.25.8.405; McClintock B, 1941, GENETICS, V26, P234; MCEACHERN MJ, 1995, NATURE, V376, P403, DOI 10.1038/376403a0; Muller H.J., 1938, COLLECTING NET, V13, P181; Nimmo ER, 1998, NATURE, V392, P825, DOI 10.1038/33941; Ouellette MM, 2000, J BIOL CHEM, V275, P10072, DOI 10.1074/jbc.275.14.10072; Peterson SE, 2001, NAT GENET, V27, P64, DOI 10.1038/83778; PIETRAS DF, 1983, NUCLEIC ACIDS RES, V11, P6965, DOI 10.1093/nar/11.20.6965; SHAMPAY J, 1988, P NATL ACAD SCI USA, V85, P534, DOI 10.1073/pnas.85.2.534; Slijepcevic P, 1998, CHROMOSOMA, V107, P136, DOI 10.1007/s004120050289; vanSteensel B, 1997, NATURE, V385, P740, DOI 10.1038/385740a0; Wong KK, 2000, NAT GENET, V26, P85, DOI 10.1038/79232; Zhu JY, 1999, P NATL ACAD SCI USA, V96, P3723, DOI 10.1073/pnas.96.7.3723	50	861	889	3	53	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 5	2001	107	1					67	77		10.1016/S0092-8674(01)00504-9	http://dx.doi.org/10.1016/S0092-8674(01)00504-9			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	480GF	11595186	Bronze			2022-12-24	WOS:000171453100010
J	Ling, H; Boudsocq, F; Woodgate, R; Yang, W				Ling, H; Boudsocq, F; Woodgate, R; Yang, W			Crystal structure of a Y-family DNA polymerase in action: A mechanism for error-prone and lesion-bypass replication	CELL			English	Article							REPAIR PROTEIN MUTS; ESCHERICHIA-COLI; MISMATCH REPAIR; GENE ENCODES; LARGE FRAGMENT; THYMINE DIMER; FIDELITY; COMPLEX; IOTA; ETA	Sulfolobus solfataricus P2 DNA polymerase IV [Dpo4) is a DinB homolog that belongs to the recently described Y-family of DNA polymerases, which are best characterized by their low-fidelity synthesis on undamaged DNA templates and propensity to traverse normally replication-blocking lesions. Crystal structures of Dpo4 in ternary complexes with DNA and an incoming nucleotide, either correct or incorrect, have been solved at 1.7 Angstrom and 2.1 Angstrom resolution, respectively. Despite a conserved active site and a hand-like configuration similar to all known polymerases, Dpo4 makes limited and nonspecific contacts with the replicating base pair, thus relaxing base selection. Dpo4 is also captured in the crystal translocating two template bases to the active site at once, suggesting a possible mechanism for bypassing thymine dimers.	NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; NICHHD, Sect DNA Replicat Repair & Mutagenesis, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Yang, W (corresponding author), NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA.		Yang, Wei/D-4926-2011; Yang, Wei/ABB-4785-2020; Ling, Hong/E-3729-2010	Yang, Wei/0000-0002-3591-2195; Yang, Wei/0000-0002-3591-2195; Woodgate, Roger/0000-0001-5581-4616	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001500] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK036119, ZIADK036119] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BOUDSOCQ F, 2001, IN PRESS NUCL ACIDS; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CARSON M, 1987, J MOL GRAPHICS, V5, P103, DOI 10.1016/0263-7855(87)80010-3; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Doublie S, 1999, STRUCTURE, V7, pR31, DOI 10.1016/S0969-2126(99)80017-3; Eom SH, 1996, NATURE, V382, P278, DOI 10.1038/382278a0; Franklin MC, 2001, CELL, V105, P657, DOI 10.1016/S0092-8674(01)00367-1; Friedberg EC, 1999, CELL, V98, P413, DOI 10.1016/S0092-8674(00)81970-4; Goodman MF, 2000, NAT REV MOL CELL BIO, V1, P101, DOI 10.1038/35040051; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; Holm L, 1998, NUCLEIC ACIDS RES, V26, P316, DOI 10.1093/nar/26.1.316; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; Ishikawa T, 2001, J BIOL CHEM, V276, P15155, DOI 10.1074/jbc.M009822200; JOHNSON KA, 1993, ANNU REV BIOCHEM, V62, P685, DOI 10.1146/annurev.bi.62.070193.003345; Johnson RE, 2000, NATURE, V406, P1015, DOI 10.1038/35023030; Johnson RE, 1999, SCIENCE, V283, P1001, DOI 10.1126/science.283.5404.1001; Johnson RE, 2000, P NATL ACAD SCI USA, V97, P3838, DOI 10.1073/pnas.97.8.3838; Johnson RE, 2000, J BIOL CHEM, V275, P7447, DOI 10.1074/jbc.275.11.7447; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kiefer JR, 1998, NATURE, V391, P304, DOI 10.1038/34693; Kondratick CM, 2001, MOL CELL BIOL, V21, P2018, DOI 10.1128/MCB.21.6.2018-2025.2001; Kulaeva OI, 1996, MUTAT RES-FUND MOL M, V357, P245, DOI 10.1016/0027-5107(96)00164-9; Kunkel TA, 2000, ANNU REV BIOCHEM, V69, P497, DOI 10.1146/annurev.biochem.69.1.497; Lamers MH, 2000, NATURE, V407, P711, DOI 10.1038/35037523; Li Y, 1998, EMBO J, V17, P7514, DOI 10.1093/emboj/17.24.7514; Lindahl T, 1999, SCIENCE, V286, P1897, DOI 10.1126/science.286.5446.1897; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; Masutani C, 1999, EMBO J, V18, P3491, DOI 10.1093/emboj/18.12.3491; McKenzie GJ, 2001, MOL CELL, V7, P571, DOI 10.1016/S1097-2765(01)00204-0; Muchmore CRA, 1998, PROTEIN SCI, V7, P39, DOI 10.1002/pro.5560070104; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Obmolova G, 2000, NATURE, V407, P703, DOI 10.1038/35037509; Ohashi E, 2000, GENE DEV, V14, P1589; Ohashi E, 2000, J BIOL CHEM, V275, P39678, DOI 10.1074/jbc.M005309200; Ohmori H, 2001, MOL CELL, V8, P7, DOI 10.1016/S1097-2765(01)00278-7; OLLIS DL, 1985, NATURE, V313, P762, DOI 10.1038/313762a0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pelletier H, 1996, BIOCHEMISTRY-US, V35, P12742, DOI 10.1021/bi952955d; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P11205, DOI 10.1021/bi9703812; SCHAAPER RM, 1993, J BIOL CHEM, V268, P23762; She Q, 2001, P NATL ACAD SCI USA, V98, P7835, DOI 10.1073/pnas.141222098; Steitz TA, 1999, J BIOL CHEM, V274, P17395, DOI 10.1074/jbc.274.25.17395; Strauss BS, 2000, J BACTERIOL, V182, P6742, DOI 10.1128/JB.182.23.6742-6750.2000; Tang MJ, 2000, NATURE, V404, P1014, DOI 10.1038/35010020; Tang MJ, 1999, P NATL ACAD SCI USA, V96, P8919, DOI 10.1073/pnas.96.16.8919; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Tissier A, 2000, GENE DEV, V14, P1642; Trincao J, 2001, MOL CELL, V8, P417, DOI 10.1016/S1097-2765(01)00306-9; Vaisman A, 2001, J BIOL CHEM, V276, P30615, DOI 10.1074/jbc.M102694200; Wagner J, 1999, MOL CELL, V4, P281, DOI 10.1016/S1097-2765(00)80376-7; Wood RD, 2001, SCIENCE, V291, P1284, DOI 10.1126/science.1056154; Woodgate R, 1999, GENE DEV, V13, P2191, DOI 10.1101/gad.13.17.2191; Zhang YB, 2000, NUCLEIC ACIDS RES, V28, P4138, DOI 10.1093/nar/28.21.4138; Zhang YB, 2000, MOL CELL BIOL, V20, P7099, DOI 10.1128/MCB.20.19.7099-7108.2000; Zhou BL, 2001, MOL CELL, V8, P427, DOI 10.1016/S1097-2765(01)00310-0	56	533	541	2	29	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 5	2001	107	1					91	102		10.1016/S0092-8674(01)00515-3	http://dx.doi.org/10.1016/S0092-8674(01)00515-3			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	480GF	11595188	Bronze			2022-12-24	WOS:000171453100012
J	Johnson, ME; Viggiano, L; Bailey, JA; Abdul-Rauf, M; Goodwin, G; Rocchi, M; Eichler, EE				Johnson, ME; Viggiano, L; Bailey, JA; Abdul-Rauf, M; Goodwin, G; Rocchi, M; Eichler, EE			Positive selection of a gene family during the emergence of humans and African apes	NATURE			English	Article							DARWINIAN SELECTION; RAPID EVOLUTION; HUMAN-GENOME; DNA; DUPLICATIONS	Gene duplication followed by adaptive evolution is one of the primary forces for the emergence of new gene function(1). Here we describe the recent proliferation, transposition and selection of a 20-kilobase (kb) duplicated segment throughout 15 Mb of the short arm of human chromosome 16. The dispersal of this segment was accompanied by considerable variation in chromosomal-map location and copy number among hominoid species. In humans, we identified a gene family (morpheus) within the duplicated segment. Comparison of putative protein-encoding exons revealed the most extreme case of positive selection among hominoids. The major episode of enhanced amino-acid replacement occurred after the separation of human and great-ape lineages from the orangutan. Positive selection continued to alter amino-acid composition after the divergence of human and chimpanzee lineages. The rapidity and bias for amino-acid-altering nucleotide changes suggest adaptive evolution of the morpheus gene family during the emergence of humans and African apes. Moreover, some genes emerge and evolve very rapidly, generating copies that bear little similarity to their ancestral precursors. Consequently, a small fraction of human genes may not possess discernible orthologues within the genomes of model organisms.	Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Ctr Human Genet, Cleveland, OH 44106 USA; Univ Hosp Cleveland, Cleveland, OH 44106 USA; DAPEG, Sez Genet, I-70126 Bari, Italy; Inst Canc Res, Sect Mol Carcinogenesis, Haddow Labs, Surrey MS2 5NG, England	Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland; University of London; Institute of Cancer Research - UK	Eichler, EE (corresponding author), Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA.	eee@po.cwru.edu	Rocchi, Mariano/B-8451-2011	Viggiano, Luigi/0000-0002-2067-5166	Telethon [C.50] Funding Source: Medline	Telethon(Fondazione Telethon)		Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; DAVIS LI, 1986, CELL, V45, P699, DOI 10.1016/0092-8674(86)90784-1; Duda TF, 1999, P NATL ACAD SCI USA, V96, P6820, DOI 10.1073/pnas.96.12.6820; Goodman M, 1999, AM J HUM GENET, V64, P31, DOI 10.1086/302218; Horvath JE, 2000, GENOME RES, V10, P839, DOI 10.1101/gr.10.6.839; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; JUKES T H, 1969, P21; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li W-H, 1997, MOL EVOLUTION; LICHTER P, 1990, SCIENCE, V247, P64, DOI 10.1126/science.2294592; Loftus BJ, 1999, GENOMICS, V60, P295, DOI 10.1006/geno.1999.5927; Messler W, 1997, NATURE, V385, P151, DOI 10.1038/385151a0; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nei M., 2000, MOL EVOLUTION PHYLOG; Nurminsky DI, 1998, NATURE, V396, P572, DOI 10.1038/25126; Ohno S., 1970, EVOLUTION GENE DUPLI; STALLINGS RL, 1993, CYTOGENET CELL GENET, V63, P97, DOI 10.1159/000133509; TAJIMA F, 1993, GENETICS, V135, P599; Ting CT, 1998, SCIENCE, V282, P1501, DOI 10.1126/science.282.5393.1501; Vacquier VD, 1997, J MOL EVOL, V44, pS15, DOI 10.1007/PL00000049; Wyckoff GJ, 2000, NATURE, V403, P304, DOI 10.1038/35002070; Zhang JZ, 1998, P NATL ACAD SCI USA, V95, P3708, DOI 10.1073/pnas.95.7.3708	22	233	241	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 4	2001	413	6855					514	519		10.1038/35097067	http://dx.doi.org/10.1038/35097067			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	478HG	11586358				2022-12-24	WOS:000171340500045
J	Jones, JK; Fife, D; Curkendall, S; Goehring, E; Guo, JJF; Shannon, M				Jones, JK; Fife, D; Curkendall, S; Goehring, E; Guo, JJF; Shannon, M			Coprescribing and codispensing of cisapride and contraindicated drugs	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IMPACT	Context Cisapride, an oral prokinetic drug indicated for the symptomatic treatment of nocturnal heartburn due to gastroesophageal reflux disease, was approved by the US Food and Drug Administration in July 1993. After reports of serious cardiac arrhythmias and deaths during administration of cisapride, most involving concomitant exposure to another drug, a series of label changes and warnings were issued in February 1995, October 1995, June 1998, and June 1999. Cisapride was removed from general distribution in July 2000. Objective To determine the frequency of contraindicted coprescribing and codispensings, in which cisapride and a contraindicated drug were prescribed or dispensed to the same patient for overlapping periods, and the proportion of contraindicated coprescribing by the same physicians and codispensing by the same pharmacies. Design and Setting Retrospective study of prescription claims from a managed care organization database for all patients with cisapride prescriptions between July 1993 and December 1998. Participants A total of 38757 adult and pediatric patients who had a cisapride prescription immediately preceded by at least 60 days of insurance eligibility. Main Outcome Measure Proportion of cisapride prescriptions or dispensing occurring during the same treatment period as a drug contraindicated at that time prescribed by the same physicians or dispensed by the same pharmacies. Results Of 131485 cisapride prescriptions dispensed after the warnings began, 4414 (3.4%) overlapped with at least 1 drug contraindicated in the labeling at the time of the prescription. Of all overlapping prescription pairs, 2190 (50%) were by the same physicians, 3908 (89%) were by the same pharmacies, and 765 (17%) were dispensed on the same day. Conclusion Prescriptions dispensed by the same pharmacies accounted for afar higher proportion of contraindicated medication pairs than prescriptions from the same physicians. The pharmacy may be an important and underutilized intervention point to prevent contraindicated drugs from being used together.	Degge Grp Ltd, Res, Arlington, VA 22209 USA; Janssen Res Inst, Dept Epidemiol Drug Safety & Surveillance, Titusville, NJ USA; Univ Cincinnati, Med Ctr, Coll Pharm, Cincinnati, OH 45267 USA; Jorie Kent Associates Inc, Milton, DE USA	Johnson & Johnson; Johnson & Johnson USA; University System of Ohio; University of Cincinnati	Curkendall, S (corresponding author), Degge Grp Ltd, Res, 1616 N Ft Myer Dr,1430, Arlington, VA 22209 USA.							Cavuto NJ, 1996, JAMA-J AM MED ASSOC, V275, P1086, DOI 10.1001/jama.275.14.1086; McMullin ST, 1999, ARCH INTERN MED, V159, P2077, DOI 10.1001/archinte.159.17.2077; *MED EC CO, 2000, PHYS DESK REF, P1451; Piquette RK, 1999, ANN PHARMACOTHER, V33, P22, DOI 10.1345/aph.18107; Smalley W, 2000, JAMA-J AM MED ASSOC, V284, P3036, DOI 10.1001/jama.284.23.3036; SOUMERAI SB, 1989, MILBANK Q, V67, P268, DOI 10.2307/3350142; SOUMERAI SB, 1987, AM J PUBLIC HEALTH, V77, P1518, DOI 10.2105/AJPH.77.12.1518; Thompson D, 1996, JAMA-J AM MED ASSOC, V275, P1339, DOI 10.1001/jama.275.17.1339; *US FOOD DRUG ADM, 2000, JAMA-J AM MED ASSOC, V283, P2228; Wysowski DK, 1996, NEW ENGL J MED, V335, P290, DOI 10.1056/NEJM199607253350416	10	42	43	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 3	2001	286	13					1607	1609		10.1001/jama.286.13.1607	http://dx.doi.org/10.1001/jama.286.13.1607			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	478HH	11585484	Bronze			2022-12-24	WOS:000171340600028
J	Jutel, M; Watanabe, T; Klunker, S; Akdis, M; Thomet, OAR; Malolepszy, J; Zak-Nejmark, T; Koga, R; Kobayashi, T; Blaser, K; Akdis, CA				Jutel, M; Watanabe, T; Klunker, S; Akdis, M; Thomet, OAR; Malolepszy, J; Zak-Nejmark, T; Koga, R; Kobayashi, T; Blaser, K; Akdis, CA			Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors	NATURE			English	Article							BEE VENOM IMMUNOTHERAPY; MOLECULAR-BASIS; LYMPHOCYTES; MICE; INDUCTION; IMMUNITY	Many pathological processes, including those causing allergies and autoimmune diseases, are associated with the presence of specialized subsets of T helper cells (T(H)1 and T(H)2) at the site of inflammation(1-4). The diversity of T(H)1 and T(H)2 function is not predetermined but depends on signals that drive the cells towards either subset(1-4). Histamine, released from effector cells (mast cells and basophils) during inflammatory reactions can influence immune response(5-8). Here we report that histamine enhances T(H)1-type responses by triggering the histamine receptor type 1 (H1R), whereas both T(H)1- and T(H)2-type responses are negatively regulated by H2R through the activation of different biochemical intracellular signals. In mice, deletion of H1R results in suppression of interferon (IFN)-gamma and dominant secretion of T(H)2 cytokines (interleukin (IL)-4 and IL-13). Mutant mice lacking H2R showed upregulation of both T(H)1 and T(H)2 cytokines. Relevant to T-cell cytokine profiles, mice lacking H1R displayed increased specific antibody response with increased immunoglobulin-e (IgE) and IgG1, IgG2b and IgG3 compared with mice lacking H2R. These findings account for an important regulatory mechanism in the control of inflammatory functions through effector-cell-derived histamine.	Swiss Inst Allergy & Asthma Res, CH-7270 Davos, Switzerland; Kyushu Univ, Med Inst Bioregulat, Higashi Ku, Fukuoka 8128582, Japan; Wroclaw Med Univ, Dept Internal Med & Allergol, PL-50417 Wroclaw, Poland	Swiss Institute of Allergy & Asthma Research; Kyushu University; Wroclaw Medical University	Jutel, M (corresponding author), Swiss Inst Allergy & Asthma Res, Obere Str 22, CH-7270 Davos, Switzerland.		Akdis, Cezmi/AAV-4844-2020	Akdis, Cezmi/0000-0001-8020-019X				Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Akdis CA, 1998, J CLIN INVEST, V102, P98, DOI 10.1172/JCI2250; Akdis CA, 2000, FASEB J, V14, P1666; Akdis CA, 1999, FASEB J, V13, P603, DOI 10.1096/fasebj.13.6.603; Banu Y, 1999, J EXP MED, V189, P673, DOI 10.1084/jem.189.4.673; BEER DJ, 1987, CRC CR REV IMMUNOL, V7, P55; Bodor J, 1996, P NATL ACAD SCI USA, V93, P3536, DOI 10.1073/pnas.93.8.3536; Boss V, 1996, J BIOL CHEM, V271, P10429, DOI 10.1074/jbc.271.18.10429; Chen Q, 2000, NATURE, V407, P916, DOI 10.1038/35038103; Corry DB, 1999, NATURE, V402, pB18; DELPRETE GF, 1991, J CLIN INVEST, V88, P344; Faith A, 1997, J IMMUNOL, V159, P53; GANTZ I, 1992, J BIOL CHEM, V267, P20840; Inoue I, 1996, P NATL ACAD SCI USA, V93, P13316, DOI 10.1073/pnas.93.23.13316; Jutel M, 1996, CLIN EXP ALLERGY, V26, P1112, DOI 10.1111/j.1365-2222.1996.tb00496.x; JUTEL M, 1995, J IMMUNOL, V154, P4187; Kobayashi T, 2000, J CLIN INVEST, V105, P1741, DOI 10.1172/JCI9441; Lantz CS, 1998, NATURE, V392, P90, DOI 10.1038/32190; LEURS R, 1995, PHARMACOL THERAPEUT, V66, P413, DOI 10.1016/0163-7258(95)00006-3; Mobarakeh JI, 2000, EUR J PHARMACOL, V391, P81, DOI 10.1016/S0014-2999(00)00060-1; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; NOVAK TJ, 1990, P NATL ACAD SCI USA, V87, P9353, DOI 10.1073/pnas.87.23.9353; PLAUT M, 1983, J IMMUNOL, V131, P2945; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; ROSZKOWSKI W, 1977, SCIENCE, V195, P683, DOI 10.1126/science.190677; Sallusto F, 1997, SCIENCE, V277, P2005, DOI 10.1126/science.277.5334.2005; VANNIER E, 1993, J CLIN INVEST, V92, P281, DOI 10.1172/JCI116562; WATANABE N, 1988, P NATL ACAD SCI USA, V85, P4460, DOI 10.1073/pnas.85.12.4460; YAMASHITA M, 1991, P NATL ACAD SCI USA, V88, P11515, DOI 10.1073/pnas.88.24.11515	29	437	463	2	33	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 27	2001	413	6854					420	425		10.1038/35096564	http://dx.doi.org/10.1038/35096564			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475UY	11574888				2022-12-24	WOS:000171188700054
J	Malik, I; Danesh, J; Whincup, P; Bhatia, V; Papacosta, O; Walker, M; Lennon, L; Thomson, A; Haskard, D				Malik, I; Danesh, J; Whincup, P; Bhatia, V; Papacosta, O; Walker, M; Lennon, L; Thomson, A; Haskard, D			Soluble adhesion molecules and prediction of coronary heart disease: a prospective study and meta-analysis	LANCET			English	Article							C-REACTIVE PROTEIN; MIDDLE-AGED MEN; CARDIOVASCULAR RISK-FACTORS; APPARENTLY HEALTHY-MEN; UNSTABLE ANGINA; E-SELECTIN; MYOCARDIAL-INFARCTION; P-SELECTIN; PLASMA-CONCENTRATION; HELICOBACTER-PYLORI	Background Previous studies have suggested that circulating concentrations of soluble adhesion molecules are useful predictors of risk of coronary heart disease (CHD). Larger studies are needed, however, to test this hypothesis. Methods We measured serum concentrations of four soluble cell adhesion molecules (intercellular adhesion molecule-1 [ICAM-1], vascular cell adhesion molecule-1 [VCAM-1], E-selectin, and P-selectin) in the stored baseline serum samples of 643 men with coronary heart disease and 1278 controls nested in a prospective study of 5661 men who were monitored for 16 years. We also did a meta-analysis of previous relevant studies to place our findings in context. Results Concentrations of soluble adhesion molecules were significantly associated with one another, with other markers of inflammation, and with some classic coronary risk factors. For ICAM-1, the odds ratio for CHD was 1.68 (95% Cl 1.32-2.14) in a comparison of men in the top third with those in the bottom third of baseline measurements after adjustments for age and town. This decreased to 1.11 (0.75-1.64) after adjustment for some classic coronary risk factors and indicators of socioeconomic status. For the three other cell adhesion molecules, the odds ratios for CHD, first adjusted for age and town only, and then additionally adjusted for other risk factors, were: VCAM-1:1.26 (0.99-1.61) and 0.96 (0.66-1.40); E-selectin: 1.27 (1.00-1.61) and 1.13 (0.78-1.62); and P-selectin: 1.23 (0.96-1.56) and 1.20 (0.81-.1.76). Interpretation The measurement of these adhesion molecules is unlikely to add much predictive information to that provided by more established risk factors.	Hammersmith Hosp, Imperial Coll Sch Med, BHF Cardiovasc Med Unit, Natl Heart & Lung Inst, London W12 0NN, England; Univ Cambridge, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge CB2 1TN, England; Univ London St Georges Hosp, Sch Med, Dept Publ Hlth Sci, London SW17 0RE, England; UCL Royal Free & UCL Med Sch, Dept Primary Care & Populat Sci, London, England	Imperial College London; University of Cambridge; St Georges University London; University of London; University College London	Haskard, D (corresponding author), Hammersmith Hosp, Imperial Coll Sch Med, BHF Cardiovasc Med Unit, Natl Heart & Lung Inst, London W12 0NN, England.	d.haskard@ic.ac.uk	Lennon, Lucy/ABB-9433-2020; Lennon, Lucy/AFT-1973-2022	Lennon, Lucy/0000-0002-1738-1351; Papacosta, Olia/0000-0001-8781-6747; Whincup, Peter/0000-0002-5589-4107				Blann AD, 1997, ATHEROSCLEROSIS, V132, P151, DOI 10.1016/S0021-9150(97)00081-6; Clarke R, 1999, AM J EPIDEMIOL, V150, P341; Collins RG, 2000, J EXP MED, V191, P189, DOI 10.1084/jem.191.1.189; Danesh J, 2000, BRIT MED J, V321, P208, DOI 10.1136/bmj.321.7255.208; Danesh J, 2000, BMJ-BRIT MED J, V321, P199, DOI 10.1136/bmj.321.7255.199; Danesh J, 1998, JAMA-J AM MED ASSOC, V279, P1477, DOI 10.1001/jama.279.18.1477; DAVIES MJ, 1993, J PATHOL, V171, P223, DOI 10.1002/path.1711710311; de Lemos JA, 2000, J AM COLL CARDIOL, V36, P423, DOI 10.1016/S0735-1097(00)00742-7; Dong ZM, 1998, J CLIN INVEST, V102, P145, DOI 10.1172/JCI3001; GEARING AJH, 1993, IMMUNOL TODAY, V14, P506, DOI 10.1016/0167-5699(93)90267-O; Ghaisas NK, 1997, AM J CARDIOL, V80, P617, DOI 10.1016/S0002-9149(97)00432-3; Haverkate F, 1997, LANCET, V349, P462, DOI 10.1016/S0140-6736(96)07591-5; Hwang SJ, 1997, CIRCULATION, V96, P4219; Johnson RC, 1997, J CLIN INVEST, V99, P1037, DOI 10.1172/JCI119231; Kaikita K, 1997, JPN CIRC J, V61, P741, DOI 10.1253/jcj.61.741; LIUZZO G, 1994, NEW ENGL J MED, V331, P417, DOI 10.1056/NEJM199408183310701; Nageh MF, 1997, ARTERIOSCL THROM VAS, V17, P1517, DOI 10.1161/01.ATV.17.8.1517; POSTON RN, 1992, AM J PATHOL, V140, P665; Rebuzzi AG, 1998, AM J CARDIOL, V82, P715, DOI 10.1016/S0002-9149(98)00458-5; Ridker PM, 1998, LANCET, V351, P88, DOI 10.1016/S0140-6736(97)09032-6; Ridker PM, 2001, CIRCULATION, V103, P491, DOI 10.1161/01.CIR.103.4.491; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Rohde LEP, 1999, ARTERIOSCL THROM VAS, V19, P1595, DOI 10.1161/01.ATV.19.7.1595; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; SHAPER AG, 1981, BRIT MED J, V283, P179, DOI 10.1136/bmj.283.6285.179; Shyu KG, 1996, CHEST, V109, P1627, DOI 10.1378/chest.109.6.1627; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; TEDDER TF, 1995, FASEB J, V9, P866, DOI 10.1096/fasebj.9.10.7542213; Walker M, 2000, J PUBLIC HEALTH MED, V22, P479, DOI 10.1093/pubmed/22.4.479; Wallen NH, 1999, EUR HEART J, V20, P1039; Whincup P, 2000, CIRCULATION, V101, P1647; Whincup PH, 1996, HEART, V75, P568, DOI 10.1136/hrt.75.6.568	32	311	328	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 22	2001	358	9286					971	975		10.1016/S0140-6736(01)06104-9	http://dx.doi.org/10.1016/S0140-6736(01)06104-9			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	474YR	11583751				2022-12-24	WOS:000171135300018
J	Mjolsness, E; DeCoste, D				Mjolsness, E; DeCoste, D			Machine learning for science: State of the art and future prospects	SCIENCE			English	Editorial Material							PREDICTION	Recent advances in machine learning methods, along with successful applications across a wide variety of fields such as planetary science and bioinformatics, promise powerful new tools for practicing scientists. This viewpoint highlights some useful characteristics of modern machine learning methods and their relevance to scientific applications. We conclude with some speculations on near-term progress and promising directions.	CALTECH, Jet Prop Lab, Machine Learning Syst Grp, Pasadena, CA 91109 USA	California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Mjolsness, E (corresponding author), CALTECH, Jet Prop Lab, Machine Learning Syst Grp, 4800 Oak Grove Dr, Pasadena, CA 91109 USA.	mjolsness@jpl.nasa.gov						BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; BROWN M, 2000, P NATL ACAD SCI USA, V97, P1; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Burl MC, 1998, MACH LEARN, V30, P165, DOI 10.1023/A:1007400206189; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Jung TP, 2001, P IEEE, V89, P1107, DOI 10.1109/5.939827; Mitchell T.M, 2003, MACH LEARN; Mjolsness E, 2000, ADV NEUR IN, V12, P928; Roweis ST, 2000, SCIENCE, V290, P2323, DOI 10.1126/science.290.5500.2323; Scholkopf B, 1999, ADVANCES IN KERNEL METHODS, P327; Shiozawa M, 1999, NUCL INSTRUM METH A, V433, P240, DOI 10.1016/S0168-9002(99)00359-9; Shoemaker DD, 2001, NATURE, V409, P922, DOI 10.1038/35057141; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Zien A, 2000, BIOINFORMATICS, V16, P799, DOI 10.1093/bioinformatics/16.9.799	15	202	223	11	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 14	2001	293	5537					2051	+		10.1126/science.293.5537.2051	http://dx.doi.org/10.1126/science.293.5537.2051			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473FB	11557883				2022-12-24	WOS:000171028700064
J	Beecham, L; Dorozynski, A; Sheldon, T; Turone, F; Mach, A; Bosch, X; Charatan, FB; Mahkorn, DT; Siegel-Itzkovich, J				Beecham, L; Dorozynski, A; Sheldon, T; Turone, F; Mach, A; Bosch, X; Charatan, FB; Mahkorn, DT; Siegel-Itzkovich, J			Viagra falls: the debate over rationing continues	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	6	6	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	SEP 26	1998	317	7162					836	838						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	125DN	11645103				2022-12-24	WOS:000076222300013
J	Padkin, A; Rowan, K; Black, N				Padkin, A; Rowan, K; Black, N			Using high quality clinical databases to complement the results of randomised controlled trials: the case of recombinant human activated protein C	BRITISH MEDICAL JOURNAL			English	Article							CARE		Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, Hlth Serv Res Unit, London WC1E 7HT, England; Intens Care Natl Audit & Res Ctr, London WC1H 9HR, England	University of London; London School of Hygiene & Tropical Medicine; Intensive Care National Audit & Research Centre	Padkin, A (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, Hlth Serv Res Unit, London WC1E 7HT, England.							APPLEBY P, 1994, LANCET, V343, P311, DOI 10.1016/S0140-6736(94)91161-4; Assmann SF, 2000, LANCET, V355, P1064, DOI 10.1016/S0140-6736(00)02039-0; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Black N, 2001, BRIT MED J, V323, P275, DOI 10.1136/bmj.323.7307.275; Black N, 1996, BRIT MED J, V312, P1215; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; *BRIT MED ASS, 1992, 33 BMA RPS; Britton A, 1999, J Health Serv Res Policy, V4, P112; Goldfrad C, 2000, LANCET, V355, P1138, DOI 10.1016/S0140-6736(00)02062-6; MATHER CMP, 1995, ANAESTHESIA, V50, P189, DOI 10.1111/j.1365-2044.1995.tb04552.x; MOHER D, 1995, CONTROL CLIN TRIALS, V16, P62, DOI 10.1016/0197-2456(94)00031-W; Roland M, 1998, BRIT MED J, V316, P285, DOI 10.1136/bmj.316.7127.285; ROWAN K, 2001, PROGRAMME INTENSIVE, P51; ROWAN K, 2000, HLTH CARE UK     SPR, P42; Turner S, 1998, BRIT MED J, V316, P343, DOI 10.1136/bmj.316.7128.343	15	43	43	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 20	2001	323	7318					923	926		10.1136/bmj.323.7318.923	http://dx.doi.org/10.1136/bmj.323.7318.923			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	486BH	11668142	Green Accepted, Green Published			2022-12-24	WOS:000171798200028
J	Piccirillo, JF; Mager, DE; Frisse, ME; Brophy, RH; Goggin, A				Piccirillo, JF; Mager, DE; Frisse, ME; Brophy, RH; Goggin, A			Impact of first-line vs second-line antibiotics for the treatment of acute uncomplicated sinusitis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PLACEBO-CONTROLLED TRIAL; ANTIMICROBIAL TREATMENT; AMOXICILLIN; ADULTS; RHINOSINUSITIS; THERAPY; INFECTIONS; PRINCIPLES; CURE	Context Studies suggest little benefit in relief of acute sinusitis symptoms from the use of newer and more expensive (second-line) antibiotics instead of older and less expensive (first-line) antibiotics. However, researchers have failed to include development of complications and cost of care in their analyses. Objective To compare the effectiveness and cost of first-line with second-line antibiotics for the treatment of acute uncomplicated sinusitis in adults. Design, Setting, and Patients Retrospective cohort study using a pharmaceutical database containing demographic, clinical (International Classification of Diseases, Ninth Revision), treatment, and charge information for 29102 adults with a diagnosis of acute sinusitis receiving initial antibiotic treatment between July 1, 1996, and June 30, 1997. Main Outcome Measures Absence of additional claim for an antibiotic in the 28 days after the initial antibiotic, presence of a claim for a second antibiotic, serious complications of sinusitis, and direct charges and use for the acute sinusitis treatment. Results There were 17 different antibiotics prescribed in this study. The majority (59.5%) of patients received 1 of the first-line antibiotics. The overall success rate was 90.4% (95% confidence interval [CI], 90.0%-90.8%). The success rate for the 17 329 patients who received a first-line antibiotic was 90.1% and for the 11773 patients who received a second-line antibiotic was 90.8%, a difference of 0.7% (95% CI, 0.01%-1.40%; P<.05). There were 2 cases of periorbital cellulitis, one in each treatment group. The average total direct charge for patients receiving a first-line antibiotic was $68.98 and a second-line antibiotic was $135.17, a difference of $66.19 (95% Cl, $64.95-$67.43; P<.001). This difference was due entirely to the difference in charge of antibiotics and not other charges, such as professional fees, laboratory tests, or emergency department visits. Conclusions Patients treated with a first-line antibiotic for acute uncomplicated sinusitis did not have clinically significant differences in outcomes vs those treated with a second-line antibiotic. However, cost of care was significantly higher for patients treated with a second-line antibiotic.	Washington Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Div Clin Outcomes Res, St Louis, MO 63110 USA; Express Scripts Inc, Maryland Hts, MO USA	Washington University (WUSTL); Express Scripts Holding Company	Piccirillo, JF (corresponding author), Washington Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Div Clin Outcomes Res, Campus Box 8115,660 S Euclid Ave, St Louis, MO 63110 USA.	piccirij@msnotes.wustl.edu	Frisse, Mark E/B-3824-2016; Brophy, Robert H/AAX-8562-2021	Frisse, Mark E/0000-0003-0382-6222; Brophy, Robert H/0000-0002-2912-8265				Adelglass J, 1999, OTOLARYNG HEAD NECK, V120, P320, DOI 10.1016/S0194-5998(99)70269-X; Adelglass J, 1998, CLIN THER, V20, P1115, DOI 10.1016/S0149-2918(98)80108-2; *AG HLTH CAR POL R, 1999, 999E015 AG HLTH CAR; Benninger MS, 1997, ARCH OTOLARYNGOL, V123, P1175; BERG O, 1986, Rhinology (Utrecht), V24, P223; Bro F, 1988, Scand J Prim Health Care, V6, P175, DOI 10.3109/02813438809009312; Burke T, 1999, CLIN THER, V21, P1664, DOI 10.1016/S0149-2918(99)80046-0; De Bock Geertruida H., 1994, Scandinavian Journal of Primary Health Care, V12, P9, DOI 10.3109/02813439408997050; de Bock GH, 2001, SCAND J PRIM HEALTH, V19, P58, DOI 10.1080/028134301300034729; de Ferranti SD, 1998, BMJ-BRIT MED J, V317, P632, DOI 10.1136/bmj.317.7159.632; deBock GH, 1997, J CLIN EPIDEMIOL, V50, P881, DOI 10.1016/S0895-4356(97)00117-0; DINGLE JH, 1964, ILLNESS HOME STUDY 2, P347; Dowell SF, 1999, PEDIATR INFECT DIS J, V18, P1, DOI 10.1097/00006454-199901000-00002; EDELSTEIN DR, 1993, LARYNGOSCOPE, V103, P33; Garbutt JM, 2001, PEDIATRICS, V107, P619, DOI 10.1542/peds.107.4.619; GEHANNO P, 1990, J ANTIMICROB CHEMOTH, V26, P87, DOI 10.1093/jac/26.suppl_E.87; Gonzales R, 2001, ANN INTERN MED, V134, P479, DOI 10.7326/0003-4819-134-6-200103200-00013; Halpern M, 2000, AM J HEALTH-SYST PH, V57, P875, DOI 10.1093/ajhp/57.9.875; Hickner JM, 2001, ANN INTERN MED, V134, P498, DOI 10.7326/0003-4819-134-6-200103200-00017; HORWITZ RI, 1990, AM J MED, V89, P630, DOI 10.1016/0002-9343(90)90182-D; KENNEDY DW, 1990, OTOLARYNG HEAD NECK, V103, P887, DOI 10.1177/01945998901030S510; Lanza DC, 1997, OTOLARYNG HEAD NECK, V117, pS1, DOI 10.1016/S0194-5998(97)70001-9; Levy SB, 1998, SCI AM, V278, P46, DOI 10.1038/scientificamerican0398-46; Lindbaek M, 1996, BMJ-BRIT MED J, V313, P325, DOI 10.1136/bmj.313.7053.325; MANN W, 1981, HNO, V29, P92; Mansfield E L, 1994, J La State Med Soc, V146, P287; MCCAIG LF, 1995, JAMA-J AM MED ASSOC, V273, P214, DOI 10.1001/jama.273.3.214; MCCOMBS JS, 1995, PHARMACOECONOMICS, V7, P543, DOI 10.2165/00019053-199507060-00008; Piccirillo JF, 1995, AM J RHINOL, V9, P297, DOI 10.2500/105065895781808711; POOLE MD, 1999, AM J MED, V106, P385; *RHIN TASK FORC CO, 1997, OTOLARYNGOL HEAD NEC, V117, pS1; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; RUBIN DB, 1991, STAT MED, V10, P585, DOI 10.1002/sim.4780100410; Schrag SJ, 2001, JAMA-J AM MED ASSOC, V286, P49, DOI 10.1001/jama.286.1.49; *SIN ALL HLTH PART, 2000, OTOLARYNGOL HEAD NEC, V123, pS1; Snow V, 2001, ANN INTERN MED, V134, P495, DOI 10.7326/0003-4819-134-6-200103200-00016; vanBuchem FL, 1997, LANCET, V349, P683, DOI 10.1016/S0140-6736(96)07585-X; WAGENMANN M, 1992, J ALLERGY CLIN IMMUN, V90, P552, DOI 10.1016/0091-6749(92)90184-4; WILLIAMS JW, 1993, JAMA-J AM MED ASSOC, V270, P1242, DOI 10.1001/jama.270.10.1242; WILLIAMS JW, 1995, JAMA-J AM MED ASSOC, V273, P1015, DOI 10.1001/jama.273.13.1015; WILLIAMS JW, 2001, ANTIBIOTICS ACUTE MA	41	72	73	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 17	2001	286	15					1849	1856		10.1001/jama.286.15.1849	http://dx.doi.org/10.1001/jama.286.15.1849			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	482UH	11597286	Bronze			2022-12-24	WOS:000171595300025
J	Strasser, K; Hurt, E				Strasser, K; Hurt, E			Splicing factor Sub2p is required for nuclear mRNA export through its interaction with Yra1p	NATURE			English	Article							YEAST HOMOLOG; MEX67P; IDENTIFICATION; BINDING; PROTEIN	The yeast nuclear protein Yra1p is an essential export factor for mRNA. Yra1p interacts directly with the mRNA transport factor Mex67p/Mtr2p, which is associated with the nuclear pore(1,2). Here, we report a genetic interaction between YRA1 and SUB2, the gene for a DEAD box helicase involved in splicing(3-5). Mutation of SUB2 as well as its overexpression leads to a defect in mRNA export. Moreover, Yra1p and Sub2p bind directly to each other both in vivo and in vitro. Significantly, Sub2p and Mex67p/Mtr2p bind to the same domains of Yra1p, and the proteins compete for binding to Yra1p. Together, these data indicate that the spliceosomal component Sub2p is also important in mRNA export and may function to recruit Yra1p to the mRNA. Sub2p may then be displaced from Yra1p by the binding of Mex67p/Mtr2p, which participates in the export of mRNA through the nuclear pores.	BZH, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Hurt, E (corresponding author), BZH, Neuenheimer Feld 328, D-69120 Heidelberg, Germany.	eg5@ix.urz.uni-heidelberg.de	Ed Hurt, Dr./AAE-8874-2019	Ed Hurt, Dr./0000-0002-4535-8255; Strasser, Katja/0000-0003-3533-5516				Bousquet-Antonelli C, 2000, CELL, V102, P765, DOI 10.1016/S0092-8674(00)00065-9; Bruhn L, 1997, GENE DEV, V11, P640, DOI 10.1101/gad.11.5.640; Hellmuth K, 1998, MOL CELL BIOL, V18, P6374, DOI 10.1128/MCB.18.11.6374; Huang YQ, 2001, MOL CELL, V7, P899, DOI 10.1016/S1097-2765(01)00233-7; Hurt E, 2000, J BIOL CHEM, V275, P8361, DOI 10.1074/jbc.275.12.8361; Jensen TH, 2001, MOL CELL, V7, P887, DOI 10.1016/S1097-2765(01)00232-5; Kistler AL, 2001, GENE DEV, V15, P42, DOI 10.1101/gad.851301; Libri D, 2001, GENE DEV, V15, P36, DOI 10.1101/gad.852101; Portenoy RK, 1997, J PALLIATIVE CARE, V13, P56; Segref A, 1997, EMBO J, V16, P3256, DOI 10.1093/emboj/16.11.3256; Siniossoglou S, 1996, CELL, V84, P265, DOI 10.1016/S0092-8674(00)80981-2; Strasser K, 2000, EMBO J, V19, P410, DOI 10.1093/emboj/19.3.410; Stutz F, 2000, RNA, V6, P638, DOI 10.1017/S1355838200000078; Virbasius CMA, 1999, MOL CELL, V4, P219, DOI 10.1016/S1097-2765(00)80369-X; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Zhang M, 2001, GENE DEV, V15, P30, DOI 10.1101/gad.851701; Zhou ZL, 2000, NATURE, V407, P401, DOI 10.1038/35030160	17	242	246	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 11	2001	413	6856					648	652		10.1038/35098113	http://dx.doi.org/10.1038/35098113			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480WE	11675790				2022-12-24	WOS:000171485700053
J	Duchek, P; Somogyi, K; Jekely, G; Beccari, S; Rorth, P				Duchek, P; Somogyi, K; Jekely, G; Beccari, S; Rorth, P			Guidance of cell migration by the Drosophila PDGF/VEGF receptor	CELL			English	Article							SH2/SH3 ADAPTER PROTEIN; TYROSINE KINASE; MYOBLAST CITY; EGF RECEPTOR; ACTIVATION; OOGENESIS; MORPHOGENESIS; PHAGOCYTOSIS; CHEMOTAXIS; MEMBRANE	Directed cell migrations are important for development, but the signaling pathways and mechanisms responsible for guiding cell migration in vivo are poorly understood. Migration of border cells during Drosophila oogenesis is a simple and attractive model system in which to address these questions. We demonstrate that PVR, a receptor tyrosine kinase related to mammalian PDGF and VEGF receptors, acts in border cells to guide them to the oocyte. The oocyte is the source of a ligand for PVR, PDGF/VEGF factor 1 (PVF1). Intriguingly, the guidance function of PVR is largely redundant with that of EGFR. We present evidence implicating Rac and the Rac activator Mbc/DOCK180/CED-5 as mediators of the guidance signal.	European Mol Biol Lab, Dev Biol Programme, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Rorth, P (corresponding author), European Mol Biol Lab, Dev Biol Programme, D-69117 Heidelberg, Germany.		Rørth, Pernille/H-3020-2011; Jékely, Gáspár/I-8708-2012	Jékely, Gáspár/0000-0001-8496-9836				Albert ML, 2000, NAT CELL BIOL, V2, P899, DOI 10.1038/35046549; Bai JW, 2000, CELL, V103, P1047, DOI 10.1016/S0092-8674(00)00208-7; BRAND AH, 1993, DEVELOPMENT, V118, P401; Bruckner K, 2000, NATURE, V406, P411, DOI 10.1038/35019075; BUNCH TA, 1988, NUCLEIC ACIDS RES, V16, P1043, DOI 10.1093/nar/16.3.1043; Chen J, 2001, NAT CELL BIOL, V3, P204, DOI 10.1038/35055120; CHEN P, 1994, J CELL BIOL, V124, P547, DOI 10.1083/jcb.124.4.547; Cheresh DA, 1999, J CELL BIOL, V146, P1107, DOI 10.1083/jcb.146.5.1107; Duchek P, 2001, SCIENCE, V291, P131, DOI 10.1126/science.291.5501.131; Edwards KA, 1996, DEVELOPMENT, V122, P1499; Erickson MRS, 1997, J CELL BIOL, V138, P589, DOI 10.1083/jcb.138.3.589; Firtel RA, 2000, BIOESSAYS, V22, P603, DOI 10.1002/1521-1878(200007)22:7<603::AID-BIES3>3.0.CO;2-#; Gabay L, 1997, SCIENCE, V277, P1103, DOI 10.1126/science.277.5329.1103; Galletta BJ, 1999, GENE, V228, P243, DOI 10.1016/S0378-1119(99)00010-4; Garrity PA, 1996, CELL, V85, P639, DOI 10.1016/S0092-8674(00)81231-3; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hasegawa H, 1996, MOL CELL BIOL, V16, P1770; Holder N, 1999, DEVELOPMENT, V126, P2033; KING RC, 1970, OVARIAN DEV DROSOPHL; Kiyokawa E, 1998, GENE DEV, V12, P3331, DOI 10.1101/gad.12.21.3331; Klemke RL, 1998, J CELL BIOL, V140, P961, DOI 10.1083/jcb.140.4.961; KUNDRA V, 1994, NATURE, V367, P474, DOI 10.1038/367474a0; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lee T, 1996, GENE DEV, V10, P2912, DOI 10.1101/gad.10.22.2912; Liu YR, 2001, DEVELOPMENT, V128, P321; Luschnig S, 2000, MOL CELL, V5, P231, DOI 10.1016/S1097-2765(00)80419-0; Mata J, 2000, CELL, V101, P511, DOI 10.1016/S0092-8674(00)80861-2; MONTELL DJ, 1992, CELL, V71, P51, DOI 10.1016/0092-8674(92)90265-E; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Murphy AM, 1996, J CELL BIOL, V133, P617, DOI 10.1083/jcb.133.3.617; NeumanSilberberg FS, 1996, MECH DEVELOP, V59, P105, DOI 10.1016/0925-4773(96)00567-9; Newsome TP, 2000, CELL, V101, P283, DOI 10.1016/S0092-8674(00)80838-7; Niewiadomska P, 1999, J CELL BIOL, V144, P533, DOI 10.1083/jcb.144.3.533; NOBES CD, 1995, J CELL SCI, V108, P225; Nolan KM, 1998, GENE DEV, V12, P3337, DOI 10.1101/gad.12.21.3337; O'Keefe L, 1997, DEVELOPMENT, V124, P4837; Parent CA, 1999, SCIENCE, V284, P765, DOI 10.1126/science.284.5415.765; Queenan AM, 1997, DEVELOPMENT, V124, P3871; RAABE T, 1995, EMBO J, V14, P2509, DOI 10.1002/j.1460-2075.1995.tb07248.x; Raabe T, 1996, CELL, V85, P911, DOI 10.1016/S0092-8674(00)81274-X; Reddien PW, 2000, NAT CELL BIOL, V2, P131, DOI 10.1038/35004000; Reich A, 1999, DEVELOPMENT, V126, P4139; RIDELY AJ, 1992, CELL, V70, P401; Rorth P, 1998, MECH DEVELOP, V78, P113, DOI 10.1016/S0925-4773(98)00157-9; Rorth P, 1998, DEVELOPMENT, V125, P1049; Rorth P, 1996, P NATL ACAD SCI USA, V93, P12418, DOI 10.1073/pnas.93.22.12418; RUSHTON E, 1995, DEVELOPMENT, V121, P1979; Schweitzer R, 1997, TRENDS GENET, V13, P191, DOI 10.1016/S0168-9525(97)01091-3; Tallquist MD, 2000, GENE DEV, V14, P3179, DOI 10.1101/gad.844700; WENNSTROM S, 1994, ONCOGENE, V9, P651; Wilkinson DG, 2001, NAT REV NEUROSCI, V2, P155, DOI 10.1038/35058515; Wu W, 1999, NATURE, V400, P331, DOI 10.1038/22477; Wu YC, 1998, NATURE, V392, P501, DOI 10.1038/33163; XU T, 1993, DEVELOPMENT, V117, P1223	54	346	350	1	21	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 5	2001	107	1					17	26		10.1016/S0092-8674(01)00502-5	http://dx.doi.org/10.1016/S0092-8674(01)00502-5			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	480GF	11595182	Bronze			2022-12-24	WOS:000171453100006
J	Raghuraman, MK; Winzeler, EA; Collingwood, D; Hunt, S; Wodicka, L; Conway, A; Lockhart, DJ; Davis, RW; Brewer, BJ; Fangman, WL				Raghuraman, MK; Winzeler, EA; Collingwood, D; Hunt, S; Wodicka, L; Conway, A; Lockhart, DJ; Davis, RW; Brewer, BJ; Fangman, WL			Replication dynamics of the yeast genome	SCIENCE			English	Article							CEREVISIAE CHROMOSOME-VI; S-PHASE; SACCHAROMYCES-CEREVISIAE; DNA-REPLICATION; ORIGIN ACTIVATION; MAMMALIAN-CELLS; ARS ELEMENTS; TIME; INITIATION; TELOMERES	Oligonucleotide microarrays were used to map the detailed topography of chromosome replication in the budding yeast Saccharomyces cerevisiae. The times of replication of thousands of sites across the genome were determined by hybridizing replicated and unreplicated DNAs, isolated at different times in S phase, to the microarrays. Origin activations take place continuously throughout S phase but with most firings near mid-S phase. Rates of replication fork movement vary greatly from region to region in the genome. The two ends of each of the 16 chromosomes are highly correlated in their times of replication. This microarray approach is readily applicable to other organisms, including humans.	Univ Washington, Dept Genet, Seattle, WA 98195 USA; Univ Washington, Dept Math, Seattle, WA 98195 USA; Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; Affymetrix, Santa Clara, CA USA; Silicon Genet, San Carlos, CA 94070 USA; Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Novartis; Affymetrix; Stanford University	Raghuraman, MK (corresponding author), Univ Washington, Dept Genet, Seattle, WA 98195 USA.		Winzeler, Elizabeth/AAP-6752-2020	Winzeler, Elizabeth/0000-0002-4049-2113				APARICIO O, COMMUNICATION; Bousset K, 1998, GENE DEV, V12, P480, DOI 10.1101/gad.12.4.480; Donaldson AD, 1998, MOL CELL, V2, P173, DOI 10.1016/S1097-2765(00)80127-6; Donaldson AD, 1998, GENE DEV, V12, P491, DOI 10.1101/gad.12.4.491; Donaldson AD, 1999, CURR OPIN GENET DEV, V9, P62, DOI 10.1016/S0959-437X(99)80009-4; DROUIN R, 1990, CHROMOSOMA, V99, P273, DOI 10.1007/BF01731703; FERGUSON BM, 1991, CELL, V65, P507, DOI 10.1016/0092-8674(91)90468-E; FERGUSON BM, 1992, CELL, V68, P333, DOI 10.1016/0092-8674(92)90474-Q; Friedman KL, 1996, GENE DEV, V10, P1595, DOI 10.1101/gad.10.13.1595; Friedman KL, 1997, GENES CELLS, V2, P667, DOI 10.1046/j.1365-2443.1997.1520350.x; HAND R, 1975, J CELL BIOL, V64, P89, DOI 10.1083/jcb.64.1.89; HATTON KS, 1988, MOL CELL BIOL, V8, P2149, DOI 10.1128/MCB.8.5.2149; KEARSEY S, 1984, CELL, V37, P299, DOI 10.1016/0092-8674(84)90326-X; Khodursky AB, 2000, P NATL ACAD SCI USA, V97, P9419, DOI 10.1073/pnas.97.17.9419; KOLOR K, UNPUB; Lengronne A, 2001, NUCLEIC ACIDS RES, V29, P1433, DOI 10.1093/nar/29.7.1433; MCCARROLL RM, 1988, CELL, V54, P505, DOI 10.1016/0092-8674(88)90072-4; NATALE DA, 1992, P NATL ACAD SCI USA, V89, P2654, DOI 10.1073/pnas.89.7.2654; NEWLON CS, 1993, CURR OPIN GENET DEV, V3, P752, DOI 10.1016/S0959-437X(05)80094-2; NEWLON CS, 1980, ICN UCLA S MOL CELL, V19, P399; Pasero P, 2000, CURR OPIN GENET DEV, V10, P178, DOI 10.1016/S0959-437X(00)00067-8; REYNOLDS AE, 1989, MOL CELL BIOL, V9, P4488, DOI 10.1128/MCB.9.10.4488; RIVIN CJ, 1980, J CELL BIOL, V85, P108, DOI 10.1083/jcb.85.1.108; Seoighe C, 1999, GENE, V238, P253, DOI 10.1016/S0378-1119(99)00319-4; SHARP PM, 1993, NUCLEIC ACIDS RES, V21, P179, DOI 10.1093/nar/21.2.179; Stevenson JB, 1999, GENE DEV, V13, P146, DOI 10.1101/gad.13.2.146; Toone WM, 1997, ANNU REV MICROBIOL, V51, P125, DOI 10.1146/annurev.micro.51.1.125; VANHOUTEN JV, 1990, MOL CELL BIOL, V10, P3917, DOI 10.1128/MCB.10.8.3917; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; WELLINGER RJ, 1993, CELL, V72, P51, DOI 10.1016/0092-8674(93)90049-V; Winzeler EA, 1998, SCIENCE, V281, P1194, DOI 10.1126/science.281.5380.1194; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; WOLFFE AP, 1994, DEV GENET, V15, P463, DOI 10.1002/dvg.1020150604; Wyrick JJ, 1999, NATURE, V402, P418, DOI 10.1038/46567; Yamashita M, 1997, GENES CELLS, V2, P655, DOI 10.1046/j.1365-2443.1997.1530351.x	35	597	608	1	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 5	2001	294	5540					115	121		10.1126/science.294.5540.115	http://dx.doi.org/10.1126/science.294.5540.115			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	480EJ	11588253				2022-12-24	WOS:000171448800041
J	Miyamoto, K; Miyake, S; Yamamura, T				Miyamoto, K; Miyake, S; Yamamura, T			A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing T(H)2 bias of natural killer T cells	NATURE			English	Article							ALTERED PEPTIDE LIGAND; ALPHA-GALACTOSYLCERAMIDE; SELECTIVE REDUCTION; MULTIPLE-SCLEROSIS; NKT CELLS; TCR; RECOGNITION; ACTIVATION; ANTIGENS; DISEASE	Experimental autoimmune encephalomyelitis (EAE) is a prototype autoimmune disease mediated by type 1 helper T (T(H)1) cells and under the control of regulatory cells(1-3). Here we report that a synthetic glycolipid ligand for CD1d-restricted natural killer T (NKT) cells expressing the semi-invariant T-cell receptor (V alpha 14(+)) is preventive against EAE. The ligand is an analogue of alpha -galactosylceramide (alpha -GC), a prototype NKT cell ligand, with a truncated sphingosine chain. alpha -GC causes NKT cells to produce both interferon (IFN)-gamma and interleukin (IL)-4 (refs 4, 5). However, this new ligand can induce a predominant production of IL-4 by the NKT cells. A single injection of this glycolipid, but not of alpha -GC, consistently induced T(H)2 bias of autoimmune T cells by causing NKT cells to produce IL-4, leading to suppression of EAE. The lack of polymorphism of CD1d and cross-reactive response of mouse and human NKT cells to the same ligand(6) indicates that targeting NKT cells with this ligand may be an attractive means for intervening in human autoimmune diseases such as multiple sclerosis.	NCNP, Natl Inst Neurosci, Dept Immunol, Tokyo 1878502, Japan	National Center for Neurology & Psychiatry - Japan	Yamamura, T (corresponding author), NCNP, Natl Inst Neurosci, Dept Immunol, 4-1-1 Ogawahigashi, Tokyo 1878502, Japan.							Bendelac A, 1997, ANNU REV IMMUNOL, V15, P535, DOI 10.1146/annurev.immunol.15.1.535; BIX M, 1995, J IMMUNOL, V155, P1020; Brossay L, 1998, J EXP MED, V188, P1521, DOI 10.1084/jem.188.8.1521; Godfrey DI, 2000, IMMUNOL TODAY, V21, P573, DOI 10.1016/S0167-5699(00)01735-7; Illes Z, 2000, J IMMUNOL, V164, P4375, DOI 10.4049/jimmunol.164.8.4375; Kappos L, 2000, NAT MED, V6, P1176, DOI 10.1038/80525; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; KIRSTEN JL, 1998, J EXP MED, V187, P1047; Kumar V, 1997, J EXP MED, V185, P1725, DOI 10.1084/jem.185.10.1725; Matsuda JL, 2000, J EXP MED, V192, P741, DOI 10.1084/jem.192.5.741; Mieza MA, 1996, J IMMUNOL, V156, P4035; Moody DB, 1999, IMMUNOL REV, V172, P285, DOI 10.1111/j.1600-065X.1999.tb01373.x; MORITA M, 1995, BIOORG MED CHEM LETT, V5, P699, DOI 10.1016/0960-894X(95)00097-D; Nicholson LB, 1996, CURR OPIN IMMUNOL, V8, P837, DOI 10.1016/S0952-7915(96)80013-6; Pal E, 2001, J IMMUNOL, V166, P662, DOI 10.4049/jimmunol.166.1.662; Pedotti R, 2001, NAT IMMUNOL, V2, P216, DOI 10.1038/85266; SloanLancaster J, 1996, ANNU REV IMMUNOL, V14, P1, DOI 10.1146/annurev.immunol.14.1.1; Spada FM, 1998, J EXP MED, V188, P1529, DOI 10.1084/jem.188.8.1529; SUMIDA T, 1995, J EXP MED, V182, P1163, DOI 10.1084/jem.182.4.1163; Wilson SB, 1998, NATURE, V391, P177, DOI 10.1038/34419; Zhang BN, 1997, J EXP MED, V186, P1677, DOI 10.1084/jem.186.10.1677	21	720	785	1	20	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 4	2001	413	6855					531	534		10.1038/35097097	http://dx.doi.org/10.1038/35097097			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	478HG	11586362				2022-12-24	WOS:000171340500049
J	McCracken, KG; Wilson, RE; McCracken, PJ; Johnson, KP				McCracken, KG; Wilson, RE; McCracken, PJ; Johnson, KP			Sexual selection - Are ducks impressed by Drakes' display?	NATURE			English	Article									Univ Alaska Fairbanks, Inst Arctic Biol, Fairbanks, AK 99775 USA; Univ Alaska Fairbanks, Dept Biol & Wildlife, Fairbanks, AK 99775 USA; Univ Alaska Museum, Fairbanks, AK 99775 USA; Illinois Nat Hist Survey, Champaign, IL 61820 USA	University of Alaska System; University of Alaska Fairbanks; University of Alaska System; University of Alaska Fairbanks; University of Alaska System; University of Alaska Fairbanks; Illinois Natural History Survey	McCracken, KG (corresponding author), Univ Alaska Fairbanks, Inst Arctic Biol, Fairbanks, AK 99775 USA.							Birkhead TR, 1992, SPERM COMPETITION BI; Briskie JV, 1997, J AVIAN BIOL, V28, P73, DOI 10.2307/3677097; JOHNSGARD PA, 1996, RUDDY DUCKS OTHER ST; McCracken KG, 2000, AUK, V117, P820, DOI 10.1642/0004-8038(2000)117[0820:TCSPOT]2.0.CO;2; Mead C, 2000, NATURE, V407, P461, DOI 10.1038/35035183	5	10	11	1	15	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 13	2001	413	6852					128	128		10.1038/35093160	http://dx.doi.org/10.1038/35093160			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471FU	11557968	Bronze			2022-12-24	WOS:000170918800034
J	Richardson, DK; Heffner, LJ				Richardson, DK; Heffner, LJ			Fetal-lung maturity: tests mature, interpretation not	LANCET			English	Editorial Material							AMNIOTIC-FLUID; PRETERM LABOR; INDEXES		Beth Israel Deaconess Med Ctr, Dept Neonatol, Boston, MA 02215 USA; Brigham & Womens Hosp, Dept Obstet & Gynecol, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Brigham & Women's Hospital	Richardson, DK (corresponding author), Beth Israel Deaconess Med Ctr, Dept Neonatol, Boston, MA 02215 USA.			Heffner, Linda/0000-0001-9623-7210				ACOG educational bulletin, 1997, INT J GYNECOL OBSTET, V56, P191; ASHWOOD ER, 1993, OBSTET GYNECOL, V81, P619; DUBIN SB, 1990, CLIN CHEM, V36, P1867; FAGAN TJ, 1975, NEW ENGL J MED, V293, P257; Field NT, 1997, CLIN OBSTET GYNECOL, V40, P366, DOI 10.1097/00003081-199706000-00012; Ghidini A, 1997, AM J PERINAT, V14, P75, DOI 10.1055/s-2007-994101; GILSTRAP LC, 1995, JAMA-J AM MED ASSOC, V273, P413, DOI 10.1001/jama.1995.03520290065031; GLUCK L, 1971, AM J OBSTET GYNECOL, V109, P440, DOI 10.1016/0002-9378(71)90342-5; HALLMAN M, 1976, AM J OBSTET GYNECOL, V125, P613, DOI 10.1016/0002-9378(76)90782-1; HUNINK MGM, 1990, MED DECIS MAKING, V10, P201, DOI 10.1177/0272989X9001000307; Lauria MR, 1996, J REPROD MED, V41, P685; Macones GA, 1998, BRIT J OBSTET GYNAEC, V105, P541, DOI 10.1111/j.1471-0528.1998.tb10156.x; Myers ER, 1997, OBSTET GYNECOL, V90, P824, DOI 10.1016/S0029-7844(97)00412-2; Wijnberger LDE, 2001, BRIT J OBSTET GYNAEC, V108, P583, DOI 10.1111/j.1471-0528.2001.00142.x	14	9	9	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 1	2001	358	9283					684	686		10.1016/S0140-6736(01)05848-2	http://dx.doi.org/10.1016/S0140-6736(01)05848-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	467XR	11551571				2022-12-24	WOS:000170729500004
J	BOWRING, SA; GROTZINGER, JP; ISACHSEN, CE; KNOLL, AH; PELECHATY, SM; KOLOSOV, P				BOWRING, SA; GROTZINGER, JP; ISACHSEN, CE; KNOLL, AH; PELECHATY, SM; KOLOSOV, P			CALIBRATING RATES OF EARLY CAMBRIAN EVOLUTION	SCIENCE			English	Article							PHANEROZOIC TAXONOMIC DIVERSITY; SOUTHERN BRITAIN; IGNEOUS ROCKS; KINETIC-MODEL; TIME-SCALE; AGES; SURVIVORSHIP; ORDOVICIAN; BOUNDARY	An explosive episode of biological diversification occurred near the beginning of the Cambrian period. Evolutionary rates in the Cambrian have been difficult to quantify accurately because of a lack of high-precision ages. Currently, uranium-lead zircon geochronology is the most powerful method for dating rocks of Cambrian age. Uranium-lead zircon data from lower Cambrian rocks located in northeast Siberia indicate that the Cambrian period began at approximately 544 million years ago and that its oldest (Manykaian) stage lasted no less than 10 million years. Other data indicate that the Tommotian and Atdabanian stages together lasted only 5 to 10 million years. The resulting compression of Early Cambrian time accentuates the rapidity of both the faunal diversification and subsequent Cambrian turnover.	YAKUTIAN GEOSCI INST, YAKUTSK, RUSSIA; HARVARD UNIV, BOT MUSEUM, CAMBRIDGE, MA 02138 USA	Diamond & Precious Metal Geology Institute Siberian Branch of Russian Academy of Sciences; Harvard University	BOWRING, SA (corresponding author), MIT, DEPT EARTH ATMOSPHER & PLANETARY SCI, CAMBRIDGE, MA 02139 USA.		Koroleva, Olga/C-1306-2012; Kolosov, Petr/J-9338-2018					Benus AP., 1988, GEOLOGICAL SURVEY B, P8; BOWRING SA, 1992, AM J SCI, V292, P1, DOI 10.2475/ajs.292.1.1; COMPSTON W, 1992, J GEOL SOC LONDON, V149, P171, DOI 10.1144/gsjgs.149.2.0171; Compston W., 1984, Journal of Geophysical Research, V89, P525, DOI 10.1029/JB089iS02p0B525; COOPER JA, 1992, J GEOL SOC LONDON, V149, P185, DOI 10.1144/gsjgs.149.2.0185; COWIE JW, 1989, PRECAMBRIAN CAMBRIAN, P186; Crimes T.P., 1989, Oxford Monographs on Geology and Geophysics, V12, P166; DROSER ML, 1988, GEOLOGY, V16, P233, DOI 10.1130/0091-7613(1988)016<0233:TIDAEO>2.3.CO;2; FOOTE M, 1988, PALEOBIOLOGY, V14, P258, DOI 10.1017/S0094837300011994; Gould, 1990, WONDERFUL LIFE; Harland W. B., 1989, GEOLOGIC TIME SCALE; ISACHSEN CE, UNPUB; KARLOVA GA, 1987, 1ST FINDINGS SKELETA, V292, P204; KHOMENTOVSKY VV, 1986, GEOL MAG, V123, P333, DOI 10.1017/S0016756800033422; KHOMENTOVSKY VV, 1966, GEOL MAG, V154; KNOLL AG, UNPUB; KOMAR VA, 1966, UPPER PRECAMBRIAN ST, V154; KRASILSHCHIKOV AA, 1970, GEOLOGIYA SSSR 1, V18, P91; KROGH TE, 1973, GEOCHIM COSMOCHIM AC, V37, P485, DOI 10.1016/0016-7037(73)90213-5; KROGH TE, 1982, GEOCHIM COSMOCHIM AC, V46, P637, DOI 10.1016/0016-7037(82)90165-X; Landing E., 1992, ORIGIN EARLY EVOLUTI, P283; LUDWIG KR, 1988, 88557 US GEOL SURV O; Meshkova N.P., 1973, PROBLEMY PALEONTOLOG; MISSARZHEVSKY VV, 1989, PROBLEMS UPPER PROTE, P59; MISSARZHEVSKY VV, 1989, OLDEST SKELETAL FOSS; MOCZYDLOWSKA M, 1991, ACRITARCH BIOSTRATIG, V29; ODIN GS, 1983, NATURE, V301, P21, DOI 10.1038/301021a0; OGURTSOVA RN, 1975, INT GEOL REV, V18, P921; PATCHETT PJ, 1980, J GEOL SOC LONDON, V137, P649, DOI 10.1144/gsjgs.137.5.0649; RAUP DM, 1978, PALEOBIOLOGY, V4, P1; Repina L. N., 1974, LOWER CAMBRIAN BIOST; Rozanov A.Yu., 1992, ORIGIN EARLY EVOLUTI, P205; SAMSON SD, 1992, GEOL SOC AM ABSTR, V24, P117; Sepkoski J.J. Jr, 1992, P553; SEPKOSKI JJ, 1978, PALEOBIOLOGY, V4, P223, DOI 10.1017/S0094837300005972; SEPKOSKI JJ, 1979, PALEOBIOLOGY, V5, P222, DOI 10.1017/S0094837300006539; SEPKOSKI JJ, 1988, PALEOBIOLOGY, V14, P221, DOI 10.1017/S0094837300011969; SHPUNT BR, 1982, GEOLOGY USSR W PART; STACEY JS, 1975, EARTH PLANET SC LETT, V26, P207, DOI 10.1016/0012-821X(75)90088-6; TUCKER RD, 1990, EARTH PLANET SC LETT, V100, P51, DOI 10.1016/0012-821X(90)90175-W; TUCKER RD, 1991, J GEOL SOC LONDON, V148, P435, DOI 10.1144/gsjgs.148.3.0435; VALENTINE JW, 1991, EVOLUTIONARY BIOL, V25, P279; WRIGHT AE, 1993, GEOL MAG, V130, P257, DOI 10.1017/S0016756800009900; [No title captured]	44	434	459	3	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 3	1993	261	5126					1293	1298		10.1126/science.11539488	http://dx.doi.org/10.1126/science.11539488			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LV656	11539488				2022-12-24	WOS:A1993LV65600019
J	MCCLURE, BA; GUILFOYLE, T				MCCLURE, BA; GUILFOYLE, T			RAPID REDISTRIBUTION OF AUXIN-REGULATED RNAS DURING GRAVITROPISM	SCIENCE			English	Article									UNIV MISSOURI,DEPT BIOCHEM,COLUMBIA,MO 65211	University of Missouri System; University of Missouri Columbia					NIDCD NIH HHS [DCB 8517676] Funding Source: Medline	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BRIGGS WR, 1963, ANN REV PLANT PHYSL, V38, P311; CASSAB GI, 1987, J CELL BIOL, V105, P2581, DOI 10.1083/jcb.105.6.2581; HAGEN G, 1984, PLANTA, V162, P147, DOI 10.1007/BF00410211; MCCLURE BA, 1987, PLANT MOL BIOL, V9, P611, DOI 10.1007/BF00020537; MCCLURE BA, UNPUB; THEOLOGIS A, 1985, J MOL BIOL, V183, P53, DOI 10.1016/0022-2836(85)90280-3; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; TREWAVAS A, 1981, PLANT CELL ENVIRON, V4, P203, DOI 10.1111/j.1365-3040.1981.tb01048.x; VANDERHOEF LN, 1975, P NATL ACAD SCI USA, V72, P1822, DOI 10.1073/pnas.72.5.1822; WALKER JC, 1982, P NATL ACAD SCI-BIOL, V79, P7185, DOI 10.1073/pnas.79.23.7185	10	150	155	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JAN 6	1989	243	4887					91	93		10.1126/science.11540631	http://dx.doi.org/10.1126/science.11540631			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	R6469	11540631				2022-12-24	WOS:A1989R646900039
J	Rice, WR; Chippindale, AK				Rice, WR; Chippindale, AK			Sexual recombination and the power of natural selection	SCIENCE			English	Article							DELETERIOUS MUTATIONS; DIRECTIONAL SELECTION; GENETIC-VARIABILITY; ADVANTAGE; EVOLUTION; FITNESS; ACCUMULATION; EPISTASIS; LINKAGE; LIMITS	Theory predicts that recombination will increase the effectiveness of natural selection. A Drosophila melanogaster model system was developed that increased experimental power with the use of high experimental replication, explicit tracking of individual genes, and high but natural levels of background selection. Each of 34 independent experiments traced the fate of a newly arisen mutation located within genome-wide, synthetic chromosomes that were propagated with or without recombination. An intrinsic advantage to recombination was demonstrated by the finding that the realized strength of selection on new mutations was markedly increased when recombination was present.	Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Rice, WR (corresponding author), Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA.	rice@lifesci.ucsb.edu						BARTON NH, 1995, GENETICS, V140, P821; Birdsell J, 1996, P NATL ACAD SCI USA, V93, P908, DOI 10.1073/pnas.93.2.908; CARSON HL, 1958, COLD SPRING HARB SYM, V23, P291, DOI 10.1101/SQB.1958.023.01.030; CHAO L, 1990, NATURE, V348, P454, DOI 10.1038/348454a0; CHARLESWORTH B, 1994, GENET RES, V63, P213, DOI 10.1017/S0016672300032365; CHARLESWORTH D, 1993, J HERED, V84, P321, DOI 10.1093/oxfordjournals.jhered.a111351; Chippindale AK, 2001, P NATL ACAD SCI USA, V98, P1671, DOI 10.1073/pnas.041378098; CROW JAMES F., 1965, AMER NATUR, V99, P439, DOI 10.1086/282389; deVisser JAGM, 1996, P ROY SOC B-BIOL SCI, V263, P193, DOI 10.1098/rspb.1996.0031; Endler J.A., 1986, Monographs in Population Biology, pviii; FELSENSTEIN J, 1974, GENETICS, V78, P737; Fisher R. A., 1930, GENETICAL THEORY NAT, P135; FLEXON PB, 1982, NATURE, V298, P672, DOI 10.1038/298672a0; Fowler K, 1997, P ROY SOC B-BIOL SCI, V264, P191, DOI 10.1098/rspb.1997.0027; GEER BW, 1962, AM NAT, V96, P175, DOI 10.1086/282220; HILL WG, 1966, GENET RES, V8, P269, DOI 10.1017/S0016672300010156; KIMURA M, 1968, GENET RES, V11, P247, DOI 10.1017/S0016672300011459; KIMURA M, 1966, GENETICS, V54, P1337; KONDRASHOV AS, 1984, GENET RES, V44, P199, DOI 10.1017/S0016672300026392; KOROL AB, 1994, HEREDITY, V72, P64, DOI 10.1038/hdy.1994.7; LI WH, 1978, GENETICS, V90, P349; Lynch M, 1999, EVOLUTION, V53, P645, DOI 10.1111/j.1558-5646.1999.tb05361.x; MALMBERG RL, 1977, GENETICS, V86, P607; MANNING JT, 1984, ACTA BIOTHEOR, V33, P219, DOI 10.1007/BF00048429; MARKOW TA, 1975, GENETICS, V79, P527; Maynard Smith J., 1978, EVOLUTION SEX; MCPHEE CP, 1970, GENET RES, V16, P1, DOI 10.1017/S0016672300002238; MULLER HJ, 1964, MUTAT RES, V1, P2, DOI 10.1016/0027-5107(64)90047-8; PECK JR, 1994, GENETICS, V137, P597; Rice WR, 1998, GENETICA, V102-3, P71, DOI 10.1023/A:1017055429755; RICE WR, 1994, SCIENCE, V263, P230, DOI 10.1126/science.8284674; Rice WR, 1996, BIOSCIENCE, V46, P331, DOI 10.2307/1312947; Rice WR, 1999, J EVOLUTION BIOL, V12, P1047; Rice WR, 1996, NATURE, V381, P232, DOI 10.1038/381232a0; THOMPSON V, 1977, GENETICS, V85, P125; THOMPSON V, 1976, Evolutionary Theory, V1, P131; van Valen L., 1973, EVOL THEOR, V1, P1, DOI DOI 10.1038/344864A0; WOLF HG, 1987, GENETICA, V72, P151, DOI 10.1007/BF00123174; Wright S, 1931, GENETICS, V16, P0097; Zeyl C, 1997, NATURE, V388, P465, DOI 10.1038/41312	40	119	126	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 19	2001	294	5542					555	559		10.1126/science.1061380	http://dx.doi.org/10.1126/science.1061380			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	484NC	11641490				2022-12-24	WOS:000171695600036
J	Schalkwijk, J; Zweers, MC; Steijlen, PM; Dean, WB; Taylor, G; van Vlijmen, IM; van Haren, B; Miller, WL; Bristow, J				Schalkwijk, J; Zweers, MC; Steijlen, PM; Dean, WB; Taylor, G; van Vlijmen, IM; van Haren, B; Miller, WL; Bristow, J			A recessive form of the Ehlers-Danlos syndrome caused by tenascin-X deficiency.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SYNDROME TYPE-I; COL5A1 GENE; COLLAGEN FIBRILS; GRAVIS FORM; EXPRESSION; PROPEPTIDE; MUTATIONS; NOSOLOGY; KNOCKOUT; DISTINCT	Background: The Ehlers-Danlos syndrome is a heritable connective-tissue disorder caused by defects in fibrillar-collagen metabolism. Mutations in the type V collagen genes account for up to 50 percent of cases of classic Ehlers-Danlos syndrome, but many other cases are unexplained. We investigated whether the deficiency of the tenascins, extracellular-matrix proteins that are highly expressed in connective tissues, was associated with the Ehlers-Danlos syndrome. Methods: We screened serum samples from 151 patients with the classic, hypermobility, or vascular types of the Ehlers-Danlos syndrome; 75 patients with psoriasis; 93 patients with rheumatoid arthritis; and 21 healthy persons for the presence of tenascin-X and tenascin-C by enzyme-linked immunosorbent assay. We examined the expression of tenascins and type V collagen in skin by immunohistochemical methods and sequenced the tenascin-X gene. Results: Tenascin-X was present in serum from all normal subjects, all patients with psoriasis, all patients with rheumatoid arthritis, and 146 of 151 patients with the Ehlers-Danlos syndrome. Tenascin-X was absent from the serum of the five remaining patients with Ehlers-Danlos syndrome, who were unrelated. Tenascin-X deficiency was confirmed in these patients by analysis of skin fibroblasts and by immunostaining of skin. The expression of tenascin-C and type V collagen was normal in these patients. All five of these patients had hypermobile joints, hyperelastic skin, and easy bruising, without atrophic scarring. Tenascin-X mutations were identified in all tenascin-X-deficient patients; one patient had a homozygous tenascin-X gene deletion, one was heterozygous for the deletion, and three others had homozygous truncating point mutations, confirming a causative role for tenascin-X and a recessive pattern of inheritance. Conclusions: Tenascin-X deficiency causes a clinically distinct, recessive form of the Ehlers-Danlos syndrome. This finding indicates that factors other than the collagens or collagen-processing enzymes can cause the syndrome and suggests a central role for tenascin-X in maintaining the integrity of collagenous matrix. (N Engl J Med 2001;345:1167-75.) Copyright (C) 2001 Massachusetts Medical Society.	Univ Calif San Francisco, Dept Pediat, Laurel Hts Campus,3333 Calif St,Box 1245, San Francisco, CA 94118 USA; Univ Med Ctr Nijmegen, Dept Dermatol, NL-6500 HB Nijmegen, Netherlands	University of California System; University of California San Francisco; Radboud University Nijmegen	Schalkwijk, J (corresponding author), Univ Calif San Francisco, Dept Pediat, Laurel Hts Campus,3333 Calif St,Box 1245, San Francisco, CA 94118 USA.	j.schalkwijk@derma.azn.nl	Steijlen, Peter/X-2729-2019; Zweers, Manon/E-5090-2016; van Vlijmen-Willems, Ivonne MJJ/P-5336-2015; Schalkwijk, Joost/R-7509-2019; Miller, Walter L/J-3696-2012; Schalkwijk, Joost/N-1774-2013	van Vlijmen-Willems, Ivonne MJJ/0000-0002-3522-2573; Schalkwijk, Joost/0000-0002-1308-1319; 	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042154, R01DK037922] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL02695] Funding Source: Medline; NIDDK NIH HHS [DK37922, DK42154] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Beighton P, 1998, AM J MED GENET, V77, P31, DOI 10.1002/(SICI)1096-8628(19980428)77:1<31::AID-AJMG8>3.3.CO;2-P; BEIGHTON P, 1988, AM J MED GENET, V29, P581, DOI 10.1002/ajmg.1320290316; BRISTOW J, 1993, J CELL BIOL, V122, P265, DOI 10.1083/jcb.122.1.265; Burch GH, 1997, NAT GENET, V17, P104, DOI 10.1038/ng0997-104; BURCH GH, 1995, DEV DYNAM, V203, P491, DOI 10.1002/aja.1002030411; Burrows NP, 1998, AM J HUM GENET, V63, P390, DOI 10.1086/301948; BYERS PH, 1994, J INVEST DERMATOL, V103, pS47, DOI 10.1038/jid.1994.9; DePaepe A, 1997, AM J HUM GENET, V60, P547; Elefteriou F, 1997, J BIOL CHEM, V272, P22866, DOI 10.1074/jbc.272.36.22866; Erickson HP, 1993, CURR OPIN CELL BIOL, V5, P869, DOI 10.1016/0955-0674(93)90037-Q; ERICKSON HP, 1993, J CELL BIOL, V120, P1079, DOI 10.1083/jcb.120.5.1079; Erickson HP, 1997, NAT GENET, V17, P5, DOI 10.1038/ng0997-5; GEFFROTIN C, 1995, EUR J BIOCHEM, V231, P83, DOI 10.1111/j.1432-1033.1995.0083f.x; GITELMAN SE, 1992, MOL CELL BIOL, V12, P2124, DOI 10.1128/MCB.12.5.2124; Giunta C, 2000, AM J MED GENET, V90, P72, DOI 10.1002/(SICI)1096-8628(20000103)90:1<72::AID-AJMG13>3.0.CO;2-C; HYLAND J, 1992, NAT GENET, V2, P228, DOI 10.1038/ng1192-228; Latijnhouwers MAHE, 1998, ACTA DERM-VENEREOL, V78, P331; Lethias C, 1996, MATRIX BIOL, V15, P11, DOI 10.1016/S0945-053X(96)90122-5; Mackie EJ, 1999, J CELL SCI, V112, P3847; Mackie EJ, 1996, J ANAT, V188, P157; Mao JR, 2001, J CLIN INVEST, V107, P1063, DOI 10.1172/JCI12881; MATSUMOTO K, 1994, J CELL BIOL, V125, P483, DOI 10.1083/jcb.125.2.483; MOREL Y, 1989, P NATL ACAD SCI USA, V86, P6582, DOI 10.1073/pnas.86.17.6582; Oberhauser AF, 1998, NATURE, V393, P181, DOI 10.1038/30270; SCHALKWIJK J, 1991, AM J PATHOL, V139, P1143; Schwarze U, 2000, AM J HUM GENET, V66, P1757, DOI 10.1086/302933; SMITH LT, 1992, AM J HUM GENET, V51, P235; Smith LT, 1997, J INVEST DERMATOL, V108, P241, DOI 10.1111/1523-1747.ep12286441; TEE MK, 1995, GENOMICS, V28, P171, DOI 10.1006/geno.1995.1128; Toriello HV, 1996, NAT GENET, V13, P361, DOI 10.1038/ng0796-361; VERSTRAETEN AA, 1992, BRIT J DERMATOL, V127, P571, DOI 10.1111/j.1365-2133.1992.tb14867.x; VOGEL A, 1979, LAB INVEST, V40, P201; Wenstrup RJ, 1996, HUM MOL GENET, V5, P1733, DOI 10.1093/hmg/5.11.1733; Wenstrup RJ, 2000, AM J HUM GENET, V66, P1766, DOI 10.1086/302930	34	274	276	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 18	2001	345	16					1167	1175		10.1056/NEJMoa002939	http://dx.doi.org/10.1056/NEJMoa002939			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	482YX	11642233	Green Published			2022-12-24	WOS:000171605800004
J	Hyde, TB; Gay, K; Stephens, DS; Vugia, DJ; Pass, M; Johnson, S; Barrett, NL; Schaffner, W; Cieslak, PR; Maupin, PS; Zell, ER; Jorgensen, JH; Facklam, RR; Whitney, CG				Hyde, TB; Gay, K; Stephens, DS; Vugia, DJ; Pass, M; Johnson, S; Barrett, NL; Schaffner, W; Cieslak, PR; Maupin, PS; Zell, ER; Jorgensen, JH; Facklam, RR; Whitney, CG		Active Bacterial Core Surveillance	Macrolide resistance among invasive Streptococcus pneumoniae isolates	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; UNITED-STATES; ANTIBIOTICS; LINCOSAMIDE; PREVALENCE; MECHANISMS; EMERGENCE; COLONIZATION; AZITHROMYCIN; SURVEILLANCE	Context Macrolide antibiotics, including erythromycin, clarithromycin, and azithromycin, are the mainstays of empirical pneumonia therapy. Macrolide resistance among Streptococcus pneumoniae, the most common cause of community-acquired pneumonia, is increasing in the United States. Whether resistance is a significant problem or whether macrolides remain useful for treatment of most resistant strains is unknown. Objective To examine the epidemiology of macrolide-resistant pneumococci in the United States. Design and Setting Analysis of 15481 invasive isolates from 1995 to 1999 collected by the Centers for Disease Control and Prevention's Active Bacterial Core surveillance system in 8 states. Main Outcome Measures Trends in macrolide use (1993-1999) and resistance and factors associated with resistance, including examination of 2 subtypes, the M phenotype, associated with moderate minimum inhibitory concentrations (MICs), and the MLS8 phenotype, associated with high MICs and clindamycin resistance. Results From 1993 to 1999, macrolide use increased 13% macrolide use increased 320% among children younger than 5 years. Macrolide resistance increased from 10.6% in 1995 to 20.4% in 1999. M phenotype isolates increased from 7.4% to 16.5% (P<.001), while the proportion with the MLSB phenotype was stable (3%-4%). The median erythromycin MIC (MIC50) of M phenotype isolates increased from 4 <mu>g/mL to 8 mug/mL. In 1999, M phenotype strains were more often from children than persons 5 years or older (25.2% vs 12.6%; P<.001) and from whites than blacks (19.3% vs 11.2%; P<.001). Conclusions In the setting of increasing macrolide use, pneumococcal resistance has become common. Most resistant strains have MICs in the range in which treatment failures have been reported. Further study and surveillance are critical to understanding the clinical implications of our findings.	CDCP, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; CDCP, Epidem Intelligence Serv, Epidemiol Program Off, Atlanta, GA USA; Emory Univ, Sch Med, Dept Vet Affairs Med Ctr, Atlanta, GA USA; Calif Dept Hlth & Human Serv, Berkeley, CA USA; Johns Hopkins Univ, Sch Hyg & Publ Hlth, Baltimore, MD USA; Minnesota Dept Hlth, Sch Publ Hlth, Minneapolis, MN USA; Connecticut Dept Publ Hlth, Hartford, CT USA; Vanderbilt Univ Sch Med, Dept Prevent Med, Nashville, TN USA; Oregon Dept Human Serv, Hlth Div, Portland, OR USA; Monroe Cty Hlth Dept Human Serv, Rochester, NY USA; Univ Texas, Hlth Sci Ctr, San Antonio, TX USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Emory University; California Health & Human Services Agency; Johns Hopkins University; Minnesota Department of Health (MHD); Vanderbilt University; University of Texas System; University of Texas Health San Antonio	Whitney, CG (corresponding author), CDCP, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, 1600 Clifton Rd NE,Mailstop C-23, Atlanta, GA 30333 USA.		Stephens, David S/A-8788-2012					Amsden GW, 1999, J ANTIMICROB CHEMOTH, V44, P1, DOI 10.1093/jac/44.1.1; ARTHUR M, 1987, J ANTIMICROB CHEMOTH, V20, P783, DOI 10.1093/jac/20.6.783; Bartlett John G., 2000, Clinical Infectious Diseases, V31, P347, DOI 10.1086/313954; BOKEN DJ, 1995, PEDIATR INFECT DIS J, V14, P879, DOI 10.1097/00006454-199510000-00012; BREIMAN RF, 1994, JAMA-J AM MED ASSOC, V271, P1831, DOI 10.1001/jama.271.23.1831; DOEM GV, 1996, ANTIMICROB AGENTS CH, V40, P1208; DUCHIN JS, 1995, PEDIATR INFECT DIS J, V14, P745, DOI 10.1097/00006454-199509000-00004; Gay K, 2000, J INFECT DIS, V182, P1417, DOI 10.1086/315853; GLADUE RP, 1989, ANTIMICROB AGENTS CH, V33, P277, DOI 10.1128/AAC.33.3.277; Heffelfinger JD, 2000, ARCH INTERN MED, V160, P1399, DOI 10.1001/archinte.160.10.1399; Johnston NJ, 1998, ANTIMICROB AGENTS CH, V42, P2425, DOI 10.1128/AAC.42.9.2425; Kelley MA, 2000, CLIN INFECT DIS, V31, P1008, DOI 10.1086/318157; Lagrou K, 2000, J ANTIMICROB CHEMOTH, V45, P119, DOI 10.1093/jac/45.1.119; Marchese A, 1999, J ANTIMICROB CHEMOTH, V44, P461, DOI 10.1093/jac/44.4.461; Marston BJ, 1997, ARCH INTERN MED, V157, P1709, DOI 10.1001/archinte.157.15.1709; MCCAIG LF, 1995, JAMA-J AM MED ASSOC, V273, P214, DOI 10.1001/jama.273.3.214; McCracken GH, 1997, PEDIATR INFECT DIS J, V16, P432, DOI 10.1097/00006454-199704000-00026; *NAT COMM CLIN LAB, 2001, M100S10 NCCLS; *NAT CTR HLTH STAT, 2001, NAT HOSP AMB MED CAR; *NAT CTR HLTH STAT, 2001, NAT AMB MED CAR SURV; NIEDERMAN MS, 1993, AM REV RESPIR DIS, V148, P1418, DOI 10.1164/ajrccm/148.5.1418; Nishijima T, 1999, J ANTIMICROB CHEMOTH, V43, P637, DOI 10.1093/jac/43.5.637; Roberts MC, 1999, ANTIMICROB AGENTS CH, V43, P2823, DOI 10.1128/AAC.43.12.2823; Robinson KA, 2001, JAMA-J AM MED ASSOC, V285, P1729, DOI 10.1001/jama.285.13.1729; Seppala H, 1997, NEW ENGL J MED, V337, P441, DOI 10.1056/NEJM199708143370701; Shortridge VD, 1999, CLIN INFECT DIS, V29, P1186, DOI 10.1086/313452; Sutcliffe J, 1996, ANTIMICROB AGENTS CH, V40, P1817, DOI 10.1128/AAC.40.8.1817; Tait-Kamradt A, 2000, ANTIMICROB AGENTS CH, V44, P3395, DOI 10.1128/AAC.44.12.3395-3401.2000; Waites K, 2000, J CLIN MICROBIOL, V38, P1731, DOI 10.1128/JCM.38.5.1731-1734.2000; WEISBLUM B, 1985, J ANTIMICROB CHEMOTH, V16, P63, DOI 10.1093/jac/16.suppl_A.63; Whitney CG, 2000, NEW ENGL J MED, V343, P1917, DOI 10.1056/NEJM200012283432603; Widdowson CA, 1998, EMERG INFECT DIS, V4, P277, DOI 10.3201/eid0402.980216; ZENNI MK, 1995, J PEDIATR-US, V127, P533, DOI 10.1016/S0022-3476(95)70108-7	33	240	266	0	9	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 17	2001	286	15					1857	1862		10.1001/jama.286.15.1857	http://dx.doi.org/10.1001/jama.286.15.1857			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	482UH	11597287				2022-12-24	WOS:000171595300026
J	Armstrong, RJE; Barker, RA				Armstrong, RJE; Barker, RA			Neurodegeneration: a failure of neuroregeneration?	LANCET			English	Article							NEURAL STEM-CELLS; DENTATE GYRUS; ADULT; NEUROGENESIS; DIFFERENTIATION; PROLIFERATION; PATHOGENESIS; INDUCTION; NEOCORTEX; NEURONS	Evidence suggests that the brain, like many other tissues, Is In a state of dynamic equilibrium. It has an endogenous population of stem cells that proliferate in response to environmental and pharmacological manipulations and that can replace cells lost In some experimental lesions. However, the fact remains that neurodegenerative disorders such as Alzheimer's, Parkinson's, and Huntington's diseases are characterised by continuous loss of neurons that are not replaced. In this hypothesis, we postulate that a primary deficit In neural stem-cell proliferation; migration, or differentiation, or both, might contribute to net cell loss and neuronal circuit disruption In these disorders. Experimental validation of this hypothesis would not only substantially advance understanding of the pathogenesis of these diseases, but could also have profound implications for future treatment of these Incurable disorders.	Univ Cambridge, Cambridge Ctr Brain Repair, Cambridge CB2 2PY, England; Univ Cambridge, Dept Neurol, Cambridge, England	University of Cambridge; University of Cambridge	Barker, RA (corresponding author), Univ Cambridge, Cambridge Ctr Brain Repair, Forvie Site,Robinson Way, Cambridge CB2 2PY, England.	rab46@cus.cam.ac.uk		Barker, Roger Alistair/0000-0001-8843-7730				Aboody KS, 2000, P NATL ACAD SCI USA, V97, P12846, DOI 10.1073/pnas.97.23.12846; BARKER RA, 1999, NEUROPSY REHABIL MOD, P1; CAMERON HA, 1994, NEUROSCIENCE, V61, P203, DOI 10.1016/0306-4522(94)90224-0; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Fallon J, 2000, P NATL ACAD SCI USA, V97, P14686, DOI 10.1073/pnas.97.26.14686; Fuchs E, 2000, CELL, V100, P143, DOI 10.1016/S0092-8674(00)81691-8; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gheusi C, 2000, P NATL ACAD SCI USA, V97, P1823, DOI 10.1073/pnas.97.4.1823; Gould E, 1999, SCIENCE, V286, P548, DOI 10.1126/science.286.5439.548; Johansson CB, 1999, EXP CELL RES, V253, P733, DOI 10.1006/excr.1999.4678; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kempermann G, 1997, P NATL ACAD SCI USA, V94, P10409, DOI 10.1073/pnas.94.19.10409; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; MOTT SH, 1995, ANN NEUROL, V37, P810, DOI 10.1002/ana.410370616; Olanow CW, 1999, ANNU REV NEUROSCI, V22, P123, DOI 10.1002/mds.23732; Palmer TD, 2001, NATURE, V411, P42, DOI 10.1038/35075141; Roy NS, 2000, NAT MED, V6, P271; Schulz JB, 1999, CURR OPIN NEUROL, V12, P433, DOI 10.1097/00019052-199908000-00010; Shastry BS, 1999, BRAIN RES BULL, V48, P121, DOI 10.1016/S0361-9230(98)00156-7; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Sinden JD, 2000, NOVART FDN SYMP, V231, P270, DOI 10.1002/0470870834.ch16; Snyder EY, 1997, P NATL ACAD SCI USA, V94, P11663, DOI 10.1073/pnas.94.21.11663; Temple S, 1999, CURR OPIN NEUROBIOL, V9, P135, DOI 10.1016/S0959-4388(99)80017-8; Temple S, 1999, CURR BIOL, V9, pR397, DOI 10.1016/S0960-9822(99)80252-8; Trojanowski JQ, 2000, ANN NY ACAD SCI, V924, P62; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; ZHAO M, 2000, SOC NEUROSCI, V26, P302; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	31	95	103	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 6	2001	358	9288					1174	1176		10.1016/S0140-6736(01)06260-2	http://dx.doi.org/10.1016/S0140-6736(01)06260-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	479HM	11597694				2022-12-24	WOS:000171399000036
J	Levy, GG; Nichols, WC; Lian, EC; Foroud, T; McClintick, JN; McGee, BM; Yang, AY; Siemieniak, DR; Stark, KR; Gruppo, R; Sarode, R; Shurin, SB; Chandrasekaran, V; Stabler, SP; Sabio, H; Bouhassira, EE; Upshaw, JD; Ginsburg, D; Tsai, HM				Levy, GG; Nichols, WC; Lian, EC; Foroud, T; McClintick, JN; McGee, BM; Yang, AY; Siemieniak, DR; Stark, KR; Gruppo, R; Sarode, R; Shurin, SB; Chandrasekaran, V; Stabler, SP; Sabio, H; Bouhassira, EE; Upshaw, JD; Ginsburg, D; Tsai, HM			Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura	NATURE			English	Article							VON-WILLEBRAND-FACTOR; HEMOLYTIC-UREMIC SYNDROME; FACTOR-CLEAVING PROTEASE; PLASMA VONWILLEBRAND-FACTOR; ENDOTHELIAL-CELLS; LINKAGE ANALYSIS; METALLOPROTEINASE; CLEAVAGE; PURIFICATION; DERMATOSPARAXIS	Thrombotic thrombocytopenic purpura (TTP) is a life-threatening systemic illness of abrupt onset and unknown cause. Proteolysis of the blood-clotting protein von Willebrand factor (VWF) observed in normal plasma is decreased in TTP patients. However, the identity of the responsible protease and its role in the pathophysiology of TTP remain unknown. We performed genome-wide linkage analysis in four pedigrees of humans with congenital TTP and mapped the responsible genetic locus to chromosome 9q34. A predicted gene in the identifed interval corresponds to a segment of a much larger transcript, identifying a new member of the ADAMTS family of zinc metalloproteinase genes (ADAMTS13). Analysis of patients' genomic DNA identified 12 mutations in the ADAMTS13 gene, accounting for 14 of the 15 disease alleles studied. We show that deficiency of ADAMTS13 is the molecular mechanism responsible for TTP, and suggest that physiologic proteolysis of VWF and/or other ADAMTS13 substrates is required for normal vascular homeostasis.	Univ Michigan, Med Ctr, Howard Hughes Med Inst, Dept Internal Med, Ann Arbor, MI 48109 USA; Univ Michigan, Med Ctr, Howard Hughes Med Inst, Dept Human Genet, Ann Arbor, MI 48109 USA; Univ Michigan, Med Ctr, Mol & Cellular Biol Program, Ann Arbor, MI 48109 USA; Childrens Hosp, Med Ctr, Div Human Genet, Cincinnati, OH 45229 USA; Univ Miami, Hemophilia & Thrombosis Ctr, Miami, FL 33136 USA; Univ Miami, Sylvester Canc Ctr, Miami, FL 33136 USA; Vet Affairs Med Ctr, Miami, FL 33136 USA; Indiana Univ, Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; Childrens Hosp, Med Ctr, Div Hematol Oncol, Cincinnati, OH 45229 USA; Univ Texas, SW Med Sch, Blood Bank, Dallas, TX 75390 USA; Rainbow Babies & Childrens Hosp, Dept Pediat, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Cleveland, OH 44106 USA; Long Isl Jewish Med Ctr, Blood Bank, New Hyde Pk, NY 11040 USA; Albert Einstein Coll Med, New Hyde Pk, NY 11040 USA; Univ Colorado, Hlth Sci Ctr, Dept Med, Denver, CO 80262 USA; Med Coll Georgia, Augusta, GA 30912 USA; Albert Einstein Coll Med, Dept Med Hematol, Bronx, NY 10461 USA; Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA; Memphis Canc Ctr, Memphis, TN 38119 USA; Montefiore Med Ctr, Div Hematol, Bronx, NY 10467 USA; Albert Einstein Coll Med, Bronx, NY 10467 USA	Howard Hughes Medical Institute; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Cincinnati Children's Hospital Medical Center; University of Miami; University of Miami; US Department of Veterans Affairs; Veterans Health Administration (VHA); Indiana University System; Indiana University-Purdue University Indianapolis; Cincinnati Children's Hospital Medical Center; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital; Case Western Reserve University; Northwell Health; Yeshiva University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University System of Georgia; Augusta University; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Ginsburg, D (corresponding author), Univ Michigan, Med Ctr, Howard Hughes Med Inst, Dept Internal Med, Ann Arbor, MI 48109 USA.	ginsburg@umich.edu	Bouhassira, Eric/AAZ-4184-2021		NHLBI NIH HHS [R37 HL039693, R01 HL062136] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062136, R37HL039693] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bennett CL, 2000, NEW ENGL J MED, V342, P1773, DOI 10.1056/NEJM200006153422402; Blobel CP, 1997, CELL, V90, P589, DOI 10.1016/S0092-8674(00)80519-X; BORK P, 1993, J MOL BIOL, V231, P539, DOI 10.1006/jmbi.1993.1305; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; BURNS ER, 1982, BLOOD, V60, P1030; Cines DB, 2000, THROMB HAEMOSTASIS, V84, P528; Colige A, 1999, AM J HUM GENET, V65, P308, DOI 10.1086/302504; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Fernandes RJ, 2001, J BIOL CHEM, V276, P31502, DOI 10.1074/jbc.M103466200; Fujikawa K, 2001, BLOOD, V98, P1662, DOI 10.1182/blood.V98.6.1662; Furlan M, 1998, NEW ENGL J MED, V339, P1578, DOI 10.1056/NEJM199811263392202; Furlan M, 1996, BLOOD, V87, P4223, DOI 10.1182/blood.V87.10.4223.bloodjournal87104223; George JN, 2000, BLOOD, V96, P1223, DOI 10.1182/blood.V96.4.1223.h8001223_1223_1229; Gerritsen HE, 2001, BLOOD, V98, P1654, DOI 10.1182/blood.V98.6.1654; GINSBURG D, 1985, SCIENCE, V228, P1401, DOI 10.1126/science.3874428; Hurskainen TL, 1999, J BIOL CHEM, V274, P25555, DOI 10.1074/jbc.274.36.25555; Kaushal GP, 2000, J CLIN INVEST, V105, P1335, DOI 10.1172/JCI10078; Kuno K, 1997, J BIOL CHEM, V272, P556, DOI 10.1074/jbc.272.1.556; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LYONS SE, 1992, J BIOL CHEM, V267, P4424; MANNUCCI PM, 1989, BLOOD, V74, P978; Matsushita M, 2001, IMMUNOL REV, V180, P78, DOI 10.1034/j.1600-065X.2001.1800107.x; Mitra D, 1997, BLOOD, V89, P1224, DOI 10.1182/blood.V89.4.1224; MOAKE JL, 1982, NEW ENGL J MED, V307, P1432, DOI 10.1056/NEJM198212023072306; Nagase T, 1998, DNA Res, V5, P31, DOI 10.1093/dnares/5.1.31; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; ROCK GA, 1991, NEW ENGL J MED, V325, P393, DOI 10.1056/NEJM199108083250604; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; Shindo T, 2000, J CLIN INVEST, V105, P1345, DOI 10.1172/JCI8635; SIDDIQUI FA, 1985, J CLIN INVEST, V76, P1330, DOI 10.1172/JCI112107; Tang BL, 2001, INT J BIOCHEM CELL B, V33, P33, DOI 10.1016/S1357-2725(00)00061-3; Tang BL, 1999, FEBS LETT, V445, P223, DOI 10.1016/S0014-5793(99)00119-2; Tortorella MD, 1999, SCIENCE, V284, P1664, DOI 10.1126/science.284.5420.1664; Tsai H M, 2001, Clin Lab, V47, P387; Tsai HM, 1997, BLOOD, V89, P1954, DOI 10.1182/blood.V89.6.1954; Tsai HM, 2000, ANN INTERN MED, V132, P794, DOI 10.7326/0003-4819-132-10-200005160-00005; Tsai HM, 1998, NEW ENGL J MED, V339, P1585, DOI 10.1056/NEJM199811263392203; Tsai HM, 1996, BLOOD, V87, P4235, DOI 10.1182/blood.V87.10.4235.bloodjournal87104235; UPSHAW JD, 1978, NEW ENGL J MED, V298, P1350, DOI 10.1056/NEJM197806152982407; ZIMMERMAN TS, 1986, J CLIN INVEST, V77, P947, DOI 10.1172/JCI112394	40	1257	1348	0	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 4	2001	413	6855					488	494		10.1038/35097008	http://dx.doi.org/10.1038/35097008			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	478HG	11586351	Green Published			2022-12-24	WOS:000171340500038
J	Riipi, M; Alatalo, RV; Lindstrom, L; Mappes, J				Riipi, M; Alatalo, RV; Lindstrom, L; Mappes, J			Multiple benefits of gregariousness cover detectability costs in aposematic aggregations	NATURE			English	Article							KIN SELECTION; EVOLUTION; PREDATION; COLORATION; PROTECTION; LARVAE	Understanding the early evolution of aposematic (warning) coloration has been a challenge for scientists, as a new conspicuous morph in a population of cryptic insects would have a high predation risk and would probably die out before local predators learnt to avoid it(1-4). Fisher(5) presented the idea of aggregation benefit through the survival of related individuals; however, his theory has been strongly debated(6-8) as the mechanisms that favour grouping have never been explored experimentally with the incorporation of detectability costs. Here we create a comprehensive 'novel world' experiment with the great tit (Parus major) as a predator to explore simultaneously the predation-related benefits and costs for aposematic aggregated prey, manipulating both group size and signal strength. Our results show that grouping would have been highly beneficial for the first aposematic prey individuals surrounded by naive predators, because (1) detectability risk increased only asymptotically with group size; (2) additional detectability costs due to conspicuous signals were marginal in groups; (3) even naive predators deserted the group after detecting unpalatability (dilution effect); and (4) avoidance learning of signal was faster in groups. None of these mechanisms require kin selection.	Univ Jyvaskyla, Dept Biol & Environm Sci, Konnevesi Res Stn, FIN-40351 Jyvaskyla, Finland	University of Jyvaskyla	Riipi, M (corresponding author), Univ Jyvaskyla, Dept Biol & Environm Sci, Konnevesi Res Stn, POB 35, FIN-40351 Jyvaskyla, Finland.	marianna.riipi@utu.fi; mappes@cc.jyu.fi	Lindstrom, Leena/B-2326-2012; Mappes, Johanna/AAZ-3627-2021	Lindstrom, Leena/0000-0002-6452-4538; Mappes, Johanna/0000-0002-1117-5629				Alatalo RV, 1996, NATURE, V382, P708, DOI 10.1038/382708a0; ENDLER JA, 1988, PHILOS T R SOC B, V319, P505, DOI 10.1098/rstb.1988.0062; Fisher R. A., 1930, GENETICAL THEORY NAT, DOI 10.5962/bhl.title.27468; GAGLIARDO A, 1993, P ROY SOC B-BIOL SCI, V251, P69, DOI 10.1098/rspb.1993.0010; GUILFORD T, 1985, OIKOS, V45, P31, DOI 10.2307/3565219; Guilford T., 1990, P23; HAMILTON WD, 1971, J THEOR BIOL, V31, P295, DOI 10.1016/0022-5193(71)90189-5; JARVI T, 1981, OIKOS, V36, P267, DOI 10.2307/3544623; Lindstrom L, 1999, NATURE, V397, P249, DOI 10.1038/16692; LINDSTROM L, P R SOC LOND B, V268, P357; MALLET J, 1987, BIOL J LINN SOC, V32, P337, DOI 10.1111/j.1095-8312.1987.tb00435.x; Mallet J, 1999, ANNU REV ECOL SYST, V30, P201, DOI 10.1146/annurev.ecolsys.30.1.201; MARPLES NM, 1994, ANIM BEHAV, V48, P967, DOI 10.1006/anbe.1994.1322; Rivero A, 2000, ANIM BEHAV, V60, P187, DOI 10.1006/anbe.2000.1452; SCHULER W, 1992, ADV STUD BEHAV, V21, P111, DOI 10.1016/S0065-3454(08)60143-6; SILLENTULLBERG B, 1982, OIKOS, V39, P131, DOI 10.2307/3544476; SILLENTULLBERG B, 1988, AM NAT, V132, P723, DOI 10.1086/284884; TREISMAN M, 1975, ANIM BEHAV, V23, P779, DOI 10.1016/0003-3472(75)90106-2; Tullberg BS, 2000, ANIM BEHAV, V59, P281, DOI 10.1006/anbe.1999.1302; TURNER GF, 1986, AM NAT, V128, P228, DOI 10.1086/284556; Weismann A, 1882, STUDIES THEORY DESCE	21	155	156	0	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 4	2001	413	6855					512	514		10.1038/35097061	http://dx.doi.org/10.1038/35097061			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	478HG	11586357				2022-12-24	WOS:000171340500044
J	Geldner, N; Friml, J; Stierhof, YD; Jurgens, G; Palme, K				Geldner, N; Friml, J; Stierhof, YD; Jurgens, G; Palme, K			Auxin transport inhibitors block PIN1 cycling and vesicle traficking	NATURE			English	Article							BREFELDIN-A; ARABIDOPSIS-THALIANA; PLASMA-MEMBRANE; ACID-BINDING; CYTOSKELETON; PROTEIN; EFFLUX; CELLS; PLANT; ROOT	Polar transport of the phytohormone auxin mediates various processes in plant growth and development, such as apical dominance, tropisms, vascular patterning and axis formation(1,2). This view is based largely on the effects of polar auxin transport inhibitors. These compounds disrupt auxin efflux from the cell but their mode of action is unknown(3). It is thought that polar auxin flux is caused by the asymmetric distribution of efflux carriers acting at the plasma membrane(4). The polar localization of efflux carrier candidate PIN1 supports this model(4). Here we show that the seemingly static localization of PIN1 results from rapid actin-dependent cycling between the plasma membrane and endosomal compartments. Auxin transport inhibitors block PIN1 cycling and inhibit trafficking of membrane proteins that are unrelated to auxin transport. Our data suggest that PIN1 cycling is of central importance for auxin transport and that auxin transport inhibitors affect efflux by generally interfering with membrane-trafficking processes. In support of our conclusion, the vesicle-trafficking inhibitor brefeldin A mimics physiological effects of auxin transport inhibitors.	Univ Tubingen, Zentrum Mol Biol Pflanzen, D-72076 Tubingen, Germany; Max Planck Gesell, Max Delbruck Lab, D-50829 Cologne, Germany; Masaryk Univ, Fac Sci, Dept Biochem, CS-61137 Brno, Czech Republic	Eberhard Karls University of Tubingen; Max Planck Society; Masaryk University Brno	Jurgens, G (corresponding author), Univ Tubingen, Zentrum Mol Biol Pflanzen, Morgenstelle 3, D-72076 Tubingen, Germany.		Friml, Jiri/D-9511-2012; Geldner, Niko/Y-2481-2019; Palme, Klaus/A-9524-2013	Friml, Jiri/0000-0002-8302-7596; Palme, Klaus/0000-0002-2728-3835; Geldner, Niko/0000-0002-2300-9644				Berleth T, 2001, CURR OPIN PLANT BIOL, V4, P57, DOI 10.1016/S1369-5266(00)00136-9; Bernasconi P, 1996, PLANT PHYSIOL, V111, P427, DOI 10.1104/pp.111.2.427; COX DN, 1994, PLANT CELL, V6, P1941, DOI 10.1105/tpc.6.12.1941; Delbarre A, 1998, PLANT PHYSIOL, V116, P833, DOI 10.1104/pp.116.2.833; Estelle M, 1998, PLANT CELL, V10, P1775, DOI 10.1105/tpc.10.11.1775; Fujita H, 1996, PLANT CELL PHYSIOL, V37, P1094, DOI 10.1093/oxfordjournals.pcp.a029059; Fujita H, 1997, PLANT J, V12, P583, DOI 10.1046/j.1365-313X.1997.00583.x; Galweiler L, 1998, SCIENCE, V282, P2226, DOI 10.1126/science.282.5397.2226; Garbers C, 1996, EMBO J, V15, P2115, DOI 10.1002/j.1460-2075.1996.tb00565.x; Hadfi K, 1998, DEVELOPMENT, V125, P879; HAGER A, 1991, PLANTA, V185, P527, DOI 10.1007/BF00202963; KATEKAR GF, 1977, PLANT PHYSIOL, V60, P826, DOI 10.1104/pp.60.6.826; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Lauber MH, 1997, J CELL BIOL, V139, P1485, DOI 10.1083/jcb.139.6.1485; LIPPINCOTTSCHWARTZ J, 1990, CELL, V60, P821, DOI 10.1016/0092-8674(90)90096-W; Mathur J, 1999, DEVELOPMENT, V126, P5559; Mattsson J, 1999, DEVELOPMENT, V126, P2979; MICHALKE W, 1992, PLANTA, V187, P254, DOI 10.1007/BF00201948; Morris DA, 1998, PLANTA, V205, P606, DOI 10.1007/s004250050363; Morris DA, 2000, PLANT GROWTH REGUL, V32, P161, DOI 10.1023/A:1010701527848; Muller A, 1998, EMBO J, V17, P6903, DOI 10.1093/emboj/17.23.6903; Palme K, 1999, CURR OPIN PLANT BIOL, V2, P375, DOI 10.1016/S1369-5266(99)00008-4; Ruegger M, 1997, PLANT CELL, V9, P745, DOI 10.1105/tpc.9.5.745; Sabatini S, 1999, CELL, V99, P463, DOI 10.1016/S0092-8674(00)81535-4; SatiatJeunemaitre B, 1996, J MICROSC-OXFORD, V181, P162, DOI 10.1046/j.1365-2818.1996.112393.x; SatiatJeunemaitre B, 1996, PROTOPLASMA, V191, P21, DOI 10.1007/BF01280822; SATIATJEUNEMAITRE B, 1992, J CELL SCI, V103, P1153; Steinmann T, 1999, SCIENCE, V286, P316, DOI 10.1126/science.286.5438.316; VOLKER A, IN PRESS J CELL SCI; WOOD SA, 1991, CELL, V67, P591, DOI 10.1016/0092-8674(91)90533-5	30	919	977	11	170	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 27	2001	413	6854					425	428		10.1038/35096571	http://dx.doi.org/10.1038/35096571			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475UY	11574889				2022-12-24	WOS:000171188700055
J	Israel, E; Banerjee, TR; Fitzmaurice, GM; Kotlov, TV; LaHive, K; LeBoff, MS				Israel, E; Banerjee, TR; Fitzmaurice, GM; Kotlov, TV; LaHive, K; LeBoff, MS			Effects of inhaled glucocorticoids on bone density in premenopausal women.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MINERAL DENSITY; ASTHMATIC-PATIENTS; BECLOMETHASONE DIPROPIONATE; INDUCED OSTEOPOROSIS; CORTICOSTEROIDS; THERAPY; FLUTICASONE; BUDESONIDE; METABOLISM; STEROIDS	Background: Inhaled glucocorticoids are the most commonly used medications for the long-term treatment of patients with asthma. Whether long-term therapy with inhaled glucocorticoids reduces bone mass, as oral glucocorticoid therapy does, is controversial. In a three-year prospective study, we examined the relation between the dose of inhaled glucocorticoids and the rate of bone loss in premenopausal women with asthma. Methods: We studied 109 premenopausal women, 18 to 45 years of age, who had asthma and no known conditions that cause bone loss and who were treated with inhaled triamcinolone acetonide (100 mu-g per puff). We measured bone density by dual-photon absorptiometry at base line, at six months, and at one, two, and three years. Serum osteocalcin and parathyroid hormone and urinary N-telopeptide, cortisol, and calcium excretion were measured serially. We measured inhaled glucocorticoid use by means of monthly diaries, supported by the use of an automated actuator-monitoring device. Results: Inhaled glucocorticoid therapy was associated with a dose-related decline in bone density at both the total hip and the trochanter of 0.00044 g per square centimeter per puff per year of treatment (P=0.01 and P=0.005, respectively). No dose-related effect was noted at the femoral neck or the spine. Even after the exclusion of all women who received oral or parenteral glucocorticoids at any time during the study, there was still an association between the decline in bone density and the number of puffs per year of use. Serum and urinary markers of bone turnover or adrenal function did not predict the degree of bone loss. Conclusions: Inhaled glucocorticoids lead to a dose-related loss of bone at the hip in premenopausal women. (N Engl J Med 2001;345:941-7.) Copyright (C) 2001 Massachusetts Medical Society.	Brigham & Womens Hosp, Div Pulm & Crit Care Med, Dept Med, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Endocrine Hypertens, Skeletal Hlth & Osteoporosis Program, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; Harvard Pilgrim Hlth Care, Dept Internal Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard Pilgrim Health Care	Israel, E (corresponding author), Brigham & Womens Hosp, Div Pulm & Crit Care Med, Dept Med, 75 Francis St, Boston, MA 02115 USA.	eisrael@partners.org			NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR002635] Funding Source: NIH RePORTER; NCRR NIH HHS [M01-RR-02635] Funding Source: Medline; NHLBI NIH HHS [HL0843] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BAYLINK DJ, 1983, NEW ENGL J MED, V309, P306, DOI 10.1056/NEJM198308043090509; Boulet LP, 1999, AM J RESP CRIT CARE, V159, P838, DOI 10.1164/ajrccm.159.3.9802096; Carey VJ, 1997, AM J EPIDEMIOL, V145, P614, DOI 10.1093/oxfordjournals.aje.a009158; CUMMINGS SR, 1993, LANCET, V341, P72, DOI 10.1016/0140-6736(93)92555-8; Ebeling PR, 1998, J BONE MINER RES, V13, P1283, DOI 10.1359/jbmr.1998.13.8.1283; Egan JJ, 1999, EUR RESPIR J, V13, P1267, DOI 10.1183/09031936.99.13612769; EL-HAJJ FULEIHAN G, 1995, J BONE MINER RES, V10, P1004; Hughes JA, 1999, THORAX, V54, P223, DOI 10.1136/thx.54.3.223; IP M, 1994, CHEST, V105, P1722, DOI 10.1378/chest.105.6.1722; Kamada AK, 1996, AM J RESP CRIT CARE, V153, P1739, DOI 10.1164/ajrccm.153.6.8665030; KRISKA AM, 1992, DIABETES METAB REV, V8, P355, DOI 10.1002/dmr.5610080404; Lipworth BJ, 1999, ARCH INTERN MED, V159, P941, DOI 10.1001/archinte.159.9.941; Luengo M, 1997, EUR RESPIR J, V10, P2110, DOI 10.1183/09031936.97.10092110; LUENGO M, 1990, AM REV RESPIR DIS, V142, P104, DOI 10.1164/ajrccm/142.1.104; LUKERT BP, 1992, J BONE MINER RES, V7, P1063; MELTON LJ, 1983, OSTEOPOROTIC SYNDROM, P45; *NAT ASTHM ED PREV, 1997, NIH PUBL; *NHLBI, 1995, NIH PUBL; Packe GE, 1996, J ROY COLL PHYS LOND, V30, P128; PACKE GE, 1992, THORAX, V47, P414, DOI 10.1136/thx.47.6.414; RICH GM, 1992, J HEART LUNG TRANSPL, V11, P950; Saag KG, 1998, NEW ENGL J MED, V339, P292, DOI 10.1056/NEJM199807303390502; TOOGOOD JH, 1995, J ALLERGY CLIN IMMUN, V96, P157, DOI 10.1016/S0091-6749(95)70003-X; Wisniewski AF, 1997, THORAX, V52, P853, DOI 10.1136/thx.52.10.853; Wong CA, 2000, LANCET, V355, P1399, DOI 10.1016/S0140-6736(00)02138-3	25	218	227	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 27	2001	345	13					941	947		10.1056/NEJMoa002304	http://dx.doi.org/10.1056/NEJMoa002304			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	475NF	11575285	Green Published			2022-12-24	WOS:000171170000002
J	Emanuel, EJ; Miller, FG				Emanuel, EJ; Miller, FG			The ethics of placebo-controlled trials - A middle ground.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CISPLATIN-INDUCED NAUSEA; HIGH-DOSE METOCLOPRAMIDE; MAMMARY-ARTERY LIGATION; ACTIVE-CONTROL TRIALS; CLINICAL-RESEARCH; ONDANSETRON GR-38032F; SEROTONIN ANTAGONIST; DOUBLE-BLIND; EFFICACY; PREVENTION		NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	Emanuel, EJ (corresponding author), NIH, Bldg 10, Bethesda, MD 20892 USA.							[Anonymous], 1989, NEW ENGL J MED, V321, P406; BECK TM, 1993, ANN INTERN MED, V118, P407, DOI 10.7326/0003-4819-118-6-199303150-00002; Bienenfeld L, 1996, AM HEART J, V132, P1207, DOI 10.1016/S0002-8703(96)90465-2; Brody BA, 1997, CONTROL CLIN TRIALS, V18, P602, DOI 10.1016/S0197-2456(97)00006-8; COBB LA, 1959, NEW ENGL J MED, V260, P1115, DOI 10.1056/NEJM195905282602204; CUBEDDU LX, 1990, NEW ENGL J MED, V322, P810, DOI 10.1056/NEJM199003223221204; DIMOND EG, 1958, CIRCULATION, V18, P712; Ellenberg SS, 2000, ANN INTERN MED, V133, P464, DOI 10.7326/0003-4819-133-6-200009190-00015; Emanuel EJ, 2000, JAMA-J AM MED ASSOC, V283, P2701, DOI 10.1001/jama.283.20.2701; Enserink M, 2000, SCIENCE, V290, P418, DOI 10.1126/science.290.5491.418; FEINSTEIN AR, 1980, EUR J CLIN PHARMACOL, V17, P1, DOI 10.1007/BF00561669; Freedman B, 1996, J LAW MED ETHICS, V24, P243, DOI 10.1111/j.1748-720X.1996.tb01859.x; Freedman B, 1996, J LAW MED ETHICS, V24, P252, DOI 10.1111/j.1748-720X.1996.tb01860.x; Freedman Benjamin, 1990, IRB, V12, P1, DOI 10.2307/3564541; GANDARA DR, 1992, SEMIN ONCOL, V19, P67; GLASSER SP, 1991, JAMA-J AM MED ASSOC, V265, P1550, DOI 10.1001/jama.265.12.1550; GRALLA RJ, 1981, NEW ENGL J MED, V305, P905, DOI 10.1056/NEJM198110153051601; HAINSWORTH J, 1991, J CLIN ONCOL, V9, P721, DOI 10.1200/JCO.1991.9.5.721; HAIT WN, 1990, NEW ENGL J MED, V323, P1485; Hrobjartsson A, 2001, NEW ENGL J MED, V344, P1594, DOI 10.1056/NEJM200105243442106; Khan A, 2000, ARCH GEN PSYCHIAT, V57, P311, DOI 10.1001/archpsyc.57.4.311; Koski G, 2001, NEW ENGL J MED, V345, P136, DOI 10.1056/NEJM200107123450211; LASAGNA L, 1979, EUR J CLIN PHARMACOL, V15, P373, DOI 10.1007/BF00561733; LASAGNA L, 1954, AM J MED, V16, P770, DOI 10.1016/0002-9343(54)90441-6; Leon AC, 2000, ARCH GEN PSYCHIAT, V57, P329, DOI 10.1001/archpsyc.57.4.329; LILIENFELD AM, 1982, B HIST MED, V56, P1; MARTY M, 1990, NEW ENGL J MED, V322, P816, DOI 10.1056/NEJM199003223221205; Miller FG, 2000, BIOL PSYCHIAT, V47, P707, DOI 10.1016/S0006-3223(00)00833-7; Rothman KJ, 2000, BMJ-BRIT MED J, V321, P442, DOI 10.1136/bmj.321.7258.442; ROTHMAN KJ, 1994, NEW ENGL J MED, V331, P394, DOI 10.1056/NEJM199408113310611; RUTSTEIN DD, 1970, EXPT HUMAN SUBJECTS, P383; SENN S, IN PRESS APPL CLIN T; SENN S, 1997, STAT ISSUES DRUG DEV, P207; Shapiro HT, 2001, NEW ENGL J MED, V345, P139, DOI 10.1056/NEJM200107123450212; Temple R, 2000, ANN INTERN MED, V133, P455, DOI 10.7326/0003-4819-133-6-200009190-00014; Temple R, 1982, DRUG INF J, V10-17, DOI DOI 10.1177/009286158201600102; Temple Robert, 1996, Account Res, V4, P267, DOI 10.1080/08989629608573887; VANRIJ AM, 1994, CIRCULATION, V90, P1194, DOI 10.1161/01.CIR.90.3.1194; Vastag B, 2000, JAMA-J AM MED ASSOC, V284, P2983, DOI 10.1001/jama.284.23.2983; WAY WL, 1984, NEW ENGL J MED, V311, P413; WINSLOW R, 2000, WALL STREET J   1019, pB14; *WORLD MED ASS DEC, 2001, ETH PRINC MED RES IN	42	232	241	0	28	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 20	2001	345	12					915	919		10.1056/NEJM200109203451211	http://dx.doi.org/10.1056/NEJM200109203451211			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	473JW	11565527				2022-12-24	WOS:000171039600011
J	Moll, J; Barzaghi, P; Lin, S; Bezakova, G; Lochmuller, H; Engvall, E; Muller, U; Ruegg, MA				Moll, J; Barzaghi, P; Lin, S; Bezakova, G; Lochmuller, H; Engvall, E; Muller, U; Ruegg, MA			An agrin minigene rescues dystrophic symptoms in a mouse model for congenital muscular dystrophy	NATURE			English	Article							CREATINE-KINASE GENE; NEUROMUSCULAR-JUNCTION; EXTRACELLULAR-MATRIX; BASEMENT-MEMBRANE; SKELETAL-MUSCLE; LAMININ; MICE; EXPRESSION; DIFFERENTIATION; DYSTROGLYCAN	Congenital muscular dystrophy is a heterogeneous and severe, progressive muscle-wasting disease that frequently leads to death in early childhood(1,2). Most cases of congenital muscular dystrophy are caused by mutations in LAMA2, the gene encoding the alpha2 chain of the main laminin isoforms expressed by muscle fibres. Muscle fibre deterioration in this disease is thought to be caused by the failure to form the primary laminin scaffold, which is necessary for basement membrane structure(3), and the missing interaction between muscle basement membrane and the dystrophin-glycoprotein complex (DGC)(4) or the integrins(5). With the aim to restore muscle function in a mouse model for this disease, we have designed a minigene of agrin, a protein known for its role in the formation of the neuromuscular junction(6). Here we show that this mini-agrin-which binds to basement membrane(7) and to alpha -dystroglycan(8), a member of the DGC-amends muscle pathology by a mechanism that includes agrin-mediated stabilization of alpha -dystroglycan and the laminin alpha5 chain. Our data provides in vivo evidence that a non-homologous protein in combination with rational protein design can be used to devise therapeutic tools that may restore muscle function in human muscular dystrophies.	Univ Basel, Biozentrum, Dept Pharmacol Neurobiol, CH-4056 Basel, Switzerland; Univ Munich, Genzentrum Munich, D-81377 Munich, Germany; Burnham Inst, La Jolla, CA 92037 USA; Friedrich Miescher Inst, CH-4058 Basel, Switzerland	University of Basel; University of Munich; Sanford Burnham Prebys Medical Discovery Institute; Friedrich Miescher Institute for Biomedical Research	Ruegg, MA (corresponding author), Univ Basel, Biozentrum, Dept Pharmacol Neurobiol, Klingelbergstr 70, CH-4056 Basel, Switzerland.		Ruegg, Markus/X-7256-2019	Ruegg, Markus/0000-0002-4974-9384; Lochmuller, Hanns/0000-0003-2324-8001; Lin, Shuo/0000-0003-2317-0339				Burgess RW, 1999, NEURON, V23, P33, DOI 10.1016/S0896-6273(00)80751-5; CAMPBELL KP, 1995, CELL, V80, P675, DOI 10.1016/0092-8674(95)90344-5; Colognato H, 1999, CURR BIOL, V9, P1327, DOI 10.1016/S0960-9822(00)80056-1; Colognato H, 2000, DEV DYNAM, V218, P213, DOI 10.1002/(SICI)1097-0177(200006)218:2<213::AID-DVDY1>3.0.CO;2-R; Cote PD, 1999, NAT GENET, V23, P338, DOI 10.1038/15519; Denzer AJ, 1997, J CELL BIOL, V137, P671, DOI 10.1083/jcb.137.3.671; Denzer AJ, 1998, EMBO J, V17, P335, DOI 10.1093/emboj/17.2.335; ERVASTI JM, 1991, J BIOL CHEM, V266, P9161; Gesemann M, 1998, J BIOL CHEM, V273, P600, DOI 10.1074/jbc.273.1.600; Henry MD, 1998, CELL, V95, P859, DOI 10.1016/S0092-8674(00)81708-0; Herrmann R, 2000, HUM MOL GENET, V9, P2335, DOI 10.1093/oxfordjournals.hmg.a018926; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; JAYNES JB, 1986, MOL CELL BIOL, V6, P2855, DOI 10.1128/MCB.6.8.2855; Kuang W, 1998, J CLIN INVEST, V102, P844, DOI 10.1172/JCI3705; MACPIKE AD, 1976, P SOC EXP BIOL MED, V151, P670, DOI 10.3181/00379727-151-39283; Mayer U, 1997, NAT GENET, V17, P318, DOI 10.1038/ng1197-318; Meier T, 1998, EUR J NEUROSCI, V10, P3141, DOI 10.1046/j.1460-9568.1998.00320.x; Miyagoe-Suzuki Y, 2000, MICROSC RES TECHNIQ, V48, P181, DOI 10.1002/(SICI)1097-0029(20000201/15)48:3/4<181::AID-JEMT6>3.0.CO;2-Q; Patton BL, 1997, J CELL BIOL, V139, P1507, DOI 10.1083/jcb.139.6.1507; Ringelmann B, 1999, EXP CELL RES, V246, P165, DOI 10.1006/excr.1998.4244; Ruegg MA, 1998, TRENDS NEUROSCI, V21, P22, DOI 10.1016/S0166-2236(97)01154-5; SCHULZE B, 1995, EUR J BIOCHEM, V231, P551, DOI 10.1111/j.1432-1033.1995.tb20731.x; Sorokin LM, 1997, DEV DYNAM, V210, P446, DOI 10.1002/(SICI)1097-0177(199712)210:4<446::AID-AJA8>3.0.CO;2-G; STERNBERG EA, 1988, MOL CELL BIOL, V8, P2896, DOI 10.1128/MCB.8.7.2896; SUNADA Y, 1994, J BIOL CHEM, V269, P13729; Talts JF, 2000, J BIOL CHEM, V275, P35192, DOI 10.1074/jbc.M003261200; TOME FMS, 1998, NEUROMUSCULAR DISORD, P21; Turney SG, 1996, J NEUROSCI METH, V64, P199, DOI 10.1016/0165-0270(95)00135-2; XU H, 1994, NAT GENET, V8, P297, DOI 10.1038/ng1194-297; XU H, 1994, P NATL ACAD SCI USA, V91, P5572, DOI 10.1073/pnas.91.12.5572	30	175	180	0	3	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 20	2001	413	6853					302	307		10.1038/35095054	http://dx.doi.org/10.1038/35095054			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473KB	11565031				2022-12-24	WOS:000171040500038
J	Beech, BAL				Beech, BAL			How could I breast feed with a man in the room?	BRITISH MEDICAL JOURNAL			English	Editorial Material																		Dillner L, 1996, BRIT MED J, V312, P200	1	3	3	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JAN 27	1996	312	7025					256	256						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TT486	11644767				2022-12-24	WOS:A1996TT48600085
J	MORRISON, R				MORRISON, R			PATIENTS SENSE OF COMPLETION	BRITISH MEDICAL JOURNAL			English	Editorial Material											MORRISON, R (corresponding author), EASTBOURNE HOSP NHS TRUST,EASTBOURNE,E SUSSEX,ENGLAND.								0	9	9	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUN 25	1994	308	6945					1722	1722		10.1136/bmj.308.6945.1722	http://dx.doi.org/10.1136/bmj.308.6945.1722			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NU483	11644549	Green Published			2022-12-24	WOS:A1994NU48300095
J	Bernard, P; Maure, JF; Partridge, JF; Genier, S; Javerzat, JP; Allshire, RC				Bernard, P; Maure, JF; Partridge, JF; Genier, S; Javerzat, JP; Allshire, RC			Requirement of heterochromatin for cohesion at centromeres	SCIENCE			English	Article							FISSION YEAST CENTROMERES; MITOTIC SPINDLES; CHROMOSOME ARMS; ANAPHASE; SEPARATION; COMPONENT; DOMAINS	Centromeres are heterochromatic in many organisms, but the mitotic function of this silent chromatin remains unknown. During cell division, newly replicated sister chromatids must cohere until anaphase when Scc1/Rad21-mediated cohesion is destroyed. In metazoans, chromosome arm cohesins dissociate during prophase, leaving centromeres as the only linkage before anaphase. it is not known what distinguishes centromere cohesion from arm cohesion. Fission yeast Swi6 (a Heterochromatin protein 1 counterpart) is a component of si[ent heterochromatin. Here we show that this heterochromatin is specifically required for cohesion between sister centromeres. Swi6 is required for association of Rad21-cohesin with centromeres but not along chromosome arms and, thus, acts to distinguish centromere from arm cohesion. Therefore, one function of centromeric heterochromatin is to attract cohesin, thereby ensuring sister centromere cohesion and proper chromosome segregation.	Western Gen Hosp, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; Inst Biochim & Genet Cellulaires, CNRS, Unite Mixte Rech 5095, F-33077 Bordeaux, France	University of Edinburgh; Centre National de la Recherche Scientifique (CNRS)	Allshire, RC (corresponding author), Western Gen Hosp, MRC, Human Genet Unit, Crewe Rd, Edinburgh EH4 2XU, Midlothian, Scotland.		Partridge, Janet/M-9352-2018; Bernard, Pascal/I-1859-2015	Partridge, Janet/0000-0003-1102-6305; Bernard, Pascal/0000-0003-2732-9685; Allshire, Robin/0000-0002-8005-3625				ALLSHIRE RC, 1995, GENE DEV, V9, P218, DOI 10.1101/gad.9.2.218; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bernard P, 1998, J CELL BIOL, V143, P1775, DOI 10.1083/jcb.143.7.1775; Cimini D, 2001, J CELL BIOL, V153, P517, DOI 10.1083/jcb.153.3.517; Dej KJ, 2000, TRENDS CELL BIOL, V10, P392, DOI 10.1016/S0962-8924(00)01821-3; DING R, 1993, J CELL BIOL, V120, P141, DOI 10.1083/jcb.120.1.141; EKWALL K, 1995, SCIENCE, V269, P1429, DOI 10.1126/science.7660126; Ekwall K, 1997, CELL, V91, P1021, DOI 10.1016/S0092-8674(00)80492-4; Karpen GH, 1996, SCIENCE, V273, P118, DOI 10.1126/science.273.5271.118; Karpen GH, 1997, TRENDS GENET, V13, P489, DOI 10.1016/S0168-9525(97)01298-5; Laloraya S, 2000, J CELL BIOL, V151, P1047, DOI 10.1083/jcb.151.5.1047; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; O'Toole ET, 1999, MOL BIOL CELL, V10, P2017, DOI 10.1091/mbc.10.6.2017; Partridge JF, 2000, GENE DEV, V14, P783; Pidoux AL, 2000, J CELL SCI, V113, P4177; PIDOUX AL, UNPUB; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Taddei A, 2001, NAT CELL BIOL, V3, P114, DOI 10.1038/35055010; Tanaka TU, 2000, NAT CELL BIOL, V2, P492, DOI 10.1038/35019529; Tanaka TU, 1999, CELL, V98, P847, DOI 10.1016/S0092-8674(00)81518-4; Tomonaga T, 2000, GENE DEV, V14, P2757, DOI 10.1101/gad.832000; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Waizenegger IC, 2000, CELL, V103, P399, DOI 10.1016/S0092-8674(00)00132-X; Warren WD, 2000, CURR BIOL, V10, P1463, DOI 10.1016/S0960-9822(00)00806-X; Watanabe Y, 2001, NATURE, V409, P359, DOI 10.1038/35053103; WINES DR, 1992, GENETICS, V131, P683; Yamada H, 1997, J CELL SCI, V110, P1793	27	486	501	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 21	2001	294	5551					2539	2542		10.1126/science.1064027	http://dx.doi.org/10.1126/science.1064027			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	505QU	11598266				2022-12-24	WOS:000172927700056
J	Porse, BT; Pedersen, TA; Xu, XF; Lindberg, B; Wewer, UM; Friis-Hansen, L; Nerlov, C				Porse, BT; Pedersen, TA; Xu, XF; Lindberg, B; Wewer, UM; Friis-Hansen, L; Nerlov, C			E2F repression by C/EBP alpha is required for adipogenesis and granulopoiesis in vivo	CELL			English	Article							BINDING-PROTEIN-ALPHA; CELL-PROLIFERATION; S-PHASE; RETINOBLASTOMA PROTEIN; LINEAGE COMMITMENT; ADIPOSE CONVERSION; PROGENITOR CELLS; GENE-EXPRESSION; NEWBORN MICE; DIFFERENTIATION	The C/EBP alpha transcription factor is required for differentiation of adipocytes and neutrophil granulocytes, and controls cellular proliferation in vivo. To address the molecular mechanisms of C/EBP alpha action, we have identified C/EBP alpha mutants defective in repression of E2F-dependent transcription and found them to be impaired in their ability to suppress cellular proliferation, and to induce adipocyte differentiation in vitro. Using targeted mutagenesis of the mouse germline, we show that E2F repression-deficient C/EBP alpha alleles failed to support adipocyte and granulocyte differentiation in vivo. These results indicate that E2F repression by C/EBP alpha is critical for its ability to induce terminal differentiation, and thus provide genetic evidence that direct cell cycle control by a mammalian lineageinstructive transcription factor couples cellular growth arrest and differentiation.	Univ Copenhagen Hosp, Lab Gene Therapy Res, DK-2100 Copenhagen O, Denmark; Univ Copenhagen Hosp, Inst Pathol, DK-2100 Copenhagen, Denmark; Univ Copenhagen Hosp, Dept Clin Biochem, DK-2100 Copenhagen O, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen	Nerlov, C (corresponding author), Univ Copenhagen Hosp, Lab Gene Therapy Res, DK-2100 Copenhagen O, Denmark.		Porse, Bo/B-1332-2012	Porse, Bo/0000-0001-6043-0844; Friis-Hansen, Lennart/0000-0002-7222-0163				Bergh G, 1999, BLOOD, V94, P1971; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; Chen PL, 1996, GENE DEV, V10, P2794, DOI 10.1101/gad.10.21.2794; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CLARKE AR, 1992, NATURE, V359, P328, DOI 10.1038/359328a0; Crosson SM, 2000, J BIOL CHEM, V275, P5804, DOI 10.1074/jbc.275.8.5804; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; Dicker AJ, 2000, ONCOGENE, V19, P2887, DOI 10.1038/sj.onc.1203610; Flodby P, 1996, J BIOL CHEM, V271, P24753, DOI 10.1074/jbc.271.40.24753; HANAUER A, 1984, EMBO J, V3, P2627, DOI 10.1002/j.1460-2075.1984.tb02185.x; HENDRICKSTAYLOR LR, 1995, NUCLEIC ACIDS RES, V23, P4726, DOI 10.1093/nar/23.22.4726; JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0; Johansen LM, 2001, MOL CELL BIOL, V21, P3789, DOI 10.1128/MCB.21.11.3789-3806.2001; LEE EYHP, 1992, NATURE, V359, P288, DOI 10.1038/359288a0; Lee YH, 1997, MOL CELL BIOL, V17, P6014, DOI 10.1128/MCB.17.10.6014; LIN FT, 1992, GENE DEV, V6, P533, DOI 10.1101/gad.6.4.533; McNagny KM, 1998, EMBO J, V17, P3669, DOI 10.1093/emboj/17.13.3669; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Mori A, 1999, ONCOGENE, V18, P6209, DOI 10.1038/sj.onc.1203044; Muller C, 1999, P NATL ACAD SCI USA, V96, P7276, DOI 10.1073/pnas.96.13.7276; NERLOV C, 1994, GENE DEV, V8, P350, DOI 10.1101/gad.8.3.350; Pabst T, 2001, NAT GENET, V27, P263, DOI 10.1038/85820; Park JS, 2000, MOL BIOL CELL, V11, P2915, DOI 10.1091/mbc.11.9.2915; Querfurth E, 2000, GENE DEV, V14, P2515, DOI 10.1101/gad.177200; RAMIREZZACARIAS JL, 1992, HISTOCHEMISTRY, V97, P493, DOI 10.1007/BF00316069; Ross SE, 1999, MOL CELL BIOL, V19, P8433; Slomiany BA, 2000, MOL CELL BIOL, V20, P5986, DOI 10.1128/MCB.20.16.5986-5997.2000; Strominger A, 1998, J HIGH ENERGY PHYS; Timchenko NA, 1999, NUCLEIC ACIDS RES, V27, P3621, DOI 10.1093/nar/27.17.3621; Timchenko NA, 1996, GENE DEV, V10, P804, DOI 10.1101/gad.10.7.804; Timchenko NA, 1997, MOL CELL BIOL, V17, P7353, DOI 10.1128/MCB.17.12.7353; Timchenko NA, 1999, MOL CELL BIOL, V19, P2936; Tsai KY, 1998, MOL CELL, V2, P293, DOI 10.1016/S1097-2765(00)80274-9; UMEK RM, 1991, SCIENCE, V251, P288, DOI 10.1126/science.1987644; Vigo E, 1999, MOL CELL BIOL, V19, P6379; WANG J, 1995, CELL GROWTH DIFFER, V6, P1299; WANG ND, 1995, SCIENCE, V269, P1108, DOI 10.1126/science.7652557; Wu H, 1996, GENE DEV, V10, P245, DOI 10.1101/gad.10.3.245; Zhang DE, 1997, P NATL ACAD SCI USA, V94, P569, DOI 10.1073/pnas.94.2.569; Ziebold U, 2001, GENE DEV, V15, P386, DOI 10.1101/gad.858801	40	277	283	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	OCT 19	2001	107	2					247	258		10.1016/S0092-8674(01)00516-5	http://dx.doi.org/10.1016/S0092-8674(01)00516-5			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	484MU	11672531	Bronze			2022-12-24	WOS:000171694800013
J	Rhew, DC				Rhew, DC			Quality indicators for the management of pneumonia in vulnerable elders	ANNALS OF INTERNAL MEDICINE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; PNEUMOCOCCAL POLYSACCHARIDE VACCINE; PROSPECTIVE PAYMENT SYSTEM; INFLUENZA VACCINATION; HOSPITALIZED-PATIENTS; PRACTICE GUIDELINE; EARLY SWITCH; LOW-RISK; IMMUNIZATION; EFFICACY		Zynx Hlth Inc, Beverly Hills, CA 90212 USA; Univ Calif Los Angeles, Los Angeles, CA 90024 USA; Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA USA	University of California System; University of California Los Angeles; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	Rhew, DC (corresponding author), Zynx Hlth Inc, 9100 Wilshire Blvd,Suite 655 E Tower, Beverly Hills, CA 90212 USA.	rhew@zynx.com						*ACP TASK FORC AD, 1994, GUID AD IMM, P107; ARNSTEN JH, 1995, J GEN INTERN MED S, V10, pA97; Bartlett JG, 1998, CLIN INFECT DIS, V26, P811, DOI 10.1086/513953; Bartlett John G., 2000, Clinical Infectious Diseases, V31, P347, DOI 10.1086/313954; BLOOM HG, 1988, J AM GERIATR SOC, V36, P897, DOI 10.1111/j.1532-5415.1988.tb05782.x; BREIMAN RF, 1990, ARCH INTERN MED, V150, P1401, DOI 10.1001/archinte.150.7.1401; BUFFINGTON J, 1991, J GEN INTERN MED, V6, P204, DOI 10.1007/BF02598961; BUTLER JC, 1993, JAMA-J AM MED ASSOC, V270, P1826, DOI 10.1001/jama.270.15.1826; *CDCP NAT CTR HLTH, 1998, NAT VIT STAT REP; CELLI BR, 1995, AM J RESP CRIT CARE, V152, pS77; CROUSE BJ, 1994, J FAM PRACTICE, V38, P258; *CTR DIS CONTR PRE, 1998, JAMA-J AM MED ASSOC, V280, P1818; DUNN WF, 1991, AM REV RESPIR DIS, V144, P526, DOI 10.1164/ajrccm/144.3_Pt_1.526; FARR BM, 1995, ARCH INTERN MED, V155, P2336, DOI 10.1001/archinte.155.21.2336; FEDSON DS, 1983, AM J PUBLIC HEALTH, V73, P442, DOI 10.2105/AJPH.73.4.442; FEDSON DS, 1990, JAMA-J AM MED ASSOC, V264, P1117; FEDSON DS, 1985, J AM GERIATR SOC, V33, P142, DOI 10.1111/j.1532-5415.1985.tb02281.x; FEDSON KS, 1994, VACCINES, P517; Fine MJ, 1996, JAMA-J AM MED ASSOC, V275, P134, DOI 10.1001/jama.275.2.134; FINE MJ, 1994, ARCH INTERN MED, V154, P2666, DOI 10.1001/archinte.1994.00420230051007; Fiore MC, 2000, JAMA-J AM MED ASSOC, V283, P3244; GAILLAT J, 1985, REV EPIDEMIOL SANTE, V33, P437; GROSS PA, 1995, ANN INTERN MED, V123, P518, DOI 10.7326/0003-4819-123-7-199510010-00008; GYORKOS TW, 1994, CAN J PUBLIC HEALTH, V85, pS14; Halm EA, 1998, JAMA-J AM MED ASSOC, V279, P1452, DOI 10.1001/jama.279.18.1452; HERMAN CJ, 1994, J AM GERIATR SOC, V42, P1154, DOI 10.1111/j.1532-5415.1994.tb06981.x; Honkanen PO, 1997, VACCINE, V15, P317, DOI 10.1016/S0264-410X(96)00171-5; KAHN KL, 1990, JAMA-J AM MED ASSOC, V264, P1969, DOI 10.1001/jama.264.15.1969; KOSECOFF J, 1990, JAMA-J AM MED ASSOC, V264, P1980, DOI 10.1001/jama.264.15.1980; Lave JR, 1999, SEM RESP CRIT CARE M, V20, P189, DOI 10.1055/s-2007-1021315; LAW M, 1995, ARCH INTERN MED, V155, P1933, DOI 10.1001/archinte.155.18.1933; MAGNUSSEN CR, 1984, ARCH INTERN MED, V144, P1755, DOI 10.1001/archinte.144.9.1755; Marrie TJ, 2000, JAMA-J AM MED ASSOC, V283, P749, DOI 10.1001/jama.283.6.749; Marston BJ, 1997, ARCH INTERN MED, V157, P1709, DOI 10.1001/archinte.157.15.1709; McGarvey R N, 1993, QRB Qual Rev Bull, V19, P124; Meehan TP, 1997, JAMA-J AM MED ASSOC, V278, P2080, DOI 10.1001/jama.278.23.2080; MUSHER DM, 1990, J INFECT DIS, V161, P728, DOI 10.1093/infdis/161.4.728; Nichol KL, 1998, ARCH INTERN MED, V158, P1769, DOI 10.1001/archinte.158.16.1769; Nuorti JP, 1998, NEW ENGL J MED, V338, P1861, DOI 10.1056/NEJM199806253382601; Plans Rubio P, 1995, Rev Esp Salud Publica, V69, P409; Potter J, 1997, J INFECT DIS, V175, P1, DOI 10.1093/infdis/175.1.1; *PREV PNEUM DIS, 1997, MMWR-MORBID MORTAL W, V46, P1; Ramirez JA, 1999, ARCH INTERN MED, V159, P2449, DOI 10.1001/archinte.159.20.2449; RAMIREZ JA, 1995, ARCH INTERN MED, V155, P1273, DOI 10.1001/archinte.155.12.1273; Rhew DC, 1998, CHEST, V114, P115, DOI 10.1378/chest.114.1.115; SAHN SA, 1993, AM REV RESPIR DIS, V148, P813, DOI 10.1164/ajrccm/148.3.813; SETIA U, 1985, J AM GERIATR SOC, V33, P856, DOI 10.1111/j.1532-5415.1985.tb05440.x; SHAPIRO ED, 1991, NEW ENGL J MED, V325, P1453, DOI 10.1056/NEJM199111213252101; Shekelle PG, 2001, ANN INTERN MED, V135, P647, DOI 10.7326/0003-4819-135-8_Part_2-200110161-00003; *US PUBL HLTH SERV, 2001, HEALTH PEOPL, V1; Wait MA, 1997, CHEST, V111, P1548, DOI 10.1378/chest.111.6.1548; WEINGARTEN SR, 1994, CHEST, V105, P1109, DOI 10.1378/chest.105.4.1109; Weingarten SR, 1996, AM J RESP CRIT CARE, V153, P1110, DOI 10.1164/ajrccm.153.3.8630553	53	18	20	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 16	2001	135	8	2				736	743		10.7326/0003-4819-135-8_Part_2-200110161-00013	http://dx.doi.org/10.7326/0003-4819-135-8_Part_2-200110161-00013			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	481WA	11601957				2022-12-24	WOS:000171542400013
J	Taylor, CM				Taylor, CM			Complement factor H and the haemolytic uraemic syndrome	LANCET			English	Editorial Material							MUTATIONS; PROTECTS; CELLS		Birmingham Childrens Hosp, Dept Nephrol, Birmingham B4 6NH, W Midlands, England	University of Birmingham	Taylor, CM (corresponding author), Birmingham Childrens Hosp, Dept Nephrol, Birmingham B4 6NH, W Midlands, England.	cm.taylor@bhamchildrens.wmids.nhs.uk						Aslam M, 2001, J MOL BIOL, V309, P1117, DOI 10.1006/jmbi.2001.4720; Ault BH, 2000, PEDIATR NEPHROL, V14, P1045, DOI 10.1007/s004670050069; Buddles MRH, 2000, AM J HUM GENET, V66, P1721, DOI 10.1086/302877; Caprioli J, 2001, J AM SOC NEPHROL, V12, P297, DOI 10.1681/ASN.V122297; Fitzpatrick MM, 1992, HEMOLYTIC UREMIC SYN, P163; Gershov D, 2000, J EXP MED, V192, P1353, DOI 10.1084/jem.192.9.1353; Hindmarsh EJ, 1998, J IMMUNOL, V160, P6128; Jokiranta TS, 2000, J BIOL CHEM, V275, P27657; Landau D, 2001, J PEDIATR-US, V138, P412, DOI 10.1067/mpd.2001.112649; Nangaku M, 1998, J AM SOC NEPHROL, V9, P590; Noris M, 1999, J AM SOC NEPHROL, V10, P281; Pangburn MK, 2000, J IMMUNOL, V164, P4742, DOI 10.4049/jimmunol.164.9.4742; Perez-Caballero D, 2001, AM J HUM GENET, V68, P478, DOI 10.1086/318201; Richards A, 2001, AM J HUM GENET, V68, P485, DOI 10.1086/318203; Taylor CM, 2001, SEMIN THROMB HEMOST, V27, P185, DOI 10.1055/s-2001-15247; Warwicker P, 1998, KIDNEY INT, V53, P836, DOI 10.1111/j.1523-1755.1998.00824.x; Ying LH, 1999, AM J HUM GENET, V65, P1538, DOI 10.1086/302673; Zipfel PF, 2001, SEMIN THROMB HEMOST, V27, P191, DOI 10.1055/s-2001-15248	18	48	49	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 13	2001	358	9289					1200	1202		10.1016/S0140-6736(01)06339-5	http://dx.doi.org/10.1016/S0140-6736(01)06339-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	481NX	11675053				2022-12-24	WOS:000171527000005
J	Dolmetsch, RE; Pajvani, U; Fife, K; Spotts, JM; Greenberg, ME				Dolmetsch, RE; Pajvani, U; Fife, K; Spotts, JM; Greenberg, ME			Signaling to the nucleus by an L-type calcium channel - Calmodulin complex through the MAP kinase pathway	SCIENCE			English	Article							GENE-EXPRESSION; CREB PHOSPHORYLATION; CA2+-DEPENDENT INACTIVATION; HIPPOCAMPAL-NEURONS; CA2+ CHANNELS; TRANSCRIPTION; MECHANISM; MOTIF; FACILITATION; SUPPORTS	Increases in the intracellutar concentration of calcium ([Ca2+](i)) activate various signaling pathways that lead to the expression of genes that are essential for dendritic development, neuronal. survival, and synaptic plasticity. The mode of Ca2+ entry into a neuron plays a key rote in determining which signaling pathways are activated and thus specifies the cellular response to Ca2+. Ca2+ influx through L-type voltage-activated channels (LTCs) is particularly effective at activating transcription factors such as CREB and MEF-2. We developed a functional knock-in technique to investigate the features of LTCs that specifically couple them to the signaling pathways that regulate gene expression. We found that an isoleucine-glutamine ("IQ") motif in the carboxyl terminus of the LTC that binds Ca2+-calmodutin (CaM) is critical for conveying the Ca2+ signal to the nucleus. Ca2+-CaM binding to the LTC was necessary for activation of the Ras/mitogen-activated protein kinase (MAPK) pathway, which conveys local Ca2+ signals from the mouth of the LTC to the nucleus. CaM functions as a local Ca2+ sensor at the mouth of the LTC that activates the MAPK pathway and leads to the stimulation of genes that are essential for neuronal survival and plasticity.	Childrens Hosp, Div Neurosci, Boston, MA 02115 USA; Harvard Univ, Sch Med, Enders Pediat Res Labs, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Greenberg, ME (corresponding author), Childrens Hosp, Div Neurosci, Boston, MA 02115 USA.		soler, martha maricel m gomez/L-6025-2014; Oka, Yoshitaka/C-9670-2010	soler, martha maricel m gomez/0000-0002-4412-8108; Oka, Yoshitaka/0000-0002-3482-3051	NICHD NIH HHS [P30-HD18655] Funding Source: Medline; NINDS NIH HHS [NS28829] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028829, R37NS028829] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; BONNI A, 1995, MOL CELL NEUROSCI, V6, P168, DOI 10.1006/mcne.1995.1015; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; COWAN CE, UNPUB; Deisseroth K, 1998, NATURE, V392, P198, DOI 10.1038/32448; DOLMETSCH RE, UNPUB; GINTY DD, 1993, SCIENCE, V260, P238, DOI 10.1126/science.8097062; Hardingham GE, 1997, NATURE, V385, P260, DOI 10.1038/385260a0; Hardingham GE, 2001, NAT NEUROSCI, V4, P261, DOI 10.1038/85109; He M, 1997, J BIOL CHEM, V272, P2629, DOI 10.1074/jbc.272.5.2629; Kato Y, 1997, EMBO J, V16, P7054, DOI 10.1093/emboj/16.23.7054; Lee A, 1999, NATURE, V399, P155, DOI 10.1038/20194; Mao ZX, 1999, SCIENCE, V286, P785, DOI 10.1126/science.286.5440.785; Naya FJ, 1999, CURR OPIN CELL BIOL, V11, P683, DOI 10.1016/S0955-0674(99)00036-8; Peterson BZ, 2000, BIOPHYS J, V78, P1906, DOI 10.1016/S0006-3495(00)76739-7; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; RANDALL A, 1995, J NEUROSCI, V15, P2995; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; SNUTCH TP, 1991, NEURON, V7, P45, DOI 10.1016/0896-6273(91)90073-9; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Westenbroek RE, 1998, J NEUROSCI, V18, P6319; Wu GY, 2001, P NATL ACAD SCI USA, V98, P2808, DOI 10.1073/pnas.051634198; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758; Xia ZG, 1996, J NEUROSCI, V16, P5425; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959; Zuhlke RD, 2000, J BIOL CHEM, V275, P21121, DOI 10.1074/jbc.M002986200; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	31	682	705	0	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 12	2001	294	5541					333	339		10.1126/science.1063395	http://dx.doi.org/10.1126/science.1063395			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	482WZ	11598293				2022-12-24	WOS:000171601400033
J	Wilkin, T; Devendra, D; Dequeker, J; Luyten, FP				Wilkin, T; Devendra, D; Dequeker, J; Luyten, FP			For and against - Bone densitometry is not a good predictor of hip fracture	BRITISH MEDICAL JOURNAL			English	Article							MINERAL DENSITY; RISK; WOMEN; OSTEOPOROSIS; TRIAL	Bone densitometry is widely used in osteoporosis clinics to identify people at increased risk of fracture. Terence Wilkin and Devasenan Devendra. believe that evidence for the efficacy of bone densitometry is weak, but Jan Dequeker and Frank P Luyten argue that their interpretation of the evidence is too narrow and that screening high risk patients is cost effective.	Derriford Hosp, Postgrad Med Sch, Dept Med, Plymouth PL6 8DH, Devon, England	Derriford Hospital; University of Plymouth	Wilkin, T (corresponding author), Derriford Hosp, Postgrad Med Sch, Dept Med, Plymouth PL6 8DH, Devon, England.		Luyten, Frank/GPS-7793-2022					Burger H, 1999, BONE, V25, P369, DOI 10.1016/S8756-3282(99)00173-8; Cummings SR, 1998, JAMA-J AM MED ASSOC, V280, P2077, DOI 10.1001/jama.280.24.2077; CUMMINGS SR, 1993, LANCET, V341, P72, DOI 10.1016/0140-6736(93)92555-8; DeLaet CEDH, 1997, BRIT MED J, V315, P221, DOI 10.1136/bmj.315.7102.221; Ettinger B, 1999, JAMA-J AM MED ASSOC, V282, P637, DOI 10.1001/jama.282.7.637; Faulkner KG, 2000, J BONE MINER RES, V15, P183, DOI 10.1359/jbmr.2000.15.2.183; Harris ST, 1999, JAMA-J AM MED ASSOC, V282, P1344, DOI 10.1001/jama.282.14.1344; HUI SL, 1988, J CLIN INVEST, V81, P1804, DOI 10.1172/JCI113523; Jonsson B, 1999, OSTEOPOROSIS INT, V10, P193, DOI 10.1007/s001980050215; Kanis JA, 2000, BONE, V26, P387, DOI 10.1016/S8756-3282(00)00238-6; Michaelsson K, 1998, BMJ-BRIT MED J, V316, P1858; Sackett D. L., 1995, EVIDENCE BASED MED, V1, P5; TOBIAS JH, 1994, CLIN SCI, V87, P587, DOI 10.1042/cs0870587; Wasnich RD, 2000, J CLIN ENDOCR METAB, V85, P231, DOI 10.1210/jc.85.1.231; Wilkin TJ, 1999, BRIT MED J, V318, P862, DOI 10.1136/bmj.318.7187.862; World Health Organization, 1994, WHO TECHN REP SER, V843; Xiaoge D, 2000, CALCIFIED TISSUE INT, V67, P195, DOI 10.1007/s002230001139	17	38	41	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 6	2001	323	7316					795	797		10.1136/bmj.323.7316.795	http://dx.doi.org/10.1136/bmj.323.7316.795			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	481LK	11588087	Green Published			2022-12-24	WOS:000171520600034
J	Dalton, R				Dalton, R			Bilateral Vietnam study plans to assess war fallout of dioxin	NATURE			English	News Item																		2000, NATURE, V406, P818	1	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 4	2001	413	6855					442	442		10.1038/35097221	http://dx.doi.org/10.1038/35097221			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	478HG	11586310	Bronze			2022-12-24	WOS:000171340500004
J	Mann, K; Fox, SP; Abbs, SJ; Yau, SC; Scriven, PN; Docherty, Z; Ogilvie, CM				Mann, K; Fox, SP; Abbs, SJ; Yau, SC; Scriven, PN; Docherty, Z; Ogilvie, CM			Development and implementation of a new rapid aneuploidy diagnostic service within the UK National Health Service and implications for the future of prenatal diagnosis	LANCET			English	Article							POLYMERASE CHAIN-REACTION; IN-SITU HYBRIDIZATION; CHROMOSOME ANEUPLOIDIES; DOWNS-SYNDROME; PCR; POLYMORPHISMS; INTEGRATION; GENE; SEX	Background Prenatal diagnosis for chromosome abnormality is routinely undertaken by full karyotype analysis of chromosomes from cultured cells; pregnant women must wait on average 13-14 days for their results. Autosomal trisomies, which account for around 80% of significant abnormalities, can be detected by quantitative fluorescence (QF) PCR. We report on the development and implementation of this technique as the first such routine service within a diagnostic department of the UK National Health Service (NHS). Methods We designed a "one-tube test" comprising four primer pairs for polymorphic tetranucleotide repeat sequences on chromosome 21, four primer pairs for sequences on chromosome 18, three primer pairs for sequences on chromosome 13, and one primer pair to identify the sex chromosomes. All prenatal samples received by our NHS diagnostic department between April, 2000, and April, 2001, were tested. After DNA extraction, PCR amplification was done and the products separated on a capillary-based genetic analyser; the results were interpreted with dedicated software. Follow-up karyotype analysis was done on all samples. Findings 1148 amniotic fluid samples, 188 chorionic villus samples, and 37 fetal tissue samples were tested; the amplification failure rate was zero with our current protocol. QF-PCR results were obtained and reported on 1314 (98%) of the prenatal samples; the remaining 22 (2%) were uninformative because of maternal-cell contamination. One case of mosaicism in a chorionic villus sample, and two cases indicating somatic expansion of a tetranucleotide repeat were found. No false positive or false negative results were obtained. The mean reporting time for the last 4 months of data collection was 1.25 working days. Interpretation QF-PCR aneuploidy testing is an efficient and accurate technique for the detection of autosomal trisomies in prenatal samples. Implementation of this service has led to the rapid diagnosis of abnormalities and early reassurance for women with normal results.	Guys & St Thomas Hosp Trust, Genet Ctr, London, England	Guy's & St Thomas' NHS Foundation Trust	Ogilvie, CM (corresponding author), Dept Cytogenet, 5th Floor,Guys Tower,St Thomas St, London SE1 9RT, England.		Ogilve, Caroline/AAW-3793-2021	Scriven, Paul/0000-0002-0036-984X				Bosch A, 1996, EUR J HUM GENET, V4, P135; CHUMAKOV I, 1992, NATURE, V359, P380, DOI 10.1038/359380a0; Cirigliano V, 1999, PRENATAL DIAG, V19, P1099, DOI 10.1002/(SICI)1097-0223(199912)19:12<1099::AID-PD709>3.0.CO;2-2; GERKEN S, 1994, GENOMICS, V24, P612, DOI 10.1006/geno.1994.1679; KLINGER K, 1992, AM J HUM GENET, V51, P55; Levett LJ, 2001, ULTRASOUND OBST GYN, V17, P115, DOI 10.1046/j.1469-0705.2001.00340.x; MANSFIELD ES, 1993, HUM MOL GENET, V2, P43, DOI 10.1093/hmg/2.1.43; MCINNIS MG, 1991, GENOMICS, V11, P573, DOI 10.1016/0888-7543(91)90064-L; Morris A, 1999, PRENATAL DIAG, V19, P546, DOI 10.1002/(SICI)1097-0223(199906)19:6<546::AID-PD589>3.0.CO;2-8; *NEQAS, 2000, NAT EXT QUAL ASS SCH; Pertl B, 1996, HUM GENET, V98, P55, DOI 10.1007/s004390050159; Pertl B, 1997, AM J OBSTET GYNECOL, V177, P899, DOI 10.1016/S0002-9378(97)70292-8; Pertl B, 1999, J MED GENET, V36, P300; PERTL B, 1994, LANCET, V343, P1197, DOI 10.1016/S0140-6736(94)92404-X; Schmidt W, 2000, MOL HUM REPROD, V6, P855, DOI 10.1093/molehr/6.9.855; SPATHAS DH, 1994, PRENATAL DIAG, V14, P1049, DOI 10.1002/pd.1970141107; SULLIVAN KM, 1993, BIOTECHNIQUES, V15, P636; Thilaganathan B, 2000, BRIT J OBSTET GYNAEC, V107, P262, DOI 10.1111/j.1471-0528.2000.tb11698.x; Verma L, 1998, LANCET, V352, P9, DOI 10.1016/S0140-6736(97)11090-X	19	165	206	0	9	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 29	2001	358	9287					1057	1061		10.1016/S0140-6736(01)06183-9	http://dx.doi.org/10.1016/S0140-6736(01)06183-9			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	479EY	11589937				2022-12-24	WOS:000171393100012
J	Haxby, JV; Gobbini, MI; Furey, ML; Ishai, A; Schouten, JL; Pietrini, P				Haxby, JV; Gobbini, MI; Furey, ML; Ishai, A; Schouten, JL; Pietrini, P			Distributed and overlapping representations of faces and objects in ventral temporal cortex	SCIENCE			English	Article							INFEROTEMPORAL CORTEX; PERCEPTION; AREA; RECOGNITION; COMPONENTS; EXPERTISE; STIMULI; SPACE	The functional architecture of the object vision pathway in the human brain was investigated using functional magnetic resonance imaging to measure patterns of response in ventral temporal cortex white subjects viewed faces, cats, five categories of man-made objects, and nonsense pictures. A distinct pattern of response was found for each stimulus category. The distinctiveness of the response to a given category was not due simply to the regions that responded maximally to that category, because the category being viewed also could be identified on the basis of the pattern of response when those regions were excluded from the analysis. Patterns of response that discriminated among A categories were found even within cortical regions that responded maximally to only one category. These results indicate that the representations of faces and objects in ventral temporal cortex are widely distributed and overlapping.	NIMH, Lab Brain & Cognit, NIH, Bethesda, MD 20892 USA; Univ Pisa, Dept Human & Environm Sci, I-56126 Pisa, Italy; Univ Pisa, Dept Expt Pathol, Lab Clin Biochem, I-56126 Pisa, Italy	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of Pisa; University of Pisa	Haxby, JV (corresponding author), NIMH, Lab Brain & Cognit, NIH, Bethesda, MD 20892 USA.		Patanaik, Amiya/G-4336-2010; Pietrini, Pietro/Z-4202-2019; Furey, Maura/H-5273-2013	Pietrini, Pietro/0000-0002-6768-5556				Aguirre GK, 1998, NEURON, V21, P373, DOI 10.1016/S0896-6273(00)80546-2; Allison T, 1999, CEREB CORTEX, V9, P415, DOI 10.1093/cercor/9.5.415; BIEDERMAN I, 1987, PSYCHOL REV, V94, P115, DOI 10.1037/0033-295X.94.2.115; Blanz V, 2000, PERCEPTION, V29, P885, DOI 10.1068/p2851; Chao LL, 1999, NAT NEUROSCI, V2, P913, DOI 10.1038/13217; DAMASIO AR, 1982, NEUROLOGY, V32, P331, DOI 10.1212/WNL.32.4.331; DEVALOIS RL, 1965, COLD SPRING HARB SYM, V30, P567, DOI 10.1101/SQB.1965.030.01.055; Edelman S, 1998, PSYCHOBIOLOGY, V26, P309; Edelman S, 1997, TRENDS COGN SCI, V1, P296, DOI 10.1016/S1364-6613(97)01090-5; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Gauthier I, 2000, NAT NEUROSCI, V3, P191, DOI 10.1038/72140; Gauthier I, 1999, NAT NEUROSCI, V2, P568, DOI 10.1038/9224; Gauthier I, 2000, J COGNITIVE NEUROSCI, V12, P495, DOI 10.1162/089892900562165; Gauthier I, 2000, TRENDS COGN SCI, V4, P1, DOI 10.1016/S1364-6613(99)01416-3; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; GROSS CG, 1972, J NEUROPHYSIOL, V35, P96, DOI 10.1152/jn.1972.35.1.96; Hancock PJB, 1996, MEM COGNITION, V24, P26, DOI 10.3758/BF03197270; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Haxby JV, 1999, NEURON, V22, P189, DOI 10.1016/S0896-6273(00)80690-X; Haxby JV, 2000, TRENDS COGN SCI, V4, P3, DOI 10.1016/S1364-6613(99)01423-0; HAXBY JV, IN PRESS MAPPING MOD; Hecaen H., 1962, ARCH NEUROL-CHICAGO, V7, P24; Hering E., 1964, OUTLINES THEORY LIGH; HURVICH LM, 1957, PSYCHOL REV, V64, P384, DOI 10.1037/h0041403; Ishai A, 1999, P NATL ACAD SCI USA, V96, P9379, DOI 10.1073/pnas.96.16.9379; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Lanitis A, 1997, IEEE T PATTERN ANAL, V19, P743, DOI 10.1109/34.598231; Leopold DA, 2001, NAT NEUROSCI, V4, P89, DOI 10.1038/82947; Logothetis NK, 1996, ANNU REV NEUROSCI, V19, P577, DOI 10.1146/annurev.ne.19.030196.003045; MARTIN A, 1999, NEW COGNITIVE NEUROS, P1023; McCarthy G, 1997, J COGNITIVE NEUROSCI, V9, P605, DOI 10.1162/jocn.1997.9.5.605; OTOOLE AJ, 1993, J OPT SOC AM A, V10, P405, DOI 10.1364/JOSAA.10.000405; TALAIRACH J, 1988, COPLANAR STEREOTOXIC; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; WARRINGTON EK, 1984, BRAIN, V107, P829, DOI 10.1093/brain/107.3.829	35	2479	2512	7	283	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 28	2001	293	5539					2425	2430		10.1126/science.1063736	http://dx.doi.org/10.1126/science.1063736			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	476PD	11577229	Green Accepted			2022-12-24	WOS:000171237200038
J	Reilly, BM				Reilly, BM			Pronouncing	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Cook Cty Hosp, Dept Med, Chicago, IL 60612 USA; Rush Med Coll, Chicago, IL 60612 USA	John H Stroger Junior Hospital Cook County; Rush University	Reilly, BM (corresponding author), Cook Cty Hosp, Dept Med, Room 2129,1835 W Harrison St, Chicago, IL 60612 USA.								0	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 18	2001	135	6					467	470		10.7326/0003-4819-135-6-200109180-00017	http://dx.doi.org/10.7326/0003-4819-135-6-200109180-00017			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	472FH	11560461				2022-12-24	WOS:000170972500009
J	Harrison, SP; Yu, G; Takahara, H; Prentice, IC				Harrison, SP; Yu, G; Takahara, H; Prentice, IC			Palaeovegetation - Diversity of temperate plants in east Asia	NATURE			English	Article									Max Planck Inst Biogeochem, D-07701 Jena, Germany; Lund Univ, S-22300 Lund, Sweden; Chinese Acad Sci, Nanjing Inst Geog & Limnol, Nanjing, Peoples R China; Kyoto Prefectural Univ, Univ Forest, Kyoto 606, Japan	Max Planck Society; Lund University; Chinese Academy of Sciences; Nanjing Institute of Geography & Limnology, CAS; Kyoto Prefectural University	Harrison, SP (corresponding author), Max Planck Inst Biogeochem, POB 100164, D-07701 Jena, Germany.		Takahara, Hikaru/AAZ-6642-2020	Harrison, Sandy/0000-0001-5687-1903					0	314	340	1	108	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 13	2001	413	6852					129	130		10.1038/35093166	http://dx.doi.org/10.1038/35093166			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471FU	11557970				2022-12-24	WOS:000170918800036
J	Cederberg, A; Gronning, LM; Ahren, B; Tasken, K; Carlsson, P; Enerback, S				Cederberg, A; Gronning, LM; Ahren, B; Tasken, K; Carlsson, P; Enerback, S			FOXC2 is a winged helix gene that counteracts obesity, hypertriglyceridemia, and diet-induced insulin resistance	CELL			English	Article							ENHANCER-BINDING-PROTEIN; PPAR-GAMMA ACTIVATORS; TARGETED DISRUPTION; ADIPOSE-TISSUE; ADIPOCYTE DIFFERENTIATION; TRANSCRIPTION FACTOR; UNCOUPLING PROTEIN; EXPRESSION; ALPHA; MICE	Obesity, hyperlipidemia, and insulin resistance are common forerunners of type 2 diabetes mellitus. We have identified the human winged helix/forkhead transcription factor gene FOXC2 as a key regulator of adipocyte metabolism. Increased FOXC2 expression, in adipocytes, has a pleiotropic effect on gene expression, which leads to a lean and insulin sensitive phenotype. FOXC2 affects adipocyte metabolism by increasing the sensitivity of the beta -adrenergic-cAMP-protein kinase A (PIKA) signaling pathway through alteration of adipocyte PKA holoenzyme composition. Increased FOXC2 levels, induced by high fat diet, seem to counteract most of the symptoms associated with obesity, including hypertriglyceridemia and diet-induced insulin resistance-a likely consequence hereof would bo protection against type 2 diabetes.	Univ Gothenburg, Dept Med Biochem, SE-40530 Gothenburg, Sweden; Univ Oslo, Inst Med Biochem, N-0317 Oslo, Norway; Lund Univ, Malmo Univ Hosp, Dept Med, SE-20520 Malmo, Sweden	University of Gothenburg; University of Oslo; Lund University; Skane University Hospital	Enerback, S (corresponding author), Univ Gothenburg, Dept Med Biochem, Box 440, SE-40530 Gothenburg, Sweden.	sven.enerback@medgen.gu.se	Carlsson, Peter/B-5551-2008	Carlsson, Peter/0000-0001-6535-5927; Tasken, Kjetil/0000-0003-2841-4697				ABBOTT WGH, 1987, METABOLISM, V36, P576, DOI 10.1016/0026-0495(87)90170-3; Boden G, 1997, DIABETES, V46, P3, DOI 10.2337/diabetes.46.1.3; BOUCHARD C, 1990, NEW ENGL J MED, V322, P1477, DOI 10.1056/NEJM199005243222101; CHRISTY RJ, 1989, GENE DEV, V3, P1323, DOI 10.1101/gad.3.9.1323; Coe NR, 1999, J LIPID RES, V40, P967; Cummings DE, 1996, NATURE, V382, P622, DOI 10.1038/382622a0; DOSTMANN WRG, 1990, J BIOL CHEM, V265, P10484; ENERBACK S, 1992, MOL CELL BIOL, V12, P4622, DOI 10.1128/MCB.12.10.4622; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Fajas L, 1999, MOL CELL BIOL, V19, P5495; FLIER JS, 1995, CELL, V80, P15, DOI 10.1016/0092-8674(95)90445-X; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Hamann A, 1996, ENDOCRINOLOGY, V137, P21, DOI 10.1210/en.137.1.21; HIMMSHAGEN J, 1994, AM J PHYSIOL, V266, pR1371, DOI 10.1152/ajpregu.1994.266.4.R1371; Iida K, 1997, DEVELOPMENT, V124, P4627; KAESTNER KH, 1990, P NATL ACAD SCI USA, V87, P251, DOI 10.1073/pnas.87.1.251; Kim JB, 1996, GENE DEV, V10, P1096, DOI 10.1101/gad.10.9.1096; Levine JA, 1999, SCIENCE, V283, P212, DOI 10.1126/science.283.5399.212; LIN FT, 1994, P NATL ACAD SCI USA, V91, P8757, DOI 10.1073/pnas.91.19.8757; Lopez JM, 1996, P NATL ACAD SCI USA, V93, P1049, DOI 10.1073/pnas.93.3.1049; Lowell BB, 1997, ANNU REV MED, V48, P307; Martin G, 1997, J BIOL CHEM, V272, P28210, DOI 10.1074/jbc.272.45.28210; Moitra J, 1998, GENE DEV, V12, P3168, DOI 10.1101/gad.12.20.3168; Murray I, 1999, J BIOL CHEM, V274, P36219, DOI 10.1074/jbc.274.51.36219; ORahilly S, 1997, NAT MED, V3, P1080, DOI 10.1038/nm1097-1080; Osuga J, 2000, P NATL ACAD SCI USA, V97, P787, DOI 10.1073/pnas.97.2.787; PARK EA, 1990, MOL CELL BIOL, V10, P6264, DOI 10.1128/MCB.10.12.6264; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; ROSS SR, 1990, P NATL ACAD SCI USA, V87, P9590, DOI 10.1073/pnas.87.24.9590; Schoonjans K, 1996, EMBO J, V15, P5336, DOI 10.1002/j.1460-2075.1996.tb00918.x; SHEPHERD PR, 1993, J BIOL CHEM, V268, P22243; Shimomura I, 1998, GENE DEV, V12, P3182, DOI 10.1101/gad.12.20.3182; SUSULIC VS, 1995, J BIOL CHEM, V270, P29483, DOI 10.1074/jbc.270.49.29483; TASKEN K, 1993, J BIOL CHEM, V268, P23483; TONTONOZ P, 1995, MOL CELL BIOL, V15, P351, DOI 10.1128/MCB.15.1.351; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Unger RH, 2000, INT J OBESITY, V24, pS28, DOI 10.1038/sj.ijo.0801498; Winnier GE, 1997, GENE DEV, V11, P926, DOI 10.1101/gad.11.7.926; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Wu ZD, 1999, MOL CELL, V3, P151, DOI 10.1016/S1097-2765(00)80306-8; YOSHIDA T, 1994, LIFE SCI, V54, P491, DOI 10.1016/0024-3205(94)00408-0; YUBERO P, 1994, BIOCHEM BIOPH RES CO, V198, P653, DOI 10.1006/bbrc.1994.1095; Zimmet PZ, 1997, LANCET, V350, pSI1	43	414	439	0	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 7	2001	106	5					563	573		10.1016/S0092-8674(01)00474-3	http://dx.doi.org/10.1016/S0092-8674(01)00474-3			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	472FQ	11551504	Bronze			2022-12-24	WOS:000170973200007
J	HOWARD, R				HOWARD, R			MEMORABLE PATIENTS - INSIGHT AND HONESTY	BRITISH MEDICAL JOURNAL			English	Editorial Material														Howard, Robert/0000-0002-3071-2338					0	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	MAR 20	1993	306	6880					764	764		10.1136/bmj.306.6880.764	http://dx.doi.org/10.1136/bmj.306.6880.764			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU173	11643118	Bronze, Green Published			2022-12-24	WOS:A1993KU17300027
J	CALDEIRA, K; KASTING, JF				CALDEIRA, K; KASTING, JF			SUSCEPTIBILITY OF THE EARLY EARTH TO IRREVERSIBLE GLACIATION CAUSED BY CARBON-DIOXIDE CLOUDS	NATURE			English	Article							CLIMATE; CO2; LUMINOSITY; FEEDBACK; MARS	SIMPLE energy-balance climate models of the Budyko/Sellers type1,2 predict that a small (2-5%) decrease in solar output could result in runaway glaciation on the Earth. But solar fluxes 25-30% lower early in the Earth's history3,4 apparently did not lead to this result. One currently favoured explanation is that high partial pressures of carbon dioxide, caused by higher volcanic outgassing rates and/or slower rates of silicate weathering, created a large enough greenhouse effect to keep the planet warm5-7. This does not resolve the problem of climate stability, however, because as we argue here, the oceans can freeze much more quickly than CO2 can accumulate in the atmosphere. Had such a transient global glaciation occurred in the distant past when solar luminosity was low, it might have been irreversible because of the formation of highly reflective CO2 clouds, similar to those encountered in climate simulations of early Mars8. Our simulations of the early Earth, incorporating the possible formation of such clouds, suggest that the Earth might not be habitable today had it not been warm during the first part of its history.	PENN STATE UNIV,DEPT GEOSCI,UNIV PK,PA 16802	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	CALDEIRA, K (corresponding author), PENN STATE UNIV,CTR EARTH SYST SCI,UNIV PK,PA 16802, USA.		Caldeira, Ken/E-7914-2011; Kasting, James/AAF-6851-2020	Caldeira, Ken/0000-0002-4591-643X; 				Allaart J. H., 1976, EARLY HIST EARTH, P177; BUDYKO MI, 1969, TELLUS, V21, P611, DOI 10.3402/tellusa.v21i5.10109; CAHALAN RF, 1979, J ATMOS SCI, V36, P1178, DOI 10.1175/1520-0469(1979)036<1178:ASTFEB>2.0.CO;2; GOUGH DO, 1981, SOL PHYS, V74, P21, DOI 10.1007/BF00151270; HAMBREY MJ, 1985, PALAEOGEOGR PALAEOCL, V51, P255, DOI 10.1016/0031-0182(85)90088-4; Holland H. D., 1978, CHEM ATMOSPHERE OCEA; KASTING JF, 1991, ICARUS, V94, P1, DOI 10.1016/0019-1035(91)90137-I; KASTING JF, 1986, SCIENCE, V234, P1383, DOI 10.1126/science.11539665; KASTING JF, IN PRESS ICARUS; KIEHL JT, 1987, J GEOPHYS RES-ATMOS, V92, P2991, DOI 10.1029/JD092iD03p02991; MARSHALL HG, 1988, J GEOPHYS RES-ATMOS, V93, P791, DOI 10.1029/JD093iD01p00791; MCWILLIAMS MO, 1980, J GEOL, V88, P1, DOI 10.1086/628470; NORTH GR, 1981, REV GEOPHYS, V19, P91, DOI 10.1029/RG019i001p00091; NORTH GR, 1979, J ATMOS SCI, V36, P1189, DOI 10.1175/1520-0469(1979)036<1189:DBSAMA>2.0.CO;2; OWEN T, 1979, NATURE, V277, P640, DOI 10.1038/277640a0; ROSSOW WB, 1982, SCIENCE, V217, P1245, DOI 10.1126/science.217.4566.1245; SAGAN C, 1972, SCIENCE, V177, P52, DOI 10.1126/science.177.4043.52; Sellers W.D., 1969, J APPL METEOROL, V8, P392, DOI [DOI 10.1175/1520-0450(1969)008<0392:AGCMBO>2.0.CO;2, 10.1175/1520-0450(1969)0082.0.CO;2]; SUNDQUIST ET, 1991, QUATERNARY SCI REV, V10, P283, DOI 10.1016/0277-3791(91)90026-Q; WALKER JCG, 1981, J GEOPHYS RES-OCEANS, V86, P9776, DOI 10.1029/JC086iC10p09776; WALTER M, 1979, AM SCI, V67, P142; WARREN SG, 1986, APPL OPTICS, V25, P2650, DOI 10.1364/AO.25.002650; WORSLEY TR, 1992, GEOLOGY, V19, P1161	23	159	168	2	84	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	SEP 17	1992	359	6392					226	228		10.1038/359226a0	http://dx.doi.org/10.1038/359226a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JN944	11540934				2022-12-24	WOS:A1992JN94400057
J	Winklbauer, R; Medina, A; Swain, RK; Steinbeisser, H				Winklbauer, R; Medina, A; Swain, RK; Steinbeisser, H			Frizzled-7 signalling controls tissue separation during Xenopus gastrulation	NATURE			English	Article							CONVERGENT EXTENSION MOVEMENTS; GLYCOGEN-SYNTHASE KINASE-3; BETA-CATENIN; SIGNALING PATHWAYS; WNT; MORPHOGENESIS; MESODERM; EMBRYOS; TARGET	Cell signalling through Frizzled receptors has evolved to considerable complexity within the metazoans. The Frizzled-dependent signalling cascade comprises several branches, whose differential activation depends on specific Wnt ligands, Frizzled receptor isoforms and the cellular context. In Xenopus laevis embryos, the canonical beta -catenin pathway contributes to the establishment of the dorsal-ventral axis(1). A different branch, referred to as the planar cell polarity pathway, is essential for cell polarization during elongation of the axial mesoderm by convergent extension(2). Here we demonstrate that a third branch of the cascade is independent of Dishevelled function and involves signalling through trimeric G proteins and protein kinase C (PKC). During gastrulation, Frizzled-7 (Fz7)-dependent PKC signalling controls cell-sorting behaviour in the mesoderm. Loss of zygotic Fz7 function results in the inability of involuted anterior mesoderm to separate from the ectoderm, which leads to severe gastrulation defects. This result provides a developmentally relevant in vivo function for the Fz/PKC pathway in vertebrates.	Max Planck Inst Dev Biol, Dept Cell Biol, D-72076 Tubingen, Germany	Max Planck Society	Steinbeisser, H (corresponding author), Max Planck Inst Dev Biol, Dept Cell Biol, Spemann Str 35, D-72076 Tubingen, Germany.			Swain, Rajeeb/0000-0003-4815-8221				Deardorff' MA, 1998, DEVELOPMENT, V125, P2687; Djiane A, 2000, DEVELOPMENT, V127, P3091; HE X, 1995, NATURE, V374, P617, DOI 10.1038/374617a0; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Hsu SC, 1998, MOL CELL BIOL, V18, P4807, DOI 10.1128/MCB.18.8.4807; Medina A, 2000, DEV DYNAM, V218, P671, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1017>3.0.CO;2-9; Medina A, 2000, MECH DEVELOP, V92, P227, DOI 10.1016/S0925-4773(00)00240-9; Miller JR, 1999, ONCOGENE, V18, P7860, DOI 10.1038/sj.onc.1203245; Munchberg SR, 1999, MECH DEVELOP, V80, P53, DOI 10.1016/S0925-4773(98)00193-2; OTTE AP, 1992, CELL, V68, P1021, DOI 10.1016/0092-8674(92)90074-M; Rothbacher U, 2000, EMBO J, V19, P1010, DOI 10.1093/emboj/19.5.1010; Sheldahl LC, 1999, CURR BIOL, V9, P695, DOI 10.1016/S0960-9822(99)80310-8; Shi DL, 1998, MECH DEVELOP, V70, P35, DOI 10.1016/S0925-4773(97)00166-4; Slusarski DC, 1997, NATURE, V390, P410, DOI 10.1038/37138; Sokol SY, 1996, CURR BIOL, V6, P1456, DOI 10.1016/S0960-9822(96)00750-6; Sumanas S, 2000, DEVELOPMENT, V127, P1981; Tada M, 2000, DEVELOPMENT, V127, P2227; Wacker S, 2000, DEV BIOL, V224, P428, DOI 10.1006/dbio.2000.9794; Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077; Winklbauer R, 1999, DEVELOPMENT, V126, P3703; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443	21	215	223	0	6	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 25	2001	413	6858					856	860		10.1038/35101621	http://dx.doi.org/10.1038/35101621			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	485JA	11677610				2022-12-24	WOS:000171750200049
J	Roose, SP; Glassman, AH; Seidman, SN				Roose, SP; Glassman, AH; Seidman, SN			Relationship between depression and other medical illnesses	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; ASSOCIATION; EVENTS; MEN		Columbia Univ Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; New York State Psychiat Inst & Hosp, New York, NY 10032 USA	Columbia University; New York State Psychiatry Institute	Roose, SP (corresponding author), Columbia Univ Coll Phys & Surg, Dept Psychiat, 1051 Riverside Dr, New York, NY 10032 USA.	spr2@columbia.edu						AROMAA A, 1994, ACTA PSYCHIAT SCAND, V89, P77, DOI 10.1111/j.1600-0447.1994.tb05807.x; Berkman LF, 2000, AM HEART J, V139, P1; CARNEY RM, 1988, PSYCHOSOM MED, V50, P627, DOI 10.1097/00006842-198811000-00009; Carney RM, 2001, PSYCHOSOM MED, V63, P102; CONNERNEY I, 2000, P AM PSYCH SOC MARCH; FORD DE, 1994, CIRCULATION, V90, P614; FRASURESMITH N, 1993, JAMA-J AM MED ASSOC, V270, P1819, DOI 10.1001/jama.270.15.1819; FRASURESMITH N, 1995, CIRCULATION, V91, P999, DOI 10.1161/01.CIR.91.4.999; GLASSMAN A, 2001, POST PRES AM PSYCH A; GLASSMAN AH, 1993, JAMA-J AM MED ASSOC, V269, P2673, DOI 10.1001/jama.269.20.2673; Glassman AH, 1998, AM J PSYCHIAT, V155, P4, DOI 10.1176/ajp.155.1.4; KEMPER JW, 1957, ANN INTERN MED, V46, P831, DOI 10.7326/0003-4819-46-5-831; Kessler RC, 1997, ANNU REV PSYCHOL, V48, P191, DOI 10.1146/annurev.psych.48.1.191; LaghrissiThode F, 1997, BIOL PSYCHIAT, V42, P290, DOI 10.1016/S0006-3223(96)00345-9; Lesperance F, 1998, J AM COLL CARDIOL, V31, p208A, DOI 10.1016/S0735-1097(97)84610-4; MORRIS PLP, 1993, AM J PSYCHIAT, V150, P124; Musselman DL, 1998, ARCH GEN PSYCHIAT, V55, P580, DOI 10.1001/archpsyc.55.7.580; POLLOCK BG, 1995, 34 ANN M AM COLL NEU; ROBINSON RG, 1983, COMPR PSYCHIAT, V24, P555, DOI 10.1016/0010-440X(83)90024-X; Roose SP, 1998, JAMA-J AM MED ASSOC, V279, P287, DOI 10.1001/jama.279.4.287; Roose SP, 1998, AM J PSYCHIAT, V155, P660, DOI 10.1176/ajp.155.5.660; ROOSE SP, 1991, J CLIN PSYCHIAT, V52, P34; ROSS R, 1976, SCIENCE, V193, P1094, DOI 10.1126/science.822515; SCHLEIFER SJ, 1989, ARCH INTERN MED, V149, P1785, DOI 10.1001/archinte.149.8.1785; SEIDMAN SN, IN PRESS AM J PSYCHI; Seidman SN, 1999, PSYCHIAT CLIN N AM, P21; Shabsigh R, 1998, UROLOGY, V52, P848, DOI 10.1016/S0090-4295(98)00292-1; Shapiro PA, 1999, AM HEART J, V137, P1100, DOI 10.1016/S0002-8703(99)70369-8; SIMONSICK EM, 1995, PSYCHOSOM MED, V57, P427, DOI 10.1097/00006842-199509000-00003; TROXLER RG, 1977, ATHEROSCLEROSIS, V26, P151, DOI 10.1016/0021-9150(77)90098-3	30	56	56	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 10	2001	286	14					1687	1690		10.1001/jama.286.14.1687	http://dx.doi.org/10.1001/jama.286.14.1687			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	480NC	11594878				2022-12-24	WOS:000171466800001
J	Larkin, M				Larkin, M			New York physicians respond to the terror, tragedy, and trauma	LANCET			English	Article																			0	3	3	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 22	2001	358	9286					940	940		10.1016/S0140-6736(01)06117-7	http://dx.doi.org/10.1016/S0140-6736(01)06117-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	474YR	11584817				2022-12-24	WOS:000171135300003
J	Kang, HJ; Sun, LD; Atkins, CM; Soderling, TR; Wilson, MA; Tonegawa, S				Kang, HJ; Sun, LD; Atkins, CM; Soderling, TR; Wilson, MA; Tonegawa, S			An important role of neural activity-dependent CaMKIV signaling in the consolidation of long-term memory	CELL			English	Article							ELEMENT-BINDING PROTEIN; LATE-PHASE; CREB PHOSPHORYLATION; RETROGRADE-AMNESIA; ADENYLYL-CYCLASE; CONTEXTUAL FEAR; DORSAL STRIATUM; KINASE-IV; CALCIUM; TRANSCRIPTION	Calcium/calmodulin-dependent protein kinase IV (CaMKIV) has been implicated in the regulation of CRE-dependent transcription. To investigate the role of this kinase in neuronal plasticity and memory, we generated transgenic mice in which the expression of a dominant-negative form of CaMKIV (dnCaMKIV) is restricted to the postnatal forebrain. In these transgenic mice, activity-induced CREB phosphorylation and c-Fos expression were significantly attenuated. Hippocampal late LTP (L-LTP) was also impaired, whereas basic synaptic function and early LTP (E-LTP) were unaffected. These deficits correlated with impairments in long-term memory, specifically in its consolidation/retention phase but not in the acquisition phase. These results indicate that neural activity-dependent CaMKIV signaling in the neuronal nucleus plays an important role in the consolidation/retention of hippocampus-dependent long-term memory.	MIT, RIKEN MIT Neurosci Res Ctr, Dept Biol, Howard Hughes Med Inst, Cambridge, MA 02139 USA; MIT, Ctr Learning & Memory, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); RIKEN; Massachusetts Institute of Technology (MIT); Oregon Health & Science University	Tonegawa, S (corresponding author), MIT, RIKEN MIT Neurosci Res Ctr, Dept Biol, Howard Hughes Med Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	tonegawa@mit.edu		Atkins, Coleen/0000-0003-4718-7493	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027037, R01NS032925] Funding Source: NIH RePORTER; NINDS NIH HHS [R01-NS27037, R01-NS32925] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; Anagnostaras SG, 1999, J NEUROSCI, V19, P1106; Anagnostaras SG, 2000, LEARN MEMORY, V7, P58, DOI 10.1101/lm.7.1.58; BARTSCH D, 1995, CELL, V83, P979, DOI 10.1016/0092-8674(95)90213-9; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Blendy JA, 1996, EMBO J, V15, P1098, DOI 10.1002/j.1460-2075.1996.tb00447.x; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Blitzer RD, 1995, NEURON, V15, P1403, DOI 10.1016/0896-6273(95)90018-7; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Chawla S, 1998, SCIENCE, V281, P1505, DOI 10.1126/science.281.5382.1505; Churchill L, 1998, J NEUROSCI, V18, P8074; CRUZ APM, 1994, PHARMACOL BIOCHEM BE, V49, P171, DOI 10.1016/0091-3057(94)90472-3; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; Devan BD, 1999, J NEUROSCI, V19, P2789; Enslen H, 1996, P NATL ACAD SCI USA, V93, P10803, DOI 10.1073/pnas.93.20.10803; Finkbeiner S, 1997, NEURON, V19, P1031, DOI 10.1016/S0896-6273(00)80395-5; FREY U, 1988, BRAIN RES, V452, P57, DOI 10.1016/0006-8993(88)90008-X; Grewal SS, 2000, J BIOL CHEM, V275, P34433, DOI 10.1074/jbc.M004728200; Gringhuis SI, 1997, J BIOL CHEM, V272, P31809, DOI 10.1074/jbc.272.50.31809; Hardingham GE, 1999, NEURON, V22, P789, DOI 10.1016/S0896-6273(00)80737-0; Ho N, 2000, J NEUROSCI, V20, P6459, DOI 10.1523/JNEUROSCI.20-17-06459.2000; Hu SC, 1999, NEURON, V22, P799, DOI 10.1016/S0896-6273(00)80738-2; Impey S, 1996, NEURON, V16, P973, DOI 10.1016/S0896-6273(00)80120-8; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; JENSEN KF, 1991, P NATL ACAD SCI USA, V88, P2850, DOI 10.1073/pnas.88.7.2850; Kim JJ, 2001, J NEUROSCI, V21, P5222, DOI 10.1523/JNEUROSCI.21-14-05222.2001; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Kogan JH, 1997, CURR BIOL, V7, P1, DOI 10.1016/S0960-9822(06)00022-4; MCDONALD RJ, 1994, BEHAV NEURAL BIOL, V61, P260, DOI 10.1016/S0163-1047(05)80009-3; MIYAKAWA T, 2001, IN PRESS J NEUROSCI; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; MORRIS RGM, 1981, LEARN MOTIV, V12, P239, DOI 10.1016/0023-9690(81)90020-5; NAKAMURA Y, 1995, NEUROSCIENCE, V68, P181, DOI 10.1016/0306-4522(95)00092-W; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; PICCIOTTO MR, 1995, SYNAPSE, V20, P75, DOI 10.1002/syn.890200111; Ribar TJ, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-22-j0004.2000; SHENG M, 1990, NEURON, V4, P477, DOI 10.1016/0896-6273(90)90106-P; Shieh PB, 1998, NEURON, V20, P727, DOI 10.1016/S0896-6273(00)81011-9; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; Soderling TR, 2000, TRENDS NEUROSCI, V23, P75, DOI 10.1016/S0166-2236(99)01490-3; Sun PQ, 1996, J BIOL CHEM, V271, P3066, DOI 10.1074/jbc.271.6.3066; Tokumitsu H, 1996, J BIOL CHEM, V271, P5617, DOI 10.1074/jbc.271.10.5617; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Wayman GA, 1996, MOL CELL BIOL, V16, P6075; Winder DG, 1998, CELL, V92, P25, DOI 10.1016/S0092-8674(00)80896-X; Wong ST, 1999, NEURON, V23, P787, DOI 10.1016/S0896-6273(01)80036-2; Wu GY, 2001, P NATL ACAD SCI USA, V98, P2808, DOI 10.1073/pnas.051634198; Wu JY, 2000, NAT GENET, V25, P448, DOI 10.1038/78153; YAMAMOTO KK, 1988, NATURE, V334, P494, DOI 10.1038/334494a0; YIN JCP, 1995, CELL, V81, P107, DOI 10.1016/0092-8674(95)90375-5; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9	52	226	236	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 21	2001	106	6					771	783		10.1016/S0092-8674(01)00497-4	http://dx.doi.org/10.1016/S0092-8674(01)00497-4			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	476EJ	11572782	Bronze			2022-12-24	WOS:000171213000013
J	Pimm, SL; Ayres, M; Balmford, A; Branch, G; Brandon, K; Brooks, T; Bustamante, R; Costanza, R; Cowling, R; Curran, LM; Dobson, A; Farber, S; da Fonseca, GAB; Gascon, C; Kitching, R; McNeely, J; Lovejoy, T; Mittermeier, RA; Myers, N; Patz, JA; Raffle, B; Rapport, D; Raven, P; Roberts, C; Rodriguez, JP; Rylands, AB; Tucker, C; Safina, C; Samper, C; Stiassny, MLJ; Supriatna, J; Hall, DH; Wilcove, D				Pimm, SL; Ayres, M; Balmford, A; Branch, G; Brandon, K; Brooks, T; Bustamante, R; Costanza, R; Cowling, R; Curran, LM; Dobson, A; Farber, S; da Fonseca, GAB; Gascon, C; Kitching, R; McNeely, J; Lovejoy, T; Mittermeier, RA; Myers, N; Patz, JA; Raffle, B; Rapport, D; Raven, P; Roberts, C; Rodriguez, JP; Rylands, AB; Tucker, C; Safina, C; Samper, C; Stiassny, MLJ; Supriatna, J; Hall, DH; Wilcove, D			Environment - Can we defy nature's end?	SCIENCE			English	Editorial Material							CONSERVATION		Columbia Univ, Ctr Environm Res & Conservat, New York, NY 10027 USA	Columbia University	Pimm, SL (corresponding author), Columbia Univ, Ctr Environm Res & Conservat, MC 5556, New York, NY 10027 USA.	StuartPimm@aol.com	Costanza, Robert/A-4912-2008; Costanza, Robert/AAJ-3546-2021; Wall, Diana H/F-5491-2011; Rodriguez, Jon P/G-7224-2012; Rodriguez, Jon P/A-1491-2009; Ayres, Matthew/AAI-6873-2020; Kitching, Roger/C-5102-2009	Costanza, Robert/0000-0001-6348-8734; Rodriguez, Jon P/0000-0001-5019-2870; Ayres, Matthew/0000-0001-6120-9068; Balmford, Andrew/0000-0002-0144-3589; Wilcove, David S./0000-0002-1354-0503; Brooks, Thomas/0000-0001-8159-3116				Cincotta RP, 2000, NATURE, V404, P990, DOI 10.1038/35010105; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; DYNESIUS M, 1994, SCIENCE, V266, P753, DOI 10.1126/science.266.5186.753; GRAINGER A, 1988, International Tree Crops Journal, V5, P31; HARDNER JJ, 2000, MITIG ADAPT STRAT GL, V5, P61, DOI DOI 10.1023/A:1009685323704; James A, 2000, NATURE, V404, P120, DOI 10.1038/35004750; Kremen C, 2000, SCIENCE, V288, P1828, DOI 10.1126/science.288.5472.1828; Kress WJ, 2001, SCIENCE, V291, P828; LUDWIG D, 1993, SCIENCE, V260, P17, DOI 10.1126/science.260.5104.17; MICKLIN PP, 1988, SCIENCE, V241, P1170, DOI 10.1126/science.241.4870.1170; Milazzo M, 1998, WTP406; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Myers N, 1998, NATURE, V392, P327, DOI 10.1038/32761; Myers N, 2001, PERVERSE SUBSIDIES T; MYERS N, 1992, PRIMARY SOURCE TROPI; National Research Council, 1980, RES PRIOR TROP BIOL; Nepstad DC, 1999, NATURE, V398, P505, DOI 10.1038/19066; Patz JA, 2000, ANNU REV PUBL HEALTH, V21, P271, DOI 10.1146/annurev.publhealth.21.1.271; Pimm S. L., 2001, WORLD ACCORDING PIMM; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Pimm SL, 1998, SCIENCE, V279, P2068, DOI 10.1126/science.279.5359.2068; Reisner M., 1986, CADILLAC DESERT AM W; Roberts CM, 1999, TRENDS ECOL EVOL, V14, P241, DOI 10.1016/S0169-5347(98)01584-5; SIZER N, 2001, INCREASED INVESTMENT; Smith AT, 2000, SCIENCE, V290, P2073; Stein B., 2000, PRECIOUS HERITAGE ST; Sugden A, 2000, SCIENCE, V289, P2305; *UN ENV PROGR, 2000, STAT DES IMPL UN PLA; *UN FAO, 2000, STAT WORLD FISH AQ 2; Wilkins DA, 1999, TRENDS ECOL EVOL, V14, P69, DOI 10.1016/S0169-5347(98)01449-9; Wilson EO, 2000, SCIENCE, V289, P2279	31	178	187	1	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 21	2001	293	5538					2207	2208		10.1126/science.1061626	http://dx.doi.org/10.1126/science.1061626			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	475AL	11567124				2022-12-24	WOS:000171139400024
J	Giles, J				Giles, J			Mad cow disease comes to Japan	NATURE			English	News Item																			0	9	10	0	1	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 20	2001	413	6853					240	240		10.1038/35095180	http://dx.doi.org/10.1038/35095180			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	473KB	11564996	Bronze			2022-12-24	WOS:000171040500005
J	Scott, SH; Gribble, PL; Graham, KM; Cabel, DW				Scott, SH; Gribble, PL; Graham, KM; Cabel, DW			Dissociation between hand motion and population vectors from neural activity in motor cortex	NATURE			English	Article							ARM MOVEMENTS; REACHING MOVEMENTS; CORTICAL CONTROL; DIRECTION; REPRESENTATION; SHOULDER; MUSCLE; PATHS; SPACE	The population vector hypothesis was introduced almost twenty years ago to illustrate that a population vector constructed from neural activity in primary motor cortex (MI) of non-human primates could predict the direction of hand movement during reaching(1-6). Alternative explanations for this population signal have been suggested(7,8) but could not be tested experimentally owing to movement complexity in the standard reaching model. We re-examined this issue by recording the activity of neurons in contralateral MI of monkeys while they made reaching movements with their right arms oriented in the horizontal plane-where the mechanics of limb motion are measurable and anisotropic. Here we found systematic biases between the population vector and the direction of hand movement. These errors were attributed to a non-uniform distribution of preferred directions of neurons and the non-uniformity covaried with peak joint power at the shoulder and elbow. These observations contradict the population vector hypothesis and show that non-human primates are capable of generating reaching movements to spatial targets even though population vectors based on MI activity do not point in the direction of hand motion.	Queens Univ, CIHR Grp Sensory Motor Syst, Ctr Neurosci Studies, Dept Anat & Cell Biol, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Scott, SH (corresponding author), Queens Univ, CIHR Grp Sensory Motor Syst, Ctr Neurosci Studies, Dept Anat & Cell Biol, Kingston, ON K7L 3N6, Canada.	steve@biomed.queensu.ca		Gribble, Paul/0000-0002-1368-032X				BATSCHELET E, 1981, MATH BIOL CIRCULAR S; CAMINITI R, 1990, J NEUROSCI, V10, P2039; Cheng EJ, 2000, J MORPHOL, V245, P206, DOI 10.1002/1097-4687(200009)245:3<206::AID-JMOR3>3.3.CO;2-L; GABEL DW, IN PRESS J NEUROPHYS; GEORGOPOULOS AP, 1988, J NEUROSCI, V8, P2928; GEORGOPOULOS AP, 1995, TRENDS NEUROSCI, V18, P506, DOI 10.1016/0166-2236(95)92775-L; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; GEORGOPOULOS AP, 1983, EXP BRAIN RES, V49, P327; Gomi H, 1996, SCIENCE, V272, P117, DOI 10.1126/science.272.5258.117; GORDON J, 1994, EXP BRAIN RES, V99, P112, DOI 10.1007/BF00241416; HOLLERBACH JM, 1982, BIOL CYBERN, V44, P67, DOI 10.1007/BF00353957; Kakei S, 1999, SCIENCE, V285, P2136, DOI 10.1126/science.285.5436.2136; KALASKA JF, 1989, J NEUROSCI, V9, P2080; Kalaska JF, 1997, CURR OPIN NEUROBIOL, V7, P849, DOI 10.1016/S0959-4388(97)80146-8; KARST GM, 1991, J NEUROPHYSIOL, V66, P1594, DOI 10.1152/jn.1991.66.5.1594; Moran DW, 1999, J NEUROPHYSIOL, V82, P2676, DOI 10.1152/jn.1999.82.5.2676; MUSSAIVALDI FA, 1988, NEUROSCI LETT, V91, P106, DOI 10.1016/0304-3940(88)90257-1; MUSSAIVALDI FA, 1985, J NEUROSCI, V5, P2732; Sainburg RL, 1999, J NEUROPHYSIOL, V81, P1045, DOI 10.1152/jn.1999.81.3.1045; SANGER TD, 1994, NEURAL COMPUT, V6, P29, DOI 10.1162/neco.1994.6.1.29; Sanger TD, 1996, J NEUROPHYSIOL, V76, P2790, DOI 10.1152/jn.1996.76.4.2790; Scott SH, 1999, J NEUROSCI METH, V89, P119, DOI 10.1016/S0165-0270(99)00053-9; Scott SH, 1996, J MUSCLE RES CELL M, V17, P207, DOI 10.1007/BF00124243; Scott SH, 1997, J NEUROPHYSIOL, V77, P826, DOI 10.1152/jn.1997.77.2.826; SCOTT SH, 1995, J NEUROPHYSIOL, V73, P2563, DOI 10.1152/jn.1995.73.6.2563; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Shen LM, 1997, J NEUROPHYSIOL, V77, P1195, DOI 10.1152/jn.1997.77.3.1195; Todorov E, 2000, NAT NEUROSCI, V3, P391, DOI 10.1038/73964; WINTER DA, 1984, CRIT REV BIOMED ENG, V9, P287; Zhang KC, 1998, J NEUROPHYSIOL, V79, P1017, DOI 10.1152/jn.1998.79.2.1017	30	122	123	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 13	2001	413	6852					161	165		10.1038/35093102	http://dx.doi.org/10.1038/35093102			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	471FU	11557980				2022-12-24	WOS:000170918800046
J	Lykke-Andersen, J; Shu, MD; Steitz, JA				Lykke-Andersen, J; Shu, MD; Steitz, JA			Communication of the position of exon-exon junctions to the mRNA surveillance machinery by the protein RNPS1	SCIENCE			English	Article							NONSENSE-MEDIATED DECAY; CAENORHABDITIS-ELEGANS; UPF PROTEINS; TRANSLATION; TERMINATION; INTERACTS; NUCLEUS; MESSAGE; COMPLEX; EXPORT	In mammalian cells, splice junctions play a dual rote in mRNA quality control: They mediate selective nuclear export of mature mRNA and they serve as a mark for mRNA surveillance, which subjects aberrant mRNAs with premature termination codons to nonsense-mediated decay (NMD). Here, we demonstrate that the protein RNPS1, a component of the postsplicing complex that is deposited 5' to exon-exon junctions, interacts with the evolutionarily conserved human Upf complex, a central component of NMD. Significantly, RNPS1 triggers NMD when tethered to the 3' untranslated region of beta -globin mRNA, demonstrating its role as a subunit of the postsplicing complex directly involved in mRNA surveillance.	Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06536 USA	Howard Hughes Medical Institute; Yale University	Steitz, JA (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, 295 Congress Ave, New Haven, CT 06536 USA.	joan.steitz@yale.edu		Lykke-Andersen, Jens/0000-0003-1821-0754	NATIONAL CANCER INSTITUTE [P01CA016038] Funding Source: NIH RePORTER; NCI NIH HHS [CA 16038] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Blencowe BJ, 1998, GENE DEV, V12, P996, DOI 10.1101/gad.12.7.996; Culbertson MR, 1999, TRENDS GENET, V15, P74, DOI 10.1016/S0168-9525(98)01658-8; Czaplinski K, 1999, BIOESSAYS, V21, P685, DOI 10.1002/(SICI)1521-1878(199908)21:8<685::AID-BIES8>3.0.CO;2-4; Czaplinski K, 1998, GENE DEV, V12, P1665, DOI 10.1101/gad.12.11.1665; Frischmeyer PA, 1999, HUM MOL GENET, V8, P1893, DOI 10.1093/hmg/8.10.1893; Gonzalez CI, 2000, MOL CELL, V5, P489, DOI 10.1016/S1097-2765(00)80443-8; He F, 1997, MOL CELL BIOL, V17, P1580, DOI 10.1128/MCB.17.3.1580; Hentze MW, 1999, CELL, V96, P307, DOI 10.1016/S0092-8674(00)80542-5; Hilleren P, 1999, ANNU REV GENET, V33, P229, DOI 10.1146/annurev.genet.33.1.229; Jacobson A, 2000, COLD SPRING HARBOR M, V39, P827; Kataoka N, 2000, MOL CELL, V6, P673, DOI 10.1016/S1097-2765(00)00065-4; Kim VN, 2001, EMBO J, V20, P2062, DOI 10.1093/emboj/20.8.2062; Le Hir H, 2000, EMBO J, V19, P6860, DOI 10.1093/emboj/19.24.6860; Li SL, 1998, IMMUNITY, V8, P135, DOI 10.1016/S1074-7613(00)80466-5; Luo MJ, 1999, P NATL ACAD SCI USA, V96, P14937, DOI 10.1073/pnas.96.26.14937; Lykke-Andersen J, 2001, CURR BIOL, V11, pR88, DOI 10.1016/S0960-9822(01)00036-7; Lykke-Andersen J, 2000, CELL, V103, P1121, DOI 10.1016/S0092-8674(00)00214-2; LYKKEANDERSEN J, UNPUB; Maquat LE, 2000, COLD SPRING HARBOR M, V39, P849; Mayeda A, 1999, EMBO J, V18, P4560, DOI 10.1093/emboj/18.16.4560; McGarvey T, 2000, J CELL BIOL, V150, P309, DOI 10.1083/jcb.150.2.309; Mendell JT, 2000, MOL CELL BIOL, V20, P8944, DOI 10.1128/MCB.20.23.8944-8957.2000; Page MF, 1999, MOL CELL BIOL, V19, P5943; Pal M, 2001, RNA, V7, P5, DOI 10.1017/S1355838201000127; PULAK R, 1993, GENE DEV, V7, P1885, DOI 10.1101/gad.7.10.1885; Rodrigues JP, 2001, P NATL ACAD SCI USA, V98, P1030, DOI 10.1073/pnas.98.3.1030; Serin G, 2001, MOL CELL BIOL, V21, P209, DOI 10.1128/MCB.21.1.209-223.2001; Stutz F, 2000, RNA, V6, P638, DOI 10.1017/S1355838200000078; Sun XL, 1998, P NATL ACAD SCI USA, V95, P10009, DOI 10.1073/pnas.95.17.10009; Wang WR, 2001, EMBO J, V20, P880, DOI 10.1093/emboj/20.4.880; Zhang J, 1998, RNA, V4, P801, DOI 10.1017/S1355838298971849; Zhou ZL, 2000, NATURE, V407, P401, DOI 10.1038/35030160	32	301	314	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 7	2001	293	5536					1836	1839		10.1126/science.1062786	http://dx.doi.org/10.1126/science.1062786			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	470WN	11546874				2022-12-24	WOS:000170894400049
J	Thornton, S				Thornton, S			Personal view - The child B case - Reflections of a chief executive	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUN 21	1997	314	7097					1838	1839		10.1136/bmj.314.7097.1838a	http://dx.doi.org/10.1136/bmj.314.7097.1838a			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XG166	11644948	Green Published			2022-12-24	WOS:A1997XG16600064
J	SUMMERS, DP; CHANG, S				SUMMERS, DP; CHANG, S			PREBIOTIC AMMONIA FROM REDUCTION OF NITRITE BY IRON(II) ON THE EARLY EARTH	NATURE			English	Article							AQUEOUS-SOLUTION; CARBON-DIOXIDE; ATMOSPHERE; EVOLUTION; NITROGEN; FIXATION; SEAWATER; IMPACTS; OXYGEN; SULFUR	THEORIES for the origin of life require the availability of reduced (or 'fixed') nitrogen-containing compounds, in particular ammonia. In reducing atmospheres, such compounds are readily formed by electrical discharges1-2, but geochemical evidence suggests that the early Earth had a non-reducing atmosphere1,3-6, in which discharges would have instead produced NO (refs 7-10). This would have been converted into nitric and nitrous acids and delivered to the early oceans as acid rain11. It is known12-15, however, that Fe(II) was present in the early oceans at much higher concentrations than are found today, and thus the oxidation of Fe(II) to Fe(III) provides a possible means for reducing nitrites and nitrates to ammonia. Here we explore this possibility in a series of experiments which mimic a broad range of prebiotic seawater conditions (the actual conditions on the early Earth remain poorly constrained). We find that the reduction by Fe(II) of nitrites and nitrates to ammonia could have been a significant source of reduced nitrogen on the early Earth, provided that the ocean pH exceeded 7.3 and is favoured for temperatures greater than about 25-degrees-C.			SUMMERS, DP (corresponding author), NASA,AMES RES CTR,MOFFETT FIELD,CA 94035, USA.							BADA JL, 1968, SCIENCE, V159, P423, DOI 10.1126/science.159.3813.423; Broecker W.S., 1982, TRACERS SEA, P243; BURESH RJ, 1976, J ENVIRON QUAL, V5, P320, DOI 10.2134/jeq1976.00472425000500030021x; Butler J. N., 1982, CARBON DIOXIDE EQUIL, DOI 10.1016/0146-6380(83)90006-2; CHAMEIDES WL, 1981, ORIGINS LIFE EVOL B, V11, P291, DOI 10.1007/BF00931483; CHYBA C, 1991, ORIGINS LIFE EVOL B, V21, P3, DOI 10.1007/BF01809509; DERRY LA, 1990, GEOCHIM COSMOCHIM AC, V54, P2965, DOI 10.1016/0016-7037(90)90114-Z; DOYLE MP, 1984, J AM CHEM SOC, V106, P3678, DOI 10.1021/ja00324a049; FEGLEY B, 1986, NATURE, V319, P305, DOI 10.1038/319305a0; Freier R.K., 1976, AQUEOUS SOLUTIONS; GRATZEL M, 1970, BERICH BUNSEN GESELL, V74, P1003; GREGOR CB, 1988, CHEM CYCLES EVOLUTIO, P42; HOLLAND HD, 1973, ECON GEOL, V68, P1169, DOI 10.2113/gsecongeo.68.7.1169; HOLLAND HD, CHEM EVOLUTION ATMOS, P205; HOLLAND HD, 1989, CHEM EVOLUTION ATMOS, pCH4; KASTING JF, 1990, ORIGINS LIFE EVOL B, V20, P199, DOI 10.1007/BF01808105; KASTING JF, 1987, PRECAMBRIAN RES, V34, P205, DOI 10.1016/0301-9268(87)90001-5; KASTING JF, 1982, J GEOPHYS RES-OCEANS, V87, P3091, DOI 10.1029/JC087iC04p03091; KASTING JF, 1989, ORIGINS LIFE EVOL B, V19, P95, DOI 10.1007/BF01808144; KUHN WR, 1983, NATURE, V301, P53, DOI 10.1038/301053a0; MANCINELLI RL, 1988, ORIGINS LIFE EVOL B, V18, P311, DOI 10.1007/BF01808213; MATTIOLI GS, 1986, NATURE, V322, P626, DOI 10.1038/322626a0; SCHOPF JW, 1983, EARTHS EARLIEST BIOS, P53; STRIBLING R, 1987, ORIGINS LIFE EVOL B, V17, P261, DOI 10.1007/BF02386466; TURCOTTE DL, 1980, EARTH PLANET SC LETT, V48, P50; WALKER JCG, 1985, PRECAMBRIAN RES, V28, P205, DOI 10.1016/0301-9268(85)90031-2; WALKER JCG, 1985, ORIGINS LIFE EVOL B, V16, P117, DOI 10.1007/BF01809466; WALKER JCG, 1983, EARTHS EARLIEST BIOS, P260; YUNG YL, 1979, SCIENCE, V203, P1002, DOI 10.1126/science.203.4384.1002; ZAFIRIOU OC, 1979, MAR CHEM, V8, P9, DOI 10.1016/0304-4203(79)90029-X; [No title captured]	31	128	130	1	62	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	OCT 14	1993	365	6447					630	632		10.1038/365630a0	http://dx.doi.org/10.1038/365630a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB846	11540245				2022-12-24	WOS:A1993MB84600053
J	BRAHAMS, D				BRAHAMS, D			CHLORAMBUCIL INFERTILITY AND SPERM BANKING	LANCET			English	Editorial Material																			0	4	4	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	FEB 15	1992	339	8790					420	420		10.1016/0140-6736(92)90098-N	http://dx.doi.org/10.1016/0140-6736(92)90098-N			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HD659	11659388				2022-12-24	WOS:A1992HD65900016
J	[Anonymous]				[Anonymous]			PATIENTS RIGHT TO KNOW IN JAPAN	LANCET			English	Editorial Material																		BRAHAMS D, 1989, LANCET, V2, P173; JOSEPH J, 1990, TIMES           1102; KIMURA R, 1988, BIOETHICAL SOCIOLEGA	3	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 24	1990	336	8726					1309	1310						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ943	11642858				2022-12-24	WOS:A1990EJ94300021
J	Long, MY; Thornton, K				Long, MY; Thornton, K			Gene duplication and evolution	SCIENCE			English	Editorial Material							PRESERVATION; DROSOPHILA		Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; Univ Chicago, Comm Genet, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Long, MY (corresponding author), Univ Chicago, Dept Ecol & Evolut, 1101 E 57th St, Chicago, IL 60637 USA.		Vision, Todd J/B-4867-2010	Vision, Todd J/0000-0002-6133-2581; Thornton, Kevin/0000-0003-0743-4445				Force A, 1999, GENETICS, V151, P1531; Li W-H, 1997, MOL EVOLUTION; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Lynch M, 2000, GENETICS, V154, P459; Petrov DA, 1996, NATURE, V384, P346, DOI 10.1038/384346a0; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Wang W, 2000, MOL BIOL EVOL, V17, P1294, DOI 10.1093/oxfordjournals.molbev.a026413; Weichenhan D, 1998, CYTOGENET CELL GENET, V80, P226, DOI 10.1159/000014985; Zeng LW, 1998, GENETICA, V102-3, P369, DOI 10.1023/A:1017035109224	9	62	65	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 31	2001	293	5535					1551	1551						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	469FA	11533445				2022-12-24	WOS:000170802900001
J	Boettcher, B				Boettcher, B			Fatal episodes in medical history	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	DEC 5	1998	317	7172					1603	1603						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	146VC	9836691				2022-12-24	WOS:000077451700090
J	AOUN, H				AOUN, H			FROM THE EYE OF THE STORM, WITH THE EYES OF A PHYSICIAN	ANNALS OF INTERNAL MEDICINE			English	Note						ACQUIRED IMMUNODEFICIENCY SYNDROME; PHYSICIAN-PATIENT RELATIONS; EDUCATION, MEDICAL; SOCIAL SUPPORT; ETHICS, MEDICAL		A physician acquires a terrible disease and, as a patient, is confronted with aspects of medical care that contribute to the suffering rather than the healing. As a result of these experiences, his views on what constitutes a good physician become simpler. A good physician cares for his patients and works toward preserving their dignity and independence. The issue is raised of whether current medical education can be effective in producing that caring physician, for it is particularly in caring for patients with catastrophic or incurable illnesses that the role of the physician is more, not less, important.										AOUN H, 1989, NEW ENGL J MED, V321, P693, DOI 10.1056/NEJM198909073211020; AOUN H, 1991, NEW ENGL J MED, V324, P265, DOI 10.1056/NEJM199101243240412; Harrison TR, 1950, PRINCIPLES INTERNAL; NATELSON BH, 1990, TOMORROWS DOCTORS PA; Peabody FW, 1927, J AMER MED ASSOC, V88, P0877, DOI 10.1001/jama.1927.02680380001001; RABIN D, 1982, NEW ENGL J MED, V307, P506, DOI 10.1056/NEJM198208193070827; RABIN R, 1985, 6 PARTS LOVE ONE FAM; TOSTESON DC, 1990, NEW ENGL J MED, V322, P234, DOI 10.1056/NEJM199001253220405	8	23	23	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 15	1992	116	4					335	338		10.7326/0003-4819-116-4-335	http://dx.doi.org/10.7326/0003-4819-116-4-335			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HD546	11651175				2022-12-24	WOS:A1992HD54600012
